https://labreadai.com/en/ AI lab test interpreter: upload a photo or PDF and get blood test, urine and CBC results explained free in 30 seconds. No sign-up, 300+ parameters, 4,000+ test types supported. en 2026 LabReadAI LabReadAI RSS Generator https://www.rssboard.org/rss-specification 60 Sat, 04 Apr 2026 09:50:46 GMT https://labreadai.com/og-image.jpg https://labreadai.com/en/ https://labreadai.com/en/posts/angina https://labreadai.com/en/posts/angina Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Angina pectoris — cardiac ischaemia on exertion: symptoms of an attack, blood tests, types of angina, treatment with nitrates and statins, and when surgery is needed. Articles article A pressing sensation behind the sternum when climbing stairs. Tightness in the chest walking fast in cold air. Discomfort that fades within a few minutes of rest — but returns again. This is classic angina: manageable, predictable, and at the same time a serious form of coronary artery disease. It does not kill instantly — but without correct treatment it leads steadily towards heart attack. This article covers what happens in the heart during angina, how it is diagnosed, and how it is treated. What Is Angina and Why Does It Develop Angina (from the Latin angina pectoris — "chest tightness") is a clinical syndrome caused by temporary myocardial ischaemia: the heart muscle receives less blood — and therefore less oxygen — than it needs at that moment. Crucially, this is not cellular death as in infarction — it is "starvation" of the cells, which ends when blood supply is restored. The primary cause of angina is atherosclerosis of the coronary arteries. Cholesterol plaques narrow the vessel lumen. At rest, the narrowed artery can still deliver enough blood. Under exertion, myocardial oxygen demand rises sharply — but the narrowed vessel cannot proportionally increase flow. A mismatch develops: demand exceeds available supply. The myocardium signals this imbalance through pain. Atherosclerosis is not the only cause. Coronary artery spasm (Prinzmetal's variant angina) produces ischaemia without plaques — through abrupt smooth muscle contraction. Severe anaemia, myocardial hypertrophy in arterial hypertension, and aortic stenosis can also cause angina with anatomically normal coronary arteries. Risk factors mirror those for any atherosclerotic disease: male sex, age, smoking, high LDL, low HDL, diabetes, hypertension, and a family history of early coronary artery disease. The combination of several risk factors does not add — it multiplies risk. Symptoms of Angina: Recognising an Attack The classic angina attack carries several defining features, knowledge of which helps distinguish it from other causes of chest pain. Pressure or squeezing in character. Patients describe it as: "an elephant sitting on my chest," "a metal band tightening around the ribcage," "a heavy weight behind the sternum." The pain is rarely sharp or stabbing — more often dull, diffuse, and non-localised. Clear relation to exertion. An attack is triggered by physical effort (walking, climbing stairs, carrying loads), emotional stress, cold air, or a large meal. It disappears within 3–5 minutes after stopping the trigger. Radiation. Pain frequently radiates to the left shoulder, arm (particularly along its inner surface to the little finger), neck, lower jaw, or epigastrium. Radiation to the right side is possible but atypical. Brief duration. A typical attack lasts 1–15 minutes. Pain lasting more than 20 minutes is unstable angina or infarction and requires immediate hospitalisation. Rapid response to nitroglycerine. A sublingual tablet or spray relieves the attack within 2–5 minutes. If pain persists 15–20 minutes after the second dose — call emergency services. Atypical presentation — a special problem in women, older adults, and diabetic patients. Instead of pain: breathlessness, fatigue, nausea, back pain, or jaw discomfort. These "masks" of angina frequently lead to delayed diagnosis and worse outcomes. Types of Angina: Stable and Unstable The distinction between stable and unstable angina is a critical clinical decision that determines the entire management approach. Stable exertional angina — attacks are reproducible: the same level of exertion produces the same symptom. The patient knows their threshold: "I can walk 200 metres on flat ground, but climbing one flight of stairs brings on the pain." Classified by functional class (FC I–IV, CCS scale): from "pain only with extreme exertion" to "pain at rest." Unstable angina — a warning requiring hospitalisation. Criteria for instability: new-onset angina (within the past two months); crescendo angina (attacks are more frequent, triggered by less effort, or last longer); and rest angina (pain without exertion). Unstable angina is a pre-infarction state: the risk of myocardial infarction within the next few weeks is 10–20%. Prinzmetal's variant angina — coronary artery spasm, most often occurring at night or in the early morning hours. Pain can be intense and prolonged. ECG during the attack shows characteristic ST-segment elevation. Diagnosis of Angina: Tests and Investigations Diagnosis of angina combines clinical assessment, resting and stress ECG, and non-invasive imaging. Blood tests are used to assess risk and exclude other causes of pain. Troponin — the first-priority test in any chest pain syndrome. Normal troponin in stable angina: the myocardium experienced ischaemia but cells did not die. Elevated troponin indicates transition to acute coronary syndrome or infarction. CK-MB — a supplementary marker of myocardial necrosis. Normal in stable angina. Elevation indicates that injury has already occurred. Total cholesterol, LDL, HDL, and triglycerides from a lipid panel — a mandatory component of assessment for atherosclerotic risk stratification and statin therapy titration. The LDL target in angina is below 1.4 mmol/L (very high cardiovascular risk category). Resting ECG — often normal in angina patients between attacks. Stress ECG (bicycle ergometry, treadmill test) reproduces ischaemia: ST-segment depression on exercise is the classic sign of myocardial ischaemia. Stress echocardiography and myocardial perfusion scintigraphy are more sensitive methods for detecting regional wall motion abnormalities during ischaemia. Coronary angiography is the gold standard for precisely locating and quantifying atherosclerotic stenoses. Performed when revascularisation (stenting or bypass surgery) is being planned. Treatment of Angina: Medications and Procedures The goals of treatment are to relieve symptoms, prevent infarction, and improve prognosis. These are three distinct objectives addressed by different methods. Relieving an attack. Sublingual nitroglycerine is the standard. It dilates coronary arteries and reduces preload on the heart. Onset within 2–3 minutes. If two doses five minutes apart produce no effect — call emergency services. Antiplatelet agents (aspirin, clopidogrel) — prevent thrombus formation on the surface of an atherosclerotic plaque. They reduce the risk of infarction and cardiovascular death in coronary artery disease. Aspirin 75–100 mg/day — lifelong in all patients with confirmed coronary artery disease. Beta-blockers (metoprolol, bisoprolol) — reduce heart rate and myocardial oxygen demand. First-line anti-anginal therapy for stable angina. Statins — mandatory in any form of angina. They lower LDL to the target level (< 1.4 mmol/L), stabilise atherosclerotic plaques, and reduce the risk of plaque rupture. In metabolic syndrome, controlling all its components — blood pressure, blood sugar, weight — is part of angina management. Long-acting nitrates (isosorbide mononitrate) — prophylaxis against attacks in FC II–III. Taken with a nitrate-free interval (8–12 hours per day) to prevent tolerance. Revascularisation — stenting or CABG — indicated for unstable angina, high functional class stable angina, and haemodynamically significant stenoses ( 70%) on angiography. Stenting restores vessel patency immediately; coronary artery bypass grafting (CABG) creates alternative routes of blood supply to the myocardium. Angina and Heart Attack: the Fundamental Difference The key distinction: in angina, ischaemia is temporary and reversible. In myocardial infarction, an area of heart muscle dies irreversibly because of complete arterial occlusion. The practical three-minute rule: pain that resolves within 3–5 minutes of stopping exertion or 2–3 minutes after nitroglycerine — probable angina. Pain lasting 20 or more minutes, unresponsive to two doses of nitroglycerine and worsening — treat as infarction and call emergency services immediately. Unstable angina occupies a dangerous intermediate position: the artery is not yet completely blocked, but the plaque is unstable and can rupture to form an occlusive thrombus at any moment. It requires the same emergency response as infarction. When to Call Emergency Services or See a Doctor Urgently Call emergency services immediately if: - An attack lasts more than 20 minutes and is not relieved by two doses of nitroglycerine at 5–10-minute intervals. - Angina occurs at rest — without any physical or emotional trigger. - The frequency or intensity of attacks has been increasing over recent days or weeks — signs of disease destabilisation. - Chest pain of this type appears for the first time in your life — even if it resolved: urgent evaluation by a cardiologist is mandatory. - An attack is accompanied by loss of consciousness, severe breathlessness, or a sharp fall in blood pressure. - A known angina patient experiences an attack that behaves differently from the usual pattern. See a cardiologist on a planned basis: when angina is poorly controlled by medication; when functional class is rising (attacks provoked by progressively less exertion); or when coronary angiography is being considered to evaluate revascularisation options. This article is for informational purposes only and does not replace medical consultation. For symptoms consistent with angina — always consult a cardiologist. https://labreadai.com/en/posts/ankylosing-spondylitis https://labreadai.com/en/posts/ankylosing-spondylitis Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ankylosing spondylitis — spinal and sacroiliac joint inflammation: early symptoms, blood tests, HLA-B27, biologic therapy and long-term prognosis. Articles article Low back pain in a young man that worsens at rest and eases with movement. Morning stiffness that lasts more than an hour. This is not "disc disease" — this is the classic presentation of ankylosing spondylitis (AS), a chronic inflammatory disease of the spine. In early disease, with timely diagnosis and treatment, most patients maintain normal mobility and quality of life; delayed treatment leads to irreversible spinal fusion. What Is Ankylosing Spondylitis (Sacroiliitis) and How Does It Develop Ankylosing spondylitis is part of the seronegative spondyloarthritis group — inflammatory diseases of the axial skeleton and joints that are not associated with rheumatoid factor. The primary targets are the sacroiliac joints (sacroiliitis) and the spine; peripheral joints, eyes, heart, and bowel are less commonly affected. Inflammation in AS develops at entheses — the sites where tendons, ligaments, and joint capsules attach to bone. Chronic entheseal inflammation triggers pathological bone formation: fibrous and ultimately bony "bridges" — syndesmophytes — form between vertebrae and progressively fuse the spinal column. The end result of untreated progressive disease is the "bamboo spine": complete fusion of the entire vertebral column. The key genetic marker is the HLA-B27 antigen: present in 90–95% of AS patients, while occurring in only 6–8% of the general population. However, HLA-B27 is not itself a diagnosis: only 1–5% of carriers ever develop AS. The disease occurs 2–3 times more often in men and typically begins between ages 15 and 35. Symptoms of Ankylosing Spondylitis: Inflammatory Back Pain and Morning Stiffness Inflammatory low back pain — the hallmark of AS and its primary distinction from mechanical back pain. Criteria for inflammatory pattern: onset before age 45; gradual onset; improvement with physical activity and movement; no relief with rest; nocturnal worsening (especially in the second half of the night). Morning stiffness lasting more than 30 minutes is an almost universal feature. Mechanical pain from disc degeneration, by contrast, worsens with movement, improves with rest, and does not wake the patient at night. Sacroiliitis — inflammation of the sacroiliac joints — is frequently the first manifestation, appearing years before spinal involvement. It presents as buttock pain, often alternating sides, radiating to the thighs. Restricted spinal mobility develops as the disease progresses. The finger-to-floor distance on forward bending increases; chest expansion decreases (normal 5 cm). Peripheral arthritis occurs in 25–35% of patients: large lower limb joints — hip and knee — are most commonly affected. Hip involvement carries the greatest functional disability burden in AS. Enthesitis — pain at tendon insertion sites: the Achilles tendon, plantar fascia, and costochondral junctions are the most typical locations. Uveitis — acute inflammation of the uveal tract — develops in 30–40% of AS patients. It presents with sudden eye pain, redness, and photophobia. Immediate ophthalmological treatment is required to prevent vision loss. Extra-articular manifestations: inflammatory bowel disease (Crohn's disease, ulcerative colitis) coexists with AS in 5–10% of patients; psoriasis in approximately 10%. Diagnosing Ankylosing Spondylitis: Tests and Methods The diagnosis of AS is clinical, based on a combination of symptoms, laboratory findings, and imaging. The Modified New York Criteria (1984) and the ASAS criteria for axial spondyloarthritis (2009) remain the standard frameworks. HLA-B27 — a genetic marker. A positive result substantially raises the probability of AS in the appropriate clinical context, but is not a diagnostic criterion on its own. In a patient with inflammatory back pain and positive HLA-B27, the probability of AS is approximately 50%. Inflammatory markers. C-reactive protein and ESR are elevated in 40–70% of patients with active AS — but in a subset of patients (particularly those with predominantly axial disease) these markers may remain normal even with high disease activity. Normal CRP and ESR do not exclude AS — clinical judgement outweighs laboratory findings. Rheumatoid factor and anti-CCP antibodies are typically negative in AS — this is why AS is called a "seronegative" spondyloarthritis. These tests are ordered primarily to differentiate AS from rheumatoid arthritis. Complete blood count — mild normochromic anaemia in active disease, thrombocytosis as an acute-phase response. MRI of the sacroiliac joints — the most sensitive tool for early diagnosis. It detects active inflammation (bone marrow oedema) before structural changes are visible on X-ray — sometimes 5–10 years earlier. It is the mandatory first-line imaging modality when axial spondyloarthritis is suspected in a young patient. Plain radiography of the pelvis and spine — the standard for assessing structural damage. Sacroiliitis on X-ray (joint space widening, then sclerosis and ankylosis), syndesmophytes in the spine — these are late findings indicating damage that has already occurred. Ankylosing Spondylitis Blood Tests and Interpretation Marker Normal In AS ----------------------- HLA-B27 Negative Positive in 90–95% of AS patients CRP < 5 mg/L Elevated in 40–70% with active disease ESR < 20 mm/h Mildly elevated; normal in a subset of patients RF < 14 IU/mL Negative (seronegative arthritis) Anti-CCP < 17 U/mL Negative Disease activity is assessed with the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) — a 6-question patient-completed scale from 0 to 10. BASDAI ≥ 4 despite maximum-dose NSAIDs for 3 months is the threshold for initiating biologic therapy. Ankylosing Spondylitis Treatment: NSAIDs and Biologic Therapy NSAIDs (non-steroidal anti-inflammatory drugs) — the first-line pharmacological treatment. Indometacin, diclofenac, naproxen, and etoricoxib at therapeutic doses reduce pain and stiffness and slow radiographic progression when taken regularly. Continuous rather than on-demand NSAID use is more effective for structural protection. Exercise therapy — an inseparable part of treatment alongside pharmacotherapy. Regular stretching, breathing exercises, and swimming maintain spinal and chest mobility and slow ankylosis. AS is the only rheumatological condition in which physical exercise is the first — not a supplementary — non-pharmacological intervention. Biologic therapy. TNF-α inhibitors (etanercept, adalimumab, infliximab, certolizumab) — the standard when NSAIDs are insufficient or not tolerated. They reduce BASDAI activity and significantly improve function and quality of life. IL-17A inhibitors (secukinumab, ixekizumab) — an alternative when TNF inhibitors fail or when AS is associated with psoriasis. JAK inhibitors (upadacitinib) — an oral alternative to biologics. Systemic glucocorticoids are poorly effective in AS and not used for long-term management. Local injections into the sacroiliac joints are an option for managing acute sacroiliitis flares. In patients with hip joint involvement causing significant functional limitation — total hip arthroplasty (joint replacement). This is one of the most effective orthopaedic procedures in AS. Differential Diagnosis: AS vs Rheumatoid Arthritis vs Other Arthropathies Differentiating AS from rheumatoid arthritis is one of the most common tasks in rheumatology. Key differences: AS affects the axial skeleton (spine, sacroiliac joints); RA predominantly targets small peripheral hand joints. AS is seronegative (RF and anti-CCP negative); RA is seropositive in most cases. Men develop AS twice as often as women; RA affects women predominantly. NSAIDs produce dramatically better responses in AS than in RA. Gout affects lower limb joints with acute attacks and elevated uric acid — clinically a completely different picture. Psoriatic arthritis and reactive arthritis are other spondyloarthritis forms with similar serological findings (HLA-B27, seronegativity) but distinct clinical characteristics. When to See a Doctor Urgently Immediate rheumatology consultation or emergency care is required when: - Acute eye pain with redness and photophobia in an AS patient — anterior uveitis requiring immediate ophthalmological treatment; without treatment, vision loss is possible. - Sudden onset of neurological symptoms (numbness, leg weakness, bladder dysfunction) in a patient with advanced cervical ankylosis — possible cauda equina syndrome from spinal instability or fracture. - First-ever inflammatory back pain in a young man lasting more than 3 months — indication for rheumatology referral, MRI of the sacroiliac joints, and HLA-B27 testing. - BASDAI ≥ 4 despite maximum NSAID doses for 3 months — the threshold for switching to biologic therapy; delay leads to progressive structural damage. - An established AS patient develops breathlessness or progressive restriction of chest expansion — possible cardiopulmonary involvement requiring further investigation. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/chest-pain https://labreadai.com/en/posts/chest-pain Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Chest pain causes: cardiac and non-cardiac origins, blood markers for heart attack, how doctors diagnose chest pain and warning signs that need emergency care. Articles article Chest pain is one of the most frightening symptoms — and one of the most ambiguous. Behind it can lie a life-threatening heart attack or a simple intercostal muscle spasm. Reading the situation correctly within the first minutes can save a life or prevent unnecessary panic. This article covers the causes, diagnostic tests, and the central question: when to call emergency services. Why the Chest Hurts: The Anatomy of the Symptom The chest is a complex, multi-layered structure. Pain here can originate from dozens of sources: the heart, lungs, pleura, oesophagus, stomach, ribs, cartilage, intercostal muscles, nerve roots, and even the skin. The brain does not always accurately "address" the pain signal: cardiac pain frequently radiates to the shoulder, jaw, or arm — a phenomenon called referred pain. Pain from the oesophagus can mimic angina in extraordinary detail. This is precisely why self-diagnosis of chest pain is dangerous in both directions. Someone having a heart attack may convince themselves it is "the stomach" or "a pulled muscle" — and loses critically important time. Someone with intercostal neuralgia may wait for an ambulance they do not need. The key principle: with any chest pain of unknown cause — rule out the life-threatening first, then look for benign causes. Never the other way around. High-risk individuals — patients with atherosclerosis, those with diabetes, smokers, people with obesity and hypertension, elderly men — should have chest pain evaluated by a cardiologist as the default. Cardiac Causes of Chest Pain Acute coronary syndrome (ACS) — the most dangerous cause, encompassing unstable angina and myocardial infarction. The classic picture: crushing, squeezing pressure behind the sternum, radiating to the left shoulder, arm, jaw, or back. Duration — 20 minutes or longer. Not relieved by nitroglycerine (in infarction). Accompanied by cold sweat, fear of death, breathlessness, and nausea. In women, older adults, and diabetic patients, ACS frequently presents atypically: minimal or absent chest pain, with predominant weakness and breathlessness. Stable angina — episodes of pain or chest discomfort triggered by physical or emotional exertion, relieved by rest or nitroglycerine within 3–5 minutes. This is a manageable form of ischaemia: the myocardium experiences inadequate blood supply under demand but does not die. Heart failure in decompensated stages can produce chest pain through ischaemia driven by congestion. The characteristic combination: pain + severe orthopnoea (breathlessness when lying flat) + leg oedema. Pericarditis — inflammation of the pericardial sac. Pain is sharp and stabbing, worsens on inspiration and when lying supine, and improves when leaning forward. A viral illness 1–2 weeks before onset is common. Aortic dissection — rare but catastrophic. Pain is sudden, tearing or ripping in character, maximal from the very first second, radiating to the back. Unlike infarction — it does not build; it peaks immediately. Requires surgical intervention within hours. Non-Cardiac Causes of Chest Pain Approximately 50–60% of patients admitted with chest pain have a non-cardiac cause. This is not "imaginary" — it is real pain requiring its own treatment. Pulmonary embolism (PE). Pulmonary embolism is one of the most dangerous non-cardiac causes. The pain is pleuritic: sharp, worsens on breathing and coughing, and is localised to one area. Associated with sudden breathlessness, haemoptysis, and a fast heart rate. Classically occurs after prolonged immobility (long flight, bed rest), surgery, or in the setting of thrombophilia. Pneumothorax — air in the pleural cavity. Pain is sudden, sharp, on the affected side, with rapidly worsening breathlessness. More common in tall young men or in chronic lung disease. Gastro-oesophageal reflux disease (GORD) — the most common non-cardiac cause of retrosternal pain. The pain is burning, linked to meals and lying flat, relieved by antacids. It can mimic angina so convincingly that cardiac causes must be excluded before settling on this diagnosis. Musculoskeletal causes. Tietze syndrome (inflammation of costochondral junctions), intercostal neuralgia, myositis — pain worsens on palpation, movement, and deep breathing. Pressing a finger on the tender spot reproduces the identical pain. Shingles (herpes zoster) can cause intense burning pain along an intercostal nerve for several days before the rash appears. Before the rash — diagnosis is difficult. Panic attack — chest pain is one of its cardinal symptoms. It cannot be distinguished from cardiac pain without investigation, which means "reassuring" a patient without excluding ACS is a clinical error. Which Blood Tests Are Ordered for Chest Pain On arrival with chest pain, the emergency physician simultaneously performs an ECG and draws blood for markers of myocardial injury. Together they allow infarction to be confirmed or excluded within 1–3 hours. Troponin (I or T) — the primary marker of infarction. Troponin is a protein found inside cardiomyocytes. When they die, it enters the bloodstream. High-sensitivity troponin begins rising within 1–3 hours of infarction onset and remains elevated for 10–14 days. A negative troponin 3 hours after pain onset has a high negative predictive value for ruling out infarction. CK-MB (MB fraction of creatine phosphokinase) — an earlier but less specific marker. Used to estimate the time of infarction onset and quantify its extent. Rises in the first 4–8 hours, normalises within 48–72 hours — making it useful when a patient presents late, after troponin has already begun to fall. LDH (lactate dehydrogenase) — a late-rising marker. Increases at 24–48 hours and remains elevated for up to two weeks. Valuable when patients present very late and other markers have already normalised. BNP/NT-proBNP — a marker of heart failure. Markedly elevated when chest pain is caused by acute decompensated heart failure. A normal BNP value in the setting of chest pain virtually excludes heart failure as the cause. Fibrinogen and a complete blood count complete the picture: leucocytosis points to inflammation or infection; elevated fibrinogen indicates activation of coagulation in thrombotic conditions. For excluding PE, D-dimer is measured: a normal result with high confidence rules out thromboembolism when clinical pre-test probability is low to moderate. Reference Values for Myocardial Injury Markers Marker Normal First Rise Peak Normalisation ----------------------------------------------- High-sensitivity troponin I < 34 ng/L (men), < 16 ng/L (women) 1–3 h 12–24 h 10–14 days CK-MB < 5 µg/L 4–8 h 12–24 h 48–72 h LDH 135–225 U/L 24–48 h 3–5 days 10–14 days BNP < 100 pg/mL — — — An important nuance: troponin rises in conditions other than infarction. Elevated results are seen in myocarditis, PE, sepsis, renal failure, acute stroke, and after cardioversion — so-called "non-ischaemic" troponin elevation. The clinical picture, troponin kinetics (in infarction: rise followed by fall), and additional investigations allow the cause to be differentiated. How to Describe Chest Pain to a Doctor The emergency physician will ask specific questions, and the more precisely you answer, the faster a diagnosis can be reached. Think through the OPQRST framework in advance: O — Onset. When did it start? Sudden or gradual? Related to exertion, stress, eating, or body position? P — Provocation/Palliation. Does it worsen with breathing, movement, or pressure? Is it relieved by nitroglycerine? Does eating or antacids help? Q — Quality. Pressure, burning, stabbing, tearing, dull? Precisely localised or diffuse? R — Radiation. Does it spread to the arm, shoulder, neck, jaw, back, or abdomen? S — Severity. On a scale of 0 to 10? T — Time. How long has it lasted? Constant or episodic? "Chest pain for two days, worse on deep breath, pressing on the rib reproduces it exactly" — a picture that practically excludes infarction. "Crushing central chest pain for 30 minutes, radiating to the left arm, nitroglycerine not working" — ACS until proven otherwise. When to Call Emergency Services Immediately Call 999/112/911 immediately if chest pain is: - Pressing, squeezing, or burning, behind the sternum or on the left, with radiation to the arm, shoulder, jaw, or neck — even if it does not feel dramatic. Atypical infarctions present less intensely than expected. - Lasting more than 15–20 minutes without resolution at rest — a criterion of instability. - Accompanied by breathlessness, cold sweats, weakness, fainting, or near-fainting. - Sudden, maximally intense from the very first second ("the worst pain of my life") — possible aortic dissection. - Combined with coughing up blood after a long flight, surgery, or prolonged immobility — possible PE. - Any character of pain in someone with known coronary artery disease, a prior heart attack, or a coronary stent — the threshold for calling emergency services should be very low. Do not wait. The time from infarction onset to opening the artery determines how much myocardium dies. Every 10 minutes of delay represents real cells that will not recover. This article is for informational purposes only and does not replace medical consultation. For chest pain of unknown cause — seek medical attention. https://labreadai.com/en/posts/coronary-artery-disease https://labreadai.com/en/posts/coronary-artery-disease Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CAD — impaired myocardial blood supply: angina, heart attack, ECG and blood test diagnosis, statin treatment, when coronary stenting or bypass surgery is needed. Articles article Coronary artery disease is the leading cause of death worldwide. More than 9 million people die from it every year. At the same time, CAD is one of the most preventable and controllable conditions in cardiology. The gap between these two facts has a simple explanation: the disease runs silently for decades, and when symptoms finally appear, a heart attack is often the first sign. This article covers the mechanism, symptoms, diagnostic workup, and modern treatment of CAD. What Is Coronary Artery Disease CAD is a clinical syndrome caused by a mismatch between the myocardium's oxygen demand and its actual supply through the coronary arteries. The heart muscle "starves" — and signals this through pain, arrhythmias, or reduced pumping function. The anatomical basis of CAD in the overwhelming majority of cases is atherosclerosis of the coronary arteries. Cholesterol plaques narrow the arterial lumen, reduce blood flow, and destabilise the vessel wall. Rupture of an unstable plaque with thrombus formation is the mechanism of acute coronary syndrome. CAD is not a single disease but a group of clinical entities sharing the same pathogenesis. It includes: stable exertional angina — predictable episodes of ischaemia under demand; unstable angina — escalating attacks that precede infarction; myocardial infarction — acute necrosis of a myocardial territory; silent myocardial ischaemia — ischaemia without clinical symptoms, common in diabetic patients; post-infarction cardiosclerosis — scar tissue following a previous infarction; and ischaemic cardiomyopathy — progressive myocardial dysfunction from chronic ischaemia. Causes and Risk Factors for CAD The primary cause of CAD is atherosclerotic coronary artery disease. Plaque formation begins in young adulthood and progresses over decades. By the time an artery is narrowed by 50–70% and first symptoms appear, the pathological process is already deeply established. CAD risk factors fall into non-modifiable and modifiable categories. Non-modifiable: age (risk rises sharply after 45 in men, after 55 in women), male sex (oestrogens protect the vasculature before the menopause), and family history (early CAD in first-degree relatives). Modifiable: dyslipidaemia (high LDL, low HDL), arterial hypertension, smoking, diabetes, obesity, metabolic syndrome, physical inactivity, and chronic inflammation. The risk of infarction with multiple concurrent factors does not add — it multiplies. A hypertensive patient with high LDL who smokes carries 5–8 times the risk of an age-matched person with none of these factors. Symptoms of CAD: From Angina to Silent Ischaemia Typical exertional angina. Crushing, squeezing pressure behind the sternum during physical exertion, cold exposure, or emotional stress. Resolves at rest within 3–5 minutes or after nitroglycerine. Radiation to the left arm, shoulder, or lower jaw is characteristic. For a detailed approach to chest pain symptoms, see the chest pain article. Atypical CAD. In women, older patients, and diabetic individuals, ischaemia frequently presents differently: breathlessness without pain, unexplained fatigue, back or epigastric discomfort, nausea. Silent infarctions in diabetes are a major reason for late presentation. Silent ischaemia — ischaemic ECG changes or abnormal stress test without subjective symptoms. Found in 25–30% of CAD patients, particularly in diabetics. Prognostically no less dangerous than symptomatic ischaemia. Unstable angina — deterioration of stable angina: attacks triggered by less exertion, occurring at rest, lasting longer, and responding poorly to nitroglycerine. This is an acute coronary syndrome — an indication for emergency hospitalisation. Diagnosing CAD: Blood Tests and Investigations CAD diagnosis is multi-layered, combining blood tests, functional investigations, and coronary imaging. Blood tests in CAD. Troponin (I or T) — the key marker for excluding acute infarction in any chest pain syndrome. A normal high-sensitivity troponin at 3 hours from symptom onset virtually rules out infarction. CK-MB — an additional marker of myocardial necrosis; used to estimate the time of infarction onset and quantify its extent. The lipid panel is the essential investigation for atherosclerotic risk assessment and therapy monitoring. Target LDL in established CAD is below 1.4 mmol/L (very high risk category per ESC guidelines). Statin efficacy is first checked 4–6 weeks after initiating therapy, then every 3–6 months. Total cholesterol on its own provides limited risk information in established CAD; the full lipid profile with LDL, HDL, and triglycerides is required. The complete blood count — anaemia as a factor worsening ischaemia: reduced haemoglobin lowers the oxygen-carrying capacity of the blood and increases the metabolic stress on already ischaemic myocardium. Functional and imaging investigations. Resting ECG — often normal in stable CAD. Stress ECG (bicycle ergometry, treadmill) — reproduces ischaemia; ST-segment depression on exercise confirms the diagnosis. Stress echocardiography and myocardial perfusion scintigraphy are more sensitive. Coronary CT angiography — non-invasive visualisation of the coronary arteries, detecting plaques and quantifying stenosis. Coronary angiography — the gold standard for precise staging and revascularisation planning. Treatment of CAD: Medications and Procedures CAD treatment has two distinct goals: relieving symptoms and improving prognosis (reducing the risk of infarction and death). These are addressed by different instruments. Lifestyle modification — the foundation without which any treatment is incomplete. Smoking cessation (the single most powerful intervention — halves infarction risk), a Mediterranean diet, regular aerobic exercise within the safe exertion threshold, and weight normalisation. Antiplatelet therapy (aspirin 75–100 mg/day) — lifelong in all patients with established CAD. Prevents thrombus formation on plaque surfaces. In high-risk patients or after stenting — dual antiplatelet therapy (aspirin + clopidogrel or ticagrelor) for 6–12 months. Statins — mandatory in all forms of CAD regardless of baseline cholesterol. Dual mechanism: they lower LDL and stabilise atherosclerotic plaques, reducing the risk of rupture. Atorvastatin 40–80 mg or rosuvastatin 20–40 mg are standard doses in CAD. Beta-blockers reduce myocardial oxygen demand, lower heart rate and blood pressure. Particularly indicated when LV systolic function is impaired and after myocardial infarction. ACE inhibitors / ARBs — reduce afterload, provide cardioprotection. Indicated in CAD combined with hypertension, diabetes, or reduced ejection fraction. Nitrates — relieve and prevent angina attacks. They do not alter prognosis but meaningfully improve quality of life. Revascularisation. Percutaneous coronary intervention (PCI, stenting) — restores the lumen of a stenosed artery via balloon catheterisation and stent implantation. The procedure of choice in acute coronary syndromes and significant single-vessel disease. Coronary artery bypass grafting (CABG) — surgical creation of alternative blood supply routes to the myocardium. Preferred for multivessel disease, left main stem disease, or in diabetic patients. Prevention of CAD: What Actually Works Primary prevention — stopping CAD from developing in people without established disease. The key tools: blood pressure control (target < 130/80 mmHg), LDL lowering at high calculated risk, smoking cessation, diabetes treatment, regular physical activity. 10-year cardiovascular event risk is calculated using SCORE2 (Europe) or the Framingham risk score (USA) — and the result drives the strategy: observation, pharmacological prevention, or invasive intervention. Secondary prevention — preventing recurrent events in patients with established CAD. The approach is more aggressive: LDL < 1.4 mmol/L is mandatory; dual antiplatelet therapy follows stenting; cardiac rehabilitation is standard after myocardial infarction. When to Call Emergency Services Call emergency services immediately if: - Crushing or burning central chest pain lasting more than 15–20 minutes that is not relieved by nitroglycerine — acute coronary syndrome until proven otherwise. - A usual angina attack behaves differently: lasts longer, is triggered by less exertion, or occurs at rest — signs of CAD destabilisation. - Sudden severe breathlessness, cold sweat, and fear of death alongside chest pain — the classic presentation of infarction. - Syncope or near-syncope in a patient with known CAD — possible life-threatening arrhythmia on an ischaemic background. - Any new cardiac symptom in a patient with established CAD — the threshold for seeking medical attention should be very low. For planned consultation: if a routine check reveals high LDL, arterial hypertension, or an incidental ECG abnormality — see a cardiologist for risk calculation and a decision on preventive therapy. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/elevated-esr https://labreadai.com/en/posts/elevated-esr Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Elevated ESR blood test: normal ranges by age and sex, causes from infection to malignancy, how ESR compares with CRP, and when results need urgent review. Articles article Your blood test comes back and the ESR line is flagged high. Or your doctor mentions "raised ESR" as a reason for further investigation — even though you feel perfectly well. Erythrocyte sedimentation rate is one of the oldest and simultaneously one of the least specific markers in laboratory medicine. That is precisely the point: a high ESR says that "something may be wrong" but does not say what. This article covers reference ranges, causes, and how to correctly interpret this result. What Is ESR and Why Is It Tested ESR stands for erythrocyte sedimentation rate. When blood is placed with an anticoagulant in a vertical tube and left to stand for an hour, red blood cells settle to the bottom under gravity — forming a red column below and a clear plasma layer above. The rate at which they settle, measured in millimetres per hour, is the ESR. Why does ESR change with illness? Red blood cells carry a negative surface charge and normally repel each other, settling slowly. During inflammation, acute-phase proteins accumulate in blood plasma: fibrinogen, immunoglobulins, α-2-globulins. These proteins coat red blood cells, neutralise their negative charge, and promote the formation of "rouleaux" — stacked chains of cells that settle significantly faster. This is why ESR is an indirect marker of inflammation, not a direct measure of it. ESR is part of the complete blood count and is one of the most frequently ordered tests in outpatient medicine. It does not point to a specific disease but acts as a sensitive alarm: a significantly elevated ESR without an obvious cause is grounds for targeted investigation. An important limitation: ESR is a slow marker. It begins to rise 24–48 hours after inflammation starts and normalises with a similar delay — sometimes weeks after recovery. For assessing acute, immediate inflammation, C-reactive protein is far more accurate: it responds within 6–12 hours and falls equally quickly when treatment is effective. How to Prepare for an ESR Test ESR is measured in venous or capillary blood as part of a complete blood count. Preparation is minimal, but ignoring the basic rules can distort the result. Timing. Preferably in the morning, between 7 and 11 am. ESR shows small circadian variation — it is marginally higher in the afternoon. For serial monitoring, always test at the same time of day. Food. A fatty meal the evening before raises plasma chylomicron levels, which — like inflammatory proteins — accelerate red cell sedimentation. A light dinner and a 4–8-hour fast before the draw is recommended; water is unrestricted. Exercise and stress. Intense exercise the day before and acute stress transiently elevate ESR. Avoid both for 24 hours before the test. Infections and vaccination. Even a mild respiratory infection raises ESR for several weeks. For a planned test, postpone until 3–4 weeks after full recovery. Vaccination also produces a brief elevation. Methods. The Westergren method is the international standard. The Panchenkov method is used in some countries and gives comparable but not fully interchangeable results. When comparing serial measurements, ensure the same method is used at the same laboratory throughout. ESR Normal Range by Age and Sex ESR varies substantially with sex and age. Reference values are higher in women than men — partly due to lower haematocrit and the influence of sex hormones on plasma protein composition. The physiological normal range rises gradually with age. Group ESR Normal Range (Westergren) Notes --------------------------------------------- Men under 50 0–15 mm/h — Men over 50 0–20 mm/h Physiological rise Women under 50 0–20 mm/h — Women over 50 0–30 mm/h Physiological rise Pregnant women Up to 45–50 mm/h Physiologically normal Children under 12 2–12 mm/h Age-dependent Clinical significance thresholds: - 20–40 mm/h — mild elevation: context-dependent; often physiological or minor inflammation. - 40–70 mm/h — marked elevation: active inflammation, autoimmune process, or infection. - 100 mm/h — significantly accelerated: serious organic pathology; source must be found promptly. The key interpretive rule: an isolated elevated ESR with a normal full blood count, normal CRP, and no symptoms warrants a repeat test in 2–4 weeks — not an immediate oncology workup. Causes of Elevated ESR: Inflammation, Infection and Beyond ESR rises in any condition that alters plasma protein composition or red cell morphology. The list of causes is very broad — which is precisely why the test lacks specificity. Autoimmune and Inflammatory Diseases The most common cause of high ESR in rheumatological practice. Rheumatoid arthritis — ESR in active disease typically reaches 40–80 mm/h and correlates with the DAS28 disease activity index. Falling ESR on treatment is a reliable marker of therapeutic response. Systemic lupus erythematosus, dermatomyositis, and systemic sclerosis — ESR rises predictably during flares. Inflammatory bowel disease (Crohn's disease, ulcerative colitis) produces moderate-to-marked ESR acceleration in the active phase. For all autoimmune processes, ESR is assessed alongside rheumatoid factor and other disease-specific markers — never in isolation. Infections Acute bacterial infections — pneumonia, pyelonephritis, abscesses, bacterial endocarditis — produce a rapid, substantial rise in ESR, frequently above 60–80 mm/h. Viral infections elevate ESR more modestly. Infectious mononucleosis is a notable exception — it can markedly elevate ESR alongside a rise in atypical lymphocytes in the blood count. Chronic infections — tuberculosis, chronic hepatitis, autoimmune hepatitis — cause persistently moderate-to-marked ESR acceleration, often discovered incidentally on routine testing. Anaemia and Other Causes Iron deficiency anaemia is one of the most common causes of moderately elevated ESR in the absence of inflammation. The mechanism: fewer red cells per unit volume reduces the physical opposition to sedimentation. The distinguishing feature: CRP is normal in pure iron deficiency anaemia. Pregnancy is a physiological cause of high ESR requiring no further investigation: values up to 45–50 mm/h in the third trimester are normal and resolve within 3–6 weeks of delivery. Malignancies — particularly lymphomas, multiple myeloma, renal cell carcinoma, and ovarian cancer — frequently present with persistently elevated ESR without obvious symptoms. In multiple myeloma, ESR can exceed 100 mm/h due to massive paraprotein production. Other causes: renal failure (accumulation of uraemic proteins), hypothyroidism, obesity, and smoking. Very High ESR: What Does a Result Above 100 mm/h Mean ESR above 100 mm/h is not simply "elevated" — it is a clinical situation that almost always indicates serious organic pathology and requires immediate investigation. Statistically, the causes of ESR 100 mm/h break down as follows: approximately 35% — infections (most commonly severe bacterial: tuberculosis, bacterial endocarditis, deep abscesses); approximately 25% — malignancies (particularly haematological — lymphomas, multiple myeloma); approximately 20% — systemic autoimmune diseases (vasculitis, polymyalgia rheumatica, Sjögren's syndrome); the remainder — renal failure and severe chronic disease. When ESR exceeds 100 mm/h without an established diagnosis, the standard investigation algorithm includes: full blood count with differential; CRP, fibrinogen, serum protein electrophoresis; liver and kidney biochemistry; urinalysis; chest X-ray; tumour marker screen; rheumatological markers. Normal results across all of the above with persistently very high ESR is an indication for haematology referral and PET/CT. Low ESR: Causes and Clinical Significance ESR below 2 mm/h in adults is far less common than elevation, and in most cases is not pathological. Polycythaemia vera — a pathologically elevated haematocrit. The densely packed red cells physically cannot settle quickly — ESR falls to 1–2 mm/h. This is a useful indirect sign of polycythaemia when acute-phase proteins are normal. Sickle cell anaemia — the abnormal shape of sickle cells prevents rouleaux formation, which is required for sedimentation to occur. Hyperviscosity states in certain conditions (protein deficiency, cachexia) also reduce ESR. Technical causes: incorrect blood-to-anticoagulant ratio, delayed processing, or inappropriate temperature during storage. When ESR is unexpectedly very low, the first step is to verify the conditions of sample collection and handling. An isolated low ESR in the presence of normal other tests in an asymptomatic person is not a cause for concern. When to See a Doctor Urgently Seek prompt medical attention in the following situations: - ESR above 100 mm/h under any circumstances — even without symptoms: this value always requires an active search for the underlying cause. - Elevated ESR ( 40 mm/h) combined with night sweats, unexplained weight loss, and lymph node enlargement — the classic "B-symptom" triad of lymphoma, warranting haematological evaluation. - Persistently elevated ESR over 3 or more months without an identified cause — indication for a comprehensive systematic workup. - ESR rises sharply after a period of normal values without any apparent cause (no infection, no injury) — possible marker of a new inflammatory or neoplastic process. - High ESR in an older adult (over 60) with pain and stiffness in the shoulder and pelvic girdle — the characteristic picture of polymyalgia rheumatica, which responds rapidly to glucocorticoids when diagnosed promptly. - Elevated ESR in a patient on immunosuppressive therapy — the immune system may not mount a full response to infection; ESR may be the only laboratory signal of an occult infective process. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/high-cholesterol-what-to-do https://labreadai.com/en/posts/high-cholesterol-what-to-do Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) High cholesterol: normal LDL, HDL and triglyceride values, diet and exercise to lower levels, when statins are prescribed and how to cut heart attack risk. Articles article Your blood test comes back — cholesterol is high. Your doctor says it needs to come down; you search online for "how to lower cholesterol fast" and find hundreds of tips, half of which contradict the other half. Here is a clear-eyed look at the facts: what high cholesterol actually means, when it is genuinely dangerous, when diet and exercise are enough, and when statins are the right call. Why Cholesterol Rises and Why It Matters Cholesterol is not a poison. It is an essential building material: cell membranes are assembled from it, and the body uses it to synthesise sex hormones, cortisol, and vitamin D. The problem is not cholesterol itself, but excess quantities and which form predominates in the blood. The liver produces about 80% of the body's cholesterol; the remaining 20% comes from food. When there is too much cholesterol in circulation, the surplus begins accumulating in arterial walls, forming atherosclerotic plaques. Plaques narrow the vessel, reduce blood flow, and can rupture — triggering clot formation. This mechanism underlies most myocardial infarctions and ischaemic strokes. The full progression of this damage is described in the article on atherosclerosis. Causes of elevated cholesterol fall into non-modifiable and modifiable categories. Non-modifiable: familial hypercholesterolaemia (a genetic defect in LDL receptors), age (cholesterol rises with years), and male sex (men under 50–55 tend to have higher levels). Modifiable: excess weight and obesity, low physical activity, diets high in saturated and trans fats, smoking, heavy alcohol use, type 2 diabetes, hypothyroidism, and chronic kidney disease. Elevated cholesterol produces no symptoms — it is a silent threat. A person can carry a high cholesterol level for years and feel completely healthy, until the first manifestation turns out to be a heart attack. How to Read a Lipid Panel: LDL, HDL and Triglycerides Total cholesterol is just a single sum that says little about actual cardiovascular risk. Clinical decisions require a full lipid panel — it breaks cholesterol into its fractions and gives a far more accurate picture. LDL (low-density lipoprotein) — "bad" cholesterol. LDL carries cholesterol from the liver into tissues and deposits it in arterial walls. The higher the LDL, the higher the risk of atherosclerosis. It is the primary treatment target: each 1 mmol/L reduction in LDL cuts the risk of heart attack by approximately 22%. HDL (high-density lipoprotein) — "good" cholesterol. HDL works in reverse: it collects cholesterol from tissues and delivers it back to the liver for processing. High HDL is protective. Low HDL (< 1.0 mmol/L in men, < 1.2 mmol/L in women) is an independent cardiovascular risk factor even when total cholesterol is normal. Triglycerides are neutral fats circulating in the blood. They rise after meals, in obesity, with heavy alcohol use, and in diabetes. Levels above 5.6 mmol/L sharply raise the risk of acute pancreatitis. Moderate elevation (1.7–5.6 mmol/L) is an additional cardiovascular risk factor. The atherogenicity index = (total cholesterol − HDL) / HDL. Normal is below 3.0. Values above 4–5 are associated with substantially increased risk of atherosclerotic disease. Cholesterol Targets by Cardiovascular Risk Category Target LDL values are not based on a single universal "normal" — they depend on the patient's individual cardiovascular risk. The higher the risk, the tighter the target. Risk Category LDL Target Typical Patients ------------------------------------------ Very high < 1.4 mmol/L Prior heart attack or stroke, diabetes with organ damage High < 1.8 mmol/L Diabetes without complications, severe CKD, 10-yr CV risk 10% Moderate < 2.6 mmol/L Moderate risk factors, 10-yr CV risk 1–10% Low < 3.0 mmol/L No significant risk factors Total cholesterol: optimal < 5.0 mmol/L; in high-risk patients < 4.0 mmol/L. HDL: men ≥ 1.0 mmol/L, women ≥ 1.2 mmol/L. Triglycerides: < 1.7 mmol/L optimal; 1.7–5.6 mmol/L elevated; 5.6 mmol/L critically high. The practical rule: if your LDL is above the target for your risk category, that is a reason to discuss strategy with your doctor — regardless of whether you have symptoms. Diet for High Cholesterol: What to Eat and What to Cut A well-designed diet lowers LDL by an average of 10–20%. For most people this is not enough to reach target values alone, but dietary change is a mandatory foundation of any strategy, with or without medication. The main enemy — saturated and trans fats. Saturated fats (fatty meat, butter, coconut oil, high-fat cheese, palm oil) stimulate LDL production in the liver. Trans fats (margarine, industrial baked goods, fried fast food) both raise LDL and lower HDL — a double blow to the cardiovascular system. Replacing saturated fats with unsaturated fats reduces LDL by 8–10% on average. What genuinely lowers cholesterol. Soluble fibre — oat bran, legumes, apples, citrus, barley — binds cholesterol in the gut and removes it with faeces. 5–10 g of soluble fibre daily reduces LDL by 5–7%. Omega-3 fatty acids from oily fish (salmon, sardines, mackerel) primarily lower triglycerides — by 20–30% at 2–3 servings per week. Plant sterols and stanols (fortified margarines, functional yoghurts) block intestinal cholesterol absorption — daily use lowers LDL by 7–12%. In fatty liver disease, which frequently accompanies hypercholesterolaemia, restricting simple carbohydrates and alcohol is particularly important: they drive hepatic triglyceride synthesis and further raise LDL through a VLDL-mediated mechanism. Practical menu: the foundation should be vegetables, legumes, whole grains, fish, lean poultry, and olive oil. Limit red meat to 1–2 times per week; choose low-fat dairy products. Eliminate trans fats, industrial baked goods, and fast food. Physical Activity, Weight Loss and Lifestyle Exercise has a more modest direct effect on cholesterol than diet — LDL falls 5–8% — but its effect on HDL is valuable: it rises by 5–10%. Raising "good" cholesterol pharmacologically is considerably harder than lowering "bad" cholesterol, making exercise a uniquely effective tool for HDL improvement. Recommended minimum: 150 minutes of moderate aerobic activity per week (brisk walking, cycling, swimming) or 75 minutes of vigorous activity. Consistency is what counts: occasional intense sessions do not work; daily or regularly alternating activity does. Weight loss in overweight patients is one of the most powerful levers available. Every 5 kg lost reduces LDL by approximately 0.2 mmol/L and raises HDL by 0.1 mmol/L. In metabolic syndrome — the combination of abdominal obesity, high triglycerides, low HDL, and elevated blood pressure — weight correction can sometimes normalise the entire lipid profile without medication. Smoking lowers HDL and oxidises LDL, making it more atherogenic. Quitting within a year raises HDL by 5–10% and substantially reduces overall cardiovascular risk — independently of cholesterol levels. Managing blood pressure in arterial hypertension is critical in the overall picture: elevated pressure damages the arterial endothelium, making it vulnerable to LDL deposition even at moderate LDL concentrations. Statins and Other Medications: When Are They Needed Diet and exercise are the first step. But if LDL has not reached its target after 3–6 months, or the risk is already high, or LDL is very elevated to begin with — medications are required. Statins (atorvastatin, rosuvastatin, pitavastatin) are the cornerstone of drug therapy. They inhibit the enzyme HMG-CoA reductase in the liver, reducing cholesterol synthesis. LDL falls 30–55% depending on the drug and dose. Taken once daily in the evening (the liver synthesises cholesterol primarily at night). Safety is well established: myopathy occurs in less than 1% of patients; serious rhabdomyolysis in 1 per 10 000. The myth that statins "damage the liver" is not supported by evidence: clinically significant elevation of liver enzymes at correctly titrated doses occurs in fewer than 1% of patients. Statin effectiveness is monitored via total cholesterol and the full lipid panel: first check at 4–6 weeks after starting therapy, then every 3–6 months until stable, then annually. Ezetimibe is the second agent added when statin response is insufficient or high statin doses are not tolerated. It blocks intestinal cholesterol absorption and lowers LDL by an additional 15–20% on top of statin therapy. PCSK9 inhibitors (alirocumab, evolocumab) are injectable biologics. They lower LDL by 50–60% on top of maximum-dose statin therapy. Prescribed for very high-risk patients, familial hypercholesterolaemia, or statin intolerance. Fibrates are used primarily for elevated triglycerides: they lower triglycerides by 30–50% and modestly raise HDL. Their effect on LDL is weaker than statins. When to See a Doctor Urgently Call emergency services immediately if, in the context of known high cholesterol, you develop: - Chest pain or pressure radiating to the left arm, jaw, or back — classic signs of acute coronary syndrome. - Sudden weakness on one side of the body, facial asymmetry, speech or vision disturbance — signs of stroke; every minute of delay destroys roughly two million neurons. - Abdominal pain after eating combined with very high triglycerides ( 10 mmol/L) — risk of acute pancreatitis. - Xanthomas — firm yellowish nodules under the skin at tendons, eyelids, or palms — a sign of familial hypercholesterolaemia with years of cholesterol deposition in tissues. See your doctor on a planned basis if: LDL exceeds 4.9 mmol/L — the threshold for familial hypercholesterolaemia; cholesterol is elevated in a child or young adult under 30 without obesity; or after 3–6 months of diet and exercise, LDL has not reached the target value — medication is needed. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/how-to-increase-hemoglobin https://labreadai.com/en/posts/how-to-increase-hemoglobin Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Low haemoglobin causes: iron deficiency, vitamin B12, folate. Best foods and iron supplements to raise levels, and when diet alone is not enough to treat anaemia. Articles article Unexplained fatigue, persistent pallor, breathlessness on a single flight of stairs — and then a blood test comes back with haemoglobin flagged low. A familiar picture? Low haemoglobin affects roughly one in five adults worldwide and remains one of the most common laboratory findings. But to raise haemoglobin effectively, you need to understand the cause first — otherwise treatment is like filling a bucket with a hole in it. This article covers the mechanism of haemoglobin decline, the right tests to order, and concrete steps from dietary changes to medical therapy. Why Haemoglobin Falls: Causes and Mechanisms Haemoglobin is the protein inside red blood cells that carries oxygen from the lungs to every cell in the body. Its decline is not a standalone disease — it is a symptom. The underlying causes are fundamentally different from one another. Iron deficiency — the most common cause. Iron is the raw material for haem, the part of the haemoglobin molecule that binds oxygen. Without enough iron, red blood cells are produced small and pale — clinicians call this microcytic hypochromic anaemia. Iron deficiency develops through chronic blood loss (heavy periods, gastrointestinal bleeding), inadequate dietary intake, impaired absorption (coeliac disease, gastric surgery), or sharply increased demand (pregnancy, adolescent growth spurts). This is the pathway for the majority of patients with iron deficiency anaemia. Vitamin B12 or folate deficiency — the second most common mechanism. These vitamins are essential for normal division of red blood cell precursors in the bone marrow. Without them, cells enlarge and become non-functional — megaloblastic anaemia. Unlike iron-deficiency anaemia, here the haemoglobin content per cell may actually be normal or high; there are simply too few viable cells. Chronic disease. Chronic inflammation — rheumatoid arthritis, Crohn's disease, chronic kidney disease, malignancy — blocks iron utilisation even when iron stores are adequate. This is the anaemia of chronic disease: iron supplements are ineffective and targeting the cause is what matters. Acute or chronic blood loss directly reduces red cell mass and haemoglobin. Sometimes the source is obvious (trauma, childbirth); sometimes it is hidden (peptic ulcer, bowel polyps). Understanding the cause is the key to correct treatment. The same haemoglobin of 90 g/L requires completely different approaches in a patient with iron deficiency and in a patient with chronic kidney failure. Which Blood Tests to Order for Low Haemoglobin The first step is not to reach for iron supplements — it is to establish the cause. A minimal set of investigations does this efficiently. A complete blood count is the starting point. It shows not only haemoglobin but also the size of red blood cells (MCV): small cells point to iron deficiency; large cells to B12 or folate deficiency; normal-sized cells to chronic disease or blood loss. This alone significantly narrows the diagnostic search at the first step. An iron panel is essential when iron deficiency is suspected. It includes serum iron, total iron-binding capacity (TIBC), and transferrin saturation. The most critical value is ferritin: the body's iron storage protein. Ferritin falls first — long before haemoglobin drops. Normal serum iron alongside low ferritin means reserves are already depleted; the body is still compensating. Vitamin B12 and folate in blood are ordered when MCV is normal or elevated — to exclude megaloblastic anaemia. This is particularly important in vegans, strict vegetarians, and older adults, in whom B12 absorption from food declines with age. Depending on the clinical picture, the doctor may also request reticulocytes (bone marrow response), C-reactive protein, and TSH — to exclude chronic inflammation and hypothyroidism as contributing causes. Foods That Raise Haemoglobin Diet is effective in mild anaemia and is a mandatory complement to medical treatment in moderate cases. But there is a critical distinction: food contains two fundamentally different forms of iron. Haem iron (from meat and fish) — absorbed at 15–35%. Best sources: beef and pork liver (6–7 mg per 100 g), beef and lamb (2–3 mg/100 g), mussels and oysters (up to 6 mg/100 g), dark turkey and duck meat. Non-haem iron (from plants) — absorbed at only 2–8%, but found abundantly in lentils, spinach, tofu, pumpkin seeds, and fortified cereals. To raise non-haem iron absorption to near-meat levels, vitamin C is essential. Vitamin C is iron's most important ally. It converts iron from the ferric form (poorly absorbed) to the ferrous form. A bowl of lentils with a glass of fresh orange juice absorbs 2–4 times more iron than lentils alone. Adding bell pepper to buckwheat achieves the same effect. What blocks iron absorption matters just as much. Tea, coffee, and red wine contain tannins and polyphenols that bind iron directly in the gut. Milk and dairy products — calcium competes with iron at the same intestinal transporter. Wholegrains, legumes, and nuts contain phytates and oxalates that form insoluble complexes with iron. None of these foods need to be eliminated — simply avoid eating them at the same meal as iron-rich foods. A 1–2-hour gap is sufficient. Increases iron absorption Decreases iron absorption ---------------------------------------------------- Vitamin C (citrus, peppers) Tea and coffee Meat broth Milk and calcium Acidic foods (fermented veg) Wholegrains with phytates Cooked legumes Red wine Iron Supplements: When Diet Is Not Enough At haemoglobin below 100–110 g/L, or with low ferritin (< 15–20 ng/mL), diet alone cannot keep up with the body's need to replenish stores. Supplements are required. Iron preparations fall into two broad categories. Ferrous salts (ferrous sulphate, fumarate, gluconate) — less expensive and well studied, but more likely to cause gastrointestinal side effects: nausea, constipation, dark stools. Ferric compounds (ferric polymaltose complex) and chelated forms (ferrous bisglycinate) — better tolerated, less gut irritation, but more expensive. How to take them correctly. On an empty stomach or 30 minutes before food — absorption is up to 40% higher than with meals. Take with water or vitamin C-containing juice. Avoid co-administration with calcium supplements, antacids, and certain antibiotics (tetracyclines, fluoroquinolones) — these block iron absorption. If the stomach cannot tolerate fasting doses, take with food, accepting reduced but still clinically useful absorption. Dosing. For treating iron-deficiency anaemia in adults, 100–200 mg of elemental iron per day is standard (not the total tablet weight — elemental iron content is stated separately in the product information). For prevention and latent deficiency, 30–60 mg/day is sufficient. Duration. After haemoglobin normalises, supplements continue for another 2–3 months — to replenish tissue stores (ferritin). Stopping at haemoglobin normalisation is one of the most common errors: ferritin remains at zero, and anaemia returns within months. In severe cases (oral iron intolerance, malabsorption, haemoglobin below 70–80 g/L), intravenous iron is given — rapid and highly effective, but only in a clinical setting under observation. Raising Haemoglobin When B12 or Folate Is Low When the CBC shows enlarged red blood cells (MCV 100 fL), the problem is not iron. This is megaloblastic anaemia, and iron supplements are not only unhelpful but can be harmful if taken without indication. Vitamin B12 comes exclusively from animal foods: meat, fish, eggs, dairy. Vegans and strict vegetarians are at inherent risk and need continuous B12 supplementation. A second high-risk group is older adults: gastric production of intrinsic factor — required for B12 absorption — declines with age. Long-term use of metformin and proton pump inhibitors also suppresses B12 levels. For moderate deficiency, high-dose oral B12 (1000–2000 mcg/day) is effective — at these doses, passive diffusion bypasses the need for intrinsic factor. For severe deficiency, neurological symptoms, or absorption disorders, intramuscular injections of cyanocobalamin or hydroxocobalamin are used. Folate (vitamin B9) is found in leafy greens, legumes, citrus fruits, and liver. Its deficiency is especially dangerous in pregnancy — low folate in the first weeks after conception increases the risk of neural tube defects. This is why folic acid is recommended for all women planning pregnancy, starting 1–3 months before conception. In vitamin B12 deficiency it is critical not to prescribe folic acid in isolation without first ruling out B12 deficiency: folate corrects the blood picture but does not protect against the neurological damage of B12 deficiency, which can be irreversible. How Long Does It Take for Haemoglobin to Rise This is one of the most frequently asked questions — and the most frequent source of disappointment. Haemoglobin does not normalise in a week. Here is a realistic timeline. 2–4 weeks. The first sign of treatment response is a rise in reticulocytes (young red blood cells) in the blood. This means the bone marrow has received iron and has begun actively producing new cells. Patients often feel better at this stage before haemoglobin itself has visibly changed. 4–8 weeks. Haemoglobin begins rising steadily — typically 10–20 g/L per month with correct treatment. The target is to reach the lower limit of the reference range (120 g/L in women, 130 g/L in men). 2–4 months. Full haemoglobin normalisation and the start of ferritin recovery. Treatment continues beyond haemoglobin normalisation — the goal now is to raise ferritin above 30–50 ng/mL. If haemoglobin has not risen by at least 10 g/L after 4 weeks of treatment, this is a signal: either the diagnosis is incorrect (not iron-deficiency anaemia), the supplement is not being absorbed, or there is an ongoing hidden blood loss. A repeat medical visit is needed. When to See a Doctor Urgently Not all low haemoglobin situations can be managed independently. Some require immediate medical attention. Seek emergency care if: haemoglobin is below 70 g/L in an adult — at this level the heart is under severe strain and hospitalisation is often needed; haemoglobin is falling rapidly over days or weeks — possible acute bleeding; low haemoglobin is accompanied by abdominal pain, black tarry stools, or visible blood in the stool — signs of gastrointestinal haemorrhage; anaemia fails to respond to iron supplements after 4 weeks — a different cause needs to be found; multiple blood counts are simultaneously low (haemoglobin, white cells, and platelets) — possible bone marrow pathology requiring specialist evaluation. Self-treatment for anaemia is appropriate only in mild cases with an obvious cause such as heavy periods. In all other situations — tests first, treatment second. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/how-to-lower-blood-sugar https://labreadai.com/en/posts/how-to-lower-blood-sugar Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) How to lower blood sugar in type 2 diabetes and prediabetes: low-GI diet, physical activity, metformin and insulin — evidence-based steps explained clearly. Articles article Your test came back with elevated blood sugar — and now you need to know what to do. Or your sugar has been high for a while and you are hoping to manage it through food alone. The good news: in prediabetes and early type 2 diabetes, non-pharmacological methods work very well — when applied consistently and correctly. The less welcome news: "lowering sugar fast" addresses an acute episode, not the underlying cause. This article is a step-by-step breakdown — from the mechanism of elevation to the concrete tools for bringing it down. Why Blood Sugar Rises and Why It Matters Glucose is the primary fuel for cells. For glucose to enter a cell, insulin is required — a hormone that acts as a key, unlocking cellular receptors. When this mechanism breaks down, glucose stays in the blood instead of nourishing tissue. Two fundamentally different failures exist. In insulin resistance, insulin is produced in sufficient or even excessive amounts, but cells respond to it poorly — the locks have seized. The pancreas compensates by producing more and more insulin until it is exhausted. This is the progression from normal glucose to prediabetes and then to type 2 diabetes. In type 1 diabetes the mechanism is different: the immune system destroys beta cells; insulin is critically absent and injections are essential from the outset. Chronically elevated glucose destroys the body slowly and silently. Excess sugar glycates proteins in vessel walls, nerve fibres, and the lens of the eye — producing the classic diabetic complications: nephropathy, retinopathy, neuropathy, and a dramatically elevated risk of heart attack and stroke. These develop over years, invisibly — which is exactly why lowering blood sugar should begin when a test first shows an abnormality, not when symptoms appear. Which Tests Are Needed for High Blood Sugar A fasting glucose level is only an instant snapshot. Two key measurements provide a complete picture. Glycated haemoglobin (HbA1c) reflects the average blood glucose over the previous 2–3 months. It "remembers" everything that happened with blood sugar, is unaffected by the most recent meal, and cannot be manipulated by a single good reading. It is the primary metric for diagnosis and treatment monitoring: normal — below 5.7%; prediabetes — 5.7–6.4%; diabetes — 6.5% and above. The treatment target in established type 2 diabetes is generally below 7.0% (individualised with the treating physician). C-peptide shows how much insulin the pancreas is producing on its own. This is critical for choosing the right approach: if C-peptide is normal or elevated, the gland is functioning and non-pharmacological strategies have real potential. If C-peptide is markedly low, beta cells are depleted and insulin or secretagogues will be needed regardless of lifestyle effort. The doctor may additionally order a glucose tolerance test (75 g oral glucose load) — particularly when fasting values are borderline. To screen for end-organ damage: urine microalbumin, serum creatinine, and an eye examination are standard. Diet for Lowering Blood Sugar: Glycaemic Index in Practice Nutrition is the most powerful of the non-pharmacological tools. The right diet lowers HbA1c by an average of 1.0–1.5% — comparable to the effect of metformin at its starting dose. The core principle — managing glycaemic response. Not all carbohydrates are equal. The glycaemic index (GI) indicates how quickly a food raises blood sugar: high GI produces a sharp spike; low GI a gradual, manageable rise. White bread, white rice, mashed potatoes, sweet drinks — GI above 70, causing glucose and insulin peaks. Legumes, most vegetables, whole grains, nuts, berries — GI below 55, stable glucose without spikes. What lowers blood sugar over the long term. Dietary fibre (vegetables, legumes, whole grains) slows carbohydrate absorption and reduces post-meal glucose peaks. Protein (fish, poultry, eggs, cottage cheese) raises glucose minimally and creates satiety. Unsaturated fats (olive oil, avocado, nuts) reduce insulin resistance with regular consumption. Vinegar and acidic foods slow gastric emptying and lower post-meal glucose by 20–30%. What sharply raises blood sugar — eliminate or strictly limit. Sugar and all its "natural" equivalents (honey, maple syrup, cane sugar) raise glucose identically. Sweetened drinks — including juices: 200 mL of orange juice contains as much sugar as three oranges but without the fibre that slows absorption. White flour and refined grains. Alcohol — initially causes hypoglycaemia (blocks hepatic glucose release), then hyperglycaemia — unpredictable swings that are especially dangerous in patients on insulin. The plate method in practice. Half the plate — non-starchy vegetables (cucumber, tomatoes, greens, broccoli, cabbage). A quarter — protein (fish, chicken, eggs, cottage cheese). A quarter — complex carbohydrates (buckwheat, bulgur, legumes, wholegrain bread). This simple structure, without calorie counting, reliably reduces post-meal glucose spikes when used consistently. In obesity — the primary risk factor for type 2 diabetes — weight loss of just 5–10% of starting body weight reduces HbA1c by 0.5–1.0% and meaningfully restores insulin sensitivity. It is one of the most powerful tools available without a prescription. Physical Activity: How Exercise Lowers Blood Sugar Muscles are the body's primary glucose consumers. During exercise, muscle tissue absorbs glucose directly, without insulin — via the GLUT4 transporter, which is mechanically activated by muscle contraction. This means: even in the presence of significant insulin resistance, physical activity lowers blood sugar. Aerobic exercise (walking, cycling, swimming, Nordic walking) lowers glucose during the session and for several hours afterwards. Meta-analyses show that regular aerobic activity reduces HbA1c by 0.7% on average — comparable to an individual pharmacological agent. The recommended minimum is 150 minutes of moderate exercise per week, distributed across 3–5 sessions. Resistance training builds muscle mass — and every kilogram of muscle continuously consumes glucose, even at rest. The combination of aerobic and resistance training reduces HbA1c more than either type alone. The practical post-meal rule. A 15–20-minute walk after eating reduces the post-meal glucose peak by 20–30%. This is one of the simplest and most accessible tools — particularly for anyone who finds it difficult to schedule formal workouts. In metabolic syndrome — the combination of abdominal obesity, elevated triglycerides, low HDL, and high blood pressure — regular exercise simultaneously corrects multiple components of the syndrome, not only blood sugar. An important caution. When baseline glucose is very high (above 13–14 mmol/L), intense exercise can paradoxically raise blood sugar: stress hormones (adrenaline, cortisol) release stored hepatic glucose. Before beginning vigorous training at high blood sugar levels, discuss the approach with your doctor. Medications to Lower Blood Sugar: When They Are Needed Non-pharmacological measures are the foundation. But if HbA1c remains above target after 3 months of intensive lifestyle change — medications are needed. This is not a failure: the pancreas has already sustained damage, and its recovery capacity is limited. Metformin is the first-line agent for type 2 diabetes and high-risk prediabetes. It reduces hepatic glucose production, improves tissue sensitivity to insulin, and modestly slows intestinal glucose absorption. It lowers HbA1c by 1.0–1.5%. It does not cause hypoglycaemia or weight gain — a rare combination in a glucose-lowering drug. The only common side effect is gastrointestinal discomfort at initiation, which resolves with gradual dose escalation. SGLT-2 inhibitors (empagliflozin, dapagliflozin) excrete glucose in urine, lowering blood levels independently of insulin. They additionally reduce weight, blood pressure, and the risk of cardiovascular events. Particularly indicated when diabetes coexists with heart failure or chronic kidney disease. GLP-1 receptor agonists (semaglutide, liraglutide) amplify the insulin response after meals, suppress appetite, and slow gastric emptying. They lower HbA1c by 1.0–1.8% and body weight by 3–5 kg. The most effective drugs for simultaneously reducing blood sugar and weight. Insulin is prescribed when beta-cell function is substantially impaired (low C-peptide), in type 1 diabetes, and when glucose targets cannot be met by other means. Needing insulin does not mean diabetes is "end stage" — it is simply the next instrument in the toolkit when earlier options are insufficient. The choice of a specific agent or combination is always individualised, depending on HbA1c level, comorbidities, weight, age, and hypoglycaemia risk. Selecting or adjusting a treatment regimen independently is not appropriate or safe. How to Lower Blood Sugar in Gestational Diabetes Gestational diabetes — elevated blood sugar first detected during pregnancy — requires a specific approach: many medications are contraindicated in pregnancy or lack sufficient safety data for the foetus. The primary and essential tool is diet. The principles are the same: restrict fast carbohydrates, use the plate method, eat in smaller portions across 5–6 meals per day. A pregnancy-specific note: even fruit with a high GI (bananas, grapes, melon) should be limited. Self-monitoring of blood glucose 4–7 times daily is mandatory. Moderate physical activity during an uncomplicated pregnancy is both safe and effective: a walk after each meal significantly blunts post-meal glucose peaks. If target glucose values are not reached within 1–2 weeks of dietary intervention, insulin therapy is initiated. Metformin is used as an alternative in some countries, but its use during pregnancy is always discussed individually with the treating physician. After delivery, blood sugar typically normalises, but the 10-year risk of developing type 2 diabetes in these women is 7–10 times higher — making regular glucose monitoring an ongoing priority. When to See a Doctor Urgently Call emergency services or go to an emergency department immediately if: - Glucose is above 16–17 mmol/L with nausea, vomiting, abdominal pain, or an acetone smell on the breath — signs of diabetic ketoacidosis, a life-threatening emergency. - Glucose is above 20–25 mmol/L without ketoacidosis symptoms but with severe weakness and confusion — hyperosmolar hyperglycaemic state, also requires emergency care. - Sudden weakness, sweating, tremor, hunger, palpitations — signs of hypoglycaemia (blood sugar below 3.9 mmol/L). If mild: take 15–20 g of fast-acting carbohydrates (four sugar lumps, half a glass of juice). If consciousness is impaired — call emergency services; do not attempt to give food or drink. - Fasting glucose above 7.0 mmol/L or HbA1c above 6.5% on first detection — diagnostic criteria for diabetes, requiring confirmation and a management plan with an endocrinologist. - High blood sugar combined with weight loss, constant thirst, and frequent urination in a young, non-obese person — possible type 1 diabetes, requiring urgent initiation of insulin therapy. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/how-to-prepare-blood-test https://labreadai.com/en/posts/how-to-prepare-blood-test Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) How to prepare for a blood test correctly: fasting rules, medication effects, and specifics for CBC, biochemistry, hormone and coagulation panels. Articles article You had a cholesterol test done — and the numbers came back alarming. It turned out there was a large dinner with wine the evening before. Or the opposite: your TSH result was "normal" despite clear hypothyroid symptoms — and it emerged later that you had taken your levothyroxine tablet two hours before the blood draw. Preparation for a blood test is not bureaucratic box-ticking. It is the condition that makes the result diagnostically meaningful in the first place. This guide covers everything: how long to fast, what you can and cannot drink, which medications affect results, and how to prepare for different panels. Why Blood Test Preparation Affects Results Blood is not a static fluid. Its composition changes hour by hour in response to food, movement, stress, body temperature, and dozens of other inputs. Drink a coffee — cortisol rises for 20–30 minutes. Run for the bus — white cell count spikes transiently, so does creatinine. Eat a fatty meal — triglycerides increase several-fold and remain elevated for 8–10 hours. The laboratory measures whatever is in the blood at the moment of collection — with no adjustment for what you did an hour before. Reference ranges are calculated under specific standard conditions: morning, fasting, at rest, without acute illness. Drawing blood outside these conditions produces a result outside the normal range for a perfectly healthy person — or, conversely, within the normal range for a sick person whose abnormality has been masked by food. Preparation rules exist precisely to bring the body to those standard conditions under which the reference ranges were established. Knowing how to prepare properly is the foundation of accurate diagnostics — this is not excessive caution but physiology. How Long to Fast Before a Blood Test The answer depends on exactly which test you are having. Different analytes respond differently to food intake. 8–12 hours is the standard requirement for most biochemical tests: glucose, cholesterol, triglycerides, ALT, AST, urea, creatinine, proteins, and enzymes. This is "classic" fasting: last meal the previous evening, blood drawn in the morning. Strictly 12 hours — for the lipid profile (cholesterol, LDL, HDL, triglycerides). Dietary fats circulate as chylomicrons for 10–12 hours after eating — a shorter gap gives falsely elevated triglycerides. At least 8 hours — for hormones, coagulation tests, and immunological assays (including rheumatoid factor and anti-CCP). No strict restriction — a complete blood count can technically be drawn at any time of day because the cellular composition of blood is not directly affected by food. In practice, morning fasting is still recommended for reproducibility and comparability over time. Fasting beyond 16–18 hours is also harmful. Prolonged starvation triggers catabolism: ketones, bilirubin, and free fatty acids rise in the blood. The result will again fall outside reference ranges — for the opposite reason. The optimal regime for most planned tests: a light dinner the evening before, no later than 8 pm, and blood drawn the next morning between 7 and 11 am. Following this schedule helps prepare the body for the most accurate result. What You Can and Cannot Drink Before a Blood Test The most common misconception is that "fasting" means "no fluids at all." It does not. Water may and should be drunk — freely, right up to the moment of blood collection. Water does not change analyte concentrations in serum. Good hydration also improves venous filling, makes blood collection easier, and reduces the risk of sample haemolysis. Tea and coffee — no, even without sugar. Caffeine stimulates cortisol and adrenaline release, accelerates heart rate, and influences platelet aggregation. Tea contains tannins that can interfere with some immunological assays. Juices, fruit drinks, squash — no. These are liquid food: their simple sugars are absorbed immediately and raise glucose. Even a small amount of a sweet drink makes a glucose result unreliable. Alcohol — exclude entirely for 24 hours before standard tests and 48 hours before liver enzyme tests (ALT, AST, GGT). Alcohol elevates hepatic enzyme activity even after modest intake. Energy drinks and sports formulas — same rule as juice: not permitted. Still or sparkling mineral water — acceptable in reasonable amounts. Which Medications Affect Blood Test Results This is one of the most underestimated variables. Many patients conscientiously fast for 12 hours but "forget" to mention drugs they take daily. Anticoagulants (warfarin, rivaroxaban, heparin) directly alter coagulation panel results. This is expected — but the laboratory must know, as results will be interpreted in the context of therapy. Oral contraceptives and hormone therapy affect levels of sex hormones, prolactin, SHBG, triglycerides, and coagulation parameters. NSAIDs (ibuprofen, diclofenac, aspirin) affect platelet function and can falsely reduce inflammatory markers. Thyroid medications (levothyroxine, carbimazole) taken before the test produce falsely shifted TSH and thyroid hormone values. The standard rule: have blood drawn for TSH before taking the morning dose. Metformin and other glucose-lowering drugs taken before the test can falsely lower fasting glucose. Immunosuppressants (methotrexate, biologics) reduce autoantibody levels including anti-CCP and rheumatoid factor. The cardinal rule: never stop medications on your own, especially essential ones (antihypertensives, antidiabetics, antiepileptics). Inform the laboratory about all medications — the clinician will factor this into interpretation. For planned diagnostic tests (not treatment monitoring), ask the requesting doctor in advance whether a temporary pause is needed. Preparation Specifics for Different Types of Blood Tests Complete Blood Count A complete blood count is the least demanding in terms of preparation. That said: draw blood in the morning, after rest, with no strenuous exercise in the preceding 24 hours. Physical stress transiently raises white cells (physiological leukocytosis), platelets, and haemoglobin (through haemoconcentration). For women, the day of the menstrual cycle matters for interpreting haemoglobin and haematocrit. Biochemistry and Lipid Panel Liver function tests — strictly 8–12 hours fasting; alcohol excluded for 48 hours. Fatty food elevates ALT, AST, and alkaline phosphatase. Lipid panel — the strictest requirements. A full 12 hours of fasting is needed (10 hours risks falsely elevated triglycerides). For 3 days before the test, eat a normal balanced diet — do not go on a special diet, as short-term dietary restriction can artificially improve the result. Thyroid Hormones A thyroid panel — TSH can be drawn at any time of day as it has no significant circadian rhythm. For reproducibility on follow-up testing, however, draw consistently in the morning. Take levothyroxine after the blood draw, not before. If calcitonin is included in the panel — strictly fasting and no smoking from the previous evening: both factors meaningfully stimulate C-cell secretion. Coagulation Panel A coagulation panel — 12 hours fasting, fatty food excluded. Fibrinogen responds to lipid load and alters plasma rheology. The tourniquet should be released promptly: prolonged venous compression activates local fibrinolysis and falsely lowers fibrinogen. All anticoagulant medications must be disclosed. Hormone and Vitamin Panels Hormone panels — most require morning collection between 8 and 10 am, as sex hormones and cortisol follow a strong circadian pattern. Prolactin should be drawn 2–3 hours after waking, at rest: stress and physical activity sharply elevate prolactin. Vitamin panels — strictly fasting. This is especially important for vitamin D: taking a vitamin D supplement the day before the test will falsely elevate the result. When monitoring treatment, vitamin D should be drawn 3 days after the last dose. Iron Studies An iron panel — morning, strictly fasting. Iron supplements must be stopped 5–7 days before the test (unless advised otherwise): a single dose of an iron-containing preparation raises serum iron 3–4 fold, rendering the result meaningless. Menstruation lowers serum iron — draw blood after the period ends where possible. When to Reschedule: Temporary Contraindications In some circumstances a result is predictably unreliable — and it is better to postpone than to obtain an inaccurate result that triggers unnecessary further investigation. Acute viral or bacterial infection. Any infection elevates white cells, ESR, C-reactive protein, and fibrinogen, and depresses haemoglobin and albumin. Planned tests drawn during a cold or flu will reflect acute inflammation, not the patient's baseline. Wait two weeks after full recovery. Vaccination. In the 2–3 weeks following any vaccine, the immune system is activated — white cells, lymphocytes, and immunoglobulins may be elevated, ESR mildly raised. Postpone planned immunological tests (anti-CCP, rheumatoid factor, thyroid antibodies) for three weeks after vaccination. Menstruation. Standard biochemical and clinical tests are unaffected. However, sex hormone tests (FSH, LH, oestradiol, progesterone) have strict cycle-day requirements — the requesting clinician will specify these. Physiotherapy, X-ray, MRI. These do not directly affect blood chemistry, but drawing blood before rather than after procedures is good practice. Psychological stress. Acute stress (conflict, poor sleep, an exam) raises cortisol, adrenaline, glucose, platelets, and white cells. If the previous day was particularly stressful, postponing a non-urgent test by 1–2 days is reasonable. What to Do on the Day of the Blood Draw Correct preparation does not end at waking up — a few details on the day of collection also matter. In the morning: wake up calmly, drink a glass of water, avoid rushing. Do not smoke — at least 2 hours before the draw (nicotine affects calcitonin, prolactin, and haemodynamics). Most medications should be taken after blood is drawn — confirm this with your doctor beforehand. Getting to the clinic: if you arrived hurried or stressed, sit in the waiting area for 10–15 minutes before the draw. This brief rest normalises heart rate, lowers adrenaline, and meaningfully improves accurate hormonal results. Before the procedure: tell the phlebotomist about all medications taken in the last 24–48 hours. Ask whether you should clench your fist — for some tests (potassium, lactate) this is prohibited, as local muscle activity alters ion concentrations in the drawn sample. After the draw: press the puncture site with the cotton swab for 3–5 minutes. Do not flex the arm sharply — this increases the risk of bruising. If you feel faint or dizzy, tell the phlebotomist immediately and do not stand up on your own. When results arrive, compare them with the reference ranges printed on your own report — different laboratories may use slightly different intervals. Any concerning deviation warrants a conversation with your doctor, not a search engine. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/lupus https://labreadai.com/en/posts/lupus Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) SLE — autoimmune disease affecting skin, joints, kidneys and heart: symptoms, blood tests, diagnostic criteria, anti-dsDNA antibodies and modern treatment. Articles article A butterfly-shaped rash across the cheeks, aching joints, persistent fatigue — and a blood panel with multiple abnormal markers. Systemic lupus erythematosus (SLE) is one of the most protean autoimmune diseases: it can affect virtually any organ, and its symptoms shift so unpredictably that years can pass between the first complaints and the correct diagnosis. This article covers how lupus presents, how it is diagnosed, and how it is treated today. What Is Lupus (SLE) and Why Does It Develop SLE is a chronic systemic autoimmune disease in which the immune system produces antibodies against the body's own cellular structures: DNA, nuclear proteins, and membrane antigens. The resulting immune complexes (antigen + antibody) deposit in vessel walls, renal glomeruli, joint tissues, and serosal membranes — triggering complement-mediated inflammation at each site. The mechanism that initiates the disease is not fully understood. Three groups of factors play central roles. Genetic predisposition: carriage of certain HLA-DR2 and HLA-DR3 alleles doubles or triples SLE risk; deficiencies of complement components (C1q, C4) increase it dramatically. Hormonal factors: the disease is nine times more common in women than men, debuts predominantly in the reproductive years — oestrogens amplify autoimmune responses. Environmental triggers: ultraviolet radiation (the best-established precipitant of flares), viral infections (Epstein–Barr virus), and certain drugs (hydralazine, procainamide — causing drug-induced lupus). SLE prevalence is approximately 50–100 cases per 100 000 population. Rates are substantially higher among women of reproductive age; in women of African and Asian descent, the disease tends to follow a more severe course. Lupus Symptoms: How SLE Presents SLE is the "great imitator" — it can masquerade as dozens of other conditions. Symptoms are characteristically relapsing and remitting. Skin manifestations. The classic sign is the malar rash — a butterfly-shaped erythema across the cheeks and nasal bridge, appearing or worsening after sun exposure. Present in 50–60% of patients; its absence does not exclude the diagnosis. Discoid lupus produces firm erythematous plaques with central atrophy and depigmentation, primarily on the face and scalp. Photosensitivity — exacerbation of skin and systemic manifestations after even brief sun exposure — is one of the formal diagnostic criteria. Joint involvement occurs in 90% of patients and is frequently the presenting symptom. Unlike rheumatoid arthritis, lupus arthritis is typically non-erosive — joints are painful and swollen but structural destruction does not occur. The symmetrical involvement of small hand, wrist, and knee joints is characteristic. Lupus nephritis — renal involvement — is the most serious organ manifestation and the primary determinant of long-term prognosis. It develops in 40–60% of patients and presents with proteinuria, haematuria, and rising creatinine. Without treatment it progresses to chronic kidney failure. Serositis. Pleuritis (pleuritic chest pain worsening on breathing) and pericarditis (retrosternal pain with a pericardial friction rub) are common manifestations of active SLE. Haematological abnormalities. Autoimmune haemolytic anaemia, leucopenia (particularly lymphopenia — a characteristic activity marker), and thrombocytopenia. All three cell lines may be simultaneously suppressed. Neuropsychiatric SLE — headaches, seizures, cognitive impairment, psychosis, stroke. This is one of the most diagnostically challenging aspects of the disease. Constitutional symptoms — chronic fatigue, low-grade fever, weight loss — frequently precede organ manifestations by months. Lupus Diagnosis: SLE Diagnostic Criteria and Blood Tests Diagnosis is made against the EULAR/ACR 2019 classification criteria. The system awards points for clinical and immunological features: a score of ≥10 points plus positive antinuclear antibodies (ANA) confirms the diagnosis. Antinuclear antibodies (ANA) — the obligatory entry-level test. Detected in 95–99% of SLE patients by indirect immunofluorescence. Critically: a positive ANA is non-specific — it occurs in 5–15% of healthy individuals and in many other conditions. A negative ANA at high clinical probability is grounds to repeat the test or perform an extended antibody panel. Anti-double-stranded DNA antibodies (anti-dsDNA) — the most specific marker of SLE (specificity 95%). Their titre correlates with disease activity, particularly with lupus nephritis. Rising anti-dsDNA often precedes a clinical flare by 4–8 weeks — making the marker valuable for monitoring. Rheumatoid factor — moderately elevated in approximately 25–30% of SLE patients. Its presence in lupus does not imply coexisting rheumatoid arthritis, although overlap syndromes exist. Inflammatory markers and blood cell counts. C-reactive protein behaves atypically in SLE: even with high disease activity it is often normal or mildly elevated. A substantial CRP rise in an SLE patient is more likely to indicate a concomitant infection than a lupus flare. ESR, conversely, is reliably elevated in active SLE. The complete blood count — leucopenia, lymphopenia, anaemia, thrombocytopenia — reflects the degree of immune-mediated cell destruction. Complement system. Falls in C3 and C4 are markers of active complement consumption by immune complexes. Simultaneous low C3, low C4, and rising anti-dsDNA is the classic laboratory signature of a lupus nephritis flare. Antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, anti-β2-glycoprotein I) — detected in 30–40% of SLE patients and indicate the risk of antiphospholipid syndrome: thrombosis and obstetric complications. Lupus Antibodies: Reference Values for Key SLE Markers Marker Normal Significance in SLE ------------------------------------- ANA (IF) < 1:80 ≥ 1:80 positive; 1:320 high titre Anti-dsDNA < 10 IU/mL 10 positive; correlates with activity C3 complement 0.9–1.8 g/L Fall indicates active consumption C4 complement 0.1–0.4 g/L Fall characteristic of nephritis flare ESR < 20 mm/h In active SLE: 40–100 mm/h or higher CRP < 5 mg/L Typically normal or mildly elevated in SLE The key interpretive rule: in SLE, diagnosis and activity assessment are based on the composite of all markers, not a single value. Clinicians use the SLEDAI (SLE Disease Activity Index) — an integrated score combining clinical and laboratory data into a single numeric scale. Systemic Lupus Erythematosus Treatment There is no cure for SLE, but modern therapy allows most patients to achieve remission and live a normal life. Hydroxychloroquine (Plaquenil) — the cornerstone of background therapy for all SLE patients without contraindications. It reduces flare frequency, protects the kidneys and heart, and lowers mortality. Prescribed lifelong. Annual ophthalmological monitoring is required because of the risk of retinopathy with prolonged use. Glucocorticoids (prednisolone, methylprednisolone) — the primary tool for managing flares. In severe organ involvement (nephritis, neuropsychiatric SLE) — intravenous methylprednisolone pulse therapy. Long-term high-dose use is limited by cumulative toxicity: osteoporosis, infections, cataracts, arterial hypertension. Immunosuppressants. Mycophenolate mofetil and azathioprine are the backbone of maintenance therapy in nephritis. Cyclophosphamide is used in severe class III–IV nephritis and neuropsychiatric SLE. Methotrexate is an option for joint and skin manifestations. Biologics. Belimumab (BLyS/BAFF inhibitor) — the first biologic approved specifically for SLE: it reduces disease activity and allows glucocorticoid dose reduction. Anifrolumab (type I interferon receptor inhibitor) — a newer agent for moderate-to-severe disease. Sun protection — not a recommendation but a medical necessity: UV radiation is the primary trigger for flares. Daily SPF 50+, UV-protective clothing, and avoiding peak sun hours are part of treatment. Lupus Complications and Comorbidities SLE substantially raises cardiovascular risk: the risk of myocardial infarction in young women with SLE is up to 50 times higher than in age-matched women without the disease. Drivers include chronic inflammation, accelerated atherosclerosis, hypertension from renal involvement, and glucocorticoid side effects. Antiphospholipid syndrome in SLE — venous and arterial thrombosis risk, recurrent pregnancy loss. Requires anticoagulant therapy. In chronic kidney disease from lupus nephritis — renoprotective strategy: ACE inhibitors, blood pressure below 130/80 mmHg, protein restriction. Hypothyroidism occurs in SLE patients more frequently than in the general population: autoimmune thyroiditis is a common comorbidity. Routine TSH monitoring is standard in all SLE patients. When to See a Doctor Urgently Immediate rheumatology consultation or hospitalisation is required when: - Worsening proteinuria or rising creatinine in a patient with SLE — possible lupus nephritis flare requiring kidney biopsy and aggressive immunosuppression. - Acute pleuritic pain with breathlessness — serositis or thromboembolism; in patients with antiphospholipid antibodies, PE is especially likely. - Seizures, psychosis, or acute stroke in a young woman with SLE — neuropsychiatric SLE or antiphospholipid syndrome. - High fever ( 38.5°C) on immunosuppressive therapy — differentiating a lupus flare from infection is critical; CRP helps: a marked rise points toward infection. - Anti-dsDNA titre rises sharply on routine monitoring — a clinical flare may follow in 4–8 weeks; adjusting therapy before manifestation improves prognosis. - First presentation: the combination of joint involvement, skin changes, haematological abnormalities, and fatigue in a young woman — SLE until excluded. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/rheumatoid-arthritis https://labreadai.com/en/posts/rheumatoid-arthritis Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Rheumatoid arthritis: early joint symptoms, blood tests including anti-CCP and RF, modern treatment with DMARDs and biologics, and long-term disease prognosis. Articles article Morning stiffness that takes more than an hour to ease. Swollen, tender knuckles — symmetrically, both hands. This is not "just tiredness" or wear-and-tear arthritis: this picture is the classic onset of rheumatoid arthritis. The disease affects roughly 1% of the world's population and is three times more common in women than men. The earlier the diagnosis, the greater the chance of preserving joint function for decades to come. This article covers everything essential: symptoms, diagnostic tests, and treatment. What Is Rheumatoid Arthritis and How It Develops Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the synovial lining of joints. The synovium — a thin membrane that produces lubricating fluid — becomes inflamed, thickens, and begins to proliferate. The result is a structure called pannus: aggressive inflammatory tissue that literally erodes cartilage and the underlying bone. Without treatment, RA leads to irreversible joint destruction within a few years. The key mechanism: citrullination of synovial proteins triggers an autoimmune response — the immune system begins producing antibodies against its own tissues. This process can start years before the first symptoms appear: anti-CCP antibodies and rheumatoid factor may already be positive in the blood while the joints still look and feel normal. The precise cause of RA is unknown. Identified risk factors include female sex (oestrogens modulate immune regulation), genetic susceptibility (HLA-DRB1 variants), smoking (the strongest modifiable risk factor — it doubles or triples RA risk), and chronic periodontal disease. The "silent" phase — from antibody appearance to first symptoms — can span 5–10 years. RA is not confined to joints. In systemic disease, the lungs (interstitial pneumonitis), blood vessels (rheumatoid vasculitis), pericardium, eyes (episcleritis), and peripheral nerves are all potential targets. Systemic manifestations correlate with high antibody titres and aggressive disease course. Early Symptoms of Rheumatoid Arthritis Recognising RA early is challenging: the disease disguises itself well. Between first symptoms and diagnosis, an average of 6–12 months passes — and this time is not harmless. Early bone erosions begin forming within the first months of active synovitis. Morning stiffness is the most characteristic early sign. Joints need at least 30–60 minutes — often longer than an hour — to loosen up. This duration distinguishes inflammatory arthritis from mechanical osteoarthritis, where stiffness resolves within a few minutes. Symmetrical involvement of small joints is the second hallmark. The classic pattern: the metacarpophalangeal and proximal interphalangeal joints of the hands, and the metatarsophalangeal joints of the feet. Distal interphalangeal joints (closest to the fingertips) are typically spared in RA — a clinically useful distinguishing feature. Swelling and tenderness on palpation — joints are visibly puffy, warm to touch, and painful when pressed. Unlike gout, the pain in RA is constant rather than arriving in acute attacks. Systemic symptoms — fatigue, low-grade fever (37.0–37.5°C), weight loss, reduced appetite — frequently precede joint involvement by weeks. This is systemic inflammation, not simply "joint pain." Symptoms requiring prompt attention. Progressive symptoms for more than six weeks without obvious trauma, viral illness, or another identifiable cause; firm subcutaneous nodules over the elbows, occiput, or sacrum; persistent joint swelling unresponsive to standard pain relief. Diagnosis of Rheumatoid Arthritis: Which Tests Are Needed The diagnosis of RA is established against a composite of clinical, laboratory, and imaging findings under the ACR/EULAR 2010 classification criteria. No single test is sufficient. A complete blood count is the first step. In active RA: normochromic or mildly hypochromic anaemia (anaemia of chronic disease), thrombocytosis, mild or normal leucocytosis, and elevated ESR (above 40–50 mm/h in high disease activity) are the expected pattern. Serological markers are the backbone of laboratory diagnosis. Anti-CCP antibodies have a specificity above 95% for RA and may appear years before clinical manifestations. Rheumatoid factor is less specific but, when combined with positive anti-CCP, the probability of RA exceeds 95%. Inflammatory markers. C-reactive protein and ESR reflect current inflammatory activity and are used to assess treatment response and monitor remission. Normalisation of CRP and ESR on therapy is a reliable indicator of remission. Imaging. Plain radiographs of the hands and feet are the standard for initial diagnosis and monitoring of structural damage. However, early erosions are not visible on X-ray: MRI and joint ultrasound detect synovitis and erosions 2–3 years before radiographic changes appear. In early arthritis (under six months), MRI is the preferred imaging modality. Reference Values and Interpretation of RA Blood Tests Serological results are always interpreted alongside the clinical picture — isolated elevated markers without symptoms are not sufficient for diagnosis. Marker Normal Significance in RA ----------------------------------- Anti-CCP < 17 U/mL 17 positive; 200 U/mL strongly positive Rheumatoid factor < 14 IU/mL 14 positive; 100 IU/mL high titre CRP < 5 mg/L In active RA: 20–100 mg/L or higher ESR < 20 mm/h women, < 15 mm/h men In active RA: 40–80 mm/h Disease activity is quantified using the DAS28 (Disease Activity Score in 28 joints) and SDAI indices, which aggregate tender and swollen joint counts, ESR or CRP, and the patient's global assessment. These are the rheumatologist's standard working tools: remission, low, moderate, or high activity — each category has specific numerical thresholds. Seronegative RA — approximately 20–30% of patients have negative anti-CCP and RF despite a clinically convincing picture. In these cases diagnosis rests on clinical criteria, imaging findings, and exclusion of other arthropathies. Seronegative disease is not necessarily milder: a subset of these patients experiences significant joint destruction. Treatment of Rheumatoid Arthritis: Modern Approaches The goal of RA treatment is remission or low disease activity. This is not aspirational: with timely therapy, remission is achieved in 40–60% of patients. Treat-to-target strategy — the current standard of care. Disease activity is assessed every 1–3 months; if the target is not met within 3–6 months, the treatment regimen is changed. Delaying therapy escalation is the single most common reason for progressive joint destruction. Conventional synthetic DMARDs (csDMARDs) — the foundation of treatment. Methotrexate is the "gold standard" first-line agent: it reduces disease activity, slows joint destruction, and is well tolerated at appropriate doses. Mandatory co-prescription of folic acid reduces the incidence of side effects. In cases of contraindication or intolerance: leflunomide or sulfasalazine. Biological DMARDs are added when response to csDMARDs is insufficient. TNF-α inhibitors (adalimumab, etanercept, infliximab), IL-6 inhibitors (tocilizumab), B-cell depleting agents (rituximab). They reduce disease activity in most patients refractory to conventional therapy. JAK inhibitors (tofacitinib, baricitinib, upadacitinib) — oral targeted synthetic DMARDs. Comparable in efficacy to biologics, convenient to administer. NSAIDs (ibuprofen, naproxen, diclofenac) — symptomatic relief of pain and stiffness. They do not modify disease progression and are not disease-modifying agents. Long-term use requires gastric protection with a proton pump inhibitor. Glucocorticoids (prednisolone) — used in low doses as a bridge while awaiting DMARD effect and during flares. Prolonged high-dose use is avoided due to cumulative side effects. Complications and Comorbidities RA is a systemic disease with a broad spectrum of extra-articular manifestations and comorbid conditions. Osteoporosis is one of the most common complications. Chronic inflammation, reduced mobility, and glucocorticoid use together deplete bone mineral density. Patients with RA receiving glucocorticoids should have baseline densitometry and receive prophylactic calcium and vitamin D. Cardiovascular disease. Chronic systemic inflammation in RA accelerates atherogenesis — the risk of myocardial infarction and stroke is roughly twice that of the general population. This is comparable to the cardiovascular risk conferred by metabolic syndrome, which is why cardiovascular risk reduction (blood pressure, lipids, smoking cessation) is formally part of RA management. Differential diagnosis of RA includes several conditions with overlapping presentations. Systemic lupus erythematosus (SLE) — an autoimmune disease with joint involvement, the characteristic facial butterfly rash, and specific antibodies (anti-dsDNA). Psoriatic arthritis — joint inflammation in psoriasis, often affecting distal joints and nails. Gout — crystal arthritis caused by urate deposition, presenting with acute attacks predominantly affecting the first metatarsophalangeal joint. Interstitial lung disease develops in 10–20% of patients with long-standing RA and high antibody titres. Exertional breathlessness and dry cough in a patient with RA are a reason for immediate pulmonary investigation. When to See a Doctor Urgently In established or suspected RA, seek emergency care or call emergency services immediately if: - Sudden severe swelling, redness, and intense pain in a single large joint (knee, elbow, ankle) — possible septic arthritis or crystal arthropathy, requiring urgent aspiration and treatment. - Progressive breathlessness and cough in a patient with RA taking methotrexate — methotrexate-induced pneumonitis must be excluded promptly. - High fever (above 38.5°C) on biologic therapy — risk of severe infection; immunosuppression masks classical infective signs. - First-ever morning stiffness lasting more than 30 minutes with symmetrical small-joint involvement persisting for more than six weeks — the "window of opportunity" for early therapy is open; delay in rheumatology referral directly affects long-term prognosis. - Marked increase in pain and structural progression on current therapy — indication for treatment escalation or regimen change. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/thyroid-cancer https://labreadai.com/en/posts/thyroid-cancer Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Thyroid cancer: types of tumour, symptoms, blood markers including calcitonin and CEA, treatment options, and 10-year survival rates by cancer type. Articles article An ultrasound found a thyroid nodule. Or the doctor said "suspicious" and ordered a biopsy. Or a calcitonin test came back elevated. Thyroid cancer is one of the most heterogeneous groups of malignant diseases: some forms carry a 10-year survival above 95%, others are among the most aggressive tumours in oncology. Understanding the difference matters. This article covers the types of thyroid cancer, their symptoms, relevant blood tests, and treatment approaches. Types of Thyroid Cancer and How They Differ The thyroid gland contains two fundamentally different cell populations — follicular thyrocytes (which produce thyroxine and triiodothyronine) and parafollicular C-cells (which produce calcitonin). Three types of cancer arise from thyrocytes; one type from C-cells. This is not merely a classification exercise: the cell of origin determines the tumour's behaviour, its sensitivity to treatment, and the patient's prognosis. Papillary thyroid cancer — the most common, comprising 80–85% of all cases. It grows slowly, metastasises predominantly to cervical lymph nodes, and rarely to lungs or bones. It readily absorbs radioactive iodine — making radioiodine therapy highly effective. Prognosis is excellent: the 10-year survival rate for localised disease exceeds 98%. Follicular thyroid cancer — approximately 10–15%. Less likely to spread via lymphatics but prone to haematogenous dissemination: bone and lung metastases. Also sensitive to radioiodine. Prognosis is good when detected early; substantially worse with distant metastases. Medullary thyroid cancer — about 5–10%. It arises from C-cells, does not absorb iodine, and does not respond to radioiodine therapy. Approximately 25% of cases are hereditary, linked to RET gene mutations. It frequently occurs as part of MEN-2A syndrome (combined with phaeochromocytoma and hyperparathyroidism) or MEN-2B. Prognosis is moderate: 10-year survival around 75%. Anaplastic thyroid cancer — fewer than 2% of cases, but the most aggressive. Cells lose all differentiation; the tumour grows explosively. Median survival is 3–5 months. It occurs almost exclusively in patients over 60, frequently arising from a long-standing papillary or follicular cancer. Type Proportion Cell of Origin Radioiodine 10-Year Survival -------------------------------------------------------------- Papillary 80–85% Thyrocyte Yes 98% (localised) Follicular 10–15% Thyrocyte Yes 85–95% Medullary 5–10% C-cell No 75% Anaplastic < 2% Thyrocyte No < 10% Symptoms of Thyroid Cancer: When to Suspect It The paradox of thyroid cancer is that most early forms produce no symptoms at all. Tumours are discovered incidentally: on routine neck ultrasound, during workup for another condition, or when the patient notices a lump while touching their throat. A thyroid nodule is the most common initial finding. The critical point: the vast majority of thyroid nodules are benign. Population studies show nodules in 20–40% of adults on ultrasound, yet only 5–15% prove malignant. Nevertheless, every newly identified nodule requires assessment of cancer risk. Features that raise suspicion for malignancy: rapid growth over weeks or months; a hard, "stony" consistency on palpation; fixation to surrounding tissues (does not move on swallowing); enlarged cervical lymph nodes; age below 20 or above 60; male sex (nodules are less frequent in men but more often malignant); family history of thyroid cancer or MEN syndrome. Symptoms of local spread appear with large or invasive tumours: hoarseness (recurrent laryngeal nerve involvement), difficulty swallowing, breathing difficulty, neck pain radiating to the ear. These symptoms indicate locally advanced disease and require urgent oncological assessment. Systemic symptoms are unusual in early thyroid cancer. In medullary cancer, excess calcitonin secretion occasionally causes diarrhoea — one of the rare paraneoplastic manifestations. In hyperthyroidism associated with a functionally active cancer (rare, seen in some follicular cancers), tachycardia, weight loss, and sweating may be the presenting features. Diagnosing Thyroid Cancer: Tests and Methods Diagnosis combines imaging and laboratory testing. Neither alone provides a complete answer. Thyroid ultrasound is the first and essential investigation for any suspected thyroid malignancy. It evaluates nodule characteristics using the TIRADS system (Thyroid Imaging Reporting and Data System): echogenicity, shape, margins, presence of microcalcifications, and vascularity. High-risk nodules (TIRADS 4–5) are referred for biopsy regardless of size. Fine-needle aspiration biopsy (FNAB) — the primary method for obtaining tissue. Performed under ultrasound guidance, cells are aspirated with a fine needle for cytological examination. The Bethesda System classification (categories I–VI) determines subsequent management: from observation to immediate surgery. Laboratory testing. TSH is the primary hormonal test. Its level helps assess thyroid function and provides indirect information about nodule type: functionally active ("hot") nodules are rarely malignant. A complete hormonal assessment uses the thyroid panel — TSH, free T4, and anti-TPO antibodies when indicated. Tumour markers in thyroid cancer are used selectively. Thyroglobulin (Tg) is a marker for papillary and follicular cancer. It is poorly informative diagnostically (elevated in many benign conditions) but indispensable for post-operative surveillance: after total thyroidectomy, Tg should be undetectable. Any rise in Tg post-operatively is a signal of recurrence or metastasis. Molecular-genetic testing of biopsy material is used in diagnostically indeterminate cytological categories (Bethesda III–IV): analysis of BRAF V600E, RET/PTC, RAS, and other mutations helps clarify malignancy before surgery. Calcitonin and CEA: Markers for Medullary Thyroid Cancer Medullary cancer is the only type of thyroid malignancy with highly specific biochemical blood markers. This makes it simultaneously one of the best-diagnosable and best-monitorable forms of the disease. Calcitonin is the primary marker. C-cells — the origin of medullary cancer — retain the ability to secrete calcitonin in large quantities. A calcitonin level above 100 pg/mL in an adult is highly suspicious; above 500 pg/mL, the probability of medullary cancer approaches 100%. This is why European guidelines recommend measuring calcitonin in all patients with thyroid nodules before biopsy or surgical decision-making. CEA (carcinoembryonic antigen) is the second marker for medullary cancer. It is less specific (rises in many cancers) but within the context of medullary disease its role is significant. The relative dynamics of calcitonin and CEA carry prognostic weight: when CEA rises faster than calcitonin, this indicates tumour dedifferentiation — a sign of more aggressive behaviour. Post-operative monitoring in medullary cancer: after total thyroidectomy, both calcitonin and CEA should fall to undetectable levels. Persistently detectable calcitonin indicates incomplete tumour removal or occult metastases. Rising values on serial measurements over months are an indication for imaging to search for recurrence (neck and chest CT, MRI, scintigraphy). For carriers of hereditary RET gene mutations (familial medullary cancer, MEN-2 syndromes), prophylactic thyroidectomy is recommended before cancer develops — in childhood or early adulthood depending on the specific mutation. This is the only type of thyroid cancer in which genetic testing of relatives is mandatory. Treatment of Thyroid Cancer Surgery is the cornerstone of treatment for all types of thyroid cancer. The extent of the operation depends on tumour type, size, and the presence of metastases. Thyroidectomy (removal of the entire gland) is the standard for medullary cancer, anaplastic cancer, and most intermediate- and high-risk papillary and follicular cancers. For low-risk papillary cancer (tumour under 1 cm, no evidence of spread), hemithyroidectomy — removal of one lobe — is sometimes sufficient. Radioiodine therapy (I-131) is used after total thyroidectomy for papillary and follicular cancer. Residual thyroid cells and metastases absorb the radioactive iodine and are destroyed from within. Efficacy is high: in most patients it eliminates microscopic metastases completely. TSH-suppressive thyroxine therapy. After thyroidectomy, the patient takes L-thyroxine lifelong — not only as replacement therapy for hypothyroidism but also to suppress TSH to subnormal levels. TSH drives thyrocyte proliferation (including in tumour cells), so its suppression reduces recurrence risk in differentiated cancer. Targeted therapy. For metastatic medullary cancer — tyrosine kinase inhibitors (vandetanib, cabozantinib) targeting RET and other molecular drivers. For progressive refractory papillary cancer — lenvatinib, sorafenib. For anaplastic cancer harbouring the BRAF V600E mutation — the combination of dabrafenib and trametinib. External beam radiotherapy is used in medullary and anaplastic cancer, and for local recurrence in differentiated cancer patients. Prognosis and Life After Thyroid Surgery Most patients with papillary and follicular thyroid cancer live a normal lifespan. The five-year survival rate for localised papillary cancer approaches 100% — a figure better than virtually any other malignancy. After total thyroidectomy, lifelong replacement therapy is required: with the gland removed, hypothyroidism is inevitable. Dose titration of L-thyroxine takes a few weeks, after which quality of life is generally indistinguishable from normal. A possible surgical complication is hypoparathyroidism: during thyroid removal, the blood supply to the parathyroid glands may be compromised. This causes low blood calcium — numbness, muscle cramps, and spasms in the hands and feet. It is managed with calcium supplements and vitamin D. Long-term surveillance for differentiated cancer includes: thyroglobulin and anti-Tg antibodies every 6–12 months; neck ultrasound annually for the first 3–5 years; I-131 scintigraphy if thyroglobulin rises. Recurrence risk is greatest in the first five years; after a 10-year disease-free period it is minimal. When to See a Doctor Urgently Seek prompt medical attention if: - Calcitonin measured during a thyroid nodule workup exceeds 100 pg/mL — the threshold for high oncological concern; urgent endocrinology-oncology consultation is required. - A neck mass is growing visibly over weeks: rapid growth is one of the primary red flags for malignancy. - Hoarseness appears without a preceding cold or vocal strain — a possible sign of recurrent laryngeal nerve involvement by a growing tumour. - Progressive difficulty swallowing or breathing develops alongside neck enlargement. - Family history: a first-degree relative with medullary thyroid cancer or MEN-2 syndrome — an indication for prophylactic genetic testing and calcitonin measurement even without any symptoms. - After thyroid surgery, thyroglobulin or calcitonin begins rising on serial measurements — a possible sign of recurrence. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/what-does-blood-test-show https://labreadai.com/en/posts/what-does-blood-test-show Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) What does a blood test show: CBC, biochemistry, hormones, lipids, tumour markers and vitamins — a guide to every major panel, normal ranges and abnormal results. Articles article A sheet of numbers, upward and downward arrows, and cryptic abbreviations — that is what a blood test result looks like to most patients. What does it actually tell a doctor, and how are those figures connected to health and disease? This article is a comprehensive breakdown of all the main categories of blood tests, from a routine full blood count to tumour markers. Before taking any of them, correct preparation matters — detailed rules are covered in the blood test preparation guide. Complete Blood Count: Cells, Haemoglobin and Immune Signals The complete blood count (CBC) is the most widely ordered investigation in medicine. It evaluates three cellular lines and provides an initial snapshot of the whole body's condition. Red cells and haemoglobin. Haemoglobin is the oxygen-carrying protein inside red cells. Its fall — anaemia — presents as fatigue, pallor, and breathlessness. Normal range: 130–170 g/L in men, 120–160 g/L in women. MCV — mean red cell volume — is the critical differentiator: small cells point to iron deficiency; large cells to vitamin B12 or folate deficiency. This is the first step in the differential diagnosis of iron deficiency anaemia and other forms. White blood cells. Leukocytes are the cells of immune defence. An elevated count signals infection, inflammation, stress, or leukaemia; a low count indicates bone marrow suppression, severe viral illness, or a drug side effect. Normal range: 4–9 × 10⁹/L. The differential count (extended CBC) clarifies which cells are affected: neutrophils in bacterial infection, lymphocytes in viral illness, eosinophils in allergy and parasitic disease. Platelets. Platelets carry out primary haemostasis — the first seal on a damaged vessel. A count below 100 × 10⁹/L raises a bleeding risk; a fall below 20–30 × 10⁹/L carries the threat of spontaneous haemorrhage. Elevated platelets often accompany inflammatory conditions or iron deficiency. A single CBC does not establish a diagnosis — it points in a direction. Low haemoglobin, small red cells, and a high platelet count together almost certainly mean iron deficiency; simultaneously low counts across all three lines (anaemia, leucopenia, thrombocytopenia) is a signal to investigate the bone marrow. Biochemistry Panel: Liver, Kidneys and Metabolism Biochemistry is the principal tool for assessing organ function. It is ordered in virtually every chronic disease workup. Liver function tests. The liver function test panel measures several markers with distinct clinical meanings. ALT and AST are enzymes that "leak" from damaged hepatocytes into the blood — their elevation marks active liver cell destruction in hepatitis, fatty liver disease, or drug-induced injury. GGT is particularly sensitive to alcohol and cholestasis; bilirubin reflects haemoglobin processing and bile flow; albumin measures the liver's synthetic capacity — its ability to produce proteins. Albumin below 30 g/L indicates severe hepatic failure or major systemic inflammation. Kidney function markers. The kidney function test includes creatinine and urea. Creatinine is a waste product of muscle metabolism cleared by the kidneys: its accumulation indicates falling glomerular filtration rate (GFR). GFR — calculated from creatinine — is the primary staging marker for chronic kidney disease. Urea is less specific and is influenced by diet and tissue breakdown, but in combination with creatinine it helps track renal function over time. Glucose. Glucose in a biochemistry panel screens for diabetes and prediabetes. Normal fasting value: below 5.6 mmol/L. Values of 5.6–6.9 indicate prediabetes; 7.0 or above on two measurements meets the diagnostic threshold for diabetes. Glucose is interpreted alongside C-peptide — which quantifies the pancreas's residual insulin output — when differentiating type 1 from type 2 diabetes is clinically necessary. Hormone Tests: Thyroid, Diabetes and Reproductive Health Hormones regulate metabolism, reproduction, growth, and stress responses. Their abnormalities produce symptoms that frequently mimic other diseases — from fatigue to depression. Thyroid hormones. The thyroid panel — TSH, free T4, and where indicated free T3 with antibodies — is the essential set for diagnosing thyroid dysfunction. TSH is the most sensitive marker: its elevation means the pituitary is signalling the thyroid to work harder — a sign of hypothyroidism. A suppressed TSH indicates a hyperactive gland. Free T4 clarifies whether hormone levels are genuinely low (primary hypothyroidism) or the problem lies in the pituitary (secondary). For thyroid nodules, calcitonin is always added — the marker of medullary thyroid cancer. Sex hormones and adrenal markers. The hormone panel covers FSH, LH, oestradiol, testosterone, progesterone, and prolactin. It is ordered for menstrual irregularities, infertility, menopausal symptoms, and hypogonadism. Every hormone has a strict dependency on the time of day and day of the cycle — results can only be interpreted with these parameters accounted for. Some conditions require simultaneous assessment of multiple systems: polycystic ovary syndrome combines an FSH/LH imbalance with insulin resistance, so sex hormones and fasting insulin are measured together. Lipid Panel: Cholesterol and Cardiovascular Risk Cardiovascular disease is the leading cause of death worldwide, and its primary laboratory predictor is a disturbed lipid profile. The lipid panel provides four key measurements. Total cholesterol is the sum of all lipoprotein fractions — meaningful only in context. "Bad" LDL deposits in arterial walls and is the main treatment target: its goal level ranges from < 3.0 to < 1.4 mmol/L depending on individual cardiovascular risk. "Good" HDL carries cholesterol back to the liver — a protective factor; its fall below 1.0 mmol/L in men is independently hazardous. Triglycerides are neutral blood fats; a rise above 5.6 mmol/L sharply elevates the risk of acute pancreatitis. A disturbed lipid profile is the primary laboratory marker of atherosclerosis. This is why a lipid panel is recommended as a screening test for all adults over 40, and tested every 3–6 months in patients on statin therapy to monitor treatment effectiveness. Inflammation, Autoimmunity and Thrombosis Markers This group of tests is critical for diagnosing systemic processes and thrombotic complications. Inflammatory markers. C-reactive protein is a fast and accurate marker of active inflammation — responding within 6–12 hours. ESR is a slower, indirect marker that normalises weeks after recovery. Both rise in infections, autoimmune diseases, malignancies, and after trauma. A persistently elevated ESR without an established cause warrants targeted investigation — covered in detail in the elevated ESR article. When rheumatoid arthritis is suspected, rheumatoid factor and anti-CCP antibodies are added to CRP and ESR. Coagulation and thrombosis markers. The coagulation panel assesses the overall haemostatic system. Fibrinogen is simultaneously an acute-phase protein and the raw material for clot formation: its sustained elevation is an independent cardiovascular risk factor. D-dimer is a product of fibrin breakdown — its rise indicates active clot formation somewhere in the circulation. A normal D-dimer at low pre-test probability virtually excludes pulmonary embolism. Cardiac markers. Troponin is the primary marker of cardiomyocyte death: its rise within 1–3 hours of chest pain onset is the criterion for acute myocardial infarction. A normal high-sensitivity troponin at 3 hours from symptom onset has a high negative predictive value for ruling out infarction. Tumour Markers, Vitamins and Electrolytes Tumour markers. The tumour marker panel is not a population screening tool: most tumour markers rise in benign conditions and lack sufficient specificity for independent diagnosis. The exception is calcitonin: its elevation above 100 pg/mL in the setting of thyroid nodules is highly specific for medullary thyroid cancer and requires immediate oncological evaluation. Tumour markers are primarily used for post-treatment surveillance, not initial cancer detection. Vitamins and micronutrients. The vitamin panel covers both fat-soluble and water-soluble vitamins. Vitamin D deficiency affects 50–80% of people in northern latitudes and is associated with immune impairment, osteoporosis, and muscle weakness; the optimal level is above 75 nmol/L. Vitamin B12 is essential for the nervous system and red cell production: its deficiency in vegetarians and older adults often presents as depression or early cognitive decline. Ferritin — the body's iron storage protein — falls long before haemoglobin drops and is the first marker of latent iron deficiency. The full iron panel is ordered when a more complete assessment of iron status is needed. Electrolytes. The electrolyte panel measures sodium, potassium, chloride, and bicarbonate. Calcium governs neuromuscular transmission and bone density: its fall causes cramps and tetany; its rise causes weakness and cardiac arrhythmias. Sodium determines the body's water balance: a critical fall below 125 mmol/L can lead to cerebral oedema. Potassium controls cardiac rhythm: values above 6.5 or below 2.5 mmol/L threaten life-threatening arrhythmias and require emergency correction. When Blood Test Results Need Urgent Medical Attention Most abnormal results warrant a planned consultation — not immediate alarm. But certain values require emergency action. Call emergency services immediately if: glucose exceeds 16 mmol/L or falls below 2.5 mmol/L on a fasting sample — possible hypoglycaemic shock or diabetic ketoacidosis; in patients with type 2 diabetes these thresholds should be stored in memory; troponin is elevated with chest pain — a sign of acute infarction; potassium falls below 2.5 or exceeds 6.5 mmol/L — imminent cardiac arrest risk; haemoglobin falls below 70 g/L — severe anaemia often requiring hospitalisation; fibrinogen drops below 1.0 g/L in the setting of active bleeding — DIC syndrome; calcitonin exceeds 100 pg/mL with a thyroid nodule — urgent oncology referral. A planned consultation is indicated when: any marker is consistently outside the reference range on two or more successive tests; a result has changed substantially from a previous value despite correct preparation; a serological test (rheumatoid factor, anti-CCP antibodies, tumour markers) returns strongly positive — a single test never establishes a diagnosis; it requires clinical interpretation. Blood tests are a physician's tool. Understanding their language is useful. Interpreting them without clinical context is dangerous. The same number in two different patients can mean two entirely different things. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/anti-ccp https://labreadai.com/en/indicators/anti-ccp Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Anti-CCP blood test: reference ranges, causes of elevated results, and why anti-CCP is more specific than rheumatoid factor for early arthritis detection. Indicators article Your joints are swollen and stiff — and your doctor ordered an "anti-CCP" test. The name may sound unfamiliar, but it represents one of the most accurate immunological markers in rheumatology. Unlike many other blood tests, anti-CCP antibodies can detect rheumatoid arthritis years before visible joint changes appear. Let's walk through what this test measures, what the reference ranges are, and when a positive result genuinely matters. What Are Anti-CCP Antibodies and Why Is This Test Ordered Citrulline is an amino acid produced inside cells when arginine undergoes post-translational modification. Under normal conditions this is a quiet, unremarkable process. In rheumatoid arthritis, protein metabolism in the synovial lining of joints is disrupted: citrullinated proteins accumulate abnormally, and the immune system begins treating them as foreign. In response it produces anti-cyclic citrullinated peptide antibodies (anti-CCP, also called ACPA) — and this is exactly what the test measures. The clinical importance of this discovery is hard to overstate: anti-CCP antibodies appear in the blood 3–5 years before the first clinical symptoms of arthritis emerge. This makes anti-CCP the primary tool for early diagnosis and one of the official classification criteria of the American College of Rheumatology (ACR/EULAR 2010) for rheumatoid arthritis. The test is ordered when a patient has: pain, stiffness, and symmetrical swelling of joints — especially small ones in the hands and feet; suspected rheumatoid arthritis with a negative or borderline rheumatoid factor; monitoring of disease activity during treatment; and differential diagnosis of inflammatory arthropathies. Anti-CCP is frequently ordered alongside a complete blood count to assess the broader inflammatory picture. How to Prepare for an Anti-CCP Test Blood is collected from a vein, typically in the morning. Compared with acute-phase inflammatory markers, anti-CCP levels are relatively stable and less sensitive to short-term fluctuations — but standard preparation still applies. Fasting: blood should be drawn after an 8-hour fast. Water is unrestricted. A fatty meal the evening before may affect serum quality. Physical activity: avoid strenuous exercise in the 24 hours before the test. Physical stress activates immune responses and may marginally affect results. Medications: immunosuppressants (methotrexate, leflunomide, biologics) reliably lower anti-CCP levels — this is part of how they work. For initial diagnostic testing, clarify medication timing with your doctor. For monitoring on established treatment, blood is drawn under routine conditions. Infections: acute viral illness has minimal impact on anti-CCP — unlike rheumatoid factor, which is more sensitive to infectious stimuli. For a planned test during a severe respiratory illness, postponing 2–3 weeks is reasonable. Method: the assay uses second-generation ELISA, which detects antibodies against a broad panel of citrullinated proteins rather than a single peptide. This delivers sensitivity of approximately 70–75% for rheumatoid arthritis at a specificity exceeding 95%. Results are typically ready within 1–3 business days. Anti-CCP Normal Range: Reference Values Units and cutoff values may differ slightly between laboratories and test generations. The table below reflects the most widely used thresholds — always follow the reference range on your own report. Result Value (U/mL) Interpretation ------------------------------------- Negative < 17 Normal, anti-CCP not detected Weakly positive 17–50 Borderline zone, needs clarification Moderately positive 50–200 High probability of autoimmune arthritis Strongly positive 200 Very high specificity for RA The standard cutoff in most laboratories is 17 U/mL (some systems use 20 U/mL). Beyond the threshold, what matters most is the degree of elevation: values above 200 U/mL in a symptomatic patient point strongly to rheumatoid arthritis. Reference values are not adjusted for sex or age. Anti-CCP is rarely tested in children except in the context of juvenile idiopathic arthritis, using the same reference range. After treatment is started, anti-CCP levels decline gradually — a process that takes months to years. A sustained fall in anti-CCP is a good prognostic sign; persistently elevated levels on therapy suggest inadequate disease control. Causes of Elevated Anti-CCP Antibodies The primary and most clinically significant cause is rheumatoid arthritis. With a specificity above 95%, a positive result almost always reflects RA as the underlying condition. A high anti-CCP level in RA correlates with more rapid joint destruction, bone erosion, and severe systemic manifestations — making the result relevant not only for diagnosis but for prognostication. The intensity of the inflammatory process is simultaneously reflected by C-reactive protein: a rise in both anti-CCP and CRP is a classic pattern in active rheumatoid arthritis or other inflammatory arthropathies. Other causes of anti-CCP positivity are considerably rarer: - Other inflammatory arthropathies: anti-CCP is positive in approximately 5–10% of systemic lupus patients and even less often in psoriatic arthritis. Positivity in these conditions does not exclude coexisting RA. - Chronic lung disease: silicosis and certain interstitial pneumonias. Citrullination of lung proteins can trigger anti-CCP production without any joint involvement — the so-called "pulmonary" pathway of RA autoimmunity initiation. - Chronic infections: pulmonary tuberculosis rarely produces weakly positive results through cross-reactivity with bacterial antigens. False-positive results for anti-CCP are substantially less frequent than for rheumatoid factor — this is precisely what gives the test its diagnostic value. Negative Anti-CCP With Joint Symptoms: What to Do Next A normal anti-CCP level does not rule out rheumatoid arthritis. Seronegative forms of the disease — in which neither anti-CCP nor rheumatoid factor is detected — account for approximately 20–30% of all RA cases. Disease activity and risk of joint destruction in seronegative patients can be just as high as in seropositive RA. When the test is negative but symptoms are convincing (swelling, stiffness, symmetrical involvement of small joints), the diagnostic workup continues: - Excluding other inflammatory arthropathies: psoriatic arthritis, ankylosing spondylitis, reactive arthritis, gout. - Joint ultrasound — detects synovitis and tenosynovitis at a stage when X-ray is still normal. - MRI — the most sensitive method for early bone erosions. - Synovial biopsy — reserved for diagnostically challenging cases. Rheumatoid arthritis is diagnosed against a composite of ACR/EULAR 2010 criteria — laboratory data are one part of the overall clinical picture. Anti-CCP vs Rheumatoid Factor: Key Differences Both markers are used in the diagnosis of rheumatoid arthritis — but they work differently. Rheumatoid factor is an older and less specific test: it rises in many conditions, including chronic infections, liver disease, and normal ageing. Feature Anti-CCP Rheumatoid Factor -------------------------------------- Sensitivity for RA 70–75% 70–80% Specificity for RA 95% 80–85% Detectable before symptoms 3–5 years 1–2 years False positives Rare Common (infections, age) Correlation with activity Weak Moderate Prognostic value High Moderate When both tests are simultaneously positive, the probability of rheumatoid arthritis exceeds 95% — the most convincing serological pattern possible. This is exactly why both are ordered together: they complement rather than duplicate each other. In patients with early undifferentiated arthritis, anti-CCP is the strongest predictor of progression to full-blown RA. A positive result signals high risk of deterioration and supports the case for early initiation of disease-modifying therapy. When to See a Doctor Prompt evaluation by a rheumatologist or GP is warranted when: - Anti-CCP is significantly elevated — especially above 100–200 U/mL. - Elevated anti-CCP is accompanied by joint swelling, pain, and morning stiffness lasting more than 30 minutes. - Both anti-CCP and rheumatoid factor are positive simultaneously — the most specific serological combination for RA. - Symmetrical involvement of small hand or foot joints is present — the hallmark pattern of early RA. - Symptoms are progressing over weeks, are unrelated to injury, and do not resolve with rest. Delaying treatment carries real consequences: irreversible joint changes begin forming within the first 6–12 months of disease. Early use of disease-modifying antirheumatic drugs (DMARDs) or biologic therapy can halt this process — especially when anti-CCP is high, signalling a more aggressive disease course. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/anti-dsdna https://labreadai.com/en/indicators/anti-dsdna Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Anti-dsDNA antibodies — the most specific blood marker for systemic lupus erythematosus: reference ranges, causes of elevation, link to lupus nephritis and disease monitoring. Indicators article You have been ordered a test for "anti-double-stranded DNA antibodies" — and you are wondering why the immune system would attack its own DNA. That is exactly what happens in systemic lupus erythematosus (SLE): the immune system mistakenly produces antibodies against the double-stranded DNA of cell nuclei. Anti-dsDNA is one of the few serological markers in immunology that combines high specificity for a single disease with genuine prognostic value. This article explains what the test shows, what the reference ranges mean, and when a result requires urgent attention. What Are Anti-dsDNA Antibodies and Why Are They Tested Double-stranded DNA (dsDNA) is the core molecule of every living cell. Under normal circumstances the immune system does not react to the body's own DNA — tolerance mechanisms prevent autoantibody production. In systemic lupus erythematosus these mechanisms break down: apoptotic cells release nuclear material which, under the influence of UV radiation or viral infections, is recognised by the immune system as "foreign." Antibodies directed against nuclear components — including dsDNA — are produced in response. Anti-dsDNA antibodies are pathogenically dangerous: they form immune complexes with DNA that deposit in renal glomeruli, vessel walls, and joint synovium — activating complement-mediated inflammation at each site. This is the direct mechanism of lupus nephritis development. The clinical value of the test is defined by two properties. Specificity: anti-dsDNA is detected almost exclusively in SLE — specificity exceeds 95%, making it one of the most accurate tests in autoimmune diagnostics. Correlation with activity: unlike most autoantibodies, anti-dsDNA levels track disease activity — rising with flares and falling in remission. This makes the test useful not only for diagnosis but for longitudinal monitoring. The test is ordered for: confirming the diagnosis when ANA is positive; suspected SLE based on clinical presentation; monitoring disease activity in established SLE; and assessing the risk of flares and lupus nephritis. How to Prepare for an Anti-dsDNA Test Blood is drawn from a vein, typically in the morning. The test is relatively robust against short-term external factors, but a few rules matter. Fasting: the last meal should be at least 8 hours before the blood draw. Fatty food alters the optical properties of serum, which may affect immunofluorescence-based detection methods. Immunosuppressive medications: glucocorticoids and cytotoxic agents lower anti-dsDNA titres — this reflects their therapeutic effect. For initial diagnostic testing, clarify with your doctor whether a temporary pause is appropriate. For monitoring — blood is drawn on current therapy. Acute infections: they can transiently influence the immune background. For a planned test, postpone until 2–3 weeks after recovery from any acute illness. Methods: immunofluorescence on Crithidia luciliae cells (the high-specificity gold standard), ELISA (more widely available, slightly less specific), and chemiluminescence immunoassay. Different methods produce different numerical ranges — direct comparison of results from different laboratories is not valid. Anti-dsDNA Normal Range: Reference Values Reference ranges differ between methods and laboratories. The values below are the most widely used benchmarks — always follow the range on your own report. Result Value Interpretation ------------------------------- Negative < 10 IU/mL (ELISA) Normal Weakly positive 10–25 IU/mL Borderline — needs clarification Moderately positive 25–100 IU/mL Suspicion for SLE; high clinical vigilance Strongly positive 100 IU/mL Highly specific for SLE; risk of active nephritis Several clinically important nuances. A negative anti-dsDNA does not exclude SLE: approximately 30–40% of patients with confirmed disease have a negative or weakly positive result. In these cases diagnosis is established on the composite of clinical and other serological data — anti-Sm antibodies, anti-Ro/SS-A, complement levels. A positive anti-dsDNA without SLE symptoms warrants monitoring: some such individuals develop overt disease within years, and early identification improves outcomes. The anti-dsDNA titre is not the sole activity marker. A simultaneous fall in complement C3 and C4 together with rising anti-dsDNA is a far more convincing sign of an impending flare than either value alone. Causes of Elevated Anti-dsDNA Systemic lupus erythematosus is the primary and practically the only clinically significant cause of substantially elevated anti-dsDNA. With specificity above 95%, a strongly positive result identifies SLE in 9 of 10 cases. Anti-dsDNA levels in SLE are dynamic. A doubling or greater rise from baseline is one of the earliest predictors of a flare, anticipating clinical symptoms by 4–8 weeks. The strongest correlation is with lupus nephritis activity: high anti-dsDNA in a patient with proteinuria and rising CRP is an indication for kidney biopsy. Other autoimmune diseases. Weakly positive values (typically within 10–25 IU/mL) can occur in Sjögren's syndrome, mixed connective tissue disease, and chronic active autoimmune hepatitis. These findings are generally low-titre and unaccompanied by complement consumption. Drug-induced lupus — a distinct condition triggered by certain medications (hydralazine, procainamide, isoniazid, some biologics). It often produces positive ANA, but anti-dsDNA — unlike idiopathic SLE — is usually negative or weakly positive. Chronic infections — hepatitis B and C, HIV — may produce weakly positive results through non-specific polyclonal B-cell activation. These levels rarely reach the range characteristic of SLE. Anti-dsDNA vs ANA: Differences and Combined Use ANA (antinuclear antibodies) is a screening test that detects antibodies against any nuclear component. High sensitivity (95–99% in SLE) but low specificity: ANA is positive in 5–15% of healthy people and in dozens of autoimmune and infectious conditions. Anti-dsDNA is a confirmatory test: evaluated after a positive ANA to verify an SLE diagnosis. Its high specificity ( 95%) compensates for lower sensitivity. Feature ANA Anti-dsDNA -------------------------- Sensitivity in SLE 95–99% 60–70% Specificity in SLE 57–65% 95% Correlation with activity Weak High Role Screening Confirmation + monitoring The algorithm: negative ANA → SLE is unlikely (rare exceptions exist). Positive ANA → extended panel including anti-dsDNA. High anti-dsDNA → high probability of SLE; evaluate against EULAR/ACR 2019 criteria. The complete blood count with differential is always examined in parallel — leucopenia, lymphopenia, and anaemia in SLE are independent diagnostic criteria. Monitoring Anti-dsDNA During SLE Treatment Anti-dsDNA is one of the principal tools for assessing treatment effectiveness and detecting flares early. With successful therapy, the titre gradually falls — a marker of remission. Persistently elevated levels on immunosuppression indicate inadequate disease control. Monitoring frequency: every 1–3 months in active disease; every 6 months in stable remission. Complement C3 and C4, a complete blood count, and a urine test for proteinuria are always assessed in parallel. Dynamic anti-dsDNA monitoring allows therapy to be intensified before a clinical flare develops — one of the principal strategies for reducing cumulative organ damage in SLE. When to See a Doctor Urgently Immediate rheumatology consultation is required when: - Anti-dsDNA is markedly elevated ( 100 IU/mL) on initial testing — combined with clinical symptoms, this is a high probability of SLE requiring prompt treatment. - In known SLE, anti-dsDNA rises sharply compared with the previous value — a likely approaching flare; pre-emptive therapy adjustment reduces organ damage risk. - High anti-dsDNA is accompanied by proteinuria, rising creatinine, or oedema — signs of active lupus nephritis requiring kidney biopsy. - Simultaneous falls in C3 and C4 alongside rising anti-dsDNA — the classic laboratory signature of an impending nephritis flare. - Anti-dsDNA is weakly positive but rising on successive serial measurements — rheumatology follow-up is mandatory: some of these patients develop overt SLE within 1–3 years. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/c-peptide https://labreadai.com/en/indicators/c-peptide Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) C-peptide blood test: reference ranges for adults, causes of high and low results, how it differs from insulin, and what it shows in type 1 and type 2 diabetes. Indicators article Your doctor ordered a C-peptide test — and you are not quite sure how it differs from a regular insulin level or why a separate test is needed. C-peptide is one of the most informative markers for assessing pancreatic function: it reveals exactly how much insulin your own body is producing, even if you are already receiving insulin injections. This article explains what C-peptide is, what the reference ranges mean, and when abnormal results require action. What Is C-Peptide and Why Is It Measured Separately from Insulin When pancreatic beta cells synthesise insulin, they first produce a precursor molecule called proinsulin. Proinsulin is a chain made of three segments: the A-chain, the B-chain, and the C-peptide (connecting peptide) that links them. Before secretion into the bloodstream, the enzyme protease cleaves proinsulin: the A- and B-chains join via disulphide bridges to form active insulin, while C-peptide is released as a separate molecule into the circulation. The critical property of C-peptide is that it is secreted in equimolar amounts with insulin at every pancreatic release. Measuring C-peptide therefore tells us precisely how much endogenous (self-produced) insulin the pancreas has generated. Why not simply measure insulin? Three reasons make C-peptide the preferred marker. First: the liver extracts around 50% of insulin on first pass — peripheral blood concentrations reflect only the remainder. C-peptide is barely absorbed by the liver and is cleared more slowly, making its level more stable and a more accurate reflection of beta-cell secretory activity. Second: in patients receiving exogenous insulin injections, endogenous and injected insulin are indistinguishable — but C-peptide is purely endogenous, as synthetic insulin contains none. Third: insulin assays are subject to interference from anti-insulin antibodies, which are frequently present in type 1 diabetes. The test is ordered for: differential diagnosis of type 1 versus type 2 diabetes; assessment of residual beta-cell function during insulin therapy; suspected insulinoma (an insulin-secreting pancreatic tumour); factitious hypoglycaemia; and monitoring after pancreatic or islet cell transplantation. How to Prepare for a C-Peptide Test Blood is drawn from a vein, typically in the morning. C-peptide is sensitive to food intake and other factors — accurate results depend substantially on correct preparation. Fasting: strictly required — no food for 8–12 hours. A carbohydrate load triggers insulin and C-peptide release; eating before the test will falsely elevate the basal result. Physical activity: avoid strenuous exercise for 24 hours beforehand. Physical stress influences counter-regulatory hormones (cortisol, adrenaline), which indirectly alter C-peptide levels. Stimulation test: for a more complete assessment of pancreatic reserve, a glucagon stimulation test is used — C-peptide is measured before and six minutes after intravenous glucagon. Stimulated C-peptide is considerably more informative than the basal value: it reveals the maximum secretory capacity of beta cells. The test is performed in an endocrinology clinic or inpatient setting. Medications: sulphonylureas (glibenclamide, glimepiride) stimulate insulin secretion and raise C-peptide. Exogenous insulin does not directly affect C-peptide but suppresses endogenous secretion via feedback. Clarify medication timing with your doctor before testing. Method: immunochemiluminescence assay (ICLA) or ELISA. Results are available within 1–2 business days. C-Peptide Normal Range: Reference Values Basal (fasting) C-peptide reference values are the same for men and women. Minor differences between laboratories reflect different analyser generations — always use the range on your own report. State Basal C-Peptide Notes ------------------------------ Normal (fasting) 0.9–7.1 ng/mL (298–2350 pmol/L) Same for both sexes After glucagon stimulation 1.8 ng/mL Threshold for adequate beta-cell reserve Type 1 diabetes at onset < 0.2 ng/mL Near-complete beta-cell failure Type 2 diabetes Normal or elevated Depends on stage and treatment Clinical thresholds: - < 0.2 ng/mL — critically low: severe insulin deficiency; absolute indication for insulin therapy in diabetes. - 0.2–0.9 ng/mL — reduced: partial beta-cell preservation or early depletion. - 0.9–7.1 ng/mL — normal: adequate beta-cell function. - 7.1 ng/mL — elevated: hyperinsulinism; differential diagnosis of insulinoma, obesity, and type 2 diabetes. Causes of Elevated C-Peptide High C-peptide means the pancreas is producing excess insulin. Causes are varied. Early type 2 diabetes and insulin resistance. In insulin resistance, body cells respond weakly to insulin — the pancreas compensates by increasing production. C-peptide is elevated while blood glucose may still be normal or borderline. This pre-diabetic stage, once identified, offers a window for prevention. Obesity. Visceral fat tissue releases pro-inflammatory cytokines that impair insulin signalling. The mechanism is the same: compensatory hyperinsulinaemia with correspondingly high C-peptide. Insulinoma. A tumour of pancreatic beta cells that autonomously secretes insulin regardless of blood glucose. Clinically it presents as fasting hypoglycaemia relieved by eating sugar. C-peptide is significantly elevated simultaneously with hypoglycaemia — this is the key diagnostic pattern. When insulinoma is suspected, insulin and C-peptide are always measured during the hypoglycaemic episode. Sulphonylurea medications. Patients taking these drugs will have elevated C-peptide — an expected pharmacological effect, not a pathological finding. Gestational diabetes. In gestational diabetes, placental hormone-driven insulin resistance triggers compensatory C-peptide elevation. Monitoring C-peptide during pregnancy helps assess whether the mother's pancreas is coping with the increased demand. Causes of Low C-Peptide Low C-peptide always signals inadequate beta-cell function. Clinical significance depends on the degree of reduction. Type 1 diabetes. Autoimmune destruction of beta cells is the primary cause of critically low C-peptide. In type 1 diabetes, the immune system produces antibodies against beta cells and progressively destroys them. At disease onset, C-peptide falls below 0.2 ng/mL and becomes essentially undetectable thereafter. Measuring C-peptide allows clinicians to distinguish type 1 from type 2 diabetes — a distinction that is critical for treatment planning. LADA (latent autoimmune diabetes in adults). A slowly progressive form of autoimmune diabetes that initially resembles type 2 clinically but has an immunological basis. C-peptide in LADA declines gradually over years — unlike the rapid fall in classic type 1 diabetes. Identifying LADA matters because these patients will ultimately require insulin therapy. Long-standing decompensated type 2 diabetes. Chronic beta-cell overload leads to gradual depletion — C-peptide falls over the course of the disease. When C-peptide drops below 0.5 ng/mL in type 2 diabetes, oral agents lose effectiveness and insulin is needed. Hypoglycaemia from exogenous insulin. Low C-peptide during hypoglycaemia is direct evidence that the episode was caused by exogenously administered insulin — factitious or iatrogenic — rather than insulinoma. In insulinoma, C-peptide during hypoglycaemia is invariably high. Chronic pancreatitis and pancreatectomy. Inflammatory destruction or surgical removal of the pancreas destroys beta cells — C-peptide falls proportionally to the tissue lost. C-Peptide in Diabetes: Practical Significance C-peptide is one of the endocrinologist's most useful tools in diabetes care. For differential diagnosis: C-peptide differentiates type 1 from type 2 diabetes and identifies LADA — directly influencing management. Type 1 requires insulin from day one; type 2 treatment is escalated stepwise, with insulin introduced only when oral therapy is exhausted. For insulin timing decisions: in type 2 diabetes patients already on oral medications, a C-peptide below 0.5 ng/mL is a clear signal that the pancreatic reserve is depleted and insulin should be added. For monitoring the honeymoon period: in newly diagnosed type 1 diabetes, a partial remission phase often follows the start of insulin therapy — C-peptide temporarily rises above zero. Monitoring C-peptide tracks the duration and end of this window. For transplant monitoring: after pancreatic or islet cell transplantation, a rising C-peptide is the first sign of graft survival and functional recovery. When to See a Doctor Prompt endocrinology consultation is warranted when: - C-peptide is below 0.2 ng/mL — especially in young, non-obese patients: type 1 diabetes or LADA is likely, requiring immediate insulin therapy. - High C-peptide is accompanied by episodes of loss of consciousness, sweating, or tremor when fasting — insulinoma is possible; urgent evaluation with pancreatic MRI is needed. - In type 2 diabetes, C-peptide is declining progressively on oral therapy — an indication to reassess treatment and likely initiate insulin. - C-peptide is markedly elevated alongside normal or low blood glucose — the classic pattern of insulinoma, requiring further investigation. - In prediabetes, C-peptide is above normal — a sign of active insulin resistance; timely lifestyle intervention can prevent progression to full type 2 diabetes. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/calcitonin https://labreadai.com/en/indicators/calcitonin Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Calcitonin blood test: normal ranges for men and women, why elevated calcitonin points to medullary thyroid cancer, and when to see a doctor urgently. Indicators article You had thyroid hormone tests done — and the report includes calcitonin with an upward arrow. Or your doctor ordered it before a planned thyroid procedure. Either way the same question arises: what does it mean? Calcitonin is one of the few hormones that simultaneously regulates calcium metabolism and serves as a highly specific tumour marker. This article explains what it measures, what the reference ranges are, and why an elevated result must not be overlooked. What Is Calcitonin and What Does It Do Calcitonin is produced by parafollicular C-cells of the thyroid gland — a small population of cells scattered among the follicular thyrocytes. Unlike thyroxine and triiodothyronine, calcitonin does not depend on TSH: it is regulated directly by blood calcium levels. When calcium rises, calcitonin secretion increases in response. Physiologically, calcitonin lowers blood calcium by inhibiting osteoclast-mediated bone resorption and increasing urinary calcium excretion. In clinical practice this function has limited importance — even complete calcitonin deficiency after total thyroidectomy does not cause meaningful disturbance of calcium metabolism in adults. The main reason calcitonin is measured clinically is entirely different: thyroid C-cells are the origin of medullary thyroid carcinoma, and the tumour retains the ability to secrete calcitonin in large quantities. This makes calcitonin a sensitive and specific tumour marker — one of the few in endocrinology with genuine diagnostic value. The test is ordered for: thyroid nodules before biopsy or surgery; suspected medullary thyroid cancer on ultrasound or cytology; hereditary MEN-2 syndromes (multiple endocrine neoplasia); post-operative surveillance after medullary thyroid cancer surgery; and family history of medullary thyroid cancer or phaeochromocytoma. How to Prepare for a Calcitonin Test Blood is drawn from a vein, preferably in the morning. Calcitonin levels are sensitive to several physiological factors — ignoring preparation requirements can produce falsely elevated results and unnecessary anxiety. Fasting: strictly required — no food for at least 8–12 hours. Even a light meal stimulates calcitonin secretion via a gastrin-dependent mechanism and can raise the result 1.5–2 fold. Smoking: nicotine stimulates calcitonin secretion. Refrain from smoking for at least 2 hours before the blood draw — ideally from the evening before. Physical activity and stress: avoid intense exercise for 24 hours. Acute physical or emotional stress activates the sympathetic nervous system and can transiently elevate calcitonin. Medications: proton pump inhibitors (omeprazole, pantoprazole), pentagastrin, and calcium supplements affect calcitonin levels. Discuss temporary discontinuation with your doctor before a planned test. Stimulation test: in diagnostically challenging cases, an intravenous calcium or pentagastrin stimulation test is used. Stimulated calcitonin is far more sensitive than the basal value — particularly for early-stage medullary cancer and carriers of RET mutations. This test is performed only in specialist inpatient settings. The assay uses immunochemiluminescence (ICLA) or electrochemiluminescence (ECLA). Results are ready within 1–2 business days. Calcitonin Normal Range: Reference Values Calcitonin reference ranges differ substantially between men and women — one of the few situations in laboratory diagnostics where sex is critically important. Different analyser generations and reagents also produce slightly different thresholds; always use the range on your own report. Group Basal Calcitonin Borderline Zone Significantly Elevated ----------------------------------------------------------------- Men < 9.52 pg/mL 9.52–100 pg/mL 100 pg/mL Women < 6.4 pg/mL 6.4–30 pg/mL 30 pg/mL Infants under 6 months up to 40 pg/mL — 100 pg/mL The borderline zone deserves a separate note. A result in the range of 10–100 pg/mL in men or 6–30 pg/mL in women does not automatically indicate cancer: such values occur in C-cell hyperplasia (a benign condition), chronic kidney disease, and neuroendocrine tumours of other origins. A stimulation test and repeat measurement in follow-up are the standard approach in this zone. Values above 100 pg/mL in an adult — regardless of sex — are considered highly suspicious for medullary thyroid carcinoma and require immediate oncological evaluation. At levels above 500 pg/mL the probability of medullary cancer approaches 100%. After successful surgery for medullary thyroid cancer, calcitonin should fall to undetectable levels. Persistent elevation or renewed rise on follow-up measurement indicates residual disease, recurrence, or metastases. Calcitonin as a Tumour Marker for Medullary Thyroid Cancer Medullary thyroid carcinoma accounts for approximately 5–10% of all thyroid malignancies but follows a more aggressive course than papillary or follicular types. Around 25% of cases are linked to inherited RET gene mutations — these patients often present as part of MEN-2A or MEN-2B syndromes, in which medullary cancer is combined with phaeochromocytoma and hyperparathyroidism. The key distinction of calcitonin from most tumour markers is its high specificity. PSA, for example, rises with any prostate inflammation and is not a strict marker of malignancy. Calcitonin, by contrast, rises almost exclusively in C-cell pathology — giving it a diagnostic precision that is rare among oncological markers. In a comprehensive workup for suspected thyroid malignancy, calcitonin is assessed alongside CEA — carcinoembryonic antigen, also secreted by medullary cancer cells. Simultaneous elevation of both markers is a characteristic combination confirming the diagnosis. The ratio between the two carries prognostic weight: rapid CEA growth while calcitonin stabilises may indicate tumour dedifferentiation. For a complete thyroid hormonal workup, calcitonin is included in the extended thyroid panel. The standard panel (TSH, T4, T3) does not include calcitonin — it is added specifically when nodular lesions are present. In 2022 the European Society of Endocrinology recommended routine calcitonin measurement in all patients with thyroid nodules before biopsy or surgery decisions. This enables detection of medullary cancer at an early stage — when surgical outcomes are best. Non-Oncological Causes of Elevated Calcitonin Elevated calcitonin does not always mean cancer. The list of benign causes is substantial, and a clinician will always consider these before initiating extended oncological evaluation. C-cell hyperplasia. A benign increase in C-cell numbers — often a precursor to medullary cancer in RET mutation carriers, but in most patients a stable finding. Calcitonin is mildly elevated, and the stimulation test may be positive. Requires dynamic monitoring. Chronic kidney disease. The kidneys participate in calcitonin clearance. As glomerular filtration rate declines, the hormone accumulates — often reaching borderline values. Neuroendocrine tumours of other sites. Certain lung, pancreatic, and intestinal carcinoids can ectopically secrete calcitonin. Levels are usually moderately elevated. Acute conditions: severe sepsis, acute pancreatitis, and extensive burns produce reactive calcitonin elevation — sometimes reaching 100–200 pg/mL. This is an acute-phase response unrelated to oncology. Autoimmune thyroiditis during flares can produce mild elevation, likely from inflammatory stimulation of C-cells. Physiological factors: pregnancy and lactation are accompanied by expected calcitonin rises as part of calcium metabolism adaptation. Low Calcitonin: When Is It a Problem A result of "below normal" or "undetectable" is common — particularly in women, where the basal level may fall below the analyser detection threshold. This is not pathological. After total thyroidectomy, calcitonin becomes undetectable: the gland is removed, C-cells are gone. This is the expected and desirable outcome when monitoring after medullary thyroid cancer surgery. Clinically significant calcitonin deficiency is extremely rare and does not typically require treatment — unlike deficiency of TSH-regulated thyroid hormones. When to See a Doctor Prompt evaluation by an endocrinologist or oncologist is required when: - Calcitonin exceeds 100 pg/mL in an adult under any conditions — the threshold for high oncological concern. - Elevated calcitonin is found alongside a thyroid nodule on ultrasound — the combination warrants urgent biopsy and oncology consultation. - The result exceeds 500 pg/mL — the probability of medullary cancer is critically high; hospitalisation and staging workup are needed. - Calcitonin is rising on serial measurements — even if absolute values are moderate, the trend matters more than any single result. - Family history includes medullary thyroid cancer, phaeochromocytoma, or MEN-2 syndrome — planned screening is mandatory even without symptoms. - Calcitonin fails to fall to zero after thyroid surgery — a sign of incomplete tumour removal or early recurrence. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/fibrinogen https://labreadai.com/en/indicators/fibrinogen Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Fibrinogen blood test: normal ranges for adults and in pregnancy, causes of high and low results, role in blood clotting, and when to see a doctor. Indicators article You had a clotting screen done — and fibrinogen comes back above the reference range. Or, unexpectedly, it is too low. This protein sits at the very centre of the coagulation system: without it, even a minor cut would not stop bleeding. Yet when fibrinogen is too high, it becomes a threat itself — raising the risk of thrombosis and cardiovascular events. This article explains what the test measures, what the reference ranges mean, and when an abnormal result genuinely demands attention. What Is Fibrinogen and Its Role in Haemostasis Think of the coagulation system as an emergency repair crew: when a blood vessel is damaged, the crew rushes to the site, stops the leak, and patches the wall. Fibrinogen is the building material for the final patch. Under the action of the enzyme thrombin it converts into fibrin — insoluble protein strands that form the scaffold of the clot and seal the damage firmly. Fibrinogen is synthesised exclusively in the liver and circulates continuously in dissolved form in blood plasma. Beyond its clotting role, it is an acute-phase protein: any infection, trauma, surgery, or tissue necrosis sharply raises its production — a protective mechanism that prepares the body for possible blood loss. The fibrinogen test is part of the standard coagulation panel and is ordered for: surgical or obstetric pre-assessment; suspected clotting disorder; thrombotic risk evaluation; diagnosis and monitoring of disseminated intravascular coagulation (DIC); and chronic inflammatory or autoimmune disease. How to Prepare for a Fibrinogen Test Blood is drawn from a vein, preferably in the morning, and the test is typically part of a full coagulation screen. Failing to follow preparation steps can meaningfully distort results in either direction. Fasting: strictly required — no food for at least 12 hours. Fatty food directly affects plasma rheology and can falsely elevate fibrinogen. Physical activity and stress: avoid intense exercise for 24 hours beforehand. Acute physical stress activates the coagulation system as an adaptive response, producing a transient rise in fibrinogen. Medications: anticoagulants (warfarin, heparin, rivaroxaban), oral contraceptives, and hormone therapy directly influence coagulation parameters. Do not stop any medication without medical advice — always inform the laboratory about any drug that affects clotting. Tourniquet: the phlebotomist should apply the tourniquet for the minimum time necessary. Prolonged venous compression activates local fibrinolysis and can falsely lower the result. Method: the assay uses the Clauss method (kinetic coagulometric) — the gold standard for measuring functional fibrinogen. Results are available within hours as part of the full coagulation panel. Fibrinogen Normal Range: Reference Values The reference interval for adults is essentially the same in men and women outside of pregnancy. Substantial physiological changes occur only during pregnancy — covered in a dedicated section below. Group Fibrinogen Normal Range Notes -------------------------------------- Adults 18–60 years 2.0–4.0 g/L Same for both sexes Adults over 60 2.0–4.5 g/L Mild physiological rise Newborns 1.25–3.0 g/L Lower than adult range Threshold values that require attention: - < 1.0 g/L — critically low: high risk of non-coagulable haemorrhage; urgent assessment needed. - 5.0 g/L — significantly elevated: acute-phase response or thrombotic risk. - 8.0 g/L — marked hyperfibrinogenaemia: typically severe inflammation or malignancy. Fibrinogen is never interpreted in isolation. It forms part of the broader coagulation picture — together with prothrombin time, APTT, and thrombin time — and only the composite result yields a clinically meaningful conclusion. Causes of Elevated Fibrinogen High fibrinogen is one of the most common incidental findings in routine blood work. Causes fall into physiological and pathological categories. Acute-phase response. Any infection, trauma, surgical procedure, or tissue necrosis triggers hepatic synthesis of acute-phase proteins — primarily fibrinogen and C-reactive protein. In severe sepsis or major surgery fibrinogen may reach 8–10 g/L; this is a protective reaction, not a haemostatic disorder. Chronic inflammatory diseases. In rheumatoid arthritis, inflammatory bowel disease, and autoimmune hepatitis, fibrinogen remains persistently elevated alongside ESR and C-reactive protein. Thrombotic conditions. In thrombophilia — hereditary or acquired tendency to clotting — elevated fibrinogen acts simultaneously as a marker and a risk factor. Patients with established deep vein thrombosis almost invariably show levels well above the reference range. Cardiovascular disease. Large epidemiological studies show that a fibrinogen level above 3.5 g/L independently raises the risk of myocardial infarction and stroke. In chest pain assessment, fibrinogen forms part of the acute coronary syndrome panel alongside troponin and D-dimer. Metabolic disorders. Obesity, type 2 diabetes, and metabolic syndrome are accompanied by chronically elevated fibrinogen as part of the systemic pro-inflammatory state these conditions produce. Smoking. Nicotine stimulates hepatic fibrinogen synthesis. Smokers' fibrinogen levels average 0.5–1.0 g/L higher than non-smokers', even without other risk factors. Malignancies. Many cancers produce pro-inflammatory cytokines that drive hepatic fibrinogen production. Persistently elevated fibrinogen without an obvious cause warrants oncological screening. Causes of Low Fibrinogen: Hypofibrinogenaemia Low fibrinogen is far less common than elevation, but it carries a more immediately dangerous implication — the risk of uncontrolled haemorrhage. Disseminated intravascular coagulation (DIC) is the most dangerous cause. In severe sepsis, obstetric emergencies (placental abruption, amniotic fluid embolism), or massive trauma, the coagulation system activates throughout the circulation and consumes all available fibrinogen. Levels fall below 1 g/L, producing a paradox: clots form in small vessels simultaneously with uncontrollable bleeding from large ones. Severe liver disease. Fibrinogen is synthesised only by hepatocytes. In end-stage liver cirrhosis, synthesis falls sharply. Low fibrinogen is one of the markers of hepatic failure. Primary fibrinolysis. In certain conditions (prostate cancer, acute promyelocytic leukaemia) the fibrinolytic system activates pathologically and destroys fibrinogen faster than the liver can produce it. Hereditary afibrinogenaemia and hypofibrinogenaemia are rare genetic defects causing absent or critically low fibrinogen synthesis. They present with severe bleeding from early childhood. Thrombolytic therapy. Administration of streptokinase, alteplase, or other thrombolytics in myocardial infarction or thromboembolism deliberately lowers fibrinogen — an expected and monitored treatment effect. Fibrinogen in Pregnancy: Trimester Reference Ranges Pregnancy is the only physiological state in which fibrinogen levels routinely exceed the standard adult range. This is not pathology: the body deliberately raises coagulation readiness in preparation for possible blood loss during delivery. Trimester Fibrinogen Normal Range Notes ------------------------------------------ First trimester 2.4–5.1 g/L Rise begins Second trimester 2.9–5.4 g/L Moderate elevation Third trimester 3.7–6.2 g/L Peak before delivery Post-partum 2.0–4.0 g/L Returns to baseline within 3–5 days A fall below 2.0 g/L at any stage of pregnancy is an alarm signal: it may indicate early DIC, placental abruption, or severe pre-eclampsia — all obstetric emergencies requiring immediate hospitalisation. A rise above 7.0 g/L in any trimester also warrants investigation: such levels are associated with thromboembolic complications, which remain a leading cause of maternal mortality in high-income countries. When to See a Doctor Prompt medical evaluation — or emergency care — is warranted when: - Fibrinogen is below 1.0 g/L — critical risk of uncontrollable haemorrhage, especially before surgery or in the third trimester. - Fibrinogen is falling on serial measurements during severe infection or after surgery — possible early DIC. - Fibrinogen is markedly elevated ( 6 g/L) combined with breathlessness, leg pain, or chest discomfort — a clinical picture consistent with pulmonary embolism, a life-threatening condition. - During pregnancy, fibrinogen falls below 2.0 g/L or exceeds 7.0 g/L — immediate obstetric assessment is needed. - Fibrinogen remains persistently above 5.0 g/L for months without a clear inflammatory cause — indication for comprehensive workup including cancer screening. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/indicators/rheumatoid-factor https://labreadai.com/en/indicators/rheumatoid-factor Sun, 29 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Rheumatoid factor blood test: what elevated RF means, normal ranges for women and men, causes of false-positive results, and when to see a rheumatologist. Indicators article You get your blood test results back and spot "rheumatoid factor" flagged as high. The word "autoimmune" is already in your search bar — and the worry sets in quickly. Don't jump to conclusions: an elevated RF does not always mean disease, and in many cases this value rises even in completely healthy people. This article covers what rheumatoid factor is, the reference ranges, what a high result actually indicates, and when you need to see a rheumatologist urgently. What Is Rheumatoid Factor and Why Is It Tested Think of the immune system as a precisely calibrated radar: in health it targets foreign threats while leaving the body's own tissue untouched. In some conditions this calibration fails — and the radar starts firing at friendly targets. Rheumatoid factor (RF) consists of IgM antibodies that the immune system mistakenly produces against its own IgG immunoglobulins. In effect, one class of protective proteins attacks another. RF was first described in 1940 by Norwegian researcher Erik Waaler and has since become one of the core assays in rheumatology and immunology. The test is ordered when a patient has: joint pain, swelling, or stiffness — particularly on waking; symmetrical involvement of small hand and foot joints; signs of systemic inflammation (fever, fatigue, weight loss); or suspected connective tissue autoimmune disease. RF is often ordered alongside a complete blood count to assess leukocyte and platelet levels and check for anaemia, which frequently accompanies inflammatory conditions. A positive RF most commonly points to rheumatoid arthritis — the most prevalent chronic inflammatory joint disease. However, it is not a definitive diagnostic test: the result must always be interpreted in the context of clinical findings and other investigations. RF is not a population screening test. Ordering it in people without joint symptoms leads to a high rate of false-positive results and unnecessary anxiety. How to Prepare for a Rheumatoid Factor Test Blood is drawn from a vein, typically the antecubital fossa. Preparation is straightforward, but a few steps matter for an accurate result. When to go: ideally in the morning, between 7 and 11 am. Fast for at least 8–12 hours beforehand — a full meal can affect the rheological properties of serum and reduce the accuracy of immunological tests. Drinking water is fine. 24 hours before the test: avoid strenuous exercise and alcohol. If you are acutely unwell or have been vaccinated within the past 2–3 weeks, let your doctor know — this can temporarily elevate the result. Medications: certain immunosuppressants (methotrexate, prednisolone, hydroxychloroquine) and NSAIDs can lower RF levels. Do not stop any medication without medical advice — ask your doctor whether a temporary pause is needed before testing. Testing methods: modern laboratories use latex agglutination (semi-quantitative), nephelometry, immunoturbidimetry (both quantitative), and ELISA. Different methods use different units and cutoff values, which is why results from different laboratories should not be directly compared without checking the method used. Results are typically available within 1–2 business days. Rheumatoid Factor Normal Range: Reference Values Most laboratories apply a single reference range for all adults regardless of sex. Minor differences between labs reflect different methods and reagents — always use the range printed on your own report. Group RF Normal Range Notes ------------------------------ Adults 18–65 < 14 IU/mL Sex-independent Children under 12 < 12.5 IU/mL Rarely tested in paediatrics Adults over 65 Up to 20 IU/mL Mild elevation may be physiologically normal The clinical significance of an elevated RF is graded by level: - 14–50 IU/mL — weakly positive. May be physiological or infection-related; needs clarification. - 50–100 IU/mL — moderately positive. Raises suspicion of autoimmune inflammation; comprehensive workup indicated. - 100 IU/mL — strongly positive. Significant autoimmune involvement, most often rheumatoid arthritis or another systemic disease. The reference range is a probability boundary, not an absolute threshold. A value of 15 IU/mL with no symptoms requires no treatment; 12 IU/mL in the setting of active synovitis absolutely does. Causes of Elevated Rheumatoid Factor An elevated RF is a signal for investigation, not a diagnosis. Causes fall into two distinct categories. Autoimmune and Inflammatory Conditions The most common and clinically significant cause is rheumatoid arthritis: 70–80% of patients test positive, even in early disease. High RF in RA correlates with a more aggressive disease course and a greater risk of joint destruction. Other conditions associated with elevated RF include Sjögren's syndrome (75–95% positivity — among the highest rates of any condition), systemic lupus erythematosus, mixed connective tissue disease, systemic sclerosis, dermatomyositis, and antiphospholipid syndrome. Autoimmune activity is consistently confirmed by a parallel rise in C-reactive protein — an acute-phase marker that reflects the intensity of the current inflammatory process. Non-Autoimmune Causes Chronic infections can produce moderate or even significant RF elevation. This is not an immune error but a normal response to prolonged antigenic stimulation. The most frequent infectious causes are viral hepatitis B and C, tuberculosis, infective endocarditis, and chronic Lyme disease. Non-infectious, non-autoimmune causes include chronic lung disease (chronic bronchitis, sarcoidosis), liver cirrhosis, and haematological malignancies (lymphomas, chronic lymphocytic leukaemia). ESR is also elevated in these settings, and comparing it with RF and C-reactive protein helps clinicians decide which diagnostic direction to pursue. Negative Rheumatoid Factor: Seronegative Arthritis In 20–30% of patients with confirmed rheumatoid arthritis, RF remains within the normal range. This is called seronegative disease — it follows the same clinical course as classic RA but is invisible to the RF test. The underlying reason is often genetic: certain HLA-DRB1 gene variants are associated with a tendency toward seronegative disease. In these patients joint inflammation can be just as active as in seropositive RA, and in some cases even more destructive. This is where anti-cyclic citrullinated peptide antibodies (anti-CCP) become critical. The test is considerably more specific for rheumatoid arthritis and can detect the disease in seronegative cases. In some patients, anti-CCP turns positive years before clinical symptoms appear — allowing early intervention. A negative RF with no symptoms is simply normal. If joint symptoms are present, a normal result does not exclude disease, and further diagnostic workup should continue. False-Positive RF: When the Result Does Not Mean Arthritis False-positive results are one of the main sources of anxiety for patients who discover elevated RF during a routine health screen. Age. In people over 65, a mild elevation (up to 15–25 IU/mL) occurs in 10–25% of individuals without any underlying disease. This reflects normal age-related changes in immune regulation. Recent infections and vaccination. An acute viral illness or vaccination within 2–3 weeks before testing temporarily activates the immune system and can produce a mild RF elevation, which typically resolves after recovery. Pregnancy. Normal immune changes during pregnancy are sometimes reflected in false-positive immunological tests, including RF. Other chronic conditions. Haematological malignancies, primary biliary cirrhosis, and sarcoidosis can all raise RF without any joint involvement. A single elevated RF cannot support a diagnosis. The clinician will always correlate the result with symptoms, physical examination findings, additional blood tests, and imaging. When to See a Doctor Prompt evaluation by a GP or rheumatologist is warranted when: - RF exceeds the upper limit of normal by a factor of 3 or more ( 42 IU/mL when the cutoff is 14 IU/mL). - Elevated RF is accompanied by joint swelling, pain, and morning stiffness lasting more than 30–60 minutes. - C-reactive protein and ESR are simultaneously elevated — a pattern of active systemic inflammation requiring prompt diagnosis. - Symptoms extend beyond joints: persistent dry eyes and mouth, a butterfly-shaped facial rash, hair loss, or unrelenting fatigue and weight loss. - Several small joints of the hands or feet are symmetrically affected — particularly in women aged 30–50. Early treatment is critical: for rheumatoid arthritis, therapy initiated within the first 3–6 months of symptom onset can prevent irreversible cartilage and bone destruction. Delaying by 6–12 months significantly worsens long-term prognosis. This article is for informational purposes only and does not replace medical consultation. Result interpretation and diagnosis are made by a qualified physician. https://labreadai.com/en/posts/chronic-kidney-disease https://labreadai.com/en/posts/chronic-kidney-disease Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) What chronic kidney disease is and how to determine its stage by GFR and urine protein. Causes, symptoms, diet and CKD treatment — and when a nephrologist's consultation is needed. Articles article Kidneys do not hurt — until 70–80% of their function has been lost. This is precisely what makes chronic kidney disease (CKD) so dangerous: it develops over years, progresses without symptoms, and is frequently discovered incidentally — on a routine blood or urine test. This article explains what CKD is, how it is diagnosed by stage, which tests are needed, how to slow its progression, and when urgent nephrology consultation is required. What Is Chronic Kidney Disease and How Is It Defined Chronic kidney disease is a sustained reduction in kidney function or the presence of markers of kidney damage for three or more months. The three-month criterion is fundamental: a single low GFR or proteinuria result is not yet CKD — the changes must be persistent. Two key diagnostic markers: GFR (glomerular filtration rate) — the volume of blood the kidneys filter per minute. Calculated from blood creatinine using the CKD-EPI formula, adjusted for age, sex, and race. Normal is above 90 mL/min/1.73 m². Albuminuria / proteinuria — the presence of protein in urine. Healthy kidneys do not allow protein through. Persistent proteinuria is one of the earliest and most sensitive markers of glomerular filter damage. CKD is diagnosed when at least one of these markers is present over three months. Importantly, a normal GFR does not exclude CKD — if persistent proteinuria or structural kidney changes (on ultrasound) are present, the diagnosis is valid. CKD Stages: GFR and Albuminuria Classification The international KDIGO classification divides CKD into five GFR stages and three albuminuria categories — their combination determines the risk of progression and cardiovascular complications. Stage GFR (mL/min/1.73 m²) Description --------- G1 ≥ 90 Normal or high GFR + damage marker G2 60–89 Mildly reduced + damage marker G3a 45–59 Mildly to moderately reduced G3b 30–44 Moderately to severely reduced G4 15–29 Severely reduced G5 < 15 Kidney failure (end-stage) Albuminuria categories: A1 — normal or mildly increased (< 30 mg/g), A2 — moderately increased (30–300 mg/g, microalbuminuria), A3 — severely increased ( 300 mg/g, macroalbuminuria). The combination of stage and category creates a risk colour map: green — low, yellow — moderate, orange — high, red — very high. A patient classified G3b A3 faces very high risk of progression and cardiovascular events. Causes of Chronic Kidney Disease Any chronic condition that damages kidney tissue can lead to CKD. Two causes dominate by a wide margin: Type 2 diabetes — the most common cause of CKD worldwide. Diabetic nephropathy develops in 30–40% of patients with long-standing diabetes. Chronically elevated glucose damages the glomerular endothelium and basement membrane — first microalbuminuria appears, then proteinuria, then GFR declines. In diabetes, testing the albumin-to-creatinine ratio in urine annually is essential — it allows nephropathy to be caught at a stage when it is still reversible. Hypertension — the second most common cause. Chronically elevated blood pressure damages the afferent arterioles of the glomeruli, increases intraglomerular pressure, and leads to nephron loss. Keeping blood pressure below 130/80 mmHg is one of the most important measures for slowing CKD. Other causes: chronic glomerulonephritis (autoimmune glomerular disease), chronic pyelonephritis and other interstitial nephritides, polycystic kidney disease (hereditary), systemic diseases (systemic lupus erythematosus, amyloidosis, vasculitis), long-term nephrotoxic drug use (NSAIDs, certain antibiotics, contrast agents), and urolithiasis with chronic obstruction. Symptoms of CKD: Why They Are Absent for So Long At stages G1–G3 (GFR above 30), CKD produces virtually no symptoms — there are still enough functioning nephrons to compensate. Symptoms appear gradually as GFR falls. Early signs (frequently dismissed): - Nocturia — increased night-time urination (kidneys losing concentrating ability) - Morning puffiness — particularly periorbital - Rising blood pressure without another explanation - Unexplained fatigue At GFR 15–30 (stage G4): - Significant ankle and leg oedema - Anaemia (kidneys reduce erythropoietin production) - Increasing weakness - Reduced appetite, nausea At end-stage (GFR < 15): - Uraemia — accumulation of toxins the kidneys no longer excrete: nausea, vomiting, skin itching, neurological symptoms, pericarditis - Severe anaemia - Hyperkalaemia — life-threatening cardiac arrhythmia risk - Severe oedema, dyspnoea Which Tests Are Needed in CKD CKD monitoring involves regular tracking of several parameter groups. Frequency depends on stage: G1–G2 — annually; G3 — every 6 months; G4–G5 — every 3 months or more frequently. Kidney function: creatinine with GFR calculation — the primary dynamic marker. Urea — additional azotaemia marker. The kidney function test covers both parameters. Urinary sediment: general urinalysis and spot urine albumin-to-creatinine ratio — for quantitative proteinuria assessment. Urinalysis also evaluates inflammatory activity. Electrolytes: potassium — hyperkalaemia risk rises when GFR < 30; sodium — fluid and electrolyte disorders; bicarbonate — metabolic acidosis in CKD. Bone and mineral metabolism (when GFR < 45): calcium, phosphorus, parathyroid hormone — secondary hyperparathyroidism develops in most patients with CKD stages 3b–5. For more on the PTH–CKD relationship, see the article parathyroid hormone: what this hormone is. Vitamin D — activation in the kidneys is impaired in CKD; deficiency is universal and requires correction. Complete blood count — to detect renal anaemia (haemoglobin fall due to erythropoietin deficiency). Treatment and Slowing CKD Progression CKD is not curable in the sense that lost nephrons do not regenerate. But progression can be substantially slowed — and in some causes (early diabetic nephropathy) partially reversed. Blood pressure control — target < 130/80 mmHg in CKD with proteinuria. Preferred agents are ACE inhibitors or ARBs (angiotensin receptor blockers): they not only lower blood pressure but also reduce intraglomerular pressure, decrease proteinuria, and slow progression independently of the antihypertensive effect. Glucose control in diabetes — target HbA1c < 7–7.5%. SGLT-2 inhibitors (empagliflozin, dapagliflozin) lower glucose and have proven nephroprotective effects. Proteinuria reduction — the lower the urinary protein, the slower CKD progresses. Target in diabetic nephropathy: albuminuria < 30 mg/g. CKD diet: - Protein restriction (0.6–0.8 g/kg/day when GFR < 30) reduces the load on remaining nephrons - Phosphorus restriction (dairy products, nuts, legumes, carbonated drinks) for hyperphosphataemia - Potassium restriction (bananas, potatoes, tomatoes, oranges) for hyperkalaemia - Sodium restriction (< 2 g/day) for blood pressure and oedema control Renal replacement therapy (RRT) at end-stage CKD (GFR < 10–15): haemodialysis, peritoneal dialysis, or kidney transplantation. Preparation for RRT begins well in advance — when GFR falls below 20. When to Seek Urgent Nephrology Consultation A routine nephrology referral is appropriate when GFR first falls below 60, or at any CKD stage with worsening proteinuria. Urgent consultation is needed for: - Rapid GFR decline — more than 5 mL/min/1.73 m² per year, or an acute fall over several weeks (acute-on-chronic kidney injury) - Hyperkalaemia — potassium above 6.0 mmol/L: life-threatening arrhythmia risk - Severe uncontrolled hypertension in the context of CKD - Marked oedema with nephrotic-range proteinuria ( 3 g/day) - Uraemic symptoms — escalating nausea, vomiting, encephalopathy CKD is a diagnosis that changes a person's lifestyle — but it is not a sentence. Detected at an early stage and managed correctly, many patients maintain stable kidney function for decades. The key is regular monitoring, blood pressure and glucose control, and early nephroprotective therapy. This article is for informational purposes only and does not replace medical advice. For any suspected kidney disease, consult a nephrologist or general practitioner. https://labreadai.com/en/posts/kak-rasshifrovat-analiz-krovi https://labreadai.com/en/posts/kak-rasshifrovat-analiz-krovi Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) How to interpret a complete blood count: hemoglobin, leukocytes, platelets, ESR and the differential — normal values, causes of abnormalities and when to see a doctor. Articles article A results sheet with two dozen rows of numbers and upward or downward arrows — familiar territory for most patients. The complete blood count (CBC) is the most frequently ordered laboratory test: for any suspected infection, before surgery, at a routine check-up. But understanding what it actually says without an explanation is difficult. This article walks through every indicator of the complete blood count in order: what is measured, what counts as normal, and what deviations mean. The goal is not to replace a doctor — but to help you arrive at the appointment prepared. How a Complete Blood Count Is Structured A CBC consists of three interconnected components: - Red cell indices: hemoglobin, red blood cells, haematocrit, MCV, MCH, MCHC, RDW — assess oxygen-carrying function and red cell morphology - White cell indices: total leukocyte count and the differential (five-part count) — assess immune status - Platelet indices: platelets, MPV — assess primary haemostasis Results are expressed in absolute numbers (×10⁹/L or ×10¹²/L) or percentages. The laboratory prints a reference range next to every parameter — compare against this, not against internet averages: norms vary by equipment and reagent. Read the panel as a whole: one isolated deviation is less significant than several indicators shifting in the same direction. Each indicator is best explained in context — not in isolation. Hemoglobin and Red Blood Cells: Oxygen Transport Hemoglobin (HGB, Hb) — the oxygen-carrying protein in red cells. The primary measure of blood oxygen transport. Normal: men 130–174 g/L, women 117–155 g/L, pregnant women from 105 g/L. Low hemoglobin — anaemia. Graded by severity: mild (90 g/L to lower normal limit), moderate (70–89 g/L), severe (< 70 g/L). Symptoms: fatigue, breathlessness, pallor. Full breakdown of causes and treatment: low hemoglobin. High hemoglobin — haemoconcentration (dehydration, polycythaemia). Thrombotic risk with chronic elevation. Red blood cells (RBC) — normal: men 4.3–5.7 ×10¹²/L, women 3.8–5.1 ×10¹²/L. Reduction parallel to hemoglobin — anaemia. Isolated low RBC with normal hemoglobin — rare (minor thalassaemia). Haematocrit (HCT) — the proportion of red cells in total blood volume, %. Normal: men 40–52%, women 35–47%. Low — anaemia or hypervolaemia; high — dehydration, polycythaemia. MCV, MCH and RDW: Red Cell Morphology These three parameters are the key to identifying the type of anaemia and narrowing the diagnostic workup immediately. MCV (mean corpuscular volume) — normal 80–100 fL. The most important index: - MCV < 80 fL (microcytosis) — iron deficiency anaemia, thalassaemia - MCV 80–100 fL (normocytosis) — anaemia of chronic disease, haemolysis, acute blood loss - MCV 100 fL (macrocytosis) — vitamin B12 or folate deficiency, alcoholism, hypothyroidism MCH (mean corpuscular haemoglobin) — normal 27–34 pg. Reduced in iron deficiency (hypochromia); elevated in macrocytic anaemias. RDW (red cell distribution width / anisocytosis) — normal 11.5–14.5%. Elevated means red cells vary significantly in size. Low MCV + high RDW — classic iron deficiency anaemia (unlike thalassaemia, where RDW is normal). Leukocytes and the Differential Count Leukocytes (WBC) — white blood cells, the immune army. Normal in adults 4.0–9.0 ×10⁹/L. Elevated (leukocytosis) — infection, inflammation, stress, blood malignancy. Reduced (leukopenia) — viral infections, immunodeficiency, bone marrow disease. The total leukocyte count without a differential is only the starting point — this indicator alone cannot be explained without breaking it down further. A doctor always evaluates the five-part differential — the leukocyte formula. Neutrophils — normal 48–78% (1.8–7.7 ×10⁹/L). The most numerous fraction. Elevated (neutrophilia) — bacterial infection, inflammation, stress, corticosteroids. A "left shift" — appearance of immature forms (band cells 5%) — signals severe infection or sepsis. Reduced (neutropenia) — viral infections, cytotoxics, aplastic anaemia. Lymphocytes — normal 19–37% (1.0–3.5 ×10⁹/L). Elevated (lymphocytosis) — viral infections, chronic lymphocytic leukaemia. Reduced (lymphopenia) — immunodeficiency, HIV, prolonged steroid therapy. Monocytes — normal 3–11% (0.09–0.6 ×10⁹/L). Elevated — chronic infections (tuberculosis, brucellosis), inflammatory bowel disease, recovery phase. Eosinophils — normal 1–5% (0.02–0.44 ×10⁹/L). Elevated — allergic disease, parasitic infections, drug reactions. Basophils — normal 0–1% (0–0.08 ×10⁹/L). Elevated in allergy, hypothyroidism, chronic myelogenous leukaemia. Platelets and MPV: Haemostasis Platelets (PLT) — blood cells that form the primary haemostatic plug. Normal 150–400 ×10⁹/L. Reduced (thrombocytopenia < 150) — bleeding risk. Below 50 — spontaneous haemorrhage; below 20 — life-threatening. Causes: immune thrombocytopenia, DIC, leukaemia, cirrhosis. Elevated (thrombocytosis 400) — inflammation, iron deficiency, post-splenectomy, myeloproliferative disorders. MPV (mean platelet volume) — normal 7–12 fL. Large platelets (high MPV) — young, active cells: seen after blood loss, in immune thrombocytopenia. Small platelets (low MPV) — aplastic anaemia, chemotherapy. ESR: The Inflammation Marker ESR (erythrocyte sedimentation rate) — an indirect marker of systemic inflammation. Normal: men up to 15 mm/h, women up to 20 mm/h (Westergren method). Higher limits in older adults. ESR is non-specific: it rises with any inflammation, infection, autoimmune condition, malignancy — and even in normal pregnancy. On its own, an elevated ESR does not reveal what is inflamed — only that inflammation exists. High ESR ( 50–60 mm/h) with otherwise normal CBC — a red flag: requires a search for the cause: malignancy, myeloma, systemic connective tissue disease. Mildly elevated ESR (20–40 mm/h) with good wellbeing is often a physiological variant or residual from a recent infection. ESR responds slowly — it may remain elevated for weeks after recovery. It is not used to assess the acuity of a current condition — only for tracking trends. How to Read Your Blood Count Report: A Step-by-Step Approach 1. Use the laboratory's reference range, not internet averages. 2. Distinguish isolated from combined abnormalities. A single mild deviation is less significant than several parameters shifting together. 3. Assess the trend over time. Hemoglobin 118 g/L in a woman whose previous value was 135 g/L is significant, even if technically "within normal." 4. Match results to symptoms. Leukocytosis with a fever of 39 °C is a very different context from the same leukocytosis after an intense gym session with no symptoms. 5. One test is not a diagnosis. Any significant deviation warrants a repeat test and a medical consultation. Common Patterns of Deviation and What They Mean Several clinically important patterns that a doctor recognises at a glance — each explained by the combination of indicators rather than a single value: Low hemoglobin + low MCV + high RDW → iron deficiency anaemia — the most common pattern in practice. Low hemoglobin + high MCV + normal leukocytes and platelets → B12 or folate deficiency. High leukocytes + neutrophilia + left shift → bacterial infection or sepsis. High leukocytes + lymphocytosis + atypical lymphocytes → viral infection (infectious mononucleosis, CMV). Low leukocytes + low platelets + low hemoglobin → pancytopenia — suppression of all bone marrow cell lines. Requires urgent haematology workup. High ESR + normal leukocytes → chronic inflammation, autoimmune process, malignancy. High platelets + low MCV + low hemoglobin → iron deficiency anaemia (reactive thrombocytosis in iron deficiency). When CBC Abnormalities Require Urgent Medical Attention Most moderate deviations warrant a scheduled appointment. But when critical indicators are present, the urgency is explained by the risk of immediate complications: - Hemoglobin < 70 g/L regardless of symptoms - Leukocytes 30 × 10⁹/L or < 1.0 × 10⁹/L - Platelets < 30 × 10⁹/L — haemorrhage risk - Blast cells on the smear — sign of acute leukaemia - Pancytopenia — simultaneous reduction of all three cell lines - Neutrophils < 0.5 × 10⁹/L — agranulocytosis - Any critical deviation in a pregnant woman This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/kreatinin-v-krovi https://labreadai.com/en/posts/kreatinin-v-krovi Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Creatinine blood test explained: normal ranges for men, women and children, causes of high creatinine, eGFR calculation and when to see a nephrologist. Articles article You received a biochemical blood panel and noticed creatinine is above normal. The first question is: how serious is this? The answer depends on many factors — how far above normal, whether symptoms are present, how it relates to muscle mass, and what the calculated eGFR shows. Creatinine is the end product of energy metabolism in muscles, and it is cleared exclusively by the kidneys. This makes its blood concentration one of the simplest and most reliable markers of renal filtration. This article covers normal ranges by sex and age, causes of deviation, and when an abnormal result demands urgent action. What Is Creatinine and Why Is It Tested? Creatine is a substance muscles use as a rapid energy source. The final product of this metabolism is creatinine. The body neither reuses nor reabsorbs it: the kidneys filter it through the glomeruli and excrete it in urine in an almost constant daily amount. This makes it a convenient marker: when the kidneys function well, creatinine is cleared at a stable rate. The moment filtration declines — it accumulates in the blood. An important limitation: blood creatinine depends on muscle mass. A muscular man will have a legitimately higher level than a frail elderly woman — even with equally healthy kidneys. This is why creatinine alone is insufficient for assessing kidney function: the doctor uses it to calculate eGFR (estimated glomerular filtration rate), adjusted for age, sex, and race. For a comprehensive renal assessment, creatinine is always evaluated within the kidney function test. Indications for ordering the test: - Routine screening in hypertension, diabetes mellitus, or obesity - Symptoms of renal pathology: oedema, changes in urine colour, flank pain - Monitoring nephrotoxic drugs: NSAIDs, aminoglycosides, contrast agents, lithium - Pre-operative evaluation - Monitoring established chronic kidney disease - Assessing dialysis adequacy in patients with end-stage renal failure How to Prepare for the Test Creatinine is sensitive to several physiological factors that must be controlled before the draw to avoid a falsely elevated result. Preparation guidelines: - Blood drawn fasting in the morning — at least 8–12 hours after the last meal. - Limit red meat and organ meats for 24 hours beforehand: high-protein digestion raises creatinine by 10–20%. - Do not take creatine sports supplements the day before — they sharply elevate the level. - Avoid intense physical exercise for 24 hours: muscle protein breakdown temporarily raises creatinine. - Do not become dehydrated: fluid deficit concentrates the blood and inflates the result. - Inform your doctor about NSAIDs, ACE inhibitors, and angiotensin receptor blockers — they reduce renal perfusion and affect the level. - For serial monitoring — always use the same laboratory: eGFR calculation methods differ between labs. Normal Creatinine Range: Table by Sex and Age Normal values depend on muscle mass and change with age. Reference ranges may vary slightly between laboratories — always check the values printed on your own report. Category Normal (µmol/L) Normal (mg/dL) --------- Men 18–60 years 62–115 0.7–1.3 Men 60 years 65–120 0.73–1.36 Women 18–60 years 53–97 0.6–1.1 Women 60 years 50–100 0.57–1.13 Children 1–12 years 27–62 0.3–0.7 Adolescents 13–17 years 44–88 0.5–1.0 Pregnant women (any trimester) 40–80 0.45–0.9 Why men's normal is higher: men have greater muscle mass and therefore higher daily creatinine production. Athletes with significant muscle hypertrophy will have a legitimately elevated "normal" for themselves. Why pregnant women's normal is lower: during pregnancy, renal blood flow and GFR increase by 40–65%, accelerating creatinine excretion. A value that is "normal" in a non-pregnant woman may already indicate impaired function during pregnancy. Important caveat: elderly patients with sarcopaenia (age-related muscle loss) produce less creatinine. Their "normal" level may be lower than in young adults — while their GFR is already reduced. This is why creatinine alone should never be used in older patients without calculating eGFR. High Creatinine: Causes and What It Means A creatinine above the upper reference limit requires interpretation in the context of the clinical picture and eGFR. By mechanism, causes fall into three categories. Pre-renal causes — reduced renal blood flow with intact kidney tissue: - Dehydration — the most common cause of transient elevation. Blood is concentrated, renal blood flow falls, filtration drops. Normalises with rehydration. - Heart failure, shock — reduced cardiac output decreases renal perfusion - Major haemorrhage, burns — loss of circulating volume - NSAIDs in patients with chronic kidney disease — prostaglandin blockade reduces glomerular filtration Renal causes — damage to kidney tissue itself: - Acute kidney injury (AKI) — rapid creatinine rise over hours to days. Causes: acute tubular necrosis (ischaemia, nephrotoxins), glomerulonephritis, interstitial nephritis, myoglobinuria from rhabdomyolysis - Chronic kidney disease (CKD) — gradual rise over months to years. Full details on progression mechanisms and staging: chronic kidney disease - Diabetic nephropathy, hypertensive nephropathy — leading causes of CKD worldwide - Glomerulonephritis of various origins Post-renal causes — obstructed urine outflow: - Urinary stone disease with ureteral obstruction - Benign prostatic hyperplasia — chronic outflow obstruction in older men - Urinary tract tumours Extra-renal causes of elevation (not related to reduced filtration): - Rhabdomyolysis — massive muscle breakdown (trauma, extreme exertion, high-dose statins) sharply increases daily creatinine production - Acromegaly — excess growth hormone increases muscle mass - Hyperthyroidism — accelerated metabolism increases protein turnover Low Creatinine: When It Matters Low creatinine is a less common and less alarming finding, but several situations warrant attention. Causes of low creatinine: - Sarcopaenia and cachexia — muscle mass reduction in ageing, malignancy, or severe chronic illness. Low creatinine in an emaciated patient is a marker of poor prognosis. - Pregnancy — physiological reduction (see table above) - Vegetarian and vegan diet — absence of animal protein reduces precursor (creatine) intake - Hypothyroidism — slowed metabolic rate reduces creatinine production - Myopathies — genetic or acquired muscle diseases with atrophy Isolated low creatinine with normal eGFR and good general health is most often a normal variant requiring no treatment. Low creatinine combined with weakness, weight loss, and other symptoms warrants investigation. eGFR and Creatinine: How Kidney Function Is Calculated Estimated GFR is the most important derived value calculated from creatinine. It — not the raw creatinine — is the basis for staging chronic kidney disease and guiding clinical decisions. Modern formulas (CKD-EPI, MDRD) combine creatinine with age, sex, and race. The result is expressed in mL/min/1.73 m² and shows how many millilitres of blood the kidneys filter per minute. Normal eGFR in adults: above 90 mL/min/1.73 m². Decline staging: eGFR (mL/min) CKD stage Description --------- ≥ 90 G1 Normal / damage markers present 60–89 G2 Mildly reduced 45–59 G3a Mildly-moderately reduced 30–44 G3b Moderately-severely reduced 15–29 G4 Severely reduced < 15 G5 Kidney failure The same creatinine level produces very different eGFR values in different individuals. For example, creatinine of 120 µmol/L in a muscular young man corresponds to an eGFR of around 70–75 mL/min — mildly reduced. The same level in a 75-year-old woman gives an eGFR of approximately 40–45 mL/min — moderately-severely reduced. Alongside creatinine, urinalysis is checked for renal function assessment: albuminuria is an early marker of filtration barrier damage, appearing before eGFR falls. When High Creatinine Requires Urgent Medical Attention A moderate single elevation without symptoms — repeat the test in 1–2 weeks under proper conditions. But several situations call for immediate consultation: - Creatinine above 200 µmol/L without a known pre-existing kidney condition - Creatinine doubling within a few days from a previously normal baseline - Newly discovered eGFR below 30 mL/min - Reduced urine output or complete anuria - Dark or cloudy urine combined with rising creatinine - Worsening oedema, hypertension, or breathlessness alongside high creatinine - Hyperkalaemia (potassium 6.0 mmol/L) with high creatinine — arrhythmia risk - Rhabdomyolysis: acute muscle pain + dark urine + rising creatinine - Any creatinine rise in a pregnant woman — immediate obstetric review With a stable elevated creatinine from established chronic kidney disease — regular nephrology monitoring and control of all contributing risk factors: blood pressure, blood glucose, nephrotoxic drug avoidance. Conclusion Creatinine is a simple, accessible marker — but correct interpretation requires context: sex, age, muscle mass, medical history, and eGFR calculation. A single moderate elevation above the reference range is not a diagnosis; it is a signal to repeat the test under controlled conditions. Persistent elevation, a worsening trend, or a sudden rise warrants a full nephrology workup. Protect the kidneys while they are still silent: by the time symptoms appear, significant function may already have been lost. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/melatonin-what-it-is https://labreadai.com/en/posts/melatonin-what-it-is Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Melatonin is the pineal hormone regulating sleep and circadian rhythms. Normal blood levels, deficiency causes, effects on immunity and how to raise it naturally. Articles article You lie down but sleep does not come for hours. Or you wake at three in the morning and cannot drift off again. Or after a transatlantic flight your body is running on an entirely different schedule. Behind all of this is a disruption of one small hormone that most people know only by name. Melatonin is produced by the pineal gland exclusively in darkness and acts as the master conductor of the body's daily rhythms. This article explains how it works, what disrupts it, what normal levels look like, and what genuinely helps when it is deficient. What Is Melatonin and Where Is It Produced? Melatonin is a derivative of the amino acid tryptophan, synthesised primarily in the pineal gland of the brain. Small amounts are also produced in the retina, intestine, leukocytes, and platelets — but it is pineal melatonin that governs sleep regulation and circadian rhythms. The defining feature of melatonin: it is produced only in darkness. The signal travels from the retina through the retinohypothalamic tract to the suprachiasmatic nucleus of the hypothalamus — the body's master biological clock — and from there to the pineal gland. Even low-level light, particularly in the blue spectrum (smartphones, screens), suppresses melatonin synthesis. Melatonin does not directly induce sleep — it signals to the body that night has arrived and triggers a cascade of changes: falling core body temperature, slowed metabolism, reduced heart rate. This creates the conditions for sleep onset, but it is not a sedative in the strict sense. The relationship between melatonin and other hormones is reciprocal: elevated cortisol suppresses melatonin synthesis, and vice versa. This is why chronic stress is one of the primary enemies of healthy sleep. Melatonin Levels: When and How It Is Tested A melatonin test is a specialised assay, rarely ordered in routine clinical practice. This reflects the hormone's unusual behaviour: its level shifts by a factor of ten or more across the day, making a single blood draw largely uninformative. The standard method is a 24-hour melatonin profile from saliva or urine, with samples collected at fixed time points. Approximate reference values for serum melatonin: Time of day Level (pg/mL) ------ Daytime (10:00–12:00) 1–10 Early night (23:00–01:00) 20–70 Peak night (02:00–04:00) 70–200 Elderly 65 years (night) 20–80 The melatonin peak falls between 2 and 4 a.m., after which levels gradually decline toward dawn. With age, the nocturnal peak becomes lower and shorter — one of the physiological reasons older adults experience lighter and shorter sleep. Indications for testing: - Chronic insomnia unresponsive to standard treatment - Diagnosis of circadian rhythm disorders (delayed sleep phase syndrome) - Evaluating light therapy efficacy in seasonal depression - Research and specialised sleep medicine protocols In most cases, a clinical diagnosis of a sleep disorder is made without a melatonin assay — based on symptoms, a sleep diary, and actigraphy. How Melatonin Affects Health: Beyond Sleep Melatonin is a far more multifunctional hormone than simply a "night signal." Its receptors have been identified in virtually every tissue in the body. Antioxidant protection. Melatonin is one of the most potent natural antioxidants. It neutralises free radicals directly in mitochondria — where oxidative stress is generated most heavily. Unlike most antioxidants, it crosses all biological barriers, including the blood-brain barrier. Immune regulation. The nocturnal melatonin peak coincides with peak immune system activity: cytokine synthesis, NK cell activation, lymphocyte proliferation. Chronic melatonin deficiency impairs immune response and accelerates immune ageing. Oncological protection. Epidemiological data show higher rates of breast, prostate, and colorectal cancer in people with chronic circadian disruption — night shift workers, blind individuals without light input, patients with chronic sleep disorders. Melatonin inhibits tumour cell proliferation and angiogenesis in vitro, though clinical evidence remains preliminary. Metabolic regulation. The relationship between melatonin, glucose metabolism, and metabolic syndrome is under active investigation. Melatonin deficiency impairs insulin sensitivity, potentially contributing to type 2 diabetes in night-shift workers. Neuroprotection. In Alzheimer's disease, melatonin levels are substantially reduced, correlating with the circadian disruption characteristic of these patients. Melatonin protects neurons from beta-amyloid toxicity in experimental models. Causes of Melatonin Deficiency Melatonin deficiency is rarely isolated — it is most often a consequence of lifestyle or age-related changes. Light pollution and screens. The primary modern cause. Blue light (wavelength 460–480 nm) from smartphone, tablet, and laptop screens maximally suppresses melatonin synthesis. Two hours of evening smartphone use delays melatonin onset by 1.5–3 hours and reduces the nocturnal peak by 22%. Night and shift work. Chronic exposure to artificial light at night irreversibly disrupts the circadian rhythm. The WHO classifies shift work involving circadian disruption as a probable carcinogen (Group 2A). Age. After age 40–45, melatonin synthesis begins to decline; after 60, the drop becomes substantial. This is one mechanism behind the age-related deterioration in sleep quality and immune function in older adults. Stress and hypercortisolaemia. Chronically elevated cortisol directly suppresses melatonin synthesis in the pineal gland. This creates a vicious cycle: stress → poor sleep → greater stress. Certain medications: - Beta-blockers (atenolol, metoprolol) — suppress synthesis via β₁-adrenergic receptors - NSAIDs with prolonged use - Benzodiazepines paradoxically disrupt sleep architecture despite their sedative effect - Evening caffeine Tryptophan deficiency — the essential amino acid from which serotonin and then melatonin are synthesised. Strict low-protein diets reduce the substrate for synthesis. How to Raise Melatonin: Behavioural Strategies and Supplements Most sleep problems related to melatonin deficiency respond to behavioural interventions — without medication. Light hygiene: - Bright morning light exposure (sunlight especially) — synchronises biological clocks and amplifies the nocturnal melatonin peak - Dark sleeping environment: blackout curtains, sleep mask. Even dim ambient light suppresses synthesis - Avoid screens 1–2 hours before bed, or use amber-tinted glasses (block blue light) - Night mode apps (Night Shift, f.lux) reduce melatonin suppression but do not eliminate it Temperature: - Bedroom temperature of 17–19 °C — mimics the nocturnal core body temperature drop that accompanies melatonin release - A warm bath or shower 1–2 hours before bed paradoxically helps — the subsequent body cooling accelerates sleep onset Nutrition: - Tryptophan-rich foods: turkey, eggs, hard cheeses, nuts, bananas - Melatonin-containing foods: tart cherries (especially concentrated juice), walnuts, tomatoes. Concentrations are low but clinical effects have been described - Moderate carbohydrates at dinner increase tryptophan availability, improving serotonin and melatonin synthesis Melatonin supplements: Synthetic melatonin is indicated in specific situations: jet lag, delayed sleep phase syndrome, insomnia in older adults (age-related deficiency), shift work adaptation. Principles of use: - Low doses (0.5–1 mg) are more effective than high doses (5–10 mg) for circadian phase-shifting - For jet lag — take by destination time zone, starting on arrival day - For insomnia — 30–60 minutes before the desired sleep time - Not a sedative — does not cause immediate sleep, not suitable for acute insomnia Melatonin is safe for short-term use in adults. Long-term data in children are limited — use only on medical recommendation. Melatonin and Seasonal Disorders: Winter, Depression and Photoperiodism Day length is the primary photoperiodism signal in most mammals. In humans, this mechanism is partially preserved: during short winter days, the duration of the nocturnal melatonin peak lengthens, which can influence mood, appetite, and energy. Seasonal affective disorder (SAD, "winter depression") involves circadian rhythm disruption under conditions of insufficient light exposure. The primary treatment is bright light therapy (10,000 lux, 20–30 minutes in the morning): it suppresses excessive melatonin synthesis and normalises the secretion phase. In severe cases, combined with antidepressants. Melatonin also modulates reproductive function through its influence on estradiol and gonadotropins. Women with chronic sleep disturbance show higher rates of menstrual irregularities — for more on hormonal links to the cycle, see ovulation: what it is and how to track it. When Sleep and Melatonin Disorders Require Medical Attention Most sleep problems respond to sleep hygiene and lifestyle adjustments. But several situations warrant medical consultation: - Insomnia persists for more than 3 months despite proper sleep hygiene - Sleep disturbance is accompanied by depressed mood, anxiety, or loss of interest in life - Excessive daytime sleepiness despite adequate night sleep — possible sleep apnoea - Pronounced delayed sleep phase: unable to fall asleep before 2–3 a.m. - Sleep behaviour disorders: movements, talking, getting out of bed — possible REM parasomnia - Older adult with worsening cognition and disrupted sleep — exclude neurodegeneration - Sleep disruption on beta-blockers — discuss switching medication with prescribing doctor This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/nizkie-leykocity https://labreadai.com/en/posts/nizkie-leykocity Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Low white blood cells (leukopenia): normal ranges, causes in adults and children, warning signs of neutropenia and when to seek urgent medical care. Articles article You received your complete blood count and your white blood cells are below normal. The instinct is to worry. But before drawing conclusions, know this: the degree of the drop, which cell fraction is affected, and the clinical context determine everything. A mild transient leukopenia after a viral illness is one thing; a sharp fall during cancer treatment is another entirely. This article explains what white blood cell count is considered low, what causes the decrease, why neutropenia is the most dangerous variant, and when you need to seek care without delay. White Blood Cell Normal Range: When Is a Value Considered Low? Leukocytes — white blood cells — are the body's immune army. They are not uniform: each fraction — neutrophils, lymphocytes, monocytes, eosinophils, basophils — defends a different aspect of immunity. A low total count and a low individual fraction carry different clinical meanings. Leukopenia is defined as a total white blood cell count below 4.0 × 10⁹/L in adults. Normal values shift with age: Category Normal range (× 10⁹/L) ------ Adults 4.0–9.0 Pregnant women 6.0–11.0 Infants under 1 year 6.0–17.5 Children 1–6 years 5.0–15.5 Children 6–12 years 4.5–13.5 Adolescents 4.5–11.0 An important caveat: 3–5% of otherwise healthy adults — more commonly people of African descent — have chronically low white blood cell counts in the 3.0–4.0 × 10⁹/L range with no underlying disease. This is called benign ethnic neutropenia and is diagnosed only after all other causes have been excluded. Severity classification: - Mild: 3.0–4.0 × 10⁹/L — often asymptomatic and transient - Moderate: 2.0–3.0 × 10⁹/L — requires investigation and monitoring - Severe: below 2.0 × 10⁹/L — significant risk of infectious complications Causes of Low White Blood Cells in Adults The causes of leukopenia fall into three broad categories: suppressed production in the bone marrow, accelerated destruction or consumption of leukocytes, and redistribution — where cells are present but pool in tissues or the spleen. Viral infections — the most common cause of transient leukopenia. Influenza, common respiratory viruses, cytomegalovirus, Epstein-Barr virus, hepatitis B and C all temporarily suppress leukocyte production or accelerate their destruction. A classic example: in infectious mononucleosis, white blood cells often fall in the early phase of illness before giving way to a reactive lymphocyte surge. Viral leukopenia typically resolves on its own within one to three weeks. Medications — the second most common cause in adults. Drugs known to cause leukopenia include: - Cytotoxic and chemotherapy agents — direct bone marrow suppression - Certain antibiotics (chloramphenicol, linezolid, trimethoprim) - Antipsychotics, especially clozapine - Anticonvulsants (carbamazepine, valproate) - Antithyroid drugs (methimazole, propylthiouracil) - Metamizole sodium (dipyrone) with prolonged use Autoimmune diseases — systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome. In these conditions, the immune system produces antibodies against leukocytes or their bone marrow precursors. Vitamin B12 and folate deficiency — both vitamins are essential for cell division in the bone marrow. Their deficiency disrupts production of all blood cell lines, including white cells. Leukopenia typically appears alongside anemia and thrombocytopenia — a tri-lineage suppression pattern. Hypersplenism — an enlarged, overactive spleen (from liver cirrhosis, sarcoidosis, lymphomas) traps and destroys excess leukocytes. Bone marrow disorders — aplastic anemia, myelodysplastic syndrome, leukemia, metastatic infiltration. These conditions disrupt blood cell production at the source. All three cell lines are usually affected simultaneously. HIV infection — the virus targets CD4 lymphocytes specifically, making chronic lymphopenia one of the early markers of disease progression. Low White Blood Cells in Children: Ranges and Special Considerations In children, normal white blood cell counts are significantly higher than in adults and decline gradually with age. This means that a value of 5.0 × 10⁹/L in an infant under one year warrants close attention, whereas the same number in an adult is perfectly normal. The most common causes of leukopenia in children: - Viral infections — the most frequent and most benign cause, just as in adults. Particularly characteristic of the first days of influenza and adenoviral infection. - Primary immunodeficiencies — rare, but childhood is when these conditions first manifest. Recurrent infections alongside persistently low white blood cells should prompt an immunology referral. - Cyclic neutropenia — a rare genetic condition in which neutrophils drop to critically low levels every 21 days before recovering spontaneously. If a child had a respiratory illness and a follow-up blood count shows low leukocytes, a repeat test in two to four weeks is usually sufficient. The vast majority of these cases resolve without treatment. Low White Blood Cells During Pregnancy Leukopenia in pregnancy is relatively uncommon, because pregnancy itself causes a physiological leukocytosis. Normal values in pregnant women are elevated — 6.0–11.0 × 10⁹/L — from the first trimester onward. A value below 4.0 × 10⁹/L in a pregnant woman is therefore not expected physiologically and requires investigation. Possible causes include: - Autoimmune conditions — systemic lupus erythematosus and antiphospholipid syndrome, which often first present during pregnancy - Vitamin B12 and folate deficiency — especially in multiple pregnancy or inadequate nutrition - Viral infections — parvovirus B19, cytomegalovirus Leukopenia during pregnancy requires coordinated management between a haematologist and an obstetrician, as several immunomodulatory treatments are contraindicated in pregnancy. Neutropenia: The Most Dangerous Form of Leukopenia Of all white blood cell fractions, a drop in neutrophils is the most clinically critical. Neutrophils make up 50–70% of all white blood cells and are the front line of defence against bacterial and fungal infections. As neutrophil counts fall, the risk of serious infection rises exponentially. Neutropenia severity by absolute neutrophil count (× 10⁹/L): Grade Value Infection risk --------- Mild 1.0–1.5 Slightly elevated Moderate 0.5–1.0 Substantially elevated Severe (agranulocytosis) < 0.5 High: life-threatening infections Agranulocytosis — virtual absence of neutrophils — is a life-threatening emergency. Organisms that a healthy immune system handles without difficulty become potentially fatal. Any fever during agranulocytosis is a medical emergency. A critical clinical point: the total white blood cell count can be within normal range while neutrophils are dangerously low — and this constitutes neutropenia with all its risks. This is why leukopenia always warrants a full differential count, not just the total white cell number. Symptoms Associated with Leukopenia Mild leukopenia is often entirely asymptomatic and discovered incidentally on a routine blood test. Symptoms emerge when immune defences fall far enough that the body can no longer handle ordinary microbial exposure. Non-specific symptoms: - Persistent fatigue and low energy - Frequent respiratory infections that are more severe than usual and slow to resolve - Slow-healing cuts, boils, or mouth ulcers - Low-grade fever without an obvious source Symptoms of severe neutropenia — seek emergency care: - Fever above 38 °C — combined with neutropenia, this is "neutropenic fever" and requires urgent hospitalisation - Ulceration and necrosis of the oral and throat mucosa - Signs of sepsis: rigors, rapid deterioration, falling blood pressure An important clinical caveat: in severe neutropenia, the classic signs of infection — pus, pronounced redness, swelling — may be absent, because there are too few neutrophils to produce these inflammatory responses. Fever may be the only warning sign. When Low White Blood Cells Require Urgent Medical Attention A mild post-viral leukopenia without symptoms and with a good general sense of wellbeing — a repeat test in three to four weeks is usually appropriate. But several situations call for immediate consultation: - Total white blood cell count below 2.0 × 10⁹/L — regardless of symptoms - Absolute neutrophil count below 0.5 × 10⁹/L — agranulocytosis - Leukopenia combined with anaemia and thrombocytopenia — tri-lineage suppression - Fever above 38 °C in a patient with known leukopenia — emergency - White blood cell count declining across successive tests without an obvious cause - Enlarged lymph nodes or spleen alongside leukopenia - Leukopenia in a child without a preceding illness, or in a newborn The workup for leukopenia includes a full differential blood count, biochemical panel, vitamin B12 and folate levels, autoimmune markers, and — when indicated — a haematology consultation with consideration of bone marrow biopsy. Conclusion Low white blood cells — leukopenia — is a finding, not a diagnosis. Behind it can lie conditions that vary enormously in seriousness: transient post-viral suppression, a drug side effect, an autoimmune process, or bone marrow disease. The key questions when interpreting the result are: how low, which fraction, are there symptoms, and is there a downward trend? Mild asymptomatic leukopenia warrants a repeat test in three to four weeks. Severe neutropenia or fever alongside leukopenia demands urgent medical care without delay. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/nizkiy-gemoglobin https://labreadai.com/en/posts/nizkiy-gemoglobin Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Low hemoglobin in adults and children: causes of anemia — iron deficiency, B12, chronic disease, symptoms, severity grades and what actually works to treat it. Articles article Fatigue that persists even after a full night of sleep, breathlessness climbing a single flight of stairs, pale skin, and a constant feeling of cold — these are the classic signs that tissues are not getting enough oxygen. Low hemoglobin is one of the most common abnormalities found on a complete blood count: anaemia affects one in four people worldwide. But "low hemoglobin" is not a diagnosis — it is a symptom. The conditions behind it vary enormously in nature and severity, and treatment differs fundamentally depending on the cause. This article covers why hemoglobin falls, how it presents, and what genuinely works to raise it. What Low Hemoglobin Means and What the Normal Range Is Hemoglobin is a protein in red blood cells that carries oxygen. When it falls below normal, the blood delivers less oxygen to tissues — anaemia develops. Lower limits of normal (WHO criteria): Category Anaemia defined as (g/L) ------ Men < 130 Non-pregnant women < 120 Pregnant women < 110 (1st & 3rd trim.), < 105 (2nd trim.) Children 6–59 months < 110 Children 5–11 years < 115 Children 12–14 years < 120 Anaemia severity grades: - Mild: 90 g/L – lower limit of normal. Often asymptomatic or mild fatigue only. - Moderate: 70–89 g/L. Exertional breathlessness, palpitations, reduced capacity. - Severe: < 70 g/L. Breathlessness at rest, tachycardia, dizziness, syncope. - Critical: < 40–50 g/L. Risk of cardiac failure and death. An important nuance: symptoms do not always correspond to the hemoglobin level. Chronic anaemia that has developed over years is tolerated far better than an acute haemorrhage to the same hemoglobin level — the body has had time to adapt. Causes of Low Hemoglobin: Three Mechanisms All causes of anaemia fit into three basic mechanisms: too little produced, too much lost, or destroyed too fast. Insufficient Red Cell Production Iron deficiency anaemia — the most common form worldwide, accounting for roughly 50% of all anaemias. Iron is an essential component of hemoglobin; without it, hemoglobin synthesis cannot proceed. Red cells come out small and pale (microcytic hypochromic anaemia). The earliest marker of deficiency is reduced ferritin — it falls before hemoglobin does. Full details on causes, diagnosis, and treatment: iron deficiency anaemia. Causes of iron deficiency: - Chronic blood loss: heavy menstruation, gastrointestinal bleeding (ulcer, polyps, haemorrhoids, colorectal cancer) - Insufficient intake: vegetarian diet without supplementation, poor nutrition - Increased demand: pregnancy, growth periods in children - Impaired absorption: coeliac disease, Crohn's disease, post-gastrectomy, H. pylori infection Vitamin B12 or folate deficiency — megaloblastic anaemia. Without these vitamins, DNA synthesis in red cell precursors is impaired; cells fail to divide normally and grow into large, immature forms. MCV is elevated ( 100 fL). Symptoms extend to neurological: tingling in the limbs, coordination problems. Anaemia of chronic disease (ACD) — develops in chronic inflammation, malignancy, chronic kidney disease, and rheumatic conditions. Inflammatory cytokines suppress erythropoiesis and block iron release from storage. Ferritin is normal or elevated — unlike in iron deficiency. Treating the underlying disease improves the anaemia. Aplastic anaemia — suppression of all bone marrow cell lines. Leukocytes and platelets fall simultaneously. Rare but serious, requiring inpatient haematology management. Blood Loss Acute blood loss — trauma, surgery, gastrointestinal haemorrhage. Hemoglobin falls rapidly; symptoms are acute — weakness, dizziness, tachycardia, falling blood pressure. An important caveat: in the first hours after acute bleeding, hemoglobin may appear "normal" — haemodilution occurs later. Chronic blood loss — the most insidious variant. Small but constant losses (a few millilitres per day) deplete iron stores over months. The person gradually adjusts to weakness without noticing the worsening anaemia. Particularly dangerous in the context of gastrointestinal malignancy — colorectal cancer frequently presents as iron deficiency anaemia. Accelerated Red Cell Destruction (Haemolysis) In haemolytic anaemia, red cells are destroyed faster than the bone marrow can replace them. Signs: jaundice, dark urine, splenomegaly. Causes: - Autoimmune haemolysis — antibodies against the patient's own red cells - Inherited haemolytic anaemias: sickle cell disease, thalassaemia, hereditary spherocytosis - Infections: malaria — the classic cause in endemic areas - Toxic haemolysis: venoms, certain medications Symptoms of Low Hemoglobin Symptoms are determined by two factors: the hemoglobin level and the speed of its decline. Chronic anaemia stays hidden longer — the body adapts by increasing heart rate and redistributing blood flow. General tissue hypoxia symptoms: - Persistent fatigue, weakness, reduced capacity for work - Breathlessness with ordinary physical activity - Rapid heartbeat (tachycardia) - Dizziness, "floaters" before the eyes - Headaches - Impaired concentration and memory Specific signs of iron deficiency (in addition to the above): - Pale skin and mucous membranes - Brittle nails with transverse ridging or spoon shape (koilonychia) - Hair loss - Dry skin and cracks at the corners of the mouth (angular cheilitis) - Smooth, painful tongue (glossitis) - Pica — craving chalk, earth, ice - Taste for unusual smells: petrol, paint Signs of B12 deficiency: - Tingling and numbness in hands and feet - Coordination problems, unsteady gait - Cognitive impairment, depression — particularly in older adults Diagnosis: Finding the Cause of Low Hemoglobin Detecting anaemia is straightforward — a blood count suffices. Finding the cause takes more work. A doctor works through the differential systematically, guided by the morphology of red cells. Key indicators for differential diagnosis: - MCV: microcytosis (< 80 fL) — iron deficiency or thalassaemia; macrocytosis ( 100 fL) — B12 or folate deficiency; normocytosis — anaemia of chronic disease, haemolysis, acute blood loss - Ferritin: reduced in iron deficiency; normal or elevated in ACD - Reticulocytes: elevated in blood loss and haemolysis (bone marrow in overdrive); reduced in aplastic anaemia and vitamin deficiencies - Bilirubin and LDH: elevated in haemolysis When occult bleeding is suspected, a faecal occult blood test is ordered. Unexplained iron deficiency anaemia in an adult always mandates endoscopy — upper and lower gastrointestinal scope. How to Raise Hemoglobin: Treatment by Cause The fundamental rule: treat the cause, not the number. Iron tablets will not help B12-deficiency anaemia; B12 will not help iron deficiency. Iron deficiency anaemia: - Oral iron preparations (ferrous sulphate, fumarate, bisglycinate) — the cornerstone of treatment. Taken fasting or with vitamin C for better absorption. Treatment course 3–6 months: hemoglobin normalises in 4–8 weeks, then iron stores are replenished. - Intravenous iron — for malabsorption, oral intolerance, or severe anaemia requiring rapid correction. - Eliminating the source of blood loss — without this, any treatment is temporary. - Diet: red meat, liver, offal, legumes. Vitamin C enhances non-haem iron absorption. Coffee, tea, and calcium reduce absorption — do not take with iron preparations. B12 deficiency: - When absorption is impaired (atrophic gastritis, pernicious anaemia) — intramuscular cyanocobalamin injections, lifelong. - For dietary deficiency — high-dose oral B12. Anaemia of chronic disease: - Treating the underlying disease is primary. - In chronic kidney disease — erythropoiesis-stimulating agents (epoetin). - Red cell transfusion — only for severe symptomatic anaemia. Haemolytic anaemia: - Autoimmune — glucocorticoids, immunosuppression, splenectomy in severe cases. - Inherited forms — supportive care; thalassaemia requires transfusions; some patients undergo bone marrow transplant. When Low Hemoglobin Requires Urgent Medical Attention Moderate chronic anaemia warrants a scheduled GP appointment. But several situations require immediate action: - Hemoglobin below 70 g/L — regardless of symptoms - Rapid hemoglobin drop alongside visible or occult blood loss - Black tarry stools or blood in faeces — possible gastrointestinal haemorrhage - Breathlessness at rest or heart rate above 100 bpm alongside anaemia - Anaemia combined with simultaneous decline in leukocytes and platelets - Anaemia in an infant under 1 year with hemoglobin below 90 g/L - Anaemia in pregnancy with hemoglobin below 100 g/L - No response to iron therapy after 4 weeks of correct treatment This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/norma-gemoglobina https://labreadai.com/en/posts/norma-gemoglobina Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hemoglobin normal ranges for men, women, children and pregnancy: complete reference table, anemia grades, causes of abnormal results and when to see a doctor. Articles article Hemoglobin is in every complete blood count, yet few people understand why the normal range differs between men and women, why it is lower in pregnancy, and why newborns have values far above the adult range. Understanding these distinctions matters — both to avoid unnecessary alarm and to know when a result genuinely warrants medical attention. This article provides complete reference tables, explains the logic behind the differences, and gives a clear interpretation of what deviations mean. What Is Hemoglobin and Why Is It Measured? Hemoglobin is a protein inside red blood cells that contains an iron atom. It carries oxygen from the lungs to every tissue in the body and transports carbon dioxide back. Without enough hemoglobin, cells begin to "suffocate" — even with normal breathing and heart function. Hemoglobin is measured as part of a complete blood count — there is no separate "hemoglobin-only" test. Results are expressed in grams per litre (g/L) or grams per decilitre (g/dL): 1 g/dL = 10 g/L. Why do normal ranges differ between groups? Because hemoglobin levels depend on several physiological factors: - Sex: testosterone in men stimulates erythropoietin production and haemoglobin synthesis. As a result, men's normal hemoglobin is 10–20 g/L higher than women's. - Age: newborns have very high hemoglobin (foetal hemoglobin, adapted to low oxygen in the womb), which then drops sharply by 2–3 months, rises again toward school age, and reaches adult values by adolescence. - Pregnancy: plasma volume expands by 40–50% during pregnancy, while red cell mass increases by only 20–30%. Blood is "diluted," physiologically lowering hemoglobin. - Altitude: residents of high-altitude areas have elevated hemoglobin as an adaptation to reduced oxygen partial pressure. How to Get Tested Hemoglobin is measured by automated analyser from capillary (fingerstick) or venous blood. It is relatively stable and does not require the strict preparation needed for hormonal tests. A few guidelines nonetheless: - Ideally draw blood fasting in the morning — eating beforehand can cause a mild haemodilutional drop. - Avoid intense physical exercise for 24 hours: strenuous activity causes transient haemoconcentration. - Smoking within 30 minutes before the draw raises carboxyhaemoglobin (an inactive form), slightly inflating the total. - For serial monitoring — always use the same laboratory: different measurement methods yield marginally different values. - Important: dehydration (heat, vomiting, diarrhoea) falsely elevates hemoglobin through haemoconcentration. Conversely, excessive fluid intake causes haemodilution and a falsely low result. Normal Hemoglobin in Adults: Men and Women Adult reference ranges are well established. Minor differences between laboratories are possible, but the overall picture is consistent. Category Normal (g/L) Normal (g/dL) --------- Men 18–64 years 130–174 13.0–17.4 Men 65 years and older 126–174 12.6–17.4 Women 18–49 years 117–155 11.7–15.5 Women 50 years and older 117–161 11.7–16.1 The lower limit of normal is the key practical threshold: it is at this point that an anaemia diagnosis is made. For men, the anaemia cut-off is below 130 g/L; for non-pregnant women, below 120 g/L (WHO criteria). The upper limit matters too: values above 174 g/L in men or above 161 g/L in women require investigation — polycythaemia, chronic hypoxia, or dehydration. In older men, the lower limit is slightly reduced — physiologically related to declining testosterone and erythropoietin levels with age. A hemoglobin of 126–130 g/L in an older man is not automatically pathological, but warrants monitoring. Normal Hemoglobin in Children: Table by Age Children's reference ranges differ substantially from adults and change throughout the growth period. Adult references must never be applied to children's results. Age Normal (g/L) ------ Newborns (1–3 days) 145–225 1 week 135–215 1 month 100–180 2–3 months 90–135 6 months 105–140 1 year 105–140 2–6 years 110–140 7–12 years 115–145 Boys 13–17 years 125–165 Girls 13–17 years 112–152 Key points: - Physiological anaemia of infancy — by 2–3 months hemoglobin drops to its nadir (90–110 g/L). This is normal: foetal hemoglobin breaks down while adult hemoglobin production is still ramping up. No treatment is required. - Iron deficiency anaemia is the most common cause of low hemoglobin in children aged 6 months to 3 years (a period of rapid growth with high iron demand). - Sex differences in adolescents emerge at puberty: boys' hemoglobin rises under the influence of testosterone; girls' hemoglobin falls with the onset of menstruation and regular blood loss. Normal Hemoglobin in Pregnancy Pregnancy is the one physiological state for which the WHO establishes separate, lower reference ranges for healthy women. This is not pathology — it is a normal adaptation. Trimester Normal (g/L) Anaemia defined as (g/L) --------- 1st trimester 110–160 < 110 2nd trimester 105–160 < 105 3rd trimester 110–160 < 110 The second-trimester drop reflects the peak haemodilutional effect — plasma volume reaches its maximum. By the third trimester, hemoglobin recovers slightly as red cell production accelerates. Anaemia in pregnancy is common: the WHO estimates it affects approximately 40% of pregnant women worldwide. Even mild anaemia is associated with an increased risk of preterm birth, foetal growth restriction, and postpartum haemorrhage. For detailed norms and CBC interpretation during pregnancy, see complete blood count in pregnancy. Low Hemoglobin: Grades of Anaemia and Main Causes Anaemia is hemoglobin below the lower limit of normal for sex and age. Severity is classified by level: Grade Hemoglobin (g/L) Symptoms --------- Mild 90 – lower limit of normal Often asymptomatic or mild fatigue Moderate 70–89 Exertional breathlessness, palpitations, pallor Severe < 70 Breathlessness at rest, tachycardia, dizziness, syncope Life-threatening < 40–50 Heart failure, altered consciousness Causes of low hemoglobin by mechanism: Insufficient red cell production: - Iron deficiency anaemia — the most common anaemia worldwide. Ferritin is low, red cells are small (microcytosis). Full details: iron deficiency anaemia. - Vitamin B12 or folate deficiency — megaloblastic anaemia, red cells are large (macrocytosis) - Anaemia of chronic disease — inflammation, malignancy, chronic kidney disease - Aplastic anaemia — bone marrow suppression Accelerated red cell destruction (haemolysis): - Autoimmune haemolytic anaemia - Inherited haemolytic anaemias (sickle cell disease, thalassaemia) - Infections (malaria) Blood loss: - Acute — trauma, surgery, gastrointestinal haemorrhage - Chronic — heavy menstruation, peptic ulcer, polyps, occult bleeding High Hemoglobin: When It Matters Elevated hemoglobin is a less obvious concern than low, but clinically equally significant. Excess hemoglobin makes blood viscous, slowing microcirculation and raising thrombotic risk. Physiological causes (no treatment needed): - High-altitude residence - Intense regular athletic training - Dehydration — spurious haemoconcentration, normalises with rehydration - Smoking — chronic hypoxia from carboxyhaemoglobin Pathological causes requiring investigation: - Polycythaemia vera — a myeloproliferative disorder with autonomous red cell overproduction. Hemoglobin 185 g/L in men, 165 g/L in women - Secondary erythrocytosis — from chronic hypoxia: COPD, sleep apnoea, congenital heart defects, erythropoietin-secreting tumours - Anabolic steroid use — pharmacological stimulation of erythropoiesis Hemoglobin above 170 g/L in men or above 160 g/L in women warrants a GP or haematology consultation. When Hemoglobin Deviations Require Medical Attention A moderate hemoglobin drop with good general wellbeing calls for a scheduled appointment and workup. Emergency situations: - Hemoglobin below 70 g/L — regardless of symptoms - Rapid drop of 20 g/L or more in a short period — suspected acute bleeding or haemolysis - Low hemoglobin with black stools or blood in faeces — possible gastrointestinal haemorrhage - Breathlessness and palpitations at rest alongside low hemoglobin - Hemoglobin above 185 g/L in men or above 165 g/L in women — rule out polycythaemia - Anaemia in a child not responding to iron therapy after 4–6 weeks - Hemoglobin below 100 g/L in pregnancy — urgent obstetric review This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/oak-allergy https://labreadai.com/en/posts/oak-allergy Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Oak pollen allergy: when oak blooms, pollinosis symptoms, cross-reactions with birch and foods, diagnosis and effective treatment including ASIT. Articles article April and May bring worsening symptoms for many allergy sufferers, but not everyone connects them to a specific tree. Oak blooms inconspicuously — no showy flowers, almost silently — yet its fine pollen disperses for kilometres and reaches high concentrations in the air. Oak pollen allergy is one of the most common forms of pollinosis in temperate climates, though it receives far less attention than birch allergy. This article covers when and how oak blooms, what symptoms it causes, its cross-reactive partners, and how to treat it effectively. A full picture of pollen allergy is available in the complete allergy guide. When Oak Blooms and Why Its Pollen Is a Problem Oak flowers in April through early May, simultaneously with birch and alder. This spring tree season is the peak of pollinosis in temperate zones — multiple pollen types are airborne at the same time. Many patients with oak allergy have co-existing sensitisation to birch, alder, or hazel, which substantially amplifies symptoms. Oak pollen grains are slightly larger than birch, so they penetrate the lower airways somewhat less readily. Nevertheless, at high airborne concentrations — especially in dry, windy conditions — they cause pronounced rhinoconjunctivitis and can trigger bronchospasm in susceptible patients. Oak pollen concentration peaks in the morning (9:00–12:00) on dry, windy days. Rain dramatically reduces it — and symptoms with it. The active pollen period lasts 2–3 weeks but can extend in unfavourable weather. One interesting feature: in cities with many oak trees (parks, avenues), pollen concentrations are often higher than in forested areas, due to the clustering of trees and pollen reflection off buildings. Symptoms of Oak Allergy: How to Distinguish It from a Cold Pollinosis symptoms from oak pollen are typical of any pollen allergy — virtually indistinguishable from birch or alder reactions. What differentiates it is the timing of the season and the cross-reactive profile. Typical symptoms: - Profuse watery nasal discharge, paroxysmal sneezing - Itching of the nose, eyes, palate, and ears - Red, watering, puffy eyes (allergic conjunctivitis) - Nasal congestion, especially at night and in the morning - Dry, persistent cough that worsens outdoors and disappears indoors - Throat tickle How to tell it apart from a cold: - No fever or general malaise - Symptoms appear rapidly when going outside and subside in closed spaces - Rainy weather brings clear relief - Lasts the entire season (2–4 weeks), not 5–7 days - Antihistamines work; antivirals do not Severe manifestations requiring immediate medical attention: - Wheezing, breathlessness — signs of allergic bronchospasm - Angioedema: swelling of the lips, tongue, throat - Anaphylaxis — sudden blood pressure drop, loss of consciousness Some patients experience an atopic dermatitis flare during oak season. Cutaneous allergy manifestations are covered in detail in atopic dermatitis. Oak Cross-Reactive Allergy: What It Is Linked To Oak belongs to the Fagaceae family, whose allergens are structurally similar to those of the Betulaceae (birch family). This determines a broad cross-reactive spectrum — one of the most clinically important features of oak allergy. Cross-reactions with other trees: - Birch — the primary cross-reactive partner. The major birch allergen Bet v 1 and its homologues in oak pollen share 50–70% structural identity. Approximately 50–60% of people sensitised to birch also react to oak. This is why the spring tree season is so difficult for many patients. For details on birch allergy, see birch allergy (pollinosis). - Alder, hazel, hornbeam — same botanical families, similar allergenic proteins - Chestnut, beech — weaker cross-reactive associations Food cross-reactions — an important practical issue. During oak flowering, the immune system — already activated by pollen allergens — begins reacting to structurally similar proteins in certain foods. Typical food triggers for oak allergy: - Apples, pears, quince, peach, plum, cherries — stone and pome fruits - Nuts: hazelnut, almond, walnut - Carrot, celery, parsley - Potato (uncommonly) - Soy and soy products Reactions manifest as a burning sensation and itching inside the mouth, with swelling of the lips and tongue immediately after contact — oral allergy syndrome (OAS). This is not classical food allergy: the allergen is a pollen protein, not the food itself. Importantly, heat destroys these proteins — cooked carrots or baked apples are generally tolerated better than raw ones. Diagnosis: How to Confirm Oak Pollen Allergy Self-diagnosing "I have oak allergy" is not a medical diagnosis. Accurate confirmation requires an allergy consultation. Skin prick tests — the gold standard. A standardised oak pollen extract is applied to the forearm with a lancet prick through the drop. A wheal ≥ 3 mm after 15–20 minutes is positive. Performed outside the pollen season. Specific IgE blood testing — measures antibodies to a specific allergen. A tree panel can be run simultaneously: oak, birch, alder, hazel, hornbeam. Safe at any degree of allergy; no antihistamine withdrawal required. Molecular (component-resolved) diagnostics — identifies specific allergenic components (e.g., Que a 1 for oak). Predicts how severe food cross-reactions will be and guides the selection of the right allergen for ASIT. On a complete blood count, allergy frequently produces eosinophilia — elevated eosinophils. This is a non-specific but useful marker of allergic inflammation that a doctor factors in when interpreting the clinical picture. Testing is best performed outside the acute season: spring testing during active flowering is less informative and reaction thresholds are lower. Treatment of Oak Allergy: From Antihistamines to ASIT Pollinosis management is built in layers — from symptom control to addressing the underlying cause. Second-generation antihistamines (cetirizine, loratadine, fexofenadine, bilastine) — first line. Taken continuously throughout the season, not just when symptoms flare. Non-sedating, 24-hour action. Intranasal corticosteroids (mometasone, fluticasone, budesonide) — most effective for moderate to severe rhinitis. Onset of action takes 3–7 days, so starting 1–2 weeks before the season peaks is important. Minimal systemic absorption; safe for long-term use. Antihistamine eye drops (olopatadine) — for prominent conjunctivitis. ASIT (allergen-specific immunotherapy) — the only treatment that addresses the cause: it reprogrammes the immune response to oak allergen. Course length 3–5 years, conducted outside the pollen season. Eliminates or substantially reduces symptoms, prevents the development of bronchial asthma, and reduces food cross-reactions. Prescribed by an allergist after precise allergen identification — the only way to ensure efficacy. For combined oak and birch allergy, multi-allergen ASIT with simultaneous treatment for several trees is available. How to Get Through Oak Season: Practical Measures Reducing allergen exposure is as important a part of management as medication. - Monitor pollen maps and apps; limit outdoor time on high-count days, especially in the morning. - Keep windows closed during peak pollen hours (10:00–16:00). Ventilate in the evening after rain. - Air conditioning with a HEPA filter removes pollen from indoor air. - Change clothes and rinse your nose with saline immediately after coming inside. - Do not hang laundry outside during the season. - Wraparound sunglasses protect the eyes from airborne pollen. - During flares, temporarily eliminate raw cross-reactive foods: fresh apples, stone fruits, hazelnuts — reducing the total allergen load. When Urgent Medical Attention Is Needed Most oak pollinosis presentations are well managed on an outpatient basis. But some symptoms demand immediate help: - Breathlessness, wheezing, chest tightness — allergic bronchospasm - Angioedema: rapidly worsening swelling of the face, lips, tongue, or throat - Anaphylaxis: sudden weakness, blood pressure drop, loss of consciousness, widespread urticaria - Symptoms uncontrolled by standard-dose antihistamines - First-time pollinosis in a child under 3 - Season-on-season worsening with new cough and breathlessness — risk of progression to asthma This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/obshchiy-analiz-mochi https://labreadai.com/en/posts/obshchiy-analiz-mochi Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) How to read a urine test: color, protein, glucose, leukocytes, red blood cells and casts — what every indicator means and when abnormal results need medical attention. Articles article You are holding a results sheet with two dozen rows — colour, pH, protein, leukocytes, casts, nitrites — and do not know where to start. Urinalysis is one of the most commonly ordered laboratory tests, and at the same time one of the least understood by patients. This article walks through every indicator in order: what is being measured, what value counts as normal, what deviations mean, and how serious they are. Not to replace your doctor — but so you can arrive at the appointment prepared and understand what is being discussed. How a Urinalysis Is Structured and How to Read It A urinalysis consists of three sequential components: - Physical properties — what can be seen with the naked eye and assessed with a urinometer: colour, clarity, odour, specific gravity, and acidity (pH) - Chemical analysis — a dipstick detects the presence or absence of substances that should not normally appear in urine: protein, glucose, ketones, bilirubin, nitrites - Sediment microscopy — after centrifuging the sample, the laboratory technician examines the sediment under a microscope, counting cells, casts, and crystals The three components complement each other. Physical properties give an overall first impression. Chemistry clarifies: are there pathological substances present? Microscopy shows where they come from — glomeruli, tubules, bladder, or prostate. How to read the report: next to each parameter, the laboratory prints its reference range — the normal value for its specific method. Compare against this, not against averaged internet figures: norms differ between equipment and reagents. Physical Properties: Colour, Clarity, Specific Gravity and pH Colour — the first thing the technician evaluates. Normal: straw-yellow to amber. Intensity depends on hydration: a dehydrated body produces dark concentrated urine; a well-hydrated one produces light urine. Deviations: - Red or pink — blood (haematuria), beetroot, rifampicin - Dark brown, "strong tea" colour — bilirubinuria, liver disease - Cloudy white — pyuria in severe infection, phosphaturia - Nearly colourless — polyuria, diabetes insipidus, excessive fluid intake Clarity — normally full. Turbidity indicates bacteria, leukocytes, mucus, epithelium, or salts. Mild turbidity from a sample left standing is an artefact, not pathology. Specific gravity — normal 1.010–1.025. Reflects the kidneys' ability to concentrate urine. Persistently low density (hyposthenuria < 1.010) indicates impaired concentrating function, characteristic of chronic renal insufficiency. High density ( 1.030) — dehydration, diabetes mellitus. pH — normal 4.5–8.0. Acidic urine is typical of a high-meat diet, fever, and gout. Alkaline urine — vegetarian diet, urinary tract infection (bacteria break down urea into ammonia), prolonged sample storage. Chemical Indicators: Protein, Glucose and Ketones Protein (proteinuria) — normal: absent or trace up to 0.033 g/L. Protein in urine is one of the most important signals of kidney filter damage. Even a small excess warrants attention. Types and causes of proteinuria: - Physiological (functional) — after strenuous exercise, fever, or cold exposure. Disappears at rest. - Orthostatic — in young people, protein appears only in daytime upright urine, absent at night. A benign variant. - Pathological glomerular — in glomerulonephritis, nephrotic syndrome, diabetic nephropathy. Protein 1–3 g/L, often combined with red blood cells and casts. - Tubular — from tubular damage: tubulointerstitial nephritis, Fanconi syndrome. For a detailed article on causes and clinical significance, see protein in urine. Glucose (glycosuria) — normal: absent. Appears when blood glucose exceeds the renal threshold (9–10 mmol/L). Main causes: diabetes mellitus, stress hyperglycaemia, renal glycosuria (impaired tubular reabsorption with normal blood sugar). Glucose in urine without hyperglycaemia is a reason to check tubular function. Ketone bodies — normal: absent. Acetone, acetoacetate, and beta-hydroxybutyrate appear with accelerated fat breakdown: fasting, low-carbohydrate diet, diabetic ketoacidosis, alcoholic ketoacidosis, severe vomiting in pregnancy. A distinction is important: trace ketones on a ketogenic diet are an expected finding. Marked ketonuria with symptoms is an emergency. Everything about ketones — in ketones in urine. Liver Function Markers: Bilirubin and Urobilinogen Bilirubin — normal: absent. Only direct (conjugated) bilirubin, being water-soluble, passes through the kidney filter. Its presence in urine signals cholestasis or parenchymal liver disease: viral hepatitis, cirrhosis, gallstone disease with obstruction, pancreatic cancer. Urine darkens and froths when shaken. Indirect (unconjugated) bilirubin does not enter urine — it is bound to albumin and water-insoluble. This is why in haemolytic anaemia with elevated indirect bilirubin, urine remains light-coloured. Urobilinogen — a product of bilirubin reduction by intestinal bacteria. Normal: up to 17 µmol/L. Elevated in haemolysis (increased red cell breakdown), impaired hepatic excretion (hepatitis, cirrhosis), and constipation. Complete absence of urobilinogen alongside bilirubinuria indicates total bile duct obstruction. Nitrites and Bacteria: Infection Markers Nitrites — normal: absent. Gram-negative bacteria (E. coli, Klebsiella, Proteus) convert urinary nitrates to nitrites. A positive nitrite test from a properly collected sample is a highly specific sign of bacterial infection. An important limitation: gram-positive bacteria (staphylococci, enterococci) do not possess nitrate reductase — when infection is caused by them, nitrites will be negative even with a high bacterial count. A negative nitrite result does not rule out infection. Bacteria — normally absent in a properly collected sample. Bacteria on microscopy combined with pyuria is grounds for ordering a urine culture with antibiotic sensitivity. Bacteria without pyuria suggests sample contamination. Sediment Microscopy: Leukocytes, Red Blood Cells and Casts Leukocytes — normal: up to 5 per high-power field in women, up to 3 in men. Pyuria (leukocyturia) means inflammation in the urinary tract. The level roughly reflects severity: 5–15 mild, 15–50 moderate, above 50 severe. A full breakdown of the indicator: leukocytes in urine. Key for interpretation: pyuria without nitrites or bacteria is called sterile pyuria. Causes include renal tuberculosis, chlamydial infection, analgesic nephropathy, and interstitial nephritis — situations where a standard urine culture is negative but inflammation is present. Red blood cells — normal: 0–3 per high-power field. Haematuria — blood in urine. The character of red cells suggests the source: - Intact (fresh) red blood cells — bleeding from the lower tract: bladder, urethra, prostate. Causes: cystitis, kidney stone, tumour. - Dysmorphic ("ghost") red blood cells — have passed through the glomerular filter. Sign of glomerulonephritis. Their presence with protein and casts = nephritic syndrome. Casts are protein moulds formed in renal tubules. Their presence indicates pathology specifically in the renal parenchyma. Cast type Composition Significance --------- Hyaline Pure protein Occasional — normal; many — proteinuria, exercise Granular Protein + cellular debris Tubular damage, chronic disease Waxy Dense protein Chronic renal failure, amyloidosis Red blood cell Protein + RBCs Glomerulonephritis, vasculitis — pathognomonic White blood cell Protein + WBCs Pyelonephritis, interstitial nephritis Epithelial Protein + tubular epithelium Acute tubular necrosis, nephrotoxins Red blood cell and waxy casts are alarming findings requiring urgent nephrology consultation. Epithelial cells — occasional transitional and squamous cells are acceptable. Massive shedding of renal (tubular) epithelium indicates acute tubular necrosis or nephrotoxic injury. Crystals — precipitated salts. Occasional oxalate or urate crystals at normal urine output are not pathological. Massive crystalluria with flank pain suggests nephrolithiasis. Cystine crystals are a rare marker of cystinuria. Mucus — trace amounts are acceptable. Abundant mucus indicates sample contamination or chronic urethral irritation. How to Read a Urinalysis Report: A Step-by-Step Approach A few practical steps for independent orientation: 1. Start with the laboratory's reference range — printed next to each parameter. This, not internet averages, is your baseline. 2. Distinguish isolated from combined abnormalities. A single isolated finding (trace protein with no leukocytes or casts) is generally less significant than a combination (protein + red blood cell casts + high leukocytes). 3. Match the result to symptoms. Pyuria with burning on urination and positive nitrites is most likely cystitis. The same pyuria without symptoms in an elderly man is a different diagnostic context entirely. 4. Check collection conditions. A contaminated sample (abundant squamous epithelium, heavy mucus) makes the entire test unreliable. If in doubt — repeat with proper technique. 5. Do not diagnose from a single test. A one-off abnormality warrants a repeat. Consistent abnormalities on two or more tests are the basis for further investigation. When Urinalysis Results Require Urgent Medical Attention Most findings call for a scheduled appointment. But certain results demand immediate action: - Visible blood in urine or red blood cells 50 per field — urgent - Red blood cell or waxy casts — nephrology emergency - Protein 1 g/L combined with oedema and elevated blood pressure — nephrotic or nephritic syndrome - Pyuria 50 per field + fever + flank pain — possible pyelonephritis - Marked glycosuria with ketones and symptoms — possible diabetic ketoacidosis - Any pathological finding in a pregnant woman — immediate consultation This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/ovulation-what-it-is https://labreadai.com/en/posts/ovulation-what-it-is Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ovulation is the only window for conception each cycle. Signs, home tracking methods, what affects timing, and when irregular ovulation needs medical attention. Articles article Every menstrual cycle is the body's preparation for a potential pregnancy — and ovulation is the moment everything hinges on. It lasts only a matter of hours, yet conception is only possible during this narrow window. Understanding when ovulation occurs, how to recognise it, and what to do if it is disrupted is useful for every woman, whether she is trying to conceive or simply wants to understand her own cycle. What Is Ovulation and How Does It Happen? Ovulation is the release of a mature egg from an ovarian follicle into the fallopian tube. Simple in concept, it is the product of a precise hormonal sequence that resets with every cycle. In the first half of the cycle (the follicular phase), follicle-stimulating hormone (FSH) prompts several follicles in the ovary to begin maturing. One — the dominant follicle — outpaces the rest and continues to grow. As it grows, it secretes increasing amounts of estradiol: when estradiol reaches its peak, it signals the pituitary gland to release a surge of luteinizing hormone (LH). This LH surge triggers the final maturation of the egg. Approximately 36–40 hours later, the follicle ruptures and the egg is released. After rupture, the empty follicle transforms into the corpus luteum — a temporary gland that begins producing progesterone. Progesterone primes the endometrium for implantation. If fertilisation does not occur, the corpus luteum degenerates within 10–14 days, progesterone falls, and menstruation begins. When Does Ovulation Occur: Calculating Your Day The key rule: ovulation happens approximately 14 days before the next menstrual period — not 14 days after the previous one began, as is commonly assumed. This distinction matters with irregular cycles. For a perfect 28-day cycle, both calculations give the same answer — day 14. But for a 35-day cycle, ovulation falls around day 21, not day 14. The calculation: - Find your average cycle length over the last 3–6 months - Subtract 14 — that is your estimated ovulation day For a 26-day cycle: 26 − 14 = day 12 For a 32-day cycle: 32 − 14 = day 18 This is an estimate only. Even in women with regular cycles, the actual ovulation day can shift by 1–3 days depending on stress, illness, sleep disruption, and other factors. Signs of Ovulation: How to Recognise When It Happens The body gives several signals around ovulation. They are not universal — some women notice none of them, while others experience them clearly. Changes in cervical mucus — the most reliable physical sign. In the days leading up to ovulation, discharge becomes abundant, clear, and stretchy, resembling raw egg white. This consistency facilitates sperm movement. After ovulation, mucus quickly becomes thick and scant. Mid-cycle pelvic pain (Mittelschmerz) — a dull or cramping pain on one side of the lower abdomen, lasting from a few minutes to several hours. It is caused by peritoneal irritation when the follicle ruptures. Occurs in 20–40% of women. Increased libido — physiologically driven: the peak in estrogens and androgens around ovulation heightens sexual desire. Mild breast tenderness — a result of the hormonal shift before and during ovulation. Light spotting — a small amount of bloody discharge at the moment of follicular rupture. Uncommon, but a normal variant. Rise in basal body temperature (BBT) — after ovulation, progesterone raises BBT by 0.2–0.5 °C. This is a retrospective sign: the temperature rise happens after the egg has already been released, confirming that ovulation has occurred. How to Detect Ovulation at Home Several methods exist, with varying accuracy and practicality. Ovulation predictor kits (LH tests) — the most accurate home method. They detect the LH surge in urine. A positive result means ovulation is expected within 24–36 hours. Testing should begin 4–5 days before the estimated ovulation day, twice daily — morning and midday (not the first morning urine, unlike a pregnancy test). Basal body temperature (BBT) charting — rectal or oral temperature measured every morning before getting up. After ovulation, temperature rises and stays elevated until menstruation. The method requires consistency across at least 3 cycles to identify a pattern and is unreliable with disrupted sleep, fever, or anti-inflammatory medication. Cervical mucus method (Billings method) — observing the character of vaginal discharge. It requires practice but has reasonable accuracy when applied correctly. Ultrasound folliculometry — the gold standard for medical purposes. A series of ultrasounds tracks the dominant follicle's growth and the moment of rupture. Ordered when planning pregnancy, treating infertility, or monitoring ovulation induction. Cycle-tracking apps are useful as supplementary tools but should not be relied upon for conception planning: they calculate from an algorithm, not from actual hormone measurements. How Long Ovulation Lasts and What the Fertile Window Means The actual release of the egg takes only a few minutes. The egg survives 12–24 hours after release — 48 hours at most. That sounds like a very narrow target. But sperm can survive in favorable cervical mucus for up to 5 days. This is why the fertile window — the period when conception is possible — spans approximately 6 days: the five days before ovulation and one day after. This explains why unprotected sex several days before ovulation can be just as effective as sex on the day of egg release itself. For more on what happens in the body after successful fertilisation, see first signs of pregnancy. Ovulation with an Irregular Cycle An irregular cycle — varying by more than 7–8 days from month to month — makes calendar prediction unreliable. If your cycle ranges from 24 to 38 days, the ovulation date shifts accordingly, and the simple "minus 14" formula falls short. In these cases, LH tests or folliculometry are far more practical. Testing should begin earlier — from day 8–10 of the cycle — and continue for longer. It is important to distinguish an irregular but ovulatory cycle from a cycle with no ovulation at all. With an irregular ovulatory cycle, periods still come, however unpredictably. With an anovulatory cycle, menstruation may arrive on schedule — but the follicle never ruptured, no egg was released, and conception was impossible that month. Ovulation Disorders: Causes and Contributing Factors Absent or infrequent ovulation is one of the leading causes of female infertility. The causes are varied. Polycystic ovary syndrome (PCOS) — the most common cause of chronic anovulation. Multiple small follicles develop but none becomes dominant. Accompanied by menstrual irregularity, elevated androgens, and often insulin resistance. Thyroid dysfunction — both hypothyroidism and hyperthyroidism interfere with sex hormone synthesis and can suppress ovulation. TSH is part of the standard hormonal workup for cycle irregularities. Hyperprolactinemia — elevated prolactin inhibits FSH and LH secretion, which are required for follicle maturation. Often accompanied by nipple discharge outside of pregnancy or breastfeeding. For more on this hormone and its causes: prolactin: what is this hormone. Significant weight loss and low body weight — adipose tissue participates in estrogen synthesis. At a BMI below 17–18 kg/m², the hypothalamus reduces gonadotropin output and ovulation ceases. The same occurs in eating disorders. Intense athletic training — female athletes with high training loads and low body fat percentage frequently develop the "female athlete triad": anovulation, osteoporosis, and energy deficiency. Chronic stress — cortisol suppresses pulsatile GnRH secretion, disrupting the entire hormonal axis. A single stressful event can delay ovulation by a few days; chronic stress can cause prolonged cycle disruption. Age-related decline in ovarian reserve — after age 35–37, the quantity and quality of follicles progressively decreases, and anovulatory cycles become increasingly frequent. When to See a Doctor Most women do not track ovulation routinely — and that is perfectly normal. But several situations call for a consultation with a gynaecologist or reproductive specialist: - Cycles consistently shorter than 21 or longer than 38 days over 3 or more months - Absence of menstruation for more than 3 months with pregnancy ruled out - No conception after 12 months of regular unprotected intercourse (6 months after age 35) - Confirmed absent ovulation based on LH tests or BBT across several consecutive cycles - Nipple discharge unrelated to pregnancy or breastfeeding - Progressively worsening mid-cycle pain from month to month Ovulation disorders respond well to treatment when identified early. In most cases, addressing the underlying cause — normalising weight, correcting hormone levels, or reducing training load — is sufficient. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/parathyroid-hormone-pth https://labreadai.com/en/posts/parathyroid-hormone-pth Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Parathyroid hormone (PTH) regulates calcium and phosphorus. Normal ranges, causes of hyperparathyroidism and hypoparathyroidism, links to kidneys and bones. Articles article Bone pain without injury, recurrent kidney stones, persistent weakness — or at the opposite extreme, muscle cramps and numb fingertips. All of these can point to dysfunction of four tiny glands that most people have never heard of. Parathyroid hormone (PTH) is produced by the parathyroid glands and serves as the body's primary regulator of calcium metabolism. When it deviates from normal — in either direction — it disrupts the function of bones, kidneys, muscles, and the nervous system. This article explains how PTH works, what constitutes a normal result, why it becomes abnormal, and when treatment is needed. What Is Parathyroid Hormone and How Does It Regulate Calcium? The parathyroid glands are four small, rice-grain-sized structures located on the posterior surface of the thyroid. Despite their size, they control one of the body's most critical mineral balances. PTH is a polypeptide hormone whose primary task is to keep calcium in the blood within the narrow range of 2.15–2.55 mmol/L. This range is critical: calcium is required for muscle contraction, nerve impulse transmission, blood clotting, and bone mineralisation. Even minor deviations disrupt these processes. The regulatory mechanism is a classic negative feedback loop: - Blood calcium falls → parathyroid glands release PTH - PTH acts on three target organs: bone (stimulates resorption, releasing calcium into the blood), kidneys (enhances calcium reabsorption and activates vitamin D), and intestine (via vitamin D, increases dietary calcium absorption) - Blood calcium rises → PTH secretion is suppressed PTH simultaneously reduces phosphorus reabsorption in the kidneys, which is why hyperparathyroidism produces a characteristic laboratory pair: rising calcium and falling phosphorus. The close relationship between PTH and vitamin D makes their combined assessment essential: vitamin D deficiency is one of the leading causes of secondary PTH elevation. How to Get Tested for PTH PTH is measured in serum using immunoassay or electrochemiluminescence methods. It is almost always ordered alongside total and ionised calcium, phosphorus, and vitamin D — only in this combination does the result become clinically meaningful. Preparation guidelines: - Blood is drawn fasting in the morning — at least 8–12 hours after the last meal. - Avoid alcohol and intense exercise for 24 hours beforehand. - Calcium supplements and vitamin D should be stopped 2–3 days before the test in consultation with your doctor — they can artificially normalise the picture. - Lithium, thiazide diuretics, and corticosteroids affect calcium metabolism — inform your doctor. - For follow-up testing, always use the same laboratory: PTH assay methods vary significantly between labs. Indications for ordering PTH: - Hypercalcaemia or hypocalcaemia found on a biochemical panel - Urinary stone disease, especially calcium-based stones - Osteoporosis or reduced bone mineral density on densitometry - Chronic kidney disease — mandatory monitoring - Symptoms of hypocalcaemia: cramps, numbness, tingling - Incidental finding during workup for fatigue or weakness Parathyroid Hormone Normal Range: Table by Age Reference ranges vary depending on the analytical method and laboratory. Category Normal (pg/mL) Normal (pmol/L) --------- Adults 18–30 years 10–65 1.05–6.84 Adults 30–70 years 15–65 1.58–6.84 Elderly 70 years 15–75 1.58–7.89 Pregnant women 10–60 1.05–6.31 In older adults, the upper reference limit is slightly higher — a physiological consequence of decreased calcium absorption and reduced vitamin D activation with age. A mild PTH elevation in this group does not always require treatment; the context of calcium and vitamin D levels is decisive. During pregnancy, PTH physiologically decreases in the first half due to active calcium transfer to the foetus through the placenta and increased intestinal calcium absorption. A rise in PTH during pregnancy warrants investigation. High PTH (Hyperparathyroidism): Causes and Symptoms Hyperparathyroidism — excess PTH secretion — comes in three forms: primary, secondary, and tertiary. Primary hyperparathyroidism — autonomous PTH hypersecretion by the parathyroid glands themselves, independent of blood calcium. Causes: parathyroid adenoma (80–85% of cases), hyperplasia of all four glands, rarely carcinoma. Laboratory pattern: high PTH + high calcium + low phosphorus. This is the most common cause of hypercalcaemia in outpatients. Symptoms of primary hyperparathyroidism are classically described as "bones, stones, and groans": - Bones: bone pain, pathological fractures, osteoporosis, cystic lesions - Stones: recurrent kidney stones — calcium oxalate and phosphate calculi - Groans (gastrointestinal): nausea, constipation, peptic ulcer, pancreatitis - Neuropsychiatric symptoms: fatigue, depression, cognitive impairment; in severe hypercalcaemia — stupor and coma Secondary hyperparathyroidism — a reactive rise in PTH in response to chronic hypocalcaemia or impaired vitamin D metabolism. The parathyroid glands are functioning normally but are forced to secrete more because of persistently low calcium. The main causes: - Chronic kidney disease — the most common cause of secondary hyperparathyroidism in adults. Damaged kidneys fail to activate vitamin D and retain phosphorus, driving calcium down and PTH up compensatorily. In chronic kidney disease, PTH is monitored at every visit. - Vitamin D deficiency — especially with poor nutrition, sedentary lifestyle, or malabsorption - Malabsorption syndromes (coeliac disease, Crohn's disease, bowel resection) - Pregnancy and breastfeeding with insufficient calcium intake In secondary hyperparathyroidism, calcium is normal or low — unlike primary, where it is elevated. This is the key differential finding. Tertiary hyperparathyroidism — develops after years of secondary hyperparathyroidism (most often in dialysis patients), when the glands acquire autonomy and continue to hypersecrete PTH even after calcium is normalised. Low PTH (Hypoparathyroidism): Causes and Manifestations Hypoparathyroidism — insufficient PTH secretion — is less common than hyperparathyroidism but clinically equally significant. Causes of hypoparathyroidism: - Post-surgical — the most common cause. Accidental removal or damage to the parathyroid glands during thyroid or neck surgery. Transient hypoparathyroidism occurs in 10–30% of patients after total thyroidectomy; permanent hypoparathyroidism in 1–3%. - Autoimmune — antibodies against parathyroid cells, often as part of polyglandular autoimmune syndromes. - Genetic — congenital absence or underdevelopment of the parathyroid glands (DiGeorge syndrome). - Hypomagnesaemia — severe magnesium deficiency blocks PTH secretion: another reason why phosphorus and magnesium are always checked alongside calcium in calcium metabolism disorders. - Metastatic involvement of the glands by malignant tumours. Symptoms of hypoparathyroidism are a direct consequence of hypocalcaemia: - Tetany — painful muscle spasms and cramps - Paraesthesia — numbness and tingling around the mouth, hands, and feet - Chvostek's sign (facial muscle twitch on tapping the facial nerve) - Trousseau's sign (carpal spasm with blood pressure cuff inflation) - Laryngospasm — potentially life-threatening - Seizures and psychosis in severe hypocalcaemia - Cataracts and basal ganglia calcification with prolonged disease When PTH Results Require Medical Attention A PTH result is always interpreted together with calcium, phosphorus, and vitamin D — in isolation it conveys little. Reasons to consult an endocrinologist: - PTH above 100 pg/mL combined with hypercalcaemia — high probability of primary hyperparathyroidism - PTH elevated with normal or low calcium — secondary hyperparathyroidism; vitamin D deficiency and kidney disease must be excluded - Calcium above 3.0 mmol/L regardless of PTH level — possible hypercalcaemic crisis - Symptoms of hypocalcaemia (cramps, numbness) with low PTH — hypoparathyroidism requiring replacement therapy - Recurrent calcium kidney stones — screen for hyperparathyroidism - Osteoporosis in young patients without obvious risk factors — rule out hyperparathyroidism - After thyroid surgery — PTH and calcium monitoring in the first 24 hours Treatment depends on the form: symptomatic primary hyperparathyroidism is treated surgically — parathyroidectomy. Secondary forms are managed by addressing the cause. Hypoparathyroidism is treated with calcium supplements and active vitamin D analogues. Conclusion Parathyroid hormone is an unassuming but indispensable regulator, working in constant dialogue with calcium, phosphorus, and vitamin D. Its deviation upward or downward is not a diagnosis — it is a signal: of vitamin D deficiency, a kidney problem, a parathyroid adenoma, or a surgical consequence. Correct interpretation requires combining PTH with calcium and the full clinical picture. Any abnormality warrants an endocrinology consultation and further workup — not self-treatment with calcium supplements. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/poplar-allergy https://labreadai.com/en/posts/poplar-allergy Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Poplar allergy explained: why poplar fluff is not the real allergen, symptoms of pollinosis, cross-reactions with grasses and how to manage the season effectively. Articles article Every summer, millions of people blame poplar fluff for their runny noses, watery eyes, and sneezing fits. But this accusation has one problem: poplar fluff is not itself an allergen. This is one of the most persistent medical myths — and it prevents people from getting the right treatment. This article explains what actually triggers allergic symptoms during poplar season, why the fluff is more of a witness than a culprit, what genuine pollinosis looks like, and how to get through the season with minimum suffering. For a complete overview of allergy mechanisms and treatment, see the complete allergy guide. What Is Poplar Allergy and What Role Does the Fluff Play? The poplar is a dioecious plant: male and female trees are separate. Allergy is caused exclusively by pollen from male poplar trees — microscopic grains that disperse through the air during the flowering period. These grains contain allergenic proteins capable of triggering an immune response in sensitised individuals. Poplar fluff is the seed of female poplar trees, covered in fine fibres for wind dispersal. The fluff itself is hypoallergenic: the fibres are too large to reach the bronchi and alveoli, and they contain no significant allergenic proteins. However, fluff works brilliantly as a carrier: it collects pollen from other plants — grasses, birch, alder, mugwort — and deposits it directly onto mucous membranes. This is why symptoms during fluff season are so intense: simultaneous contact with multiple allergens. The key insight: if you react "to poplar fluff," your true allergen is most likely grass pollen or another plant flowering at the same time. This distinction matters enormously for getting the right treatment. When Poplar Blooms and the Difference Between Pollen and Fluff The poplar season in temperate climates divides into two distinct phases: Poplar flowering (April – early May) — male poplars release fine pollen well before the fluff appears. At this stage the trees are bare, heavy with catkins. The pollen is light and travels for kilometres; airborne concentrations can be high. People sensitised to poplar pollen begin experiencing pollinosis symptoms now. This period typically overlaps with birch flowering — many patients have cross-sensitivity to both trees. Fluff season (late May – June) — female poplars release their mature seeds on white fibres. Visually it resembles a snowfall. At exactly this time, grass pollens are at their peak — timothy, cocksfoot, meadow foxtail. Most "poplar fluff allergies" are actually reactions to these grass pollens, which the fluff mechanically transports. To find out exactly what you are allergic to, allergy testing with skin prick tests or specific IgE blood testing is needed. Without this, you risk treating the wrong allergen. Symptoms of Poplar Allergy: How to Tell It Apart from a Cold Pollinosis symptoms during poplar season are typical of any pollen allergy. The key distinction from a cold is the character, rhythm, and seasonality of symptoms. Typical symptoms: - Profuse watery nasal discharge — clear, odourless - Paroxysmal sneezing, often in bursts of 5–10 consecutive sneezes - Itching of the nose, eyes, palate, and ears — relentless and impossible to stop - Red, watering eyes (allergic conjunctivitis) - Nasal congestion, especially at night - Dry, persistent cough that worsens outdoors How to distinguish from a cold: - No fever or general malaise with allergy - Symptoms appear within minutes of allergen exposure - Improve rapidly in rainy weather and indoors with windows closed - Last the entire season, not the 5–7 days typical of a respiratory infection - Antihistamines help; antiviral medications do not In some patients, pollinosis is accompanied by skin manifestations: urticaria or a flare of atopic dermatitis. Cutaneous allergy presentations are covered in detail in atopic dermatitis. In severe pollinosis, allergic bronchospasm can develop — wheezing, breathlessness. This requires prompt medical attention: without treatment, pollinosis can progress to bronchial asthma. Cross-Reactive Allergy: What Is Poplar Linked To? Allergy is rarely isolated. Allergenic proteins from different plants share structural similarities, and an immune system trained on one allergen begins reacting to others — cross-reactivity. Poplar has the following cross-reactive associations: - Grasses — the most clinically important cross-reactive group. Timothy, cocksfoot, and meadow foxtail bloom simultaneously with poplar fluff. Most people who believe they are allergic "to poplar" have grass pollen as their primary allergen. More detail in grass pollen allergy. - Birch and alder — bloom earlier than poplar, but their pollen proteins are structurally similar. Approximately 40% of people with birch allergy also react to poplar. - Mugwort — a late-summer allergen with shared epitopes with poplar. - Food allergens — sensitisation to poplar may be associated with reactions to apples, pears, stone fruits (peach, plum), carrots, and celery during the pollen season. Cross-reactivity explains why symptoms during fluff season can be so severe: the body is simultaneously responding to multiple structurally similar allergens. Diagnosis: Which Tests to Order Self-diagnosing "I'm allergic to poplar fluff" is not a medical diagnosis. Accurate allergen identification is essential for effective treatment. Skin prick tests — the gold standard of allergy diagnosis. Standardised allergen extracts are applied to the forearm and a small prick is made through each drop. After 15–20 minutes, a wheal larger than 3 mm is considered positive. Tests are performed outside the pollen season and after antihistamines have been stopped. Specific IgE blood testing — an alternative to skin prick tests. Allows simultaneous testing of a panel of 20–30 allergens: tree pollens, grasses, weeds, dust mites, mould. No medication withdrawal is required, and it is safe regardless of symptom severity. On a complete blood count, allergy frequently produces eosinophilia — elevation of the eosinophil fraction. This is a non-specific marker of allergic inflammation that helps a doctor suspect an allergic cause before specific testing is performed. Testing is best done with an allergist outside the acute season: during the season, skin tests are less informative and the risk of a pronounced reaction is higher. Treatment During Poplar Season Managing pollinosis works on three levels: symptom relief, anti-inflammatory therapy, and — when indicated — allergen-specific immunotherapy (ASIT). Second-generation antihistamines (loratadine, cetirizine, fexofenadine) — first line. Non-sedating, 24-hour action, effective for itching, sneezing, and watery eyes. Taken continuously throughout the season, not just when symptoms flare. Intranasal corticosteroids (mometasone, fluticasone, budesonide) — the most effective treatment for moderate and severe rhinitis. Onset of action takes 3–7 days, so starting 1–2 weeks before the season begins is important. Minimal systemic absorption — safe for long-term use. Antihistamine or mast cell-stabilising eye drops (olopatadine, cromoglicic acid) — for prominent conjunctivitis. ASIT (allergen-specific immunotherapy) — the only treatment that addresses the cause of allergy rather than symptoms. A course lasts 3–5 years and is conducted outside the pollen season. It significantly outperforms symptom-based treatment and prevents the development of asthma. Prescribed by an allergist after precise allergen identification. How to Survive Poplar Season: Practical Advice Reducing allergen load means fewer symptoms even with the same medication. Several evidence-based strategies: - Monitor pollen maps and apps with real-time pollen counts; plan outdoor activities on low-count days. - Rain washes pollen out of the air — the best time to go outside. - Keep windows closed during peak pollen hours (10:00–17:00). Ventilate in the late evening and at night. - An air conditioner with a HEPA filter substantially cleans indoor air. - After coming home, change clothes immediately and rinse your nose with saline — removing deposited pollen from mucous membranes. - Do not hang laundry outside during the season; pollen settles on fabric. - Wraparound sunglasses provide partial protection for the eyes against airborne pollen. - For severe allergy, consider leaving the city at peak season: mountain and coastal areas typically have significantly lower pollen concentrations. When to Seek Urgent Medical Attention Most pollinosis cases are well managed on an outpatient basis. But certain symptoms require immediate care: - A choking episode, significant breathlessness, or wheezing — possible allergic bronchospasm - Angioedema: swelling of the lips, tongue, or throat — risk of airway obstruction - Anaphylaxis: sudden drop in blood pressure, loss of consciousness, widespread urticaria - Symptoms not controlled by standard-dose antihistamines - Pollinosis appearing for the first time in a child under 3 — paediatric allergology consultation required - Season-on-season worsening with new cough and breathlessness — risk of progression to asthma This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/povyshennyy-leykocit-v-krovi https://labreadai.com/en/posts/povyshennyy-leykocit-v-krovi Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) High white blood cells (leukocytosis): normal ranges, causes in adults and children — from infections to cancer, types by cell fraction and when to seek urgent care. Articles article You received your complete blood count and found that your white blood cell count is above normal. The first thought is usually infection. In most cases that is correct: leukocytosis is the immune system's signal that it is fighting something. But sometimes elevated white blood cells reflect a medication, stress, pregnancy, or — in rare cases — a blood malignancy. What it means and how serious it is depends not on the total number alone, but on the full differential count together with the clinical picture. This article covers normal ranges, causes of leukocytosis by cell fraction, and when the elevation requires urgent attention. Normal White Blood Cell Count: When Is a Value Considered High? Leukocytes — white blood cells — are the immune system's primary weapons against infection, inflammation, and foreign cells. Leukocytosis is a total white blood cell count above the upper limit of normal. Normal white blood cell count: Category Normal (× 10⁹/L) ------ Adults 4.0–9.0 Pregnant women 6.0–11.0 Infants under 1 year 6.0–17.5 Children 1–6 years 5.0–15.5 Children 6–12 years 4.5–13.5 Adolescents 4.5–11.0 Leukocytosis grades: - Mild: 10–15 × 10⁹/L — often physiological or reactive - Moderate: 15–30 × 10⁹/L — typically infectious or inflammatory - Severe: above 30 × 10⁹/L — mandatory workup to rule out haematological pathology - Hyperleukocytosis: above 100 × 10⁹/L — critical, characteristic of leukaemia A key principle: the total white cell count without a differential is only the starting point. A doctor always evaluates the leukocyte differential to determine which cell population is elevated — this fundamentally changes the diagnostic picture. Physiological Leukocytosis: When Elevation Is Normal Not all leukocytosis signals disease. Several conditions cause physiological white cell elevation that resolves on its own and requires no treatment. Alimentary leukocytosis — after a large meal, especially high in protein. This is why a blood count must be drawn strictly fasting: eating 2–3 hours before the draw can falsely elevate white cells by 20–30%. Exercise-induced leukocytosis — after intense physical exertion, white cells redistribute from tissue reservoirs into the bloodstream. Levels return to normal within hours. Emotional leukocytosis — stress, fear, and pain trigger catecholamine release, mobilising white cells from the bone marrow. Testing during acute emotional distress risks a false result. Pregnancy — physiological leukocytosis from the second trimester onward. Normal in pregnancy is up to 11.0 × 10⁹/L; levels may reach 12–15 × 10⁹/L before delivery. Smoking — chronic tobacco smoke exposure causes a persistent mild leukocytosis from chronic airway inflammation. Newborns — white cell counts of 10–30 × 10⁹/L are normal in the first days of life, gradually declining toward school age. Causes of Leukocytosis in Adults: From Infections to Malignancy Pathological leukocytosis always has a cause. The pattern of elevation and the affected fraction are the key to finding it. Infections — the most common cause: - Bacterial infections (pneumonia, pyelonephritis, tonsillitis, sepsis) produce neutrophilia with a left shift — appearance of immature neutrophils (band cells, metamyelocytes). The more severe the infection, the more pronounced the shift. - Viral infections cause lymphocytosis with normal or mildly elevated total white cells. A classic example: infectious mononucleosis, in which lymphocytes rise sharply with atypical forms appearing on the smear. - Parasitic infestations and allergies — eosinophilia: leukocytosis driven specifically by the eosinophil fraction. Inflammatory and autoimmune diseases: - Rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease — moderate neutrophilia without infection. - Acute myocardial infarction — pronounced neutrophilia in the first 12–24 hours, reflecting tissue necrosis. Medications: - Glucocorticoids (prednisone, dexamethasone) — the most common pharmacological cause of neutrophilia. - Epinephrine and beta-agonists — mobilise the marginal neutrophil pool. - Lithium — stimulates bone marrow granulopoiesis. - G-CSF (granulocyte colony-stimulating factor) — used in oncology; produces pronounced neutrophilia as its intended effect. Oncological and haematological causes — considered with persistent leukocytosis of no apparent cause: - Acute leukaemia — chaotic blast-cell leukocytosis, anaemia, thrombocytopenia. - Chronic myelogenous leukaemia — gradually rising leukocytosis to 50–300 × 10⁹/L, splenomegaly. - Chronic lymphocytic leukaemia — persistent lymphocytosis in older adults. - Myeloproliferative disorders — polycythemia vera, essential thrombocythaemia. Stress and trauma: - Major burns, severe trauma, post-operative state — neutrophilia as a marker of tissue damage. - Splenic or intestinal infarction — acute pronounced neutrophilia. Types of Leukocytosis by Elevated Fraction Knowing which fraction is elevated immediately narrows the list of possible diagnoses. Neutrophilia (neutrophils above 7.5 × 10⁹/L) — the most common type of leukocytosis. Indicates bacterial infection, inflammation, stress, or corticosteroid use. A left shift (band cells 5%) signals active bacterial infection or sepsis. Lymphocytosis (lymphocytes above 3.5 × 10⁹/L) — viral infections, chronic lymphocytic leukaemia, tuberculosis, toxoplasmosis. Atypical lymphocytes on the smear are characteristic of infectious mononucleosis and cytomegalovirus infection. Monocytosis (monocytes above 0.8 × 10⁹/L) — chronic infections (tuberculosis, brucellosis), inflammatory bowel disease, recovery phase of acute infections. Eosinophilia (eosinophils above 0.5 × 10⁹/L) — allergic diseases (bronchial asthma, atopic dermatitis), parasitic infections, drug reactions, malignancies. Basophilia (basophils above 0.1 × 10⁹/L) — allergies, hypothyroidism, chronic myelogenous leukaemia. High White Blood Cells in Children: Ranges and Interpretation In children, normal white cell counts are substantially higher than in adults, and change with age. This means that an "elevated" value in a child must be compared against age-specific norms, not adult references. Characteristics of childhood leukocytosis: - In children under 5, lymphocytes physiologically predominate (up to 60%), not neutrophils — the physiological "crossover." Moderate lymphocytosis in a 2–4 year old is a normal variant, not a sign of disease. - Reactive leukocytosis during a respiratory illness in children often reaches 15–20 × 10⁹/L — not alarming if symptoms are mild and the differential shows a viral pattern. - In newborns, even 20–30 × 10⁹/L can be within the normal range. - Persistent unexplained leukocytosis in a child without infectious symptoms warrants a paediatric haematology consultation. For correct interpretation in children, see complete blood count in children with detailed age-specific reference ranges. High White Blood Cells in Pregnancy Leukocytosis during pregnancy is physiological, driven by increased immune activity, expanded blood volume, and cortisol release. The normal upper limit in pregnancy is 11.0 × 10⁹/L. Nevertheless, leukocytosis in pregnancy requires attention in several situations: - White cells above 15 × 10⁹/L — infection must be excluded: pyelonephritis, chorioamnionitis, appendicitis. - Pronounced neutrophilia with a left shift — signs of active bacterial inflammation. - Any rise in white cells combined with fever, pain, or urinary abnormalities — immediate obstetric consultation. When High White Blood Cells Require Urgent Medical Attention A mild transient leukocytosis after a respiratory illness or physical exertion does not require emergency action. But several situations call for immediate consultation: - White cells above 30 × 10⁹/L without an identifiable infectious cause - Hyperleukocytosis above 100 × 10⁹/L — medical emergency - Leukocytosis combined with anaemia and thrombocytopenia — tri-lineage involvement - Blast cells found on the blood smear — sign of acute leukaemia - Persistently elevated white cells on two or more tests without infection symptoms - Enlarged lymph nodes, spleen, or liver combined with leukocytosis - Pronounced leukocytosis in a child without an obvious cause - Neutrophilia with a left shift + fever above 38.5 °C + deteriorating condition — possible sepsis For moderate leukocytosis with respiratory symptoms and good overall wellbeing — a repeat test 2–3 weeks after recovery. If white cells remain elevated, a scheduled GP visit is appropriate. Conclusion Elevated white blood cells are a symptom, not a disease. Behind leukocytosis can stand dozens of conditions ranging enormously in severity — from a common cold to haematological malignancy. The key to correct interpretation is looking beyond the total count to the differential, the trend, the clinical symptoms, and the patient's history. Moderate leukocytosis during an infection that normalises after recovery is the expected immune response. Persistent elevation without an explainable cause warrants a full diagnostic workup. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/prolactin-what-is-it https://labreadai.com/en/posts/prolactin-what-is-it Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Prolactin is a pituitary hormone controlling lactation and reproductive health. Normal ranges for women and men, causes of hyperprolactinemia and when to see a doctor. Articles article Nipple discharge outside of pregnancy and breastfeeding, unexplained menstrual irregularities, or a significant drop in libido in a man — all of these can point to excess of a single hormone. Prolactin is produced by the pituitary gland and orchestrates lactation, but its influence on the body extends much further: it interferes with sex hormones, immune function, and even pain perception. Elevated prolactin is one of the most common endocrine findings on routine testing — and one of the most underestimated. This article explains what the hormone does, what counts as normal, why it rises, and what to do when levels are chronically elevated. What Is Prolactin and What Does It Do? Prolactin is a protein hormone synthesised by lactotroph cells in the anterior pituitary gland. Its best-known function is stimulating milk production after delivery. But the hormone's role extends well beyond that. What else prolactin does: - Suppresses ovulation — the high prolactin of breastfeeding provides physiological contraception. The same mechanism, when triggered pathologically, disrupts the menstrual cycle and causes infertility. - Affects libido and potency — it inhibits gonadotropin secretion (FSH and LH), reducing testosterone production in men and oestrogen in women. - Participates in immune function — prolactin receptors are expressed on lymphocytes, and the hormone modulates inflammation. - Regulates fluid and salt balance — acting on the kidneys alongside aldosterone. - Has analgesic properties — elevated prolactin during stress partially raises pain thresholds. Prolactin secretion is regulated by dopamine: dopamine tonically inhibits prolactin release from the pituitary. Any factor that reduces dopamine levels or blocks its receptors leads to a rise in prolactin — which explains most drug-induced and stress-related hyperprolactinaemias. How to Get Tested: Preparation and Conditions Prolactin is one of the most sensitive hormones from a pre-analytical standpoint. Its level responds to dozens of physiological stimuli, and without proper preparation the result will be unreliable. Preparation guidelines: - Blood is drawn fasting in the morning — at least 8–12 hours after the last meal. - At least 2–3 hours should pass between waking and the blood draw: prolactin is physiologically elevated in the first hours after sleep. - Avoid sexual activity and breast stimulation for 24 hours — these are powerful physiological triggers of prolactin secretion. - Avoid intense physical exercise for 24 hours beforehand. - Minimise stress before the draw — even venepuncture itself raises prolactin in anxious patients. In cases of significant anxiety, blood may be drawn through an intravenous catheter after 30 minutes of rest. - Inform your doctor of all medications: antipsychotics, antidepressants, metoclopramide, verapamil, domperidone, and many others raise prolactin pharmacologically. For monitoring prolactin over time — always use the same laboratory and the same collection conditions. A single elevated result without symptoms is not a diagnosis: the level can rise from a breast examination performed just hours before the draw. An important concept: macroprolactin. Approximately 15–25% of laboratory hyperprolactinaemia is explained by circulating large prolactin molecules (macroprolactin), which are biologically inactive. These patients have no symptoms but the test shows a high level. To exclude this, a macroprolactin test using polyethylene glycol precipitation is ordered. Prolactin Normal Range: Table for Women, Men and Pregnancy Reference ranges differ substantially by sex, age, and physiological state. Units also vary: mIU/L and ng/mL (1 ng/mL ≈ 21 mIU/L). Category Normal (mIU/L) Normal (ng/mL) --------- Women of reproductive age 40–530 2–25 Postmenopausal women 40–290 2–14 Men 40–360 2–17 Pregnant (1st trimester) up to 3,500 up to 165 Pregnant (2nd trimester) up to 7,000 up to 330 Pregnant (3rd trimester) up to 10,000 up to 470 Breastfeeding women up to 20,000+ up to 950+ The rise in prolactin during pregnancy is physiological, driven by oestrogen stimulation — entirely normal. In non-breastfeeding women after delivery, levels return to normal within 2–3 weeks; in breastfeeding women, they remain elevated throughout lactation. Norms vary considerably between laboratories depending on the method — always check the reference range on your specific report. High Prolactin (Hyperprolactinaemia): Causes and Symptoms Hyperprolactinaemia is a prolactin level above the upper limit of normal for one's sex and physiological state. By mechanism, it is divided into physiological, pharmacological, pathological, and idiopathic forms. Physiological causes (normal, no treatment needed): - Pregnancy and breastfeeding - Sleep and the first hours after waking - Physical exertion, stress, pain - Sexual intercourse and breast stimulation - Hypoglycaemia Pharmacological causes — the second most common group in non-pregnant individuals: - Antipsychotics (haloperidol, risperidone, chlorpromazine) — block dopamine receptors - Metoclopramide, domperidone — prokinetics frequently prescribed for nausea - Antidepressants (tricyclics, some SSRIs) - Verapamil — a calcium channel blocker - Oral contraceptives with high oestrogen doses - Opioid analgesics with prolonged use Pathological causes — require investigation and treatment: - Prolactinoma — a benign pituitary adenoma that secretes prolactin. The most common hormonally active pituitary tumour. Microprolactinomas (< 10 mm) are far more common in women; macroadenomas ( 10 mm) are more frequent in men. Prolactin in prolactinoma often exceeds 2,000–3,000 mIU/L; with a macroadenoma it can reach 100,000 mIU/L or more. - Hypothyroidism — reduced thyroid function raises TSH, which stimulates prolactin release. This is why TSH is always checked alongside prolactin when cycle irregularities are investigated — the connection is direct and clinically significant. - Polycystic ovary syndrome (PCOS) — mild hyperprolactinaemia occurs in 15–20% of women with PCOS. - Kidney and liver disease — impair prolactin clearance. - Other hypothalamic-pituitary tumours — craniopharyngioma, meningioma — can mechanically disrupt dopaminergic control through a "stalk effect." Symptoms of hyperprolactinaemia in women: - Menstrual cycle disorders — from irregular periods to complete amenorrhoea - Galactorrhoea — nipple discharge unrelated to pregnancy or breastfeeding - Infertility due to suppressed ovulation - Reduced libido and vaginal dryness - Osteoporosis from prolonged oestrogen deficiency Symptoms in men: - Reduced libido and erectile dysfunction - Gynaecomastia — breast tissue enlargement - Galactorrhoea (uncommon) - Impaired fertility — disrupted spermatogenesis - Osteoporosis with prolonged disease Prolactin and Reproductive Health: Effect on the Cycle and Fertility Prolactin is one of the primary disruptors of the reproductive axis. The mechanism is straightforward: hyperprolactinaemia suppresses pulsatile GnRH secretion in the hypothalamus, reducing FSH and LH output from the pituitary. Without adequate levels of these hormones, follicles cannot mature to the dominant stage, ovulation does not occur, and the cycle becomes anovulatory. For more on how suppressed ovulation manifests clinically and which methods confirm an anovulatory cycle, see ovulation: what it is and how to track it. In men, elevated prolactin suppresses testosterone synthesis in Leydig cells and impairs sperm maturation. This is frequently discovered when couples are investigated for infertility — moderate hyperprolactinaemia is found in the male partner with a normal pituitary MRI, and fertility recovers after prolactin is normalised. The good news: most hyperprolactinaemias respond well to medical treatment. Dopamine agonists (cabergoline, bromocriptine) normalise prolactin in 80–90% of patients, restoring menstrual cycles and fertility without surgery. Low Prolactin: When Does It Matter? Hypoprolactinaemia — prolactin below the lower reference limit — is far less common than hyperprolactinaemia and is clinically insignificant in most cases outside the postpartum period. The exception is the postpartum period. If prolactin does not rise after delivery and a woman cannot breastfeed, this may indicate Sheehan's syndrome — pituitary necrosis from massive blood loss during childbirth. This is rare but serious, and affects the entire pituitary function. In all other settings, a low prolactin without symptoms is a laboratory finding with no clinical significance. It may occur with dopamine agonist therapy, levodopa use, or hypopituitarism of any cause. When Prolactin Results Require Medical Attention A mildly elevated prolactin (up to 1,000–1,500 mIU/L) without symptoms calls for a repeat test under proper conditions before drawing any conclusions. But several situations require prompt endocrinology consultation: - Prolactin above 2,000 mIU/L on two tests with proper preparation — high likelihood of prolactinoma - Prolactin above 5,000 mIU/L — pituitary MRI is mandatory - Galactorrhoea in a woman who is not breastfeeding, or in any man - Menstrual cycle disruption or amenorrhoea combined with elevated prolactin - Infertility in a couple with confirmed hyperprolactinaemia in one partner - Headaches and visual disturbance (bitemporal hemianopia) with high prolactin — signs of a large pituitary tumour - Erectile dysfunction and reduced libido in a man with elevated prolactin - High prolactin with a normal pituitary MRI — secondary causes must be excluded: hypothyroidism, renal failure, drug effect Treatment depends on the cause: drug-induced hyperprolactinaemia is managed by switching the medication; prolactinoma is treated with dopamine agonists; secondary forms are addressed by treating the underlying disease. Self-treatment without an established cause is not appropriate. Conclusion Prolactin is a hormone that extends far beyond lactation. Chronically elevated levels disrupt the menstrual cycle, suppress ovulation, reduce libido in both women and men, lead to infertility, and — over time — to osteoporosis. Correct interpretation requires two things: proper sample preparation (to exclude physiological causes) and a full clinical assessment (to avoid treating a laboratory number rather than a patient). For persistent hyperprolactinaemia with symptoms, an endocrinology consultation and pituitary MRI are the right next steps — not attempts to lower the level through unproven remedies. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/spermogramma-po-kryugeru https://labreadai.com/en/posts/spermogramma-po-kryugeru Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) How to interpret Kruger strict criteria sperm morphology: norms, WHO 2021 values, causes of teratozoospermia and ways to improve results. When to see a doctor. Articles article A couple has been trying to conceive for several months without success — and the doctor refers the man for a semen analysis. The report reads: "Kruger morphology — 2%." What does this mean and how serious is it? The Kruger strict criteria spermogram is the most rigorous standard for assessing sperm morphology, used in reproductive medicine and IVF preparation. Unlike a standard semen analysis, Kruger criteria evaluate the shape of each spermatozoon with exceptional precision. This article explains what is measured, how to interpret the result, what causes abnormalities, and what can genuinely be done to improve them. What Is the Kruger Spermogram and How It Differs from a Standard Analysis A spermogram is a comprehensive semen analysis that covers several parameters: volume, concentration, motility, and morphology of spermatozoa. A standard WHO spermogram assesses morphology using "loose" criteria — only an obviously malformed sperm cell is classified as abnormal. The Kruger strict criteria spermogram (Tygerberg strict criteria) applies a fundamentally different approach: only a spermatozoon with a perfect head, neck, and tail geometry is considered normal. Any deviation from the ideal disqualifies the cell. This is why the percentage of normal forms by Kruger criteria is always significantly lower than by standard criteria. Why such strictness? Research has shown that Kruger morphology correlates with fertility far more accurately than loose criteria. When morphology falls below 4%, the probability of fertilisation in natural conception and standard IVF drops sharply. This indicator is what determines whether ICSI (intracytoplasmic sperm injection) is needed instead of conventional IVF. Spermogram Reference Values: Full WHO 2021 Table The current WHO reference values (5th and 6th edition guidelines) are the international standard for semen analysis interpretation. Parameter Normal (WHO 2021) ------ Ejaculate volume ≥ 1.4 mL Sperm concentration ≥ 16 million/mL Total sperm count ≥ 39 million Progressive motility (PR) ≥ 30% Total motility (PR + NP) ≥ 42% Morphology by Kruger (normal forms) ≥ 4% Vitality (live spermatozoa) ≥ 54% pH 7.2–8.0 Liquefaction time ≤ 60 minutes One key point after the table: the 4% Kruger morphology threshold reflects the fact that in most fertile men only 4–15% of spermatozoa have an ideal shape. This is not an error — it reflects biological reality: nature produces large numbers of "imperfect" cells, but even a small percentage of morphologically normal ones is sufficient for fertilisation. Interpreting Kruger Morphology: What Is Assessed Strict Kruger criteria evaluate each spermatozoon across three sections. Head — the most critical part. A normal head is oval, with a smooth outline, length 3–5 µm, width 2–3 µm, length-to-width ratio 1.5–1.75. The acrosome covers 40–70% of the head area. Any deviation — large, small, double, pyriform, round, pin, or amorphous head — classifies the cell as abnormal. Neck and midpiece — must be thin and regular, without thickenings or angulations. Tail — straight or slightly curved, approximately 45 µm long. Coiled, shortened, double, or broken tails are abnormal. A high proportion of abnormal forms is called teratozoospermia — defined as morphology below 4% by Kruger criteria. Isolated teratozoospermia with normal concentration and motility often responds well to correction. Other terms commonly seen in semen analysis reports: oligozoospermia (reduced concentration < 16 million/mL), asthenozoospermia (reduced motility), azoospermia (no spermatozoa present), oligoasthenoteratozoospermia (OAT syndrome) — combined impairment of all three parameters. Causes of Spermogram Abnormalities Spermogram abnormalities are rarely isolated — most have one of several well-studied underlying causes. Hormonal disorders. Reduced testosterone impairs spermatogenesis — testosterone is the primary anabolic signal for the spermatogenic epithelium. Hyperprolactinaemia: elevated prolactin suppresses LH and reduces testosterone, indirectly impairing sperm production. Thyroid disorders (abnormal TSH) also affect sperm quality through hormonal environment changes. Varicocele — dilation of the pampiniform venous plexus. The most common correctable cause of male infertility: it raises testicular temperature, impairs blood supply, and worsens all spermogram parameters. Identified by ultrasound. Inflammatory conditions. Past orchitis (especially mumps orchitis in adults), epididymitis, and chronic prostatitis all reduce sperm quality. In a complete blood count, active inflammation produces leucocytosis. Cryptorchidism — a history of undescended testis, even after surgical correction, reduces spermatogenesis. Lifestyle and environmental factors. Chronic stress via cortisol suppresses testosterone — the mechanism is explained in the article how to lower cortisol (the stress physiology is identical in both sexes). Testicular overheating (hot baths, saunas, prolonged sitting, tight underwear) — testes must be kept 2–4°C below body temperature. Smoking, alcohol, anabolic steroids (the latter completely suppress endogenous testosterone and halt spermatogenesis). Occupational hazards: pesticides, heavy metals, radiation, organic solvents. Genetic causes. Klinefelter syndrome (XXY), Y-chromosome microdeletions, CFTR gene mutations — when azoospermia or severe oligozoospermia is found, genetic testing is mandatory. How to Prepare for a Spermogram Preparation critically affects the result — failure to follow these rules renders the analysis meaningless: - Sexual abstinence of 2–5 days before the test. Less than 2 days — insufficient concentration and count. More than 7 days — motility and morphology worsen as sperm "age." - No alcohol for at least 5–7 days, ideally 2–3 weeks. - No overheating for 2–3 weeks: sauna, hot bath, exercise causing groin overheating. - No acute illness or fever in the 3 months before testing — the spermatogenesis cycle takes 72–74 days, and any febrile illness will impair results for months. - Collection — by masturbation into a sterile container, preferably at the laboratory. Condoms and coitus interruptus are not acceptable — contamination. - Delivery — within 30–60 minutes at body temperature (carried in a breast pocket). When an initial result is poor, always repeat the analysis after 2–3 months. A single poor spermogram is not a diagnosis: stress, illness, or failure to prepare correctly can temporarily worsen all parameters. How to Improve Spermogram Results The fundamental principle: spermatogenesis takes 72–74 days. The results of any lifestyle changes or treatment cannot be assessed in less than 3 months. For varicocele — surgical treatment (microsurgical varicocelectomy) improves spermogram parameters in 60–80% of patients and increases the probability of natural conception. The decision is made by the andrologist based on the clinical picture. For hormonal disorders — correct the underlying cause. Normalising testosterone, reducing prolactin with dopamine agonists, and treating hypothyroidism with levothyroxine often independently improve the spermogram. For more detail on testosterone, see the article how to increase testosterone in men. Lifestyle: normalise sleep (testosterone is synthesised at night), reduce stress, stop alcohol and smoking, take moderate exercise (avoiding groin overheating), achieve a healthy weight. Antioxidants: oxidative stress is a leading cause of sperm DNA damage. Coenzyme Q10, vitamin C, vitamin E, zinc, selenium, and folic acid — the evidence base is moderate, but a combination of risk factors combined with these nutrients at physiological doses is reasonable. ICSI — when Kruger morphology is below 4% and teratozoospermia is severe, the standard ART procedure is not conventional IVF but ICSI: a single selected normal spermatozoon is injected directly into the egg. This bypasses the requirement for a large number of normal-form sperm. When to See an Andrologist or Reproductive Specialist A routine appointment is appropriate when any spermogram parameter is abnormal on a confirmed repeat test at 2–3 months. Urgent consultation is needed for: - Azoospermia (no spermatozoa present) — urgent diagnostics: secretory versus obstructive cause, genetics, hormonal profile - Severe oligozoospermia (< 5 million/mL) — high probability of a genetic cause - Poor spermogram combined with testicular pain, asymmetry, or a palpable lump — rule out varicocele and testicular tumour In a couple where the woman's ovulation and cycle are normal yet pregnancy does not occur — a male factor is present in approximately 50% of cases. A Kruger spermogram is neither a verdict nor a final answer — it is the starting point of a diagnostic process that, for most causes, has a concrete treatment path. This article is for informational purposes only and does not replace medical advice. For any spermogram abnormalities, consult an andrologist or reproductive specialist. https://labreadai.com/en/indicators/basophils https://labreadai.com/en/indicators/basophils Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Basophils are the rarest white blood cells, key to allergy and inflammation. Normal ranges, causes of basophilia and basopenia, and when to seek medical advice. Indicators article Picture this: out of the entire white blood cell army, basophils account for less than one percent. It sounds insignificant — but these rare cells trigger anaphylactic shock, orchestrate the acute allergic response, and are among the first to react when parasites invade. If your complete blood count came back with an unfamiliar basophil result, this article will explain what it means, what normal looks like, and when a deviation warrants medical attention. What Are Basophils and What Do They Do? Basophils are granulocytes — a subtype of leukocytes — named for the dark blue granules that stain readily with basic dyes. Inside those granules is a powerful chemical arsenal: histamine, heparin, serotonin, and leukotrienes. When the body encounters an allergen or parasite, basophils "explode" — releasing granule contents directly into surrounding tissue. Histamine dilates blood vessels and triggers itching. Heparin prevents clotting, stopping infections from walling themselves off. The result is a rapid, somewhat chaotic, but highly effective first wave of immune response. Beyond emergency reactions, basophils participate in chronic inflammation, regulate the activity of other immune cells, and — according to recent research — may play a role in antitumor immunity. How to Get Tested: Preparation and What the Test Includes Basophils are measured as part of the differential white blood cell count — an expanded complete blood count with differential. There is no separate test for basophils alone. Preparation guidelines: - Blood is drawn in the morning on an empty stomach — no food for at least 8–12 hours beforehand. - Avoid alcohol and intense physical activity for 24 hours before the test. - Do not smoke for 30 minutes before the draw. - If you take antihistamines or glucocorticoids, inform your doctor — these medications significantly alter the results. Results are expressed two ways: as a percentage of total leukocytes (relative value) and in absolute numbers — ×10⁹/L. The absolute value is more diagnostically useful because it is not affected by changes in other cell populations. Normal Basophil Range: Table for Adults, Children, and Pregnant Women Basophils are the smallest fraction of the leukocyte differential. Their count is so low that many hematology analyzers simply report 0%. Category Normal (%) Normal (×10⁹/L) --------- Adults 0–1% 0–0.08 Infants under 1 year 0–0.5% 0–0.04 Children 1–12 years 0–0.75% 0–0.06 Adolescents 0–1% 0–0.08 Pregnant women 0–0.5% 0–0.04 Reference ranges may vary slightly by laboratory — always check the reference values printed on your results sheet. During pregnancy, basophils naturally decrease — this is a normal immune adaptation that requires no treatment. High Basophils (Basophilia): Causes and What It Means Basophilia is defined as basophils exceeding 1% or 0.1 ×10⁹/L. On its own, this is a laboratory finding — not a diagnosis. Physiological causes (no treatment needed): - First days of the menstrual cycle - Ovulation period - Mild iron deficiency - Chronic stress and poor sleep Pathological causes — require further evaluation: - Allergic reactions — urticaria, bronchial asthma, atopic dermatitis. Basophils and eosinophils form the primary allergic duo in the blood. - Hypothyroidism — reduced thyroid function slows clearance of basophils from the bloodstream. - Chronic inflammatory conditions — ulcerative colitis, rheumatoid arthritis. - Parasitic infections — giardiasis, ascariasis. - Myeloproliferative disorders — chronic myelogenous leukemia, polycythemia vera. These are rare but serious causes of persistently elevated basophils above 0.5 ×10⁹/L. Isolated mild basophilia (1–2%) in the setting of allergic symptoms is a common, non-alarming finding. Persistent basophilia above 2% without a clear cause warrants a hematology consultation. Low Basophils (Basopenia): When Does It Matter? Basopenia refers to basophils falling below the lower limit of normal. Since normal is already close to zero, the diagnostic significance of basopenia is considerably lower than that of basophilia. Situations where basopenia occurs: - Acute allergic reactions — cells migrate rapidly into tissues - Use of glucocorticoids (prednisone, dexamethasone) - Hyperthyroidism — accelerated metabolism speeds up cell turnover - Cushing's syndrome - Acute infections — temporary redistribution of leukocytes - Pregnancy (physiological norm) Complete absence of basophils (0%) in an otherwise normal blood count with no symptoms is a normal variant. This is not analogous to neutropenia or thrombocytopenia, where zero values are clinically critical. Basophils and Allergy: The Direct Connection If you have allergies, basophils are the primary culprits behind acute symptoms. Together with mast cells in tissues, they store histamine and release it the moment an allergen arrives. The mechanism is straightforward: allergen → IgE antibodies on the basophil surface → degranulation → histamine and leukotrienes → swelling, itching, redness. The entire cycle takes minutes. This is why antihistamines work so well — they block histamine receptors after basophils have already released their payload. For a deeper look at allergy mechanisms and types, see the complete allergy guide. In chronic allergy, basophils may be mildly elevated during flares and return to normal in remission. This is expected and not concerning. When High Basophils Require Urgent Medical Attention Most basophil abnormalities are moderate and explainable. But some situations require prompt consultation: - Basophils persistently above 2% on two or more tests taken 2–4 weeks apart - Basophilia combined with a leukocyte count above 15 ×10⁹/L - Unexplained fatigue, night sweats, enlarged lymph nodes or spleen - Basophils above 10% on any single test — a red flag for myeloproliferative disease - A child with basophilia above 1% without obvious allergy or infection Remember: basophils are one value among many. A doctor always interprets them in the context of the full leukocyte differential, symptoms, and medical history. Conclusion Basophils are a tiny but powerful component of the immune system. Their normal range is below 1%, and a result of 0% is not pathological. A mild rise during allergy or inflammation is entirely expected. Persistent basophilia without a clear explanation — especially combined with other blood count abnormalities — deserves specialist attention. Do not interpret your blood results in isolation. Laboratory values are always read alongside the clinical picture. If something concerns you, consult a general practitioner or hematologist. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/calcium https://labreadai.com/en/indicators/calcium Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal levels of total and ionized calcium in adults — tables by age. Causes of hypercalcemia and hypocalcemia, connection with PTH and vitamin D explained. Indicators article Every time your heart contracts, calcium is what triggers the muscle cells to act. When a nerve fires, when a blood clot forms, when a bone bears load — calcium is involved in all of it. A calcium blood test is part of standard biochemistry and can reveal parathyroid disorders, kidney disease, or nutritional deficiencies long before symptoms appear. This article covers what is measured, what the norms are, and what each type of deviation means. What Is Calcium in Blood and Why Is It Measured The human body contains about 1–1.5 kg of calcium. Roughly 99% is stored in bones and teeth as a strategic reserve. Only 1% circulates in the blood and tissues — but this fraction is critical for every cell in the body. Calcium exists in three forms in serum: - Ionized (free) calcium — about 50% of the total. The biologically active form that directly regulates muscle contraction, nerve conduction, hormone secretion, and blood clotting. - Protein-bound calcium — 40–45%, held mainly by albumin. Biologically inactive, it acts as a reservoir for maintaining the ionized fraction. - Complexed calcium — 5–10%, bound to citrate, phosphate, and bicarbonate. Also inactive. A standard biochemical panel measures total calcium — the sum of all three forms. Ionized calcium can be ordered separately and more accurately reflects physiological activity. This distinction matters: when albumin is low, total calcium appears falsely reduced even when the ionized fraction is normal, which is why doctors use the corrected calcium formula. Normal Calcium Levels: Total and Ionized Reference ranges depend on age and the specific laboratory method. Total Calcium Norms Age Normal range, mmol/L ------ Newborns (up to 10 days) 1.90–2.60 Children under 2 years 2.25–2.75 Children 2–14 years 2.20–2.70 Adults 18–60 years 2.15–2.55 Adults over 60 years 2.10–2.50 Differences of ±0.05 mmol/L between laboratories are normal. Always use the reference range printed on your own lab report. Ionized Calcium Norms Group Normal range, mmol/L ------ Adults 1.15–1.30 Children 1.22–1.40 Corrected Calcium When Albumin Is Low If albumin is below 40 g/L, apply the correction formula: Corrected Ca (mmol/L) = measured Ca + 0.02 × (40 − albumin, g/L) For example, with albumin at 28 g/L and total calcium at 2.05 mmol/L, the corrected value is 2.05 + 0.02 × 12 = 2.29 mmol/L — within normal range. Without this calculation, the patient would receive a false diagnosis of hypocalcemia. How to Properly Prepare for a Calcium Blood Test A few points that genuinely affect the result and are rarely explained. Fasting. Blood should be drawn fasting — last meal 8–12 hours before. Avoid dairy products, nuts, and calcium supplements the evening before. Calcium and vitamin D supplements. If you take supplements, inform your doctor: they may temporarily elevate the result. Some are paused 48–72 hours before testing; others are not — this is a clinical decision. Tourniquet time. Prolonged tourniquet application (over 1 minute) before venipuncture can raise total calcium by 5–10% due to local hemoconcentration. Quality labs follow proper protocols. Exercise. Intense physical activity has a minor effect on ionized calcium — avoid vigorous exercise 24 hours before the test. Repeat testing. Any abnormal result should be repeated in the same laboratory before conclusions are drawn. A single reading is not a diagnosis. High Calcium in Blood: Causes of Hypercalcemia Hypercalcemia is total calcium above 2.55–2.60 mmol/L. Mild elevation (up to 3.0 mmol/L) is often asymptomatic and found incidentally. Above 3.0 mmol/L: fatigue, nausea, constipation, excessive urination. Above 3.5 mmol/L — a medical emergency: confusion, arrhythmias, risk of acute kidney injury. Cause Mechanism ------ Primary hyperparathyroidism Adenoma or hyperplasia of parathyroid glands — excess PTH mobilizes Ca from bones Malignancy Bone metastases or tumor-secreted PTHrP (parathyroid hormone-related protein) Vitamin D toxicity Excess calcitriol increases Ca absorption in the gut Sarcoidosis and granulomatoses Activated macrophages produce calcitriol independently Thiazide diuretics Reduce urinary calcium excretion Prolonged immobilization Accelerated bone resorption elevates Ca in blood Milk-alkali syndrome Excess combined intake of calcium and alkaline antacids Hyperthyroidism Accelerated bone turnover Primary hyperparathyroidism and malignancy together account for over 90% of hypercalcemia cases in outpatient adults. When elevated calcium is found, these two conditions are ruled out first. Low Calcium in Blood: Causes of Hypocalcemia Hypocalcemia is total calcium below 2.10–2.15 mmol/L or ionized calcium below 1.15 mmol/L. Symptoms range from tingling in the fingertips and around the mouth to severe muscle cramps. Severe hypocalcemia can cause laryngospasm and life-threatening cardiac arrhythmias. Cause Mechanism ------ Hypoparathyroidism PTH deficiency — Ca not mobilized from bone, renal reabsorption reduced Vitamin D deficiency Impaired Ca absorption in the small intestine Chronic kidney disease Impaired vitamin D activation, phosphate retention — double blow to calcium metabolism Hypomagnesemia Blocks PTH secretion and reduces tissue sensitivity to it Acute pancreatitis Calcium binds to fatty acids in the zone of fat necrosis Hypoalbuminemia Reduced protein-bound fraction (ionized calcium usually normal) Hungry bone syndrome Post-parathyroidectomy — bones rapidly absorb Ca from blood Massive blood transfusions Citrate preservative chelates ionized calcium Celiac disease / malabsorption Impaired absorption of Ca and vitamin D in the intestine Before diagnosing true hypocalcemia, the clinician always checks albumin and applies the correction formula if needed — to rule out a spuriously low result caused by low protein. Calcium, PTH, and Vitamin D: The Regulatory Triangle Calcium levels do not exist in isolation — they are maintained by three interlinked regulators. Parathyroid hormone (PTH) is released by the parathyroid glands within seconds of a calcium drop. It acts on three fronts simultaneously: it mobilizes Ca from bone, increases Ca reabsorption in the kidneys, and stimulates production of active vitamin D to enhance intestinal Ca absorption. Vitamin D (calcitriol) is activated in the kidneys under PTH control. Its main role in calcium metabolism is to drive Ca absorption in the small intestine. When vitamin D is deficient, the body cannot properly absorb calcium from food — regardless of how much is consumed. Phosphorus is calcium's functional antagonist. Rising phosphate stimulates PTH secretion and simultaneously suppresses renal vitamin D activation. This is the mechanism behind secondary hyperparathyroidism in chronic kidney disease with phosphate retention — elevated PTH alongside low calcium. This triangle explains clinical practice: when calcium is abnormal, doctors typically order a panel — PTH, vitamin D, phosphorus, and magnesium. Calcium alone tells only half the story. When to See a Doctor Urgently Many calcium disorders progress silently and require planned investigation. But certain signs call for immediate action. Signs suggesting hypercalcemia: - Confusion, drowsiness, or progressive weakness - Persistent vomiting, abdominal pain, or intense thirst - Irregular heartbeat - Calcium above 3.0 mmol/L on a lab result — even without symptoms Signs suggesting hypocalcemia: - Muscle cramps or convulsions that do not resolve spontaneously - Stridor (wheezing, labored breathing) — a sign of laryngospasm - Numbness and tingling spreading to the face and trunk - Ionized calcium below 0.90 mmol/L on a lab result If your test shows an abnormality for the first time — do not panic, but do not delay. Repeat the test and see your GP: they will review the full picture and if necessary order further tests such as PTH, vitamin D levels, or a parathyroid ultrasound. Taking calcium supplements on your own without understanding the cause is unsafe — too much calcium is just as dangerous as too little and can lead to kidney stones, vascular calcification, and arrhythmias. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/testosterone https://labreadai.com/en/indicators/testosterone Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal total and free testosterone in men and women by age. Causes of high and low levels, the role of SHBG, how to test correctly, and when to see an endocrinologist. Indicators article Testosterone is a hormone most people have opinions about but few truly understand. In men it is associated with strength and libido; in women it is often seen as "male" and unwanted. Reality is more nuanced: testosterone is essential for both sexes, normal ranges differ dramatically between them, and the raw number in a test result can be misleading without accounting for SHBG (sex hormone-binding globulin). Here is what to measure, how to interpret it, and when an abnormal result actually warrants attention. What Is Testosterone and Why Is It Measured Testosterone is a steroid hormone from the androgen group. In men, approximately 95% is produced by Leydig cells in the testes under the control of luteinising hormone (LH) from the pituitary gland. In women, testosterone is synthesised in the ovaries, adrenal glands, and peripheral tissues — in considerably smaller amounts, but with an important biological role. Testosterone's functions extend well beyond reproduction. It regulates muscle mass and strength, bone density, fat distribution, libido, erythropoiesis (hence the higher haemoglobin in men), mood, and cognitive function. In women, testosterone influences libido, energy, and muscle tone. Testing is ordered for: symptoms of deficiency in men (reduced libido, erectile dysfunction, fatigue, muscle loss), signs of excess in women (acne, hirsutism, cycle disorders — PCOS), infertility, gynaecomastia in men, delayed puberty in adolescents, and monitoring of hormonal therapy. Normal Testosterone Levels: Total, Free and SHBG Testosterone in the bloodstream exists in three forms. Approximately 60% is tightly bound to SHBG — biologically inactive. Around 38% is loosely bound to albumin — weakly enough to be released. Only 1–3% is free testosterone, acting directly on cellular receptors. This is why normal total testosterone does not guarantee normal hormonal status: when SHBG is elevated, the active fraction may be reduced despite a normal total figure. This is especially relevant in older men and women taking oestrogen-containing medications (oral contraceptives raise SHBG and lower free testosterone). Normal total testosterone in men: Age Normal range (nmol/L) ------ 18–50 years 12.0–35.0 50–60 years 10.0–30.0 Over 60 years 8.0–28.0 Normal total testosterone in women: Age Normal range (nmol/L) ------ 18–50 years (reproductive) 0.31–3.78 Postmenopause 0.10–1.70 Free testosterone in men: 0.20–0.70 nmol/L (5.8–20.5 pg/mL) Free testosterone in women: 0.003–0.030 nmol/L Reference ranges vary substantially between laboratories and methods — always use the values printed on your specific report. Why Is Testosterone Low in Men? Total testosterone below 12 nmol/L in men is called hypogonadism. It is divided into primary (testicular failure) and secondary (insufficient pituitary stimulation). Primary hypogonadism: testicular trauma, orchitis, cryptorchidism, chemotherapy or radiotherapy, Klinefelter syndrome (XXY), age-related testicular decline. Secondary hypogonadism — LH/FSH deficiency: pituitary adenoma, hyperprolactinaemia (prolactin suppresses LH), hypothyroidism (disrupted GnRH regulation via TSH changes), chronic stress (elevated cortisol competes with testosterone for pregnenolone), obesity (adipose tissue aromatase converts testosterone to oestradiol), insulin resistance and type 2 diabetes. Symptoms of low testosterone in men: reduced libido, erectile dysfunction, chronic fatigue, loss of muscle mass and strength, increased abdominal fat, gynaecomastia, depression, cognitive impairment, and reduced bone density. For a detailed discussion of causes and correction strategies, see the article how to increase testosterone in men. Why Is Testosterone High in Women? In women, moderately elevated testosterone is one of the key biochemical markers of PCOS and hyperandrogenaemia. Polycystic ovary syndrome (PCOS) — the most common cause of hyperandrogenaemia in women of reproductive age. Total and free testosterone are elevated; SHBG is often reduced, amplifying the androgenic effect. Congenital adrenal hyperplasia (CAH) — impaired cortisol synthesis leads to excess production of androgenic precursors. Androgen-secreting ovarian or adrenal tumours — rare but important. Very high testosterone ( 5–6 nmol/L in a woman) makes a tumour the first priority to exclude. Symptoms of hyperandrogenaemia in women: acne (particularly on the chin and neck), hirsutism (excess hair growth in a male-pattern distribution), male-pattern hair thinning, menstrual irregularities, anovulation and infertility, and voice deepening in severe cases. Testosterone and Cardiovascular Risk The relationship between testosterone and cardiometabolic health is bidirectional. Low testosterone in men is associated with insulin resistance, dyslipidaemia (reduced HDL, elevated LDL), obesity, and increased cardiovascular risk. Monitoring the lipid profile via a lipid panel is part of a comprehensive assessment in hypogonadism. In women with PCOS, elevated testosterone frequently coexists with metabolic syndrome and an increased risk of diabetes. How to Prepare for a Testosterone Test Testosterone has a pronounced diurnal rhythm: it peaks in the morning (7:00–10:00 am) and falls by 20–35% by evening. Therefore: - Blood must be drawn strictly in the morning, between 7:00 and 10:00 am, fasting - Avoid intense physical exercise for 24–48 hours before the test — it temporarily raises testosterone - Avoid stress the day before — elevated cortisol suppresses testosterone - Inform the doctor about hormonal medications, anabolic steroids, and corticosteroids - For suspected hypogonadism — repeat on a second day to confirm For a complete picture, testosterone is always evaluated alongside SHBG — only then can free testosterone be calculated and true androgenic activity assessed. When secondary hypogonadism is suspected, LH, FSH, and prolactin are also measured. Spermatogenesis in the context of low testosterone is evaluated separately through a semen analysis. When to See a Doctor Schedule an appointment with an endocrinologist or andrologist if: - Testosterone is persistently low (two measurements below 12 nmol/L in men) with clinical symptoms - Signs of hyperandrogenaemia in a woman — acne, hirsutism, cycle irregularities - Infertility in a couple — testosterone is part of the baseline investigation for both partners - Gynaecomastia in a man — requires excluding a hormonal cause Urgent consultation is needed for: - Very high testosterone in a woman ( 5 nmol/L) — to rule out an androgen-secreting tumour - Low testosterone combined with visual field defects or severe headaches — possible pituitary adenoma Testosterone is easy to measure incorrectly and easy to interpret out of context. A morning draw, SHBG assessment, and clinical picture — three conditions without which a number on a report tells you very little. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/uric-acid https://labreadai.com/en/indicators/uric-acid Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Uric acid blood test: normal ranges for men, women and elderly, causes of hyperuricemia — from diet to kidney failure, link with gout and when to start treatment. Indicators article A sudden, excruciating attack of pain in the big toe in the middle of the night — so intense that the weight of a sheet is unbearable — is the classic first presentation of gout. But by the time that pain finally announces itself, uric acid has been silently accumulating in the blood for years, crystallising in joints and damaging renal tubules. Uric acid is the final breakdown product of purines in the body. Its blood level reflects diet, kidney function, the rate of cellular turnover, and a range of metabolic disorders simultaneously. This article covers normal ranges for every group, causes of deviation, and what to do when the level is chronically elevated. What Is Uric Acid and Why Is It Tested? Purines are nitrogen-containing compounds that form the building blocks of DNA and RNA in every cell. When cells renew, age, or break down, purines are metabolised into uric acid. It is produced in the liver and cleared primarily by the kidneys — approximately 70% of the daily load — with the remainder excreted via the gut. Under normal conditions, production and excretion are in equilibrium. When this balance is disrupted — through excess production or insufficient excretion — uric acid accumulates in the plasma. At physiological concentrations, uric acid is not a villain: it has antioxidant properties and protects cells from oxidative damage. The problem begins when its concentration chronically exceeds the solubility threshold — approximately 360 µmol/L for women and 420 µmol/L for men. Above these levels, uric acid crystallises as monosodium urate and deposits in tissues. A uric acid test is ordered in several situations: - Diagnosis and monitoring of gout - Assessment of urinary stone risk (urate kidney stones) - Chronic kidney disease — uric acid both damages kidneys and accumulates when they are impaired - Metabolic syndrome, obesity, type 2 diabetes - Monitoring during chemotherapy — tumour cell breakdown sharply elevates the level - Long-term use of diuretics — particularly thiazides For a comprehensive evaluation of renal excretory function, uric acid is assessed alongside the kidney function test: declining eGFR and rising uric acid frequently travel together. How to Prepare and Get Tested Uric acid is sensitive to diet and lifestyle — preparation errors produce false results that mislead both patient and doctor. Preparation guidelines: - Blood is drawn fasting in the morning — at least 8–12 hours after the last meal. - Avoid alcohol for 24 hours: even a small amount of beer or wine inhibits renal urate excretion and transiently raises levels by 20–30%. - Limit purine-rich foods for 24 hours: red meat, organ meats, seafood, anchovies, sardines, and legumes. A large meat portion the day before can produce a false elevation. - Avoid intense exercise for 24 hours: increased muscle cell breakdown raises uric acid. - Tell your doctor about all medications: low-dose aspirin, thiazide diuretics, cyclosporin, and pyrazinamide raise uric acid; allopurinol, fenofibrate, and high-dose aspirin lower it. - For monitoring gout therapy or allopurinol treatment — always test at the same time of day and in the same laboratory. A 24-hour urine uric acid test may also be ordered: it distinguishes overproduction ( 700 mg/day in urine) from underexcretion (< 700 mg/day despite high serum levels) — a crucial distinction for choosing treatment. Uric Acid Normal Range: Table by Sex and Age Normal values depend significantly on sex, age, and analytical method — always check the reference range on your own report. Category Normal (µmol/L) Normal (mg/dL) --------- Men 18–59 years 200–430 3.4–7.2 Men over 60 250–480 4.2–8.0 Women 18–49 years 140–360 2.4–6.0 Women post-menopause 200–430 3.4–7.2 Children 1–12 years 120–320 2.0–5.4 Pregnant women 120–270 2.0–4.5 In women of reproductive age, uric acid is substantially lower than in men — oestrogens enhance renal urate excretion. After menopause, this protective effect disappears, and normal values in older women approach those of men. This explains why gout in women is almost exclusively a post-menopausal disease. The crystallisation threshold — 360 µmol/L for women and 420 µmol/L for men — is critically important for interpretation: values above these points create conditions for tissue crystal deposition even in the absence of obvious symptoms. High Uric Acid (Hyperuricaemia): Causes and What It Means Hyperuricaemia is defined as uric acid above 360 µmol/L in women or above 420 µmol/L in men. Three mechanisms account for the excess: Overproduction — synthesis exceeds the kidney's capacity to excrete: - Diet high in purines: red meat, organ meats, shellfish, alcohol (especially beer, rich in guanosine) - Haematological malignancies with high cell turnover: leukaemia, lymphoma - Tumour lysis syndrome during chemotherapy — massive cell breakdown - Haemolytic anaemias, psoriasis, rhabdomyolysis Underexcretion — kidneys fail to clear urates adequately: - Chronic kidney disease — the leading cause of persistent hyperuricaemia in older adults - Thiazide and loop diuretics — compete with urates for tubular secretion - Dehydration — reduced renal blood flow concentrates urates - Arterial hypertension - Hypothyroidism — slows renal urate excretion Mixed mechanism: - Alcohol — simultaneously increases synthesis and inhibits excretion - Insulin resistance and metabolic syndrome — insulin reduces renal uric acid clearance - Obesity — elevated cellular turnover combined with reduced renal clearance Asymptomatic hyperuricaemia — elevated uric acid without clinical manifestations — affects 5–8% of the population. Long considered benign, it is now understood to be an independent risk factor for hypertension, cardiovascular disease, and chronic kidney disease progression. Gout: How Excess Urate Destroys Joints and Tissues Gout is a chronic disease in which monosodium urate crystals deposit in joints, tendons, and soft tissues. Far from a simple "disease of excess," it is an immunoinflammatory condition with a precise pathogenesis. Mechanism of an acute attack: urate crystals in the joint space are engulfed by neutrophils. The neutrophil attempts to digest the crystal — and destroys itself in the process, releasing a cascade of pro-inflammatory mediators. The result is acute inflammation with intense swelling, redness, heat, and unbearable pain. The classic site of the first attack is the first metatarsophalangeal joint — the base of the big toe. Triggers of an acute attack: a heavy meal of meat and alcohol, dehydration, physical trauma, surgery, or — paradoxically — the start of allopurinol therapy, when a rapid fall in uric acid mobilises crystals from tissue deposits into the joint space. In untreated chronic gout, tophi develop — firm, chalky nodules of urate crystals depositing under the skin over the ears, joints, and tendons. Tophi erode articular surfaces and may ulcerate. A key clinical principle: gout is diagnosed clinically and confirmed by polarised light microscopy of synovial fluid — not by serum uric acid alone. During an acute flare, serum levels may be normal or even low, as crystals have migrated from plasma into the inflamed joint. Uric acid for diagnostic and therapeutic purposes is measured two to four weeks after the flare has resolved. Uric Acid and the Kidneys: Urate Nephropathy and Kidney Stones The kidneys are both the victim and the perpetuator of high uric acid. This bidirectional relationship makes the kidney central to managing patients with hyperuricaemia. Urate nephropathy — chronic damage to the renal tubules and interstitium from urate crystal deposition. Mechanism: crystals accumulate in the renal medulla, triggering inflammation and fibrosis. Clinically: slowly progressive decline in kidney function, often with mild proteinuria. A rising creatinine trend in a patient with chronic hyperuricaemia should raise suspicion of urate-related renal injury. Acute uric acid nephropathy — massive tubular obstruction by urate crystals, causing acute obstructive renal failure. The classic scenario is tumour lysis syndrome during chemotherapy. Uric acid exceeds 700–900 µmol/L, and urine turns dark brown. This is a medical emergency requiring immediate hydration and rasburicase administration. Urate nephrolithiasis — kidney stone disease with uric acid stones. Accounts for approximately 10% of all renal stones. A distinctive feature: urate stones are radiolucent — invisible on plain X-ray, but clearly visible on ultrasound and CT. Risk factors: acidic urine (pH < 5.5), dehydration, high purine intake. Unlike calcium stones, urate stones can be dissolved medically by alkalinising the urine. The mineral workup in recurrent stone disease always includes calcium and phosphorus alongside uric acid. An important therapeutic point: lowering uric acid with allopurinol in chronic kidney disease slows its progression — this has been demonstrated in several randomised controlled trials. Low Uric Acid (Hypouricaemia): When Does It Matter? Hypouricaemia — uric acid below 120 µmol/L in adults — is far less common than hyperuricaemia and carries less clinical weight, but several underlying causes warrant exclusion. Causes of hypouricaemia: - Fanconi syndrome and tubular reabsorption defects — the kidneys lose urates alongside other substances (glucose, amino acids, phosphorus) - Extremely purine-poor diet — strict veganism with minimal protein intake - Uricosuric agents — probenecid, losartan, high-dose aspirin - Severe liver disease — impaired synthesis of xanthine oxidase, the enzyme that converts xanthine to uric acid - Xanthinuria — a rare inherited disorder of purine metabolism - SIADH — plasma dilution in syndrome of inappropriate ADH secretion An isolated low uric acid in a patient on uricosuric therapy is an expected result, not a pathology. Persistently low levels without a clear cause warrant evaluation by a nephrologist or endocrinologist. When Uric Acid Results Require Medical Attention Mild asymptomatic hyperuricaemia without organ damage calls for dietary adjustment and a repeat test in three to six months. But several situations require prompt consultation: - Uric acid above 540 µmol/L (9 mg/dL) — crystal deposition risk rises sharply - A first acute arthritis flare with joint redness and pain — see a rheumatologist promptly - Uric acid above 700 µmol/L in a patient with a malignancy or after chemotherapy — risk of acute urate nephropathy - Persistent elevation combined with rising creatinine — possible urate kidney injury - Discovery of tophi or radiologically confirmed joint damage - Recurrent kidney stones of the urate type - Uric acid above 480 µmol/L in a patient with hypertension or metabolic syndrome — discuss pharmacological lowering with your doctor The treatment target in gout is below 360 µmol/L (6 mg/dL); with tophi, below 300 µmol/L. Reaching the target usually requires several months of therapy and regular monitoring. Conclusion Uric acid sits at the intersection of diet, kidney function, and purine metabolism. Its chronic elevation sets off a chain of organ damage — joints, kidneys, blood vessels — that develops silently over years. Normal ranges differ substantially by sex and age: in young women they are roughly half those of men the same age, equalising only after menopause. For mild asymptomatic hyperuricaemia, the first step is dietary and hydration changes. At levels above 480–540 µmol/L or with clinical manifestations, a rheumatology or nephrology consultation and a discussion of pharmacological treatment are warranted. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/coagulation-test https://labreadai.com/en/tests/coagulation-test Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Coagulation panel — PT, INR, APTT, fibrinogen and D-dimer: normal ranges for adults and pregnancy, how to prepare for the test and what abnormal results mean. Tests article Blood must be able to do two opposite things at once: stop bleeding instantly when a vessel is damaged — while never clotting inside intact vessels where a clot should not form. This fragile equilibrium is maintained by the haemostasis system, and when it fails in either direction — excessive clotting or its deficiency — the consequences can be life-threatening. A coagulation test is a group of laboratory assays that evaluate the clotting system from multiple angles simultaneously. This article covers what the panel includes, how to prepare, what normal values look like, and what each deviation means. What Is a Coagulation Test and How Does the Clotting Cascade Work? Blood coagulation is a multi-step biochemical cascade in which clotting factors are sequentially activated until a firm fibrin clot forms and seals the site of injury. The process is divided into two converging pathways. The extrinsic pathway is triggered when tissue is damaged outside the vessel wall: tissue factor (factor III) meets factor VII and initiates the cascade. This pathway is fast — and it is what prothrombin time measures. The intrinsic pathway activates when blood contacts damaged vessel wall from inside: it is slower and more complex, initiated through factors XII, XI, IX, and VIII. APTT assesses this pathway. Both pathways converge on factor X, after which thrombin is generated along the common pathway, and soluble fibrinogen is converted into insoluble fibrin. Simultaneously, the anticoagulant system — antithrombin, proteins C and S — prevents the clot from propagating beyond the injury site. A third system — fibrinolysis — dissolves the clot once healing is complete. A coagulation panel evaluates all three elements: the speed of clot formation, the status of individual factors, and fibrinolytic activity. When Is a Coagulation Test Ordered? Indications range from emergencies to routine pre-procedure screening. A coagulation panel is mandatory before any surgical procedure or invasive intervention — unrecognised clotting defects can turn intraoperative bleeding into a catastrophe. Symptomatic indications: - Unexplained bleeding: nosebleeds, gum bleeding, uterine, or gastrointestinal haemorrhage - Bruising without trauma (petechiae, ecchymoses) - Prolonged bleeding after minor cuts or dental extractions - Suspected deep vein thrombosis or pulmonary embolism - Unexplained leg pain with swelling — possible thrombosis Routine and monitoring indications: - Pre-operative preparation — mandatory before any surgery - Pregnancy — at booking, each trimester, and before delivery - Monitoring anticoagulant therapy (warfarin, heparin, direct oral anticoagulants) - Liver disease — the liver synthesises most clotting factors - Diagnosis of DIC in severe infection, sepsis, or shock - Malignancy — cancer substantially elevates thrombotic risk - Systemic autoimmune diseases: antiphospholipid syndrome, lupus How to Prepare and Get Tested Blood for a coagulation panel is drawn into a tube containing sodium citrate, which binds calcium and halts clotting until analysis begins. Sample collection technique matters here more than in almost any other blood test — errors produce false results with striking frequency. Preparation guidelines: - Blood must be drawn strictly fasting — at least 8–12 hours after the last meal. A fatty meal beforehand causes lipaemia that interferes with optical detection methods. - Avoid alcohol for 24 hours — it impairs hepatic synthesis of clotting factors. - Do not smoke for 30 minutes before the draw: nicotine causes transient platelet activation. - Inform your doctor of all medications. Anticoagulants (warfarin, rivaroxaban, heparin), antiplatelets (aspirin, clopidogrel), oral contraceptives, antibiotics, and NSAIDs all significantly affect results. - Do not stop anticoagulant therapy before the test without medical instruction — this is dangerous. - The tube must not be shaken or chilled: haemolysis of the sample markedly shortens the prothrombin time and invalidates the entire panel. - When monitoring warfarin therapy — always test at the same time of day: INR fluctuates slightly across the day. A critical technical point: the ratio of blood to citrate in the tube must be exactly 9:1. An underfilled tube disrupts this ratio, and results — particularly APTT and INR — will be falsely prolonged. The laboratory is obligated to reject an incorrectly filled tube. What the Panel Includes: PT, INR, APTT, Fibrinogen and D-dimer The composition of the panel depends on the clinical question — from a minimal screen to a full thrombophilia workup. Prothrombin time (PT) and prothrombin index (PTI) assess the extrinsic and common pathways. PT is measured in seconds; normal in adults is 11–16 seconds. PTI is the ratio of normal PT to the patient's PT, expressed as a percentage; normal is 80–120%. Prolonged PT and reduced PTI indicate impairment of the extrinsic pathway: deficiency of factors VII, X, V, II, or hepatic failure. INR (International Normalised Ratio) is a standardised expression of the PT result that allows comparison across laboratories. Normal in healthy individuals: 0.85–1.15. INR is the primary marker for warfarin therapy monitoring: the therapeutic range for thrombosis treatment is 2.0–3.0. A value above 3.5 without a therapeutic reason signals bleeding risk; below 0.8 may indicate hypercoagulability. APTT (activated partial thromboplastin time) evaluates the intrinsic pathway. Normal: 25–37 seconds. APTT is prolonged by deficiencies of factors VIII, IX, XI, and XII — including haemophilia A and B, antiphospholipid syndrome, and heparin therapy. A shortened APTT points to hypercoagulability. Thrombin time (TT) evaluates the final step: the conversion of fibrinogen to fibrin by thrombin. Normal: 14–21 seconds. Prolongation indicates deficiency or structural abnormality of fibrinogen, or the effect of direct thrombin inhibitors (dabigatran). Fibrinogen is the protein precursor to fibrin, synthesised in the liver. Normal: 2.0–4.0 g/L. Fibrinogen is an acute-phase protein: it rises sharply with inflammation, infection, and trauma. Chronically elevated fibrinogen is an independent cardiovascular risk factor. A level below 1.5 g/L reflects consumption in DIC or severe hepatic failure. D-dimer is the breakdown product of fibrin — a marker of active clot formation and fibrinolysis. It is the only coagulation panel indicator that measures not clotting potential but its real-time activation. For the full clinical significance of this marker and its role in thrombosis diagnosis, see D-dimer. Antithrombin III (AT III) is the primary physiological inhibitor of clotting. Normal: 80–120%. Reduced levels indicate inherited or acquired deficiency — with a sharply elevated thrombotic risk. Ordered when thrombophilia is suspected. Platelets are evaluated alongside plasma factors because primary haemostasis is the platelet plug. A fall in the count or function of platelets with normal plasma factors is itself an independent cause of bleeding. Coagulation Test Normal Values: Summary Table Reference ranges depend on the analytical method and laboratory equipment — always check the values on your own report. Parameter Adults Pregnancy (3rd trimester) --------- PT (sec) 11–16 9.5–13.5 INR 0.85–1.15 0.80–1.20 PTI (%) 80–120 90–130 APTT (sec) 25–37 17–30 Thrombin time (sec) 14–21 14–20 Fibrinogen (g/L) 2.0–4.0 3.5–6.5 D-dimer (µg/L FEU) < 500 < 1000 (I) / < 1500 (II) / < 2000 (III) Antithrombin III (%) 80–120 85–110 Pregnancy physiologically shifts the coagulation system toward hypercoagulability — a protective mechanism against blood loss during delivery. APTT shortens, fibrinogen and D-dimer rise, and PT is slightly shortened. D-dimer norms in pregnancy are substantially higher than in non-pregnant adults, with a separate reference range for each trimester. Applying standard non-pregnant cut-offs to pregnant women leads to significant overdiagnosis of thrombosis. Interpreting Deviations: Hypercoagulability and Hypocoagulability A doctor reads the coagulation panel as an interconnected system of markers, not as isolated numbers. The pattern of combined changes points to the specific disorder. Prolonged PT/INR with normal APTT — extrinsic pathway impairment: factor VII deficiency (the shortest-lived clotting factor, the first to fall in liver disease), start of warfarin therapy, or early DIC. Prolonged APTT with normal PT — intrinsic pathway impairment: haemophilia A (factor VIII deficiency) or B (factor IX deficiency), von Willebrand disease, heparin therapy, antiphospholipid syndrome. Both PT and APTT prolonged — common pathway impairment or multiple factor deficiency: severe hepatic failure, hypocoagulable DIC, vitamin K deficiency, massive transfusion. DIC (disseminated intravascular coagulation) — one of the most dangerous haemostatic emergencies: initially, widespread thrombosis occurs (hypercoagulable phase: short APTT and PT, high D-dimer), then clotting factors and platelets are consumed — giving way to profound hypocoagulability with uncontrollable bleeding. DIC develops in severe sepsis, obstetric catastrophes, major trauma, and oncological complications. Hypercoagulability — shortened APTT and/or PT, elevated fibrinogen, rising D-dimer — signals elevated thrombotic risk. Clinically significant patterns: antiphospholipid syndrome (paradoxically prolonged APTT combined with thrombotic episodes), thrombophilia (AT III deficiency, protein C or S deficiency, factor V Leiden), and malignancy. The thrombotic risks associated with hypercoagulable states are discussed in detail in the article deep vein thrombosis. Isolated D-dimer elevation with normal PT and APTT is not a clotting disorder — it is a marker of an existing clot already formed and being dissolved. D-dimer is used to rule out pulmonary embolism in clinical decision pathways: a negative result in a low-probability patient avoids the need for CT pulmonary angiography. The diagnostic approach to suspected embolism is covered in pulmonary embolism. When Coagulation Test Results Require Urgent Medical Attention Most moderate coagulation abnormalities call for a scheduled appointment with a GP, haematologist, or obstetrician. But some situations are medical emergencies: - INR above 5.0 in a patient on warfarin — risk of spontaneous haemorrhage - APTT above 100 seconds or PT above 30 seconds without anticoagulant therapy - Sharply elevated D-dimer with leg pain and swelling plus breathlessness — possible PE - Fibrinogen below 1.0 g/L — imminent uncontrollable bleeding - Simultaneous prolongation of PT and APTT, rising D-dimer, falling platelets — DIC - Any coagulation abnormality in a pregnant woman with symptoms — immediate evaluation - Heavy post-operative bleeding with a previously normal pre-operative panel - Newly discovered prolonged APTT in a child with a bleeding history — rule out haemophilia A special case: antiphospholipid syndrome. APTT is paradoxically prolonged in the test tube, while in the body the patient has hypercoagulability. Patients with this pattern and a history of thrombosis need rheumatology referral and antiphospholipid antibody testing. Conclusion A coagulation panel is not a single assay but a carefully designed set of markers, each illuminating a different component of the haemostatic system. PT and INR evaluate the extrinsic pathway; APTT the intrinsic; fibrinogen the raw material for the clot; D-dimer the evidence of its formation and breakdown. It is the combination of results — not any single value — that points to the nature of the disorder. Proper preparation — fasting, no alcohol, a full medication list, and a correctly filled collection tube — ensures reliable results. When abnormalities are found, particularly alongside clinical symptoms, do not attempt self-interpretation: disorders of haemostasis require full clinical context. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/electrolyte-panel https://labreadai.com/en/tests/electrolyte-panel Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Electrolyte panel — sodium, potassium, chloride and bicarbonate: normal ranges for adults and pregnancy, preparation for the test and causes of dangerous imbalances. Tests article Night cramps in the calves, unexplained palpitations, sudden profound weakness after a bout of vomiting or diarrhoea — behind all of these symptoms, electrolyte imbalance is a common culprit. Electrolytes are charged mineral ions that govern the electrical activity of every cell in the body: from the nerve impulse to the heartbeat. An electrolyte panel is one of the core biochemical tests used to assess this balance from a single blood draw. This article covers what the panel includes, how to prepare, what counts as normal, and what each deviation means. What Are Electrolytes and Why Is the Panel Needed? Electrolytes are ions dissolved in blood and interstitial fluid: sodium, potassium, chloride, bicarbonate, calcium, magnesium, and phosphorus. They perform several critically important functions simultaneously. First, they maintain osmotic pressure — regulating how much water sits inside cells versus outside. Think of a cell as a bag with a semi-permeable wall: the concentration of electrolytes on each side determines whether water flows in or out. Disrupt this balance and cells either swell or shrink. Second, electrolytes generate the electrochemical gradients that underpin nerve and muscle function. Every nerve impulse is a wave of sodium and potassium redistribution across the neuron membrane. Every heartbeat is the result of precisely coordinated ion flows. Even a small deviation from normal can trigger an arrhythmia or muscle cramp. Third, electrolytes maintain acid-base equilibrium — blood pH must remain within the narrow range of 7.35–7.45. Bicarbonate and chloride are the primary buffering systems of this balance. The kidneys are the central regulators of electrolyte balance: they filter the entire blood volume approximately 50 times per day, reabsorbing what is needed and excreting what is not. This is why any serious impairment of kidney function is immediately reflected in the electrolyte panel. For a comprehensive renal assessment, the electrolyte panel is ordered alongside the kidney function test. When Is an Electrolyte Panel Ordered? Indications span a wide range of clinical situations — from emergencies to routine monitoring. Acute conditions where the panel is mandatory: - Severe vomiting or diarrhoea — electrolytes are lost with fluid at a critical rate - Dehydration of any degree - Cardiac arrhythmia of unknown cause - Muscle cramps, weakness, or paralysis - Altered consciousness or confusion - Diuretic overdose or toxicity Routine and preventive monitoring: - Chronic kidney disease — electrolytes checked at every visit - Diabetes mellitus — particularly during decompensation and diabetic ketoacidosis - Long-term use of diuretics, ACE inhibitors, angiotensin receptor blockers, or digoxin - Arterial hypertension — monitoring the effect of antihypertensive therapy - Adrenal insufficiency and primary hyperaldosteronism - Eating disorders, anorexia, or refeeding syndrome - Pregnancy — screening each trimester when complications are present How to Prepare and Get Tested Serum electrolytes are relatively stable, but several factors can significantly distort the result. Preparation guidelines: - Blood is drawn fasting — at least 8–12 hours after the last meal. This matters most for potassium: a meal rich in potassium (bananas, potatoes, nuts) the evening before can transiently raise the level. - Avoid alcohol and intense physical exercise for 24 hours: strenuous training causes a temporary shift of potassium from muscle cells into the bloodstream. - Inform your doctor of all medications: diuretics, NSAIDs, ACE inhibitors, glucocorticoids, and lithium all affect electrolyte balance. - The tourniquet should not compress the vein for more than one minute: prolonged stasis causes a false rise in potassium as ions leak from cells — pseudo-hyperkalaemia. - For treatment monitoring, always test at the same laboratory at the same time of day. A key technical note: haemolysis of the sample — breakdown of red blood cells during transport or storage — dramatically elevates potassium in the tube. If potassium is abnormally high with no symptoms, sample haemolysis is the first thing to exclude — not a pathological condition. What the Panel Includes: Basic and Extended Versions The composition of the panel depends on the clinical question. There are two standard formats. The basic metabolic panel includes four core electrolytes: Sodium (Na⁺) — the main extracellular cation, determining plasma osmolality and circulating fluid volume. Regulated by aldosterone and antidiuretic hormone. Normal: 136–145 mmol/L. Sodium is the best marker of the body's fluid balance: its changes reflect not so much the sodium content itself as the ratio of water to salt in the body. Potassium (K⁺) — the main intracellular cation. Although only 2% of total body potassium circulates in plasma, it is its plasma concentration that governs the excitability of muscles and the cardiac myocardium. Normal: 3.5–5.1 mmol/L. This is the most clinically critical electrolyte: a deviation of 1–2 mmol/L in either direction creates a real risk of life-threatening arrhythmia. Chloride (Cl⁻) — the primary extracellular anion, following sodium to maintain electroneutrality. Normal: 98–107 mmol/L. Chloride is rarely assessed in isolation: its changes almost always mirror those of sodium or bicarbonate. Hypochloraemia in vomiting and hyperchloraemia in diarrhoea are classic patterns. Bicarbonate (HCO₃⁻) — the principal buffer of acid-base balance. Normal: 22–29 mmol/L. A low level indicates metabolic acidosis (diabetic ketoacidosis, renal failure, lactic acidosis); a high level points to metabolic alkalosis (prolonged vomiting, diuretic overuse). The extended panel adds: Calcium (Ca²⁺) — regulates neuromuscular conduction, blood clotting, and bone mineralisation. Normal total calcium: 2.15–2.55 mmol/L. The ionised (free) fraction is the biologically active form; its level depends on blood pH and albumin concentration. Magnesium (Mg²⁺) — a cofactor for over 300 enzymes; influences cardiac function, the nervous system, and muscle contraction. It frequently falls alongside potassium — and without correcting magnesium, normalising potassium can be impossible. Normal: 0.7–1.0 mmol/L. Phosphorus (PO₄³⁻) — involved in energy metabolism (ATP) and bone mineralisation. Regulated by parathyroid hormone together with calcium. Normal: 0.87–1.45 mmol/L. It is chronically elevated in chronic kidney disease, accelerating vascular calcification. Electrolyte Normal Values: Summary Table Reference ranges may vary slightly between laboratories — always check the values on your own report. Electrolyte Adults Pregnancy Children 1–12 years ------------ Sodium (mmol/L) 136–145 133–143 136–145 Potassium (mmol/L) 3.5–5.1 3.3–5.0 3.4–4.7 Chloride (mmol/L) 98–107 97–109 98–106 Bicarbonate (mmol/L) 22–29 18–25 20–28 Total calcium (mmol/L) 2.15–2.55 2.10–2.50 2.20–2.70 Magnesium (mmol/L) 0.7–1.0 0.65–1.0 0.7–1.0 Phosphorus (mmol/L) 0.87–1.45 0.80–1.40 1.29–1.78 In pregnant women, bicarbonate is physiologically lower due to compensatory respiratory alkalosis: faster breathing exhales more CO₂ and shifts the acid-base balance. This is a normal adaptation, not a pathological finding. Sodium is also slightly lower in pregnancy due to the physiological dilution of blood by an expanded plasma volume. Interpreting Deviations: Potassium and Sodium Disorders Doctors read the electrolyte panel as a whole, evaluating the interplay of ions alongside the clinical picture. Potassium disorders — the most clinically dangerous. Hypokalaemia (potassium < 3.5 mmol/L): muscle weakness, cramps, constipation, palpitations. On ECG — flattening of the T wave and appearance of U waves. In severe hypokalaemia (< 2.5 mmol/L) — risk of ventricular arrhythmia. Causes: thiazide and loop diuretics, vomiting and diarrhoea, primary hyperaldosteronism, Cushing's syndrome, glucocorticoid use. Hyperkalaemia (potassium 5.5 mmol/L): muscle weakness, ascending paralysis, bradycardia. On ECG — tall peaked T waves, widening of the QRS complex. At potassium above 7.0 mmol/L — risk of cardiac arrest. Causes: chronic kidney disease (leading cause), ACE inhibitors, spironolactone, adrenal insufficiency, massive tissue breakdown (rhabdomyolysis, tumour lysis syndrome). Sodium disorders — the most common in clinical practice. Hyponatraemia (sodium < 136 mmol/L) — the most prevalent electrolyte disorder in hospitalised patients. Symptoms depend on the rate of onset: chronic reduction causes minimal symptoms; acute reduction causes nausea, headache, confusion, seizures, and cerebral oedema. Causes are varied: heart failure, liver cirrhosis, syndrome of inappropriate ADH secretion (SIADH), hypothyroidism, thiazide diuretics, psychogenic polydipsia. Hypernatraemia (sodium 145 mmol/L): thirst, dry mucous membranes, confusion; in severe cases — seizures and coma. It almost always reflects a water deficit relative to sodium: diabetes insipidus, significant fluid losses (fever, severe diarrhoea) without adequate replacement. Calcium and magnesium disorders. Hypocalcaemia manifests as tetany — painful muscle spasms, Chvostek's sign (facial muscle twitch on tapping the facial nerve), and Trousseau's sign. Hypercalcaemia — "bones, stones, and groans": osteoporosis, kidney stones, weakness, and depression. Hypomagnesaemia accompanies hypokalaemia and hypocalcaemia, rendering both refractory to treatment until magnesium is corrected simultaneously. When Electrolyte Imbalances Are Life-Threatening Most moderate electrolyte abnormalities can be managed with scheduled outpatient care. But the following situations are medical emergencies: - Potassium above 6.5 mmol/L or below 2.5 mmol/L — regardless of symptoms - Any potassium abnormality combined with ECG changes - Sodium below 120 mmol/L, or an acute fall of more than 10 mmol/L within 24 hours - Calcium above 3.5 mmol/L — hypercalcaemic crisis: nausea, vomiting, confusion, coma - Bicarbonate below 10 mmol/L — severe metabolic acidosis - Any electrolyte abnormality in a pregnant woman — immediate consultation - Multiple concurrent electrolyte abnormalities — a sign of serious systemic disease A dangerous pitfall in treating hyponatraemia is correcting it too quickly. Raising sodium faster than 8–10 mmol/L per day causes osmotic demyelination — irreversible damage to the nerve fibres of the brain. This is precisely why electrolyte correction must always be managed by a physician. Conclusion An electrolyte panel is a fast, accurate tool for assessing the ionic balance on which the heart, muscles, kidneys, and nervous system all depend. The four core ions — sodium, potassium, chloride, and bicarbonate — are read together as an interconnected system: a change in one almost always triggers compensatory shifts in the others. Proper preparation — eliminating factors that cause pseudo-abnormalities such as prolonged tourniquet use, haemolysis, or a potassium-rich meal beforehand — ensures a reliable result. If you experience cramps, palpitations, or significant weakness after vomiting or diarrhoea, do not delay testing and medical assessment. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/kidney-function-test https://labreadai.com/en/tests/kidney-function-test Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Kidney function test — creatinine, BUN, electrolytes and albumin: normal ranges for adults and pregnancy, how to prepare for the panel and what abnormal results mean. Tests article The kidneys work silently — until they stop coping. Chronic kidney disease progresses without symptoms for years, and by the time oedema, fatigue, and changes in urine appear, the organ may have already lost a significant portion of its functional reserve. A kidney function test is a group of biochemical assays that can assess the kidneys' filtering and excretory capacity long before clinical signs appear. This article covers which markers make up the renal panel, how to prepare, what counts as normal, and how to interpret abnormalities in each value. What Is a Kidney Function Test and What Does It Assess? The kidneys perform three essential tasks: filtering waste products from the blood, regulating the body's fluid and electrolyte balance, and maintaining acid-base equilibrium. When any of these functions is impaired, substances that should be excreted in urine accumulate in the blood — and their concentrations become measurable markers of damage. The renal panel is not a single test but a set of assays reflecting different aspects of kidney function: - Filtration — how efficiently the glomeruli clean the blood: creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR) - Fluid and electrolyte balance — the kidney's ability to regulate ions: sodium, potassium, chloride, phosphorus - Synthetic and excretory function — markers of filtration barrier damage: urinary albumin, uric acid - Acid-base balance — bicarbonate and pH A doctor selects the specific tests based on the clinical question: a minimal screening set includes only creatinine and eGFR; an expanded panel adds BUN, electrolytes, uric acid, and urine albumin testing. When Is a Kidney Function Test Ordered? Indications are divided into diagnostic, preventive, and monitoring categories. Symptoms that make the test mandatory: - Oedema of the legs, face, or around the eyes — especially on waking - Changes in urine: dark, frothy, or reddish - Significant decrease or increase in daily urine volume - Flank or lower back pain - Persistent hypertension that does not respond to standard treatment - Unexplained fatigue and nausea Preventive screening is recommended for: - Diabetes mellitus — annually, regardless of symptoms - Arterial hypertension — at least once a year - Long-term use of nephrotoxic drugs: NSAIDs, aminoglycosides, lithium, certain antivirals - Systemic diseases: lupus, rheumatoid arthritis, vasculitis - Obesity and metabolic syndrome - Pregnancy — screening each trimester - Family history of chronic kidney disease A urine test always accompanies the blood panel: together they give the full picture. Urinalysis reveals protein, red blood cells, and casts — signs of filter damage — where blood tests may still be silent. How to Prepare and Get Tested Kidney function markers are sensitive to several external factors that can significantly shift results. Preparation guidelines: - Blood is drawn fasting — at least 8–12 hours after the last meal. A high-protein meal the evening before elevates BUN and, to a lesser degree, creatinine. - Limit meat intake for 24 hours beforehand: a large serving of red meat or creatine supplements can transiently raise creatinine. - Do not become dehydrated: fluid deficit concentrates all markers and can mimic kidney failure. - Avoid intense physical activity for 24 hours — exercise raises creatinine through increased muscle breakdown. - Inform your doctor of all medications: NSAIDs, ACE inhibitors, angiotensin receptor blockers, and certain antibiotics affect the results or the kidneys directly. - For monitoring purposes, always test at the same laboratory at the same time of day — differences in eGFR calculation formulas between labs make cross-comparison unreliable. What the Panel Includes: Core Kidney Function Markers Creatinine is the end product of creatine metabolism in muscles, excreted exclusively by the kidneys. It is the central marker of filtration function: its blood concentration rises proportionally as kidney function declines. An important caveat: creatinine levels depend on muscle mass, so in elderly patients and women with low muscle mass, the kidneys can be significantly impaired while creatinine still appears normal. Estimated GFR (eGFR) is a derived value calculated using the CKD-EPI or MDRD formula from creatinine, age, sex, and race. It is the best integrated measure of kidney function, expressed in mL/min/1.73 m², and directly shows how many millilitres of blood the kidneys filter per minute. Normal in adults: above 90 mL/min/1.73 m². A declining eGFR is the basis for staging chronic kidney disease. Blood urea nitrogen (BUN / urea) is a protein metabolism waste product cleared by the kidneys. It is less specific than creatinine: BUN rises with high-protein diet, dehydration, gastrointestinal bleeding, and catabolic states. It is evaluated alongside creatinine — the BUN-to-creatinine ratio helps distinguish a renal from a pre-renal cause of elevation. Uric acid is the end product of purine metabolism. The kidneys excrete approximately 70% of the daily load. Chronically elevated uric acid directly damages renal tubules — creating a vicious cycle: gout impairs kidney function, and kidney failure worsens hyperuricemia. Electrolytes (sodium, potassium, chloride, phosphorus) — their balance is actively regulated by the kidneys. Disturbances are characteristic of advanced kidney failure: potassium accumulates and creates arrhythmia risk, phosphorus rises and disrupts calcium metabolism, and sodium reflects the body's fluid balance. Urinary albumin (albuminuria) is a sensitive early marker of glomerular filter damage. Normally, albumin does not pass through. Microalbuminuria (30–300 mg/g creatinine) is the first laboratory sign of diabetic nephropathy, preceding eGFR changes by years. Albumin in urine is mandatory screening in diabetes and hypertension. Cystatin C is an alternative eGFR marker independent of muscle mass. It is ordered in complex diagnostic cases — in patients with sarcopenia, in elderly individuals, in pregnancy — when the standard creatinine-based calculation is unreliable. Kidney Panel Normal Values: Summary Table Reference ranges vary between laboratories — always check the values on your own report. Parameter Men Women Pregnancy ------------ Creatinine (µmol/L) 62–115 53–97 40–80 eGFR (mL/min/1.73 m²) 90 90 90 BUN / Urea (mmol/L) 2.5–8.3 2.5–7.5 2.0–6.5 Uric acid (µmol/L) 200–430 140–360 120–270 Sodium (mmol/L) 136–145 136–145 133–143 Potassium (mmol/L) 3.5–5.1 3.5–5.1 3.3–5.0 Albuminuria (mg/g) < 30 < 30 < 30 In pregnancy, eGFR physiologically increases by 40–65% due to elevated cardiac output and renal blood flow — meaning a creatinine value that is normal for a non-pregnant adult may already signal impaired function during pregnancy. Interpreting Deviations: What Rising Creatinine and Falling eGFR Mean Doctors interpret the renal panel as a whole, looking for patterns of change rather than isolated numbers. Rising creatinine + falling eGFR — the central pattern of kidney failure. Three subtypes by cause: - Pre-renal — the kidneys are intact but blood flow to them is reduced: dehydration, heart failure, shock. BUN rises disproportionately; the BUN-to-creatinine ratio exceeds 20. Restoring fluid volume normalises results rapidly. - Renal — damage to the kidney tissue itself: glomerulonephritis, acute tubular necrosis, drug-induced nephropathy. BUN and creatinine rise roughly proportionally. - Post-renal — obstruction of urine outflow: kidney stone, tumour, enlarged prostate. Ultrasound confirms the cause. Chronic eGFR decline is staged by the CKD classification: Stage eGFR (mL/min) Description --------- G1 ≥ 90 Normal or high, but damage markers present G2 60–89 Mildly reduced G3a 45–59 Mildly to moderately reduced G3b 30–44 Moderately to severely reduced G4 15–29 Severely reduced G5 < 15 Kidney failure Hyperkalaemia (potassium above 5.5 mmol/L) in kidney failure is an emergency: life-threatening arrhythmias can develop rapidly. Isolated microalbuminuria with normal eGFR is an early signal of glomerular damage, especially in diabetics and hypertensives. This is the point at which intensive treatment is most effective at slowing progression. When Kidney Function Test Results Require Urgent Medical Attention Most changes in the renal panel call for a scheduled appointment. But some situations are medical emergencies: - Creatinine doubling within a few days from a previously normal baseline - eGFR below 15 mL/min without a previously established CKD diagnosis - Potassium above 6.0 mmol/L — risk of cardiac arrest - Anuria or sharply reduced urine output (less than 400 mL per day) - Oedema + hypertension + frothy urine simultaneously — nephrotic syndrome - Any abnormality in a pregnant woman, particularly in the second half of pregnancy: pre-eclampsia progresses rapidly and is life-threatening - Progressive uraemic symptoms: nausea, vomiting, confusion, metallic taste in the mouth With moderate abnormalities and no symptoms, a scheduled visit to a GP or nephrologist is sufficient. Restricting fluid or protein intake in response to "bad kidney results" without medical guidance is a potentially dangerous mistake. Conclusion A kidney function test is a multi-angle evaluation of the organ: filtration capacity, metabolic waste clearance, electrolyte balance, and filtration barrier integrity — all assessed together. No single marker tells the full story; diagnostic value comes from the pattern of results. The key to reliable findings is proper preparation: moderate protein intake the day before, normal hydration, and avoiding nephrotoxic drugs as advised by your doctor. Early detection of kidney impairment is the only way to halt progression before irreversible damage occurs. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/liver-function-test https://labreadai.com/en/tests/liver-function-test Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Liver function tests (ALT, AST, GGT, bilirubin, albumin): normal ranges for adults and pregnancy, how to prepare for the panel and what abnormal results mean. Tests article A yellowish tint to the skin, heaviness in the right upper abdomen, unexplained fatigue — these are signals that will prompt a doctor to order liver function tests (LFTs) as a first step. But LFTs are also ordered without symptoms: to monitor hepatotoxic medications, during routine checkups, before surgery, and throughout pregnancy. A liver function panel is a group of biochemical blood markers, each illuminating a different aspect of liver health: some detect cell death, others signal impaired bile flow, and still others reflect the organ's declining ability to synthesize proteins. This article covers what the panel includes, how to prepare, and what each deviation means. What Are Liver Function Tests and What Do They Show? The liver is the body's largest internal organ and its metabolic hub: it neutralizes toxins, synthesizes blood proteins, produces bile, and participates in the metabolism of virtually every nutrient. When liver cells are damaged, they release intracellular enzymes into the bloodstream. When bile flow is obstructed, bilirubin accumulates. When the liver loses its ability to synthesize proteins, albumin falls. Liver function tests detect precisely these changes. A standard panel evaluates three pathological syndromes simultaneously: - Cytolysis — hepatocyte destruction: markers ALT and AST - Cholestasis — impaired bile flow: markers GGT, alkaline phosphatase, direct bilirubin - Impaired synthetic function — markers total protein, albumin, prothrombin time An important note: LFTs identify the fact and character of damage — they do not establish a diagnosis. Cirrhosis, hepatitis, fatty liver disease, and gallstones can all produce similar laboratory patterns. A diagnosis is made from the full clinical picture. When Liver Function Tests Are Ordered Indications fall into symptomatic and preventive categories. Symptoms that will prompt an LFT order: - Jaundice — yellowing of the skin or whites of the eyes - Dark urine and pale stools - Pain or heaviness in the right upper abdomen - Nausea or aversion to fatty foods - Unexplained skin itching without a rash Preventive and monitoring indications: - Long-term use of hepatotoxic drugs — statins, antituberculosis agents, certain antibiotics, NSAIDs - History of significant alcohol use - Obesity and metabolic syndrome — screening for non-alcoholic fatty liver disease - Known or suspected viral hepatitis B or C - Pregnancy — mandatory screening each trimester - Pre-operative evaluation - Annual health screening after age 40 How to Prepare and Get Tested Liver function tests are part of a biochemical blood panel — blood is drawn from a vein, typically in the morning. Preparation guidelines: - Blood must be drawn strictly fasting: no food for 8–12 hours beforehand. A fatty meal the night before can falsely elevate alkaline phosphatase and GGT — making a repeat test necessary. - Avoid alcohol for 48 hours before the draw. Even a small amount elevates GGT and AST for several days. - Do not smoke for 30 minutes before the draw. - Inform your doctor of all medications you are taking: dozens of drugs affect liver enzymes, and this must be considered when interpreting results. - Intense physical activity within 24 hours elevates AST — do not test after a workout. - If you are taking a hepatotoxic drug and the goal is to monitor its safety, test at the same time of day as previous draws to keep trends comparable. What the Panel Includes: ALT, AST, GGT, Bilirubin and Albumin The exact composition of the panel varies by clinical question. Here are the core markers and what each reflects. ALT (alanine aminotransferase) is an enzyme concentrated primarily in liver cells. Its elevation is the most specific marker of cytolysis. Even a two- to three-fold rise above normal warrants further investigation. For a detailed breakdown of the indicator and its causes, see ALT in blood. AST (aspartate aminotransferase) is less liver-specific: significant AST is also found in cardiac muscle and skeletal muscle. The AST/ALT ratio (de Ritis ratio) helps characterize the damage: above 2 is typical of alcoholic hepatitis; below 1 is more consistent with viral hepatitis. GGT (gamma-glutamyl transferase) is a sensitive marker of cholestasis and alcohol-related liver injury. Isolated GGT elevation with normal ALT and AST often points to alcohol use, certain medications, or non-alcoholic fatty liver disease. Alkaline phosphatase (ALP) is a second cholestasis marker. A high ALP with normal GGT should prompt a search for non-hepatic causes: bone disease, hyperparathyroidism, or normal physiological elevation in growing children and pregnant women. Bilirubin (total, direct, indirect) is the breakdown product of hemoglobin, processed and cleared by the liver. Bilirubin exists in two forms: indirect (free, toxic) and direct (conjugated, water-soluble). A predominance of indirect bilirubin suggests increased red blood cell breakdown; a predominance of direct bilirubin points to bile flow obstruction. Total protein and albumin are markers of the liver's synthetic function. Albumin is the main plasma protein, produced exclusively in the liver. Its decline in chronic liver disease signals that the organ is losing its functional reserve — a late but significant finding. Prothrombin time (PT/INR) is a coagulation test that indirectly reflects hepatic synthetic function. A fall in clotting factor levels is another sign of depleted liver reserve. Liver Panel Normal Values: Summary Table Reference ranges vary between laboratories — always check the values printed on your own report. Parameter Men Women Pregnancy ------------ ALT (U/L) < 45 < 34 < 35 AST (U/L) < 40 < 32 < 32 GGT (U/L) < 55 < 38 < 38 ALP (U/L) 40–130 35–105 up to 250 (3rd trimester) Total bilirubin (µmol/L) 3.4–17.1 3.4–17.1 3.4–14.0 Direct bilirubin (µmol/L) 0–5.1 0–5.1 0–4.3 Albumin (g/L) 35–50 35–50 28–44 Total protein (g/L) 64–83 64–83 56–80 ALP rises physiologically in the third trimester due to the placental isoenzyme — this is normal, not pathological. A mild ALT rise in the first trimester may be related to morning sickness and does not always require treatment. Interpreting Deviations: Cytolysis and Cholestasis Syndromes Doctors interpret LFTs not by individual values but by patterns — combinations of changes that point to specific pathological processes. Cytolysis syndrome — significantly elevated ALT and AST. The greater the multiple of the upper limit, the more acute the process. A 2- to 5-fold rise is moderate, typical of fatty liver disease, drug-induced injury, or mild alcoholic hepatitis. A 10- to 50-fold or greater rise suggests acute viral or toxic hepatitis. Normal ALT and AST do not rule out chronic hepatitis or cirrhosis: in advanced cirrhosis, there are too few surviving cells left to release enzymes. Cholestasis syndrome — predominantly elevated GGT, ALP, and direct bilirubin, with mildly elevated or normal transaminases. This indicates impaired bile flow — either within the liver (primary biliary cholangitis, drug-induced cholestasis) or outside it (gallstones, pancreatic tumor, ductal compression). Hepatic failure syndrome — falling albumin, prolonged prothrombin time, often combined with a drop in cholesterol. This indicates severe or long-standing injury with loss of synthetic capacity. Isolated hyperbilirubinemia (predominantly indirect bilirubin with normal enzymes) — Gilbert's syndrome. This is a benign, genetically determined variant found in 5–10% of the population. It requires no treatment. When Liver Function Test Results Require Urgent Medical Attention Most mild LFT abnormalities call for a scheduled visit to a GP or gastroenterologist. Some findings, however, require prompt evaluation: - ALT or AST more than 10 times the upper limit of normal — possible acute hepatitis - Rapidly deepening jaundice with abdominal pain — cholangitis or acute biliary obstruction - Albumin below 28 g/L with prolonged INR — signs of severe hepatic failure - Any abnormality in a pregnant woman, especially in the second half of pregnancy: HELLP syndrome and acute fatty liver of pregnancy are life-threatening conditions - Dark urine, jaundice, and fever simultaneously — Charcot's triad of cholangitis Mild deviations without symptoms should not be self-interpreted — clinical context changes everything. Conclusion Liver function tests are not a single assay but a carefully designed combination of markers, each illuminating a different facet of liver function. ALT and AST capture cell death; GGT and alkaline phosphatase flag impaired bile flow; albumin and prothrombin time reflect the organ's synthetic reserve. Proper preparation — fasting, avoiding alcohol and intense exercise beforehand — ensures reliable results. When something looks abnormal, resist drawing immediate conclusions: a final diagnosis always depends on the full clinical picture, not one lab sheet. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/urinalysis https://labreadai.com/en/tests/urinalysis Sun, 22 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Urine test (UA) explained: color, clarity, protein, glucose, leukocytes and sediment. Normal ranges for every indicator and causes of abnormalities in one table. Tests article You get a results sheet with two dozen rows — color, pH, protein, leukocytes, casts — and not a single number speaks for itself. A urinalysis (UA) is one of the most commonly ordered laboratory tests, capable of pointing to kidney inflammation, diabetes, urinary tract infections, and even liver problems before obvious symptoms appear. This article walks through every indicator: what it measures, what a normal result looks like, and what deviations mean. For a step-by-step walkthrough of your personal results, see how to read a urinalysis. What Is a Urinalysis and Why Is It Ordered? A UA is a comprehensive laboratory test that evaluates the physical properties of urine, its chemical composition, and the cellular sediment under a microscope. These three components together provide a full picture of kidney and urinary tract function, and indirectly reflect metabolic and immune status. A doctor orders a UA in several situations: - Routine health screening or annual checkup - Symptoms such as painful urination, increased frequency, or changes in urine color - Monitoring treatment of cystitis, pyelonephritis, or urinary stones - Ongoing management of diabetes, hypertension, or pregnancy - Pre-operative evaluation The test takes 1–2 hours in the lab and requires no special preparation beyond correct sample collection. How to Collect the Sample: Preparation for a Urinalysis Collection errors are the most common cause of false results. Contamination of the sample with epithelial cells, bacteria, or secretions makes the analysis unreliable — and means the test has to be repeated. Collection guidelines: - Collect the first morning void — the most concentrated sample, reflecting kidney function at rest. - Clean the genital area thoroughly beforehand, without antibacterial soap. - Let the first 1–2 seconds of urine pass into the toilet, then catch the midstream portion in a sterile container. - Volume: at least 30–50 mL. - Use a pharmacy-grade sterile container, not a jar from home. - Deliver to the lab within 1–2 hours. Refrigerator storage is acceptable for up to 4 hours; longer than that distorts results. Women should avoid collecting urine during menstruation — blood will contaminate the sample and produce false positives for red blood cells and protein. If the test is urgent, use a tampon. Physical Properties of Urine: Color, Clarity, Odor, and Density The lab technician evaluates these parameters visually and with a urinometer before chemical analysis. They provide the first overall impression of the sample. Color is normally straw-yellow to amber. Intensity depends on hydration: the less fluid consumed, the darker the urine. Deviations: - Red or brown — blood (hematuria), beets, certain medications - Dark brown, "beer-colored" — bilirubinuria, liver disease - Cloudy white — pus in severe infection - Nearly colorless — excessive fluid intake or diabetes insipidus Clarity is normally full. Turbidity suggests the presence of bacteria, leukocytes, mucus, or salt crystals. Odor is normally mild and specific. An ammonia smell indicates bacterial decomposition. An acetone smell suggests ketoacidosis, characteristic of decompensated diabetes. Specific gravity (1.010–1.025) reflects the kidney's ability to concentrate urine. Persistently low density is a sign of chronic kidney insufficiency or diabetes insipidus. pH is normally 4.5–8.0. Strongly acidic urine occurs with a high-meat diet and gout; alkaline urine with urinary tract infections and a vegetarian diet. Chemical Indicators in a Urinalysis: Normal and Abnormal A dipstick test detects in seconds the presence or absence of key substances that should not normally appear in urine. Protein. Normal — absent or trace amounts up to 0.033 g/L. The presence of protein (proteinuria) is one of the most important signs of damage to the kidney filter. Read more: protein in urine — causes, severity levels, and when it is dangerous. Glucose. Normally absent. Appears when blood sugar exceeds the renal threshold (approximately 9–10 mmol/L) — most commonly in diabetes mellitus. Ketone bodies. Normally absent. Acetone and other ketones appear during fasting, low-carbohydrate diets, and — critically — diabetic ketoacidosis. More on this indicator: ketones in urine. Bilirubin. Normally absent. Appears in liver and biliary tract disease. Urobilinogen. Up to 17 µmol/L is acceptable. Elevated levels suggest hemolysis or impaired liver function. Nitrites. Normally absent. Appear when bacteria convert urinary nitrates to nitrites. A positive nitrite test is a signal of cystitis or pyelonephritis. Urine Sediment Microscopy: Cells, Casts, and Crystals After centrifuging the sample, the lab technician examines the sediment under a microscope. This is the most informative part of the urinalysis. Leukocytes — normal up to 5 per high-power field in women, up to 3 in men. Exceeding this (pyuria) indicates inflammation in the urinary tract. The higher the count, the more active the process. Everything you need to know: leukocytes in urine. Red blood cells — normal 0–3 per high-power field. Higher values (hematuria) require investigation: urinary stones, tumors, glomerulonephritis, trauma. Casts are protein molds formed in the renal tubules. Occasional hyaline casts are acceptable. Granular, waxy, or red blood cell casts indicate serious kidney pathology. Bacteria — normally absent. Detection in a properly collected sample is an indication for urine culture to identify the organism and its antibiotic sensitivity. Crystals are salts precipitated out of solution. Occasional oxalate or urate crystals are not pathological. Massive crystalluria with symptoms may suggest urolithiasis. Epithelial cells — occasional transitional or squamous cells are acceptable. Abundant renal (tubular) epithelium indicates tubular damage. Urinalysis Normal Values: Summary Table Parameter Normal ------ Color Straw-yellow Clarity Clear Odor Mild, specific pH 4.5–8.0 Specific gravity 1.010–1.025 Protein Absent / up to 0.033 g/L Glucose Absent Ketone bodies Absent Bilirubin Absent Urobilinogen Up to 17 µmol/L Nitrites Absent Leukocytes Up to 5 HPF (women) / 3 HPF (men) Red blood cells 0–3 per high-power field Hyaline casts Occasional / absent Bacteria Absent Epithelial cells Occasional Reference ranges may vary slightly by laboratory method and equipment — always check the reference values on your specific results sheet. When Urinalysis Results Require Urgent Medical Attention Most UA abnormalities are mild and warrant a scheduled appointment. But some findings call for prompt evaluation: - Visible blood in urine, or hematuria above 10–15 red blood cells per field - Leukocyturia above 30–50 per field — massive inflammation - Red blood cell or waxy casts — severe kidney pathology - Protein above 1 g/L, especially combined with edema and elevated blood pressure - Significant bacteriuria with fever and flank pain — possible pyelonephritis - Heavy ketonuria with vomiting and altered consciousness — risk of diabetic ketoacidosis If your UA shows abnormalities for the first time, do not interpret the result on your own. A doctor will evaluate it in the context of your symptoms, history, and other investigations. Conclusion A urinalysis is a simple, accessible, and highly informative test. Its three components — physical properties, chemical composition, and sediment microscopy — together paint a picture of kidney and urinary tract function, and sometimes reveal systemic metabolic disorders. The key to an accurate result is correct sample collection. If anything on your results sheet concerns you, consult a general practitioner or urologist — most abnormalities respond well to treatment when caught early. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/antiphospholipid-syndrome https://labreadai.com/en/posts/antiphospholipid-syndrome Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) APS is an autoimmune clotting disorder causing thrombosis and pregnancy loss. Diagnostic antibodies, lupus anticoagulant, pregnancy management and anticoagulation. Articles article A young woman suffers a stroke without atherosclerosis or hypertension. Another has three consecutive miscarriages with no gynaecological explanation. A third patient — deep vein thrombosis at 30 with no apparent cause. Behind all three presentations may lie a single diagnosis: antiphospholipid syndrome. This autoimmune disease causes the immune system to produce antibodies that attack the body's own phospholipids, triggering pathological clot formation. What Is Antiphospholipid Syndrome and How Does It Develop Antiphospholipid syndrome (APS, Hughes syndrome) is an acquired autoimmune thrombophilic condition in which antiphospholipid antibodies (aPL) circulate in the blood, increasing the tendency to thrombosis in arteries and veins, and in pregnant women — to placental pathology and pregnancy loss. In health, phospholipids — components of cell membranes — are inaccessible to the immune system. In APS, for reasons not fully understood, the immune system begins producing antibodies against phospholipids (primarily cardiolipin and beta-2-glycoprotein I) and their associated proteins. These antibodies disrupt the normal coagulation system at multiple points: they activate platelets and vascular endothelial cells, suppress natural anticoagulant mechanisms and impair fibrinolysis. The result is pathological clot formation in vessels of any calibre and any location. APS belongs to the group of thrombophilias — conditions with an elevated tendency to clot. Its defining distinction from hereditary thrombophilias (protein C deficiency, factor V Leiden mutation) is its acquired and autoimmune nature. This means that unlike genetic defects, APS is theoretically amenable to treatment directed at the immune system. APS may exist as a standalone condition (primary APS) or in the context of another autoimmune disease — most commonly systemic lupus erythematosus (secondary APS). Approximately 30–40% of patients with SLE have antiphospholipid antibodies, and a subset develops clinically overt APS. Causes and Risk Factors for Antiphospholipid Syndrome The precise trigger for aPL production is unknown. As with most autoimmune diseases, an interaction between genetic predisposition and environmental triggers is likely. Genetic factors. APS is not inherited in the strict sense, but certain HLA variants are associated with a higher likelihood of aPL production. Infectious triggers. Several infections — Epstein–Barr virus, cytomegalovirus, parvovirus B19, certain bacteria — can induce transient aPL in healthy individuals. These typically disappear within months and do not cause thrombosis; only antibodies persisting beyond 12 weeks are considered clinically significant. Medications. Some drugs (hydralazine, procainamide, chlorpromazine) can induce aPL, but drug-induced APS rarely manifests as thrombosis. Co-existing autoimmune diseases. Systemic lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome are the most significant risk factors for secondary APS. Sex and age. APS is substantially more common in women (female-to-male ratio approximately 5:1), predominantly at reproductive age. In men, disease onset is more often associated with arterial rather than venous thrombosis. Symptoms of Antiphospholipid Syndrome: Thrombosis and Autoimmune Signs The clinical picture of APS is determined by the site of thrombosis and the degree of organ involvement. The condition can affect virtually any organ. Venous thrombosis — the most common manifestation. Deep vein thrombosis of the lower limbs followed by pulmonary embolism occurs in approximately half of all patients with thrombotic APS. Recurrence without adequate anticoagulation is characteristic. Arterial thrombosis — ischaemic stroke and transient ischaemic attacks (TIA) in young adults (under 45–50) without traditional risk factors is one of the key clinical red flags for APS. Myocardial infarction in young people without atherosclerosis, retinal vascular occlusion and limb ischaemia are also well-recognised. Obstetric complications — covered in detail in the next section. Thrombocytopenia — a reduction in platelet count, usually mild (typically 50–150 × 10⁹/L). It paradoxically co-exists with thrombosis rather than bleeding, because platelets in APS are hyperactivated. Livedo reticularis — a characteristic bluish-purple net-like pattern on the skin, particularly on the limbs, due to disrupted microcirculation. Not dangerous in itself, but an important clinical marker of APS. Cardiac valve disease — vegetations or thickening of the mitral and aortic valves (Libman–Sacks endocarditis) are detected echocardiographically in a proportion of patients. Renal involvement — renal artery or arteriolar thrombosis, nephrotic syndrome; nephrotic syndrome in APS is less common than in lupus nephritis. Hypertension in APS is often linked to renal vascular involvement and may respond poorly to standard antihypertensive therapy. Catastrophic APS (CAPS) — rare (< 1%) but life-threatening: simultaneous thrombosis of small vessels in multiple organs over several days. Mortality without treatment approaches 50%. APS in Pregnancy: Miscarriage Risk and Obstetric Complications Obstetric APS is one of the leading causes of recurrent pregnancy loss and severe obstetric complications. Antiphospholipid antibodies damage the placenta through thrombosis of its vessels and direct injury to trophoblast cells. Criteria for obstetric APS include: - three or more consecutive miscarriages before 10 weeks of gestation; - one or more losses of a morphologically normal fetus after 10 weeks; - premature birth before 34 weeks due to severe pre-eclampsia or placental insufficiency. Early miscarriages in APS differ from chromosomal losses in that they occur repeatedly and the embryo is morphologically normal. Testing for aPL is mandatory in the investigation of recurrent pregnancy loss. Without treatment, pregnancy loss rates in APS exceed 90%. With a combination of low-molecular-weight heparin and low-dose aspirin initiated from confirmed pregnancy — or in some cases from the planning stage — live birth rates reach 70–80%. Pregnancy planning in APS requires a joint consultation with a haematologist or rheumatologist and an obstetrician. For monitoring early pregnancy signs in APS, see first signs of pregnancy. Antiphospholipid Syndrome Diagnosis: Antibodies and Blood Tests That Confirm APS APS is diagnosed according to the Sydney Criteria (2006) when at least one clinical criterion and at least one laboratory criterion are met, the latter confirmed on two separate occasions at least 12 weeks apart. Laboratory criteria — three antibody groups: - Lupus anticoagulant (LA) — a functional assay: antibodies prolong phospholipid-dependent coagulation tests in vitro. Detected through coagulation testing (aPTT, dRVVT). The paradox: an "anticoagulant" in the test tube is a powerful procoagulant in the body. - Anticardiolipin antibodies (aCL) IgG and IgM — ELISA; diagnostically significant at medium and high titres ( 40 GPL or MPL). - Anti-beta-2-glycoprotein I antibodies (anti-β₂GPI) IgG and IgM — the most specific marker for true APS. Positivity for all three antibody groups ("triple positivity") marks the highest thrombotic risk profile. Additional investigations: - D-dimer — elevated in active thrombosis; used to confirm a thrombotic event and monitor treatment response. - Full blood count — thrombocytopenia as a manifestation of APS. - Antinuclear antibodies (ANA), anti-dsDNA — to exclude co-existing SLE. - Kidney function tests — to assess renal involvement. A fundamental rule: a positive aPL test on first testing is not a diagnosis. Mandatory confirmation ≥ 12 weeks later is required. Transient aPL associated with infections are clinically insignificant. Treatment of Antiphospholipid Syndrome APS treatment aims to prevent recurrent thrombosis and obstetric complications — current medicine cannot eliminate the autoimmune process or eradicate the antibodies. For thrombotic APS: - Warfarin — historically the primary agent for long-term secondary thrombosis prevention in APS. Target INR 2.0–3.0 for venous thrombosis; for arterial thrombosis — often 3.0–4.0. Requires regular laboratory monitoring. - Direct oral anticoagulants (DOACs) (rivaroxaban, apixaban) — less effective in "triple-positive" patients based on clinical trial data; used only in low-risk profiles or when warfarin is not feasible. - Hydroxychloroquine — an immunomodulator with antithrombotic properties; recommended for all APS patients, particularly those with co-existing SLE. - Statins and low-dose aspirin — added when cardiovascular risk is high. Duration of therapy: with "triple positivity" or an arterial thrombotic event, most guidelines support lifelong anticoagulation; with isolated antibody positivity and a first venous event, a shorter course may be considered after careful individual risk assessment. For obstetric APS (no prior thrombosis): - Combination of low-molecular-weight heparin (LMWH) + low-dose aspirin (75–100 mg/day) from confirmed pregnancy — or from the planning stage in some cases — through to 34–36 weeks, then aspirin alone. - Hydroxychloroquine or intravenous immunoglobulin are added when the standard regimen fails. For catastrophic APS — intensive care: high-dose heparin anticoagulation, glucocorticoids, plasmapheresis, intravenous immunoglobulin. When to See a Doctor Mandatory rheumatology or haematology referral when: - thrombosis at any site in a person under 50 without traditional risk factors; - stroke or TIA in a young adult without hypertension or atherosclerosis; - two or more consecutive miscarriages or one pregnancy loss after 10 weeks; - combination of thrombocytopenia and thrombotic events; - characteristic livedo reticularis combined with any of the above. Testing positive for aPL without clinical events — "aPL carriership" — is not a diagnosis of APS and does not require anticoagulation, but does call for elimination of additional thrombotic risk factors. Do not interpret test results independently — management is determined by a physician. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/autoimmune-polyendocrine-syndrome https://labreadai.com/en/posts/autoimmune-polyendocrine-syndrome Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Autoimmune polyendocrine syndrome combines multiple endocrine diseases in one patient. APS types, screening strategy after first diagnosis and treatment priorities. Articles article Hashimoto's thyroiditis and type 1 diabetes in the same patient. Adrenal insufficiency alongside hypothyroidism and vitiligo. Chronic candidiasis, hypoparathyroidism and Addison's disease from childhood. These are not coincidences — they are manifestations of autoimmune polyendocrine syndrome, in which the immune system attacks several endocrine glands in succession. Understanding this syndrome matters because when one autoimmune endocrine disease is confirmed, the others must be actively sought. What Is Autoimmune Polyendocrine Syndrome Autoimmune polyendocrine syndrome (APS, polyglandular autoimmune syndrome, PAS) is a clinical condition in which a single patient develops two or more autoimmune diseases affecting endocrine glands and/or other organs with tissue-specific autoantibodies, either simultaneously or sequentially. APS is rooted in a breakdown of immunological tolerance — the immune system's ability to ignore the body's own tissues. In APS this mechanism fails at multiple points simultaneously. This is partly explained by shared genetic factors: many autoimmune endocrine diseases are associated with the same HLA variants (particularly HLA-DR3 and HLA-DR4), creating a common genetic substrate for multiple autoimmune processes in a predisposed individual. Among endocrinologists, the rule is clear: when any autoimmune endocrine disease is diagnosed, don't wait for symptoms of the next — screen actively. This rule saves lives, especially where adrenal insufficiency is concerned: unrecognised adrenal insufficiency can cause a life-threatening crisis under the stress of intercurrent illness or surgery. Classification: Types of Autoimmune Polyendocrine Syndrome Several classification systems exist for APS. The most widely used divides the condition into four types, each with characteristic components and genetic features. APS-1 (APECED, Whitaker syndrome) — a rare hereditary condition with autosomal recessive inheritance caused by mutations in the AIRE gene (autoimmune regulator). AIRE ensures that immune cells in the thymus "learn" to tolerate the body's own tissues — without it, self-tolerance fails. Disease presents in childhood. Classic triad: - chronic mucocutaneous candidiasis (usually the first sign, appearing at age 3–5); - hypoparathyroidism (seizures from hypocalcaemia); - Addison's disease (adrenal insufficiency). Additional components of APS-1: hypogonadism, atrophic gastritis, coeliac disease, alopecia, vitiligo, chronic hepatitis. APS-2 (Schmidt syndrome) — the most common type, occurring in adults and significantly more often in women. The obligatory component is Addison's disease, to which one or more of the following are added: - Hashimoto's thyroiditis or Graves' disease; - type 1 diabetes mellitus. APS-3 — autoimmune thyroid disease (Hashimoto's or Graves') combined with another autoimmune condition but without Addison's disease: - APS-3a: thyroid disease + type 1 diabetes; - APS-3b: thyroid disease + atrophic gastritis / pernicious anaemia; - APS-3c: thyroid disease + vitiligo or alopecia; - APS-3d: thyroid disease + other autoimmune condition. APS-4 — a combination of two or more autoimmune endocrine diseases that does not fit types 1–3. In practice, APS-3a (Hashimoto's + type 1 diabetes) and APS-2 are encountered most frequently. Some specialists simplify the classification to two groups: APS-1 (monogenic, paediatric) and APS-2 (polygenic, adult). Autoimmune Polyendocrine Syndrome Symptoms: How Multiple Diseases Present The symptoms of APS are the sum of the manifestations of each constituent disease, but their combination frequently produces atypical clinical pictures that complicate diagnosis. Profound fatigue and weakness — in APS-2, the combination of hypothyroidism and adrenal insufficiency produces a degree of asthenia substantially greater than either condition alone. Patients often spend years treated for "fatigue" without the adrenal component being identified. Hypoglycaemia during insulin therapy — in APS-2 combining type 1 diabetes with adrenal insufficiency, previously adequate insulin doses begin causing dangerous hypoglycaemic episodes because cortisol — a counter-regulatory hormone — is deficient. This is an important clinical trap. Impaired response to levothyroxine — in a patient with hypothyroidism starting thyroid hormone replacement, undiagnosed adrenal insufficiency may be unmasked: thyroxine accelerates cortisol metabolism and the inadequate adrenal reserve becomes symptomatic. Starting thyroid hormone replacement without first excluding adrenal insufficiency is a classic error that can precipitate a crisis. Seizures and paraesthesiae in APS-1 — a consequence of hypocalcaemia from hypoparathyroidism. Blood calcium and parathyroid hormone should be checked in all APS-1 patients regardless of symptoms. Skin manifestations — vitiligo (skin depigmentation) and alopecia (hair loss) frequently accompany any type of APS and serve as visible markers of ongoing autoimmune activity in the individual patient. Polyendocrine Syndrome Diagnosis and Screening After the First Autoimmune Disease The key diagnostic principle in APS: don't wait for symptoms — search actively. Once any autoimmune endocrine disease is confirmed, regular screening for related conditions is mandatory. Screening frequency depends on APS type and individual risk — typically annually. In Hashimoto's thyroiditis or hypothyroidism — screen for: - 21-hydroxylase antibodies and morning cortisol — to exclude subclinical adrenal insufficiency; - fasting glucose and anti-GAD / ICA antibodies — to exclude type 1 diabetes; - vitamin B12 and intrinsic factor antibodies — to exclude pernicious anaemia. In type 1 diabetes mellitus — screen for: - TSH and anti-TPO antibodies — thyroiditis is found in 15–30% of patients with type 1 diabetes; - 21-hydroxylase antibodies — Addison's disease occurs in 0.5% of type 1 diabetes patients, but risk is many-fold higher when antibodies are present; - anti-transglutaminase antibodies — coeliac disease occurs in 5–10% of type 1 diabetes patients. In Addison's disease — the broadest screening is warranted given the high comorbidity: TSH + anti-TPO, fasting glucose, anti-parietal cell and anti-intrinsic factor antibodies, anti-17α-hydroxylase antibodies (for autoimmune hypogonadism). Instrumental workup: - bone densitometry — bone density is reduced in hypoparathyroidism (APS-1) and adrenal insufficiency; - complete blood count — to detect anaemia in pernicious anaemia or coeliac disease. Genetic Aspects: Which Relatives Need Testing For APS-1 (AIRE mutation) — autosomal recessive inheritance. Testing of siblings is mandatory, particularly when there is a history of recurrent candidiasis or childhood seizures. For APS-2 and APS-3 — polygenic predisposition. No single candidate gene has been identified, so genetic screening of relatives is not standardised. However, first-degree relatives of APS-2 patients are advised to have periodic TSH and fasting glucose measurements as a minimum monitoring approach. In women with PCOS and cycle disturbances when an autoimmune endocrine disease is already established, autoimmune oophoritis as a component of APS should be excluded — particularly when premature ovarian insufficiency develops. Treatment of Autoimmune Polyendocrine Syndrome Treatment of APS is the treatment of each of its constituent diseases. No unified pathogenetic therapy capable of halting the autoimmune process in multiple glands simultaneously currently exists. Priority of life-saving replacement therapy. In APS-2 combining hypothyroidism and Addison's disease: glucocorticoid replacement (adrenal insufficiency treatment) is initiated first, and levothyroxine is added only after stabilisation. The reverse order is dangerous. Dose monitoring. With type 1 diabetes combined with adrenal insufficiency, insulin doses typically require downward adjustment once glucocorticoid therapy is started, and upward adjustment if glucocorticoid doses are ever reduced. Glycaemic management becomes considerably more complex. Hypoparathyroidism in APS-1 is treated with calcium supplements and active vitamin D analogues (alfacalcidol, calcitriol). Unlike ordinary hypoparathyroidism, recombinant parathyroid hormone is recommended in severe APS-1 cases. Immunosuppression. In APS-1 with severe cutaneous or systemic manifestations, tacrolimus or other immunosuppressants are used. In other APS types, immunosuppression has limited indications and generally does not alter the endocrine component of the disease. All patients with APS are advised to wear a medical alert bracelet stating their adrenal insufficiency diagnosis, and to learn emergency hydrocortisone self-injection technique — particularly given the risk of acute crisis during intercurrent illness. When to See an Endocrinologist See an endocrinologist for APS screening when: - you have been diagnosed with Hashimoto's thyroiditis, type 1 diabetes or Addison's disease — annual screening for related autoimmune conditions is recommended; - a child has recurrent mucocutaneous candidiasis, seizure episodes or unexplained developmental delay — exclude APS-1; - a patient on insulin begins experiencing unexpectedly severe hypoglycaemia — adrenal insufficiency must be excluded; - multiple first-degree relatives have different autoimmune endocrine diseases — screening is warranted. Screening for vitamin B12 deficiency is important in all APS types: atrophic gastritis with pernicious anaemia frequently accompanies autoimmune thyroid disease and often goes unrecognised. Do not interpret symptoms independently — consult a physician. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/breast-cancer https://labreadai.com/en/posts/breast-cancer Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Breast cancer — the most common cancer in women. Early symptoms, mammography, BRCA mutations, ER and HER2 molecular subtypes and modern treatment options explained. Articles article One in eight women globally will develop breast cancer during her lifetime. It is the most common cancer in women — and simultaneously one of the most treatable when found early: five-year survival at stage I exceeds 95%. The gap between that figure and real-world mortality comes down to one thing — late diagnosis. Understanding symptoms, risk factors and screening principles is what genuinely saves lives. What Breast Cancer Is and Its Molecular Subtypes Breast cancer is a malignant tumour arising from the glandular tissue or ducts of the breast. In 80–85% of cases it is invasive ductal carcinoma (IDC) — a tumour from duct cells invading surrounding tissue. Lobular carcinoma (ILC, 10–15%) arises from the lobules and is often found simultaneously in both breasts. Modern oncology classifies breast cancer primarily by molecular subtype rather than histological type — this determines treatment selection: Subtype Receptor profile Proportion Prognosis ------------ Luminal A ER+/PR+, HER2–, low Ki-67 40–45% Best Luminal B ER+/PR±, HER2– or HER2+, high Ki-67 20–25% Intermediate HER2-enriched ER–/PR–, HER2+ 10–15% Improved with targeted therapy Triple negative ER–/PR–, HER2– 15–20% Most aggressive Luminal subtypes are hormone-dependent: oestradiol and progesterone stimulate their growth, which is why anti-oestrogenic therapy is central to their treatment. HER2-enriched tumours depend on HER2 receptor overactivation — specific targeted agents have transformed their prognosis. Triple-negative breast cancer (TNBC) lacks all three receptors and is the most challenging to treat: aggressive, more frequent in young women and BRCA1 mutation carriers. TNM staging: Stage Description 5-year survival --------- 0 Carcinoma in situ (DCIS, LCIS) 99% I Tumour ≤ 2 cm, no nodal involvement 95–99% II Tumour 2–5 cm or 1–3 positive axillary nodes 75–90% III Locally advanced disease 40–70% IV Distant metastases (bone, lung, liver, brain) 20–30% Causes and Risk Factors Breast cancer has well-characterised risk factors. Approximately 30% of all cases are potentially linked to modifiable lifestyle factors. BRCA1 and BRCA2 mutations — the most significant hereditary risk factors. Lifetime breast cancer risk with BRCA1 reaches 70–80%; with BRCA2, 45–85%. The same mutations dramatically raise the risk of ovarian cancer, which is why carriers are offered either prophylactic bilateral mastectomy or an intensive surveillance protocol. Other high-risk genes include PALB2 (35–60% risk), CHEK2, ATM and TP53 (Li–Fraumeni syndrome — risk up to 85%). Age and reproductive history. Risk rises steeply after age 40 and accelerates after 50. Early menarche (before 12), late menopause (after 55) and nulliparity increase cumulative oestrogen exposure to breast tissue, raising risk by 20–50%. Hormone replacement therapy (HRT): combined oestrogen-progestogen HRT used for more than 5 years raises breast cancer risk by 20–25%. Oestrogen-only therapy in women after hysterectomy carries considerably lower risk and only when used for more than 10 years. Obesity after menopause: adipose tissue is the primary source of oestrogen in postmenopause through peripheral aromatisation of androgens. BMI above 30 raises postmenopausal breast cancer risk by 30–60%. Before menopause, obesity modestly reduces luminal subtype risk while raising triple-negative risk. Alcohol: one of the few well-established dietary risk factors. Each 10 g of alcohol per day raises breast cancer risk by 7–10%, mediated through elevated circulating oestradiol. Breast tissue density: high mammographic density (BI-RADS category D) increases risk fourfold to sixfold and simultaneously impairs tumour detection on mammography — supplemental ultrasound or MRI is needed. Prior chest radiotherapy in young age (for example, for Hodgkin's lymphoma) — a significant risk factor: breast cancer may develop 15–30 years after irradiation. Symptoms: Early and Late Signs Early breast cancer often has no symptoms and is detected only on mammography — which is precisely why regular screening is so important. When symptoms appear, this often indicates a more advanced process. Signs requiring prompt medical evaluation: - A new lump or thickening in the breast or axilla that was not previously present. Most palpable lumps are benign (cysts, fibroadenomas), but any new finding requires assessment - A change in breast shape or size - Peau d'orange — diffuse skin thickening and oedema resembling the surface of an orange. A sign of lymphovascular invasion — characteristic of inflammatory breast cancer - Skin or nipple retraction — a sign of tethering by Cooper's ligaments - Nipple discharge — particularly bloody or from one breast only - Redness, weeping or ulceration of the areola or nipple — a sign of Paget's disease of the breast - Persistent swelling, redness and warmth of the entire breast without signs of infection — inflammatory breast cancer requiring urgent evaluation Breast pain is not a characteristic symptom of breast cancer. Most painful lumps prove to be benign. However, the absence of pain is not a marker of benignity — most malignant tumours are painless at early stages. Diagnosis: Mammography, Biopsy and Blood Tests Diagnosis proceeds through three levels: screening investigation → confirmatory imaging → morphological verification by biopsy. Mammography — the gold standard for screening in women from age 40–50. Digital two-projection mammography detects tumours of 5–10 mm, inaccessible to palpation. Digital breast tomosynthesis (3D mammography) reduces false-positive rates in women with dense breast tissue. Breast ultrasound — supplementary for dense tissue, women under 40, palpable masses and to differentiate cystic from solid lesions. Contrast-enhanced breast MRI — the most sensitive method (95%). Indicated for: BRCA1/2 carriers; indeterminate mammography/ultrasound findings; extent assessment before breast-conserving surgery; lobular carcinoma (frequently multifocal). Biopsy — the only method of morphological diagnosis. Core-needle biopsy under ultrasound or stereotactic guidance is the standard: it provides tissue for histology and immunohistochemistry (ER, PR, HER2, Ki-67). Vacuum-assisted biopsy is used for microcalcifications. Laboratory tests once diagnosis is confirmed: Complete blood count — baseline haematopoietic status before chemotherapy; neutropenia and anaemia are the most common dose-limiting toxicities of cytotoxic therapy. Liver function tests — when hepatic metastases are suspected and for monitoring hepatotoxicity of targeted agents (trastuzumab, lapatinib). Tumour marker panel — CA 15-3 and CEA are used for monitoring in metastatic breast cancer: rising levels during remission are an early sign of progression. Not used for primary diagnosis. Molecular Diagnostics: Receptor Status and Mutations The pathology report from biopsy is the most important document in breast cancer management. Beyond histological type, it contains: Receptor status: ER (oestrogen receptor) and PR (progesterone receptor) determine sensitivity to hormonal therapy. ER positivity (≥ 1% staining) indicates eligibility for anti-oestrogenic treatment. High expression (Allred score ≥ 6) predicts maximum benefit. HER2 status: determined by immunohistochemistry (3+ = positive; 2+ = equivocal → FISH/CISH for clarification). HER2 positivity is the indication for trastuzumab, pertuzumab and other targeted agents. The emerging category "HER2-ultralow" (1+) is a potential target for trastuzumab deruxtecan. Ki-67: proliferation index. Ki-67 above 20–30% — high proliferative activity, an adverse prognostic factor and indication for more intensive systemic therapy. Genomic tests (Oncotype DX, MammaPrint) — in early-stage luminal disease, calculate the risk of distant recurrence and guide the decision on chemotherapy. In low-genomic-risk patients, chemotherapy does not improve survival — allowing avoidance of its toxicity. BRCA1/2 testing is indicated in all patients under 50, triple-negative breast cancer at any age, and when family history includes breast or ovarian cancer. Identifying a mutation changes systemic treatment strategy (PARP inhibitors) and determines surveillance for the contralateral breast. Treatment of Breast Cancer Breast cancer treatment is multidisciplinary: surgeon, oncologist, radiologist, reconstructive surgeon and psychologist work as a team. Strategy is determined by stage, molecular subtype, receptor and HER2 status. Surgery: - Breast-conserving surgery (lumpectomy/wide local excision) followed by radiotherapy — for tumours ≤ 3–4 cm without multifocality. Equivalent to mastectomy in overall survival when indications are met - Mastectomy — for multifocal disease, contraindications to radiotherapy, BRCA carriership or patient preference. Immediate reconstruction is the standard in modern centres - Sentinel lymph node biopsy has replaced routine axillary lymph node dissection when nodes are clinically uninvolved, dramatically reducing lymphoedema rates with equivalent oncological outcomes Radiotherapy: after breast-conserving surgery — mandatory. After mastectomy — when ≥ 4 nodes are involved, tumour is large or resection margins are positive. Chemotherapy: - Neoadjuvant (before surgery): shrinks the tumour for breast conservation and assesses in vivo response. Achieving pathological complete response (pCR) significantly improves prognosis - Adjuvant (after surgery): standard for HER2+ and TNBC; in luminal subtypes — guided by genomic testing and stage - Regimens: anthracyclines (doxorubicin, epirubicin) ± taxanes (paclitaxel, docetaxel) — the foundation of most protocols Hormonal (endocrine) therapy — only for ER+/PR+ tumours: - Tamoxifen (SERM): blocks oestrogen receptors in breast tissue; standard for premenopausal women; 5–10 years reduces recurrence risk by 40–50% - Aromatase inhibitors (letrozole, anastrozole, exemestane): block peripheral oestradiol synthesis; outperform tamoxifen in postmenopausal women - CDK4/6 inhibitors (palbociclib, ribociclib, abemaciclib) + aromatase inhibitor — first-line standard for metastatic ER+/HER2– breast cancer: approximately double median progression-free survival HER2-targeted therapy: - Trastuzumab (Herceptin) — in adjuvant setting reduces recurrence risk by 50% in HER2+ tumours; 12 months - Pertuzumab — added to trastuzumab at high risk; synergistic effect - Trastuzumab deruxtecan (T-DXd) — antibody-drug conjugate; has transformed metastatic HER2+ and HER2-low breast cancer outcomes: median progression-free survival in DESTINY-Breast04 was 9.9 versus 5.1 months with chemotherapy PARP inhibitors (olaparib, talazoparib): in metastatic breast cancer with germline BRCA1/2 mutations — significantly improve progression-free survival compared with chemotherapy. Immunotherapy: pembrolizumab + chemotherapy — first-line standard for metastatic PD-L1-positive TNBC; in the neoadjuvant setting for high-risk early TNBC, increases pCR rates. Screening and Prevention Mammographic screening: - Average risk: annually or every 2 years from age 40 (NCCN, ACR) or 50 (some European guidelines) to age 74–75; the optimal starting age is debated across countries — confirm with your gynaecologist - High risk (BRCA, PALB2, lifetime risk 20%): annual MRI + mammography from age 25–30 Breast self-examination: monthly on days 5–7 of the cycle. Does not replace mammography, but allows changes to be noticed between screening visits. Familiarity with the normal look and feel of one's breasts is a valuable skill. Prevention: - Maintain healthy weight — particularly after menopause - Limit alcohol to ≤ 1 drink per day or abstain - Regular physical activity (≥ 150 minutes moderate-intensity per week reduces risk by 10–20%) - Breastfeeding ≥ 12 cumulative months — reduces risk by 10–15% - For BRCA1/2 carriers — discuss prophylactic bilateral mastectomy: reduces breast cancer risk by 95% When to See a Doctor Consult a breast surgeon or gynaecologist promptly when any of the following apply: - a new lump or thickening in the breast or axilla; - change in breast shape, size or symmetry; - skin or nipple retraction, or peau d'orange; - bloody or unilateral nipple discharge; - persistent redness, swelling or warmth of the breast without infection. If you are over 40 and have not had a mammogram in more than two years — arrange screening without waiting for symptoms. With a family history of breast or ovarian cancer, discuss BRCA1/2 testing and an individualised surveillance protocol with your doctor. Early breast cancer is highly treatable. Five-year survival at stage I is 95–99%. Do not delay evaluation — the cost of postponement in this diagnosis is measured in stage, and therefore in treatment options. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/celiac-disease https://labreadai.com/en/posts/celiac-disease Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Celiac disease is an autoimmune condition triggered by gluten. Symptoms in adults, blood tests for diagnosis, gluten-free diet rules, and complications to prevent. Articles article Bloating after meals, chronic fatigue, and anaemia that refuses to respond to iron supplements — each of these complaints can share one overlooked cause. Celiac disease affects about 1% of the global population, yet only one in five sufferers has ever received a diagnosis. The rest continue treating the consequences without knowing the root cause. What Is Celiac Disease and How Does Gluten Damage the Intestine Celiac disease is an autoimmune condition in which gluten consumption triggers an immune attack on the lining of the small intestine. Gluten is a protein found in wheat, rye, and barley. In a healthy person it is digested without consequence. In someone with celiac disease, one of its fragments — gliadin — is misread by the immune system as a threat. Think of the intestinal villi as the pile of a carpet: their purpose is to maximise the surface area available to absorb nutrients. With each exposure to gluten, the immune system attacks those villi; they gradually flatten and eventually disappear. The intestine is transformed from a thick carpet into bare floor — and nutrient absorption collapses. The key distinction from food allergy or lactose intolerance is the autoimmune nature of the damage: even microscopic amounts of gluten continue to destroy the mucosa even when there are no symptoms. Without a gluten-free diet, the harm accumulates silently over years. Celiac disease has a strong genetic basis: nearly all patients carry the HLA-DQ2 or HLA-DQ8 genes. Having these genes does not mean the disease will develop — they create a susceptibility that may be triggered by infection, stress, pregnancy, or surgery. Symptoms of Celiac Disease in Adults: Typical and Hidden In children, celiac disease typically presents with classic malabsorption: diarrhoea, bloating, growth failure, weight loss. In adults, atypical presentations dominate — and they are the ones that go unrecognised for years. Intestinal symptoms: chronic diarrhoea or constipation, flatulence, abdominal pain, nausea after gluten-containing meals. Stools are often fatty and foul-smelling due to impaired fat absorption. Extra-intestinal symptoms are actually more common in adults than gut symptoms: - Anaemia — the most frequent extra-intestinal manifestation. Most often iron deficiency anaemia resistant to iron supplements, because iron cannot be absorbed from the damaged mucosa. - Fatigue and weakness — consequence of iron, B-vitamin deficiency, and impaired tissue nutrition. - Bone and joint pain — result of calcium and vitamin D deficiency. - Neurological symptoms: peripheral neuropathy (numbness, tingling in hands and feet), cerebellar ataxia (unsteady gait). - Reproductive problems: irregular periods, infertility, recurrent miscarriage. - Depression and anxiety — frequent companions of chronic intestinal hypersensitivity and nutrient deficiency. - Dermatitis herpetiformis — the skin form of celiac disease: intensely itchy blisters on elbows, knees, buttocks, and shoulders. A particularly difficult form is silent celiac disease: no symptoms, but serological markers are elevated and biopsy shows villous atrophy. These patients discover their diagnosis by accident during workup for something else. Blood Tests for Celiac Disease Diagnosis Diagnosis rests on three levels: serology, genetics, and histology. One critical rule: do not start a gluten-free diet before completing the workup — antibodies will fall and the biopsy will normalise, making diagnosis impossible. Serological tests — first step: - Anti-tTG IgA (anti-tissue transglutaminase) — the primary screening test, sensitivity 95%, specificity 98%. A positive result makes celiac disease highly likely. - Total IgA — measured alongside anti-tTG: IgA deficiency occurs in 2–3% of celiac patients and causes false-negative results. When IgA is deficient, IgG-class tests are used instead. - Anti-DGP IgG (deamidated gliadin peptides) — used in IgA deficiency or children under 2 years. Genetic testing (HLA-DQ2/DQ8) is used primarily to rule out celiac disease: if both alleles are absent, the condition is extremely unlikely. The presence of these genes does not confirm the diagnosis — they are found in 30% of healthy people. Small intestinal biopsy is the gold standard. During upper endoscopy, at least 4–6 biopsies are taken from the duodenum. The pathologist grades villous atrophy on the Marsh scale (0 = normal, 3 = complete atrophy). A complete blood count is essential in the initial workup: it reveals the degree of anaemia, the type of red cell changes, and the overall state of blood cell production. Which Blood Tests Are Abnormal in Celiac Disease Impaired absorption affects many parameters simultaneously. The typical laboratory picture in celiac disease includes: Parameter Change Cause --------- Haemoglobin ↓ Iron, B12, folate deficiency Ferritin ↓ Impaired iron absorption Folate ↓ Absorbed in proximal jejunum — zone of maximal damage Vitamin B12 ↓ (in severe atrophy) Impaired absorption in ileum Vitamin D ↓ Fat-soluble — depends on normal fat absorption Calcium ↓ Consequence of vitamin D deficiency + direct absorption impairment Albumin ↓ (severe cases) Overall protein deficiency The anaemia pattern in celiac disease can be mixed: simultaneous iron and folate deficiency means red cells are neither clearly small nor clearly large — MCV lands in the normal range despite genuine anaemia. This is one of the reasons celiac disease stays undetected for so long. After starting a strict gluten-free diet, blood parameters begin to recover: iron and haemoglobin within 3–6 months; vitamin D and bone metabolism significantly more slowly. Gluten-Free Diet: What to Eliminate and What to Watch For A gluten-free diet is the only effective treatment for celiac disease. No medication yet exists that can switch off the immune reaction to gluten. With strict adherence, the intestinal villi recover over 1–2 years in adults (faster in children). Absolutely prohibited: wheat in all forms (including spelt, kamut, semolina, bulgur, couscous), rye, barley, triticale. Derivatives: regular bread, pasta, baked goods, most instant cereals, beer. Permitted: rice, maize, buckwheat, millet, quinoa, potatoes, legumes, meat, fish, eggs, dairy, vegetables, and fruit — provided there is no cross-contamination. Hidden gluten is the biggest trap. It lurks in soy sauce, most condiments and marinades, processed meats, imitation seafood, some medications, and even oats (due to cross-contamination during production). The rule: read every ingredient label without exception and look for certified gluten-free marking. Cross-contamination during cooking is another real risk. A shared chopping board, the same pan, one toaster used for both gluten-containing and gluten-free foods — enough to trigger an immune response in sensitive patients. In untreated celiac disease or with repeated diet lapses, serious complications develop — including megaloblastic anaemia from sustained folate and vitamin B12 deficiency driven by chronic malabsorption. Complications of Celiac Disease When Left Untreated Unrecognised or deliberately ignored celiac disease accumulates damage, some of it irreversible. Osteoporosis is one of the most serious long-term consequences. Chronic calcium and vitamin D deficiency in celiac disease reduces bone mineral density even in young patients. Fracture risk in unrecognised celiac disease is 2–3 times higher than average. Infertility and obstetric complications. Women with unrecognised celiac disease have higher rates of delayed menstruation, anovulation, and early recurrent miscarriage. Men may have reduced sperm quality. After starting a gluten-free diet, fertility often recovers. T-cell lymphoma of the small intestine — rare but serious in long-standing unrecognised celiac disease. This is why even the silent form requires strict dietary adherence. Refractory celiac disease — a state in which symptoms and mucosal damage persist despite a strict gluten-free diet. Rare; requires management at a specialist gastroenterology centre. When to See a Doctor and What to Expect See a general practitioner or gastroenterologist if you have a combination of several of the following: - anaemia unresponsive to iron treatment; - chronic diarrhoea or bloating without an identified cause; - unexplained weight loss; - bone pain and frequent fractures without obvious risk factors; - peripheral neuropathy without diabetes or another explanation; - skin rash — blisters on extensor surfaces of the limbs; - infertility or recurrent pregnancy loss; - a first-degree relative with confirmed celiac disease — screening is recommended even without symptoms. Remember: self-initiated trial of a gluten-free diet before testing is a poor strategy. It can normalise antibodies and make diagnosis impossible. Tests first, diet second. Do not interpret your results independently — consult a doctor who can guide the workup. https://labreadai.com/en/posts/colorectal-cancer https://labreadai.com/en/posts/colorectal-cancer Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Colorectal cancer is the second deadliest cancer globally. Early symptoms, CEA tumour marker, colonoscopy, screening from age 45 and current treatment options. Articles article Most people in whom colorectal cancer is found at an early stage had not suspected it for a single day. The tumour grew silently — without pain, without blood in the stool, without any alarming signal — until a colonoscopy or a stool test detected it during routine screening. This is precisely why colorectal cancer ranks second globally in cancer mortality: not because it is incurable, but because it is found far too late, far too often. What Colorectal Cancer Is and Its Stages Colorectal cancer (CRC) is a malignant tumour arising from the epithelial lining of the large bowel or rectum. In 95% of cases it is an adenocarcinoma — a tumour originating from glandular cells. Approximately 60% arise in the colon and 40% in the rectum. This distinction matters for treatment, as rectal cancer requires a specific approach due to the anatomical constraints of the pelvis. The majority of colorectal cancers develop from adenomatous polyps — benign growths of the mucosal lining. The progression from normal epithelium through a polyp to cancer takes on average 10–15 years, and it is this long window that makes screening so effective: a detected and removed polyp is a prevented cancer. TNM staging determines treatment strategy and prognosis: Stage Description 5-year survival --------- I Tumour confined to bowel wall, no nodes 90% II Through the wall, no nodal involvement 75–85% III Regional lymph node involvement 40–70% IV Distant metastases (liver, lungs) 10–15% More than 1.9 million new cases of CRC are diagnosed worldwide each year. Incidence is rising among people under 50 — increasing by roughly 50% in young adults over the past two decades, making the revision of recommended screening age increasingly urgent. Causes and Risk Factors Colorectal cancer is a disease in which lifestyle plays no smaller a role than genetics. Up to 55% of all cases are potentially preventable through modification of known risk factors. Age is the dominant independent risk factor: 90% of cases are diagnosed in people over 50. Yet over the past 20 years, rates in 20–50-year-olds have risen steadily — attributed in large part to the global obesity epidemic and changes in dietary habits in younger generations. Diet. Red meat (beef, pork, lamb) and especially processed meat (sausages, hot dogs, bacon, ham) are documented risk factors. Processed meat is classified by the WHO as a Group 1 carcinogen for colorectal cancer. Each additional 50 g of processed meat per day increases risk by 18%. Conversely, a diet high in fibre from wholegrains, legumes, vegetables and fruit reduces risk by 25–40%. Obesity raises colorectal cancer risk by 30–35%, especially colon cancer in men. Visceral adipose tissue drives chronic inflammation and hyperinsulinaemia — both promote intestinal epithelial proliferation. Type 2 diabetes and insulin resistance are independent risk factors: chronically elevated insulin and IGF-1 stimulate tumour cell growth through insulin receptors. Inflammatory bowel disease: ulcerative colitis and Crohn's disease markedly increase risk — after more than 10 years of extensive colitis, risk is 5–10 times higher than in the general population. Chronic mucosal inflammation creates conditions for the accumulation of oncogenic mutations. Alcohol and smoking: moderate to heavy alcohol intake raises risk by 40–50%. Smoking is most strongly linked to cancers of the right colon. Hereditary syndromes: Lynch syndrome (hereditary non-polyposis CRC) accounts for 3–5% of all cases; lifetime risk in carriers reaches 70–80%. Familial adenomatous polyposis (FAP) — more than 100 polyps with near 100% malignant transformation without prophylactic colectomy. A positive family history without an identifiable syndrome doubles risk. Symptoms: Early and Late Signs The insidious nature of colorectal cancer lies in its silence: early-stage tumours produce essentially no symptoms as they grow inside the bowel lumen for years before disrupting bowel function or causing visible bleeding. Symptoms that require prompt medical evaluation: - Blood in the stool or on toilet paper — even once. Do not attribute it to haemorrhoids without investigation: haemorrhoids and rectal cancer can coexist - Persistent change in bowel habit lasting 3 weeks or more: alternating constipation and diarrhoea, or a change in the calibre of stools (pencil-thin stools) - Unexplained weight loss — 5% or more of body weight over 6 months - Persistent abdominal discomfort or pain, a sensation of incomplete bowel emptying (tenesmus) - Progressive fatigue and weakness — often the only symptom of occult intestinal bleeding and worsening anaemia Anaemia is one of the most common presentations of right-sided colon cancer. Tumours in the right colon bleed slowly and invisibly: blood mixes with stool and cannot be seen, but gradually depletes haemoglobin stores. The patient arrives at a haematologist with iron deficiency anaemia in an adult without a clear explanation — this is an absolute indication for colonoscopy. Diagnosis: Colonoscopy and Blood Tests Colonoscopy is the gold standard for diagnosis and screening. It is the only method that visualises the entire large bowel, identifies polyps and early tumours, and removes found polyps in the same session. Sensitivity for cancer reaches 95%; for polyps 1 cm, 85–90%. Alternative screening methods when colonoscopy is refused or contraindicated: - Faecal immunochemical test (FIT) — annually; high specificity for human haemoglobin, no dietary restrictions required - Stool DNA test (Cologuard) — every 3 years; detects tumour-derived DNA and haemoglobin - CT colonography (virtual colonoscopy) — every 5 years; polyps 6 mm found on CT require conventional colonoscopy for biopsy Laboratory tests complement imaging: Complete blood count — detects hypochromic microcytic anaemia as an indirect sign of chronic intestinal bleeding. Normocytic anaemia may occur in metastatic disease. Liver function tests — when hepatic metastases are suspected: elevated bilirubin, alkaline phosphatase and ALT point to parenchymal involvement. LDH rises with extensive metastatic disease as a marker of tumour necrosis. Tumour marker panel — includes CEA and CA 19-9 as the principal markers for post-treatment monitoring and response assessment. Tumour Markers in Colorectal Cancer Tumour markers in CRC have a specific role: they are not intended for primary diagnosis, but are indispensable for monitoring after treatment. CEA (carcinoembryonic antigen) — the principal CRC marker. Normal in non-smokers < 3 ng/mL, in smokers < 5 ng/mL. The clinical logic of CEA: - Before surgery: baseline level. High CEA ( 10 ng/mL) correlates with later stage and worse prognosis - After curative resection: should normalise within 4–6 weeks. Persistent elevation indicates incomplete resection or occult metastases - Surveillance: a rising CEA after normalisation is an early sign of recurrence, often preceding CT detection by 3–6 months - CEA is not used for primary diagnosis: its sensitivity is only 36–50%, and in 30% of patients with early CRC it remains normal CA 19-9 as an additional marker is useful in patients with normal CEA despite confirmed tumour, and for differential diagnosis versus pancreatic cancer when hepatic metastases are present. Full details are in the CA 19-9 tumour marker article. False-positive CEA elevation occurs in hepatic insufficiency, cirrhosis, inflammatory bowel disease and smoking — interpretation always requires clinical context. Treatment of Colorectal Cancer Treatment selection is driven by stage, tumour location and molecular characteristics (RAS and BRAF mutation status, MSI status). Surgery is the foundation of treatment for stages I–III. Right-sided cancers are treated by right hemicolectomy; left-sided by left hemicolectomy or sigmoid resection. Rectal cancers are treated by anterior resection with sphincter preservation or, for low rectal tumours, abdominoperineal resection. Laparoscopic procedures for CRC achieve equivalent oncological outcomes to open surgery with fewer complications. Chemotherapy for stage III (adjuvant) and stage IV (palliative or conversion): - FOLFOX (oxaliplatin + 5-fluorouracil + leucovorin) — standard adjuvant therapy for stage III; reduces recurrence risk by 20–25% - FOLFIRI (irinotecan + 5-FU + leucovorin) — for metastatic disease, particularly when oxaliplatin is not tolerated Targeted therapy in metastatic CRC: - Bevacizumab (anti-VEGF) — added to chemotherapy regardless of molecular subtype; improves overall survival - Cetuximab / panitumumab (anti-EGFR) — only for RAS (KRAS, NRAS) wild-type and BRAF wild-type tumours; RAS mutation is an absolute contraindication to these agents Immunotherapy: pembrolizumab and other PD-1 inhibitors are effective in MSI-H/dMMR tumours — approximately 15% of all CRC. In these patients, immunotherapy delivers substantially better outcomes than standard chemotherapy. Radiotherapy is used primarily in rectal cancer: preoperative chemoradiation reduces tumour size and lowers the risk of local recurrence. Screening and Prevention: How to Detect Cancer Early Colorectal cancer screening is one of the few medical interventions with a proven mortality reduction: regular screening programmes lower CRC mortality by 30–40%. The mechanism is straightforward — detecting and removing precancerous polyps interrupts the polyp-to-cancer chain. Who should screen and when: - Average risk (no family history, no IBD, no hereditary syndrome): colonoscopy from age 45, repeated every 10 years if no pathology found. Alternative: annual FIT test - Increased risk (one first-degree relative with CRC or advanced adenoma below age 60, or two first-degree relatives): start at 40 or 10 years before the affected relative's age, colonoscopy every 5 years - High risk (Lynch syndrome, FAP, IBD): individual protocol, often from age 20–25 Prevention: reduce red and processed meat consumption; increase dietary fibre from wholegrains, legumes and vegetables; maintain a healthy body weight; physical activity ≥ 150 minutes of moderate intensity per week reduces CRC risk by 20–30%; limit alcohol; avoid smoking. Aspirin reduces CRC risk in Lynch syndrome carriers, but is not recommended routinely in the general population due to gastrointestinal bleeding risk. When to See a Doctor Consult a GP or gastroenterologist promptly when any of the following applies: - blood in the stool or dark, tarry stools; - change in bowel habit lasting more than 3 weeks; - unexplained weight loss exceeding 5% over 6 months; - iron deficiency anaemia in a man or a postmenopausal woman without a clear cause; - progressive weakness and pallor without an established diagnosis; - you are aged 45 or over and have never had CRC screening. Early colorectal cancer is highly treatable. Five-year survival when detected at stage I exceeds 90%. At stage IV it falls to around 10–15%. The difference between these figures is the value of screening. Do not wait for symptoms before arranging a colonoscopy — by the time symptoms appear, the window for early treatment may already have closed. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/cushing-syndrome https://labreadai.com/en/posts/cushing-syndrome Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Cushing's syndrome is caused by excess cortisol. Moon face, central obesity, hypertension and diabetes are key signs. Cortisol tests, causes and treatment options. Articles article A moon-shaped face, a fat hump on the back of the neck, purple stretch marks across the abdomen, and blood pressure that refuses to respond to treatment — if this cluster of findings appeared over a matter of months, it is not simply weight gain or fatigue. Cushing's syndrome is one of the most serious endocrine disorders, in which the body is saturated with excess cortisol for months or years. Without treatment it simultaneously destroys bones, blood vessels, immunity, and mental health. What Is Cushing's Syndrome and How It Differs from Cushing's Disease Cushing's syndrome is the clinical picture that results from prolonged exposure of body tissues to excess glucocorticoids — primarily cortisol. Two terms are frequently confused: - Cushing's disease — a specific cause of the syndrome: a pituitary adenoma that secretes excess ACTH. ACTH stimulates the adrenal glands, which produce too much cortisol. - Cushing's syndrome — the broader term: any source of excess cortisol, including adrenal tumours, ectopic ACTH secretion by non-pituitary tumours, and — the most common cause globally — long-term glucocorticoid medication use (iatrogenic Cushing's syndrome). In practice, Cushing's disease (pituitary origin) accounts for approximately 70% of endogenous cases, so the two terms are often used interchangeably in clinical speech — technically incorrectly. Cortisol is essential in normal amounts: it regulates the stress response, maintains blood pressure, participates in glucose metabolism, and restrains excessive inflammation. The problem begins when there is too much for too long. Excess cortisol acts as a systemic wrecker: it breaks down muscle, redistributes fat, raises blood pressure, disrupts glucose regulation, suppresses immunity, and thins bones. Causes of Cushing's Syndrome Iatrogenic (drug-induced) — the most common cause worldwide. Long-term use of prednisolone, dexamethasone, or other glucocorticoids for asthma, rheumatoid arthritis, inflammatory bowel disease, or other conditions reproduces the full clinical picture of Cushing's syndrome. This form does not require a tumour search — only therapy adjustment. Cushing's disease (ACTH-secreting pituitary adenoma) — 65–70% of endogenous cases. Most commonly a microadenoma (< 10 mm) — so small that MRI may not detect it even with obvious clinical signs. Three to five times more common in women, peak age 20–45 years. Adrenal tumours (adenoma or carcinoma) — 15–20% of endogenous cases. The adrenal tumour autonomously produces cortisol, ignoring regulatory signals from the pituitary. ACTH is suppressed — an important diagnostic clue. Ectopic ACTH secretion — lung tumours (especially small-cell carcinoma), pancreatic tumours, thymoma, or carcinoids secrete ACTH. The ectopic form often progresses rapidly and severely: the classic Cushingoid appearance may not have time to develop. Cortisol and ACTH levels are extremely high. Symptoms of Cushing's Syndrome: The Classic Picture Cushing's syndrome has several signs that together create an almost unmistakeable appearance — yet each individual sign occurs in many other conditions. Fat redistribution: - central obesity — prominent abdomen with relatively thin arms and legs; - "moon face" — rounded, full, with flushed cheeks; - "buffalo hump" — a fat pad between the shoulder blades at the back of the neck. Skin changes — among the most specific signs: - purple striae (stretch marks) 1 cm wide on the abdomen, thighs, and armpits — violaceous, not the pale marks of ordinary weight gain; - thinning of the skin with easy bruising from minor trauma; - slow wound healing; - acne, skin hyperpigmentation. Muscle weakness — cortisol degrades muscle protein. Proximal muscle weakness is characteristic: difficulty rising from a chair without arm support, climbing stairs, lifting arms above the head. Arterial hypertension — present in 70–85% of patients. Cortisol promotes sodium retention and activates mineralocorticoid receptors. Hypertension in Cushing's syndrome often responds poorly to standard antihypertensive regimens. Glucose dysregulation — glucose is elevated in 30–40% of patients; 10–15% develop overt diabetes. HbA1c is frequently raised even when fasting glucose appears normal. Osteoporosis — cortisol suppresses osteoblasts and enhances bone resorption. Vertebral compression fractures are a frequent serious complication. Menstrual and sexual dysfunction — in women, periods become irregular or stop; in men, testosterone and libido fall. Psychiatric disorders — depression, anxiety, emotional lability, memory and concentration difficulties. Occasionally severe psychosis. Psychiatric symptoms in Cushing's syndrome are not a reaction to illness — they are the direct biochemical effect of cortisol on the brain. Immunosuppression — susceptibility to frequent infections, unusual organisms (fungi, atypical mycobacteria), and poor recovery from them. Diagnosis: How to Confirm Cushing's Syndrome Diagnosis proceeds in two stages: first confirm hypercortisolism, then localise its source. Stage 1 — Confirming hypercortisolism (screening tests): A single elevated serum cortisol is insufficient — cortisol normally follows a diurnal rhythm and spikes with any stress, including venepuncture itself. Three confirming tests are used: - 24-hour urinary free cortisol — integrates secretion over the whole day. Normal < 250 nmol/day. Elevation more than 3–4 times the upper limit is a strong argument for the diagnosis. - Overnight 1 mg dexamethasone suppression test — 1 mg of dexamethasone is taken in the evening; morning cortisol should suppress below 50 nmol/L. Failure to suppress is pathological. - Late-night salivary cortisol — in Cushing's syndrome the normal nocturnal cortisol nadir is lost. Midnight cortisol remains inappropriately high. The diagnosis requires two positive tests. Stage 2 — Source localisation: - Plasma ACTH — the key differentiating test. Elevated ACTH → pituitary or ectopic source. Suppressed ACTH → adrenal source. - Pituitary MRI — when ACTH is elevated. Caveat: up to 40% of pituitary adenomas in Cushing's disease are invisible even on modern MRI. - Adrenal CT — when ACTH is suppressed. - Bilateral inferior petrosal sinus sampling (BIPSS) — the gold standard for confirming pituitary versus ectopic ACTH source when the picture is unclear; ACTH is measured in venous drainage from the pituitary and compared with peripheral levels. - PET-CT or somatostatin scintigraphy — for locating an ectopic source. Alongside diagnostic tests, consequences are assessed: blood potassium (hypokalaemia is characteristic of ectopic disease and requires differential diagnosis from primary aldosteronism, which also presents with resistant hypertension and hypokalaemia), glucose, LDH when malignancy is suspected, and bone densitometry. Treatment of Cushing's Syndrome Treatment differs fundamentally depending on the cause. Iatrogenic Cushing's syndrome — gradual tapering of the glucocorticoid dose under medical supervision. Abrupt withdrawal is dangerous: the adrenal glands have atrophied and cannot immediately resume normal secretion, risking acute adrenal insufficiency. Cushing's disease — transsphenoidal adenomectomy (endoscopic removal of the pituitary adenoma through the nose). Remission rates of 70–90% at expert centres. For recurrence or inoperable cases: repeat surgery, pituitary radiation, bilateral adrenalectomy (as a last resort), or pharmacological cortisol suppression. Adrenal tumour — laparoscopic or open adrenalectomy. For a benign adenoma, surgery is almost always curative. For adrenocortical carcinoma, prognosis is considerably worse and additional mitotane therapy is required. Ectopic ACTH secretion — removal of the tumour source; if unresectable, pharmacological cortisol suppression (ketoconazole, metyrapone, mitotane) or bilateral adrenalectomy. After successful treatment, patients frequently go through a period of adrenal insufficiency requiring replacement therapy: adrenal glands suppressed for years cannot immediately resume normal function. Complications and Prognosis Untreated Cushing's syndrome shortens life: mortality is five times higher than in the general population — primarily from cardiovascular events, infections, and complications of type 2 diabetes. With successful treatment, most features are reversible, though full recovery of bone density and muscle mass takes years. After bilateral adrenalectomy for Cushing's disease, Nelson's syndrome can develop: freed from cortisol's suppressive effect, the pituitary adenoma grows aggressively, driving an extreme rise in ACTH and generalised skin hyperpigmentation. When to Seek Medical Attention See an endocrinologist promptly if any of the following combination has developed or worsened over the past 6–12 months: - rapid weight gain around the abdomen and face while limbs remain thin; - wide purple marks on the abdomen or thighs; - muscle weakness on rising from a chair or climbing stairs; - blood pressure unresponsive to two or three medications; - frequent infections or wounds that will not heal; - irregular periods in a young woman without obvious cause. Cushing's syndrome is a rare diagnosis — and that rarity causes delay: the average time from first symptom to diagnosis is 3–6 years. Do not interpret your symptoms on your own; see a doctor who can order the appropriate hormonal tests. https://labreadai.com/en/posts/endometriosis https://labreadai.com/en/posts/endometriosis Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Endometriosis — chronic endometrial growth outside the uterus causing pain and infertility. Stages, CA-125, laparoscopy, ovarian cancer risk and treatment explained. Articles article One in five women with endometriosis is told by a doctor that her pain is just "normal period pain" — and sent home with painkillers. On average, seven to ten years pass between the first symptoms and a confirmed diagnosis. During that time, endometriotic lesions grow, form adhesions and quietly erode fertility. Understanding what is happening in the body is the first step toward the right diagnosis. What Endometriosis Is and How It Develops Endometriosis is a chronic, hormone-dependent disease in which tissue resembling the endometrium — the inner lining of the uterus — is found and functions outside the uterine cavity. These lesions respond to cyclic oestrogen fluctuations: they swell in the luteal phase and "bleed" during menstruation — but the blood from ectopic deposits has nowhere to drain. It accumulates, triggers an inflammatory reaction, and leads to adhesions and "chocolate cysts" (endometriomas). The most widely accepted theory of origin is retrograde menstruation: part of the menstrual blood carrying endometrial cells passes through the fallopian tubes into the peritoneal cavity. This occurs in most women, but a normally functioning immune system destroys these displaced cells. In endometriosis, something in this mechanism is defective: the cells implant, survive and proliferate. Genetic predisposition explains why first-degree female relatives of affected women face a seven- to tenfold higher risk. The location of lesions determines the clinical picture. The most commonly affected sites are the ovaries (endometriomas), the rectouterine pouch, the uterosacral ligaments and the pelvic peritoneum. In deep infiltrating endometriosis (DIE), lesions penetrate the bladder, ureters, rectum and rectovaginal septum. Staging by the rASRM classification (I–IV) reflects the extent and severity of adhesions but correlates poorly with pain. Clinically, it is more meaningful to distinguish between superficial peritoneal endometriosis, ovarian endometriomas and DIE — the last requiring a fundamentally different surgical approach. Causes and Risk Factors The precise cause of endometriosis is unknown. The contemporary model regards it as multifactorial — genetic susceptibility, immune dysregulation, hormonal imbalance and environmental factors all interact. Genetics: a mother or sister with endometriosis increases risk seven- to tenfold. Several susceptibility loci have been identified but no single "endometriosis gene" exists. Hormonal environment: endometriosis is oestrogen-dependent. Lesions contain excess aromatase enzyme, which synthesises oestradiol directly at the implantation site — local hyperoestrogenaemia sustains growth. Simultaneously, resistance to progesterone is impaired. Immune dysfunction: peritoneal NK cells and macrophages are less effective at eliminating ectopic endometrial cells. Pro-inflammatory cytokines in the peritoneal fluid create conditions favourable for implantation and growth. Factors that increase risk: early menarche (before 12), short cycles (< 27 days), heavy periods, nulliparity, low BMI. Factors that reduce risk: pregnancies, lactation, long-term oral contraceptive use, regular physical exercise. An important distinction: polycystic ovary syndrome and endometriosis are not the same condition, though both impair reproductive function. PCOS is characterised by androgen excess and anovulation; endometriosis by hyperoestrogenaemia and pain. In some women both coexist, substantially complicating diagnosis. Symptoms: Pain and Infertility The two hallmarks of endometriosis are chronic pelvic pain and reduced fertility. Their severity does not correlate with disease stage. Pain: - Dysmenorrhoea — painful periods not controlled by standard NSAIDs. Periods that are disabling for one to two days a month require investigation, not simply painkillers - Chronic pelvic pain — dull or cramping pain in the lower abdomen or spine persisting outside menstruation for more than 6 months - Dyspareunia — painful intercourse with deep penetration. Classically associated with endometriosis of the posterior Douglas pouch - Dyschezia — painful defecation worsening during menstruation. Characteristic of rectovaginal endometriosis - Dysuria — painful urination intensifying before menstruation Menstrual disturbances: heavy periods (menorrhagia), intermenstrual spotting, premenstrual brown discharge. Infertility: endometriosis is found in 25–50% of women presenting with infertility. Adhesions distort the fallopian tubes; endometriomas reduce ovarian reserve; the peritoneal inflammatory milieu is toxic to sperm and embryos; immune abnormalities interfere with implantation. Diagnosis: Laparoscopy, Ultrasound and Blood Tests Laparoscopy with biopsy and histological confirmation remains the gold standard. However, current guidelines support a clinical diagnosis when history and ultrasound findings are characteristic — treatment may be started without surgery. Transvaginal ultrasound — the first-line investigation. Sensitivity for ovarian endometriomas is 90–95%: the characteristic appearance is a unilocular cyst with homogeneous ground-glass echogenicity. MRI of the pelvis is best for mapping DIE involving the bowel and urinary tract. Laparoscopy with biopsy — mandatory for atypical presentations, suspected DIE, or failure of hormonal therapy. Laboratory tests: CA-125 — elevated in 75–80% of stage III–IV patients but only 20–25% at stage I–II. The main value is monitoring: a rising level after surgery or during treatment signals progression. CA-125 above 200 U/mL in an endometrioma requires extended oncological evaluation with HE4 and the ROMA index. Sex hormone panel — FSH, LH, oestradiol, AMH. AMH is critical: endometriomas reduce ovarian reserve, and AMH below 1.0 ng/mL before surgery signals risk of further depletion. This determines the approach for women planning pregnancy. Complete blood count — heavy periods frequently cause iron deficiency anaemia: recurrent large blood loss depletes iron stores progressively. Endometriosis and the Risk of Ovarian Cancer The link between endometriosis and ovarian cancer is real and clinically significant: women with endometriosis have approximately three times the population risk of ovarian cancer. But the absolute risk remains low — the vast majority of women with endometriosis never develop cancer. The histological subtypes most closely associated with endometriosis are clear cell carcinoma and endometrioid carcinoma. The mechanism is malignant transformation of endometrioma cells driven by chronic oxidative stress and inflammation. Features associated with elevated transformation risk: disease duration above 10 years, large endometriomas ( 9 cm), growth of the cyst or new solid component on follow-up imaging, age over 45, postmenopausal status. When these features are present, ultrasound intervals are shortened to 3 months and HE4 with ROMA index calculation is added. Treatment: Hormones, Surgery and Pain Management Treating endometriosis is a long-term strategy. Three factors determine the approach: severity of pain, desire to preserve fertility, and stage and location of lesions. Hormonal therapy: Combined oral contraceptives (COCs) — first-line for dysmenorrhoea and chronic pelvic pain. A continuous regimen (no placebo interval) is more effective than cyclic dosing. Progestins (dienogest, medroxyprogesterone) — as effective as COCs for pain; dienogest is superior for deep endometriosis and reduces endometrioma size with prolonged use. GnRH agonists (leuprorelin, buserelin) — induce medical menopause. Effective for severe pain and IVF preparation. Mandatory "add-back" low-dose oestrogen-progestin therapy protects bone density; without it, treatment is limited to 6 months. Surgical treatment: Laparoscopic lesion excision is preferred over coagulation: it provides histological confirmation and lower recurrence risk. For endometriomas: cystectomy reduces recurrence but irreversibly reduces ovarian reserve. AMH must be measured before ovarian surgery in women planning pregnancy. DIE involving the bowel or urinary tract requires surgery in a specialist endometriosis centre with a gynaecologist, colorectal surgeon and urologist. Fertility treatment: stage I–II with patent tubes — ovulation induction with or without IUI. Stage III–IV or previous treatment failure — IVF. When to See a Doctor Painful periods that interfere with daily life are not a normal variant and require investigation, not simply analgesics. See a gynaecologist when one or more of the following apply: - dysmenorrhoea severe enough to require prescription pain relief or to miss work or studies; - chronic pelvic pain outside menstruation lasting more than 3 months; - deep dyspareunia; - difficulty conceiving after 6–12 months of regular unprotected intercourse; - an ovarian cyst with endometrioma characteristics found incidentally; - a mother or sister has been diagnosed with endometriosis. Endometriosis is a chronic condition without a definitive cure, but effective symptom control and fertility preservation are achievable. Early diagnosis and a long-term treatment strategy agreed with a specialist are the keys to a better prognosis. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/fatty-liver-disease https://labreadai.com/en/posts/fatty-liver-disease Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Non-alcoholic fatty liver disease (NAFLD): fat build-up in liver cells, causes, ALT and AST changes, insulin resistance link and treatment approaches. Articles article An ultrasound reports "fatty infiltration", ALT is slightly above normal, and you feel reasonably well — this is how most people discover they have fatty liver disease. NAFLD (non-alcoholic fatty liver disease) is today the most prevalent chronic liver condition worldwide: large population studies estimate it affects one in four adults. Most patients are unaware of their diagnosis until it appears as an incidental finding. Silent progression is not the same as safe. What Is NAFLD and How Does Fatty Liver Develop NAFLD is the accumulation of fat (primarily triglycerides) in liver cells — hepatocytes — in people who do not drink excessively. The threshold for "non-alcoholic" is defined as fewer than 20–30 g of ethanol per day for men and fewer than 10–20 g for women. Fatty liver disease is not a single entity but a spectrum from benign to progressive: - Simple steatosis (NAFLD) — fat in hepatocytes without inflammation. Stable in most patients for years; progression risk roughly 20–25%. - Non-alcoholic steatohepatitis (NASH) — steatosis plus inflammation plus cell damage. This is the stage where the disease begins to progress actively. - Liver fibrosis — scarring in response to chronic inflammation. Reversible in early stages if the underlying cause is addressed. - Liver cirrhosis — end-stage fibrosis with disrupted liver architecture and impaired function. Irreversible. - Hepatocellular carcinoma — liver cancer that can develop even without cirrhosis in long-standing NASH. The central mechanism of NAFLD is insulin resistance. When muscle and liver cells stop responding normally to insulin, the pancreas compensates by raising insulin levels. High insulin drives hepatic fatty acid synthesis and suppresses fat oxidation — fat accumulates in hepatocytes. A second hit comes from free fatty acids delivered from visceral adipose tissue via the portal vein, further overloading hepatic metabolism. The term NAFLD is gradually being replaced by MAFLD (metabolic-associated fatty liver disease) — to emphasise the metabolic rather than simply "non-alcoholic" nature of the condition. Causes and Risk Factors for NAFLD Insulin resistance and metabolic syndrome form the backdrop for most cases. Specific risk factors include: Metabolic: - obesity — particularly visceral (waist 94 cm in men, 80 cm in women); - type 2 diabetes — present in 70–80% of NAFLD patients; - dyslipidaemia — elevated triglycerides and reduced HDL; - hypothyroidism and polycystic ovary syndrome (both worsen insulin sensitivity). Dietary: - high fructose intake (especially from sugar-sweetened beverages) — fructose is metabolised exclusively in the liver and directly stimulates lipogenesis; - diet rich in saturated fats and ultra-processed foods; - rapid weight loss or prolonged fasting — paradoxically accelerates fat mobilisation into the liver. Drug-induced and other: - tamoxifen, methotrexate, amiodarone, valproic acid; - small intestinal bacterial overgrowth — gut microbiome disruption can contribute to hepatic inflammation; - genetic factors — the PNPLA3 gene variant substantially raises the risk of NASH and fibrosis. NAFLD at normal weight. Approximately 10–15% of NAFLD patients have a normal BMI. They typically share low muscle mass, high visceral fat despite normal weight, and genetic predisposition. Normal weight does not rule out the diagnosis. Symptoms of Fatty Liver Disease: Stages and Signs Simple steatosis is usually asymptomatic — which makes it particularly treacherous. Complaints emerge when the disease has already progressed to NASH or fibrosis has developed. In simple steatosis — no symptoms, or minimal: - dull heaviness or discomfort in the right upper abdomen after fatty meals; - generalised fatigue without a clear cause. In steatohepatitis (NASH): - pronounced weakness and reduced work capacity; - heaviness and pain in the right upper abdomen; - nausea after fatty food; - an enlarged liver detectable on physical examination or ultrasound. In fibrosis and pre-cirrhotic change: - intensification of all previous symptoms; - unintentional weight loss; - intermittent yellowing of the skin or sclera; - leg oedema — a sign of developing portal hypertension. In many patients, NASH and even early fibrosis produce no symptoms at all. This is why NAFLD is identified predominantly as an incidental finding — elevated liver enzymes or an abdominal ultrasound performed for an unrelated reason. Which Blood Tests Show Fatty Liver Disease Laboratory findings in NAFLD are often subtle, especially in simple steatosis. Enzymes can be entirely normal even in significant fibrosis. Liver enzymes: - ALT — the most sensitive marker of hepatocyte damage. In NAFLD, typically mildly elevated at 1.5–3 times the upper limit of normal. ALT AST is the characteristic pattern in NAFLD (unlike alcoholic liver disease, where AST usually exceeds ALT). - AST — rises in parallel with ALT. An AST/ALT ratio 2 in NAFLD is a warning sign suggesting possible progression toward cirrhosis. - GGT — gamma-glutamyl transferase rises with fatty degeneration and serves as a marker of hepatic metabolic stress. Elevated GGT with normal ALT/AST does not exclude NAFLD. Comprehensive assessment via liver function tests also covers albumin (falls with severe damage), bilirubin (rises with decompensation), and prothrombin time. Metabolic context: - fasting glucose and HbA1c — to detect co-existing type 2 diabetes; - full lipid profile — high triglycerides and low HDL are typical in NAFLD; - fasting insulin and HOMA-IR — confirm insulin resistance as the driving force. Normal liver enzymes do NOT exclude NAFLD, and certainly do not exclude fibrosis. Approximately 30% of patients with histologically confirmed NASH have enzymes within the normal range. Diagnosing NAFLD: From Ultrasound to Biopsy Liver ultrasound — the standard first step. Detects steatosis when fat accumulation exceeds 20–33% of hepatocytes: the liver appears hyperechoic ("bright") compared with the kidney. Sensitivity falls in obesity and mild steatosis. Ultrasound cannot distinguish steatosis from NASH and does not assess fibrosis stage. Liver elastography (FibroScan) — ultrasound or MR elastographic measurement of liver stiffness. Allows non-invasive staging of fibrosis (F0–F4). Considerably more accurate than standard ultrasound for diagnosing cirrhosis. Non-invasive fibrosis scores: - FIB-4 = (age × AST) / (platelets × √ALT) — a value < 1.3 makes significant fibrosis unlikely; 2.67 indicates high risk. - NAFLD Fibrosis Score (NFS) — incorporates BMI, age, glucose, platelets, and albumin. These scores guide decisions about who needs deeper investigation and who can be safely monitored. Liver biopsy — the only method that precisely distinguishes steatosis from NASH and determines exact fibrosis stage. Reserved for cases where non-invasive methods are inconclusive and the choice of treatment depends critically on staging. MRI proton density fat fraction (MR-PDFF) — the most accurate non-invasive method for quantifying liver fat; used primarily in research and for treatment monitoring. Treatment and Correction of Fatty Liver Disease Specific pharmacological treatments for NAFLD remain limited — lifestyle modification is the foundation. The good news: fatty liver is reversible at the steatosis and early fibrosis stages with sufficient weight loss. Weight loss — the primary therapeutic lever: - 3–5% reduction from baseline reduces steatosis; - 7–10% eliminates inflammation (NASH) in the majority of patients; - 10% can achieve fibrosis regression. Nutrition: no single "correct" diet exists for NAFLD, but strong evidence supports the Mediterranean dietary pattern — it reduces liver fat independently of weight loss. The main hepatic enemies in NAFLD: fructose from beverages, red and processed meat, trans fats. Complete alcohol abstinence in NASH and fibrosis is mandatory, not optional. Physical activity: both aerobic and resistance training reduce liver fat independently of each other — even without weight loss. 150–300 minutes of moderate activity per week is the target minimum. Pharmacological therapy: - Vitamin E (800 IU/day) — proven to reduce inflammation in NASH in patients without diabetes; not used in cirrhosis, does not prevent fibrosis. - GLP-1 receptor agonists (semaglutide, liraglutide) — reduce weight and liver fat; drugs of choice in NAFLD with co-existing obesity or diabetes. - Resmetirom (thyroid hormone receptor agonist) — the first drug approved by the FDA (2024) specifically for NASH with fibrosis stage 2–3. - Metformin and statins: metformin does not reduce steatosis directly but is indicated for co-existing diabetes; statins are safe in NAFLD and reduce cardiovascular risk. Liver transplantation — for decompensated cirrhosis related to NAFLD; NAFLD has become one of the leading transplant indications in developed countries. When to See a Doctor See a gastroenterologist or hepatologist if: - an ultrasound has identified "fatty infiltration" or a "bright liver" on any examination; - ALT or AST are elevated on more than one test without an obvious cause; - you have metabolic syndrome: obesity + raised blood sugar + hypertension + dyslipidaemia; - a first-degree relative has cirrhosis of non-alcoholic origin; - you develop worsening right upper abdominal discomfort, yellowing of the skin, or increasing fatigue. NAFLD responds well to treatment in its early stages. Lifestyle change can reverse the disease — but only if started before fibrosis becomes established. Do not interpret ultrasound results or blood tests on your own; consult a doctor. https://labreadai.com/en/posts/heart-failure https://labreadai.com/en/posts/heart-failure Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Heart failure — impaired cardiac pump function causing breathlessness and oedema. BNP and troponin diagnosis, causes, ejection fraction types and treatment. Articles article Breathlessness climbing a single flight of stairs when it was never an issue before. Ankles so swollen by evening that shoes no longer fit. Needing two pillows to sleep because lying flat makes breathing impossible. These complaints may seem ordinary, but they are the hallmark of heart failure — a condition in which the heart can no longer meet the body's demand for blood flow. More than 64 million people worldwide live with it, and the number continues to rise. What Is Heart Failure and How Does It Develop Heart failure is a clinical syndrome in which the heart cannot supply organs and tissues with sufficient blood to meet their metabolic needs, or can only do so at the cost of abnormally elevated filling pressures. It is not a disease in its own right but the final common pathway of many cardiovascular conditions. The mechanism can be described as a vicious cycle: the myocardium is damaged or overloaded → contractility or filling is reduced → cardiac output falls → the kidneys perceive reduced perfusion and retain sodium and water → blood volume expands → the load on the weakened heart increases further. Without treatment this cycle accelerates. The key biomarker of this process is BNP (B-type natriuretic peptide). Overloaded ventricular walls release BNP and its precursor NT-proBNP as a "distress signal". This is why measuring BNP has become the standard laboratory test for heart failure: it rises in proportion to the severity of volume overload and is an independent predictor of hospitalisation and death. Types of Heart Failure Classification by left ventricular ejection fraction (LVEF) underpins modern management, because different phenotypes respond differently to therapy. HFrEF — heart failure with reduced ejection fraction (< 40%). The myocardium contracts weakly — classic "systolic" failure. More common in men, typically following myocardial infarction. Most evidence-based treatments have been proven in this phenotype. HFpEF — heart failure with preserved ejection fraction (≥ 50%). The heart contracts normally but has become stiff and relaxes poorly — "diastolic" failure. More common in older women with hypertension and obesity. Harder to treat: specific therapies were lacking for years. HFmrEF — mildly reduced ejection fraction (41–49%). A "grey zone" that in characteristics and outcomes sits between the two. By course, heart failure is classified as acute or chronic. Acute failure develops over hours — for example, during myocardial infarction or a severe arrhythmia — and requires immediate hospitalisation. Chronic failure develops over months and years, cycling through periods of compensation and decompensation. Causes of Heart Failure Any condition that chronically damages or overloads the myocardium can lead to heart failure. Coronary artery disease and myocardial infarction — the leading cause in most countries. After a myocardial infarction, the necrotic zone is replaced by scar tissue that does not contribute to contraction. The larger the scar, the worse the function. Arterial hypertension — chronic pressure overload forces the left ventricle to hypertrophy, then to "fatigue". Hypertension is the leading cause of HFpEF. Valvular heart disease — mitral or aortic regurgitation or stenosis creates volume or pressure overload on cardiac chambers. Cardiomyopathies — dilated (stretched, weak ventricle), hypertrophic (thickened, stiff), restrictive (myocardial infiltration in amyloidosis, sarcoidosis). Some cases are genetically determined. Atherosclerosis — chronic coronary artery disease leads to ischaemic myocardial remodelling even without overt myocardial infarction. Arrhythmias — prolonged tachycardia (particularly fast atrial fibrillation) gradually exhausts the myocardium ("tachycardiomyopathy"). Other causes: toxic damage (alcohol, chemotherapy, cocaine), viral myocarditis, endocrine disorders (hypothyroidism, thyrotoxicosis), severe anaemia. Symptoms of Heart Failure Symptoms fall into two groups: congestive features (fluid accumulation) and low-output features. Congestive features — the most frequent complaints: - Breathlessness — the dominant symptom. Initially on exertion, later at rest. Orthopnoea is characteristic — breathlessness when lying flat, relieved by sitting up on pillows (due to fluid redistributing into the lungs). Paroxysmal nocturnal dyspnoea — sudden suffocating breathlessness that literally wakes the patient at 2–4 am. - Leg oedema — symmetrical, worsening in the evening, soft, pit-forming on pressure. In severe failure it extends to the thighs, abdomen (ascites), and scrotum. - Rapid weight gain from fluid retention — often the first sign of impending decompensation. An increase of 2 kg over 2–3 days is an alarm signal. - Bibasal crackles on lung auscultation. - Distended neck veins — sign of elevated right-sided filling pressure. Low-output features: - profound fatigue and reduced exercise tolerance; - dizziness and near-syncope; - cold extremities; - confusion in elderly patients — from reduced cerebral perfusion. Symptom severity is graded by the NYHA classification (class I–IV): from symptoms only with significant exertion (I) to symptoms at rest (IV). Diagnosis: Which Tests Are Ordered for Heart Failure Diagnosis rests on the combination of symptoms, echocardiography, and biomarkers. Key biomarkers: - BNP / NT-proBNP — the primary laboratory test when heart failure is suspected. A normal BNP virtually excludes the diagnosis in a breathless patient. NT-proBNP 125 pg/mL in chronic patients or 300 pg/mL in acute breathlessness marks the threshold for further workup. - Troponin — elevated in acute myocardial injury; detectable even in chronic HF reflecting ongoing micro-injury. A high troponin during decompensation points to an ischaemic aetiology or acute myocarditis. - Creatinine and eGFR — kidneys suffer from reduced perfusion in heart failure; worsening acute kidney injury during treatment (cardiorenal syndrome) is a common clinical challenge. - Serum sodium — hyponatraemia in heart failure reflects neurohormonal activation and is associated with a poor prognosis. - LDH — non-specific marker of tissue damage; elevated in decompensated HF due to hepatic hypoperfusion and congestive hepatopathy. - Kidney function test — comprehensive assessment before prescribing diuretics and RAAS inhibitors. Echocardiography — the indispensable imaging test: measures ejection fraction, chamber dimensions, valve morphology, and wall motion abnormalities. Heart failure cannot be formally confirmed without echo. ECG — detects arrhythmias, signs of previous myocardial infarction, and ventricular hypertrophy. A normal ECG makes systolic failure unlikely. Treatment of Heart Failure Treatment of HFrEF (reduced EF) is one of the most evidence-based areas in cardiology. Four drug classes reduce mortality — the "fantastic four": - ACE inhibitors / ARBs / ARNIs — reduce neurohormonal activation, limit ventricular remodelling. Sacubitril/valsartan (ARNI) is preferred over standard ACE inhibitors based on recent evidence. - Beta-blockers — lower heart rate, reduce myocardial oxygen demand, reduce mortality. - Mineralocorticoid receptor antagonists (spironolactone, eplerenone) — block excess sodium retention and myocardial fibrosis. - SGLT2 inhibitors (dapagliflozin, empagliflozin) — originally developed as glucose-lowering agents, they proved powerful in HF regardless of diabetes status. Loop diuretics (furosemide, torasemide) — relieve congestive symptoms. They do not improve prognosis but restore quality of life; daily weight monitoring and dose self-titration are key skills for the patient. Devices: implantable cardioverter-defibrillators (ICD) reduce sudden death risk when EF < 35%; cardiac resynchronisation therapy (CRT) improves contractile synchrony in conduction abnormalities. In HFpEF the evidence base is narrower; SGLT2 inhibitors are currently the only class with proven reduction in hospitalisation. Non-pharmacological: salt restriction to 2–3 g/day, daily morning weight monitoring, fluid restriction in severe oedema, cardiac rehabilitation — moderate-intensity aerobic exercise improves prognosis and quality of life. Complications of Chronic Heart Failure Heart failure is a systemic disease that affects virtually every organ. Cardiorenal syndrome — mutual worsening of cardiac and renal function. Reduced cardiac output impairs renal perfusion; venous congestion elevates renal venous pressure — both mechanisms reduce glomerular filtration. Paradoxically, diuretics required for fluid relief can themselves worsen renal function. Arrhythmias — atrial fibrillation occurs in 30–40% of HF patients and worsens prognosis bidirectionally. Ventricular arrhythmias are the leading cause of sudden cardiac death. Cardiac cachexia — in severe long-standing HF, progressive loss of muscle and fat mass develops from chronic inflammation, malabsorption, and anorexia. Cachexia dramatically worsens prognosis. Depression — present in 20–30% of patients, reduces medication adherence, and independently increases mortality. When to Seek Emergency Care Call emergency services immediately if: - sudden severe breathlessness or suffocation develops at rest; - pink frothy sputum appears — a sign of acute pulmonary oedema; - blood pressure falls below 90/60 mmHg with dizziness; - weight increases sharply ( 2 kg in one day) alongside worsening breathlessness; - palpitations or irregular heartbeat accompany a deterioration in symptoms. Decompensation can develop rapidly even in "stable" HF — most often triggered by dietary indiscretion, missed medications, intercurrent infection, or arrhythmia. Early hospitalisation at the first sign of worsening improves outcomes. Do not manage deterioration on your own — contact your doctor or call emergency services. https://labreadai.com/en/posts/hepatocellular-carcinoma https://labreadai.com/en/posts/hepatocellular-carcinoma Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hepatocellular carcinoma is primary liver cancer linked to cirrhosis and hepatitis. AFP tumour marker, ultrasound screening, BCLC stages and treatment options. Articles article Most patients with hepatocellular carcinoma already have serious liver disease — cirrhosis, chronic hepatitis or fatty liver — long before the tumour makes itself known. This is why liver cancer ranks fifth among cancer deaths worldwide despite a comparatively modest share of overall incidence: it is almost always found late, in a patient who is already seriously ill. What Hepatocellular Carcinoma Is Hepatocellular carcinoma (HCC) is a malignant tumour arising from hepatocytes — the principal cells of the liver parenchyma. It accounts for 90% of all primary liver malignancies. It must not be confused with metastatic liver cancer, which occurs 20–30 times more frequently (breast, colorectal, gastric and other cancers regularly spread to the liver) and requires an entirely different approach to treatment. 80–90% of HCC develops on a background of liver cirrhosis. This is not coincidental: chronic inflammation, fibrosis and accelerated hepatocyte turnover during regeneration create the ideal environment for oncogenic mutation accumulation. The path from a healthy liver to HCC takes years to decades — typically passing through chronic hepatitis or progressive fibrosis. Approximately 900,000 new cases of HCC are diagnosed worldwide each year. Incidence continues to rise, driven predominantly by the epidemic of non-alcoholic fatty liver disease (NAFLD) and its metabolic sequela, cirrhosis. While viral hepatitis B and C can be treated and controlled, the wave of NAFLD-associated HCC is still growing. BCLC (Barcelona Clinic Liver Cancer) staging incorporates not only tumour size but also liver function according to the Child–Pugh score and the patient's performance status — this integrated approach determines treatment strategy: BCLC stage Description Recommended treatment --------- 0 (very early) Single tumour < 2 cm, preserved liver function Resection or ablation A (early) 1–3 tumours ≤ 3 cm, compensated cirrhosis Resection, transplant, ablation B (intermediate) Multinodular, no vascular invasion TACE C (advanced) Vascular invasion or metastases Systemic therapy D (terminal) Decompensated cirrhosis Palliative care Liver Cancer Risk Factors: Cirrhosis, Hepatitis and Beyond Chronic hepatitis B virus (HBV) — the leading cause of HCC globally, responsible for 50–55% of all cases. HBV integrates into the hepatocyte genome and directly activates oncogenes even before cirrhosis develops — distinguishing it from most other causes, where HCC arises almost exclusively in cirrhotic tissue. HBV vaccination is the only proven oncological prevention measure, reducing HCC incidence by 60–70% in vaccinated populations. Chronic hepatitis C virus (HCV) — accounts for 25–30% of cases in high-income countries. Unlike HBV, HCV causes HCC almost exclusively through cirrhosis. Modern direct-acting antivirals (DAAs) achieve viral clearance in 95–99% of patients, but the risk of HCC in patients who already have cirrhosis persists for years after sustained virological response — these patients must continue surveillance. Chronic hepatitis and cirrhosis from any cause: alcohol, autoimmune hepatitis, primary biliary cholangitis, Wilson's disease or hereditary haemochromatosis. Fatty liver disease (NAFLD) — a rapidly growing cause of HCC in Western countries. A clinically important feature: HCC in NAFLD develops before cirrhosis in approximately 20–30% of cases — substantially complicating screening. Obesity and type 2 diabetes, the main drivers of NAFLD, are simultaneously independent risk factors for HCC. Alcohol raises HCC risk two- to threefold; when combined with hepatitis B or C, risks multiply. Aflatoxin B1 — a mycotoxin produced in mouldy groundnuts, cereals and maize in tropical climates. A direct mutagen targeting the TP53 tumour-suppressor gene. In combination with HBV infection, risk of HCC increases approximately 60-fold. Genetic conditions: haemochromatosis (iron overload), Wilson's disease (copper accumulation) and alpha-1-antitrypsin deficiency — all three impose chronic toxic stress on hepatocytes and lead to cirrhosis with elevated HCC risk. Early Signs and Symptoms of Liver Cancer: Why HCC Is Diagnosed Late The liver parenchyma contains no pain receptors. A tumour can grow to a considerable size without causing pain or visible functional impairment. Early symptoms often blend imperceptibly with manifestations of underlying cirrhosis or chronic hepatitis. Symptoms that warrant investigation: - New or worsening discomfort in the right upper abdomen — in a patient with cirrhosis this is an important signal even when attributed to "usual" sensations - Sudden deterioration of previously compensated cirrhosis: worsening ascites, new encephalopathy or jaundice without an obvious precipitating cause - Unexplained weight loss and progressive weakness - A palpable mass in the right upper quadrant Complications that often constitute the initial clinical presentation: - Tumour rupture with haemoperitoneum — sudden severe abdominal pain, haemodynamic instability, requires emergency surgery - Portal vein thrombosis — abrupt worsening of ascites and variceal haemorrhage - Paraneoplastic syndromes: hypoglycaemia (IGF-2 secretion by the tumour), hypercalcaemia, erythrocytosis (ectopic erythropoietin production) Jaundice in HCC is a late sign, indicating either bile duct compression by the tumour or decompensation of liver function. Its appearance in a previously compensated cirrhotic patient is an urgent signal requiring immediate investigation. The majority of HCC cases detected today are found on surveillance ultrasound in patients with known cirrhosis — incidentally, not because of symptoms. This again underscores why regular screening in this group is critically important. Diagnosis: Imaging, Biopsy and Laboratory Tests HCC diagnosis is unique in that it does not always require biopsy: a characteristic pattern on contrast-enhanced imaging is considered sufficient for diagnosis in the appropriate clinical setting. Dynamic contrast-enhanced CT or MRI — the gold standard. The diagnostic hallmark of HCC is "arterial phase hyperenhancement with washout": the tumour avidly enhances in the arterial phase (due to abundant neovascularisation) and rapidly loses contrast in the portal venous and delayed phases — unlike the surrounding liver tissue. This pattern for a nodule 1 cm in a cirrhotic liver is pathognomonic for HCC: biopsy is not required. Image-guided biopsy is indicated for atypical imaging appearances or in the absence of cirrhosis. The main risk is rare but documented needle-track tumour seeding. Ultrasound — the first-line screening modality: twice yearly in all patients with cirrhosis. Any nodule 1 cm detected on surveillance requires immediate CT or MRI confirmation. Laboratory tests: Liver function tests — assessment of functional reserve: bilirubin, albumin and prothrombin time constitute the Child–Pugh score that determines resectability. Rising bilirubin and falling albumin signal decompensation. Complete blood count — thrombocytopaenia and leucopaenia from hypersplenism as markers of portal hypertension severity; normochromic anaemia in chronic disease. Tumour markers — AFP and PIVKA-II (also known as des-gamma-carboxyprothrombin, DCP): both used for screening, diagnosis and treatment monitoring in HCC. AFP Tumour Marker: Role in Diagnosis and Monitoring AFP (alpha-fetoprotein) — the principal biomarker for HCC. Normal range in adults < 10–20 ng/mL (laboratory-dependent). Physiologically elevated AFP is present only in the fetus and in pregnant women. Sensitivity and specificity in HCC: At a threshold of 20 ng/mL: sensitivity 60%, specificity 90%. At 200 ng/mL: sensitivity falls to 22%, but specificity rises to 99%. A markedly elevated AFP ( 400–500 ng/mL) combined with characteristic CT/MRI findings is virtually diagnostic of HCC. Limitations of AFP: - 30–40% of patients with HCC have a normal AFP — particularly with small tumours and the fibrolamellar subtype. Normal AFP does not exclude cancer - False-positive elevation occurs in chronic hepatitis flares, cirrhosis, acute liver failure and pregnancy - Elevated AFP without a visible lesion on ultrasound in a hepatitis patient warrants repeat imaging at 3 months, not immediate biopsy Clinical applications: - Screening: AFP + ultrasound every 6 months in all cirrhotic patients - Monitoring: AFP decline after surgery, ablation or systemic therapy is a marker of response; rising AFP signals progression or recurrence - A baseline AFP 1000 ng/mL is associated with more aggressive disease and is used as a selection criterion in several transplantation protocols Treatment of Hepatocellular Carcinoma Treatment of HCC faces a dual challenge: attacking the tumour while preserving what remains of an already-damaged cirrhotic liver. Treatment selection is guided by BCLC stage. Surgical resection — the optimal approach at BCLC stage 0/A in the absence of cirrhosis or in compensated cirrhosis (Child–Pugh A) with sufficient residual parenchymal volume. Five-year survival: 50–70%. The primary limitation is that cirrhosis in most patients does not allow adequate resection without risk of post-operative liver failure. Liver transplantation — a radical option that simultaneously removes the tumour and eliminates cirrhosis as the source of future malignancy. The Milan criteria (single tumour ≤ 5 cm or up to 3 tumours each ≤ 3 cm, no macrovascular invasion, no extrahepatic spread) define suitable candidates; five-year survival reaches 70–75%. Extended criteria (UCSF, "up-to-seven" rule) allow inclusion of more patients with comparable outcomes. The primary barrier is the shortage of donor organs and waiting list time. Ablation — tumour destruction by physical methods: radiofrequency ablation (RFA) or microwave ablation. Effective for nodules ≤ 3 cm that are not amenable to resection. Five-year survival for small tumours is comparable to surgery — 50–60%. Minimally invasive; also used as a "bridge" to transplantation. Transarterial chemoembolisation (TACE) — the standard for intermediate-stage BCLC B (multinodular HCC without vascular invasion). A catheter delivers embolic material combined with a chemotherapeutic agent (doxorubicin, cisplatin) into the hepatic artery feeding the tumour, causing ischaemia and local cytotoxic effect. Median survival: 20–26 months; also used as a bridge to transplantation. Systemic therapy (BCLC C): - Atezolizumab + bevacizumab — the first-line standard: a combination of anti-PD-L1 immunotherapy and anti-VEGF antiangiogenic therapy. In the IMbrave150 trial, median overall survival was 19.2 months versus 13.4 months with sorafenib monotherapy - Sorafenib — the first targeted agent approved for HCC (2007); a multikinase inhibitor blocking angiogenesis and tumour proliferation; used when immunotherapy is contraindicated - Lenvatinib — an alternative first-line option for patients without main portal vein invasion - Second-line options: nivolumab, pembrolizumab, ramucirumab (for AFP ≥ 400 ng/mL) Radiotherapy: stereotactic body radiotherapy (SBRT) is an emerging option for tumours not amenable to ablation or with tumour portal vein thrombus. Screening and When to See a Doctor HCC surveillance is strongly recommended and proven effective for high-risk groups. Abdominal ultrasound plus AFP every 6 months is the international standard of care for: - all patients with cirrhosis from any cause (Child–Pugh A and B) - patients with chronic hepatitis B even without cirrhosis — when viral load is high or there is a family history of HCC - patients with chronic hepatitis C who have achieved sustained virological response but had established cirrhosis at the time of treatment Regular surveillance reduces HCC mortality by 37–39% in cohort studies. Early detection through screening is the reason countries with strong surveillance programmes achieve significantly higher rates of curative treatment. See a gastroenterologist or hepatologist without delay when any of the following apply: - you have cirrhosis or chronic hepatitis and have not had surveillance ultrasound with AFP within the past 6 months; - new or worsening pain in the right upper abdomen has developed; - previously compensated cirrhosis has suddenly worsened — accumulating ascites, new jaundice; - significant weight loss and weakness have developed on a background of chronic liver disease; - AFP measured for any other reason has come back elevated. HCC is substantially more treatable at early stages. Five-year survival at BCLC stage 0/A is 50–70%; at BCLC stage C it falls to below 15%. Complete HBV elimination through vaccination and HCV eradication with direct-acting antivirals are the most powerful preventive tools available. Do not delay either surveillance or treatment of underlying liver disease. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/hypercalcemia https://labreadai.com/en/posts/hypercalcemia Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) High blood calcium (hypercalcaemia) — calcium above 2.6 mmol/L. Main causes, symptoms, which tests confirm the diagnosis, and when to seek urgent care. Articles article Finding "calcium elevated" on a blood test report is a signal that should not be put off until the next appointment. Calcium in blood governs nerve conduction, muscle contraction, blood clotting and bone mineral density. When levels exceed the normal range, the body sends a broad spectrum of signals — from persistent fatigue and thirst to dangerous cardiac arrhythmias. This article explains what hypercalcaemia is, why it develops and what steps to take when blood calcium is high. What Is Hypercalcaemia and What Are Normal Blood Calcium Levels Hypercalcaemia is defined as a serum total calcium above 2.6 mmol/L, or an ionised calcium above 1.3 mmol/L. The normal range for adults is: total calcium 2.15–2.55 mmol/L, ionised calcium 1.15–1.30 mmol/L. Severity is classified in three tiers: Grade Total calcium Clinical significance ------------------------------------------- Mild 2.6–3.0 mmol/L Often asymptomatic, found incidentally Moderate 3.0–3.5 mmol/L Symptoms present, treatment required Severe 3.5 mmol/L Life-threatening, emergency care needed Mild hypercalcaemia is frequently discovered on a routine biochemistry panel when the patient feels perfectly well. Moderate and severe forms produce a clear clinical picture that must not be missed. Symptoms of High Blood Calcium The classic symptom complex is captured by the medical mnemonic bones, stones, groans and psychic moans, reflecting four main systemic effects of excess calcium. Bones: bone and joint pain, pathological fractures from minor trauma as calcium leaches from the skeleton into the bloodstream. Stones: the kidneys try to excrete the calcium overload, leading to oxalate and phosphate kidney stones — flank pain, haematuria and recurrent renal colic. Groans (gastrointestinal): nausea, vomiting, constipation, loss of appetite and abdominal pain. Excess calcium inhibits smooth muscle throughout the gut. Psychic moans (neuropsychiatric): fatigue, lethargy, difficulty concentrating, low mood, confusion. In severe hypercalcaemia, coma is possible. Cardiovascular: shortening of the QT interval on ECG, bradycardia, risk of arrhythmias. In patients taking cardiac glycosides, hypercalcaemia greatly amplifies toxicity. Polyuria and polydipsia: frequent urination and persistent thirst — excess calcium blunts the kidney's response to antidiuretic hormone. Causes of Hypercalcaemia: From Hyperparathyroidism to Cancer Over 90% of hypercalcaemia cases are explained by just two causes — primary hyperparathyroidism and malignancy. Primary hyperparathyroidism is the most common cause in outpatient settings. One or more parathyroid glands begin autonomously producing excess parathyroid hormone, instructing bones to release calcium and the kidneys to retain it. A benign adenoma is the usual culprit. For a detailed look at the condition, see primary hyperparathyroidism. Malignancy is the leading cause among hospitalised patients. Tumours may secrete PTH-related protein (PTHrP), directly destroy bone, or synthesise active vitamin D. Hypercalcaemia is especially common in multiple myeloma, as well as lung, breast and renal cancers. Excess vitamin D. Uncontrolled high-dose vitamin D supplementation enhances intestinal calcium absorption — one reason why self-prescribing megadoses is risky. For more on vitamin D imbalance, see vitamin D deficiency. Sarcoidosis and granulomatous diseases. Activated macrophages within granulomas synthesise calcitriol (active vitamin D), increasing calcium absorption from the diet. Other causes: prolonged immobilisation (calcium mobilises from inactive bone), thiazide diuretics, familial hypocalciuric hypercalcaemia — a rare inherited condition with a benign course. How Hypercalcaemia Is Diagnosed: Which Tests Are Needed Detecting high calcium is only the first step. The key task is finding the cause. The standard diagnostic algorithm proceeds as follows. Step 1 — confirm hypercalcaemia. A single elevated result may be artefactual: a prolonged tourniquet, haemolysis or a high albumin level all inflate total calcium. Total and ionised calcium are repeated, and albumin is measured for corrected calcium calculation. Step 2 — parathyroid hormone (PTH). This is the pivotal differential test. High PTH with high calcium → primary hyperparathyroidism. Low PTH with high calcium → malignancy, vitamin D toxicity, sarcoidosis. Step 3 — additional markers: Test Purpose --------------- Blood phosphorus Low in hyperparathyroidism; elevated in renal failure Creatinine Renal function assessment — calcium is nephrotoxic Vitamin D (25-OH) Rule out hypervitaminosis D PTH-related protein (PTHrP) Marker of paraneoplastic hypercalcaemia A full kidney function test is mandatory in any hypercalcaemia — the kidneys are the first organ damaged by sustained calcium overload. Complications of Hypercalcaemia Chronic hypercalcaemia, even mild, causes systemic damage over time. Kidneys. Nephrocalcinosis — calcium deposits in renal tissue — leads to progressive kidney failure. The acute form is acute kidney injury triggered by severe hypercalcaemia combined with dehydration. Bones. Prolonged stimulation of bone resorption causes osteoporosis and pathological fractures. The paradox: blood calcium is high while the skeleton is being depleted. Heart. A shortened QT interval raises the risk of ventricular arrhythmias. Patients on digoxin are particularly vulnerable, as hypercalcaemia multiplies glycoside toxicity. Gastrointestinal tract. Elevated calcium stimulates gastrin secretion, raising the risk of peptic ulcers. Chronic constipation significantly impairs quality of life. Treatment of Hypercalcaemia Treatment depends on severity and the underlying cause. Mild hypercalcaemia (2.6–3.0 mmol/L) due to asymptomatic primary hyperparathyroidism in older patients may need only surveillance: calcium monitoring every 6–12 months, adequate fluid intake (at least 2 litres daily) and moderate weight-bearing exercise, which slows bone resorption. Moderate and severe hypercalcaemia requires active intervention: - Aggressive IV hydration with isotonic saline — the first and most critical step. Restoring circulating volume enhances renal calcium excretion. - Bisphosphonates (zoledronic acid, pamidronate) — suppress bone resorption. Effect develops within 48–72 hours. - Calcitonin — rapidly lowers calcium but the effect is short-lived. - Glucocorticoids — effective for hypercalcaemia caused by sarcoidosis, other granulomatoses and haematological malignancies. - Dialysis — in severe renal failure when other measures are insufficient. In symptomatic primary hyperparathyroidism, surgical removal of the adenoma offers definitive, long-lasting cure. When High Calcium Is a Medical Emergency Hypercalcaemic crisis is a life-threatening condition that develops when calcium exceeds 3.5 mmol/L, often triggered by dehydration or acute illness. Signs requiring immediate emergency care: - sudden severe weakness, confusion or disorientation - intractable vomiting with progressive dehydration - cardiac arrhythmias or haemodynamic instability - oliguria — markedly reduced urine output Self-treatment and watchful waiting are not options in this situation. Even a moderate asymptomatic rise in calcium is reason to see an endocrinologist for full investigation — not simply to "repeat the test next month." Key Takeaways Hypercalcaemia is always a symptom, not a disease in itself. Behind elevated calcium may be a benign parathyroid adenoma or an early-stage malignancy. That is why any result above the normal range warrants thorough investigation — with PTH, phosphorus and a renal function assessment. The earlier the cause is found, the more effective the treatment and the better the long-term outcome. This article is for informational purposes only. Interpretation of test results and treatment decisions should be made by a qualified healthcare professional. https://labreadai.com/en/posts/hyperparathyroidism https://labreadai.com/en/posts/hyperparathyroidism Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hyperparathyroidism: excess PTH causes hypercalcaemia, kidney stones and bone loss. Primary vs secondary forms, PTH and calcium blood tests, indications for surgery. Articles article Bone pain, recurrent kidney stones, chronic fatigue and persistent thirst — four symptoms that may share one overlooked cause. Hyperparathyroidism — excess secretion of parathyroid hormone by the parathyroid glands — leaches calcium from bone, overloads the kidneys and disrupts the nervous system. Yet a third of patients have no symptoms at all and discover their diagnosis by chance when a blood test reveals elevated calcium. What Is Hyperparathyroidism and How Does Parathyroid Hormone Work The parathyroid glands — four small structures on the posterior surface of the thyroid — produce parathyroid hormone (PTH). Its job: to maintain blood calcium within a narrow range. When calcium falls, PTH immediately activates three mechanisms: it mobilises calcium from bone (by stimulating osteoclasts), increases calcium reabsorption in the kidney tubules, and stimulates synthesis of active vitamin D, which enhances intestinal calcium absorption. Calcium rises — PTH falls. A textbook negative feedback loop. In hyperparathyroidism this balance is broken: PTH is secreted in excess regardless of the calcium level. The consequences — chronically high blood calcium (hypercalcaemia), progressive destruction of bone tissue and renal overload. Types of Hyperparathyroidism: Primary, Secondary and Tertiary The distinction between forms is fundamental — it determines the entire treatment approach. Primary hyperparathyroidism — the most common form. One or more parathyroid glands begin functioning autonomously, independent of calcium levels. In 80–85% of cases the cause is a single benign parathyroid adenoma. Less commonly — hyperplasia of all four glands (10–15%) or parathyroid carcinoma (< 1%). It affects 1 in 500–1000 adults, significantly more often in postmenopausal women. Secondary hyperparathyroidism — a reactive rise in PTH in response to chronically low calcium. The parathyroid glands are working correctly — they are responding to genuine calcium deficiency. The most common cause is chronic kidney disease: failing kidneys cannot activate vitamin D, calcium falls, PTH rises compensatorily. Other causes: severe vitamin D deficiency, malabsorption syndromes. Tertiary hyperparathyroidism — develops in patients with long-standing secondary hyperparathyroidism (most often after years of dialysis): the hyperplastic glands acquire autonomy and continue secreting excess PTH even after calcium is corrected, for example after kidney transplantation. The key laboratory distinction: in primary hyperparathyroidism, PTH is elevated alongside high calcium. In secondary hyperparathyroidism, PTH is elevated alongside normal or low calcium. This difference makes simultaneously drawn PTH and calcium measurements the single most important diagnostic tool. Symptoms of Hyperparathyroidism The classic clinical mnemonic — "bones, stones, groans, and psychic moans" — describes the four systems damaged by prolonged PTH excess. Asymptomatic form. Today approximately 50–80% of patients with primary hyperparathyroidism have no specific complaints. Diagnosis is made incidentally when hypercalcaemia is found on a biochemical panel. Renal symptoms — the most common in symptomatic disease: - recurrent kidney stones (nephrolithiasis) — in 15–20% of patients; - nephrocalcinosis — calcium deposits within the renal parenchyma; - polyuria and polydipsia — impaired renal concentrating ability from excess calcium. Skeletal symptoms: - diffuse bone pain, particularly in the back, ribs and joints; - osteoporosis — reduced bone mineral density, elevated fracture risk; - in severe cases — osteitis fibrosa cystica (rarely seen today with early diagnosis). Gastrointestinal symptoms (groans): nausea, poor appetite, constipation, abdominal pain. Elevated calcium stimulates gastrin secretion, which may lead to peptic ulcer disease. Recurrent pancreatitis is an important if uncommon association. Neuropsychiatric symptoms (psychic moans): chronic fatigue, muscle weakness, depression, impaired concentration, irritability. Cognitive complaints frequently persist for years before diagnosis and improve substantially after treatment. Cardiovascular manifestations: hypertension, shortening of the QT interval on ECG, accelerated valve calcification. Diagnosis: Which Tests Confirm Hyperparathyroidism Diagnosis proceeds in two stages: confirming hyperparathyroidism and identifying its cause. Core laboratory tests: - Calcium and PTH simultaneously — the key pair. Elevated PTH with elevated calcium is virtually sufficient to diagnose primary hyperparathyroidism. Ionised calcium is more accurate than total calcium, especially when albumin is altered. - Serum phosphorus — low or at the lower end of normal in primary hyperparathyroidism: PTH drives renal phosphorus excretion. - Vitamin D (25-OH) — deficiency can mask hypercalcaemia in primary hyperparathyroidism and is the cause of secondary disease. - Kidney function test — assessment of estimated GFR: chronic hypercalcaemia damages the kidneys; reduced filtration can itself cause secondary hyperparathyroidism. - 24-hour urinary calcium — essential to distinguish primary hyperparathyroidism from familial hypocalciuric hypercalcaemia (FHH): in FHH calcium is not excreted in urine, whereas in primary hyperparathyroidism urinary calcium is actively elevated. Imaging to localise the source: - Neck ultrasound — identifies a parathyroid adenoma in 70–80% of cases with an experienced examiner. - Technetium-99m sestamibi scintigraphy — the gold standard for pre-operative adenoma localisation. - 4D-CT or MRI — when ultrasound and scintigraphy are inconclusive. All patients with confirmed primary hyperparathyroidism also undergo bone densitometry (DXA) and renal ultrasound to assess existing end-organ damage. Treatment of Hyperparathyroidism Surgery — the only curative treatment for primary hyperparathyroidism. Parathyroidectomy (removal of the adenoma or hyperplastic glands) normalises calcium and PTH in 95–98% of patients when performed by an experienced parathyroid surgeon. Indications for surgery in primary hyperparathyroidism: - calcium 0.25 mmol/L above the upper limit of normal; - estimated GFR < 60 mL/min/1.73 m²; - DXA T-score < –2.5 at any site; - nephrolithiasis or nephrocalcinosis; - age < 50 years (surgery is recommended even in "mild" disease in young patients). In asymptomatic elderly patients who do not meet surgical criteria, watchful waiting is an option: calcium and PTH every 6–12 months, annual densitometry, annual renal ultrasound. Medical treatment for primary hyperparathyroidism: - Cinacalcet (calcimimetic) — lowers PTH and calcium without affecting bone density; used when surgery is not possible, in parathyroid carcinoma or patient refusal. - Bisphosphonates — to protect bone density when surgery cannot be performed. - Adequate fluid intake (2–2.5 litres/day) — mandatory for kidney stone prevention. Treatment of secondary hyperparathyroidism addresses the underlying cause: correcting vitamin D deficiency, normalising dietary phosphorus intake and using phosphate binders in chronic kidney disease. Cinacalcet or paricalcitol are used in decompensated secondary disease. Complications of Untreated Hyperparathyroidism Years of excess PTH accumulate damage across several organs simultaneously. The skeleton bears the greatest burden: cortical bone (forearm radius, femoral neck) loses density faster than trabecular bone. Pathological fractures from minimal trauma are a characteristic complication of severe primary hyperparathyroidism. The kidneys suffer in two ways: nephrolithiasis with recurrent colic, and nephrocalcinosis with progressive functional decline. Some nephrocalcinosis is irreversible even after the hyperparathyroidism is cured. The cardiovascular system: chronically elevated calcium accelerates coronary artery and valve calcification. The risk of cardiovascular events in primary hyperparathyroidism is higher than in the general population, though the magnitude of this excess risk in mild asymptomatic disease continues to be studied. Neuropsychiatric impairment: in some patients depression, fatigue and cognitive symptoms are not fully reversible after surgery — particularly after years of uncorrected disease. When to See a Doctor See an endocrinologist when any of the following are found: - calcium above normal on two consecutive tests, especially combined with elevated PTH; - recurrent kidney stones without another obvious cause; - osteoporosis in a premenopausal woman or a man under 60; - chronic fatigue and muscle weakness combined with thirst and frequent urination; - incidental finding of a mass in the neck region on ultrasound. For urgent management of hypercalcaemic crisis (calcium 3.5 mmol/L with neurological symptoms or cardiac arrhythmia), see the hypercalcaemia article. Do not interpret blood tests independently — treatment is guided by an endocrinologist or parathyroid surgeon. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/hypertension https://labreadai.com/en/posts/hypertension Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hypertension — blood pressure above 140/90. Causes, symptoms, blood and kidney tests for hypertension diagnosis, and signs of hypertensive crisis explained. Articles article High blood pressure has earned the name "silent killer" for good reason: in most patients, hypertension runs for years without a single symptom, quietly damaging blood vessels, the heart, and kidneys. According to the WHO, one in three adults worldwide has arterial hypertension — and nearly half of them have no idea. This article covers what blood pressure levels mean, why pressure rises, and what to do about it. What Is Arterial Hypertension and Blood Pressure Norms Blood pressure is the force exerted by blood against vessel walls. It is expressed as two numbers: systolic (upper) — pressure during cardiac contraction; diastolic (lower) — pressure during relaxation. Category Systolic Diastolic --------- Optimal < 120 < 80 Normal 120–129 80–84 High normal 130–139 85–89 Grade 1 hypertension 140–159 90–99 Grade 2 hypertension 160–179 100–109 Grade 3 hypertension ≥ 180 ≥ 110 A diagnosis of hypertension requires systolic pressure ≥140 mmHg and/or diastolic ≥90 mmHg on two or more separate visits. A single elevated reading is not a diagnosis. An important note: in older patients, systolic pressure carries greater prognostic weight than diastolic. Isolated systolic hypertension (systolic ≥140, diastolic < 90) is the most common form in people over 60 and carries the same vascular risk as classical hypertension. Causes of Hypertension: Primary and Secondary Forms Primary (essential) hypertension accounts for 90–95% of all cases. There is no single identifiable cause — it is a combination of genetic predisposition and lifestyle factors: excess weight, high salt intake, physical inactivity, chronic stress, smoking, excessive alcohol, and age. In people with a family history of hypertension, all these factors hit harder. Secondary hypertension — 5–10% of cases — has a specific, potentially reversible cause: - Kidney disease — the most common cause of secondary hypertension. In chronic kidney disease, sodium and water regulation is disrupted and the renin-angiotensin-aldosterone system becomes chronically activated. - Primary aldosteronism — an adrenal tumour secreting excess aldosterone, causing sodium and water retention. It should be suspected in hypertension with low blood potassium and poor response to standard medications. - Phaeochromocytoma — a rare catecholamine-secreting adrenal tumour: the classic picture is episodic sudden pressure spikes with palpitations, sweating, and headache. - Cushing's syndrome — excess cortisol causes sodium retention, characteristic fat redistribution, and hypertension. - Sleep apnoea — nocturnal hypoxia activates the sympathetic nervous system and renin-angiotensin axis; hypertension in these patients is often uncontrollable until the apnoea is treated. - Medications — oral contraceptives, NSAIDs, decongestants, and some antidepressants can raise blood pressure. Secondary causes are always ruled out in young patients (under 40) with newly diagnosed hypertension, and in anyone with hypertension that fails to respond to three medications. Symptoms of Hypertension and Hypertensive Crisis The great deception of hypertension is its prolonged asymptomatic course. "No headache means my pressure is fine" is a dangerous misconception. Many patients with a pressure of 160/100 feel perfectly well because the body adapts to chronically elevated pressure. When symptoms do appear, the most common are: - occipital headache, especially in the morning; - ringing in the ears, visual disturbances ("spots" before the eyes); - dizziness on sudden standing; - nosebleeds; - a heavy sensation in the chest on exertion. Hypertensive crisis — acute severe elevation, usually above 180/120 mmHg — divides into two critically different scenarios: - Uncomplicated crisis — severely elevated pressure without signs of end-organ damage. The patient feels unwell, but there is no immediate threat to an organ. Pressure is reduced gradually over several hours. - Complicated crisis (hypertensive emergency) — severely elevated pressure plus signs of acute organ damage: escalating chest pain (myocardial infarction), neurological deficits (stroke), sudden vision loss, progressive breathlessness (pulmonary oedema). This is a medical emergency. Which Tests Are Ordered for Hypertension The workup for hypertension serves three goals: assess end-organ damage, find a possible secondary cause, and identify co-existing cardiovascular risk factors. Standard minimum panel: - Creatinine and estimated GFR — the kidneys are the first target of chronic high pressure and can simultaneously be its cause. Rising creatinine signals hypertensive nephropathy. - Kidney function test — comprehensive assessment: urea, electrolytes, eGFR. - Lipid panel — LDL cholesterol combined with hypertension multiplies cardiovascular risk several-fold. - Fasting glucose and HbA1c — hypertension and type 2 diabetes frequently co-exist; their combination dramatically elevates stroke and myocardial infarction risk. - Urinalysis — microalbuminuria is an early marker of renal end-organ damage. - ECG — left ventricular hypertrophy as evidence of chronic pressure overload. - Serum potassium — hypokalaemia in hypertension triggers a search for primary aldosteronism. If workup reveals secondary hypertension or end-organ damage disproportionate to the measured pressure, the investigation is extended: renal and adrenal ultrasound, ambulatory blood pressure monitoring (ABPM), and specific hormonal tests. End-Organ Damage in Chronic Hypertension Hypertension destroys vessels gradually through mechanical stress and vascular wall inflammation. Organs with abundant small vessels are most vulnerable. Heart. The left ventricle works constantly against elevated resistance — its walls thicken (hypertrophy), then lose elasticity. The result: first diastolic dysfunction, then heart failure. Hypertension is the leading cause of heart failure with preserved ejection fraction. Blood vessels. Chronic pressure accelerates atherosclerosis: plaques grow faster, and the risk of plaque rupture triggering myocardial infarction or stroke is higher. Large arteries lose elasticity — arterial stiffness itself becomes an additional source of pressure elevation. Kidneys. Narrowing and thickening of intrarenal vessels reduces glomerular filtration; over time hypertensive nephropathy leads to chronic kidney disease — which in turn maintains high pressure, creating a vicious cycle. Brain. Chronic hypertension is the leading modifiable risk factor for both ischaemic and haemorrhagic stroke, as well as vascular dementia. Small brain arteries are especially vulnerable. Retina. Long-standing hypertension produces hypertensive retinopathy — vascular changes visible on fundoscopy. In severe cases, haemorrhages and vision loss develop. The combination of hypertension with insulin resistance and obesity within the metabolic syndrome sharply accelerates all these risks — target organs are damaged much faster. Treatment of Arterial Hypertension The goal of treatment is to lower pressure to target values (for most patients < 140/90 mmHg; in younger patients and high-risk cases < 130/80) and reduce the risk of complications. Non-pharmacological treatment — the foundation that works at every stage of hypertension: - Reducing salt intake to < 5 g/day (systolic pressure falls 5–7 mmHg) - Weight loss in obesity — every 5 kg lost reduces systolic pressure by approximately 4–5 mmHg - Aerobic exercise 30–45 minutes five times per week - Limiting alcohol to ≤14 units per week for men, ≤8 for women - Stopping smoking — pressure change is modest, but cardiovascular risk falls sharply Pharmacological treatment. Five first-line drug classes: ACE inhibitors (or ARBs), calcium antagonists, thiazide-like diuretics, and beta-blockers. Current guidelines favour two-drug combination therapy from the start when pressure is ≥160/100 — monotherapy rarely achieves targets. In secondary hypertension, treating the underlying cause often normalises pressure without lifelong medication: surgery for phaeochromocytoma, treatment of sleep apnoea, correction of aldosteronism. When to Seek Emergency Care Call emergency services immediately if high blood pressure is accompanied by any of the following: - sudden severe headache unlike anything before ("the worst headache of your life"); - weakness or numbness in an arm or leg, facial drooping, speech difficulties; - acute chest pain radiating to the left arm or jaw; - sudden vision loss or double vision; - rapidly worsening breathlessness that is worse when lying down; - pressure above 180/120 mmHg with headache, nausea, or visual disturbance. Pressure above 180/120 without symptoms warrants a same-day or urgent medical review — do not attempt to self-treat. Dropping blood pressure too rapidly without medical supervision can trigger stroke or myocardial infarction. Hypertension is a chronic condition requiring lifelong management. Properly guided therapy reduces stroke risk by 35–40% and myocardial infarction risk by 20–25%. Do not interpret blood pressure readings in isolation — see a doctor who can select treatment tailored to your full risk profile. https://labreadai.com/en/posts/insulin-resistance https://labreadai.com/en/posts/insulin-resistance Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Insulin resistance — an early stage of diabetes and metabolic syndrome. Symptoms, HOMA-IR index, fasting insulin and glucose tests, and how to reverse it. Articles article Excess weight around the abdomen, persistent fatigue after meals, and a craving for sugar that feels impossible to control — behind these seemingly ordinary complaints can lie insulin resistance. Estimates suggest it affects 30–40% of adults in developed countries, yet most people are unaware of it until prediabetes or metabolic syndrome has already developed. Here is what it is, how to recognise it, and what to do. What Is Insulin Resistance and How Does It Develop Insulin is a pancreatic hormone whose main job is to "open the door" into cells for glucose. Normally, after a meal blood glucose rises, the pancreas releases insulin, it binds to receptors on muscle, liver, and fat cells — and glucose enters, providing energy or being stored. In insulin resistance, cells stop responding normally to insulin. Think of a rusted lock: the right key is inserted, but the door will not open. The pancreas "sees" that glucose is not clearing from the blood and begins releasing more and more insulin to overcome the resistance. This works — but only for a while. As the pancreatic reserve is exhausted, prediabetes develops, and eventually type 2 diabetes. Chronically elevated insulin is itself harmful: it stimulates fat deposition (especially visceral fat around internal organs), suppresses fat breakdown, drives androgen production in the ovaries, and activates the sympathetic nervous system — raising blood pressure. This is how insulin resistance becomes the engine driving several chronic diseases simultaneously. Causes and Risk Factors for Insulin Resistance Obesity, especially visceral. Abdominal fat is metabolically active: it releases inflammatory cytokines and free fatty acids that disrupt insulin signalling in muscle and liver cells. This is the primary cause in the majority of patients. Physical inactivity. Muscle is the body's main consumer of glucose. With low activity, muscle mass falls, the number of insulin receptors decreases, and insulin sensitivity drops. Just a few days of bed rest in a healthy person reduces insulin sensitivity by 25–40%. Poor sleep and chronic stress. Sleeping fewer than 6 hours per night raises cortisol and reduces insulin sensitivity within 1–2 weeks. Chronic stress acts through the same mechanism. High glycaemic load diet. A diet rich in refined carbohydrates and sugar creates frequent glucose spikes — the pancreas constantly operates under high load, and receptors gradually "fatigue" their response. Genetic predisposition. Insulin resistance has a strong familial component: if parents had type 2 diabetes, personal risk is significantly elevated. Hormonal conditions. Polycystic ovary syndrome (PCOS) — approximately 70% of women with this diagnosis have insulin resistance. Hypothyroidism, Cushing's syndrome, and hyperprolactinaemia also worsen insulin sensitivity. Ethnicity. People of South Asian, Latin American, and Middle Eastern descent are genetically more prone to insulin resistance at the same BMI as Europeans. Symptoms of Insulin Resistance: How to Suspect the Condition Insulin resistance is asymptomatic for a long time. But a cluster of indirect signs appears frequently enough to be worth knowing. Metabolic signs: - weight gain predominantly in the abdomen (waist circumference 94 cm in men, 80 cm in women); - difficulty losing weight even when calories are restricted; - pronounced fatigue and drowsiness 1–2 hours after a carbohydrate-rich meal. Skin signs: - acanthosis nigricans — darkening and thickening of skin in body folds (neck, armpits, groin, elbows). This is a direct result of chronically elevated insulin stimulating keratinocyte proliferation; - multiple small skin tags (acrochordons) on the neck and in the armpits. Other signs: - cravings for sugar and carbohydrates that intensify in the afternoon; - difficulty concentrating, "brain fog"; - in women — irregular periods, excess hair growth (hirsutism), acne — signs of hyperandrogenism driven by high insulin acting on ovarian cells. None of these signs is specific to insulin resistance. Diagnosis is established through blood tests, not symptoms alone. Tests and HOMA-IR Index: How to Diagnose Insulin Resistance There is no universally standardised clinical test for insulin resistance — the "gold standard" (euglycaemic hyperinsulinaemic clamp) is used only in research. In clinical practice, indirect markers are used. HOMA-IR index — the most widely used calculated measure: HOMA-IR = (fasting glucose, mmol/L × fasting insulin, µIU/mL) ÷ 22.5 A value above 2.7 (in some laboratories above 2.5) indicates insulin resistance. Critically: both fasting glucose and fasting insulin must be drawn strictly after an 8–12 hour fast — otherwise the result is unreliable. Glycated haemoglobin (HbA1c) — reflects average glucose over the past 2–3 months. In insulin resistance it is often in the upper normal range (5.5–5.9%) or already in the prediabetes range (6.0–6.4%). Lipid profile: the characteristic pattern in insulin resistance is elevated triglycerides ( 1.7 mmol/L) and reduced HDL cholesterol (< 1.0 in men, < 1.3 in women). This combination with visceral obesity and hypertension constitutes the full metabolic syndrome. Oral glucose tolerance test — a more sensitive approach: glucose is measured fasting and again 2 hours after ingesting 75 g of glucose. A 2-hour value of 7.8–11.0 mmol/L indicates impaired glucose tolerance — the intermediate state between insulin resistance and overt diabetes. Insulin Resistance and Associated Conditions Insulin resistance rarely exists in isolation — it is the pathophysiological foundation for a cluster of interconnected conditions. Type 2 diabetes — the direct downstream consequence of progressive insulin resistance. As beta-cell capacity is exhausted, glucose can no longer be controlled even by high insulin levels — overt diabetes develops. Insulin resistance precedes diabetes by years or decades: this is the best window for prevention. Arterial hypertension — chronically elevated insulin activates the sympathetic nervous system and promotes renal sodium retention. Approximately 50% of patients with hypertension have co-existing insulin resistance. Non-alcoholic fatty liver disease (NAFLD) — excessive free fatty acid influx and enhanced hepatic lipogenesis driven by high insulin lead to fat accumulation in hepatocytes. NAFLD and insulin resistance mutually reinforce each other. Polycystic ovary syndrome — high insulin stimulates excessive androgen production in the ovaries, disrupting follicle maturation. This is one of the core mechanisms of PCOS, explaining why metformin (an insulin-sensitising drug) is effective in this condition. Cardiovascular disease — the dyslipidaemia, hypertension, and chronic inflammation accompanying insulin resistance accelerate atherosclerosis and elevate myocardial infarction risk independently of glucose levels. Reversing Insulin Resistance: Diet, Activity and Medication The good news: insulin resistance is reversible — especially in its early stages. Lifestyle change outperforms any single medication. Physical activity is the most powerful tool. Resistance training increases muscle mass and insulin receptor density; aerobic exercise reduces visceral fat and systemic inflammation. Even 150 minutes of moderate aerobic activity per week reduces HOMA-IR by 25–30% over 3 months. Nutrition. No single "correct" diet exists, but evidence-backed principles include: - prioritising whole foods with a low glycaemic load (vegetables, legumes, wholegrains, lean proteins); - reducing refined carbohydrates, sugar-sweetened beverages, and trans fats; - modest caloric deficit: a 5–7% reduction in body weight is sufficient to meaningfully improve insulin sensitivity; - the Mediterranean or DASH dietary pattern — the most studied and effective models for insulin resistance. Sleep normalisation. At least 7 hours per night is a non-negotiable baseline. Chronic sleep deprivation negates even optimal diet and exercise in terms of insulin sensitivity. Pharmacological therapy. When insulin resistance is confirmed alongside glucose dysregulation, metformin is prescribed — it reduces hepatic glucose output and improves peripheral tissue sensitivity. In PCOS, it additionally lowers androgen levels. GLP-1 receptor agonists (semaglutide, liraglutide) produce significant weight loss and improve insulin sensitivity — indicated in obesity and prediabetes. When to See a Doctor See an endocrinologist or general practitioner if several of the following apply: - waist circumference above threshold combined with post-meal fatigue and sugar cravings; - darkening of skin folds on the neck or in the armpits; - irregular periods in women without another identified cause; - fasting glucose 5.6–6.9 mmol/L on more than one test; - HbA1c in the 5.7–6.4% range; - triglycerides above 1.7 mmol/L and low HDL; - a first-degree relative with type 2 diabetes. Insulin resistance is not a verdict — it is a signal caught early enough to change the trajectory and prevent diabetes, myocardial infarction, and other downstream consequences. Do not self-diagnose based on symptoms and an online calculator — see a doctor for a full workup. https://labreadai.com/en/posts/kidney-stones https://labreadai.com/en/posts/kidney-stones Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Kidney stones (nephrolithiasis) — causes of urate, oxalate and calcium stones, renal colic symptoms, diagnostic tests, treatment options and relapse prevention. Articles article The pain of renal colic is described as among the most intense in clinical medicine — sharp, cramping, radiating from the flank to the groin, offering no position of relief. This is how a stone that has left the kidney travels through the ureter. Kidney stones affect 10–15% of adults worldwide, recur in every second patient within 10 years, and remain one of the leading causes of emergency urology admissions. What Are Kidney Stones and How Do They Form Kidney stones (nephrolithiasis, urolithiasis) are hard crystalline deposits forming in the kidneys, ureters, bladder, or urethra as a result of changes in the chemical composition of urine. When the concentration of certain substances exceeds their solubility threshold, they begin to crystallise and gradually aggregate into stones. Stone formation takes months or years. A microscopic crystal acts as a "nucleus" onto which new layers deposit. While a stone remains in the renal pelvis without obstructing flow, it may cause no symptoms at all — sometimes for years. Pain begins the moment the stone moves and lodges in the ureter, blocking urine drainage. Three core conditions are required for stone formation: - urine supersaturation — excessively high concentrations of stone-forming substances (oxalate, calcium, uric acid, phosphate); - insufficient urine volume — low fluid intake raises concentrations; - deficiency of inhibitors — citrate, magnesium, and other substances normally prevent crystallisation; their reduction creates conditions for stone growth. Causes and Risk Factors for Kidney Stones Insufficient fluid intake — the most common and most correctable factor. When daily urine output falls below 1 litre, stone-forming risk is maximal. Hot climates and intense physical activity without fluid replacement produce the same effect. Diet. Excess animal protein increases urinary excretion of uric acid, oxalate, and calcium. High salt intake raises urinary calcium excretion. Large amounts of oxalate-rich foods (spinach, beets, nuts, chocolate) raise the risk of calcium oxalate stones. Metabolic abnormalities: - Elevated uric acid — the primary risk factor for urate stones; frequently accompanies hyperuricaemia and gout. - Elevated blood calcium — in hypercalcaemia and hyperparathyroidism, excess calcium is filtered into the urine and precipitates stones. - Hyperoxaluria — primary (genetic) or secondary (malabsorption, celiac disease, bowel resection). - Urinary citrate deficiency — citrate binds calcium and prevents crystallisation; its reduction is typical in chronic acidosis and persistent diarrhoea. Systemic conditions: - Chronic kidney disease disrupts regulation of calcium and phosphate excretion. - Arterial hypertension — an independent risk factor, partly through impaired renal calcium reabsorption. - Obesity and type 2 diabetes — lower urinary pH (acidic urine favours urate stones) and increase oxalate excretion. - Crohn's disease and ileal resection — impaired fat absorption causes intraluminal calcium binding, increasing oxalate absorption. Anatomical factors: structural abnormalities of the collecting system (horseshoe kidney, ureteral strictures) promote urine stasis and stone formation. Heredity. A family history of kidney stones raises individual risk two- to three-fold. Rare genetic conditions — cystinuria, primary hyperoxaluria — produce recurrent stones from childhood. Symptoms of Kidney Stones: Renal Colic and Other Presentations The clinical picture depends on stone size, location, and whether obstruction is present. Stone in the renal pelvis without obstruction — usually asymptomatic. Large staghorn calculi are often found incidentally on ultrasound. The only complaint may be a dull persistent flank ache. Renal colic — acute ureteral obstruction. The classic picture: - severe, excruciating cramping flank pain radiating along the ureter toward the groin, inner thigh, and genitals; - the pain is colicky — it waxes and wanes but never fully resolves — and the patient cannot find a comfortable position (in contrast to peritoneal pain, where movement worsens everything); - nausea and vomiting — reflex in origin; - frequent, painful urination when the stone is in the lower third of the ureter; - blood in the urine (haematuria) — visible or microscopic. Stone size predicts outcome: stones up to 4–5 mm pass spontaneously in 80–90% of cases; 5–7 mm in approximately 50%; above 7–8 mm they almost always require instrumentation or surgery. Infected stone — the most dangerous scenario. Ureteral obstruction combined with urinary tract infection creates the risk of obstructive pyelonephritis and urosepsis: high fever, rigors, escalating flank pain. This is an indication for emergency renal drainage. Chronic course — recurrent colic episodes, chronic dull flank pain, recurrent urinary tract infections, gradual decline in renal function. Types of Kidney Stones by Chemical Composition Stone composition determines its cause, treatment, and prevention strategy. Stone type Prevalence CT density Key cause ------------ Calcium oxalate 60–70% Dense, white Hyperoxaluria, hypercalciuria Calcium phosphate 10–20% Very dense Hyperparathyroidism, renal tubular acidosis Urate 10–15% Radiolucent (invisible on X-ray) High uric acid, acidic urine Struvite 5–10% Staghorn shape Chronic urease-producing infection Cystine < 1% Mildly dense Cystinuria (genetic disorder) Urate stones are the only type that can be dissolved conservatively — by alkalinising urine to pH 6.5–7.0 with citrate preparations — without any surgical procedure. Struvite (staghorn) stones form in chronic infection by urease-producing bacteria (Proteus, Klebsiella); they fill the entire renal pelvis and almost never pass spontaneously. Diagnosing Kidney Stones Imaging: - Non-contrast CT of the abdomen (NCCT) — the gold standard in acute renal colic. Detects stones of any composition (except rare drug-induced calculi), determines size, location, and degree of obstruction. Sensitivity 97–98%. - Renal ultrasound — first-line in surveillance and in pregnancy. Identifies stones in the renal pelvis and collecting system dilatation as an indirect obstruction sign; poor sensitivity for ureteral stones. - Plain abdominal X-ray — visualises only radiopaque stones (oxalate, phosphate); urate and cystine stones are invisible. Laboratory workup — essential minimum: - Urinalysis — red cells (haematuria), white cells (infection), crystals, urine pH. Acidic pH (< 5.5) is typical for urate stones; alkaline ( 7.0) for struvite. - Kidney function test — creatinine and eGFR assess the degree of obstruction-related renal impairment. - Serum uric acid, calcium, and phosphate — identify metabolic drivers. Extended metabolic workup (for recurrent stones and young patients): - 24-hour urine for calcium, oxalate, citrate, uric acid, and volume — identifies the specific metabolic defect. - Parathyroid hormone — excludes primary hyperparathyroidism. - Stone composition analysis — more informative than any blood test in establishing the cause. Treatment of Kidney Stones Conservative management (stones up to 5–6 mm): - Liberal fluid intake — accelerates stone passage; target daily urine output ≥ 2–2.5 litres. - Analgesia — NSAIDs (diclofenac, ketorolac) are first-line: they relieve ureteral spasm and mucosal oedema. Opioids when NSAIDs are insufficient. - Alpha-blockers (tamsulosin) — relax the smooth muscle of the lower ureter, facilitating spontaneous passage. - Urine alkalinisation (potassium citrate, sodium bicarbonate) — effective for urate stones. Instrumentation and surgery: - Extracorporeal shock wave lithotripsy (ESWL) — non-invasive fragmentation by external shock waves; suitable for stones up to 15–20 mm in the renal pelvis and upper ureter. - Ureteroscopy with laser lithotripsy (URS) — an endoscope is passed through the urethra to the stone; a laser fragments it. Effective for ureteral stones at any level. - Percutaneous nephrolithotomy (PCNL) — percutaneous renal access to remove large ( 20 mm) or staghorn calculi. - Laparoscopic and open surgery — reserved for complex anatomical cases or failed minimally invasive approaches. Pharmacological relapse prevention is tailored to metabolic workup findings: - hyperuricosuria — allopurinol reduces uric acid production; - hyperoxaluria — pyridoxine and dietary oxalate restriction; - hypercalciuria — thiazide diuretics reduce urinary calcium excretion; - low citrate — potassium citrate supplementation. Prevention and When to See a Doctor Universal prevention measures that work for any stone type: - Fluid: drink at least 2.5–3 litres per day, aiming for urine output ≥ 2–2.5 litres. Water is the foundation; moderate amounts of lemon juice add urinary citrate. Sugar-sweetened drinks and grapefruit juice increase risk. - Limit salt to 4–5 g/day — reduces urinary calcium excretion. - Moderate animal protein — no more than 0.8–1.0 g/kg/day. - Maintain normal dietary calcium intake (1000–1200 mg/day) — do not restrict, as intestinal calcium binds oxalate and reduces its absorption. Restricting calcium paradoxically raises the risk of oxalate stones. - Maintain a healthy weight — obesity independently increases recurrence risk regardless of stone type. See a urologist if: - you have had a first episode of renal colic — even if the stone passed spontaneously; - stones have recurred — full metabolic workup is indicated; - stones occur in children or young adults (under 30) — a genetic or metabolic cause is highly likely; - bilateral stones or a stone in a solitary kidney; - progressive decline in kidney function on blood tests. Call emergency services immediately if flank pain is accompanied by high fever and rigors — these are signs of obstructive pyelonephritis, a life-threatening condition requiring emergency renal drainage. Do not interpret your test results on your own; consult a urologist for treatment and relapse prevention planning. https://labreadai.com/en/posts/megaloblastic-anemia https://labreadai.com/en/posts/megaloblastic-anemia Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Megaloblastic anaemia caused by vitamin B12 or folate deficiency: enlarged red blood cells, neurological symptoms, CBC test findings and treatment options. Articles article Fatigue builds over months, blood tests show low haemoglobin, yet iron supplements make no difference. Then comes tingling in the fingers, unsteadiness on your feet, a strange numbness spreading up the legs. This is how megaloblastic anaemia often begins — a condition in which blood cells become abnormally large and lose the ability to function normally. What Is Megaloblastic Anaemia and How Does It Develop Megaloblastic anaemia is anaemia caused by impaired DNA synthesis in blood cell precursors in the bone marrow. The main culprits are vitamin B12 deficiency and folate deficiency: both nutrients are required for normal cell division. When DNA synthesis is disrupted, red cell precursors keep growing and accumulating haemoglobin, but cannot divide. Imagine a factory where workers keep assembling components but the production line never moves — output builds up yet nothing reaches the end-user. The result is a bone marrow full of abnormally large, immature cells called megaloblasts. The red cells that do make it into the bloodstream are also oversized (macrocytes) and live a shorter-than-normal lifespan. The same disruption affects all rapidly dividing cells — white cells and platelets — so in severe megaloblastic anaemia, all three cell lines may fall. Two distinct scenarios matter clinically: - Vitamin B12 deficiency → anaemia + potential irreversible neurological damage if untreated - Folate deficiency → anaemia only, without neurological involvement This distinction is critical: treating B12 deficiency with folate alone will mask the anaemia while neurological damage continues to progress undetected. Symptoms of Megaloblastic Anaemia Megaloblastic anaemia develops slowly — liver stores of B12 last 3–5 years, whereas folate reserves last only 3–4 months. B12 deficiency therefore creeps up unnoticed, and its symptoms are often attributed to overwork or normal ageing. General anaemia symptoms: - pronounced weakness and rapid fatigue; - breathlessness on exertion that was not present before; - pallor with a slight yellowish tinge — caused by simultaneous breakdown of oversized red cells; - palpitations. Neurological signs (B12 deficiency): - tingling and numbness in hands and feet — the "gloves and socks" distribution; - unsteady gait, difficulty walking in the dark (proprioception loss); - muscle spasticity, leg weakness; - cognitive impairment: memory decline, poor concentration, irritability; - depression, occasionally psychosis — particularly in elderly patients. Oral and gastrointestinal signs: - glossitis — a smooth, painful, bright red tongue (Hunter's glossitis); - burning tongue sensation; - poor appetite, nausea. The yellowish skin tint in megaloblastic anaemia reflects intramedullary destruction of megaloblasts and the shortened lifespan of macrocytes — this is so-called ineffective erythropoiesis with an element of haemolytic anaemia. The word "anaemia" here does not simply mean "too little blood" — it describes a complex pathological process with multiple simultaneous mechanisms. Megaloblastic Anaemia Blood Test Findings The laboratory picture is characteristic enough to point toward the diagnosis even before specific tests are ordered. Parameter Change Mechanism --------- Haemoglobin ↓ Insufficient red cell production MCV ↑ markedly Megalocytes and macrocytes instead of normal-sized cells Reticulocytes ↓ Ineffective erythropoiesis — few mature cells reach the bloodstream LDH ↑ markedly Intramedullary destruction of megaloblasts Bilirubin ↑ (unconjugated) Haemolysis of short-lived macrocytes White blood cells ↓ (severe cases) Impaired precursor division Platelets ↓ (severe cases) Same mechanism A characteristic microscopic finding is hypersegmented neutrophils (five or more nuclear lobes in ≥5% of neutrophils). This is an early and specific sign of megaloblastosis that can appear even before haemoglobin falls. A markedly elevated LDH alongside macrocytic anaemia is practically a diagnostic combination that points directly to megaloblastic anaemia rather than other causes of macrocytosis. Causes: Pernicious Anaemia, B12 Deficiency and Folate Deficiency Vitamin B12 deficiency arises through one of several pathways: - Pernicious anaemia (autoimmune gastritis type A) — the most common cause of B12 deficiency in adults. The immune system attacks the gastric cells that produce intrinsic factor — the protein without which B12 cannot be absorbed in the ileum. Pernicious anaemia is autoimmune and often co-exists with other autoimmune diseases. - Strict veganism — the only reliable B12 sources are animal products. Without supplements, deficiency typically develops after 3–5 years. - Gastric surgery (gastrectomy, bariatric procedures) — removing part of the stomach reduces intrinsic factor production. - Crohn's disease, celiac disease — inflammation or atrophy in the ileum impairs B12 absorption. - Long-term metformin use — blocks calcium-dependent intestinal B12 absorption; B12 levels should be checked annually after more than 3 years of use. Folate deficiency develops much faster (reserves last 3–4 months) and is more commonly caused by: - Poor diet — especially in elderly patients and people who consume excessive alcohol (alcohol blocks folate absorption); - Pregnancy — folate requirements increase sharply for rapid DNA synthesis in the developing foetus; - Malabsorption — celiac disease, inflammatory bowel disease; - Medications — methotrexate, trimethoprim, some anticonvulsants. Diagnosing Macrocytic Anaemia: Which Tests Are Ordered When macrocytic anaemia or characteristic neurological symptoms are present, the following workup is performed: - Vitamin B12 level — the primary test. Below 150 pmol/L is clear deficiency; 150–220 pmol/L is a grey zone where clinically significant deficiency is possible despite a borderline result. - Serum folate — below 7 nmol/L indicates deficiency. Serum folate reflects recent dietary intake (last few weeks); red cell folate is measured when a longer-term status marker is needed. - Complete blood count with morphology — essential: identifies MCV elevation, anaemia severity, and hypersegmented neutrophils. - Methylmalonic acid (MMA) — rises with B12 deficiency before the serum B12 level falls, making it an extremely sensitive early marker. Invaluable at borderline B12 values. - Intrinsic factor antibodies and anti-parietal cell antibodies — confirm pernicious anaemia as the cause. - Homocysteine — elevated in both B12 and folate deficiency (unlike MMA, which is specific to B12 alone). Treatment of Megaloblastic Anaemia Treatment depends on whether B12, folate, or both are deficient. For vitamin B12 deficiency: - Intramuscular cyanocobalamin injections — standard of care for pernicious anaemia and any malabsorption. Daily injections for 1–2 weeks, then monthly maintenance injections lifelong. - High-dose oral B12 (1000–2000 µg/day) — proven effective even in pernicious anaemia, because a small fraction of B12 is absorbed by passive diffusion without intrinsic factor. Suitable for patients without severe neurological involvement. The response to B12 treatment is rapid: within 3–5 days a reticulocyte surge occurs — a sign that the bone marrow has reactivated. Haemoglobin normalises over 6–8 weeks. Neurological symptoms recover much more slowly — months to a year; long-established changes may be permanent. For folate deficiency: - Oral folic acid 1–5 mg/day for 4 months or until the underlying cause is corrected. A critical warning: never start folic acid empirically in macrocytic anaemia before ruling out B12 deficiency. Folate will correct the anaemia but cannot halt the neurological damage from B12 deficiency — and the subjective sense of improvement will mislead both patient and doctor. This is a classic and dangerous trap. When pernicious anaemia is confirmed, long-term monitoring includes periodic gastroscopy due to an elevated risk of gastric cancer. For a detailed review of B12 sources and symptoms, see the article on vitamin B12 deficiency. When to Seek Urgent Care Seek medical attention promptly if any of the following appear alongside anaemia: - rapidly worsening leg weakness or difficulty walking; - spreading numbness and tingling in the limbs; - balance problems or unsteadiness in the dark; - confusion or disorientation — especially in elderly patients; - breathlessness at rest or palpitations with minimal activity. Megaloblastic anaemia responds well to treatment when caught early. Neurological complications from prolonged B12 deficiency can be irreversible — which is why delaying diagnosis carries real risk. Do not interpret blood test results on your own; consult a doctor. https://labreadai.com/en/posts/obesity https://labreadai.com/en/posts/obesity Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Obesity — BMI above 30. Causes, severity grades, complications including diabetes, hypertension and sleep apnoea, blood tests and treatment options. Articles article More than 650 million adults worldwide are living with obesity. Many more have excess weight that already activates the same pathological processes, just more slowly. Obesity has long ceased to be a problem of appearance — it is a chronic disease with clearly defined diagnostic criteria, serious complications and evidence-based treatments that work. The key is an accurate assessment and timely action. What Is Obesity: Definition and Diagnostic Criteria Obesity is a chronic metabolic disease characterised by excess fat accumulation that impairs health. The word "disease" is deliberate: it is not a failure of willpower or insufficient effort, but a pathological condition with well-understood biological mechanisms. Body mass index (BMI) is the primary screening tool, calculated as weight in kilograms divided by height in metres squared. Category BMI (kg/m²) ------ Normal 18.5–24.9 Overweight 25.0–29.9 Obesity grade I 30.0–34.9 Obesity grade II 35.0–39.9 Obesity grade III (morbid) ≥ 40.0 BMI is convenient but imperfect: it does not distinguish between muscle and fat mass. This is why waist circumference is measured alongside BMI: above 94 cm in men and 80 cm in women indicates elevated metabolic risk regardless of BMI. Visceral fat — the fat inside the abdomen around internal organs — is metabolically the most active and most dangerous type. Fat distribution matters: abdominal (android) obesity ("apple shape") carries higher cardiovascular risk than gynoid ("pear shape") obesity with fat deposited predominantly around the hips and thighs. Why Obesity Develops: Causes and Risk Factors Obesity results from a sustained positive energy balance — more calories consumed than expended. But behind this simple formula lies complex biology. Genetics accounts for 40–70% of individual susceptibility to obesity. More than 1000 genetic loci are associated with BMI. Genes influence hunger and satiety signalling, basal metabolic rate and fat distribution. Heredity is not destiny, but it determines how easily a person gains weight under the same lifestyle conditions. Lifestyle — the primary modifiable factor: excess ultra-processed, energy-dense foods; sedentary behaviour; curtailed sleep. Sleep restriction (below 6 hours) disrupts leptin and ghrelin — the satiety and hunger hormones — within one to two weeks, increasing appetite and cravings for calorie-dense foods. Hormonal causes are frequently overlooked. Hypothyroidism reduces basal metabolic rate and drives weight gain. Insulin resistance creates a vicious cycle: elevated insulin stimulates fat deposition, which intensifies insulin resistance. Cushing's syndrome, polycystic ovary syndrome and other endocrine conditions commonly present with weight gain. Medications that cause weight gain: antipsychotics, antidepressants (especially tricyclics), corticosteroids, some glucose-lowering agents (insulin, sulphonylureas), and beta-blockers. Gut microbiome — an actively studied factor: the composition of intestinal bacteria influences the efficiency of energy extraction from food and the degree of systemic inflammation. Psychoemotional factors: chronic stress, through cortisol activation, drives visceral fat accumulation. Binge eating disorder and emotional eating are distinct clinical conditions requiring psychological intervention. Symptoms of Obesity Obesity is one of the few diseases visible at a glance, but behind the obvious sign lie symptoms that reduce quality of life well before serious complications develop. Physical symptoms: - breathlessness on minimal exertion — adipose tissue compresses the diaphragm, reducing respiratory volumes; - joint pain in knees, hips and the lumbar spine — mechanical overloading; - excessive sweating, skin fold intertrigo; - varicose veins of the lower limbs; - disturbed sleep — from simple snoring to apnoea episodes. Metabolic symptoms (often asymptomatic until detected by blood tests): - elevated fasting glucose; - abnormal lipid profile; - elevated blood pressure. Psychological symptoms: low self-esteem, depression, social withdrawal, stigmatisation. The psychological burden of obesity is frequently underestimated, yet it substantially undermines treatment adherence. Acanthosis nigricans — darkening and thickening of skin in body folds (neck, armpits) — is a visible marker of significant insulin resistance. Blood Tests Ordered in Obesity Initial laboratory assessment in obesity serves two goals: detect existing metabolic disorders and exclude hormonal causes. Carbohydrate metabolism screening: - Fasting plasma glucose — baseline; ≥ 7.0 mmol/L indicates diabetes, 5.6–6.9 mmol/L prediabetes - Glycated haemoglobin HbA1c — reflects average glucose over 2–3 months; more reliable than a single fasting glucose for diabetes screening Lipid profile: total cholesterol, LDL, HDL, triglycerides — dyslipidaemia is present in 60–70% of people with obesity. Liver function tests: ALT, AST, GGT — to exclude and monitor hepatic steatosis; fatty liver disease is present in 75–90% of patients with obesity. Hormonal screening: TSH — to exclude hypothyroidism as a cause; fasting insulin and HOMA-IR — to detect insulin resistance. Uric acid — elevated in obesity due to enhanced urate synthesis; a baseline reference for gout risk assessment. A full blood count rounds out the picture: mild leukocytosis reflects the chronic low-grade inflammation of adipose tissue that accompanies obesity. Complications of Obesity It is the complications that make obesity a life-threatening condition rather than a cosmetic concern. Type 2 diabetes mellitus — the most tightly linked complication. 80–90% of patients with type 2 diabetes have excess weight or obesity. A 5–7% weight loss in prediabetes reduces progression to diabetes by 58%. Cardiovascular disease. Obesity is an independent risk factor for arterial hypertension, present in 60–70% of people with obesity. Atherosclerosis is simultaneously accelerated by dyslipidaemia and chronic inflammation. Fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) is a direct consequence of visceral obesity. Without weight correction it progresses from steatosis to steatohepatitis and cirrhosis. Sleep apnoea. Sleep apnoea affects 40–70% of people with obesity: excess adipose tissue in the neck narrows the upper airway. Apnoea in turn worsens insulin resistance and makes weight loss harder — a vicious cycle. Cancer. Obesity is associated with elevated risk of breast, colorectal, endometrial, renal and several other cancers. The WHO estimates obesity causes 13% of all cancer cases globally. Musculoskeletal damage. Osteoarthritis of the knee and hip joints is a direct consequence of mechanical overloading. Each additional 10 kg of body weight adds approximately 40 kg of force to the knee joint during walking. Metabolic syndrome — obesity is its central component, clustering all the above disorders into a single high cardiovascular-risk phenotype. Treatment of Obesity: Current Approaches Obesity treatment is a long-term process requiring a comprehensive approach. There is no single "correct" diet or exercise — there are principles that work. Lifestyle modification — the foundation: - A caloric deficit of 500–750 kcal/day leads to 0.5–0.75 kg/week weight loss — a realistic and safe pace - Prioritising whole foods rich in protein and fibre; limiting refined carbohydrates and ultra-processed products - Aerobic exercise 150–300 minutes of moderate intensity per week combined with resistance training twice weekly - Sleep normalisation (7–9 hours) — a non-negotiable requirement; without it any dietary intervention is substantially less effective Pharmacological treatment is indicated at BMI ≥ 30, or at BMI ≥ 27 with complications, when lifestyle changes are insufficient: - GLP-1 receptor agonists (semaglutide, liraglutide) — the most effective agents currently available; weight reduction of 10–15% with semaglutide, up to 20% with tirzepatide; acting through appetite suppression and delayed gastric emptying - Orlistat — blocks intestinal fat absorption; modest additional efficacy (3–5% beyond diet), but a good safety profile Bariatric surgery is indicated at BMI ≥ 40, or BMI ≥ 35 with serious complications. Procedures (sleeve gastrectomy, gastric bypass) achieve 25–35% weight loss and frequently produce remission of type 2 diabetes. When to See a Doctor With obesity, there is no "right moment" to wait for, and self-treatment through the latest internet diet is not advisable. See a doctor (endocrinologist, GP) when BMI is ≥ 30, or at BMI ≥ 27 with co-existing conditions such as hypertension, diabetes or sleep apnoea. A physician will investigate for hormonal causes and design an individualised treatment plan. Weight is just one biomarker of health. A 5–10% weight loss already meaningfully improves metabolic markers, reduces blood pressure and relieves joint load — even when the goal of a "normal" BMI remains distant. Do not interpret symptoms independently — consult a doctor for a comprehensive assessment. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/ovarian-cancer https://labreadai.com/en/posts/ovarian-cancer Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ovarian cancer — a 'silent' malignancy with high mortality due to late diagnosis. Symptoms, CA-125 marker, ultrasound, BRCA genetics and treatment options. Articles article Seven in ten women with ovarian cancer learn their diagnosis at stage III or IV — when the tumour has long since spread beyond the ovary. Not because the disease is undetectable, but because its symptoms are too ordinary: abdominal bloating, pelvic heaviness, early satiety at meals. It is precisely this camouflage behind everyday discomfort that has earned ovarian cancer the name "the silent killer". What Ovarian Cancer Is and Its Types Ovarian cancer is a malignant tumour arising from the cells of the ovaries, fallopian tubes or peritoneum. It ranks fourth among cancer deaths in women despite relatively modest incidence — the reason is overwhelmingly late diagnosis. Epithelial cancer accounts for 90% of all cases and includes several histological subtypes with distinct biological behaviour: - High-grade serous carcinoma — the most frequent and aggressive subtype, closely linked to BRCA1/2 mutations; often originates from the fimbrial end of the fallopian tube rather than the ovary itself - Clear cell and endometrioid carcinoma — strongly associated with endometriosis: ectopic endometrial lesions within the ovary undergo malignant transformation in 1–3% of cases - Mucinous carcinoma — a rare subtype (3–4%); characteristically elevates CEA alongside CA-125, requiring differential diagnosis from metastatic gastrointestinal cancer Germ cell tumours (5–7%) arise from the egg-producing cells and occur predominantly in young women and adolescents. They are marked by hCG, AFP and LDH. They respond well to chemotherapy — prognosis with timely treatment is favourable even in advanced disease. Stromal tumours (5%) — granulosa and theca cell tumours; they produce oestrogens, manifesting as uterine bleeding in postmenopausal women or precocious puberty in girls. FIGO staging determines the extent of surgery and prognosis: Stage Description 5-year survival --------- I Tumour confined to ovaries or fallopian tubes 90–92% II Extension to pelvic organs 70–80% III Peritoneal involvement and/or regional lymph nodes 20–40% IV Distant metastases (pleura, liver parenchyma) 5–20% Causes and Risk Factors The exact cause of malignant transformation is unknown, but risk factors are well established. Understanding them matters: some are modifiable, and others allow risk stratification to guide surveillance decisions. BRCA1 and BRCA2 mutations — the most significant hereditary risk factors. Women with a BRCA1 mutation face a lifetime ovarian cancer risk of 39–46%; with BRCA2 the risk is 10–27%. The population risk, by comparison, is approximately 1–2%. The same mutations dramatically elevate the risk of breast cancer, which is why genetic counselling is essential when family history involves both tumour types. Lynch syndrome (MMR gene mutations) raises ovarian cancer risk to 8–12%, in addition to its well-known association with colorectal cancer. Endometriosis triples the risk; the greatest risk is associated with ovarian endometriomas. Chronic inflammation and oxidative stress in ectopic lesions promote the accumulation of oncogenic mutations. Obesity — a moderate but established factor: BMI above 30 increases risk by 25–30%, particularly for the endometrioid subtype. Reproductive history. Each pregnancy and period of lactation reduces risk — through fewer lifetime ovulations and the protective action of progesterone. Women who have never been pregnant have 30–60% higher risk. Oral contraceptive use reduces ovarian cancer risk by 30–50% depending on duration of use, with the protective effect persisting for up to 30 years after discontinuation. Age: 50% of cases are diagnosed in women over 63. Below age 40, ovarian cancer is uncommon and more often a germ cell tumour. Protective factors: pregnancy, lactation, combined oral contraceptives, tubal ligation and salpingectomy (removal of the fallopian tubes during elective pelvic surgery reduces serous ovarian cancer risk by 40–60%). Symptoms: Why Ovarian Cancer Is Silent The absence of specific early symptoms is the primary driver of high mortality. A tumour growing in the peritoneal cavity causes no urinary, bowel or sexual dysfunction for a prolonged period. The first complaints appear when the tumour reaches a considerable size or ascites — fluid accumulation in the abdomen — develops. Symptoms that should prompt evaluation: - Abdominal bloating or visible increase in abdominal girth unrelated to food — particularly when progressive over several weeks - Persistent sensation of pressure or heaviness in the lower abdomen or pelvis - Early satiety at meals, reduced appetite - Increased urinary frequency or a feeling of bladder pressure without an infectious cause - Unexplained fatigue and weakness - Change in bowel habit without an obvious cause - Lower back pain The treachery of these symptoms lies in their non-specificity: each is readily explained by irritable bowel syndrome, dietary changes or stress. Most women with early ovarian cancer symptoms delay seeking medical attention by five to six months, assuming the cause is trivial. Urgent warning signs requiring immediate evaluation: - Sudden severe abdominal pain (possible ovarian torsion or cyst rupture) - Rapidly progressive abdominal distension over days (rapidly accumulating ascites) - Several of the above symptoms occurring together and persisting for more than 3 weeks Diagnosis: Ultrasound, Laboratory Tests and Surgery Diagnosis relies on the combination of clinical assessment, imaging and laboratory markers. A definitive diagnosis is established only histologically — through biopsy or surgery. Transvaginal ultrasound is the first-line investigation for any suspected ovarian pathology. Assessment includes size, morphology (cystic, solid, mixed), septal thickness, papillary projections and Doppler vascularity. Features that raise malignancy concern: solid component, thick irregular septa, bilateral disease, ascites. CT of the abdomen and pelvis with contrast — for staging: assessment of peritoneal disease, lymph nodes and liver metastases. MRI provides additional characterisation in complex cases. Diagnostic laparotomy is the only method for definitive histological diagnosis and accurate surgical staging. Percutaneous ultrasound-guided biopsy of ovarian masses is contraindicated — it risks peritoneal dissemination of tumour cells, which worsens prognosis. Laboratory tests: Complete blood count — detects anaemia in chronic disease. Thrombocytosis ( 400 × 10⁹/L) is a frequent accompaniment of ovarian cancer and an independent adverse prognostic factor: tumour-derived thrombopoietic cytokines drive platelet overproduction. Tumour marker panel — CA-125 is mandatory when ovarian cancer is suspected; for germ cell tumours, hCG and AFP are added; HE4 is measured alongside CA-125 for ROMA index calculation. CA-125 Tumour Marker: Capabilities and Limitations CA-125 (carbohydrate antigen 125) is a glycoprotein produced by serous epithelial cells. The normal upper limit in non-pregnant women is 35 U/mL. What CA-125 provides: - Elevated in only 50% of stage I patients — the central argument against its use as a general population screening test - Elevated in 85–90% of patients at stages III–IV - After cytoreductive surgery and chemotherapy — the principal instrument for monitoring treatment response and detecting recurrence - A rising CA-125 after remission precedes clinical recurrence by an average of 3–4 months Limitations of CA-125: The marker lacks specificity. It rises in endometriosis, pelvic inflammatory disease, pregnancy, liver cirrhosis, pericarditis, pleural effusion and several other malignancies including endometrial, pancreatic and breast cancers. One to two percent of healthy premenopausal women have mildly elevated CA-125 physiologically, and levels rise transiently during menstruation. ROMA index (Risk of Ovarian Malignancy Algorithm) — a combination of CA-125 + HE4 adjusted for menopausal status. It achieves substantially higher specificity than CA-125 alone, correctly classifying benign from malignant ovarian masses with up to 90% accuracy in postmenopausal women. IOTA algorithm — an evidence-based ultrasound classification system for ovarian masses; used alongside CA-125 in specialised centres to determine the likelihood of malignancy before surgery. Treatment of Ovarian Cancer The cornerstone of treatment is surgery combined with chemotherapy. The extent of the operation and the systemic therapy regimen are determined by stage, histological subtype and molecular characteristics. Surgery. For early stages (I–II): total hysterectomy with bilateral salpingo-oophorectomy, omentectomy and peritoneal biopsy. For stages III–IV: cytoreductive surgery aiming to remove all visible tumour. Achieving R0 resection (no macroscopic residual disease) is the single most important surgical prognostic factor: in optimally debulked stage III disease, 5-year survival is two to three times higher than in suboptimally debulked patients. In young women who wish to preserve fertility, a conservative approach removing only the affected ovary is acceptable for stage IA G1 disease. Chemotherapy. The standard regimen is carboplatin + paclitaxel for 6 cycles. Intraperitoneal chemotherapy in stage III patients with optimal debulking significantly improves survival but is less well tolerated. PARP inhibitors (olaparib, niraparib) — maintenance therapy after platinum-based chemotherapy. They block DNA repair in tumour cells carrying a homologous recombination defect (BRCA mutations, HRD). Olaparib reduces progression risk by 70% in BRCA-mutant patients; the median progression-free survival at stage III increases from 14 to 56 months with maintenance olaparib. Bevacizumab (anti-VEGF) is added to chemotherapy at stages III–IV and used as maintenance; it significantly extends time to progression in high-risk subtypes. At recurrence, treatment strategy is guided by platinum sensitivity: platinum-sensitive relapse (occurring more than 6 months after first-line therapy) responds well to repeated platinum-based regimens; platinum-resistant relapse requires alternative approaches. When to See a Doctor and Screening Screening for ovarian cancer is not recommended in the general population: the landmark UKCTOCS trial (200,000 women) demonstrated that neither CA-125 nor transvaginal ultrasound as screening tools reduce mortality. For women at high risk (BRCA1/2 mutations, Lynch syndrome), a surveillance protocol is in place: transvaginal ultrasound plus CA-125 every 6 months from age 25–35. These women are also offered risk-reducing salpingo-oophorectomy after completing childbearing — it reduces ovarian cancer risk by 80% and breast cancer risk by 50% in BRCA1 carriers. See a gynaecologist promptly when one or more of the following apply: - progressive abdominal bloating unrelated to diet, persisting more than 3 weeks; - constant pressure sensation in the lower abdomen or pelvis; - early satiety and poor appetite occurring alongside other symptoms; - a palpable mass in the lower abdomen; - an incidental ovarian mass found on ultrasound performed for any other reason. If you or close female relatives have had ovarian, breast, colorectal or endometrial cancer — discuss BRCA1/2 and MMR genetic testing with your doctor or a clinical geneticist. Early identification of carrier status transforms the surveillance strategy and makes genuine prevention possible. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/pancreatic-cancer https://labreadai.com/en/posts/pancreatic-cancer Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Pancreatic cancer — an aggressive malignancy almost always diagnosed late. Symptoms, CA 19-9 tumour marker, obstructive jaundice, treatment stages and risk factors. Articles article The skin turns yellow. A dull ache in the upper abdomen begins radiating into the back. Weight is dropping for no apparent reason and appetite has been absent for weeks. This is how it typically begins — not dramatically, but gradually and without obvious cause. Pancreatic cancer is found at a surgically resectable stage in only 15–20% of patients: the organ sits deep in the retroperitoneum, and by the time symptoms emerge the tumour has usually already spread beyond it. What Pancreatic Cancer Is and Its Types Pancreatic cancer is a malignant tumour arising from cells of the pancreas. In 90–95% of cases it is pancreatic ductal adenocarcinoma (PDAC), a tumour of the duct-lining epithelium. It is one of the most aggressive malignancies known: five-year overall survival across all stages is approximately 11–12%. The anatomical location of the tumour determines the clinical picture. Cancer of the pancreatic head (60–70% of cases) compresses the common bile duct early, producing the characteristic painless obstructive jaundice. Cancer of the body and tail (30–40%) grows silently for much longer: the bile duct is not involved, there is no jaundice, and symptoms appear only when the tumour invades adjacent organs or encases major vessels. Rare forms include pancreatic neuroendocrine tumours (pNETs, 5%) — significantly less aggressive, often hormonally active (insulinoma, gastrinoma, glucagonoma). Their markers and treatment are fundamentally different from PDAC. TNM/AJCC staging: Stage Description 5-year survival --------- I Tumour confined to the pancreas 20–25% II Local spread without major vessel involvement 8–12% III Involvement of the coeliac axis or superior mesenteric artery 3–5% IV Distant metastases (liver, peritoneum, lungs) 1–3% Approximately 80–85% of patients present at stage III or IV. This is the principal cause of the dismal prognosis: not the biology of the tumour alone, but chronically lost time. Causes and Risk Factors Smoking — the most significant modifiable factor, accounting for 20–30% of all cases. Risk in smokers is approximately double that of non-smokers; it approaches population risk within 10 years of cessation. Chronic pancreatitis — one of the strongest risk factors: risk is 10–20 times higher than in the general population. The mechanism is chronic inflammation with cellular damage and accumulation of oncogenic mutations. Risk is particularly high in hereditary pancreatitis (PRSS1 gene mutations). Type 2 diabetes approximately doubles the risk. There is an important bidirectional signal: newly diagnosed diabetes in a person over 50 who is not overweight and has no family history of diabetes may be paraneoplastic — the tumour destroys the insulin-producing islet cells. New-onset diabetes in an "atypical" patient is a reason to exclude pancreatic cancer. Obesity raises risk by 20–40%, particularly in combination with a sedentary lifestyle. Visceral fat drives chronic inflammation and hyperinsulinaemia. Age: 90% of cases are diagnosed after age 55; peak incidence is at 65–75 years. Alcohol: heavy use increases risk through acute pancreatitis evolving into chronic disease. Hereditary factors account for 5–10% of cases: - BRCA2 and PALB2 mutations — 3–6 times higher risk; especially important when family history includes breast and ovarian cancer - ATM mutations — 4–5 times higher risk - Lynch syndrome (MMR genes) — 8–9 times higher risk - Peutz–Jeghers syndrome (STK11) — risk approximately 130 times higher - FAMMM syndrome (CDKN2A) — principally associated with melanoma but carries 10–20 times elevated pancreatic cancer risk Symptoms: Why Pancreatic Cancer Is Diagnosed So Late The pancreas is a "silent" organ: it has no pain receptors on its surface, lies behind the stomach and intestinal loops, and is separated from the body surface by several centimetres of tissue. A small tumour there can grow for years without producing any symptoms. Symptoms of head of pancreas cancer: - Jaundice — yellowing of the skin and sclerae, dark urine, pale stools. This is not inflammatory jaundice but painless mechanical obstruction: bile cannot drain into the intestine because the bile duct is compressed by the tumour. The painless character of this jaundice distinguishes it from gallstone-related obstruction, where pain almost invariably accompanies or precedes the yellowing - Pruritus — caused by accumulation of bile salts in the skin during cholestasis - Pain in the right upper quadrant or epigastrium Symptoms of body and tail cancer: - Dull aching pain in the upper abdomen radiating to the back and lower spine. A characteristic feature: pain worsens when lying supine and eases when leaning forward — the tumour is pressing on the coeliac plexus - New or dramatically worsened diabetes without an obvious cause General symptoms (any location): - Unexplained weight loss — often the first and most noticeable symptom: 5–10% of body weight over 3–6 months with no clear explanation - Marked loss of appetite, aversion to fatty food - Steatorrhoea — greasy, floating, foul-smelling stools from exocrine pancreatic insufficiency - Migratory superficial thrombophlebitis (Trousseau's syndrome) — recurrent painful vein inflammation at different sites without an obvious cause; a paraneoplastic syndrome particularly characteristic of pancreatic cancer - Depression and anxiety — documented to precede the diagnosis by several months through a mechanism that remains incompletely understood Incidental detection: in approximately 10–15% of patients the tumour is found incidentally during CT or ultrasound performed for another reason — the only realistic route to early-stage detection in the absence of a general screening programme. Diagnosis: CT, Endosonography and Laboratory Tests Diagnosis rests on the combination of imaging and laboratory data. Morphological confirmation is mandatory before any treatment is started. Multiphase pancreatic-protocol CT — the investigation of choice for initial staging. Triphasic contrast enhancement visualises the tumour, assesses its relationship to the superior mesenteric artery, coeliac axis and portal vein (the key determinant of resectability), and detects hepatic metastases and enlarged lymph nodes. Endoscopic ultrasound (EUS) — the most sensitive method for small tumours (< 2 cm). The probe is positioned immediately adjacent to the pancreas in the stomach or duodenum, eliminating the distance problem. EUS also permits simultaneous fine-needle aspiration biopsy for histological confirmation. ERCP (endoscopic retrograde cholangiopancreatography) — for obstructive jaundice: permits biliary stenting and cytological sampling. MRI with MRCP — for detailed assessment of biliary and pancreatic duct anatomy and characterisation of cystic lesions. Laboratory tests: Complete blood count — normochromic normocytic anaemia in chronic disease; thrombocytosis as a paraneoplastic phenomenon driven by tumour-derived thrombopoietic cytokines. Tumour marker panel — CA 19-9 and CEA; interpreted only after imaging has established the diagnosis. Liver biochemistry — bilirubin (total and direct), alkaline phosphatase, GGT, ALT, AST: a cholestatic pattern confirms bile duct obstruction. LDH rises with extensive hepatic metastatic involvement. Pancreatic panel — amylase and lipase: in pancreatic cancer these are often normal or only mildly elevated; significant elevation points more to obstructive pancreatitis than to the tumour itself. Glucose and HbA1c — when new-onset diabetes may be paraneoplastic. Tumour Markers: CA 19-9 and Its Role CA 19-9 (carbohydrate antigen 19-9) — the primary tumour marker for pancreatic cancer. Normal range < 37 U/mL. Sensitivity for PDAC: 70–80%; specificity: 80–90%. It is the best available marker, but its limitations are clinically important. A biological limitation: 5–10% of people are genetically unable to produce CA 19-9 — they are Lewis-antigen-negative. In these individuals the marker remains at or near zero even in advanced disease. This is not reassuring — it simply reflects a biological characteristic that must be accounted for in interpretation. False-positive elevation of CA 19-9 occurs with any cause of obstructive jaundice (bile acids stimulate its synthesis), chronic pancreatitis, liver cirrhosis, gastric cancer and colorectal cancer. A high CA 19-9 in a jaundiced patient does not confirm pancreatic cancer — jaundice itself raises it. Reassessing after biliary drainage and bilirubin normalisation is a mandatory step before clinical conclusions are drawn. Clinical applications of CA 19-9: - Post-operative monitoring: normalisation within 3–4 weeks is a favourable sign; persistent elevation suggests incomplete resection or occult metastases - Chemotherapy response: a fall of 50–75% after 2–3 cycles indicates response; a rise during treatment signals progression - Early relapse detection: rising CA 19-9 after remission often precedes CT evidence of recurrence by 4–6 weeks - CA 19-9 is not used for primary diagnosis: no tumour marker replaces biopsy Treatment of Pancreatic Cancer Treatment strategy is determined by resectability — the central concept in pancreatic surgery, assessed by the tumour's relationship to the superior mesenteric artery, coeliac axis and portal vein. Surgery — the only potentially curative option; applicable to 15–20% of patients at presentation. The Whipple procedure (pancreaticoduodenectomy) is performed for cancer of the head: it removes the pancreatic head, duodenum, gallbladder, common bile duct, part of the stomach and regional lymph nodes. This is one of the most technically demanding operations in abdominal surgery; in specialist centres, operative mortality is below 3%. Distal pancreatectomy — for body and tail cancers: the left half of the pancreas is removed together with the spleen. After surgery — adjuvant chemotherapy for 6 months: the mFOLFIRINOX regimen (oxaliplatin + irinotecan + 5-FU) reduces recurrence risk by 35–40% compared with gemcitabine monotherapy. Borderline resectable disease: the tumour abuts but does not circumferentially encase major vessels. Strategy: upfront chemotherapy, then CT reassessment. Approximately 30–40% of such patients achieve resectability. Locally advanced (unresectable) cancer (stage III): FOLFIRINOX ± radiotherapy. Median survival 12–15 months; secondary resection is achievable in a subset of responders. Metastatic cancer (stage IV): - Good performance status (ECOG 0–1): mFOLFIRINOX — median overall survival 11–12 months - Frail patients: gemcitabine + nab-paclitaxel — median 8–9 months - BRCA1/2 or PALB2 mutations: platinum-based regimens followed by maintenance olaparib; key trials showed this approximately doubles progression-free survival - MSI-H tumours (1% of PDAC): pembrolizumab Palliative interventions: - Biliary stenting — relieves obstructive jaundice in inoperable head cancers - Coeliac plexus block — highly effective pain management when the tumour invades the retroperitoneal space - Pancreatic enzyme replacement therapy (PERT) — corrects exocrine insufficiency, improves nutritional status and quality of life When to See a Doctor and Prevention Consult a doctor (gastroenterologist or surgeon) promptly when one or more of the following apply: - painless yellowing of the skin or whites of the eyes; - dull back pain in the upper spine not related to movement or posture; - unexplained weight loss of 5% or more over 2–3 months; - newly diagnosed or dramatically worsening diabetes in someone over 50 without obesity or family history; - recurrent episodes of superficial vein inflammation at different body sites; - persistent loss of appetite lasting more than 3 weeks. Screening in the general population is not currently recommended. For high-risk groups (Lynch syndrome, BRCA2 mutation, FAMMM, Peutz–Jeghers syndrome, hereditary chronic pancreatitis), surveillance protocols exist: annual EUS plus MRI/MRCP beginning at age 40 or 10 years before the youngest affected family member's diagnosis. Prevention: smoking cessation is the single evidence-based strategy that measurably reduces population risk. Weight management, alcohol limitation and timely treatment of chronic pancreatitis offer additional risk reduction. Pancreatic cancer remains one of the most challenging diagnoses in oncology. But when identified at a resectable stage, long-term survival is genuinely achievable. The only path to that outcome is not dismissing symptoms and seeking evaluation without delay. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/primary-aldosteronism https://labreadai.com/en/posts/primary-aldosteronism Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Primary hyperaldosteronism (Conn's syndrome) — a common cause of resistant hypertension. Symptoms, aldosterone and renin testing, adrenal adenoma treatment. Articles article Blood pressure stays elevated despite three different medications at full doses. Potassium keeps falling with no obvious explanation. Muscle weakness, nocturnal cramps and persistent thirst have become the background of daily life. Behind this picture, in 5–20% of cases, lies primary hyperaldosteronism — one of the most common yet most underdiagnosed causes of secondary hypertension. What Is Primary Hyperaldosteronism Primary hyperaldosteronism (Conn's syndrome) is an endocrine condition in which one or both adrenal glands produce excessive aldosterone autonomously — independently of normal physiological regulatory signals. Under normal conditions, aldosterone production is governed by the renin-angiotensin-aldosterone system: pressure falls → renin rises → aldosterone rises → pressure is restored. In primary hyperaldosteronism this chain is broken: the adrenal gland secretes aldosterone regardless of renin, and blood pressure stays persistently elevated. Excess aldosterone acts as a dam on two channels simultaneously: it retains sodium — and water — in the body while driving potassium out through the urine. The result is an expanding blood volume that presses against vessel walls, while falling potassium triggers a cascade of muscular and cardiac disturbances. Historically, Conn's syndrome was described as a rare condition with a classic triad: hypertension — hypokalaemia — adrenal adenoma. Modern screening programmes have overturned this picture: hypokalaemia is present in only 40–50% of patients, and the syndrome is now identified in 5–10% of all hypertensive patients and in one in five with resistant hypertension. Causes: Adrenal Adenoma or Hyperplasia Two main morphological variants exist, and distinguishing between them is fundamental to treatment planning. Aldosterone-producing adenoma (aldosteronoma) — a benign tumour of one adrenal gland, typically small (0.5–2 cm), responsible for 60–65% of cases. Most common in women aged 30–50. The adenoma functions entirely autonomously: renin is suppressed, aldosterone is elevated, and sodium loading fails to suppress its secretion. This is the surgically curable form. Bilateral idiopathic adrenal hyperplasia — diffuse or nodular growth of aldosterone-producing cells in both adrenal glands. Accounts for 30–35% of cases. Unlike an adenoma, aldosterone secretion in this form retains partial dependence on the renin-angiotensin system. Removing one adrenal gland is largely ineffective — medical therapy is the mainstay of treatment. Rare forms include unilateral adrenal hyperplasia (< 2%), familial hyperaldosteronism types I–IV (< 1%), and adrenocortical carcinoma (< 1%). Malignant aldosteronomas are typically larger ( 4–5 cm) and show features of invasion or metastasis. Symptoms of Primary Hyperaldosteronism The clinical picture of Conn's syndrome consists of two components: the consequences of chronically elevated blood pressure and the consequences of hypokalaemia. Patients often spend years being treated for "ordinary" hypertension without the underlying cause ever being suspected. Hypertension is present in 95–100% of patients. Features that distinguish it from essential hypertension: - resistance to standard therapy — three medications at full doses without effect; - diastolic pressure frequently exceeds 110 mmHg; - absence of the normal nocturnal blood pressure dip on ambulatory monitoring ("non-dipper" pattern). Hypokalaemia is present in 40–50% of patients. It manifests as muscle weakness (especially in the legs), rapid fatigue, nocturnal cramps, polyuria (frequent urination, particularly at night) and polydipsia (persistent thirst). Severe hypokalaemia can cause life-threatening cardiac arrhythmias. Other features: headaches, impaired concentration, heightened anxiety. Oedema is uncommon: despite sodium retention, the aldosterone "escape" phenomenon partially compensates for fluid accumulation in chronic disease. Approximately 25% of patients with Conn's syndrome have no symptoms at all — hypertension is found incidentally and potassium is normal. This is particularly characteristic of bilateral hyperplasia, where the clinical presentation is milder. Diagnosis: Renin, Aldosterone and Confirmatory Tests The diagnostic algorithm comprises three sequential stages: screening → confirmation → localisation (identifying the source). Stage 1 — Screening: renin-to-aldosterone ratio (RAR) Simultaneous sampling of aldosterone and renin is the first-line test whenever primary hyperaldosteronism is suspected. RAR above 30 combined with aldosterone above 150 pg/mL constitutes a positive screening result. Interpreting the RAR without knowing the absolute aldosterone value is invalid: low renin with normal aldosterone is not hyperaldosteronism. Stage 2 — Confirmatory tests A positive screen requires confirmation by one of four methods: - IV saline infusion test: 2 litres of normal saline over 4 hours — in primary hyperaldosteronism aldosterone remains 10 ng/dL; autonomous secretion is not suppressed; - Fludrocortisone suppression test: 4 days of the drug with salt loading — aldosterone 6 ng/dL on day 4 confirms the diagnosis; - Captopril challenge test: blockade of angiotensin I → II conversion; aldosterone fails to fall in Conn's syndrome; - Oral salt loading: 3 days of high-sodium diet — urinary aldosterone excretion 12–14 µg/24 h confirms autonomous secretion. Stage 3 — Localisation CT of the adrenal glands is performed only after biochemical confirmation of the diagnosis. Crucially, CT findings alone do not determine management: a small adenoma may be missed, and a nodule on CT may prove to be a non-functioning incidentaloma. The gold standard for patients planning surgery is adrenal vein sampling (AVS) — bilateral selective catheterisation with separate aldosterone measurement from each side. AVS reliably distinguishes unilateral from bilateral secretion and thereby determines whether surgery or medical therapy is appropriate. Blood Tests Ordered in Conn's Syndrome The standard diagnostic workup when primary hyperaldosteronism is suspected covers several test groups. Mandatory minimum: - Aldosterone + renin simultaneously — for RAR calculation - Electrolyte panel — potassium, sodium, chloride: hypokalaemia and sodium excess corroborate the clinical picture - Kidney function tests — creatinine, eGFR: chronic hypokalaemia is nephrotoxic and long-standing hypertension in Conn's syndrome accelerates eGFR decline Additional when an adrenal tumour is found: - Cortisol — to exclude concomitant cortisol overproduction (Cushing's syndrome or subclinical hypercortisolism) - Plasma or urinary metanephrines — phaeochromocytoma must be excluded before any invasive procedures - ECG — assessment for hypokalaemia signs: T-wave flattening, U waves, prolonged QT interval Treatment: Surgery or Aldosterone Antagonists The choice of treatment depends entirely on the form of the disease established at localisation. Surgery is indicated for unilateral aldosteronoma or unilateral hyperplasia. Laparoscopic adrenalectomy is the procedure of choice. Outcomes: - hypokalaemia resolves in 98–100% of patients; - arterial hypertension is completely cured in 30–60% of operated patients; - in the remainder, blood pressure decreases and requires fewer medications. Predictors of complete blood pressure normalisation after surgery: short duration of hypertension, younger age, no target organ damage, no family history of hypertension. Medical treatment is indicated for bilateral adrenal hyperplasia, contraindications to surgery, or patient refusal of the operation. Mineralocorticoid receptor antagonists form the cornerstone of pharmacotherapy: - Spironolactone — the most studied and effective agent: blocks aldosterone receptors, normalises blood pressure and potassium. The main drawback is anti-androgenic side effects (gynaecomastia in men, menstrual irregularities in women) with long-term use; - Eplerenone — a selective antagonist without androgenic side effects, somewhat less potent in lowering blood pressure. Target potassium during medical treatment: 4.0–4.5 mmol/L. Thiazide and loop diuretics should not be used as the basis of antihypertensive therapy in Conn's syndrome — they worsen hypokalaemia. When to See a Doctor Primary hyperaldosteronism raises the risk of cardiovascular events independently of blood pressure level. In patients with untreated Conn's syndrome, the risk of myocardial infarction, stroke, atrial fibrillation and kidney stones (via chronic hypokalaemia and hypercalciuria) is significantly higher than in patients with essential hypertension at the same blood pressure. Consult an endocrinologist when any of the following apply: - blood pressure uncontrolled on three medications at full doses; - potassium below 3.5 mmol/L without diuretic use; - incidentally discovered adrenal mass on CT or MRI; - hypertension diagnosed before age 40; - family history of Conn's syndrome or stroke at a young age. Early diagnosis in Conn's syndrome is not merely about lowering blood pressure. When an adrenal adenoma is the cause, timely surgery offers the chance of complete cure. The shorter the interval between hypertension onset and surgery, the greater the likelihood of full blood pressure normalisation. Do not postpone the evaluation. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/scurvy https://labreadai.com/en/posts/scurvy Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Scurvy is severe vitamin C deficiency causing bleeding gums and joint pain. Symptoms by stage, modern risk groups in adults, blood test confirmation and treatment. Articles article Bleeding gums, bruises from the lightest touch and fatigue that does not lift for weeks — in the twenty-first century this does not look like the disease described in sixteenth-century maritime logs. Yet scurvy has not disappeared: it is identified in care homes, in people with eating disorders, in patients on highly restrictive diets and in anyone who goes months without fresh fruit or vegetables. What Scurvy Is and How Vitamin C Deficiency Causes It Scurvy is the clinical manifestation of severe vitamin C (ascorbic acid) depletion. It develops when ascorbic acid reserves are so exhausted that collagen synthesis is impaired — collagen being the structural protein that maintains the integrity of blood vessels, skin, gums and bone. The mechanism is straightforward: vitamin C is an indispensable cofactor for prolyl and lysyl hydroxylase enzymes, which hydroxylate proline and lysine residues during collagen assembly. Without hydroxylation, the collagen triple helix cannot stabilise — defective molecules form instead of strong fibres. Collagen-dependent structures throughout the body begin to break down faster than they can be rebuilt. The human body cannot synthesise vitamin C: the GULO gene encoding the final enzyme of ascorbate synthesis from glucose is non-functional. Food is therefore the only source. When dietary supply stops entirely, clinical symptoms appear within 4–6 weeks; a full clinical picture develops within 1–3 months. Historically, scurvy devastated armies and naval expeditions. James Lind's 1747 observation that citrus fruit prevents the disease was one of the first controlled clinical trials in the history of medicine. Today scurvy persists — its portrait has simply changed. Causes of Scurvy in Adults and Risk Groups In the modern world, scurvy is a disease of specific social and medical vulnerabilities. Recognising risk groups enables diagnosis where it is least expected. Older adults — the most important risk group in high-income countries. Narrowing dietary variety (subsistence on tinned food and convenience meals), reduced cooking activity, social isolation and impaired intestinal absorption gradually deplete vitamin C stores. Studies in residential care homes find suboptimal levels in 10–30% of residents. People with eating disorders: anorexia nervosa, avoidant/restrictive food intake disorder (ARFID), severe orthorexia. Strict self-imposed food restriction in these conditions frequently excludes fresh fruit and vegetables. Alcohol use disorder: ethanol impairs vitamin C intestinal absorption, accelerates metabolic degradation and displaces adequate nutrition. Chronic alcoholism is one of the leading causes of scurvy in middle-aged men. Smoking: nicotine and tobacco smoke oxidants sharply accelerate ascorbic acid turnover — plasma vitamin C in smokers is on average 30–40% lower than in non-smokers at equivalent dietary intake. The recommended daily allowance for smokers is 35 mg/day higher, a requirement that is frequently unmet. Haemodialysis: ascorbic acid is water-soluble and is actively removed during each dialysis session — patients require regular supplementation. Highly restrictive elimination diets: elimination of all fresh plant foods (carnivore-only diets without supplementation), monotonous diets excluding fruit and vegetables for more than 4–6 weeks. Inflammatory bowel disease: impaired micronutrient absorption from inflamed mucosa — coeliac disease, Crohn's disease. Infants on inadequate feeds: historically important, now rare — prolonged exclusive feeding with boiled milk without fresh food introduction. Symptoms of Scurvy by Stage Scurvy develops in stages. Understanding this progression allows the diagnosis to be suspected long before the classic clinical picture is established. Early stage (4–8 weeks of deficiency, plasma vitamin C < 11 µmol/L): - Non-specific fatigue and irritability — the first symptoms, typically attributed to overwork or stress by the patient themselves - Reduced appetite - Joint and muscle pain — particularly in the lower limbs, worsening with physical activity - Early hyperkeratosis — hair follicles become more prominent; skin coarsens Established stage (8–12 weeks, plasma vitamin C < 6 µmol/L): - Perifollicular haemorrhages — pin-point bleeds around hair roots, most prominent on the shins, thighs and buttocks. One of the most specific early signs: ascorbic acid is required to maintain capillary wall integrity - Corkscrew hairs — a keratinisation defect causes new hairs to grow coiled, breaking at the base - Gum bleeding and hyperplasia — swollen, spongy, easily bleeding gums. The interdental papillae are classically affected first. Teeth begin to loosen - Large skin bruises — at points of minor trauma and spontaneously: defective collagen fails to support vessel walls - Delayed wound healing and breakdown of previously healed scars - Progressive weakness — the patient struggles to rise from bed Severe stage ( 3 months without vitamin C): - Tooth loss — progressive destruction of the periodontal ligament - Widespread haemorrhage — haemarthroses, intramuscular haematomas, haematuria, gastrointestinal bleeding - Generalised oedema — from increased vascular permeability - Seizures, loss of consciousness — from massive blood loss - Death — from cardiac failure caused by pericardial haemorrhage or direct cardiac vascular involvement. This is the stage that killed sailors on long voyages A diagnostic pitfall: in older or edentulous patients, the classic gum changes may be absent — substantially complicating recognition of the disease. Diagnosis: Blood Tests and Clinical Features Scurvy is diagnosed on clinical and laboratory grounds. A typical presentation combined with a characteristic dietary history (fruit- and vegetable-poor diet, membership of a risk group) supports diagnosis and treatment initiation even before blood results return. Plasma vitamin C — the primary laboratory test. A level below 11 µmol/L confirms deficiency; below 6 µmol/L places the patient in the scurvy risk zone. Preanalytical handling is critical: ascorbic acid is light-sensitive and the tube must be shielded from ultraviolet exposure immediately after collection. Complete blood count — normochromic or hypochromic anaemia: scurvy impairs both iron absorption (vitamin C is required for Fe³⁺ → Fe²⁺ reduction) and causes ongoing blood loss that depletes stores. Blood biochemistry — elevated LDH with extensive muscle haemorrhage and tissue breakdown. Plasma calcium and phosphorus remain normal in isolated scurvy — distinguishing it from rickets, with which it can occasionally be confused in children. Radiography in children with scurvy shows characteristic changes: the Trümmerfeld zone (dense metaphyseal line), Pelkan's spurs and periosteal haematomas. Bony radiological changes are not typical in adults. Differential diagnosis: thrombocytopaenic purpura (platelets are normal in scurvy), vasculitis (CRP and ESR elevated; autoantibodies present), haemophilia (coagulation cascade is abnormal; coagulation screen is normal in scurvy), megaloblastic anaemia (when vitamin B12 or folate deficiency coexists). Treatment of Scurvy Treatment is simple, available and rapidly effective — when the diagnosis is made in time. Ascorbic acid replacement: - Standard adult regimen: 500–1000 mg ascorbic acid per day in 2–3 divided doses for 1–2 weeks, followed by a maintenance dose of 100–200 mg/day - Joint and muscle pain begins to improve within 24–48 hours of starting treatment - Gum bleeding is substantially reduced within 1–2 weeks - Full recovery takes 2–4 weeks; petechiae, bruises and skin changes resolve progressively - Teeth already lost do not regenerate — but those that remain and have loosened are re-secured Dietary correction alongside supplementation: - Immediate introduction of vitamin C-rich foods: red bell pepper (150–200 mg per 100 g), kiwi fruit (80–90 mg), citrus fruits, broccoli, strawberries - Fresh food is preferred over cooked: heat processing destroys 40–60% of ascorbic acid - Maintain adequate daily intake (≥ 75–90 mg) after completing the treatment course Correction of co-existing deficiencies: scurvy frequently coexists with deficiency of vitamin D, iron, vitamin B12 and folate — particularly in older patients. After restoring vitamin C, a comprehensive nutritional assessment is appropriate. Supportive care in severe cases: haemostatic support for significant active bleeding; joint protection and analgesia for haemarthroses until haematomas resolve; iron supplementation for severe anaemia. Prognosis with timely treatment is excellent: the overwhelming majority of symptoms are fully reversible. Exceptions are irreversible tooth loss, vision loss from orbital haemorrhage and neurological sequelae from large compressive haematomas — all consequences of delayed diagnosis. When to See a Doctor Scurvy should be suspected when characteristic symptoms coincide with dietary risk factors — there is no need to wait for the full clinical picture. See a doctor (GP, gastroenterologist or haematologist) when: - progressive gum bleeding occurs alongside joint pain and fatigue; - unexplained petechiae appear on the skin — particularly around hair follicles on the shins; - wound healing is markedly delayed or a previously healed scar breaks down; - you belong to a risk group (older age, alcohol use disorder, highly restrictive diet, haemodialysis) and have any of the above symptoms. Do not attempt to self-treat suspected scurvy without laboratory confirmation: similar symptoms (petechiae, mucosal bleeding) are produced by thrombocytopaenia and vasculitis, which require fundamentally different management. Diagnosis must be made by a clinician. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/sleep-apnea https://labreadai.com/en/posts/sleep-apnea Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Sleep apnoea: breathing stops during sleep causing daytime fatigue and cardiovascular risk. Symptoms, polysomnography, link to obesity and CPAP treatment explained. Articles article Your partner says you snore loudly and sometimes stop breathing altogether. You wake up feeling as though you haven't slept at all. You nod off during the day despite spending eight hours in bed. These are the classic symptoms of sleep apnoea — one of the most common and most underdiagnosed conditions in medicine, affecting 15–30% of men and 10–15% of women, while the vast majority remain unaware of their diagnosis. What Is Sleep Apnoea and Its Types Obstructive sleep apnoea (OSA) is a sleep-disordered breathing condition characterised by repeated episodes of partial or complete upper airway obstruction lasting at least 10 seconds, accompanied by falls in blood oxygen saturation and sleep fragmentation. The mechanism of obstructive apnoea: during sleep, the pharyngeal muscles relax, the soft palate and tongue base drop and occlude the airway. Blood oxygen falls, the brain registers the threat and "wakes" the person for a fraction of a second — enough for the muscles to re-tense and breathing to resume. The person rarely remembers these arousals, yet there may be dozens or hundreds per night. This is why sufferers wake feeling unrefreshed regardless of how long they spent in bed. Severity is graded by the apnoea-hypopnoea index (AHI) — the number of breathing cessations and reductions per hour of sleep: Severity AHI (events/hour) ------ Mild 5–14 Moderate 15–29 Severe ≥ 30 Beyond obstructive apnoea, a central form (CSA) exists — respiratory efforts cease completely due to disrupted central respiratory drive. CSA is less common and typically associated with heart failure or post-stroke status. A mixed form combines both mechanisms. Causes and Risk Factors Obesity — the leading and most prevalent risk factor. Obesity is present in 60–70% of OSA patients: excess adipose tissue in the neck (circumference 43 cm in men, 38 cm in women) directly narrows the pharyngeal lumen, while chest and abdominal fat further restricts diaphragmatic excursion. Anatomical features: retrognathia (recessed jaw), tonsillar and adenoid hypertrophy, elongated uvula, and deviated nasal septum. This is why OSA frequently occurs in lean individuals with specific craniofacial anatomy. Sex and age: men are two to three times more commonly affected than women of reproductive age. After menopause, the gap narrows — progesterone, which maintains pharyngeal muscle tone, is no longer produced. After age 50, OSA prevalence increases sharply in both sexes. Alcohol and sedatives — worsen apnoea: they relax pharyngeal muscles and suppress the arousal response. Smoking — chronic upper airway mucosal inflammation increases pharyngeal collapsibility. Body position: most patients have worse apnoea when sleeping supine — gravity displaces the tongue and soft tissue posteriorly. Hypothyroidism — one of the most common endocrine contributors; it reduces pharyngeal muscle tone and causes soft tissue oedema. This is why TSH is checked in all patients with newly diagnosed OSA. Symptoms of Sleep Apnoea: Night and Day OSA symptoms divide into those occurring at night (witnessed by a partner or recorded by devices) and those experienced during the day. Night-time symptoms: - Loud, intermittent snoring with silent pauses (breathing cessations) — the most characteristic sign - Witnessed apnoeas followed by a loud gasp or snort as breathing resumes - Restless sleep with frequent position changes - Night sweats - Nocturia — frequent night-time urination (caused by increased intrathoracic pressure and atrial natriuretic peptide release) - Night-time headaches, choking sensations, awakenings Daytime symptoms: - Excessive daytime sleepiness — the central symptom. Patients fall asleep while driving, in meetings, watching television. Epworth Sleepiness Scale score 10 is clinically significant - Morning headache — from hypercapnia (CO₂ accumulation) during nocturnal apnoeas - Impaired concentration and memory - Irritability, depression, emotional lability - Reduced libido and erectile dysfunction in men Important: many patients adapt to chronic sleepiness and stop perceiving it as abnormal, considering their state "normal". Systematic questioning about apnoea symptoms is therefore more productive than waiting for spontaneous complaints. Diagnosing Sleep Apnoea OSA diagnosis is based on objective sleep monitoring — subjective symptoms and sleepiness scales merely justify referral but do not confirm the diagnosis. Polysomnography (PSG) — the gold standard. Overnight monitoring in a sleep laboratory records simultaneously: EEG (sleep stages), EOG (eye movements), chin EMG (muscle tone), ECG, respiratory effort (thoracic and abdominal bands), oronasal airflow, pulse oximetry and body position. It provides a complete picture of all breathing disorders and sleep architecture. Ambulatory polygraphy (home sleep testing) — a simplified PSG without EEG. The patient wears a portable device at home. Adequate for confirming moderate and severe OSA but may underestimate severity in mild disease. More accessible and convenient — used as the initial test when pre-test probability is high. Epworth Sleepiness Scale (ESS) — an eight-item self-questionnaire rating the likelihood of dozing in different situations. ESS 10 is an indication for diagnostic evaluation. ENT examination — mandatory to identify anatomical factors (tonsillar hypertrophy, septal deviation) that influence treatment selection. What Blood Tests Are Ordered in Sleep Apnoea No laboratory tests are specific to OSA. However, several tests are mandatory in initial evaluation — they identify causes and complications. - TSH — exclude hypothyroidism as a cause of apnoea and daytime sleepiness - Haemoglobin and haematocrit — secondary polycythaemia (elevated haemoglobin as a response to chronic hypoxia) occurs in severe untreated OSA; an unexpectedly high haemoglobin is itself a reason to screen for OSA - Metabolic syndrome assessment — glucose, lipid profile, blood pressure: OSA and metabolic syndrome are tightly clustered, each worsening the other - Insulin resistance markers — chronic nocturnal hypoxia in OSA reduces insulin sensitivity independently of obesity Overnight pulse oximetry — a simple home monitoring of blood oxygen saturation — does not replace PSG but provides supporting evidence when OSA is suspected: desaturation below 90% during sleep is a characteristic pattern. Sleep Apnoea and Cardiovascular Disease OSA is not merely a "sleep problem" — it is a systemic condition with far-reaching cardiovascular consequences. Arterial hypertension is present in 50% of OSA patients. Mechanism: repetitive apnoeas activate the sympathetic nervous system and RAAS, sustaining elevated blood pressure. A characteristic pattern in OSA-related hypertension is nocturnal and morning elevation with absent physiological overnight dipping ("non-dipper" pattern). OSA is the most common cause of resistant hypertension. Heart failure — OSA is present in 30–40% of patients with chronic HF. Apnoea worsens heart failure through nocturnal hypoxia, sympathetic activation and increased left ventricular afterload. Treating OSA in HF patients improves ejection fraction and reduces hospitalisations. Atherosclerosis — chronic nocturnal hypoxia and oxidative stress accelerate coronary and carotid atherosclerotic plaque development. The risk of myocardial infarction and stroke with severe untreated OSA is two to three times higher than background risk. Type 2 diabetes — OSA is an independent risk factor. Nocturnal hypoxia impairs insulin secretion and elevates cortisol, independently worsening glycaemic control. Atrial fibrillation — risk is two to four times higher in OSA. Apnoea causes mechanical atrial stretch, sympathetic activation and conditions conducive to arrhythmia development. Treatment: CPAP Therapy and Other Approaches Treatment of OSA depends on severity, dominant contributing factors and co-existing conditions. Continuous positive airway pressure (CPAP) therapy — the gold standard for moderate and severe OSA. The device delivers air at constant pressure through a mask, preventing pharyngeal collapse. With regular use (≥ 4 hours per night): - elimination of snoring and apnoeas in 90–95% of patients; - reduction in daytime sleepiness, often from the very first night; - systolic blood pressure reduction of 2–7 mmHg in resistant hypertension; - reduced cardiovascular event risk with long-term use. The main challenge with CPAP is adherence: approximately 30–50% of patients discontinue treatment in the first months due to mask discomfort or device noise. Mask fitting, regular follow-up and specialist support are critical for success. Weight loss — a 10% weight reduction decreases AHI by approximately 26% on average. In patients who achieve significant weight loss through bariatric surgery, OSA resolves entirely in 40–80%. Positional therapy — for position-dependent OSA (worse supine): devices or positional pillows preventing supine sleep. Effective in mild to moderate positional OSA. Mandibular advancement devices (MAD) — oral appliances that advance the lower jaw forward. An alternative to CPAP in mild to moderate OSA; less effective on average but better tolerated by some patients. Surgical treatment — tonsillectomy for tonsillar hypertrophy (particularly in children), uvulopalatopharyngoplasty, nasal septal surgery. Surgery is less predictable than CPAP and applied for specific anatomical indications. Hypoglossal nerve stimulation — a modern option for CPAP-intolerant patients: an implanted neurostimulator synchronised with breathing activates the tongue muscles at each inhale. When to See a Doctor See a sleep medicine specialist, pulmonologist or ENT physician when two or more of the following apply: - loud snoring witnessed by a bed partner; - observed breathing pauses during sleep; - excessive daytime sleepiness despite adequate time in bed; - recurring morning headaches; - hypertension not responding to standard medication; - obesity with neck circumference 43 cm in men or 38 cm in women. Untreated apnoea gradually and silently damages health: it raises blood pressure, overloads the heart and disrupts metabolic balance. At the same time, CPAP therapy often transforms a patient's life after a single night of use. Do not postpone seeing a doctor. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/afp https://labreadai.com/en/indicators/afp Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) AFP (alpha-fetoprotein) is the primary marker for liver cancer and germ cell tumours. Normal adult range under 7 U/mL, elevation in cirrhosis and hepatitis, prenatal screening. Indicators article AFP is a protein produced in large quantities by the fetus and almost entirely absent from the blood after birth. In a healthy adult, its concentration is negligible. This is precisely why any significant AFP elevation in a non-pregnant adult woman or in a man is a serious signal that warrants further investigation. Here is what this marker measures, which diseases cause it to rise, and how to interpret the result correctly. What Is Alpha-Fetoprotein (AFP) and Why Is It Ordered AFP (alpha-fetoprotein) is a glycoprotein that serves as the principal transport protein of the embryo and fetus — it carries fatty acids, hormones and bilirubin, performing in the fetus the same role that albumin performs in the adult. Synthesised by the yolk sac and fetal liver, AFP peaks at the end of the first trimester and then gradually falls. After birth, levels drop sharply and reach adult values by 1–2 years of age. In a healthy adult's blood, AFP is present only in trace amounts. A pathological rise in adults means one of two things: either cells have begun synthesising a protein characteristic of the embryonic period (typical of malignant tumours), or significant liver damage with regenerative activation has occurred. Clinical roles of AFP: - Treatment monitoring of hepatocellular carcinoma (HCC) — the primary liver cancer. AFP dynamics after surgery, transarterial chemoembolisation or systemic therapy are a key criterion of treatment response. - HCC screening in high-risk patients — liver cirrhosis, chronic viral hepatitis B and C. AFP combined with liver ultrasound every 6 months is the standard surveillance protocol for these patients. - Diagnosis and monitoring of germ cell tumours — non-seminomatous testicular and ovarian germ cell tumours. AFP is the first-line tumour marker in this setting. - Prenatal screening — maternal serum AFP and amniotic fluid AFP are used to detect neural tube defects and chromosomal abnormalities in the fetus. Like CEA, CA-125 and CA 19-9, AFP is part of the standard tumour marker panel and is ordered for specific clinical indications, not preventively. AFP Normal Range Group Normal range ------ Adult men < 7.0 IU/mL (ng/mL) Non-pregnant women < 7.0 IU/mL (ng/mL) Pregnant women substantially higher — see trimester table below Different laboratories use different units and assay methods — always refer to the reference range on your own report. AFP during pregnancy — normal ranges by gestational age: Gestational age Normal (IU/mL) ------ 1–12 weeks < 15 13–15 weeks 15–60 16–19 weeks 15–95 20–24 weeks 27–125 25–27 weeks 52–140 28–30 weeks 67–150 31–32 weeks up to 250 Interpretation outside pregnancy: - < 7.0 IU/mL — normal - 7–20 IU/mL — borderline; repeat measurement and clinical context assessment required - 20–400 IU/mL — mild to moderate elevation. More often related to active liver injury than to tumour - 400 IU/mL — high; probability of a malignant process rises substantially - 1000 IU/mL in a patient with cirrhosis or hepatitis — diagnostic threshold for HCC under many international criteria AFP as Tumour Marker: Hepatocellular Carcinoma and Germ Cell Tumours Hepatocellular carcinoma (HCC) — the primary clinical application of AFP in adults. The marker is elevated in 60–70% of HCC patients. The key diagnostic threshold: AFP 400 IU/mL in a patient with cirrhosis and a typical lesion on CT/MRI meets AASLD criteria for HCC diagnosis without biopsy. The higher the AFP, the worse the prognosis and the more advanced the tumour. Critical limitation: 30–40% of HCCs are AFP-negative. A normal AFP does not exclude primary liver cancer. This is why HCC surveillance in cirrhosis is built on the combination of AFP and ultrasound, not AFP alone. Non-seminomatous germ cell tumours of the testis — AFP is elevated in non-seminoma, embryonal carcinoma and yolk sac tumour. Pure seminoma does not raise AFP — if AFP is elevated in a patient diagnosed with pure seminoma, this indicates a non-seminomatous component and changes treatment. AFP is always measured alongside HCG: together they provide the complete marker profile for germ cell tumours. Germ cell tumours of the ovary — yolk sac tumours and mixed germ cell tumours of the ovary raise AFP analogously to testicular tumours. Hepatoblastoma — the malignant paediatric liver tumour. AFP is elevated in 90% of patients, often reaching hundreds of thousands of IU/mL. AFP dynamics are the primary criterion of chemotherapy response in hepatoblastoma. Liver metastases — AFP is mildly elevated in some patients with metastatic hepatic involvement of various origin, but it is not the marker of choice in this setting. AFP in Cirrhosis, Hepatitis and Other Non-Cancer Causes Mild AFP elevation in adults more commonly reflects benign liver disease than a tumour. Liver cirrhosis — in active cirrhosis, AFP is chronically mildly elevated (usually < 200 IU/mL), a consequence of active hepatocyte regeneration: dividing cells resume synthesis of this embryonic protein. This is why a moderate AFP rise in a patient with cirrhosis cannot be unambiguously attributed to early HCC — serial measurement, ultrasound and CT are required. Chronic viral hepatitis B and C — active inflammation and hepatocyte necrosis stimulate AFP synthesis. Levels are generally < 100 IU/mL; during flares, potentially higher. Successful antiviral therapy normalises AFP. Acute hepatitis — massive hepatocyte necrosis (acute viral hepatitis, toxic liver injury) can produce a substantial AFP rise — sometimes reaching 200–400 IU/mL — as a regenerative response. This is a "false" elevation that resolves with recovery. Pregnancy — physiologically elevated AFP is measured in maternal serum as part of prenatal screening. Assessment of elevated AFP always includes liver function tests with ALT, AST, bilirubin and liver ultrasound. How to Prepare for an AFP Blood Test - Fasting — blood is drawn 8–12 hours after the last meal; required for reproducibility in serial monitoring. - Active hepatitis or flares of chronic liver disease — during active inflammation, AFP will reflect regenerative activity rather than tumour status. Where possible, defer testing until remission. - One laboratory for the entire monitoring course — different assay platforms produce non-comparable absolute values. - High-dose biotin — discontinue 48 hours before the draw. - A newly elevated AFP always requires simultaneous abdominal ultrasound: interpreting an isolated AFP rise without imaging is not possible. AFP Interpretation: Trends in Cancer Monitoring As with all tumour markers, the trend in AFP drives clinical decisions. Normalisation after HCC treatment — after radical surgery or ablation, AFP should fall to normal within 4–8 weeks. Failure to normalise indicates residual tumour. Rising AFP during cirrhosis surveillance — a doubling or more from baseline on two consecutive measurements 3–6 months apart requires contrast-enhanced CT to exclude HCC, even if the absolute value is not yet very high. In germ cell tumours — AFP normalisation after chemotherapy is a criterion of complete response. Persistently elevated AFP after completing treatment is an indication for additional chemotherapy cycles or surgical removal of residual disease. Rapidly rising AFP — a rise of tens of times over several weeks in a patient with established cirrhosis is a near-pathognomonic sign of malignant transformation. Prenatal Screening: AFP in Pregnancy In obstetrics, AFP is used as part of the combined prenatal screening — the "triple test" or "quadruple test" — alongside HCG, unconjugated oestriol and inhibin A. Elevated maternal AFP ( 2.5 MoM — multiples of the median) indicates increased risk of neural tube defects (spina bifida, anencephaly), anterior abdominal wall defects (gastroschisis, omphalocele), multiple pregnancy, or fetal demise. Low maternal AFP in combination with other markers is a sign of increased risk for Down syndrome (trisomy 21) and other chromosomal abnormalities. Important: maternal serum AFP is a screening, not a diagnostic test. Any deviation from normal is an indication for detailed ultrasound and genetics consultation — it is not a diagnosis in itself. When to See a Doctor Urgent hepatology or oncology referral when: - AFP 400 IU/mL in a patient with cirrhosis or chronic hepatitis — emergency contrast-enhanced CT or MRI of the liver is required - Any AFP elevation in a man with a testicular mass — requires immediate urological assessment - Rising AFP during follow-up of HCC or germ cell tumour in remission Scheduled gastroenterology or hepatology appointment when: - AFP 20–400 IU/mL in a patient without oncological history — assess liver function and perform ultrasound - Persistently mild AFP elevation in cirrhosis or chronic hepatitis — review HCC surveillance protocol No emergency action needed: - AFP mildly elevated during active acute hepatitis with a clear cause — retest after recovery - AFP elevation in pregnancy — assessed by the obstetrician as part of prenatal screening Elevated AFP is not a diagnosis — it is a signal for a structured diagnostic search. Do not interpret tumour markers independently; consult a physician. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/aldosterone https://labreadai.com/en/indicators/aldosterone Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Aldosterone is an adrenal hormone regulating blood pressure and potassium levels. Normal ranges, causes of high and low aldosterone, and test preparation. Indicators article Blood pressure stays high despite three medications, potassium keeps dropping for no clear reason, and muscle weakness lingers — often, one hormone is behind all of it. Aldosterone in the blood quietly governs blood pressure and electrolyte balance until its level moves outside the normal range. Aldosterone is a steroid hormone produced by the zona glomerulosa of the adrenal cortex. It belongs to the mineralocorticoid class and carries out one central function: in the renal tubules, it promotes reabsorption of sodium and excretion of potassium. Retaining sodium means retaining water, which raises blood volume and blood pressure. This is a normal physiological mechanism. Problems arise when the hormone is produced in excess or falls short. How the Adrenal Hormone Aldosterone Regulates Blood Pressure Think of aldosterone as a pressure-regulating valve: open too wide and pressure climbs while potassium falls; close it off and pressure drops while potassium accumulates. Three main signals govern its secretion. The most important is the renin-angiotensin-aldosterone system (RAAS). When blood pressure or blood volume falls, the kidneys release renin → a cascade follows: renin → angiotensin I → angiotensin II → stimulation of the adrenal zona glomerulosa → aldosterone rises → the kidneys retain sodium and water → pressure is restored. The system runs in reverse: high pressure suppresses renin → aldosterone declines. The second regulator is blood potassium. A rise of just 0.1–0.2 mmol/L directly stimulates aldosterone secretion — a fast emergency mechanism against dangerous hyperkalaemia. The third is ACTH (adrenocorticotropic hormone). Its influence on aldosterone is far weaker than on cortisol and becomes relevant mainly in acute stress or pituitary disease. Normal Aldosterone Levels The normal range for aldosterone depends critically on body position at the time of blood collection — this is why the result must always note whether it was drawn supine or standing. Body position Normal range (pg/mL) Normal range (pmol/L) --------- Supine (recumbent sample) 15–100 40–280 Standing (upright sample) 40–300 110–830 Reference ranges vary considerably between laboratories — always compare with your own laboratory's values printed on the report. An isolated result without renin is almost uninterpretable: the same number points to primary hyperaldosteronism when renin is suppressed, but to a normal compensatory response when renin is elevated. In children, ranges are higher than in adults. During pregnancy, aldosterone physiologically rises two- to fourfold — this is normal, not pathological: the placenta activates the RAAS and the body appropriately retains more fluid. How to Prepare for an Aldosterone Blood Test Aldosterone is among the most condition-sensitive hormonal tests in clinical practice. Inadequate preparation can double or halve the result and lead to false conclusions. Diet: for two weeks before the test, maintain your usual salt intake — neither restrict nor increase it. A low-sodium diet falsely elevates aldosterone; excess salt falsely suppresses it. Position and timing: the standard protocol is a morning sample (before 10:00 a.m.) after at least 30 minutes lying down (recumbent sample). When primary hyperaldosteronism is suspected, a second draw is added after two hours standing or walking — the upright sample is more sensitive for this diagnosis. Medication washout — only under medical supervision: - spironolactone, eplerenone — 4–6 weeks before the test; - ACE inhibitors, ARBs, beta-blockers, thiazide diuretics — 2 weeks; - NSAIDs — 1 week. On the day of the test: no smoking for 2 hours beforehand; avoid physical exertion in the morning. Causes of High Aldosterone Elevated aldosterone — hyperaldosteronism — is either primary or secondary. The distinction is impossible without measuring renin. Primary hyperaldosteronism (Conn's syndrome) — the adrenal gland secretes aldosterone autonomously, independently of renin. Renin is suppressed (low), aldosterone is high. This is the most common endocrine cause of secondary hypertension — primary hyperaldosteronism is identified in 5–10% of all hypertensive patients and in up to 20% with resistant hypertension. Causes: - adrenal adenoma (aldosteronoma) — 60–65% of cases; - bilateral idiopathic adrenal hyperplasia — 30–35%; - adrenocortical carcinoma — rare (< 1%). Clinical picture: arterial hypertension (often resistant — three medications without effect), hypokalaemia (muscle weakness, cramps, polyuria, thirst), and metabolic alkalosis. Hypokalaemia is present in only 40–50% of patients — its absence does not exclude the diagnosis. Secondary hyperaldosteronism — renin is elevated → aldosterone responds physiologically: - heart failure — reduced cardiac output activates the RAAS; - liver cirrhosis with ascites — reduced effective circulating volume; - renal artery stenosis — renal ischaemia drives renin release; - nephrotic syndrome — protein loss reduces oncotic pressure → RAAS activation; - prolonged diuretic use or a low-sodium diet. Causes of Low Aldosterone Aldosterone deficiency — hypoaldosteronism — presents with hypotension, hyperkalaemia and urinary sodium wasting. Adrenal insufficiency (Addison's disease) — destruction of the adrenal cortex by autoimmune, tuberculous or other processes simultaneously depletes both cortisol and aldosterone. In an acute Addisonian crisis, life-threatening hyperkalaemia and hypotension can develop within hours. Hyporeninemic hypoaldosteronism (type IV renal tubular acidosis) — common in diabetic nephropathy: the kidneys produce insufficient renin → aldosterone falls → hyperkalaemia develops that is disproportionate to the degree of GFR reduction. Iatrogenic causes: ACE inhibitors, ARBs and direct renin inhibitors reduce angiotensin II → aldosterone falls. Prolonged heparin use directly suppresses adrenal aldosterone synthesis. Cushing's syndrome with exogenous glucocorticoids — chronic ACTH suppression reduces adrenal stimulation and aldosterone consequently declines. Renin-to-Aldosterone Ratio The renin-to-aldosterone ratio (RAR) is the primary screening tool for primary hyperaldosteronism. The principle is straightforward: if aldosterone is high while renin is suppressed, the adrenal gland itself is the autonomous source — not the signalling cascade responding to a physiological need. RAR = aldosterone (pg/mL) ÷ plasma renin activity (ng/mL·h) An RAR above 30 combined with aldosterone above 150 pg/mL is highly suspicious for Conn's syndrome and triggers confirmatory testing (salt loading, fludrocortisone suppression test, postural test). The ratio alone, without the absolute aldosterone value, can yield false-positives when renin is suppressed for other reasons — interpretation is always clinical. For an accurate RAR, both tests must be drawn simultaneously under identical preparation conditions. A baseline electrolyte panel is mandatory: the initial potassium and sodium levels influence both the RAR value and its interpretation. When to See a Doctor About Aldosterone Test Results Aldosterone testing is warranted when one or more of the following apply: - blood pressure that cannot be controlled with three or more medications at full doses; - hypokalaemia (potassium below 3.5 mmol/L) without a clear cause, particularly in the absence of diuretic use; - incidentally discovered adrenal tumour (incidentaloma) on CT or ultrasound; - hypertension diagnosed before age 40; - family history of primary hyperaldosteronism or stroke at a young age; - hypotension combined with hyperkalaemia and profound weakness without another explanation. Aldosterone is not a routine test. It is ordered when hypertension is unexplained, the electrolyte balance is disrupted, or adrenal pathology is suspected. A standalone number without renin, electrolytes and clinical context cannot be interpreted — do not draw conclusions independently; consult an endocrinologist. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/ca-125 https://labreadai.com/en/indicators/ca-125 Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CA-125 is the primary tumour marker for ovarian cancer monitoring. Normal range under 35 U/mL, non-oncological causes of elevation in endometriosis and cysts, serial monitoring. Indicators article An elevated CA-125 result is one of the most anxiety-provoking findings for a woman. Before alarming conclusions are drawn, the most important thing to understand is this: CA-125 rises in dozens of entirely benign conditions, while ovarian cancer at early stages frequently produces a normal result. Here is what this marker actually measures and in which situations it is genuinely informative. What Is CA-125 and Why Is It Ordered CA-125 (cancer antigen 125) is a high-molecular-weight glycoprotein produced by coelomic epithelial cells: the mesothelium of the peritoneum, pleura and pericardium, and the epithelium of the fallopian tubes, endometrium and endocervix. Under normal conditions, only trace amounts circulate in the blood. When these cells are inflamed, irritated or malignantly transformed, CA-125 secretion into the bloodstream rises substantially. Like CEA, CA-125 is a monitoring marker, not a diagnostic one: - Primary application — monitoring treatment of epithelial ovarian cancer. CA-125 is elevated in approximately 80% of patients with advanced disease. Its dynamics following surgery and chemotherapy are one of the key criteria of treatment response. - Early recurrence detection — rising CA-125 precedes clinical symptoms and CT evidence of ovarian cancer recurrence by an average of 3–5 months. - Staging — a very high baseline level correlates with disease extent. What CA-125 cannot do: - Screen for ovarian cancer in healthy women — sensitivity and specificity are insufficient - Confirm or exclude cancer on primary workup without additional data (ultrasound, clinical findings) - Replace biopsy in establishing a diagnosis The test is part of the standard tumour marker panel and is ordered by an oncologist, gynaecologist, or gynaecological oncologist. CA-125 Normal Range The standard reference range for CA-125 in adult women: Status Normal range ------ Premenopausal women < 35 U/mL Postmenopause < 20 U/mL (some laboratories) Pregnant women (1st trimester) may reach 100–200 U/mL — physiological Men < 35 U/mL In men, CA-125 is detectable at low concentrations as a normal finding — the marker is not exclusively female, but its clinical significance in men is limited, chiefly to pleural mesothelioma and pericarditis. Key interpretation points: - 35–200 U/mL — mild elevation. In the vast majority of premenopausal women without an oncological history, this reflects a benign cause. - 200 U/mL — significant elevation, particularly in combination with a pelvic mass and postmenopausal status — urgent exclusion of ovarian cancer is required. - 1000 U/mL — almost invariably a malignant process, frequently with evidence of peritoneal dissemination. CA-125 rises predictably during the first days of menstruation (up to 2–3 times the upper limit). This is a physiological variation, not pathology. The test should therefore not be drawn during a period. Which Cancers Are Associated with Elevated CA-125 CA-125 is non-specific — it rises in several malignancy types, not only gynaecological ones. Ovarian cancer — the primary clinical application. CA-125 is elevated in approximately 50% of patients with stage I disease and in 80–90% with stage III–IV epithelial ovarian cancer. High-grade serous adenocarcinoma produces the most pronounced elevations. Mucinous ovarian tumours raise CA-125 far less consistently — CA 19-9 is a more informative marker for that subtype. Endometrial cancer — elevated in 20–30% of patients, more commonly in advanced disease. Fallopian tube cancer and primary peritoneal cancer — anatomically close to the ovaries and express CA-125 as actively. Pancreatic, gastric, colorectal, lung and breast cancers — CA-125 may be mildly elevated in some patients but is not the marker of choice for these tumours. Pleural and peritoneal mesothelioma — a malignancy in which CA-125 is frequently markedly elevated in both sexes. Non-Oncological Causes of Elevated CA-125 This is the most critically underappreciated category: in premenopausal women, the majority of CA-125 elevations are not cancer. Endometriosis — one of the most common causes of chronically elevated CA-125, often reaching 50–300 U/mL. Ectopic endometrial tissue produces CA-125 just as actively as ovarian cancer cells. In endometriosis, the level correlates with disease stage — stages III–IV produce the highest values. Uterine fibroids — mild elevation, particularly with large or submucosal fibroids. Benign ovarian cysts — follicular cysts and corpus luteum cysts can transiently raise CA-125. Acute pelvic inflammatory disease — salpingitis, pelvioperitonitis. CA-125 is substantially elevated due to peritoneal mesothelial activation. Pregnancy — physiologically elevated CA-125 in the first trimester is related to chorionic villus formation and requires no further investigation. Liver disease — liver cirrhosis and acute hepatitis. The peritoneal mesothelium actively expresses CA-125 in the presence of ascites or hepatic inflammation. Other causes: pericarditis, pleuritis, ascites of any origin, renal failure, autoimmune diseases. Assessment of kidney function and liver function is part of the workup for unexplained CA-125 elevation. How to Prepare for a CA-125 Blood Test CA-125 is measured in venous blood. A few practical rules improve the reliability of results: - Cycle timing — avoid testing during menstruation and the first 3–4 days after it ends: the physiological rise during a period can create a falsely elevated result. The optimal window is from cycle day 5 onwards. - Fasting — blood is drawn 8–12 hours after the last meal, for reproducibility in serial monitoring. - Active infections or inflammation — CA-125 may be transiently elevated during a urinary tract infection, respiratory illness, or pelvic inflammatory disease. If the test is not urgent, wait until recovery. - One laboratory for the entire monitoring course: different immunoassay platforms yield non-comparable absolute values. - High-dose biotin — discontinue 48 hours before the draw. A note on initial workup: an isolated CA-125 without pelvic ultrasound is poorly informative. Gynaecologists assess CA-125 alongside transvaginal ultrasound: the combination of elevated CA-125 and a suspicious adnexal mass on imaging is an indication for surgical clarification. CA-125 Trends: How to Interpret Serial Results During ovarian cancer monitoring, the trend is interpreted through several key patterns: Normalisation after treatment — following radical surgery and chemotherapy, CA-125 should fall to below 35 U/mL. Failure to normalise within the first 3–6 months suggests residual disease or insufficient treatment response. Progressive decline — even if CA-125 remains above normal after initial treatment cycles, a sustained downward trend indicates chemotherapy effectiveness. Treatment should not be changed on the basis of a single elevated value. Rise from nadir — a doubling of CA-125 from its lowest confirmed value on two consecutive measurements four weeks apart is the internationally accepted criterion for biochemical recurrence. This triggers imaging workup even in the absence of clinical symptoms. "Flare" reaction — a transient CA-125 rise in the first one to two chemotherapy cycles does not indicate treatment failure; it reflects antigen release from dying tumour cells. No CA-125 result is ever assessed without clinical context. Any significant elevation — especially in a postmenopausal woman with symptoms — warrants timely medical review. When to See a Doctor Urgent referral to a gynaecologist or gynaecological oncologist when: - CA-125 above 200 U/mL in a postmenopausal woman, especially with a pelvic mass on ultrasound - Any CA-125 elevation combined with lower abdominal pain, bloating, urinary frequency, or unexplained weight loss - Rising CA-125 in a patient with treated ovarian cancer in remission Scheduled gynaecology appointment when: - CA-125 35–100 U/mL in a premenopausal woman without symptoms — exclude endometriosis, pelvic inflammatory disease, benign cyst - Mildly elevated chronic values with known endometriosis — assess disease activity No immediate action needed: - Mild elevation (< 50 U/mL) during or immediately after menstruation — retest mid-cycle - Moderate elevation during an acute infection — retest after recovery An elevated CA-125 is not a diagnosis — it is a prompt for a structured diagnostic workup. Do not interpret tumour markers on your own; see a gynaecologist who can assess the full clinical picture. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/ca-19-9 https://labreadai.com/en/indicators/ca-19-9 Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CA 19-9 is the main marker for pancreatic and biliary tract cancers. Normal range under 37 U/mL, causes of elevation in cholestasis and pancreatitis, monitoring role. Indicators article CA 19-9 is one of the few tumour markers that can rise dramatically in conditions entirely unrelated to cancer. Jaundice, gallstone disease and pancreatitis can push CA 19-9 tens of times above the normal range — none of which is malignancy. Understanding the difference between a "dangerous" and a "benign" elevation is essential for correct interpretation of this result. What Is CA 19-9 and Where Is It Used CA 19-9 (carbohydrate antigen 19-9) is a sialylated Lewis blood group antigen produced by the epithelium of the gastrointestinal tract and biliary system. Under normal conditions only trace amounts circulate in the blood. When these cells are affected by malignant transformation or certain inflammatory processes, CA 19-9 synthesis increases substantially and the antigen enters the bloodstream at measurable concentrations. Like other tumour markers — CEA and CA-125 — CA 19-9 is not a diagnostic test for cancer. Its primary clinical roles are: - Treatment monitoring of pancreatic cancer, cholangiocarcinoma, and gastric cancer. The dynamics of CA 19-9 after surgery or chemotherapy are a key criterion of treatment response. - Early recurrence detection — rising CA 19-9 after normalisation precedes clinical and CT evidence of disease return by several months. - Prognostic assessment — a very high baseline level ( 1000 U/mL) in pancreatic cancer correlates with unresectability and a worse prognosis. - Supplementary marker for mucinous ovarian tumours — used together with CA-125. The test is part of the standard tumour marker panel. An important biological caveat: approximately 5–10% of people genetically lack the Lewis antigen (Lewis-negative phenotype, Le(a-b-)). In these individuals, CA 19-9 is zero or undetectable regardless of whether a tumour is present. This means the marker is entirely uninformative in this subgroup — a negative result does not exclude pancreatic cancer. CA 19-9 Normal Range Group Normal range ------ Adults (both sexes) < 37 U/mL The normal range is the same for men and women and does not vary substantially with age in the adult range. Interpretation zones: - < 37 U/mL — normal - 37–200 U/mL — mild elevation. In most cases explained by benign causes: cholestasis, pancreatitis, gallstone disease - 200–1000 U/mL — significant elevation. Probability of malignancy increases, but benign causes remain possible with severe cholestasis - 1000 U/mL — very high; in most cases a malignant process, frequently with metastases A critically important point: in the presence of jaundice (biliary cholestasis), CA 19-9 can be substantially elevated — often reaching 500–1000 U/mL — with no tumour at all. This is a direct consequence of impaired antigen clearance through bile. CA 19-9 cannot be interpreted without knowing the bilirubin level: high CA 19-9 in the context of jaundice means resolving the cholestasis first, then reassessing the marker. Which Cancers Are Associated with Elevated CA 19-9 Pancreatic cancer — the primary clinical application. CA 19-9 is elevated in 70–80% of patients with pancreatic cancer. Sensitivity for localised disease is lower — 50–60%; for metastatic disease — 75–85%. The central limitation: at early resectable stages, CA 19-9 is normal in a substantial proportion of patients. Cholangiocarcinoma (bile duct cancer) — CA 19-9 is elevated in 60–80% of patients, often in the context of significant cholestasis, which further complicates interpretation. Gastric cancer — CA 19-9 is mildly elevated in 20–40% of patients, particularly in advanced disease. Used here alongside CEA. Colorectal cancer — elevated in 20–30% of patients; used as a supplement to CEA, not independently. Mucinous ovarian tumours — CA 19-9 is more informative here than CA-125: mucinous cells actively express CA 19-9 while CA-125 is often normal in this tumour subtype. Hepatocellular carcinoma — CA 19-9 is mildly elevated in some patients; the primary marker for this tumour is AFP. Non-Oncological Causes of Elevated CA 19-9 This is the most important section for correctly understanding the marker. Most mild CA 19-9 elevations (37–200 U/mL) are not cancer. Cholestasis and gallstone disease — the leading non-oncological cause of high CA 19-9. Any impairment of bile flow — from a stone in a bile duct to an anastomotic stricture after surgery — leads to substantial CA 19-9 accumulation in the blood. Values of 300–500 U/mL in gallstone disease are not uncommon. Pancreatitis — both acute and chronic inflammation of the pancreas mildly raise CA 19-9. In acute pancreatitis, levels are generally < 100 U/mL; in chronic calcific pancreatitis, occasionally higher. Cirrhosis and chronic liver disease — liver cirrhosis, autoimmune hepatitis, primary biliary cholangitis. Impaired clearance and co-existing cholestasis elevate CA 19-9. Inflammatory bowel disease — Crohn's disease and ulcerative colitis produce a mild chronic elevation. Benign pancreatic and ovarian cysts — may mildly elevate CA 19-9. Chronic cholecystitis and post-cholecystectomy syndrome — persistent mild elevation from chronic biliary inflammation. When CA 19-9 is mildly elevated without an oncological history, the first step is to evaluate liver function through liver function tests and bilirubin — to exclude cholestasis as the primary driver. How to Prepare for a CA 19-9 Blood Test - Fasting — blood is drawn 8–12 hours after the last meal; mandatory for reproducibility in serial monitoring. - Avoid testing during acute biliary or pancreatic illness — during jaundice, active pancreatitis or cholangitis, CA 19-9 reflects inflammation rather than tumour activity. Where possible, defer testing until the acute episode has resolved. - One laboratory for the entire monitoring course — different immunoassay platforms produce non-comparable absolute values. - High-dose biotin — discontinue 48 hours before the draw. - When CA 19-9 is elevated for the first time, bilirubin and ALT should always be assessed simultaneously — cholestasis must be excluded as a cause before an oncological workup is initiated. CA 19-9 Trends in Cancer Monitoring As with other tumour markers, trends matter far more than individual values. Decline after surgery or chemotherapy — indicates good treatment response. After curative pancreatic resection, CA 19-9 should normalise within 4–6 weeks. Persistently elevated CA 19-9 after surgery — suggests residual tumour or micrometastases not removed during the procedure. Rise from nadir — a doubling or more from the lowest confirmed value on two consecutive measurements warrants imaging: CT, MRI, or PET. "Flare" phenomenon — a transient rise in the first one to two chemotherapy cycles does not indicate progression and should not trigger an immediate change of treatment. In clinical practice, CA 19-9 in pancreatic cancer is almost always assessed alongside imaging (contrast-enhanced CT) — the combination of marker and visualisation is what guides clinical decision-making. When to See a Doctor Urgent gastroenterology or oncology referral when: - CA 19-9 above 200 U/mL without clear signs of cholestasis or pancreatitis - Mild elevation combined with upper abdominal pain, jaundice, weight loss, or appetite changes - Rising CA 19-9 in a patient with treated malignancy in remission Scheduled consultation when: - CA 19-9 37–100 U/mL in the context of known gallstone disease or chronic pancreatitis — observation and liver function assessment - Mild elevation in a patient with cirrhosis — serial monitoring No emergency workup needed: - CA 19-9 elevated in the setting of active jaundice — retest after cholestasis resolves - A single mild elevation without symptoms — repeat in 4–6 weeks CA 19-9 is an auxiliary tool in the hands of a specialist. Its value is essentially uninterpretable without clinical context, ultrasound findings, and liver function tests. Do not attempt to interpret tumour markers independently. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/cea https://labreadai.com/en/indicators/cea Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CEA (carcinoembryonic antigen) monitors cancer treatment response. Normal ranges for smokers and non-smokers, non-oncological causes of elevation and clinical significance. Indicators article A blood test shows elevated CEA — and the first thought is cancer. That fear is understandable but rarely justified. Carcinoembryonic antigen rises in dozens of conditions that have nothing to do with malignancy, and is not a diagnostic test for cancer in the first place. Here is what CEA actually measures, when it genuinely matters clinically, and how to make sense of the result. What Is CEA and Why Is It Ordered CEA (carcinoembryonic antigen) is a glycoprotein produced in large amounts by the fetal gastrointestinal tract during intrauterine development. After birth, synthesis drops sharply, and in healthy adults CEA is detectable in the blood only at trace concentrations. The most important thing to understand immediately: CEA is not a test to diagnose cancer. It can neither confirm nor rule out a malignant tumour in someone without an established diagnosis. CEA's sensitivity and specificity are insufficient for population screening — many patients with early-stage cancer have normal levels, and many healthy people are mildly elevated. CEA's real clinical value lies in monitoring: - Assessing treatment response — following chemotherapy, radiotherapy, or surgery. A falling CEA after treatment indicates effectiveness. - Early detection of recurrence — in patients with treated colorectal cancer, regular CEA monitoring can detect disease return 3–6 months before clinical symptoms or CT changes appear. - Staging — very high CEA at initial diagnosis correlates with metastatic disease and carries a worse prognosis. The test is part of the standard tumour marker panel and is ordered for specific clinical indications, never as a preventive screen. CEA Normal Range: Values for Different Groups Reference ranges depend on the assay method and laboratory. The values below are approximate. Group Normal range ------ Non-smoking adults < 3.0 ng/mL (µg/L) Smoking adults < 5.0 ng/mL (µg/L) Why is the threshold higher for smokers? Tobacco smoke directly stimulates CEA synthesis in the bronchial and gastrointestinal mucosa. This is a physiological response to chronic irritation, not a sign of disease. Former smokers typically return to non-smoking reference values within several months of quitting. Interpretation zones (approximate, for non-smokers): - < 3.0 ng/mL — normal; oncological pathology is an unlikely sole explanation - 3–10 ng/mL — mild elevation; requires clinical context. Non-oncological causes are more common at this range - 10 ng/mL — significant elevation; probability of malignancy is higher; detailed investigation needed - 20 ng/mL — high probability of advanced malignancy, especially when symptoms are present In monitoring: the absolute value matters far less than trend. A drop from 50 to 8 ng/mL is a positive treatment response, even if 8 ng/mL exceeds the reference limit. Which Cancers Are Associated with Elevated CEA CEA is a non-specific tumour marker — it may rise in several types of malignancy. Colorectal cancer — the primary clinical application for CEA. The marker is elevated in 70–80% of patients with metastatic colorectal cancer and in 40–50% with localised disease. After curative resection, CEA should normalise within 4–8 weeks. Failure to do so suggests residual metastases. Post-operative CEA monitoring for colorectal cancer is typically performed every 3 months for the first 2–3 years. Lung cancer, especially adenocarcinoma — CEA is elevated in approximately 40–60% of patients and is used as a supplementary marker during treatment monitoring. Breast, gastric, pancreatic, medullary thyroid and ovarian cancers — CEA may be mildly elevated in these malignancies but is not the marker of choice. A fundamental limitation: CEA is normal in early-stage disease for most tumour types. A negative result does not exclude cancer. Non-Oncological Causes of Elevated CEA This is the most underappreciated category. The majority of mild CEA elevations (3–10 ng/mL) are explained by conditions unrelated to cancer. Liver disease: - Liver cirrhosis — impaired CEA clearance by damaged hepatocytes; chronically elevated CEA in cirrhosis does not mean cancer - Chronic hepatitis — particularly viral; CEA is mildly elevated during active inflammation - Alcoholic liver disease Inflammatory bowel disease — Crohn's disease and ulcerative colitis produce a mild chronic CEA elevation from mucosal inflammation. Gallstone disease and pancreatitis — biliary obstruction from any cause impairs CEA clearance, causing it to accumulate. Benign pulmonary conditions — COPD, bronchiectasis, chronic pneumonia. Smoking — as noted, physiologically elevates CEA. When CEA is mildly elevated in a patient without an oncological history, the first priority is to exclude hepatic pathology and inflammatory disease — through liver function tests and clinical assessment. How to Prepare for a CEA Blood Test CEA is measured in venous blood. No demanding preparation is required, but a few rules improve reproducibility: - Blood is drawn fasting (8–12 hours) — food has minimal impact on CEA, but fasting standardises conditions for serial comparisons. - Smoking — refrain for 1–2 hours before the draw. Acute nicotine exposure minimally raises CEA; more importantly, smoking status should always be noted when interpreting results. - Always use the same laboratory for serial monitoring: different immunoassay platforms yield non-comparable absolute values. Switching laboratories mid-monitoring requires cross-calibration. - High-dose biotin interferes with immunoassays — discontinue 48 hours before the draw. A specific note on post-surgical interpretation: after tumour resection, CEA falls slowly — the half-life is approximately 2–8 days. The first follow-up test should not be performed earlier than 4–6 weeks after surgery. Values measured in the first post-operative weeks are unreliable due to the inflammatory response and tumour cell breakdown. CEA Trends: How to Interpret Changes Over Time In oncological monitoring, the trend matters far more than any single value. Falling CEA after surgery or chemotherapy is a good prognostic sign and indicates treatment effectiveness. After curative tumour removal, CEA should normalise within 4–8 weeks. Rising CEA after a period of normalisation is a warning sign of possible recurrence. A 30–50% rise from the established nadir on two consecutive measurements 4–6 weeks apart warrants imaging — CT, PET. Persistently elevated CEA with no downward trend during treatment suggests an insufficient response and may prompt a treatment plan revision. Transient early rise in the first 6–8 weeks of chemotherapy — the so-called "flare" phenomenon — is a recognised reaction that does not indicate progression. Treatment should not be changed on the basis of a single early elevation. CEA is never interpreted in isolation — always in combination with imaging and clinical findings. When to See a Doctor Scheduled referral to an oncologist or gastroenterologist when: - CEA above 10 ng/mL in a non-smoker on first-time testing with no oncological history - CEA mildly elevated alongside bowel symptoms — rectal bleeding, change in bowel habit, unexplained weight loss - CEA is rising on serial monitoring in a patient with previously treated malignancy Not a cause for alarm: - CEA 3–6 ng/mL in a smoker without symptoms - Mildly elevated CEA on a background of known cirrhosis or chronic hepatitis with stable values - A single isolated result without a trend and without symptoms A mildly elevated CEA in an otherwise healthy person calls for clinical assessment — not immediate colonoscopy. The appropriate workup is determined by the physician, weighing risk factors, symptoms, and a repeat measurement 4–8 weeks later. Do not interpret tumour markers on your own. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/folate https://labreadai.com/en/indicators/folate Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Folate is essential for DNA synthesis and lowering homocysteine. Normal serum and red cell ranges, causes of deficiency, link with B12 and pregnancy. Indicators article Folic acid is strongly associated with pregnancy — and rightly so, but that association captures only part of the picture. Folate is needed by every dividing cell: bone marrow, mucosal lining, immune cells. Its deficiency produces the same blood count picture as vitamin B12 deficiency — enlarged immature red cells and falling haemoglobin. This is precisely why these two markers are always measured together: an identical haematological pattern, but fundamentally different mechanisms and consequences. Here is what folate does, when it becomes deficient and how to identify it. What Is Folate and Why Is It Needed Folate is the collective name for a group of water-soluble B9 vitamins. In food it exists as folates (polyglutamate forms); in supplements and fortified foods as folic acid (a synthetic monoglutamate form with higher bioavailability). The body cannot synthesise folate — it comes exclusively from diet or supplementation. Inside the cell, folate performs two key biochemical roles. The first is nucleotide and DNA synthesis. Active folate (tetrahydrofolate) participates in producing purines and thymidine — the building blocks of DNA. Without adequate folate, cells cannot divide normally: DNA is synthesised with errors, cells grow large but cannot complete mitosis. This is what produces megaloblastic anaemia with enlarged immature red cells — an elevated MCV on the complete blood count. The second is homocysteine metabolism. Folate (together with vitamins B12 and B6) participates in remethylating homocysteine to methionine. Homocysteine is a toxic intermediate of amino acid metabolism. Its excess damages the vascular endothelium, raises the risk of thrombosis and atherosclerosis, and during pregnancy increases the risk of neural tube defects. Folate deficiency → rising homocysteine → vascular and neurological consequences. The critical distinction from vitamin B12: folate does not participate in myelin synthesis. Therefore, folate deficiency causes anaemia but does not cause neuropathy or spinal cord damage — that is the exclusive domain of B12 deficiency. Normal Folate Levels in Blood Folate can be measured in two ways, each carrying distinct information. Serum folate reflects current dietary intake over the preceding few days. It responds quickly to dietary changes: a week without green vegetables and serum folate falls, even if cellular stores are still adequate. Red cell folate reflects intracellular stores accumulated over the past 2–3 months (the lifespan of a red blood cell). It is a far more stable and clinically meaningful marker: it does not respond to short-term dietary variation and reflects true tissue folate status. Measure Normal range ------ Serum folate 7–45 nmol/L (3.1–20 ng/mL) Red cell folate 370–1470 nmol/L (163–649 ng/mL) Deficiency (serum) < 7 nmol/L Borderline (serum) 7–10 nmol/L Reference ranges at your specific laboratory may differ. Always use the values printed on your own lab report. Two practical conclusions from this distinction: When the goal is to assess actual folate status — red cell folate is preferred, or both measures together. A normal serum folate with low red cell folate indicates that dietary intake has recently improved, but cellular stores have not yet recovered. For standard biochemical screening — serum folate is sufficient. Frank deficiency (< 7 nmol/L) is captured well by both methods. How to Prepare for a Folate Blood Test Fasting. Blood should be drawn fasting — 8–12 hours. This is especially important for serum folate: eating foods rich in green vegetables or fortified products transiently raises the serum level. Folic acid supplements. If the patient is taking folate or multivitamin supplements, the serum folate result will reflect their intake rather than true tissue status. Ideally, stop supplements 2 weeks before the test for diagnostic (not monitoring) purposes. If the goal is to monitor therapy response, continue as usual. Alcohol. Avoid for 24–48 hours. Alcohol impairs folate absorption in the small intestine and accelerates its urinary excretion. Test with B12 simultaneously. Both markers are drawn in a single blood sample. Differential diagnosis of megaloblastic anaemia is impossible without knowing both values. Light and temperature. Folate is light-sensitive — samples must be protected from direct sunlight during transport. Quality laboratories observe this protocol as standard. Folate Deficiency: Causes Folate deficiency develops faster than B12 deficiency: body stores are relatively small (5–20 mg, mainly in the liver) and are depleted within 3–4 months of zero intake. Cause Mechanism Who is at risk --------- Inadequate dietary intake Primary cause; folate is found in dark leafy vegetables, legumes, liver, eggs. When the diet is completely devoid of fresh vegetables and fruit, vitamin C is simultaneously depleted — in such cases scurvy may develop as a co-occurring feature of combined nutritional deficiency Unbalanced diet, elderly, socioeconomically deprived Pregnancy and lactation Demand rises sharply (to 600 µg/day vs 400 µg for non-pregnant) All pregnant women without supplements Alcohol use disorder Impaired absorption + poor diet + accelerated urinary loss Chronic alcohol overuse Coeliac disease and Crohn's disease Small intestinal mucosal atrophy → impaired absorption IBD and coeliac disease Methotrexate use Direct dihydrofolate reductase antagonist — blocks folate activation Oncology patients, rheumatoid arthritis Sulfasalazine, trimethoprim Partial inhibition of folate metabolism Patients on these drugs Haemodialysis Folate lost across the dialysis membrane End-stage renal failure Haemolytic anaemia Accelerated red cell turnover requires more folate Sickle cell disease, thalassaemia Symptoms of folate deficiency. Unlike B12 deficiency, the clinical picture of folate deficiency is almost entirely haematological. There are no neurological deficits — this is the defining differential feature. - Weakness, rapid fatigue, dyspnoea on exertion — from anaemia - Pallor, sometimes with a faint yellow tinge — from destruction of defective red cells - Inflamed tongue (glossitis) — present but less common than in B12 deficiency - Gastrointestinal symptoms: diarrhoea, reduced appetite - In pregnancy: neural tube defects (anencephaly, spina bifida) when deficiency occurs in the periconceptional period — which is why supplements are prescribed 1–3 months before planned conception High Folate: When It Is Elevated Folate above the reference range is far less clinically significant than deficiency. However, a few situations deserve attention. Supplement use and fortified foods — the most common cause of high serum folate. Not pathological as such, but very high folate ( 45 nmol/L) with simultaneously low or normal B12 creates a diagnostic problem: excess folate can "mask" the haematological signs of B12 deficiency, allowing anaemia to remain absent while neurological damage from B12 deficiency progresses. This is not theoretical — cases of severe neuropathy have been described in patients with normal blood counts who were taking high-dose folic acid. Pernicious anaemia. Paradoxically, in severe B12 deficiency (especially pernicious anaemia) serum folate can be elevated: impaired cellular folate uptake due to dysfunction of the "methyl trap" mechanism causes folate to accumulate in the blood rather than entering cells. Vegetarian and vegan diets — abundant green vegetables, legumes and fortified foods physiologically raise folate; not pathological. Folate and Vitamin B12: Distinguishing the Two Deficiencies This is a practically critical question, since both deficiencies produce an identical haematological picture — megaloblastic anaemia with elevated MCV. The distinction is vital because treatment is fundamentally different. Feature Folate deficiency Vitamin B12 deficiency --------- Macrocytosis (↑ MCV) Yes Yes Low haemoglobin Yes Yes Neuropathy, ataxia No Yes — the distinguishing feature Serum folate ↓ Normal or mildly reduced Serum B12 Normal or secondarily reduced ↓ Red cell folate ↓ ↓ (secondary — methyl trap) Homocysteine ↑ ↑ Methylmalonic acid Normal ↑ (specific for B12) The key differentiating tests are methylmalonic acid (elevated only in B12 deficiency) and the patient's neurological status. Red cell folate in B12 deficiency is often secondarily reduced — this does not indicate a primary folate deficiency. The critical clinical rule: treating an unrecognised B12 deficiency with folic acid alone is dangerous. The anaemia will improve, but neurological damage will continue to progress. Full detail in the B12-deficiency anaemia article. Full anaemia work-up is performed with a complete blood count that includes haemoglobin and MCV. When to See a Doctor - Pregnancy planning — begin folic acid supplementation 1–3 months before conception, without waiting to confirm pregnancy. Neural tube defects form at weeks 3–4 after fertilisation — when most women are not yet aware they are pregnant - Megaloblastic anaemia (MCV 100 fL, reduced haemoglobin) — mandatory simultaneous measurement of folate and B12 to select the correct treatment - Methotrexate or sulfasalazine use — routine folate monitoring; prophylactic supplementation is typically co-prescribed with these drugs - Chronic inflammatory bowel disease — malabsorption risk; regular folate and B12 monitoring is mandatory - Alcohol use disorder — routine nutritional status screening - Elderly patients with anaemia and neurological symptoms — simultaneous assessment of folate, B12 and homocysteine Folate is one of the few nutrients whose deficiency is preventable by straightforward measures: a varied diet rich in green vegetables and legumes meets the daily requirement of most adults without supplements. The exception is pregnancy and lactation, where demand rises sharply enough that targeted supplementation cannot be avoided. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/renin https://labreadai.com/en/indicators/renin Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Renin controls blood pressure through the RAAS. Normal blood levels, high and low renin causes, the renin-aldosterone ratio and how to prepare for the test. Indicators article Blood pressure refuses to respond to standard medications. Potassium is low for no obvious reason. The doctor orders renin and aldosterone simultaneously — but it is unclear why this particular test is needed and what the results mean. Renin is not a routine blood marker; its value is correctly read only alongside aldosterone and in clinical context. What Renin Is and Its Role in the RAAS Renin is a proteolytic enzyme (aspartyl protease) synthesised by the juxtaglomerular cells of the renal afferent arterioles. Its principal biological function is to initiate the renin-angiotensin-aldosterone system (RAAS) — the central regulator of blood pressure and fluid-electrolyte balance. The RAAS cascade works as follows. When the kidneys detect a fall in afferent arteriolar pressure, reduced sodium delivery to the tubules, or sympathetic nervous system activation, the juxtaglomerular cells release renin into the bloodstream. Renin cleaves angiotensinogen (a protein made by the liver) to angiotensin I. Angiotensin-converting enzyme (ACE) in the pulmonary and vascular endothelium converts angiotensin I to angiotensin II — a potent vasoconstrictor that narrows blood vessels and simultaneously stimulates the adrenal cortex to produce aldosterone, which retains sodium and water in the kidneys, further raising blood pressure. This is a closed-loop negative feedback system: once pressure and blood volume normalise, renin secretion is suppressed. Understanding this cascade is essential for interpreting the test: the renin level reveals where the signal to raise aldosterone is coming from — from the adrenal gland itself (in which case renin is suppressed) or from a systemic pressure or volume disturbance (in which case renin is elevated). Renin is measured in two formats: - Plasma renin activity (PRA) — a functional assay measuring the rate of angiotensin I generation in vitro: result in ng/mL/h - Direct renin concentration (DRC) — an immunological measurement of renin molecule count: result in µIU/mL or pg/mL Both formats are used for renin-to-aldosterone ratio (RAR) calculation, but reference ranges and threshold values differ. Always confirm which method your laboratory uses. Normal Renin Blood Levels Reference values depend critically on body position at the time of collection and on the measurement method. Approximate ranges for plasma renin activity: Body position PRA (ng/mL/h) ------ Supine (recumbent) 0.2–1.6 Standing (upright) 0.7–3.3 For direct renin concentration: 2–35 µIU/mL supine, 4–46 µIU/mL standing. Always compare against the reference ranges on your own laboratory report. Key physiological factors affecting renin levels: Posture: transitioning from supine to standing raises PRA two- to threefold within 30–60 minutes. This is why the standard protocol strictly specifies position and duration before blood collection. Diet: a low-sodium diet stimulates renin (reduced circulating volume); a high-sodium diet suppresses it. Non-standard dietary intake in the week before the test substantially shifts the result. Age: renin physiologically declines with age — normal values in older adults are lower than in younger individuals. Pregnancy: the RAAS is physiologically activated; renin and aldosterone are elevated two- to threefold — this is normal, not pathological. Menstrual cycle phase: renin is modestly higher in the luteal phase. How to Prepare for a Renin Blood Test Renin is among the most condition-sensitive hormonal tests in clinical practice. Inadequate preparation renders the result uninterpretable. Diet and lifestyle: - For 2 weeks: maintain usual salt intake — neither restrict nor increase it - The day before: avoid heavy meals, alcohol and intense physical exertion - On the day of the test: morning blood draw before 10:00 a.m. Body position — critical: - Recumbent sample: at least 30 minutes lying flat before collection - Upright sample: 2 hours of standing or sitting with legs down before collection; used as a supplementary test when primary hyperaldosteronism is suspected Medication washout — only under medical supervision, as stopping antihypertensives may be unsafe: - ACE inhibitors and angiotensin receptor blockers: raise renin → false-positive elevation; stop 2 weeks before - Beta-blockers: lower renin → false-negative results; stop 2 weeks before - Spironolactone and eplerenone: markedly raise renin after washout; stop 4–6 weeks before - Thiazide and loop diuretics: raise renin; stop 2 weeks before - NSAIDs: lower renin; stop 1 week before Renin and aldosterone must always be drawn simultaneously under identical conditions — a time gap between the two collections invalidates the RAR calculation. Baseline electrolyte panel assessment is mandatory alongside renin: the potassium level affects both renin and aldosterone and is essential for interpretation. Causes of High Renin Elevated renin means the RAAS is receiving a signal that blood volume or pressure is insufficient and is actively trying to restore it. This may reflect true reduced perfusion or pathological volume loss. Secondary hyperaldosteronism — the most common cause of high renin: - Heart failure: reduced cardiac output → the kidneys perceive inadequate perfusion → RAAS activation - Liver cirrhosis with ascites: fluid redistribution into the peritoneal cavity reduces effective circulating volume - Nephrotic syndrome: protein loss lowers oncotic pressure - Renal artery stenosis: renal ischaemia is a direct stimulus for juxtaglomerular renin release; the classic cause of renovascular hypertension resistant to treatment - Diuretic use, low-sodium diet, blood loss, dehydration Renovascular hypertension — an important specific form: atherosclerotic stenosis or fibromuscular dysplasia of the renal artery. Renin is markedly elevated, aldosterone is reactively elevated. Suspect this in treatment-resistant hypertension in a young woman, or when renal asymmetry is found on ultrasound. Renin-secreting tumour (reninoma) — rare: a juxtaglomerular cell tumour autonomously secretes renin → extremely high renin, high aldosterone, severe hypertension and hypokalaemia in a young patient. Distinguished from primary hyperaldosteronism by markedly elevated rather than suppressed renin. Acute kidney injury and end-stage renal disease: renal parenchymal ischaemia activates the juxtaglomerular apparatus. Hypothyroidism and Addison's disease (adrenal insufficiency): sodium wasting activates the RAAS. Causes of Low Renin Suppressed renin indicates autonomous secretion of aldosterone or other mineralocorticoids independent of blood pressure and volume status. Primary hyperaldosteronism — the most clinically important cause of suppressed renin. An adrenal adenoma (aldosteronoma) or bilateral adrenal hyperplasia autonomously secretes aldosterone, raising pressure "from within" → the RAAS shuts off via negative feedback → renin is suppressed. The combination of low renin and high aldosterone is the diagnostic key. Essential hypertension with low renin ("low-renin hypertension"): a subset of patients with ordinary hypertension have chronically suppressed renin — probably through subclinical sodium retention. This form responds particularly well to thiazide diuretics and aldosterone antagonists. Cushing's syndrome: excess cortisol exerts weak mineralocorticoid activity, retains sodium and suppresses renin. Congenital adrenal hyperplasia (11β-hydroxylase or 17α-hydroxylase defects): accumulation of intermediate steroids with mineralocorticoid activity suppresses renin. Liddle's syndrome: a rare genetic condition in which epithelial sodium channels (ENaC) are constitutively activated → sodium retention without aldosterone → both renin and aldosterone are suppressed in the presence of hypertension and hypokalaemia. NSAIDs, beta-blockers, ciclosporin: pharmacological suppression of renin synthesis. The Renin-to-Aldosterone Ratio The renin-to-aldosterone ratio (RAR) is a calculated index that distinguishes primary from secondary hyperaldosteronism. It is the number-one screening tool for resistant hypertension. Formula: RAR = aldosterone (pg/mL or ng/dL) ÷ plasma renin activity (ng/mL/h) Interpretation: Pattern Conclusion ------ Aldosterone ↑ + Renin ↓ → RAR 30 Primary hyperaldosteronism Aldosterone ↑ + Renin ↑ → RAR < 10 Secondary hyperaldosteronism Aldosterone normal + Renin ↓ → RAR elevated Low-renin essential hypertension Aldosterone ↓ + Renin ↓ Liddle's syndrome, exogenous glucocorticoids Important limitations of the RAR: the ratio cannot be interpreted without the absolute aldosterone value. Low renin with normal aldosterone produces an elevated RAR — this is a calculation artefact, not primary hyperaldosteronism. A positive RAR ( 30 with aldosterone 150 pg/mL) requires confirmatory functional testing before any diagnosis is made. Simultaneous measurement of electrolytes (hypokalaemia supports the diagnosis) and kidney function is mandatory: eGFR affects both renin secretion and the interpretation of results in patients with chronic kidney disease. When to See a Doctor The renin test is ordered by an endocrinologist or cardiologist for specific clinical indications — it is not a routine blood marker. Testing for renin is warranted when one or more of the following apply: - blood pressure uncontrolled on three or more medications at full doses; - hypokalaemia (potassium below 3.5 mmol/L) without an obvious cause on a normal diet; - severe hypertension in a young patient without a family history of essential hypertension; - incidentally discovered adrenal tumour on CT or MRI; - suspected renovascular hypertension (renal size asymmetry, systolic bruit over the renal arteries); - monitoring of a patient with established primary or secondary hyperaldosteronism. Renin is analytically and preanalytically complex. An isolated result without aldosterone, electrolytes and knowledge of current medications cannot be interpreted. Do not draw independent conclusions — this test is always read in clinical context by an endocrinologist. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/troponin https://labreadai.com/en/indicators/troponin Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Troponin is the key marker of heart muscle damage. hsTnI and hsTnT normal values, dynamics in infarction, non-cardiac causes and when to seek emergency care. Indicators article Troponin is a protein that in healthy people exists exclusively inside cardiomyocytes. When heart muscle cells die, troponin is released into the bloodstream — and its presence there is essentially direct evidence of myocardial injury. This is why troponin has become the central biomarker in heart attack diagnosis, replacing older and less specific markers. But elevated troponin is not always a heart attack — and understanding that distinction is critically important. What Troponin Is and Why It Is Heart-Specific Troponin is a regulatory protein complex that controls the interaction between actin and myosin during muscle contraction. It consists of three subunits: troponin C (TnC), troponin I (TnI), and troponin T (TnT). Two types are clinically relevant: Cardiac troponin I (cTnI) — expressed exclusively in cardiomyocytes. Skeletal muscle contains a different TnI isoform that is not detected by cardiac-specific antibodies. This makes cTnI a highly specific marker of cardiac injury. Cardiac troponin T (cTnT) — also cardiac-specific, though present in trace amounts in regenerating skeletal muscle. Modern fourth- and fifth-generation assays (high-sensitivity troponin T, hsTnT) are sufficiently selective. In healthy individuals, troponin barely enters the blood: cardiomyocytes do not turn over the way blood cells do. Any significant elevation signals either necrosis or reversible myocardial injury with disrupted cell membrane integrity. This is why troponin is the cornerstone of myocardial infarction diagnosis in contemporary clinical guidelines. Troponin Normal Ranges: Standard and High-Sensitivity Assays Reference values depend substantially on the assay platform and specific analyzer. Always use the reference range printed by the specific laboratory — not a generic table. Assay / marker Normal (99th percentile) Notes --------- Standard TnI (4th generation) < 0.04–0.10 ng/mL (assay-dependent) Less sensitive; rises later Standard TnT (4th generation) < 0.01–0.03 ng/mL Standard before hsTnT adoption High-sensitivity hsTnI < 16–52 ng/L (sex- and assay-dependent) Male threshold higher than female High-sensitivity hsTnT < 14–19 ng/L Unified thresholds for both sexes in most assays Diagnostically relevant thresholds with high-sensitivity assays: hsTn level Probability of acute MI ------ Below normal Acute MI extremely unlikely (NPV 99%) Within normal but 20% rise over 1–2 hours High probability of acute MI Above normal, moderate dynamics Requires differential diagnosis Markedly elevated ( 5× ULN) Acute MI, chronic disease, or multi-organ injury Important: female reference values for hsTnI are 40–50% lower than male values on average. Applying a "male" threshold to women reduces the sensitivity of MI diagnosis in this group. How to Test Troponin and Why Serial Measurement Matters Troponin is not a one-time measurement — it is a dynamic assay. A single value is almost never sufficient to diagnose or rule out acute myocardial infarction. Troponin kinetics in acute MI: - Onset of rise: 2–4 hours after onset of necrosis - Peak: 12–24 hours (earlier with successful reperfusion) - Normalization: 7–14 days (TnI), 10–14 days (TnT) Standard protocol for suspected acute coronary syndrome: - Blood draw at presentation (0 hours) - Repeat at 1–2 hours (0/1h or 0/2h protocol with high-sensitivity assays) - Additional measurement at 3–6 hours if needed The diagnostically significant finding is a rise or fall (delta) in troponin on serial measurement — the hallmark of an acute, dynamically evolving process. A persistently elevated troponin without significant delta more often reflects chronic myocardial injury (chronic heart failure, renal failure) rather than acute infarction. No special preparation is required. The test can be drawn at any time, fasting or not — neither affects troponin levels. Causes of Elevated Troponin: Cardiac and Non-Cardiac Elevated troponin means myocardial injury — but not necessarily infarction. This is a fundamental distinction. Acute cardiac causes: Condition Pattern of elevation ------ Acute myocardial infarction Acute rise with delta, often marked Unstable angina Minimal rise or normal Myocarditis Moderate elevation, slow dynamics Tachyarrhythmia (AF, VT) Mild elevation during prolonged episode Hypertensive crisis Moderate elevation with target organ damage Acute heart failure Proportional to severity Acute non-cardiac causes: - Pulmonary embolism — acute right ventricular pressure overload causes subendocardial ischemia and troponin elevation in 30–50% of patients with massive PE - Sepsis and critical illness — systemic inflammation and microcirculatory failure injure cardiomyocytes - Acute stroke — neurogenic myocardial injury, particularly in subarachnoid hemorrhage - Rhabdomyolysis — massive skeletal muscle breakdown can affect the myocardium Chronic causes of stably elevated troponin: - Chronic heart failure - Chronic kidney disease — impaired troponin clearance and accumulation - Hypertrophic cardiomyopathy - Chemotherapy and cardiotoxic agents - Severe diabetes with cardiac autonomic neuropathy In chronic troponin elevation, C-reactive protein and a complete blood count help assess systemic inflammation and exclude infectious causes of myocardial damage — myocarditis and endocarditis. High-Sensitivity Troponin: What Changed in Diagnosis The transition to high-sensitivity assays (hsTn, 5th generation) is one of the most important advances in cardiac diagnostics of the past decade. What high-sensitivity assays deliver: - Detection of troponin in blood of 50–90% of healthy individuals (previously < 5%): it became clear that "undetectable" troponin was a measurement limit, not a biological reality - Shorter diagnostic protocols: acute MI can be excluded within 1–2 hours rather than 6–12 with standard assays - Identification of "chronically elevated" troponin as an independent cardiovascular risk marker - Detection of small infarctions previously missed due to insufficient assay sensitivity The trade-off for sensitivity: reduced specificity. High-sensitivity troponin is more frequently elevated in non-cardiac conditions — renal failure, sepsis, PE — requiring careful clinical contextualization. CK-MB retains its role in diagnosing reinfarction: it normalizes within 48–72 hours (faster than troponin), so a new CK-MB rise against a background of already-elevated troponin confirms reinfarction. False Results: When Troponin Can Mislead Despite its specificity, troponin is not without analytical pitfalls. Falsely elevated troponin: - Heterophilic antibodies — a rare but documented phenomenon: antibodies in the patient's serum cross-react with assay reagents, producing a false-positive. Characteristic pattern: very high level with no clinical symptoms and no delta on repeat testing with a different assay platform - High-dose biotin — like HbA1c, interferes with certain immunoassay formats - Rheumatoid factor — occasionally produces a technical artifact with hsTnT in rare cases Falsely normal troponin (missed infarction): - Blood draw too early (< 2 hours from symptom onset) — troponin has not yet risen - Using a standard rather than high-sensitivity assay for a small infarction - Pre-analytical errors: prolonged storage at room temperature, wrong collection tube When a false result is suspected: repeat measurement 1–3 hours later with a different assay platform or at a different laboratory. When Elevated Troponin Requires Emergency Action Troponin is not a routine screening test — it is measured for specific clinical indications. Any troponin elevation requires medical evaluation, but the urgency depends on the clinical picture. Call emergency services immediately if troponin elevation is accompanied by: - Chest pain, breathlessness, or loss of consciousness — regardless of the level - Rapid rising dynamics on serial measurement - ECG changes (ST elevation or depression, new left bundle branch block) - Hemodynamic instability: falling blood pressure, acute pulmonary edema Scheduled outpatient evaluation for stable patients with mildly and stably elevated troponin — to clarify the chronic underlying cause (heart failure, renal disease, cardiomyopathy). Troponin is not a preventive screening test for asymptomatic people. An unexpectedly elevated troponin discovered incidentally during testing for another reason is always a reason to discuss the finding with a cardiologist or GP. This article is for informational purposes only and does not replace professional medical advice. Call emergency services immediately if you experience chest pain or suspect a heart attack. https://labreadai.com/en/indicators/vitamin-a https://labreadai.com/en/indicators/vitamin-a Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Vitamin A (retinol): normal blood levels, deficiency and toxicity symptoms. Risk groups, causes of low retinol, safe supplementation and test preparation explained. Indicators article The first sign many patients notice themselves is difficulty adapting their eyes in dim light: a familiar room becomes hard to navigate, and oncoming headlights are blinding in a way they never used to be. Impaired twilight vision is not merely an inconvenience — it is an early biomarker of retinol deficiency. A blood test for vitamin A can reveal the problem before more serious consequences take hold. What Vitamin A Is and Its Different Forms Vitamin A is a group of fat-soluble compounds that share a common biological action. In the body it exists in two primary forms: retinol — preformed vitamin A obtained from animal foods — and carotenoids, the plant-derived provitamins A that are converted into retinol in the intestinal wall. The most familiar carotenoid is beta-carotene, responsible for the orange colour of carrots and pumpkin. The biological functions of vitamin A span three critical systems. The first is vision: retinol is a structural component of rhodopsin, the light-sensitive pigment of retinal rod cells. Rhodopsin captures photons in dim light and converts the light signal into a nerve impulse. This is precisely why retinol deficiency impairs twilight and night vision before any other symptom appears. The second system is immunity. Vitamin A is required for the differentiation and maturation of T-lymphocytes and mucosal epithelial cells, which form the primary barrier against infection. Retinol deficiency dramatically increases mortality from measles and diarrhoeal disease in children — this is among the most robust findings in nutritional epidemiology. The third is cellular growth and differentiation. Through nuclear receptors (RAR and RXR), vitamin A regulates the expression of hundreds of genes governing cell division and specialisation in the skin, respiratory epithelium and gastrointestinal tract. In deficiency, normal columnar epithelium is replaced by keratinising squamous cells — a process called squamous metaplasia. Retinol is transported in blood by retinol-binding protein (RBP), the synthesis of which requires both zinc and dietary protein. This is why zinc deficiency can lower plasma retinol even when hepatic stores are normal: the liver holds vitamin A but cannot release it without RBP. Normal Vitamin A Blood Levels Vitamin A in blood is measured as plasma retinol by high-performance liquid chromatography (HPLC). Status Plasma retinol level ------ Normal 1.05–3.50 µmol/L (30–100 µg/dL) Suboptimal 0.70–1.05 µmol/L Deficient < 0.70 µmol/L Severely deficient < 0.35 µmol/L Potentially toxic 3.50 µmol/L Reference ranges vary between laboratories — always compare against the values printed on your own report. An important interpretive caveat: plasma retinol is not the most sensitive marker of body stores. The liver holds 85–90% of total vitamin A and sustains normal plasma levels for a prolonged period by gradually drawing down hepatic reserves. A fall in plasma retinol occurs only when hepatic stores are already substantially depleted. More precise assessments — the relative dose response (RDR) test and isotope dilution — are used in research, not routine clinical practice. Reference ranges are lower in children than in adults. In pregnancy, levels decline modestly in the third trimester as retinol is transferred to the fetus. Acute-phase proteins released during any inflammatory condition reduce hepatic RBP synthesis, falsely lowering plasma retinol. Vitamin A should never be interpreted during an active infection, pneumonia or other inflammatory illness. How to Prepare for a Vitamin A Blood Test Vitamin A is a fat-soluble analyte that is stable under correct storage conditions but sensitive to light exposure and dietary status before collection. Preparation: - Draw blood strictly fasting — 8–12 hours without food - Stop vitamin A supplements and multivitamins 24–48 hours beforehand - For one week before, avoid abnormally large amounts of carotenoid-rich foods (e.g. litres of carrot juice) - No smoking for 2 hours before the draw The blood tube must be shielded from light immediately after collection. Retinol degrades rapidly on exposure to ultraviolet light — the laboratory must handle the sample under protected conditions. For a comprehensive picture of nutritional status, a combined vitamin panel provides simultaneous assessment of multiple fat-soluble and water-soluble vitamins, eliminating the risk of an isolated false result and revealing co-existing deficiencies. Causes and Symptoms of Vitamin A Deficiency Vitamin A deficiency remains the leading preventable cause of childhood blindness globally: the WHO estimates 250 million pre-school children are affected. In high-income countries clinical deficiency is rare, but suboptimal levels are found in 5–10% of adults — particularly in at-risk groups. Main causes: - A diet low in retinol: strict veganism without dietary planning, monotonous diets in older adults - Impaired fat absorption: coeliac disease, Crohn's disease, cystic fibrosis, chronic pancreatitis, bariatric surgery. Since vitamin A is fat-soluble, absorption collapses when fat digestion is impaired regardless of dietary intake - Zinc deficiency: without adequate zinc, the liver cannot release stored retinol via RBP - Liver cirrhosis: a damaged liver loses its capacity to store vitamin A and synthesise RBP - Chronic alcoholism: impaired absorption and competition between alcohol and retinol for shared enzyme systems - Prematurity: the fetus accumulates most of its vitamin A reserves during the final trimester Clinical stages: Early deficiency presents as impaired twilight vision — nyctalopia ("night blindness"). This is fully reversible with repletion. Simultaneously, resistance to infections declines: patients experience more frequent respiratory and gastrointestinal infections, with prolonged recovery. Moderate deficiency adds skin and mucosal involvement: hyperkeratosis (dry, flaking skin, "goose flesh" on the upper arms and thighs), conjunctival dryness and reduced tear production. The skin loses elasticity and becomes prone to fissuring. Thinning of the respiratory and intestinal mucosa increases vulnerability to infection. Severe deficiency leads to xerophthalmia — progressive corneal disease. Dryness advances to Bitot's spots (greyish plaques on the conjunctiva), then to keratomalacia — softening and perforation of the cornea with irreversible blindness. At this stage, ocular damage is permanent. Hypervitaminosis A: The Risks of Excess Vitamin A is one of the few vitamins that accumulates in the liver and can reach toxic concentrations. Unlike water-soluble vitamins excreted rapidly by the kidneys, retinol is stored, and chronic overdose leads to serious consequences. Acute hypervitaminosis A develops after a single very large dose ( 200,000 IU in adults). It was historically documented in polar explorers who consumed polar bear or seal liver. Manifestations include severe headache, nausea, vomiting, vertigo and raised intracranial pressure. Chronic hypervitaminosis A is far more common and more insidious. It develops with sustained supplementation exceeding 10,000 IU/day over months to years. Symptoms accumulate gradually: dry and peeling skin (especially the lips), hair loss, bone and joint pain, chronic fatigue, hepatomegaly and elevated liver transaminases. The principal long-term risk is hepatotoxicity — fibrosis progressing to cirrhosis with very high doses sustained over years. The second serious risk is osteoporosis: chronically elevated retinol activates osteoclasts and suppresses osteoblasts, reducing bone mineral density and raising fracture risk. This effect is most pronounced in older women. Teratogenicity is an absolute contraindication to high doses in the first trimester of pregnancy. Retinoic acid is a potent regulator of embryogenesis: supplemental doses above 10,000 IU/day during pregnancy are associated with malformations of the heart, central nervous system and face. Carotenoids from plant foods are safe: their conversion to retinol in the intestine is tightly regulated and does not cause hypervitaminosis A. Carotenaemia — yellow-orange skin discolouration from dietary beta-carotene excess — is harmless and fully reversible. It is not hypervitaminosis A, as carotenoids are not converted to toxic retinol quantities. Vitamin A and Other Fat-Soluble Vitamins Vitamin A does not act in isolation. As a fat-soluble compound, it shares absorption and metabolic pathways with other fat-soluble vitamins — and between them exist both synergies and competition. Vitamin D and vitamin A share the RXR nuclear receptor. When both are simultaneously deficient, each deficiency worsens the other; correcting one without the other produces an incomplete response. This is particularly relevant for older patients and those in northern latitudes where both vitamins are systemically low. Vitamin E — the primary fat-soluble antioxidant — protects retinol stores in cell membranes from oxidative degradation. When vitamin E is deficient, retinol is consumed more rapidly. Vitamin K2 governs calcium distribution in bone; its deficiency in the presence of excess vitamin A amplifies bone mineral loss. In practice: supplementing vitamin A in isolation without assessing the status of other fat-soluble vitamins is incomplete management. All fat-soluble vitamins also share a dependency on dietary fat for absorption — taking supplements on an empty stomach or with fat-free food dramatically reduces bioavailability. When to See a Doctor Testing for vitamin A is warranted when one or more of the following apply: - impaired twilight vision or abnormal sensitivity to bright light; - dry, flaking skin — particularly on the upper arms and thighs — without another explanation; - frequent respiratory or gastrointestinal infections; - diagnosed fat malabsorption: coeliac disease, Crohn's disease, chronic pancreatitis; - long-term supplementation with vitamin A above 5000 IU/day; - pregnancy planning or first trimester — to confirm a safe circulating level. Self-prescribing high-dose retinol supplements without a blood test is hazardous: chronic hypervitaminosis develops gradually and its early symptoms are non-specific. For a comprehensive evaluation of nutritional status, ask your doctor for a combined vitamin panel — a single assessment that reveals deficiencies and excesses across multiple vitamins simultaneously. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/vitamin-b12 https://labreadai.com/en/indicators/vitamin-b12 Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Vitamin B12 blood test: normal ranges for adults and elderly, classic deficiency symptoms, causes of low cobalamin, megaloblastic anemia and when to start treatment. Indicators article Fatigue, tingling in the hands and feet, persistent forgetfulness — these symptoms are easy to blame on stress or poor sleep. Yet behind them, surprisingly often, lies vitamin B12 deficiency: a condition that develops slowly over years and leaves irreversible damage in the nervous system if it goes undetected. A complete blood count is usually the first clue — enlarged red blood cells and falling haemoglobin — but confirmation requires a direct measurement of serum B12. This article explains what makes B12 irreplaceable, what normal and abnormal results look like, and what to do when deficiency is confirmed. What Is Vitamin B12 and What Does It Do? Vitamin B12, or cobalamin, is a water-soluble vitamin the body cannot synthesise on its own. It is obtained exclusively from animal-source foods: meat, fish, eggs, and dairy. In the stomach lining, a protein called intrinsic factor is produced — without it, B12 simply cannot be absorbed in the small intestine. This makes the journey from plate to cell unusually long and vulnerable. What B12 does at the cellular level: - DNA synthesis — B12 is a cofactor for an enzyme essential for cell division. Rapidly dividing cells — primarily blood cells and mucosal epithelium — are the first to suffer. - Myelin sheath formation — the vitamin participates in myelin synthesis, the protective coating around nerve fibres. Without it, nerve conduction becomes impaired, producing neurological symptoms. - Homocysteine conversion — B12 is required to convert homocysteine into methionine. Deficiency leads to homocysteine accumulation — an independent risk factor for cardiovascular disease. - Haematopoiesis — together with folate, B12 ensures normal maturation of red blood cell precursors in the bone marrow. The body's hepatic reserves are substantial — 2–5 mg — sufficient to sustain normal function for three to five years after intake completely stops. This is precisely why deficiency develops silently and goes unnoticed for so long. How to Get Tested: Preparation and What Is Measured Vitamin B12 is measured in serum using immunoassay or chemiluminescence methods. Functional deficiency markers — methylmalonic acid (MMA) and homocysteine — may also be ordered: they rise before serum B12 falls, revealing tissue-level deficiency when serum values are borderline. Preparation guidelines: - Blood is drawn fasting in the morning — no food for at least 8–12 hours. - Avoid alcohol and intense exercise for 24 hours. - B12 supplements must be stopped 1–2 weeks before the test — otherwise the result will appear falsely normal while tissue deficiency persists. - High-dose biotin interferes with immunoassay methods — discontinue 48 hours before the draw. - Metformin reduces intestinal B12 absorption: patients on long-term therapy should check their level every one to two years. For a complete anaemia workup, B12 results are interpreted alongside MCV and the full blood count: enlarged red blood cells (macrocytosis) with low B12 immediately point to a megaloblastic pattern. Vitamin B12 Normal Range: Table by Age and Group Reference ranges vary by analytical method and laboratory. The values below are approximate — always check the reference range on your own report. Category Normal (pmol/L) Normal (pg/mL) --------- Adults 148–664 200–900 Elderly ( 65 years) 148–664 200–900 Pregnant women 118–438 160–600 Infants under 1 year 216–935 293–1268 Children 1–12 years 185–779 251–1056 Adolescents 148–664 200–900 Interpretation zones for adults: - 300 pmol/L ( 406 pg/mL) — sufficient; deficiency unlikely - 148–300 pmol/L (200–406 pg/mL) — grey zone: tissue deficiency is possible even with a normal serum level; homocysteine and MMA should be assessed - < 148 pmol/L (< 200 pg/mL) — vitamin B12 deficiency requiring treatment In older adults, functional deficiency frequently develops at "normal" serum levels due to declining transcobalamin-II — the transport protein that delivers B12 into cells. This is another reason to rely on homocysteine rather than the raw serum value alone when clinical suspicion is high. Symptoms and Causes of Vitamin B12 Deficiency B12 deficiency mimics dozens of other conditions — which is what makes it clinically deceptive. Symptoms fall into haematological, neurological, and psychiatric categories. Haematological symptoms: - Weakness, shortness of breath on exertion, pallor — signs of anaemia - Burning and soreness of the tongue (Hunner's glossitis) - Slight yellowish skin tint from mild haemolysis Neurological symptoms (appear with prolonged deficiency): - Tingling, numbness, "pins and needles" in hands and feet - Impaired coordination, unsteady gait - Leg weakness - In severe cases — subacute combined degeneration of the spinal cord Cognitive and psychiatric symptoms: - Impaired memory and concentration - Depression and irritability - In older adults — a clinical picture that can mimic dementia An important caveat: neurological damage may be irreversible if deficiency goes untreated for a prolonged period. B12-deficiency anaemia responds well to treatment; neuropathy responds much less reliably. Causes fall into dietary and absorptive categories: - Insufficient intake — vegan and strict vegetarian diets without B12 supplementation. With an extremely restricted diet that excludes both animal products and fresh produce, vitamin C is depleted simultaneously: in this setting, scurvy can develop as a co-occurring manifestation of combined nutritional depletion - Atrophic gastritis — reduced or absent intrinsic factor secretion; the most common cause in older adults - Pernicious anaemia — autoimmune destruction of gastric parietal cells, completely blocking absorption - Gastric surgery — gastrectomy, bariatric procedures - Small bowel disease — Crohn's disease, coeliac disease, small intestinal bacterial overgrowth - Long-term metformin use — reduces B12 absorption in the ileum - Proton pump inhibitors taken for more than two years Megaloblastic Anaemia: How B12 Deficiency Changes the Blood Count The classic laboratory portrait of B12-deficiency anaemia is distinctive and immediately recognisable. Haemoglobin is reduced — below 120 g/L in women, below 130 g/L in men. But the hallmark is the size of the red blood cells. B12 deficiency impairs DNA synthesis in erythroid precursors: they cannot divide normally and grow large and immature — megaloblasts. In peripheral blood this appears as macrocytosis: MCV exceeds 100 fL, often reaching 110–120 fL. Simultaneously, the blood smear shows hypersegmented neutrophils — their nuclei contain five or more lobes instead of the normal two to three. This is a pathognomonic sign of megaloblastic haematopoiesis. In severe deficiency, all three cell lines are affected: pancytopenia develops — a simultaneous fall in red cells, white cells, and platelets. Ferritin in B12-deficiency anaemia is often normal or elevated — unlike iron deficiency anaemia, where it is reduced. This is a key differential diagnostic point when deciding on treatment. For the complete clinical picture, diagnostic criteria and treatment approach, see the dedicated article on megaloblastic anaemia. High Vitamin B12: When It Is a Warning Sign Finding excess B12 in the serum is surprising for most patients — after all, "a vitamin can't be harmful." In fact, it can be a signal worth investigating. Physiological reasons for high B12 (not dangerous): - Supplementation or high-dose injectable B12 - Diet very rich in animal products Pathological causes requiring investigation: - Liver disease — cirrhosis, acute hepatitis, fatty liver disease. Damaged hepatocytes release stored B12 into the circulation. - Myeloproliferative disorders — chronic myelogenous leukaemia, polycythemia vera, myelofibrosis. Tumour cells produce excessive amounts of B12 transport proteins. - Solid tumours — breast, colorectal, and gastric cancer. Persistently unexplained B12 above 1000 pmol/L without supplement use warrants oncological screening and liver function evaluation. Hypervitaminosis from oral supplements does not cause toxicity — excess is excreted in urine. However, supplementation can mask a pathologically elevated level of clinical significance. When Results Require Urgent Medical Attention Mild deficiency without pronounced symptoms calls for a scheduled appointment. Several situations require prompt evaluation: - B12 below 100 pmol/L — severe deficiency, regardless of how the person feels - Neurological symptoms: unsteady gait, limb numbness, weakness — even with borderline B12 - Haemoglobin below 80 g/L combined with macrocytosis - Pancytopenia — simultaneous decline in all three blood cell lines - Cognitive impairment or new depression in an older person with low B12 - Persistently elevated B12 without an obvious cause — rule out malignancy and liver disease Treatment depends on the underlying cause. For dietary deficiency, oral supplementation is sufficient. For absorption failure (atrophic gastritis, pernicious anaemia, gastrectomy), intramuscular injections of cyanocobalamin or hydroxocobalamin are required — the oral route does not work when intrinsic factor is absent. Conclusion Vitamin B12 is one of those deficiencies that is easy to miss but difficult to correct once neurological damage has taken hold. A normal serum level does not always mean adequate tissue supply — in borderline cases, homocysteine and MMA provide the missing piece of the picture. High-risk groups — vegans, older adults, post-gastric surgery patients, and long-term metformin users — should check their B12 at least annually. Treatment at any stage reverses the anaemia completely, but neurological recovery depends heavily on how early therapy begins. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/vitamin-c https://labreadai.com/en/indicators/vitamin-c Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Vitamin C is an antioxidant essential for immunity and collagen synthesis. Blood levels, deficiency symptoms, risk groups and when to order the ascorbic acid test. Indicators article A bruise appears from the lightest touch. Gums bleed during toothbrushing. A small cut that should heal in two days stays open for a week. These are the classic signs of vitamin C deficiency — ascorbic acid that the human body cannot synthesise on its own. A blood test for vitamin C reveals the actual absorbed level: not what is printed on a multivitamin label, but what is genuinely circulating in the plasma. What Vitamin C Does and Why It Matters Vitamin C (ascorbic acid) is a water-soluble vitamin and one of the primary intracellular antioxidants. Humans and other primates lost the gene for the enzyme required to synthesise ascorbic acid from glucose — without daily dietary intake, reserves deplete rapidly. The central biochemical role is collagen synthesis. Vitamin C serves as a cofactor for the hydroxylation of proline and lysine, without which collagen molecules cannot form stable cross-links. This is precisely why deficiency first affects tissues with high collagen turnover: gums, vessel walls and skin lose structural integrity and begin to bleed long before other symptoms appear. A second critical function is enhancing the absorption of non-haem iron in the intestine. Ascorbic acid converts ferric iron (Fe³⁺) to ferrous iron (Fe²⁺), which is absorbed two to four times more efficiently. This underpins the practical recommendation to take iron supplements alongside vitamin C-rich foods. Vitamin C is also required for the synthesis of noradrenaline and carnitine, activates neutrophils — the first-line cells of the immune response — and regenerates oxidised vitamin E: two antioxidants work as a pair, mutually maintaining and restoring each other. This synergy explains why supplementing one antioxidant in isolation is often insufficient. Normal Vitamin C Blood Levels Reference values depend on the analytical method — high-performance liquid chromatography (HPLC) is the most accurate. Results are expressed in µmol/L. Status Plasma level ------ Normal 28–85 µmol/L Suboptimal 11–28 µmol/L Deficient < 11 µmol/L Scurvy risk < 6 µmol/L Potentially toxic 85 µmol/L Ranges vary between laboratories — always compare against the reference interval on your own report. Smoking is the most important factor lowering levels: in smokers, vitamin C is on average 30–40% lower than in non-smokers at equivalent dietary intake, because oxidative stress from tobacco smoke accelerates ascorbic acid degradation. The recommended daily intake for smokers is 35 mg/day above the standard. Pregnancy, lactation and chronic inflammatory disease also sharply increase consumption. An important interpretive point: plasma vitamin C reflects short-term status (the preceding one to two weeks), while leucocyte levels more accurately represent long-term tissue stores. Plasma is the standard clinical measurement — more accessible and better standardised. How to Prepare for a Vitamin C Blood Test Vitamin C is one of the most analytically unstable laboratory measurements: ascorbic acid oxidises rapidly in light and on contact with oxygen. Failure to follow preanalytical protocols produces falsely low results. Preparation: - Stop vitamin C supplements and multivitamins 24–48 hours before the test - Blood should be drawn fasting (8–12 hours without food) - No smoking for 2 hours before the draw The laboratory must process the sample within 30 minutes of collection: blood is immediately shielded from light and placed on ice. Delays or sunlight exposure on the tube can halve the measured level — this reflects a handling error, not impaired metabolism. When several micronutrients need to be assessed simultaneously, identical preanalytical conditions for all analytes are best achieved with a combined panel. A standalone result without dietary context and clinical assessment is unreliable. Causes and Symptoms of Vitamin C Deficiency Suboptimal ascorbic acid status is more prevalent than commonly assumed: population studies find levels below the normal range in 13–23% of adults in high-income countries. Main causes: - A diet low in fresh fruit and vegetables — the primary cause; heat processing destroys 40–60% of vitamin C in food - Smoking: oxidative stress from tobacco accelerates degradation and increases requirements - Chronic alcoholism: impaired absorption and reduced dietary quality - Older age: narrowing of food variety and declining intestinal absorptive function - Inflammatory bowel disease: impaired micronutrient absorption - Haemodialysis: vitamin C is removed during each session; dialysis patients require supplementation - Serious illness or major surgery: requirements rise sharply for tissue repair Clinical stages: At the subclinical stage (11–28 µmol/L): non-specific complaints — chronic fatigue, irritability, reduced concentration and increased susceptibility to infections. The person does not connect these symptoms to a vitamin deficiency, which is why suboptimal levels often go undetected for years. At overt deficiency (< 11 µmol/L): characteristic signs emerge — bleeding and spongy gums, perifollicular haemorrhages (pin-point bleeds around hair follicles), delayed wound healing, joint and muscle pain, hair loss and skin hyperkeratosis. Worsening anaemia at this stage reflects both impaired iron absorption and ongoing blood loss from mucosal bleeding. Scurvy: The Extreme Stage of Ascorbic Acid Deficiency Scurvy develops when plasma vitamin C falls below 6 µmol/L — typically when intake is below 10 mg/day for four to twelve weeks. Historically it killed more sailors on long voyages than storms and battles combined: fresh produce ran out rapidly. Modern scurvy is not a historical curiosity. It is regularly identified in elderly people with monotonous diets, patients with severe depression and eating disorders, chronic alcoholics, and children on inadequate nutrition. Classic presentation: extensive gum haemorrhage, tooth loss, widespread skin bruising, severe limb pain, and progressive anaemia. Diagnosis is straightforward: plasma vitamin C level. Treatment is ascorbic acid supplementation; clinical symptoms begin to resolve within days and full recovery occurs over two to four weeks. Causes of Elevated Vitamin C Levels High vitamin C in plasma is almost exclusively caused by megadose supplementation (1000 mg/day or more). The vitamin is water-soluble and the kidneys actively excrete the surplus, but sustained megadoses carry real clinical risks. The principal risk is oxalate kidney stone formation: excess ascorbic acid is metabolised to oxalate, which crystallises in the urinary tract in predisposed individuals. The risk is clinically meaningful at regular intakes above 1000–2000 mg/day, particularly when fluid intake is inadequate. A second hazard is laboratory interference: high doses falsely lower blood glucose when measured by the glucose oxidase method, and can produce false-positive results on faecal occult blood tests. Vitamin C supplements should be stopped 24–48 hours before any blood or stool tests. Antioxidant defence functions as an interdependent network. Without sufficient zinc, selenium and other cofactors, megadoses of ascorbic acid cannot compensate for systemic micronutrient deficiency — and in some conditions (haemochromatosis, G6PD deficiency) may cause harm. When to See a Doctor Testing for vitamin C is warranted when one or more of the following apply: - bleeding gums or pin-point skin haemorrhages without a clear cause; - slow or failed wound healing; - marked fatigue despite adequate sleep and nutrition; - membership of a risk group: smoking, alcoholism, older age, inflammatory bowel disease, haemodialysis. Do not self-prescribe high-dose ascorbic acid: megadoses provide no additional benefit in people with normal levels but increase kidney stone risk in predisposed individuals. For a comprehensive assessment of vitamin and mineral status, ask your doctor for a vitamin panel — a single test that evaluates the full picture. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/indicators/zinc https://labreadai.com/en/indicators/zinc Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Zinc is essential for immunity, wound healing and DNA synthesis. Normal zinc blood levels, deficiency symptoms, risk groups and how to prepare for the test. Indicators article Hair is shedding more than usual. Small cuts take longer to heal than they should. Food has lost some of its flavour — as though someone turned the dial down. These symptoms are easy to attribute to stress or tiredness, yet behind them often lies zinc deficiency — a shortfall of the mineral without which hundreds of enzymes cannot function and DNA cannot be synthesised. A zinc blood test reveals the actual circulating level before symptoms become unmistakable. What Zinc Does in the Body Zinc is an essential trace element: it is not synthesised in the body and must be supplied daily through food. It is the second most abundant trace element in the body after iron. Approximately 85% of total zinc is stored in muscle and bone; the remainder is distributed across the liver, kidneys, retina, prostate and red blood cells. Zinc is a structural or catalytic component of more than 300 enzymes and influences the activity of over 1000 transcription factors. This is not an exaggeration — virtually every foundational biochemical process depends on zinc: DNA and RNA synthesis, cell division, carbohydrate metabolism, protein synthesis and DNA repair. Immune function is among the most studied roles. Zinc is required for the development and maturation of T-lymphocytes, neutrophils and natural killer cells. In deficiency, the thymus — where T-cells mature — shrinks and produces less thymulin. This is why zinc deficiency in children is associated with a marked rise in infectious disease susceptibility. Wound healing is another key domain. Zinc participates in all three phases: inflammation, proliferation and tissue remodelling. Surgeons have long noted that patients with zinc deficiency show slower post-operative wound closure and higher infection rates. The link with vitamin A is direct and practically important: zinc is required for the synthesis of retinol-binding protein (RBP), which transports vitamin A from the liver to peripheral tissues. When zinc is insufficient, RBP cannot be produced in adequate quantities — and plasma vitamin A falls even when hepatic retinol stores are intact. This is a classic example of one nutrient deficiency masquerading as another. Finally, zinc regulates testosterone: it inhibits aromatase, the enzyme that converts testosterone to oestradiol. Significant zinc deficiency in men independently lowers testosterone, manifesting as reduced libido, impaired sperm quality and increasing fatigue. Normal Zinc Blood Levels Zinc in blood is measured by atomic absorption spectrometry or inductively coupled plasma mass spectrometry (ICP-MS). Results are reported in µmol/L or µg/dL. Status Serum level ------ Normal 11.5–18.5 µmol/L (75–120 µg/dL) Suboptimal 9.0–11.5 µmol/L Deficient < 9.0 µmol/L Potentially toxic 30 µmol/L Reference ranges vary between laboratories — always compare against the values on your own report. Men have slightly higher levels than women; in pregnancy, zinc physiologically declines from the first trimester onwards as the fetus actively draws on maternal supplies. A critical interpretive limitation: serum zinc is an unreliable marker of total body stores. The body tightly defends blood zinc levels by mobilising tissue reserves, so a fall in serum zinc occurs late — only after tissue stores are already substantially depleted. A normal result does not guarantee tissue adequacy, and borderline values require clinical interpretation. A further limitation: acute infection, trauma and inflammation redistribute zinc from serum to the liver as part of the acute-phase response, producing a falsely low result. Zinc should not be interpreted during active inflammatory illness. How to Prepare for a Zinc Blood Test Serum zinc is exceptionally vulnerable to contamination. Zinc is present in rubber stoppers, latex gloves and some antiseptics — any contact with the sample produces a falsely elevated result. Patient preparation: - Strict fasting: 8–12 hours without food; water is permitted - Stop zinc supplements and multivitamins 24 hours before the draw - No smoking for 2 hours beforehand Laboratory preanalytics: - Trace-element tubes (zinc-free collection tubes) - Metal or plastic needles only — not rubber - Latex gloves must not contact the sample Failure to meet any of these conditions renders the result unreliable. If there is doubt about preanalytical quality, repeat the test at a laboratory specialising in trace elements. For a comprehensive assessment of nutritional status, a vitamin panel provides simultaneous measurement of zinc alongside magnesium, selenium and vitamins — revealing co-existing deficiencies that reinforce each other's symptoms and are invisible when tested in isolation. Causes and Symptoms of Zinc Deficiency The WHO estimates approximately 17% of the global population has suboptimal zinc status. In high-income countries, severe deficiency is uncommon but mild to moderate deficiency is substantially more prevalent than diagnosed. Main causes: Dietary insufficiency is the most widespread cause. Red meat, seafood (oysters are outstanding — 74 mg per 100 g) and poultry provide zinc in a highly bioavailable form. In vegetarians and vegans, zinc from grains and legumes has markedly reduced bioavailability due to phytates — they form insoluble complexes with zinc in the intestinal lumen. Impaired absorption: coeliac disease, Crohn's disease, short bowel syndrome and post-bariatric surgery. An inflamed or surgically altered intestinal mucosa loses its capacity for adequate zinc uptake. Increased losses: chronic diarrhoea (especially in children), extensive exudative skin conditions (burns, widespread psoriasis), and chronic renal failure. Haemodialysis actively removes zinc across the dialysis membrane. Competitive inhibition: high-dose iron supplementation ( 25 mg/day elemental iron) competes with zinc for the intestinal transporter DMT-1 and impairs zinc absorption. This is particularly relevant for pregnant women receiving large iron doses without zinc supplementation. Alcoholism: ethanol impairs intestinal zinc absorption and increases urinary losses. Clinical symptoms: Early signs are non-specific: impaired taste and smell (hypogeusia and hyposmia), reduced twilight vision, increased susceptibility to infection, and slower healing of wounds and skin fissures. Moderate deficiency adds: diffuse hair shedding (telogen effluvium), dry and flaky skin, brittle nails with white spots (leukonychia), reduced libido and — in men — impaired sperm quality. In children, moderate chronic deficiency impairs linear growth and delays puberty, making it one of the leading mechanisms of growth stunting in nutritionally deprived populations. Severe deficiency — typically in acrodermatitis enteropathica, a rare inherited disorder of zinc absorption — produces a florid picture: vesicular and pustular dermatitis around the mouth, on the extremities and perianally, alopecia, chronic diarrhoea and severe immunodeficiency with recurrent infections. Without treatment the condition is life-threatening. Causes of Elevated Zinc Levels True zinc excess is rare in clinical practice and almost always iatrogenic: prolonged high-dose zinc supplementation ( 40–50 mg/day of elemental zinc), occupational exposure to zinc oxide fumes (metal fume fever — an acute inflammatory condition), or accidental ingestion of zinc-containing objects by children or in psychiatric illness. Chronic zinc excess is harmful primarily through antagonism with other trace elements. The principal victim is selenium: excess zinc impairs intestinal selenium absorption and reduces activity of selenium-dependent enzymes (glutathione peroxidase, thioredoxin reductase). Simultaneously, copper status falls: zinc induces intestinal metallothionein, which binds copper with high affinity and blocks its absorption. Copper deficiency secondary to zinc excess presents as anaemia, peripheral neuropathy and neutropenia. Acute high-dose intoxication causes nausea, vomiting, abdominal pain and diarrhoea. Prolonged intake above 100 mg/day without medical indication produces an adverse lipid profile (reduced HDL cholesterol) and paradoxical immune suppression — the opposite of zinc's normal immunostimulatory role. Zinc and Other Trace Elements Trace elements are not isolated actors but participants in a tightly interconnected network. Understanding these interactions is essential for rational supplementation. Zinc and copper are classical antagonists. At physiological concentrations they compete for intestinal absorption; the optimal dietary Zn:Cu ratio is 8–15:1. Long-term zinc supplementation without monitoring copper levels predictably lowers copper to levels sufficient to cause anaemia and neurological dysfunction. Zinc and iron: high-dose iron ( 25 mg/day) suppresses zinc absorption via DMT-1 competition. For pregnant women with iron-deficiency anaemia and concurrent zinc deficiency, taking the two supplements separately — with a 2–3 hour interval — avoids mutual interference. Zinc and selenium interact at the level of antioxidant defence: both neutralise reactive oxygen species but through different mechanisms and in different cellular compartments. Their co-deficiency substantially impairs immune response and oxidative stress resistance compared with either isolated deficiency alone. Vitamin A and zinc: as established above, without adequate zinc the liver cannot release stored vitamin A into the bloodstream via RBP. In patients deficient in both (typical in regions with poor dietary diversity), correcting vitamin A without first correcting zinc fails to resolve the visual symptoms. Zinc must be restored first. When to See a Doctor Testing for zinc is warranted when one or more of the following apply: - unexplained diffuse hair shedding; - slow wound healing, chronic skin ulcers; - reduced sense of taste or smell; - frequent infections with prolonged recovery; - growth delay or delayed puberty in children; - membership of a risk group: vegetarianism, fat malabsorption, haemodialysis, alcoholism. Do not self-prescribe zinc supplements without a blood test. Zinc at 25–45 mg/day already competes with copper and can cause secondary copper deficiency with prolonged use. For a complete picture of nutritional status — including zinc, copper, selenium and vitamins — ask your doctor for a combined vitamin panel. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/hormone-panel https://labreadai.com/en/tests/hormone-panel Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Comprehensive hormone panel: thyroid hormones, cortisol, sex hormones and insulin. What the test includes, how to prepare and how to interpret abnormal results. Tests article Fatigue, hair loss, unexplained weight gain, irregular periods, low libido, mood swings — all of these complaints share one possible underlying cause: hormonal imbalance. Hormones regulate virtually every process in the body, and their disruptions rarely produce a clear-cut clinical picture. A comprehensive hormone panel addresses exactly this diagnostic challenge. What Is a Comprehensive Hormone Panel A comprehensive hormone panel is a set of blood tests that simultaneously evaluates several hormonal systems, providing an overall picture of a patient's endocrine status. Unlike specialised panels — for example, the thyroid panel or the sex hormone panel, each covering a single axis — a comprehensive hormone panel combines markers from several regulatory systems in one blood draw. This approach is particularly valuable for non-specific complaints: when symptoms are present but it is unclear which system to investigate first. The panel can cover multiple possible causes simultaneously, saving the time and cost of sequential testing. The composition of a hormone panel is not standardised — different laboratories offer different combinations. Understanding which hormones were ordered and what each one means is therefore essential. Which Hormones Are Included in the Panel Thyroid hormones: TSH (thyroid-stimulating hormone) is the primary regulator of thyroid function, produced by the pituitary gland. It rises in hypothyroidism and falls in hyperthyroidism — the standard first marker in any thyroid screening. Free T4 is the active form of thyroxine produced by the thyroid gland. It is assessed alongside TSH to understand the level and cause of any abnormality. Adrenal hormones: Cortisol — the "stress hormone" secreted by the adrenal cortex — is drawn strictly in the morning between 8:00 and 10:00 am, when its level is at its daily peak. Sustained elevation points toward hypercortisolism; a morning value below the lower reference limit raises concern for adrenal insufficiency. Sex hormones: Testosterone — the principal androgen — determines muscle mass, sexual drive, and energy levels in men; it is also present and important in women, albeit at far lower concentrations. FSH (follicle-stimulating hormone) regulates the maturation of reproductive cells. In women it reflects ovarian reserve; in men it reflects spermatogenesis quality. A sharp FSH rise in a woman of reproductive age is a sign of declining ovarian function. Metabolic hormones: Fasting insulin enables calculation of the HOMA-IR insulin resistance index when combined with fasting glucose. Elevated fasting insulin with normal glucose is an early marker of insulin resistance — detectable years before overt diabetes develops. Circadian hormones: Melatonin — the pineal gland hormone that regulates the sleep–wake cycle — is included in the panel when chronic sleep disturbance is the main complaint. Accurate measurement requires a night-time blood draw (around 2:00–3:00 am) or a salivary test; a standard morning sample does not reflect pineal function. Extended versions of the panel may additionally include oestradiol, LH, prolactin, DHEA-S, and parathyroid hormone, depending on the clinical question. How to Prepare for a Hormone Panel Test Preparation is a critical step. Most hormones follow a diurnal rhythm, depend on menstrual cycle phase, food intake, and stress. Poor preparation produces false results and can lead to unnecessary treatment. Universal rules for all hormones: - blood is drawn strictly fasting after 10–12 hours without food; plain water is allowed; - avoid alcohol, intense exercise, and sauna for 2–3 days beforehand; - do not smoke for at least 1 hour before the blood draw; - avoid testing during an acute illness with fever; - inform your doctor of all medications — hormonal contraceptives, steroids, metformin, antidepressants, and others directly affect results. Specific rules by hormone: Cortisol: must be drawn between 8:00 and 10:00 am. An afternoon cortisol has no diagnostic value for primary screening. Testosterone: drawn in the morning between 7:00 and 11:00 am, when levels are highest. An evening sample in men may show a falsely reduced result. Sex hormones in women (FSH, LH, oestradiol, prolactin): typically drawn on cycle days 2–5, unless otherwise specified by the doctor. This timing captures basal hormone levels, which are most comparable to reference ranges. Insulin: strictly fasting (8–12 hours). Even a small snack before the test sharply elevates insulin, making the result unreliable. Melatonin: a circadian profile requires a night-time draw (around 2:00–3:00 am) or a salivary test; standard morning sampling is uninformative for pineal function evaluation. Normal Hormone Levels: Reference Value Table Reference ranges depend on age, sex, and menstrual cycle phase in women. The values below are approximate; always use the reference ranges of the specific laboratory where the sample was processed. Hormone Men Women (follicular phase) Units ------------ TSH 0.4–4.0 0.4–4.0 mIU/L Free T4 10.3–24.5 10.3–24.5 pmol/L Cortisol (morning) 140–690 140–690 nmol/L Testosterone 12.1–38.0 0.3–2.8 nmol/L FSH 1.5–12.4 2.5–10.2 IU/L Fasting insulin 2.6–24.9 2.6–24.9 µIU/mL A "normal" range represents the values seen in 95% of healthy individuals. Five per cent of healthy people will fall outside it by pure statistics. A result at the boundary of normal is therefore not automatically pathological — its clinical significance is always interpreted in the context of symptoms, age, and trends over time. Causes of Hormone Abnormalities A single abnormal result rarely points to one specific disease — what matters is the pattern of changes in the context of the patient's complaints. TSH and thyroid hormone abnormalities. Elevated TSH with low free T4 is the picture of primary hypothyroidism: fatigue, cold intolerance, weight gain, and a slowed metabolism. Suppressed TSH with elevated free T4 indicates hyperthyroidism: palpitations, weight loss, tremor, and irritability. Cortisol abnormalities. Chronically elevated cortisol combined with characteristic signs — central obesity, wide purple stretch marks, and proximal muscle weakness — requires exclusion of Cushing's syndrome. A morning cortisol below 140 nmol/L raises concern for adrenal insufficiency. Sex hormone abnormalities. Elevated FSH combined with irregular cycles and raised androgens in a woman is one of the key laboratory findings in PCOS. Reduced testosterone in men is accompanied by fatigue, decreased libido, and muscle mass loss. Insulin abnormalities. High fasting insulin with normal glucose is early insulin resistance — detectable years before diabetes. This is precisely why it is a valuable finding: it opens a preventive window. Interpreting hormone tests horizontally — looking at the relationship between values — is more informative than reading each in isolation. TSH in the upper third of the normal range alongside low-normal free T4 may signal subclinical hypothyroidism even when both values are technically "normal". Who Needs a Hormone Panel and When Indications in women: irregular or absent periods, difficulty conceiving, acne and hirsutism in young women, significant mood swings or depression, symptoms of perimenopause. Indications in men: reduced libido and erectile dysfunction, unexplained loss of muscle mass despite adequate nutrition, gynaecomastia, infertility. General indications: unexplained chronic fatigue unrelieved by rest, diffuse hair loss, unexplained weight gain or loss, chronic sleep disturbance, elevated blood pressure in a young patient with a suspected endocrine cause, routine monitoring for an established endocrine condition. Routine preventive screening without symptoms has no proven benefit for most hormones in healthy adults. The exception is TSH, which is recommended for women over 35 and for anyone with any symptoms suggestive of thyroid dysfunction. How to Read Results and What to Do With Abnormalities Several practical principles for making sense of a hormone panel report: A single out-of-range value is not a diagnosis. Stress during venepuncture, a missed fasting window, and other preparatory errors can all skew individual hormones. A repeat test with proper preparation usually clarifies the picture. Trends matter more than single values. A TSH that has fallen from 3.5 to 0.8 mIU/L over 6 months alongside worsening symptoms carries more weight than any single measurement. Time of draw is critical. Cortisol measured at 4:00 pm cannot be compared against the morning reference range. Testosterone measured in the evening in men cannot be compared against the standard male morning reference. Use your laboratory's own reference ranges. Reference intervals depend on the analytical method and the specific analyser — values from the internet may not apply to your result. At any significant deviation from normal, see an endocrinologist or gynaecologist (for women with cycle-related complaints). Self-treating with hormonal preparations without an accurate diagnosis is dangerous: hormonal disorders require individually tailored therapy and regular laboratory monitoring. https://labreadai.com/en/tests/sex-hormone-panel https://labreadai.com/en/tests/sex-hormone-panel Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) The sex hormone panel includes testosterone, estradiol, FSH, LH and prolactin. Normal ranges for men and women, test interpretation and when the panel is ordered. Tests article Irregular periods, difficulty conceiving, low libido, unexplained weight gain or hair loss — behind all of these symptoms, hormonal imbalance is often the underlying cause. The sex hormone panel brings together several markers, each carrying its own diagnostic information. Interpreting them requires looking at the whole picture, taking into account sex, age, and — in women — the day of the menstrual cycle. What the Reproductive Hormone Blood Test Includes: FSH, Testosterone, Estradiol The standard panel covers five key markers that together provide a complete picture of the hypothalamic-pituitary-gonadal axis. Testosterone — the primary male sex hormone, produced by the testes in men and by the ovaries and adrenal glands in women. In men it governs spermatogenesis, muscle mass, libido and erection. In women at physiological concentrations it supports libido, muscle tone and bone density. Both total and free testosterone are measured: total testosterone includes bound (inactive) and free (biologically active) fractions. Estradiol — the principal oestrogen in women of reproductive age, produced by ovarian follicles. It regulates the menstrual cycle, maintains the endometrium and influences bone density. In men it is produced in small amounts through peripheral conversion of testosterone and is essential for bone health and sexual function. FSH (follicle-stimulating hormone) — a pituitary hormone. In women it drives follicle maturation and oestrogen production. In men it stimulates spermatogenesis. Elevated FSH alongside low sex hormones points to primary gonadal insufficiency (hypergonadotrophic hypogonadism). LH (luteinising hormone) — also a pituitary hormone. In women, the mid-cycle LH surge triggers ovulation. In men it stimulates the Leydig cells of the testes to produce testosterone. The LH/FSH ratio is an important diagnostic index: in polycystic ovary syndrome it frequently exceeds 2–3. Prolactin — a pituitary hormone whose physiological role is lactation. Chronically elevated prolactin (hyperprolactinaemia) suppresses FSH and LH secretion, disrupting the menstrual cycle in women and reducing testosterone in men. Prolactin is included in every sex hormone panel when reproductive dysfunction is being investigated. Normal Ranges for Sex Hormones in Men and Women Reference ranges vary considerably by sex, age, and — in women — cycle phase. Testosterone (total) Group Normal range ------ Men 18–50 years 12–33 nmol/L (350–950 ng/dL) Men 50 years 10–28 nmol/L Women of reproductive age 0.3–2.8 nmol/L Postmenopausal women 0.1–1.8 nmol/L Estradiol Group Normal range ------ Women, follicular phase (days 1–13) 68–1270 pmol/L Women, ovulatory peak (day 14) 131–1655 pmol/L Women, luteal phase (days 15–28) 91–861 pmol/L Postmenopausal women < 73 pmol/L Men 40–160 pmol/L FSH Group Normal range ------ Women, follicular phase 2.8–11.3 IU/L Women, ovulatory peak 5.8–21 IU/L Women, luteal phase 1.2–9 IU/L Postmenopausal women 25–135 IU/L Men 1.5–12.4 IU/L LH Group Normal range ------ Women, follicular phase 1.1–11.6 IU/L Women, ovulatory peak 17–77 IU/L Women, luteal phase 0–14.7 IU/L Postmenopausal women 11.3–40 IU/L Men 1.7–8.6 IU/L Prolactin Group Normal range ------ Non-pregnant women 102–496 mIU/L Pregnant women up to 10,000 mIU/L Men 86–324 mIU/L When and How to Test Correctly The accuracy of hormonal results depends critically on when and how the blood is drawn. For women: most sex hormones are tested on cycle days 3–5 — the standard "basal" window when the ovaries are at rest and baseline FSH, LH, estradiol and testosterone levels are most informative. Exception: progesterone and ovulation assessment — days 21–23 (mid-luteal phase). With an irregular or absent cycle, testing can be done on any day, and this should be clearly communicated to the doctor. For men: there is no cycle to follow, but testosterone reaches its peak in the early morning (7:00–10:00 AM) and drops by 20–30% by evening — blood must be drawn in the morning. General rules: fast for 8–12 hours; avoid alcohol, intense exercise, and sexual activity for 24 hours beforehand; no smoking for at least 1 hour before the draw; minimise stress before the test — prolactin reacts to any emotional arousal; inform the doctor about hormonal contraceptives, antidepressants, and antipsychotics, as all of these affect results. During hormonal contraception, results reflect pharmacological suppression of the axis, not actual ovarian function. Reassessment should be done 2–3 months after discontinuation. Sex Hormone Panel Interpretation: Typical Abnormality Patterns In Women High FSH + low estradiol — signals reduced ovarian reserve or menopause. FSH above 10 IU/L on cycle day 3 is associated with lower IVF success rates. FSH above 25–40 IU/L in a woman of reproductive age indicates menopause or premature ovarian insufficiency. High LH with moderately elevated or normal FSH + LH/FSH ratio 2 — the pattern characteristic of polycystic ovary syndrome (PCOS). This is accompanied by elevated testosterone and, frequently, signs of insulin resistance. Elevated prolactin — menstrual irregularity, anovulation, galactorrhoea. Causes include pituitary microadenoma, antidepressants or antipsychotic medications, and hypothyroidism. Before diagnosing hyperprolactinaemia, a stress-related transient rise must be excluded: a single high result is always repeated in calm conditions. Low FSH + low LH + low estradiol — central (secondary) hypogonadism: the pituitary is not signalling the ovaries. Causes: stress-related amenorrhoea, low body weight, pituitary tumours, Sheehan's syndrome. In Men Low testosterone + high FSH/LH — primary hypogonadism (testes not responding to stimulation). Causes: orchitis, varicocele, chromosomal abnormalities (Klinefelter syndrome). Low testosterone + low FSH/LH — secondary hypogonadism (pituitary not stimulating the testes). Causes: pituitary tumours, hyperprolactinaemia, haemochromatosis, prior anabolic steroid use. Elevated estradiol in a man — gynaecomastia, reduced libido and sperm quality. Seen in obesity (adipose tissue converts testosterone to oestrogen), liver cirrhosis, and certain tumours. When the Sex Hormone Panel Is Ordered: Infertility, Menopause and Beyond The panel is indicated across a wide range of clinical scenarios. In women: menstrual irregularities or absence of periods, infertility, suspected PCOS, ovarian reserve assessment, diagnosis of menopause or premature ovarian insufficiency, monitoring hormonal therapy. In men: reduced libido and erectile dysfunction, male infertility, assessment of androgen deficiency symptoms, gynaecomastia. In both sexes: delayed or precocious puberty, growth disturbances in children and adolescents. When non-specific symptoms make it unclear which hormonal system is the primary source, a doctor may order a comprehensive hormone panel covering multiple axes in a single blood draw. This article is for informational purposes only. Interpretation of results and treatment decisions are carried out by a gynaecologist, endocrinologist or andrologist. https://labreadai.com/en/tests/thyroid-panel https://labreadai.com/en/tests/thyroid-panel Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Thyroid hormones — TSH, free T4, free T3 and TPO antibodies: normal ranges for adults and pregnancy, how to prepare for the test and causes of abnormal results. Tests article Fatigue that persists even after a full night's sleep, weight gain without changes in diet, or — on the opposite end — unexplained weight loss, constant chills or heat intolerance: all of these can be signals from the thyroid gland. A thyroid panel is a group of blood tests that assess the function of one of the body's primary metabolic regulators. This article covers everything in the panel: what tests are included, how to prepare, what normal values look like, and what deviations in each indicator mean. What Is a Thyroid Panel and When Is It Ordered? The thyroid gland — a small butterfly-shaped organ at the front of the neck — produces hormones that govern the pace of virtually every metabolic process in the body: heart rate, body temperature, nutrient absorption, and nervous system function. When the gland is overactive or underactive, nearly every organ feels the effect. A thyroid panel is not a single test but a group of tests that a doctor selects based on the clinical situation. The minimum screening set includes only TSH. An expanded panel adds free T4, free T3, and antibodies. Indications for ordering the panel: - Symptoms of chronic fatigue, hair loss, edema, or unexplained weight changes - Cardiac arrhythmias without a cardiological cause - Menstrual irregularities or fertility problems - Pregnancy planning or the first trimester - Monitoring treatment of known hypothyroidism or hyperthyroidism - Routine screening after age 35, especially in women - Family history of thyroid disease How to Prepare and Get Tested Thyroid hormones are relatively stable throughout the day, but several factors can distort results enough to require a repeat test. Preparation guidelines: - Blood is drawn in the morning on an empty stomach — no food for at least 8–10 hours. - Avoid alcohol and intense physical activity for 24 hours beforehand. - If you take levothyroxine, take your tablet after the blood draw, not before. Taking it beforehand produces a falsely elevated free T4. - Iodine-containing supplements should be stopped 2–3 days before the test, in consultation with your doctor. - High-dose biotin (vitamin B7) should be discontinued 48 hours before the test — it interferes with immunoassay methods and can falsely lower TSH and elevate T4. - Glucocorticoids and certain psychiatric medications also affect results — inform your doctor. - Acute stress and recent respiratory illness can temporarily shift TSH. If the test is not urgent, it is better to wait until recovery. For treatment monitoring, always test at the same laboratory using the same equipment: reference ranges and methods vary between labs, and trends are only reliable when tracked under consistent conditions. What the Panel Includes: TSH, T3, Free T4 and Antibodies Depending on the clinical question, the panel can contain from one to six indicators. TSH (thyroid-stimulating hormone) is the primary regulator of thyroid function, produced by the pituitary gland. It is the first-choice marker for screening: it responds to abnormalities earlier than T3 and T4 and covers the widest range of disorders. TSH is the only value needed for initial screening; the others are added when clarification is required. Free T4 (FT4) is the main hormone secreted directly by the thyroid gland. Only the free (protein-unbound) fraction is biologically active. It is analyzed alongside TSH when pathology is suspected. Free T3 (FT3) is the active form of the thyroid hormone, produced primarily by conversion of T4 in peripheral tissues. It is ordered less frequently — mainly when isolated T3 toxicosis is suspected or for monitoring after thyroid surgery. TPO antibodies (anti-TPO) are a marker of autoimmune damage. They are elevated in Hashimoto's thyroiditis — the most common cause of hypothyroidism in adults. TG antibodies (anti-TG) are a second autoimmune marker. Less specific than anti-TPO, they are primarily used for follow-up after treatment of thyroid cancer. Thyroglobulin is the protein precursor to thyroid hormones. It is used exclusively for follow-up after treatment of papillary or follicular thyroid cancer and is not part of the standard diagnostic panel. Thyroid Hormone Normal Values: Table for Adults and Pregnant Women Reference ranges vary considerably by laboratory and analytical method — particularly for TSH during pregnancy, where normal values shift by trimester. The values below are approximate; always check the reference ranges printed on your report. Parameter Non-pregnant adults 1st trimester 2nd trimester 3rd trimester --------------- TSH (mIU/L) 0.4–4.0 0.1–2.5 0.2–3.0 0.3–3.0 Free T4 (pmol/L) 9.0–19.0 10.0–20.0 9.0–18.0 8.0–17.0 Free T3 (pmol/L) 2.6–5.7 2.6–6.0 2.6–5.7 2.6–5.5 Anti-TPO < 34 IU/mL < 34 IU/mL < 34 IU/mL < 34 IU/mL Anti-TG < 115 IU/mL < 115 IU/mL < 115 IU/mL < 115 IU/mL In pregnant women, TSH norms shift downward — human chorionic gonadotropin (hCG) stimulates the thyroid, so a mild TSH decrease in the first trimester is physiologically normal, not pathological. In older adults (over 70), the upper limit of normal TSH extends to 6–7 mIU/L — again, a physiological feature, not an automatic indication for treatment. Interpreting Deviations: High and Low TSH TSH operates on a negative feedback loop: when the thyroid produces too few hormones, the pituitary increases stimulation — TSH rises. When hormones are excessive, the pituitary pulls back — TSH falls. This is why TSH interpretation is always "mirror" to the state of the gland. High TSH (above 4.0 mIU/L) + low free T4 → hypothyroidism. The thyroid is underperforming. Symptoms include fatigue, edema, constipation, weight gain, depression, and dry skin. The most common cause is Hashimoto's autoimmune thyroiditis. For a complete overview of the disease and its treatment, see hypothyroidism. High TSH with normal free T4 → subclinical hypothyroidism. Symptoms may be absent, but it is an early warning. Management ranges from watchful waiting to treatment, depending on TSH level and symptoms. Low TSH (below 0.4 mIU/L) + high free T4 → hyperthyroidism (thyrotoxicosis). The gland is overactive. Symptoms include palpitations, hand tremor, irritability, weight loss, and heat intolerance. Common causes include Graves' disease and toxic nodular goiter. Full details: hyperthyroidism. Low TSH with normal free T4 → subclinical hyperthyroidism. Particular caution is warranted in elderly patients: even mild thyrotoxicosis increases the risk of atrial fibrillation and osteoporosis. Isolated change in free T3 with normal TSH and T4 is an atypical pattern requiring repeat testing and physician evaluation. TPO and TG Antibodies: When They Matter and What They Mean Thyroid antibodies are markers of autoimmune inflammation. Their presence does not automatically mean disease — approximately 10–15% of healthy people have mildly elevated anti-TPO with normal TSH and no symptoms. Clinical significance: - Anti-TPO above 34 IU/mL + elevated TSH → confirms Hashimoto's autoimmune thyroiditis. This is an indication to start levothyroxine therapy. - Elevated anti-TPO with normal TSH → increased future risk of hypothyroidism. Annual TSH monitoring is recommended. - Elevated anti-TPO during pregnancy — a serious risk factor: it increases the likelihood of postpartum thyroiditis and early-pregnancy miscarriage. - Anti-TG in cancer monitoring — the only context where this marker has independent diagnostic value. An important note: reducing antibody levels is not the goal of treatment. Treatment targets the clinical picture and TSH level — not the antibody number. Attempts to "lower anti-TPO" through supplementation without medical supervision are a common but mistaken approach. When Thyroid Panel Results Require Urgent Medical Attention Most thyroid panel abnormalities develop slowly and do not require emergency care. Some situations are exceptions: - TSH below 0.01 mIU/L — severe thyrotoxicosis, especially with heart rate above 100 bpm, elevated blood pressure, or fever - TSH above 10 mIU/L with marked symptoms: facial edema, very low blood pressure, or altered consciousness - Sensation of a lump in the throat, difficulty swallowing or breathing — possible gland enlargement requiring ultrasound - Any abnormality in a pregnant woman — prompt endocrinologist referral, as maternal thyroid dysfunction directly affects fetal neurological development If results are abnormal for the first time and symptoms are absent, a scheduled visit to a GP or endocrinologist is generally sufficient. Do not adjust levothyroxine dose on your own and do not start treatment without a prescription. Conclusion A thyroid panel is an accurate and accessible way to evaluate one of the body's key hormonal regulators. A well-designed panel of TSH, free T4, and antibodies gives a doctor all the information needed to make a diagnosis. The key to reliable results is proper preparation: holding levothyroxine and biotin before the blood draw and observing the correct fasting interval. When results show deviations, resist the urge to draw immediate conclusions — thyroid hormone interpretation requires full clinical context. If symptoms suggest dysfunction across multiple hormonal systems simultaneously, a doctor may extend the workup to a comprehensive hormone panel. When fatigue and hair loss persist despite a normal TSH, nutritional status is worth investigating: deficiencies in vitamin D, selenium and zinc directly impair the conversion of T4 to active T3 and can mimic hypothyroid symptoms — all of which are covered by a vitamin and mineral panel. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/tests/vitamin-panel https://labreadai.com/en/tests/vitamin-panel Sat, 28 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Vitamin panel tests vitamins D, B12, A, C, zinc, selenium and folate together. Reveals combined deficiencies behind fatigue, low immunity and hair loss. Tests article Persistent fatigue with no clear explanation. Hair thinning, brittle nails, immunity that weakens with every passing season. Tests come back "normal" — yet the symptoms remain. Behind this picture, in many cases, lies not one but several simultaneous micronutrient deficiencies that cannot be detected by a single measurement. The vitamin and mineral panel resolves this: one blood draw, one comprehensive picture of nutritional status. What a Vitamin Panel Is and Why Testing Together Matters A vitamin panel is a set of laboratory tests that simultaneously measures the levels of multiple vitamins and minerals in blood. Unlike isolated individual tests, the combined assessment solves a fundamentally different problem: it reveals interdependent deficiencies that reinforce each other and remain invisible when tested separately. The logic is straightforward. Vitamins and minerals do not act in isolation — they form functional networks. Zinc is required for vitamin A transport. Vitamin D cannot be properly activated without adequate magnesium. Vitamin B12 and folate operate in the same metabolic cycle and their deficiencies produce overlapping symptoms. Assessing one marker without the others yields an incomplete picture that can easily mislead. Moreover, correcting a single deficiency while a co-existing one goes untreated is ineffective. A patient may take vitamin D for months without benefit simply because, without adequate magnesium, the kidneys cannot activate it. A panel identifies exactly these situations. There is also a practical preanalytical advantage. One blood draw under identical conditions — strictly fasting, with appropriate light protection — generates reliable results across all markers simultaneously. This is more accurate than ordering each vitamin separately on different days with varying preparation and inevitable preanalytical variability. What a Standard Vitamin and Mineral Panel Includes Panel composition varies between laboratories. The following is a standard comprehensive set covering the most clinically relevant markers. Fat-soluble vitamins: — Vitamin D (25-OH) — the principal marker of calcium-phosphate metabolism and immune status. Deficiency affects 40–80% of people in northern latitudes. — Vitamin A (retinol) — regulator of vision, immunity and cell differentiation. Always interpreted alongside zinc — without it, retinol cannot leave the liver. Water-soluble vitamins: — Vitamin B12 (cobalamin) — essential for DNA synthesis and myelin integrity. Deficiency develops silently over months to years, particularly in vegetarians and older adults. — Folate (vitamin B9) — B12's partner in the one-carbon metabolic cycle. Their deficiencies are always assessed together. — Vitamin C (ascorbic acid) — antioxidant and cofactor for collagen synthesis. Among the most analytically unstable markers in the panel — correct preanalytical handling is critical. Minerals and trace elements: — Zinc — transporter of vitamin A, regulator of immunity and testosterone. The second most common elemental deficiency after iron. — Selenium — antioxidant protection via glutathione peroxidase, regulation of thyroid hormone activation. Critically important during pregnancy. — Magnesium — cofactor for 300+ enzymes and an essential precondition for vitamin D activation. Its deficiency negates the clinical benefit of cholecalciferol supplementation. Some extended panels additionally include vitamin B6, vitamin B1 (thiamine), copper, manganese and iodine — based on clinical indications. How to Prepare for a Vitamin Panel A vitamin panel is a technically demanding investigation. Failure to follow preparation requirements produces false results across multiple markers simultaneously. Food and supplements: - Strictly fasting: 8–12 hours without food. Dietary fat immediately raises fat-soluble vitamins (A, D) in plasma within 2–4 hours — results will be falsely elevated if taken after eating. - Stop all vitamin supplements and multivitamins 48–72 hours before the draw. Taking a supplement just before testing shows a transient plasma peak, not actual tissue status. - Do not radically change your diet in the week before — for example, do not suddenly start drinking litres of carrot juice, or stop eating meat if you normally do. On the day of the draw: - Blood should be taken in the morning, ideally before 10:00 a.m. — several markers show circadian variation. - No smoking for 2 hours: nicotine lowers plasma vitamin C by 30–40%. - Avoid physical exertion the morning before the draw. Critical laboratory conditions: - Vitamin C and vitamin A are unstable in light: the tube must be shielded from ultraviolet exposure immediately after collection. - Zinc requires trace-element collection tubes free of zinc contamination. Latex gloves must not contact the sample. - All markers are drawn simultaneously from one vein into separate collection tubes. Inflammation shifts multiple results at once: the acute-phase response lowers vitamin A, zinc and selenium while paradoxically normalising vitamin B12. Testing the vitamin panel during a respiratory infection, an active inflammatory flare or within two weeks of recovering from illness is uninformative and should be postponed. How to Interpret Vitamin Panel Results Panel results are interpreted as a connected set, not as isolated numbers — this is the fundamental difference from a random collection of separate tests. Key interpretive principles: A normal blood level does not always mean tissue sufficiency. Plasma vitamin B12 can be normal while tissue stores are already depleted — methylmalonic acid and homocysteine help clarify this. Serum zinc declines late, only after tissue reserves are substantially exhausted. Plasma magnesium is maintained at the expense of bone stores. Borderline values therefore require clinical interpretation, not a simple "all normal" dismissal. An isolated deficiency in one marker is a reason to look for an explanation, not merely to supplement. Low vitamin A despite adequate dietary intake? Check zinc — without it retinol is trapped in the liver. Vitamin D failing to rise despite supplementation? Look at magnesium — its deficiency blocks renal activation of cholecalciferol. Low B12 in a young adult without dietary restrictions? Exclude coeliac disease — impaired small intestinal absorption is a common and overlooked cause. Simultaneous deficiency of B12 and folate combined with elevated homocysteine and macrocytosis on a full blood count is the classic presentation requiring exclusion of megaloblastic anaemia. Vitamin D deficiency together with low calcium, low phosphate and elevated parathyroid hormone in an older patient signals significant risk of osteoporosis and demands prompt treatment, not watchful waiting. After deficiencies are identified and treatment is started, repeat testing is recommended after 2–3 months for water-soluble vitamins and 3–6 months for fat-soluble ones (vitamins D and A accumulate slowly). Repeating the full panel at every follow-up is unnecessary — retesting only the abnormal markers is sufficient. Combined Deficiencies: Why They Occur Together An isolated deficiency of one vitamin with all others normal is the exception rather than the rule. Most clinical situations involve clusters of deficiencies sharing a common underlying cause. Fat malabsorption (coeliac disease, Crohn's disease, pancreatitis, bariatric surgery) — produces simultaneous deficiency of all fat-soluble vitamins: D, A, E and K. Zinc, magnesium and calcium absorption are impaired in parallel. Treating the downstream deficiencies without addressing the root cause is futile. Strict veganism without dietary planning — classically depletes vitamin B12 (absent from plant foods), zinc (low bioavailability from plant sources), iron and vitamin D. Plasma vitamin A may appear normal due to circulating carotenoids while functional retinol status is reduced. Older age — systemic decline in vitamin D (reduced cutaneous synthesis and less outdoor time), B12 (atrophic gastritis reduces intrinsic factor), magnesium (reduced absorption and increased urinary losses) and zinc (narrowing dietary variety). Chronic alcoholism — B12, folate, thiamine (B1), magnesium, zinc and vitamin A are all affected. Alcohol impairs absorption, accelerates excretion and competes with nutrient metabolic pathways. Pregnancy — physiologically elevated demand for iron, folate, zinc, iodine and vitamin D as the fetus actively draws on maternal stores for organ development. Without monitoring through a panel, these deficiencies develop silently and affect fetal growth. Who Needs a Vitamin Panel and When A vitamin panel is not a routine screen for the general population. But for specific groups it is essential diagnostics. Indications for initial testing: - Chronic fatigue, cognitive impairment and reduced work capacity without an organic explanation on standard investigation - Diffuse hair loss, brittle nails, dry skin — particularly when several signs coexist - Frequent infections and prolonged recovery from common illnesses - Suspected malabsorption: coeliac disease, Crohn's disease, pancreatitis, intestinal surgery - Strict vegetarianism and veganism — check every 1–2 years even without symptoms - Pregnancy and preconception planning - Age above 60 — preventively every 1–2 years - Long-term use of metformin (lowers B12), proton pump inhibitors (lower B12 and magnesium), or oral contraceptives (lower B6, B12, folate and zinc) - Current or prior oncological illness — chemotherapy disrupts nutrient metabolism Monitoring frequency: - After a deficiency is identified: retest 2–3 months after starting treatment - With ongoing risk factors (veganism, chronic disease): annually - With normal results and no risk factors: every 2–3 years is sufficient When to See a Doctor Self-interpreting vitamin panel results is unreliable. Results depend on health status at the time of collection, current medications, the presence of inflammation and individual metabolic variation. A number outside the reference range is not a diagnosis — it is an indication for clinical review. Consult a GP or dietitian with the panel results whenever any abnormality is found, and also when the symptoms described above are present even if all values appear "normal" — borderline figures in the right clinical context deserve the same attention as frank deficiency. Do not self-prescribe high-dose supplements. Excess fat-soluble vitamins A and D are toxic. Excess zinc causes copper deficiency. Unmonitored high-dose folic acid in undetected B12 deficiency corrects the blood count while neurological damage progresses silently. Correcting nutrient deficiencies is a medical procedure requiring calculated dosing and follow-up. This content is for informational purposes only and does not replace professional medical advice. https://labreadai.com/en/posts/alder-allergy https://labreadai.com/en/posts/alder-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Alder allergy opens the spring hay fever season. Symptoms, cross-reactive foods, diagnostic tests and treatment — including immunotherapy for long-term relief. Articles article Alder is one of the first trees to flower — sometimes as early as February, while snow is still on the ground. For anyone with hay fever, that means one thing: the season has started. Alder allergy opens the spring pollen cycle and is often the first wake-up call that sends someone to an allergist for the first time. Here's what causes it, what symptoms look like, which foods trigger cross-reactions, and how to treat it — from antihistamines to immunotherapy. Why Alder Causes Allergy Alder belongs to the birch family and produces some of the most aggressive pollen in temperate climates. The main culprit is a protein called Aln g 1, which is structurally similar to key proteins in birch, hazel, and hornbeam pollen. This similarity explains why sensitivity to alder almost always comes with reactions to other related trees. The allergic immune system works like an overzealous security guard: it identifies the harmless pollen protein as a threat and launches a full inflammatory response. Histamine floods in, blood vessels dilate, and mucous membranes swell — leaving the person sneezing, weeping, and struggling to breathe, even though nothing dangerous is actually present. Key risk factors: - Genetics — if both parents have allergies, the child's risk reaches 60–80%. - Living in regions with abundant alder — especially near rivers and wetlands. - Pre-existing birch or nut allergy — cross-sensitization works in both directions. Symptoms of Alder Allergy Depending on the region, alder flowering runs from late February through April. Symptoms appear with the first warm days and disappear as soon as flowering ends — this seasonal pattern is what distinguishes pollinosis from chronic rhinitis. Typical symptoms: - Runny nose — watery, clear discharge with paroxysmal sneezing in runs of 10–15 times. - Conjunctivitis — red, itchy eyes with tearing and a "sand in the eye" sensation. - Itching in the nose, palate, and throat — a persistent tickle that can't be scratched away. - Dry cough — paroxysmal; wheezing may indicate bronchospasm. - Fatigue and headache — often mistaken for a cold. A tell-tale sign: symptoms sharply worsen outdoors on dry and windy days — especially in the morning — and ease significantly after rain or indoors with windows closed. Cross-Reactivity: Which Foods to Avoid Alder pollen allergy almost always comes with cross-reactions. The Aln g 1 protein is structurally similar to proteins in certain fruits, vegetables, and nuts — the immune system treats them the same way. Group Foods ------ Trees Birch, hazel, hornbeam, oak Fruits and berries Apples, pears, cherries, peaches, apricots, plums Vegetables Carrots, celery, potatoes, parsley Nuts Hazelnuts, almonds Other Kiwi, birch sap Cross-reactivity usually presents as oral allergy syndrome: itching and tingling in the mouth and throat within minutes of eating raw foods. Heat destroys the allergenic protein — cooked carrots are usually safe, raw ones are not. Most patients with alder allergy also struggle during the birch season. The triggers and cross-reactive foods largely overlap — see our guide to birch allergy for a detailed comparison. How to Confirm the Diagnosis: Tests Symptoms alone can't confirm alder allergy — they look too similar to a cold or other allergic conditions. An allergist will order: - Skin prick tests — a small amount of alder allergen (code t2) is placed on the skin and pricked. Results in 20 minutes. Performed outside the pollen season and at least 2 weeks after stopping antihistamines. - Specific IgE blood test for alder — measures antibody levels. Can be done any time of year; antihistamines don't affect the result. - Molecular diagnostics — identifies exactly which protein is triggering the reaction and predicts the risk of severe systemic responses. - Complete blood count — an indirect marker: eosinophils are often elevated during allergic conditions. Not diagnostic on its own, but supports the picture. How to Treat Alder Allergy Treatment works on three levels — only their combination produces lasting results. Avoidance: Reduce Pollen Exposure - Stay indoors on dry, windy days during flowering season, especially between 6 and 11 am when pollen counts peak. - Keep windows closed; use a HEPA air purifier at home. - After every outing: shower, rinse your nose with saline, change clothes. - Wear wraparound sunglasses — they physically block pollen from reaching your eyes. Medication - Second-generation antihistamines (cetirizine, fexofenadine, bilastine) — taken daily throughout the season, starting 2 weeks before the expected bloom. - Intranasal corticosteroids (mometasone, fluticasone) — the most effective way to reduce swelling and congestion. They act locally and are not absorbed into the bloodstream. - Eye drops (azelastine, olopatadine) — for allergic conjunctivitis. - Cromones — useful for mild symptoms and preventive treatment. Immunotherapy — The Only Cause-Based Treatment Allergen-specific immunotherapy (AIT) doesn't just manage symptoms — it tries to retrain the immune response itself. Patients receive gradually increasing doses of alder allergen (sublingual or by injection), teaching the immune system to tolerate it. The course runs 3–5 years. Most patients see a 50–70% symptom reduction in the first year, and many achieve long-term remission after completing the course. AIT is started only during remission — in autumn or winter, well outside the pollen season. When to Seek Urgent Medical Attention Call emergency services immediately if: - You experience difficulty breathing, wheezing, or a feeling of suffocation. - Swelling of the lips, tongue, or throat (angioedema) develops. - Blood pressure drops suddenly, you feel dizzy or lose consciousness. Schedule a routine visit to an allergist if: - Symptoms recur every spring and affect your daily life. - Antihistamines no longer provide adequate relief. - You notice reactions to cross-reactive foods listed above. - You want to start a course of immunotherapy. Conclusion Alder allergy is more than spring discomfort. Without treatment it tends to progress: the list of triggers expands, reactions intensify, and the risk of asthma rises. But this is one of the best-managed allergic conditions — and even reversible with immunotherapy. The earlier treatment begins, the better the chances of lasting remission. Any hay fever symptoms warrant a consultation with an allergist. Self-prescribing medications for pollinosis can be dangerous — treatment is always prescribed by a doctor after proper diagnosis. https://labreadai.com/en/posts/alkaline-phosphatase-what-it-is https://labreadai.com/en/posts/alkaline-phosphatase-what-it-is Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) ALP is a liver and bone enzyme in routine blood chemistry. Normal values by age and sex, causes of high and low results, when it's physiological and when it needs treatment. Articles article Your blood chemistry came back with an abnormal alkaline phosphatase — and it's not clear what that actually means. Don't panic yet: ALP shifts with dozens of conditions, many of which are entirely normal. Here's what alkaline phosphatase is, what counts as normal at different ages and for each sex, why the enzyme may be high or low, and when that actually calls for a doctor's visit. What Is Alkaline Phosphatase and Why Is It Measured? Alkaline phosphatase is an enzyme present in virtually every cell in the body, but in significant concentrations mainly in the liver, bile ducts, bones, and placenta. Its job is to cleave phosphate groups from organic molecules and shuttle them where they're needed — growing bone, bile, cell membranes. It's most active in an alkaline environment, which is how it got its name. In clinical practice, ALP is part of a standard blood chemistry panel. It's ordered whenever there's suspicion of liver disease, bile duct obstruction, or bone disorders. Alongside ALT and AST, it makes up the "liver profile" — a core set of markers for assessing organ function. One thing to understand from the start: alkaline phosphatase is a marker, not a diagnosis. An elevated result alone is not enough to conclude there's a disease. It's always interpreted together with age, sex, pregnancy status, and other tests. Where Does ALP Come From: Liver, Bones, and Beyond Alkaline phosphatase isn't a single substance — it's a family of isoenzymes, each produced by a different organ. This is directly relevant to how you interpret an abnormal result. Liver and bile ducts. The most prominent source of ALP in adults. When bile flow is obstructed — by a stone, inflammation, or tumor — the enzyme leaks into the bloodstream. This is why ALP is the first marker to rise in cholestasis. Bone tissue. Osteoblasts — the cells that build bone — are heavy producers of ALP. The more active the bone growth or repair, the higher the level. In children and teenagers, the bone fraction dominates: ALP can run 2–3 times above the adult range, and that's completely normal. Placenta. From around week 16 of pregnancy, the placenta produces its own isoenzyme, and ALP rises predictably through to delivery. Intestines. A small intestinal fraction enters the bloodstream after fatty meals — one more reason to fast before the test. Standard labs measure total ALP — the sum of all fractions. If the source needs identifying, the doctor may order ALP isoenzymes or GGT: if both ALP and GGT are elevated together, the problem is almost certainly liver or biliary in origin. Normal ALP Ranges by Age and Sex ALP norms vary significantly with age — the reference range for a growing child and a middle-aged man are worlds apart. Always compare your result against your age group's values, and always use the reference range printed on your specific lab report, since measurement methods differ between laboratories. Age / Category Normal Range (U/L) ------ Newborns (<2 weeks) 83–248 Infants (up to 1 year) 122–469 Children 1–10 years 142–335 Adolescents 10–13 years 129–417 Girls 13–15 years 57–254 Boys 13–15 years 116–468 Girls 16–19 years 45–87 Boys 16–19 years 55–149 Women over 19 35–105 Men over 19 40–130 Pregnant women up to 130–150 Worth noting: adolescent reference ranges overlap with what would be a high-alert level in adults. That's not pathology — it reflects the skeleton's growth activity. Why Is Alkaline Phosphatase High? The Main Causes Elevated ALP is the most common scenario in practice. Causes split into physiological (no treatment needed) and pathological. Physiological causes — normal variants: - Childhood and adolescence (active bone growth). - Pregnancy, especially the third trimester (placental fraction). - Fracture healing (osteoblasts working at full capacity). - Certain medications: acetaminophen, antibiotics, oral contraceptives. Liver and bile duct disease — the most common pathological cause in adults: - Cholestasis of any origin: stones, inflammation, tumor compression. - Viral, toxic, or drug-induced hepatitis. - Cirrhosis, primary or metastatic liver cancer. - Gallstone disease, cholecystitis, cholangitis. Bone disorders: - Paget's disease (osteitis deformans) — ALP can be elevated tenfold or more. - Osteomalacia and rickets — vitamin D deficiency impairs mineralization. - Bone metastases (most commonly breast, prostate, and lung cancer). - Hyperparathyroidism — excess parathyroid hormone accelerates bone turnover. - Osteosarcoma and other bone tumors. There's a practical rule: if both ALP and GGT are elevated, the problem is in the liver or biliary system. If ALP rises while GGT stays normal, the source is more likely the bones. Why Is Alkaline Phosphatase Low? What to Watch For Low ALP draws less attention than high ALP — and that's a mistake. Hypophosphatasia is a rare inherited disorder in which the gene encoding ALP is defective, leaving the enzyme severely depleted. Without sufficient ALP, bones can't mineralize properly: they soften, deform, and teeth may fall out in early childhood. Seizures are possible. This is why persistently low ALP without an obvious explanation warrants a genetics referral, not a reassuring "all clear." Acquired causes: - Hypothyroidism — reduced thyroid function slows the entire metabolism, including enzyme synthesis. - Severe anemia — when hemoglobin falls significantly, the activity of many enzymes drops. - Zinc and magnesium deficiency — both micronutrients are required for normal ALP function. - Prolonged fasting and malnutrition. - Certain oral contraceptives. How to Prepare for an ALP Blood Test Draw blood in the morning, fasting — after 8–12 hours without food. For 24 hours before the test, avoid fatty meals and alcohol: fat stimulates the intestinal ALP fraction, alcohol stresses the liver. Limit intense physical activity the day before as well. Always tell your doctor about any medications you're taking. Acetaminophen, some antibiotics, anticonvulsants, and hormonal contraceptives can all raise ALP without any underlying disease. If there's doubt, your doctor will decide whether to pause a medication before testing. For a meaningful picture, ALP should be measured alongside ALT, AST, GGT, bilirubin, calcium, and phosphorus. An isolated ALP result tells you very little. If you're getting a chemistry panel for the first time, ask for the full profile rather than a single marker. When to See a Doctor Urgently Seek immediate medical attention if, alongside an abnormal ALP, you develop: - Jaundice — yellowing of the skin or whites of the eyes. - Dark urine and pale stools — a sign of blocked bile flow. - Acute pain in the right upper abdomen. - A pathological fracture — bone broken by minimal force. - Seizures in a child combined with a low ALP result. - High fever and signs of systemic illness alongside abnormal blood chemistry. A routine appointment with a doctor is warranted if: - ALP is outside reference ranges without a clear physiological explanation (growth, pregnancy, fracture). - Multiple consecutive tests show the same abnormal trend. - You're taking liver-affecting medications and monitoring your biochemistry over time. Conclusion Alkaline phosphatase is a broad marker that keeps an eye on the liver, biliary system, and skeleton all at once. In adults, an elevated level most often points to the liver or bile ducts. In children, it almost always reflects normal growth. A low level deserves equal attention: it may signal a micronutrient deficiency or, in rare cases, a genetic disorder. Interpreting ALP in isolation, without the rest of the blood chemistry, is a dead end. Evaluate the result in context and don't put off seeing a doctor if the numbers are out of range. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/posts/alt-v-krovi https://labreadai.com/en/posts/alt-v-krovi Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) ALT is the key liver damage marker in blood chemistry. Normal values by sex and age, causes of high and low results, how to read ALT alongside AST, and when to seek medical care. Articles article Your blood chemistry came back with ALT flagged — and now you're wondering whether this is something to worry about or just a reason to repeat the test. ALT is one of the most sensitive markers of liver health, but a single abnormal result doesn't automatically mean disease. Here's what alanine aminotransferase is, what counts as normal for men, women, and children, why the enzyme rises or falls, and when a result genuinely calls for urgent medical attention. What Is ALT and Why Does It Matter in Blood Chemistry ALT, or alanine aminotransferase, is an enzyme involved in amino acid metabolism. It's found in highest concentrations in liver cells — hepatocytes — and in smaller amounts in the kidneys, heart muscle, and skeletal muscle. Under normal circumstances, very little ALT enters the bloodstream. When hepatocytes are damaged or destroyed — by inflammation, toxins, or viral infection — the enzyme leaks into the blood and levels rise sharply. This is why ALT is called a specific marker of liver damage: it responds to the problem before any symptoms appear. In a biochemical blood panel, ALT is almost always reported alongside AST — together, the two enzymes tell the doctor far more than either one alone. On lab reports, the marker appears as ALT or ALAT. Normal ALT Levels by Sex and Age ALT reference ranges depend on sex and age. Men have a higher upper limit than women, linked to greater muscle mass and hormonal differences. Infants under one year have higher values than adults due to rapid growth and liver development. Group Normal Range (U/L) ------ Men up to 41 Women up to 31 Pregnant women up to 35 Children under 1 year up to 54 Children 1–14 years up to 39 Reference ranges can differ slightly between laboratories depending on the measurement method. Always use the ranges printed on your specific lab report — not values from the internet. Why Is ALT High? Causes and Degrees of Elevation Elevated ALT almost always signals liver cell damage. But the degree of elevation matters: a mild rise is interpreted very differently from a tenfold or hundredfold increase. Mild elevation (2–5 times the upper limit) is most commonly linked to non-alcoholic fatty liver disease (fat accumulation in the liver from obesity or metabolic syndrome), medications (statins, antibiotics, high-dose acetaminophen, antifungals), moderate alcohol consumption, or intense physical exercise the day before the test. Moderate elevation (5–10 times) is characteristic of chronic viral hepatitis B or C, autoimmune hepatitis, early-stage cirrhosis, or bile duct obstruction from gallstones. Marked elevation (more than 10 times) signals acute liver injury. Acute viral hepatitis A, drug-induced or toxic liver damage, and ischemic hepatitis — which can follow a sudden loss of liver blood supply during events like myocardial infarction — can drive ALT dozens or even hundreds of times above normal. One important caveat: ALT doesn't only rise with liver disease. Skeletal muscle damage from major trauma, rhabdomyolysis, or very intense training also causes a moderate increase. This is why the result is always interpreted in the context of symptoms and other laboratory findings. Why Is ALT Low? What to Pay Attention To Low ALT gets far less attention than high ALT — and that's a mistake. The most common explanation for below-normal values is vitamin B6 (pyridoxine) deficiency: B6 is a coenzyme that the body needs to synthesize ALT. Without it, production drops. A similar picture appears with prolonged fasting and severe malnutrition. End-stage cirrhosis produces a counterintuitive but important scenario: when almost no hepatocytes remain, there's nothing left to produce ALT. A normal or low ALT in the context of other signs of liver failure is a warning sign, not reassurance. Severe renal failure disrupts overall metabolism and can suppress the activity of many enzymes, including ALT. Isolated low ALT without clinical context rarely requires treatment — but it's worth mentioning to a doctor. ALT and AST: How to Read Both Together ALT alone gives an incomplete picture. Paired with AST (aspartate aminotransferase), it allows the doctor not just to confirm cellular damage, but to identify which organ is most affected. Marker Main Source What elevation suggests --------- ALT Liver Hepatocyte damage AST Heart, muscles, liver Heart or muscle damage The key tool is the de Ritis ratio (AST/ALT). In health, this ratio hovers around 1. When it falls below 1, liver disease — viral hepatitis, fatty liver — becomes more likely. When it rises above 2, alcoholic liver disease or cardiac muscle damage moves to the top of the list. This simple calculation helps the doctor narrow the differential before any additional tests are ordered. For a complete picture of liver function, ALT and AST are supplemented with alkaline phosphatase, GGT, and bilirubin. When metabolic dysfunction is suspected, it's worth checking blood glucose at the same time — fatty liver disease and insulin resistance frequently go hand in hand. How to Prepare for an ALT Blood Test Poor preparation can skew the result and produce a false elevation. The rules are simple but strict. Blood is drawn fasting — at least 8–12 hours after the last meal. Fatty food stimulates enzyme release and can temporarily raise ALT. Alcohol and intense physical activity should be avoided for 24 hours beforehand: even a standard gym workout produces a moderate ALT rise from micro-damage to muscle fibers. No smoking for 30 minutes before the draw. Always tell your doctor about any medications you're taking. Statins, acetaminophen, antibiotics, antifungals, and oral contraceptives all affect ALT levels. Sometimes the doctor will recommend pausing a medication before the test; sometimes they'll simply factor it into the interpretation. When to See a Doctor Urgently Seek immediate medical attention if elevated ALT is accompanied by: - Jaundice — yellowing of the skin or whites of the eyes. - Dark urine and pale stools. - Acute pain in the right upper abdomen. - High fever and signs of systemic illness. Schedule a routine appointment with a GP or gastroenterologist if: - ALT exceeds the upper limit of normal by more than twice — even without any symptoms. - Elevation is confirmed on a repeat test one to two weeks later. - You are taking hepatotoxic medications and want to monitor their effect on the liver. A result ten times or more above normal warrants a visit within days, not weeks. Values at that level require urgent investigation. Conclusion ALT is an early and sensitive signal of liver health. A mild deviation often turns out to be temporary and resolves after lifestyle changes or stopping a medication. A significant rise calls for a full workup, starting with a GP visit and an expanded chemistry panel. Interpreting ALT in isolation — without AST, clinical context, and the rest of the biochemistry — means risking the wrong conclusion in either direction. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/posts/ast-v-krovi https://labreadai.com/en/posts/ast-v-krovi Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) AST is a marker of heart, muscle and liver damage in blood chemistry. Normal values by sex and age, causes of elevation, the de Ritis ratio and when to seek care. Articles article In a biochemical blood panel, AST and ALT almost always appear side by side — and many people treat them as interchangeable. They're not. While ALT points mainly at the liver, AST watches over the heart and muscles as well, which makes it a broader and in some ways more complex marker to interpret. Here's what aspartate aminotransferase is, what counts as a normal result, why the enzyme rises or falls, and when an elevated AST means you should call emergency services rather than book a routine appointment. What Is AST and How Does It Differ from ALT AST, or aspartate aminotransferase, is an enzyme involved in amino acid metabolism. Unlike ALT, which is concentrated mainly in the liver, AST is present in meaningful quantities across several tissues simultaneously: the heart muscle, skeletal muscle, liver, kidneys, and brain. This breadth is what defines its diagnostic character. An isolated rise in ALT almost certainly points to the liver. A rise in AST is a wider signal — it tells you cells are being damaged somewhere, but it doesn't say which organ. To find out, you need to look at both enzymes together and calculate their ratio. Under normal conditions, AST stays inside cells and barely enters the bloodstream. When any of these tissues are damaged — by inflammation, toxins, loss of blood supply, or physical trauma — the enzyme leaks out and circulates at elevated levels. On lab reports it appears as AST or ASAT. Normal AST Levels by Sex and Age AST reference ranges depend on sex and age. Men have a slightly higher upper limit due to greater muscle mass. Infants under one year show considerably higher values than adults — this is physiological and reflects rapid growth and organ development. Group Normal Range (U/L) ------ Men up to 40 Women up to 32 Pregnant women up to 32 Children under 1 year up to 58 Children 1–14 years up to 44 Reference ranges can differ slightly between laboratories depending on the measurement method. Always use the ranges printed on your specific lab report. Why Is AST High? Heart, Liver or Muscles The defining feature of AST is that it responds to several organs at once, and the degree of elevation helps orient the search for a cause. Myocardial infarction was historically one of the first laboratory markers of acute cardiac damage. When heart muscle cells die, AST begins rising within six to twelve hours of the event, peaks around the end of the first day, and normalises over three to five days. Modern cardiology relies on more sensitive markers — troponin and CK-MB — but AST remains part of the standard cardiac workup. A high AST alongside chest pain is a reason to call emergency services, not schedule a clinic appointment. More on the clinical picture in the article on myocardial infarction. Liver disease raises AST alongside ALT, but usually to a lesser degree. The exception is alcoholic liver disease, where AST frequently exceeds ALT — and this asymmetry is precisely what the de Ritis ratio captures. Viral hepatitis, cirrhosis, fatty liver disease, and toxic or drug-induced liver injury all elevate both enzymes simultaneously. Skeletal muscle damage — rhabdomyolysis from severe trauma, crush injury, prolonged immobilisation, or intense exercise, and inflammatory myositis — produces a moderate AST rise with a normal or only mildly elevated ALT. This is why strenuous activity should be avoided for twenty-four hours before testing: an ordinary gym session is enough to distort the result in an otherwise healthy person. Other causes include chronic heart failure with circulatory congestion, pulmonary embolism, and medications — statins, antibiotics, antifungal drugs — which can raise AST without underlying disease. Why Is AST Low? When It Actually Matters Low AST is an uncommon finding and in most cases needs no treatment on its own. The most frequent explanation is vitamin B6 (pyridoxine) deficiency. B6 is a coenzyme that aspartate aminotransferase cannot function without — when B6 is depleted through poor nutrition, chronic alcohol use, or certain medications (isoniazid, penicillamine), AST production falls. End-stage liver cirrhosis creates a counterintuitive picture: when almost no hepatocytes remain, there is nothing left to produce the enzyme. A normal or low AST in the setting of clinical liver failure is a warning sign, not reassurance. Severe kidney failure disrupts overall metabolism and can suppress the activity of multiple enzymes, including AST. The De Ritis Ratio: How to Read AST and ALT Together Interpreting AST without ALT is like reading only half of a sentence. Their ratio — the de Ritis ratio (AST/ALT) — is what narrows the differential. De Ritis Ratio Most Likely Cause ------ Below 1 Liver disease: viral hepatitis, fatty liver 1–2 Non-specific; further testing needed Above 2 Alcoholic liver disease or cardiac/muscle damage The calculation is straightforward: divide your AST value by your ALT value from the same report. For example, AST = 80, ALT = 35 gives a ratio of 2.3 — pointing toward alcohol or the heart rather than a primary liver condition. For a complete assessment, AST and ALT are supplemented with alkaline phosphatase, GGT, and bilirubin when liver disease is suspected, or with troponin and CK-MB when cardiac involvement is on the table. A complete blood count helps establish the inflammatory background and rule out systemic causes that might be driving the enzyme changes. For a comprehensive liver assessment, the full liver function panel is the most practical approach. How to Prepare for an AST Blood Test Preparation is straightforward but matters: failing to follow the rules is one of the most common reasons for a falsely elevated result. Blood is drawn fasting — after eight to twelve hours without food. Alcohol and intense physical activity should be avoided for twenty-four hours beforehand: muscle exertion breaks down myofibrils and raises AST even in a perfectly healthy person. No smoking for thirty minutes before the draw. Tell your doctor about all medications you're taking. Statins, antibiotics, antifungals, and pain relievers can all elevate AST independently of any disease. The doctor will either factor this in during interpretation or recommend temporarily pausing the medication before the test. When to Seek Urgent Medical Attention Call emergency services immediately if high AST is accompanied by: - Chest pain or pressure, especially radiating to the arm, jaw, or back. - Shortness of breath, sudden severe weakness, or cold sweating. - Rapid heartbeat or palpitations. These may be signs of an acute coronary event. Every minute matters. Schedule a routine appointment with a GP if: - AST exceeds the upper limit of normal by more than twice, even without symptoms. - AST is elevated alongside ALT and you have signs of liver involvement: jaundice, right upper abdominal discomfort, dark urine. - Elevation is confirmed on a repeat test one to two weeks later. Conclusion AST is a versatile marker of cellular damage that keeps watch over the heart, muscles, and liver simultaneously. Its real diagnostic power emerges only when read alongside ALT: their ratio steers the clinical search in the right direction before any additional tests are ordered. Interpreting AST in isolation risks missing an important signal — or raising a false alarm over a result that reflects nothing more than yesterday's workout. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/posts/atherosclerosis https://labreadai.com/en/posts/atherosclerosis Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Atherosclerosis is the leading cause of heart attacks and strokes. How plaques form, the role of LDL and HDL, lipid panel reference ranges and treatment options. Articles article Atherosclerosis begins in youth — the first fatty streaks in the aortic wall appear in teenagers. For decades the disease progresses without symptoms, and the first sign is often a heart attack or stroke. Let's look at how an atherosclerotic plaque forms, which tests detect risk at an early stage, and what actually works to slow progression. What Is Atherosclerosis and How Plaques Form Atherosclerosis is a chronic inflammatory disease of the arteries in which lipids accumulate in their walls, forming atherosclerotic plaques. Plaques narrow the arterial lumen, disrupt blood flow, and can rupture — triggering thrombosis and acute vessel occlusion. The mechanism is a multi-act story. It begins with endothelial damage — injury to the inner lining of the artery. High blood pressure, smoking, elevated glucose, chronic inflammation — all scratch this fragile surface. LDL (bad cholesterol) molecules penetrate the damaged area, oxidize, and are engulfed by macrophages that transform into "foam cells" — lipid depots that can no longer leave the vessel wall. Gradually a fibrous plaque forms with a lipid core and fibrous cap. Rupture of that cap is the trigger for thrombosis and heart attack. Risk Factors for Atherosclerosis Non-modifiable: age (men over 45, women over 55); male sex; family history (heart attack in first-degree relatives before 55 in men, 65 in women). Modifiable: elevated LDL and low HDL; arterial hypertension; smoking — doubles risk; type 2 diabetes; obesity; physical inactivity; elevated triglycerides; chronic inflammation — marker C-reactive protein. Symptoms of Atherosclerosis: When the Plaque Obstructs Atherosclerosis is usually asymptomatic until an artery narrows by 50–70%. Symptoms depend on which arteries are affected. Coronary arteries: angina pectoris (chest pain on exertion), myocardial infarction. Carotid and cerebral arteries: transient ischemic attacks (TIA), stroke; tinnitus, memory and concentration decline. Lower limb arteries: intermittent claudication — leg pain on walking that resolves at rest; in advanced cases, critical ischemia and gangrene. Renal arteries: renovascular hypertension resistant to treatment. Diagnosis: Lipid Panel Is the Central Test The primary tool for atherosclerosis risk assessment is the lipid panel. Marker Optimal High risk --------- LDL < 3.0 mmol/L ≥ 4.0 mmol/L HDL (men) 1.0 mmol/L < 1.0 mmol/L HDL (women) 1.2 mmol/L < 1.2 mmol/L Triglycerides < 1.7 mmol/L ≥ 2.3 mmol/L Total cholesterol < 5.0 mmol/L ≥ 6.2 mmol/L After a heart attack or stroke, the target LDL level is far stricter — below 1.4–1.8 mmol/L. High-sensitivity C-reactive protein — an inflammatory marker and independent predictor of cardiovascular events. CRP above 3 mg/L with normal LDL is a reason for more aggressive prevention. Imaging: carotid ultrasound with intima-media thickness (IMT) measurement — direct plaque visualization; coronary calcium score (CT) — quantitative assessment of coronary artery calcification; coronary angiography — when significant stenosis is suspected. Treatment and Prevention of Atherosclerosis Treatment means reducing total cardiovascular risk — not just lowering cholesterol. Lifestyle Changes A diet low in saturated fats (red meat, butter, cheese) and trans fats (processed baked goods, fast food). The Mediterranean diet reduces cardiovascular events by 30%. Physical activity — 150 minutes of moderate exercise per week: raises HDL, lowers triglycerides and inflammation. Smoking cessation — the single most powerful risk-reduction intervention. Statins HMG-CoA reductase inhibitors (atorvastatin, rosuvastatin) — first-line drugs. Reduce LDL by 30–60%, decrease plaque inflammation, and stabilize the fibrous cap. Taken lifelong at high risk. Muscle pain is the most common side effect and requires monitoring. Additional Therapy When LDL target is not reached on statins: ezetimibe or PCSK9 inhibitors (evolocumab, alirocumab) — the latter reduce LDL by an additional 50–60%. When to Seek Urgent Medical Attention Immediately if: crushing chest pain radiating to the arm or jaw — possible myocardial infarction; sudden weakness or numbness of half the face, arm, or leg — possible stroke; sudden vision loss in one eye; leg pain at rest with skin color change — critical limb ischemia. Summary Atherosclerosis is a manageable disease with early diagnosis and active treatment. A lipid panel every 5 years from age 35–40 is the minimum screening standard. The earlier elevated LDL is found and corrected, the fewer plaques have time to form. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/belok-v-moche https://labreadai.com/en/posts/belok-v-moche Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Protein in urine can be normal or a sign of kidney disease. Normal ranges, types of proteinuria, microalbuminuria as an early marker and when to act. Articles article The line "protein: trace" on a urine test alarms many people — often completely unnecessarily. Trace protein after exercise or in pregnancy is normal. But protein above 0.3 g/L found on three consecutive tests, or microalbuminuria in a diabetic patient, is a signal that cannot be ignored. Let's look at which protein in urine is physiological, which points to kidney disease, and why microalbuminuria matters more than most people realize. What Is Protein in Urine and How It Gets There Healthy kidneys are an ideal filter: they allow water, electrolytes, and metabolic waste into urine while retaining large molecules — primarily proteins. Normally, only a minimal amount of protein passes through the glomerular filter, and almost all of it is reabsorbed in the tubules back into the blood. As a result, no more than 150 mg of protein per day reaches the urine — this is the physiological norm. When the filter is damaged or tubules cannot handle reabsorption, protein accumulates in the urine — this is proteinuria. The main urinary protein is albumin: its presence and quantity determines the clinical significance of proteinuria. Normal Values for Protein in Urine Measurement method Normal Microalbuminuria Significant proteinuria ------------ Spot urine (g/L) < 0.033 — ≥ 0.3 g/L 24-hour urine (mg/day) < 150 — ≥ 300 Albumin-to-creatinine ratio (mg/g) < 30 30–300 300 The urine albumin-to-creatinine ratio (ACR) is the most reliable method: it is independent of urine dilution and doesn't require 24-hour collection. It is the preferred tool for screening early-stage chronic kidney disease. Types of Proteinuria: Physiological and Pathological Physiological — normal or transient Orthostatic proteinuria — protein appears only in daytime urine after prolonged standing and is absent in the morning sample. Common in teenagers and young adults, clinically insignificant. Confirmed simply: normal morning sample + protein in daytime urine. Exertional proteinuria — after intense physical activity (marathon, heavy training). Resolves within 24–48 hours. Repeat test after rest is clean. Febrile proteinuria — transient, disappears after temperature normalizes. In pregnancy — up to 0.3 g/day is acceptable. Exceeding this threshold in the 2nd–3rd trimester is a sign of preeclampsia. Pathological — requires investigation Glomerular proteinuria — glomerular filter damage, primarily albuminuria. Causes: glomerulonephritis, diabetic nephropathy, hypertensive nephropathy. Ranges from mild to massive (nephrotic). Tubular proteinuria — impaired tubular reabsorption. Low-molecular-weight protein predominates (not albumin). Causes: interstitial nephritis, toxic tubular injury (NSAIDs, heavy metals, contrast agents). Overflow proteinuria — excess low-molecular-weight proteins in blood pass through a healthy filter. Characteristic of multiple myeloma (Bence-Jones protein). Microalbuminuria: Why It Matters More Than It Seems A standard urinalysis detects protein above 150–200 mg/L. But kidney damage in diabetes and hypertension begins far earlier — when urine albumin is 30–300 mg/g by ACR. This range is called microalbuminuria and is not detected by standard UA. Why this is critical: microalbuminuria identifies diabetic nephropathy at a stage when the process is still reversible with proper treatment. Once macroalbuminuria develops ( 300 mg/g), progression of chronic kidney disease can only be slowed, not stopped. This is why in type 2 diabetes and arterial hypertension, ACR is checked annually — regardless of standard UA results. Causes of Pathological Proteinuria The most common causes in adults: Type 2 diabetes — diabetic nephropathy develops in 30–40% of patients. The first sign is microalbuminuria, appearing 5–10 years after disease onset. Arterial hypertension — chronically elevated pressure damages glomerular capillaries. Proteinuria here is both a marker and a driver of progression: the more protein, the faster kidney function declines. Chronic kidney disease of any cause — proteinuria is part of the diagnostic criteria for CKD alongside reduced GFR. Glomerulonephritis — immune inflammation of the glomeruli. Often combined with hematuria (blood in urine). Hypothyroidism — severe hypothyroidism reduces GFR and can cause mild proteinuria. One reason to check TSH in proteinuria without an obvious cause. Heart failure — congestive kidneys produce proteinuria through glomerular ischemia. Nephrotic Syndrome: When Protein Loss Is Massive When protein loss exceeds 3.5 g/day, the term nephrotic syndrome applies. This is not a separate disease but a clinical syndrome with a characteristic triad: massive proteinuria + low blood albumin (hypoalbuminaemia) + severe oedema. Additionally — elevated blood lipids (triglycerides, LDL) as a compensatory liver response. The logic is straightforward: albumin is lost in urine → plasma oncotic pressure drops → fluid shifts into tissues → oedema. This explains why oedema in nephrotic syndrome develops rapidly and can be massive — up to anasarca. How to Test for Protein in Urine Correctly Spot urinalysis — convenient for screening but depends on urine concentration. False-positive with dehydration, false-negative with excess fluid intake. Urine albumin-to-creatinine ratio (ACR) — preferred method for CKD and diabetic nephropathy screening. Morning spot urine, no 24-hour collection required. 24-hour urine protein — accurate quantitative method when proteinuria is already established. Full 24-hour collection with proper storage conditions. Before testing: avoid intense exercise the day before, maintain normal fluid intake, avoid a heavy protein load. Follow all urinalysis collection rules: mid-stream, clean container. When to Seek Urgent Medical Attention Immediately: protein in urine + progressive oedema of the face and legs developing over a few days — possible nephrotic syndrome; protein + blood in urine + rising creatinine — possible acute glomerulonephritis; protein above 0.3 g/L in pregnancy in the 2nd–3rd trimester — rule out preeclampsia. Routine nephrology referral: protein confirmed on two tests 3 months apart; ACR above 300 mg/g; proteinuria without obvious cause in a non-smoker without diabetes or hypertension. Summary Protein in urine spans a spectrum from physiological normal to severe kidney disease. A single "trace" result after exercise needs nothing more than a repeat test. But microalbuminuria in a diabetic or hypertensive patient is a window of opportunity: at this stage, treatment can genuinely halt the progression of CKD. Don't postpone ACR testing if you are in a risk group. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/birch-allergy-pollen-fever https://labreadai.com/en/posts/birch-allergy-pollen-fever Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Birch allergy is the most common spring hay fever. Symptoms, cross-reactions with fruits and vegetables, diagnostic tests and immunotherapy options. Articles article Every spring, as soon as birch catkins open, millions of people reach for antihistamines and close their windows. Birch allergy is the most common spring hay fever in temperate climates — in some regions affecting one in five adults. But birch allergy has a distinctive feature that sets it apart from other pollens: it almost always comes with reactions to apples, carrots, hazelnuts, and dozens of other foods. Let's look at why this happens and what to do about it. Why Birch Pollen Causes Hay Fever and Allergy The main birch pollen allergen is Bet v 1, a protein belonging to the PR-10 family (pathogenesis-related proteins). The allergic immune system recognizes it as a threat and produces specific IgE antibodies. On re-exposure to pollen, an immediate allergic reaction occurs: mast cells release histamine, blood vessels dilate, and mucous membranes swell. Several factors make birch an especially aggressive allergen. A single birch tree produces up to 5 million pollen grains per day. Small and lightweight, they travel on the wind up to 100–400 kilometres — a reaction is possible even where no birch trees are visible. Peak pollen concentrations occur in the morning hours on dry, windy days. The structural similarity of Bet v 1 to key proteins of related trees — alder (Aln g 1) and hazel (Cor a 1) — explains why birch allergy almost always co-occurs with allergy to these trees. Sensitization happens to one, but the immune system reacts to all of them. Birch Flowering Season Birch blooms later than alder and hazel: depending on the region, from late March through May. In central regions the peak falls in April. The season lasts 2–4 weeks, but a prolonged cold spring can extend it. Practically important: pollen grains settle on clothing, hair, furniture, and pet fur and continue to trigger symptoms even after flowering ends — until washed away by rain or removed by damp cleaning. Symptoms of Birch Allergy Symptoms appear with the first warm days of April and disappear immediately after flowering ends. Their intensity correlates directly with airborne pollen concentration. Allergic rhinitis — nasal congestion, abundant watery discharge, paroxysmal sneezing. Often accompanied by postnasal drip — the sensation of mucus running down the back of the throat. Allergic conjunctivitis — redness, itch, tearing, a "sand in the eye" sensation, light sensitivity. In some patients this is more prominent than nasal symptoms. Bronchospasm — in patients with asthma or pre-asthma, the birch season may trigger coughing attacks and breathlessness. General symptoms — fatigue, headache, disrupted sleep from nasal congestion and itching. Chronic sleep deprivation during the season is a serious problem that significantly reduces daily functioning. Characteristic pattern: symptoms sharply worsen in dry, windy weather and disappear after rain or indoors with windows closed and an air purifier running. Visiting a forest during the flowering season means maximum pollen exposure. Cross-Reactive Foods and Oral Allergy Syndrome in Birch Allergy Cross-reactivity in birch pollinosis is not a rare complication — it is the rule: it occurs in 50–70% of patients. The mechanism is straightforward: Bet v 1 is structurally similar to proteins found in many plant foods, and the immune system confuses them. The reaction manifests as oral allergy syndrome (OAS): itching, burning, and tingling in the lips, tongue, palate, and throat within minutes of eating raw foods. Usually mild and brief, OAS rarely progresses to a systemic reaction. The key feature: heat destroys Bet v 1 — cooked or baked carrots are safe, while raw ones trigger a reaction. Group Foods ------ Trees and shrubs Alder, hazel, hornbeam, oak Pome fruits Apples, pears, quince Stone fruits Cherries, sweet cherries, peaches, apricots, plums Nuts Hazelnuts, almonds, walnuts Vegetables Carrots, celery, potatoes, parsnip, parsley Other Kiwi, mango, soy, peanuts, birch sap Important: reactions to specific foods are individual. There is no need to eliminate everything on the list — only foods that actually cause symptoms. Blanket restrictions without symptoms reduce quality of life without benefit. Diagnosing Birch Allergy Spring hay fever symptoms are characteristic but require confirmation — they resemble a cold and other forms of allergy. Skin prick tests with birch pollen extract (code t3) — the diagnostic standard. Performed outside the pollen season, at least 2 weeks after stopping antihistamines. Results in 15–20 minutes. Specific IgE blood test for birch — can be done any time of year; antihistamines don't affect the result. Especially valuable when prick tests are not possible (severe atopic dermatitis, beta-blocker therapy). Molecular diagnostics (Bet v 1, Bet v 2, Bet v 4) — refines the sensitization profile. High Bet v 1 correlates with pronounced OAS and predicts AIT efficacy. Bet v 2 and v 4 are panallergens linked to reactions across unrelated plant species. Complete blood count — elevated eosinophils indirectly support allergic inflammation. A normal count does not exclude hay fever. Treatment of Birch Allergy Treatment operates on three levels — only their combination produces lasting control. Reducing Pollen Exposure - Avoid outdoor activity in dry, windy weather between 6 and 11 am during flowering season — peak pollen hour - Keep windows closed; use a HEPA air purifier indoors - After every outing: shower, rinse your nose with saline, change clothes - Wear wraparound sunglasses — they physically reduce pollen reaching the eyes - Follow pollen forecasts and local pollen calendar alerts Medication Second-generation antihistamines (cetirizine, fexofenadine, bilastine, loratadine) — taken daily throughout the season, starting 1–2 weeks before expected bloom. Starting after symptoms appear is less effective. Intranasal corticosteroids (mometasone, fluticasone, budesonide) — the most effective drug for allergic rhinitis. Act locally with negligible systemic absorption. Start 2 weeks before the season. No tolerance develops with course use. Eye drops with antihistamine or mast cell-stabilizing action (azelastine, olopatadine, cromoglicate) — for significant allergic conjunctivitis. Antileukotriene agents (montelukast) — when rhinitis is combined with asthma or antihistamines provide insufficient relief. AIT — The Only Cause-Based Treatment Allergen-specific immunotherapy with birch allergen is the only treatment that modifies the immune response rather than suppressing symptoms. Patients receive gradually increasing doses of birch allergen sublingually (drops or tablets) or by subcutaneous injection, progressively building immunological tolerance. Course duration: 3–5 years. Efficacy is clinically established: after the first year most patients report 40–60% symptom reduction; after a full course many achieve years of remission. An additional benefit: birch AIT often reduces the severity of OAS and cross-reactions to alder and hazel. AIT is started only during remission — in autumn or winter, at least 3–4 months before the expected bloom. When to Seek Urgent Medical Attention Call emergency services immediately for: difficulty or wheezing breathing, feeling of suffocation; swelling of lips, tongue, or throat (angioedema); sudden drop in blood pressure, loss of consciousness — these are signs of anaphylaxis. Schedule a routine allergist visit if: symptoms recur every spring and reduce quality of life; antihistamines no longer provide adequate relief; cross-reactive food reactions are worsening or expanding; you want to start AIT. Summary Birch allergy without treatment tends to progress: the allergen spectrum widens, symptoms intensify, and asthma risk rises. AIT offers a real path to long-term remission. Medications control symptoms during the season but do not alter the disease course. The earlier specific treatment begins, the better the long-term outcome. If hay fever is part of a broader atopic picture, see the full allergy guide. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/cbc-children-interpretation https://labreadai.com/en/posts/cbc-children-interpretation Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CBC norms in children differ from adults and change with age. Hemoglobin, WBC, differential and platelets by age group, including the physiological crossover. Articles article When parents get their child's blood test back, the alarm bells often go off: "WBC elevated," "not enough neutrophils." But comparing a child's results to adult reference ranges is a fundamental mistake. A child's blood follows its own rules: the composition changes rapidly in the first years of life, and what is pathological in an adult is completely normal in a three-year-old. Let's go through the complete blood count norms by age group and explain the physiological phenomena that most often cause unnecessary worry. Why Children's Norms Differ From Adults At birth, a newborn's blood carries the imprint of intrauterine life: high hemoglobin (fetal HbF), large red cells (MCV above adult range), and very high WBC — a response to birth stress. Over the first years of life these values reorganize, passing through predictable physiological peaks and crossovers. This is why every result must be evaluated strictly against age-specific norms — preferably from the reference ranges of the specific laboratory used. Hemoglobin in Children: Normal Ranges by Age Hemoglobin is the parameter that changes most intensively in children. Age Normal hemoglobin (g/L) ------ Newborns (1–3 days) 145–225 1 month 100–180 3–6 months 95–135 6 months – 2 years 105–135 2–6 years 110–140 6–12 years 115–145 12–18 years (boys) 120–160 12–18 years (girls) 112–152 Physiological anaemia of infancy is a normal occurrence at 2–3 months of age. After birth, fetal hemoglobin is replaced by adult hemoglobin, erythropoiesis temporarily "pauses," and hemoglobin physiologically drops to 95–115 g/L. This is not iron deficiency and not a disease — it is normal physiology. The way to distinguish it from true anaemia is ferritin: in physiological anaemia ferritin is normal or elevated; in iron deficiency anaemia it is low. After 6 months, iron stores acquired from the mother are depleted, and the risk of true iron deficiency anaemia rises — especially in breastfed infants without introduced complementary foods. Red Cells and MCV in Children Age RBC (×10¹²/L) MCV (fL) --------- Newborns 4.0–6.6 98–118 1–6 months 3.4–5.2 85–105 6 months – 2 years 3.7–5.3 70–86 2–12 years 3.9–5.3 75–87 12–18 years 3.9–5.6 78–95 High MCV in newborns is normal — not a sign of B12 or folate deficiency. MCV below 70 fL in a child older than 6 months is a warning sign of microcytosis, with iron deficiency anaemia as the most likely cause. WBC in Children: Norms and the Physiological Crossover The most common reason for parental alarm — "high WBC." Normal WBC counts in children are significantly higher than in adults and gradually decrease with age. Age Normal WBC (×10⁹/L) ------ Newborns 10.0–30.0 1 month 9.0–18.0 6 months – 2 years 6.0–17.0 2–6 years 5.0–15.5 6–12 years 4.5–13.5 12–18 years 4.5–11.0 Neonatal leukocytosis up to 30×10⁹/L in the first days of life is a physiological response to birth stress, not a sign of infection. The Physiological WBC Differential Crossover In adults, neutrophils make up 50–70% of WBC and lymphocytes 20–40%. In children this ratio reverses twice during development: First crossover — occurs on days 4–5 of life: neutrophils fall, lymphocytes rise, and they equalize (45% each). After the first crossover, lymphocytes dominate: in children under 4–5 years lymphocytosis is normal. Lymphocytes at 50–70% in a two-year-old are physiology, not a sign of viral infection. Second crossover — occurs at 4–6 years of age: neutrophils and lymphocytes equalize again, after which neutrophils resume adult-pattern dominance. This explains why the rule "many lymphocytes = virus, few neutrophils = problem" simply does not apply to preschool-age children. Neutrophils and Lymphocytes: Normal Ranges by Age Age Neutrophils (%) Lymphocytes (%) --------- Newborns 60–70 20–30 Days 5–7 40–50 40–50 1 month – 4 years 25–45 45–65 4–6 years 40–55 35–50 6–12 years 45–65 25–45 12–18 years 50–70 20–40 Pathological neutrophilia in children (neutrophils 70–80% with a left shift) is a sign of bacterial infection. Pathological lymphopenia (lymphocytes < 15–20%) at any age warrants exclusion of immunodeficiency. Eosinophils in Children Eosinophils normally make up 1–5% in children. Mild elevation (5–10%) without symptoms is often linked to helminth infections or atopy. Eosinophilia above 10% is a reason for parasitological investigation and allergology consultation. Platelets in Children Normal platelet counts in children are essentially the same as in adults throughout life: Age Normal platelets (×10⁹/L) ------ Newborns 150–400 Children of all ages 150–400 Thrombocytopenia (platelets below 100×10⁹/L) in a child warrants urgent haematology consultation. The most common cause in children is immune thrombocytopenic purpura (ITP), typically developing after a viral infection. How to Collect a Blood Sample in a Child In children under 3, blood is usually taken from a fingertip (capillary); in older children from a vein. Venous blood gives more accurate results — especially for platelets and differential. Key conditions: fasting for children over 1 year; calm state — crying and stress produce transient leukocytosis. In infants, time of day and feeding have less impact. After acute infection, values recover gradually: leukocytosis may persist 1–2 weeks after recovery, ESR up to 3–4 weeks. When to Seek Urgent Medical Attention Immediately if: hemoglobin below 70 g/L at any age; WBC above 30×10⁹/L in a child older than one month; platelets below 50×10⁹/L; blast cells in the differential — possible leukaemia. Routine paediatric or haematology referral: hemoglobin below age-specific norm on repeat tests; eosinophilia above 10%; neutrophilia with left shift without clinical infection signs; thrombocytopenia below 100×10⁹/L. Summary Reading a child's blood test without age-specific norms is like measuring a child's height with an adult ruler. Physiological lymphocytosis, high MCV in newborns, and wide WBC ranges are all normal stages of haematopoietic development. If a value falls outside the age-specific norm — exclude physiology first, then look for pathology. The complete blood count is a powerful tool in children, but its value depends entirely on age-appropriate interpretation. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/cbc-pregnancy-interpretation https://labreadai.com/en/posts/cbc-pregnancy-interpretation Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CBC in pregnancy is read differently from standard norms. Haemodilution effect, hemoglobin targets by trimester, physiological leukocytosis and gestational thrombocytopenia. Articles article A blood test during pregnancy is one of the most common sources of anxiety. "Haemoglobin is low," "WBC is elevated" — and the woman leaves the clinic worried for no good reason. But pregnancy fundamentally changes blood composition, and most of these apparent abnormalities are not disease — they are normal physiology. The key is knowing where the boundary lies between physiological adaptation and something that genuinely needs treatment. Let's go through the complete blood count in pregnancy trimester by trimester. The Central Phenomenon: Haemodilution Pregnancy is a state of controlled blood "dilution." Circulating plasma volume expands by 40–50% by the end of the second trimester, while red cell volume increases by only 20–30%. As a result, all "red" parameters — haemoglobin, haematocrit, red cell count — fall relative to non-pregnant norms. This is called physiological haemodilution. Haemodilution is not accidental. It reduces blood viscosity, improves uteroplacental blood flow, and protects against thrombosis. The body deliberately "dilutes" blood for the benefit of the fetus. The practical implication: CBC norms in pregnancy are lower than usual, and that is correct. Comparing a pregnant woman's result to non-pregnant reference ranges is inappropriate. Haemoglobin in Pregnancy: Normal Ranges by Trimester Trimester Normal haemoglobin (g/L) Mild anaemia Moderate anaemia ------------ I (1–13 wk) 110–160 100–109 70–99 II (14–27 wk) 105–155 100–104 70–99 III (28–40 wk) 100–155 100–104 70–99 The lowest haemoglobin is expected in the second trimester — that is when haemodilution peaks. After 30 weeks plasma volume stabilizes and haemoglobin partially recovers. Physiological fall vs true anaemia The key clinical question: how to distinguish normal haemodilution from iron deficiency anaemia that genuinely requires treatment? Haemoglobin alone does not answer this. Ferritin is needed: - Ferritin ≥ 30 µg/L — iron stores are adequate; the haemoglobin fall is physiological dilution. - Ferritin < 30 µg/L — iron deficiency exists, even if haemoglobin is still within the pregnant-women range. - Ferritin < 12 µg/L — significant deficiency; iron supplementation is required. Iron deficiency anaemia of pregnancy is the most common cause of true anaemia during pregnancy. Iron requirements in the second and third trimester rise to 27 mg/day (versus 18 mg outside pregnancy). Without supplementation, most women cannot meet this demand. MCV: A Useful Additional Marker MCV helps differentiate types of anaemia: - Low MCV (< 80 fL) — microcytic anaemia → rule out iron deficiency first - Normal MCV — dilutional anaemia or mixed - High MCV ( 100 fL) — macrocytic anaemia → B12 or folate deficiency; during pregnancy folate is especially important for neural tube defect prevention WBC in Pregnancy: Physiological Leukocytosis WBC rises predictably during pregnancy — this is not a sign of infection. Period Normal WBC (×10⁹/L) ------ Non-pregnant 4.0–9.0 1st trimester 6.0–12.0 2nd trimester 7.0–14.0 3rd trimester 8.0–15.0 Labour and first 24 hours postpartum up to 25–30 Mechanism: oestrogen and cortisol stimulate neutrophil release from bone marrow — an evolutionary protective response. WBC of 10–14×10⁹/L in the second and third trimester is normal. Signs of pathological leukocytosis requiring attention: WBC above 15–16×10⁹/L in the first trimester, or a sudden spike with fever and other symptoms; left shift (band neutrophils 6–10%); elevated C-reactive protein — that is an inflammatory response, not physiology. Platelets in Pregnancy: Gestational Thrombocytopenia In 5–8% of pregnant women, platelets fall to 100–150×10⁹/L without any underlying pathology — this is gestational thrombocytopenia. Mechanism: accelerated platelet destruction in the placenta plus haemodilution. Platelet level Interpretation ------ 150–400 × 10⁹/L Normal 100–149 × 10⁹/L Mild thrombocytopenia — most often gestational 70–99 × 10⁹/L Cause requires clarification < 70 × 10⁹/L Urgent haematology consultation Gestational thrombocytopenia: appears in the third trimester, is not accompanied by bleeding, and resolves spontaneously after delivery. It must be distinguished from HELLP syndrome (thrombocytopenia + liver dysfunction + haemolysis) and immune thrombocytopenia — both require active treatment. Other Parameters: What Else Matters in Pregnancy ESR physiologically accelerates during pregnancy — up to 40–50 mm/h in the third trimester. Using ESR as an inflammation marker in pregnancy is essentially impossible — the baseline is too high. Reticulocytes — if anaemia is worsening, the doctor may order reticulocytes to assess erythropoiesis activity. A normal level in dilutional anaemia; reduced in true deficiency states. HbA1c and glucose — gestational diabetes screening is mandatory during pregnancy. HbA1c is less informative in pregnancy due to accelerated red cell turnover — the oral glucose tolerance test is preferred. When Falling Haemoglobin in Pregnancy Is Dangerous Anaemia in pregnancy is not merely discomfort. Severe anaemia (haemoglobin < 70 g/L) increases the risk of: preterm birth; low birth weight; postpartum haemorrhage; impaired neonatal neurological development. Moderate anaemia (70–99 g/L) in pregnancy is treated with oral iron — generally effective. Severe anaemia or intolerance of oral preparations is an indication for intravenous iron. When to Seek Urgent Medical Attention Immediately: haemoglobin below 70 g/L; platelets below 70×10⁹/L; WBC above 16×10⁹/L with fever and pain; combination of thrombocytopenia + jaundice + right upper quadrant pain — possible HELLP syndrome. Within a few days: protein in urine + elevated blood pressure — rule out preeclampsia; haemoglobin below 100 g/L at the first first-trimester test — check ferritin immediately; platelets below 100×10⁹/L in the first or second trimester — cause requires clarification. Summary A CBC in pregnancy is a separate language with separate norms. Haemodilution lowers haemoglobin, pregnancy raises WBC, and the placenta "consumes" platelets — all of this is physiology. The fundamental question is always: adaptation or disease? The answer comes from ferritin for anaemia, differential count and CRP for leukocytosis, and clinical picture for thrombocytopenia. Have a complete blood count done each trimester and discuss results with your obstetrician — do not interpret them on your own. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/complete-blood-count-cbc-differential https://labreadai.com/en/posts/complete-blood-count-cbc-differential Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CBC with differential adds the WBC formula to a standard blood count. Neutrophils, lymphocytes, monocytes, eosinophils and basophils — norms and left shift. Articles article The doctor ordered a "complete blood count with differential" — and the report came back with unfamiliar words: neutrophils, lymphocytes, monocytes, left shift. A standard complete blood count counts cells; CBC/Diff goes one level deeper: it adds the white cell formula showing exactly which leukocytes are present and in what ratio. This is a fundamental difference — like the difference between counting people in a crowd and knowing which ones are doctors and which are police officers. In this article every part of the formula is explained with normal ranges, clinical meaning and practical tips for reading your results. What Is the CBC Differential Formula and How It Differs From a Standard CBC A standard complete blood count includes haemoglobin, red cells, WBC, platelets, and MCV. CBC with differential adds the white cell formula — the percentage and absolute count of five white blood cell populations. Why this matters: WBC 12×10⁹/L tells you "how many." The formula answers "which ones": neutrophilia from a bacterial infection, lymphocytosis from a viral one, and eosinophilia from allergy or parasites are three entirely different clinical situations at the same elevated WBC count. Key Rule: Absolute Counts Matter More Than Percentages The most common mistake when reading a differential is looking only at percentages. A percentage is a relative value that depends on the total WBC count. What matters is the absolute count of each population. Example: lymphocytes 15% with WBC 3×10⁹/L means lymphopenia (0.45×10⁹/L — very low). Lymphocytes 15% with WBC 20×10⁹/L means a normal absolute lymphocyte count (3.0×10⁹/L). The same percentage — opposite interpretations. Neutrophils: The Primary Defense Against Bacteria Neutrophils make up 50–70% of all leukocytes in adults and are the first cells to arrive at the site of bacterial infection. They engulf and destroy bacteria by phagocytosis. Marker Normal (adults) ------ Neutrophils % 50–70% Absolute count 1.8–7.5 × 10⁹/L Segmented (mature) 47–67% Band (immature) 1–5% Neutrophilia ( 7.5×10⁹/L) — classic sign of bacterial infection, inflammation, stress, corticosteroid use, or physical exertion. Neutropenia (< 1.8×10⁹/L) — reduces resistance to infections. Causes: viral infections (influenza, COVID-19), autoimmune diseases, certain medications, aplastic anaemia. Left Shift: What It Means "Left shift" means the appearance of immature neutrophil forms in peripheral blood. Normally, bone marrow releases only mature segmented neutrophils. In severe bacterial infection, the supply of mature cells is depleted and the marrow releases immature forms — band neutrophils ( 5–6%) and, in very severe cases, even earlier forms — metamyelocytes and myelocytes. A band shift is not simply "more neutrophils." It signals that the body is working at the limit of its reserves against a serious infection or inflammatory process. Combined with elevated CRP and WBC 15×10⁹/L, it is a compelling reason for urgent consultation. Lymphocytes: The Memory of the Immune System Lymphocytes are the adaptive immune cells: B-lymphocytes produce antibodies, T-lymphocytes destroy infected cells, and NK cells are the first line of antitumour defence. Marker Normal (adults) ------ Lymphocytes % 20–40% Absolute count 1.0–3.5 × 10⁹/L Lymphocytosis ( 3.5×10⁹/L) — viral infections (EBV mononucleosis, cytomegalovirus, whooping cough), chronic lymphocytic leukaemia in the elderly. Important: in children under 4–5 years, lymphocytosis is a physiological norm — see the CBC in children article. Lymphopenia (< 1.0×10⁹/L) — severe viral infections (COVID-19, HIV), corticosteroids, immunodeficiency, sepsis. Lymphopenia in COVID-19 correlates with disease severity. Atypical lymphocytes in the differential ( 10%) are a characteristic sign of infectious mononucleosis: EBV-infected B-lymphocytes acquire an unusual appearance. Monocytes: Long-Lived Scavengers Monocytes are the largest blood cells, migrating into tissues and transforming into macrophages. They participate in chronic inflammation, phagocytose cellular debris, and present antigens to lymphocytes. Marker Normal ------ Monocytes % 3–11% Absolute count 0.2–0.8 × 10⁹/L Monocytosis ( 0.8×10⁹/L) — chronic infections (tuberculosis, brucellosis, endocarditis), autoimmune diseases, inflammatory bowel disease, recovery period after acute infections. Persistent monocytosis without an obvious cause warrants exclusion of chronic myelomonocytic leukaemia. Eosinophils: The Signal for Allergy and Parasites Eosinophils specialise in fighting parasites and participate in allergic reactions — in health their numbers are low. Marker Normal ------ Eosinophils % 1–5% Absolute count 0.05–0.5 × 10⁹/L Eosinophilia — the degree of elevation has different clinical implications: - Mild (0.5–1.5×10⁹/L) — allergic diseases (atopic dermatitis, asthma, hay fever), mild helminth infections - Moderate (1.5–5.0×10⁹/L) — invasive helminthiases (toxocariasis, migrating ascariasis), drug reactions - Severe ( 5.0×10⁹/L) — rare hypereosinophilic syndromes with organ involvement; urgent consultation required Basophils: Rare but Informative Basophils are the least numerous leukocytes, participating in immediate-type allergic reactions through histamine release. Marker Normal ------ Basophils % 0–1% Absolute count 0–0.1 × 10⁹/L Basophilia ( 0.1×10⁹/L) is uncommon. Causes: allergic reactions, hypothyroidism, chronic myeloproliferative diseases — basophilia is a classic feature of chronic myeloid leukaemia. The Formula Explained: Differential Pattern in Common Conditions Condition Neutrophils Lymphocytes Monocytes Eosinophils --------------- Bacterial infection ↑↑ (left shift) ↓ normal/↑ normal Viral infection ↓ or normal ↑ normal/↑ normal Allergy / parasites normal normal normal ↑↑ Chronic inflammation normal/↑ normal ↑ normal Stress / corticosteroids ↑ ↓ normal ↓ This table is a guide, not an algorithm. Every result is interpreted together with clinical data, CRP, and ESR. How to Prepare for the Test Fasting — 8–12 hours without food, morning draw. Avoid intense exercise the day before — it causes leukocyte redistribution. Stress, infections, corticosteroids, and smoking all affect the differential. For serial monitoring: draw blood under the same conditions, ideally at the same laboratory. When to Seek Urgent Medical Attention Immediately: neutrophils < 0.5×10⁹/L (agranulocytosis — life-threatening); blast cells in the differential — possible leukaemia; WBC 30×10⁹/L in an adult without a known cause. Routine referral: persistent neutropenia < 1.5×10⁹/L; lymphocytosis 5×10⁹/L in an adult without infection; eosinophilia 1.5×10⁹/L without allergy or parasitic disease; monocytosis 1.0×10⁹/L for more than 3 months. Summary CBC/Diff is a standard blood count plus the white cell formula — a breakdown of "who exactly" among the leukocytes. As explained above, neutrophilic left shift points to bacterial infection, lymphocytosis to viral, eosinophilia to allergy or parasites, and monocytosis to chronic inflammation. The formula must be read in absolute numbers, not percentages alone — and always in the context of the clinical picture and other inflammatory markers. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/daily-calorie-intake-nutrition-science https://labreadai.com/en/posts/daily-calorie-intake-nutrition-science Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Your calorie norm depends on BMR, activity level and goals. The Mifflin formula, activity multipliers, macronutrient split and how nutrition affects blood tests. Articles article "Eat 2000 calories a day" — advice that is simultaneously correct for some people and completely useless for others. The energy needs of a 25-year-old marathon runner and a 60-year-old woman with a desk job differ by a factor of one and a half to two. Let's look at how to calculate your actual calorie norm, what TDEE and BMR really mean, how to distribute macronutrients, and how nutrition directly affects your blood test results. BMR and TDEE: The Difference and Why It Matters Most people confuse two fundamentally different concepts. BMR (Basal Metabolic Rate) — the number of calories the body burns at complete rest: breathing, heartbeat, temperature maintenance, protein synthesis. This is the energy you would burn lying in bed all day without moving. TDEE (Total Daily Energy Expenditure) — the actual number of calories you burn accounting for all daily activity: work, exercise, household activity, even the thermic effect of food. TDEE is your actual calorie norm. Why many people "eat to their norm" and don't lose weight: they confuse BMR with TDEE or overestimate their activity level. How to Calculate BMR: The Mifflin-St Jeor Formula The most accurate widely available formula for basal metabolic rate: For men: BMR = 10 × weight (kg) + 6.25 × height (cm) − 5 × age (years) + 5 For women: BMR = 10 × weight (kg) + 6.25 × height (cm) − 5 × age (years) − 161 Example: a 35-year-old woman, 65 kg, 168 cm. BMR = 10×65 + 6.25×168 − 5×35 − 161 = 650 + 1050 − 175 − 161 = 1364 kcal/day This is her basal metabolic rate. To get her actual calorie norm, multiply by an activity multiplier. Activity Multipliers: The Main Trap Activity level Description Multiplier --------- Sedentary Desk job, no exercise × 1.2 Light 1–2 light workouts per week × 1.375 Moderate 3–5 workouts per week × 1.55 Active 6–7 intense workouts × 1.725 Very active Physical labour + daily training × 1.9 The main trap: most people choose a multiplier one level above their actual activity. A person with a desk job and three weekly workouts is "moderate," not "active." Overestimating by one level adds 200–400 extra kcal per day — over a year that is a 7–14 kg difference. For our example (woman, moderate activity): TDEE = 1364 × 1.55 = 2114 kcal/day — her actual maintenance calorie norm. Calorie Norms for Different Goals Goal Adjustment Expected result --------- Weight loss (gentle) TDEE − 300–400 kcal 0.3–0.4 kg/week Weight loss (standard) TDEE − 500 kcal 0.5 kg/week Weight loss (aggressive) TDEE − 750–1000 kcal 0.7–1.0 kg/week Weight maintenance = TDEE stable weight Muscle gain TDEE + 200–400 kcal 0.2–0.4 kg/week The physics of fat loss is simple: 1 kg of fat tissue ≈ 7700 kcal. A 500 kcal/day deficit yields roughly 0.5 kg per week. This is mathematics, not a diet. Minimum threshold: going below 1200 kcal for women and 1500 kcal for men is not recommended without medical supervision. With prolonged deficit, the body lowers BMR — "adaptive thermogenesis" — and weight loss slows. Macronutrients: How Much Protein, Fat and Carbohydrate Calories are not equal. The same energy from protein, fat, and carbohydrate affects body composition, satiety, and health very differently. Protein: The Most Important Macronutrient Protein is more satiating than carbohydrates or fat, preserves muscle mass during weight loss, and requires more energy to digest (thermic effect 20–30% vs 5–10% for fat and carbohydrate). Goal Protein norm ------ Sedentary lifestyle 0.8–1.0 g/kg Moderate activity 1.2–1.6 g/kg Strength training / weight loss 1.6–2.2 g/kg Intense sport 2.0–2.5 g/kg Protein deficiency during weight loss is the primary cause of losing muscle instead of fat. Fat: Essential, But Not All Equal Minimum fat intake: 0.8–1.0 g/kg. Fats are critical for hormone synthesis — including testosterone and estradiol — absorption of fat-soluble vitamins A, D, E, K, and nervous system function. Fat quality directly affects the lipid panel: saturated fats (red meat, butter) raise LDL; unsaturated fats (fish, olive oil, nuts) raise HDL and lower triglycerides. Carbohydrates: Fuel for Brain and Muscle The remaining calories after protein and fat. Quality matters more than quantity: whole grains, legumes, and vegetables cause a gradual rise in blood glucose; simple sugars and refined products cause a sharp insulin spike. High intake of simple carbohydrates raises triglycerides and lowers HDL — a direct path to metabolic syndrome. Dietary glycaemic control is the first step in preventing type 2 diabetes. How Nutrition Affects Blood Test Results Diet is a powerful modifier of laboratory markers. Changes in eating habits produce results faster than most people expect. Lipid panel: A Mediterranean diet lowers LDL by 10–15% and raises HDL. Reducing trans fats and saturated fats is the most evidence-based dietary intervention for atherosclerosis. Glucose and HbA1c: Reducing simple carbohydrates and increasing fibre lowers postprandial glycaemia. In prediabetes, dietary change lowers HbA1c by 0.3–0.5% — comparable to initial metformin doses. Triglycerides: The most diet-responsive marker — they fall within 2–4 weeks of reducing simple carbohydrates and alcohol. This is exactly why a lipid panel must be drawn strictly fasting. Micronutrient deficiency: Restrictive diets below 1400–1500 kcal frequently lower ferritin and lead to iron deficiency anaemia. Unplanned veganism depletes vitamin B12, calcium, and zinc. Practical Principles of Healthy Eating Nutrition is complex in details but simple in core principles. Following these gives 80% of the result: Protein at every meal — preserves muscle mass and reduces total calorie intake through satiety. Minimally processed foods — whole grains instead of white flour, legumes, vegetables, fruit, lean meat, fish. They deliver more fibre and micronutrients at lower calorie density. Control liquid calories — juices, sweet drinks, alcohol provide no satiety but plenty of calories. A glass of orange juice equals 4 oranges in calories but without the fibre. Meal timing — 3–4 meals with adequate gaps between them reduces total calorie intake better than eating every 2 hours for most people. When to See a Specialist See a doctor or registered dietitian for: unintentional weight loss ( 5% of body weight in 6 months); BMI below 18.5 (underweight); disordered eating patterns; chronic diseases (diabetes, CKD, cancer) — calorie norms differ substantially; no results despite a correctly calculated deficit after 3 months — worth checking TSH and fasting glucose. Summary A calorie norm is not a fixed number but a formula: BMR × activity multiplier ± goal adjustment. The Mifflin formula gives a starting point; reality fine-tunes it over 3–4 weeks of observation. Diet quality affects health through measurable laboratory markers — lipid panel, glucose, triglycerides — and this is quantifiable. No diet works as a short-term project: lasting change requires rebuilding habits, not willpower. This article is for informational purposes only. Before making significant dietary changes — especially with chronic conditions — consult a doctor or registered dietitian. https://labreadai.com/en/posts/dust-mite-allergy https://labreadai.com/en/posts/dust-mite-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Dust mite allergy is the leading cause of year-round indoor rhinitis and asthma. Learn the symptoms, diagnostic tests, environmental control strategies and immunotherapy options. Articles article A runny nose and congestion that never lets up, a morning cough the moment you wake up, itchy eyes with no pollen in sight — this is the classic presentation of dust mite allergy. Unlike hay fever, this allergy has no season: it's with you year-round, because the mites live exactly where you do. Let's look at who these mites are, why they're so hard to avoid, and what actually helps. What Are Dust Mites and Why Do They Cause Allergy House dust mites are microscopic arachnids 0.1–0.3 mm in size — invisible to the naked eye. The two main species are Dermatophagoides pteronyssinus and Dermatophagoides farinae. They feed on shed skin scales from humans and pets and live wherever organic matter accumulates: mattresses, pillows, duvets, upholstered furniture, carpets, and soft toys. The allergen is not the mites themselves but their waste products: fecal particles and fragments of dead mites. The main allergen, Der p 1, is a protease that damages the mucosal epithelial barrier, making it easier for allergen to penetrate tissue. This is why mite allergy so commonly progresses to asthma. Optimal conditions for mites: temperature 20–25°C, humidity above 50%. A standard urban apartment is an ideal habitat. Symptoms of Dust Mite Allergy The key difference from hay fever: symptoms are present year-round and worsen indoors, not outside. Typical signs: - Morning symptoms — nasal congestion, sneezing, watery eyes immediately on waking: mites are most concentrated in bedding, and exposure is greatest during sleep - Allergic rhinitis — chronic congestion, watery discharge, nasal itching - Conjunctivitis — redness, itching, a gritty eye sensation - Cough and wheezing — with lower airway involvement; some patients develop asthma - Atopic dermatitis flares — in patients with skin manifestations A characteristic pattern: symptoms worsen during vacuuming (dust disturbance), changing bedding, in damp rooms, or after moving into a new apartment with carpets. Diagnosis: Confirming Dust Mite Allergy Year-round rhinitis symptoms are nonspecific — they must be distinguished from chronic non-allergic rhinitis, nasal polyps, and vasomotor rhinitis. An allergist will order: - Skin prick tests with mite extract (D. pteronyssinus, D. farinae) — the diagnostic standard. Results in 15–20 minutes. Performed outside flares, at least 2 weeks after stopping antihistamines - Specific IgE blood test for mite allergens — can be done any time; antihistamines don't affect the result. Especially useful in severe dermatitis when skin tests are not feasible - Molecular diagnostics (Der p 1, Der p 2, Der p 23) — refines the sensitization profile and helps predict AIT efficacy - Complete blood count — elevated eosinophils indirectly support an allergic cause Reducing Mite Exposure: Environmental Control Complete elimination is impossible, but reducing mite concentrations several-fold is achievable — and this is the only non-drug strategy that works. The Bedroom — Top Priority The mattress, pillows, and duvet are the main mite reservoir: - Allergen-impermeable (encasing) covers for the mattress, pillows, and duvet — reduce allergen load by 80–90% - Wash bedding at 60°C weekly — temperatures above 55°C kill mites - Replace feather pillows and duvets with synthetic ones - Vacuum regularly with a HEPA-filter vacuum — a standard vacuum disperses allergen into the air The Rest of the Home - Keep indoor humidity below 50% using a dehumidifier — mites do not survive at low humidity - Remove carpets (especially from the bedroom) or treat with acaricides - Remove soft toys or wash them at 60°C - Wet-dust rather than dry-dust; the allergic person should avoid being present during cleaning Dust Mite Allergy Treatment: Medications Environmental control reduces symptoms but does not cure the allergy. Medications manage symptoms: - Intranasal corticosteroids (mometasone, fluticasone) — most effective for allergic rhinitis; act locally - Second-generation antihistamines (cetirizine, loratadine, bilastine) — for symptom relief; often taken continuously for year-round allergy - Eye drops for conjunctivitis - Bronchodilators and inhaled corticosteroids for asthma — strictly by prescription Immunotherapy for Dust Mite Allergy — Treating the Cause Allergen-specific immunotherapy with mite allergens is the only treatment that modifies the immune response rather than suppressing symptoms. The course runs 3–5 years; sublingual drops or tablets (convenient, no injections) or subcutaneous injections are available. After the first year most patients report a 30–50% symptom reduction; after completing the course many achieve lasting remission and reduced asthma risk. Mite AIT can be started at any time of year — there is no "season" as with pollen allergy. When to Seek Urgent Medical Attention Immediately if: wheezing and breathlessness not relieved by a bronchodilator; progressive throat or lip swelling; sudden severe deterioration after cleaning or changing bedding. Routine allergist visit: chronic rhinitis persisting 3 or more months; night-time cough and breathing difficulty; suspected asthma; wanting to start AIT. Summary Dust mite allergy is chronic but highly manageable. The combination of environmental control, medication, and AIT allows most patients to return to normal quality of life. The key is not to delay diagnosis: the earlier specific treatment starts, the lower the risk of progression to asthma. Any year-round rhinitis symptoms warrant a consultation with an allergist. Self-treatment for allergy can be unsafe. https://labreadai.com/en/posts/esr-westergren-blood-test-interpretation https://labreadai.com/en/posts/esr-westergren-blood-test-interpretation Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) ESR by Westergren is a sensitive inflammation marker. Normal ranges by age and sex, how it differs from other methods, causes of high and low ESR and CRP link. Articles article ESR is one of the oldest laboratory tests — over a hundred years old — and one of the most frequently ordered. Yet it is also among the three most commonly misinterpreted markers: patients worry about any deviation, and clinicians sometimes overestimate its specificity. Let's look at what ESR actually measures, why the method matters, how to read a result in context, and when an elevated ESR genuinely demands serious attention. What Is ESR and How Is It Measured ESR (erythrocyte sedimentation rate) — the speed at which red blood cells settle to the bottom of a tube over 1 hour. Normally, red cells carry a negative charge and repel each other, settling slowly. During inflammation, acute-phase proteins — fibrinogen, immunoglobulins, C-reactive protein — accumulate in the blood. They coat red cells, neutralise their charge, causing them to clump into "rouleaux" (coin-stack formations) and sediment faster. In other words, ESR is an indirect reflection of inflammatory proteins in the blood, not a direct measurement of inflammation. Westergren vs Other Methods The Westergren method — venous blood with citrate in a 200 mm tube — is the WHO international standard and the most widely used method globally. It gives higher values than older methods, especially when ESR is elevated. Practically important: if you previously tested by a different method and now use Westergren, results cannot be directly compared. Westergren typically reads 5–20 mm/h higher for the same health status. Normal ESR Values (Westergren) Group Normal range (mm/h) ------ Men under 50 0–15 Men over 50 0–20 Women under 50 0–20 Women over 50 0–30 Pregnancy (2nd–3rd trimester) up to 40–50 Children 1 month – 14 years 3–15 ESR rises predictably with age — due to increasing chronic low-grade inflammation and changes in plasma protein composition. Applying young-adult norms to elderly patients is a diagnostic error. A simple formula for age-adjusted upper limits: - Men: age ÷ 2 - Women: (age + 10) ÷ 2 Why ESR Rises: Mechanism and Causes ESR rises whenever acute-phase proteins accumulate or plasma protein ratios shift. This occurs in a vast number of conditions — which is precisely why ESR is non-specific. Infectious and Inflammatory Causes Acute bacterial infections produce moderate ESR elevation — 30–60 mm/h. Viral infections raise ESR far less than bacterial ones. Chronic infections (tuberculosis, osteomyelitis, endocarditis) produce sustained elevation in the range of 40–80 mm/h. Autoimmune diseases — rheumatoid arthritis, systemic lupus erythematosus, vasculitis — typically cause pronounced and persistent ESR elevation, often above 60 mm/h. Malignancy ESR above 100 mm/h is a red flag requiring oncological evaluation. Particularly characteristic of multiple myeloma (paraproteins dramatically accelerate sedimentation), lymphomas, and metastatic disease. Sustained unexplained ESR 100 mm/h in an adult is an unconditional indication for comprehensive investigation. Anaemia In iron deficiency anaemia and other forms of anaemia, fewer red cells are present and they sediment faster — ESR rises. Important: elevated ESR in anaemia does not indicate inflammation; it is a mechanical effect of reduced blood viscosity. Kidney and Liver Disease Chronic kidney disease lowers albumin and alters plasma protein ratios — ESR rises. Nephrotic syndrome with massive albumin loss produces particularly high ESR. Endocrine Disorders Hypothyroidism is frequently accompanied by moderate ESR elevation — through changes in protein metabolism. ESR falls when thyroid function is restored. Physiological Causes Pregnancy (especially second and third trimester), menstruation, the postpartum period, and older age all cause physiological ESR rise without pathology. Obesity also moderately raises ESR through chronic subclinical inflammation. Why ESR Falls Below Normal Very low ESR (0–1 mm/h) is less common but also informative. Causes: polycythaemia (excess red cells), sickle cell anaemia, spherocytosis, hypofibrinogenaemia, severe heart failure, cachexia. In sickle cell anaemia, deformed red cells cannot form rouleaux — ESR is abnormally low even in the presence of inflammation. ESR and CRP: Why They Are Read Together C-reactive protein (CRP) and ESR both reflect inflammation but differ in their temporal response: CRP ESR --------- Rise begins 6–12 hours 24–48 hours Peak 24–72 hours 3–5 days Normalisation 3–7 days 2–4 weeks Specificity Higher Lower Practical significance: CRP reacts fast and normalises fast — an excellent acute-phase marker. ESR reflects a longer process and normalises slowly — a useful marker of chronic inflammation and treatment response. Discordance between ESR and CRP is often more informative than either alone: high ESR with normal CRP — more likely a chronic process or physiological cause; high CRP with normal ESR — acute inflammation in the first hours before ESR has had time to respond. How to Prepare and What Affects Results ESR is part of the standard complete blood count. Blood is drawn fasting in the morning. Important: the sample must be processed within 2 hours of collection, otherwise results are unreliable. Factors that affect ESR: corticosteroids (lower ESR), NSAIDs (slightly lower), oral contraceptives (raise), pregnancy (raise physiologically), time of day (peak in the afternoon). After an acute infection, ESR normalises slowly — over 2–4 weeks. A "control" test one week after a respiratory infection will always show elevation even in a fully recovered person. Degrees of Elevation and Their Clinical Significance ESR (mm/h) Degree Most likely causes --------- Up to 20–30 (F), 15–20 (M) Normal — 20–40 Mild elevation Viral infection, stress, mild inflammation, age 40–70 Significant elevation Bacterial infection, autoimmune disease, anaemia 70–100 Marked elevation Severe infections, autoimmune disease in flare 100 Extreme elevation Myeloma, lymphoma, severe sepsis — urgent workup These are approximate guides, not algorithms. ESR 40 mm/h in a young pregnant woman is normal; the same value in a 40-year-old man with no complaints warrants investigation. When to Seek Urgent Medical Attention Immediately: ESR above 100 mm/h for the first time, especially without an obvious cause — serious infection or malignancy must be excluded first. Within a few days: ESR 40–70 mm/h in a person under 50 without signs of acute infection; rising ESR on serial testing; ESR above normal combined with unexplained weight loss, night sweats, or enlarged lymph nodes. Summary ESR is a sensitive but non-specific marker: it signals that something is happening, but not what. Its value lies in trends and in combination with C-reactive protein and the clinical picture. An isolated moderate ESR elevation in an elderly person or pregnant woman is generally not alarming. ESR above 100 mm/h always warrants comprehensive investigation. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/estradiol-what-it-is https://labreadai.com/en/posts/estradiol-what-it-is Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Estradiol is the most potent estrogen with norms that shift by cycle phase. Its role in bones, heart and mood, normal ranges in women and men, and causes of changes. Articles article Estradiol is called the primary female hormone — and for good reason. But behind this familiar label lies a substance with a far broader role: it governs not only the menstrual cycle and fertility, but also bone density, vascular health, mood, and even the lipid profile of the blood. Let's look at what estradiol actually is, why its normal values change every week of the menstrual cycle, and what elevated or low levels mean. What Is Estradiol and How It Differs From Estrogen "Estrogen" is a collective term for a group of hormones. The human body produces three: estrone (E1), estradiol (E2), and estriol (E3). Estradiol is the most potent of the three — 10 to 80 times more active than estrone — and it is the dominant form during reproductive years. In women, estradiol is produced primarily in the ovaries (granulosa cells of follicles); in men, in the testes and through peripheral conversion of testosterone in adipose tissue. Small amounts are produced by the adrenal glands in both sexes. Estradiol receptors are present in virtually every tissue: uterus, breasts, bones, blood vessels, brain, skin, intestines. This is why changes in estradiol levels are felt across many systems simultaneously — from mood to joint health. The Role of Estradiol in the Body Reproductive function. Estradiol drives follicle growth, prepares the endometrium for implantation, and regulates ovulation through feedback with the pituitary gland (an estradiol surge triggers the LH peak). Without adequate estradiol, a normal cycle is not possible. Bone tissue. Estradiol inhibits bone resorption by osteoclasts. After menopause, when its level falls, bone breakdown accelerates faster than it can be rebuilt — this is the foundation of postmenopausal osteoporosis. Adequate calcium, vitamin D, and estradiol are all required for normal bone mineralisation — all three are interconnected. Cardiovascular system. Estradiol protects the vascular endothelium, raises HDL, and lowers LDL. This explains why women before menopause have significantly lower coronary artery disease risk than men of the same age — and why that risk rises sharply after menopause. Central nervous system. Estradiol influences serotonin and dopamine synthesis. Premenstrual syndrome, postpartum depression, and mood instability in perimenopause are largely consequences of estradiol fluctuations. In men. Normal estradiol is necessary for libido, erectile function, bone density, and normal spermatogenesis. Too low estradiol in men is as much a problem as too high. Normal Estradiol Values in Women by Cycle Phase The key feature of estradiol interpretation in women of reproductive age: normal values differ fundamentally by cycle phase. Evaluating the result without specifying the cycle day is meaningless. Cycle phase Normal estradiol (pmol/L) Normal (pg/mL) --------- Follicular (days 1–13) 68–1270 18–147 Ovulatory peak (day 14) 131–1655 36–450 Luteal (days 15–28) 91–861 25–235 Postmenopause < 73 < 20 Pregnancy 1st trimester 215–4300 58–1170 During pregnancy, estradiol is produced by the placenta — levels rise hundreds of times above non-pregnant norms. Normal Estradiol Values in Men Group Normal (pmol/L) Normal (pg/mL) --------- Adult men 40–161 11–44 In men, elevated estradiol is most commonly linked to obesity (adipose tissue converts testosterone to estradiol) or anabolic steroid use. When to Test Estradiol For women of reproductive age: on days 2–5 of the cycle (early follicular phase), when the goal is to assess basal levels and ovarian function. To assess ovulation — around the middle of the cycle (days 12–14). Always fast before the draw. For postmenopausal women and men — any day, morning, fasting. Always note the cycle day on the test request — without it, the laboratory cannot apply the correct reference range. Causes of Elevated Estradiol In women: estrogen-producing ovarian tumours; endometriosis — ectopic endometrial tissue produces estradiol locally; obesity — adipose tissue produces estrone, which partially converts to estradiol; liver cirrhosis — impaired estrogen metabolism; use of estrogen-containing medications (combined oral contraceptives, HRT); physiological pre-ovulatory surge — not pathological. In men: obesity (the main cause); testicular tumours; liver cirrhosis; primary hypogonadism with elevated FSH and LH. Causes of Low Estradiol In women: primary ovarian insufficiency (premature menopause); hypogonadotropic hypogonadism — impaired pituitary signalling; anorexia nervosa or rapid weight loss — adipose tissue is needed for estrogen synthesis; intense athletic training (athletic amenorrhoea); hyperprolactinaemia — excess prolactin suppresses estradiol production; hypothyroidism — thyroid dysfunction disrupts hormonal balance; perimenopause and menopause — physiological decline of ovarian function. In men: primary hypogonadism; use of aromatase inhibitors. Estradiol and PCOS In polycystic ovary syndrome, estradiol is often normal or mildly elevated — but the pattern is disrupted: many small follicles, none dominant, ovulation does not occur. Testosterone and LH are elevated, and the LH/FSH ratio exceeds 2. Estradiol in this context is just one of several markers; PCOS diagnosis requires a combination of criteria. Estradiol and Menopause The decline of estradiol in perimenopause is gradual but systemic. Hot flushes, sleep disruption, mucosal dryness, accelerated bone loss, and a shift in the lipid profile toward atherogenicity — all are direct consequences of estradiol deficiency. Menopausal hormone therapy (MHT) is directed specifically at replenishing estradiol. When to See a Doctor Routine referral to a gynaecological endocrinologist for: menstrual irregularities (amenorrhoea, oligomenorrhoea) lasting more than 3 months; infertility; symptoms of early menopause before age 40; gynaecomastia in men; symptoms of estrogen deficiency (hot flushes, vaginal dryness, osteoporosis at a young age). Summary Estradiol has a remarkably wide spectrum of action that extends far beyond the reproductive system. Its level must always be assessed in the context of the cycle phase in women, and alongside other hormones — FSH, LH, prolactin, testosterone. An isolated number without clinical context tells almost nothing. Long-term estradiol deficiency affects bones, blood vessels, and the brain — it is not "just a hormonal imbalance." This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/ferritin-blood-test-interpretation https://labreadai.com/en/posts/ferritin-blood-test-interpretation Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ferritin is the best marker of iron stores and an acute-phase protein. Normal ranges by sex and age, deficiency thresholds, the inflammation trap and high ferritin. Articles article Ferritin is one of the most informative laboratory markers — and one of the most easily misread. "Normal ferritin" during chronic inflammation can conceal true iron deficiency. "High ferritin" in someone with fever and pain almost certainly reflects an acute-phase reaction, not an iron storage disease. Let's look at how to read this test correctly and when the result is misleading. What Is Ferritin and Why It Matters More Than Haemoglobin for Diagnosing Iron Deficiency Ferritin is the storage protein: it holds iron in liver cells, bone marrow, spleen, and muscle in an inactive, non-toxic form. A small amount of ferritin circulates in the blood — this is what we measure in the test. Serum ferritin directly reflects the body's iron stores. This makes it a fundamentally earlier deficiency marker than haemoglobin: ferritin begins to fall weeks to months before haemoglobin drops and true iron deficiency anaemia develops. The three-stage logic of iron depletion: 1. Ferritin falls — iron stores are exhausted; haemoglobin still normal 2. Serum iron and transferrin saturation fall — transport reserve depleted 3. Haemoglobin falls, MCV decreases — iron deficiency anaemia This is why normal haemoglobin does not exclude iron deficiency — ferritin must be checked. Normal Ferritin Values Group Normal ferritin (µg/L) ------ Women 18–45 years 10–120 Women over 45 years 10–200 Men 20–250 Children 1–5 years 6–24 Children 5–15 years 10–55 Pregnancy ≥ 30 (target) Reference ranges vary between laboratories — always use the values on your specific report. Three Clinically Important Ferritin Thresholds Being formally "within range" is not always "sufficient." Here are the thresholds that carry clinical weight: Ferritin < 12–15 µg/L — overt iron deficiency. Stores are essentially exhausted; anaemia risk is high. Iron supplementation is indicated regardless of haemoglobin level. Ferritin 12–30 µg/L — borderline zone. With symptoms (fatigue, hair loss, reduced stamina) — functional deficiency. In pregnancy this range already requires iron supplementation. Ferritin < 30 µg/L in pregnancy — indication for iron supplementation, as demand rises sharply and stores are depleted quickly. Ferritin 30–100 µg/L — optimal range for most adults. No deficiency, no toxicity. Ferritin 200–300 µg/L in women, 300–400 µg/L in men — hyperferritinaemia requiring interpretation. The Key Trap: Ferritin as an Acute-Phase Protein This is the single most important thing to know about ferritin. Beyond its role as an iron storage protein, ferritin is an acute-phase reactant: during inflammation, infection, or tissue injury, its blood concentration rises sharply — independently of actual iron stores. Practical implication: a patient with chronic inflammation (rheumatoid arthritis, chronic infection, malignancy) may have normal or even elevated ferritin while true iron stores are depleted. This is anaemia of chronic disease — one of the most diagnostically challenging forms of anaemia. How to untangle this: always read ferritin alongside C-reactive protein (CRP): - Low ferritin + normal CRP → true iron deficiency - Normal/high ferritin + elevated CRP → inflammation masking possible deficiency; full iron panel needed (transferrin saturation < 16% indicates deficiency even with normal ferritin) - Low ferritin + elevated CRP → iron deficiency coexisting with inflammation — both conditions are present Causes of Low Ferritin Low ferritin almost always means iron deficiency. The question is why: Increased iron losses: heavy menstruation — the main cause in women of reproductive age; chronic gastrointestinal blood loss (ulcer, polyps, haemorrhoids, colorectal cancer — especially in men and postmenopausal women); regular blood donation. Insufficient intake: strict vegetarianism and veganism without supplementation; restrictive diets. Impaired absorption: coeliac disease, inflammatory bowel disease, atrophic gastritis, gastric surgery (including bariatric procedures). Increased demand: pregnancy and breastfeeding, active growth in children and adolescents, intensive athletic training. Causes of Elevated Ferritin (Hyperferritinaemia) Elevated ferritin is not always a sign of iron excess. Causes must be distinguished: Reactive elevation (acute phase): acute infections, inflammatory diseases, myocardial infarction, trauma, malignancy. Here ferritin is a marker of inflammation, not iron. As CRP normalises, ferritin follows. Liver injury: acute hepatitis, cirrhosis — ferritin leaks from damaged cells. Liver function tests are also abnormal. Chronic diseases: type 2 diabetes and metabolic syndrome — moderate hyperferritinaemia without iron excess; chronic kidney disease — ferritin accumulation from impaired clearance. Hereditary haemochromatosis — genetic disorder of excess iron absorption. Ferritin 300 µg/L in women and 400 µg/L in men with transferrin saturation 45–50% — the classic pattern. Requires confirmation by genetic testing (HFE mutation). Macrophage activation syndrome (haemophagocytic lymphohistiocytosis) — rare but life-threatening. Ferritin is extremely high — often 10 000 µg/L. Combined with fever, cytopenias, and abnormal liver function tests. How to Prepare for a Ferritin Test Ferritin does not require fasting — food intake has minimal effect on the result. Key recommendations: - Draw blood in the morning under consistent conditions for serial monitoring - Do not test during acute infections or active chronic disease flares — ferritin will be reactively elevated and will not reflect true stores - When monitoring iron deficiency anaemia treatment — repeat after 3 months from haemoglobin normalisation, not sooner: this is how long it takes to replenish stores Ferritin is part of the standard iron panel alongside serum iron, transferrin, and TIBC — a combined assessment is more accurate than ferritin alone. When to Seek Urgent Medical Attention Immediately: ferritin 10 000 µg/L with fever, cytopenias, and organ dysfunction — possible macrophage activation syndrome. Within a few days: ferritin < 10 µg/L in pregnancy; ferritin 500 µg/L without an obvious cause (acute inflammation or trauma) — exclude haemochromatosis and liver pathology; rising ferritin on serial testing without treatment. Summary Ferritin is a two-faced marker. Low — almost always iron deficiency, cause to be found. High — must be distinguished: inflammation, liver injury, diabetes, or true iron excess. Reading ferritin without CRP and clinical context gives half the picture. Combined with a complete blood count and a full iron panel, ferritin delivers a complete view of iron metabolism. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/food-allergy https://labreadai.com/en/posts/food-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Food allergy is an IgE-mediated reaction to foods. Symptoms, the big eight allergens, anaphylaxis, diagnosis through specific IgE and elimination diet basics. Articles article Reactions to food are among the most common reasons for visiting an allergist. But not every unpleasant food reaction is an allergy: most are food intolerances, with a fundamentally different mechanism. Let's clarify what true food allergy is, how it differs from intolerance, which foods most commonly cause it, and how to get an accurate diagnosis. Food Allergy vs Food Intolerance: A Critical Distinction Food allergy is an immune reaction: the immune system mistakenly identifies a food protein as a threat and produces IgE antibodies. On repeat exposure, IgE triggers histamine release and symptoms develop. The reaction can be acute and severe — up to anaphylaxis. Food intolerance has nothing to do with the immune system. Examples: lactase deficiency (missing enzyme for milk sugar digestion), gluten intolerance/celiac disease (autoimmune but not IgE-mediated), reactions to histamine or tyramine in foods. Intolerance causes discomfort but never anaphylaxis. The distinction is critical: treatment and restrictions differ completely between allergy and intolerance. Top Eight Food Allergens: From Milk and Peanut Allergy to Shellfish Eight food groups account for more than 90% of all food allergies: Allergen Notes ------ Cow's milk Leading cause in children under 3; most outgrow it by school age Hen's eggs Second most common allergen in children; usually to the white, not yolk Peanuts Among the most common in adults; high anaphylaxis risk Tree nuts Cashews, hazelnuts, walnuts, almonds — cross-reactions common Fish More common in adults; often persists lifelong Shellfish Shrimp, crab, lobster; often persists in adults Wheat Wheat allergy ≠ celiac disease — different mechanisms Soy Common in children with milk allergy Food Allergy Symptoms in Adults and Children Symptoms appear within minutes to 2 hours after eating the trigger food. Skin: urticaria (hives with itching); angioedema (swelling of lips, tongue, eyelids); skin flushing. Gastrointestinal: nausea, vomiting, abdominal pain, diarrhea. Respiratory: nasal congestion, sneezing, wheezing, cough. Systemic — anaphylaxis: sudden blood pressure drop, loss of consciousness, laryngeal edema with breathing difficulty — a life-threatening emergency requiring immediate epinephrine. Severity is unpredictable: a previous mild reaction does not guarantee the next won't be anaphylaxis. Diagnosis of Food Allergy The diagnosis cannot be made from symptoms alone or by self-imposed food elimination. Specific IgE Blood Test Blood test for specific IgE to suspected foods — can be done at any time, antihistamines don't affect the result. High IgE confirms sensitization, but does not always mean clinical allergy: a person may be sensitized but tolerate the food without symptoms. A complete blood count indirectly indicates allergy: eosinophils are elevated in active allergic processes. Skin Prick Tests Performed by an allergist outside of flares, at least 2–4 weeks after stopping antihistamines. Results in 15–20 minutes. Correlate well with clinical allergy. Oral Food Challenge (Double-Blind, Placebo-Controlled) The gold standard — but performed only in an allergy clinic due to the risk of severe reaction. The patient receives the suspected food in gradually increasing doses under observation. Elimination Diet with Food Diary Eliminating the suspected food for 2–4 weeks followed by controlled reintroduction helps establish the link between symptoms and a specific food. Treatment of Food Allergy Strict allergen avoidance — the only reliable prevention. General allergy classification and diagnostic principles are covered in the allergy guide. Reading ingredient labels carefully is essential: milk, eggs, and peanuts hide under many names. Antihistamines (cetirizine, loratadine) — relieve mild skin and respiratory symptoms. Epinephrine autoinjector (EpiPen) — mandatory for patients at high anaphylaxis risk. Those with confirmed severe food allergy must carry it at all times. Oral immunotherapy (OIT) — gradual introduction of increasing allergen doses to reduce sensitivity. Used for peanut, milk, and egg allergy; a peanut OIT product (Palforzia) is approved. Performed only under allergist supervision. When to Seek Urgent Medical Attention Call emergency services immediately for: difficulty breathing, wheezing; tongue or throat swelling; sudden drop in blood pressure, loss of consciousness; hives combined with any of the above — this is anaphylaxis. Scheduled allergist visit: repeated reactions to the same food; unexplained reaction with skin symptoms; confirmation of diagnosis and anaphylaxis management education. Summary Food allergy requires accurate diagnosis — not self-imposed elimination of entire food groups. Unnecessarily broad exclusion diets can lead to nutritional deficiencies, especially in children. Only an allergist using specific IgE testing and skin prick tests can confirm the diagnosis and create a rational dietary plan. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/glucose-blood-test-decoding https://labreadai.com/en/posts/glucose-blood-test-decoding Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Fasting glucose, HbA1c and the glucose tolerance test — three windows into carb metabolism. Norms for venous and capillary blood, prediabetes and HOMA-IR. Articles article "Glucose 6.1 — is that already diabetes?" is one of the most common questions after a blood test. The answer depends on whether blood was drawn from a vein or a fingertip, whether it was fasting, and which reference range applies. Let's break down all three glucose measurement methods, why vein and fingertip norms differ, what prediabetes means, and when a result genuinely warrants attention. Three Testing Methods: How They Differ When people say "blood sugar test," they may mean three fundamentally different tests — each looking at carbohydrate metabolism through a different window. Fasting glucose — an instant snapshot: blood sugar right now, after 8–12 hours without food. Reflects basal insulin secretion and hepatic gluconeogenesis. Simple and fast, but cannot detect what happens after meals. Glycated haemoglobin (HbA1c) — a 2–3 month archive. Reflects what average glucose has been over that period. Independent of what was eaten the day before. The gold standard for monitoring type 2 diabetes treatment and one of the diagnostic criteria. Oral glucose tolerance test (OGTT) — the dynamic response to a sugar load. Glucose is measured fasting and 2 hours after drinking 75 g of glucose solution. It detects impaired glucose tolerance — a prediabetes stage that a single fasting test cannot reveal. Capillary vs Venous Blood: Why the Norms Differ This is one of the most common sources of confusion. A glucometer and a laboratory give different readings — and that is expected. Blood source Normal fasting Prediabetes Diabetes ------------ Venous plasma (laboratory) < 6.1 mmol/L 6.1–6.9 mmol/L ≥ 7.0 mmol/L Capillary blood (glucometer, fingertip) < 5.6 mmol/L 5.6–6.0 mmol/L ≥ 6.1 mmol/L Venous plasma and whole capillary blood give different values because of differences in water content and analytical method. WHO diagnostic criteria and most national standards are based on venous plasma — which is what laboratories use. Practical rule: if blood was drawn from a vein at a laboratory, compare with venous plasma norms. If measured with a glucometer (fingertip), compare with capillary blood norms. Comparing a glucometer reading to laboratory reference ranges is incorrect. Fasting Glucose Norms and Their Clinical Meaning Level (venous plasma) Interpretation ------ < 6.1 mmol/L Normal 6.1–6.9 mmol/L Impaired fasting glucose (prediabetes) ≥ 7.0 mmol/L (single) Suspected diabetes — requires confirmation ≥ 7.0 mmol/L (twice) Diabetes A reading of 6.1 mmol/L from a vein is already prediabetes, not normal. This range must not be ignored: at this stage, lifestyle change is most effective and can fully normalise blood sugar. A common question: "I got 5.8 — is that too high?" From a fasting venous sample — yes, that is impaired fasting glucose. Time to check HbA1c and consider an OGTT, rather than waiting for the number to climb. HbA1c: Normal Ranges and Diagnostic Thresholds HbA1c Interpretation ------ < 5.7% Normal 5.7–6.4% Prediabetes ≥ 6.5% Diabetes (confirmed once) < 7.0% Treatment target in diabetes HbA1c is independent of recent food — it can be drawn any time of day. Limitations: unreliable in haemolytic anaemia, certain haemoglobinopathies, and pregnancy (accelerated red cell turnover lowers the result). In iron deficiency anaemia, HbA1c may be falsely elevated — check ferritin when results don't match the clinical picture. Glucose Tolerance Test: What the Results Mean The OGTT is the primary test for detecting impaired glucose tolerance (IGT): a state where fasting glucose is still normal but glucose clears too slowly after a carbohydrate load. 2 hours after 75 g glucose Interpretation ------ < 7.8 mmol/L Normal 7.8–11.0 mmol/L Impaired glucose tolerance (prediabetes) ≥ 11.1 mmol/L Diabetes OGTT is indicated when: fasting glucose is 6.1–6.9 mmol/L; fasting glucose is normal but risk factors are present (obesity, family history, previous gestational diabetes); in pregnancy at weeks 24–28 for gestational diabetes screening. Insulin Resistance and HOMA-IR Glucose can be normal while insulin resistance is already significant. The HOMA-IR index is used to detect it: HOMA-IR = (fasting glucose mmol/L × fasting insulin µIU/mL) ÷ 22.5 HOMA-IR Interpretation ------ < 2.5 Normal 2.5–5.0 Insulin resistance 5.0 Significant insulin resistance Insulin resistance without diabetes is an important early marker of metabolic syndrome. It is often accompanied by elevated triglycerides, reduced HDL, and abdominal obesity. This is why a lipid panel is indicated when insulin resistance is found. Hypoglycaemia: When Glucose Is Too Low Hyperglycaemia gets most of the attention, but low blood sugar can be equally dangerous. Hypoglycaemia — glucose below 3.9 mmol/L (in people without diabetes, symptoms typically appear below 3.5 mmol/L). Symptoms: trembling, sweating, palpitations, anxiety, pallor — these are adrenergic symptoms from the initial fall. With greater decline — impaired concentration, confusion; in severe cases, loss of consciousness. Reactive (postprandial) hypoglycaemia — glucose drop 2–4 hours after eating. The person feels weakness, trembling, and intense hunger a few hours after a meal. Common in insulin resistance, after bariatric surgery, and with high simple carbohydrate intake. Causes of fasting hypoglycaemia require medical investigation: insulinoma (pancreatic tumour), adrenal insufficiency, severe liver disease. How to Prepare for a Blood Glucose Test - Strict fasting — 8–12 hours without food. Even unsweetened coffee or chewing gum can affect the result - Avoid intense exercise the day before - Do not test during acute illness — stress and infection transiently elevate glucose - For OGTT — eat normally for 3 days beforehand (do not restrict carbohydrates before the test — this distorts the result) - HbA1c — any time of day, no fasting required What Else Is Checked Alongside Glucose When carbohydrate metabolism abnormalities are found, comprehensive assessment includes: HbA1c — to understand average glycaemia over 3 months. Fasting insulin — to calculate HOMA-IR and assess insulin resistance. Lipid panel — in type 2 diabetes, lipid abnormalities are almost universal: elevated triglycerides and reduced HDL. Kidney function test — diabetic nephropathy develops in a third of patients; microalbuminuria is an early marker. Ferritin — to exclude iron deficiency as a cause of falsely elevated HbA1c. When to Seek Urgent Medical Attention Immediately: glucose above 16–17 mmol/L with nausea and vomiting — possible ketoacidosis; symptoms of severe hypoglycaemia (loss of consciousness, seizures). Within a few days: fasting glucose ≥ 7.0 mmol/L on first measurement — confirm with a repeat test; glucose 6.1–6.9 mmol/L — consultation to assess risk and decide on OGTT; symptoms of reactive hypoglycaemia (weakness 2–3 hours after meals). Summary A blood glucose test is not a single number but a system of tests with different time horizons: fasting shows now, HbA1c shows the past 3 months, OGTT shows the response to a load. Norms for venous and capillary blood differ — always compare with the correct reference. Prediabetes (6.1–6.9 mmol/L from a vein) is not "almost normal" — it is a clear signal where lifestyle change can genuinely reverse the trajectory. For more on the mechanism of diabetes development, see the type 2 diabetes article. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/glyukoza-v-krovi https://labreadai.com/en/posts/glyukoza-v-krovi Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Glucose is the body's primary fuel. How insulin and glucagon regulate it, why the brain depends on it, causes of high and low levels and when to test. Articles article Understanding why blood glucose matters is fundamental to health. Glucose is a molecule without which life as we know it is impossible. The brain consumes around 120 grams of glucose per day and has almost no capacity to switch to an alternative fuel source. This is why the body maintains blood glucose within a very narrow range — 3.9 to 5.5 mmol/L — with the precision of a finely tuned regulator. Let's look at how this system works, what disrupts it, and what a blood glucose test tells us. What Glucose Is and Why the Body Needs It Glucose is a simple monosaccharide and the universal energy source for all cells. Through glycolysis and oxidative phosphorylation, one glucose molecule yields 36–38 ATP molecules — the primary "energy currency" of the cell. The brain occupies a unique position. Neurons have virtually no glycogen stores of their own and are completely dependent on a continuous glucose supply from the blood. When glucose falls below 2.5–3.0 mmol/L, consciousness is impaired. This is why the body never allows glucose to drop below a critical threshold — powerful protective mechanisms are engaged immediately. Other important roles of glucose: glycogen synthesis (the reserve energy storage form in liver and muscle); fatty acid synthesis when in excess (hence the link between carbohydrate overconsumption and fat accumulation); and as a building block for certain amino acids and nucleic acids. How Glucose Is Regulated: Four Key Hormones Blood glucose is the result of a constant balance between its input (from food and hepatic synthesis) and consumption (by all organ cells). Four hormones govern this balance. Insulin — the principal glucose-lowering hormone. Produced by pancreatic β-cells in response to rising blood glucose after meals. Insulin opens the "gates" for glucose entry into muscle and fat cells, stimulates glycogen synthesis in the liver, and inhibits hepatic glucose release. Without insulin, glucose cannot enter most cells — which is what happens in type 1 diabetes. Glucagon — insulin's antagonist. Produced by pancreatic α-cells when glucose falls. Stimulates glycogen breakdown in the liver (glycogenolysis) and glucose synthesis from non-carbohydrate substrates (gluconeogenesis), releasing glucose into the blood. Cortisol — the stress hormone. Raises blood glucose by stimulating gluconeogenesis and reducing tissue insulin sensitivity. This is why chronic stress and chronically elevated cortisol can push fasting glucose above normal even without diabetes. Adrenaline — the acute stress hormone. Instantly raises glucose through glycogenolysis in liver and muscle — "fuel for flight." A significant spike in adrenaline before a blood draw (anxiety, argument) can transiently elevate the result. Where Blood Glucose Comes From Glucose enters the blood from three sources: Food — after digestion of carbohydrates (starch, sucrose, lactose are broken down to glucose and other monosaccharides) absorbed in the small intestine. Blood glucose peaks 30–60 minutes after a meal and normalises within 2 hours. Glycogen — the polysaccharide stored in the liver (100 g) and muscles (400 g). When glucose falls or during exercise, liver glycogen is broken down and glucose enters the blood. Muscle glycogen is used only by the muscles themselves. Gluconeogenesis — glucose synthesis in the liver from amino acids, lactate, and glycerol. Active during fasting, intense exercise, and stress. The balance between these three sources and cellular glucose consumption determines blood glucose at any given moment. How tightly glucose is regulated becomes clear when any one source is disrupted. Glucose Normal Ranges: Quick Reference State Normal (venous plasma) ------ Fasting (8–12 hours without food) 3.9–6.0 mmol/L 2 hours after a meal < 7.8 mmol/L Random (any time of day) < 11.1 mmol/L Norms for capillary blood (fingertip) differ from venous plasma. For full details on norms, prediabetes thresholds, and interpretation rules, see how to read a blood glucose test. Causes of Elevated Glucose Hyperglycaemia signals a disruption in carbohydrate metabolism regulation. This is why knowing the causes matters for timely intervention. Type 2 diabetes — the most common cause. Cells lose insulin sensitivity (insulin resistance); the pancreas produces more and more insulin, but eventually exhausts its capacity. Glucose rises gradually over years. Type 1 diabetes — autoimmune destruction of β-cells; absolute insulin deficiency. Develops rapidly, more often in young people. Stress and acute illness — cortisol and adrenaline transiently elevate glucose. This is physiological and is not diabetes. Chronically elevated cortisol — Cushing's syndrome, prolonged glucocorticoid use. Pancreatic dysfunction — pancreatitis, pancreatic cancer impair insulin production. Hormonal disorders — acromegaly (growth hormone excess), hyperthyroidism, phaeochromocytoma. Prediabetes — fasting glucose 6.1–6.9 mmol/L or 7.8–11.0 mmol/L after a glucose load. A reversible stage where lifestyle change alters the outcome. Causes of Low Glucose Hypoglycaemia is no less important than hyperglycaemia — and understanding it matters just as much. Reactive hypoglycaemia — glucose drop 2–4 hours after a meal rich in simple carbohydrates. Linked to insulin resistance and excessive insulin release. Insulin or hypoglycaemic drug overdose — the most common cause of clinically significant hypoglycaemia. Alcohol — blocks gluconeogenesis in the liver. Alcohol-induced hypoglycaemia is particularly dangerous overnight and on an empty stomach. Prolonged fasting with depleted glycogen stores. Insulinoma — a rare pancreatic tumour secreting insulin autonomously. Adrenal insufficiency — cortisol deficiency reduces gluconeogenesis. Glucose and Related Lab Markers Blood glucose does not exist in isolation — it is tightly regulated and linked to several other laboratory markers. HbA1c — reflects average glucose over the past 2–3 months. Fasting glucose and HbA1c together give the full picture: the first is an instant snapshot, the second is a 3-month archive. Insulin and HOMA-IR — reveal insulin resistance before glucose becomes elevated. Normal glucose with high fasting insulin is an early sign of metabolic dysregulation. Triglycerides — in insulin resistance and type 2 diabetes, triglycerides are almost always elevated: excess carbohydrates are converted to fat. LDL and HDL — glucose metabolism disorders alter the lipid panel: LDL rises, HDL falls. Cortisol — chronic elevation from stress or Cushing's syndrome impairs glucose metabolism by reducing insulin sensitivity. What Affects Blood Glucose in Daily Life Understanding these factors explains result fluctuations: Diet — fast carbohydrates (white bread, sugar, juices) produce a sharp glucose peak and rapid fall. Slow carbohydrates (whole grains, legumes, vegetables) give a gradual rise without a spike. Physical activity — working muscles absorb glucose independently of insulin. Regular exercise increases long-term insulin sensitivity — lowering baseline glucose and triglycerides. Stress — acute adrenaline and cortisol release transiently raises glucose. Testing after an argument or in a state of anxiety produces a falsely elevated result. Sleep — sleep deprivation raises cortisol and reduces insulin sensitivity. Chronic poor sleep is an independent risk factor for type 2 diabetes. Time of day — the "dawn phenomenon": in some people, fasting glucose is higher in the morning from pre-waking cortisol and growth hormone release. This is why fasting tests are drawn in the morning. When to Get a Blood Glucose Test Annual fasting glucose screening is recommended for: age over 40; obesity (BMI 25); family history of diabetes; hypertension; lipid panel abnormalities; previous gestational diabetes; polycystic ovary syndrome. Immediately for symptoms: thirst + frequent urination + unexplained weight loss (hyperglycaemia); trembling, sweating, intense hunger, confusion (hypoglycaemia). Summary Blood glucose is not simply "sugar." It is a central metabolic marker reflecting the balance between carbohydrate intake, pancreatic function, tissue insulin sensitivity, and hormonal status. A single fasting number provides orientation but not the full picture — for that, HbA1c and when needed a glucose tolerance test are required. For detailed interpretation rules and diagnostic thresholds, see how to read a blood glucose test. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/grass-pollen-allergy https://labreadai.com/en/posts/grass-pollen-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Grass pollen allergy is the second most common hay fever in temperate climates. Symptoms, cross-reactivity, timothy grass diagnosis and immunotherapy. Season: May to July. Articles article Sneezing and watery eyes in June that arrive like clockwork every year — most likely grass pollen allergy. It is the second most common hay fever in temperate climates: grasses surround us everywhere — lawns, meadows, roadsides, parks. Let's look at exactly which grasses are responsible, why one positive test covers the entire family, and how to treat this hay fever effectively. Which Grasses Cause Allergy The grass family (Poaceae/Gramineae) contains thousands of species, most of which produce allergenic pollen. The most clinically relevant in temperate climates: - Timothy grass (Phleum pratense) — the "gold standard" for diagnosis and AIT product manufacturing. Its allergens Phl p 1 and Phl p 5 cross-react with equivalent proteins in all grass species - Cocksfoot / orchard grass (Dactylis glomerata) — an early-flowering grass that opens the season - Rye (Secale cereale) — one of the most allergenic grasses - Kentucky bluegrass / meadow grass (Poa pratensis) - Meadow fescue (Festuca pratensis) - Meadow foxtail (Alopecurus pratensis) - Perennial ryegrass (Lolium perenne) — especially relevant in Western Europe Key fact: all grasses cross-react with each other. A patient sensitised to timothy grass reacts to rye, cocksfoot, bluegrass, and all other grass pollens. This is why testing one or two species is sufficient for diagnosis — there is no need to test all two hundred. The primary allergen is Phl p 1 (β-expansin): present in all grass pollens and cross-reactive in 95% of grass-allergic patients. Phl p 5 is the second most important — more specific to timothy. Grass Pollen Season Grasses flower from late April through July, peaking in May–June. Exact timing depends on climate zone and weather: a warm spring advances the season. Important context: the grass season begins as the birch pollen season ends. Patients allergic to both birch and grasses may have uninterrupted hay fever from late March through July. At the end of the grass season, wormwood and ragweed begin. Polysensitised patients can suffer throughout virtually the entire warm season. Peak airborne grass pollen concentrations occur in the morning hours (6–11 am) on dry, windy days. After rain and in overcast weather, concentrations are minimal. Symptoms of Grass Pollen Allergy The clinical picture of grass pollinosis is typical of seasonal allergic rhinitis, but often intense due to high airborne pollen concentrations. Allergic rhinitis — paroxysmal sneezing in runs, abundant clear nasal discharge, congestion, nasal and soft palate itch. In some patients, congestion dominates over rhinorrhoea. Allergic conjunctivitis — redness, burning, itch, tearing, a "gritty" eye sensation. Often as prominent as rhinitis. Bronchospasm — in patients with asthma or predisposition to it. Grass pollen is one of the leading triggers of summer asthma. Contact reactions — skin itch and redness with direct grass contact (walking barefoot through grass, mowing, lying on a lawn). Systemic symptoms — fatigue, headache, reduced concentration, sleep disruption. Quality of life can fall significantly at peak season. Characteristic pattern: symptoms worsen in the morning, intensify outdoors in windy weather and during grass cutting, ease after rain and indoors with windows closed. Cross-Reactivity in Grass Pollinosis Food cross-reactivity in grass pollinosis is less pronounced than in birch or ragweed allergy, but present in some patients. The main mechanism is the panallergen Phl p 12 (profilin): a structurally conserved cytoskeletal protein present in all eukaryotic cells. Profilin is associated with reactions to a wide range of foods, but reactions are usually mild (oral allergy syndrome). Group Foods ------ Grains Wheat, rye, barley, oats (raw or as bran) Vegetables Tomatoes, potatoes, peppers Legumes Peanuts (via profilin) Fruits Melon, watermelon (via profilin) Other Grass herbal teas Important: reactions to grain foods (bread, pasta, porridge) in grass-pollen patients are rare. Cooking destroys profilin. Grass pollen allergy and gluten intolerance (coeliac disease) are entirely different mechanisms with no connection between them. Diagnosing Grass Pollen Allergy Skin prick tests with a grass mix or timothy (Phleum pratense) — the diagnostic standard. One positive test on any grass confirms allergy to the entire family. Performed outside the season, at least 2 weeks after stopping antihistamines. Specific IgE blood test for Phl p 1 and Phl p 5 — done any time of year, regardless of antihistamine use. Particularly valuable when prick testing is not possible (severe atopic dermatitis, beta-blocker therapy). Molecular diagnostics (Phl p 1, Phl p 2, Phl p 4, Phl p 5, Phl p 12) — refines sensitisation profile. High Phl p 1 and/or Phl p 5 — specific grass sensitisation, good AIT response predicted. Isolated Phl p 12 (profilin) elevation — panallergen, less specific, poorer AIT response. Complete blood count — elevated eosinophils during peak season indirectly confirm allergic inflammation. Treatment of Grass Pollen Allergy Reducing Pollen Exposure - During flowering (May–June), avoid outdoor activity in the morning (6–11 am) on dry, windy days - Keep windows closed; use a HEPA air purifier - After every outing: shower, rinse nose with saline, change clothes - Avoid walking through long grass and being present during lawn mowing - Monitor pollen count forecasts and adjust outdoor plans accordingly - Wear wraparound sunglasses Medication Second-generation antihistamines (cetirizine, fexofenadine, bilastine, loratadine) — start 1–2 weeks before expected bloom; take daily throughout the season. Intranasal corticosteroids (mometasone, fluticasone) — most effective for rhinitis; start 2 weeks before the season; effect builds gradually. Eye drops (azelastine, olopatadine, cromoglicate) — for significant allergic conjunctivitis. Antileukotriene agents (montelukast) — when rhinitis is combined with asthma. AIT for Grass Pollen Allergy AIT with grass allergens is the only treatment that modifies the underlying immune response. Course: 3–5 years; sublingual drops or tablets (no injections needed) or subcutaneous injections. Grass AIT has the strongest evidence base of any allergen-specific immunotherapy: sublingual timothy tablets are among the best-studied AIT products available. After the first year most patients report 30–50% symptom reduction; after a full course — lasting multi-year remission. AIT is started during remission — in autumn or winter, at least 4 months before the expected bloom. With co-sensitisation to grasses and birch, an allergist may prescribe AIT targeting both allergens simultaneously. When to Seek Urgent Medical Attention Immediately if: difficulty or wheezing breathing; swelling of lips, tongue, or throat; sudden blood pressure drop, loss of consciousness. Routine allergist visit: symptoms recur every summer and reduce quality of life; antihistamines no longer provide adequate relief; asthma symptoms have appeared; you want to start AIT. Summary Grass pollen allergy is one of the most manageable hay fevers: AIT with timothy grass has the strongest evidence base of any pollen immunotherapy, and sublingual tablets make treatment highly convenient. All grasses cross-react — a positive test for one species means allergy to the entire family. With co-sensitisation to grasses, birch, wormwood, and ragweed — AIT planning should begin as early as possible. For more on allergy mechanisms, see the complete allergy guide. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/hazel-allergy https://labreadai.com/en/posts/hazel-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hazel pollen allergy is the earliest spring hay fever. Symptoms, cross-reactivity with birch and hazelnuts, two distinct reaction mechanisms and immunotherapy for remission. Articles article When your nose starts running in February with snow still on the ground — hazel is almost certainly the cause. Common hazel (Corylus avellana) flowers earlier than any other tree in temperate climates — sometimes as early as January in a warm winter. It is the very first "start" of the spring hay fever season, and it is easily mistaken for a cold. Let's look at how hazel connects to birch and alder, why hazelnut reactions come in two fundamentally different types, and how to treat this hay fever effectively. Why Hazel Causes Allergy: The Birch Cluster Connection The main hazel allergen is Cor a 1, a PR-10 family protein. It is structurally nearly identical to Bet v 1 of birch and Aln g 1 of alder — not by coincidence: all three trees belong to the birch family (Betulaceae). This is why allergy to hazel, alder, and birch is essentially one allergy to one protein cluster, expressing at different times of year. A typical pattern: a patient with hazel allergy almost always reacts to alder and birch as well. Sensitisation often begins with hazel — as the first tree encountered by the immune system in spring. The immune system then "recognises" similar proteins in alder and birch and reacts to those too. The combined "birch cluster season" for such patients runs from January through May: hazel (January–March) → alder (February–April) → birch (April–May). Hazel Flowering Season Hazel blooms from late January through March — earlier than any other tree. In southern regions the season can begin in December–January during a mild winter. In central zones, typically mid-February through late March. Duration: 2–4 weeks. A distinctive feature: hazel often flowers during unstable weather — mild spells alternating with cold snaps. Pollen concentrations spike sharply on warm sunny days and fall when cold returns. Symptoms therefore appear in "waves" depending on the weather. Hazel pollen is wind-carried for tens of kilometres — reactions are possible in cities where hazel does not grow locally if it is flowering in surrounding woodlands. Symptoms of Hazel Allergy Symptoms are typical of hay fever and virtually indistinguishable from alder or birch allergy. In February they are easily confused with a cold — particularly since the cold and flu season coincides. Allergic rhinitis — abundant watery discharge, paroxysmal sneezing in runs, nasal and soft palate itch, congestion. Symptoms worsen on warm sunny days and ease in cold weather. Allergic conjunctivitis — redness, itch, tearing, light sensitivity, gritty eye sensation. Bronchospasm — in patients with asthma or a predisposition to it. General symptoms — fatigue, headache, sleep disruption. How to distinguish from a cold: allergy causes no fever, discharge is clear and watery, symptoms worsen outdoors in warm weather and disappear indoors, and they return every year at the same time. Cross-Reactivity: Two Different Hazelnut Reaction Scenarios This is the most important and least widely known aspect of hazel allergy. Hazelnut reactions involve two fundamentally different mechanisms — and they require very different clinical approaches. Scenario 1: Pollen cross-reaction via Cor a 1 (oral allergy syndrome) Cor a 1 is a pollen allergen, but it is also present in the flesh of raw hazelnuts. The immune system sensitised to Cor a 1 from pollen reacts to the same protein in the nut. Reaction: oral allergy syndrome — itch and tingling in the lips, tongue, and throat within minutes of eating raw hazelnuts. Typically mild and brief. Key feature: Cor a 1 is heat-labile — it is destroyed by heating. So roasted hazelnuts, hazelnut paste, and baked goods containing hazelnut do not trigger a reaction in these patients. If there is a reaction to raw hazelnuts but not roasted — this is Cor a 1, a pollen cross-reaction, clinically mild. Scenario 2: True nut allergy via Cor a 9 and Cor a 14 (systemic reactions) Cor a 9 (11S globulin) and Cor a 14 (2S albumin) are storage proteins of the nut itself — unrelated to pollen. They are heat-stable and are not destroyed by cooking. Reaction: can be systemic — urticaria, angioedema, bronchospasm, anaphylaxis. Occurs with any form of hazelnut — raw, roasted, or in confectionery. Key feature: this type of allergy is unrelated to hay fever and requires strict hazelnut avoidance and an adrenaline auto-injector. Allergen Reaction type Roasted hazelnut Risk level ------------ Cor a 1 (pollen) Oral allergy syndrome No reaction Mild, safe Cor a 9 / Cor a 14 (nut) Systemic, anaphylaxis Reaction present Serious — EpiPen needed This is why molecular diagnostics are critically important in hazelnut allergy — they distinguish these two scenarios and determine clinical management. Other Cross-Reactive Foods Via Cor a 1, all foods in the birch cluster cross-react: apples, pears, peaches, cherries, carrots, celery, soy (Gly m 4). The full list mirrors birch allergy — the mechanism is identical. Diagnosing Hazel Allergy Skin prick tests with hazel pollen extract — the diagnostic standard. Performed outside the season, at least 2 weeks after stopping antihistamines. Suspected hazelnut food allergy requires separate testing with nut extract. Specific IgE blood test for Cor a 1 — done any time of year. For suspected true hazelnut allergy — additionally Cor a 9 and Cor a 14. Molecular diagnostics — critically important specifically in hazel allergy to distinguish Cor a 1 (mild pollen cross-reaction) from Cor a 9/Cor a 14 (serious true nut allergy). This result changes clinical management entirely. Complete blood count — elevated eosinophils during the flowering season indirectly confirm allergic inflammation. Treatment of Hazel Allergy Reducing Pollen Exposure - During flowering (February–March) avoid walks in woodland and parks on warm sunny days - Monitor temperature forecasts — pollen concentrations peak on warming days - Keep windows closed on warm days; use a HEPA air purifier - After outings: shower, nasal rinse, change clothes - Wear wraparound sunglasses Medication The approach mirrors alder and birch allergy management: Second-generation antihistamines (cetirizine, fexofenadine, bilastine) — start 1–2 weeks before expected bloom; take daily throughout the season. Intranasal corticosteroids (mometasone, fluticasone) — most effective for rhinitis; start 2 weeks before the season. Eye drops (azelastine, olopatadine) — for significant conjunctivitis. AIT for Hazel Allergy AIT specifically for hazel is used but is far less common than birch AIT — primarily because Cor a 1 and Bet v 1 are near-identical. Most patients with hazel allergy also react to birch, and birch AIT often reduces hazel-season symptoms through cross-reactive immunological tolerance. AIT is started during remission — in autumn or winter, 3–4 months before the expected bloom. The allergist determines which allergen or combination to use based on the patient's sensitisation profile. When to Seek Urgent Medical Attention Immediately if: breathing difficulty or wheezing; swelling of lips, tongue, or throat; sudden drop in blood pressure, loss of consciousness — signs of anaphylaxis. Especially urgent: any reaction to roasted hazelnuts or hazelnut in baked goods — this is Cor a 9/Cor a 14, systemic allergy requiring an adrenaline auto-injector prescription. Routine allergist visit: symptoms recur every winter-spring; hazelnut reactions; you want to start AIT. Summary Hazel allergy is the opening page of the spring hay fever diary. Cor a 1 links it with alder and birch into a single cluster. The most important thing to understand about hazelnuts: an oral reaction to raw nuts via Cor a 1 is mild and safe; a reaction to roasted nuts via Cor a 9/14 is systemic and requires serious attention. Molecular diagnostics separates these two scenarios — and that changes everything about clinical management. For more on allergy mechanisms, see the complete allergy guide. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/herpes-on-lip https://labreadai.com/en/posts/herpes-on-lip Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Cold sore on the lip: outbreak stages, what triggers recurrence and which antivirals work best. When to see a doctor and how to reduce herpes flare-up frequency. Articles article That familiar tingling at the corner of the lip — and a few hours later a blister appears. Cold sores are among the most widespread infections in the world: HSV-1 is estimated to infect 67–80% of the global adult population. But "everyone gets them" doesn't mean "nothing to worry about": in weakened immunity, pregnancy, or immunodeficiency, the virus can behave unpredictably. Let's break down how the virus works, why it keeps returning, and what genuinely helps treat and prevent outbreaks. What HSV-1 Is and Why It Stays Forever The cause of labial herpes is herpes simplex virus type 1 (HSV-1). It belongs to the herpesviridae family — a group of DNA viruses that establish lifelong latent infection in nerve cells. After the initial infection, the virus enters sensory nerve endings around the mouth and travels along nerve fibers to the trigeminal ganglion — a nerve cluster at the base of the skull. There it enters latency: it stops replicating but does not disappear. The immune system can detect it but cannot eliminate it: the virus hides inside a neuron, where antibodies cannot reach it. Under certain conditions — stress, cold, illness — the virus reactivates, travels back along the nerve to the skin, and causes a recurrence. This is not a new infection; it is the old virus waking up. It is important to distinguish HSV-1 from HSV-2: HSV-2 is the genital herpes virus, although both types can infect any site. The overwhelming majority of cold sores are caused by HSV-1. Stages of a Cold Sore: From Tingling to Healed A typical recurrence passes through five stages. Knowing them matters: antiviral medications work most effectively only within the first 48–72 hours. Stage Duration What happens --------- Prodrome 6–48 hours Tingling, burning, itching, sometimes pain at the future outbreak site Papule 1–2 days Redness and slight skin thickening; mild swelling Vesicle 2–3 days One or more small fluid-filled blisters appear Ulcer 1–2 days Blisters rupture, leaving painful weeping erosions Crust 3–5 days Erosions form a scab that gradually falls off without scarring A full uncomplicated recurrence cycle lasts 8–12 days. Treatment with acyclovir or another antiviral started in the prodromal stage can shorten this to 4–6 days — or prevent blisters from appearing at all. The virus is most contagious in the vesicular and ulcer stages — blister fluid contains a high concentration of viral particles. However, viral shedding also occurs during asymptomatic periods (asymptomatic viral shedding) — this is the main reason HSV-1 spreads so widely. Why Cold Sores Keep Coming Back: Outbreak Triggers In some people cold sores appear once every few years; in others, every month. The difference is determined by immune system status and the presence of external triggers. Immune fatigue is the most common mechanism. Any condition that reduces T-cell activity can provoke reactivation: a cold, influenza, another viral infection. It is no coincidence that cold sores are colloquially called "fever blisters" — they genuinely appear most often during or after a viral illness. Chronic stress. Cortisol suppresses cellular immunity — specifically the arm that keeps HSV replication in check. Chronically elevated cortisol reduces NK-cell and cytotoxic T-lymphocyte activity, giving the virus a window for reactivation. Ultraviolet radiation. One of the most thoroughly studied triggers. UV exposure of the lips — at the beach or on a ski slope — directly reactivates HSV-1 in the trigeminal ganglion neurons. A lip balm with SPF protection is a proven preventive measure in people with frequent recurrences. Cold and heat exposure. Thermal stress reduces local mucosal and skin immunity. Hormonal changes. In some women, recurrences are clearly tied to the menstrual cycle — typically the premenstrual phase, when immune reactivity is physiologically reduced. Lip trauma and procedures. Dental work, lip tattooing, and dermabrasion can trigger reactivation by mechanically irritating the trigeminal nerve branches. Diagnosis: When Lab Tests Are Needed In most cases, diagnosis is clinical — based on the characteristic appearance of the lesions. Laboratory confirmation is needed for atypical presentations and for assessing immune status. PCR of blister fluid — the gold standard for atypical lesions or when HSV-1 and HSV-2 need to be distinguished. Highly sensitive; results in 1–2 days. Anti-HSV-1 IgG antibodies — confirm past infection (lifelong positive in carriers). Anti-HSV-1 IgM appears during primary infection and in some reactivations, but is less reliable. Complete blood count — in severe or atypical cases, helps assess the inflammatory response. Elevated leukocytes with a neutrophilic shift points to bacterial superinfection, which frequently complicates open erosions. C-reactive protein — when dissemination or complications are suspected: herpetic stomatitis, eczema herpeticum, or CNS involvement. In patients with recurrent herpes occurring six or more times per year, an immune workup is warranted: HIV testing, immunoglobulin levels, and cellular immunity assessment. Frequent severe recurrences in an adult without obvious cause should prompt exclusion of infectious mononucleosis and other conditions affecting the lymphocyte arm of immunity. Treatment: What Works There is currently no cure that removes HSV-1 from neurons. However, treatment demonstrably shortens episode duration, accelerates healing, and reduces recurrence frequency. Antiviral medications — the mainstay of treatment: Drug Form Regimen for recurrence Notes ------------ Acyclovir (Zovirax) 5% cream / tablets Cream 5× daily for 4 days; tablets 200 mg 5× daily for 5 days First line; topical form only effective when started early Valacyclovir (Valtrex) Tablets 2000 mg × 2 doses in one day Higher bioavailability; convenient 1-day course Famciclovir Tablets 1500 mg single dose Single-dose regimen; comparable efficacy to valacyclovir Penciclovir 1% cream Every 2 hours for 4 days Higher topical activity compared to acyclovir cream The golden rule: starting treatment in the prodromal stage — before blisters form — delivers maximum benefit. Applying cream to an already ruptured erosion is substantially less effective. Symptomatic topical agents: - Lidocaine gel — reduces erosion pain - Zinc paste — dries the lesion and protects against secondary infection - SPF lip balm during healing — prevents UV triggering the next recurrence What does not work: iodine, gentian violet, toothpaste, essential oils — none of these have antiviral activity against HSV-1. They may superficially dry the lesion but do not affect viral replication. Suppressive therapy — daily low-dose antiviral medication for patients with six or more recurrences per year. Valacyclovir 500 mg/day reduces recurrence frequency by 70–80%. This is a clinical decision made after evaluating indications and contraindications. Cold Sores During Pregnancy and in Immunodeficiency Pregnancy. A labial herpes recurrence in a pregnant woman is not, in most cases, a threat to the fetus: maternal IgG antibodies protect the baby. Far more dangerous is a primary HSV-1 infection in the third trimester: the mother has no protective antibodies, and the virus can be transmitted to the newborn during delivery or in the first days of life. Neonatal herpes is rare but severe: CNS, eye, and organ involvement. This is why primary HSV infection in the third trimester prompts acyclovir treatment and a joint decision about mode of delivery. For recurrent herpes during pregnancy — shared decision-making with the obstetrician-gynecologist. Acyclovir in pregnancy is considered relatively safe, with a substantial evidence base from thousands of treated patients. Immunodeficiency. In HIV infection, organ transplantation, or cancer chemotherapy, herpes can present atypically: extensive necrotizing ulcers, acyclovir-resistant strains, and dissemination to internal organs. In these patients, herpetic lesions require urgent infectious disease evaluation and may need systemic intravenous acyclovir or foscarnet. Preventing Recurrences: What Genuinely Helps Eliminating recurrences entirely in latent HSV-1 carriers is not currently possible, but their frequency and severity can be substantially reduced. UV protection. SPF 30 or higher lip balm during sun exposure — especially in mountains and near water. Apply before symptoms appear, not after. Stress management and immune support. Chronic psychoemotional stress is the leading lifestyle-driven trigger. Normalizing sleep, regular moderate physical activity, and stress-reduction techniques reduce reactivation frequency by supporting the cellular immune response. Personal trigger list. Most people with frequent recurrences can identify their individual triggers within 2–3 months of observation. Keeping a log of episodes — "when it appeared, what preceded it" — reveals a pattern that can be directly targeted. Hygiene. During an active outbreak: avoid kissing, sharing utensils, sharing towels. Do not touch the lesion with fingers — risk of spreading virus to the eyes (herpetic keratitis) or fingertips (herpetic whitlow). Wash hands after contact with the affected area. Vaccination. There is currently no approved vaccine against HSV-1, though clinical trials are ongoing. This article is for informational purposes only and does not replace professional medical advice. Consult a dermatologist or infectious disease specialist for frequent recurrences or atypical cold sore presentations. https://labreadai.com/en/posts/how-to-get-rid-of-bloating https://labreadai.com/en/posts/how-to-get-rid-of-bloating Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Bloating and gas: causes from food triggers to gut conditions. How to eliminate bloating through diet and lifestyle changes and when chronic symptoms need investigation. Articles article Your stomach feels fine in the morning but expands noticeably by evening. Or discomfort sets in reliably about an hour after eating — regardless of what you had. Bloating is one of the most common complaints in gastroenterology consultations, and one of the most underestimated: millions of people live with it for years without realizing the cause is identifiable and fixable. Let's break down where bloating comes from, which foods and conditions drive it, and what genuinely works to relieve it. What Bloating Is and How It Develops Bloating is a sensation of excess pressure or fullness in the abdomen, which may or may not be accompanied by visible abdominal distension. The medical term is meteorism, from the Greek for "elevated." The mechanism is straightforward: gas accumulates in the gut in amounts that exceed normal or that exceed an individual's tolerance threshold. Intestinal gas enters by three routes: it is swallowed during eating and drinking (aerophagia), produced by microbiome bacteria fermenting unabsorbed carbohydrates, or diffused from the blood. A healthy adult passes 200–2000 mL of gas per day. In bloating, this volume increases, or the gut's ability to move it along is impaired. A key insight: the sensation of bloating does not always correlate with the actual amount of gas present. In people with heightened visceral sensitivity — primarily those with irritable bowel syndrome — a normal gas volume is perceived as painful discomfort. This is not psychosomatic in a dismissive sense; it is a real physiological characteristic with a measurable impact on quality of life. Main Causes of Bloating Bloating causes divide into functional (no structural gut damage) and organic (linked to a specific disease). Cause Mechanism Characteristic features --------- Excess FODMAP carbohydrates Bacterial fermentation of unabsorbed short-chain carbs Worsens after legumes, onions, milk, wheat Gut dysbiosis Overgrowth of H₂ and CH₄-producing bacteria Chronic bloating, unstable bowel habits SIBO (small intestinal bacterial overgrowth) Bacteria in the small bowel ferment food prematurely Bloating within 30–60 minutes of eating Irritable bowel syndrome Heightened visceral sensitivity Combined with pain, diarrhea, or constipation Lactose intolerance Lactase deficiency → bacterial fermentation of lactose Bloating specifically after dairy Celiac disease Immune reaction to gluten, villous atrophy Bloating + diarrhea + weight loss Gastroparesis Delayed gastric emptying Upper abdominal bloating after meals Constipation Stool accumulation in the colon Worsens toward evening, relieved by bowel movement Gynecological causes Endometriosis, ovarian cysts In women; often cyclical pattern Systemic causes Hypothyroidism, diabetes, celiac disease Bloating as one of multiple symptoms Aerophagia deserves separate mention: swallowing air while eating quickly, talking during meals, chewing gum, and drinking carbonated beverages. It is the simplest and most commonly overlooked cause of upper abdominal bloating and belching. Foods That Cause Bloating: What to Cut and What to Add The main dietary tool for chronic bloating is understanding FODMAPs — fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. These are short-chain carbohydrates that are poorly absorbed in the small intestine and actively fermented by colonic bacteria. High-FODMAP foods (primary triggers): - Legumes: beans, lentils, chickpeas, peas - Onions, garlic, leeks — in any form - Lactose-containing dairy: milk, soft cheeses, ice cream - Wheat and rye in large quantities - Apples, pears, mango, watermelon - Sugar alcohols: sorbitol, mannitol, xylitol (found in "sugar-free" gum and "diet" products) What helps reduce bloating: - Cooking, braising, and fermentation reduce FODMAP content: boiled lentils cause less bloating than roasted ones; yogurt is better tolerated than milk - Ginger — documented prokinetic effect: speeds gastric emptying - Fennel and caraway relax intestinal smooth muscle and reduce spasm - Probiotics (lactobacilli, bifidobacteria) reduce gas production in some people with IBS when taken regularly — the effect is highly individual The food–bloating connection is rarely straightforward: the same item can cause intense discomfort in one person and nothing in another. A two-to-four week food diary — logging "what I ate → how I felt one to three hours later" — is often more informative than any blood test. Lifestyle Factors That Drive Bloating Beyond Diet Eating speed. Eating quickly guarantees aerophagia and insufficient chewing. Slowing down (at least 15–20 minutes per meal) reduces air swallowing and gives the stomach time to initiate digestion properly. Physical activity. A 15–20 minute walk after eating accelerates intestinal motility and moves gas along. This is one of the most effective and accessible ways to quickly relieve post-meal bloating. A sedentary lifestyle is an independent driver of chronic meteorism. Stress and the gut–brain axis. The gut has its own nervous system — the enteric nervous system — and directly responds to psychological state. Acute stress slows gastric emptying and amplifies visceral sensitivity. Chronic stress is one of the main sustaining factors in IBS and functional bloating. Reducing chronic stress load through mindfulness practices, sleep normalization, and cortisol management is a legitimate part of functional bloating treatment. Body position. Lying down immediately after eating slows gastric emptying. The optimal position is sitting or slow walking for the first 30–60 minutes after a meal. Using a footstool to achieve a squatting posture during defecation reduces residual colonic volume. Carbonated drinks and gum. Every sip of sparkling water introduces CO₂ into the stomach; most exits via belching, but some passes into the intestines. Sugar-free gum with sorbitol delivers a double hit: aerophagia plus sorbitol as a FODMAP trigger. When Bloating Is a Disease Symptom Functional bloating is the most frequent cause — but not the only one. Several systemic conditions first manifest with gastrointestinal symptoms. Hypothyroidism slows motility throughout the entire gastrointestinal tract: gastric emptying is delayed, the bowel becomes sluggish, constipation worsens, and bloating follows. Bloating and constipation alongside fatigue, cold intolerance, and weight gain is a classic triad that requires thyroid disease to be ruled out. Insulin resistance and diabetes. In type 2 diabetes, diabetic gastroparesis — delayed gastric emptying due to vagal nerve damage — is a common complication. Checking blood glucose in people with chronic functional bloating and excess weight is worthwhile: insulin resistance is associated with dysbiosis and reduced intestinal motility. Inflammatory bowel disease (IBD) — Crohn's disease and ulcerative colitis. Chronic bloating combined with blood in the stool, weight loss, and nocturnal symptoms are alarming signs requiring urgent investigation. C-reactive protein is the first laboratory marker of active intestinal inflammation. Celiac disease — autoimmune gluten intolerance. Classic presentation: bloating, diarrhea, weight loss, and deficiency states (anemia, osteoporosis). Screening uses anti-tissue transglutaminase IgA antibodies (anti-tTG IgA) combined with total IgA. Malignant causes. Gradually worsening bloating — especially asymmetric distension, a palpable mass, altered bowel habits, or blood in the stool — is an indication for colonoscopy. Diagnosis for Chronic Bloating If bloating occurs more than three times a week for several months running, it warrants investigation — not just dietary adjustments. Standard first-line workup: Laboratory tests: - Complete blood count — rule out anemia (celiac disease, IBD); evaluate the differential - C-reactive protein and ESR — inflammatory markers when IBD is suspected - TSH — exclude hypothyroidism as the driver of reduced motility - Anti-tTG IgA antibodies — celiac disease screening - Fecal calprotectin — highly sensitive marker of intestinal inflammation Imaging and functional tests: - Abdominal ultrasound — rule out structural pathology, ascites, tumors - Hydrogen breath test — diagnoses SIBO and lactose/fructose intolerance - Colonoscopy — for alarm symptoms, age over 45, or a family history of colorectal cancer Treatment and When to See a Gastroenterologist Self-help for acute bloating: - A 15–20 minute walk - Clockwise abdominal massage - Squatting position or knee-chest posture — aids passage of gas - A warm heating pad on the abdomen — relieves smooth muscle spasm - Simethicone (Gas-X and equivalents) — breaks up gas bubbles; safe and non-absorbed For functional chronic bloating: - Low-FODMAP diet for 4–6 weeks with gradual systematic reintroduction — the gold standard for IBS and functional meteorism; ideally guided by a dietitian - Probiotics — require individual selection; not universally effective - Antispasmodics (mebeverine, trimebutine) — for bloating with a pain component See a gastroenterologist if: - Bloating persists for more than 3 months despite dietary changes - Bloating is accompanied by blood in the stool, significant weight loss, or nocturnal symptoms - Bloating appeared for the first time after age 45 - The abdomen is tender on palpation or a mass is felt - Progressive abdominal distension suggests possible ascites Seek urgent care for acute severe bloating with sharp pain, vomiting, and absence of stool or gas — this picture suggests intestinal obstruction, a surgical emergency. This article is for informational purposes only and does not replace professional medical advice. Consult a gastroenterologist or GP for chronic bloating. https://labreadai.com/en/posts/how-to-increase-testosterone https://labreadai.com/en/posts/how-to-increase-testosterone Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Low testosterone in men: symptoms, causes and proven ways to raise levels. Which tests to order, lifestyle changes with real impact and when hormone therapy is needed. Articles article Fatigue that a full night's sleep doesn't resolve, diminishing interest in sex, muscles that won't grow despite consistent training, and stubborn abdominal fat that won't respond to diet. Men often attribute these symptoms to age or stress — and miss the specific hormonal cause. There are proven methods to address this deficiency, both lifestyle-based and medical. Testosterone deficiency affects roughly one in four men over 45, and it's appearing earlier in life than it used to. Let's examine why it develops, how to identify it, and what genuinely works to restore it. Why Testosterone Declines in Men Testosterone is produced by Leydig cells in the testes under the direction of luteinizing hormone (LH) from the pituitary gland. This forms a classic axis: hypothalamus → pituitary → testes. A disruption at any level produces testosterone deficiency. Age-related decline is the most common cause. After the age of 30, total testosterone falls by approximately 1–2% per year. By age 50, some men reach clinically significant deficiency — referred to as late-onset hypogonadism. Obesity is the second most frequent factor. Adipose tissue contains aromatase, an enzyme that converts testosterone to estradiol. The more visceral fat, the more active this conversion. A self-reinforcing cycle forms: low testosterone promotes fat accumulation, and excess fat further suppresses testosterone. Chronic stress and sleep deprivation. Testosterone is produced primarily at night, during deep sleep phases. With consistent undersleeping (under 6 hours), levels fall by 10–15% within a single week. Chronically elevated cortisol directly suppresses LH and testosterone secretion. Primary hypogonadism — damage to the testes themselves: Klinefelter syndrome, cryptorchidism, trauma, orchitis after mumps, toxic exposures, and radiation. Secondary hypogonadism — disruption at the pituitary or hypothalamic level: tumors, hyperprolactinemia, hemochromatosis, and prior anabolic steroid use (which suppresses endogenous LH production). Comorbid conditions: type 2 diabetes, metabolic syndrome, chronic kidney and liver disease, and HIV all reliably lower testosterone — and low testosterone in turn worsens the course of these conditions. Symptoms of Low Testosterone in Men Testosterone deficiency acts systemically and develops gradually — which is precisely why it is easily mistaken for normal aging or burnout. Domain Symptoms of testosterone deficiency ------ Sexual function Reduced libido, erectile dysfunction, decreased ejaculate volume Body composition Loss of muscle mass and strength; increased fat (especially abdominal) Energy and mood Chronic fatigue, apathy, reduced motivation, irritability Cognitive function Poor concentration, memory decline, "brain fog" Sleep Sleep disturbances, night sweats Bone Reduced bone density, elevated fracture risk Physical signs Reduced shaving frequency, decreased testicular volume, gynecomastia None of these symptoms is specific to testosterone deficiency in isolation. Diagnosis is only valid when the clinical picture is confirmed by laboratory testing — there is no other way. Diagnosis: Which Tests to Order Before attempting to raise testosterone, it is essential to establish the actual level and identify the underlying cause of any reduction. Total and free testosterone — the baseline markers. Total testosterone provides screening; free (bioavailable) testosterone is a more precise assessment, particularly important in obese men and older patients, where sex hormone-binding globulin (SHBG) is elevated and binds a larger fraction. Blood must be drawn in the morning (8:00–10:00 AM) — this is when testosterone is at its daily peak. Fasting or 2–3 hours after a light breakfast. A diagnosis of hypogonadism requires confirmation by two separate measurements on different days. LH and FSH — distinguish primary hypogonadism (high LH with low testosterone: the testes are not responding to the signal) from secondary (low LH with low testosterone: the signal is not being sent). SHBG — determines how much testosterone is biologically available. It is reduced in obesity and elevated in cirrhosis. Complete blood count — to assess hematocrit and hemoglobin. Testosterone stimulates erythropoiesis; its deficiency is often accompanied by anemia. Prolactin — to rule out hyperprolactinemia as a cause of secondary hypogonadism. Estradiol — especially when gynecomastia or obesity is present. How to Boost Testosterone Without Medication: Lifestyle For functional testosterone decline — without organic pathology — lifestyle methods produce significant and measurable results. These are not generic health recommendations but interventions with documented impact on the hypothalamic–pituitary–gonadal axis, each shown to increase testosterone through a specific mechanism. Sleep is the foundation of testosterone. Approximately 70% of daily testosterone production occurs at night, concentrated in slow-wave sleep phases. The target is 7–9 hours with a consistent wake time. In one controlled experiment, healthy young men who slept five hours per night for one week had testosterone levels drop by 10–15% — equivalent to the effect of 10–15 years of aging. Resistance training. Compound strength exercises are the most effective non-pharmacological testosterone stimulus. Working at 70–85% of maximum load (3–5 sets of 5–8 reps), with multi-joint movements (squats, deadlifts, bench press), produces the greatest hormonal response. Moderate aerobic exercise is also beneficial but raises testosterone to a lesser degree. Weight loss. A 10–15% reduction in body weight in obese men increases testosterone by 15–30% — driven by reduced aromatase activity in adipose tissue. This is one of the most effective medication-free approaches available. Stress management and cortisol reduction. Chronically elevated cortisol suppresses GnRH (gonadotropin-releasing hormone) — the starting signal of the entire reproductive axis. Reducing psychological load, practicing stress management techniques, and normalizing sleep all work on testosterone specifically through this mechanism. Eliminating toxins. Chronic heavy alcohol use is directly toxic to Leydig cells. Even moderate regular intake ( 2–3 units per day) reduces testosterone by 6–23%. Tobacco, prior anabolic steroid use, and exposure to endocrine disruptors (bisphenol A from plastics, phthalates) are additional suppressive factors. Nutrition and Low Testosterone Testosterone is a steroid hormone, and cholesterol is required for its synthesis. Severely restricting dietary fat when testosterone is already low is counterproductive. Key nutrients: Vitamin D functions as a prohormone and directly regulates the testosterone synthesis gene in Leydig cells. Men with sufficient vitamin D have measurably higher testosterone than those who are deficient. Sources: sunlight, fatty fish, egg yolks; supplementation under blood level monitoring when deficient. Zinc — a cofactor of the enzyme involved in testosterone synthesis. Zinc deficiency directly lowers LH and testosterone. Sources: oysters (by far the richest source), red meat, pumpkin seeds, legumes. In men without deficiency, zinc supplements do not raise testosterone further — they only correct a deficit. Magnesium — influences testosterone bioavailability by reducing SHBG binding. Sources: nuts, spinach, buckwheat. Adequate fat intake. Optimal fat consumption is 20–35% of total calories, with emphasis on monounsaturated fats (olive oil, avocado) and moderate animal saturated fats. What lowers testosterone through diet: chronic caloric excess and obesity, excess sugar and refined carbohydrates (drive insulin resistance and aromatase activity), large habitual soy intake (contains phytoestrogens), and extreme caloric restriction below 1,500–1,800 kcal per day. Testosterone and Other Hormones: Systemic Connections Testosterone does not operate in isolation — its level is woven into the broader hormonal context. Testosterone and insulin resistance. Low testosterone amplifies insulin resistance; insulin resistance lowers testosterone. This mutually reinforcing cycle is one of the mechanisms linking androgen deficiency to type 2 diabetes. Improving insulin sensitivity is a legitimate therapeutic target in hypogonadism associated with metabolic syndrome. Testosterone and estradiol. A portion of testosterone is normally converted to estradiol by aromatase — and this is physiologically necessary: estradiol protects bone, cardiovascular function, and cognition in men. In obesity, conversion becomes excessive, which manifests as gynecomastia and progressive suppression of the pituitary–testicular axis. Testosterone and prolactin. Hyperprolactinemia is one of the most common endocrine causes of secondary hypogonadism in men under 40. Elevated prolactin suppresses GnRH, reducing LH and testosterone. Excluding this cause is a mandatory step in the diagnostic workup. Testosterone and the thyroid. Hypothyroidism lowers SHBG and disrupts the gonadal axis, producing reduced libido and erectile dysfunction with a technically normal testosterone level. When androgen deficiency symptoms are present, thyroid function assessment is part of the standard evaluation. Medical Treatment and When to See a Doctor Lifestyle and nutritional methods work for functional testosterone decline. In organic hypogonadism — primary or secondary — they address aggravating factors but medical methods are needed to resolve the underlying problem. Testosterone replacement therapy (TRT) is prescribed for confirmed hypogonadism with symptoms. Delivery forms: daily gels, injections (every 1–12 weeks depending on the preparation), patches, and subcutaneous pellets. The choice of form is a joint decision between patient and endocrinologist based on lifestyle, preferences, and comorbidities. Key contraindications to TRT: prostate or male breast cancer, high hematocrit ( 54%), uncontrolled heart failure, and desire to preserve fertility (TRT suppresses spermatogenesis). Alternatives for secondary hypogonadism when fertility is desired: human chorionic gonadotropin (hCG) and clomiphene citrate — both stimulate endogenous testosterone production through the pituitary–testicular axis. Consult an endocrinologist or urologist-andrologist if you have: - Testosterone below 12 nmol/L combined with symptoms - Erectile dysfunction with no other clear cause - Gynecomastia at any age - Couple infertility with a normal semen analysis from the female partner - Suspected primary hypogonadism (reduced testicular volume, elevated LH) Seek urgent care if pituitary adenoma symptoms develop: progressive headache, visual field defects, or simultaneous decline in multiple pituitary hormones. This article is for informational purposes only and does not replace professional medical advice. Diagnosis and treatment of hypogonadism should be managed by an endocrinologist or urologist-andrologist. https://labreadai.com/en/posts/how-to-lower-cortisol-in-women https://labreadai.com/en/posts/how-to-lower-cortisol-in-women Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) High cortisol in women: symptoms, causes of chronic stress and proven ways to reduce levels. Which tests to order, lifestyle changes that work and when to see a doctor. Articles article Persistent fatigue that sleep doesn't fix, weight accumulating around the abdomen despite a careful diet, anxiety, and irregular periods — these may not simply be "stress." They can reflect a specific biochemical reality: chronically elevated cortisol. In women, this pattern occurs two to three times more often than in men and frequently goes unrecognized for years. Let's break down where high cortisol comes from, how to identify it, and what genuinely works to bring it down. Why Cortisol Becomes Elevated in Women Cortisol — the body's primary stress hormone — is produced by the adrenal glands on command from the pituitary. In an acute situation it is indispensable: it mobilizes energy, raises blood pressure and alertness, and blunts pain. This is an evolutionary survival tool. The problem starts when the stressor does not go away. The brain cannot distinguish a life-threatening danger from a deadline or a difficult conversation — both trigger the same hormonal cascade. Under chronic stress, cortisol remains persistently elevated instead of returning quickly to its baseline. In women, several physiological amplifiers increase cortisol reactivity: Hormonal fluctuations. Estrogen in physiological amounts buffers the stress response, but during PMS, perimenopause, and the postpartum period, estrogen levels become unstable — and adrenal reactivity intensifies. Perfectionism and cognitive load. Women on average spend more time mentally replaying stressful events after they have passed — this sustains cortisol secretion even at rest. Sleep disruption. Sleep deprivation is itself a potent adrenal stimulus. During deep sleep at night, cortisol should be at its lowest. With chronic sleep restriction, this trough disappears. Pathological causes. Cushing's disease (pituitary tumor), Cushing's syndrome (adrenal tumor or ectopic ACTH secretion), and prolonged glucocorticoid use are medical diagnoses requiring specialized treatment. Symptoms of High Cortisol in Women Chronically elevated cortisol acts systemically — its effects span multiple organs and systems simultaneously. System Symptoms of high cortisol ------ Metabolism Weight gain concentrated in the abdomen and face; insulin resistance Cardiovascular Elevated blood pressure; resting tachycardia Nervous system Anxiety, irritability, memory and concentration difficulties Sleep Difficulty falling asleep, frequent waking, unrefreshing sleep Skin and hair Acne, skin thinning, increased facial hair Reproductive Irregular menstrual cycle, low libido, difficulty conceiving Immunity Frequent infections, slow wound healing Musculoskeletal Proximal muscle weakness, back pain, reduced bone density The classic "cushingoid" appearance in pathological forms: moon face, dorsocervical fat pad ("buffalo hump"), and wide purple-red stretch marks on the abdomen and thighs. These features call for immediate endocrinology evaluation. Cortisol consistently elevates blood glucose by reducing cellular insulin sensitivity. This is why chronic stress is an independent risk factor for developing type 2 diabetes. Diagnosis: Which Tests to Order Before attempting to lower cortisol, it is important to establish the actual level and understand the cause. Symptom-based self-diagnosis is unreliable — most symptoms are nonspecific. Salivary cortisol — the preferred method for assessing the diurnal rhythm. Collected four times throughout the day (morning, midday, evening, bedtime). Reveals flattening or inversion of the normal daily cortisol profile. 24-hour urinary cortisol — reflects total secretion over a full day. Elevation above the reference range points to an organic cause (Cushing's syndrome) rather than functional stress. Blood cortisol — measured at 8:00–9:00 AM and at 11:00 PM. Informative in context but less precise for chronic states than 24-hour urine. Low-dose dexamethasone suppression test — a screening test when Cushing's disease or syndrome is suspected. The patient takes dexamethasone in the evening; cortisol is measured the next morning. With normal regulation it is suppressed; with pathology it is not. Tests are ordered as a panel: cortisol is typically combined with ACTH, and when elevation is confirmed — MRI of the pituitary or CT of the adrenal glands. How to Lower Cortisol Without Medication: Lifestyle Interventions For functional elevation — without organic pathology — lifestyle changes produce real and measurable effects. These are not generic wellness recommendations but interventions with documented impact on the hypothalamic–pituitary–adrenal (HPA) axis. Sleep is the top priority. Each hour of sleep deprivation raises morning cortisol by approximately 15–20%. The target is 7–9 hours with sleep onset before midnight. A dark, cool room, no screens for an hour before bed, and a consistent wake time are not suggestions — they are the foundation of adrenal regulation. Exercise — in the right dose. Moderate aerobic activity (30–45 minutes of walking, swimming, or cycling) lowers cortisol. Intense exercise lasting more than an hour raises it. For women with already-elevated cortisol, daily high-intensity interval training is counterproductive. Reducing stress reactivity. Diaphragmatic breathing (slow 4–6 second exhale) activates the parasympathetic nervous system and lowers cortisol within minutes. Mindfulness meditation practiced regularly for 8 weeks reduces morning cortisol by an average of 14–20% in controlled studies. Social connection. Quality time with trusted people lowers cortisol — this is biochemically confirmed. Oxytocin released during physical closeness and genuine social engagement directly inhibits HPA axis activity. Light exposure. Bright natural light in the first 30–60 minutes after waking normalizes the cortisol diurnal curve and strengthens nighttime melatonin production. This is one of the most underestimated yet effective regulatory tools available. Diet and Nutrition for High Cortisol Nutrition does not treat hypercortisolism, but it removes factors that sustain it. Stable blood glucose. Sharp glucose spikes — sweets on an empty stomach, skipping meals — are independent cortisol triggers. Three balanced meals a day with adequate protein and complex carbohydrates is the baseline principle. Foods that reduce adrenal reactivity: - Dark chocolate ( 70% cacao) — contains flavonoids shown in clinical studies to lower cortisol - Fatty fish (salmon, mackerel) — omega-3 fatty acids reduce the inflammatory component of the stress response - Magnesium-rich foods (pumpkin seeds, spinach, almonds) — magnesium deficiency amplifies adrenal stress reactivity - Fermented foods (kefir, plain yogurt) — gut microbiome health influences stress response regulation via the gut–brain axis What keeps cortisol elevated: - High caffeine intake ( 3 cups per day) amplifies cortisol secretion, especially in already-stressed individuals - Alcohol disrupts the cortisol diurnal rhythm and degrades sleep architecture - Very-low-calorie diets (< 1000 kcal) are perceived by the body as a survival threat — and cortisol rises in response Cortisol and Hormonal Balance in Women Chronically high cortisol is not an isolated problem — it disrupts the function of virtually every female hormone. Cortisol and the reproductive system. Cortisol competes with progesterone at receptor sites and suppresses gonadotropin-releasing hormone, the signal that initiates ovulation. The result: irregular cycles, anovulation, and reduced libido. This mechanism is sometimes described as "progesterone steal." Cortisol and prolactin. Chronic stress drives prolactin elevation. Elevated prolactin further suppresses ovulation, creating a closed loop: stress → cortisol → prolactin → cycle disruption → stress about cycle disruption. Cortisol and the thyroid. Elevated cortisol impairs the conversion of inactive T4 to active T3 and raises reverse T3 (rT3), which occupies thyroid receptors without activating them. This produces hypothyroid symptoms — fatigue, cold intolerance, hair loss — with a technically normal standard thyroid panel, a pattern that is frequently missed. Cortisol and adrenal fatigue. "Adrenal fatigue" is not a recognized medical diagnosis, but a subset of women following prolonged hypercortisolism develop a flattened diurnal pattern: cortisol neither clearly high nor low — simply "flat," with no morning peak. This requires a full endocrinology workup. When Medical Help Is Needed Lifestyle and dietary changes work for functional, stress-related cortisol elevation. But there are situations where self-management is not only insufficient — it is actively harmful. Consult an endocrinologist if you have: - Characteristic fat redistribution: moon face, dorsocervical fat pad, thin limbs with a prominent abdomen - Purple-red stretch marks wider than 1 cm on the abdomen, thighs, or shoulders - Persistently elevated blood pressure with no other explanation - Proximal muscle weakness (difficulty rising from a chair without using your arms) - Menstrual irregularities combined with two or more other symptoms from the table above - Long-term glucocorticoid use for any condition Seek urgent care if psychotic symptoms, severe depression with suicidal ideation, or a hypertensive crisis develop — these can all be manifestations of severe hypercortisolism. This article is for informational purposes only and does not replace professional medical advice. Consult an endocrinologist if you suspect elevated cortisol. https://labreadai.com/en/posts/how-to-read-tsh-thyroid-stimulating-hormone https://labreadai.com/en/posts/how-to-read-tsh-thyroid-stimulating-hormone Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) TSH explained: normal ranges by age and pregnancy, causes of high and low results. How TSH relates to T3 and T4 and when your result needs medical attention. Articles article You received a TSH test result — and the number is either above or below the reference range on your lab report. Sometimes it's an incidental finding from a routine check-up; sometimes it finally explains months of fatigue, weight gain, or a racing heart. TSH is one of the most informative hormonal markers available, but reading it correctly requires understanding a few key principles. Let's go through it step by step. What TSH Is and What It Measures TSH — thyroid-stimulating hormone — is produced by the pituitary gland, a small structure at the base of the brain. Its sole function: to regulate the thyroid gland. When the thyroid produces too few hormones (T3 and T4), the pituitary increases TSH output — essentially pressing the accelerator. When thyroid hormones are excessive, TSH falls — releasing that pressure. This makes TSH an exceptionally sensitive marker: it responds to changes in thyroid function before T3 and T4 themselves move outside the normal range. That's why TSH is the first and primary test for any suspected thyroid condition. For a deeper look at how TSH regulates the thyroid and what happens during chronic deviation, see the article thyroid-stimulating hormone (TSH). One important nuance: TSH does not directly measure how much thyroid hormone is currently in the blood — it reflects how the pituitary is evaluating that level. It's a "top-down view," not a direct measurement. For a complete picture, TSH is always read alongside the full thyroid panel. TSH Normal Ranges by Age and During Pregnancy Reference values for TSH vary significantly with age and physiological state. The same number can be entirely normal in an older adult and pathological in a pregnant woman. Group TSH normal range (mIU/L) ------ Newborns (days 1–4) 1.0–39.0 Infants under 6 weeks 1.7–9.1 Infants 6 weeks – 14 months 0.7–6.4 Children 14 months – 5 years 0.7–5.97 Children 5–14 years 0.6–4.84 Adults 18–60 years 0.4–4.0 Adults over 60 years 0.5–8.0 Pregnancy — 1st trimester 0.1–2.5 Pregnancy — 2nd trimester 0.2–3.0 Pregnancy — 3rd trimester 0.3–3.5 During pregnancy, TSH reference ranges are substantially lower than outside of it — this is not pathology, but a physiological effect: human chorionic gonadotropin (hCG) in the first trimester directly stimulates the thyroid, suppressing TSH. Two practical rules when reading your report: 1. Always check the reference range printed by your specific laboratory — it may differ slightly from the table above 2. A minor deviation (0.1–0.2 units) without symptoms is not a cause for alarm, but it is reason for a repeat test in 3–6 months How to Prepare for a TSH Test TSH is one of the few hormones considered relatively stable throughout the day. Even so, several factors significantly affect the result. - Fast or eat a light meal 3–4 hours before the draw - Optimal timing: morning, between 8 and 11 AM — TSH concentration peaks at this time - Avoid intense physical exercise and alcohol for 48 hours beforehand - Minimize acute stress before testing — it can transiently suppress TSH - Keep conditions consistent for follow-up tests: if the first draw was done fasting in the morning, repeat all subsequent tests the same way If you take thyroid hormone medication (levothyroxine): the standard recommendation is to draw blood before taking your morning dose. Otherwise the result will reflect the drug's peak level, not the true background TSH. Oral contraceptives, glucocorticoids, amiodarone, and lithium all significantly influence TSH — always inform your doctor about these medications. High TSH: What It Means and Common Causes A high TSH means the pituitary is sending strong signals for the thyroid to work harder — indicating that the thyroid is underperforming or struggling to keep up. Hypothyroidism is the most common cause. In overt hypothyroidism, TSH is markedly elevated (typically 10 mIU/L) and free T4 is low. Symptoms include fatigue, drowsiness, weight gain, cold intolerance, dry skin, constipation, and slowed thinking and speech. For full details on diagnosis and treatment, see hypothyroidism. Subclinical hypothyroidism — TSH is elevated (usually 4–10 mIU/L) but free T4 remains within normal range. Symptoms may be absent or very mild. This is a borderline state requiring monitoring: some cases progress to overt hypothyroidism; others normalize spontaneously. Hashimoto's thyroiditis — autoimmune inflammation of the thyroid. The most common cause of hypothyroidism in iodine-sufficient regions. TSH rises gradually as thyroid tissue is progressively destroyed. Other causes: recovery phase after thyrotoxicosis, TSH-secreting pituitary adenomas, adrenal insufficiency, recovery from severe systemic illness, and certain medications (amiodarone, lithium, some antipsychotics). Transient TSH elevation can follow severe stress, surgery, or acute illness — in such cases a repeat test 4–6 weeks later typically normalizes without treatment. Low TSH: What It Means and Common Causes A low TSH means the pituitary has gone quiet — the thyroid is either overproducing hormones or receiving stimulation that bypasses normal pituitary control. Hyperthyroidism (thyrotoxicosis) — the thyroid produces excess hormones. TSH is suppressed or undetectable (< 0.01 mIU/L) and free T4 is elevated. Symptoms include palpitations, hand tremor, weight loss despite normal appetite, sweating, insomnia, and irritability. All clinical details and treatment are covered in hyperthyroidism. Subclinical thyrotoxicosis — TSH is low (< 0.4 mIU/L) but T3 and T4 are normal. Symptoms are minimal or absent. In older patients, this condition increases the risk of atrial fibrillation and osteoporosis even without overt symptoms. Graves' disease (diffuse toxic goiter) — an autoimmune condition in which antibodies mimic TSH, driving autonomous thyroid activity. One of the most common causes of persistently low TSH in young women. Toxic nodular goiter — individual thyroid nodules begin secreting hormones autonomously, independent of TSH. More common after age 50. Levothyroxine overdose — when hypothyroidism is treated with too high a dose. Requires dose adjustment, not discontinuation of therapy. Other causes: central hypothyroidism from pituitary damage (paradoxically: low TSH with low T3/T4), euthyroid sick syndrome in systemic illness, and the first trimester of pregnancy (physiological). TSH, T3, and T4: Reading the Tests Together An isolated TSH is a good screening tool, but understanding the cause of any deviation requires looking at free T4 (and sometimes free T3). Here is how the combinations work: TSH Free T4 Interpretation --------- High Low Overt hypothyroidism High Normal Subclinical hypothyroidism Low High Overt hyperthyroidism (thyrotoxicosis) Low Normal Subclinical thyrotoxicosis Normal Normal Euthyroidism — thyroid function is normal Low Low Central hypothyroidism (pituitary pathology) High High Thyroid hormone resistance (rare) Central hypothyroidism is a rare but deceptive condition: TSH is low (or "normal" but functionally inactive) while T4 is also low. Without awareness of this pattern, the diagnosis is easily missed. Anti-TPO (thyroid peroxidase) and anti-thyroglobulin antibodies are added to the workup when TSH is elevated, to confirm or rule out an autoimmune cause — this matters for prognosis and management decisions. When a TSH Deviation Requires Treatment and Who to See Not every abnormal TSH result requires immediate treatment. The approach depends on the degree of deviation, whether symptoms are present, and what T3/T4 show. For elevated TSH: - TSH 4–10 mIU/L, T4 normal, no symptoms → monitoring, repeat test in 3–6 months - TSH 10 mIU/L or symptoms of hypothyroidism → endocrinologist referral; levothyroxine therapy is likely - Pregnancy with TSH 2.5 mIU/L in the first trimester → endocrinologist urgently For low TSH: - TSH 0.1–0.4 mIU/L, T4 normal, no symptoms → monitoring, repeat test in 3–6 months - TSH < 0.1 mIU/L or symptoms of thyrotoxicosis → endocrinologist within days - Any TSH suppression during pregnancy → endocrinologist immediately Seek urgent care if you have TSH abnormality combined with: rapid palpitations or arrhythmia, high fever with neck pain (possible thyroiditis), or altered consciousness and marked lethargy (possible myxedema coma in severe undiagnosed hypothyroidism). This article is for informational purposes only and does not replace professional medical advice. TSH interpretation should be performed by an endocrinologist or GP in the context of the full clinical picture. https://labreadai.com/en/posts/how-to-read-urinalysis https://labreadai.com/en/posts/how-to-read-urinalysis Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Urinalysis explained: what protein, leukocytes, pH, glucose and urine sediment mean. Reference values for adults, causes of abnormalities and when to retest. Articles article You're looking at a urinalysis report filled with numbers, symbols, and Latin abbreviations — and it's not obvious what any of it means. The good news: urinalysis follows a consistent logic, and most values can be understood once you know a few basic principles. This is a complete guide to the UA report: from color to sediment, with reference values and plain-language explanations for every section. What a Urinalysis Measures and Why It Matters Urine is a concentrate of what the kidneys filtered from the blood. Its composition reflects the function of several systems at once: the urinary tract, the endocrine system, and the vasculature. That's why urinalysis is included in the standard workup for a wide range of conditions — including many that have nothing to do with the kidneys directly. The report is divided into three sections: - Physical properties — color, clarity, odor, specific gravity, pH - Chemical markers — protein, glucose, ketones, bilirubin, urobilinogen, nitrites, blood - Urine sediment microscopy — leukocytes, red blood cells, casts, epithelial cells, bacteria, crystals Each section provides a different dimension of information. Accurate interpretation always means reading the full picture — not any single value in isolation. Physical Properties: Reference Values and What Deviations Mean Physical parameters are assessed visually and with a urinometer. Many can be noticed before submitting the sample. Parameter Normal Deviation and possible cause --------- Color Pale to medium yellow Colorless — excess fluids, diabetes insipidus; dark yellow — dehydration; reddish — RBCs or food pigments; brown — hemoglobin, bile pigments Clarity Clear Cloudy — leukocytes, bacteria, mucus, salt crystals Odor Mild, characteristic Acetone — ketones; ammonia — bladder infection; fruity — decompensated diabetes Specific gravity 1.010–1.025 < 1.010 — renal insufficiency, diabetes insipidus; 1.025 — dehydration, glycosuria pH 5.0–7.0 < 5.0 — acidosis, high-protein diet; 7.0 — infection, vegetarian diet, renal tubular acidosis Specific gravity is a sensitive indicator of the kidney's ability to concentrate urine. A monotonously low specific gravity of around 1.010 in all urine fractions throughout the day is a finding that deserves dedicated investigation. Chemical Markers: Protein, Glucose, Ketones and More The chemical panel is the core of the urinalysis. This is where substances that should not normally be in urine are identified, or where concentrations exceed acceptable limits. Marker Normal Deviation: what it may indicate --------- Protein (PRO) Negative or < 0.14 g/L Elevated — nephritis, nephrotic syndrome, urinary tract infection, preeclampsia Glucose (GLU) Negative Present — diabetes mellitus, renal glucosuria, acute pancreatitis Ketones (KET) Negative Present — fasting, ketogenic diet, diabetic ketoacidosis, pregnancy sickness Bilirubin (BIL) Negative Present — hepatic or obstructive jaundice, hepatitis Urobilinogen (URO) Trace (up to 17 µmol/L) Elevated — hemolysis, liver disease; absent — bile duct obstruction Nitrites (NIT) Negative Positive — bacteriuria, urinary tract infection Blood / hemoglobin (BLD) Negative Positive — red blood cells in urine, hemolysis, myoglobinuria Protein in urine is one of the most clinically significant values. Even a modest sustained elevation above the reference range warrants further investigation — what it can mean is covered in detail in the article on protein in urine. Ketones in urine should be interpreted alongside blood glucose: ketones with normal blood sugar usually point to fasting or a low-carbohydrate diet; ketones with elevated blood sugar require ruling out diabetic ketoacidosis. The clinical significance of each dipstick grade is explained in the article on ketones in urine. Urine Sediment Microscopy: Leukocytes, RBCs and Casts Microscopy is the most informative section for diagnosing inflammation and kidney tissue damage. The lab technician centrifuges the sample and examines the pellet under a microscope. Element Normal Deviation: what it may indicate --------- Leukocytes (WBC) F: up to 6/hpf; M: up to 3/hpf Elevated — cystitis, pyelonephritis, urethritis, prostatitis Red blood cells (RBC) 0–2 per field Elevated — kidney stones, glomerulonephritis, tumor, trauma Hyaline casts 0–1 per field A few — normal; many — exercise, fever, dehydration Granular casts Absent Present — glomerulonephritis, pyelonephritis, diabetic nephropathy Red cell casts Absent Present — acute glomerulonephritis, vasculitis, endocarditis Squamous epithelium Few Many in women — sample contamination from vaginal secretions Renal tubular epithelium Absent Present — tubular injury Bacteria Absent Present — urinary tract infection (with correct collection) Oxalate crystals Few Many — oxaluria, kidney stone risk Red cell casts are among the most specific signs of glomerular damage. Their detection always calls for nephrology consultation. Elevated leukocytes in the sediment are the most common incidental finding in routine urinalysis. Reference values, causes, and clinical approach are covered in the article on leukocytes in urine. How to Collect Urine Correctly for Reliable Results A perfectly analyzed specimen is worthless if it was collected incorrectly. The vast majority of "abnormal" urinalyses are the result of collection errors, not actual disease. The day before: - Avoid beets, carrots, and blueberries — they discolor urine - Skip diuretics and high-dose vitamin C — they distort chemical markers - Limit intense exercise — protein and casts can transiently rise after heavy workouts On collection day: - Use the first morning void — most concentrated and informative - Wash without antibacterial soap; collect the midstream portion - Use a sterile pharmacy container - Deliver to the lab within 1–2 hours; do not leave in a warm environment Women should postpone the test 3–5 days after the end of menstruation — blood will reliably distort sediment and chemical values. When the Result Needs to Be Repeated A single abnormal value is not a diagnosis. Before drawing conclusions, the physician checks whether there are technical reasons for a false result. A repeat urinalysis is required when: - The first sample was collected incorrectly - Leukocytes or protein were found with no clinical symptoms — contamination must be excluded - The deviation is mild and borderline - More than 2 hours elapsed between collection and analysis If the deviation is confirmed on a repeat test, further workup is ordered: Nechiporenko count, Zimnitsky test, 24-hour proteinuria, or urine culture. When Urinalysis Results Require Prompt Medical Attention Most urinalysis abnormalities warrant a scheduled visit to a GP or nephrologist. But certain findings call for immediate action. Seek medical care promptly if the urinalysis shows: - Red cell casts — sign of acute glomerulonephritis - Significant proteinuria ( 3 g/L) — possible nephrotic syndrome - Glucose and ketones together with symptoms — suspected diabetic ketoacidosis - Marked leukocyturia ( 50/hpf) with fever above 38°C — acute pyelonephritis - Gross hematuria (visibly red urine) — requires urgent exclusion of tumor or severe inflammation If you are pregnant and find any of the above — go to the hospital without waiting for a scheduled appointment. This article is for informational purposes only and does not replace professional medical advice. Urinalysis interpretation should be performed by a clinician in the context of the patient's full clinical picture. https://labreadai.com/en/posts/hyperthyroidism https://labreadai.com/en/posts/hyperthyroidism Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hyperthyroidism means excess thyroid hormones. Symptoms of thyrotoxicosis, TSH and T4 reference ranges, causes including Graves' disease and three evidence-based treatments. Articles article A heart racing even at rest, weight loss despite a good appetite, hand tremor, and irritability with no clear external cause — these can all be signs of thyrotoxicosis. Hyperthyroidism is a state in which the thyroid gland produces too many hormones and essentially "over-revs" the entire body. Let's break down how to recognize it, which tests confirm the diagnosis, and what treatment involves. What Is Hyperthyroidism and Thyrotoxicosis Hyperthyroidism means the thyroid produces excess T4 and T3. Thyrotoxicosis is the broader term for any state of excess thyroid hormone — including levothyroxine overdose. In practice both terms are often used interchangeably. Where hypothyroidism slows everything down, hyperthyroidism speeds everything up. Thyroid hormones are the metabolic accelerator, and in excess they push the engine into overdrive. Causes of Hyperthyroidism Graves' disease (diffuse toxic goiter) — the most common cause, especially in young women. An autoimmune condition: antibodies mimic TSH and keep the gland switched on at full output. The hallmark sign is exophthalmos (protruding eyes). Toxic multinodular goiter — more common in older adults. Individual nodules begin producing hormones autonomously, ignoring pituitary signals. Toxic adenoma — a single autonomously functioning nodule. Destructive thyroiditis — in De Quervain's or postpartum thyroiditis, hormones leak from damaged cells. The hyperthyroid phase is temporary and often transitions into hypothyroidism. Levothyroxine overdose — iatrogenic thyrotoxicosis in patients being treated for hypothyroidism. Symptoms of Hyperthyroidism Cardiovascular: rapid heartbeat (resting heart rate above 90); atrial fibrillation — especially in older patients; elevated systolic blood pressure. Metabolic: weight loss despite normal or increased appetite; excessive sweating; heat intolerance. Neuromuscular: hand tremor; muscle weakness; insomnia; irritability, anxiety, emotional instability. Gastrointestinal: frequent loose stools, diarrhea. Specific to Graves' disease: exophthalmos, eye pressure and swelling, pretibial myxedema (skin thickening on the shins). Diagnosis: Low TSH Is the Key Finding Diagnosis uses a thyroid panel. The logic is the inverse of hypothyroidism: when T4 and T3 are excessive, the pituitary "brakes" — TSH drops toward zero. Marker Normal Subclinical hyperthyroidism Overt hyperthyroidism ------------ TSH 0.4–4.0 mIU/L < 0.4 mIU/L < 0.1 mIU/L Free T4 9–20 pmol/L Normal Elevated Free T3 3.5–6.5 pmol/L Normal Elevated Subclinical hyperthyroidism — TSH is suppressed but T4 and T3 are normal. Symptoms may be absent, but atrial fibrillation and bone loss risk already exist. Additional tests: - TSH receptor antibodies (TRAb) — confirm Graves' disease - Thyroid ultrasound with Doppler — assesses volume and blood flow - Scintigraphy — when cause is unclear, to differentiate Graves', adenoma, and thyroiditis Hyperthyroidism Treatment: Antithyroid Drugs, Radioiodine and Surgery Choice depends on the cause, patient age, gland size, pregnancy plans, and patient preference. Antithyroid drugs (conservative) Methimazole and propylthiouracil block thyroid hormone synthesis. For Graves' disease, the course is 12–18 months. Remission after stopping is achieved in 30–50% of patients. Relapse leads to radioiodine or surgery. Radioiodine therapy (¹³¹I) Radioactive iodine selectively accumulates in the thyroid and destroys its tissue. Effect develops over 3–6 months. The usual outcome is hypothyroidism requiring lifelong levothyroxine. Contraindicated in pregnancy. Surgery (thyroidectomy) Indicated for large goiter compressing neck structures; antithyroid drug intolerance; suspected malignancy; or pregnancy planned in the near future. After total thyroidectomy — lifelong replacement therapy. Complications: Heart Palpitations, Osteoporosis and Thyroid Storm - Atrial fibrillation — chronic thyrotoxicosis raises the risk 3–5 fold; stroke risk rises accordingly - Osteoporosis — excess thyroid hormones accelerate bone resorption; fracture risk increases - Heart failure — in prolonged untreated thyrotoxicosis - Thyroid storm — rare but life-threatening: abrupt worsening of all symptoms, high fever, confusion When to See a Doctor Urgently Immediately if: resting heart rate above 120, palpitations or irregular rhythm; sudden high fever and confusion in a known hyperthyroid patient (storm); eye swelling, protrusion, or vision disturbance; TSH below 0.01 mIU/L found on testing — urgent endocrinologist appointment. Summary Hyperthyroidism responds well to treatment when caught early. The key is TSH: its suppression is detectable before symptoms appear. Three treatment options allow an individualized approach. Untreated thyrotoxicosis hits the heart and bones hardest — two organs that are difficult to recover once damaged. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/hypothyroidism https://labreadai.com/en/posts/hypothyroidism Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hypothyroidism is underactive thyroid function. Key symptoms, TSH and T4 reference ranges, subclinical form, common causes and levothyroxine treatment in adults and pregnancy. Articles article Unexplained fatigue, weight gain without any change in diet, feeling cold even in summer, depression that has no obvious trigger — these symptoms are written off as "burnout" for years. Yet in one in ten women over 40 they have a specific laboratory cause: hypothyroidism. Let's look at how the thyroid works, why its failure stays hidden for so long, and what tests reveal it. What Is Hypothyroidism and Why It Goes Unnoticed Hypothyroidism means the thyroid gland produces less T4 and T3 than the body needs. Thyroid hormones set the metabolic pace for every cell: heart rate, how fast food is converted to energy, body temperature, thinking speed. When hormone levels drop, everything slows — gradually and uniformly. This gradual onset is precisely what makes hypothyroidism so easy to miss: people adapt to their new lower energy baseline. Causes of Hypothyroidism Hashimoto's thyroiditis — the leading cause in developed countries. The immune system mistakenly attacks thyroid tissue, progressively destroying it. Treatment of hyperthyroidism — radioiodine therapy and thyroid surgery frequently result in hypothyroidism requiring lifelong replacement therapy. Iodine deficiency — relevant in endemic goiter regions. Congenital hypothyroidism — detected by newborn screening in the first days of life. Central hypothyroidism — rare: the thyroid is healthy but the pituitary produces insufficient TSH to stimulate it. Symptoms of Hypothyroidism Metabolic: weight gain without dietary changes; cold intolerance; constipation. Neurological and psychological: chronic fatigue; slowed thinking, memory impairment; depression, apathy. Cardiovascular: bradycardia (heart rate below 60); elevated diastolic blood pressure. Skin and hair: dry skin; hair loss; facial puffiness — especially around the eyes in the morning. Reproductive: menstrual cycle irregularities; difficulty conceiving. Diagnosis: TSH Is the Key Test Diagnosis uses a thyroid panel, with TSH (thyroid-stimulating hormone) at its center. TSH is the pituitary hormone that controls the thyroid. When T4 drops, the pituitary pumps out more TSH — like a thermostat turning up the heat when temperature falls. This is why TSH rises before T4 drops below normal. Marker Normal Subclinical hypothyroidism Overt hypothyroidism ------------ TSH 0.4–4.0 mIU/L 4.0 mIU/L 10 mIU/L Free T4 9–20 pmol/L Normal Low Free T3 3.5–6.5 pmol/L Normal Low or normal If Hashimoto's is suspected, anti-TPO antibodies are added. Subclinical Hypothyroidism: Treat or Watch Clear indications for treatment: pregnancy or planning pregnancy; pronounced symptoms; significantly elevated anti-TPO antibodies; TSH above 10 mIU/L. Otherwise — individualized decision by the physician. Treatment: Levothyroxine The standard is levothyroxine (L-T4), taken daily in the morning on an empty stomach 30–60 minutes before food. Target: TSH 0.5–2.5 mIU/L. TSH is checked 6–8 weeks after any dose change. Hypothyroidism in Pregnancy Untreated hypothyroidism in pregnancy poses serious risks to fetal brain development. TSH is checked at the first prenatal visit. First-trimester target: below 2.5 mIU/L. When to See a Doctor Urgently TSH above 10 mIU/L — schedule an endocrinologist appointment. Hypothyroid symptoms + pregnancy — without delay. Myxedema coma (loss of consciousness, hypothermia, bradycardia) — call emergency services immediately. Summary One test — TSH — gives the answer. If you have characteristic symptoms or risk factors (female sex, age over 35, family history of thyroid disease) — it's worth checking. Treatment is simple, safe, and effective. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/infectious-mononucleosis https://labreadai.com/en/posts/infectious-mononucleosis Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Infectious mononucleosis is an EBV infection with fever and tonsillitis. Symptoms, blood test findings, spleen rupture risk and activity restrictions. Articles article Severe sore throat, high fever, swollen lymph nodes — and the doctor says it is not ordinary tonsillitis but infectious mononucleosis. The diagnosis sounds unfamiliar, but the disease is far more common than most people realise: Epstein-Barr virus (EBV) infects around 95% of people during their lifetime. Let's look at how to distinguish mononucleosis from strep throat, which tests confirm the diagnosis, and why physical activity is genuinely dangerous with this illness. What Is Infectious Mononucleosis and What Causes It Infectious mononucleosis is an acute viral infection caused by Epstein-Barr virus (EBV, HHV-4) in 90% of cases. In 5–7% the causative agent is cytomegalovirus (CMV); rarely — other herpesviruses, toxoplasma, or primary HIV infection. EBV is transmitted primarily through saliva — hence the unofficial name "kissing disease." It also spreads through shared utensils, toothbrushes, and blood transfusion. Incubation period: 4–6 weeks in adults, 1–2 weeks in children. EBV is tropic to B-lymphocytes: it enters them via the CD21 receptor and drives their proliferation. In response, T-lymphocytes activate and attack the infected B-cells — these activated T-cells are what we see in the blood test as "atypical lymphocytes." They are not pathological cells in the classical sense; they are cytotoxic T-lymphocytes doing exactly their job. After the acute infection, EBV persists lifelong in B-lymphocytes in a latent state. In people with a normal immune system, this causes no problems. Symptoms of Infectious Mononucleosis The classic presentation is a tetrad of symptoms found in most patients: 1. Fever — typically 38.5–40°C, lasting 1–2 weeks. May be continuous or wave-like. 2. Tonsillitis — severe sore throat. Tonsils are enlarged and covered with white or greyish-yellow exudate. Appears similar to streptococcal tonsillitis but does not respond to penicillins. In some patients the exudate is so extensive it nearly obstructs the pharynx. 3. Lymphadenopathy — enlarged lymph nodes, primarily cervical (especially posterior cervical — behind the sternocleidomastoid muscle). Axillary, inguinal, and mesenteric nodes may also enlarge. Nodes are tender, firm, and not fixed to the skin. 4. Splenomegaly — splenic enlargement, detected in 50–80% of patients. This finding defines the main restriction during illness. Rare but dangerous: splenic rupture with physical exertion. Additional features: - Hepatomegaly — in 10–15%; abnormal liver function tests — in most patients - Rash — appears in 5–10% of patients without provocation - Periorbital oedema (puffiness around the eyes) — a characteristic sign that distinguishes mononucleosis from other infections - Palatal enanthem (petechiae on the soft palate) - Profound fatigue — may persist for weeks to months after the acute phase Mononucleosis and Antibiotics: A Critical Mistake to Know Everyone should be aware: giving amoxicillin or ampicillin during mononucleosis causes a rash in 80–90% of patients. The mechanism is not a true allergic reaction — it is a specific immune phenomenon linked to EBV infection. Nevertheless, this rash is frequently and incorrectly documented as "amoxicillin allergy," permanently closing access to important antibiotics. Why this happens: a doctor sees tonsillitis and prescribes penicillin thinking of streptococcus. In mononucleosis, tonsillitis is indeed accompanied by streptococcal co-infection in 15–30% of cases — but treating streptococcus during mononucleosis requires not amoxicillin, but other antibiotics — cephalosporins or macrolides if a penicillin-class drug is needed. Diagnosing Mononucleosis from Blood Tests Complete Blood Count with Differential The complete blood count in mononucleosis produces a characteristic picture that is hard to mistake for another condition. Leukocytosis — usually 10–20×10⁹/L, sometimes up to 30×10⁹/L. This may suggest bacterial infection — but the differential clarifies everything. Lymphocytosis — lymphocytes make up 60–80% of all leukocytes (normal 20–40%). This is the most characteristic shift. Atypical lymphocytes — present at more than 10% of all leukocytes. These are activated cytotoxic T-lymphocytes (CD8+) responding to EBV-infected B-cells. Under the microscope: large cells with wide basophilic cytoplasm and an "indented" nucleus. This finding is virtually pathognomonic for mononucleosis in the right clinical setting. Mild thrombocytopenia — platelets fall to 100–150×10⁹/L in some patients. This resolves spontaneously without treatment. ESR and CRP — moderately elevated, confirming active inflammation. Biochemical Markers Liver function tests are abnormal in most patients: ALT and AST elevated 2–10 times. This is EBV hepatitis — usually mild and self-limiting, but requires monitoring. Jaundice is rare (5%). Serological Tests Heterophile antibodies (Paul-Bunnell test, "monospot test") — rapid screening: specific IgM antibodies appearing in EBV infection. Sensitivity 85–90% in adults. Limitations: false-negative in the first week of illness and in children under 4 (often negative in this age group regardless of EBV). Specific EBV serology (VCA IgM, VCA IgG, EA IgG, EBNA IgG) — the gold standard. Precisely identifies the phase of infection: acute, past, or reactivation. Marker Acute infection Past infection --------- VCA IgM + − VCA IgG + + EA IgG + − (usually) EBNA IgG − + EBNA IgG appears 3–6 months after acute infection and persists for life — its presence confirms past infection. The Main Danger: Splenic Rupture Splenomegaly in mononucleosis is not just an incidental ultrasound finding. The enlarged, inflamed spleen becomes fragile and vulnerable to mechanical trauma. Splenic rupture occurs in approximately 0.1–0.5% of patients — but this is a life-threatening haemorrhage requiring emergency surgery. Half of ruptures occur spontaneously, without obvious trauma. The rest follow physical contact, heavy lifting, coughing, or vomiting. This is why the following are absolutely prohibited in mononucleosis: - Contact sports (football, wrestling, basketball) - Weightlifting and heavy lifting - Running and any intense physical exertion Activity restriction: minimum 3–4 weeks from illness onset; if splenomegaly is confirmed on ultrasound — until splenic size normalises. Signs of splenic rupture: sudden severe pain in the left upper abdomen radiating to the left shoulder (Kehr's sign), rapidly worsening weakness, pallor, falling blood pressure — call emergency services immediately. Treatment of Infectious Mononucleosis There is no specific antiviral treatment proven effective in uncomplicated mononucleosis. Aciclovir and valaciclovir suppress EBV replication in the lab but have shown no clinical benefit in routine mononucleosis. Treatment is symptomatic: - Antipyretics and analgesics: paracetamol, ibuprofen. Aspirin is contraindicated in children and adolescents (risk of Reye's syndrome) - Adequate hydration - Rest and activity restriction - Throat gargles with antiseptic solutions - For severe tonsillar swelling with airway compromise risk — a short course of systemic corticosteroids Antibiotics — only for confirmed concurrent bacterial infection (streptococcus confirmed by throat swab or rapid antigen test). Choice: cephalosporins or macrolides — never amoxicillin/ampicillin. When to Seek Urgent Medical Attention Call emergency services immediately for: sudden severe left upper abdominal pain — possible splenic rupture; worsening dyspnoea and stridor — airway obstruction from massively enlarged tonsils; high fever without improvement after 5 days in an infant. See a doctor within 24 hours for: significant jaundice; neurological symptoms (severe headache, neck stiffness); rash after amoxicillin; temperature above 40°C not responding to antipyretics. Summary Infectious mononucleosis is a self-limiting viral illness: most patients recover within 2–4 weeks. The main dangers are splenic rupture during physical activity and the erroneous prescription of amoxicillin. The diagnostic key is a complete blood count with differential: lymphocytosis with atypical lymphocytes exceeding 10%, combined with the clinical picture, is nearly unmistakable. Post-mononucleosis fatigue may persist for months — this is normal and does not require specific treatment. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/iron-deficiency-anemia https://labreadai.com/en/posts/iron-deficiency-anemia Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Iron deficiency anemia is the most common form of anemia worldwide. Symptoms, blood tests that confirm it, what the numbers mean and how to treat iron deficiency. Articles article Fatigue after a short walk, shortness of breath climbing one flight of stairs, pallor that others notice before you do — these aren't just signs of stress or poor sleep. Iron deficiency anemia — the most common form of anemia worldwide — develops slowly and stays hidden for months, because the body expertly depletes its reserves before giving up. Let's look at how it works, which tests reveal it, and how to treat it properly. What Is Iron Deficiency Anemia and How It Develops Iron is the raw material for hemoglobin, the protein in red blood cells that carries oxygen from the lungs to every cell in the body. When iron runs short, hemoglobin synthesis falls, red blood cells become small and pale, and tissues begin to chronically "suffocate." Iron is depleted in stages — imagine a warehouse with three storage sections. First to empty is the reserve: stores of ferritin in the liver and bone marrow. Next, transport iron drops — the iron circulating in the blood bound to transferrin. Only last does hemoglobin fall — the body's "combat reserve," protected until the very end. This is why ferritin drops months before a complete blood count shows anemia. By the time hemoglobin dips below normal, iron deficiency has existed for a long time. Causes of Iron Deficiency Anemia Iron deficiency develops when losses exceed intake. There are three reasons: insufficient intake, poor absorption, and increased losses. Chronic Blood Loss This is the leading cause in adults. In women of reproductive age — heavy periods: losing more than 80 ml of blood per month creates a negative iron balance. In men and postmenopausal women with newly diagnosed anemia, hidden gastrointestinal bleeding (ulcer, polyps, colon cancer) must be ruled out first. Regular use of NSAIDs (aspirin, ibuprofen) also causes microbleeding from the stomach lining. Impaired Absorption Even with adequate dietary iron, absorption may be reduced. Celiac disease, inflammatory bowel disease, gastric surgery (including bariatric), and chronic atrophic gastritis all impair iron absorption in the duodenum. Increased Demand Pregnancy, breastfeeding, and active growth in children and adolescents are periods when the body needs significantly more iron than usual. If diet doesn't compensate, deficiency is inevitable. Symptoms: How Iron Deficiency Presents Symptoms of iron deficiency anemia fall into two groups: general signs of oxygen starvation and specific signs unique to iron deficiency. General symptoms appear when hemoglobin is already low: chronic fatigue that doesn't resolve with rest; shortness of breath with exertion that was previously easy; rapid heartbeat; pale skin and mucous membranes; dizziness and ringing in the ears. Specific iron deficiency symptoms — signs that should point directly to this diagnosis: brittle, spoon-shaped nails (koilonychia); hair loss; dry skin and cracks at the corners of the mouth (cheilitis); pica — craving chalk, clay, or ice; restless legs syndrome at night; difficulty concentrating. Important: specific symptoms can appear at the latent deficiency stage — when hemoglobin is still normal but ferritin is already low. Which Tests Confirm Iron Deficiency Anemia Diagnosis is two-level. First, a complete blood count identifies the anemia itself; then an iron panel reveals the cause. Complete Blood Count Picture Marker In IDA Normal (adults) --------- Hemoglobin (Hb) Low F: 120–155 g/L, M: 130–170 g/L MCV (red cell volume) Low < 80 fL 80–100 fL MCH (color index) Low 27–33 pg Platelets Often elevated 150–400 × 10⁹/L A low MCV is the key finding: small (microcytic) and pale (hypochromic) red blood cells. Iron Panel Picture Marker In IDA Normal --------- Ferritin Low < 12 µg/L F: 10–120 µg/L, M: 20–250 µg/L Serum iron Low 9–30 µmol/L Transferrin Elevated 2.0–3.6 g/L Transferrin saturation Low < 16% 20–50% Ferritin below 30 µg/L in a woman with fatigue symptoms is sufficient reason to address iron deficiency — even if hemoglobin is within normal range. Three Stages of Iron Deficiency 1. Pre-latent deficiency — ferritin stores are depleted, but transport iron and hemoglobin are normal. Blood count is clean. Symptoms may already be present. 2. Latent deficiency — ferritin and serum iron are low, transferrin is elevated, but hemoglobin still holds. Deficiency exists; anemia does not. 3. Iron deficiency anemia — hemoglobin is low, red cells are small and pale. Symptoms are pronounced. Treatment of Iron Deficiency Anemia Treatment has two mandatory parts: replenishing iron stores and eliminating the cause. If the source of blood loss is not found and addressed, iron supplements will only provide temporary relief. The standard is oral iron. Key rules: take 30–60 minutes before meals; avoid tea, coffee, and dairy at the same time; vitamin C improves absorption; dark stools are a normal reaction. Hemoglobin begins to rise within 3–4 weeks. For more on how to increase haemoglobin, see the dedicated article. After hemoglobin normalizes, treatment continues for another 3–6 months to replenish ferritin stores. Intravenous iron is used when absorption is impaired, oral forms are not tolerated, or anemia is severe. When to See a Doctor Urgently Seek immediate help if: hemoglobin is below 70 g/L; anemia is newly diagnosed in a man or postmenopausal woman — bowel cancer must be excluded; progressive breathlessness at rest, chest pain, or fainting; anemia fails to respond to treatment within 4 weeks. Summary Iron deficiency anemia responds well to treatment — but only when the underlying cause is found. Ferritin should always be measured alongside hemoglobin: it drops earlier and more accurately reflects true iron stores. If fatigue persists and the blood count looks "normal" — that's a reason to check the iron panel and ferritin separately. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/ketony-v-moche https://labreadai.com/en/posts/ketony-v-moche Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ketone bodies in urine: normal levels, why acetone appears and what it means for diabetes and pregnancy. How to read your urinalysis and when to seek medical care. Articles article Acetone breath, unexplained fatigue, and an unusual result on a urinalysis — that's often how ketones are first discovered. Sometimes it's simply a consequence of skipping meals or following a strict diet. But sometimes it signals a dangerous condition requiring urgent care. Let's break down what ketone bodies in urine actually are, where they come from, and when the numbers in your results should genuinely concern you. What Are Ketone Bodies and Why Do They Appear in Urine Ketone bodies are three organic compounds: acetone, acetoacetate, and beta-hydroxybutyrate. They are produced in the liver when the body switches from glucose to fat as its primary energy source. Under normal conditions this process runs slowly and at low volume. Ketones are consumed by tissues — the brain, muscles, and heart. The kidneys excrete the remainder in urine, and in small amounts this is entirely physiological. The problem starts with ketonuria — when ketones are produced faster than the body can use them. The surplus accumulates in the blood and is actively cleared by the kidneys. The higher the blood ketone concentration, the more pronounced the acetone odor on the breath and the higher the level in urine. Think of it like a furnace burning the wrong fuel: instead of clean combustion, you get acrid smoke. Ketones are that metabolic "smoke." Normal Ketone Levels in Urine: When Results Are Fine In healthy people, urine contains either no ketones or a concentration too low to register on standard tests. Method Normal Abnormal --------- Dipstick (qualitative) Negative (neg) Trace, +, ++, +++ Nitroprusside test < 0.5 mmol/L ≥ 0.5 mmol/L Quantitative (lab) < 1 mmol/L 1–3 mmol/L moderate; 3 mmol/L high risk A single "+" on a dipstick corresponds to roughly 1.5 mmol/L; "++" to about 4 mmol/L; "+++" to 8–16 mmol/L. A "+++" result in a person with diabetes carries a high risk of diabetic ketoacidosis — a life-threatening emergency. In a healthy person without diabetes, a single faint "+" after fasting or heavy exercise is not catastrophic. But context always matters — it shouldn't be ignored. How to Collect Urine Correctly for Ketone Testing Ketones are chemically unstable. Poor collection or prolonged storage can produce both false-positive and false-negative results. Key rules: - Collect the first morning midstream urine — it is the most concentrated - Use a sterile pharmacy container - Deliver to the lab within 1–2 hours — ketones evaporate on standing - Do not leave the sample at room temperature longer than 30 minutes For rapid home testing, pharmacy dipsticks give a result in 60 seconds. They are less reliable at very low concentrations but work well for significant ketonuria. What Causes Ketones in Urine Fasting and low-carbohydrate diets. The most common everyday cause. On a ketogenic diet or after skipping several meals, the body switches to fat for fuel — ketones appear predictably. This is not a disease, but a signal to review your diet. Intense physical exercise. Marathon running or prolonged training on an empty stomach depletes glycogen stores rapidly, triggering hepatic ketogenesis. Vomiting and diarrhea. During acute gastrointestinal illness with repeated vomiting, the body is deprived of carbohydrates and turns to fat. In children this shift happens especially fast — ketones in urine can appear within hours of a fever. Alcohol intoxication. Ethanol impairs hepatic glucose synthesis and drives ketogenesis. Alcoholic ketoacidosis is a real and underrecognized diagnosis. Diabetes mellitus. The most dangerous cause — covered separately below. Hyperthyroidism and other endocrine disorders. Excess thyroid hormones accelerate fat breakdown, increasing ketone production. Blood glucose is often unstable in parallel. Pregnancy with severe morning sickness. Repeated vomiting creates a caloric deficit that drives the body into ketogenesis. Ketones in Urine with Diabetes: When It Becomes Dangerous In type 2 diabetes — and especially in type 1 — ketones in urine are a warning marker. The reason: when insulin is deficient or its action is impaired, cells cannot absorb glucose. The body interprets this as starvation and launches ketogenesis — despite glucose being abundant in the bloodstream. Rising ketones lead to diabetic ketoacidosis (DKA) — one of the most serious complications of diabetes: DKA severity Urine ketones Blood pH Clinical picture ------------ Mild + (trace–1+) 7.25–7.30 Nausea, weakness Moderate ++ (2+) 7.10–7.24 Vomiting, abdominal pain Severe +++ (3+) < 7.10 Altered consciousness For long-term glucose monitoring in diabetes, glycated hemoglobin measures average blood sugar over 3 months and helps prevent crises before they develop. People with diabetes should test urine for ketones when blood glucose exceeds 13–14 mmol/L, during any acute illness with fever, and after missed insulin doses. Ketones in Urine During Pregnancy Pregnancy is a special context. The maternal metabolism reorganizes: glucose is prioritized for the fetus, and the mother increasingly relies on fat. This creates physiological "accelerated starvation" — ketogenesis is triggered faster during pregnancy than outside it. Moderate ketonuria with early morning sickness (up to 12 weeks) is common and typically resolves as nausea improves and food intake normalizes. When it crosses the line: - Ketones "++" and above — sign of significant dehydration and energy depletion - Ketones alongside elevated glucose — possible gestational diabetes - Persistent ketonuria in the 2nd–3rd trimester — hospitalization required Prolonged ketone exposure can impair fetal neurological development. Even a single "+" during pregnancy warrants an OB-GYN consultation within a few days. It is worth noting that ketonuria in pregnancy often coincides with protein in urine — which requires differential diagnosis with preeclampsia. When to Seek Urgent Help and How Ketonuria Is Treated Call emergency services immediately if: - Ketones "+++ " with blood glucose 14 mmol/L in a diabetic patient - Confusion, disorientation, or sudden severe weakness - Uncontrollable vomiting — unable to keep water down - Deep, labored, rapid breathing (Kussmaul breathing) — sign of severe acidosis - You are pregnant with "++" or higher and vomiting continues Managing moderate ketonuria without alarming symptoms: A faint "+" from fasting or diet — restore normal eating with complex carbohydrates (oatmeal, bread, potatoes) and drink plenty of fluids. Ketones usually clear within 12–24 hours. "+" or "++" from a gastrointestinal infection — oral rehydration therapy, small sips every 10–15 minutes. Escalate to a hospital if symptoms worsen. In diabetes — the approach depends on diabetes type and the treating physician's instructions: typically an additional insulin dose, increased fluid intake, blood glucose checks every 2–4 hours, and repeat ketone testing. This article is for informational purposes only and does not replace professional medical advice. Consult a general practitioner or endocrinologist if ketones are detected in your urine. https://labreadai.com/en/posts/leykocity-v-moche https://labreadai.com/en/posts/leykocity-v-moche Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) What leukocyte levels in urine are normal for adults and children, why they rise and what diseases it signals. How to read the test and when to see a doctor. Articles article You got your urinalysis results and noticed elevated leukocytes — marked as "high" or above the reference range. Sometimes it's just a collection error. But this is also exactly how a hidden kidney or bladder infection gets discovered before any pain begins. Let's break down what leukocytes in urine actually mean, what counts as normal, and when to act — without delay. What Are Leukocytes in Urine and Why Do They Appear Leukocytes — white blood cells — are your immune system's first responders. In healthy people, small amounts pass through kidney capillary walls and end up in urine as a normal physiological process. A few cells per field of view is entirely expected. The problem starts when numbers spike. This is called leukocyturia — white blood cell counts exceeding acceptable limits. In severe cases (pyuria), urine turns visibly cloudy, which is detectable with the naked eye. The mechanism is direct: inflammation somewhere along the urinary tract — kidneys, ureters, bladder, or urethra — draws immune cells to the site, and some spill into urine. The stronger the inflammation, the higher the count in your urinalysis. Normal Leukocyte Levels in Urine for Adults, Children and Pregnant Women Reference values depend on the testing method. Three approaches are used in clinical practice: Method Women Men --------- Microscopy per field of view up to 6 up to 3 Nechiporenko method (per 1 ml) up to 2,000 up to 2,000 Amburger method (per 1 min) up to 2,500 up to 2,000 Women's threshold is slightly higher due to anatomy — the urethra is shorter, so vaginal cells can contaminate the sample when collection technique is poor. In children, up to 5–7 cells per field is acceptable, with a slightly higher threshold for girls than boys. During pregnancy, modest elevation to 8–10 cells per field often reflects uterine pressure on the bladder and increased pelvic blood flow. This still warrants medical attention: gestational pyelonephritis can be nearly symptom-free and is easily missed. How to Collect Urine Correctly for Accurate Results False positives are extremely common and one of the leading causes of alarming lab reports. Before collecting: - Wash without antibacterial soap (it distorts microbiology but doesn't remove cells) - Discard the first few milliliters; collect the midstream portion - Use a sterile pharmacy-grade container - Deliver to the lab within 1–2 hours Women should avoid collecting during menstruation — blood contamination will skew every value. If rescheduling is impossible, use a tampon before collection. What Causes High Leukocytes in Urine Urinary tract infections are the leading cause, accounting for the vast majority of cases. Cystitis gives sharp elevation with burning and frequent urination. Urethritis raises counts in men especially. Pyelonephritis — kidney infection — combines leukocyturia with back pain and fever. Chronic pyelonephritis can be nearly asymptomatic, making routine urinalysis the only clue. Kidney stones. A stone irritates the mucosal lining, causing local inflammation — often paired with protein in urine and episodes of intense flank pain. Glomerulonephritis — autoimmune kidney disease — elevates leukocytes alongside red blood cells in the sediment. Prostatitis in men. The inflamed prostate secretes cells directly into the urethra. Always worth considering when interpreting results in men over 40. Non-urinary causes: systemic autoimmune conditions, high fever of any origin, and certain medications — NSAIDs and some antibiotics. In such cases C-reactive protein in blood is typically elevated in parallel, helping the doctor distinguish infectious from drug-induced inflammation. Leukocytes in Urine During Pregnancy This deserves special attention. Pregnancy physiologically suppresses immunity to prevent fetal rejection. The side effect: the urinary tract becomes more vulnerable to infection. Gestational pyelonephritis develops in roughly 2–10% of pregnancies and can be entirely symptom-free. Routine urinalysis monitoring during pregnancy isn't administrative bureaucracy — it's real protection. Infections caught early are treated with antibiotics safe for the fetus. Untreated pyelonephritis risks preterm labor and low birth weight. Any elevation above normal during pregnancy is a reason to contact your obstetrician-gynecologist immediately — even if nothing hurts. When Leukocyturia Requires Urgent Care Some situations shouldn't wait for a scheduled appointment. Seek urgent care if: - Leukocytes are sharply elevated (50 per field) combined with high fever - Flank pain is one-sided, severe, and doesn't ease with rest - Blood appears in the urine — a sign of serious inflammation or kidney stones - Symptoms worsen despite treatment already started - You are pregnant and the test shows any abnormality An ascending infection — from bladder to kidneys — can develop within hours, especially in people with diabetes or compromised immunity. Repeated untreated episodes are a direct path to chronic kidney disease. How Elevated Leukocytes in Urine Are Treated Treatment depends entirely on the cause — which is why self-treatment is inappropriate here. The standard clinical approach: 1. Identify the cause: urine culture identifies the pathogen and its antibiotic sensitivity; kidney and bladder ultrasound rules out structural problems; if needed — a complete blood count to assess systemic inflammation 2. Antibiotic therapy for infectious causes — typically a 5–14 day course depending on location 3. Follow-up urinalysis — 7–10 days after finishing the course to confirm normalization 4. Address underlying factors: stones → lithotripsy or surgery; autoimmune nephritis → immunosuppressive therapy One rule worth remembering: symptom relief does not mean the infection is gone. The follow-up test is non-negotiable. This article is for informational purposes only and does not replace professional medical advice. Consult a urologist, nephrologist, or general practitioner if your urinalysis results show any abnormalities. https://labreadai.com/en/posts/pasteurella-multocida-infection https://labreadai.com/en/posts/pasteurella-multocida-infection Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Pasteurella multocida: cat and dog bite infection, symptoms, antibiotics and first aid. When a wound becomes dangerous and how to avoid serious complications. Articles article A cat bites your finger — and within a few hours your hand is red, hot, and swollen. Most people assume it will heal on its own. It won't. This is the typical onset of a Pasteurella multocida infection — a bacterium that lives in the mouths of nearly every cat and roughly half of all dogs. Let's break down why it's so dangerous, how it's treated, and when an animal bite becomes a genuine medical emergency. What Is Pasteurella multocida and Where Does It Live Pasteurella multocida is a gram-negative coccobacillus — an opportunistic pathogen. For its natural hosts — cats and dogs — it is completely harmless: simply part of the normal microbial flora of the mouth, pharynx, and upper respiratory tract. The numbers are striking: the bacterium is found in 70–90% of domestic cats and 50–70% of dogs. The animal looks and acts perfectly healthy — there are no signs of infection because there are none. This is exactly why the risk is so often underestimated. In humans, however, Pasteurella multocida is a true pathogen. Once introduced into tissues through broken skin, it triggers rapidly progressive inflammation. Its defining feature — what sets it apart from most bacterial infections — is its speed: first symptoms appear within 3–24 hours of exposure. How Infection Spreads: Bites, Scratches and Mucosal Contact Bites are the primary route of transmission, and cat wounds are more dangerous than dog wounds. Cat teeth are thin and needle-sharp: they create a deep puncture canal that places bacteria far below the surface. The wound is hard to clean, immune cells arrive slowly — ideal conditions for bacterial proliferation. Dog bites cause more tissue trauma, but the wound is wider and bleeds more actively, partially flushing out bacteria. Scratches are the second most common route. Bacteria reach the claws when cats groom themselves — they lick their paws and Pasteurella multocida transfers to the nails. A scratch then introduces it directly into the wound. Licking. If a cat or dog licks an open abrasion, cut, or skin around an unhealed wound — that is sufficient for infection. This is especially relevant for people with diabetes or leg ulcers. Less common routes: inhalation of aerosols from close animal contact (pneumonia cases have been reported in people who sleep with cats) and occupational exposure in veterinary settings. Symptoms of Pasteurella multocida Infection The defining characteristic is speed. While most animal-derived bacterial infections take 2–3 days to declare themselves, pasteurellosis announces itself within hours. Local manifestations (cellulitis, wound infection): - Redness around the bite or scratch — appears within 3–6 hours - Swelling with a sense of pressure — spreads quickly; by the end of the first day it often involves the entire finger or hand - Pain — intense, disproportionate to the wound size; patients commonly describe it as throbbing or pulsating - Local skin warmth - Purulent discharge from the wound — develops later, within 24–48 hours In more severe cases, lymphangitis develops — a red streak running from the wound toward the nearest lymph node. This signals that the infection is spreading through the lymphatic vessels and requires immediate medical attention. Systemic manifestations (when infection spreads beyond the wound): - Fever above 38°C - Marked weakness and chills - Elevated leukocytes in blood — leukocytosis as a marker of systemic inflammatory response Joint involvement. If the bite was near a joint or the infection reaches one, septic arthritis develops: severe pain, inability to move the joint, marked swelling. This is a surgical emergency. Diagnosis: How to Confirm Pasteurellosis In most cases the diagnosis is clinical: a characteristic history (animal bite or scratch) combined with a rapid-onset inflammatory picture is sufficient to start treatment without waiting for confirmation. Laboratory tests are used to assess severity and in atypical presentations: - Complete blood count — reveals leukocytosis with a left shift in the differential. The count of neutrophils rises sharply; neutrophilia with a band shift is the classic picture of bacterial infection - C-reactive protein — a sensitive inflammation marker that rises quickly and proportionally to disease severity; useful for monitoring treatment response - Wound swab or blood culture — confirms the pathogen and determines antibiotic sensitivity; takes 2–5 days and does not affect the initial treatment decision Imaging. When joint or bone involvement is suspected — X-ray or MRI. Soft tissue ultrasound helps detect fluid collections requiring surgical drainage. Treatment and Antibiotics for Pasteurella multocida Good news: Pasteurella multocida is susceptible to several commonly available antibiotics, and treatment started promptly leads to full recovery in the vast majority of cases. Drug of choice — amoxicillin-clavulanate (Augmentin, Co-amoxiclav). It covers Pasteurella multocida as well as other pathogens common in animal bite wounds. Duration for uncomplicated wound infection: 5–7 days. Alternatives in case of penicillin allergy: - Doxycycline — effective, but contraindicated in children under 8 and pregnant women - Fluoroquinolones (levofloxacin, moxifloxacin) — for adults with severe presentations - Co-trimoxazole — for moderate cases Critical to know: several widely used antibiotics have poor activity against Pasteurella multocida. Cephalexin, clindamycin, and erythromycin — frequently prescribed for skin infections — are not reliable choices here. If one of these was prescribed after a cat bite and the wound is worsening, return to the doctor and ask for a treatment review. Systemic infection (sepsis, meningitis, endocarditis) requires hospitalization, intravenous antibiotics, and 2–6 weeks of treatment depending on the site. Local wound care runs in parallel: irrigation, antiseptic, and surgical debridement when needed. Primary closure of bite wounds is generally avoided — it increases the risk of anaerobic co-infection. Complications and High-Risk Groups In most healthy individuals, pasteurellosis stays localized to the wound and responds well to treatment. But for certain groups, the same bacterium poses a far more serious threat. Serious complications: - Septic arthritis and osteomyelitis — from bites near joints or the hand; require surgical drainage and prolonged antibiotic therapy - Sepsis — systemic inflammatory response with multi-organ involvement; rising creatinine signals acute kidney injury as part of the cascade - Meningitis — reported in neonates and elderly patients; carries significant morbidity - Endocarditis — rare but life-threatening in patients with pre-existing valvular heart disease when bacteremia occurs High-risk groups: - People with diabetes — impaired wound healing and blunted immune response - Patients on immunosuppressive therapy (transplant recipients, autoimmune conditions) - People with liver cirrhosis or chronic kidney disease - Adults over 65 - Neonates — when transmitted from a mother with animal contact If you belong to any of these groups, any cat or dog bite warrants medical attention within a few hours — without waiting for visible inflammation to develop. First Aid After an Animal Bite and Prevention What to do immediately after a bite or scratch: 1. Wash the wound under running water with soap — for at least 5 minutes. This mechanically removes the majority of bacteria. This step matters more than any antiseptic 2. Apply an antiseptic — iodine solution, chlorhexidine, or hydrogen peroxide 3. Cover with a sterile dressing — do not bandage tightly 4. See a doctor or go to urgent care within 24 hours after a cat bite and within 48 hours after a dog bite — even if the wound looks minor The physician will assess whether preventive antibiotic therapy is warranted. It is indicated for cat bites, wounds on the face, hands or near joints, and in immunocompromised patients — even before any inflammation appears. Don't forget tetanus. If the last vaccine was more than 5 years ago, a booster is needed. Urgent care will check this automatically. Long-term prevention: don't let cats or dogs lick open wounds or abrasions. Wash hands with soap after any scratch. People in high-risk groups should discuss a bite management plan with their doctor in advance — before it's needed. This article is for informational purposes only and does not replace professional medical advice. After any animal bite, visit urgent care or a general practitioner — especially for wounds on the hand or face. https://labreadai.com/en/posts/pulmonary-embolism https://labreadai.com/en/posts/pulmonary-embolism Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Pulmonary embolism is an acute blockage of the lung artery by a clot. Symptoms, D-dimer and CT angiography diagnosis, treatment and prevention. Articles article Sudden shortness of breath, chest pain, a racing heart — these symptoms could mean many things. But when a person has recently had surgery, a long flight, or has been confined to bed for a while, pulmonary embolism must be at the top of the differential. PE is the third most common acute cardiovascular emergency after heart attack and stroke — and one of the most underdiagnosed. Here's what causes it, what it looks like, how it is diagnosed, and how it is treated. What Is Pulmonary Embolism and How Does It Develop Pulmonary embolism is the acute blockage of the pulmonary artery or its branches by a clot — which usually formed not in the lungs but in the veins of the legs or pelvis. The clot detaches, travels through the bloodstream, passes through the right side of the heart, and lodges in a pulmonary vessel — cutting off blood supply to part of the lung. The causes of clot formation are described by Virchow's triad — three factors that, alone or in combination, set the process in motion: 1. Slow blood flow — prolonged immobilisation: bed rest, a long flight or car journey, the post-operative period, limb paralysis. 2. Vessel wall damage — trauma, surgical procedures, venous inflammation (phlebitis), catheters and intravenous access. 3. Increased clotting tendency (hypercoagulability) — malignancy (especially pancreatic, lung, and gastric cancer), pregnancy and the postpartum period, hormone therapy and oral contraceptives, hereditary thrombophilia (protein C or S deficiency, Factor V Leiden mutation), antiphospholipid syndrome. Imagine a river with sluggish current, a damaged bank, and thickened water — a clot in this environment is almost inevitable. PE is what happens when the resulting "blockage" drifts downstream and obstructs a critical channel. Classification of PE by Severity The severity of PE is determined by how severely right ventricular function is compromised — the chamber that pumps blood into the lungs. Massive PE — blockage of the main trunk or large branches. Right ventricular pressure rises acutely and the chamber fails. Clinical picture: cardiogenic shock (systolic BP < 90 mmHg), loss of consciousness, cardiac arrest. Mortality without treatment: 30–50%. Submassive PE — significant clot burden without shock, but with evidence of right ventricular strain on ECG, echocardiography, or elevated troponin. Moderate risk. Requires hospitalisation and active treatment. Non-massive (small) PE — blockage of small branches, normal haemodynamics, no right ventricular strain. Low mortality with timely treatment. Symptoms of PE: Why It Gets Missed PE is treacherous because its symptoms are non-specific and are easily attributed to other conditions. The classic PE triad: - Dyspnoea — sudden, without obvious cause, worsening with exertion. The most common symptom (present in 80% of patients). - Chest pain — usually pleuritic (worsens with breathing and coughing), less commonly substernal as in infarction. Present in 40–60%. - Haemoptysis — blood in sputum. A sign of pulmonary infarction, present in only 10–15% — when a small branch has been occluded and lung tissue has died. Other symptoms: tachycardia, anxiety and a sense of impending doom, sweating, cough, cyanosis (blue lips in massive PE), syncope. Signs of deep vein thrombosis (DVT) — the clot source: pain, swelling, and redness in one leg (usually the calf or thigh) — present in only 25–30% of PE patients, because by then the clot has already left. The principal diagnostic trap: PE symptoms are identical to pneumonia (dyspnoea, pleuritic pain, cough) and pericarditis (chest pain). This is exactly why instrumental confirmation is essential. Diagnosing PE: From D-Dimer to CT Angiography PE cannot be diagnosed from symptoms alone — laboratory and imaging investigations are required. Clinical probability assessment — the first step. The doctor uses the Wells score or Geneva score: points for risk factors (recent surgery, prior DVT, tachycardia, malignancy) establish how likely PE is before any tests are ordered. D-dimer — a fibrin breakdown product, a marker of active clot formation and dissolution. With low clinical probability, a normal D-dimer effectively rules out PE. The problem: D-dimer is extremely non-specific — it rises with any inflammation, in pregnancy, after surgery, and in malignancy. An elevated D-dimer does not confirm PE — it simply says "further investigation is needed." CT pulmonary angiography (CTPA) — the gold standard. Contrast is injected intravenously and the scanner visualises the clot directly within the vessel. Sensitivity and specificity exceed 95%. With high clinical probability, CTPA is ordered directly, bypassing D-dimer. ECG — changes in PE are often non-specific (tachycardia, right-sided changes, the S1Q3T3 pattern). Helps exclude myocardial infarction as the cause of symptoms. Severity markers: troponin (rises with right ventricular overload — indicates severity and risk), BNP/NT-proBNP. A coagulation panel is important before starting anticoagulation and when thrombophilia is suspected. A complete blood count excludes anaemia as a cause of dyspnoea and detects leucocytosis suggesting pneumonia (differential diagnosis). CRP helps assess the inflammatory component. Echocardiography — in massive PE, right ventricular overload and a "D-shaped" interventricular septum are visible. In unstable patients who cannot undergo CTPA, echocardiography becomes the primary tool. Treatment of PE The goals of treatment are to arrest and dissolve the clot, restore pulmonary blood flow, and prevent recurrence. Anticoagulation — the foundation of treatment for non-massive and submassive PE. Anticoagulants do not dissolve an existing clot but prevent it from growing and stop new ones forming: - Direct oral anticoagulants (DOACs) — rivaroxaban, apixaban. First choice for most patients: fixed doses, no routine laboratory monitoring needed, suitable for outpatient treatment. - Low-molecular-weight heparins (enoxaparin) — for hospitalised patients, pregnancy, and malignancy. - Warfarin — for mechanical heart valves and long-term treatment. Requires regular INR monitoring (target INR 2.0–3.0) via a coagulation panel. Duration: 3 months for provoked PE (after surgery); 6 months or longer for unprovoked PE; indefinite for recurrent or malignancy-associated PE. Thrombolytic therapy (thrombolysis) — intravenous agents that dissolve the clot (alteplase). Indicated for massive PE with cardiogenic shock. Rapidly restores blood flow but carries a high bleeding risk, including intracranial haemorrhage. Used only in an intensive care setting. Surgical treatment — embolectomy (clot removal) or catheter-directed fragmentation when thrombolysis is contraindicated. Oxygen therapy and supportive care — for all forms of PE. When to Call Emergency Services Call an ambulance immediately for: - Sudden dyspnoea at rest — especially after surgery, prolonged immobilisation, or a long flight. - Chest pain that worsens with breathing. - Coughing up blood. - Loss of consciousness or sudden severe drop in blood pressure. - Rapid heartbeat combined with dyspnoea and leg pain or swelling. Any of these in isolation does not necessarily mean PE. Their combination in the presence of risk factors is sufficient reason to call emergency services without waiting. Preventing PE After Surgery and During Travel Most cases of PE are preventable. Key measures: In hospital: compression stockings and pneumatic calf compression during immobilisation; prophylactic heparin or DOAC dosing in high-risk surgical patients; early mobilisation after surgery. During travel: stand and walk for a few minutes every two hours on long flights ( 4 hours); wear compression stockings; stay hydrated. Long-term: treating varicose vein disease; managing malignancy; discontinuing oral contraceptives when thrombophilia is identified; prolonged anticoagulation for recurrent thrombosis. Conclusion Pulmonary embolism is an emergency that can be missed — and prevented. Its danger lies in symptoms that mimic pneumonia or heart attack. The key to diagnosis is clinical thinking: with any sudden dyspnoea against a background of risk factors, PE must be on the differential. The key to treatment is rapid anticoagulation, which when started promptly reduces mortality five to eight times. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/posts/ragweed-allergy https://labreadai.com/en/posts/ragweed-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ragweed allergy is the most aggressive autumn hay fever. Symptoms, cross-reactions with melon and banana, diagnostic tests and immunotherapy (SCIT/SLIT). Articles article If every August brings relentless sneezing, watery eyes, and a cough that won't quit — ragweed is likely the cause. This invasive weed has become the primary allergological quarantine plant: its pollen is so fine and light that it travels 400 or more kilometres on the wind — causing symptoms in regions where ragweed doesn't even grow. Let's look at why ragweed is so aggressive, which foods trigger cross-reactions, and what to do about it. Why Ragweed Causes Allergy Ragweed (Ambrosia) belongs to the daisy family (Asteraceae) — the same family as wormwood. Its main allergen is Amb a 1, one of the most potent plant allergens known: its sensitising capacity significantly exceeds that of birch's Bet v 1. This is why ragweed allergy often follows a more severe course than birch hay fever. A single ragweed plant produces up to one billion pollen grains per season. The grains are extremely small — 18–22 µm — and travel on wind for 400–700 kilometres. This means people in cities where ragweed doesn't grow can suffer symptoms during its flowering season in neighbouring regions. Peak airborne pollen concentrations occur in the morning hours on dry, windy days. Ragweed is an invasive species that has expanded its range significantly over recent decades — growing on wastelands, roadsides, and near residential buildings, making avoidance difficult. Ragweed Flowering Season Ragweed blooms from late July through October, peaking in August–September. This is one of the latest pollen seasons, ending with the first frosts. Important context: the ragweed season overlaps with wormwood and late grass pollens. Patients sensitised to all three may have uninterrupted hay fever from June through October. This polysensitised group benefits most from early AIT. Symptoms of Ragweed Allergy The clinical picture does not differ from other hay fevers, but is often more intense due to the high allergenicity of Amb a 1. Allergic rhinitis — abundant clear discharge, paroxysmal sneezing, nasal congestion, nasal and palatal itch. In severe cases — near-complete blockage, postnasal drip, headache. Allergic conjunctivitis — redness, itch, tearing, gritty eye sensation, light sensitivity. In some patients conjunctivitis dominates over nasal symptoms. Bronchospasm — in 30–40% of ragweed-allergic patients, asthma develops or worsens. Ragweed is one of the most common pollen triggers for asthma. General symptoms — marked fatigue, reduced productivity, sleep disruption from constant congestion. In severe cases, significantly impaired quality of life for 2–3 months a year. Characteristic pattern: symptoms worsen in the morning and in dry, windy weather; ease after rain and indoors with windows closed and an air purifier running. Cross-Reactivity: The Ragweed–Melon–Banana Syndrome Food cross-reactivity in ragweed pollinosis involves a distinctive set of foods. The main mechanism is structural similarity between Amb a 1 and proteins of certain fruits and vegetables — primarily cucurbits and bananas. Group Foods ------ Asteraceae Wormwood, chrysanthemum, chamomile, sunflower, Jerusalem artichoke Cucurbits Melon, watermelon, cucumber, courgette, pumpkin Bananas Banana Other Avocado, kiwi, peaches (via panallergen), honey from Asteraceae Reactions present as oral allergy syndrome: itching, burning, and tingling in the mouth, lips, and throat within minutes of eating raw foods. Usually mild and brief. A distinctive feature of ragweed cross-reactivity: reactions to melon are the most common and can be pronounced. In some patients — not only oral syndrome but urticaria or swelling. Heat destroys most cross-reactive proteins — cooked or processed versions of listed foods are usually well tolerated. Diagnosing Ragweed Allergy Skin prick tests with ragweed pollen extract — the diagnostic standard. Performed outside the season, at least 2 weeks after stopping antihistamines. Wormwood and grasses are often tested simultaneously — co-sensitisation to autumn allergens is very common. Specific IgE blood test for Amb a 1 — done any time of year. Advantage over prick testing: unaffected by antihistamine use, safe in severe atopic dermatitis. Molecular diagnostics (Amb a 1, Amb a 8, Amb a 11) — refines the sensitisation profile. Amb a 8 is a profilin (panallergen), linked to reactions across a wide range of plants. Amb a 11 is a cysteine protease associated with more severe reactions. Complete blood count — elevated eosinophils indirectly confirm allergic inflammation, particularly notable during the flowering season. Treatment of Ragweed Allergy Reducing Pollen Exposure - During the season, avoid outdoor activity in the morning (6–10 am) on dry, windy days - Keep windows closed; use a HEPA air purifier - After every outing: shower, rinse nose with saline, change clothes - Monitor pollen count maps — on high-concentration days, limit outdoor time - Wear wraparound sunglasses - When travelling: in southern regions ragweed concentrations peak in August–September Medication Second-generation antihistamines (cetirizine, fexofenadine, bilastine) — start 1–2 weeks before the expected season; take daily throughout the flowering period. Intranasal corticosteroids (mometasone, fluticasone) — most effective for rhinitis; start 2 weeks before the season. Antileukotriene agents (montelukast) — when rhinitis is combined with asthma. Eye drops (azelastine, olopatadine) — for significant conjunctivitis. AIT for Ragweed Allergy Allergen-specific immunotherapy with ragweed allergen is the only treatment that modifies the immune response rather than suppressing symptoms. Sublingual or subcutaneous forms; course 3–5 years. Most patients report 40–70% symptom reduction after the first year. AIT is started during remission — in winter or spring, at least 3 months before the expected bloom. With co-sensitisation to ragweed and wormwood, an allergist may prescribe AIT targeting both allergens simultaneously. A distinctive benefit of ragweed AIT: in some patients, cross-reactive food reactions to melon and banana also diminish — an additional effect of specific therapy. When to Seek Urgent Medical Attention Immediately if: difficulty breathing or wheezing; swelling of lips, tongue, or throat; sudden drop in blood pressure, loss of consciousness — signs of anaphylaxis. Routine allergist visit: symptoms recur every summer-autumn and reduce quality of life; antihistamines no longer provide adequate relief; reactions to melon, banana, or other cross-reactive foods have appeared; you want to start AIT. Summary Ragweed allergy is among the most severe hay fevers in terms of symptom intensity and season length. AIT offers a real path to remission — with particularly strong evidence for ragweed. If hay fever is complicated by co-sensitisation to wormwood and grasses, evaluation should begin as early as possible — not at the start of the next season. For more on allergy mechanisms, see the complete allergy guide. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/serotonin-what-it-is https://labreadai.com/en/posts/serotonin-what-it-is Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Serotonin is a neurotransmitter and hormone. Where it is made, how it affects mood and the gut, what a blood test shows and serotonin syndrome explained. Articles article "Serotonin is the happiness hormone" — one of the most popular and simultaneously most misleading simplifications in biology. Yes, serotonin affects mood. But 95% of all serotonin in the body is not in the brain — it is in the gut, where it regulates intestinal motility and has nothing to do with emotions. Let's look at what serotonin actually is, why it serves three entirely different roles in the body, and why a blood test for serotonin tells you almost nothing about your mood. What Is Serotonin and Where Is It Made Serotonin (5-hydroxytryptamine, 5-HT) is a biologically active substance that functions simultaneously as a neurotransmitter, a local hormone, and a signalling molecule. It is synthesised from the amino acid tryptophan in two steps: tryptophan → 5-hydroxytryptophan (5-HTP) → serotonin. The key enzyme in the second step is DOPA-decarboxylase. Serotonin synthesis occurs in three main locations — and understanding this is fundamental to understanding its functions: The gut (95%) — enterochromaffin cells of the small intestinal mucosa synthesise the vast majority of the body's serotonin. This serotonin regulates intestinal motility and does not cross the blood-brain barrier — it has no effect on mood whatsoever. The brain (5%) — neurons in serotonergic nuclei (primarily the raphe nuclei) synthesise serotonin that acts as a neurotransmitter. This small pool is responsible for regulating mood, sleep, appetite, and cognitive function. Tryptophan enters the brain from the blood — so diet and plasma tryptophan levels indirectly influence brain serotonin synthesis. Platelets — do not synthesise serotonin themselves but take it up from blood and store it. When platelets activate, serotonin is released and participates in aggregation and vasoconstriction. Three Roles of Serotonin: Neurotransmitter, Gut Regulator, Platelet Factor Serotonin in the Brain: Mood, Sleep, Appetite In the central nervous system, serotonin modulates a wide range of functions: mood and emotional stability; the sleep-wake cycle (serotonin is the precursor of melatonin); appetite and satiety; pain sensitivity; anxiety and impulsivity. Reduced serotonergic transmission is linked to depression, anxiety disorders, and OCD. This is why most modern antidepressants are selective serotonin reuptake inhibitors (SSRIs): they increase serotonin concentration in the synaptic cleft without boosting its synthesis. An important clarification: serotonin is not the "happiness hormone" in any direct sense. It creates a background emotional tone — calm, stability, contentment. Acute pleasure and euphoria involve dopamine and endorphins, not serotonin. Serotonin in the Gut: Peristalsis and the "Second Brain" The gut is called the "second brain" for good reason — it has its own nervous system (the enteric nervous system), in which serotonin plays a central role. It triggers peristaltic reflexes, regulates the speed of intestinal transit, stimulates secretion, and influences abdominal pain perception. In irritable bowel syndrome, serotonergic signalling is disrupted — which is why some IBS medications target serotonin receptors (5-HT3 and 5-HT4 agonists and antagonists). The gut-brain connection through serotonin works in both directions: stress disrupts intestinal motility, and an unhealthy gut can influence mood — through the vagus nerve and systemic inflammation. Serotonin in Blood: Platelets and Vessels Platelet serotonin, released on platelet activation, causes vasoconstriction of damaged vessels and enhances aggregation — an important component of primary haemostasis. This platelet pool is what a standard blood test measures — and it has no direct relationship to brain serotonin. Blood Test for Serotonin: When and Why It Is Ordered An important misconception to address: a blood test for serotonin does not measure serotonin levels in the brain. It reflects serotonin in platelets and plasma — primarily of intestinal origin. Brain serotonin does not reach peripheral blood because of the blood-brain barrier. Genuine indications for a serotonin blood test: Carcinoid tumours — neuroendocrine tumours of the gut or lungs that autonomously produce large amounts of serotonin. Carcinoid syndrome: episodes of flushing, diarrhoea, bronchospasm, cardiac valve involvement. Blood serotonin in carcinoid: 300–1700 nmol/L (vs normal 40–80 nmol/L). The 24-hour urine 5-HIAA (5-hydroxyindoleacetic acid) — a serotonin metabolite — is actually a more specific diagnostic marker. Normal serotonin level in blood — 40–80 nmol/L (50–200 ng/mL; reference ranges vary between laboratories). Ordering a serotonin test "to check for depression" or "to assess mood" has no clinical rationale. Depression is diagnosed using clinical scales and interviews — not blood serotonin levels. What Affects Brain Serotonin Since brain serotonin is synthesised from dietary tryptophan, nutrition and lifestyle indirectly influence its level. Dietary tryptophan. Turkey, eggs, cheese, fish, nuts, legumes, pumpkin seeds — rich tryptophan sources. But intake alone is not enough: transport into the brain depends on the ratio of tryptophan to other large neutral amino acids (they compete for the same transporter). Carbohydrates indirectly increase brain tryptophan availability by stimulating insulin release — which is why people crave sweets when mood is low. Physical activity. Regular aerobic exercise increases serotonin synthesis and release in the brain — one of the proven mechanisms behind the antidepressant effect of exercise. Sunlight. Bright light stimulates the serotonergic system and vitamin D synthesis. This explains seasonal affective disorder (winter depression) — shorter days reduce serotonergic activity and accelerate melatonin synthesis. Gut microbiome. Intestinal bacteria regulate serotonin synthesis in enterochromaffin cells. Microbiome disruption (dysbiosis) reduces intestinal serotonin and may influence the central serotonergic system through the gut-brain axis. Cortisol. Chronic stress and chronically elevated cortisol reduce serotonin receptor expression and impair serotonergic transmission. This is the biochemical mechanism linking chronic stress and depression. Serotonin Syndrome: When There Is Too Much Serotonin Excess serotonin is dangerous. Serotonin syndrome develops from excessive serotonergic stimulation — most commonly from combinations or overdoses of serotonergic drugs: SSRIs + MAOIs, SSRIs + triptans, SSRIs + tramadol, SSRIs + lithium, and others. The classic symptom triad: - Neuromuscular abnormalities — tremor, myoclonus, hyperreflexia, muscle rigidity - Autonomic dysfunction — tachycardia, hypertension, hyperthermia, diaphoresis, diarrhoea - Altered mental status — agitation, confusion, restlessness Serotonin syndrome is a medical emergency: in severe cases body temperature can exceed 41°C, and rhabdomyolysis and multi-organ failure may develop. The first step is immediate discontinuation of all serotonergic agents. Serotonin and Melatonin: A Direct Biochemical Link Serotonin is the immediate precursor of melatonin: in the pineal gland, serotonin is converted to N-acetylserotonin and then to melatonin. This process is activated by darkness and suppressed by light. Practical implication: tryptophan deficiency → reduced serotonin → reduced melatonin → disrupted sleep. This is why depression and sleep disorders so frequently co-occur — they share a common biochemical substrate. Under chronic stress with elevated cortisol, both serotonergic transmission and the nocturnal melatonin peak are disrupted simultaneously — a double hit to sleep and mood. When to See a Doctor Immediately for symptoms of serotonin syndrome: tremor + tachycardia + high temperature + agitation after starting or combining serotonergic medications. Routine referral to a psychiatrist or neurologist: persistent low mood, anxiety, or sleep disturbance lasting more than 2 weeks; suspected carcinoid tumour (episodic flushing, chronic diarrhoea, bronchospasm). Summary Serotonin is a multifunctional molecule with three entirely different roles. 95% of it is in the gut, where it regulates motility. 5% is in the brain, where it shapes mood and sleep. A blood serotonin test measures the platelet pool — not the brain pool — and is not used for depression diagnosis. Its synthesis depends on tryptophan, physical activity, light, and gut microbiome health. And the most important fact about serotonin: too much is just as dangerous as too little. This article is for informational purposes only. For symptoms of depression, anxiety, or sleep disorders — medical consultation is essential. https://labreadai.com/en/posts/tsh-thyroid-stimulating-hormone https://labreadai.com/en/posts/tsh-thyroid-stimulating-hormone Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) TSH is the key marker of thyroid function. Normal ranges by age, why TSH changes before T4, causes of high and low values and therapy monitoring guidelines. Articles article TSH is one of the most frequently ordered hormonal tests — and for good reason. A single marker can detect hidden hypothyroidism in a woman with unexplained fatigue or early hyperthyroidism in an elderly patient with atrial fibrillation. Yet TSH is also easily misinterpreted: in pregnant women, elderly patients, and those on therapy, the norms are fundamentally different. Let's look at how this hormone works and how to read its result in different clinical situations. What Is Thyroid-Stimulating Hormone (TSH) and Why It Changes Before T4 TSH (thyroid-stimulating hormone) is a pituitary hormone that regulates thyroid gland activity. When thyroid hormone levels (T4 and T3) fall, the pituitary "detects" this and increases TSH output — stimulating the thyroid to work harder. When T4 and T3 are excessive, TSH is suppressed. This relationship is non-linear (logarithmic). A small change in T4 causes a disproportionately large shift in TSH — the pituitary is roughly 100 times more sensitive to T4 fluctuations than standard T4 tests. This is why TSH becomes abnormal before T4 exits its reference range. Subclinical hypothyroidism is exactly this: TSH is already elevated but T4 is still normal — the pituitary detects the problem before it becomes clinically apparent. This sensitivity makes TSH the best primary screening test. If TSH is normal, thyroid function is preserved and expanding the panel is unnecessary. TSH Normal Range by Age, in Women and During Pregnancy The standard adult reference range — 0.4–4.0 mIU/L — is not universal. Norms differ substantially across situations. Normal Ranges by Age Age TSH normal range (mIU/L) ------ Newborns (days 1–4) 1.0–39.0 Under 1 year 0.7–8.4 1–6 years 0.6–5.5 7–14 years 0.4–4.5 15–18 years 0.4–4.2 Adults 18–60 years 0.4–4.0 Over 60 years 0.4–6.0 In older adults the upper limit is higher — TSH physiologically shifts upward with age. Applying young-adult norms to a 75-year-old means over-diagnosing hypothyroidism. Normal Ranges in Pregnancy During pregnancy TSH norms are significantly stricter — especially in the first trimester, when hCG stimulates TSH receptors and physiologically lowers TSH. Trimester TSH normal range (mIU/L) ------ 1st (weeks 1–12) 0.1–2.5 2nd (weeks 13–26) 0.2–3.0 3rd (weeks 27–40) 0.3–3.0 Untreated hypothyroidism in pregnancy poses serious risks to fetal brain development. TSH is checked at the first obstetric visit. Target Values During Levothyroxine Therapy In hypothyroidism on therapy, the target is TSH in the range 0.5–2.5 mIU/L. In pregnancy — stricter: 0.1–2.5 mIU/L in the first trimester. In thyroid cancer after surgery — TSH is intentionally suppressed below 0.1 mIU/L. TSH High: Causes, Hypothyroidism and Subclinical Hypothyroidism TSH 4.0 mIU/L (in adults 18–60) signals reduced thyroid function. Subclinical hypothyroidism — TSH elevated (4–10 mIU/L) but free T4 still normal. Symptoms may be non-specific or absent. This is the most common finding on a thyroid panel. Manifest (overt) hypothyroidism — TSH 10 mIU/L + reduced free T4. Symptoms are pronounced: fatigue, weight gain, cold intolerance, slowed thinking, dry skin, bradycardia. Other causes of high TSH: Hashimoto's autoimmune thyroiditis — the most common cause; thyroidectomy or radioiodine therapy; amiodarone, lithium; recovery phase after acute thyroiditis. The TSH–lipid connection: in hypothyroidism, LDL and triglycerides often rise through impaired cholesterol clearance. This is why TSH is always checked when lipid panel abnormalities appear without an obvious cause. TSH Low: Causes and Hyperthyroidism TSH < 0.4 mIU/L — pituitary suppression from excess thyroid hormones or exogenous T4. Subclinical hyperthyroidism — TSH suppressed, free T4 normal. Symptoms may be absent. Risks: atrial fibrillation (especially in the elderly), accelerated bone loss. Manifest hyperthyroidism — TSH < 0.1 mIU/L + elevated free T4 or T3. Symptoms: tachycardia, weight loss, tremor, sweating, irritability, exophthalmos in Graves' disease. Other causes of low TSH: Graves' disease — main cause in young women; toxic nodular goitre — more common in the elderly; excessive levothyroxine dose; acute destructive thyroiditis (temporary); first-trimester pregnancy — physiological hCG-mediated TSH suppression. When to Test TSH: Diurnal Rhythm and Blood Test Interpretation TSH has a pronounced diurnal rhythm: peak at night (2–4 am), nadir around noon. The difference between peak and nadir can reach 50–100%. Practical rules: - Draw blood in the morning, fasting (8–12 hours without food) - For treatment monitoring — always at the same time of day - For levothyroxine monitoring — draw blood before taking the morning tablet Serial measurements at different times of day are not comparable. This is one of the most common sources of spurious "change" in TSH. What Distorts TSH Results Acute illness and stress — any severe illness can temporarily suppress TSH (euthyroid sick syndrome). Testing TSH during acute infection or hospitalisation is unreliable. Biotin (vitamin B7) — high-dose biotin supplementation ( 5 mg/day, common in "hair and nails" products) causes false-low TSH results in immunoassays. Biotin must be stopped at least 72 hours before testing. Medications: amiodarone raises TSH; corticosteroids, dopamine, and octreotide lower TSH; biotin-containing supplements interfere with immunoassay. Heterophile antibodies — some people carry antibodies that interfere with immunochemical TSH measurement, producing spurious results. When TSH does not match the clinical picture — repeat at a different laboratory. TSH and T4 Interpretation: Monitoring Levothyroxine Treatment Free T4 — clarifies the degree of dysfunction. The algorithm: start with TSH; if abnormal, add free T4. More detail in the thyroid panel article. Anti-TPO — when TSH is abnormal, confirms autoimmune cause. High anti-TPO predicts progression of subclinical to overt hypothyroidism. Prolactin — often elevated in hypothyroidism. The pituitary simultaneously increases both TSH and prolactin output. In hyperprolactinaemia without an obvious cause — TSH is checked. Estradiol — oestrogens affect thyroid hormone-binding proteins. In menstrual irregularities and low estradiol, TSH is one of the first tests ordered. When to Seek Urgent Medical Attention Immediately: TSH < 0.01 mIU/L with thyrotoxicosis symptoms (HR 120, high fever, agitation) — possible thyroid storm; TSH 20 mIU/L with severe hypothyroidism symptoms (stupor, hypothermia) — possible myxoedema coma. Routine endocrinology referral: TSH 4.0 mIU/L on repeat testing; TSH < 0.4 mIU/L without thyroid medication; any TSH abnormality in pregnancy; failure to reach target TSH after 6–8 weeks on a levothyroxine dose. Summary TSH is the best primary marker of thyroid function: sensitive, accessible, and earlier than T4. But it must be read in the context of age, pregnancy, medications, and time of day. Normal TSH rules out thyroid disease in most situations. An abnormal TSH is the trigger to add free T4, anti-TPO, and when needed — refer to an endocrinologist. For the full panel, see the thyroid panel article. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/type-2-diabetes https://labreadai.com/en/posts/type-2-diabetes Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Type 2 diabetes is a chronic glucose metabolism disorder. Early symptoms, diagnostic tests, normal glucose and HbA1c values, treatment principles and prevention. Articles article Thirst that won't go away, afternoon fatigue, and wounds that take longer to heal than they used to — it's easy to blame stress and aging. Yet type 2 diabetes can develop silently for years, and many people discover it by chance from a routine blood test. Let's break down the mechanism, the warning signs, and what lab results look like in diabetes. What Is Type 2 Diabetes: Insulin Resistance and How It Differs from Type 1 Type 2 diabetes is a disorder of glucose metabolism driven by insulin resistance. Think of insulin as a key and cell receptors as locks. In type 2 diabetes the locks have "rusted": insulin is present — often in excess — but cells stop responding to it. Glucose can't get in and accumulates in the blood. In type 1 diabetes the immune system destroys insulin-producing cells and there is no insulin at all. Type 2 is a lifestyle and genetic condition — and it can often be controlled without insulin. Risk Factors: Who Is at Risk Risk is significantly higher with: excess body weight and obesity — especially abdominal fat; age over 45; family history of diabetes; gestational diabetes; physical inactivity and poor diet; polycystic ovary syndrome; high blood pressure and lipid profile abnormalities. Symptoms of Type 2 Diabetes Type 2 diabetes may be asymptomatic for 5–10 years. When symptoms appear: frequent heavy urination and constant thirst (kidneys flush excess glucose with water); chronic fatigue; slow wound healing; recurrent infections; vision changes; numbness and tingling in the feet — an early sign of neuropathy. Diagnosis: Normal Blood Sugar Levels and Tests That Confirm Diabetes Fasting Blood Glucose Result Interpretation ------ < 6.1 mmol/L Normal 6.1–6.9 mmol/L Impaired fasting glucose (prediabetes) ≥ 7.0 mmol/L Diabetes (confirmed on two occasions) Glycated Hemoglobin (HbA1c) HbA1c reflects average glucose over the past 2–3 months and is independent of recent meals — making it the key marker for both diagnosis and treatment monitoring. HbA1c Interpretation ------ < 5.7% Normal 5.7–6.4% Prediabetes ≥ 6.5% Diabetes < 7.0% Treatment target Oral Glucose Tolerance Test (OGTT) Blood glucose measured 2 hours after drinking 75 g of glucose. Detects impaired glucose tolerance — a form of prediabetes that fasting glucose alone can miss. Additional Tests Important in Type 2 Diabetes Lipid panel — type 2 diabetes almost always raises triglycerides and lowers HDL, sharply increasing cardiovascular risk. Kidney function test with creatinine — diabetic nephropathy develops in 30–40% of patients. Early stages are detected by microalbuminuria and GFR. Treatment of Type 2 Diabetes The goal is to keep HbA1c below 7%. Losing 5–10% of body weight reduces HbA1c by 1–2% — comparable to medication. More on non-drug ways to lower blood sugar in a dedicated article. Metformin is the first-line drug. Insulin in type 2 diabetes is started when the pancreas exhausts its reserves over the long course of disease. Complications If Diabetes Is Untreated Chronically high glucose damages blood vessels, leading to: diabetic retinopathy (a leading cause of blindness); diabetic nephropathy; neuropathy and diabetic foot syndrome; atherosclerosis — heart attack and stroke risk is 2–4 times higher. When to See a Doctor Urgently Immediately if: glucose above 16–17 mmol/L with nausea and vomiting — possible ketoacidosis; sudden hypoglycemia (trembling, cold sweat, confusion); non-healing foot ulcers for more than 2 weeks; newly found glucose ≥ 7.0 mmol/L — schedule a consultation. Summary Type 2 diabetes is a manageable chronic condition. The earlier it is caught, the greater the chance of controlling it through lifestyle change. Key tests: fasting glucose and HbA1c. If you are at risk and haven't checked your blood sugar in the past 2 years — now is the time. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/wormwood-allergy https://labreadai.com/en/posts/wormwood-allergy Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Wormwood allergy is the main autumn hay fever with cross-reactions to spices and celery. Symptoms, the mugwort-celery-spice syndrome, diagnostic tests and immunotherapy. Articles article While most people think of allergy season as a spring problem, millions experience their worst symptoms in midsummer through the first frosts. Wormwood (mugwort) allergy is the main autumn hay fever in temperate climates. Its particular challenge: it rarely comes alone — wormwood belongs to the same botanical family as ragweed, and it cross-reacts with spices and vegetables that are hard to suspect as allergens. Let's look at why wormwood is so aggressive and what to do about it. Why Wormwood Causes Allergy Wormwood (Artemisia) belongs to the daisy family (Asteraceae) — one of the most allergenic plant families. The main allergen is Art v 1, which is structurally related to allergens from other members of the same family: ragweed, chrysanthemums, sunflower, and chamomile. A single wormwood plant releases up to one billion pollen grains per season. The pollen is small and light, carried by wind for tens of kilometres. Airborne concentrations are highest on dry, windy days, in wastelands, along roadsides, and near abandoned fields — exactly where wormwood grows most abundantly. A distinctive feature of wormwood: its pollen is released primarily in the evening and night hours (6 pm to 11 pm) — unlike most trees, which peak in the morning. This explains why patients with wormwood allergy often report symptoms worsening in the evenings. Wormwood Flowering Season Wormwood blooms later than spring trees and grasses: depending on the region, from late June through October, with peak concentration in August–September. An important point: the wormwood season overlaps with the ragweed and grass pollen seasons. Patients sensitised to all three can experience an uninterrupted hay fever period from June through October. This is exactly why early diagnosis and AIT matter most for polysensitised patients. Symptoms of Wormwood Allergy Symptoms appear in late June–early July and disappear after the first frosts. Clinically they do not differ from other hay fevers, but carry a characteristic evening pattern. Allergic rhinitis — nasal congestion, clear watery discharge, paroxysmal sneezing, nasal itch. Postnasal drip — the sensation of mucus running down the back of the throat — is common. Allergic conjunctivitis — redness, itch, tearing, light sensitivity. In some patients conjunctivitis is more prominent than nasal symptoms. Bronchospasm — in patients with asthma or predisposition to it. The autumn wormwood season frequently coincides with asthma flares. Skin reactions — skin itch, urticaria on contact with the plant or its extracts (cosmetics, herbal teas containing chamomile or wormwood). Characteristic pattern: symptoms worsen in the evening (peak pollen release), intensify in open areas with abundant weedy vegetation, in dry and windy conditions. Cross-Reactivity: The Mugwort–Celery–Spice Syndrome Food cross-reactivity in wormwood pollinosis is one of the most specific and least obvious. The main targets are not fruits (as with birch) but spices and aromatic vegetables. Art v 1 is structurally similar to proteins of plants in the carrot family (Apiaceae) and daisy family. This underlies the "mugwort–carrot–celery–spice syndrome" — one of the most diagnostically challenging food allergy syndromes. Group Foods ------ Asteraceae Ragweed, chrysanthemum, chamomile, sunflower, Jerusalem artichoke Apiaceae (spices) Anise, caraway, coriander, fennel, dill, parsley, tarragon Apiaceae (vegetables) Celery, carrot, parsnip Other Mango, chamomile tea, honey (from Asteraceae pollination) Reactions present as oral allergy syndrome: itching and burning in the mouth and lips within minutes of eating raw foods. In some patients — more pronounced systemic reactions to spices (coriander, caraway), especially in powder form, since inhaling spice dust additionally loads the airways. Heat destroys Art v 1 — cooked celery and carrots are usually safe, raw ones may trigger reactions. Dried ground spices are more dangerous than fresh herbs. Diagnosing Wormwood Allergy Skin prick tests with wormwood pollen extract — the diagnostic standard. Performed outside the season, at least 2 weeks after stopping antihistamines. Ragweed and grass are often tested simultaneously — co-sensitisation to several autumn allergens is common. Specific IgE blood test for Art v 1 and total wormwood allergen — done any time of year. Especially valuable in severe dermatitis or when prick testing is not feasible. Molecular diagnostics (Art v 1, Art v 3) — refines sensitisation profile. Art v 3 is a lipid transfer protein associated with more severe systemic food reactions. Complete blood count — elevated eosinophils indirectly support allergic inflammation. A normal count does not exclude hay fever. Treatment of Wormwood Allergy Reducing Pollen Exposure - During peak season (August–September), avoid outdoor activity in the evening — wormwood releases most pollen between 6 and 11 pm - Keep windows closed in the evening and at night; use a HEPA air purifier - After every outing: shower, rinse nose with saline, change clothes - Avoid wastelands, roadsides, and abandoned fields — wormwood's primary habitats - Wear wraparound sunglasses outdoors Medication Second-generation antihistamines (cetirizine, fexofenadine, bilastine) — taken daily throughout the season, starting 1–2 weeks before expected bloom. Intranasal corticosteroids (mometasone, fluticasone) — most effective for nasal symptoms; start 2 weeks before the season. Eye drops with antihistamine or mast cell-stabilising action — for significant conjunctivitis. Antileukotriene agents (montelukast) — when rhinitis is combined with asthma. AIT for Wormwood Allergy Allergen-specific immunotherapy with wormwood allergen is the only treatment that modifies the immune response rather than just controlling symptoms. Course duration: 3–5 years; sublingual or subcutaneous forms available. Most patients report 40–60% symptom reduction after the first year. AIT is started only during remission — in winter or early spring, at least 3–4 months before the expected bloom. In patients co-sensitised to wormwood and ragweed, an allergist may prescribe AIT targeting both allergens simultaneously. When to Seek Urgent Medical Attention Immediately if: breathing difficulty or wheezing; swelling of lips, tongue, or throat; sudden drop in blood pressure, loss of consciousness. Routine allergist visit: symptoms recur every summer-autumn; antihistamines no longer provide adequate relief; reactions to spices or celery have appeared; you want to start AIT. Summary Wormwood allergy is an autumn hay fever with a distinctive evening rhythm and a specific food cross-reactivity pattern. The mugwort–celery–spice syndrome often goes unrecognised for years until the patient realises that their "spice intolerance" is part of an allergic picture. Early AIT, combined with coverage of ragweed and grasses in polysensitised patients, is the best long-term control strategy. For more on allergy mechanisms, see the complete allergy guide. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/indicators/albumin https://labreadai.com/en/indicators/albumin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Albumin is the main plasma protein. Normal ranges, why low albumin matters, its key roles, acute-phase behaviour and when low levels need attention. Indicators article Albumin is the most abundant protein in blood plasma — and its reduction is seen in biochemistry panels far more often than its elevation. This is because albumin is a negative acute-phase protein: during any inflammation, physiological stress, or liver disease, the liver reduces albumin synthesis. This is exactly why low albumin has become one of the most important prognostic markers in clinical medicine: it simultaneously reflects nutritional status, liver function, and the intensity of the inflammatory response. What Is Albumin and What Does It Do Albumin is synthesised exclusively in the liver — approximately 10–15 g per day in a healthy adult. It makes up around 55–65% of all plasma protein. The albumin molecule is small, crosses capillaries freely, but under normal conditions is retained by the negative charge of glomerular capillary walls. Albumin performs three fundamentally different roles simultaneously: 1. Oncotic pressure. Albumin is the primary creator of colloid osmotic (oncotic) pressure in plasma. It is what "holds" water inside blood vessels, preventing it from leaking into the tissues. When albumin falls, oncotic pressure drops — fluid escapes into the interstitial space and oedema develops. Classic locations: legs, abdomen (ascites), pleural cavity. This explains why oedema in liver cirrhosis or nephrotic syndrome is so difficult to treat. 2. Transport function. Albumin is a universal carrier in the bloodstream. It transports fatty acids, bilirubin (in its unconjugated form), calcium, magnesium, zinc, copper, thyroid hormones, and drugs — particularly warfarin, digoxin, NSAIDs, and statins. When albumin is low, the free (unbound) fractions of drugs increase, altering both their efficacy and toxicity. 3. Nutritional status. Albumin level has traditionally been used as a marker of protein-energy malnutrition. It falls with prolonged fasting, malabsorption, and malignancy. However, there is a limitation: albumin has a long half-life (21 days), making it a poor marker of acute nutritional changes — but a reliable indicator of chronic depletion. Normal Albumin Values Group Normal Range (g/L) ------ Adults 35–52 Children under 3 25–55 Children 3–14 38–54 Pregnant — 1st trimester 31–51 Pregnant — 2nd–3rd trimester 26–45 In pregnancy, albumin physiologically falls due to increased plasma volume (haemodilution) and higher foetal demand. Values of 28–32 g/L in the second and third trimester may be normal. Reference ranges differ slightly between laboratories. Always use the values on your specific report. Why Is Albumin Low? Hypoalbuminaemia Albumin below 35 g/L is hypoalbuminaemia. Causes fall into four groups. Reduced synthesis (liver disease): The liver is the only organ that synthesises albumin. Cirrhosis, severe chronic hepatitis, acute liver failure — albumin falls predictably alongside other synthetic markers: prothrombin time (coagulation panel), cholinesterase. In severe cirrhosis, albumin below 25 g/L is a sign of marked decompensation. Together with ALT, AST, GGT, and bilirubin, albumin is part of the full liver function assessment in the liver function panel. Protein loss (nephrotic syndrome): In nephrotic syndrome, the glomerular filtration barrier fails — protein leaks into urine. Urinary albumin (proteinuria) in severe nephrotic syndrome can exceed 3–5 g per day. Blood albumin falls, oncotic pressure drops — massive oedema, ascites, pleural effusion develop. Simultaneously, creatinine rises and eGFR falls on kidney function testing. Reduced synthesis as acute-phase response: This is the most common cause of moderate albumin reduction in clinical practice. During any inflammation, infection, or malignancy, cytokines (IL-6) reduce albumin synthesis in favour of acute-phase proteins (CRP, fibrinogen). This is not depletion — it is a reallocation of hepatic synthetic priorities. This is why albumin and CRP are "mirror" markers: as CRP rises, albumin falls. Reduced protein intake: Prolonged fasting, malabsorption (coeliac disease, Crohn's disease), oncological cachexia — insufficient substrate for albumin synthesis. Here albumin falls slowly (due to its long half-life) but reliably reflects chronic depletion. Why Is Albumin High? True hyperalbuminaemia (albumin above 52 g/L) is essentially not seen in practice. The only real cause is haemoconcentration from severe dehydration: plasma volume falls and albumin concentration rises. Once fluid is replaced, albumin normalises. In this situation, haematocrit and creatinine rise in parallel. Clinical Significance of Albumin Levels Albumin Level Interpretation ------ 35–52 g/L Normal 28–34 g/L Mild hypoalbuminaemia 21–27 g/L Significant hypoalbuminaemia, high complication risk < 21 g/L Severe hypoalbuminaemia, critical state Albumin below 25 g/L is an independent predictor of in-hospital mortality, prolonged length of stay, and post-surgical complications. This is why it features in most clinical severity scores (APACHE, SOFA, NRS-2002 for nutritional risk). How to Prepare for the Test Albumin is measured in a biochemistry blood panel. Blood is drawn fasting after 8 hours. Important factors affecting interpretation: body position (lying down lowers albumin by 3–8% versus standing, due to fluid redistribution), tourniquet time (a prolonged tourniquet causes haemoconcentration that artificially elevates albumin), acute illness (lowers albumin through the acute-phase response). For complete liver function assessment, albumin is read alongside ALT, AST, GGT, bilirubin, and prothrombin time — within the liver function panel. When nephrotic syndrome is suspected — simultaneously with creatinine and urine protein testing. When to See a Doctor Schedule a routine appointment with a GP or gastroenterologist if: - Albumin is below 35 g/L on repeat testing without pregnancy or acute illness. - Low albumin is accompanied by oedema, ascites, or pleural effusion. - Albumin is declining on serial testing during treatment. Seek immediate attention for rapidly developing oedema — particularly ascites — which may indicate acute decompensation of cirrhosis or nephrotic syndrome. Conclusion Albumin is a unique marker reflecting three aspects of the body's condition simultaneously: hepatic synthetic function, renal protein losses, and nutritional status. Its reduction is almost always clinically meaningful — whether from an acute-phase response, liver disease, renal loss, or chronic depletion. As a "mirror" of CRP, it helps the clinician understand the nature of hypoalbuminaemia: when CRP is high and albumin is low — this is inflammation, not starvation. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/ck-mb https://labreadai.com/en/indicators/ck-mb Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CK-MB is the cardiac creatine kinase fraction. Normal levels, infarction kinetics, how it compares to troponin and when elevated CK-MB requires emergency evaluation. Indicators article CK-MB appears in a lab report alongside troponin — and many patients wonder why two markers are ordered at the same time. The answer lies in their different diagnostic "windows": troponin remains elevated for up to 14 days, while CK-MB normalizes within 48–72 hours. This characteristic makes CK-MB indispensable for detecting reinfarction and monitoring the effectiveness of reperfusion therapy. What CK-MB Is and How CK Isoenzymes Work CK (creatine kinase, creatine phosphokinase) is an enzyme that catalyzes the reversible phosphorylation of creatine to produce ATP. It supplies rapid energy to cells with high energy demand — primarily muscle and nerve cells. CK consists of two subunits — M (muscle) and B (brain) — and exists in three isoenzyme forms: Isoenzyme Subunits Primary location Normal proportion ------------ CK-MM M + M Skeletal muscle 95–97% CK-MB M + B Myocardium (15–25% of cardiac CK) 3–5% CK-BB B + B Brain, smooth muscle < 1% CK-MB is expressed predominantly in cardiomyocytes: in heart muscle it accounts for 15–25% of total CK. In skeletal muscle, CK-MB comprises less than 3% — this concentration gradient is the biochemical basis of the marker's cardiac specificity. When cardiomyocytes undergo necrosis or severe injury, CK-MB enters the bloodstream and becomes measurable. The mechanism parallels that of troponin, but CK-MB is released more rapidly and clears from the circulation faster — the difference in "memory" is what gives each marker its distinct clinical role. Normal CK-MB Levels Laboratories use two measurement approaches for CK-MB — activity-based and mass-based. They reflect different analytical dimensions and differ in sensitivity. CK-MB activity (catalytic enzyme activity): Group Normal ------ Adult men < 25 U/L Adult women < 25 U/L Children < 30 U/L CK-MB mass (immunochemical determination — more sensitive): Group Normal ------ Adults < 5.0–6.0 µg/L (ng/mL) CK-MB/total CK ratio — an additional diagnostic criterion: - < 3% — normal ratio; total CK elevation is most likely skeletal in origin - 3–6% — borderline - ≥ 6% — suggests cardiac origin when both CK-MB and total CK are elevated The ratio is particularly useful in massive skeletal muscle injury (rhabdomyolysis, extreme exercise), where very high total CK "dilutes" the apparent MB fraction percentage. CK-MB Kinetics in Acute Myocardial Infarction The temporal profile of CK-MB in myocardial infarction is highly predictable — and this predictability is one of the marker's primary clinical strengths. Time from symptom onset CK-MB activity ------ 0–3 hours Normal or borderline 3–6 hours Rising in most patients 12–24 hours Peak activity 48–72 hours Normalization With successful reperfusion (thrombolysis or PCI), the CK-MB curve changes characteristically: the peak arrives earlier (6–12 hours) and is higher — the "reperfusion peak" — reflecting rapid washout of the marker from the re-opened segment. Early, high CK-MB peak followed by rapid decline after reperfusion is an indirect laboratory sign of successful blood flow restoration. Collection protocol for MI monitoring: - First draw: at presentation (hour 0) - Repeat at 3–4 hours - Again at 6–8 hours if diagnosis remains uncertain - Immediately when reinfarction is suspected — at onset of new symptoms No special preparation is required — fasting status does not affect CK-MB. In acute settings the test is ordered immediately, without any preparation. Causes of Elevated CK-MB A rise in CK-MB is almost always a sign of myocardial injury or — less commonly — severe skeletal muscle damage. Cardiac causes: Condition Degree of elevation Characteristic features --------- Acute myocardial infarction Significant (5–10× ULN or higher) Acute onset; chest pain; ECG changes Unstable angina Normal or mild Usually normal — key distinction from MI Myocarditis Moderate Viral prodrome; chest discomfort Cardioversion / defibrillation Mild–moderate Transient rise after procedure Cardiac surgery Significant Expected postoperative pattern Cardiac contusion Moderate–significant Chest trauma Prolonged tachyarrhythmias Mild During sustained AF or VT episodes Non-cardiac causes (significant skeletal muscle damage releases CK-MB from its small muscle fraction): Condition Mechanism How to distinguish --------- Rhabdomyolysis Massive skeletal muscle cell death CK-MB/CK ratio < 6%; very high total CK Intense training, marathon Muscle stress Transient; no infarction symptoms Muscular dystrophies (regeneration) Regenerating muscle expresses CK-MB Chronic elevation; chronic disease context Hypothyroidism Reduced CK clearance Elevated TSH; multiple enzyme elevations Severe kidney failure Reduced clearance Changes in CBC and other markers Pulmonary embolism Right ventricular pressure overload Clinical picture of PE; ECG C-reactive protein in acute MI rises alongside CK-MB — but later (peaking at 48–72 hours) and persisting longer. Interpreting these markers together helps distinguish the early infarction phase from the subsequent inflammatory response to myocardial necrosis. CK-MB vs Troponin: The Fundamental Difference With the advent of high-sensitivity troponin, the role of CK-MB in diagnosis has evolved — but not disappeared. Understanding their differences determines when each marker is needed. Characteristic CK-MB Troponin (hsTn) --------- Onset of rise 3–6 hours 1–3 hours (hsTn) Peak 12–24 hours 12–24 hours Normalization 48–72 hours 7–14 days Sensitivity Lower Substantially higher Cardiac specificity High, but lower than troponin Very high (cTnI) Primary role today Reinfarction diagnosis; reperfusion monitoring Primary MI diagnosis Detection of small MI Misses some Detects Key conclusion: for primary infarction diagnosis, troponin is preferred — it is more precise and responds earlier. But when troponin is already elevated (where it stays for up to 2 weeks), CK-MB is the only marker that can detect a new infarction: a fresh CK-MB rise on a background of persistently elevated troponin is the diagnostic sign of reinfarction. CK-MB in Reinfarction and Reperfusion Monitoring These are the two main clinical niches of CK-MB in modern cardiology — and both remain relevant despite widespread adoption of high-sensitivity troponin. Reinfarction diagnosis. After a first infarction, troponin remains elevated for up to 14 days. If the patient develops new chest pain during this period — how do you distinguish reinfarction from post-infarction chest discomfort? Troponin is no longer useful as a dynamic marker. CK-MB has already normalized — and a new CK-MB rise of more than 20% from the previous value on repeat sampling 3–6 hours later is the diagnostic criterion for reinfarction under current guidelines. Reperfusion monitoring. After successful thrombolysis or PCI, washout of markers from reperfused myocardium accelerates: an early CK-MB peak (< 12 hours), high and rapidly declining, is a sign of successful reperfusion. A delayed, flat peak without early decline may suggest incomplete reperfusion. This "non-invasive reperfusion index" provides a laboratory surrogate for procedural success. Additionally, the absolute height of the CK-MB peak is used to roughly estimate infarct size — a higher peak correlates with a larger necrotic zone and worse prognosis. When Elevated CK-MB Requires Medical Attention CK-MB is not a routine screening test. It is ordered for specific clinical indications and almost exclusively in the context of acute cardiac presentations. Call emergency services immediately for any CK-MB elevation combined with: - Chest pain or pressure, breathlessness, or palpitations - ECG changes — regardless of CK-MB level - A new CK-MB rise in a patient who has already had a myocardial infarction Scheduled cardiology consultation when: - Moderate CK-MB elevation without clinical acute infarction — to exclude myocarditis, cardiac contusion, or other causes - Chronically elevated CK-MB with a normal CK-MB/total CK ratio — possible myopathy or hypothyroidism Important: isolated moderate CK-MB elevation with normal troponin and normal ECG requires repeat measurement 3–6 hours later — dynamics matter more than a single value. A stable level without rise substantially reduces the probability of acute infarction. This article is for informational purposes only and does not replace professional medical advice. Call emergency services immediately if you experience chest pain. https://labreadai.com/en/indicators/cortisol https://labreadai.com/en/indicators/cortisol Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Cortisol is the adrenal stress hormone. Morning and evening norms, causes of hypercortisolism and adrenal insufficiency, how to test and when to see a doctor. Indicators article Cortisol is a hormone that simultaneously saves lives and undermines health. In an acute situation it is indispensable: it mobilizes energy, suppresses inflammation, and maintains blood pressure. But in chronic excess it begins doing the very things it is meant to prevent — breaking down muscle, raising blood pressure, impairing immunity, and depositing fat on the abdomen. Let's break down its biochemistry, normal ranges, and why the time of testing is fundamentally important. What Cortisol Is and How the HPA Axis Works Cortisol is a steroid hormone of the glucocorticoid class, synthesized in the adrenal cortex (zona fasciculata). It is regulated through a three-tier hierarchy — the hypothalamic-pituitary-adrenal (HPA) axis: - The hypothalamus releases corticotropin-releasing hormone (CRH) → stimulates the pituitary - The pituitary releases ACTH (adrenocorticotropic hormone) → stimulates the adrenal cortex - The adrenal glands synthesize cortisol → through negative feedback, suppress CRH and ACTH The defining characteristic of cortisol is its pronounced circadian rhythm: concentrations are approximately 8-fold higher in the morning (peak at 6–8 AM) than late at night. This rhythm governs not only biological processes but the entire logic of diagnostics: the same value of 400 nmol/L means "normal" in the morning and "significantly elevated" late at night. Physiological functions of cortisol: - Metabolic regulation — raises blood glucose through gluconeogenesis; stimulates protein and fat breakdown as energy substrates - Anti-inflammatory action — suppresses pro-inflammatory cytokine synthesis and stabilizes immune cell membranes; this is the basis for synthetic glucocorticoid use in medicine - Vascular tone — maintains vascular sensitivity to catecholamines; in adrenal insufficiency, hypotension becomes resistant to vasopressors - Sodium retention — a mild mineralocorticoid effect; in excess (Cushing's syndrome) — hypernatremia and hypokalemia - Immunomodulation — suppresses cellular immunity; chronically high cortisol reduces NK-cell and T-lymphocyte activity A practical guide to reducing chronically elevated cortisol in women is in the article how to lower cortisol in women. Normal Cortisol Levels: Blood, Saliva and Urine Cortisol reference values critically depend on the time of day and the biological specimen. Without documentation of collection time, any cortisol value is uninterpretable. Blood cortisol (serum/plasma): Collection time Normal (nmol/L) Normal (µg/dL) --------- Morning 8:00–10:00 AM (peak) 138–690 5–25 Midday 12:00–4:00 PM 83–413 3–15 Evening 4:00–8:00 PM 69–345 2.5–12.5 Late night 11:00 PM–midnight < 50 < 1.8 Unit conversion: nmol/L ÷ 27.59 = µg/dL. Salivary cortisol (preferred for diurnal profiling and Cushing's syndrome screening): Time Normal (nmol/L) ------ Morning (30 min after waking) 10–45 Midday 2–11 Late evening (10:00–11:00 PM) < 4.3 nmol/L Late-night salivary cortisol < 4.3 nmol/L is the most sensitive single screening test for Cushing's syndrome. Free cortisol in 24-hour urine (reflects total daily cortisol output): Group Normal (nmol/24h) Normal (µg/24h) --------- Adults 55–330 20–120 During pregnancy, urinary free cortisol physiologically rises 2–3-fold — interpret with caution. How to Prepare for a Cortisol Blood Test Cortisol testing is one of the most pre-analytically demanding hormonal assays. Failure to follow conditions can completely invalidate the result. Blood cortisol: - Strictly fasting, drawn at 8:00–10:00 AM — this is when cortisol is at its physiological peak; an afternoon draw produces a physiologically low result easily mistaken for pathology - Avoid intense physical exercise and emotional stress for 24 hours beforehand — both powerfully activate the HPA axis - Blood is drawn after the patient has rested quietly for 30 minutes — venipuncture itself raises cortisol - When Cushing's syndrome is suspected — a late-night cortisol (11:00 PM) is also collected: elevation above 207 nmol/L is a diagnostic criterion for autonomous cortisol excess - Disclose all glucocorticoid use (prednisolone, dexamethasone, budesonide, even topical steroids with systemic absorption) — they suppress cortisol through HPA axis suppression Low-dose dexamethasone suppression test: The patient takes 1 mg dexamethasone at 11:00 PM; cortisol is measured at 8:00 AM. With normal HPA axis function: suppression to < 50 nmol/L. Failure to suppress is a Cushing's syndrome screening signal. The relationship with other hormones: TSH and cortisol are often measured together when patients complain of fatigue and weight changes — they mutually influence thyroid and adrenal function. Causes of High Cortisol (Hypercortisolism) Hypercortisolism is divided into endogenous (excess production within the body) and exogenous (glucocorticoid medication use). Cause Mechanism ACTH level Characteristic features ------------ Cushing's disease (pituitary ACTH adenoma) Autonomous ACTH → adrenal stimulation High Central obesity; moon face; striae Cushing's syndrome (adrenal adenoma) Autonomous adrenal cortisol Low (suppressed) Same features; unilateral adrenal mass Ectopic ACTH syndrome (lung, pancreatic tumors) Tumor produces ACTH outside the pituitary Very high Rapid onset; hypokalemia; hyperpigmentation Exogenous glucocorticoids External GC administration Very low (suppressed) Clear link to medication Chronic psychoemotional stress HPA axis activation Modestly elevated Unstable moderate elevation Obesity Impaired HPA feedback Normal Moderate elevation; no pathological Cushing's stigmata Depression and anxiety disorders Hypothalamic hyperactivation Modestly elevated Psychiatric symptoms Alcohol use disorder (pseudo-Cushing's) Alcohol-driven HPA stimulation Variable Cushing's-like features; normalizes with abstinence Clinical signs of chronic hypercortisolism: - Central obesity (moon face, dorsocervical fat pad, thin limbs) - Wide ( 1 cm) purple-red striae on abdomen, thighs, and shoulders - Proximal muscle weakness (difficulty rising from a chair without arm support) - Hypertension resistant to treatment - Diabetes or impaired glucose tolerance - Osteoporosis - Depression and cognitive impairment Even moderate sustained hypercortisolism suppresses prolactin and sex hormones through inhibitory effects on GnRH — explaining menstrual irregularities and reduced libido during chronic stress. Causes of Low Cortisol (Hypocortisolism) Reduced cortisol — adrenal insufficiency — is less common but potentially life-threatening. Cause Mechanism Characteristic features --------- Addison's disease (primary AI) Autoimmune or infectious destruction of adrenal cortex Hyperpigmentation; hypotension; hyponatremia + hyperkalemia Secondary AI (pituitary pathology) ACTH deficiency → adrenal atrophy Pallor (no ACTH → no skin pigmentation) Tertiary AI (hypothalamic pathology) CRH deficiency → ACTH deficiency Trauma, hypothalamic tumors Glucocorticoid withdrawal Long-term GCs suppressed HPA axis → adrenal atrophy Abrupt cessation after prolonged GC course Sheehan's syndrome Pituitary necrosis from postpartum hemorrhage Agalactia; amenorrhea Tuberculous adrenalitis Adrenal cortex destruction Adrenal calcifications on CT Addisonian crisis — acute adrenal insufficiency — is a rare but real medical emergency: sudden severe hypotension, circulatory collapse, hypoglycemia, hyperkalemia, vomiting, and loss of consciousness. Precipitated by stress, infection, or abrupt glucocorticoid withdrawal in a patient with chronic AI. In hypocortisolism, calcitriol synthesis is impaired and calcium absorption falls — linking cortisol deficiency to vitamin D and calcium deficiency in patients with chronic adrenal insufficiency. Cortisol and Other Hormones: Systemic Connections Cortisol is the "conductor" of the stress response — its deviations immediately ripple through the entire endocrine system. Cortisol and insulin. Cortisol is a physiological insulin antagonist: it raises blood glucose and reduces tissue insulin sensitivity. Chronic hypercortisolism is a recognized cause of secondary diabetes. Insulin resistance in metabolic syndrome is partly driven by heightened HPA axis activity. Cortisol and TSH. Cortisol impairs T4-to-T3 conversion and reduces pituitary sensitivity to TRH. This explains why patients with chronic stress frequently have hypothyroid-like symptoms with a technically normal TSH — the so-called "normal TSH with peripheral thyroid dysfunction" pattern. Cortisol and sodium. Cortisol exerts a mild mineralocorticoid effect, retaining sodium and water. In Addison's disease the opposite occurs: hyponatremia and hyperkalemia, from absence of both cortisol and aldosterone. Cortisol and prolactin. Acute stress simultaneously raises both hormones — through shared neuroendocrine pathways. Chronically elevated cortisol, however, suppresses prolactin via dopaminergic mechanisms. Distinguishing these patterns is important when evaluating hyperprolactinemia in chronically stressed patients. Cortisol and sex hormones. "Progesterone steal": under chronic stress, pregnenolone — the shared precursor of all steroid hormones — is preferentially channeled toward cortisol synthesis at the expense of sex hormones. This is one mechanism underlying cycle disruption, infertility, and reduced libido under chronic stress. When Cortisol Abnormalities Require Medical Attention Scheduled visit to an endocrinologist when: - Morning cortisol 690 nmol/L on two independent measurements with proper collection conditions — Cushing's syndrome screening - Positive dexamethasone suppression test (failure to suppress below 50 nmol/L) — pituitary MRI and/or adrenal CT is mandatory - Morning cortisol < 138 nmol/L on two measurements — exclude adrenal insufficiency; Synacthen stimulation test - Clinical signs of hyper- or hypocortisolism at any cortisol level — the clinical picture matters more than the number Call emergency services immediately when: - Sudden severe hypotension (BP < 90/60 mmHg) combined with nausea, vomiting, and abdominal pain in a patient with known AI or who has taken glucocorticoids — possible Addisonian crisis - Impaired consciousness, seizures, and hypoglycemia in a patient with AI — intravenous hydrocortisone must be given immediately This article is for informational purposes only and does not replace professional medical advice. Consult an endocrinologist if your cortisol level is outside the normal range. https://labreadai.com/en/indicators/creatinine https://labreadai.com/en/indicators/creatinine Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Creatinine is the primary marker of kidney filtration. Normal ranges by sex and age, causes of high and low levels, how eGFR is calculated and when to see a nephrologist. Indicators article Creatinine is one of those markers that stays "quiet" for years while kidney function silently declines by half. This is not a metaphor: the kidneys have enormous functional reserve, and blood creatinine only starts rising noticeably once the glomerular filtration rate falls below 50–60% of normal. This is precisely why the absolute number always comes second to the calculated eGFR — which is what actually determines the stage of kidney disease and guides treatment. What Creatinine Is and Where It Comes From Creatinine is the end product of phosphocreatine metabolism. Phosphocreatine is used by muscles for rapid ATP synthesis, and it spontaneously and irreversibly breaks down to creatinine at a rate proportional to muscle mass. This makes creatinine production relatively constant for any given individual. Once formed, creatinine enters the bloodstream and is excreted by the kidneys almost exclusively through glomerular filtration — with minimal tubular reabsorption or secretion (though a small degree of tubular secretion does exist and becomes proportionally larger at low GFR). This near-unidirectional relationship — kidneys filter, blood accumulates — makes creatinine a reliable marker of kidney function. Blood creatinine concentration is inversely proportional to GFR: when kidney function halves, creatinine approximately doubles. The relationship is nonlinear: at normal GFR (90 mL/min/1.73 m²), small changes produce little creatinine rise — the "invisible reserve." But at GFR below 30 mL/min, even a minor decline in filtration sharply elevates creatinine. A kidney function test always includes creatinine as the mandatory primary marker — it is the basis for eGFR calculation. Normal Creatinine Levels by Sex and Age Reference values differ substantially by sex and age: men have higher normal ranges due to greater muscle mass; in older adults, muscle mass declines — and creatinine falls even as kidney function deteriorates. Group Normal creatinine (µmol/L) Normal (mg/dL) --------- Infants under 1 year 18–35 0.2–0.4 Children 1–14 years 27–62 0.3–0.7 Adolescents 14–18 years 44–88 0.5–1.0 Men 18–60 years 62–115 0.7–1.3 Men over 60 years 65–120 0.7–1.4 Women 18–60 years 44–97 0.5–1.1 Women over 60 years 48–100 0.5–1.1 Pregnant women 35–70 0.4–0.8 Unit conversion: µmol/L ÷ 88.4 = mg/dL. Key nuance: an older patient with muscle atrophy may have significantly impaired kidney function with a creatinine of 80 µmol/L — technically "normal" on the lab report. This is one of the main reasons why eGFR calculation is mandatory — the absolute number alone is misleading. During pregnancy, GFR physiologically rises by 40–60%, so creatinine falls. A level of 90 µmol/L — normal outside pregnancy — in the third trimester already signals reduced kidney function. How to Prepare for a Creatinine Blood Test Creatinine is a relatively stable marker, but several factors significantly affect results. - Fasting or draw 3–4 hours after a light meal - Avoid intense physical exercise for 24–48 hours: heavy training — especially resistance exercise — raises creatinine through accelerated phosphocreatine breakdown, with a transient rise of 10–30% - Limit meat intake the day before: cooked meat and bone broth contain preformed creatinine — consuming 250 g of meat can raise levels by 20–30 µmol/L. A plant-based diet the day before is preferable - Disclose medications: metformin, trimethoprim, and cimetidine block tubular secretion and overestimate creatinine without actually reducing GFR - For serial monitoring: same laboratory, same method - Potassium, albumin, electrolytes, and urea are drawn from the same blood sample for a complete kidney function picture Causes of High Creatinine Creatinine elevation — azotemia — is classified as prerenal (reduced kidney blood flow), renal (intrinsic kidney damage), and postrenal (obstruction to urine outflow). Cause Mechanism Characteristic features --------- Dehydration and hypovolemia Reduced renal perfusion → falling GFR Reversible with fluid repletion Acute kidney injury (AKI) Direct tubular/glomerular damage Rapid rise over hours–days; oliguria Chronic kidney disease Progressive nephron loss Gradual rise over months–years Glomerulonephritis Immune-mediated glomerular injury Proteinuria; hematuria Chronic pyelonephritis Renal parenchymal scarring History of recurrent infections Diabetic nephropathy Glomerulosclerosis in diabetes Heavy proteinuria; diabetes Hypertensive nephropathy Glomerular damage from hypertension Long-standing poorly controlled hypertension Obstruction (kidney stones, tumor, prostatic enlargement) Impaired outflow → hydronephrosis Ultrasound: dilated pelvicalyceal system Rhabdomyolysis Direct myoglobin tubulotoxicity Dark urine; very high CK Nephrotoxic drugs Direct tubular injury Aminoglycosides, NSAIDs, contrast agents, calcineurin inhibitors Heart failure Cardiorenal syndrome Low cardiac output → reduced renal perfusion Nephrotoxic medications are among the most frequently underestimated causes of creatinine elevation. NSAIDs (ibuprofen, diclofenac) reduce prostaglandin synthesis that maintains afferent arteriolar vasodilation — in patients with already-reduced kidney function, this can precipitate acute kidney injury. Uric acid frequently rises alongside creatinine in CKD, reflecting the same decline in renal clearance. Causes of Low Creatinine Low creatinine — below the reference lower limit — is less common and almost always reflects reduced muscle mass, the source of creatinine production. Main causes: - Sarcopenia and muscle atrophy — in older adults, after prolonged immobility, in cachexia. Reduced muscle mass decreases creatinine production - Pregnancy — physiological reduction due to increased renal blood flow and hemodilution - Veganism and strict vegetarianism — absence of exogenous dietary creatine from meat produces a modest reduction - Severe liver disease (cirrhosis) — impaired hepatic creatine synthesis (creatinine's precursor) - Myopathies — genetic or acquired muscle diseases with reduced muscle mass An isolated low creatinine in a young person without the above conditions is most often a normal variant with low muscle mass or predominantly plant-based dietary habits. The clinically dangerous scenario: a severely cachectic patient with markedly reduced muscle mass can have a "normal" or even "elevated" creatinine of 100–120 µmol/L — with an actual GFR of 20–25 mL/min. This is the classic trap of "normal" creatinine in severe CKD in cachectic patients. eGFR: Calculation and Stages of Chronic Kidney Disease The estimated glomerular filtration rate (eGFR) is the gold standard for assessing kidney function. It is calculated from the serum creatinine level adjusted for age, sex, and race. CKD-EPI formula (the most accurate in current clinical practice): A complex mathematical equation implemented in all modern laboratory analyzers and online calculators. The result is expressed in mL/min/1.73 m². CKD stages by eGFR (KDIGO classification): Stage eGFR (mL/min/1.73 m²) Description --------- G1 ≥ 90 Normal or high — CKD only if kidney damage markers present G2 60–89 Mildly reduced G3a 45–59 Mildly to moderately reduced G3b 30–44 Moderately to severely reduced G4 15–29 Severely reduced G5 < 15 Kidney failure (dialysis or transplantation) CKD is diagnosed when kidney damage markers persist for 3 months OR when eGFR is persistently < 60 mL/min/1.73 m² regardless of cause. Important: stage G1–G2 means CKD only when additional kidney damage markers are present. Kidney damage markers that define CKD at normal eGFR: - Albuminuria 30 mg/day (or urine albumin-to-creatinine ratio 30 mg/g) - Persistent hematuria without urological explanation - Structural abnormalities on ultrasound (polycystic kidneys, scarring, hydronephrosis) When Creatinine Abnormalities Require Medical Attention Scheduled visit to a GP or nephrologist when: - Any creatinine above the upper reference limit for sex and age on repeat testing - Calculated eGFR < 60 mL/min/1.73 m² — regardless of symptoms; stage G3a and above requires nephrology follow-up - Creatinine rise 26 µmol/L within 48 hours or 50% from baseline within 7 days — acute kidney injury - Starting nephrotoxic medications in a patient with already-reduced kidney function Seek urgent care or call emergency services when: - Rapid creatinine rise combined with oliguria (urine output < 400 mL/day) or anuria - Hyperkalemia ( 6.0 mmol/L) combined with elevated creatinine — arrhythmia risk - Uremic symptoms: nausea, vomiting, confusion, ammonia breath, seizures - Sudden creatinine rise in a transplant recipient — possible rejection This article is for informational purposes only and does not replace professional medical advice. Consult a GP or nephrologist if your creatinine is outside the normal range. https://labreadai.com/en/indicators/d-dimer https://labreadai.com/en/indicators/d-dimer Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) D-dimer marks active clot formation and breakdown. Normal ranges for adults and in pregnancy, causes of elevation, role in excluding PE and DVT, and when to seek care. Indicators article D-dimer is one of the few laboratory markers used primarily to rule out a diagnosis rather than confirm one. A normal D-dimer combined with low clinical probability excludes pulmonary embolism and deep vein thrombosis with more than 99% accuracy — without CT angiography or ultrasound. This is precisely what makes it indispensable in emergency medicine. Let's break down where D-dimer comes from, why it rises, and how to interpret results correctly. What D-Dimer Is and How It Forms D-dimer is a small protein fragment produced when a fibrin clot is broken down. To understand its origin, the coagulation cycle must be understood. When a blood vessel is damaged, the coagulation cascade is activated: thrombin converts fibrinogen into fibrin, fibrin strands form a three-dimensional clot network, which is then stabilized by factor XIII. In parallel, the fibrinolytic system activates — plasmin degrades the fibrin clot to prevent excessive thrombosis. Breakdown of cross-linked (stabilized) fibrin produces characteristic fragments — D-dimers: each molecule contains two "D" domains from two adjacent fibrin molecules connected by cross-links. D-dimer is simultaneously a marker of two processes: thrombosis (no clot = no fibrin = no D-dimer) and fibrinolysis (no clot breakdown = no D-dimer release). An elevated D-dimer therefore signals an active thrombotic process — somewhere in the body, clots are both forming and being dissolved. In deep vein thrombosis and pulmonary embolism, this process reaches clinically significant proportions. This is why D-dimer is the first laboratory test ordered when venous thromboembolism is suspected. Normal D-Dimer Levels D-dimer reference values depend on the assay method and units used — it is one of the least standardized markers in laboratory diagnostics. Standard adult reference range: Units Normal ------ µg/mL FEU (fibrinogen equivalent units) < 0.5 µg/mL ng/mL FEU < 500 ng/mL µg/mL DDU (D-dimer units) < 0.25 µg/mL ng/mL DDU < 250 ng/mL Important: FEU = 2 × DDU. Different laboratories use different units, and the same value of 500 ng/mL may be normal in one unit system and pathological in another. Always compare against the reference range printed on your specific laboratory report. Age-adjusted threshold (for patients 50 years): Clinical practice uses the formula age × 10 ng/mL (FEU). For a 70-year-old patient, the PE exclusion threshold rises to 700 ng/mL instead of the standard 500 ng/mL. This increases specificity without sacrificing sensitivity in older patients. During pregnancy, D-dimer physiologically rises trimester by trimester: Trimester Approximate normal range (ng/mL FEU) ------ 1st trimester < 700–800 2nd trimester < 1000–1200 3rd trimester < 1500–2000 Pregnancy is a critical interpretive challenge: physiological elevation renders the standard 500 ng/mL threshold essentially meaningless. When PE is suspected in a pregnant patient, trimester-specific thresholds or supplementary imaging are used. How to Prepare for a D-Dimer Blood Test D-dimer is measured in citrate plasma (blue-top sodium citrate tube). No special preparation is required, but several factors influence results. - No fasting required — the test can be drawn at any time - Immediate laboratory delivery: citrate plasma is unstable at room temperature beyond 2–4 hours - Correct tube fill: under-filling the citrate tube alters the anticoagulant-to-blood ratio and distorts results - Disclose anticoagulant therapy (warfarin, heparin, DOACs) — these reduce D-dimer by suppressing clot formation - A coagulation panel is ordered concurrently when a thrombotic event is suspected — for complete hemostatic assessment - D-dimer is not a routine screening test: it is ordered for specific clinical indications, not preventively Causes of Elevated D-Dimer Elevated D-dimer is a non-specific finding: it signals active fibrinolysis somewhere in the body but does not indicate its location or cause. Cause Degree of elevation Characteristic features --------- Deep vein thrombosis Moderate–significant Swelling, pain, erythema of limb Pulmonary embolism Significant Dyspnea, pleuritic chest pain, tachycardia DIC syndrome Very high Pancytopenia; simultaneous bleeding + thrombosis Myocardial infarction Moderate ECG changes; elevated troponin Stroke Moderate Neurological deficits Malignancies Moderate–significant Chronic elevation Sepsis and severe infection Significant Systemic infection picture Pregnancy Physiological Rises through trimesters Postoperative period Moderate Expected within first 1–2 weeks Preeclampsia Significant Hypertension; proteinuria; edema Chronic heart failure Mild–moderate Correlates with severity Trauma and fractures Moderate Temporal link to injury Antiphospholipid syndrome Moderate Recurrent thrombosis; pregnancy losses C-reactive protein in thrombotic events rises in parallel — through the inflammatory response to tissue necrosis. In myocardial infarction, D-dimer rises modestly within the first hours while CRP reaches its peak at 24–48 hours. DIC (disseminated intravascular coagulation) is the most dangerous cause of sharply elevated D-dimer: massive systemic coagulation activation with simultaneous thrombosis and bleeding. D-dimer 5000–10,000 ng/mL combined with thrombocytopenia and prolonged PT — diagnostic criteria for DIC. The Primary Role of D-Dimer: Excluding PE and DVT D-dimer is above all an exclusion tool, not a confirmation test. This is its defining characteristic, distinguishing it from most laboratory markers. The clinical logic: When PE or DVT is suspected, the physician first estimates the pre-test clinical probability using validated scoring systems — the Wells Score or the Geneva Score. The result stratifies patients: Low or intermediate clinical probability: - D-dimer < 500 ng/mL (or below the age-adjusted threshold) → PE/DVT excluded with 99% probability → CT angiography is not needed - D-dimer ≥ 500 ng/mL → imaging is required (CT pulmonary angiography for PE; compression ultrasound for DVT) High clinical probability: - D-dimer is not used — proceed directly to imaging regardless of the result This algorithm saves countless patients from unnecessary radiation exposure from CT. But it only works when applied correctly — only in patients with low or intermediate pre-test probability. What D-dimer does NOT do: - Does not identify the location of a clot - Does not confirm PE when elevated (specificity is only 40–50%) - Is not used to monitor anticoagulant treatment - Is not a screening test in asymptomatic patients False Results: When D-Dimer Misleads Falsely elevated D-dimer (elevated result, but no thrombosis): - Pregnancy — physiologically high in all pregnant women - Older age — chronic mild elevation without thrombosis occurs in 50% of people over 80 - Any inflammation, infection, or malignancy - Postoperative and post-trauma periods - Liver disease — impaired clearance of fibrin degradation products - Rheumatological conditions (SLE, rheumatoid arthritis) This is precisely why a positive (high) D-dimer alone is not a diagnosis of thrombosis. Falsely normal D-dimer (thrombosis present but D-dimer is normal): - Very early-stage thrombosis (< 6–8 hours from onset) — fibrinolysis not yet significantly activated - Small isolated clot (e.g., small distal DVT) - Anticoagulant therapy already started — reduces D-dimer generation - Chronic thrombosis without active fibrinolysis A normal D-dimer in the setting of high clinical probability for PE is not grounds for excluding the diagnosis — imaging is still required. When D-Dimer Requires Medical Attention D-dimer is never interpreted in isolation — only in clinical context alongside symptoms and pre-test probability. Call emergency services immediately if D-dimer is elevated combined with: - Sudden breathlessness, chest pain, or hemoptysis — possible PE - Swelling, pain, and redness of one leg — possible DVT - Neurological symptoms or altered consciousness — possible stroke - Simultaneous bleeding and thrombosis — possible DIC Scheduled investigation for moderately elevated D-dimer without acute symptoms: - Oncological workup for persistently elevated D-dimer without an identifiable cause - Antiphospholipid syndrome testing for recurrent thromboses - Hemostatic system assessment when D-dimer is repeatedly elevated After successful thrombosis treatment, a persistently elevated D-dimer at 3–6 months is an independent recurrence risk factor. When deciding whether to discontinue anticoagulation after a first unprovoked VTE, D-dimer measured one month after stopping therapy is incorporated into decision algorithms. This article is for informational purposes only and does not replace professional medical advice. Seek immediate medical care if symptoms of thrombosis or pulmonary embolism are present. https://labreadai.com/en/indicators/esr https://labreadai.com/en/indicators/esr Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal ESR for men, women and during pregnancy. Causes of elevated ESR — infections, autoimmune diseases, anemia. How to read ESR with CBC and when to see a doctor. Indicators article In a complete blood count, ESR stands apart: it's the only value that doesn't count cells or measure proteins. It simply watches how fast red blood cells settle. And that simplicity makes it both useful and tricky — ESR responds to almost everything but points to nothing precisely. Here's what this value means, how to read it correctly, and when elevated ESR actually requires action. What Is ESR and How Is It Measured ESR (erythrocyte sedimentation rate) measures how quickly red blood cells settle to the bottom of a test tube in one hour. Normally they settle slowly — they carry a negative charge and repel each other. During inflammation, acute-phase proteins accumulate in the blood: fibrinogen, immunoglobulins, C-reactive protein. They neutralize the cells' charge, causing them to clump into "coin stacks" and settle faster. The standard method is Westergren (international standard). The result is expressed in mm/h. No strict fasting is required, but the test is best done in the morning under standard conditions — no intense exercise or acute stress the day before. Normal ESR in Adults Group Normal (mm/h) ------ Men under 50 up to 15 Men over 50 up to 20 Women under 50 up to 20 Women over 50 up to 30 Pregnant (3rd trimester) up to 45 Normal ESR values rise with age — this is physiological. In pregnancy, ESR is elevated due to changes in blood protein composition and the physiological rise in fibrinogen — this is normal and requires no investigation. Causes of Elevated ESR ESR responds to any change in blood protein composition without pointing to a specific cause. This makes it sensitive but non-specific. Infections Bacterial infections (pneumonia, pyelonephritis, tuberculosis, endocarditis) raise ESR significantly and quickly — often above 40–60 mm/h. Viral infections produce a moderate response or leave ESR normal. High ESR combined with elevated WBC and a left shift is the classic picture of acute bacterial infection. Autoimmune and rheumatic diseases Rheumatoid arthritis, systemic lupus erythematosus, systemic vasculitis, polymyalgia rheumatica — ESR can be persistently high (60–100+ mm/h). Here ESR is used to track disease activity and treatment response. Anemia When hemoglobin is low, fewer red blood cells are present to slow sedimentation through their charge. ESR rises mechanically, without any connection to inflammation. Important to remember: high ESR in the setting of anemia is not a reason to look for hidden inflammation. Malignancies Especially multiple myeloma and lymphomas — ESR can exceed 100 mm/h. But ESR is not a tumor marker: many cancers have no effect on it. Unexplained elevated ESR is one signal to consider a malignancy workup — not more. Physiological causes Menstruation, pregnancy, the first 2–4 weeks after surgery, older age. A mild elevation (up to 30–35 mm/h) in middle-aged women often has no pathological explanation. Causes of Low ESR A drop below 2 mm/h is rare. Seen in polycythemia (excess red cells slow sedimentation), sickle cell anemia (altered cell shape prevents clumping), and severe dehydration. How to Correctly Interpret ESR The cardinal rule: ESR is never interpreted in isolation. It must always be read alongside the rest of the CBC and the clinical picture. Normal ESR does not mean "all clear." ESR stays normal at the start of many infections, in most viral diseases, in some cancers, and in most surgical conditions. Elevated ESR does not make a diagnosis. The same value can be physiological in a pregnant woman, a consequence of anemia, a sign of infection, or a symptom of autoimmune disease. ESR is a "warning light on the dashboard": it signals that something is happening. What to investigate next depends on symptoms, medical history, and other test results. When to Seek Medical Evaluation - ESR above 40 mm/h with no obvious cause → full CBC, GP consultation - ESR above 80 mm/h → urgent evaluation: severe infection, autoimmune disease, malignancy must be ruled out - ESR persistently elevated across two or three tests with a normal CBC → expanded workup, possibly a rheumatologist or oncologist - Normal ESR but worsening symptoms → ESR doesn't rule out disease, further investigation needed Conclusion ESR is one of the oldest laboratory tests — over a century in use. Its strength is sensitivity: it responds to inflammation quickly and reliably. Its weakness is non-specificity: the same value can reflect dozens of different conditions. Using ESR correctly means not asking "what does this mean?" but rather "what should I check next?" ESR is not a diagnosis. It's a starting point for further investigation. What to investigate is determined by a doctor based on symptoms and the full clinical picture. https://labreadai.com/en/indicators/estradiol https://labreadai.com/en/indicators/estradiol Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Estradiol in blood: normal ranges by cycle phase, pregnancy and menopause. Causes of high and low levels, links to FSH and LH, and when to see a doctor. Indicators article Estradiol — the most biologically active of the three estrogens — governs female reproductive function, bone density, vascular health, and neurological wellbeing, while in men it supports bone integrity and normal lipid metabolism. Its concentration varies 10 to 20-fold across the menstrual cycle, pregnancy, and menopause — which is precisely why "normal estradiol" without context is meaningless. Let's break down what it does, why it deviates from normal, and how to correctly read results. What Estradiol Is and What It Does Estradiol (E2) is a steroid hormone synthesized from cholesterol via testosterone through the action of the aromatase enzyme. In women of reproductive age, the primary source is granulosa cells of ovarian follicles. In men and postmenopausal women, the source is peripheral aromatization of testosterone in adipose tissue, liver, and adrenal glands. Functions of estradiol in women: - Reproductive system — development of secondary sex characteristics, regulation of the menstrual cycle, preparation of the endometrium for implantation, follicle growth stimulation - Bone tissue — suppression of osteoclast-mediated resorption; estradiol deficiency in menopause is the primary driver of postmenopausal osteoporosis - Cardiovascular system — estradiol lowers LDL, raises HDL, and exerts vasodilatory effects; this is why premenopausal women have lower cardiovascular risk than age-matched men - Nervous system — neuroprotective effects; influence on mood, memory, and cognitive function; estradiol fluctuations are linked to premenstrual syndrome - Skin and mucous membranes — maintains moisture and elasticity In men, estradiol is required for normal spermatogenesis, bone density maintenance, and cognitive function — but at substantially lower concentrations. The full breakdown of physiology and clinical effects is in the article estradiol: what this hormone is and why it matters. Normal Estradiol Levels Estradiol reference values are the most variable of all sex hormones — fluctuating 10–20-fold within a single menstrual cycle. In women of reproductive age — by cycle phase: Cycle phase E2 normal range (pg/mL / pmol/L) ------ Early follicular (days 1–5) 20–150 pg/mL / 73–550 pmol/L Late follicular (days 6–13) 60–400 pg/mL / 220–1468 pmol/L Pre-ovulatory peak (days 12–14) 150–700 pg/mL / 551–2569 pmol/L Luteal phase (days 15–28) 30–250 pg/mL / 110–918 pmol/L Special physiological states: State E2 normal range ------ Pregnancy — 1st trimester 200–3500 pg/mL Pregnancy — 2nd trimester 1000–12,000 pg/mL Pregnancy — 3rd trimester 5000–25,000 pg/mL Perimenopause 10–150 pg/mL (highly variable) Postmenopause < 10–20 pg/mL Men 18–50 years 10–40 pg/mL / 37–147 pmol/L Men over 50 years 10–50 pg/mL Unit conversion: pg/mL × 3.671 = pmol/L. Critical point: when interpreting a result, the cycle day and phase must always be documented — without this information, comparing to reference ranges is meaningless. A value that appears "elevated" in early follicular phase may be entirely physiological at mid-cycle. How to Prepare for an Estradiol Blood Test Preparation for estradiol testing is more demanding than most hormones — because of pronounced intra-cycle variability. - Cycle day is decisive. The standard for baseline assessment is days 2–5 of the menstrual cycle (early follicular phase, when levels are at their lowest and most stable). For ovulation monitoring — follow the clinical protocol - Morning draw, fasting or 3–4 hours after a light meal - Avoid intense physical exercise for 24 hours beforehand - No alcohol for 48 hours - For IVF or ovarian stimulation monitoring — strictly follow the protocol; timing of the draw is critical - Disclose hormonal contraceptives, HRT, clomiphene, or GnRH antagonists — all directly affect E2 levels - Acute illness and stress cause transient fluctuations — repeat under baseline conditions if needed Estradiol is always interpreted alongside FSH, LH, prolactin, and the clinical picture. An isolated result without hormonal context rarely enables a diagnosis. Causes of High Estradiol (Hyperestrogenism) Estradiol elevation is a relatively common finding with fundamentally different causes in women and men. In women: Cause Mechanism Characteristic features --------- Polycystic ovary syndrome (PCOS) Chronic anovulation; no progesterone counterbalance Irregular cycle; hyperandrogenism Ovarian follicular cysts Autonomous E2 production by unreleased mature follicle Pelvic pain; missed period Endometriosis Local aromatization within endometriotic lesions Pelvic pain; dysmenorrhea Obesity Peripheral androgen aromatization in adipose tissue High BMI; insulin resistance Hormone-producing ovarian tumors (granulosa cell) Autonomous E2 hypersecretion Often — postmenopausal uterine bleeding Liver cirrhosis Impaired estrogen metabolism Gynecomastia in men; spider angiomas Exogenous estrogens (HRT, COC) Direct hormone administration Clear temporal link to drug use Hypothyroidism Elevated SHBG → relative hyperestrogenism Elevated TSH In men: Estradiol excess in men manifests as gynecomastia, reduced libido, erectile dysfunction, and suppressed spermatogenesis. Main causes: obesity (testosterone aromatization in adipose tissue), liver cirrhosis, anabolic steroid use, and feminizing testicular tumors. Chronically elevated cortisol from stress suppresses sex hormone synthesis but can produce relative hyperestrogenism through a feedback mechanism with simultaneous progesterone deficiency — particularly during perimenopause. Causes of Low Estradiol (Hypoestrogenism) Low estradiol in women of reproductive age is a serious signal of hypothalamic-pituitary-ovarian axis disruption. Cause Mechanism Characteristic features --------- Natural menopause Depletion of ovarian follicular reserve Age 45–50; elevated FSH Premature ovarian insufficiency (POI) Follicular reserve depletion before age 40 Amenorrhea; elevated FSH before age 40 Hypothalamic amenorrhea Reduced pulsatile GnRH secretion Stress; low body weight; excessive training Hyperprolactinemia Prolactin suppresses GnRH → ↓ LH/FSH → ↓ E2 Galactorrhea; cycle disruption Turner syndrome Congenital absence of functional ovaries Primary amenorrhea; karyotype 45,X Anorexia and cachexia Nutritional deficit → hypothalamic suppression BMI < 18.5 Sheehan's syndrome Pituitary necrosis after postpartum hemorrhage Agalactia; secondary amenorrhea Surgical menopause Bilateral oophorectomy Acute E2 drop after surgery Hypoestrogenism in women of any age carries significant long-term risks: osteoporosis (up to 3–5% annual bone density loss in early menopause), cardiovascular disease, urogenital atrophy, and cognitive decline. Estradiol in the Context of the Sex Hormone System Estradiol cannot be interpreted in isolation — it must be analyzed alongside FSH, LH, progesterone, and testosterone. Estradiol and FSH: the key diagnostic pair. When estradiol falls, the pituitary compensates by raising FSH — the classic pattern of declining ovarian reserve and menopause. A combination of low E2 + elevated FSH ( 25–40 IU/L) in the early follicular phase is the diagnostic criterion for reduced ovarian reserve or menopause. Isolated high E2 with suppressed FSH — possible hormone-producing tumor. Estradiol and LH: the pre-ovulatory surge. The sharp rise in estradiol just before ovulation triggers the LH surge, which initiates egg release. Monitoring both hormones is used in natural conception planning and IVF protocols. Estradiol and testosterone in men. A fraction of testosterone is normally aromatized to estradiol — this is physiologically necessary. The optimal T/E2 ratio supports fertility, bone density, and cognitive function. In obesity, this balance is disrupted: excessive aromatization lowers testosterone and raises estradiol — the classic pattern in men with metabolic syndrome. Estradiol and the thyroid. Hypothyroidism raises SHBG (sex hormone-binding globulin), altering the ratio of free to total estradiol. Normalizing TSH frequently improves sex hormone balance in parallel. When Estradiol Abnormalities Require Medical Attention Scheduled visit to a gynecologist or endocrinologist when: - Any menstrual cycle disturbance (irregularity, amenorrhea, menorrhagia) — mandatory E2 + FSH + LH panel - Infertility — ovarian reserve assessment; E2 60–80 pg/mL in the early follicular phase indicates reduced reserve - Climacteric symptoms before age 40 — rule out premature ovarian insufficiency - Gynecomastia in a man of any age — assess testosterone/estradiol ratio - Persistent hyperestrogenism without obesity or medication use — rule out hormone-producing tumor Seek urgent care when: - Amenorrhea for more than 3 months in a woman of reproductive age - Severe hot flashes, sleep disruption, and mucosal dryness in a woman under 40 — possible POI - Marked hyperestrogenism with postmenopausal uterine bleeding — rule out malignancy This article is for informational purposes only and does not replace professional medical advice. Consult a reproductive endocrinologist or endocrinologist if your estradiol level is abnormal. https://labreadai.com/en/indicators/ferritin https://labreadai.com/en/indicators/ferritin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Ferritin marks iron stores in the body. Normal ranges for men, women and children, causes of high and low levels, link to inflammation and when to seek care. Indicators article Ferritin is more than just an "iron test." It is a storage protein that reflects true iron reserves in the body far more accurately than serum iron itself. Serum iron can be normal even when reserves are completely depleted, while ferritin will reveal the deficiency weeks before anemia develops. This is precisely why ferritin is the first test ordered when iron deficiency is suspected and an essential component of a full iron status panel. What Ferritin Is and What Role It Plays Ferritin is an intracellular iron-storage protein: each ferritin molecule can hold up to 4,500 iron atoms in a non-toxic, biologically available form. It is present in virtually all cells but is most concentrated in hepatocytes, bone marrow macrophages, and reticuloendothelial cells. In serum, ferritin circulates in small amounts — it "leaks" from cells in proportion to their iron content. This is why serum ferritin correlates with total body iron stores: 1 µg/L of serum ferritin ≈ 8–10 mg of stored iron. Functions of ferritin: - Iron storage — protects cells from toxic free iron (Fe²⁺), which generates reactive oxygen species via the Fenton reaction - Erythropoiesis regulation — iron deficiency impairs hemoglobin synthesis and red cell production - Acute phase protein — during inflammation, ferritin synthesis rises sharply regardless of iron stores; this is critically important for interpreting elevated results A detailed clinical guide to interpreting ferritin across different clinical situations is available in ferritin: how to read your blood test. Normal Ferritin Levels Reference values depend substantially on sex and age. Women have significantly lower iron stores due to menstrual losses. Group Normal ferritin (µg/L / ng/mL) ------ Newborns 25–200 Infants 1–5 months 50–200 Children 6 months – 15 years 7–140 Men 18–45 years 20–250 Men 45–65 years 20–300 Women 18–45 years (premenopausal) 10–120 Women postmenopause 20–200 Pregnant (1st trimester) 10–90 Pregnant (3rd trimester) 5–50 Clinically relevant thresholds: Ferritin level (µg/L) Interpretation ------ < 12–15 Absolute iron deficiency 12–30 Depleted stores (pre-latent deficiency) 30–100 Normal (lower range) 100–300 Normal (mid to upper range) 300 (F) / 400 (M) Elevated — possible excess or inflammation 1000 Significant elevation — active diagnostic workup required Key nuance: in patients with chronic inflammatory disease, a "normal" ferritin of 50–100 µg/L may conceal genuine iron deficiency — inflammation raises ferritin independently of iron stores. In the presence of active inflammation, ferritin < 30–50 µg/L is the diagnostically meaningful threshold for iron deficiency. How to Prepare for a Ferritin Blood Test Ferritin is a relatively stable marker, but several factors influence the result. - Fasting for at least 8 hours is recommended — food has little direct effect on ferritin, but fasting is required when the full iron panel (including serum iron) is ordered simultaneously - Stop iron supplements 5–7 days before the test — iron-containing medications transiently elevate ferritin - Acute illness, infection, or active inflammation significantly raise ferritin as an acute phase protein — defer testing 6–8 weeks after resolution or interpret alongside CRP - For serial monitoring: same laboratory each time - Blood transfusion in the preceding 2–4 weeks distorts the result Ferritin is always interpreted alongside other iron status markers: serum iron, TIBC (transferrin), transferrin saturation, and when needed — soluble transferrin receptor (sTfR). Causes of Low Ferritin Low ferritin is the most reliable marker of depleted iron stores. There are virtually no other causes of sub-normal ferritin. Cause Mechanism Characteristic features --------- Chronic blood loss (menstruation, GI bleeding) Iron losses exceed intake Most common cause in women Inadequate dietary iron intake Insufficient substrate for storage synthesis Vegetarian and vegan diets; restrictive eating Impaired iron absorption Reduced duodenal absorption Celiac disease, Crohn's disease, gastrectomy Pregnancy and lactation Increased iron demand Physiological fall in 3rd trimester Chronic iron deficiency anemia Sustained deficiency with inadequate treatment Low hemoglobin + low ferritin Intense physical training "Footstrike" hemolysis, myoglobinuria, sweat losses Endurance athletes Regular blood donation Direct iron loss with each donation Frequent donors In iron deficiency anemia, ferritin falls first — well before hemoglobin drops. The sequence of iron depletion: ferritin ↓ → transferrin saturation ↓ → MCHC ↓ → hemoglobin ↓. Ferritin is the only marker that catches iron deficiency before anemia develops. Symptoms of iron depletion without anemia ("pre-latent deficiency"): chronic fatigue, difficulty concentrating, hair loss, restless legs syndrome, reduced exercise capacity. Many patients live for years with ferritin of 8–15 µg/L and normal hemoglobin, unable to explain why they feel chronically unwell. Causes of High Ferritin (Hyperferritinemia) Elevated ferritin is one of the most common "puzzling" biochemical findings: it can reflect iron accumulation, systemic inflammation, or serious disease. Cause Ferritin level Characteristic features --------- Inflammation and infection Moderate (100–500 µg/L) Elevated CRP; acute illness signs Non-alcoholic fatty liver disease Moderate–significant Obesity; elevated ALT; insulin resistance Alcoholic liver disease Moderate–significant AST/ALT 2; elevated GGT Hereditary hemochromatosis Significant ( 500–1000 µg/L) Transferrin saturation 45%; HFE mutation Malignancies Variable, often 1000 µg/L Often unrelated to actual iron stores Hemophagocytic lymphohistiocytosis (HLH) Very high ( 10,000 µg/L) Pancytopenia; fever; splenomegaly Multiple blood transfusions Significant Transfusional iron overload Chronic kidney disease Moderate Parallel erythropoiesis impairment Metabolic syndrome Mild–moderate Obesity; high TG; hypertension Hyperthyroidism Mild Falls with TSH normalization Hereditary hemochromatosis is the most important cause of significantly elevated ferritin that must not be missed. Iron accumulation in the liver, pancreas, heart, and joints — if untreated — leads to cirrhosis, diabetes, cardiomyopathy, and arthropathy. Screening marker: transferrin saturation 45% combined with ferritin 300–400 µg/L. Confirmed by genetic testing for the C282Y mutation in the HFE gene. HLH (hemophagocytic lymphohistiocytosis) — a life-threatening condition: ferritin rises to 10,000–100,000 µg/L and is a diagnostic criterion. Every clinician should recognize this threshold. Ferritin as an Iron Marker vs. an Inflammation Marker The central diagnostic challenge with ferritin is that it simultaneously reflects two entirely different things: iron stores and the inflammatory response. This makes interpretation non-trivial. In health: ferritin reflects iron stores — low = deficiency; high = excess. In inflammation, infection, or malignancy: ferritin synthesis in the liver and macrophages is sharply upregulated as an acute phase response — independent of actual iron stores. This masks true iron deficiency: Classic diagnostic trap: a patient with rheumatoid arthritis has ferritin of 80 µg/L — seemingly normal. But if CRP is 40 mg/L, the ferritin in the absence of inflammation would be around 15–20 µg/L — indicating significant iron deficiency. This is why ferritin must always be interpreted alongside CRP and the soluble transferrin receptor (sTfR) — the latter rises in iron deficiency and does not respond to inflammation. Practical decision framework: - Low ferritin + normal CRP → absolute iron deficiency; treat - Normal/high ferritin + high CRP → possible occult deficiency; check sTfR - High ferritin + normal CRP → iron overload or storage disease When Ferritin Abnormalities Require Medical Attention Scheduled visit to a doctor when: - Ferritin < 20–30 µg/L — especially in women and with symptoms (fatigue, hair loss, exercise intolerance) — prescribe iron supplementation and investigate the cause - Ferritin 300 µg/L (women) or 400 µg/L (men) without an obvious inflammatory condition — rule out hemochromatosis and liver disease - Ferritin 1000 µg/L — regardless of symptoms — active diagnostic workup required Seek urgent care when: - Ferritin 5000–10,000 µg/L — rule out HLH and hematological malignancies - Low ferritin combined with severe anemia (hemoglobin < 90 g/L) - Rapidly rising ferritin in a patient with known disease — possible decompensation or malignant transformation This article is for informational purposes only and does not replace professional medical advice. Consult a GP or hematologist if your ferritin level is outside the normal range. https://labreadai.com/en/indicators/ggt https://labreadai.com/en/indicators/ggt Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) GGT: normal ranges by sex and age, causes of elevation including alcohol and medications, how it relates to ALT and ALP, and when elevated results need medical investigation. Indicators article GGT rarely gets much attention on a routine panel — it tends to be noticed when other liver markers are also abnormal, or when a patient is puzzled by an unexpected elevation. Yet gamma-glutamyltransferase is one of the most sensitive — and least specific — hepatic markers: it reacts to virtually everything affecting the liver and biliary tract, as well as to alcohol, dozens of medications, and even obesity. Context is the key to correct interpretation. What GGT Is and Where It Is Found GGT (gamma-glutamyltransferase, gamma-GT) is an enzyme involved in glutathione metabolism and amino acid transport across cell membranes. It is present in many organs, but diagnostically relevant concentrations are found primarily in biliary epithelial cells (the lining of the bile ducts), hepatocytes, and renal tubular epithelium. Under normal conditions, only trace amounts of GGT enter the blood. Elevation occurs in two distinct ways: cell damage with enzyme leakage, and enzyme induction — an increase in synthesis without cell destruction. This distinction is fundamental. Alcohol, many medications, and cholestasis raise GGT through induction: the cells are intact but produce substantially more enzyme. This is why an elevated GGT does not always indicate cell death. The key biological role of GGT in biliary epithelial cells is participation in glutathione synthesis — the cell's principal intracellular antioxidant. With any cholestasis — impaired bile flow — biliary cells upregulate GGT expression in response to accumulating bile acids. This makes it the most sensitive biochemical marker of cholestasis, detecting it earlier than even bilirubin. Normal GGT Levels by Sex and Age Reference values for GGT depend substantially on sex: male thresholds are approximately 1.5–2 times higher than female. This reflects greater liver and biliary epithelial mass, higher microsomal enzyme activity, and differences in hormonal milieu. Group Normal GGT (U/L) ------ Newborns (under 1 month) 13–147 Infants 1–12 months 12–123 Children 1–3 years 5–18 Children 3–6 years 10–22 Children 6–12 years 11–22 Male adolescents 12–17 years 15–45 Female adolescents 12–17 years 10–30 Men 18–60 years 10–71 Men over 60 years 12–75 Women 18–45 years 6–42 Women over 45 years 8–55 Key nuances: In newborns, GGT is physiologically high during the first weeks of life — far above the adult range. This reflects immature hepatobiliary development and requires no intervention. During pregnancy, GGT often falls in the first and second trimesters due to hemodilution, then rises modestly in the third trimester. Elevation above the normal range in pregnancy is an early marker of intrahepatic cholestasis of pregnancy. Obesity and metabolic syndrome independently raise GGT — even without alcohol and without overt liver disease — through the mechanism of non-alcoholic steatohepatitis. How to Prepare for a GGT Blood Test GGT is measured in serum as part of a comprehensive liver function panel. Specific preparation is minimal, but several factors critically influence the result. - Fasting for at least 8–12 hours — fatty meals activate bile secretion and transiently elevate GGT - Complete abstinence from alcohol for 72 hours — an absolute requirement. Even a moderate dose the night before raises GGT by 20–50%; with regular consumption, the increase is several-fold. Without this condition, the result has no diagnostic value - Disclose all medications: more than 50 drug classes elevate GGT through microsomal enzyme induction - For serial monitoring: test at the same time of day in the same laboratory - Moderate physical exercise has some influence — avoid intense training for 24 hours before the draw When GGT is first found elevated: repeat after 4–6 weeks of complete alcohol abstinence and, if feasible, discontinuation of suspected medications. This separates induced elevation from organic pathology. Causes of Elevated GGT GGT is the most sensitive marker of hepatobiliary disease in the standard biochemical panel. But that sensitivity comes at the cost of specificity: the list of causes is broad. Cause Degree of elevation Characteristic features --------- Alcoholic liver disease Moderate–significant (2–20× ULN) AST/ALT 2; elevated MCV Non-alcoholic fatty liver disease (NAFLD) Mild–moderate Obesity, insulin resistance Viral hepatitis Moderate Elevated ALT/AST; positive viral markers Cholestasis (any cause) Significant Elevated ALP, bilirubin, itch Gallstones / choledocholithiasis Moderate–significant Right upper quadrant pain Liver, bile duct, or pancreatic cancer Significant Progressive jaundice, weight loss Drug-induced hepatitis Mild–significant Clear link to drug initiation Liver cirrhosis Variable Reduced albumin, thrombocytopenia Congestive heart failure Moderate Hepatomegaly, edema Type 2 diabetes mellitus Mild–moderate Obesity, insulin resistance Hyperthyroidism Mild Concurrent thyroid symptoms Chronic kidney disease Mild Parallel creatinine elevation Drug-induced GGT elevation deserves special attention. The most frequent enzyme-inducing agents: anticonvulsants (phenytoin, carbamazepine, phenobarbital), statins, antibiotics (rifampicin, isoniazid, amoxicillin/clavulanate), oral contraceptives, antipsychotics, anticoagulants (warfarin), anabolic steroids. Drug-induced GGT elevation is isolated or accompanied by modest alkaline phosphatase elevation, while ALT and AST remain normal or only minimally elevated. Mild isolated GGT elevation (up to 2× ULN) with normal ALT, AST, ALP, and bilirubin in a patient taking medications or carrying excess weight is not always pathological. But it is not a result to ignore: the first priority is to exclude alcohol and drug induction, and then — if the elevation persists — to investigate for an organic cause. GGT as a Marker of Alcohol-Related Liver Damage Among all routine laboratory tests, GGT is the most sensitive marker of chronic alcohol misuse. It is elevated in 70–80% of people with alcohol-related liver damage — well before symptoms appear and often before ALT and AST change. The mechanism is dual: alcohol simultaneously induces GGT synthesis in hepatocytes (via cytochrome P450 2E1) and causes direct toxic injury to biliary epithelial cells. Characteristic patterns in alcohol-related liver disease: - Isolated elevated GGT with normal ALT and AST — early stage or moderate consumption - Markedly elevated GGT + AST/ALT ratio 2 (de Ritis ratio 2) — alcoholic hepatitis - Elevated GGT + elevated MCV (macrocytosis on ALT blood test panel CBC) — a highly specific combination for chronic heavy alcohol use GGT dynamics during alcohol abstinence: the half-life of GGT elevation is approximately 14–26 days. With complete abstinence, levels begin falling within 1–2 weeks and normalize within 4–8 weeks. This kinetics makes GGT a useful objective measure of abstinence compliance — relevant when monitoring alcohol use disorder treatment. Important: a normal GGT does not exclude alcoholism — in patients with high alcohol tolerance, the enzyme may remain within range even with substantial intake. GGT, ALT, AST and ALP: Differential Diagnosis GGT is always interpreted alongside other liver markers — primarily alkaline phosphatase (ALP) and the transaminases. The combination of findings points to the mechanism of injury. Pattern GGT ALT/AST ALP Most likely cause --------------- Hepatocellular ↑ moderate ↑↑↑ Normal/↑ Viral hepatitis, toxic injury Cholestatic ↑↑ Normal/↑ ↑↑↑ Biliary obstruction, PBC Alcoholic ↑↑ ↑ (AST ALT) ↑ Alcoholic hepatitis / steatohepatitis Drug-induced ↑ Normal/↑ Normal/↑ Enzyme induction Infiltrative ↑ Normal ↑↑ (ALP GGT) Metastases, granulomatosis Isolated ↑ ALP + normal GGT Normal Normal ↑↑ Bone pathology (bone ALP isoenzyme) The last row is critically important: when ALP is elevated but GGT is normal, the ALP elevation is of bone origin — Paget's disease, osteomalacia, bone metastases, or active skeletal growth in children — not hepatic. GGT therefore serves as the "separator" between bone and hepatic ALP — without it, an isolated ALP elevation cannot be interpreted. A parallel elevation in GGT and CRP with normal ALT/AST may reflect systemic inflammation involving the biliary tract or early-stage inflammatory liver disease. When Elevated GGT Requires Medical Attention Mild GGT elevation (up to 2× ULN) with normal companion liver markers and a clear explanation (medications, moderate alcohol, excess weight) calls for lifestyle correction and follow-up monitoring. Any more substantial elevation or combination with other abnormalities warrants active investigation. Scheduled visit to a GP or gastroenterologist when: - GGT 2× ULN on repeat testing after 4–6 weeks of complete alcohol abstinence - GGT ULN combined with any elevation in ALT, AST, ALP, or bilirubin - Mild isolated GGT elevation without an identifiable cause - Skin itch combined with any GGT elevation — a sign of cholestasis Seek urgent care when: - GGT 5–10× ULN — regardless of symptoms - Jaundice combined with significantly elevated GGT - Right upper quadrant pain, fever, and jaundice — Charcot's triad of cholangitis - Rapidly rising GGT in a patient with known liver disease — possible decompensation or malignant transformation This article is for informational purposes only and does not replace professional medical advice. Consult a GP or gastroenterologist if your GGT is elevated. https://labreadai.com/en/indicators/glucose https://labreadai.com/en/indicators/glucose Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal fasting and postprandial blood glucose in adults. Causes of high and low blood sugar, how to prepare for the test, and when to see a doctor. Indicators article You got a blood test and see a number next to "GLU" — or your doctor mentioned "prediabetes" for the first time. Blood glucose is one of the most important health indicators, and understanding it matters to everyone, not just people with diabetes. Here's what normal looks like, what abnormal values mean, and how to prepare for the test so the result is actually reliable. What Is Blood Glucose and Why Is It Measured Glucose is the primary fuel for every cell in the body. The brain, muscles, and heart all run on glucose. It enters from food, is absorbed in the intestines, and distributed to tissues with the help of insulin — a hormone produced by the pancreas. Insulin acts like a key: it unlocks cells so glucose can enter. When this mechanism breaks down, glucose accumulates in the blood. Chronically elevated glucose damages blood vessels, kidneys, nerves, and vision. That's why a blood glucose test is a standard part of any preventive check-up — ordered alongside a complete blood count and other baseline tests. How to Prepare for the Test Glucose is one of the most unstable blood values. Improper preparation makes the result meaningless. - Strictly fasting, in the morning. At least 8–12 hours without food. Even black coffee or chewing gum can shift the result. - Plain water is allowed — still, not sparkling. - Avoid alcohol and intense exercise for 24 hours beforehand. - Don't test during illness. Any infection temporarily raises glucose — the result will be unreliable. - Tell your doctor about corticosteroids, diuretics, and oral contraceptives — they affect blood sugar levels. If you're having a post-meal test or an oral glucose tolerance test, the conditions are different. Always confirm with your doctor or lab. Normal Blood Glucose Levels in Adults Normal ranges depend on when the blood was drawn — fasting or after eating: Timing Normal Prediabetes Diabetes ------------ Fasting (mmol/L) 3.9–5.5 5.6–6.9 ≥ 7.0 2h after eating (mmol/L) < 7.8 7.8–11.0 ≥ 11.1 Fasting (mg/dL) 70–99 100–125 ≥ 126 2h after eating (mg/dL) < 140 140–199 ≥ 200 Values are for venous plasma — the standard in most modern laboratories. Fingerstick capillary values may differ slightly. Always use the reference range on your specific lab report. One elevated result is not a diagnosis. Diabetes is only diagnosed when glucose is elevated on two separate occasions, or when elevated with characteristic symptoms. High Blood Glucose: Prediabetes and Diabetes Fasting glucose of 5.6–6.9 mmol/L (100–125 mg/dL) is prediabetes — impaired fasting glucose. This doesn't yet cause organ damage, but it's a signal: the regulation mechanism is already under strain. With lifestyle changes — weight loss, physical activity, dietary adjustments — prediabetes is reversible in most people. Fasting glucose ≥ 7.0 mmol/L (≥ 126 mg/dL) on two tests is the diagnostic criterion for type 2 diabetes. This is a chronic condition requiring ongoing management. Other causes of elevated glucose: - Type 1 diabetes (autoimmune destruction of pancreatic beta cells) - Acute stress, severe infection, heart attack — transient reactive hyperglycemia - Corticosteroids, antipsychotics, thiazide diuretics - Pancreatic disease (pancreatitis, pancreatic cancer) - Endocrine disorders (Cushing's syndrome, acromegaly) Symptoms of high blood sugar: thirst and dry mouth, frequent urination, fatigue, blurred vision, slow-healing wounds. In gradual-onset type 2 diabetes, symptoms may be absent for years — which is exactly why screening matters. If glucose is elevated, it's also worth checking a urinalysis: when blood glucose exceeds the renal threshold (10 mmol/L), glucose appears in the urine — an additional diagnostic signal. Low Blood Glucose: Hypoglycemia Glucose below 3.9 mmol/L (70 mg/dL) is hypoglycemia. The brain is particularly sensitive to fuel shortage: when blood sugar drops rapidly, symptoms appear — weakness, trembling, sweating, palpitations, confusion. Main causes: - Insulin overdose or excess blood sugar medication in diabetics - Prolonged fasting or skipped meals - Intense exercise without extra carbohydrate intake - Alcohol on an empty stomach — alcohol blocks hepatic glucose production - Rarely — insulinoma (a pancreatic tumor that secretes excess insulin) Glucose below 2.8 mmol/L (50 mg/dL) can cause loss of consciousness. This is a medical emergency. Glycated Hemoglobin (HbA1c) A single glucose test is a snapshot of one moment. HbA1c reflects the average blood sugar level over the past 2–3 months: glucose binds irreversibly to hemoglobin in red blood cells, and the higher the sugar has been, the greater the percentage of "glycated" cells. HbA1c Interpretation ------ < 5.7% Normal 5.7–6.4% Prediabetes ≥ 6.5% Diabetes 7.0% (in diabetics) Inadequate control HbA1c requires no fasting and is independent of time of day. It's used for both diagnosis and monitoring treatment effectiveness. It is not reliable in hemolytic anemia or certain hemoglobin disorders — in those cases, a glucose test is used instead. When to Seek Urgent Medical Attention - Fasting glucose ≥ 7.0 mmol/L (≥ 126 mg/dL) on two tests - Glucose ≥ 11.1 mmol/L (≥ 200 mg/dL) at any time with symptoms - Glucose < 2.8 mmol/L (< 50 mg/dL) — severe hypoglycemia, call emergency services - Glucose found in a urinalysis for the first time — check blood glucose the same day Routine visit: fasting glucose 5.6–6.9 mmol/L (prediabetes) — consult your GP or endocrinologist, lifestyle changes, retest in 3–6 months. For practical tips on how to lower blood sugar, see our dedicated article. Conclusion Blood glucose is one of the few lab values where even a small deviation deserves attention: prediabetes is reversible, diabetes is not. Annual screening from age 40 — or earlier with risk factors — catches the problem at the stage where it can still be stopped. An elevated glucose result in one test is not a verdict — but it's not something to ignore either. Show the result to your doctor: they'll decide whether further testing is needed. https://labreadai.com/en/indicators/hdl https://labreadai.com/en/indicators/hdl Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) HDL is the anti-atherogenic lipoprotein. Normal ranges for men and women, causes of low and high HDL, its link to LDL and triglycerides, and how to raise it. Indicators article HDL is called "good cholesterol" — and while that is a fair label, the full picture is considerably more nuanced. High-density lipoproteins are not merely harmless compared to LDL: they actively protect arteries by collecting excess cholesterol from vessel walls and transporting it back to the liver. Low HDL is an independent cardiovascular risk factor — separate from LDL levels. Let's break down what makes HDL protective and why a low reading warrants attention. What HDL Is and How Reverse Cholesterol Transport Works HDL (high-density lipoproteins) are the smallest and densest of all lipoproteins. Unlike LDL, which carries cholesterol from the liver to peripheral tissues, HDL operates in the opposite direction: it collects excess cholesterol from peripheral tissues and arterial walls and delivers it back to the liver for processing and biliary excretion. This process is called reverse cholesterol transport and is the primary anti-atherogenic mechanism of HDL. Beyond transport, HDL has several additional protective properties: it inhibits LDL oxidation (reducing the most atherogenic oxidized forms), suppresses endothelial inflammation, participates in fibrinolysis, and exerts antithrombotic effects. HDL's key protein is apolipoprotein A-I (apo-A-I): it initiates cholesterol uptake from cells via the ABCA1 transporter and determines the particle's functional activity. Apo-A-I levels actually predict cardiovascular risk better than HDL concentration — but standard HDL measurement remains the routine clinical tool. HDL is a component of the lipid panel, and its interpretation always proceeds alongside LDL, triglycerides, and total cholesterol. HDL Normal Ranges: Sex Matters Unlike most biochemical markers, HDL reference values differ substantially between men and women: women have on average 0.3–0.5 mmol/L higher HDL than men of the same age. This is one reason why women before menopause carry lower cardiovascular risk at equal LDL levels. Group Optimal HDL Borderline Low (risk factor) ------------ Men 1.4 mmol/L 1.0–1.4 mmol/L < 1.0 mmol/L Women 1.7 mmol/L 1.2–1.7 mmol/L < 1.2 mmol/L Clinically relevant thresholds (ESC/EAS): - < 1.0 mmol/L in men and < 1.2 mmol/L in women — independent cardiovascular risk factor - Very high HDL ( 2.5–3.0 mmol/L) — paradoxically, this can also be associated with increased risk (dysfunctional HDL) With age, HDL in men changes very little, while in women it falls after menopause — parallel to the drop in estrogen, which stimulates apo-A-I synthesis. During pregnancy, HDL physiologically rises in the second trimester and falls toward the third — a normal trajectory requiring no intervention. How to Prepare for an HDL Blood Test HDL is measured in serum as a component of the lipid panel. Preparation requirements are standard across the full lipid profile. - Strictly fasting: at least 12 hours without food. HDL is only modestly affected by eating, but fasting is required for the panel as a whole and for accurate Friedewald LDL calculation - No alcohol for 48–72 hours: alcohol transiently raises HDL — giving a falsely optimistic result - Stable diet for 2–3 weeks: dietary changes (especially adding omega-3s) alter HDL gradually — the result should reflect a typical baseline - Acute illness lowers HDL by 10–30% — best to postpone testing 6–8 weeks after recovery - For serial monitoring: same laboratory under identical conditions HDL is a relatively stable marker — its analytical variability is lower than triglycerides. However, meaningful lifestyle changes require 8–12 weeks to register in test results. Causes of Low HDL Low HDL is far more common and clinically significant than elevated HDL. In most cases, reduction is driven by lifestyle and metabolic disorders — and those are precisely the targets of treatment. Cause Mechanism Characteristic features --------- Metabolic syndrome / insulin resistance Accelerated HDL catabolism; reduced apo-A-I High TG + low HDL + abdominal obesity Type 2 diabetes Glycation of apo-A-I impairs HDL function Diabetic dyslipidemia: TG↑, HDL↓, small dense LDL Physical inactivity Reduced apo-A-I synthesis Persistently low HDL in sedentary individuals Smoking Oxidative HDL damage; reduced apo-A-I synthesis Especially pronounced in men Obesity (abdominal pattern) Enhanced HDL catabolism via VLDL exchange Combined with high TG Trans fat consumption Reduced apo-A-I synthesis; increased CETP activity Chronic margarine and industrial food intake Hypothyroidism Reduced lipoprotein lipase activity Combined with elevated LDL Chronic kidney disease HDL dysfunction; accelerated catabolism Parallel TG elevation Medications Reduced synthesis or enhanced catabolism Beta-blockers, thiazides, progestins, anabolic steroids Genetic causes (hypoalphalipoproteinemia) ABCA1, APOA1, LCAT gene mutations Very low HDL < 0.5 mmol/L The combination of high triglycerides + low HDL — "atherogenic dyslipidemia" — is the hallmark pattern of metabolic syndrome and insulin resistance. These markers are mechanistically linked: VLDL particles (carrying triglycerides) and HDL exchange components in the blood; when VLDL is in excess, HDL becomes enriched with triglycerides, becomes a substrate for lipases, and is rapidly degraded. Causes of High HDL High HDL is traditionally viewed as straightforwardly favorable — and in most cases it is. However, extremely high values warrant attention. Physiological and favorable causes: - Regular physical activity — the most effective way to raise HDL - Moderate alcohol consumption (1–2 units per day) — raises HDL by 5–10% - Female sex before menopause — estrogenic stimulation of apo-A-I synthesis - Genetic variants with high apo-A-I activity Potentially problematic causes of very high HDL ( 2.5–3.0 mmol/L): - CETP gene mutations (cholesteryl ester transfer protein) — HDL is high but dysfunctional: reverse cholesterol transport is impaired - Chronic heavy alcohol use — HDL is elevated but this is a falsely reassuring marker; cardiovascular risk is not reduced - Primary biliary cholangitis — disrupted cholesterol metabolism - Hyperthyroidism — accelerated HDL synthesis and catabolism The paradox of "too-high HDL": several large studies showed a J-shaped association — at HDL 2.5–3.0 mmol/L, cardiovascular event risk and total mortality begin to rise. Proposed mechanism: at extreme HDL concentrations, particles may acquire pro-inflammatory properties. This is an active research area, but clinicians now pay attention to unexplainably elevated HDL. HDL in the Context of the Full Lipid Profile HDL cannot be meaningfully assessed in isolation — its protective role is fully apparent only alongside the other lipid markers. HDL and LDL: atherogenicity index. The most informative integrated risk measure is the LDL/HDL ratio or atherogenicity coefficient = (Total cholesterol − HDL) / HDL. Optimal value < 3.0; high risk at 4.0–5.0. At normal LDL but low HDL, the atherogenicity index remains high — and cardiovascular risk is not mitigated. HDL and triglycerides: the reciprocal link. As explained above, high TG and low HDL are mechanistically linked — they reflect the same pathogenic process. Any intervention that reduces triglycerides (lifestyle, omega-3, fibrates) predictably raises HDL. HDL and atherosclerosis: the causal link between HDL and atherosclerosis is less straightforward than for LDL. Mendelian randomization data show that genetically high HDL does not always reduce heart attack risk. This means that what matters is not just HDL concentration, but HDL functionality — the actual capacity to carry out reverse cholesterol transport. Dysfunctional HDL at normal concentrations may provide no protection. This explains the disappointing results of clinical trials of drugs that simply raised HDL levels without improving their function. How to Raise HDL and When to See a Doctor HDL is one of the most difficult lipid markers to raise pharmacologically. This is precisely why lifestyle modification plays the primary role. Most effective non-pharmacological approaches: Physical activity — the most evidence-backed way to raise HDL. Moderate-to-vigorous aerobic exercise (running, swimming, cycling) for 150 minutes per week raises HDL by 5–15% over 8–12 weeks. Resistance training provides a smaller but meaningful additional effect. Smoking cessation — within weeks of stopping, HDL rises by 5–10%. Weight loss — every 3 kg of fat lost raises HDL by approximately 0.04 mmol/L; a 10–15% weight reduction in obese individuals produces clinically meaningful results. Dietary changes: eliminate trans fats (raising HDL by 3–7%); increase monounsaturated fats (olive oil, avocado); adequate omega-3 intake (modest HDL rise via TG reduction). Moderate alcohol consumption — biochemically raises HDL, but recommending alcohol as a cardioprotective measure is clinically unacceptable given its harm to the liver, brain, cancer risk, and addiction potential. Pharmacological approaches: No existing drug has been shown to reduce cardiovascular risk purely by raising HDL — this is the central conclusion from clinical trials over the past 15 years. Statins modestly raise HDL (by 5–10%), but their cardioprotective effect is primarily attributable to LDL reduction. Fibrates and niacin substantially raise HDL (by 15–35%) and lower TG, but have not reduced cardiovascular mortality in isolated use. Fibrates are prescribed for severe hypertriglyceridemia, not for HDL elevation as a standalone goal. See a doctor when: - HDL < 1.0 mmol/L (men) or < 1.2 mmol/L (women) on repeat testing - Low HDL combined with high triglycerides and any LDL level — full cardiometabolic risk assessment needed - Family history of premature heart attack with unexplainably low HDL — genetic causes should be excluded This article is for informational purposes only and does not replace professional medical advice. Consult a cardiologist or GP if your HDL level is outside the normal range. https://labreadai.com/en/indicators/hematocrit https://labreadai.com/en/indicators/hematocrit Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hematocrit measures the proportion of red blood cells in blood. Normal ranges by sex and age, causes of low and high levels, and when to see a doctor. Indicators article Hematocrit rarely gets its own spotlight — it's usually treated as a shadow of haemoglobin. But it has its own diagnostic niche: it reflects not only the number of red cells but the ratio of cellular mass to plasma volume, which matters when assessing blood viscosity, hydration status, and deciding how to manage anaemia. Here's what hematocrit measures and where it is more informative than haemoglobin alone. What Is Hematocrit and What Does It Measure Hematocrit (Hct) is the percentage (or fraction) of total blood volume occupied by red blood cells. If red cells take up 45% of the volume in a centrifuged blood sample, the hematocrit is 45% (or 0.45). In essence, hematocrit measures how "packed" the blood is with red cells. It depends on two factors simultaneously: red cell count and plasma volume. This is what makes it unique: haemoglobin falls only when red cell numbers or quality decrease, while hematocrit can also change when the liquid component of blood shifts — rising with dehydration or falling with fluid overload. Hematocrit is especially important in two situations: assessing anaemia severity (alongside haemoglobin) and evaluating hydration status (dehydration raises hematocrit and makes blood more viscous — increasing thrombosis risk). It is automatically calculated in a complete blood count. Normal Hematocrit by Sex and Age Hematocrit norms differ significantly by sex — men have physiologically higher values due to testosterone's stimulating effect on erythropoiesis. In pregnancy, hematocrit physiologically falls due to haemodilution: plasma volume expands faster than red cell production. Group Normal Hematocrit (%) ------ Newborns 44–62 Infants 1–12 months 28–42 Children 1–12 years 33–44 Adolescents 12–18 years 35–47 Men 40–52 Women 36–46 Pregnant women 30–40 Reference ranges may vary slightly between laboratories. Always use the values on your specific report. Why Is Hematocrit Low? A low hematocrit almost always reflects a reduced number or quality of red blood cells — that is, anaemia. But an important nuance: hematocrit can be falsely low when body fluid volume is excessive (overhydration), even with a normal red cell count. Anaemia of any cause — the most common reason. Iron-deficiency, B12-deficiency, haemolytic, and aplastic anaemias all reduce red cell number or volume, and hematocrit falls alongside haemoglobin. MCV then helps identify the anaemia type. Pregnancy — physiological hematocrit fall. Plasma volume expands by 40–50% while red cell production increases by only 20–30%, resulting in "diluted" blood with hematocrit around 30–36% despite normal wellbeing. Acute blood loss — in the first hours after haemorrhage, hematocrit and haemoglobin may appear normal (blood hasn't yet been diluted by plasma). After 24–48 hours, as the body replenishes plasma, hematocrit falls — now reflecting true red cell loss. Chronic kidney disease — erythropoietin deficiency reduces red cell production and hematocrit falls gradually. Excessive intravenous fluid administration — haemodilution lowers hematocrit without actual red cell loss. Why Is Hematocrit High? Elevated hematocrit means red cells occupy a disproportionately large share of blood volume — either because their number has increased or because plasma volume has decreased. Dehydration is the most common and reversible cause. With fluid deficit, plasma volume falls, cells "concentrate," and hematocrit rises. Blood becomes viscous — risk of thrombosis, particularly venous, increases substantially. Hematocrit above 55% with clinical signs of dehydration is an urgent situation. High-altitude living — chronic hypoxia stimulates erythropoietin production; the bone marrow produces more red cells — compensatory erythrocytosis. Chronic lung disease (COPD, emphysema) — chronic hypoxia by the same mechanism. Polycythaemia vera — a myeloproliferative disorder in which the bone marrow uncontrollably overproduces red cells. Hematocrit can reach 60–70% or higher. Rare but serious — requires haematology evaluation. Gaisböck syndrome (pseudo-polycythaemia) — elevated hematocrit with normal red cell count due to reduced plasma volume. Seen in obese hypertensive men under stress. Smoking elevates carboxyhaemoglobin, impairing oxygen delivery — compensatory erythrocytosis and moderate hematocrit rise. Hematocrit and Blood Viscosity: The Practical Angle The link between hematocrit and blood viscosity is not merely theoretical. Above 50–55%, viscosity rises exponentially rather than linearly: the blood becomes harder for the heart to pump, microcirculation slows, and the risk of small vessel thrombosis increases sharply. This is why the primary treatment for polycythaemia vera is phlebotomy — removing blood to reduce hematocrit toward target values of 42–45%. And why rehydration in severe dehydration is not just fluid replacement but also thrombosis risk reduction. For complete assessment, hematocrit is always read alongside haemoglobin, red cell count, and MCV in the complete blood count. How to Prepare for the Test Hematocrit is measured in the complete blood count. Standard preparation: fasting draw. Critical point: test in a state of normal hydration — not immediately after intense exercise with fluid losses, not after prolonged fluid restriction. Dehydration will artificially raise hematocrit; excess fluid will lower it, and the result will not reflect the true state. When to See a Doctor Seek immediate medical attention if: - Hematocrit exceeds 55–60% — marked erythrocytosis requires urgent investigation. - High hematocrit is combined with headaches, facial flushing, or skin itching after a hot bath — possible polycythaemia vera. Schedule a routine GP appointment if: - Hematocrit is below 30% in adults — severe anaemia requiring investigation. - Hematocrit is persistently elevated on repeat tests without obvious dehydration or altitude adaptation. Conclusion Hematocrit sits at the intersection of two worlds: red cell count and plasma volume. This is what makes it indispensable when assessing dehydration and blood viscosity — where haemoglobin alone is insufficient. Combined with haemoglobin, red cell count, and MCV, it provides the complete morphological picture of the erythrocyte component of blood. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/hemoglobin https://labreadai.com/en/indicators/hemoglobin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal hemoglobin levels for men, women, and during pregnancy. Causes of low hemoglobin, anemia types, deficiency symptoms, severity grades, and when to see a doctor. Indicators article In a complete blood count, hemoglobin is the first value a doctor looks at. A downward arrow next to "HGB" signals anemia — and anemia always has a cause that needs to be found. Here's what the normal ranges look like for different groups, why hemoglobin drops, and what's behind it — from a simple iron deficiency to more serious conditions. What Is Hemoglobin and What Does It Do Hemoglobin is an iron-containing protein inside red blood cells that carries oxygen from the lungs to every cell in the body and returns carbon dioxide. Think of it as the lock in a taxi: the vehicle (red blood cell) without the lock (hemoglobin) can't carry the passenger (oxygen). When hemoglobin is low, tissues receive less oxygen — and the person feels it physically. Hemoglobin contains iron — which is why iron-deficiency anemia is the most common cause of low hemoglobin, and why confirming it requires a separate ferritin and iron panel. Normal Hemoglobin Levels in Adults Normal values depend on sex and physiological state: Group Normal (g/L) ------ Men 130–170 Women 120–150 Pregnant (1st trimester) 110–150 Pregnant (2nd–3rd trimester) 105–120 Men have higher values — testosterone stimulates red blood cell production in the bone marrow. In women of reproductive age, levels are lower due to regular menstrual blood loss. During pregnancy, hemoglobin falls physiologically: plasma volume grows faster than red cell mass — the blood becomes "diluted." This is normal, but values below 105 g/L require ruling out iron-deficiency anemia. Always use the reference ranges on your specific lab report. Low Hemoglobin: Types of Anemia and Their Causes Low hemoglobin is the primary sign of anemia — but anemia is a syndrome, not a single diagnosis. The CBC pattern can point toward the cause before any additional tests. Iron-deficiency anemia The most common form — about 80% of all anemias. Low hemoglobin with low MCV and MCH (small, pale red blood cells). Causes: heavy menstrual bleeding, GI blood loss, pregnancy, and impaired iron absorption in celiac disease or after gastric surgery. Confirmed with a ferritin and iron panel. B12 and folate deficiency anemia Low hemoglobin with high MCV (large red blood cells). Seen in older adults, strict vegans, patients with atrophic gastritis or Crohn's disease, and those taking metformin. Hypersegmented neutrophils in the differential are a characteristic finding. Anemia of chronic disease Mild hemoglobin reduction accompanying chronic inflammation, autoimmune, or malignant conditions. Ferritin is normal or elevated — the key distinction from iron deficiency. Treatment targets the underlying condition, not iron levels. Hemolytic anemia Red blood cells are destroyed faster than they are produced. Can be hereditary (sickle cell, thalassemia) or acquired (autoimmune, drug-induced). Reticulocytes are elevated in the CBC. Aplastic anemia The bone marrow stops producing enough blood cells. All three cell lines fall simultaneously — hemoglobin, white blood cells, and platelets — a condition called pancytopenia. Rare but serious. Symptoms of Low Hemoglobin Symptom severity depends on how quickly hemoglobin has fallen and how low it is. With gradual decline, the body adapts — the person may go unaware for a long time. Main signs: fatigue and weakness, pallor of skin and mucous membranes (check the inner lower eyelid), dizziness, shortness of breath on exertion, rapid heartbeat, headache. In iron-deficiency anemia specifically: brittle and splitting nails, hair loss and thinning, dry skin, angular cheilitis (cracked mouth corners), pica (craving to eat ice, chalk, or dirt). Anemia severity grades: Grade Hemoglobin (g/L) ------ Mild 90–120 (F) / 90–130 (M) Moderate 70–89 Severe below 70 High Hemoglobin: Causes - Dehydration — the most common reason. Plasma volume drops, hemoglobin concentration rises falsely. Repeat the test after restoring normal fluid intake. - Reactive erythrocytosis — a compensatory response to chronic hypoxia. Typical in smokers, people at high altitude, and patients with COPD or sleep apnea. - Polycythemia vera — a bone marrow disorder. Rare but serious: hemoglobin can exceed 200 g/L, blood thickens, and thrombosis risk rises sharply. Values above 185 g/L in men or 170 g/L in women require a medical evaluation. When to See a Doctor Routine visit — hemoglobin below normal with fatigue, pallor, or breathlessness; two consecutive low results. Urgently: - Hemoglobin below 70 g/L — severe anemia, often requires hospitalization - Hemoglobin above 185 g/L (men) or 170 g/L (women) - Rapid drop over a short period — possible occult bleeding - Low hemoglobin with simultaneous drop in WBC and platelets (pancytopenia) Conclusion Hemoglobin is more than a number on a lab report — it's a measure of how much oxygen your tissues are getting. A drop in hemoglobin is always a symptom, never a standalone diagnosis. The type of anemia determines the treatment: iron-deficiency needs iron supplementation, B12-deficiency needs vitamin B12, anemia of chronic disease needs treatment of the underlying condition. For a detailed guide on how to increase hemoglobin, see our dedicated article. Don't self-prescribe iron supplements without testing — they won't help B12-deficiency anemia. Always find the cause first. https://labreadai.com/en/indicators/ldl https://labreadai.com/en/indicators/ldl Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) LDL is the primary atherogenic lipoprotein. Risk-based targets, causes of high and low LDL, how to lower it through diet and medication and when statins are needed. Indicators article LDL is called "bad cholesterol" — and while that is an oversimplification, it captures the essential reality: low-density lipoproteins are the primary builders of atherosclerotic plaques in artery walls. Every 1.0 mmol/L reduction in LDL measurably reduces the risk of heart attack by approximately 22% — one of the most robustly demonstrated effects in cardiology. Let's break down what LDL is, why its level matters more than most people realize, and how to bring it down. What LDL Is and How It Drives Atherosclerosis LDL (low-density lipoproteins) are the primary transport carriers of cholesterol in the body. They form from VLDL (very-low-density lipoproteins) as triglycerides are hydrolyzed, and they carry cholesterol from the liver to peripheral tissues — muscles, adrenal glands, and cell membranes. Under normal conditions, cells capture LDL through receptors (LDL-R) and use the cholesterol for membrane synthesis and hormone production. The problem begins when LDL is in excess: uncaptured particles penetrate the subendothelial space of arteries, become oxidized, and are engulfed by macrophages, which transform into foam cells. An atherosclerotic plaque gradually develops — initially soft and lipid-rich, later fibrotic with calcification. Rupture of an unstable plaque triggers thrombosis — this is how the majority of heart attacks and strokes occur suddenly in people who had "no complaints." Particularly dangerous are small dense LDL particles (sdLDL): they penetrate the vessel wall more easily, are more susceptible to oxidation, and circulate longer. Their proportion increases with high triglycerides and insulin resistance — which is why a "normal" LDL in the setting of metabolic syndrome can carry significantly greater risk than the same value in a healthy individual. A lipid panel is the only way to objectively assess LDL and the full spectrum of lipid risk in a single test. LDL Normal Ranges: Not One Number for Everyone The key feature of LDL interpretation is that target values are determined not by the absolute figure on the lab report, but by the patient's overall cardiovascular risk. The same value of 3.0 mmol/L may be entirely normal for a young healthy individual and unacceptably high for a patient who has survived a heart attack. Population reference categories: LDL level (mmol/L) Category ------ < 1.8 Optimal 1.8–2.5 Desirable 2.5–3.0 Borderline 3.0–4.9 High ≥ 5.0 Very high Risk-based LDL targets (ESC 2019 guidelines): Risk category LDL target ------ Very high (MI, stroke, diabetes with organ damage, CKD 3–5) < 1.4 mmol/L High (diabetes without organ damage, hypertension with organ damage, CKD 1–2) < 1.8 mmol/L Moderate < 2.6 mmol/L Low < 3.0 mmol/L Patients who have experienced a heart attack or stroke have the strictest targets — even when their LDL appears "normal" on the standard reference range. High-intensity statin therapy in these patients is a guideline standard, not an option. In women before menopause, LDL is on average lower than in men of the same age — estrogens upregulate hepatic LDL receptor activity. After menopause this protection disappears and LDL rises. How to Prepare for an LDL Blood Test LDL is measured in serum as part of a lipid panel. Preparation requirements are standard across the full lipid profile. - Strictly fasting: at least 12 hours without food — eating raises triglycerides, which enter the Friedewald LDL calculation - No alcohol for 72 hours: alcohol transiently lowers LDL and substantially raises triglycerides - Stable diet for 2–3 weeks: a drastic dietary change before the test produces an unrepresentative result - Acute illness reduces LDL by 10–40% — best to postpone testing 6–8 weeks after recovery; after a heart attack, only a blood draw within the first 24 hours or after 6–8 weeks gives a reliable result - Pregnancy substantially alters LDL — interpret with caution Most laboratories calculate LDL by the Friedewald equation: LDL = Total cholesterol − HDL − TG/2.2. When triglycerides exceed 4.5 mmol/L, this formula is unreliable — direct LDL measurement is required. Causes of High LDL Elevated LDL — hypercholesterolemia — results from a combination of genetic factors, lifestyle, and comorbid conditions. Cause Mechanism Characteristic features --------- Familial hypercholesterolemia (FH) LDL receptor or apoB gene mutation LDL 5.0–6.0; family history; xanthomas Diet high in saturated fats Reduced hepatic LDL receptor activity Responds to dietary change Hypothyroidism Reduced LDL receptor synthesis and activity Combined with elevated TSH Type 2 diabetes Insulin resistance → increased VLDL synthesis High TG + high LDL Nephrotic syndrome Compensatory lipoprotein synthesis for protein losses Proteinuria; edema Chronic kidney disease Impaired VLDL→LDL catabolism Rising creatinine Gallstones / cholestasis Impaired biliary cholesterol excretion Elevated ALP, GGT Certain medications Reduced LDL receptor activity Progestins, corticosteroids, retinoids Obesity Insulin resistance → VLDL synthesis Abdominal pattern Menopause Reduced estrogen-driven LDL receptor stimulation LDL rises after age 50 Familial hypercholesterolemia (FH) — a genetic condition with LDL 5.0 mmol/L in heterozygotes ( 13–15 mmol/L in homozygotes). Affects 1 in 250–500 people. Without treatment — myocardial infarction in the 30s–40s. Diagnostic criteria include LDL level, family history, and physical signs (tendon xanthomas, xanthelasmas, premature corneal arcus before age 45). Causes of Low LDL Low LDL (< 1.0 mmol/L) is usually good news from a cardiovascular perspective. But in some situations it is a marker of systemic disease. Main causes of low LDL: - Hyperthyroidism — accelerated LDL particle catabolism - Severe liver disease (cirrhosis, acute hepatic failure) — reduced synthesis of apoB-containing lipoproteins - Malabsorption syndrome, severe starvation, cachexia — substrate deficiency - Hypobetalipoproteinemia — a rare genetic condition - Intensive statin therapy — expected and targeted reduction; LDL 0.5–1.0 mmol/L on therapy is safe - Malignancies (acute leukemias, some solid tumors) — tumor cell cholesterol consumption Very low LDL (< 0.5 mmol/L) without an explained cause — warrants excluding severe liver disease and malignancy. LDL in the Context of the Full Lipid Profile LDL is central but not the only marker of atherogenic risk. Its clinical significance is fully revealed only alongside the complete lipid panel. LDL and HDL: atherogenicity ratio. At equal LDL levels, high HDL substantially reduces risk — it transports excess cholesterol back to the liver. The atherogenicity index = (Total cholesterol − HDL) / HDL, or more simply LDL/HDL. Optimal LDL/HDL ratio: < 3.0. LDL and triglycerides: metabolic syndrome. High triglycerides, high LDL, and low HDL form the classic "atherogenic triad" of insulin resistance. Additionally: elevated triglycerides drive formation of small dense LDL (sdLDL) — the most atherogenic subfraction, not captured by standard LDL calculation. LDL and atherosclerosis: the causal relationship between LDL and atherosclerosis is one of the most established facts in medicine. Mendelian randomization data show: the lower the LDL maintained throughout life, the lower the risk of myocardial infarction — regardless of how the reduction is achieved (statins, ezetimibe, PCSK9 inhibitors, or diet). Non-HDL cholesterol = Total cholesterol − HDL. Captures LDL + VLDL + IDL. When triglycerides exceed 4.5 mmol/L and formula-calculated LDL is unreliable — non-HDL cholesterol becomes the preferred therapeutic target. How to Lower LDL and When Medication Is Needed LDL is one of the most manageable cardiovascular risk factors: both lifestyle changes and medications deliver measurable results. Lifestyle changes (reduce LDL by 5–20%): - Limit saturated fats (red meat, butter, palm oil, full-fat cheese) and trans fats (margarine, industrial baked goods) — to < 7% of daily calories - Increase soluble fiber: oat bran, legumes, apples, psyllium — reduces LDL by 5–10% - Plant sterols and stanols (phytosterol-enriched margarines, functional foods) — reduce LDL by 8–15% - Regular aerobic activity — modestly lowers LDL and raises HDL - Weight loss in obesity — every 10 kg lost reduces LDL by approximately 5–8% Pharmacological treatment: Statins — first-line when LDL reduction beyond lifestyle is needed. Mechanism: inhibition of HMG-CoA reductase → reduced hepatic cholesterol synthesis → compensatory increase in LDL receptor number → enhanced LDL clearance from blood. Reduce LDL by 30–55% depending on agent and dose. Ezetimibe — blocks intestinal cholesterol absorption. In monotherapy reduces LDL by 15–20%; in combination with statins — an additional 15–25%. PCSK9 inhibitors (evolocumab, alirocumab) — monoclonal antibodies blocking LDL receptor degradation. Reduce LDL by 50–65%. Used in familial hypercholesterolemia and statin-intolerant patients at very high cardiovascular risk. Statin initiation should be discussed with a physician. Self-discontinuing statins after LDL normalizes is one of the most common and dangerous errors: statins are prescribed lifelong in high-risk patients and only continue working with uninterrupted use. This article is for informational purposes only and does not replace professional medical advice. If you have high cholesterol or elevated LDL, consult a cardiologist or GP. https://labreadai.com/en/indicators/leukocytes https://labreadai.com/en/indicators/leukocytes Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal WBC count for adults. CBC differential explained — neutrophils, lymphocytes, eosinophils. Causes of leukocytosis, leukopenia and left shift. Indicators article If you open a complete blood count and immediately look for "high or low" — you're probably checking the white blood cells. Their level and composition directly reflect what's happening in the immune system right now. Here's what the normal range looks like, how to read the differential, and what abnormalities in either direction mean. What Are White Blood Cells and How Do They Work White blood cells (leukocytes) are immune system cells. They identify bacteria, viruses, fungi, and parasites, destroy them, and remove damaged cells. Unlike red blood cells, WBCs don't just drift through the bloodstream — they actively migrate to sites of inflammation, engulf foreign particles, and coordinate the immune response. Blood is just the transit route. The actual work happens in the tissues: lymph nodes, liver, spleen, and mucous membranes. So the WBC count in blood is a visible fraction of the immune response — not the whole picture. Normal WBC Count in Adults Total white blood cells (WBC): 4.0–9.0 × 10⁹/L. WBC levels are not constant — they fluctuate by 15–20% throughout the day. After eating, during stress, or after exercise they temporarily rise. That's why the test is done fasting in the morning in a rested state. Special cases: in the 2nd–3rd trimester of pregnancy, WBC physiologically rises to 10–12 × 10⁹/L. In newborns and children, normal ranges are higher than in adults. CBC Differential: What Each Cell Type Means The total WBC count is just the first level. The differential — the percentage breakdown of white blood cell types — tells you far more. Each type has a specific job, and the composition points to the nature of what's happening. Cell type Normal (%) Function --------- Segmented neutrophils 47–72 Kill bacteria and fungi Band neutrophils 1–6 Immature forms — few in normal blood Lymphocytes 18–40 Viral immunity, immune memory Monocytes 2–9 Phagocytosis, cellular clean-up Eosinophils 0.5–5 Allergic reactions, parasites Basophils 0–1 Allergic response mediators Left Shift and Right Shift Left shift — band neutrophils above 6%, sometimes with even more immature forms (metamyelocytes, myelocytes). It signals acute bacterial infection: the body urgently releases immature cells. The more pronounced the shift, the more severe the infection. Right shift — hypersegmented neutrophils (5 or more lobes). Characteristic of B12 or folate deficiency, chronic kidney disease, or radiation exposure. Blast cells — immature blood cell precursors that normally remain in the bone marrow. Their presence in peripheral blood is an alarming sign requiring immediate exclusion of leukemia. High WBC: Causes of Leukocytosis Leukocytosis (WBC 9.0 × 10⁹/L) means the immune system is activated. The differential tells you what's driving it: - Neutrophilia with left shift — acute bacterial infection (pneumonia, pyelonephritis, appendicitis, abscess, sepsis). The more pronounced the shift, the more severe the process. - Lymphocytosis — viral infection (flu, mononucleosis, COVID-19, chickenpox) or chronic infections (tuberculosis). - Eosinophilia — allergic reactions, parasitic infestations, certain medications. Eosinophils above 15% warrant a parasitology workup. - Monocytosis — chronic inflammatory diseases, autoimmune conditions, recovery phase after infections. - WBC 30 × 10⁹/L — leukemia must be ruled out, urgent hematology referral. Physiological leukocytosis (temporary, no pathology): after eating, exercise, stress, in the 2nd–3rd trimester of pregnancy, post-surgery. Low WBC: Causes of Leukopenia Leukopenia (WBC < 4.0 × 10⁹/L) reduces immune defense and increases vulnerability to infections. The lower the count, the more serious the risk. - Viral infections — flu, hepatitis A and B, HIV, rubella. Viruses can directly suppress WBC production in the bone marrow. - Medications — chemotherapy agents, certain antibiotics, thyroid drugs, NSAIDs, antipsychotics. Drug-induced leukopenia is common and usually reversible. - Autoimmune diseases — systemic lupus erythematosus, Felty's syndrome in rheumatoid arthritis. - Bone marrow disorders — aplastic anemia, myelodysplasia, leukemia. - B12 and folate deficiency — impairs production of all blood cells. Leukopenia can be asymptomatic but significantly raises the risk of serious infections that a healthy person would handle easily. When to Seek Urgent Medical Attention Mild fluctuations (9–12 × 10⁹/L or 3–4 × 10⁹/L) without symptoms call for a routine visit. Don't delay when: - WBC 30 × 10⁹/L — rule out leukemia, urgent hematology referral - WBC < 1.0 × 10⁹/L — critically low immunity - Blast cells in the differential — hematologist the same day - Leukopenia + fever — the body can't fight infection properly - Simultaneous drop in WBC, hemoglobin, and platelets (pancytopenia) — emergency Conclusion White blood cells aren't just "immunity" — they're a complex system of five different cell types, each responding to a different threat. A rise or fall in total WBC is only the first signal. The differential answers: what is actually happening — bacteria or virus, inflammation or allergy, acute or chronic process. Leukocytosis or leukopenia is a symptom, not a diagnosis. The same result can reflect a simple infection or a blood disease. Always have it interpreted by a doctor. https://labreadai.com/en/indicators/lymphocytes https://labreadai.com/en/indicators/lymphocytes Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Lymphocytes are the core cells of adaptive immunity. Normal ranges for adults and children, causes of lymphocytosis and lymphopenia, atypical lymphocytes and when to see a doctor. Indicators article Lymphocytes are the intelligence center of the immune system. If neutrophils represent the rapid response to invasion, lymphocytes provide long-term memory and targeted elimination of specific pathogens. They recognize viruses and tumor cells, produce antibodies, and build immunological memory — the reason we don't suffer the same illness twice. Their deviation in a complete blood count is one of the most informative signals about the body's immune status. What Lymphocytes Are and How They Are Classified Lymphocytes are agranular mononuclear leukocytes — the second most numerous white blood cell type after neutrophils. They originate in the bone marrow but mature and specialize in different organs. By origin and function, lymphocytes fall into three main classes. T-lymphocytes (thymus-derived) — mature in the thymus and constitute 60–80% of blood lymphocytes. They carry out cellular immunity: - T-helper cells (CD4+) — the "conductors" of the immune response: they coordinate other immune cells and secrete cytokines - Cytotoxic T-lymphocytes / T-killers (CD8+) — directly destroy virus-infected and tumor cells - Regulatory T cells (Treg) — suppress excessive immune responses, preventing autoimmune reactions B-lymphocytes — mature in the bone marrow and account for 10–15% of blood lymphocytes. They are the foundation of humoral immunity: when activated, they differentiate into plasma cells that produce antibodies (IgG, IgM, IgA, and others). B-lymphocytes are responsible for lasting antibody-based immunological memory. NK cells (natural killers) — make up 5–20% of lymphocytes. They require no prior sensitization to a specific antigen: they identify and kill virus-infected and tumor cells through innate recognition — the frontline of antiviral and antitumor defense. A standard complete blood count does not distinguish T, B, and NK lymphocytes — that requires immunophenotyping by flow cytometry. In routine CBC, lymphocytes are reported as a single combined figure. Normal Lymphocyte Levels by Age The proportion of lymphocytes versus neutrophils in healthy blood changes with age — a critical nuance in pediatric differential interpretation. Age Lymphocytes (%) Lymphocytes abs. (×10⁹/L) --------- Newborns 20–40 2.0–11.0 1–6 months 42–72 3.0–13.5 6 months – 1 year 48–72 3.5–12.5 1–4 years 38–72 2.5–9.5 4–6 years 33–55 2.0–8.5 6–12 years 25–50 1.5–7.0 12–18 years 22–45 1.2–5.2 Adults 19–37 1.0–4.8 Elderly 65 years 15–35 0.8–4.0 Two "physiological crossovers" — essential knowledge in pediatric hematology: - First crossover (days 4–7 of life): neutrophils = lymphocytes (≈ 40–60% each) - Second crossover (age 4–6 years): neutrophils = lymphocytes again (≈ 40–60% each) Before the second crossover, lymphocytes predominate over neutrophils in healthy children — this is entirely normal, not lymphocytosis. Applying adult reference ranges to a child under 6 is a fundamental interpretive error. In older adults, lymphocytes physiologically decline — a component of immune aging (immunosenescence): the naïve T-lymphocyte pool shrinks and the capacity to form new immune memory diminishes. How to Prepare for a Lymphocyte Count Lymphocytes are automatically calculated as part of the CBC with differential — no separate test is required. - Blood drawn from a vein, morning, fasting or 3–4 hours after a light meal - Physical exercise modestly reduces the relative lymphocyte percentage (due to neutrophil mobilization): avoid intense training for 24 hours beforehand - Corticosteroids lower lymphocytes — always inform the physician when these are being taken - Acute emotional stress transiently reduces lymphocytes via adrenaline-driven redistribution — repeat under calm conditions if the result is unexpected - When chronic lymphoid pathology is suspected — refer for immunophenotyping (flow cytometry) to characterize T/B/NK subpopulations Critical principle: the relative lymphocyte percentage must always be interpreted alongside the absolute count. 42% lymphocytes with total leukocytes of 3 × 10⁹/L is an absolute lymphopenia (1.26 × 10⁹/L), despite the apparently "high" percentage. Causes of High Lymphocytes (Lymphocytosis) Lymphocytosis — absolute count 4.8 × 10⁹/L in adults — is divided into reactive (response to an external stimulus) and clonal (proliferation of a single pathological clone). Cause Degree Characteristic features --------- Viral infections (URTI, influenza, CMV) Moderate Transient; atypical lymphocytes Infectious mononucleosis (EBV) Significant Atypical lymphocytes 10%; pharyngitis; lymphadenopathy Whooping cough (pertussis) Significant (up to 15–20 × 10⁹/L) Absolute lymphocytosis, especially in children Toxoplasmosis Moderate Lymphadenopathy; atypical lymphocytes Chronic lymphocytic leukemia (CLL) Very high ( 20–50 × 10⁹/L) Clonal; elderly; no infection symptoms Lymphoma (leukemic phase) High Lymphadenopathy; B-symptoms Thyrotoxicosis Mild Relative lymphocytosis Convalescence after infection Moderate Transient; asymptomatic Infectious mononucleosis (Epstein-Barr virus) is the classic cause of acute lymphocytosis with atypical lymphocytes. Diagnostic picture: lymphocytes 50% with atypical forms 10%, pharyngitis, generalized lymphadenopathy, splenomegaly. Confirmed serologically (EBV VCA antibodies) or by PCR. Chronic lymphocytic leukemia is the most common leukemia in adults over 60. Classic presentation: stable absolute lymphocytosis 5 × 10⁹/L in an older patient without infection signs, without rising neutrophils or CRP. Requires immunophenotyping to confirm clonal B-cell origin. Causes of Low Lymphocytes (Lymphopenia) Lymphopenia — absolute count < 1.0 × 10⁹/L in adults — indicates suppression of cellular immunity. Cause Mechanism Characteristic features --------- Glucocorticoids Redistribution to tissues and apoptosis Dose-dependent; reversible HIV/AIDS Destruction of CD4+ T-lymphocytes CD4 < 200 — severe immunodeficiency Acute viral infections (early phase) Redistribution to tissues Transient; first 1–3 days Severe bacterial infections / sepsis Lymphocyte apoptosis during systemic inflammation Parallel neutrophilia Chemotherapy and radiotherapy Direct destruction of proliferating cells Proportional to treatment intensity Autoimmune disease (SLE) Anti-lymphocyte antibodies; consumption Variable Primary immunodeficiency Impaired lymphocyte maturation Recurrent infections from birth Malnutrition and protein deficiency Reduced production and function In severe cachexia Sarcoidosis Lymphocyte sequestration in granulomas Bilateral hilar lymphadenopathy HIV infection is the most clinically important cause of chronic progressive lymphopenia. The target is CD4+ T-helper cells: as HIV progresses their count falls. At CD4 < 200 cells/µL — AIDS stage, with risk of opportunistic infections (pneumocystis pneumonia, cytomegalovirus, cerebral toxoplasmosis). Unexplained absolute lymphopenia in a standard CBC in an adult is an indication for HIV testing. Atypical Lymphocytes: What They Mean Atypical (reactive, virocytes) lymphocytes are activated lymphocytes with altered morphology in response to antigenic stimulation — most often viral. In health they are absent or rare; a clinically significant finding is their presence at 5–10% of all lymphocytes. Morphological features: enlarged cell size, abundant basophilic cytoplasm, nucleus with fine chromatin structure. On Romanowsky-Giemsa staining — characteristic blue-grey cytoplasm with irregular margins. Causes of atypical lymphocytes: - Infectious mononucleosis (EBV) — the classic: atypical lymphocytes 10–20%, also called "Downey cells" - CMV infection — similar picture, but pharyngitis is less prominent - Viral hepatitis — moderate numbers - HIV (acute seroconversion phase) — together with lymphocytosis - Allergic reactions and drug hypersensitivity C-reactive protein during viral infections with atypical lymphocytes is often normal or only mildly elevated — in contrast to bacterial infections. This helps distinguish viral lymphocytosis from bacterial neutrophilia even before specific serological results return. Atypical lymphocytes must be distinguished from blasts — malignant cells in leukemia. This is why significant lymphocytosis with atypical cells always warrants hematology consultation with expert morphological review of a stained blood smear. When Lymphocyte Abnormalities Require Medical Attention Scheduled visit to a doctor when: - Lymphocytosis 5 × 10⁹/L on repeat testing without signs of acute infection — rule out CLL and other lymphoproliferative conditions - Lymphopenia < 1.0 × 10⁹/L not explained by corticosteroid use or acute infection - Atypical lymphocytes 10% with normal or moderately elevated total leukocytes - Recurrent viral or fungal infections combined with chronic lymphopenia Seek urgent care when: - Lymphocytes 30–50 × 10⁹/L — high probability of CLL or lymphoma leukemization - Lymphopenia < 0.5 × 10⁹/L combined with fever — severe immunodeficiency with risk of opportunistic infection - Lymphocytosis with atypical cells and signs of serious systemic disease: B-symptoms (night sweats, 10% weight loss, fever 38°C), marked lymphadenopathy, splenomegaly This article is for informational purposes only and does not replace professional medical advice. Consult a GP or hematologist if your lymphocyte count is outside the normal range. https://labreadai.com/en/indicators/mcv https://labreadai.com/en/indicators/mcv Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) MCV is the mean red blood cell volume. Normal values by age, how MCV classifies anaemia into micro-, normo- and macrocytic types and causes of changes. Indicators article In a complete blood count, the MCV line is often overlooked — especially when haemoglobin is normal. Yet mean corpuscular volume is one of the most informative markers for diagnosing the cause of anaemia: it divides all anaemias into three fundamentally different types, each pointing to its own group of diseases. Without MCV, the doctor has a fact — "haemoglobin is low" — but not an answer — "why." What Is MCV and Why Is It Measured MCV (Mean Corpuscular Volume) measures the average size of a red blood cell in femtolitres (fL). Modern haematology analysers calculate it automatically from the ratio of haematocrit to red cell count. Red cell size is not a random characteristic. It depends directly on how cells mature in the bone marrow: for an erythrocyte to reach normal size, it needs the right amount of haemoglobin (meaning enough iron) and a normal cell division process (meaning adequate vitamin B12 and folate). When either is disrupted, size changes in a predictable way. This is why MCV is the primary tool for classifying anaemias — the first thing a doctor checks after haemoglobin in a complete blood count. Normal MCV by Age Age Normal MCV (fL) ------ Newborns 95–121 1–6 months 73–101 6 months–2 years 70–86 2–12 years 73–89 12–18 years 78–95 Adults 80–100 In older adults, the upper MCV limit may be slightly higher due to physiological changes in erythropoiesis. Reference ranges differ slightly between laboratories — always use your specific report's values. MCV and Anaemia Classification: Three Types A fall in haemoglobin establishes anaemia as a fact. MCV explains its nature. Three fundamental patterns: Microcytic anaemia (MCV < 80 fL) — red cells smaller than normal. The cause is almost always impaired haemoglobin synthesis. The most common cause worldwide: iron-deficiency anaemia — insufficient iron to build haem. Less commonly: thalassaemia (inherited globin defect), anaemia of chronic disease (iron is "locked" in stores during prolonged inflammation). When microcytic anaemia is suspected, the next step is an iron panel including ferritin. Normocytic anaemia (MCV 80–100 fL) — normal-sized red cells, but too few of them. The bone marrow is either not producing enough or cells are being destroyed. Causes: acute blood loss (cell size hasn't yet changed), chronic kidney disease (erythropoietin deficiency), haemolytic anaemias, aplastic anaemia, and early iron or B12 deficiency before size changes appear. Normocytic anaemia requires a broader workup. Macrocytic anaemia (MCV 100 fL) — red cells larger than normal. The cause is almost always impaired DNA synthesis during precursor cell division. Most common causes: vitamin B12 deficiency and folate deficiency — without these vitamins, cell nuclei cannot divide normally; the cell grows but doesn't divide. Other causes: chronic alcohol use (direct toxic effect on erythropoiesis), hypothyroidism, methotrexate, hydroxyurea, some antiretroviral medications. An important nuance: when iron deficiency and B12 deficiency coexist, MCV may remain normal — the "double deficiency" masks size changes. Always look at additional red cell indices: MCH, MCHC, and RDW, not MCV alone. Elevated MCV Without Anaemia: What It Means MCV can be elevated with normal haemoglobin — and this is also diagnostically significant. Chronic alcohol use is the classic cause of isolated macrocytosis without anaemia. Ethanol directly disrupts red cell maturation. The effect persists for weeks after stopping alcohol — making MCV a useful indirect marker of chronic use, alongside GGT. Hypothyroidism slows everything, including erythropoiesis — red cells "over-mature" and enlarge. Unexplained macrocytosis warrants TSH testing. Pregnancy — mild physiological macrocytosis is normal. Medications: hydroxyurea, methotrexate, zidovudine — they impair DNA synthesis and predictably cause macrocytosis. Reticulocytosis — during active recovery after blood loss or haemolysis, large immature reticulocytes appear in circulation, transiently raising MCV. Low MCV Without Anaemia Isolated low MCV with normal haemoglobin most often indicates thalassaemia trait — carriage of a defective globin gene. Red cells are small and numerous, and haemoglobin is compensated within normal range. Diagnosed by haemoglobin electrophoresis. How to Prepare for the Test MCV is measured within a complete blood count — no separate test exists. Standard preparation: fasting for eight hours, avoid intense activity beforehand. Important: MCV does not change rapidly — it reflects the average age of circulating red cells (which live for 120 days). Acute events (bleeding, onset of deficiency) alter MCV over weeks, not immediately. When evaluating anaemia, MCV is always interpreted alongside MCH (mean corpuscular haemoglobin), MCHC (mean corpuscular haemoglobin concentration), and RDW (red cell distribution width) — all present in a standard complete blood count with full indices. When to See a Doctor Schedule a routine GP appointment if: - MCV is low and haemoglobin is also low — microcytic anaemia requires investigation. - MCV is above 100 fL — especially with normal haemoglobin — to exclude B12/folate deficiency or alcohol-related damage. - MCV is abnormal without an obvious cause (diet, alcohol, medications). Conclusion MCV is a navigational marker in anaemia diagnosis: it does not establish a diagnosis on its own, but instantly directs the clinician in the right direction. Small red cells — think iron. Large ones — think B12 and folate. Normal-sized with low haemoglobin — search for other causes. This is why MCV is a mandatory component of every complete blood count. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/melatonin https://labreadai.com/en/indicators/melatonin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Melatonin: normal blood and urine levels, how to test correctly. Causes of low and high results, links to cortisol and TSH, and when testing is clinically indicated. Indicators article Melatonin is called the "hormone of darkness" — and that is an accurate description: it is produced only at night, strictly in the absence of light, and its daily oscillations signal to every cell in the body that it is nighttime and time to recover. Most people encounter melatonin through sleep supplement advertising, but as a diagnostic marker it is considerably more interesting and complex. Let's break down what it actually reflects, how to measure it correctly, and what deviations mean. What Melatonin Is and How It Is Produced Melatonin is an indolamine hormone synthesized by the pineal gland (epiphysis) from tryptophan via serotonin. Synthesis is strictly light-dependent: photoreceptors in the retina detect light and suppress pineal activity via the retinohypothalamic tract. In darkness this inhibition is removed — melatonin production begins approximately 2 hours after dark onset, peaks at 2–4 AM, and falls to near-zero by 6–8 AM. Melatonin serves several core functions. Above all, it is the principal "zeitgeber" — the circadian rhythm setter — synchronizing the internal biological clock with the external light-dark cycle. Its nocturnal peak signals every organ and tissue to enter "night mode": body temperature drops, metabolism slows, and cellular repair processes intensify. Beyond sleep regulation, melatonin is a potent antioxidant, participates in immune regulation, suppresses gonadotropin secretion in children (protecting the reproductive axis from premature activation), and exerts oncostatic effects that are being actively investigated. A full discussion of melatonin physiology and clinical applications is in the article melatonin: what it is and how to fix your sleep. Melatonin is not synthesized exclusively in the pineal gland — intestinal cells, the retina, skin, and immune cells also produce it. But only pineal melatonin circulates in diagnostically relevant quantities and delivers the systemic chronobiological signal. Normal Melatonin Levels: Blood and Urine Melatonin has fundamentally different levels at different times of day. This is why "a normal melatonin value" stated without time of collection is biologically meaningless. In blood (serum/plasma): Time of day Normal in adults (pg/mL) ------ Daytime (8:00 AM–8:00 PM) 1–10 Early evening (8:00–11:00 PM) 20–60 Night (11:00 PM–3:00 AM) 80–200 Peak (2:00–4:00 AM) 100–300 Morning (6:00–8:00 AM) < 20 In urine — 6-sulfatoxymelatonin (6-SOMT), the principal melatonin metabolite reflecting total nocturnal melatonin output: Group Normal 6-SOMT (nmol/24h) ------ Adults 18–40 years 20–50 Adults 40–65 years 15–40 Elderly over 65 years 5–25 In pre-pubertal children, melatonin levels are substantially higher than in adults — one of the reasons children sleep deeply and for long periods. At puberty, melatonin falls under the influence of sex hormones. Levels continue to decline with age: by 60–70 years, the nocturnal peak in many people is half what it was in young adulthood. During pregnancy, melatonin physiologically rises — particularly in the third trimester, where it participates in programming the fetal circadian rhythm. How to Collect Samples for Melatonin Testing A melatonin test is one of the most technically demanding in endocrinology. Errors in sample collection completely invalidate the result. Three main testing approaches: 1. Blood melatonin — single time-point draws or serial nocturnal sampling. Conditions are stricter than for any other hormone: - Blood must be drawn in complete darkness or under red light (wavelength 600 nm): any white light immediately suppresses secretion - Nocturnal draw: 2:00–4:00 AM, provided the patient went to bed no later than 11:00 PM and did not wake in the light - Daytime draw (for comparison): 10:00 AM–12:00 PM under standard conditions - No alcohol or caffeine for 48 hours - Sample must be frozen immediately — melatonin is unstable at room temperature 2. Overnight urine for 6-SOMT — technically simpler and more practical for routine clinical use: - Collect overnight urine (10:00 PM to 8:00 AM the next morning) or full 24-hour urine - Keep refrigerated throughout the collection period; add preservative (acetic acid) - No lighting restrictions — more convenient for outpatient patients 3. Saliva — the preferred method for research and for measuring the dim-light melatonin onset time (DLMO). Less commonly used in routine clinical practice. Important: blood melatonin levels do not reflect biological activity in tissues — receptor sensitivity to melatonin is individually variable. A normal blood level in a patient with insomnia does not exclude chronobiological pathology. Causes of Low Melatonin Low melatonin is a far more common clinical problem than elevated melatonin. Modern lifestyle is one of the most powerful suppressors of melatonin secretion. Light pollution and screens. Blue light at 460–480 nm (smartphone and laptop screens, LED lighting) is maximally effective at suppressing melatonin through melanopsin receptors in the retina. Screen use at night delays the melatonin onset by 1.5–3 hours — effectively phase-shifting the entire circadian rhythm. Age. Physiological decline in pineal function is a key mechanism of insomnia in older adults. Progressive pineal calcification reduces the number of active pinealocytes. By age 70, the nocturnal melatonin peak is on average 2–4 times lower than at 25–30 years. Night shifts and irregular schedules. Night work completely inverts or destroys the normal melatonin profile. Chronic circadian disruption in shift workers is associated with elevated risks of breast cancer, metabolic syndrome, and depression. Cortisol and chronic stress. Cortisol and melatonin are physiological antagonists with reciprocal daily rhythms: when one is high, the other is suppressed. Chronically elevated cortisol suppresses melatonin synthesis via GABAergic and noradrenergic mechanisms. Melatonin-lowering medications: beta-blockers (suppress noradrenergic pineal stimulation — one of the most thoroughly studied drug effects on melatonin), NSAIDs, chronic benzodiazepine use, and some antidepressants. Tryptophan and vitamin B6 deficiency — reduced substrate for serotonin → melatonin synthesis. Pineal tumors and trauma — rare but direct causes of hypomelatoninemia. Causes of Elevated Melatonin Significant melatonin elevation is less common and has a narrower clinical significance in routine practice. Pineal tumors (pineocytomas/pineoblastomas). Secreting pineal tumors in children can produce marked hypermela-toninemia. Clinically, this manifests as delayed puberty — high melatonin suppresses the gonadotropic axis. Non-secreting pineal tumors, conversely, lower melatonin by destroying gland tissue. Blindness. In patients with total light imperception, the circadian melatonin rhythm cannot synchronize with the external light-dark cycle — the rhythm becomes "free-running," often resulting in melatonin elevations during daytime hours. Psychiatric conditions. Abnormally elevated melatonin is found in some forms of depression and in bipolar disorder; seasonal affective disorder (SAD) is associated with the opposite — reduced melatonin amplitude. Chronobiological dysregulation is part of the pathophysiology of depression. Thyroid dysfunction. In hypothyroidism, reduced hepatic melatonin catabolism can lead to level accumulation. Exogenous melatonin supplementation — obviously elevates measured levels and invalidates diagnostic testing. Testing while taking melatonin supplements is uninformative. Melatonin and Other Hormones: Systemic Interactions Melatonin does not exist in isolation — it is embedded in a complex hormonal network, and its deviation frequently coexists with changes in other markers. Melatonin and cortisol — the reciprocal axis. The normal daily rhythm: melatonin peaks at 2–4 AM → falls to near-zero by 6–8 AM → at this precise moment cortisol surges, driving awakening. Under chronic stress, cortisol fails to fall by evening — and melatonin cannot rise normally. Normalizing cortisol through stress management and sleep regularity restores the melatonin rhythm far more effectively than supplementation alone. The mechanism is detailed in how to lower cortisol in women. Melatonin and TSH. Melatonin exerts an inhibitory influence on TSH secretion and thyroid hormone output — via receptors in the hypothalamus and pituitary. Chronic nocturnal melatonin deficiency may allow the thyroid axis to run in "accelerated mode." This is one proposed mechanism explaining why sleep disorders and subclinical hyperthyroidism frequently coexist. Melatonin and prolactin. Both hormones have a nocturnal peak and both are suppressed by light. Melatonin stimulates prolactin secretion through hypothalamic receptors — under a normal circadian rhythm their nocturnal peaks are synchronized. Disruption of this synchrony in night-shift workers is one mechanism explaining menstrual irregularities in this population. Melatonin and the reproductive system. In children, high melatonin suppresses premature pubertal activation. In adults, seasonal melatonin variations (longer nights = more melatonin) modulate reproductive activity in seasonally breeding mammals — in humans this effect is minor but detectable in seasonal testosterone patterns. When Melatonin Should Be Tested and Who to See Melatonin measurement is not a routine screening test. It is clinically meaningful in specific situations and is typically ordered by a specialist — sleep medicine physician, neurologist, endocrinologist, or chronobiologist. Indications for melatonin testing: - Chronic insomnia not responding to standard treatment — to assess the chronobiological component - Circadian rhythm disorders: delayed sleep phase syndrome (DSPS), advanced sleep phase syndrome, irregular sleep-wake disorder - Night shift work with pronounced sleep and metabolic disturbances - Delayed or precocious puberty in children - Suspected pineal tumor (in conjunction with brain MRI) - Monitoring chronobiological treatment effectiveness (light therapy, melatonin) - Seasonal affective disorder with depressive episodes during dark months Self-prescribing melatonin supplements without measuring levels and assessing circadian timing is frequently ineffective or counterproductive when taken at the wrong time. The question "when to take melatonin" for an individual patient requires knowing their personal DLMO (dim-light melatonin onset) — which can only be established through laboratory testing. This article is for informational purposes only and does not replace professional medical advice. Consult a sleep specialist, neurologist, or endocrinologist for sleep disturbances. https://labreadai.com/en/indicators/monocytes https://labreadai.com/en/indicators/monocytes Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Monocytes are the largest leukocytes and precursors of macrophages. Normal absolute and relative values, causes of monocytosis and when to see a doctor. Indicators article In a complete blood count, monocytes typically appear at the end of the white cell differential — and often pass unnoticed when neutrophils and lymphocytes are within range. Yet monocytes are unique cells with a double life: a few days in the bloodstream, then migration into tissues where they become macrophages — the immune system's principal long-term defenders and cleanup crews. Their elevation often signals a chronic threat rather than an acute one. Here's what the normal range looks like and what deviations mean. What Are Monocytes and What Is Their Role Monocytes are the largest cells among all leukocytes, reaching 14–21 µm in diameter — roughly twice the size of an average red blood cell. In health, they make up 2–10% of all white blood cells. The bloodstream is only a transit stage for monocytes, lasting one to three days. They then migrate into tissues and differentiate — depending on the local environment — into macrophages (universal engulfers of pathogens and cellular debris) or dendritic cells (the primary antigen presenters for T lymphocytes). In macrophage form, they remain in tissues for months to years. The functions of monocytes and their tissue derivatives span the entire immune cycle: phagocytosis of bacteria, viruses, and fungi; clearance of apoptotic cells and tissue debris; secretion of cytokines and chemokines that coordinate inflammation; participation in wound healing and tissue remodelling. Think of them as universal military engineers — they fight, build, and clean up after the battle. Unlike neutrophils, which respond immediately and briefly, monocytes are cells of the sustained response. Their elevation more often signals a chronic process than an acute infection. Normal Monocyte Counts by Age Like other leukocytes, monocytes have age-specific reference ranges. In young children, their proportion is slightly higher than in adults. Age Absolute Count (×10⁹/L) Relative (%) --------- Newborns 0.05–1.9 3–12 Under 2 years 0.05–1.1 3–10 2–12 years 0.05–0.8 3–10 Over 12 years 0.04–0.8 2–10 Adults 0.04–0.8 2–10 Reference ranges may vary slightly between laboratories. Always use the values on your specific report. Why Are Monocytes High? Monocytosis Monocytosis — an absolute monocyte count above 0.8 × 10⁹/L — is not the most common finding in clinical practice, but it is diagnostically meaningful: it often points to conditions that other markers have not yet reflected. Chronic infections are the classic territory of monocytosis. Tuberculosis is among the most prominent: in chronic TB, monocytes are persistently elevated because macrophages are the primary cells in which mycobacteria persist. The same applies to brucellosis, infective endocarditis, listeriosis, syphilis, and leishmaniasis. The defining feature of infectious monocytosis is duration — it persists for weeks and months until the primary focus is eliminated. Recovery phase after acute infections — moderate monocytosis during convalescence is physiological. After neutrophils handle the acute phase, monocytes clear the inflammatory debris. This is transient and self-resolving. Autoimmune diseases — systemic lupus erythematosus, rheumatoid arthritis, Crohn's disease, ulcerative colitis. In chronic autoimmune inflammation, monocytes and macrophages play a central role in sustaining the inflammatory cascade — and their blood levels are frequently elevated during flares. Haematological malignancies — chronic myelomonocytic leukaemia (CMML) is defined by a persistent monocyte count above 1 × 10⁹/L as a diagnostic criterion. Some other haematological conditions also cause moderate monocytosis. Sarcoidosis — a granulomatous disease in which granuloma formation depends directly on monocyte and macrophage activity. Mild physiological monocytosis can occur post-surgery, with intense physical training, and in some apparently healthy individuals — without clinical significance. Why Are Monocytes Low? Monocytopenia Monocytopenia — an absolute count below 0.04 × 10⁹/L — is far less common than monocytosis and in most cases is a consequence of another condition or its treatment. Corticosteroids are the most frequent cause. Glucocorticoids redistribute monocytes from blood into tissues and suppress their release from the bone marrow. This is a predictable and reversible treatment effect. Aplastic anaemia — when all bone marrow cell lines are suppressed, monocyte production also falls. Monocytopenia in this setting is accompanied by reduced haemoglobin, neutropenia, and thrombocytopenia. Hairy cell leukaemia — a rare but diagnostically important condition. The classic triad of pancytopenia, splenomegaly, and monocytopenia (often complete absence of circulating monocytes) is one of this disease's characteristic features. Acute severe stress — transient monocytopenia occurs at the onset of some bacterial infections and during acute physiological stress. This is brief and clinically unimportant. Reading Monocytes in the Context of the Full Differential Monocytes are rarely interpreted in isolation — their meaning emerges in combination with other leukocytes and the clinical picture. Several diagnostically significant patterns: Monocytosis + normal neutrophils + normal lymphocytes — consider chronic infection (TB, brucellosis), sarcoidosis, or an autoimmune process. Monocytosis + lymphocytosis + normal neutrophils — recovery phase after viral infection, mononucleosis in follow-up. Persistent monocytosis 1 × 10⁹/L on repeat tests without infection — grounds for haematology referral and CMML evaluation. Monocytopenia + neutropenia + anaemia — pancytopenia requiring exclusion of aplastic anaemia and hairy cell leukaemia. A complete assessment reads monocytes alongside neutrophils, lymphocytes, and ESR within a complete blood count with full differential. How to Prepare for the Test Monocytes are measured within a complete blood count with differential — no separate "monocyte test" exists. Preparation is standard. Blood is drawn fasting after eight hours without food. Intense physical activity is best avoided for twelve hours beforehand — it has a moderate effect on monocyte counts. Tell your doctor about corticosteroid use: these drugs predictably suppress monocytes and may obscure the real picture. If the purpose is monitoring a chronic condition (autoimmune or infectious), draw the test at the same time of day and under the same circumstances each time for comparable results. When to See a Doctor Schedule a routine appointment with a GP or haematologist if: - Monocytosis above 1 × 10⁹/L is confirmed on repeat tests without active infection or a known autoimmune condition. - Monocytopenia is combined with reduced counts in other cell lines — suggesting pancytopenia. - Monocytosis persists more than four to six weeks after recovery from an acute illness. - Monocytosis is discovered for the first time in an older adult without an obvious cause — CMML should be excluded. Conclusion Monocytes are cells of the long-term immune response. Moderate elevation during recovery from an infection is normal and self-resolving. Persistent monocytosis without acute inflammation signals a chronic process — infectious, autoimmune, or, less commonly, haematological. Monocytopenia combined with other low blood cell counts calls for urgent exclusion of serious bone marrow disease. In both cases, the key is a complete differential in serial testing — not a single isolated value. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/neutrophils https://labreadai.com/en/indicators/neutrophils Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Neutrophils are the primary cells of bacterial defense. Normal ranges for adults and children, causes of neutrophilia and neutropenia, left shift and when to seek care. Indicators article Neutrophils are the first cells to rush toward a site of infection. They make up approximately 50–70% of all white blood cells and serve as the primary instrument of rapid antibacterial defense: reaching the site of inflammation within 30–60 minutes, engulfing and destroying bacteria through phagocytosis, and forming purulent exudate. This is why any leukocyte differential analysis begins with neutrophils — their deviation in either direction carries the most immediate diagnostic information. What Neutrophils Are and How They Are Classified Neutrophils are granulocytic leukocytes that mature in the bone marrow from myeloblasts through several intermediate stages. Mature cells enter the bloodstream and circulate for 6–12 hours before migrating into tissues, where they survive for another 1–2 days. In the blood differential, neutrophils are divided into two subsets by nuclear shape: Segmented neutrophils (segs) — mature, fully functional cells. The nucleus is divided into 2–5 lobes connected by thin strands. They constitute the vast majority of circulating neutrophils in health (47–72%). Band neutrophils — immature cells with an unsegmented, rod-shaped or horseshoe-shaped nucleus. Normally few in number (1–6%). A significant increase in bands — the "left shift" — signals that the bone marrow is urgently releasing immature cells in response to acute infection or inflammation. In severe infections, even more immature precursors — metamyelocytes and myelocytes — may appear in the blood, indicating extreme hematopoietic stress. Neutrophil granules contain powerful bactericidal substances: myeloperoxidase, lysozyme, defensins, and lactoferrin. After engulfing a bacterium, the neutrophil destroys it through a "respiratory burst" — a sudden release of reactive oxygen species — and then self-destructs, becoming part of the pus. Normal Neutrophil Levels by Age Reference values differ substantially across childhood. A key feature: in newborns neutrophils predominate; their proportion then falls and by age 4–6 equalizes with lymphocytes — the "second physiological crossover." Adult proportions are not reached until age 10–12. Age Segmented neutrophils (%) Band neutrophils (%) Absolute neutrophils (×10⁹/L) ------------ Newborns 47–70 3–12 6.0–26.0 1 month – 1 year 15–45 1–5 1.5–8.5 1–4 years 25–55 1–5 1.5–8.5 4–6 years 35–65 1–5 1.5–8.0 6–12 years 40–60 1–5 1.8–8.0 12–18 years 40–65 1–5 1.8–7.5 Adults 47–72 1–6 1.8–7.5 The absolute neutrophil count (ANC) is the most clinically important parameter, especially for infection risk assessment and in oncology patients: - ANC 1.5 × 10⁹/L — normal - ANC 1.0–1.5 × 10⁹/L — mild neutropenia - ANC 0.5–1.0 × 10⁹/L — moderate neutropenia - ANC < 0.5 × 10⁹/L — severe neutropenia; high risk of life-threatening infection During pregnancy, neutrophils physiologically rise — especially in the third trimester and postpartum. Mild neutrophilia in pregnancy is normal and requires no additional investigation. How to Prepare for a Neutrophil Count Neutrophils are measured as part of a complete blood count with differential — there is no separate test. - Blood is drawn from a vein in the morning, fasting or 3–4 hours after a light meal - Physical exercise — even walking — transiently elevates neutrophils by mobilizing the "marginal pool" (cells adhering to vessel walls). Levels can rise 50–100% within 30 minutes. Avoid intense activity for 24 hours beforehand and rest quietly for 15–20 minutes before the draw - Smoking chronically elevates neutrophils — in smokers the upper normal limit is effectively higher - Stress (physical or emotional) raises neutrophils via an adrenaline mechanism - For serial monitoring: same laboratory, same conditions each time The differential must always be interpreted using absolute values, not percentages alone: 70% neutrophils with total leukocytes of 3 × 10⁹/L is neutropenia despite the apparently "normal" percentage. Causes of High Neutrophils (Neutrophilia) Neutrophilia — ANC 7.5 × 10⁹/L in adults — is the most common finding in infections and inflammatory conditions. Cause Degree of elevation Characteristic features --------- Acute bacterial infection Moderate–significant Left shift; elevated CRP Purulent inflammation (abscess, pneumonia) Significant Toxic granulation of neutrophils Acute myocardial infarction Moderate First 12–24 hours Chronic inflammation (flare) Mild–moderate Moderately elevated CRP Stress, physical exercise Mild, transient Normalizes within hours Corticosteroids Moderate Absent left shift Pregnancy (3rd trimester) Mild Physiological Smoking Mild, chronic Stable elevation Malignancies Variable Often without left shift Myeloproliferative disorders (CML) Very high All precursors in differential Glucocorticoids (prednisolone, dexamethasone) produce a characteristic "steroid neutrophilia": they mobilize neutrophils from the marginal pool and delay their tissue egress. Critically: there is no left shift and no toxic granulation — signs of true infection. Distinguishing steroid neutrophilia from infectious requires the clinical picture and ESR. In chronic myeloid leukemia (CML), neutrophils may reach 50–200 × 10⁹/L with all maturation stages present — from myeloblasts to mature segmented cells. This is a leukemoid reaction or hematological malignancy — urgent hematology referral is required. Causes of Low Neutrophils (Neutropenia) Neutropenia — ANC < 1.5 × 10⁹/L — substantially increases the risk of bacterial and fungal infections. At ANC < 0.5 × 10⁹/L, the risk becomes life-threatening. Cause Mechanism Characteristic features --------- Viral infections (URTI, influenza, EBV) Suppressed granulopoiesis + redistribution Elevated lymphocytes Chemotherapy and radiotherapy Direct bone marrow suppression Nadir at days 7–14 Aplastic anemia Stem cell failure Pancytopenia Autoimmune neutropenia Anti-neutrophil antibodies Isolated neutropenia Drug-induced neutropenia Immune-mediated or direct toxicity Clear link to drug initiation Cyclic neutropenia Periodic suppression every 21 days Recurrent infections Severe B12 and folate deficiency Ineffective granulopoiesis Hypersegmented neutrophils Felty's syndrome (RA + neutropenia) Splenic sequestration In rheumatoid arthritis context HIV infection Direct suppression + autoantibodies Combined with lymphopenia Drug-induced neutropenia is a serious, frequently underrecognized problem. The most common agents: antithyroid drugs (methimazole, propylthiouracil) — require CBC monitoring every 2–4 weeks; clozapine — life-threatening agranulocytosis in approximately 1% of patients; certain antibiotics (chloramphenicol, co-trimoxazole), NSAIDs, carbamazepine. Infectious mononucleosis (Epstein-Barr virus) frequently causes transient neutropenia combined with atypical lymphocytosis — a diagnostically significant combination. Neutrophil Left and Right Shift Neutrophil interpretation is incomplete without assessing the "differential shift" — the change in the ratio of mature to immature forms. Left shift — increase in band neutrophils ( 6%) and/or appearance of metamyelocytes and myelocytes in circulation. Signals that the bone marrow has accelerated neutrophil production and released immature cells prematurely. Causes: acute bacterial infection (most common), sepsis, severe inflammation, burns and major trauma, myeloproliferative disorders. Degrees of left shift: - Mild: bands 6–10%, no immature precursors - Moderate: bands 10–20%, occasional metamyelocytes - Marked: bands 20%, metamyelocytes, myelocytes present — severe infectious or septic process Right shift — reduction in band neutrophils with increased proportion of hypersegmented forms ( 5 lobes). Signals that neutrophils are "aging" — the bone marrow is producing them slowly or they are being retained in the circulation. Causes: vitamin B12 and folate deficiency (classic — hypersegmented neutrophils in megaloblastic anemia); chronic kidney failure; hydroxyurea treatment. Toxic granulation and Döhle bodies — morphological changes in neutrophils during severe infection and sepsis: intensified primary granulation (visible on microscopy of a stained smear) and pale blue-grey cytoplasmic inclusions. These findings amplify the diagnostic significance of neutrophilia when assessing severity. When Neutrophil Abnormalities Require Medical Attention Neutrophil interpretation is always multidimensional: absolute count + percentage + shift + clinical picture. Scheduled visit to a doctor when: - ANC < 1.5 × 10⁹/L on repeat testing — identify the cause of neutropenia - Neutrophilia 10 × 10⁹/L without an obvious explanation (no infection, no stress, no corticosteroids) - Mild left shift with no symptoms — rule out a hidden infection source Seek urgent care when: - ANC < 0.5 × 10⁹/L — agranulocytosis; any sign of infection (temperature 38°C) in this setting is a medical emergency - Neutrophils 30–50 × 10⁹/L with immature precursors present — leukemia must be excluded - Patient taking antithyroid drugs or clozapine with neutrophils < 1.0 × 10⁹/L — immediate drug discontinuation and hematology referral - Fever in a patient post-chemotherapy — febrile neutropenia — an infectious emergency regardless of the exact neutrophil level Febrile neutropenia — temperature 38°C with ANC < 0.5 × 10⁹/L — requires hospitalization and immediate broad-spectrum antibiotic therapy while awaiting culture results. Any delay is measured in hours, not days. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or hematologist if your neutrophil count is outside the normal range. https://labreadai.com/en/indicators/parathyroid-hormone https://labreadai.com/en/indicators/parathyroid-hormone Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) PTH in blood: normal ranges in adults, causes of hyperparathyroidism and hypoparathyroidism. How PTH relates to calcium and vitamin D and when to see an endocrinologist. Indicators article Parathyroid hormone is the invisible conductor of calcium-phosphorus metabolism. Most people never hear of it until an incidentally discovered high or low calcium prompts their doctor to order this test. Yet chronically abnormal PTH silently destroys bone, damages the kidneys, and disrupts neuromuscular function — often for years before a diagnosis is made. Let's break down how this hormone works and why it can never be interpreted without calcium and vitamin D. What PTH Is and How It Regulates Calcium Parathyroid hormone (PTH) is a polypeptide of 84 amino acids produced by the parathyroid glands. Humans have four of them — tiny structures the size of a grain of rice, located on the posterior surface of the thyroid gland. Despite their minuscule size, they control one of the most tightly regulated parameters in the body. PTH is secreted in response to falling calcium in the blood. The response is nearly instantaneous — mediated by the calcium-sensing receptor (CaSR) on parathyroid cell surfaces. The feedback loop: calcium rises → PTH falls; calcium falls → PTH rises immediately. PTH acts at three target sites: Bone — the principal calcium reservoir (99% of total body calcium). PTH activates osteoclasts, which resorb bone and release calcium and phosphorus into the blood. Chronic PTH excess leads to osteoporosis and subperiosteal resorption. Kidneys — PTH acts bidirectionally: it enhances calcium reabsorption (retaining it in blood) while increasing phosphate excretion (excreting phosphorus in urine). It also activates 1α-hydroxylase, converting inactive vitamin D₃ to active calcitriol. Intestine — indirectly, through calcitriol: active vitamin D dramatically increases intestinal calcium absorption from food. The net result: PTH raises calcium simultaneously from three sources — bone, kidneys, and intestine. This is precisely why vitamin D deficiency is one of the leading causes of secondary hyperparathyroidism: low vitamin D → poor calcium absorption → chronic hypocalcemia → persistent PTH stimulation. A complete description of the physiology and clinical forms is available in the article parathyroid hormone: what this hormone is. Normal Parathyroid Hormone Levels PTH reference values depend on the analytical method and specific laboratory. Immunoradiometric and chemiluminescent methods are used; the standard is measurement of intact PTH (iPTH, 1–84). Group Normal PTH (pg/mL) Normal PTH (pmol/L) --------- Adults 15–65 1.6–6.9 Children under 10 years 9–52 1.0–5.5 Adolescents 10–17 years 12–55 1.3–5.8 Pregnant (1st trimester) 10–60 1.1–6.4 Pregnant (3rd trimester) 6–25 0.6–2.7 Elderly over 65 years 15–75 1.6–8.0 Clinically important nuances: During pregnancy, PTH physiologically falls in the third trimester: the fetus actively demands calcium, stimulating production of placental PTHrP (parathyroid hormone-related peptide), which partially assumes PTH's regulatory functions. In chronic kidney disease, the reference range broadens: PTH of 65–300 pg/mL at CKD stage III–IV is considered "target range" by several guidelines — excessively suppressed PTH leads to adynamic bone disease, while very high PTH causes fibrous osteitis. In older adults, the upper normal limit is slightly higher due to physiologically reduced vitamin D synthesis and intestinal calcium absorption. How to Prepare for a PTH Blood Test PTH is an unstable peptide with a plasma half-life of approximately 2–4 minutes. This imposes strict pre-analytical requirements. - Draw blood strictly fasting — at least 8–12 hours without food: intake of calcium-containing foods transiently suppresses PTH - Test in the morning between 8:00 and 10:00 AM — PTH follows a diurnal rhythm: peak at night and early morning, nadir at midday; fluctuations reach 40–50% - Deliver the sample to the lab immediately — PTH degrades at room temperature. Transport on ice, centrifuge within 30 minutes - For serial monitoring: use the same laboratory and the same method — different platforms produce results differing by 15–30% - Disclose all calcium supplements, vitamin D, bisphosphonates, diuretics, and lithium The test is almost always ordered alongside calcium (total and ionized), phosphorus, vitamin D (25-OH), and kidney function — the electrolyte panel is the mandatory backdrop for PTH interpretation. Causes of High PTH (Hyperparathyroidism) Hyperparathyroidism is classified as primary, secondary, and tertiary — each with fundamentally different mechanisms and treatment strategies. Primary hyperparathyroidism — autonomous PTH hypersecretion by the parathyroid glands, independent of calcium levels. In 80–85% of cases: a single parathyroid adenoma. Less commonly: hyperplasia of all four glands (in MEN-1, MEN-2A). Very rarely: parathyroid carcinoma. Characteristic pattern: high PTH + high calcium. Phosphorus is low (kidneys actively excrete phosphate under excess PTH drive). Vitamin D is often normal. Severity PTH Calcium Clinical picture ------------ Mild (asymptomatic) 65–150 pg/mL 2.5–2.85 mmol/L Incidental finding Moderate 150–300 pg/mL 2.85–3.0 mmol/L Osteoporosis, kidney stones Severe 300 pg/mL 3.0 mmol/L Hypercalcemic crisis Secondary hyperparathyroidism — a physiologically appropriate parathyroid response to chronic hypocalcemia. The glands are functioning correctly; the problem is that calcium is persistently low. Pattern: high PTH + normal or low calcium. Main causes: - Vitamin D deficiency — the most prevalent cause in the general population. Inadequate calcium absorption → chronic hypocalcemia → continuous PTH stimulation - Chronic kidney disease — impaired active vitamin D synthesis + phosphate retention + acidosis → multiple simultaneous PTH-stimulating mechanisms - Malabsorption syndromes (celiac disease, inflammatory bowel disease) — impaired calcium and vitamin D absorption - Pregnancy and lactation — increased calcium demand Tertiary hyperparathyroidism — develops after prolonged secondary: the parathyroid glands acquire autonomous function and continue hypersecretion even after the primary cause is removed (e.g., after kidney transplantation). Pattern: high PTH + high calcium — superficially resembling primary hyperparathyroidism but in the context of preceding CKD. Causes of Low PTH (Hypoparathyroidism) Hypoparathyroidism — PTH below normal — is far less common than hyperparathyroidism but equally significant clinically. Postoperative hypoparathyroidism — the most common cause. During thyroidectomy or parathyroid surgery, the parathyroid glands may be accidentally removed or devascularized. Onset is within 24–48 hours postoperatively. May be transient (weeks) or permanent. Autoimmune hypoparathyroidism — isolated or as part of autoimmune polyglandular syndrome type 1 (APS-1, APECED). Antibodies target the calcium-sensing receptor or parathyroid gland tissue. DiGeorge syndrome — genetic defect in parathyroid gland development (22q11 deletion). Associated with cardiac malformations and immunodeficiency. Diagnosed in childhood. Hypomagnesemia — severe magnesium deficiency impairs both PTH secretion and its action on target cells. Magnesium is required for calcium-sensing receptor function. Hypoparathyroidism unresponsive to treatment should always prompt magnesium measurement. Radiation injury — following radiotherapy to the neck region. Characteristic pattern in hypoparathyroidism: low PTH + low calcium + high phosphorus. PTH, Calcium, Phosphorus and Vitamin D: Reading the Full Picture None of these markers can be interpreted in isolation. Only the combination provides a complete clinical picture. PTH Calcium Phosphorus Vitamin D Most likely cause --------------- ↑ High ↑ High ↓ Low Normal Primary hyperparathyroidism ↑ High Normal/↓ Normal/↑ ↓ Low Secondary HPT — vitamin D deficiency ↑ High Normal/↓ ↑ ↓ Low Secondary HPT — CKD ↓ Low ↓ Low ↑ High Normal Hypoparathyroidism ↓ Low ↑ High Normal Normal/↑ PTH-independent hypercalcemia (malignancy, sarcoidosis) Normal ↑ High Normal Normal Familial hypocalciuric hypercalcemia (FHH) The second-to-last row is a critical clinical trap: malignant tumors secrete PTHrP (parathyroid hormone-related peptide), which is not detected by the standard PTH assay but causes hypercalcemia. Therefore, when calcium is high and PTH is low — an oncological workup is mandatory. Kidney function is essential context for any PTH abnormality. A rising creatinine points to CKD as the driver of secondary hyperparathyroidism and determines treatment strategy. Albumin is needed to correctly interpret total calcium: in hypoalbuminemia, total calcium is falsely low and the ionized fraction must be evaluated directly. When PTH Abnormalities Require Medical Attention PTH is not a screening test. It is ordered when calcium or phosphorus deviations are already present, or when specific clinical indications exist. Scheduled visit to an endocrinologist when: - High PTH combined with high calcium — rule out primary hyperparathyroidism; parathyroid scintigraphy or ultrasound is indicated - High PTH with normal or low calcium — identify secondary causes: vitamin D, kidney function, absorption - Any PTH deviation after thyroid or parathyroid surgery - Osteoporosis in a patient under 50 — exclude primary hyperparathyroidism as the underlying cause Seek urgent care when: - Calcium 3.0 mmol/L combined with elevated PTH — risk of hypercalcemic crisis: nausea, vomiting, confusion, polyuria - Calcium < 1.8 mmol/L in hypoparathyroidism — risk of tetany and seizures - Tetany, seizures, or laryngospasm — acute severe hypocalcemia emergency Effective treatment of hyperparathyroidism from a parathyroid adenoma is surgical. Parathyroidectomy normalizes calcium and PTH in over 95% of patients and measurably reduces the risk of nephrolithiasis and fractures. This article is for informational purposes only and does not replace professional medical advice. Consult an endocrinologist if your PTH level is outside the normal range. https://labreadai.com/en/indicators/phosphorus https://labreadai.com/en/indicators/phosphorus Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Blood phosphorus levels: normal ranges for adults and children, causes of high and low results. How phosphorus relates to calcium and PTH, and when to seek treatment. Indicators article Phosphorus rarely gets much attention — it's not part of a standard blood panel, and most people only think about it when something comes back abnormal. Yet this mineral is involved in the function of every cell in the body: without it, ATP synthesis, DNA replication, and bone maintenance are impossible. Let's break down what blood phosphorus levels reveal, why they deviate from normal, and which conditions lie behind those deviations. What Phosphorus Does and Why the Body Needs It Phosphorus is the second most abundant mineral in the human body after calcium. About 85% of the body's stores are concentrated in bones and teeth; the remaining 15% are distributed across soft tissues, cell membranes, and blood. Its roles are extensive. Phosphorus is a core component of ATP — the cell's primary energy currency — meaning cells literally cannot function without it. Phospholipids containing phosphorus form the bilayer of every cell membrane. Phosphate also participates in regulating blood acid-base balance and in activating enzymes and hormones. In laboratory testing, inorganic phosphorus is measured — the fraction circulating freely in blood plasma. It represents a small but clinically meaningful portion of total body stores. The key regulatory pair is phosphorus and calcium: their blood levels are tightly interdependent. When one rises, the other often falls, and vice versa. The conductor of this balance is parathyroid hormone. Normal Blood Phosphorus Levels by Age Reference values vary by age: children have higher phosphorus levels than adults — a normal reflection of active bone growth. Age Normal range (mmol/L) ------ Newborns 1.78–2.65 Children under 2 years 1.45–2.16 Children 2–12 years 1.45–1.78 Adolescents 12–18 years 0.81–1.62 Adults 18–60 years 0.87–1.45 Adults over 60 years 0.74–1.20 In postmenopausal women, the lower reference limit is slightly reduced due to changes in phosphocalcic metabolism. During pregnancy, phosphorus levels may decrease modestly — this is physiological. Important: reference ranges can differ slightly between laboratories and analytical methods. Always compare results against the ranges printed on your specific lab report. How to Prepare for a Phosphorus Blood Test Blood phosphorus levels fluctuate throughout the day and are sensitive to food intake. For a reliable result: - Fast for at least 8 hours before the draw — eating transiently lowers phosphorus - Avoid phosphorus-rich foods the evening before: dairy, fish, nuts, legumes - Skip intense exercise before the test — it causes a transient drop in phosphorus - Inform your doctor about antacids, vitamin D supplements, and diuretics — all of these significantly affect phosphorus levels - Avoid prolonged storage of the blood sample — phosphorus leaks from red blood cells during hemolysis, causing falsely elevated readings Phosphorus is almost always ordered together with calcium, parathyroid hormone, and kidney function markers — isolated phosphorus interpretation provides very limited information. Causes of High Phosphorus in Blood (Hyperphosphatemia) Hyperphosphatemia — phosphorus above 1.45 mmol/L in adults — is most commonly caused by impaired renal excretion. Chronic kidney disease is the leading cause. As kidney function declines, the ability to excrete phosphorus diminishes. In chronic kidney disease, phosphorus rises in parallel with worsening filtration, aggravating vascular calcification and bone disease. This is why kidney function testing is always part of the workup when phosphorus is abnormal. Hypoparathyroidism — insufficient parathyroid hormone secretion. PTH normally reduces phosphorus reabsorption in the kidneys; when PTH is deficient, phosphorus is retained and calcium falls. Vitamin D excess — enhances intestinal absorption of both phosphorus and calcium. Hyperphosphatemia from vitamin D toxicity often coexists with hypercalcemia. Acute acidosis and tissue breakdown — in rhabdomyolysis, massive hemolysis, or tumor lysis syndrome, phosphorus floods out of cells into the bloodstream, causing acute hyperphosphatemia. Diet and medications — excessive phosphate-containing foods and some sodium phosphate laxatives can produce moderate elevation. Causes of Low Phosphorus in Blood (Hypophosphatemia) Hypophosphatemia — phosphorus below 0.87 mmol/L — is less common but can be severe and symptomatic. Primary hyperparathyroidism — excess PTH secretion drives urinary phosphorus excretion. Calcium is elevated in parallel — a classic reciprocal pattern. Vitamin D deficiency — impairs intestinal phosphorus absorption. Rickets in children and osteomalacia in adults are the classic manifestations of chronic hypophosphatemia combined with vitamin D deficiency. Refeeding syndrome — occurs during aggressive nutritional support after prolonged starvation. Insulin released in response to carbohydrates drives phosphorus into cells, causing a sharp plasma drop — a life-threatening emergency in intensive care settings. Chronic alcohol use disorder — impairs phosphorus absorption and increases urinary losses. Severe hypophosphatemia in this population can cause muscle weakness and neurological damage. Aluminum- and magnesium-based antacids — bind phosphorus in the gut, reducing absorption. Prolonged unsupervised use is a real-world cause of hypophosphatemia. Phosphorus, Calcium, and Parathyroid Hormone: How the System Works Understanding phosphorus deviations without considering calcium and PTH is nearly impossible — they form a single regulatory system. The logic: when blood calcium falls, the parathyroid glands release parathyroid hormone. PTH simultaneously mobilizes calcium from bone, enhances intestinal calcium absorption (by activating vitamin D), and drives phosphorus excretion in the kidneys. The net result: calcium rises, phosphorus falls. This explains the classic picture of primary hyperparathyroidism: high calcium + low phosphorus + high PTH. And the reverse pattern in hypoparathyroidism: low calcium + high phosphorus + low PTH. This is why phosphorus is almost never interpreted in isolation — it is always evaluated alongside calcium, PTH, and kidney function. Symptoms and When to See a Doctor Hyperphosphatemia is often asymptomatic at moderate elevations. With significant and prolonged elevation, soft tissue and vascular calcifications develop, along with skin itching, bone pain, and joint discomfort. Hypophosphatemia is more overtly symptomatic: muscle weakness, bone pain, fatigue, impaired concentration and memory. Severe hypophosphatemia (< 0.32 mmol/L) can cause seizures, respiratory failure from weakened breathing muscles, and hemolytic anemia. A scheduled visit to a doctor is warranted for any phosphorus deviation found on a blood test. Seek urgent care if you experience: - Severe muscle weakness combined with bone pain - Tetany, cramps, or muscle spasms — possible concurrent severe hypocalcemia - Altered consciousness in a patient with known kidney disease or diabetes - Sudden phosphorus drop after reintroduction of feeding following starvation This article is for informational purposes only and does not replace professional medical advice. Consult a general practitioner, endocrinologist, or nephrologist if your blood phosphorus is outside the normal range. https://labreadai.com/en/indicators/platelets https://labreadai.com/en/indicators/platelets Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal platelet count for adults and in pregnancy. Causes of thrombocytopenia and thrombocytosis, symptoms of abnormal levels and when to see a doctor. Indicators article Platelets are the smallest cells in blood — but their role is critical: they are the first responders to blood vessel injury and the trigger for stopping bleeding. In a complete blood count, this value stands apart: abnormalities in both directions carry different risks — too few means bleeding risk, too many means clotting risk. What Are Platelets and How Do They Work Platelets are anucleate cells produced in the bone marrow from megakaryocytes. Their primary job is primary hemostasis: adhering to the damaged vessel wall, clumping together, and forming a platelet plug that stops bleeding. They also activate the clotting cascade and release growth factors that help tissues heal. Platelets survive 7–10 days before being destroyed in the spleen. The balance between bone marrow production and splenic destruction determines their blood level. Normal Platelet Count in Adults PLT: 150–400 × 10⁹/L for adults of either sex. In women, platelets may slightly decrease during menstruation. In pregnancy, mild reduction in the 2nd–3rd trimester (gestational thrombocytopenia) occurs in 5–8% of women — this is a normal variant requiring no treatment, and levels normalize after delivery. Low Platelets: Thrombocytopenia Thrombocytopenia — platelets below 150 × 10⁹/L. The mechanism can differ: insufficient bone marrow production, accelerated destruction, or redistribution (sequestration in the spleen). Main causes: - Immune thrombocytopenia (ITP) — autoantibodies destroy one's own platelets. The most common cause of isolated low platelets in adults. - Viral infections — flu, mononucleosis, hepatitis, COVID-19 can temporarily lower platelets through several mechanisms. - Drug-induced thrombocytopenia — heparin (especially dangerous HIT — heparin-induced thrombocytopenia), certain antibiotics, diuretics, anticonvulsants. - Bone marrow disorders — aplastic anemia, leukemia, myelodysplasia. These conditions simultaneously lower hemoglobin and white blood cells. - DIC (disseminated intravascular coagulation) — massive platelet consumption in sepsis, severe trauma, or obstetric emergencies. - Hypersplenism — an enlarged spleen traps excess platelets. Symptoms: petechiae (pinpoint skin hemorrhages resembling a rash), bruising from minimal trauma, prolonged bleeding from cuts, gum and nosebleeds, heavy periods. In severe thrombocytopenia — internal organ bleeding. Risk by platelet level: Level (× 10⁹/L) Clinical significance ------ 100–150 Minimal risk — monitor 50–100 Moderate risk — activity restrictions 20–50 High risk — treatment indicated < 20 Critical — spontaneous bleeding risk High Platelets: Thrombocytosis Thrombocytosis — platelets above 400 × 10⁹/L. The distinction between two types is critical. Reactive (secondary) thrombocytosis — the most common form. It develops as a response to another process: iron deficiency, acute infections and inflammation, surgery, splenectomy. Platelets rarely exceed 700–800 × 10⁹/L, and the clotting risk is relatively low. It resolves once the underlying cause is treated. Primary thrombocytosis (essential thrombocythemia) — a myeloproliferative bone marrow disorder. Platelets can exceed 1,000 × 10⁹/L, their function is impaired, and both clotting and bleeding risk are paradoxically high. Requires treatment by a hematologist. When thrombocytosis is found alongside low hemoglobin, a ferritin test is the logical next step: correcting iron stores typically normalizes platelets too. When to Seek Urgent Medical Attention - Platelets below 50 × 10⁹/L — high bleeding risk - Petechiae, spontaneous bruising, or nosebleeds not related to injury - Platelets above 1,000 × 10⁹/L — risk of both clotting and bleeding - Simultaneous fall in platelets, hemoglobin, and WBC — pancytopenia, emergency - Sudden platelet drop in a patient receiving heparin — suspect HIT Conclusion Platelets work in concert with all other blood cells. An isolated high or low value is one conversation; simultaneous changes across multiple parameters is a very different one. That's why platelets are always evaluated in the context of the full CBC — never in isolation. Significant platelet abnormalities must not be self-treated — the approach differs completely between thrombocytopenia and thrombocytosis. Only a doctor can identify the cause. https://labreadai.com/en/indicators/potassium https://labreadai.com/en/indicators/potassium Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Blood potassium levels: normal ranges for adults and children, causes of hyperkalemia and hypokalemia. How potassium affects heart rhythm and when deviations need emergency care. Indicators article Potassium is one of the few electrolytes where a deviation in either direction can stop the heart. This is not an exaggeration: both hyperkalemia and severe hypokalemia are life-threatening — and both frequently develop without any warning symptoms until a critical threshold is crossed. This is precisely why potassium is a mandatory component of the electrolyte panel at most hospitalizations and of routine monitoring in patients with kidney disease, heart failure, or on diuretic therapy. What Potassium Does and Why the Body Needs It Potassium is the dominant intracellular cation: approximately 98% of the body's total potassium is inside cells, and only 2% in extracellular fluid, including blood plasma. This ratio — roughly 40:1 between intracellular and extracellular potassium — establishes the resting membrane potential, without which no electrical event in the body is possible. Core functions of potassium: - Action potential generation in nerve and muscle cells — including cardiomyocytes. Transmembrane potassium flow drives repolarization after every heartbeat - Intracellular osmotic balance — maintained jointly with extracellular sodium - Blood pressure regulation — through effects on vascular tone and renal sodium excretion: adequate dietary potassium intake measurably lowers blood pressure - Glucose metabolism — insulin drives potassium from plasma into cells; this mechanism is exploited therapeutically in treating hyperkalemia - Acid-base balance — potassium-hydrogen exchange participates in maintaining blood pH Potassium is regulated primarily by the kidneys, which excrete or reabsorb it according to plasma levels under aldosterone control. Adrenal cortisol in excess exerts a mineralocorticoid effect — retaining sodium and expelling potassium — which explains hypokalemia in Cushing's syndrome. Normal Blood Potassium Levels by Age Plasma potassium is maintained within a narrow range. Even small deviations carry clinical significance. Age Normal potassium (mmol/L) ------ Newborns 0–7 days 3.7–6.0 Infants 1 week – 6 months 4.1–6.7 Infants 6 months – 1 year 3.7–6.0 Children 1–2 years 4.0–5.6 Children 2–14 years 3.4–4.7 Adults 3.5–5.1 Elderly over 65 years 3.5–5.3 In newborns and young infants, the normal range is higher than in adults — reflecting physiologically higher intracellular potassium content in growing tissues. Clinically relevant thresholds in adults: K⁺ level (mmol/L) Condition ------ 6.5 Severe hyperkalemia — high arrhythmia risk 5.5–6.5 Moderate hyperkalemia 5.1–5.5 Mild hyperkalemia 3.5–5.1 Normal 3.0–3.5 Mild hypokalemia 2.5–3.0 Moderate hypokalemia < 2.5 Severe hypokalemia — high arrhythmia risk How to Prepare for a Potassium Blood Test Potassium is one of the most pre-analytically sensitive electrolytes. Incorrect collection or handling can produce falsely elevated results — pseudohyperkalemia — which is one of the most common sources of electrolyte misdiagnosis. Pseudohyperkalemia occurs with: - Sample hemolysis — red cell rupture from vigorous tube shaking, prolonged storage, or improper centrifugation releases intracellular potassium into plasma - Prolonged tourniquet application during venipuncture — local muscle ischemia causes a localized potassium release - Thrombocytosis or marked leukocytosis — clotting in the tube releases potassium from platelets and white cells (relevant when serum rather than plasma is used) Collection rules: - Draw fasting or 3–4 hours after a light meal - Do not clench the fist during venipuncture — muscular work elevates local potassium - Deliver the sample to the lab within 30–60 minutes - When pseudohyperkalemia is suspected: repeat with a plasma sample (heparin tube, not serum) and centrifuge immediately Inform the physician about potassium-sparing diuretics, ACE inhibitors, ARBs, and NSAIDs — all of these affect renal potassium excretion. Causes of High Potassium (Hyperkalemia) True hyperkalemia (after excluding pseudohyperkalemia) is a serious condition requiring immediate identification of the cause. Cause Mechanism Characteristic features --------- Chronic kidney disease Reduced renal K⁺ excretion Parallel rise in creatinine Acute kidney injury Sudden excretion failure Oliguria, rising urea Aldosterone deficiency (Addison's disease) Absent excretion stimulus Hyperkalemia + hyponatremia Metabolic acidosis K⁺ shifts out of cells in exchange for H⁺ Low blood pH Rhabdomyolysis, hemolysis Massive K⁺ release from destroyed cells Elevated CK, LDH Tumor lysis syndrome Tumor cell breakdown During chemotherapy Hyperkalemia-inducing drugs Reduced excretion or cellular release ACE inhibitors, ARBs, spironolactone, NSAIDs, trimethoprim Excess K⁺ administration Potassium supplement overdose Iatrogenic Decompensated diabetes Insulin deficiency → K⁺ cannot enter cells Hyperglycemia, ketoacidosis The most dangerous combination in clinical practice: hyperkalemia in a patient with chronic kidney disease who is taking an ACE inhibitor or ARB. Both drug classes reduce aldosterone secretion; the kidneys are already struggling to excrete potassium — and levels rise silently to a critical threshold. Causes of Low Potassium (Hypokalemia) Hypokalemia is far more common than hyperkalemia in ambulatory practice. The main routes of loss: renal, gastrointestinal, or intracellular redistribution. Cause Mechanism Characteristic features --------- Diuretics (thiazide, loop) Enhanced renal K⁺ excretion Most common clinical cause Vomiting and diarrhea GI K⁺ losses With chronic disturbances Primary hyperaldosteronism Excess aldosterone → K⁺ excretion Hypertension + hypokalemia Cushing's syndrome Mineralocorticoid effect of cortisol Hypokalemia + hypertension + obesity Metabolic alkalosis K⁺ shifts into cells in exchange for H⁺ Vomiting, antacids Insulin / glucose administration K⁺ driven into cells During ketoacidosis treatment Dietary deficiency Insufficient K⁺ intake Anorexia, extreme diets Beta-2 agonists (salbutamol) Na⁺/K⁺-ATPase stimulation At high doses during bronchospasm treatment Alcohol use disorder Poor intake + urinary losses Combined with hypomagnesemia Hypomagnesemia Mg²⁺ required to retain K⁺ inside cells Hypokalemia refractory to treatment The last entry deserves special clinical emphasis: hypokalemia coexisting with hypomagnesemia cannot be corrected without simultaneously replenishing magnesium. The Mg²⁺ ion is required for Na⁺/K⁺-ATPase function — the pump that keeps potassium inside cells. Without magnesium, administered potassium immediately leaks back out. This is why persistent hypokalemia unresponsive to potassium supplementation should always prompt magnesium measurement. Potassium and the Heart: ECG Changes in Dyscalemia The heart is the primary target organ for potassium disturbances. Cardiomyocytes are acutely sensitive to the transmembrane potassium gradient because it drives the repolarization phase of every cardiac cycle. ECG patterns in hyperkalemia — escalating with rising potassium: - 5.5–6.5 mmol/L: tall, peaked T waves ("tented" T waves) - 6.5–7.5 mmol/L: QRS widening, reduced P wave amplitude - 7.5 mmol/L: sinusoidal ("sine wave") pattern, ventricular fibrillation, asystole ECG patterns in hypokalemia: - T wave flattening and inversion, prominent U wave (following T) - QT interval prolongation — risk of polymorphic ventricular tachycardia (torsades de pointes) - In severe hypokalemia — ventricular arrhythmias, particularly dangerous in patients with ischemic heart disease Important: ECG changes in hyperkalemia may appear at levels above 5.5 mmol/L, and at levels above 7.0 mmol/L the risk of fatal arrhythmia is high even before symptoms develop. A normal ECG does not rule out dangerous hyperkalemia. Hypokalemia potentiates cardiac glycoside toxicity (digoxin): at low potassium, digoxin binds to its receptor (Na⁺/K⁺-ATPase) with substantially greater affinity — dramatically increasing the risk of digitalis-induced arrhythmia. Potassium monitoring in patients on digoxin is non-negotiable. When Potassium Abnormalities Require Medical Attention Any potassium value outside the reference range warrants medical evaluation. The urgency is determined by the absolute level, symptoms, and comorbidities. Scheduled visit to a doctor when: - Potassium 5.1–5.5 mmol/L (mild hyperkalemia) — identify cause, especially in patients on ACE inhibitors/ARBs or with kidney disease - Potassium 3.0–3.5 mmol/L (mild hypokalemia) without symptoms — review diuretic therapy and dietary intake See a doctor within hours when: - Potassium 5.5 or < 3.0 mmol/L in any condition - Muscle weakness, cramps, or paresthesias alongside any potassium deviation Call emergency services immediately when: - Potassium 6.5 mmol/L — regardless of symptoms - Potassium < 2.5 mmol/L — regardless of symptoms - Cardiac arrhythmia (palpitations, irregular heartbeat, syncope) in the context of a known potassium disturbance - Paralysis or progressive muscle weakness approaching respiratory compromise Self-correcting potassium — taking supplements or restricting dietary potassium without laboratory monitoring — is genuinely dangerous. The rate of correction in severe hypokalemia is strictly controlled: rapid intravenous potassium administration without continuous ECG monitoring is potentially fatal. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or nephrologist if your blood potassium is outside the normal range. https://labreadai.com/en/indicators/prolactin https://labreadai.com/en/indicators/prolactin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Prolactin in blood: normal ranges for women, men and pregnancy. Causes of hyperprolactinemia, macroprolactin, effects on the menstrual cycle and when to see an endocrinologist. Indicators article Prolactin is one of those hormones people only think about when something goes wrong: a disrupted menstrual cycle, lost libido, or an above-range figure on a lab report. Yet it is a multifunctional hormone with more than 300 known biological effects — and one of the noisiest in terms of laboratory diagnostics: its level shifts with stress, sleep, food, and even the act of having blood drawn. Let's break down what it does, when an elevated result is genuinely pathological, and what to do about it. What Prolactin Is and What It Does Prolactin is a polypeptide hormone produced by lactotroph cells in the anterior pituitary. It is structurally related to growth hormone and placental lactogen — all three belong to the same protein family. Unlike most pituitary hormones, prolactin is under predominantly inhibitory control: dopamine released by the hypothalamus continuously suppresses its secretion. The moment dopaminergic tone falls, prolactin rises immediately. Core functions of prolactin: - Lactation — stimulates milk production in the mammary glands after delivery; the key postpartum hormone - Suppression of reproductive function during lactation — physiological lactational amenorrhea: elevated prolactin inhibits GnRH → reduces LH and FSH → suppresses ovulation - Immunomodulation — prolactin influences lymphocyte activity and participates in immune response regulation - Osmoregulation — regulates water-electrolyte balance in the kidneys and mammary glands - Behavior and stress response — prolactin rises acutely with stress as part of the adaptive response Regulation is exquisitely sensitive to external stimuli. This is critically important for result interpretation: physical discomfort during venipuncture, breast examination before blood draw, sleep disruption, food intake, and even sexual intercourse within a few hours before testing can significantly raise prolactin — without any pathology. A full discussion of the physiology and clinical role of this hormone is available in the article prolactin: what this hormone is. Normal Prolactin Levels Reference values differ substantially by sex, age, and physiological state. Units used: mIU/L (international units) and ng/mL. Conversion: 1 ng/mL ≈ 21 mIU/L. Group Normal (mIU/L) Normal (ng/mL) --------- Men 53–360 2.5–17 Non-pregnant women 109–557 5–26 1st trimester of pregnancy 500–2000 24–95 2nd trimester of pregnancy 1500–4500 71–214 3rd trimester of pregnancy 2500–9000 119–428 Breastfeeding women up to 4000–5000 up to 200–240 Infants under 1 year 630–1820 30–87 Children 1–10 years 40–400 2–19 During pregnancy, prolactin rises 5–10 fold above the non-pregnant range — this is physiological. After delivery, non-breastfeeding women normalize within 2–4 weeks; breastfeeding women remain elevated throughout lactation. Laboratories use different assay platforms and units — always compare with the reference range on the specific lab report. When prolactin is first found elevated, a diagnostically significant result is one that consistently exceeds the reference range across two to three independent measurements under proper conditions. How to Prepare for a Prolactin Blood Test Prolactin is one of the most unstable hormonal markers. No other pituitary hormone demands more careful attention to collection conditions. Essential requirements: - Draw blood strictly in the morning — between 9:00 and 11:00 AM. Prolactin has a clear circadian rhythm: maximum during sleep (especially early morning), rapid decline toward midday - Arrive at the lab early and rest quietly for 20–30 minutes before the draw — even walking up stairs elevates prolactin - Fasting or 3–4 hours after a light breakfast without coffee - Abstain from sexual intercourse for 24 hours before - Avoid breast examination or nipple stimulation for 24 hours before — mechanical nipple stimulation is a powerful secretory stimulus - Avoid intense exercise for 24 hours before - Avoid emotional stress immediately before testing — reschedule if necessary At first elevation: a repeat test is mandatory under different conditions on a different day. A diagnosis of hyperprolactinemia requires confirmation by at least two measurements. Up to 40% of initially "elevated" results normalize on correctly repeated sampling. The phase of the menstrual cycle has a modest effect on prolactin in most women — for standardization, testing on days 3–5 of the cycle is recommended. Causes of High Prolactin (Hyperprolactinemia) Elevated prolactin is the most common pituitary disorder in women of reproductive age. A diagnostically meaningful result is one that consistently exceeds the reference range after excluding physiological and functional causes. Cause Prolactin level Characteristic features --------- Prolactinoma (pituitary adenoma) 2000–3000 mIU/L; often very high Persistent elevation; MRI findings Hypothyroidism Moderate elevation Combined with elevated TSH Polycystic ovary syndrome (PCOS) Moderate (up to 1000–1500 mIU/L) Cycle disruption, hyperandrogenism Chronic stress / hypercortisolism Moderate, unstable Falls with cortisol normalization Medications Variable Clearly linked to drug initiation Renal failure Moderate Impaired prolactin clearance Hypothalamic lesion Moderate Reduced dopaminergic tone Physiological causes Normal or mildly elevated Pregnancy, lactation, stress Macroprolactinemia Falsely high No symptoms; no treatment response Drug-induced hyperprolactinemia is one of the most frequent causes of moderate elevation in clinical practice. Prolactin-raising drugs include: antipsychotics (all typical agents and many atypical ones), metoclopramide, domperidone, antidepressants (especially SSRIs and tricyclics), verapamil, high-dose estrogens, and opiates. Always confirm the complete medication list before interpreting a result. Macroprolactinemia — a condition in which prolactin circulates as large, biologically inactive aggregates bound to immunoglobulins. The assay reads high, but there are no clinical symptoms. Confirmed by polyethylene glycol (PEG) precipitation: after removing macroprolactin, the bioactive fraction is normal or minimally elevated. Critically: macroprolactinemia requires no treatment — prescribing dopamine agonists for it is an error. Causes of Low Prolactin Prolactin below the reference range is far less common and carries less independent clinical significance. Main causes of hypoprolactinemia: - Pituitary insufficiency (hypopituitarism) — damage to lactotroph cells from tumors, ischemia (Sheehan's syndrome), or infiltration; often accompanied by deficiency of other trophic hormones - Sheehan's syndrome — postpartum pituitary necrosis following massive obstetric hemorrhage; agalactia (inability to breastfeed) is one of the earliest symptoms - Dopamine agonists (bromocriptine, cabergoline) — iatrogenic reduction during prolactinoma or PCOS treatment - High-dose glucocorticoids — suppress prolactin secretion Isolated low prolactin in a woman not taking relevant medications is an indication for a full pituitary function assessment to rule out hypopituitarism. Prolactin and the Reproductive System Hyperprolactinemia is one of the leading endocrine causes of menstrual cycle disruption and infertility. The mechanism is direct: excess prolactin suppresses pulsatile GnRH secretion → LH and FSH fall → folliculogenesis and ovulation are impaired. Clinical spectrum in women: - Menstrual irregularities: from shortening of the luteal phase to complete amenorrhea - Anovulation and infertility - Galactorrhea (breast discharge outside pregnancy and lactation) — classic but inconstant symptom: present in 30–80% of women with hyperprolactinemia - Reduced libido - Hypoestrogenism with osteoporosis when long-standing Prolactin suppresses estradiol indirectly — through reduced LH/FSH, not directly on the ovary. This is why women with hyperprolactinemia often show low estradiol and reduced ovarian reserve even with a normal pituitary MRI — functional hyperprolactinemia from chronic stress can produce the same hormonal pattern as a structural cause. In men, hyperprolactinemia is less common but often more disruptive subjectively: - Reduced libido and erectile dysfunction — typically the first symptoms - Gynecomastia and galactorrhea — less common than in women - Reduced testosterone through suppression of the pituitary–testicular axis - Infertility (impaired spermatogenesis) - With prolactinoma — neurological symptoms (headache, visual field defects with macroadenoma) Thyroid function assessment is mandatory in all patients with hyperprolactinemia: hypothyroidism is one of the few fully reversible causes. A thyroid panel should be ordered for every patient with newly identified elevated prolactin. When Prolactin Abnormalities Require Medical Attention The approach to a prolactin deviation is strictly two-step: first confirm on repeat testing — then find the cause. Scheduled visit to an endocrinologist when: - Consistent elevation above normal in two measurements with full adherence to preparation conditions - Prolactin 700–1000 mIU/L ( 33–48 ng/mL) — threshold above which functional causes become less likely - Menstrual cycle disruption combined with any degree of prolactin elevation - Galactorrhea in a woman outside pregnancy and breastfeeding - Reduced libido or erectile dysfunction in a man Seek urgent care when: - Prolactin 5000–6000 mIU/L — high probability of prolactinoma requiring pituitary MRI - Visual field defects — sign of optic chiasm compression by a macroadenoma - Sudden severe headache with visual disturbance — pituitary apoplexy (a medical emergency) Treatment of confirmed hyperprolactinemia with dopamine agonists (cabergoline, bromocriptine) is highly effective: prolactin normalization is achieved in 80–90% of patients with prolactinoma. Self-discontinuation of treatment after normalization without medical consultation is a frequent and clinically significant error. This article is for informational purposes only and does not replace professional medical advice. Consult an endocrinologist or reproductive endocrinologist if your prolactin level is outside the normal range. https://labreadai.com/en/indicators/rdw https://labreadai.com/en/indicators/rdw Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) RDW measures variation in red blood cell size. Normal RDW-CV and RDW-SD values, what elevated anisocytosis means and how RDW helps differentiate types of anemia. Indicators article In a complete blood count report, RDW sits alongside hemoglobin and MCV, and most patients have no idea what to make of it. Yet it is one of the most informative markers for identifying the cause of anemia: it answers the question of how uniform your red blood cells are in size. Anisocytosis — size variation among red cells — is not just a laboratory term; it is a direct imprint of what is happening in the bone marrow. Let's break down how RDW works and why it should always be read alongside MCV. What RDW Is and What It Measures RDW — Red Cell Distribution Width — is a parameter reflecting the degree of heterogeneity in red blood cell volume. Simply put: how much individual red cells differ from one another in size. An automated hematology analyzer measures the volume of every red cell in the sample and constructs a distribution curve. RDW is a statistical characteristic of that curve. The wider the spread, the higher the RDW — and the more pronounced the anisocytosis. Two calculation variants may appear on a lab report: RDW-CV (coefficient of variation) — expressed as a percentage. Reflects the relative spread of red cell volumes relative to the mean. The most widely used variant. RDW-SD (standard deviation) — expressed in femtoliters (fL). Reflects the absolute spread of volumes and is more sensitive to a small subpopulation of abnormally large or small cells. Less dependent on mean cell volume. RDW cannot be interpreted in isolation — its diagnostic value is fully realized only alongside MCV (mean corpuscular volume) and hemoglobin. Together these three parameters form a coordinate system for the differential diagnosis of anemia. In a complete blood count, RDW is automatically reported by all modern analyzers as a standard parameter — no separate test order is required. Normal RDW Values: RDW-CV and RDW-SD Reference values depend on the calculation method. Always check which parameter — CV or SD — is reported on the specific lab form. Parameter Normal in adults Normal in infants under 6 months --------- RDW-CV 11.5–14.5% 14.9–18.7% RDW-SD 35–47 fL 35–55 fL Key nuances: Newborns and infants under 6 months have a physiologically higher RDW — this is normal, reflecting the transition from fetal to adult hemoglobin and the uneven maturation of red cells during this period. Pregnancy modestly elevates RDW — particularly in the second and third trimesters, driven by hemodilution and functional iron deficiency. After blood transfusion, RDW is transiently elevated — donor and patient red cells differ in size, broadening the distribution curve. A minor elevation (RDW-CV 14.6–15.5%) with normal hemoglobin and no clinical symptoms is often a normal variant or early deficiency requiring monitoring but not immediate treatment. How to Prepare for an RDW Test RDW is calculated automatically as part of a standard complete blood count — no additional sample or separate test order is needed. - Blood is drawn from a vein, fasting or 3–4 hours after a light meal — normal food intake does not significantly affect RDW - The sample should be analyzed within 4–8 hours of collection: prolonged storage causes red cells to swell, which can artificially elevate RDW-SD - Recent blood transfusion (< 4–6 weeks) produces a falsely elevated RDW — mixing of donor and patient red cells - Starting treatment for deficiency anemia (iron, B12) transiently raises RDW: new young normal-size cells appear alongside existing abnormal ones — the spread temporarily increases - For serial monitoring, use the same laboratory — different analyzers produce slightly varying results Causes of High RDW (Anisocytosis) An elevated RDW means red cells are heterogeneous: cells of noticeably different sizes are circulating simultaneously. This occurs when normal red cell maturation is disrupted or when cells from multiple "generations" with different characteristics enter the bloodstream together. Cause Mechanism Characteristic MCV combination --------- Iron deficiency anemia Small hypochromic cells alongside normal ones ↓ MCV + ↑ RDW Vitamin B12 / folate deficiency Large megaloblastic cells alongside normal ones ↑ MCV + ↑ RDW Mixed anemia (Fe + B12) Simultaneously small and large cells Normal MCV + ↑ RDW Start of deficiency anemia treatment New normal cells + existing abnormal cells Transitional period Hemolytic anemia Red cell fragments + reticulocytes ↑ or normal MCV + ↑ RDW Blood transfusion Donor and patient red cells coexisting Variable Sideroblastic anemia Two populations: normal and hypochromic ↑ RDW + normal/↓ MCV Chronic liver disease Disrupted red cell membrane, target cells ↑ MCV + ↑ RDW Myelodysplastic syndrome Impaired bone marrow maturation Variable, often ↑ RDW The most clinically significant combination is low MCV + high RDW with low hemoglobin: this is virtually pathognomonic of iron deficiency anemia and calls for immediate measurement of ferritin. A separate point of interest: RDW as an inflammatory and cardiovascular risk marker. Research over the past 15 years consistently shows that elevated RDW ( 14.5%) with normal hemoglobin is independently associated with higher mortality in heart failure, sepsis, and cancer. The mechanism: chronic inflammation disrupts normal red cell maturation. This is not a diagnostic criterion but a prognostic signal worth noting. Causes of Low RDW RDW below 11.5% (CV) is rare and carries almost no independent clinical significance on its own. Main situations: - Hereditary spherocytosis — a genetic condition: all red cells are uniformly small and spherical; size variation is minimal. Characteristic combination: low or normal RDW + reduced MCV + elevated MCHC + hemolysis - Thalassemia minor — uniformly small red cells without significant size spread. An important differentiating feature from iron deficiency: in thalassemia, RDW is normal or low; in iron deficiency, it is elevated - Anemia of chronic disease in early stages — uniformly modest reduction without significant anisocytosis RDW is precisely the key laboratory feature that separates iron deficiency anemia (RDW ↑) from thalassemia (RDW normal/↓) when both present with microcytosis. RDW and MCV: Differential Diagnosis of Anemia Combining RDW and MCV is the standard first-line algorithm for classifying anemia by mechanism. This is the Bessman classification, widely used in clinical practice. MCV RDW Most likely cause --------- ↓ Low (microcytosis) ↑ High Iron deficiency anemia ↓ Low (microcytosis) Normal Thalassemia, anemia of chronic disease Normal ↑ High Early Fe or B12 deficiency, mixed anemia, hemolysis Normal Normal Anemia of chronic disease, acute blood loss ↑ High (macrocytosis) ↑ High B12 or folate deficiency, hemolysis ↑ High (macrocytosis) Normal Liver disease, hypothyroidism, aplastic anemia Practical takeaway: in a patient with microcytic anemia who needs to be distinguished between iron deficiency and thalassemia — the first step is RDW. An elevated RDW points to iron deficiency and prompts ferritin testing; a normal RDW favors thalassemia and prompts hemoglobin electrophoresis. When MCV and hemoglobin are normal but RDW is isolated elevated — checking ferritin and early B12 markers makes sense: anisocytosis often precedes an overt fall in hemoglobin by months. When RDW Abnormalities Require Medical Attention An isolated elevated RDW with normal hemoglobin and no symptoms warrants scheduled investigation — not emergency action. Scheduled visit to a doctor when: - RDW-CV 14.5% at any hemoglobin level — to identify the cause of anisocytosis - High RDW combined with low MCV — rule out iron deficiency anemia (ferritin, iron, TIBC) - High RDW combined with high MCV — rule out B12 and folate deficiency - Persistently elevated RDW on multiple sequential tests — even with normal hemoglobin Seek urgent care when: - High RDW combined with anemia (hemoglobin below normal) and symptoms: breathlessness, weakness, pallor, tachycardia - RDW-CV 17–18% — marked anisocytosis requiring exclusion of serious pathology (hemolysis, myelodysplasia) - Anemia with elevated RDW following recent chemotherapy or radiotherapy After starting deficiency anemia treatment, a transient RDW rise over 1–2 weeks is expected (the "bimodal" distribution as new normal cells appear) — this is a sign of treatment response, not deterioration. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or hematologist if your RDW is outside the normal range. https://labreadai.com/en/indicators/reticulocytes https://labreadai.com/en/indicators/reticulocytes Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Reticulocytes are immature red blood cells reflecting bone marrow activity. Normal ranges, causes of high and low counts, and their role in diagnosing different types of anemia. Indicators article Reticulocytes are young red blood cells that have just left the bone marrow. Their count in blood is a direct window into hematopoietic activity: when reticulocytes rise, the bone marrow is working harder; when they fall, erythropoiesis is suppressed. This is why reticulocytes are indispensable in the differential diagnosis of anemia — they immediately answer the question of whether the bone marrow is the problem or whether the cause lies elsewhere. This marker is rarely included in a routine blood count, but when hemoglobin deviates from normal, it becomes one of the most informative values available. What Reticulocytes Are and How They Form Reticulocytes are immature red blood cells — an intermediate stage between the normoblast (a nucleated precursor) and the mature erythrocyte. They form in the bone marrow during erythropoiesis: once an erythroblast expels its nucleus, it enters the bloodstream as a reticulocyte still containing remnants of ribosomes and mitochondria. These organelles, staining with special dyes, produce the characteristic "net-like" pattern — hence the name. Under normal conditions, a reticulocyte matures in the bloodstream within 1–2 days, becoming a fully mature anucleate red cell. Their proportion in blood directly reflects the rate of new red cell production. The principal driver of erythropoiesis is erythropoietin (EPO), produced by the kidneys in response to tissue hypoxia. The speed of the reticulocyte response to a stimulus is one of its key diagnostic features. In acute blood loss or hemolysis, the bone marrow sharply increases output: the reticulocytosis peak occurs at 5–7 days. When treatment for iron deficiency anemia begins, reticulocytes start rising within 3–5 days — the first laboratory sign of a therapeutic response. Normal Reticulocyte Levels Reticulocytes are expressed in two ways: as a percentage of total red blood cells (relative value) and as an absolute count (cells per liter). The absolute count is more informative in anemia: when total red cell count drops sharply, the relative percentage can appear "normal" even though the bone marrow is actually working inadequately. Group Normal (%) Normal (×10⁹/L) --------- Newborns (days 1–7) 2.0–6.0 110–450 Infants under 2 weeks 0.5–1.5 30–100 Infants 2 weeks – 1 year 0.5–1.5 25–85 Children 1–6 years 0.5–1.5 25–75 Children 6–12 years 0.5–1.5 25–70 Adult men 0.5–1.5 25–75 Adult women 0.5–2.0 25–85 Pregnant women up to 2.5 up to 100 A more precise tool is the reticulocyte production index (RPI): it corrects the relative percentage for the degree of anemia and the reticulocyte maturation time. RPI = (Reticulocyte% × Patient hematocrit) / (Normal hematocrit × Maturation time). RPI 2 = adequate bone marrow response; RPI < 2 = inadequate, hypoproliferative anemia. How to Prepare for a Reticulocyte Test Reticulocytes are measured as part of an extended complete blood count — using automated hematology analyzers or manual stained smear counting. - Blood is drawn from a vein in the morning, fasting or 3–4 hours after a light meal — food intake does not significantly affect the result - Intense exercise the day before transiently raises reticulocytes — avoid strenuous training for 24 hours before the draw - Blood transfusions in the preceding 4–6 weeks distort the result — donor cells alter the ratio - Recently initiated treatment with iron, vitamin B12, or folate causes reticulocytosis — this is an expected therapeutic response, not pathology; inform the physician interpreting the result - For serial monitoring (e.g., tracking treatment response) use the same laboratory each time Reticulocytes should always be interpreted alongside hemoglobin, hematocrit, and other blood indices — in isolation they provide very limited information. Causes of High Reticulocytes (Reticulocytosis) Reticulocytosis — above 2% or 100×10⁹/L — means the bone marrow has sharply accelerated red cell production. This is always a response to something: blood loss, hemolysis, or the start of anemia treatment. Blood loss. Acute or chronic blood loss is the most common cause of reticulocytosis. The hypoxia that develops with anemia stimulates EPO production, which drives the bone marrow. The response peaks on days 5–7 after the bleeding episode. Hemolytic anemia. When red cells are destroyed prematurely — by autoimmune, mechanical, or toxic mechanisms — the bone marrow increases output to compensate. Reticulocytosis in hemolysis is often marked: 5%, in severe cases 10–15%. Characteristic combination: reticulocytosis + elevated indirect bilirubin + reduced haptoglobin. Response to anemia treatment. Three to five days after starting iron therapy for iron deficiency anemia, or vitamin B12/folate for megaloblastic anemia, reticulocytes begin rising — the "reticulocyte crisis." This is the first laboratory sign of an effective treatment response. The peak occurs on days 7–10. Physiological causes: in newborns during the first week of life, reticulocytosis up to 6% is normal — fetal hemoglobin is being replaced. Moderate reticulocytosis up to 2–2.5% is also physiological in pregnancy. High-altitude residence sustains chronically elevated levels through persistent mild hypoxia. Less common causes: polycythemia vera — autonomous red cell overproduction; bone marrow metastases displacing normal cells (leukoerythroblastic reaction); extramedullary hematopoiesis in myelofibrosis. Causes of Low Reticulocytes (Reticulocytopenia) Reticulocytopenia — below 0.5% or < 20×10⁹/L in the setting of anemia — signals that the bone marrow is failing to keep up. This is a hypoproliferative anemia: the problem is not loss or destruction of red cells, but insufficient production. Deficiency anemias before treatment. In iron deficiency anemia and megaloblastic anemia (B12 or folate deficiency), the bone marrow cannot produce red cells normally because the necessary substrate is absent — reticulocytes are reduced or at the low end of normal. Aplastic anemia. Severe damage to bone marrow stem cells — autoimmune, toxic, or idiopathic. Pancytopenia with reticulocytopenia is the classic presentation: simultaneous drops in hemoglobin, leukocytes, and platelets with no reticulocyte response. Chronic kidney disease. Renal erythropoietin is the primary bone marrow stimulus. When kidney function declines, EPO production falls disproportionately — producing a normochromic normocytic anemia with an inappropriately low reticulocyte count for the degree of anemia. Malignancy and chemotherapy. Bone marrow infiltration by tumor cells or suppression of hematopoiesis by cytotoxic agents — direct causes of reticulocytopenia. Other causes: hypothyroidism (reduced metabolic demands decrease erythropoiesis), chronic inflammation (anemia of chronic disease — reticulocytes low or normal despite low hemoglobin), direct alcohol toxicity to erythroblasts. Reticulocytes in the Differential Diagnosis of Anemia The main clinical value of reticulocytes is separating anemias into regenerative and aregenerative. This is the first and most fundamental step in diagnosing any anemia. Type of anemia Reticulocytes Hemoglobin Typical cause ------------ Hemolytic Markedly ↑ ( 5%) Low Autoimmune hemolysis, hemoglobinopathies Post-hemorrhagic (acute) ↑ (peak days 5–7) Low Bleeding Iron deficiency Low or normal Low Iron deficit: low ferritin Megaloblastic (B12/folate) Low Low Vitamin B12 or folate deficiency Aplastic Markedly ↓ Low Bone marrow failure Renal (EPO deficiency) Low Low CKD, normocytosis Anemia of chronic disease Low or normal Low Inflammation, iron redistribution The algorithm is straightforward: in any anemia, look at reticulocytes first. High → investigate blood loss or hemolysis. Low → assess bone marrow, iron stores, B12, folate, kidney function. This two-step approach saves time and avoids unnecessary testing. When Reticulocyte Abnormalities Require Medical Attention An isolated minor reticulocyte deviation with normal hemoglobin is generally not a cause for concern. Clinical significance arises when reticulocytes deviate in the context of anemia or progressive symptoms. Scheduled visit to a doctor when: - Anemia with below-normal reticulocytes — to identify the cause of hypoproliferation - Reticulocytosis without an obvious cause (no recent blood loss, no anemia treatment) — rule out hemolysis - Reticulocytes 5% combined with jaundice or dark urine Seek urgent care when: - Reticulocytopenia combined with pancytopenia — possible aplastic anemia - Worsening anemia with reticulocytes < 0.2% — critically suppressed bone marrow - Reticulocytosis 10% — severe hemolytic crisis After starting anemia treatment: a follow-up reticulocyte count at 7–10 days confirms the bone marrow response before hemoglobin has time to normalize — this is the earliest reliable marker of treatment efficacy. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or hematologist if your reticulocyte count is outside the normal range. https://labreadai.com/en/indicators/sodium https://labreadai.com/en/indicators/sodium Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Blood sodium: normal ranges for adults and children, causes of hypernatremia and hyponatremia. Symptoms of dangerous imbalances and when to seek care. Indicators article Sodium is the most abundant cation in extracellular fluid and the principal regulator of blood osmolarity. Its level determines how much water is retained in the vascular space, how nerves and muscles function, and how stable blood pressure remains. Deviations in either direction — both deficit and excess — can lead to severe neurological complications within hours. Let's break down what controls sodium in the body, why it falls out of range, and when that becomes dangerous. What Sodium Does and Why It Matters Sodium is an electrolyte with approximately 90% of the body's supply located outside cells: in blood plasma, interstitial fluid, and lymph. Inside cells, sodium concentration is 10–15 times lower — a gradient maintained by the Na⁺/K⁺-ATPase, the "sodium-potassium pump" embedded in every cell membrane. Sodium serves several critical functions. First, it determines extracellular fluid osmolarity: sodium concentration decides how water moves between cells and blood. When sodium rises, water shifts out of cells into plasma; when it falls, water enters cells. Second, the sodium gradient enables action potentials in nerve and muscle cells — without it, neither thought nor movement is possible. Third, sodium reabsorption in the kidneys governs circulating blood volume and blood pressure. Several systems regulate sodium. Aldosterone (adrenal cortex hormone) promotes sodium retention in the kidneys. ADH (antidiuretic hormone, vasopressin) regulates water reabsorption — indirectly influencing sodium concentration. Atrial natriuretic peptide (ANP) promotes sodium excretion during volume overload. This is a three-tier, continuously active control system. Sodium disturbances are among the most common electrolyte disorders in clinical practice. A complete electrolyte panel always includes sodium as a mandatory component. Normal Sodium Levels in Blood Reference values for sodium in adults are stable and largely sex-independent. The range is slightly wider in newborns and young children. Group Normal sodium (mmol/L) ------ Newborns 133–146 Infants under 1 year 134–145 Children 1–14 years 136–145 Adults 136–145 Elderly over 65 years 132–146 Clinically relevant thresholds: Na⁺ level (mmol/L) Condition ------ 150 Hypernatremia — requires treatment 145–150 Borderline high — monitor 136–145 Normal 130–135 Mild hyponatremia 125–129 Moderate hyponatremia < 125 Severe hyponatremia — cerebral edema risk < 120 Critical — emergency care The rate of change is no less important than the absolute value: an acute drop to 125 mmol/L over a few hours is far more dangerous than a chronic decline to 120 mmol/L developing over weeks. How to Prepare for a Sodium Blood Test Sodium is measured in serum or plasma. No special preparation is required for most patients, but several factors influence the result. - The test does not need to be strictly fasting — normal food and water intake does not significantly affect sodium in a healthy person - Inform the physician about diuretics, corticosteroids, NSAIDs, and SSRI antidepressants — all of these affect sodium metabolism - For serial monitoring: use the same laboratory, preferably at the same time of day - Pseudohyponatremia: in significant hyperlipidemia or hyperproteinemia (multiple myeloma), some older methods produce a falsely low sodium — modern ion-selective electrode analyzers do not have this problem Sodium is always interpreted alongside potassium, creatinine, and the clinical picture — an isolated number tells very little without context: osmolarity, fluid volume status, and kidney function. Causes of High Sodium (Hypernatremia) Hypernatremia — sodium above 145 mmol/L — means a relative deficit of water relative to sodium. Simply put: either too little water, or too much sodium. Cause Mechanism Characteristic features --------- Dehydration (insufficient water intake) Loss of free water without Na⁺ loss Thirst, dark urine, reduced skin turgor Diabetes insipidus (central or nephrogenic) ADH deficiency or renal ADH resistance Polyuria, polydipsia, low urine specific gravity Insensible losses (skin, lungs) Evaporative loss during fever, high temperature Hypernatremia with reduced circulating volume Diarrhea and vomiting in infants Loss of hypotonic fluid Rapid onset in infants and young children Primary hyperaldosteronism Excess renal Na⁺ retention Hypertension, hypokalemia Glucocorticoid excess (Cushing's syndrome) Mineralocorticoid effect of cortisol Combined with hypertension and hypokalemia Iatrogenic (hypertonic saline infusion) Direct Na⁺ administration In hospital or intensive care settings Hypernatremia develops faster and is more severe in older adults and infants: older adults have a diminished thirst response; infants have a high body surface area-to-volume ratio. Even moderate dehydration can rapidly produce clinically significant hypernatremia in these groups. Causes of Low Sodium (Hyponatremia) Hyponatremia — sodium below 136 mmol/L — is the most common electrolyte disorder in clinical practice. It occurs in 15–30% of hospitalized patients. It can arise from fundamentally different mechanisms, and treatment differs radically depending on the cause. The first step in differential diagnosis is assessing extracellular fluid volume: Hypovolemic hyponatremia (reduced volume): - GI losses: vomiting, diarrhea, fistulas - Skin losses: excessive sweating, burns - Renal losses: diuretics (especially thiazides), adrenal insufficiency, salt-wasting nephropathy Euvolemic hyponatremia (normal volume) — the most common form: - Syndrome of inappropriate ADH secretion (SIADH) — the key cause: ADH is produced excessively in tumors, pneumonia, traumatic brain injury, SSRI use, and certain anticonvulsants - Hypothyroidism — reduced renal blood flow - Primary polydipsia — excessive water intake overwhelming renal excretion capacity Hypervolemic hyponatremia (increased volume): - Chronic kidney disease — impaired free water excretion - Heart failure — reduced effective circulating volume stimulates ADH - Liver cirrhosis — same mechanism via portal hypertension In chronic hyponatremia, the brain adapts by extruding osmolytes from cells, reducing edema. This explains why a patient with sodium of 120 mmol/L over several weeks may be asymptomatic — and why excessively rapid correction is lethal (osmotic demyelination syndrome). Symptoms of Sodium Disturbances The clinical picture of sodium disorders is driven by two factors: the absolute value and the rate of change. Hyponatremia symptoms — from mild to critical: - Mild (130–135 mmol/L): nausea, headache, reduced concentration, malaise - Moderate (125–129 mmol/L): progressive weakness, confusion, emotional lability - Severe (< 125 mmol/L): disorientation, seizures, impaired consciousness - Critical (< 120 mmol/L, acute): cerebral edema, coma, respiratory arrest Hypernatremia symptoms — reflecting cellular dehydration: - Mild (145–150 mmol/L): thirst, dry mucous membranes, reduced urine output - Moderate (150–160 mmol/L): weakness, irritability, altered consciousness - Severe ( 160 mmol/L): agitation or stupor, muscle twitching, seizures - Critical ( 170 mmol/L): risk of cerebral vein rupture and subdural hemorrhage from brain shrinkage In older adults, hyponatremia symptoms frequently masquerade as "cognitive decline" or "dementia" and are not recognized in time. When Sodium Abnormalities Require Medical Attention Any sodium value outside the reference range warrants medical evaluation. The urgency depends on the value and the presence of symptoms. Scheduled visit to a doctor when: - Sodium 130–135 mmol/L without symptoms — identify the cause, particularly in patients on diuretics or SSRIs - Sodium 146–150 mmol/L without symptoms — assess hydration status and kidney function See a doctor within hours when: - Sodium < 130 mmol/L or 150 mmol/L in any condition - Moderate deviation combined with symptoms: confusion, weakness, nausea Call emergency services immediately when: - Sodium < 120 mmol/L or 160 mmol/L - Seizures, loss of consciousness, or acute disorientation in the context of a known electrolyte disorder - Rapidly worsening symptoms in a child with diarrhea or vomiting Important: self-correcting sodium — taking saline solutions or restricting water intake without medical supervision — is dangerous. The rate of sodium correction in both directions is strictly regulated: no more than 8–10 mmol/L per 24 hours for chronic disturbances. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or nephrologist if your blood sodium is outside the normal range. https://labreadai.com/en/indicators/transferrin https://labreadai.com/en/indicators/transferrin Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Transferrin is the iron-transport protein. Normal values, TSAT saturation, how to tell iron-deficiency anaemia from anaemia of chronic disease and when to act. Indicators article An iron panel often includes several markers at once — and transferrin occupies a unique position among them. It answers a question that ferritin alone cannot resolve: is the anaemia there because iron is genuinely insufficient, or because inflammation is locking it away in storage? This distinction fundamentally changes the treatment approach. Here's what transferrin measures, how to calculate its saturation, and how to read the results alongside other iron markers. What Is Transferrin and Why Is It Measured Transferrin is a transport protein synthesised by the liver. Its sole function is to carry iron through the bloodstream: capturing it at points of absorption (intestine) or release (breakdown of red cells in the spleen) and delivering it where it is needed — primarily to the bone marrow for haemoglobin synthesis. A single transferrin molecule can bind two iron atoms. In health, only 20–45% of available sites are occupied — the rest remain free as reserve capacity. This free binding space is called the unsaturated iron-binding capacity (UIBC), and the total number of available sites is the total iron-binding capacity (TIBC). The key calculated value is transferrin saturation (TSAT): TSAT (%) = Serum iron / TIBC × 100 Normal TSAT: 20–45%. This percentage is the most informative single indicator of iron availability to the bone marrow in real time. Transferrin is part of the standard iron panel alongside serum iron and ferritin. Together they provide a complete picture of iron metabolism — three different "levels": the current circulating level, the transport capacity, and the storage depot state. Normal Transferrin and Saturation Values Marker Normal Range ------ Transferrin 2.0–3.6 g/L TIBC 45–75 µmol/L UIBC 25–56 µmol/L TSAT (transferrin saturation) 20–45% Women have slightly higher transferrin than men, reflecting lower baseline iron stores. During pregnancy, transferrin rises (to 4.0–4.5 g/L) — the body expands transport capacity for foetal needs. Reference ranges vary slightly between laboratories. Always use the values on your specific report. Transferrin in Iron-Deficiency Anaemia vs Anaemia of Chronic Disease This is the primary diagnostic value of transferrin — and the main reason it is included in a comprehensive iron panel. Two types of anaemia look similar on the surface (haemoglobin reduced, MCV may be low) but require fundamentally different treatment: Iron-deficiency anaemia (IDA) — iron is genuinely insufficient. The body responds by producing more transferrin to "catch" every available iron atom. Transferrin is elevated, TIBC is elevated, ferritin is low, TSAT is low (< 20%). Treatment: iron supplementation. Anaemia of chronic disease (ACD) — iron stores are adequate but inflammation "locks" iron in depots and prevents its use. During inflammation, the liver reduces transferrin synthesis. Transferrin is low, ferritin is elevated (it is an acute-phase protein), TSAT is low or normal. Treatment: treat the underlying inflammatory condition — iron supplementation is ineffective or harmful. Marker IDA ACD --------- Transferrin ↑ elevated ↓ low Ferritin ↓ low ↑ elevated TSAT ↓ low ↓ low or normal Serum iron ↓ low ↓ low TSAT is reduced in both situations — which is exactly why TSAT alone is insufficient. Only the combined analysis of transferrin and ferritin allows the two conditions to be distinguished. A combination can also exist: a patient with rheumatoid arthritis (chronic inflammation) may simultaneously have genuine iron deficiency — ferritin will be modestly elevated but transferrin also elevated, and TSAT markedly reduced. Why Is Transferrin High? Iron deficiency — the most common cause. Compensatory response: no iron → more carriers. The more severe the deficiency, the higher the transferrin. Pregnancy — physiological rise, most pronounced in the second and third trimester. Oral contraceptives — the oestrogen component stimulates transferrin synthesis in the liver. Chronic blood loss (menorrhagia, gastrointestinal bleeding) — ongoing iron losses drive a compensatory transferrin rise. Why Is Transferrin Low? Chronic inflammation and infection — cytokines (IL-6, TNF-α) suppress hepatic transferrin synthesis. Classic ACD pattern. Liver disease — in cirrhosis, hepatitis, and fatty liver disease, synthetic function declines. Transferrin falls alongside ALT, AST, and albumin. Nephrotic syndrome — transferrin is lost with protein through the kidneys. Malnutrition and malabsorption — insufficient substrate for protein synthesis. Iron overload (haemochromatosis) — feedback mechanism: excess iron → fewer carriers. TSAT is markedly elevated ( 60–70%). Hereditary atransferrinaemia — extremely rare genetic disorder with near-absent transferrin. Despite paradoxically overloaded depots, the bone marrow cannot access iron and severe anaemia develops. How to Prepare for the Iron Panel Transferrin Test Transferrin is measured as part of the iron panel. Blood is drawn fasting — after 8–12 hours without food: eating, especially iron-rich food, alters serum iron and shifts the TSAT calculation. Morning draw is preferred. Important: do not test during an acute illness or inflammatory flare — transferrin as a negative acute-phase protein will fall, creating a false ACD picture even when genuine iron deficiency is present. Tell your doctor about iron supplementation — it raises serum iron and TSAT without changing transferrin. If the goal is to assess baseline iron metabolism, test before starting treatment or several days after the last dose. When to See a Doctor Schedule a routine GP appointment if: - TSAT is below 20% combined with reduced haemoglobin — iron deficiency for erythropoiesis requires investigation of the cause. - Transferrin is low with normal or elevated ferritin in a patient without signs of inflammation — exclude liver or kidney disease. - TSAT exceeds 60% — exclude haemochromatosis. Conclusion Transferrin is a key element in anaemia diagnosis because it answers the question "why?" when haemoglobin is already reduced. Paired with ferritin, it separates genuine iron deficiency from anaemia of inflammation — two conditions with similar appearances but fundamentally different management. TSAT gives the clinician real-time information about how much iron is actually available for haematopoiesis right now. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/triglycerides https://labreadai.com/en/indicators/triglycerides Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Triglycerides: normal ranges by age, causes of elevation and links to cholesterol. How to lower levels through diet and lifestyle, and when medication is needed. Indicators article If cholesterol is the headline villain of cardiovascular risk conversations, triglycerides tend to stay in its shadow. Yet elevated triglycerides are an independent risk factor for both myocardial infarction and acute pancreatitis — and they are among the most responsive of all lipid markers to lifestyle change: the right interventions can reduce triglycerides by 30–50% without a single medication. Let's break down what triglycerides are, why they rise, and what to do about it. What Triglycerides Are and How They Form Triglycerides (TG) are esters of glycerol and three fatty acid chains. They are the primary form of fat storage in the body: triglycerides fill adipocytes (fat cells) and represent the body's main caloric reserve. Triglycerides enter the blood via two routes. The first is from the intestine after dietary fat absorption: they are packaged into chylomicrons and transported through lymph into circulation. The second is synthesized in the liver from carbohydrates and free fatty acids and secreted as very-low-density lipoproteins (VLDL). This second pathway explains a paradox that surprises many patients: triglycerides rise not only from fatty food but also from excess sugar and simple carbohydrates — the liver converts surplus carbohydrate into fat. This is precisely why a lipid panel must be drawn strictly fasting: even a light snack sharply elevates postprandial triglycerides. Once in the blood, triglycerides within VLDL are hydrolyzed by lipoprotein lipase in muscle and adipose capillaries, releasing fatty acids for energy or storage. VLDL remnants are converted to LDL — and here the direct link between triglyceride levels and the atherogenic potential of the blood becomes clear. Normal Triglyceride Levels by Age Reference values for triglycerides are largely sex-independent in adults but vary modestly with age. Risk-based threshold values are uniform for all adults. Age Normal range (mmol/L) ------ Children under 10 0.34–1.13 Children 10–19 years 0.36–1.48 Adults 20–29 years 0.45–2.27 Adults 30–39 years 0.45–2.60 Adults 40–49 years 0.45–2.71 Adults over 50 0.45–2.83 Clinically relevant thresholds for adults: TG level (mmol/L) Interpretation ------ < 1.7 Desirable 1.7–2.2 Borderline high 2.3–5.6 High — lifestyle modification mandatory 5.6 Very high — acute pancreatitis risk 11.3 Severe hypertriglyceridemia — emergency treatment During pregnancy, triglycerides physiologically rise 2–3-fold — this is normal and does not require treatment. How to Prepare for a Triglyceride Test Triglycerides are among the most unstable markers in the lipid profile. Preparation errors produce far greater result distortion than for cholesterol or glucose. - Strictly fasting: minimum 12 hours without food — optimally 12–14 hours. Even a small snack 4–6 hours before the draw can elevate results by 1.5–2-fold - No alcohol for 72 hours: alcohol acutely stimulates hepatic VLDL synthesis - Limit physical exercise the day before: intense training transiently lowers triglycerides — the result will be falsely low - Stable diet: do not radically change eating habits in the 2–3 weeks before testing — results should reflect typical levels, not a dietary intervention - Body position: draw blood seated after 5–10 minutes of rest — lying down reduces TG by approximately 5–10% When triglycerides are first found elevated — especially above 5.6 mmol/L — repeat the test under identical conditions 2–4 weeks later before making any therapeutic decisions. Causes of High Triglycerides Hypertriglyceridemia is one of the most multifaceted lipid abnormalities: the causes range from dietary habits and systemic disease to genetics and medications. Cause Mechanism Characteristic features --------- Excess simple carbohydrates and alcohol Enhanced hepatic VLDL synthesis Isolated TG elevation; falls with diet change Obesity, especially abdominal Excess free fatty acids from visceral fat Combined with low HDL Type 2 diabetes and insulin resistance Reduced lipoprotein lipase activity Diabetic dyslipidemia: TG↑, HDL↓, small dense LDL Hypothyroidism Reduced VLDL clearance Combined with elevated LDL and low HDL Chronic kidney disease Impaired VLDL catabolism Often combined with low HDL Familial hypertriglyceridemia Genetic defect in TG synthesis or catabolism Often marked elevation; family history Medications Oral estrogens, beta-blockers, retinoids, antipsychotics, tacrolimus Rise linked to specific drug Pregnancy Physiological increase in VLDL synthesis 2–3× elevation; normal in 3rd trimester The combination of high triglycerides with low HDL is the classic fingerprint of metabolic syndrome and insulin resistance. This "atherogenic duo" poses substantially greater cardiovascular risk than either marker alone. Causes of Low Triglycerides Low triglycerides (< 0.45 mmol/L) are less common but carry clinical significance. Main causes: hyperthyroidism — accelerated lipoprotein catabolism; malabsorption syndromes (celiac disease, Crohn's) — impaired dietary fat absorption; severe fasting or cachexia — depletion of fat stores; hypobetalipoproteinemia — a rare genetic defect in apo-B-containing lipoprotein synthesis. Isolated low triglycerides in a young, healthy person eating well are generally not pathological. Triglycerides, HDL and LDL: How They Are Connected Triglycerides cannot be interpreted in isolation — they are linked to the other lipid fractions through shared metabolic pathways. Triglycerides and HDL — a reciprocal relationship. HDL ("good" cholesterol) exchanges components with VLDL particles: high triglyceride levels "consume" HDL, depleting its concentration. This is why reducing triglycerides almost always raises HDL — and vice versa. A patient with TG 2.3 mmol/L and HDL < 1.0 mmol/L needs immediate lifestyle intervention. Triglycerides and LDL. Elevated TG promotes the formation of small dense LDL (sdLDL) — the most atherogenic LDL subfraction. These particles penetrate the vessel wall more easily and circulate longer. This is why high triglycerides are a risk factor for atherosclerosis even when total LDL appears "normal." Friedewald equation (calculated LDL): LDL = Total cholesterol − HDL − TG/2.2. When TG exceeds 4.5 mmol/L, this formula becomes unreliable and direct LDL measurement is required. How to Lower Triglycerides and When to See a Doctor Triglycerides are uniquely responsive to non-pharmacological interventions — more so than most other lipid markers. Diet — the primary lever: - Sharp reduction in simple carbohydrates and added sugar: replacing white bread, sweets, juices, and soft drinks with complex carbohydrates and fiber reduces TG by 20–30% - Complete elimination or strict minimization of alcohol: even moderate intake sustains hypertriglyceridemia - Increased omega-3 fatty acids: fatty fish (salmon, mackerel, sardines) 2–3 times per week reduces TG by 15–30%; for significantly elevated levels — prescription-grade omega-3 at high doses (2–4 g/day of EPA+DHA) - Replacing saturated fats with monounsaturated fats (olive oil) provides modest TG reduction Physical activity: moderate-intensity aerobic exercise for 30 minutes five times per week reduces triglycerides by 20–30% through activation of lipoprotein lipase in muscles. Weight loss: each kilogram of abdominal fat lost reduces TG by approximately 2%; losing 5–10% of body weight in obesity reduces TG by 20–30%. Drug treatment is indicated when TG 5.6 mmol/L or when lifestyle changes are insufficient in the context of high cardiovascular risk: - Fibrates (fenofibrate, bezafibrate) — first-line agents for severe hypertriglyceridemia; reduce TG by 30–50% - High-dose omega-3 — in combination with statins - Statins — modestly reduce TG (by 10–20%) and remain the foundation of therapy in high cardiovascular risk - Niacin — effective but rarely used due to side effect profile See a doctor if triglycerides exceed 2.3 mmol/L on repeat testing, and seek urgent evaluation at TG 5.6 mmol/L — the risk of acute pancreatitis at levels above 11 mmol/L is very high and requires inpatient treatment. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or cardiologist for any triglyceride abnormality. https://labreadai.com/en/indicators/tsh https://labreadai.com/en/indicators/tsh Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) TSH is the pituitary hormone that controls the thyroid. Normal ranges by age and pregnancy, what drives abnormal levels, and how to prepare for the test correctly. Indicators article TSH — thyroid-stimulating hormone — occupies a unique position among hormonal markers: it simultaneously reflects the state of the thyroid gland and actively controls it. This is why TSH is among the first tests ordered for fatigue, weight gain, hair loss, or heart rhythm disturbances — symptoms that may or may not point to thyroid pathology. Understanding the biology of this hormone is the foundation of interpreting its values correctly. What TSH Is and How It Regulates the Thyroid TSH is a glycoprotein hormone produced by thyrotroph cells in the anterior pituitary. Its structure resembles other pituitary gonadotropins (LH, FSH) and human chorionic gonadotropin (hCG): all share a common α-subunit and a hormone-specific β-subunit that determines biological activity. TSH regulation operates on a negative feedback loop: - The hypothalamus releases thyrotropin-releasing hormone (TRH), stimulating the pituitary to produce TSH - The pituitary releases TSH into the bloodstream, where it reaches the thyroid gland - The thyroid gland, under TSH stimulation, synthesizes thyroxine (T4) and triiodothyronine (T3) - T3 and T4 feed back to inhibit TSH production by the pituitary This is the classic loop: the fewer thyroid hormones in circulation, the higher the TSH (the pituitary presses the accelerator); the more thyroid hormones, the lower the TSH (the pituitary releases the pressure). This is precisely why TSH is a more sensitive indicator of thyroid dysfunction than T3 or T4 themselves — it reacts earlier, even while peripheral hormone levels are still technically normal. TSH binds to specific receptors on thyroid cells (thyrocytes) and serves two functions: it stimulates synthesis and secretion of thyroid hormones, and it drives growth of thyroid tissue. With chronically elevated TSH, the thyroid gland gradually enlarges — a goiter forms. A full practical guide to interpreting TSH results across different clinical situations is available in the article how to read TSH results. TSH Normal Ranges by Age and Physiological State TSH reference values vary substantially with age and physiological condition. Applying an adult reference range to a newborn or a pregnant woman is a significant interpretive error. Age / condition Normal TSH (mIU/L) ------ Newborns days 1–4 1.0–39.0 Infants under 6 weeks 1.7–9.1 Infants 6 weeks – 14 months 0.7–6.4 Children 14 months – 5 years 0.7–5.97 Children 5–14 years 0.6–4.84 Adults 18–60 years 0.4–4.0 Adults over 60 years 0.5–8.0 Pregnancy — 1st trimester 0.1–2.5 Pregnancy — 2nd trimester 0.2–3.0 Pregnancy — 3rd trimester 0.3–3.5 Several important nuances: Adults over 60. The upper limit of normal is higher in older adults than in young adults — this is physiologically normal and does not require treatment. Prescribing thyroid hormones to an elderly patient with a TSH of 5–6 mIU/L based solely on the laboratory value without symptoms is a recognized and undesirable clinical error. Pregnancy. The lower reference range in the first trimester reflects the fact that hCG — the pregnancy hormone — partially mimics TSH and directly stimulates the thyroid, reducing the need for pituitary-derived TSH. This is not pathological. Diurnal rhythm. TSH follows a distinct circadian pattern: peak levels occur between 2–4 AM and early morning (6–8 AM); nadir is in the afternoon (12–18 hours). The difference between morning and afternoon values can be 1.5 to 2-fold — which explains why morning testing is recommended. How to Prepare for a TSH Blood Test TSH is considered a relatively stable hormone, but several conditions significantly influence the result. - Optimal testing time: morning, 8:00–11:00 AM, fasting or 3–4 hours after a light breakfast - For serial monitoring: always test under identical conditions (same time of day, same laboratory, same dietary status) — different analytical methods can produce results differing by 0.2–0.5 mIU/L - When taking levothyroxine: draw blood before the morning dose; otherwise the result reflects the drug's peak level, not the true background TSH - Acute illness, surgery, and hospitalization can transiently suppress TSH — repeat testing after recovery TSH is almost always ordered as part of the full thyroid panel — free T4 and free T3 — and with thyroid peroxidase antibodies when autoimmune disease is suspected. High TSH: Causes and Clinical Significance Elevated TSH means the pituitary is intensively stimulating the thyroid — a response to insufficient production of thyroid hormones or a disruption of their feedback effect at the pituitary level. Primary hypothyroidism is the most common cause. The thyroid produces inadequate T4 and T3 → the pituitary compensatorily increases TSH. Causes include Hashimoto's autoimmune thyroiditis (most prevalent), thyroidectomy (including for thyroid cancer), radioiodine treatment, iodine deficiency, and congenital hypothyroidism. Clinical details and treatment are covered in hypothyroidism. Subclinical hypothyroidism — TSH elevated (typically 4–10 mIU/L) with normal T4 and minimal or absent symptoms. Requires monitoring but not always treatment. Thyroid hormone resistance — a rare genetic condition: thyroid hormone receptors are insensitive to T3 and T4; the pituitary does not register normal concentrations and continues secreting TSH. Characteristic combination: elevated TSH alongside simultaneously elevated T4 and T3. TSH-secreting pituitary adenoma — a rare cause of elevated TSH. Distinguishing feature from primary hypothyroidism: T4 is also elevated, not reduced. Transient causes: euthyroid sick syndrome during recovery from systemic illness, adrenal insufficiency, and medications (amiodarone, lithium, metoclopramide, certain antipsychotics). Low TSH: Causes and Clinical Significance Suppressed TSH means the pituitary has gone quiet — the thyroid is overproducing hormones or receiving stimulation that bypasses the normal regulatory loop. Hyperthyroidism (thyrotoxicosis) is the primary cause of suppressed TSH. Graves' disease: antibodies mimic TSH, autonomously stimulating the thyroid. Toxic nodular goiter: individual nodules function independently of TSH. In overt thyrotoxicosis, TSH is often undetectable (< 0.01 mIU/L). Details in hyperthyroidism. Subclinical thyrotoxicosis — TSH suppressed (< 0.4 mIU/L), T4 and T3 normal, minimal symptoms. In older adults, increases the risk of atrial fibrillation and bone density loss. Levothyroxine overdose — when hypothyroidism is treated with too high a dose. A common iatrogenic cause. Central hypothyroidism (secondary/tertiary) — pituitary or hypothalamic pathology. Paradoxical combination: TSH low or "normal" while T4 is also low. Causes: pituitary tumors, ischemia, infiltrative disease, head trauma. First trimester of pregnancy — physiological TSH suppression from hCG stimulation. Transient causes: acute illness, fasting, high-dose glucocorticoids, dopaminergic medications. What Affects TSH Levels: Drugs and Physiological Factors TSH is sensitive to a wide range of external influences — an essential consideration when interpreting borderline results. Drugs that raise TSH: - Amiodarone — contains iodine and directly disrupts thyroid metabolism; TSH may rise even with normal thyroid function - Lithium — concentrates in the thyroid, suppresses thyroid hormone synthesis - Metoclopramide, domperidone — dopamine antagonists, indirectly stimulate TSH secretion - Certain antipsychotics (haloperidol, chlorpromazine) Drugs that lower TSH: - High-dose glucocorticoids — suppress TRH and TSH secretion - Dopamine and bromocriptine — direct inhibitors of pituitary thyrotrophs - Excess levothyroxine or triiodothyronine - High-dose biotin (vitamin B7) — a technical artifact: does not change actual TSH but interferes with immunoassay methods, producing falsely low readings Physiological factors: - Acute psychological stress — transient decrease - Fasting — TSH reduction - Estradiol and pregnancy — reduction via hCG action and direct estrogen effects on the pituitary - Obesity — modest TSH elevation in some patients even without thyroid pathology - Biotin: if the patient takes high doses, blood should be drawn 48–72 hours after the last dose When TSH Levels Require Medical Attention Minor borderline deviations without symptoms often require only monitoring — not treatment. Clinical approach depends on the combination of the TSH value, symptoms, and T4/T3 results. See a doctor soon if you have: - TSH 4.0 mIU/L with symptoms (fatigue, cold intolerance, weight gain, hair loss) - TSH 10 mIU/L — regardless of symptoms - TSH < 0.1 mIU/L — regardless of symptoms - Any TSH deviation during pregnancy - TSH trending up or down on serial testing without an obvious explanation Seek urgent care if symptoms of thyrotoxic crisis appear — high fever, escalating heart rate 140 bpm, agitation, or altered consciousness — or myxedema coma: marked lethargy, hypothermia, and edema in a patient with known hypothyroidism. This article is for informational purposes only and does not replace professional medical advice. TSH interpretation should be performed by an endocrinologist or GP in the context of the full clinical picture. https://labreadai.com/en/tests/complete-blood-count https://labreadai.com/en/tests/complete-blood-count Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CBC normal ranges for adults: hemoglobin, WBC, platelets, ESR, MCV and MCH explained. Causes of high and low values for each parameter and when to see a doctor. Tests article Your doctor ordered a complete blood count, and now you're staring at a lab report full of abbreviations and up-and-down arrows — unsure what any of it means. This happens to almost everyone. Let's break down each CBC parameter: what it measures, what's considered normal for adults, what abnormal values suggest, and when results require urgent attention. What Does a CBC Show and Why Is It Ordered A complete blood count (CBC), also called a full blood count, is the most fundamental laboratory test — it evaluates the cellular composition of blood. Blood contains three main cell types: red blood cells (carry oxygen), white blood cells (immune defense), and platelets (clotting). The CBC measures their count, size, and ratio, plus hemoglobin levels and ESR. It's the most frequently ordered test in clinical practice, and for good reason. One report gives your doctor a snapshot of several body systems at once: the blood-forming system, the immune system, and the clotting system. A CBC is ordered at routine check-ups, when symptoms are present, to monitor ongoing treatment, and as a general health screen. How to Prepare for a CBC Blood is collected from a finger (capillary) or a vein (venous). Venous blood is more accurate — less cell trauma and more reliable differential counts. Most modern labs use venous blood as standard. Simple preparation rules: - Have the test done fasting in the morning — at least 8 hours after your last meal. Eating triggers physiological leukocytosis, temporarily raising white blood cell counts. - Avoid alcohol and intense exercise for 24 hours beforehand. - Don't smoke for 1 hour before the draw. - Tell your doctor about all medications you take — antibiotics, hormones, and anticoagulants all affect blood count values. How to Read CBC Results: Normal Ranges for Adults Red Blood Cells and Hemoglobin Red blood cells (erythrocytes) carry oxygen from the lungs to every tissue in the body and bring carbon dioxide back. Think of them as tiny delivery vehicles running non-stop through your blood vessels. RBC (red blood cell count): normal range — men 4.5–5.5 × 10¹²/L, women 3.8–5.1 × 10¹²/L. Hemoglobin (HGB) is the protein inside red blood cells that actually binds oxygen. It's the primary marker of anemia. Normal: men 130–170 g/L, women 120–150 g/L. Low hemoglobin = the main sign of anemia. High hemoglobin occurs with dehydration or polycythemia. Hematocrit (HCT) is the percentage of blood volume made up of red blood cells. Normal: men 39–49%, women 35–45%. Red Cell Indices: MCV, MCH, MCHC These three values describe the size and hemoglobin content of red blood cells. On their own they don't say much — but combined with hemoglobin level, they identify the type of anemia. Index What it measures Normal Low suggests High suggests --------------- MCV Mean cell volume 80–100 fL Iron deficiency B12/folate deficiency MCH Mean cell hemoglobin 27–33 pg Iron deficiency B12 deficiency MCHC Mean cell hemoglobin concentration 320–360 g/L Iron deficiency Spherocytosis In short: small, pale red blood cells (low MCV and MCH) point to iron-deficiency anemia. Abnormally large cells (high MCV) point to B12 or folate deficiency. White Blood Cells and Differential White blood cells (leukocytes) are the immune system's front line — they detect and destroy bacteria, viruses, and foreign agents. The normal WBC count for adults is 4.0–9.0 × 10⁹/L. Leukocytosis (elevated WBC) usually signals infection or inflammation. Leukopenia (low WBC) suggests viral infection, certain medications, or bone marrow dysfunction. But the total WBC count is only half the picture. The CBC differential — the percentage breakdown of white blood cell types — tells you far more: Cell type Normal (%) Role --------- Neutrophils 48–78 Fight bacteria and fungi Lymphocytes 18–40 Viral immunity, immune memory Monocytes 2–9 Phagocytosis, clean-up Eosinophils 0.5–5 Allergic reactions, parasites Basophils 0–1 Allergic response mediators Left shift — band (immature) neutrophils above 6%. Indicates acute bacterial infection: the body urgently releases immature cells to fight the threat. Right shift — hypersegmented neutrophils, typical of B12 deficiency or chronic disease. Platelets and Reticulocytes Platelets (PLT) are small cells that form the first plug at the site of blood vessel injury. Normal: 150–400 × 10⁹/L. Low platelets raise the risk of bleeding; high platelets raise the risk of clotting. Reticulocytes (RET) are newly released immature red blood cells fresh from the bone marrow. Normal: 0.5–2.0%. Their level shows how actively the bone marrow is producing new red cells. Elevated after blood loss or during anemia treatment; reduced in aplastic anemia. ESR ESR (erythrocyte sedimentation rate) is a non-specific inflammation marker. Normal: up to 15 mm/h in men, up to 20 mm/h in women. It rises with any inflammation, infection, anemia, autoimmune disease, or malignancy. A normal ESR doesn't rule out disease, and an elevated ESR doesn't make a diagnosis — it's a prompt to investigate further. CBC Normal Ranges: Summary Table Parameter Men Women --------- RBC (× 10¹²/L) 4.5–5.5 3.8–5.1 Hemoglobin (g/L) 130–170 120–150 Hematocrit (%) 39–49 35–45 MCV (fL) 80–100 80–100 MCH (pg) 27–33 27–33 MCHC (g/L) 320–360 320–360 WBC (× 10⁹/L) 4.0–9.0 4.0–9.0 Platelets (× 10⁹/L) 150–400 150–400 ESR (mm/h) up to 15 up to 20 Reticulocytes (%) 0.5–2.0 0.5–2.0 Reference ranges vary slightly between laboratories. Always use the ranges printed on your specific lab report — not general internet values. Causes of Abnormal CBC Results: Low Hemoglobin and High White Blood Cells Anemia: Low Hemoglobin Anemia is a syndrome, not a single diagnosis. The CBC pattern can point toward the cause before any additional tests are ordered: - Iron-deficiency anemia — low HGB, low MCV and MCH. The most common form, especially in women of reproductive age. Confirmed with a ferritin and serum iron panel: it can detect depleted iron stores before full anemia develops. - B12/folate-deficiency anemia — low HGB, high MCV, hypersegmented neutrophils in the differential. - Anemia of chronic disease — mildly low HGB, normal or slightly reduced MCV. Accompanies inflammatory, autoimmune, or oncological conditions. High White Blood Cell Count (Leukocytosis) Leukocytosis signals that the immune system is activated. The differential tells you what's driving it: - Neutrophilia with left shift — acute bacterial infection (pneumonia, pyelonephritis, abscess). - Lymphocytosis — viral infection (flu, mononucleosis, COVID-19). - Eosinophilia — allergic reaction or parasitic infestation. - WBC 30 × 10⁹/L — leukemia must be ruled out; hematologist referral is mandatory. Low Platelet Count Platelets below 100 × 10⁹/L require investigation. Causes include immune thrombocytopenia, drug side effects, viral infection, or bone marrow disease. Do not attempt self-treatment when platelets are low. When to Seek Urgent Medical Attention Most minor CBC abnormalities call for a routine visit to your doctor. But some values require immediate action: - Hemoglobin below 70 g/L — severe anemia, possible hospitalization - WBC above 30 × 10⁹/L or below 1.0 × 10⁹/L — see a doctor urgently - Platelets below 50 × 10⁹/L — high bleeding risk - Blast cells in the differential — hematologist referral the same day - Sharp drop in multiple parameters simultaneously (pancytopenia) — emergency What Can Affect Your Results Some CBC values may be falsely altered — not due to disease, but due to external factors. Worth knowing before drawing conclusions: - Eating before the test — raises WBC temporarily - Stress or exercise — temporary leukocytosis and platelet rise - Menstruation — lower hemoglobin and platelets in women - Pregnancy — physiological drop in hemoglobin, rise in WBC and ESR - Medications — nearly all drug classes can affect blood count values If a result seems surprising, repeat the test under the same conditions 1–2 weeks later before drawing conclusions. Conclusion A complete blood count is more than a paper full of numbers — it's a real-time snapshot of your body's key systems. Knowing how to read a CBC helps catch anemia, infection, or immune dysfunction early, before serious symptoms appear. But interpreting results always requires a doctor: reference ranges depend on the lab, your age, and the full clinical picture. If your CBC shows abnormalities, don't try to self-diagnose online. Show the report to your doctor — they'll evaluate it in the context of your health and order any follow-up tests if needed. https://labreadai.com/en/tests/iron-panel https://labreadai.com/en/tests/iron-panel Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal ferritin, serum iron and TIBC ranges for adults. How to detect iron deficiency before anemia develops and distinguish it from anemia of chronic disease. Tests article You got a complete blood count — hemoglobin is normal, but you're exhausted, your hair is falling out, and your nails keep breaking. Or the CBC already shows low hemoglobin and your doctor wants to find the cause. Either way, the next step is the iron panel: ferritin, serum iron, and TIBC. Here's what each value means and how to read them together. Why You Need the Iron Panel if You Already Have a CBC A CBC shows the consequence of iron deficiency — low hemoglobin and reduced red blood cells. The iron panel shows the cause and the stores — and catches the problem earlier. Iron deficiency develops in stages. First, stores are depleted: ferritin drops, but hemoglobin is still normal. The person feels tired, loses hair — yet the CBC looks clean. Then iron transport fails: TIBC rises, transferrin saturation drops. Only at the third stage does iron-deficiency anemia appear in the CBC. A full iron panel detects the problem at the first two stages — before anemia has developed. That's why doctors order it when someone feels drained with a "normal" CBC. How to Prepare for the Test The iron panel is one of the most preparation-sensitive blood tests. Mistakes in collection cause false results more often than with most other tests. - Strictly fasting, in the morning. Serum iron can rise 2–3× after eating — the result will appear falsely normal. - Stop iron supplements 5–7 days before. Even a single dose the night before makes the result unreliable. - Don't test during menstruation — iron levels will be falsely low. - Avoid alcohol and intense exercise for 48 hours beforehand. - Tell your doctor about hormonal medications, antibiotics, and oral contraceptives — they affect ferritin and transferrin levels. Ferritin — The Primary Marker of Iron Stores Ferritin is a storage protein that holds iron inside cells as a reserve. Its blood level directly reflects the body's total iron stores. It is the earliest and most sensitive marker of iron deficiency. Normal ferritin ranges: Group Normal (µg/L) ------ Men 30–300 Women 12–150 Pregnant 12–60 A value below normal is the first sign of depleted stores — even with a normal hemoglobin. This is latent iron deficiency: reserves are exhausted, no anemia yet — but the person already feels fatigue, hair loss, and cold intolerance. Key caveat: ferritin is an acute-phase protein. Any inflammation, infection, liver disease, or malignancy raises ferritin independently of iron stores. A ferritin of 80 µg/L during active inflammation may conceal a true deficiency. That's why ferritin must always be interpreted together with TIBC and transferrin saturation — never in isolation. Serum Iron, TIBC and Transferrin Saturation Three values that work as a system. Each one alone is unreliable; together they tell the full story. MCV also helps classify the type of anaemia once it has developed. Serum iron — how much iron is currently circulating in the blood bound to transferrin. Normal: men 11.6–31.3 µmol/L, women 9.0–30.4 µmol/L. This value is unstable: it shifts after meals, with stress, and throughout the day. It must be read alongside TIBC. TIBC (total iron-binding capacity) — the maximum amount of iron transferrin can carry. Normal: 45–75 µmol/L. Think of transferrin as a bus: TIBC is how many passengers (iron molecules) it can hold. When iron is scarce, transferrin goes "hungry" — TIBC rises. In inflammation or liver disease — it falls. Transferrin saturation (TSAT) = serum iron ÷ TIBC × 100%. Normal: 20–45%. Below 16% means not enough iron is reaching the bone marrow for hemoglobin synthesis — even if hemoglobin hasn't dropped yet. How to Read the Results: Interpretation Table The combination of all values distinguishes conditions that look similar on a CBC: Condition Ferritin Serum iron TIBC TSAT --------------- Normal N N N 20–45% Latent iron deficiency ↓ N ↑ N or ↓ Iron-deficiency anemia ↓↓ ↓ ↑↑ ↓↓ Anemia of chronic disease N or ↑ ↓ ↓ or N ↓ Hemochromatosis ↑↑ ↑ ↓ ↑↑ This table is most critical for separating iron-deficiency anemia from anemia of chronic disease — they can look almost identical in a CBC but require completely different treatment. IDA needs iron supplementation; anemia of chronic disease needs treatment of the underlying condition. When Is the Iron Panel Ordered - Low hemoglobin on CBC — to find the cause of anemia - Chronic fatigue, hair loss, brittle nails with a normal CBC - Pregnancy planning and pregnancy — iron deficiency in pregnancy carries serious risks - Heavy menstrual bleeding or chronic gastrointestinal blood loss - Monitoring iron supplementation (retest 4–8 weeks after starting treatment) - Before surgery when anemia is suspected When to See a Doctor Routine visit — when ferritin is below normal or TSAT is below 16% with symptoms. Treatment usually involves iron supplementation with a follow-up test in 4–8 weeks. Urgently — if ferritin exceeds 500 µg/L without obvious inflammation or acute infection: hemochromatosis, liver disease, and malignancy must be ruled out. Don't self-prescribe iron supplements. When ferritin is normal, they provide no benefit — and chronic iron excess is toxic to the liver and heart. The type, dose, and duration of treatment are determined by a doctor based on the cause of the deficiency. Conclusion An iron panel isn't just "checking iron." It's three interconnected values that together paint a complete picture: is there a deficiency, how far along is it, and what's causing it. It's especially valuable when a CBC still looks normal — but the person already feels something is wrong. Interpreting an iron panel requires looking at all values together in the context of the clinical picture. A single low ferritin during active inflammation is not a diagnosis. Only a doctor can interpret these results correctly. https://labreadai.com/en/tests/lipid-panel https://labreadai.com/en/tests/lipid-panel Sat, 21 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Lipid panel measures cholesterol, LDL, HDL and triglycerides to assess heart disease risk. Normal ranges, how to read results by risk group and when treatment is needed. Tests article A cholesterol test gets ordered for almost every patient over forty — and most people look at the single "total cholesterol" figure without realising it tells them very little on its own. The real picture of cardiovascular risk comes from four values together: total cholesterol, LDL, HDL, and triglycerides. This is the lipid panel, or lipid profile. Here's what each marker measures, what the numbers mean, and why the same result can be safe for one person and dangerous for another. What Is a Lipid Panel and Why Is It Done Lipids are fat-like substances essential to cell life: they form cell membranes, serve as raw material for hormones and bile acids, and transport fat-soluble vitamins. The problem isn't that lipids exist — it's when they accumulate in excess or their balance shifts. Too much of certain lipids in the blood triggers atherosclerosis — cholesterol depositing in arterial walls. Plaques narrow the vessels, reduce blood flow to the heart and brain, and when they rupture, they cause thrombosis — the mechanism behind myocardial infarction and stroke. The process unfolds silently over years and decades before any symptom appears. This is precisely why the lipid panel is a preventive tool: it quantifies atherosclerotic risk before a clinical event occurs and creates an opportunity to intervene. Indications: routine screening starting at age 20 (every four to six years if results are normal), annual monitoring with diabetes, hypertension, obesity, or smoking, follow-up on statin therapy, and known family history of hypercholesterolaemia. After age 40 for men and after age 50 or menopause for women — annually. What the Panel Includes: Four Key Markers A standard lipid panel reports four values. Each carries distinct diagnostic weight, and none can be dismissed in isolation. Total cholesterol is the combined content of all cholesterol forms in the blood. It's the starting point — not the treatment target. It includes both "bad" and "good" cholesterol together. A high total cholesterol alone does not indicate high risk; what matters is its composition. LDL — low-density lipoprotein ("bad" cholesterol) is the primary treatment target and the principal driver of atherosclerosis. LDL particles penetrate the arterial wall, oxidise, and form plaque. Lowering LDL is the single most evidence-based intervention for reducing heart attack and stroke risk. HDL — high-density lipoprotein ("good" cholesterol) works in the opposite direction: it collects cholesterol from vessel walls and transports it to the liver for disposal. Higher HDL is better. Low HDL is an independent cardiovascular risk factor. Triglycerides are the body's primary fat storage form. Their level reflects dietary caloric intake, alcohol consumption, and the state of fat metabolism. Elevated triglycerides frequently accompany low HDL and raised blood glucose — the classic triad of metabolic syndrome. From these primary values, the atherogenic index is calculated: (Total cholesterol − HDL) / HDL. A value above 3.0–3.5 in adults indicates elevated risk. Normal Lipid Panel Values An important feature of the lipid panel: LDL target values depend not on a single universal norm but on each patient's cardiovascular risk category. The table below shows general reference values; for patients with established heart disease or diabetes, targets are considerably lower. Marker Optimal Acceptable Elevated ------------ Total cholesterol < 5.0 mmol/L 5.0–6.1 mmol/L 6.2 mmol/L LDL < 3.0 mmol/L 3.0–4.1 mmol/L 4.1 mmol/L HDL (men) 1.0 mmol/L 0.9–1.0 mmol/L < 0.9 mmol/L HDL (women) 1.2 mmol/L 1.0–1.2 mmol/L < 1.0 mmol/L Triglycerides < 1.7 mmol/L 1.7–2.2 mmol/L 2.3 mmol/L Atherogenic index < 3.0 3.0–4.0 4.0 In children and adolescents, norms are lower. In pregnancy, cholesterol physiologically rises in the second and third trimester — results during this period must be interpreted with gestational age in mind. How to Read Results: Does Total Cholesterol or LDL Matter More This is a question that trips up many patients. A total cholesterol of 6.5 mmol/L sounds alarming — but if HDL is 2.2 and LDL is only 3.8, the atherogenic index is low and actual risk is modest. Conversely, a total cholesterol of 5.0 mmol/L with LDL of 3.9 and HDL of 0.8 is a significantly more dangerous picture. Current cardiology guidelines are clear: LDL is the primary target. Its value determines the need for therapy, and reducing it is what statins are designed to achieve. LDL treatment targets vary by cardiovascular risk category: - Low risk (young, no risk factors): LDL < 3.0 mmol/L - Moderate risk (hypertension, smoking, obesity): LDL < 2.6 mmol/L - High risk (diabetes, chronic kidney disease): LDL < 1.8 mmol/L - Very high risk (previous MI, stroke, unstable angina): LDL < 1.4 mmol/L This is why a doctor cannot give a meaningful interpretation of a lipid panel without knowing the patient's full history. The same numbers will require completely different responses depending on context. Why Lipid Values Are Elevated: Causes of Dyslipidaemia Dyslipidaemia — abnormal lipid balance in the blood — arises from two categories of causes. Primary (genetic): Familial hypercholesterolaemia is an inherited disorder of LDL receptors in which cholesterol cannot be cleared from the blood normally. LDL can reach 6–10 mmol/L from childhood. Diet alone does not control this — pharmacological therapy is needed from an early age. Secondary (acquired): far more common. The main drivers: - Diet high in saturated fats and trans fats (fast food, pastries, fatty meat). - Physical inactivity: regular aerobic exercise raises HDL. - Excess body weight and abdominal obesity. - Alcohol: even moderate regular intake markedly raises triglycerides. - Type 2 diabetes and insulin resistance disrupt the entire fat metabolism cycle. - Hypothyroidism: reduced thyroid function raises cholesterol — which is why TSH is checked when cholesterol is high without an obvious cause. - Chronic kidney disease and nephrotic syndrome. - Certain medications: beta-blockers, thiazide diuretics, retinoids, antiretrovirals. For a complete metabolic assessment, a lipid panel is frequently ordered alongside liver function tests and blood glucose — all three reflect different dimensions of metabolic health. How to Prepare for a Lipid Panel Preparation for a lipid panel is stricter than for most blood chemistry tests — and errors here produce the largest distortions. Blood must be drawn fasting for 12–14 hours (most other tests require only 8–10 hours). This is critical: even a glass of milk or a piece of bread two hours before the test will raise triglycerides by 20–50% and distort the entire profile. Avoid alcohol for 48 hours — it raises triglycerides rapidly and the effect persists. Limit fatty food for 24 hours before. Restrict intense physical activity the day before: strenuous exercise transiently shifts HDL and triglyceride levels. Do not test during an acute illness: any active infection or inflammation temporarily changes the lipid profile — LDL falls and triglycerides rise. The best time is six to eight weeks after recovery from a significant illness. Tell your doctor about all medications. Statins, fibrates, oral contraceptives, thyroid hormones — all of these affect results. If testing to monitor therapy, keep the same time of day and don't change the medication schedule before the draw. When to See a Doctor Urgently Call emergency services immediately for any sign of an acute coronary or cerebrovascular event — regardless of what the lipid panel showed: - Chest pain or pressure, especially radiating to the arm, jaw, or back. - Sudden shortness of breath, cold sweat, or air hunger. - Facial asymmetry, slurred speech, limb weakness — signs of stroke. Schedule a routine appointment with a GP or cardiologist if: - LDL exceeds 4.1 mmol/L on a first-time result. - Triglycerides exceed 5.6 mmol/L — high risk of acute pancreatitis. - Values have worsened on repeat testing despite lifestyle changes — for guidance on next steps, see high cholesterol. - Results are being interpreted for the first time and you're unsure which risk category you fall into. Conclusion A lipid panel is not just a "cholesterol test." It is a risk stratification tool: it shows how actively atherosclerosis is progressing right now and creates a window to intervene before a cardiovascular event. Looking at total cholesterol alone means seeing only part of the picture. What matters is LDL, its ratio to HDL, and context — age, risk factors, and co-existing conditions. Interpreting a lipid profile is a physician's task, because the same numbers demand different responses from different patients. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/posts/enterobiasis https://labreadai.com/en/posts/enterobiasis Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Enterobiasis is the world's most common helminthic infection in children. Pinworm symptoms, how to confirm infection with a swab, treatment for the whole family and prevention. Articles article Nocturnal itching in a child, restless sleep, irritability without obvious cause — parents often spend weeks searching for an explanation, not suspecting that a worm a few millimetres long could be responsible. Enterobiasis is the world's most common helminthic infection: according to the WHO, hundreds of millions of people are infected, most of them preschool and school-age children. The good news: it responds well to treatment. The difficult part — it comes back very easily without strict preventive measures. What Pinworms Are and How They Live in the Body The pinworm (Enterobius vermicularis) is a small white roundworm. Females reach 9–13 mm in length; males, 2–5 mm. They live in the lower small intestine and upper large intestine, clinging to the mucous membrane. The pinworm life cycle is simple — and that is precisely what makes it so persistent. At night, the fertilised female migrates out through the rectum and deposits thousands of eggs in the perianal folds. Eggs become infectious within 4–6 hours and can remain viable in the environment for up to three weeks. The entire cycle from egg to adult takes 3–4 weeks. Adult pinworms live for about three months. Without reinfection, the infestation would theoretically resolve on its own. In practice, reinfection almost always occurs — via hands, bed linen, and household objects. How Enterobiasis Spreads The route of transmission is faecal-oral and contact-based. Pinworm eggs from the perianal skin transfer to hands during scratching, then to objects, toys, door handles, bed linen and food — and from there into another person's mouth. Pinworms are among the most contagious of all helminths. Only a few eggs are needed to establish infection. This is why: - in children's settings (nursery, school) enterobiasis spreads extremely rapidly - when one family member is infected, the rest are typically infected too - self-reinfection (autoinfection) occurs constantly when a child scratches the itchy area and immediately puts their hands in their mouth Adults are infected less frequently but are not immune — especially those in close contact with infected children. Symptoms of Enterobiasis The primary and most characteristic symptom is perianal itching, which intensifies in the evening and at night. This is precisely when females emerge to deposit eggs, causing local irritation. Other symptoms: - Sleep disturbance — difficulty falling asleep, frequent waking, restlessness - Irritability and mood changes — a consequence of chronic sleep disruption - Teeth grinding (bruxism) — the link is unproven but frequently reported - Bedwetting (enuresis) — particularly in girls: pinworms can migrate to the perineal and urinary tract area, causing irritation - Abdominal pain — cramping, often in the right iliac region - Reduced appetite, nausea — with heavy infestation - Visible pinworms — thin white threads a few millimetres long, visible on inspection of the perianal area at night or early morning With light infestation, symptoms may be minimal or absent. Some studies associate chronic enterobiasis with reduced concentration and school performance in children. Diagnosis: How to Confirm Infection Clinical symptoms support suspicion but cannot confirm enterobiasis. Confirmation requires laboratory testing. Perianal swab — the primary diagnostic method. Material is collected from the perianal folds in the morning before any hygiene or toilet visit, using adhesive tape (Scotch tape test) or a cotton swab. Detailed collection and interpretation rules are covered in the enterobiasis test article. Importantly: a single swab detects infection in only about 50% of cases. When symptoms are present, three tests on consecutive or alternate days are recommended — sensitivity of this protocol exceeds 95%. Stool test for helminth eggs is not suitable for diagnosing enterobiasis: pinworms deposit eggs outside the bowel, not inside it. Eggs are rarely and only incidentally found in stool. A full blood count may show mild eosinophilia — elevated eosinophils. This is an indirect sign of parasitic infection but is non-specific and does not replace the swab. Treatment of Enterobiasis Treatment is pharmacological and highly effective. Anthelmintic drugs from the benzimidazole group (mebendazole, albendazole) or pyrantel are used. Each drug has age-specific restrictions and dosing — these are determined by the physician. Critical treatment rules: Treat the entire household simultaneously. Treating only the infected child while other family members remain a source of eggs guarantees reinfection within weeks. Repeat course after 2 weeks. Most drugs act on adult worms but not on eggs. Within two weeks, surviving eggs hatch into new larvae — a second course eliminates them before they reach maturity. Simultaneous hygiene measures (see next section) are a mandatory complement to medication. Control swabs — three tests two weeks after completing the course. Negative results confirm successful treatment. Prevention of Reinfection Treatment without hygiene measures is ineffective — pinworm eggs are distributed throughout the home of an infected person. During and after treatment: - Nails — keep short to prevent egg accumulation underneath - Hands — wash with soap after using the toilet, before eating, after playing - Bed linen — change daily during treatment, wash at 60 °C or above (heat kills eggs) - Underwear — change twice daily, wear close-fitting styles (prevents scratching during sleep) - Toys and household objects — damp clean with disinfectant - Toilet and bathroom — daily disinfection during treatment Pinworm eggs are resistant to chlorine at standard concentrations. They are effectively destroyed by boiling and heat above 60 °C. When to See a Doctor See a paediatrician or GP in the following situations: - positive swab result — prescription of an appropriate drug requires medical assessment by age and weight - symptoms persist for more than 2 weeks with negative tests — other causes of itching and sleep disturbance should be excluded, as well as other forms of helminthiasis - repeat swabs remain positive after two treatment courses — consider ongoing reinfection from environment or an untreated contact - a girl develops discharge or burning in the perineal area — pinworms can cause vulvovaginitis Following a positive result in a child, the doctor issues a note excluding the child from group settings until negative control swabs are obtained. This article is for informational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/posts/giardiasis https://labreadai.com/en/posts/giardiasis Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Giardiasis is a protozoan intestinal infection causing chronic diarrhoea and bloating. Symptoms, how to detect Giardia with tests, and effective treatment options. Articles article Persistent diarrhoea, abdominal bloating, and unexplained fatigue that last for weeks — this is the classic picture of giardiasis. Yet many people carrying Giardia have no idea they are infected: in roughly half of cases, the infection is completely asymptomatic. Giardiasis is the most common protozoan intestinal infection in the world, and it is highly prevalent in both developing and developed countries. Here is how Giardia enters the body, what symptoms it causes, and how to reliably diagnose it. What Giardia Is and How It Lives in the Intestine Giardia (Giardia lamblia, also known as Giardia intestinalis or Giardia duodenalis) is a single-celled flagellate protozoan. It exists in two forms: Trophozoite (active form) — mobile, actively feeding. Lives in the duodenum and upper small intestine, attaching to intestinal villi with a suction disc. Trophozoites cause all the symptoms: they mechanically damage the villi and impair absorption of fats and carbohydrates. Cyst (dormant form) — resistant to the environment. Forms as contents pass through the large bowel and is excreted in faeces. Cysts survive in cold water for up to three months and are resistant to chlorination at standard concentrations. Cysts are the infective form. As few as 10–25 cysts are sufficient to establish infection — an exceptionally low infectious dose that explains the high transmissibility of giardiasis. How Giardiasis Spreads Transmission routes are waterborne, foodborne, and contact-based. Waterborne — the most significant route. Giardia cysts resist standard water chlorination. Infection occurs through drinking unboiled water from open sources or wells, or accidentally swallowing water while swimming. Foodborne — eating unwashed fruit and vegetables or contaminated food. Flies and cockroaches can transfer cysts onto food. Contact transmission — through unwashed hands, shared household objects, and toys. Particularly relevant in childcare settings. Risk groups: preschool and primary school-age children, travellers to countries with poor sanitation, immunocompromised individuals, and childcare workers. Symptoms of Giardiasis Giardiasis is deceptive: approximately 50–75% of infected people have no symptoms at all — they remain asymptomatic carriers and a source of infection for others. In the remainder, clinically apparent disease develops. Acute form (first 1–3 weeks): - sudden watery diarrhoea without blood, 3–10 times per day - cramping pain in the upper and mid abdomen - pronounced bloating and gurgling - nausea, reduced appetite - low-grade fever (37.0–37.5 °C) - weakness, headache Chronic form (infestation lasting more than 3 weeks): - alternating diarrhoea and constipation - persistent abdominal bloating and flatulence - malabsorption syndrome — impaired absorption of fats and vitamins - weight loss despite normal appetite - chronic fatigue, irritability - in children — growth faltering with prolonged disease Extra-intestinal manifestations are less common but clinically important: - allergic reactions — urticaria, atopic dermatitis — Giardia may trigger or worsen atopic disease - cholecystitis and biliary dyskinesia — when Giardia penetrates the bile ducts Diagnosis: How to Detect Giardia Clinical symptoms are non-specific — diarrhoea and bloating can have dozens of other causes. Diagnosis is made only by laboratory testing. Stool microscopy for Giardia cysts (coproscopy) — the basic method. The microscopist looks for oval cysts with 2–4 nuclei. The main problem: cysts are shed intermittently, with "silent" periods during which they are absent from stool. Sensitivity of a single examination is 50–70%. Three-sample testing at 1–2 day intervals is required. Trophozoites in stool break down rapidly — the sample must reach the laboratory within 30–60 minutes, or a preservative container must be used. Detailed collection rules are in the stool parasite examination article. PCR of stool for Giardia lamblia — significantly more sensitive than microscopy (90–95%), detecting parasite DNA even with low cyst counts. The preferred method when giardiasis is suspected after negative microscopy results. Serum ELISA for Giardia antibodies — detects specific IgG and IgM. Antibodies appear 2–4 weeks after infection and persist after recovery, making it difficult to distinguish active infection from past exposure. An indirect marker is eosinophilia — elevated eosinophils on a full blood count. Present in 20–30% of patients with giardiasis, but non-specific. Treatment of Giardiasis Treatment is pharmacological. Drugs of choice are nitroimidazole derivatives (metronidazole, tinidazole, ornidazole) or nitrofuran compounds (nifuratel). Treatment regimen, dosage and duration are determined by the physician according to age, weight and comorbidities. Self-treating with antiparasitic drugs without a confirmed diagnosis is inadvisable: similar symptoms occur in irritable bowel syndrome, lactose intolerance and other conditions that require entirely different management. After treatment — a control stool test 3–4 weeks later. If symptoms persist and the test remains positive, a repeat course with a different drug is indicated: Giardia resistance to metronidazole occurs in 10–20% of cases. Diet during treatment: limit simple carbohydrates (sugar, sweets, white bread) — they fuel Giardia growth. Increasing protein and fibre intake is recommended. Prevention of Giardiasis - Drink only boiled or bottled water, especially when travelling - Wash fruit and vegetables thoroughly; scald with boiling water when necessary - Wash hands with soap after using the toilet and before eating - Avoid swallowing water when swimming in open water - Regular wet cleaning, especially in children's rooms Standard chlorination does not kill Giardia cysts — only boiling or UV disinfection is effective. When to See a Doctor See a GP or infectious disease specialist for diarrhoea lasting more than two weeks, particularly with bloating and weight loss. See a paediatrician if a child's symptoms persist for more than a week after possible contact with contaminated water, or during an outbreak in a childcare setting. When giardiasis is diagnosed in a child, all family members are screened, including asymptomatic contacts. This article is for informational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/posts/helminthiasis https://labreadai.com/en/posts/helminthiasis Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Helminthiasis is infection with parasitic worms. Types of helminths, common symptoms, how to detect worms with laboratory tests and which treatments work for each species. Articles article According to WHO estimates, more than one billion people worldwide are infected with intestinal helminths. Helminthiasis does not always cause obvious symptoms — many carriers have no idea they are infected. Chronic parasitism silently depletes the body, impairs absorption of nutrients and weakens the immune system. Here is an overview of the main helminth types, how to recognise infection and when laboratory testing is needed. What Helminthiasis Is and the Main Types of Helminths Helminths are parasitic worms that live and reproduce inside the human body. They fall into three main groups: Nematodes (roundworms) — the most widespread group: - Ascaris lumbricoides — causes ascariasis - Enterobius vermicularis — pinworm, causes enterobiasis — the most common helminthiasis in children - Trichuris trichiura — whipworm, causes trichuriasis - Toxocara canis/cati — causes toxocariasis - Ancylostoma — hookworm, causes hookworm disease Cestodes (tapeworms): - Taenia solium — pork tapeworm (taeniasis, cysticercosis) - Taenia saginata — beef tapeworm (taeniasis) - Diphyllobothrium latum — broad fish tapeworm (diphyllobothriasis) - Echinococcus granulosus — causes echinococcosis Trematodes (flukes): - Opisthorchis felineus — cat liver fluke (opisthorchiasis) — endemic to Siberia - Fasciola hepatica — liver fluke (fascioliasis) Note: Giardia, strictly speaking, is not a helminth but a protozoan — however, it is commonly discussed in the same context due to similar transmission routes and symptoms. See the giardiasis article for detail. How Helminth Infection Spreads Each helminth species specialises in a particular transmission route: Faecal-oral route — the most common. Eggs or larvae enter the mouth via contaminated hands, unwashed vegetables and fruit, or contaminated water. This is how roundworms, pinworms, whipworms and toxocara spread. Foodborne route through meat and fish — infection from undercooked pork (pork tapeworm, Trichinella), beef (beef tapeworm), or freshwater fish (broad tapeworm, opisthorchiasis). Strict temperature control during food preparation is the primary defence against these parasites. Contact transmission — via household objects, toys and bed linen. Characteristic of pinworms. Percutaneous route (through skin) — hookworm larvae and certain other nematode larvae can penetrate intact skin on contact with contaminated soil. Zoonotic route — from animals. Toxocara is transmitted from dogs and cats; Echinococcus from dogs and wild carnivores. Symptoms of Helminthiasis Symptoms depend on the parasite species, intensity of infestation and the host's immune status. Many infestations remain asymptomatic for years. Nevertheless, certain patterns should prompt investigation. Intestinal symptoms (common to most intestinal helminthiases): - intermittent abdominal pain, often cramping - diarrhoea, sometimes alternating with constipation - abdominal bloating and flatulence - nausea, reduced appetite - weight loss despite normal or increased appetite General symptoms (toxicity and allergic sensitisation): - chronic fatigue and weakness - headaches, irritability - skin itching, urticaria, worsening of atopic dermatitis — helminths release toxins that trigger allergic reactions - low-grade fever without a clear infectious focus Species-specific symptoms: - pinworms — nocturnal perianal itching, restless sleep - roundworms (larval migration phase) — cough, shortness of breath (Löffler syndrome) - toxocariasis — ocular involvement (reduced vision), fever, hepatomegaly - opisthorchiasis — right upper quadrant pain, jaundice, cholangitis - broad tapeworm — vitamin B12 deficiency, megaloblastic anaemia In children, helminthiasis symptoms often masquerade as other conditions: poor school performance, growth faltering, recurrent abdominal pain, nocturnal enuresis, teeth grinding. Laboratory marker — eosinophilia. Elevated eosinophils on a full blood count are present in most tissue helminthiases (toxocariasis, roundworm larval migration, trichinellosis). In established intestinal infestation, eosinophilia may be mild or absent. Diagnosing Helminthiasis There is no single universal test for "all worms". The diagnostic method depends on the suspected parasite species. Stool examination for helminth eggs (coproscopy) — the basic method for intestinal forms (roundworms, whipworm, hookworms, tapeworms, broad tapeworm). A single test is unreliable — three-sample testing is recommended. Detailed rules for collection and interpretation are in the stool parasite examination article. Perianal swab for enterobiasis — the only reliable method for pinworms, as they deposit eggs outside the bowel. See the enterobiasis test article. Serological methods (ELISA) — essential for tissue helminthiases where the parasite is not in the intestine: toxocariasis, echinococcosis, trichinellosis. They detect specific IgG and IgM antibodies in blood. PCR — high-sensitivity method used for certain parasites (toxocara, Opisthorchis, Echinococcus). Detects pathogen DNA even at low parasite burden. Abdominal ultrasound — when echinococcosis (liver cysts), opisthorchiasis (bile duct changes) or biliary ascariasis is suspected. Full blood count — a screening tool. Eosinophilia above 5–7% combined with compatible symptoms is a strong indication for targeted parasitological testing. Treatment of Helminthiasis Treatment depends on the parasite species. There is no universal "all-worm" drug — different helminths require different agents and regimens. Main drug groups: - Benzimidazoles (albendazole, mebendazole) — broad spectrum: roundworms, pinworms, whipworm, hookworms, some cestodes and tissue forms - Pyrantel — roundworms, pinworms, hookworms; ineffective against eggs - Praziquantel — cestodes (tapeworms, broad tapeworm) and trematodes (opisthorchiasis, fascioliasis) - Ivermectin — strongyloidiasis, onchocerciasis Self-treatment with anthelmintics without a confirmed diagnosis and parasite identification is inadvisable and potentially harmful. These drugs have contraindications, age restrictions and risks when used incorrectly. Treatment must be prescribed by a physician. After treatment, follow-up testing is mandatory — repeat tests 3–4 weeks after completion to confirm elimination of the parasite. Prevention of Helminthiasis Most helminthiases can be prevented by basic hygiene: - Wash hands with soap after using the toilet, going outdoors, touching animals, and before eating - Wash vegetables, fruit and herbs thoroughly; scald with boiling water when necessary - Cook meat and fish to safe internal temperatures (at least 63 °C in the centre) - Do not drink water from open sources without boiling - Deworm pets (cats and dogs) regularly — at least every three months - Limit children's contact with stray animals; wash hands after playing in sandpits Preventive anthelmintic treatment without laboratory-confirmed diagnosis is not recommended — it is unnecessary and creates the risk of resistance. When to See a Doctor See a GP, infectious disease specialist or parasitologist in the following situations: - elevated eosinophils on blood count with any of the symptoms described above - chronic diarrhoea, abdominal pain or weight loss lasting more than two weeks without identified cause - nocturnal perianal itching in a child (characteristic of pinworms) - reduced vision, fever and liver enlargement — possible toxocariasis - right upper quadrant pain and jaundice in a person who eats freshwater fish — exclude opisthorchiasis - helminthiasis identified in a child's group — screen all close contacts This article is for informational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/indicators/anti-hcv https://labreadai.com/en/indicators/anti-hcv Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) The anti-HCV test detects hepatitis C antibodies in blood. Learn what a positive result means, false-positive causes, confirmatory tests and when to see a doctor. Indicators article Anti-HCV refers to antibodies against the hepatitis C virus that the immune system produces in response to exposure. Detecting these antibodies in blood is the foundation of hepatitis C screening — one of the most common causes of chronic hepatitis worldwide. A positive anti-HCV result does not automatically mean active infection, but it always warrants further investigation. What Anti-HCV Antibodies Mean and Why the Test Is Ordered The anti-HCV test detects total antibodies (IgG and IgM) to structural and non-structural proteins of the hepatitis C virus. It is a screening test: its purpose is to identify individuals who have ever been exposed to the virus. A key point: antibodies do not appear immediately. The "serological window" — the interval from infection to detectable anti-HCV levels — averages 4–10 weeks, occasionally extending to 6 months. This means a negative result in the first few weeks after possible exposure does not rule out infection. Anti-HCV antibodies remain in the blood for life even after successful treatment. A positive result therefore indicates one of three scenarios: active infection, a past resolved infection, or a false-positive result. When Anti-HCV Screening Is Ordered Anti-HCV testing is part of standard screening programs and is ordered in the following situations: - Unexplained elevation of ALT or AST - Pre-surgical workup and hospital admission - Pregnancy planning and prenatal monitoring - Blood and organ donor screening - Needlestick exposure or contact with an infected person's blood - Chronic liver disease or abnormalities on a liver function test - History of injection drug use (even a single episode) - HIV infection (HCV co-infection is common) The WHO recommends at least one-time anti-HCV screening for all adults, particularly those born between 1965 and 1985 — the cohort with the highest viral prevalence. How to Prepare for an Anti-HCV Blood Test No special preparation is needed. Blood is drawn from a vein; fasting or non-fasting status does not materially affect the result, although most laboratories recommend a morning fasting draw for standardization. Medications do not affect antibody detection, with one exception: immunosuppressive therapy (post-transplant, autoimmune conditions) can suppress antibody production and yield a false-negative result despite active infection. Results are typically available within 1–2 business days. Rapid anti-HCV tests (using a finger-prick blood sample) provide a preliminary answer in 15–20 minutes, but any positive rapid test must be confirmed in a laboratory. Anti-HCV Results: Normal Range and Interpretation Result Meaning Next steps --------- Negative (antibodies not detected) No prior exposure, or test performed during serological window If recent risk — repeat in 3–6 months Positive (antibodies detected) Prior exposure to HCV: active infection, resolved infection, or false positive Confirmatory test: HCV RNA PCR Indeterminate (grey zone) Antibody level near the assay threshold Repeat testing in 2–4 weeks The key principle: a positive anti-HCV is not a diagnosis — it is a reason for further testing. Only detection of viral RNA by PCR confirms active infection. If PCR is negative with a positive anti-HCV, the virus was either cleared (spontaneously or after treatment) or the initial result was a false positive. When active infection is confirmed, bilirubin and other liver function markers are assessed to determine the degree of hepatic damage. False-Positive and False-Negative Anti-HCV Results False-positive anti-HCV occurs in 1–2% of screening tests and is associated with: - Autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus) - Hypergammaglobulinemia of any cause - Recent vaccination (particularly influenza) - Pregnancy (due to immune status changes) - Advanced age (nonspecific antibody elevation) - Laboratory technical error False-negative anti-HCV — a more dangerous situation: - Serological window (first 4–10 weeks after infection) - Severe immunosuppression (HIV with low CD4, chemotherapy, immunosuppressant use) - Hemodialysis (patients on hemodialysis may not produce sufficient antibodies) - Agammaglobulinemia When clinical suspicion is high despite a negative anti-HCV, HCV RNA PCR should be ordered directly — this method does not depend on the immune response. Positive Anti-HCV: Confirmatory Tests and Next Steps The recommended algorithm for a positive anti-HCV result: 1. Qualitative HCV RNA PCR — determines whether the virus is currently present in the blood 2. If PCR is positive — quantitative PCR (viral load) and HCV genotyping to guide treatment selection 3. Liver assessment — biochemistry panel (ALT, AST, bilirubin, albumin), liver elastography (FibroScan) or biopsy 4. Co-infection screening — HBsAg test (hepatitis B), HIV test Modern direct-acting antiviral agents (DAAs) cure chronic hepatitis C in 95–99% of cases within 8–12 weeks. Treatment is accessible, well-tolerated, and does not require interferon injections — unlike older regimens. When to See a Doctor Consult an infectious disease specialist or hepatologist if: - Your anti-HCV test came back positive — even if you feel completely well - Liver enzymes (ALT, AST) are elevated without an obvious cause - You had contact with potentially infected blood - You belong to a risk group and have never been tested for hepatitis C Do not delay evaluation: hepatitis C often progresses silently for years, and early detection and treatment prevent the development of cirrhosis and liver cancer. This article is for informational purposes only and does not replace professional medical advice. Interpretation of anti-HCV test results requires a physician's evaluation. https://labreadai.com/en/indicators/anti-tg https://labreadai.com/en/indicators/anti-tg Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Anti-TG antibodies: normal range, causes of elevation in Hashimoto's thyroiditis and cancer. Why anti-TG is critical for monitoring thyroid cancer recurrence after surgery. Indicators article Anti-thyroglobulin antibodies (anti-TG) are the second major marker of autoimmune thyroid disease. They complement anti-TPO in diagnosing Hashimoto's thyroiditis — and after total thyroidectomy for cancer, anti-TG takes on a different, critical role: it interferes with measuring thyroglobulin, the primary tumour recurrence marker, making its own trend the key monitoring tool instead. What Is Thyroglobulin and Why Does the Body Produce Antibodies Against It Thyroglobulin is a large protein produced exclusively by thyroid cells. It acts as a storage molecule and precursor for thyroid hormones T3 and T4, which are cleaved from it by enzymes before entering the bloodstream. Under normal conditions, thyroglobulin rarely leaves the thyroid, so the immune system leaves it alone. In autoimmune inflammation, this barrier breaks down: thyroglobulin enters circulation, the immune system recognises it as foreign, and produces anti-TG antibodies. These antibodies do not destroy tissue as aggressively as anti-TPO, but they are a reliable indicator of autoimmune activity. Anti-TG is often ordered together with anti-TPO, TSH and calcitonin as part of a comprehensive thyroid panel. Anti-TG Normal Range Reference values depend on the assay method, so the only reliable benchmark is your laboratory's own reference range. Most modern immunochemiluminescent assays use: Category Normal Range (IU/mL) ------ Adults (men and women) < 115 IU/mL After thyroidectomy (monitoring) target: undetectable After total thyroidectomy for cancer, the absolute value matters less than the trend: a consistent rise in anti-TG alongside undetectable thyroglobulin is a warning sign. Causes of Elevated Anti-TG Antibodies Hashimoto's thyroiditis — the most common cause. Anti-TG is elevated in 60–80% of patients. In Hashimoto's thyroiditis it typically appears alongside elevated anti-TPO, though the ratio between them varies. Graves' disease — autoimmune hyperthyroidism. Anti-TG is elevated in 50–70% of patients, but TSH receptor antibodies (TRAb) are the primary diagnostic marker here. Differentiated thyroid cancer — papillary and follicular types. Here elevation signals that anti-TG is interfering with thyroglobulin measurement, which is itself considered an unfavourable sign for post-surgical monitoring. Other autoimmune conditions — lupus, rheumatoid arthritis, pernicious anaemia. Mild anti-TG elevation can occur as a non-specific autoimmune reaction. Isolated mild elevation in anti-TG with normal anti-TPO and TSH is found in 3–5% of healthy individuals and requires observation without immediate treatment. Anti-TG in Thyroid Cancer: A Recurrence Marker After total thyroidectomy for cancer, thyroglobulin should become undetectable — the organ producing it is gone. Rising thyroglobulin signals recurrence or metastasis. The problem: anti-TG binds to thyroglobulin and interferes with its accurate measurement, artificially lowering reported values. When anti-TG is present, thyroglobulin becomes unreliable as a tumour marker. In such patients, the trend in anti-TG itself becomes the primary monitoring tool — a falling trend is reassuring, a rising trend warrants thorough investigation. Thyroid cancer has an excellent prognosis when detected and treated early, which makes monitoring precision critically important. Anti-TG vs Anti-TPO: What Is the Difference Both tests detect autoimmune thyroid involvement, but with different strengths: Marker Sensitivity in Hashimoto's Primary use --------- Anti-TPO 95% Diagnosing autoimmune thyroiditis Anti-TG 60–80% Post-thyroidectomy monitoring In practice, both are ordered together. If anti-TPO is normal but anti-TG is elevated, an autoimmune process is still present and warrants attention. How to Prepare for the Anti-TG Test Blood is drawn from a vein after an 8-hour fast. No special preparation is required, but note: - thyroid hormone medication is taken on your usual schedule unless your doctor advises otherwise - avoid iodine-containing supplements and contrast agents 2–3 days before - result is not affected by menstrual cycle phase Anti-TG should never be interpreted in isolation — it is always evaluated alongside anti-TPO, TSH and clinical findings. After thyroid surgery, add thyroglobulin to the panel. When to See a Doctor See an endocrinologist if anti-TG is elevated together with abnormal TSH or symptoms such as fatigue, weight changes, swelling, or palpitations. After thyroidectomy, any rising anti-TG trend — especially with undetectable thyroglobulin — requires investigation to rule out recurrence. This information is for educational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/indicators/anti-tpo https://labreadai.com/en/indicators/anti-tpo Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Anti-TPO antibodies test: normal values, causes of elevated levels in women. Link to Hashimoto's thyroiditis, hypothyroidism and risks during pregnancy. Indicators article You receive your blood results and notice an "anti-TPO" line with a value above the reference range. What are these antibodies, why do they appear in the blood, and what does an elevated result actually mean? Anti-thyroid peroxidase antibodies are the primary marker of autoimmune thyroid inflammation — their presence signals that the immune system is attacking the thyroid gland. What Is Thyroid Peroxidase and Why Does the Body Produce Antibodies Against It Thyroid peroxidase (TPO) is an enzyme essential for producing thyroid hormones T3 and T4. Normally, this protein is confined inside thyroid cells and is invisible to the immune system. In autoimmune inflammation, this barrier breaks down: the enzyme enters the bloodstream, the immune system identifies it as foreign, and begins producing anti-TPO antibodies. These antibodies are not merely a passive marker — they actively damage thyroid tissue by activating the complement system and triggering thyrocyte death. Chronically elevated anti-TPO therefore leads, over time, to reduced thyroid function. The test is ordered alongside TSH and Free T4 — only together can you assess both thyroid function and autoimmune activity. The full set is included in the thyroid panel. Anti-TPO Normal Range in Adults Reference values vary slightly by laboratory method, but most use a common threshold: Category Normal Range (IU/mL) ------ Adults (men and women) < 35 IU/mL Pregnant women (1st trimester) < 2.5 IU/mL (recommended) Values between 35–100 IU/mL are considered mildly elevated and warrant monitoring. Values above 100 IU/mL indicate marked elevation, typical of active autoimmune disease. Always compare your result against your specific laboratory's reference range. Why Anti-TPO Is Elevated: Main Causes Elevated anti-TPO almost always points to an autoimmune process. The most common causes: Hashimoto's thyroiditis — the most frequent cause. In Hashimoto's thyroiditis, anti-TPO can exceed the upper limit 10–1000 times. The disease gradually destroys thyroid tissue and leads to hypothyroidism. Graves' disease — autoimmune hyperthyroidism. Anti-TPO is elevated in 70–80% of patients, although TSH receptor antibodies (TRAb) are the primary diagnostic marker here. Postpartum thyroiditis — temporary autoimmune inflammation in the first year after delivery. Anti-TPO is elevated before pregnancy, allowing early identification of at-risk women. Other autoimmune diseases — type 1 diabetes, rheumatoid arthritis, lupus. Thyroid autoimmunity often accompanies systemic disease. Mildly elevated anti-TPO (35–60 IU/mL) in isolation, with a normal TSH, is found in 10–15% of healthy individuals and requires annual monitoring — not treatment. Anti-TPO in Women: Why They Are at Higher Risk Autoimmune thyroid disease is 7–10 times more common in women than in men. Elevated anti-TPO is detected in 10–15% of women of reproductive age — often without any symptoms. Anti-TPO deserves special attention when planning pregnancy. Even with normal TSH, elevated antibodies raise the risk of miscarriage in the first trimester, postpartum thyroiditis, and impaired neurodevelopment in the child if maternal hypothyroidism goes uncontrolled. This is why anti-TPO screening is included in most preconception protocols. Anti-TPO vs Anti-TG Antibodies: What Is the Difference Both markers indicate autoimmune thyroid involvement, but they target different proteins. Anti-TPO antibodies target the hormone synthesis enzyme, while anti-thyroglobulin antibodies (anti-TG) target the hormone precursor protein. For diagnosing Hashimoto's thyroiditis, anti-TPO alone is sufficient — it is positive in 95% of patients. Anti-TG is added in ambiguous cases or for post-surgical monitoring of thyroid cancer. How to Prepare for the Anti-TPO Test Blood is drawn from a vein after an 8-hour fast. Key preparation rules: - stop thyroid hormone medication 30 days before the test (consult your doctor first) - avoid iodine-containing supplements and contrast agents 2–3 days before - no intense exercise or alcohol 24 hours before - time of day and menstrual cycle phase do not affect results Results are typically ready within 1–2 business days. Interpreting anti-TPO without TSH data gives only half the picture. When to See a Doctor See an endocrinologist within a few days if anti-TPO is markedly elevated (100 IU/mL) alongside an abnormal TSH, if you are pregnant or planning pregnancy with any degree of elevation, or if you have symptoms: persistent fatigue, swelling, hair loss, palpitations, or unexplained weight changes. Elevated anti-TPO without symptoms and with normal TSH is not an emergency, but warrants annual thyroid function monitoring. This information is for educational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/indicators/hbsag https://labreadai.com/en/indicators/hbsag Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) HBsAg is the hepatitis B surface antigen and primary marker of infection. Test interpretation, normal values, preparation and what to do after a positive result. Indicators article HBsAg (Hepatitis B surface antigen) is the outer envelope protein of the hepatitis B virus and the first marker to appear in the blood after infection — typically 2 to 6 weeks before symptoms develop. This makes the HBsAg blood test the cornerstone of hepatitis B screening worldwide. Understanding what this test shows, how to interpret it, and what to do if the result is positive is essential for timely diagnosis and prevention of liver damage. What HBsAg Is and Why It Is Tested HBsAg is a protein located on the surface of the hepatitis B virus (HBV). Infected liver cells produce vastly more surface antigen than is needed for viral particle assembly — hundreds of times more. The excess HBsAg circulates in the blood as empty spherical and filamentous particles, and it is precisely these that laboratory assays detect. Clinical significance of HBsAg: - Marker of current infection — the presence of HBsAg in blood means the virus is in the body right now - Screening test — ordered during routine check-ups, before surgery, during pregnancy, and for blood donation - Chronicity criterion — if HBsAg persists in blood for more than 6 months, the hepatitis B is classified as chronic HBsAg should not be confused with anti-HBs — antibodies to the surface antigen that appear after recovery or vaccination and indicate immunity to the virus. When HBsAg Testing Is Ordered The HBsAg test is indicated in a wide range of clinical scenarios: - Routine screening during preventive health check-ups - Pre-hospitalisation and pre-surgical evaluation - Pregnancy (mandatory in the first trimester) - Blood and organ donation - Contacts of confirmed hepatitis B cases - Unexplained elevation of ALT or bilirubin - Clinical signs of hepatitis: jaundice, fatigue, right upper quadrant discomfort - Monitoring patients with chronic hepatitis B - Before starting immunosuppressive therapy (risk of viral reactivation) How to Prepare for the Test The HBsAg test requires minimal preparation, but a few guidelines ensure reliable results: - Blood is drawn from a vein, preferably fasting (last meal 8–12 hours prior) - Plain water is allowed - No special diet is needed - Medications do not affect HBsAg detection — but inform your doctor about any drugs you are taking - The result is unaffected by time of day or physical activity Turnaround time: typically 1 business day for qualitative testing, 2–3 days for quantitative. Interpreting Results: Positive and Negative HBsAg A qualitative HBsAg test yields one of two outcomes: Result Meaning Next steps --------- HBsAg negative Hepatitis B virus not detected in blood Screening passed; if clinical suspicion persists, repeat in 2–4 weeks HBsAg positive Hepatitis B surface antigen present in blood Confirmatory test + extended serological panel Important: a single positive result is not a final diagnosis. The laboratory must perform a confirmatory assay (repeat testing in duplicate, neutralisation). Only a confirmed positive carries clinical weight. False-negative HBsAg can occur in several situations: - Early infection period (first 1–4 weeks) — the "serological window" - Mutant HBV strains with an altered HBsAg structure - Very low viral load in latent infection Quantitative vs Qualitative Testing Parameter Qualitative test Quantitative test --------- What it measures Presence or absence of HBsAg HBsAg concentration in IU/mL When ordered Screening, initial diagnosis Monitoring chronic hepatitis B, assessing treatment response Result format Positive / Negative Numeric value (e.g., 2500 IU/mL) Clinical value Fact of infection Prognosis, disease stage, treatment response criterion Quantitative HBsAg is particularly important in chronic hepatitis B: - HBsAg 1000 IU/mL — high replicative activity, often correlates with high viral load (HBV DNA) - HBsAg 100–1000 IU/mL — moderate activity - HBsAg < 100 IU/mL — low activity; a persistently low level carries a favourable prognosis - Declining HBsAg during therapy — positive treatment response - HBsAg seroclearance (disappearance from blood) — functional cure, the most favourable outcome Vaccination and HBsAg The hepatitis B vaccine contains recombinant HBsAg — a purified protein, not a live virus. In response, the body produces antibodies (anti-HBs) that confer protection. A critical point: vaccination does not cause a positive HBsAg test. Modern assays detect the "natural" viral antigen and do not react to the vaccine protein. If HBsAg is positive after vaccination, it indicates infection — not a vaccine reaction. After a complete vaccination course, the level of anti-HBs is measured to assess immunity: - Anti-HBs 10 mIU/mL — protective antibody level achieved - Anti-HBs < 10 mIU/mL — immunity not established, revaccination needed What to Do If HBsAg Is Positive A confirmed positive HBsAg is not a verdict, but it requires mandatory further evaluation. The recommended pathway: 1. Extended serological panel: anti-HBs, HBeAg, anti-HBe, anti-HBc IgM and IgG — to determine the stage and activity of infection 2. Quantitative HBV DNA (PCR) — measures viral load and replicative activity 3. Biochemical panel: ALT, AST, bilirubin, alkaline phosphatase — assessing liver function and injury as part of a liver function test panel 4. Co-infection screening: anti-HCV (hepatitis C), HIV antibody 5. Liver and spleen ultrasound 6. Fibrosis assessment: liver elastography or calculated indices (FIB-4, APRI) 7. Consultation with an infectious disease specialist or hepatologist Not all patients with a positive HBsAg require antiviral therapy. The decision to treat is based on viral load, ALT level, degree of fibrosis, and the clinical situation. When to See a Doctor Seek medical attention in the following situations: - You have received a positive HBsAg result — even without symptoms - Jaundice, dark urine, or pale stools have appeared - You have had contact with a person confirmed to have hepatitis B (post-exposure prophylaxis is most effective within 48 hours) - Liver enzymes are elevated on routine testing - You are planning or have confirmed a pregnancy — to address prevention of mother-to-child transmission Hepatitis B is a manageable infection. Modern antiviral drugs can suppress viral replication and prevent disease progression. The critical step is timely diagnosis — and the HBsAg test is its foundation. This article is for informational purposes only and does not replace professional medical advice. If your HBsAg result is positive, consult an infectious disease specialist or hepatologist. https://labreadai.com/en/indicators/hiv-combo https://labreadai.com/en/indicators/hiv-combo Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) HIV Combo (HIV 1/2 antibodies + p24 antigen) is a 4th-generation screening test with a 2–6 week window. How to prepare, interpret reactive results and confirmatory testing. Indicators article The HIV Combo test is a fourth-generation assay that simultaneously detects antibodies to HIV-1 and HIV-2 along with the p24 antigen of the virus. This dual detection principle makes it the most reliable screening tool available: the p24 antigen appears in the blood before antibodies form, narrowing the diagnostic window to just 2–6 weeks after infection. Understanding how this test works, when to take it, and how to read the result helps avoid unnecessary panic and ensures timely treatment. What the HIV Combo Test Is and How It Differs from Earlier Generations HIV testing has gone through four generations of evolution. Each successive generation shortened the seronegative window — the period between infection and the moment the test can detect it. Generation What it detects Diagnostic window Current use ------------ 1st generation IgG antibodies to HIV-1 8–12 weeks Obsolete 2nd generation IgG antibodies to HIV-1 and HIV-2 6–8 weeks Rarely used 3rd generation IgM + IgG antibodies to HIV-1/2 4–6 weeks Limited use 4th generation (Combo) IgM + IgG antibodies + p24 antigen 2–6 weeks Standard of care The p24 antigen is a viral capsid protein that enters the bloodstream as early as 11–14 days after infection — before the immune system mounts an antibody response. Once the body begins producing antibodies, free p24 levels decrease (it becomes bound in immune complexes), but by that point the test already detects antibodies. The HIV Combo thus covers both phases of the immune response. The Seronegative Window: When the Test Cannot Yet Detect Infection The seronegative window is the primary source of anxiety for people after a potential exposure. For a fourth-generation test, it averages 18–45 days but in rare cases may extend to 6 weeks. Practical testing timeline recommendations: - 2 weeks after exposure — the test can detect p24 antigen in some infected individuals (sensitivity approximately 60–70%) - 4 weeks — sensitivity reaches 95% - 6 weeks — a negative result virtually excludes infection (sensitivity 99%) - 12 weeks — follow-up test for definitive exclusion (WHO and CDC recommendation) If post-exposure prophylaxis (PEP) was taken, the window may be extended — a follow-up test 12 weeks after completing the course is mandatory. When You Should Get an HIV Combo Test HIV testing is not only for suspected exposure. There are several clinical and preventive indications: - Unprotected sexual contact with a partner of unknown status - Blood exposure (needle stick, medical accident) - Pregnancy planning and prenatal care - Unexplained weight loss, prolonged fever, enlarged lymph nodes - Recurrent infections suggesting compromised immunity - Before elective surgical procedures When immunity is compromised, a complete blood count frequently reveals lymphopenia. A drop in lymphocyte levels below the reference range may be the first laboratory sign of immunodeficiency and a reason to order HIV testing. How to Prepare for the Test The HIV Combo test does not require complex preparation, but following basic guidelines reduces the chance of technical errors: - Fasting is not required — the test can be taken after eating - Abstain from alcohol for 24 hours before the test - Medications do not affect the result (except antiretroviral drugs and PEP) - Physical activity and stress do not distort the result - Blood is drawn from a vein into a standard collection tube Results are typically available within 1–3 business days. Rapid fourth-generation point-of-care versions (from capillary blood) provide an answer in 15–30 minutes, but their sensitivity is somewhat lower than laboratory-based EIA. Interpreting Results: Reactive and Non-Reactive HIV Combo results are not reported as "positive" or "negative" — the terminology used is "reactive" and "non-reactive." Result Meaning Next steps --------- Non-reactive No antibodies or p24 antigen detected If window period has elapsed — HIV infection is excluded Reactive A reaction was detected (antibodies and/or antigen) Confirmatory testing is mandatory Indeterminate / grey zone Borderline signal Repeat test in 2–4 weeks Important: a reactive screening result is not a diagnosis. Every reactive HIV Combo result must undergo confirmation by a second method. Confirmatory Testing: What Happens After a Reactive Result The confirmation algorithm varies by national protocol, but the general principle is the same: 1. Repeat EIA/CLIA — the test is repeated in duplicate from the same serum sample 2. Immunoblot (Western blot) — detects antibodies to specific HIV proteins (gp120, gp41, p24, p31, etc.). It is considered confirmatory when antibodies to at least two proteins are identified 3. HIV RNA PCR — direct detection of viral nucleic acid, used when the immunoblot is indeterminate or for early diagnosis A definitive diagnosis is established only after all stages are completed. No single reactive EIA result constitutes grounds for an HIV diagnosis. False-Positive and False-Negative Results No laboratory test has absolute accuracy. The HIV Combo has a specificity of 99.5–99.8%, but in mass screening even 0.2% false reactivity produces a noticeable number of erroneous reactive results. Causes of false-positive results: - Autoimmune diseases (systemic lupus erythematosus, rheumatoid arthritis) - Recent vaccination (influenza, hepatitis B) - Pregnancy — cross-reactivity of maternal antibodies - Multiple blood transfusions - Laboratory technical errors Causes of false-negative results: - Blood drawn during the seronegative window - Use of antiretroviral therapy or PEP - Agammaglobulinemia and severe immunodeficiencies (extremely rare) - HIV-2 infection when using assays with insufficient HIV-2 sensitivity Changes in the leukocyte differential — leukopenia or neutropenia — can accompany HIV infection and serve as an additional indirect sign during result interpretation. When to See a Doctor - Reactive HIV Combo result — seek an infectious disease specialist immediately for confirmatory testing - Non-reactive result but persistent symptoms (fever, weight loss, enlarged lymph nodes) — repeat testing in 4–6 weeks and expanded workup - Exposure to an HIV-positive partner less than 72 hours ago — emergency consultation for post-exposure prophylaxis - Planning pregnancy — both partners should be tested before conception Early detection of HIV infection and timely initiation of antiretroviral therapy allow patients to achieve an undetectable viral load, preserve immune function, and maintain a near-normal life expectancy. This article is for informational purposes only and does not replace professional medical advice. If you receive a reactive result, consult an infectious disease specialist for confirmatory testing. https://labreadai.com/en/indicators/serum-iron https://labreadai.com/en/indicators/serum-iron Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Serum iron blood test: normal levels in men, women and children. Causes of low and high results, difference from ferritin and TIBC. How to prepare for the test. Indicators article Serum iron is one of the first tests ordered when anaemia or unexplained fatigue is suspected. But serum iron levels can be misleading: they only reflect the iron currently being transported in the blood, and may appear normal even when body stores are already depleted. For a complete picture, serum iron is always evaluated alongside TIBC and ferritin. What Serum Iron Measures and Why It Is Tested Iron in the body exists in several pools. The largest — about 70% — is bound in haemoglobin inside red blood cells. Around 25% is stored in depots as ferritin and haemosiderin in the liver, spleen and bone marrow. A small fraction — less than 1% — continuously circulates in the blood, bound to the carrier protein transferrin. It is this transport fraction that serum iron measures. The test is ordered for symptoms of anaemia (fatigue, pallor, shortness of breath on exertion), hair loss, brittle nails, and chronic tiredness. It is part of the iron panel together with TIBC, ferritin and transferrin. Serum Iron Normal Range Reference values differ by sex and age: Category Normal Range (μmol/L) Normal Range (μg/dL) --------- Men 11.6–31.3 65–175 Women 9.0–30.4 50–170 Infants (under 1 year) 7.2–18.0 40–100 Children (1–14 years) 9.0–22.0 50–120 Values on your report may differ slightly depending on the laboratory's method and reagents — always use the reference range printed alongside your result. Why Serum Iron Is Low Low serum iron is the most common abnormality and falls into several categories. Iron deficiency — the classic cause. In iron deficiency anaemia, serum iron falls, TIBC rises (transferrin is "hungry" and tries to capture every available iron molecule), and ferritin is low. This triad is the diagnostic standard. Chronic inflammation and infection. In chronic conditions (rheumatoid arthritis, inflammatory bowel disease, cancer), iron is deliberately sequestered in storage depots — the body uses this mechanism to deny iron to pathogens. Ferritin is normal or elevated, TIBC is low. This is anaemia of chronic disease, and it is fundamentally different from iron deficiency. Malabsorption — coeliac disease, post-gastrectomy states, small bowel resection. Excess losses — heavy periods, chronic gastrointestinal or haemorrhoidal bleeding. Pregnancy — iron requirements increase two-to-threefold, especially in the third trimester. Why Serum Iron Is Elevated Elevated serum iron is less common but equally important. Haemochromatosis — a hereditary condition causing progressive iron overload in organs. Serum iron is high, TIBC is low (transferrin is saturated), ferritin is markedly elevated. Without treatment, it leads to liver, cardiac and pancreatic damage. Haemolytic anaemia — destruction of red blood cells releases haemoglobin iron into the circulation. Sideroblastic anaemia — impaired incorporation of iron into haem leads to iron accumulation in cells. Iron supplement overdose — a common cause of acute elevation, particularly in children. Acute hepatitis and cirrhosis — iron leaks from damaged liver cells. Serum Iron, TIBC and Ferritin: Why All Three Are Needed Think of it as a transport system: serum iron is the cargo in transit, transferrin is the delivery trucks, TIBC is the total fleet capacity, and ferritin is the warehouse. One figure without the others gives an incomplete picture. Condition Iron TIBC Ferritin ------------ Iron deficiency anaemia ↓ ↑ ↓ Anaemia of chronic disease ↓ ↓ or N ↑ or N Haemochromatosis ↑ ↓ ↑↑ Normal N N N This is why the iron panel is always a profile, not a single test. The pattern of all three results explained together is far more informative than any value in isolation. How to Prepare: Key Rules Serum iron is one of the most preparation-sensitive blood markers. - Blood must be drawn strictly fasting, after 8–12 hours without food - Time of day matters: iron peaks in the morning and drops by 30–40% by evening — draw before 10:00 am - Stop iron supplements 5–7 days before the test (they cause false elevation) - Do not test on the day of a blood transfusion or within one week after - Acute infections and inflammation cause a temporary drop — results are uninformative during an acute illness - In women, levels are slightly higher at mid-cycle — note this when interpreting borderline values When to See a Doctor Urgently Seek immediate medical attention if you have severe weakness, shortness of breath at rest, palpitations, or pallor — these indicate severe anaemia requiring urgent evaluation. Also seek urgent care for signs of iron overload: right upper abdominal pain, skin darkening, cardiac arrhythmia — this picture is characteristic of haemochromatosis with organ involvement. This information is for educational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/indicators/tibc https://labreadai.com/en/indicators/tibc Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) TIBC blood test: normal values, causes of high and low results. How to calculate transferrin saturation and use TIBC to distinguish iron deficiency from anaemia of chronic disease. Indicators article Most patients who receive a result labelled "TIBC" are not sure what it means. TIBC — Total Iron-Binding Capacity — measures how much iron transferrin, the main iron transport protein, could theoretically carry. When TIBC levels are abnormal, understanding what they indicate is essential. It is essentially the mirror image of serum iron: when iron is scarce, TIBC rises; when iron is excessive, it falls. What TIBC Measures and How It Relates to Transferrin Iron does not travel freely in the blood — it is carried bound to transferrin. Each transferrin molecule can hold two iron atoms. Under normal conditions, only 25–35% of these binding sites are occupied — the rest remain empty, waiting. TIBC measures the total capacity of these binding sites: the maximum amount of iron the serum transferrin could accept. The more empty sites there are (i.e. the less iron in the blood), the higher the TIBC — the body effectively expands its transport fleet to capture every available iron molecule. A related value often calculated alongside TIBC is UIBC (Unsaturated Iron-Binding Capacity): the difference between TIBC and current serum iron — literally "how much more iron would fit right now". TIBC Normal Range in Adults Reference values are similar for men and women: Category Normal Range (μmol/L) Normal Range (μg/dL) --------- Adults (men and women) 45–75 μmol/L 250–425 μg/dL Pregnant women (3rd trimester) up to 90 μmol/L up to 500 μg/dL Reference ranges vary slightly between laboratories — always use the range printed on your own report. Transferrin Saturation: How to Calculate and Interpret It Transferrin saturation (TS%) is one of the most important calculated parameters in anaemia diagnosis. The formula is straightforward: TS (%) = Serum Iron ÷ TIBC × 100 TS% Interpretation ------ < 16% Iron deficiency 16–45% Normal 50% (men), 45% (women) Iron overload (suspect haemochromatosis) TS above normal alongside normal or high ferritin is characteristic of haemochromatosis, which requires genetic confirmation. Causes of Elevated TIBC High TIBC means transferrin is "hungry" — many binding sites are empty and iron is scarce. Iron deficiency anaemia — the primary cause of elevated TIBC. In iron deficiency anaemia, the body synthesises more transferrin to capture every available iron atom. TIBC rises in parallel with falling serum iron and ferritin. Pregnancy — physiological TIBC elevation, most pronounced in the third trimester, reflects the sharply increased iron demand for the foetus and placenta. Oral contraceptives — oestrogens stimulate hepatic transferrin synthesis, causing moderate TIBC elevation. Causes of Low TIBC Low TIBC means transferrin is saturated or there is simply less of it. Chronic inflammation and infection — during inflammation, the liver shifts production from transferrin to acute-phase proteins. Less transferrin → lower TIBC. Serum iron is also low, while ferritin is normal or elevated. This is the classic picture of anaemia of chronic disease. Haemochromatosis — hereditary iron overload. Transferrin is maximally saturated with iron → TIBC falls. Serum iron and ferritin are both markedly elevated. Liver cirrhosis and severe liver disease — reduced transferrin synthesis due to loss of functional hepatic tissue lowers TIBC regardless of iron stores. Nephrotic syndrome — transferrin is lost in urine → TIBC falls. Hypoproteinaemia — severe protein deficiency reduces synthesis of all proteins, including transferrin. TIBC With Serum Iron and Ferritin: Interpretation Table None of these markers works in isolation. Only the combination — with each value explained in context — gives a diagnosis: Condition Serum Iron TIBC Ferritin TS% --------------- Iron deficiency anaemia ↓ ↑ ↓ < 16% Anaemia of chronic disease ↓ ↓ or N ↑ or N N or ↓ Haemochromatosis ↑ ↓ ↑↑ 50% Normal N N N 16–45% This is why TIBC is always ordered as part of the iron panel, not as a standalone test. Abnormal TIBC levels are best explained alongside serum iron, ferritin and transferrin saturation. How to Prepare for the TIBC Test TIBC is measured from the same venous blood sample as serum iron, so preparation rules are identical: - Strictly fasting — 8–12 hours without food - Optimal time: before 10:00 am (daily iron fluctuations affect calculated parameters) - Stop iron supplements 5–7 days before the test - Do not test during acute infection or inflammation — inflammation suppresses TIBC and distorts the picture - Wait at least one week after a blood transfusion Results are typically available within one business day. A physician interprets the result in the context of the full clinical picture. When to See a Doctor See a GP or haematologist if TIBC is elevated alongside weakness, pallor, breathlessness and low ferritin — this may indicate iron deficiency anaemia requiring treatment. Low TIBC with high ferritin and transferrin saturation above 50% is a reason to exclude haemochromatosis: early detection prevents liver and cardiac damage. This information is for educational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/tests/enterobiasis-test https://labreadai.com/en/tests/enterobiasis-test Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Enterobiasis test detects pinworm eggs from a perianal swab. When to test, how to collect the sample correctly, how many times to repeat, and what a positive result means. Tests article Intense itching around the anus at night — especially in a child — is one of the most tell-tale signs of pinworm infection. But confirming or ruling out enterobiasis requires a laboratory test: pinworms are not always visible to the naked eye, and young children often cannot describe their symptoms. The perianal swab for enterobiasis is the simplest, fastest, and only reliable method. Here is how to collect it correctly, how many times to repeat it, and how to read the result. What the Enterobiasis Test Detects The enterobiasis test is a microscopic examination of material collected from the perianal folds (skin around the anus) for the eggs of the pinworm Enterobius vermicularis. This is precisely where the female worm deposits her eggs — typically at night, emerging from the rectum. This is what causes the characteristic nocturnal itching. A standard stool test for parasite eggs is not suitable for diagnosing enterobiasis: eggs are not deposited inside the bowel but outside it, so they are almost never found in stool. This is a fundamental difference from other intestinal parasitic infections, which are detected via stool parasite examination. An indirect laboratory sign of infection is eosinophilia — elevated eosinophils on a full blood count. However, this finding is non-specific: eosinophilia occurs with many other parasitic infections and allergic conditions, so enterobiasis must be confirmed by the swab test. Who Should Be Tested and When The test is a routine investigation ordered for: - children enrolling in nursery, school, sports clubs, swimming pools, or summer camps - patients admitted to hospital (infection control requirement) - routine health checks for children under 14 - symptoms: nocturnal perianal itching, restless sleep, teeth grinding, unexplained bedwetting, or abdominal pain without a clear cause - when enterobiasis is detected in one family member — all close contacts are tested Adults are tested mainly on epidemiological grounds or when symptoms appear. Food industry workers, childcare staff, and healthcare workers are screened as part of occupational health checks. How to Collect the Perianal Swab Correctly Correct preparation is the single most important factor for a reliable result. Pinworm eggs are deposited at night and in the early morning hours — this is when their concentration on the skin is highest. The cardinal rule: do not wash and do not use the toilet before sample collection. The swab is taken in the morning, immediately upon waking, before any hygiene procedures or bowel movement. Collection methods: Adhesive tape (Scotch tape test) — the most widely used method in clinics. A strip of transparent tape is pressed firmly against the perianal folds, then transferred to a glass slide. The slide is delivered to the laboratory. Cotton swab or spatula — a swab moistened with saline or glycerol is rolled across the perianal folds and placed in a transport tube. Ready-to-use home collection kits are available in pharmacies — they include instructions, adhesive tape and a transport container. When used correctly, home-collected samples are as reliable as those taken in a clinical setting. Delivery time to the laboratory — within 2–3 hours of collection; if refrigerated (+2 to +8 °C), up to 8 hours. How Many Times Should the Test Be Repeated A single swab is unreliable. The female worm does not deposit eggs every night, so the probability of detecting them in one test is approximately 50%. With two tests it rises to around 90%; with three tests — 95% or above. Standard protocol: - routine screening (nursery, swimming pool) — once, as required by the institution - when symptoms are present — 3 tests on consecutive or alternate days - post-treatment control — 3 swabs taken 2 weeks after completing the course If the first result is negative but symptoms persist, repeat the test. A single negative result does not exclude infection. How to Interpret the Result The result is straightforward: Result Meaning ------ Enterobius vermicularis eggs not detected Enterobiasis not identified (if preparation rules were followed) Enterobius vermicularis eggs detected Enterobiasis confirmed — treatment required Quantitative reporting (egg count) is not routinely performed — the presence or absence of eggs is sufficient for a clinical decision. Treatment is indicated for any positive result, regardless of the number of eggs seen. Following a positive result, the entire household is treated simultaneously — even if others test negative. Pinworms spread very easily by the faecal-oral and contact route, and reinfection from an untreated family member will negate any treatment. Why the Test May Be False Negative A negative result despite actual infection is not uncommon. Main reasons: - Preparation errors: morning shower or toilet before collection washes eggs away - Wrong timing: the female did not lay eggs that particular night — skin concentration is zero - Single test only: as described, one swab is insufficient - Storage or transport failure: prolonged heat exposure destroys eggs If symptoms are characteristic and three swabs are all negative, a clinician may decide to treat empirically based on the clinical picture. When to See a Doctor See a paediatrician or GP if the result is positive — anthelmintic medication and a household treatment plan require medical supervision. Also consult a doctor if symptoms (nocturnal itching, restless sleep, abdominal pain) persist for more than two weeks despite negative tests: other causes are possible, including helminthiasis of a different type or intestinal infection. Following a positive result in a child, the doctor will issue a note excluding the child from group settings until treatment is complete and a control negative test is obtained. This article is for informational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/tests/stool-parasite-exam https://labreadai.com/en/tests/stool-parasite-exam Mon, 30 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Stool parasite examination detects intestinal worm eggs and protozoan cysts. How to collect stool correctly, how many times to repeat, and what a positive result means. Tests article Abdominal pain, diarrhoea, unexplained weight loss, persistent fatigue — any of these can be symptoms of intestinal parasites, or they can have nothing to do with them. The only way to find out is laboratory testing. A stool examination for helminth eggs and protozoan cysts detects most common intestinal parasitic infections — ascariasis, giardiasis, trichuriasis and others. But this test has important limitations, and the most important one should be understood from the outset. What the Stool Parasite Test Detects The stool examination for helminth eggs and protozoan cysts (coproscopy, or ova and parasite exam) is a microscopic study of faeces. The laboratory technician looks under a microscope for: - Helminth eggs — roundworm (Ascaris lumbricoides), whipworm (Trichuris trichiura), hookworms, toxocara, broad tapeworm, pork and beef tapeworms, and others - Cysts and trophozoites of protozoa — Giardia lamblia, Entamoeba histolytica, Balantidium coli, Cryptosporidium What the stool test does NOT detect: Pinworms (Enterobius vermicularis) — they deposit eggs outside the bowel, in the perianal skin folds, not inside the intestine. A separate enterobiasis test (perianal swab) is required to detect them. This is a very common source of confusion: a "worm test" referral does not cover the most common helminth in children. An indirect sign of helminthiasis is eosinophilia — elevated eosinophils on a full blood count. However, this is a non-specific marker, and diagnosis must be confirmed only by coproscopy or other targeted tests. Who Should Be Tested and When Routine indications: - health screening for children and adults - enrolment in nursery, school, swimming pool, or summer camp - hospital admission - occupational screening for food industry workers, childcare staff, and healthcare workers Symptom-based indications: - diarrhoea alternating with constipation lasting more than two weeks - cramping abdominal pain without obvious cause - unexplained weight loss - perianal itching, especially in children - nausea, reduced appetite - elevated eosinophils on blood count - identified parasitic infection in a family member or close contact How to Prepare and Collect the Sample Correctly Correct stool collection is half the battle. Violating any of the rules sharply reduces test sensitivity. In the days before collection: - avoid laxatives, rectal suppositories, enemas, bismuth and iron preparations for 3 days — they alter stool consistency and may mask parasites - avoid antiparasitic and antibacterial agents for 3 days — they destroy or suppress parasite forms - no special diet is needed, but a very fatty meal may interfere with microscopy Collection rules: - collect stool in the morning after a spontaneous bowel movement (no laxatives) - use a sterile container with a spoon (available at pharmacies) - collect material from 3 different parts of the stool (beginning, middle, end) — parasites are not evenly distributed - minimum amount — approximately one teaspoon (5–10 g) - do not collect from a toilet bowl with water — use a bedpan or disposable liner - urine must not contaminate the sample Delivery times: - optimal — within 1–2 hours of collection - acceptable — up to 8 hours if refrigerated (+2 to +8 °C) - for detecting trophozoites (amoeba, Giardia) — ideally within 30–60 minutes: they break down rapidly on cooling. Use a container with preservative in this case. How Many Times Should the Test Be Repeated A single stool test is unreliable. Helminth eggs and protozoan cysts are shed intermittently, and the sensitivity of a single examination is only 40–60%. Recommended protocol: - routine screening — once, as required by the institution - when symptoms are present — 3 tests on consecutive or alternate days - post-treatment control — 3 tests 3–4 weeks after completing the course A single negative result does not exclude infection when symptoms persist. How to Interpret the Results Result Meaning ------ No helminth eggs detected, no protozoan cysts detected Parasitic infection not identified (if preparation rules were followed) Eggs of [species] detected Infection with this helminth species confirmed Cysts of [species] detected Infection with this protozoan species confirmed Reports may state only presence or absence of findings. Species identification is essential: different parasites require different treatments. Most commonly detected in clinical practice: - Roundworm (Ascaris) — characteristic eggs with a rough outer coat - Whipworm (Trichuris) — lemon-shaped eggs with polar plugs - Giardia — oval cysts with 2–4 nuclei - Hookworms — thin-shelled eggs with blastomeres In giardiasis, cysts in stool are shed inconsistently — during asymptomatic carriage, shedding is intermittent. This is why three-sample testing is particularly important when giardiasis is suspected. Special Considerations for Specific Parasites Giardia: trophozoites break down rapidly — stool must be delivered within 30–60 minutes or collected into a preservative container (formalin or PVA fixative). PCR for Giardia is now more sensitive than microscopy. Amoeba: similar to Giardia — trophozoites do not survive outside the host. Ideally examine fresh, warm stool. Toxocara: eggs are rarely found in stool — toxocara more commonly causes visceral or ocular disease without intestinal involvement. Diagnosis is serological (ELISA for antibodies). Taeniasis (pork and beef tapeworm): stool is examined for proglottids and eggs. When suspected, a perianal swab may be added. When to See a Doctor See a GP or paediatrician if the result is positive — the choice of drug, dosage and duration depends on the specific parasite. Self-treating with anthelmintics without identifying the causative organism is ineffective and can be unsafe. If symptoms persist and three stool tests are all negative, a doctor may order serological tests (ELISA) for toxocariasis, trichinellosis, or echinococcosis — some parasitic infections cannot be detected by coproscopy. If pinworms are suspected, a separate enterobiasis test is ordered. This article is for informational purposes only. Diagnosis and treatment are provided exclusively by a qualified physician. https://labreadai.com/en/posts/acute-pancreatitis https://labreadai.com/en/posts/acute-pancreatitis Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Acute pancreatitis is pancreatic inflammation triggered by gallstones or alcohol. Symptoms, which blood tests confirm it, Atlanta severity criteria and modern treatment. Articles article The pain of acute pancreatitis is described with striking consistency — a band-like, unbearable sensation that allows no comfortable position. This is not coincidence: the inflamed pancreas literally begins digesting itself. Acute pancreatitis is one of the most common abdominal emergencies and requires immediate hospitalisation. Around 80% of cases are mild and resolve within days. The remaining 20% are severe — with pancreatic necrosis, multi-organ failure and significant mortality. Here is how the disease develops, how it is diagnosed, and what modern treatment looks like. What Is Acute Pancreatitis and How Does It Develop The pancreas serves two functions. Its exocrine component produces digestive enzymes — amylase, lipase, proteases — and releases them into the duodenum in inactive form (zymogens). Activation happens only there, in the intestine, under the action of enterokinase. This is a protective mechanism: if enzymes were activated inside the gland, it would digest itself. In acute pancreatitis, exactly that happens. A trigger — ductal obstruction, toxic cell damage or direct trauma — causes enzymes to activate prematurely, inside the acinar cells themselves. An autolysis cascade is set off: proteases destroy cell membranes, phospholipase A2 attacks membrane phospholipids, elastase breaks down vessel walls. The inflammatory response escalates rapidly — involving adjacent tissues, retroperitoneal fat, and in severe cases the entire body through systemic cytokine release. Critically: the severity of pancreatitis is determined not only by the extent of gland injury but by the systemic response — the development of organ dysfunction. This is why mild pancreatitis is managed in a medical ward and severe pancreatitis in the intensive care unit. Symptoms of Acute Pancreatitis The clinical picture of acute pancreatitis is characteristic enough that an experienced clinician often makes the provisional diagnosis in the emergency department. Pain — the central symptom. It begins suddenly, typically after a heavy fatty meal or alcohol. Location: epigastrium (upper abdomen), radiating to the back, left upper quadrant, or encircling the torso. The pain is intense and constant — unlike colic, it does not ease and does not change with breathing. The characteristic posture: knees drawn to the chest, lying on one side — slightly more bearable in this position. Nausea and vomiting — almost always present. Vomiting is repeated and brings no relief — this is an important distinguishing feature. If pain eases after vomiting, pancreatitis is less likely. Abdominal rigidity — mild in mild pancreatitis, pronounced in severe and necrotising forms. Peritoneal signs (board-like abdomen, rebound tenderness) appear when the process extends beyond the gland. Systemic signs in severe forms: - Tachycardia and falling blood pressure — shock from third-space fluid sequestration - Fever above 38.5°C — sign of infected necrosis or systemic inflammation - Jaundice — compression of the common bile duct by a swollen pancreatic head, or pre-existing choledocholithiasis - Periumbilical bruising (Cullen's sign) or flank bruising (Grey-Turner's sign) — retroperitoneal haemorrhage; rare but ominous Causes of Acute Pancreatitis More than 80% of all acute pancreatitis cases are explained by two causes. Cause Proportion Mechanism --------- Gallstone disease (biliary pancreatitis) 40–50% Stone impaction at the ampulla of Vater → bile reflux into the pancreatic duct → enzyme activation Alcohol 25–35% Direct acinar cell toxicity + Oddi sphincter spasm + altered pancreatic juice composition Hypertriglyceridaemia 1–4% Triglycerides 11 mmol/L → fat emboli in pancreatic vessels → ischaemia and inflammation Hypercalcaemia < 1% Calcium activates trypsinogen within the gland Trauma, ERCP 1–3% Direct mechanical duct injury Medications 1–2% Azathioprine, furosemide, tetracyclines, valproic acid and others Autoimmune pancreatitis < 1% IgG4-mediated inflammation Idiopathic 10–20% No cause found after full investigation The link with metabolic syndrome is direct and underappreciated: obesity amplifies the severity of any pancreatitis regardless of cause, and hypertriglyceridaemia is an independent trigger. A patient with abdominal obesity and triglycerides above 10 mmol/L carries a high pancreatitis risk even without alcohol or gallstones. Diagnosis: Blood Tests and Investigations The diagnosis of acute pancreatitis is made when two of three Atlanta criteria are present: 1. Characteristic abdominal pain 2. Serum lipase or amylase ≥ 3× the upper limit of normal 3. Characteristic findings on CT or MRI In practice, most patients satisfy the first two criteria — CT is reserved for diagnostic uncertainty, severe presentation, or failure to improve within 48–72 hours. Laboratory investigations: Amylase and lipase levels are the key markers. Lipase is preferred: higher specificity (85–90%) and longer elevation. At ≥ 3× ULN combined with pain, the diagnosis is rarely in doubt. C-reactive protein (CRP) — the primary severity marker. At 48 hours from onset, a CRP above 150 mg/L predicts severe pancreatitis with approximately 80% sensitivity. This timing window matters: in the first 24 hours CRP has not yet peaked, and a low value does not exclude severe disease. Liver function tests — to assess biliary aetiology: ALT elevation above 3× ULN on admission is a sensitive indicator of gallstone pancreatitis. Also needed for baseline hepatic function assessment before treatment. Full blood count: leucocytosis ( 12×10⁹/L) indicates inflammation; haematocrit 44% signals haemoconcentration from fluid sequestration — a marker of necrosis risk. Falling platelets in severe cases suggest DIC. Calcium, glucose, urea — monitoring for organ complications: hypocalcaemia (calcium sequestered in fat necrosis foci), hyperglycaemia (insulin-secreting cell damage), rising urea (pre-renal azotaemia from dehydration). Imaging: - Abdominal ultrasound — first step; detects gallstones, ductal dilatation, free fluid. The pancreas itself is often obscured by bowel gas during active pancreatitis. - Contrast-enhanced CT — gold standard for severity assessment. Identifies necrosis (non-enhancing areas), peripancreatic collections, abscesses. Optimal at 48–72 hours — before this, necrosis is not yet fully demarcated. - MRI / MRCP — when ductal anatomy needs assessment, or when CT is contraindicated (pregnancy, contrast allergy). Severity scoring using the Balthazar CT index and systemic scales (APACHE II, BISAP) guides decision-making about care intensity in severe presentations. Treatment of Acute Pancreatitis Pancreatitis management has undergone a revolution over the past 20 years: from "nothing by mouth, nothing by vein" to aggressive fluid resuscitation and early nutritional support. Mild and Moderate Pancreatitis Fluid resuscitation — the foundation of treatment. Aggressive intravenous crystalloid administration (Ringer's lactate is preferred over normal saline — reduces acidosis risk) in the first 24–48 hours prevents pancreatic necrosis by maintaining perfusion. Target: urine output 0.5–1 mL/kg/hour. Pain management — a priority from the first minutes. NSAIDs, ketamine, opioids — the choice depends on severity. The old fear that morphine causes Oddi sphincter spasm and worsens pancreatitis is not supported clinically — analgesia is not delayed. Nutrition — a paradigm shift. Previously, patients were kept nil by mouth for 5–7 days. Today, in mild pancreatitis, oral feeding is recommended as early as 24–48 hours after pain subsides, starting with liquids. Fasting does not accelerate recovery and worsens gut dysfunction. Antibiotics — only for confirmed infected necrosis (positive culture or CT showing gas within necrosis). Prophylactic antibiotics for sterile necrosis are not recommended — this is a well-established evidence base. Severe Pancreatitis and Necrosis - Intensive care — for multi-organ failure; monitoring of haemodynamics, renal function, coagulation - Enteral nutrition via nasojejunal tube — preferred over parenteral; preserves the gut barrier, reduces bacterial translocation - Endoscopic drainage (endoscopic necrosectomy under EUS guidance) — for infected necrosis; preferred over open surgery in most situations - ERCP — for biliary pancreatitis with cholangitis or persistent bile duct obstruction; performed within the first 24–72 hours - Cholecystectomy — after resolution of acute biliary pancreatitis; ideally in the same admission or within 4–6 weeks In chronic hepatitis with gallstone disease, management is coordinated with a hepatologist — underlying liver disease alters the pharmacokinetics of most medications. Complications of Acute Pancreatitis Complications are divided into early (first 1–2 weeks) and late (after 2–4 weeks). Early: - Systemic inflammatory response syndrome (SIRS) — escalating cytokine storm; risk of progression to sepsis - Multi-organ failure — renal (acute kidney injury), respiratory (ARDS), cardiovascular. This is what drives mortality in severe pancreatitis - Acute peripancreatic fluid collections — fluid around the gland; most resolve spontaneously - Hypocalcaemia — calcium is "captured" by fat necrosis foci; severe hypocalcaemia is an adverse prognostic sign Late: - Pseudocyst — an encapsulated collection of pancreatic juice forming 4–6 weeks after the attack; treatment needed only when symptomatic or infected - Walled-off necrosis (WON) — mature encapsulated necrosis zone; requires drainage when infected - Pancreatic duct fistulae — leak of ductal contents into the peritoneal or pleural cavity - Exocrine and endocrine insufficiency — after extensive necrosis; the patient may require lifelong enzyme supplementation and possibly insulin therapy When to See a Doctor Urgently Acute pancreatitis always warrants hospitalisation. Call emergency services immediately for: - Sudden, severe epigastric or band-like abdominal pain that does not ease — call an ambulance immediately - Repeated vomiting without relief combined with abdominal pain - Falling blood pressure, rapid pulse, pallor — signs of shock - Jaundice with abdominal pain — probable biliary pancreatitis with bile duct obstruction - Fever above 38.5°C with abdominal pain — possible infected necrosis Do not wait for it to "pass by itself," and do not take antispasmodics or analgesics "to see what happens" — modern clinicians work on the opposite principle. Adequate analgesia does not impair diagnosis, and delayed hospitalisation in severe pancreatitis directly increases the risk of necrosis and death. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a surgeon or gastroenterologist. https://labreadai.com/en/posts/chronic-hepatitis https://labreadai.com/en/posts/chronic-hepatitis Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Chronic hepatitis silently damages the liver for years. Types include viral, autoimmune and toxic. Which blood tests detect it, treatment by type and complications to watch. Articles article The liver is an organ of extraordinary patience. It has no pain receptors, an enormous functional reserve, and a remarkable capacity for self-repair even when substantially damaged. This is precisely why chronic hepatitis — liver inflammation lasting more than six months — progresses silently for years, and the first noticeable symptoms typically appear only when a significant portion of tissue has already been replaced by scar. Chronic hepatitis is not a single disease but a family of conditions with different causes yet a common outcome when untreated: cirrhosis and its complications. Here is how each variant develops, how to recognise them, and how they are treated. What Is Chronic Hepatitis and How It Differs from Acute Acute hepatitis is a short-lived liver inflammation that resolves on its own in most cases within several months. Chronic hepatitis is inflammation that persists beyond six months and does not resolve without treatment. The six-month threshold is a clinical convention, but an internationally accepted one: within this period it becomes clear whether the disease is subsiding or becoming established. In chronic inflammation, hepatocytes — liver cells — die and are replaced by connective tissue. This process is called fibrosis. While fibrosis is mild (F0–F1 on the METAVIR scale), liver function is largely preserved. As it advances to significant fibrosis (F3) and cirrhosis (F4), functional reserve is exhausted: the liver can no longer adequately synthesise proteins, detoxify the blood, or regulate clotting. The defining feature of chronic hepatitis is the dissociation between inflammatory activity and how the patient feels. High-grade inflammation can coexist with complete absence of symptoms. This means that feeling well is not an argument against the diagnosis — and not a reason to defer testing. Types of Chronic Hepatitis: Causes and Mechanisms "Chronic hepatitis" covers several fundamentally different diseases requiring different treatments. Identifying the type is the mandatory first step. Viral hepatitis B (HBV) — transmitted through blood, sexually, and from mother to child during delivery. Around 250 million people worldwide are chronic carriers. The virus integrates into hepatocyte DNA and can persist for life. Without treatment, 20–30% of chronic carriers develop cirrhosis over 20–30 years. Viral hepatitis C (HCV) — transmitted primarily through blood (injecting drug use, blood transfusions before 1992, non-sterile medical procedures). Becomes chronic in 75–85% of acute infections. A landmark development of the past decade: hepatitis C is now fully curable — direct-acting antiviral combinations achieve a sustained virological response in 95–99% of patients. Autoimmune hepatitis (AIH) — the immune system attacks its own hepatocytes. Cause unknown; more common in women. Characterised by markedly elevated transaminases, hypergammaglobulinaemia, and specific autoantibodies (ANA, SMA, anti-LKM-1). Responds well to immunosuppression with prednisolone and azathioprine. Toxic (drug-induced) hepatitis — direct liver injury by chemical agents: alcohol, medications, herbal supplements. Alcoholic hepatitis progresses to alcoholic cirrhosis if drinking continues. Drug-induced hepatitis can be caused by paracetamol (at high doses), methotrexate, amiodarone, isoniazid, nitrofurantoin, and many others. Non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH) — the fastest-growing type worldwide. Fat accumulates in hepatocytes, triggering inflammation. Strongly associated with obesity, insulin resistance and type 2 diabetes. In 20–30% of NASH patients fibrosis develops; some progress to cirrhosis. Symptoms of Chronic Hepatitis Most people with chronic hepatitis have no symptoms for years — or symptoms so nonspecific that they raise no concern. Early and nonspecific signs: - Chronic fatigue without another explanation — the most frequent symptom - Heaviness or discomfort in the right upper abdomen — especially after fatty food or alcohol - Reduced appetite and mild nausea - Decreased alcohol tolerance Signs of more significant liver damage: - Jaundice — yellow tinge of skin and sclerae; appears when bilirubin excretion is impaired - Dark urine ("beer-coloured") and pale stools — impaired bile flow - Skin itching — bile acids retained in the blood during cholestasis - Unexplained weight loss Signs of established cirrhosis: - Ascites — fluid accumulation in the abdomen (distended, tense belly) - Leg oedema - Palmar erythema and spider naevi on the skin - Splenomegaly - Bleeding from oesophageal varices — a life-threatening complication By the time cirrhosis becomes symptomatic, reversing the process is no longer possible — only halting further progression. Diagnosis: Blood Tests and Investigations Diagnosing chronic hepatitis involves three parallel tasks: confirming liver damage, identifying its cause, and assessing the degree of fibrosis. ALT (alanine aminotransferase) — the most specific marker of hepatocellular damage. ALT elevation above the upper limit of normal is a warning signal requiring further investigation. In chronic hepatitis, ALT may be persistently mildly elevated or fluctuate. AST (aspartate aminotransferase) — rises in parallel with ALT in hepatocellular injury. An AST:ALT ratio (de Ritis ratio) 2 is characteristic of alcoholic hepatitis; in viral hepatitis this ratio is usually below 1. Alkaline phosphatase (ALP) — a marker of cholestasis and bile duct involvement. In primary biliary cholangitis and primary sclerosing cholangitis, ALP is disproportionately elevated. GGT (gamma-glutamyltransferase) — a sensitive marker of liver pathology, particularly toxic and alcoholic components. Isolated GGT elevation with normal transaminases often points to early NAFLD or alcohol overuse. Bilirubin — rises when hepatocyte uptake and excretion are impaired. Clinical jaundice becomes visible above 35–40 µmol/L. Sustained elevation of direct (conjugated) bilirubin indicates significant cholestasis or severe hepatocellular damage. Albumin — synthesised exclusively in the liver. A fall below the normal range in chronic hepatitis signals developing hepatic insufficiency and advanced fibrosis. A normal albumin level in chronic hepatitis is a favourable prognostic sign. All the above markers form part of a standard liver function test panel — a comprehensive assessment of overall hepatic function. When pancreatic inflammation is suspected — common with gallstone disease or alcohol-related injury — amylase and lipase are additionally measured. Serological and molecular tests: - HBsAg, anti-HBc IgG, HBV DNA — for hepatitis B - Anti-HCV, HCV RNA — for hepatitis C - ANA, SMA, anti-LKM-1, IgG — for autoimmune hepatitis Fibrosis assessment: - Liver ultrasound — evaluates structure, size, presence of ascites - Transient elastography (FibroScan) — non-invasive measurement of liver stiffness; gold standard for non-invasive fibrosis staging - Liver biopsy — invasive but most precise; used when non-invasive results are inconclusive Treating Chronic Hepatitis Treatment differs fundamentally by cause — which is precisely why identifying the type comes first. Viral hepatitis B: The goal is to suppress viral replication and prevent progression to cirrhosis. Two drug classes are used: - Nucleoside/nucleotide analogues (entecavir, tenofovir) — taken long-term, often lifelong; suppress viral load to undetectable levels - Pegylated interferon-alpha — a 48-week course; a small proportion of patients achieve functional cure (loss of HBsAg) Viral hepatitis C: Complete cure is achievable in 95–99% of patients with modern direct-acting antivirals (DAAs): glecaprevir/pibrentasvir or sofosbuvir/velpatasvir combinations. Treatment duration is 8–12 weeks. After achieving a sustained virological response (SVR), the risk of cirrhosis falls sharply, and fibrosis may regress even when already present. Autoimmune hepatitis: Immunosuppressive therapy: high-dose prednisolone tapered gradually, plus azathioprine. With proper treatment, remission is achieved in 80–90% of patients. Treatment is often lifelong — withdrawal may be attempted only after sustained biochemical remission. Toxic (alcoholic) hepatitis: The only proven effective intervention is removing the cause. Complete alcohol abstinence in alcoholic hepatitis halts progression and often leads to partial fibrosis regression. Glucocorticoids are used short-term in severe alcoholic hepatitis. NAFLD/NASH: Treatment targets the underlying metabolic disturbances: - Weight loss of 7–10% from baseline reduces steatosis grade and inflammation - Physical activity independently improves histological findings regardless of weight change - Control of diabetes and dyslipidaemia is mandatory - Resmetirom — the first FDA-approved drug for NASH with F2–F3 fibrosis (2024) — represents a new specific therapeutic option Complications of Chronic Hepatitis Two major outcomes of untreated chronic hepatitis are cirrhosis and hepatocellular carcinoma (HCC). Cirrhosis — the end stage of fibrosis, in which normal liver architecture is completely replaced by scar tissue and regenerative nodules. It develops on average over 20–30 years of chronic hepatitis, but faster with high inflammatory activity or additional hepatotoxic factors. Cirrhosis complications include portal hypertension, ascites, variceal bleeding, hepatic encephalopathy, and spontaneous bacterial peritonitis. Hepatocellular carcinoma (HCC) — primary liver cancer, developing predominantly on a cirrhotic background. Risk is especially high with hepatitis B and C. HCC screening — liver ultrasound every 6 months with alpha-fetoprotein — is recommended for all patients with cirrhosis. A critical point: even at F3–F4 fibrosis (cirrhosis), treating the underlying cause of hepatitis reduces the risk of HCC and decompensation. This means it is never too late to start — but earlier is always better. When to See a Doctor Urgently Most chronic hepatitis situations are managed electively. However, several presentations require emergency assessment: - Sudden worsening of jaundice — a rapid increase in jaundice in known chronic hepatitis may indicate acute decompensation or superinfection with another hepatotropic virus - Rapidly increasing abdominal girth — new or rapidly expanding ascites; risk of spontaneous bacterial peritonitis - Bloody vomiting or black tarry stools — variceal bleeding from oesophageal or gastric varices; immediately life-threatening - Confusion or disorientation — a sign of hepatic encephalopathy - ALT or AST above 10 times the upper limit of normal on a routine test — even without symptoms, requires prompt clinical review On an elective basis: any incidentally discovered elevation of liver enzymes, the presence of risk factors (history of viral hepatitis, alcohol overuse, obesity, diabetes, long-term hepatotoxic medications), or a family history of liver disease. Chronic hepatitis is a disease that can in most cases be halted. Early detection and appropriately targeted treatment preserve liver function and prevent cirrhosis. The liver is forgiving — but only when given the opportunity in time. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a gastroenterologist or hepatologist. https://labreadai.com/en/posts/gout https://labreadai.com/en/posts/gout Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Gout is a uric acid crystal disease: symptoms of an acute attack, which blood tests to order, diet restrictions and treatment options. When to see a doctor. Articles article In the middle of the night — sudden, excruciating pain in the big toe. It's red, hot, swollen, and even the touch of a sheet is unbearable. This is the classic onset of an acute gout attack, one of the oldest diseases known to medicine. Hippocrates described it in the 5th century BC, and medieval physicians called it "the disease of kings" due to its link with rich eating. Today gout affects about 1–2% of the adult population worldwide — and that number is rising. Here is what happens in the body during an attack, why the disease keeps coming back, and how to bring it under control. What Is Gout and How Does It Develop Gout is a chronic metabolic disease in which crystals of monosodium urate deposit in joints and soft tissues. Picture the joint space as a narrow corridor where microscopic needles start to accumulate. The immune system reacts to them as foreign invaders: an inflammatory cascade fires, fluid floods the joint, tissues swell — and the person wakes up in pain that many compare to a joint being crushed in a vice. At the root of everything is uric acid. This is the final breakdown product of purines — molecules found in DNA and RNA — which come both from the body's own cell turnover and from food. Normally, uric acid is filtered out by the kidneys and excreted in urine. If too much is produced, or the kidneys clear it less efficiently than usual, the blood level rises. When it exceeds the solubility threshold (400 µmol/L), crystallisation begins. Urate salts deposit where it is slightly cooler — in peripheral joints, especially the first metatarsophalangeal joint of the foot. The disease progresses through stages: asymptomatic hyperuricemia → first acute attack → intercritical period → chronic tophaceous gout. Symptoms of Gout: What an Acute Attack Looks Like Acute gouty arthritis is one of the most painful episodes in medicine. Its features are so characteristic that an experienced clinician often makes the diagnosis clinically, before any lab results. Typical presentation: - Sudden onset, most often at night or in the early morning — when body and joint temperature is lowest, favouring crystallisation - Agonising pain escalating over 6–12 hours to a peak - Single joint involvement (monoarthritis) — in 50–70% of first episodes this is the first metatarsophalangeal joint of the big toe (podagra, from Greek for "foot trap") - Pronounced swelling, redness, and warmth over the joint; skin is stretched and shiny - Without treatment, an acute attack subsides spontaneously within 5–10 days When the disease goes untreated and attacks recur, urate crystals accumulate as tophi — firm, chalky nodules under the skin. Favourite sites: ear helix, elbow, dorsum of feet, Achilles tendon. Tophi indicate long-standing chronic gout with years of uncontrolled uric acid levels. Causes of Hyperuricemia and Risk Factors Elevated uric acid develops through two main mechanisms — and they often operate together. Excess urate production: - Purine-rich diet (red meat, organ meats, oily fish, shellfish) - Alcohol, especially beer — it simultaneously increases uric acid synthesis and impairs renal excretion - High-fructose beverages and juices - Rapid cell breakdown during chemotherapy, radiotherapy, or severe infections Impaired renal urate excretion: - Chronic kidney disease — lower filtration means slower urate clearance - Thiazide and loop diuretics - Low-dose aspirin (blocks tubular secretion of urate) - Dehydration Risk factor Relative contribution ------ Male sex (40–60 years) High — kidneys excrete urate less efficiently in men Postmenopausal women High — oestrogen's uricosuric effect is lost Purine-rich and high-fructose diet High Alcohol (especially beer) High Obesity Moderate Hypertension and diuretic use Moderate Chronic kidney disease High Heredity Moderate — multiple genes regulate urate transport Diagnosis: Which Blood Tests to Order for Gout Gout is one of the rare conditions where a single "normal" result can mislead. During an acute attack, serum uric acid often dips below its usual level — the body actively drives urate into the inflamed joint. Blood tests are most informative when drawn during the intercritical period, or at least two weeks after an attack has resolved. Uric acid in blood — the key marker. Diagnostically significant levels: above 420 µmol/L in men, above 360 µmol/L in women. The treatment target is below 360 µmol/L (below 300 µmol/L when tophi are present). Kidney function test — essential. The kidneys are affected by gout in two directions: impaired function promotes urate retention; prolonged hyperuricemia in turn damages tubular cells. This vicious cycle needs assessment from the outset. Creatinine — a marker of glomerular filtration. When elevated, GFR is reduced and doses of urate-lowering drugs require adjustment. C-reactive protein (CRP) — an acute-phase inflammation marker, sharply elevated during an attack. Helps distinguish gout from other arthritides and monitor the response to anti-inflammatory therapy. Complete blood count — leukocytosis and elevated ESR are expected during an attack. Also important for baseline assessment before starting NSAIDs. The gold standard of diagnosis is synovial fluid analysis under polarised-light microscopy — identification of needle-shaped monosodium urate crystals directly confirms the diagnosis. In most outpatient settings this is unavailable, so gout is diagnosed clinically, supported by lab data. Gout Treatment: Acute Attack and Long-Term Strategy Gout management involves two fundamentally different processes that must not be confused. Treating an acute attack — the goal is to extinguish inflammation quickly. Three options are used depending on contraindications: - NSAIDs (naproxen, indomethacin, etoricoxib) — maximum dose at the first sign; most effective when started early - Colchicine — most specific for gouty arthritis; works by suppressing neutrophil migration to urate crystals - Glucocorticoids — when the first two are contraindicated, or when multiple joints are involved A critical point that is often ignored: do not start urate-lowering therapy during an acute attack. A sudden shift in uric acid levels during active inflammation can prolong the attack or trigger a new one. Long-term urate lowering — the cornerstone of relapse prevention: - Allopurinol — blocks the enzyme xanthine oxidase, reducing uric acid synthesis; started at a low dose and titrated slowly under lab monitoring - Febuxostat — a more selective xanthine oxidase inhibitor; used when allopurinol is not tolerated - Uricosuric agents — enhance renal urate excretion; used less often, contraindicated in nephrolithiasis Treatment target: sustained uric acid below 360 µmol/L. At this level, existing crystals gradually dissolve and attack frequency falls. In patients with tophi the target is tighter — below 300 µmol/L. Gout Diet: What to Eliminate and What to Keep Diet alone cannot replace medication, but no treatment delivers lasting results without dietary correction. Category Foods Approach --------- 🔴 Eliminate Organ meats (liver, kidneys, brain), game meat, anchovies, sardines, mackerel, alcohol (especially beer), fructose-sweetened drinks Complete avoidance 🟡 Limit Red meat, seafood, poultry, legumes, spinach, asparagus, cauliflower, mushrooms No more than one portion per day 🟢 Unrestricted Low-fat dairy, eggs, most vegetables, grains, potatoes, bread, cherries No restriction A few specific points: - Water — 2–3 litres daily. Good hydration supports renal urate excretion and reduces the risk of urate kidney stones. - Cherries — have a moderate evidence base: anthocyanins reduce uric acid levels and inflammation; some trials showed a 35% reduction in attack frequency. - Coffee — paradoxically, moderate intake (2–4 cups daily) is associated with lower uric acid levels. The proposed mechanism is that caffeine competes with purines for xanthine oxidase. Gout and Comorbidities: Why a Broader View Matters Gout rarely arrives alone. It sits within a cluster of metabolic conditions and frequently coexists with diseases that require parallel management. Metabolic syndrome — obesity, insulin resistance, dyslipidaemia, and hypertension — is present in 60–70% of gout patients. Insulin resistance directly reduces renal urate excretion, which is one of the physiological links between the two conditions. Chronic kidney disease — the connection is bidirectional. Impaired renal filtration promotes urate retention; conversely, prolonged hyperuricemia can accelerate kidney damage through direct inflammatory injury to tubular cells. Monitoring kidney function in gout patients is not optional. Elevated uric acid is independently associated with increased cardiovascular risk: hypertension, coronary artery disease, and stroke. Cardiology follow-up is often part of long-term gout management. When to See a Doctor Urgently Several situations call for medical attention without delay: - First acute arthritis episode — acute joint pain always requires examination. Differentiating gout from septic arthritis, pseudogout, and reactive arthritis cannot be done at home. - Fever with arthritis — temperature above 38°C combined with a swollen joint may indicate septic arthritis, a medical emergency. - Tophi appearing — especially if growing rapidly or breaking through the skin; this signals uncontrolled hyperuricemia requiring therapy adjustment. - Flank pain or blood in urine — may indicate urate kidney stones. - Uric acid above 600 µmol/L — even without symptoms, requires medical supervision. Gout is a disease that can genuinely be controlled. With appropriate therapy and lifestyle changes, most patients achieve long-term remission without attacks. The key: do not endure the pain and do not wait for it to pass on its own. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a qualified rheumatologist or general practitioner. https://labreadai.com/en/posts/menopause https://labreadai.com/en/posts/menopause Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Menopause is a pivotal transition in women's health. Symptoms across three stages, which tests to order, when HRT is indicated and how to protect bones and heart. Articles article The average age of menopause is 51. This means a third of most women's lives is spent in postmenopause — not in disease, but in a physiological transition that nonetheless reshapes metabolism, bones, the cardiovascular system and the brain. How well a woman navigates those years depends largely on how early she understands what is happening and how effectively medical support is structured. Here is a thorough account — from the first signs of perimenopause to long-term health protection strategies. What Is Menopause: Three Stages Menopause is not a single day or moment. It is a process spanning years, conventionally divided into three stages. Perimenopause — the transition period beginning 2–10 years before the final menstrual period. The ovaries gradually exhaust their follicular reserve, cycles become irregular, and oestradiol begins to fluctuate and progressively fall. The first symptoms appear here — hot flushes, sleep disturbances, mood changes — while menstruation still continues. Diagnostically, this is the most challenging stage: hormone levels can be within "normal" ranges while symptoms are already significant. Menopause — officially defined retrospectively: 12 consecutive months without a menstrual period. The average age in Western countries is 50–52. Before age 45 — early menopause; before 40 — premature ovarian insufficiency (POI), which requires a distinct clinical approach. Postmenopause — the entire period after the last menstrual period. Acute symptoms (hot flushes) gradually subside in most women over 3–7 years, but long-term metabolic changes — falling bone density, shifting lipid profile, mucosal atrophy — continue to progress. It is postmenopause that defines long-term health risks. The core biological mechanism throughout this transition is the decline and eventual exhaustion of ovarian oestrogen production. Oestrogen is not simply a "female hormone" — it is a universal regulator: it protects bone from resorption, maintains vascular elasticity, modulates the lipid profile, and influences sleep and mood through serotonin and other neurotransmitters. Symptoms of Menopause: Three Clusters Menopausal symptoms fall into three groups, each requiring its own management approach. Vasomotor symptoms — the most widely recognised: - Hot flushes — a sudden wave of heat spreading from the chest to the neck and face; lasting from 30 seconds to several minutes; accompanied by flushing and sweating - Night sweats — hot flushes during sleep, disrupting rest - Palpitations accompanying a flush Around 75–80% of women experience vasomotor symptoms during perimenopause and postmenopause. For some they are mild and barely intrusive; for others — severe, occurring hourly, and profoundly affecting quality of life. Without treatment, hot flushes can persist for more than 7 years, and in some women indefinitely. Urogenital symptoms — progressively worsening in postmenopause as mucosal atrophy advances: - Vaginal dryness, itching, discomfort during intercourse (dyspareunia) - Urinary urgency and frequency, recurrent urinary tract infections - Reduced libido Unlike hot flushes, which tend to diminish over time, urogenital symptoms worsen without treatment. Many women tolerate them for years, dismissing them as an inevitable consequence of ageing. Psychological and cognitive symptoms: - Sleep disturbances — independent of night sweating - Anxiety, irritability, mood swings - Reduced concentration and memory ("brain fog") - Depressive episodes — the risk of depression in perimenopause is 2–4 times higher than during the reproductive years Diagnosis: Which Tests Are Needed in Menopause Menopause is a clinical diagnosis. A 51-year-old woman with 12 months of amenorrhoea does not need a blood test for confirmation. Tests are needed in specific circumstances. FSH — when the clinical picture is unclear; in younger women (under 45) to confirm premature menopause or POI; when irregular cycles need differentiating from other causes. FSH 40 IU/L combined with amenorrhoea is the laboratory criterion for postmenopause. LH — always together with FSH. A FSH:LH ratio 1 in postmenopause is physiological. If LH is disproportionately high — other causes should be excluded. Oestradiol — predictably low in postmenopause (< 30–40 pmol/L). Useful for gauging the degree of oestrogen deficiency, establishing a baseline before starting HRT, and monitoring on therapy. Lipid panel — mandatory. After menopause, total cholesterol and LDL rise, while HDL falls. This is a direct consequence of losing oestrogen's vascular protection and one of the drivers of the sharp rise in cardiovascular risk after menopause. Additionally — TSH (hypothyroidism mimics menopausal symptoms and commonly debuts at this age), full blood count, glucose, mammography and cervical cytology before starting HRT. Densitometry (DXA) — for all postmenopausal women to assess bone density and osteoporosis risk. The first scan should be performed immediately after confirmed postmenopause, or earlier in the presence of risk factors. Hormone Replacement Therapy: Who Benefits and Who Should Avoid It HRT is the most effective treatment for menopausal symptoms and simultaneously the most myth-laden. Here is what the evidence says, without distortion in either direction. HRT effectively resolves: - Hot flushes and night sweats — frequency reduction of 75–90% - Urogenital symptoms — local preparations (vaginal creams, rings) work even better than systemic therapy for isolated genitourinary atrophy - Sleep disturbances and psychological symptoms - Reduces bone loss and osteoporotic fracture risk Who should consider HRT: - Women with moderate to severe vasomotor symptoms reducing quality of life - Women with premature menopause or POI — HRT is indicated regardless of symptoms, at minimum until the average age of natural menopause (51): early oestrogen deficiency dramatically raises the risk of osteoporosis and cardiovascular disease - Women at high osteoporosis risk when antiresorptive agents are not tolerated Contraindications to systemic HRT: - Breast cancer (personal or family history requires careful individual assessment) - History of endometrial cancer - Active thrombosis or thromboembolism (transdermal formulations are significantly safer than oral) - Active liver disease - Uncontrolled hypertension Principles of modern HRT: - "Window of opportunity" — maximum benefit with minimum risk when HRT is started within 10 years of menopause or before age 60 - Women with an intact uterus must have oestrogen combined with a progestogen (to protect the endometrium) - Lowest effective dose - Transdermal formulations (gels, patches) preferred over oral — bypass hepatic first-pass metabolism, lower thrombosis risk The decision on HRT is made individually by the gynaecologist, taking into account symptoms, medical history, investigation results and patient preferences. Non-Hormonal and Alternative Approaches When HRT is not possible or not desired: - Cognitive behavioural therapy (CBT) — a proven method for reducing hot flush frequency and intensity, working through modification of the response to triggers - Physical activity — moderate aerobic exercise improves sleep, reduces anxiety, slows bone and muscle loss - SSRIs and SNRIs — reduce hot flush frequency by 50–60%; particularly indicated when depressive symptoms coexist - Gabapentin — effective for night sweats - Phytoestrogens (soy isoflavones, red clover) — moderate evidence base; more effective than placebo in some women, but substantially inferior to HRT Menopause and Long-Term Health Consequences This is what is most often left unspoken in discussions of menopause: it changes not only how a woman feels today, but her long-term risk profile for the rest of her life. Osteoporosis. In the first 5–7 years of postmenopause, a woman can lose 20–30% of bone mass — the highest rate of bone loss in a lifetime. Oestrogen normally suppresses osteoclasts; without it, resorption accelerates sharply. One in three women over 50 will sustain an osteoporotic fracture. Densitometry, vitamin D, calcium and antiresorptive agents when indicated are mandatory components of postmenopause management. Details in the osteoporosis article. Cardiovascular disease. Before menopause, women are substantially better protected from CVD than men — oestrogen maintains endothelial elasticity, a favourable lipid profile, and reduces platelet aggregation. After menopause this gap closes within 5–10 years. Monitoring the lipid profile, blood pressure and glucose becomes as important as it is for men of the same age. Cognitive changes. Oestrogen has neuroprotective effects — it supports synaptic plasticity, cerebral blood flow and acetylcholine synthesis. "Brain fog" in perimenopause is not imagined: it reflects genuine neurochemical changes. Long-term, early menopause (especially before 45) is associated with elevated dementia risk — another argument for HRT when oestrogen deficiency begins early. PCOS and menopause. Women with PCOS have a distinctive menopausal transition: their ovaries are depleted later (by 2–4 years), since follicular reserve is initially greater. However, they carry higher metabolic risks in postmenopause — insulin resistance, dyslipidaemia, obesity. Individualised postmenopause management is essential for this group. When to See a Doctor Menopause calls for planned, proactive medical care — not waiting for things to "resolve on their own." See a gynaecologist or reproductive endocrinologist when: - Cycle irregularities begin after age 40 — the start of perimenopause; time to assess baseline hormone levels and plan ahead - Severe hot flushes (more than 7–8 per day, significant night sweating, disrupted sleep) — markedly reduce quality of life; HRT or alternatives are effective - Urogenital symptoms — dryness, painful intercourse, recurrent infections; local preparations are safe and highly effective - Menopause before age 45 — mandatory consultation; early oestrogen deficiency requires active management - Any vaginal bleeding in postmenopause (after 12 months of amenorrhoea) — endometrial cancer must be excluded; this is not "the cycle returning" Menopause is not an ending but a transition. Women who actively manage their health during this period live longer and with better quality of life than those who tolerate symptoms or ignore long-term risks. Medicine today has all the tools needed. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a qualified gynaecologist. https://labreadai.com/en/posts/metabolic-syndrome https://labreadai.com/en/posts/metabolic-syndrome Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Metabolic syndrome combines abdominal obesity, high blood pressure, elevated blood sugar and dyslipidaemia. IDF diagnostic criteria, which tests to order and how to treat it. Articles article Physicians call it the "deadly quartet" — and not for dramatic effect. Metabolic syndrome is not a single disease but a combination of four interlinked disturbances: abdominal obesity, high blood pressure, impaired glucose metabolism, and dyslipidaemia. Each one individually raises cardiovascular risk. Together, they multiply it by an order of magnitude. Approximately one in four adults worldwide meets the criteria for metabolic syndrome, and most have no idea — the condition progresses silently for years, until a first heart attack or stroke. What Is Metabolic Syndrome and Why Does It Develop At the centre of metabolic syndrome sits insulin resistance — a state in which muscle, liver and adipose cells stop responding normally to insulin. Think of insulin as a key that unlocks a cell's access to glucose. In insulin resistance, the lock has seized: the key goes in, but the door will not open. The pancreas responds predictably — it produces ever more insulin to force the lock. Hyperinsulinaemia sets off a chain of disturbances: glucose accumulates in the blood, the liver ramps up triglyceride synthesis, the kidneys retain sodium — and blood pressure rises. Visceral fat — stored not under the skin but around the internal organs — acts as an active endocrine organ. It releases pro-inflammatory cytokines and free fatty acids directly into the portal vein, attacking the liver and amplifying insulin resistance. This creates a self-sustaining vicious cycle: more visceral fat → greater insulin resistance → higher insulin levels → more fat deposition. The predisposition to metabolic syndrome has a genetic basis, but it is expressed through lifestyle. Three main triggers: hypercaloric nutrition with excess simple carbohydrates and saturated fats, physical inactivity, and chronic stress — the last of which acts directly through cortisol to promote abdominal fat accumulation. Diagnostic Criteria: How to Identify Metabolic Syndrome Metabolic syndrome is diagnosed by the presence of central obesity plus any two of four additional criteria. The most widely used are the IDF (International Diabetes Federation, 2005) criteria: Criterion Threshold value ------ Waist circumference (central obesity) ≥ 94 cm in European men; ≥ 80 cm in women Triglycerides ≥ 1.7 mmol/L (or on medication) HDL cholesterol < 1.0 mmol/L in men; < 1.3 mmol/L in women (or on medication) Blood pressure ≥ 130/85 mmHg (or on antihypertensive treatment) Fasting glucose ≥ 5.6 mmol/L (or previously diagnosed type 2 diabetes) Waist circumference thresholds differ by ethnicity: in South and South-East Asian populations — ≥ 90 cm in men and ≥ 80 cm in women. One critical point: waist circumference is a mandatory criterion, not simply one of five. Without central obesity the diagnosis of metabolic syndrome is not made, even if all four other parameters are abnormal. Visceral fat — not subcutaneous — determines metabolic risk, which is why a lean person with a normal BMI but an abdominal fat pattern can have this syndrome. Symptoms of Metabolic Syndrome: Why It Is So Often Missed Metabolic syndrome does not hurt and does not interfere with daily life — for a long time. This is precisely what makes it dangerous. Indirect signs that should prompt attention: - Fat concentrated at the abdomen — even with a relatively normal overall weight. Trousers fit the hips but will not button at the waist — the classic "apple" body shape - Persistent fatigue and drowsiness after meals — especially after carbohydrate-rich food: cells cannot access glucose efficiently despite high circulating levels - Intense craving for sugar and refined carbohydrates — a consequence of unstable blood glucose levels - Elevated blood pressure, especially when found in a young adult without an obvious cause - Dark, velvety skin folds in the groin, armpits or neck (acanthosis nigricans) — a visible marker of hyperinsulinaemia - Fatty liver (NAFLD) — often found incidentally on an abdominal ultrasound In women, metabolic syndrome frequently coexists with PCOS — both share insulin resistance as a common pathogenetic root. In men, it is often accompanied by hypogonadism: excess visceral fat accelerates conversion of testosterone to oestradiol. Which Blood Tests to Order for Metabolic Syndrome The diagnosis is largely clinical — a tape measure and blood pressure cuff are sufficient. But laboratory assessment is essential for quantifying the degree of metabolic disturbance and risk of complications. Fasting glucose — the primary screening test. A level of 5.6–6.9 mmol/L indicates prediabetes; ≥ 7.0 mmol/L indicates diabetes. Blood must be drawn strictly fasting — even a light snack shifts the result. Glycated haemoglobin (HbA1c) — reflects mean glucose over the past 2–3 months. No fasting required; resistant to single-occasion dietary variation. Used both for diagnosing glucose metabolism disturbances in metabolic syndrome and for monitoring their trajectory on treatment. Triglycerides — one of the five diagnostic criteria. Levels above 1.7 mmol/L combined with low HDL constitute the atherogenic dyslipidaemia that is the characteristic lipid pattern of metabolic syndrome. HDL cholesterol — the "protective" cholesterol that transports lipids back to the liver. It is reduced in metabolic syndrome: adipose tissue and the liver disrupt its synthesis. The lower the HDL, the higher the cardiovascular risk. LDL cholesterol — not a formal diagnostic criterion, but frequently elevated in metabolic syndrome and dominated by small dense LDL particles — the most atherogenic fraction. Critical for assessing atherosclerotic risk. Lipid panel — measures all fractions simultaneously: total cholesterol, LDL, HDL, triglycerides. The starting point for initial assessment. Fasting insulin + HOMA-IR calculation — direct assessment of insulin resistance. HOMA-IR = (fasting glucose × fasting insulin) / 22.5. A value above 2.5–3.0 indicates insulin resistance. This test is not part of formal diagnostic criteria but is highly useful for gauging severity and guiding treatment. Treating Metabolic Syndrome: Diet, Exercise and Cardiometabolic Risk Reduction Metabolic syndrome is a reversible condition. This is one of the rare situations in medicine where lifestyle genuinely changes prognosis — often faster and more effectively than medication. Lifestyle Modification — First and Primary Line of Therapy Weight loss. Losing 7–10% of baseline body weight improves all five components of metabolic syndrome simultaneously: blood pressure falls, glucose normalises, HDL rises, triglycerides drop. Reducing visceral fat specifically matters most — this is most effectively achieved by combining caloric restriction with regular physical activity. Physical activity. 150–300 minutes of moderate aerobic exercise per week (brisk walking, swimming, cycling) reduces insulin resistance independently of weight change. Resistance training 2–3 times weekly adds to the effect: muscle tissue is the body's primary consumer of glucose. Nutrition. The most evidence-based dietary patterns: - Mediterranean diet — rich in fibre, unsaturated fats and polyphenols; reduces cardiovascular risk by 30% in high-risk patients - Restriction of fast carbohydrates (sugar, white flour, sugary drinks) — direct reduction of postprandial hyperinsulinaemia - Restriction of trans fats and animal saturated fats What to limit What to increase ------ Sugar and sweet drinks Vegetables and legumes (fibre) White bread, pastries, white rice Whole grains Red and processed meat Fatty fish (omega-3) Trans fats (margarine, fast food) Olive oil, nuts, avocado Alcohol Unsweetened tea, black coffee Pharmacotherapy — When Lifestyle Is Not Enough Medications are added in a targeted, stepwise manner for each disturbed component: - Metformin — for impaired glucose metabolism (prediabetes or diabetes); reduces insulin resistance, modest weight benefit - Statins — for elevated LDL and high cardiovascular risk; reduce the risk of heart attack and stroke by 25–35% - Fibrates — for isolated hypertriglyceridaemia or the combination of high triglycerides and low HDL - Antihypertensives — when blood pressure remains above 140/90 mmHg despite lifestyle changes; ACE inhibitors and ARBs are preferred as metabolically neutral or beneficial - Weight-loss medications — orlistat or GLP-1 receptor agonists (semaglutide, liraglutide) for BMI ≥ 30 or ≥ 27 with complications; GLP-1 agents simultaneously improve glycaemia and reduce cardiovascular risk Metabolic Syndrome and Associated Conditions Metabolic syndrome is the intersection of several major diseases, and these connections demand attention. Type 2 diabetes — the most frequent complication. People with metabolic syndrome face a fivefold higher risk of developing diabetes. In practical terms, metabolic syndrome is the pre-stage of diabetes — and this is where intervention is most powerful: preventing the disease rather than managing it. Atherosclerosis and cardiovascular disease — dyslipidaemia and chronic inflammation in metabolic syndrome accelerate plaque formation. The risk of myocardial infarction is 2–3 times higher than average in these patients. Non-alcoholic fatty liver disease (NAFLD) — present in 70–80% of people with metabolic syndrome. Excess insulin drives free fatty acids into the liver, where they deposit. Without treatment, NAFLD can progress to steatohepatitis and cirrhosis. Gout, PCOS and obstructive sleep apnoea each have well-documented associations with metabolic syndrome and warrant parallel assessment at the time of diagnosis. When to See a Doctor Metabolic syndrome calls for a planned but prompt visit to a GP or endocrinologist. Urgent attention is needed in these situations: - Blood pressure above 160/100 mmHg — even without symptoms; high risk of acute vascular events - Fasting glucose above 7.0 mmol/L — criterion for manifest diabetes; treatment must begin promptly - Chest pain, breathlessness or palpitations in the context of metabolic syndrome — possible signs of acute cardiac pathology - Rapidly increasing waist circumference (more than 5 cm in 6 months) — indicates accumulating visceral fat mass A diagnosis of metabolic syndrome is not a sentence — it is a warning. At this stage, lifestyle changes can fully reverse the syndrome before irreversible damage to target organs takes hold. This article is for informational purposes only. Diagnosis and treatment are the responsibility of an endocrinologist or general practitioner. https://labreadai.com/en/posts/osteoporosis https://labreadai.com/en/posts/osteoporosis Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Osteoporosis silently reduces bone density until the first fracture. How to detect it with densitometry and blood tests, which medications work and how to protect bones with age. Articles article Osteoporosis is called a "silent epidemic" — and the name fits precisely. Bone deteriorates for years without a single symptom, and the first signal is a fracture: from a minor knock, an awkward twist, or even a forceful cough. One in three women over 50 and one in five men of the same age will sustain an osteoporotic fracture in their remaining lifetime. The good news: the disease can be detected long before that moment — and its progression significantly slowed. What Is Osteoporosis and How Does It Develop Bone is living tissue in a constant state of renewal. Specialised osteoclast cells break down old bone while osteoblasts build new tissue. Normally these processes are balanced and bone maintains its strength. Peak bone mass is reached around age 25–30 — this is a kind of "bone capital" for the rest of life. After age 30–35 the balance gradually shifts: breakdown begins to outpace formation and bone density slowly declines. Osteoporosis is the point at which bone loss has progressed far enough that bone becomes brittle and fractures under loads that healthy bone would withstand with ease. Bone microarchitecture is disrupted: trabecular struts thin and perforate, and the bone begins to resemble moth-eaten sponge. Two main types are recognised: - Primary osteoporosis — postmenopausal (type I, in women in the early years after menopause when oestrogen falls) and senile (type II, in men and women over 70) - Secondary osteoporosis — a consequence of another disease (e.g. rheumatoid arthritis) or drug treatment: glucocorticoids, antiepileptics, aluminium-containing antacids Symptoms of Osteoporosis: Why the Disease Is Missed for Years Osteoporosis itself does not hurt. This is precisely what makes it so dangerous — while bone density falls, the person feels entirely well. Early indirect signs worth noting: - Loss of height — losing more than 2–3 cm compared to young adult height suggests vertebral compression fractures, which often occur silently - Chronic back pain — especially in the thoracic and lumbar spine; may be the result of "quiet" vertebral fractures - Posture changes — progressive thoracic kyphosis ("dowager's hump"): vertebrae gradually deform wedge-shaped under body weight - Fractures from minimal trauma — wrist from a fall from standing height, hip during walking, ribs from a hug Hip fracture is the most severe complication. In elderly patients it is associated with high mortality in the first year: up to 30% of patients die from complications (thromboembolism, pneumonia, heart failure) — not from the fracture itself, but from the prolonged immobilisation that follows. Low Bone Density Causes and Risk Factors Bone loss is a universal ageing process, but the rate and severity are shaped by a combination of factors. Risk factor Mechanism ------ Female sex and menopause Oestrogen brakes osteoclast activity; its fall at menopause accelerates resorption 3–5 fold Age over 65 Reduced cutaneous vitamin D synthesis, impaired calcium absorption, sarcopaenia Family history Genetics determines up to 60–80% of peak bone mass Low oestradiol / testosterone Sex hormones protect bone in both sexes Low body weight (BMI < 18.5) Less mechanical load on bone; less adipose tissue for oestrogen synthesis Smoking Accelerates oestrogen breakdown, impairs bone blood supply Alcohol ( 2 units/day) Direct toxicity to osteoblasts; impairs calcium absorption Glucocorticoids (prednisolone 3 months) Suppress osteoblasts and intestinal calcium absorption Sedentary lifestyle Bone strengthens under mechanical load — without it, it atrophies Calcium and vitamin D deficiency Impaired mineralisation of newly formed bone Diagnosing Osteoporosis: Densitometry and Blood Tests Densitometry (DXA — dual-energy X-ray absorptiometry) is the diagnostic gold standard. It measures bone mineral density (BMD) at the lumbar vertebrae and femoral neck. The result is expressed as a T-score — the deviation from peak bone mass in young adults: T-score Interpretation ------ Above −1.0 Normal −1.0 to −2.5 Osteopaenia (reduced density preceding osteoporosis) −2.5 and below Osteoporosis −2.5 and below + prior fracture Severe osteoporosis Densitometry is recommended for all women over 65, men over 70, and younger individuals with risk factors (menopause before 45, glucocorticoid use, prior fragility fracture). Blood tests are needed to exclude secondary osteoporosis and assess calcium-phosphate metabolism before starting treatment: - Calcium — total and ionised. Usually normal in primary osteoporosis; marked elevation points to hyperparathyroidism. - Vitamin D (25-OH) — essential. Vitamin D deficiency is one of the most frequent correctable risk factors; at levels below 30 nmol/L, bone mineralisation is impaired. - Parathyroid hormone (PTH) — elevated in secondary hyperparathyroidism (response to calcium/vitamin D deficiency) and in primary hyperparathyroidism as an independent cause. - Phosphorus — reduced in osteomalacia and several forms of secondary osteoporosis. - Oestradiol in women / testosterone in men — when hormonal deficiency is suspected as the cause of bone loss. - Bone turnover markers — osteocalcin (formation) and β-CrossLaps/CTX (resorption) — used to monitor treatment response. Treating Osteoporosis: Medications and Lifestyle Measures Treatment is started at T-score −2.5 or below, and also in osteopaenia when the 10-year fracture risk calculated by the FRAX tool is high. Baseline therapy — nothing else works effectively without it: - Calcium 1000–1200 mg/day as elemental calcium — from food and supplements as needed - Vitamin D3 800–2000 IU/day (dose guided by 25-OH vitamin D blood level) Antiresorptive therapy — slows bone breakdown: - Bisphosphonates (alendronate, zoledronate, ibandronate) — first line; reduce vertebral fracture risk by 40–70%, hip fracture by 40–50% - Denosumab — monoclonal antibody blocking RANKL, the key activator of osteoclasts; used when bisphosphonates are not tolerated or in renal insufficiency - Hormone replacement therapy (HRT) — in women in early postmenopause; effective bone protection, prescribed with careful consideration of cardiovascular and oncological risks Anabolic therapy — stimulates new bone formation; reserved for severe osteoporosis: - Teriparatide (PTH fragment) — the only agent that genuinely builds new bone - Romosozumab — blocks sclerostin, simultaneously stimulating formation and inhibiting resorption Note: bisphosphonates are taken in courses with "drug holidays" — after 3–5 years of treatment a break is taken under densitometry monitoring. Do not stop or switch therapy independently. Osteoporosis Prevention: Diet and Lifestyle No medication works effectively against a background of calcium and vitamin D deficiency — this is the foundation without which treatment cannot reach its target. Calcium from food — the preferred source: Food Calcium per 100 g ------ Hard cheese 700–1200 mg Milk, kefir, yoghurt 110–120 mg Canned sardines (with bones) 380 mg Tofu (calcium-set) 350 mg White cabbage 48 mg Broccoli 47 mg Daily calcium requirement: 1000 mg for adults 18–50, 1200 mg for women over 50 and men over 70. Exercise — one of the most underestimated treatment tools. Weight-bearing and resistance training stimulate osteoblasts through mechanical stress. Effective activities: walking, running, dancing, strength training, yoga, tai chi. The last two are particularly valuable for fall prevention: they improve balance and coordination. Swimming and cycling, despite their cardiovascular benefits, create minimal mechanical load on bone. Fall prevention — a separate strategy, especially in older adults: removing thresholds and slippery surfaces at home, good lighting, vision correction, discontinuing sedating medications where possible. When to See a Doctor Urgently Osteoporosis is not an emergency condition, but several situations call for prompt medical attention: - Acute back pain after minimal or no trauma — possible vertebral compression fracture; X-ray or MRI of the spine needed - A fall with pain in the hip, groin or thigh — suspected hip fracture; immediate hospitalisation required - Newly discovered T-score of −2.5 or below — planned but prompt assessment by a rheumatologist or endocrinologist to initiate therapy - Height loss of 4 cm or more — indication for spinal X-ray even in the absence of pain Early diagnosis changes outcomes radically. Starting treatment at osteopaenia can prevent the first fracture entirely. Starting after — can prevent the next one. In either case, starting now is the right call. This article is for informational purposes only. Diagnosis and choice of therapy are the responsibility of a rheumatologist or endocrinologist. https://labreadai.com/en/posts/pcos https://labreadai.com/en/posts/pcos Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) PCOS is the most common hormonal disorder in women. How to recognise it by symptoms, which blood tests to order, how it is treated and what to do when planning pregnancy. Articles article Irregular periods, weight that refuses to budge despite any diet, persistent acne past the age of 25, and unwanted hair in unexpected places — each of these signs on its own can seem trivial. Together, they may point to a single diagnosis: polycystic ovary syndrome. PCOS is the most common endocrine disorder in women of reproductive age, affecting around 10–13% of women worldwide. A significant proportion only discover they have it when they start trying to conceive. Here is what happens in the body with PCOS, and how to manage it effectively. What Is PCOS and How Does It Develop Polycystic ovary syndrome is a chronic endocrine condition rooted in dysregulation of female sex hormones. The name is slightly misleading: "polycystic" sounds like multiple cysts, but what it actually describes is a collection of small, immature follicles that cannot complete development and release an egg — in other words, anovulation. In a healthy cycle, follicle-stimulating hormone (FSH) and luteinising hormone (LH) operate in a precise rhythm: FSH drives follicle maturation, LH triggers ovulation. In PCOS this balance breaks down: LH is chronically elevated relative to FSH, with an LH:FSH ratio exceeding 2–3:1. The ovaries receive a distorted signal and begin overproducing androgens — chiefly testosterone. Excess testosterone blocks final follicular maturation, and the follicles "stall" at an intermediate stage — this is what produces the characteristic ultrasound appearance: an ovary ringed with 12 or more small follicles around its periphery. The second key mechanism is insulin resistance. In 65–70% of women with PCOS, cells respond poorly to insulin, and the pancreas compensates by secreting more. Hyperinsulinaemia directly stimulates the ovaries to produce even more androgens — closing the loop. This is why weight loss in PCOS often restores the menstrual cycle: each excess kilogram amplifies insulin resistance, and losing it breaks the vicious circle. Symptoms of PCOS in Women PCOS is a heterogeneous syndrome, and two women with the same diagnosis can look very different. Nevertheless, three clusters of features appear most consistently. Menstrual cycle disturbances: - Oligomenorrhoea — infrequent periods with cycles longer than 35 days (most common) - Amenorrhoea — absence of periods for more than 3 months - Unpredictable cycle length - Heavy periods after a long gap — due to accumulated endometrium Signs of hyperandrogenism — excess male sex hormones: - Hirsutism — male-pattern hair growth: upper lip, chin, chest, abdomen, inner thighs - Acne and oily skin resistant to standard treatment - Androgenic alopecia — thinning of scalp hair in a male pattern at the crown Metabolic disturbances: - Overweight or obesity, particularly abdominal (fat concentrated around the waist) - Dark, velvety skin folds in the armpits, neck or groin — acanthosis nigricans, a marker of severe insulin resistance - Chronic fatigue and mood fluctuations linked to unstable blood sugar levels An important caveat: PCOS can exist at normal weight and without obvious hirsutism. A slim woman with an irregular cycle is no less likely a candidate for this diagnosis than a woman with obesity and acne. Causes of PCOS and Risk Factors The exact cause of PCOS has not been established — this is one of the few areas where medicine openly acknowledges incomplete understanding. The condition clearly has a genetic basis: the risk of PCOS in daughters and sisters of affected women is 5–8 times higher than average. But genes are a predisposition, not a sentence — environment determines whether they are expressed. Factor Role ------ Heredity Strong — multiple genes regulating insulin sensitivity and steroidogenesis Excess body weight Amplifies insulin resistance → more ovarian androgens Intrauterine androgen exposure Epigenetic programming of the ovarian–pituitary axis before birth Gut dysbiosis Affects oestrogen metabolism and insulin resistance — an active research area Chronic stress Disrupts the hypothalamus–pituitary–ovarian axis via cortisol Physical inactivity Reduces tissue insulin sensitivity Diagnosing PCOS: Rotterdam Criteria and Blood Tests The diagnosis is made using the 2003 Rotterdam Criteria — at least two of three must be present: 1. Ovulatory dysfunction (oligo- or anovulation) 2. Clinical or biochemical signs of hyperandrogenism 3. Polycystic ovarian morphology on ultrasound (12+ follicles of 2–9 mm diameter in one ovary, or ovarian volume 10 mL) Before confirming PCOS, other causes of the same symptoms must be excluded: hypothyroidism, hyperprolactinaemia, congenital adrenal hyperplasia, and androgen-secreting tumours. Essential blood tests: - LH and FSH — ratio and absolute values assessed. In PCOS, LH:FSH 2–3:1, though this is not a mandatory diagnostic criterion. Drawn on cycle days 2–5. - Testosterone — total and free; elevated in 60–80% of women with PCOS. Drawn fasting in the morning on cycle days 2–5. - Oestradiol — may be normal or mildly reduced in PCOS; important for assessing follicular function. - Insulin fasting + glucose → HOMA-IR calculation. The practical gold standard for insulin resistance assessment in outpatient practice. - Glucose fasting and oral glucose tolerance test (OGTT) — the risk of prediabetes in PCOS is 5–7 times higher than in the general population. - TSH — hypothyroidism produces overlapping symptoms and must be excluded first. - HbA1c — reflects average glucose over three months; recommended as a metabolic screening tool in PCOS. Pelvic ultrasound — transvaginal preferred; ovarian morphology and endometrial thickness are assessed. Ideally performed on cycle days 5–7 when a cycle is present. Treating PCOS: Insulin Resistance, Weight Loss and What Actually Works There is no single "PCOS pill" — treatment is tailored to the specific goal: restoring the cycle, managing hirsutism and acne, preparing for pregnancy, or correcting metabolic disturbances. Lifestyle modification — first line for every goal: Weight loss of 5–10% from baseline in overweight women restores ovulation in 30–55% of patients without any medication. The mechanism is direct: less fat → less insulin resistance → fewer ovarian androgens. Moderate aerobic exercise (150 minutes per week) amplifies this effect independently of weight change. Metformin — the primary drug for the metabolic variant of PCOS: - Reduces insulin resistance and androgen levels - Restores cycle regularity in approximately 50% of women - Lowers the risk of developing type 2 diabetes - Prescribed when carbohydrate metabolism is impaired or cardiometabolic risk is high Combined oral contraceptives (COCs) — when the goal is cycle regulation and management of hirsutism/acne without wanting pregnancy: - Suppress excess LH secretion → reduce ovarian androgen synthesis - Raise sex hormone-binding globulin (SHBG) → lower free testosterone - COCs containing antiandrogenic progestins (drospirenone, cyproterone) are most effective for acne and hirsutism When pregnancy is desired: - Letrozole (aromatase inhibitor) — first-line agent for ovulation induction in PCOS; superior in efficacy to previously used clomiphene - Metformin may be added as an adjunct - IVF — when ovulation induction fails over 3–6 cycles PCOS and Pregnancy: What to Know PCOS is a common cause of anovulatory infertility, but it is not a verdict. Most women with PCOS can conceive — with treatment or, in milder cases, without it. During pregnancy, PCOS is associated with elevated risks of: - Gestational diabetes — 2–3 times higher than average (due to underlying insulin resistance) - Preeclampsia and gestational hypertension - Preterm labour - First-trimester miscarriage This does not mean pregnancy is contraindicated — it means it requires closer monitoring. Glucose and blood pressure surveillance, early gestational diabetes screening (OGTT at 24–28 weeks, or earlier when risk factors are present) are standard practice. One important point that is often not communicated: in anovulatory PCOS, standard ovulation predictor kits are unreliable — the cycle is irregular, and chronically elevated LH produces false positives on ovulation tests. Tracking ovulation in PCOS is best done with ultrasound follicle monitoring by a reproductive gynaecologist. When to See a Doctor PCOS is a chronic condition that requires ongoing management, not a one-off course of treatment. See a gynaecologist or endocrinologist if: - Cycles are irregular (longer than 35 days or shorter than 21) for more than 3 months - There is significant hair growth on the face or body, or acne that does not respond to standard treatment - Weight is increasing on a habitual diet, especially around the abdomen - Pregnancy is planned and cycles are irregular — do not wait the standard 12 months of trying that applies with regular ovulation; PCOS warrants earlier specialist review - PCOS symptoms are present in a woman with a family history of type 2 diabetes or cardiovascular disease — metabolic risk is substantially higher in this group PCOS responds well to management. A tailored approach — accounting for weight, goals and coexisting metabolic disturbances — allows most women to live with PCOS without significant impact on quality of life, and to fulfil their reproductive plans. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a gynaecologist or endocrinologist. https://labreadai.com/en/indicators/alp https://labreadai.com/en/indicators/alp Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Alkaline phosphatase rises with cholestasis and bone disease. Normal ranges by age and pregnancy, causes of elevation, and how GGT pinpoints the source. Indicators article Alkaline phosphatase is one of those markers that is easily misread without context. In a teenage child, ALP three times the adult upper limit is completely normal. In a third-trimester pregnant woman, a twofold elevation is normal too. But in a non-pregnant adult, the same level can point to serious biliary or bone pathology. This is why ALP cannot be read without accounting for age, sex and physiological state — and without simultaneously looking at GGT. Here is how to do that correctly. What Is Alkaline Phosphatase and Where Does It Come From Alkaline phosphatase (ALP) is an enzyme that catalyses the removal of phosphate groups from various molecules in an alkaline environment. Unlike ALT and AST, which are predominantly cytoplasmic enzymes, ALP is membrane-bound. It is anchored in cell membranes and enters the blood when the cells carrying it are damaged or undergo accelerated turnover. Critically: ALP in the blood is a mixture of several isoenzymes with different tissue origins. A standard laboratory test measures their combined activity without separating them by source. Main ALP isoenzymes: - Hepatic — produced by biliary duct epithelium; released when bile flow is obstructed (cholestasis) - Bone — produced by osteoblasts during new bone formation; elevated with active growth, fractures and bone disease - Intestinal — produced by small intestinal epithelium; accounts for a small fraction of total ALP in adults - Placental — produced by the placenta; rises sharply in the third trimester of pregnancy From this variety follows the central clinical task when ALP is elevated: determine which isoenzyme is raised — hepatic or bone. This is where GGT becomes indispensable. Normal Alkaline Phosphatase Levels ALP reference ranges vary considerably with age and physiological state — one of the features that sets it apart from most other biochemical markers. Group Normal ALP, U/L ------ Adult men 18–50 years 40–130 Adult men over 50 years 40–150 Adult women 18–50 years 35–105 Adult women over 50 years 35–130 Children under 1 year up to 250 Children 1–10 years up to 350 Adolescents 10–18 years up to 500 Pregnancy (third trimester) up to 250–400 Reference ranges at your specific laboratory may differ. Always use the values printed on your own lab report. Why is ALP so high in children and adolescents? Bone is being actively formed: osteoblasts are working at full capacity, releasing the bone isoenzyme into the bloodstream. During the pubertal growth spurt (typically ages 11–15), ALP can reach 300–500 U/L — a completely physiological finding that requires no investigation in the absence of other abnormalities. Why is ALP elevated in pregnancy? The placental isoenzyme rises from week 16 and peaks in the third trimester. After delivery, levels normalise within 4–6 weeks. Postmenopausal women. After menopause, ALP reference values increase slightly — the bone isoenzyme rises as bone turnover accelerates with declining oestrogen. How to Prepare for an ALP Blood Test ALP is part of a standard liver function test panel and is measured from venous blood. Fasting. Strictly fasting — last meal 8–12 hours before. After a fatty meal, the intestinal ALP isoenzyme transiently rises in people with blood groups B and O — an artefact that disappears within 2–4 hours. Medications. A wide range of drugs affects ALP. Elevating: oral contraceptives, anabolic steroids, amoxicillin-clavulanate, antifungals, methotrexate, allopurinol. Lowering: clofibrate, some antacids, high-dose vitamin D. Haemolysis. Unlike AST, ALP is not released from red blood cells — results are resistant to moderate haemolysis. Sample stability. ALP is relatively stable in storage, but activity may rise at room temperature. Samples should be kept refrigerated. Elevated ALP: Cholestasis or Bone Disease When ALP is elevated, one question must be asked first: liver or bone? The logic for distinguishing them is straightforward. If GGT is also elevated → the source is most likely hepatic (biliary ducts). GGT is not produced by bone tissue — its elevation reliably points to a hepatobiliary component. If GGT is normal → the source is most likely bone. Osteoblasts release ALP without any accompanying GGT. Cause ALP GGT ALT/AST Bilirubin --------------- Intrahepatic cholestasis (PBC, PSC, drugs) ↑↑↑ ↑↑↑ ↑ or normal ↑ or normal Extrahepatic cholestasis (stones, bile duct tumour) ↑↑↑ ↑↑↑ ↑ moderate ↑↑ Chronic hepatitis / cirrhosis ↑ moderate ↑ ↑↑ ↑ or normal Liver metastases ↑↑↑ ↑↑↑ ↑ or normal ↑ or normal Paget's disease of bone ↑↑↑ (up to 10–20× ULN) normal normal normal Osteoporosis with active remodelling ↑ moderate normal normal normal Fracture healing ↑ moderate normal normal normal Bone cancer / bone metastases ↑↑↑ normal or ↑ normal normal Primary hyperparathyroidism ↑ moderate normal normal normal Pregnancy third trimester ↑ up to 4× ULN normal normal normal Adolescence ↑ up to 3–4× ULN normal normal normal The table reflects typical patterns. Clinical presentations may combine multiple sources. Paget's disease (osteitis deformans) deserves special mention — a rare condition in which ALP can exceed the upper limit of normal 10–20-fold with completely normal GGT. This is one of the highest ALP values encountered in clinical practice without liver involvement. At the other extreme, primary biliary cholangitis (PBC) produces disproportionately high ALP, often 3–10 times the upper limit, with only moderate ALT elevation and normal or mildly raised bilirubin in early stages. Low Alkaline Phosphatase: Hypophosphatasia and Other Causes ALP below the lower limit of normal is less well known but clinically relevant. Hypophosphatasia — a rare inherited condition with ALP deficiency that impairs mineralisation of bones and teeth. This is the only disease in which ALP is persistently below the lower limit of normal from birth. Other causes of low ALP: - Hypothyroidism — reduced tissue metabolic activity - Zinc and magnesium deficiency — trace elements required for enzyme activity - Pernicious anaemia — B12 deficiency reduces the activity of several enzymes - Massive blood transfusions — dilutional effect and presence of stabilisers Isolated mild ALP reduction in an otherwise healthy adult without accompanying changes is usually an incidental finding with no clinical significance. ALP and GGT: The Key to Identifying the Source The ALP + GGT combination is one of the most practical diagnostic tools in biochemistry. The logic is clean: GGT, unlike ALP, is produced exclusively by the hepatobiliary system (liver, bile ducts, kidneys) and is absent from bone tissue. Therefore: - ALP ↑ + GGT ↑ → hepatobiliary source (cholestasis, infiltrative disease, drug-induced liver injury) - ALP ↑ + GGT normal → bone source (osteoblastic activity, Paget's disease, bone metastases, adolescent growth, pregnancy) This distinction immediately directs the diagnostic search in the right direction — without expensive isoenzyme-specific ALP tests, which are not routinely available in most laboratories. In comprehensive assessment, ALP is always evaluated within the full liver function panel — alongside ALT, AST, GGT, bilirubin and albumin. In osteoporosis and metabolic bone disease, ALP is reviewed together with calcium, vitamin D and parathyroid hormone. When to See a Doctor Urgently - ALP above 3× ULN with simultaneously elevated GGT and progressive jaundice — possible mechanical jaundice (bile duct stone or tumour); requires ultrasound and urgent specialist review - ALP above 5× ULN with normal GGT in an adult — exclude Paget's disease and bone metastases; bone radiography and tumour markers - Rising ALP on serial testing in a patient with known malignancy — possible liver or bone metastases - ALP suddenly elevated after starting a new medication — possible drug-induced cholestasis; prompt consultation needed On an elective basis: mild isolated ALP elevation (up to 2× ULN) without accompanying GGT elevation or other marker changes in an adolescent, pregnant woman or elderly person with active bone turnover is usually physiological. In an adult outside these groups, it warrants investigation. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/alt https://labreadai.com/en/indicators/alt Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) ALT is the primary marker of liver cell damage. Normal ranges for men and women, degrees of elevation, causes of abnormal results and how to read ALT with AST. Indicators article When a doctor says "your liver enzymes are elevated," they are almost always talking about ALT. Alanine aminotransferase is an enzyme that normally works inside liver cells and barely reaches the bloodstream. When cells are damaged, the enzyme leaks out — and its blood level rises. This simple mechanism makes ALT the most sensitive and specific marker of hepatocellular damage available on a routine biochemistry panel. Here is what each level of deviation means, and how to read the result correctly. What Alanine Aminotransferase (ALT) Is and Why It Enters the Blood ALT (alanine aminotransferase) is an enzyme from the transaminase family. Its biological role is to transfer an amino group from alanine to alpha-ketoglutarate — a step in the gluconeogenesis pathway. The enzyme is present in many tissues, but its highest concentration is in hepatocytes — liver cells. This is why elevated ALT points primarily to the liver. Think of a hepatocyte as a sealed vessel with a high intracellular concentration of the enzyme. As long as the cell is alive and its membrane is intact, ALT stays inside. When inflammation, toxic injury or ischaemia disrupts the membrane, the contents spill into the intercellular space and from there into the bloodstream. The greater the damage, the larger the ALT spike. One important distinction: ALT reflects liver injury, not liver function. A normal ALT in chronic hepatitis does not mean the liver is working well — it means active cell destruction is not occurring at that moment. Function is assessed by other markers — albumin, bilirubin and coagulation tests. Normal ALT Levels in Blood ALT reference values depend on sex, age and the analytical method used. The figures below are the most widely used in clinical practice. Group ALT normal range, U/L ------ Men 18–60 years up to 45 Men over 60 years up to 40 Women 18–60 years up to 34 Women over 60 years up to 30 Children under 1 year up to 54 Children 1–14 years up to 45 Reference ranges at your specific laboratory may differ slightly depending on equipment and reagents. Always use the values printed on your own lab report. The difference between male and female norms reflects greater muscle mass in men (muscle contains ALT, though at lower concentrations than liver), as well as possible hormonal influences. This is why the upper limit of normal in men is approximately 25–35% higher than in women. How to Prepare for an ALT Blood Test ALT is part of a standard biochemistry panel and is measured from a venous blood sample. Fasting. Blood should be drawn fasting — last meal 8–12 hours before. Food intake, particularly fatty meals, has a minor direct effect on ALT but can confound interpretation of the full panel. Physical exercise. Intense training within 24–48 hours before the test can elevate ALT — muscles contain the enzyme and release it when damaged. Avoid strength training before the test. Medications. A wide range of drugs raise ALT: statins, paracetamol (at high doses), NSAIDs, antibiotics, antifungals, and some supplements. Tell your doctor about any medications you are taking before testing. Alcohol. Avoid for 48–72 hours — alcohol is directly hepatotoxic and raises ALT in a dose-dependent manner. Repeat testing. For a single mild ALT elevation, repeat the test in 2–4 weeks at the same laboratory. Transient rises occur with viral infections, intense physical activity and certain medications. Elevated ALT in Hepatitis and Other Conditions: Causes and Degrees The degree of ALT elevation is an important diagnostic guide. Clinicians assess not simply whether ALT is raised, but how many times it exceeds the upper limit of normal (ULN). Degree of elevation Fold above ULN Typical causes --------- Mild 1–3× ULN NAFLD, moderate alcohol use, drug effect, coeliac disease, hypothyroidism Moderate 3–10× ULN Chronic viral hepatitis B/C, autoimmune hepatitis, alcoholic hepatitis, drug-induced hepatitis High 10–25× ULN Acute viral hepatitis, severe toxic hepatitis, ischaemic hepatitis ("shock liver") Very high 25× ULN Fulminant hepatitis, acute poisoning (paracetamol, amanita mushrooms), acute hepatic ischaemia, Reye syndrome An important clinical principle: the absolute ALT value does not always correlate with the severity of liver damage. In cirrhosis, ALT can be only mildly elevated or even normal — simply because so few viable cells remain to release the enzyme. Several specific scenarios deserve attention: Isolated mild ALT elevation (1–3× ULN) with normal GGT and bilirubin — most often NAFLD or a muscular source. Requires clarification with liver ultrasound and assessment of metabolic risk factors. High ALT with normal or only slightly elevated GGT — points to hepatocellular rather than cholestatic injury; narrows the differential. ALT 1000 U/L — always an urgent situation regardless of how the patient feels. Low ALT: When It Matters ALT below the reference range is uncommon and usually clinically insignificant. However, in certain settings it carries meaning: - Severe hepatic insufficiency — in end-stage cirrhosis, so few functioning hepatocytes remain that ALT has nowhere to be produced, and it falls below normal. This is paradoxically a marker of poor prognosis. - Vitamin B6 deficiency — pyridoxal phosphate is a cofactor for transaminase activity; its deficiency reduces ALT activity. - Uraemia in end-stage renal failure — uremic toxins inhibit enzyme activity. ALT and AST: The De Ritis Ratio ALT is never interpreted in isolation — it is always viewed alongside AST. The AST:ALT ratio (de Ritis ratio) carries its own diagnostic value. AST:ALT ratio Interpretation ------ < 1 (ALT AST) Typical of viral hepatitis, NAFLD, drug-induced liver injury ≈ 1 Non-specific 2 (AST ALT) Characteristic of alcoholic hepatitis — high specificity 2 with high absolute values Consider acute myocardial ischaemia (AST is also present in cardiomyocytes) The logic is straightforward: alcoholic injury preferentially damages the mitochondrial pool of AST (which is more abundant in the cell), while viruses and most hepatotoxins disrupt the cell membrane — releasing cytoplasmic ALT first. For a complete assessment of liver damage, ALT and AST are reviewed together as part of a comprehensive liver function test panel, which also includes GGT, alkaline phosphatase, bilirubin and albumin. High ALT — What to Do and When to See a Doctor Urgently Most cases of elevated ALT are managed electively. However, some presentations require immediate assessment: - ALT above 500 U/L — regardless of symptoms; requires urgent review and hospitalisation if confirmed - Jaundice with elevated ALT — the combination points to significant hepatic injury with functional impairment - Abdominal pain with high ALT — possible acute hepatitis, gallstone disease with cholestasis, or acute pancreatitis - Rising ALT on repeat testing — even at moderate levels, a consistent upward trend warrants investigation - Sudden fall in ALT after very high values — not always reassuring; in fulminant hepatitis this may indicate that most cells have already been destroyed On an elective basis: any ALT elevation above normal found incidentally on a routine panel warrants a visit to a GP for interpretation in the context of the full biochemistry picture. ALT is a signal, not a diagnosis. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/amylase https://labreadai.com/en/indicators/amylase Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Amylase marks pancreatic inflammation. Norms for total and pancreatic fractions, causes of elevation, and why it is always paired with lipase for diagnosis. Indicators article Sudden, severe epigastric pain radiating to the back, nausea and vomiting — and in the emergency blood panel, amylase is the first thing the physician checks. This enzyme became the marker of acute pancreatitis precisely because it bursts into the bloodstream rapidly during pancreatic inflammation — already within 2–12 hours of the attack's onset. But amylase is not produced by the pancreas alone, and its elevation is far from synonymous with pancreatitis. Here is how to interpret this marker correctly, and why it is almost never evaluated in isolation. What Is Amylase and Where Does It Come From Amylase (α-amylase) is an enzyme that cleaves starch and glycogen molecules into simple sugars. It is one of the key digestive enzymes — carbohydrate digestion begins in the mouth itself, driven by salivary amylase. In blood, amylase is represented by two fundamentally different isoenzymes: - Pancreatic amylase (P-type) — produced by pancreatic acinar cells, secreted into the duodenum. Normally enters the bloodstream only in small amounts. Accounts for approximately 40% of total amylase in adults. - Salivary amylase (S-type) — produced by the salivary glands. Normally constitutes approximately 60% of total serum amylase. A standard test measures total amylase — the sum of both fractions. When greater specificity is needed, pancreatic amylase (P-amylase) can be ordered separately — it is considerably more specific for pancreatic pathology. Amylase is a small protein that is freely filtered by the kidneys. This is why urine amylase is often measured alongside the blood test. In acute pancreatitis, urine amylase rises slightly later than serum amylase (6–10 hours) but remains elevated longer (up to 3–5 days), making it a useful supplementary test. Normal Amylase Levels in Blood Measure Normal range ------ Total amylase (adults) 25–125 U/L Pancreatic amylase (P-type) 8–53 U/L Urine amylase 10–490 U/L Children under 1 year 5–65 U/L Children 1–10 years 15–100 U/L Reference ranges at your specific laboratory may differ. Always use the values printed on your own lab report. Several physiological points are worth noting: Children under 1 year. The pancreas and salivary glands have not yet reached functional maturity, so amylase in infants is significantly lower than in adults. Norms rise gradually during the first years of life. Older adults. Amylase activity may decline slightly with age due to acinar tissue atrophy. No significant age-specific corrections are applied in standard clinical practice. Renal insufficiency. Since amylase is renally excreted, reduced filtration (elevated creatinine) leads to accumulation in the blood. With significant GFR reduction, amylase may chronically exceed the reference range without any pancreatic pathology. How to Prepare for an Amylase Blood Test Fasting. Blood should be drawn fasting — last meal 8–12 hours before. Food intake stimulates digestive enzyme secretion and can transiently affect amylase levels. Alcohol. Avoid for 48 hours — alcohol is a direct trigger of acute pancreatitis and can raise amylase even without clinical symptoms. Medications. Several drugs affect amylase levels. Elevating: morphine and other opioids (Oddi sphincter spasm → pancreatic juice stasis), thiazide diuretics, oral contraceptives, captopril, valproic acid. Lowering: fluorides, high-dose citric acid. Emergency testing. When acute pancreatitis is suspected, amylase is measured immediately — without waiting for a routine biochemistry run. In an emergency, strict fasting is not a prerequisite. Elevated Amylase in Pancreatitis and Other Conditions: Causes and Degrees The degree of amylase elevation carries significant diagnostic weight: in acute pancreatitis it is typically much higher than in other conditions. Degree of elevation Fold above ULN Typical causes --------- Mild 1–3× ULN Chronic pancreatitis (outside flare), renal insufficiency, opioid use, diabetic ketoacidosis Moderate 3–5× ULN Salivary gland disease (parotitis, duct stone), peptic ulcer perforation, bowel obstruction High 5–10× ULN Mild-to-moderate acute pancreatitis, ectopic pregnancy, mesenteric vascular occlusion Very high 10× ULN Severe acute pancreatitis, obstructive pancreatitis from common bile duct stone Important caveat: the height of amylase does not correlate with pancreatitis severity. In necrotising pancreatitis, when most acinar tissue has already been destroyed, amylase may be only moderately elevated or even normal. Severity is assessed clinically and by CT — not by amylase values. Three main sources of elevation and how to distinguish them: Pancreatic source — P-amylase elevated with normal or mildly raised S-amylase; lipase simultaneously elevated (critically important — lipase is far more specific for the pancreas); clinical picture of epigastric pain radiating to the back. Salivary gland source — S-amylase elevated with normal P-amylase; lipase not elevated; possible tenderness over the salivary glands. Causes: mumps, salivary duct stones, radiation damage, anorexia/bulimia (enlarged salivary glands from chronic vomiting). Extra-pancreatic abdominal source — hollow organ perforation, acute bowel obstruction, mesenteric ischaemia, ectopic pregnancy. The pancreas is irritated by peritoneal contents or ischaemia, producing a moderate amylase rise without specific pancreatitis. Macroamylasaemia — a special variant in which amylase forms large complexes with immunoglobulins and can no longer be filtered by the kidneys. Serum amylase is chronically elevated while urine amylase is normal — a benign condition requiring no treatment. To distinguish pancreatic from salivary gland sources, determining P-type amylase is optimal, or measuring amylase and lipase together. Low Pancreatic Amylase: What It Means Amylase below the reference range is less common than elevation but carries important diagnostic information: - Severe chronic pancreatitis with exocrine insufficiency — prolonged inflammation replaces acinar tissue with scar; the gland loses its secretory function and amylase has nowhere to be produced. This is a sign of advanced disease. - Cystic fibrosis — a genetic disease affecting exocrine glands; pancreatic enzyme production is impaired from birth. - Severe burns and trauma — due to protein redistribution and reduced synthetic function. - Hypothyroidism — reduced overall tissue metabolism. Low amylase in a patient with chronic pancreatitis and steatorrhoea (fatty stools) is a concerning sign of severe exocrine insufficiency requiring enzyme replacement therapy. Amylase and Lipase in Pancreatitis: Why They Are Always Measured Together Amylase and lipase form the standard diagnostic pair for pancreatic disease. But they do not duplicate each other — each carries unique information. Characteristic Amylase Lipase --------- Rise onset in acute pancreatitis 2–12 hours 4–8 hours Peak 12–72 hours 24–48 hours Normalisation 3–5 days 7–14 days Specificity for pancreas Moderate (60%) High (85–90%) Sources besides pancreas Salivary glands, intestine, kidneys Almost exclusively the pancreas The key conclusion: lipase is more specific and remains elevated longer. If a patient presents 3–4 days after pain onset, amylase may already have normalised while lipase remains elevated. The reverse situation — early hours when amylase is up but lipase is still normal — is much rarer. This is why current guidelines prefer lipase as the primary marker of acute pancreatitis. Amylase remains a useful supplement and a historically established marker that is widely used due to its accessibility. Both enzymes are often assessed alongside a comprehensive abdominal biochemistry work-up that includes a liver function test panel. In chronic hepatitis and gallstone disease, pancreatic involvement is frequently present — biliary pancreatitis accounts for up to 40% of all acute pancreatitis cases. The link to metabolic syndrome is also direct: hypertriglyceridaemia is the third most common cause of acute pancreatitis after alcohol and gallstones. When to See a Doctor Urgently - Amylase above 3× ULN with abdominal pain — possible acute pancreatitis; immediate hospital attendance, even if pain is tolerable - Amylase above 5× ULN without pain — urgent clarification of cause needed; macroamylasaemia, renal insufficiency or occult pancreatitis - Rising amylase on serial testing in known chronic pancreatitis — sign of a flare - High amylase combined with jaundice — probable common bile duct stone with obstructive pancreatitis; an acute emergency - Sudden fall in amylase during worsening pancreatitis pain — possible pancreatic necrosis; a paradoxical but alarming sign Mild isolated amylase elevation (1–2× ULN) without pain in a person with chronic renal insufficiency or on opioid therapy is an expected finding that does not require emergency measures. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/ast https://labreadai.com/en/indicators/ast Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) AST rises with liver, heart and muscle injury. Normal ranges for men and women, causes of abnormalities, and the AST:ALT de Ritis ratio for accurate diagnosis. Indicators article AST and ALT are almost always measured together. But there is a fundamental difference between them that changes the diagnostic logic: while ALT is predominantly a liver enzyme, aspartate aminotransferase (AST) is distributed much more widely. It is present at high concentrations in heart muscle cells, skeletal muscle and the liver simultaneously. This makes AST less specific for the liver, but more informative when the question is not whether damage has occurred — but where it is coming from. Here is how to read this marker correctly. What Aspartate Aminotransferase (AST) Is and How It Differs from ALT AST (aspartate aminotransferase) belongs to the transaminase enzyme family. It transfers an amino group from aspartate to alpha-ketoglutarate — a reaction that links amino acid metabolism to the Krebs cycle. The enzyme exists in two cellular pools: cytoplasmic (the smaller fraction) and mitochondrial (the larger fraction, around 80% of the total). This dual localisation explains a clinically important feature of AST. Mild cell injury disrupts only the outer membrane — cytoplasmic AST is released. Severe injury, particularly from alcohol, destroys mitochondria as well — mitochondrial AST pours out in large quantities. This is why AST is disproportionately elevated compared to ALT in alcoholic hepatitis. The key distinction from ALT is tissue specificity. AST is present at high concentrations in: - Cardiomyocytes — heart muscle cells - Hepatocytes — liver cells - Skeletal muscle cells - To a lesser extent — kidneys, pancreas, and erythrocytes This is why isolated AST elevation with a normal ALT should direct attention to the heart or muscles rather than the liver. Conversely, parallel elevation of both enzymes almost invariably points to hepatocellular injury. Normal AST Levels in Blood AST reference values, like those for ALT, depend on sex and age. Group AST normal range, U/L ------ Men 18–60 years up to 40 Men over 60 years up to 35 Women 18–60 years up to 32 Women over 60 years up to 30 Children under 1 year up to 58 Children 1–14 years up to 46 Reference ranges at your specific laboratory may differ slightly. Always use the values printed on your own lab report. In children, AST norms are somewhat higher than in adults — physiologically driven by active growth and tissue remodelling. In newborns during the first days of life, AST can reach 100–140 U/L — a normal finding related to perinatal stress. How to Prepare for an AST Blood Test AST is measured from venous blood as part of a biochemistry panel. Fasting. Strictly fasting — last meal 8–12 hours before. Fatty food has a minor direct effect on AST but standardising conditions is important for comparing results over time. Exercise. Particularly critical for AST: skeletal muscles contain it at high concentrations. Intense strength training, long-distance running or even intramuscular injections can raise AST 2–5 fold. Avoid strenuous activity for 48 hours before the test. Alcohol. Avoid for 48–72 hours — alcohol directly damages hepatocyte mitochondria, the very AST pool released in alcoholic hepatitis. Haemolysis. Erythrocytes contain AST. If haemolysis occurs in the sample tube during incorrect storage or transport, the result will be falsely elevated. Quality laboratories flag this in the report. Medications. Statins, antibiotics, NSAIDs, isoniazid, amiodarone and several other drugs raise AST. Inform your doctor of any medications you are taking. Elevated AST: Causes and Degrees of Elevation The key diagnostic question when AST is elevated is: where is it coming from — liver, heart or muscle? The answer usually lies in the pattern of accompanying markers rather than the absolute value alone. Degree of elevation Fold above ULN Typical causes --------- Mild 1–3× ULN NAFLD, moderate alcohol, drug effect, intense exercise, hypothyroidism Moderate 3–10× ULN Chronic hepatitis B/C, alcoholic hepatitis, autoimmune hepatitis, myositis, mild rhabdomyolysis High 10–25× ULN Acute viral hepatitis, severe alcoholic hepatitis, myocardial infarction, marked rhabdomyolysis Very high 25× ULN Fulminant hepatitis, massive myocardial infarction, massive rhabdomyolysis, acute hepatic ischaemia The absolute AST value does not equal the severity of damage. As with ALT, in end-stage cirrhosis AST may be only mildly elevated because so few viable cells remain to release it. Three main sources of AST elevation and how to distinguish them: Hepatic source — AST rises in parallel with ALT; the de Ritis ratio is variable; GGT and bilirubin are often elevated. Liver function panel and ultrasound confirm the source. Cardiac source — AST is elevated with normal or only mildly raised ALT; GGT is normal. Historically, AST was the first cardiac marker used in myocardial infarction — it begins rising 6–8 hours after ischaemia, peaks at 24–36 hours, and normalises within 4–5 days. It has been entirely superseded by troponin, which is far more specific and appears much earlier. In suspected infarction, AST has no independent diagnostic role. Muscular source — AST elevated with normal ALT and GGT. Typically linked to physical activity, trauma, seizures or statin use. Confirmed by simultaneous elevation of CK (creatine kinase), which is far more specific for muscle damage. Low AST AST below the reference range is uncommon and of limited clinical significance. It occurs in: - Vitamin B6 deficiency — pyridoxal phosphate is a cofactor for transaminase activity; its deficiency reduces enzyme activity - End-stage hepatic insufficiency — by the same logic as low ALT: no cells left to produce the enzyme - Metronidazole and certain other drugs — through competition at the enzyme's active site AST and ALT: The De Ritis Ratio in Clinical Practice The AST:ALT ratio is one of the most practical diagnostic tools in hepatology. It is calculated simply by dividing the AST value by the ALT value. AST:ALT ratio Diagnostic significance ------ < 0.8 Viral hepatitis, NAFLD, drug-induced liver injury — ALT dominates 0.8–1.2 Non-specific; requires additional contextual analysis 2.0 Alcoholic hepatitis — high specificity when GGT is also elevated 3.0 Virtually pathognomonic for alcoholic hepatitis or rhabdomyolysis An important caveat: the de Ritis ratio is only informative when both enzymes are simultaneously elevated. Calculating the ratio when both values are within normal range is meaningless. The ratio also loses diagnostic value at very high absolute levels ( 1000 U/L), where any cause of massive cytolysis can produce a similar picture. For a complete assessment, both enzymes are reviewed as part of a liver function test panel together with GGT, alkaline phosphatase, bilirubin and albumin — only this combination allows hepatocellular to be distinguished from cholestatic injury. High AST — What Does It Mean and When to See a Doctor Urgently - AST above 500 U/L — regardless of symptoms; requires urgent assessment and source identification - AST elevated with chest pain, breathlessness or palpitations — seek emergency care immediately: possible acute coronary syndrome, though diagnosis is confirmed with troponin - Rising AST on serial testing — even at moderate levels, a consistent upward trend warrants investigation - High AST with dark urine (tea- or cola-coloured) — sign of myoglobinuria in rhabdomyolysis; risk of acute kidney injury - Jaundice with high AST — significant hepatic injury with functional impairment On an elective basis: any AST elevation above normal found incidentally warrants a GP visit without delay. AST cannot be interpreted in isolation — it only tells its full story alongside ALT, GGT and the rest of the liver function panel. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/fsh https://labreadai.com/en/indicators/fsh Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) FSH regulates follicle maturation and spermatogenesis. Normal ranges by cycle phase and age, causes of high and low FSH, and its relationship with LH and ovarian reserve. Indicators article Every menstrual cycle begins with a question the pituitary asks the ovaries: is there a follicle ready to grow? To ask it, the pituitary releases follicle-stimulating hormone. FSH is the conductor of the reproductive orchestra in both sexes — in women it triggers egg maturation, in men it sustains sperm production. When something goes wrong in the pituitary–gonad–sex hormone axis, FSH either climbs high, signalling that the gonads are failing to respond, or falls low, pointing to a problem in the brain itself. Here is how to read this marker correctly. What Is Follicle-Stimulating Hormone (FSH) and How It Works FSH (follicle-stimulating hormone) is a glycoprotein hormone produced by the anterior pituitary gland. It is part of the hypothalamus–pituitary–gonad (HPG) axis: the hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulsatile bursts, which drives FSH secretion from the pituitary. In women, FSH acts on granulosa cells of ovarian follicles, stimulating their growth and oestradiol production. As the follicle matures, rising oestradiol suppresses further FSH release via negative feedback. Then comes a brief positive feedback surge, followed by an LH peak — and ovulation. After ovulation, FSH falls again. In men, FSH acts on Sertoli cells in the testes, maintaining spermatogenesis. Unlike women, in whom FSH fluctuates cyclically, in men it is relatively stable across hours and months. This feedback mechanism explains the core interpretive principle: high FSH = the pituitary is shouting because the gonads are not responding. Low FSH = the pituitary is silent because either no signal is coming from above, or sex hormone levels are already sufficient. This distinction is the key to differentiating types of hypogonadism. Normal FSH Levels in Women, Men and Menopause FSH norms in women depend substantially on cycle phase — which is why a result without the cycle day specified is nearly uninterpretable. Group Normal FSH, IU/L ------ Women, follicular phase (days 2–5) 3.5–12.5 Women, ovulatory peak (mid-cycle) 4.7–21.5 Women, luteal phase 1.7–7.7 Women, postmenopause 25.8–134.8 Men 18–70 years 1.5–12.4 Children under 1 year < 3.5 Pre-pubertal (3–10 years) 0.3–4.6 Puberty (11–18 years) gradual rise to adult levels Reference ranges at your specific laboratory may differ. Always use the values printed on your own lab report. Two key observations: Postmenopausal norms are in a different category. After ovarian function ceases, the feedback loop disappears — the pituitary raises FSH without restraint. Values of 25–135 IU/L in a woman over 50 are normal, not pathological. Confusion arises when menopausal status is not noted on the test request. In men, FSH is stable. No need to account for time of day or cycle timing — a fasting morning sample on any day is sufficient. When to Test FSH in the Cycle and How to Prepare Correct timing is critically important and is frequently overlooked when the test is ordered. Women with a regular cycle. Blood should be drawn on cycle days 2–5 (day 1 = the first day of menstrual bleeding). The basal FSH level at the start of the follicular phase is what reflects ovarian reserve: the higher the basal FSH, the lower the reserve. Testing in other cycle phases can return a normal result even when the reserve is diminished. Women with an irregular cycle or amenorrhoea. Testing can be done on any day — there is no cycle to track. The FSH:LH ratio is interpreted in conjunction with oestradiol. Men. No strict timing requirements, but morning fasting samples are standard for consistency. General rules. Blood is drawn fasting (8–12 hours). Avoid intense physical and emotional stress for 3 days before the test — stress activates the HPG axis and can transiently shift gonadotropin levels. Hormonal medications (oral contraceptives, FSH/LH preparations) should be paused for approximately one month before testing if clinically possible, in agreement with the treating physician. Never test FSH alone. Without simultaneous measurement of LH, oestradiol and TSH, an FSH result tells only half the story. Hypothyroidism is a common and easily missed cause of cycle disturbances that mimics hormonal imbalance. High FSH Causes in Women, Menopause and Men High FSH is a signal that the pituitary is trying harder than usual to stimulate the gonads — because they are not responding normally. This is always a "peripheral" type of disorder: the problem lies in the gonads themselves, not in the pituitary. Cause in women Mechanism ------ Physiological menopause Depletion of the follicular pool → no negative feedback from oestradiol Premature ovarian insufficiency (POI) Same mechanism but before age 40 — autoimmune, genetic or iatrogenic Turner syndrome (45,X) Congenital absence of normal ovarian tissue Diminished ovarian reserve Basal FSH 10–12 IU/L on cycle day 3 — marker of reduced reserve Chemotherapy and radiotherapy Gonadotoxic damage to the ovaries Smoking Accelerates depletion of the follicular pool Cause in men Mechanism ------ Primary hypogonadism (Klinefelter syndrome, orchitis, trauma) Testicular damage → reduced negative feedback from inhibin B Untreated cryptorchidism Undescended testis with impaired spermatogenesis Non-obstructive azoospermia Primary spermatogenic failure Chemotherapy and radiotherapy Direct gonadotoxic effect Significant varicocele Impaired testicular thermoregulation → reduced spermatogenesis A specific clinical situation: FSH 40 IU/L in a woman under 40 without pregnancy or exogenous hormones. This is the criterion for premature ovarian insufficiency (POI) — a condition requiring confirmation by two measurements four weeks apart and urgent referral to a reproductive specialist. Low FSH Causes: Hypogonadism and Fertility Implications Low FSH means the pituitary is not generating sufficient signal to the gonads. This is a "central" type of disorder — the problem lies above the level of the ovaries or testes. - Pregnancy — human chorionic gonadotropin suppresses FSH and LH secretion physiologically; low FSH with a missed period is a reason to perform a pregnancy test first - Hypothalamic amenorrhoea — significant weight loss, intense training or chronic stress reduces GnRH pulse frequency → FSH and LH fall - Hyperprolactinaemia — excess prolactin suppresses GnRH → secondarily reduces FSH and LH; pituitary tumour (prolactinoma) is a common cause - Pituitary tumour or damage — adenoma, head injury, Sheehan's syndrome (pituitary necrosis after postpartum haemorrhage) - Exogenous sex hormone use — oral contraceptives, anabolic steroids, testosterone preparations suppress FSH via negative feedback - Kallmann syndrome — congenital GnRH deficiency combined with anosmia FSH-to-LH Ratio in PCOS and Ovarian Reserve Assessment FSH is never interpreted without LH. The ratio of these two gonadotropins carries clinically valuable information beyond the absolute values of each. In PCOS, the LH:FSH ratio 2–3:1 with normal or mildly reduced absolute FSH is the classic pattern. The pituitary releases disproportionately high LH relative to FSH, driving the ovaries to produce androgens instead of achieving normal follicular maturation. In PCOS, this imbalance is one of the central pathogenetic mechanisms. In menopause, both gonadotropins rise sharply, but FSH rises faster and higher — the LH:FSH ratio falls below 1. In menopause, FSH 40 IU/L combined with amenorrhoea for more than 12 months is the laboratory criterion for postmenopause. In primary male hypogonadism, both gonadotropins are elevated, but the pattern of their ratio helps distinguish isolated spermatogenic failure (FSH rises more, LH relatively normal) from total testicular failure (both elevated proportionally). In hypothalamo-pituitary insufficiency, both gonadotropins are low or at the lower limit of normal — isolated reduction of one without the other is uncommon and warrants particular alertness. FSH Blood Test Interpretation: When to See a Doctor Urgently - FSH 25 IU/L in a woman under 40 without pregnancy or hormone use — suspected premature ovarian insufficiency; requires urgent confirmation and reproductive specialist referral - FSH 12 IU/L on cycle day 3 when pregnancy is planned — significant diminished ovarian reserve; assessment of IVF and ovulation induction prospects cannot be delayed - Very low FSH (< 1 IU/L) with amenorrhoea — exclude prolactinoma and other pituitary tumours; MRI of the brain required - Absent puberty by age 13–14 in girls or 14–15 in boys with low FSH — constitutional delay or hypogonadotropic hypogonadism; differential diagnosis by a paediatric endocrinologist - Sudden FSH rise in a patient who received chemo- or radiotherapy — marker of gonadotoxic damage; reproductive prognosis assessment needed FSH is a precise navigator in a complex hormonal system — but only when drawn at the correct time and interpreted in context with the other markers. Interpreting it without knowing the cycle phase, LH and oestradiol levels is like reading a compass without knowing which hemisphere you are in. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/insulin https://labreadai.com/en/indicators/insulin Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Fasting insulin and the HOMA-IR index are the primary markers of insulin resistance. Normal ranges, causes of elevated and low insulin, HOMA-IR calculation and when to test. Indicators article Most people think of insulin only in the context of diabetes. But long before diabetes develops, insulin starts sending signals: it rises and remains chronically elevated — and this pattern is called insulin resistance. The pancreas presses harder and harder on the accelerator to keep blood sugar in range, while tissues respond less and less to its efforts. Fasting insulin combined with glucose is the most accessible way to see this process at an early stage, when lifestyle changes can still reverse the course. What Is Insulin and Why Is It Measured Insulin is a polypeptide hormone produced by the beta cells of the pancreas. Its primary biological role is to open "gates" in muscle, adipose and liver cells for glucose entry after a meal. Think of insulin as a key and cell-surface receptors as locks. In a healthy state, one turn of the key — and glucose is inside, the cell gets energy, blood sugar falls. In insulin resistance, the locks start to jam: the key inserts but the door barely opens. The pancreas responds logically — it makes more keys. Insulin levels in the blood rise (hyperinsulinaemia), and for a time this compensates for reduced tissue sensitivity. Blood glucose remains normal throughout — which is precisely why a standard blood sugar test shows nothing, while insulin has been elevated for years. This explains the main clinical value of measuring insulin: it detects metabolic dysfunction at the stage when glucose has not yet exceeded the normal range. The window for intervention sits here. Beyond diagnosing insulin resistance, an insulin test is used for differential diagnosis of hypoglycaemia (suspected insulinoma), assessment of beta-cell function in type 1 and type 2 diabetes, and in the work-up for PCOS and fertility disturbances. Normal Insulin Levels in Blood Measure Normal range ------ Fasting insulin (adults) 2.6–24.9 µIU/mL Fasting insulin (optimal range) 3–10 µIU/mL Fasting insulin (children) 2.0–20.0 µIU/mL HOMA-IR (normal) < 2.5 HOMA-IR (insulin resistance) ≥ 2.7–3.0 Reference values depend on the assay method and laboratory. Always use the norms printed on your own lab report. Several clinically important nuances: "Normal" vs "optimal" insulin. A result of 20–24 µIU/mL technically falls within the laboratory reference range. Clinically, however, such a level in someone with obesity, irregular cycles or post-meal fatigue already signals significant hyperinsulinaemia. This is why the functional optimum of 3–10 µIU/mL is far more informative than the formal "up to 24" as a target benchmark. Insulin in pregnancy. Physiological insulin resistance develops normally during pregnancy — an evolutionary mechanism that ensures the placenta and foetus receive adequate glucose. Insulin in pregnant women must be interpreted with this context in mind. Adolescents. Puberty is accompanied by transient insulin resistance — a normal physiological process related to growth hormone. How to Prepare for an Insulin Blood Test Insulin is one of the most sampling-sensitive laboratory markers. A single protocol violation can render the result entirely unreliable. Strict fasting — at least 12 hours. Even a small meal, a milky coffee or a sugary drink triggers a sharp insulin surge. Two hours after eating, insulin in a healthy person can be 5–10 times higher than fasting. This rule is absolute. The evening before the test. Last meal — a light dinner no later than 8 pm. A fatty meal the previous evening can produce a prolonged insulin response extending to the following morning. Physical exercise. Intense training within 24 hours before the test lowers insulin via insulin-independent muscle glucose uptake. This falsely reduces the result. Moderate activity has no significant effect. Stress. Acute stress and anxiety raise glucose via cortisol → insulin rises reflexively. Sit quietly for 10–15 minutes before the blood draw. Medications. Metformin lowers insulin (this is its mechanism of action). Corticosteroids, thiazide diuretics and some antipsychotics raise it. Inform the physician about all medications. Always test with glucose simultaneously. Insulin without glucose is half the information: only their combination allows HOMA-IR to be calculated. Elevated Insulin: Causes Chronically elevated fasting insulin is one of the most common yet least frequently diagnosed metabolic disturbances. Many people live with hyperinsulinaemia for years without knowing it. Cause Mechanism Features --------- Insulin resistance / obesity Reduced receptor sensitivity → compensatory hypersecretion Most common cause; glucose often remains normal PCOS Insulin resistance in 65–70% of patients → hyperinsulinaemia stimulates ovarian androgen production A key pathogenetic mechanism — more detail at PCOS Metabolic syndrome Shared mechanism with IR; visceral fat → free fatty acids → impaired insulin signalling Combined with dyslipidaemia and hypertension — at metabolic syndrome Prediabetes Beta cells compensate for reduced sensitivity by overproduction; insulin high, glucose at the upper limit of normal Intermediate state before manifest diabetes Insulinoma Beta-cell tumour secreting insulin autonomously Rare but important: high insulin + low glucose Cushing's syndrome Hypercortisolaemia reduces tissue insulin sensitivity Combined with characteristic fat redistribution and hypertension Acromegaly Excess growth hormone antagonises insulin Combined with acral enlargement Certain medications Corticosteroids, atypical antipsychotics, nicotinic acid Iatrogenic hyperinsulinaemia Symptoms of chronic hyperinsulinaemia — the ones that are easily attributed to tiredness or poor diet: intense craving for sweets and carbohydrates 1–2 hours after eating, post-meal sleepiness, abdominal weight gain despite moderate intake, difficulty losing weight, dark velvety patches in skin folds (acanthosis nigricans). Low Insulin: Causes Persistently low or undetectable fasting insulin is a direct indicator of beta-cell dysfunction. - Type 1 diabetes mellitus — autoimmune destruction of beta cells; insulin falls to zero; lifelong insulin therapy required - Latent autoimmune diabetes in adults (LADA) — slowly progressive autoimmune diabetes; clinically indistinguishable from type 2 diabetes early on, but insulin progressively falls - Pancreatogenic diabetes — in severe chronic pancreatitis or after pancreatic resection, destruction of acinar tissue also involves the islets of Langerhans - Prolonged fasting — physiologically low insulin; not pathological - Intense physical exercise — transient reduction via increased muscle insulin sensitivity Low insulin with high glucose is always an alarming combination requiring immediate medical attention. Insulin and Glucose: The HOMA-IR Index HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is the standardised index for insulin resistance assessment in outpatient practice. It is calculated as follows: HOMA-IR = (fasting insulin, µIU/mL × fasting glucose, mmol/L) ÷ 22.5 Example: insulin 14 µIU/mL, glucose 5.4 mmol/L → HOMA-IR = (14 × 5.4) / 22.5 = 3.36 → insulin resistance. HOMA-IR Interpretation ------ < 1.0 Excellent insulin sensitivity 1.0–2.5 Normal for most adults 2.5–3.0 Borderline — elevated risk 3.0 Insulin resistance 5.0 Marked insulin resistance Threshold values vary across studies. Some laboratories and clinical guidelines use HOMA-IR ≥ 2.7 as the insulin resistance threshold. HOMA-IR is more informative than isolated insulin for several reasons. First, it incorporates glucose: identical insulin of 15 µIU/mL at glucose 4.8 and at glucose 6.2 represent fundamentally different situations. Second, it provides a single numerical scale for longitudinal comparison. Limitations of HOMA-IR: not applicable in patients receiving insulin therapy (exogenous insulin does not reflect beta-cell secretion); less accurate at very low or very high glucose values. In equivocal cases, more precise methods are used — the hyperinsulinaemic euglycaemic clamp — but these are available only in research centres. For a complete insulin resistance assessment, HOMA-IR is reviewed alongside HbA1c, which reflects mean glucose over three months and adds information about how long and how stably glycaemic load has been present. When to See a Doctor Most cases of elevated insulin are managed electively, but several presentations call for prompt attention. Urgently: - Episodes of hypoglycaemia (glucose below 3.5 mmol/L) with simultaneously high insulin — exclude insulinoma; hospitalisation and specialist investigation required - Undetectable insulin with glucose 11 mmol/L — probable onset of type 1 diabetes; immediate endocrinologist referral - Rapidly worsening hypoglycaemic symptoms in a patient on insulin therapy — dose adjustment required Electively but without delay: - HOMA-IR 3.0 with normal glucose — pre-clinical insulin resistance; endocrinologist consultation to develop a correction strategy - Insulin 25 µIU/mL fasting without diabetes — significant hyperinsulinaemia requiring investigation - Weight gain + acanthosis nigricans + menstrual irregularity — insulin resistance screening is mandatory, especially with PCOS - Family history of type 2 diabetes + obesity + post-meal fatigue — preventive insulin resistance testing Insulin is one of the few markers whose elevation can be reversed without medication: 7–10% weight loss, restriction of fast carbohydrates and regular physical activity reliably and sustainably reduce HOMA-IR. Early diagnosis of insulin resistance is not a cause for alarm — it is a cause for action. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/lh https://labreadai.com/en/indicators/lh Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) LH triggers ovulation and testosterone synthesis. Normal ranges by cycle phase and age, causes of high and low LH, and the LH:FSH ratio in PCOS and menopause. Indicators article If the reproductive system were a rocket launch, FSH would be the command to "fuel and prepare" — and luteinising hormone would be the button marked "launch." It is the mid-cycle LH surge that sends the signal causing the mature follicle to rupture and release the egg. Every home ovulation test is built around detecting precisely this LH peak. In men, LH is equally essential: it orders Leydig cells in the testes to synthesise testosterone. Understanding LH means understanding how two fundamental hormonal mechanisms work — and how abnormalities in LH levels can disrupt both fertility and hormonal balance. What Is LH and How It Differs from FSH LH (luteinising hormone) is a glycoprotein hormone produced by the anterior pituitary gland, just like FSH. Both are regulated by pulsatile GnRH release from the hypothalamus, and both act on the gonads — but their roles are fundamentally different. Where FSH is the hormone of growth and maturation (building the follicle in women, sustaining spermatogenesis in men), LH is the trigger hormone and steroid synthesis hormone. In women, LH has two tasks: - At mid-cycle, when a mature follicle produces a peak of oestradiol, a positive feedback loop fires — the pituitary responds with a powerful LH surge. This burst ruptures the follicle and initiates ovulation within 36–44 hours. - After ovulation, LH supports the corpus luteum — the temporary gland that forms at the site of the ruptured follicle. The corpus luteum synthesises progesterone, essential for sustaining an early pregnancy. In men, LH acts on Leydig cells in the testes, stimulating testosterone synthesis. The feedback loop works precisely: sufficient testosterone → LH falls → synthesis brakes. Too little testosterone → LH rises → Leydig cells activate. This is why male hypogonadism always requires measuring testosterone and LH together: high LH with low testosterone = primary problem in the testes (the pituitary is shouting, the testes are not listening); low LH with low testosterone = secondary problem in the pituitary or hypothalamus. Normal LH Levels in Blood Like FSH, LH in women changes throughout the cycle — and far more dramatically: the difference between the basal level and the ovulatory peak is 5–10 fold. Group Normal LH, IU/L ------ Women, follicular phase (days 2–7) 2.4–12.6 Women, ovulatory peak 14.0–95.6 Women, luteal phase 1.0–11.4 Women, postmenopause 7.7–58.5 Men 18–70 years 1.7–8.6 Children under 1 year < 3.0 Pre-pubertal (3–10 years) < 0.5 Puberty (11–18 years) gradual rise Reference ranges at your specific laboratory may differ. Always use the values printed on your own lab report. A few important observations: The ovulatory peak is a diagnostic trap. If blood happens to be drawn on the day of ovulation, LH levels can be 5–10 times higher than the "normal" basal level. Without knowing the cycle phase, such a result is easily mistaken for abnormalities. This is precisely why basal LH is always measured in the follicular phase (days 2–7). Postmenopause. After ovarian function ceases, LH rises — but less dramatically than FSH. A FSH:LH ratio 1 in postmenopause is physiological. If LH exceeds FSH in postmenopause — a gonadotropin-secreting tumour should be excluded. Pre-puberty. In children before puberty, LH levels are barely detectable (< 0.5 IU/L) — the GnRH system is in deep dormancy. A significant LH rise in a child below age 8–9 is one of the criteria for precocious puberty, and such abnormalities warrant immediate evaluation. How to Prepare for an LH Blood Test The rules are nearly identical to FSH — logically so, since they are almost always ordered together. Women with a regular cycle. Basal LH on cycle days 2–7, on the same day as FSH. This avoids sampling during the ovulatory peak and allows accurate calculation of the LH:FSH ratio. Home ovulation tests. Over-the-counter ovulation tests detect the urinary LH peak — which precedes ovulation by 24–36 hours. Testing begins 3–4 days before the estimated mid-cycle and is performed daily at the same time (preferably 14:00–18:00). In PCOS, home ovulation tests are unreliable — chronically elevated basal LH produces false-positive lines. Men. Morning fasting sample on any day; LH in men is sufficiently stable. General rules. Blood drawn fasting (8–12 hours). Avoid intense physical and emotional stress for 3 days prior. Hormonal preparations containing oestradiol, progesterone or testosterone suppress LH via negative feedback — pause for approximately one month before testing if clinically feasible, in agreement with the physician. LH without FSH is an incomplete test. Only together do they provide the picture needed for diagnosis. Elevated LH: Causes Cause in women Mechanism ------ Menopause and postmenopause Loss of oestradiol feedback → both gonadotropins rise Premature ovarian insufficiency Same mechanism before age 40 PCOS Disrupted GnRH pulsatility → chronically high LH with relatively normal FSH; LH:FSH 2 Turner syndrome Primary gonadal failure Ovulatory peak Physiological; not pathological when sampled at mid-cycle Cause in men Mechanism ------ Primary hypogonadism Reduced testosterone → no feedback suppression → LH rises Klinefelter syndrome (47,XXY) Congenital Leydig cell dysfunction Orchitis, testicular trauma Acquired testicular tissue damage Androgen resistance Tissues do not respond to testosterone → LH not suppressed by feedback A specific case — isolated high LH with normal FSH in a woman outside the ovulatory peak. This is the classic PCOS pattern. In PCOS, the pituitary produces LH at an accelerated pulse rate while FSH remains moderate. The ovaries receive a signal to "make androgens" instead of "mature a follicle." In PCOS, an LH:FSH ratio 2–3:1 is seen in 60–70% of patients and is a useful diagnostic pointer, although it is not part of the official Rotterdam criteria. Low LH: Causes Low LH is always a "signal from above": the problem lies in the pituitary or hypothalamus, not in the gonads. - Pregnancy — hCG suppresses LH and FSH physiologically; the first thing to exclude when LH is low with a missed period - Hypothalamic amenorrhoea — energy deficit (anorexia, extreme dieting), chronic stress, intensive sport reduce GnRH pulse frequency; LH and FSH fall proportionally - Hyperprolactinaemia — excess prolactin suppresses GnRH → secondary LH reduction; always check prolactin when central hypogonadism is suspected - Pituitary tumours and damage — adenoma, craniopharyngioma, radiation injury, Sheehan's syndrome - Kallmann syndrome — congenital GnRH deficiency; LH and FSH are at zero from birth - Exogenous androgens and anabolic steroids — high exogenous testosterone suppresses LH → testes stop producing endogenous testosterone → atrophy; a common cause in men using steroids without medical supervision LH and FSH: The Ratio in Clinical Practice The LH:FSH ratio is one of the most frequently used diagnostic indices in reproductive endocrinology. It is calculated by dividing the LH value by the FSH value, both measured in the follicular phase. LH:FSH ratio Clinical significance ------ 0.5–1.5 (normal range) Physiological in follicular phase 2.0–3.0 in a woman outside the peak Characteristic of PCOS — requires further investigation < 0.5 when both values are low Hypothalamo-pituitary insufficiency LH FSH in postmenopause at normal FSH Exclude LH-secreting tumour FSH LH when both are high Primary gonadal failure (menopause, POI) A practical example. A 32-year-old woman with irregular cycles: LH = 18.4 IU/L, FSH = 6.1 IU/L, oestradiol normal. LH:FSH ratio = 3.0. Combined with polycystic ovarian morphology on ultrasound and mild hirsutism — the picture fits PCOS. If instead both gonadotropins were below 1.0 IU/L — prolactin and a pituitary MRI would be the next steps. In menopause, the ratio is interpreted differently: both gonadotropins are high, but FSH should exceed LH. If a postmenopausal woman's LH unexpectedly exceeds her FSH — this is atypical and warrants investigation. When to See a Doctor Urgently - LH 40 IU/L in a woman under 40 outside the ovulatory peak — suspected premature ovarian insufficiency; urgent referral to a reproductive specialist - LH:FSH 3 with irregular cycles — probable PCOS with significant hormonal imbalance; planned but prompt gynaecological-endocrinological assessment - Very low LH (< 0.5 IU/L) with amenorrhoea in a non-pregnant woman — exclude prolactinoma; pituitary MRI mandatory - Low LH with low testosterone in a man — secondary hypogonadism; neuroimaging and endocrinologist consultation required - Elevated LH in a girl below age 8 or a boy below age 9 — criterion for precocious puberty; paediatric endocrinologist without delay - Sudden rise in LH and FSH in a patient after chemotherapy or radiotherapy — gonadotoxic damage assessment; reproductive prognosis evaluation needed LH is the hormone of action where FSH is the hormone of preparation. The first triggers ovulation and sex hormone synthesis; the second grows the follicle and supports spermatogenesis. Together they form a diagnostic pair without which reproductive abnormalities cannot be fully decoded — and interpreting LH levels in isolation is never sufficient. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/indicators/lipase https://labreadai.com/en/indicators/lipase Mon, 23 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Lipase is the most specific marker of acute pancreatitis. Normal ranges in adults, causes of elevation and when lipase is more informative than amylase. Indicators article If amylase is the first alarm signal when a patient arrives with abdominal pain, lipase is the primary confirmatory test. Current international guidelines place it first in diagnosing acute pancreatitis: it is more specific, stays elevated longer, and virtually never produces false positives from salivary gland disease. Yet lipase is not a magic number to read in isolation. Here is what it shows, when its elevation genuinely means pancreatitis, and when it does not. What Is Lipase and Why It Is More Specific Than Amylase Lipase (pancreatic lipase, triacylglycerol lipase) is an enzyme that cleaves triglycerides into fatty acids and glycerol. It is the key enzyme for fat digestion — without lipase, dietary fats cannot be absorbed in adequate amounts in the small intestine. Almost all serum lipase originates from the pancreas. Unlike amylase, which is produced in significant quantities by the salivary glands, intestine and several other tissues, lipase is manufactured almost exclusively by pancreatic acinar cells. This is precisely why its specificity for pancreatic pathology is substantially higher — approximately 85–90% versus 60% for amylase. When the pancreas is inflamed or damaged, acinar cells disintegrate and release their lipase into the bloodstream. This process begins slightly later than for amylase (4–8 hours after attack onset), but the peak is higher and it persists far longer: normalisation occurs over 7–14 days versus 3–5 days for amylase. This is clinically critical: a patient presenting 4–5 days after onset, when amylase has already returned to normal, will still show elevated lipase. A further advantage of lipase: it does not rise in parotitis or salivary gland disease. Any isolated lipase elevation with normal or mildly raised amylase points almost unambiguously to the pancreas. Normal Lipase Levels in Blood: Test Results Interpretation Group Normal lipase, U/L ------ Adults 18–60 years 13–60 Adults over 60 years 13–70 Children under 1 year 1–28 Children 1–14 years 8–48 Reference ranges at your specific laboratory may differ. Some laboratories use an upper limit of 55–67 U/L — always use the values on your own lab report. Several important points: Diagnostic threshold in pancreatitis. Clinically, a lipase elevation of 3 or more times the upper limit of normal (≥ 180–200 U/L) is the diagnostically significant threshold. This figure — not simply "above normal" — is recommended by most international guidelines as a criterion for acute pancreatitis, in combination with a compatible clinical picture. Children. Lipase norms are lower in children; the pancreas reaches mature secretory function around age 3–5. In suspected childhood pancreatitis, the diagnostic threshold remains the same 3× ULN. Renal insufficiency. Lipase is partially excreted by the kidneys; with significant GFR reduction it accumulates in the blood. Elevated lipase in renal insufficiency without pancreatitis symptoms is a well-known but frequently forgotten interpretive pitfall. How to Prepare for a Lipase Blood Test Lipase is measured from venous blood, usually as part of a biochemistry panel. Fasting. Strictly fasting — last meal 8–12 hours before. Fatty food directly stimulates pancreatic secretion and may transiently affect enzyme levels. Alcohol. Avoid for 48–72 hours — alcohol is a direct trigger of acute pancreatitis. Occasional moderate use in a person without pancreatitis has minimal effect, but regular heavy drinking significantly raises lipase. Medications. Elevating: morphine and other opioids (Oddi sphincter spasm), cholinergic drugs, thiazide diuretics, cholinesterase inhibitors. Lowering: somatostatin analogues (suppress pancreatic secretion). Hypertriglyceridaemia. At very high triglyceride levels ( 11–13 mmol/L), lipase measurements can be falsely normal or low due to interference from lipaemic serum with photometric assay methods. This is paradoxical — severe hypertriglyceridaemia is itself the third most common cause of acute pancreatitis. Emergency testing. For acute abdominal pain with suspected pancreatitis — measure immediately, without waiting for a routine biochemistry run. Elevated Lipase: Causes and Degrees of Elevation Degree of elevation Fold above ULN Typical causes --------- Mild 1–3× ULN Chronic pancreatitis (outside flare), renal insufficiency, opioid use, diabetic ketoacidosis Moderate 3–5× ULN Mild acute pancreatitis (diagnostic threshold), peptic ulcer perforation, bowel obstruction, coeliac disease High 5–10× ULN Moderate acute pancreatitis, gallstone disease with choledocholithiasis, pancreatic cancer Very high 10× ULN Severe acute pancreatitis, early-phase pancreatic necrosis Lipase height does not correlate with pancreatitis severity — this is a critical clinical rule. Severe necrotising pancreatitis can produce both very high and only moderately elevated values, depending on the volume of remaining secretory tissue. Non-pancreatic causes of elevated lipase: - Renal insufficiency — impaired clearance; lipase accumulates proportionally to GFR reduction - Hollow organ perforation — peritoneal contents irritate the pancreas; moderate elevation - Acute cholecystitis and choledocholithiasis — bile pressure on the ampulla of Vater; frequently raises both enzymes - Bowel obstruction — intestinal ischaemia and distension trigger enzyme "leak" - Pancreatic cancer — tumour destroys acinar tissue or obstructs ducts; moderate, occasionally high elevation - Severe hypertriglyceridaemia — itself causes pancreatitis via fat emboli in pancreatic vessels - Diabetic ketoacidosis — mechanism not fully established; mild lipase elevation in 15–25% of patients without clinical pancreatitis - Coeliac disease — intestinal mucosal inflammation with a mild "sympathetic" enzyme rise The key diagnostic principle: lipase elevation is only a criterion for acute pancreatitis when combined with compatible clinical features (abdominal pain, vomiting). Isolated elevated lipase without symptoms requires a search for alternative causes — primarily renal insufficiency and medications. Low Lipase: Exocrine Pancreatic Insufficiency and Other Causes Lipase below the lower limit of normal is less discussed but clinically meaningful. - Severe chronic pancreatitis with exocrine insufficiency — the main cause. After years of inflammation, acinar tissue is replaced by fibrosis; secretion of all enzymes, including lipase, falls. Clinically this manifests as fat malabsorption: steatorrhoea, weight loss, deficiency of fat-soluble vitamins (A, D, E, K). - Cystic fibrosis — genetically determined exocrine dysfunction present from birth; exocrine insufficiency develops in most patients. - Pancreatic resection — post-operative enzyme deficit; lifelong replacement therapy required. Low lipase in a patient with fatty stools and weight loss is a direct indication for faecal elastase-1 measurement (the most accessible and specific test for exocrine insufficiency) and initiation of pancreatic enzyme replacement therapy. Lipase and Amylase: When One Is Enough and When Both Are Needed A practical question: must both enzymes always be measured, or can one suffice? Lipase alone is sufficient in most clinical scenarios when acute pancreatitis is suspected. This is the recommendation of most gastroenterological societies (ACG, BSG): lipase has higher diagnostic accuracy and does not require "confirmation" by amylase. Both enzymes are preferable in the following situations: - Patient presents late ( 3 days from pain onset) — amylase has normalised; the divergence between a normal amylase and still-elevated lipase helps establish a timeline - Differential diagnosis with salivary gland pathology — isolated amylase elevation with normal lipase unambiguously indicates a salivary source - Atypical clinical picture — when the diagnosis is unclear and maximum diagnostic information is needed In comprehensive abdominal biochemistry, both enzymes are assessed alongside liver function tests: gallstone disease and biliary pathology frequently accompany pancreatitis, and simultaneous assessment immediately distinguishes biliary from alcoholic causes. In acute pancreatitis this distinction is fundamental, since it determines management. The metabolic connection is also direct: in metabolic syndrome with hypertriglyceridaemia, the risk of acute pancreatitis is substantially elevated — and this is the patient group in which lipase is most often discovered incidentally on routine testing. When to See a Doctor Urgently - Lipase above 3× ULN with abdominal pain of any intensity — diagnostic criterion for acute pancreatitis; hospitalise without delay, even if pain seems tolerable - Lipase above 5× ULN without pain — urgent clarification of cause; renal insufficiency, occult pancreatitis or pancreatic cancer - Rising lipase on serial testing in established chronic pancreatitis — sign of a flare or progression - High lipase with jaundice — probable choledocholithiasis with obstructive pancreatitis; an acute emergency - Sudden fall in previously high lipase during worsening pain — possible pancreatic necrosis; deterioration, not improvement On an elective basis: mild isolated lipase elevation (1–2× ULN) without pain in a patient with chronic renal insufficiency or on opioid therapy is an expected finding. The cause should be clarified, but no emergency measures are required. This article is for informational purposes only. Interpretation of test results and diagnosis are the responsibility of a qualified physician. https://labreadai.com/en/posts/acute-kidney-injury https://labreadai.com/en/posts/acute-kidney-injury Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) AKI is a rapid decline in kidney function over hours or days. KDIGO criteria, prerenal and renal causes, key labs (creatinine, urea), treatment and when dialysis is needed. Articles article Acute kidney injury is one of the few conditions in nephrology where time is measured in hours. The kidneys can lose a significant portion of their filtration capacity within a day, and how quickly the cause is identified and treatment started directly determines whether function recovers fully or the patient progresses to chronic kidney disease. This is why AKI is not simply a diagnosis — it is an alarm signal. What AKI Is and How It Differs from Chronic Kidney Disease Acute kidney injury (AKI) is a syndrome of rapid decline in kidney function developing over hours or days. The defining word is "acute": unlike chronic kidney disease, which evolves over months and years, AKI is a sudden event. KDIGO diagnostic criteria (2012): AKI is diagnosed when at least one of the following is present: - Rise in creatinine ≥ 26.5 µmol/L within 48 hours - Rise in creatinine ≥ 1.5-fold from baseline within 7 days - Urine output < 0.5 mL/kg/hour for ≥ 6 hours AKI stages (KDIGO): Stage Creatinine Urine output --------- 1 ×1.5–1.9 from baseline or +26.5 µmol/L < 0.5 mL/kg/h ≥ 6 h 2 ×2.0–2.9 from baseline < 0.5 mL/kg/h ≥ 12 h 3 ×3.0 or 353.6 µmol/L or dialysis initiation < 0.3 mL/kg/h ≥ 24 h or anuria ≥ 12 h The critical distinction from CKD: AKI is potentially reversible with timely treatment. Outcome depends on cause, stage, and speed of intervention. Causes of AKI: Prerenal, Renal, Postrenal Classification by mechanism is the key to treatment: different causes require fundamentally different approaches. Prerenal (reduced renal blood flow) — 55–60% of all AKI The kidneys themselves are intact but receive insufficient blood flow. Filtration falls as a compensatory response to hypovolaemia or reduced cardiac output. Reversible with rapid restoration of perfusion. - Dehydration — vomiting, diarrhoea, haemorrhage, burns, excessive sweating - Heart failure, cardiogenic shock — impaired pump function - Sepsis — peripheral vasodilation with normal or reduced cardiac output - Cirrhosis with hepatorenal syndrome - Excessive diuretic therapy - NSAIDs — block prostaglandin-dependent afferent vasodilation in glomeruli Laboratory marker of prerenal AKI: urea rises disproportionately fast — urea/creatinine ratio 80 (BUN/Cr 20 in mg/dL). Urine is concentrated; oliguria is present. Renal (intrinsic kidney parenchyma damage) — 35–40% Direct injury to nephron structures. The most common form: acute tubular necrosis (ATN). Ischaemic ATN — develops when prerenal AKI is prolonged: the kidneys "tolerated" reduced blood flow until tubular epithelium began to die. The transition from prerenal to renal AKI is the critical inflection point, after which volume restoration alone no longer normalises function immediately. Nephrotoxic ATN — direct toxic tubular injury: - Aminoglycoside antibiotics (gentamicin, amikacin) - Radiocontrast agents — especially dangerous in patients with pre-existing reduced GFR - Rhabdomyolysis — myoglobin from destroyed muscle is nephrotoxic - Chemotherapy agents (cisplatin) - Intravascular haemolysis Other renal causes: - Acute glomerulonephritis — immune glomerular injury - Acute interstitial nephritis — commonly drug-induced (NSAIDs, antibiotics, proton pump inhibitors) - Thrombotic microangiopathy (HUS, TTP) - Renal artery atheroemboli Postrenal (obstructed urine outflow) — 5–10% Urine is produced but cannot exit. Pressure builds in the tubules, filtration falls. Reversible upon relief of obstruction. - Urolithiasis with bilateral obstruction or obstruction of a solitary kidney - Benign prostatic hyperplasia or prostate cancer - Pelvic tumours with external ureteral compression - Neurogenic bladder Acute Renal Failure Symptoms: Oliguria, Uraemia and Electrolyte Crisis The clinical picture of AKI comprises symptoms of reduced filtration and symptoms of the underlying causative condition. Changes in urine output: - Oliguria (< 400 mL/day) — the most common sign; anuria (< 50 mL/day) indicates a critical state - Paradoxically: some AKI forms (contrast-induced nephropathy, some nephrotoxic injuries) occur without oliguria — "non-oliguric AKI" Uraemic symptoms (from toxin accumulation): Nausea, vomiting, reduced appetite, metallic taste, ammonia breath odour. As severity increases — confusion, seizures. Fluid and electrolyte disturbances: - Fluid overload — oedema, dyspnoea, hypertension - Hyperkalaemia — the most dangerous acute complication of AKI. At potassium 6.0–6.5 mmol/L — risk of fatal arrhythmia. Requires emergency management - Hyponatraemia, hyperphosphataemia, hypocalcaemia Metabolic acidosis — the kidneys cannot excrete acid; worsens with severe AKI. Creatinine and Other Lab Tests in AKI: What Changes and How Blood: - Creatinine — the primary marker: rapid rise over hours to days. In stage 3 AKI may exceed 350–500 µmol/L - Urea — rises in parallel, but faster in catabolic states - Potassium — hyperkalaemia in AKI is life-threatening; check every 4–6 hours in severe AKI - Sodium — hyponatraemia with fluid overload - Phosphorus — hyperphosphataemia - Bicarbonate / pH — metabolic acidosis - CBC: haemoglobin — falls in haemolysis or as part of anaemia of renal disease Urine: - Osmolality 500 mOsm/kg — concentrated urine in prerenal AKI - Osmolality < 300 mOsm/kg — impaired concentration in renal AKI - Casts in sediment: granular, epithelial — markers of tubular necrosis - Myoglobinuria (dark "tea-coloured" or "cola-coloured" urine) — in rhabdomyolysis Imaging: Renal ultrasound — mandatory in all AKI: dilated pelvicalyceal system indicates postrenal obstruction. Treatment of AKI The approach is determined by cause and stage. Eliminate the cause — top priority: - Prerenal AKI: volume restoration with crystalloid fluids; inotropes for cardiogenic shock; discontinue NSAIDs and other nephrotoxins - Postrenal AKI: urgent drainage — bladder catheterisation, nephrostomy, ureteral stents - Renal AKI: aetiology-directed treatment (immunosuppression for glomerulonephritis, steroids for interstitial nephritis); remove nephrotoxins Supportive care: - Fluid balance management: avoid both hypovolaemia and volume overload - Hyperkalaemia — emergency treatment: calcium gluconate (membrane stabilisation), insulin + glucose + bicarbonate (intracellular K⁺ shift), ion exchange resins or dialysis - Blood pressure control - Nutritional support: adequate protein intake; restricting protein in AKI is an outdated concept harmful in catabolic states - Infection prevention (AKI is a risk factor for nosocomial infections) Renal replacement therapy (dialysis): Indications for emergency dialysis in AKI: - Refractory hyperkalaemia (K⁺ 6.5 mmol/L) - Severe metabolic acidosis (pH < 7.15) - Uraemic symptoms (encephalopathy, pericarditis) - Volume overload with refractory pulmonary oedema - The absolute creatinine level is not a dialysis indication — clinical status governs the decision With timely management, most patients with prerenal and postrenal AKI recover kidney function fully. With renal AKI (especially ischaemic ATN), recovery takes 1–3 weeks; in some patients, function does not fully recover and CKD develops. When to Seek Urgent Medical Attention - Sudden sharp reduction in urine output or complete cessation — anuria always requires emergency assessment - Creatinine rise 26 µmol/L within 48 hours on lab results — urgent nephrology consultation - Weakness, arrhythmia, or numbness — possible hyperkalaemia; call emergency services - Dark tea-coloured urine after intense exercise or trauma — rule out rhabdomyolysis - Confusion in a patient with known kidney disease — possible uraemic encephalopathy This article is for informational purposes only and does not replace consultation with a qualified nephrologist. https://labreadai.com/en/posts/adrenal-insufficiency https://labreadai.com/en/posts/adrenal-insufficiency Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Adrenal insufficiency is a deficiency of cortisol and aldosterone. Causes (Addison's disease, secondary form), symptoms, cortisol-based diagnosis and treatment. Articles article Fatigue that never improves with rest, unexplained weight loss, a craving for salty food, and skin that darkens in places the sun never reaches — this rare combination of symptoms should immediately prompt a physician to consider adrenal insufficiency. The adrenal glands produce hormones without which the body cannot respond normally to stress. When this function is impaired, even a routine cold can become a life-threatening crisis. What Adrenal Insufficiency Is Adrenal insufficiency (AI) is a condition in which the adrenal cortex produces inadequate amounts of steroid hormones — primarily cortisol and aldosterone. Cortisol — the "stress hormone" — regulates metabolism, immune response, and the body's reaction to physiological demands. Aldosterone controls the balance of sodium and potassium, maintaining blood pressure. Think of the body as an emergency service: under any threat — infection, trauma, surgery — cortisol is normally released into the bloodstream and mobilises resources. In AI, this mobilisation fails, and the body cannot cope even with moderate stress. This is why AI is sometimes called "the disease that kills in stressful situations." Causes: Primary and Secondary Forms The key distinction is where the problem originates. Primary adrenal insufficiency (Addison's disease) — damage to the adrenal glands themselves. The cortex is destroyed and both hormones — cortisol and aldosterone — are no longer produced in adequate amounts. Causes in order of frequency: autoimmune adrenalitis (80–90% of cases in developed countries) — autoantibodies attack the adrenal cortex; adrenal tuberculosis — historically the leading cause, now rare; adrenal metastases; bilateral adrenalectomy; adrenal haemorrhage (Waterhouse-Friderichsen syndrome in sepsis). Autoimmune AI frequently co-occurs with other autoimmune diseases — Hashimoto's thyroiditis and type 1 diabetes. This combination is called autoimmune polyendocrine syndrome. Secondary adrenal insufficiency — the adrenal glands are intact, but the pituitary gland does not produce enough ACTH (adrenocorticotrophic hormone) to stimulate them. Causes: pituitary tumours, surgery or irradiation in that region, Sheehan's syndrome (pituitary ischaemia after postpartum haemorrhage). The most important cause is abrupt withdrawal of long-term glucocorticoid therapy: chronic prednisolone use suppresses the HPA axis, which recovers slowly. Sudden discontinuation is the classic path to acute crisis. Key distinction: in primary AI, aldosterone is absent → hyponatraemia + hyperkalaemia. In secondary AI, aldosterone is preserved (regulated through a separate pathway) → electrolyte disturbances are less pronounced. Symptoms of Adrenal Insufficiency Chronic AI develops gradually — over months to years. Symptoms are non-specific and are frequently attributed to depression, chronic fatigue syndrome, or anorexia. General symptoms: progressive weakness and fatigue — the earliest and most prominent symptom; weight loss and poor appetite; nausea, vomiting, and abdominal pain; muscle aches and cramps; orthostatic hypotension — dizziness on standing. Specific to primary AI: hyperpigmentation of skin and mucous membranes — darkening of palmar creases, surgical scars, areolae, and the inner cheeks. The mechanism: excess ACTH (the pituitary "shouting" at the adrenals) cross-stimulates melanocytes. Salt craving — the body attempts to compensate for sodium loss. Low blood pressure, potentially progressing to collapse. Symptoms of cortisol deficiency: hypoglycaemia (especially with fasting or exercise), impaired stress tolerance, cognitive fog, depression. Diagnosis: Key Tests Diagnosing AI is a multi-step process. No single test establishes the diagnosis on its own. Morning cortisol (drawn 8:00–9:00 AM) — the first step. Cortisol is highest in the morning: a value < 140 nmol/L strongly suggests AI; 500 nmol/L effectively excludes it. The "grey zone" of 140–500 nmol/L requires stimulation testing. Synacthen stimulation test (250 µg ACTH) — the gold standard. Synthetic ACTH is injected and cortisol is measured at 30 and 60 minutes. A normal response: peak 550 nmol/L. Failure to mount an adequate response confirms adrenal insufficiency. Plasma ACTH — differentiates primary from secondary AI. In primary AI, ACTH is markedly elevated (the pituitary "shouting"). In secondary AI, ACTH is low or normal. Sodium and potassium — in primary AI, hyponatraemia (< 135 mmol/L) and hyperkalaemia ( 5.0 mmol/L) are characteristic. Assessed comprehensively via the electrolyte panel. This combination alongside fatigue and hypotension is a strong pointer to primary AI. The mirror pattern — low potassium with normal or elevated sodium and resistant hypertension — is characteristic of primary aldosteronism and requires an entirely different management approach. Fasting glucose — hypoglycaemia in AI reflects cortisol's role in maintaining blood sugar through gluconeogenesis. Anti-adrenal antibodies (anti-21-hydroxylase) — confirm the autoimmune aetiology in primary AI. Pituitary MRI — in secondary AI to exclude an adenoma or other structural pathology. Adrenal Crisis: When to Call Emergency Services Acute adrenal insufficiency (adrenal crisis) is a life-threatening emergency. It develops when a patient with AI faces severe infection, trauma, or surgery without an adequate increase in their hormone dose, or when glucocorticoids are abruptly withdrawn. Signs of crisis: sudden profound weakness preventing the patient from getting up; severe abdominal pain with nausea and vomiting; critical blood pressure drop (systolic < 90 mmHg); confusion or loss of consciousness; hypoglycaemia. If adrenal crisis is suspected, call emergency services immediately. Treatment: intravenous hydrocortisone 100 mg bolus + aggressive normal saline infusion. Delaying hormone administration to draw blood tests is never appropriate — the mortality risk is high. Treatment of Adrenal Insufficiency Treatment of AI requires lifelong hormone replacement therapy. The goal is to replicate the normal diurnal cortisol rhythm. Glucocorticoids: hydrocortisone 15–25 mg/day in 2–3 doses (larger morning dose, smaller afternoon dose, none in the evening). Or prednisolone 5–7.5 mg/day. The "sick day rule": during fever, vomiting, or surgery, the dose is doubled or tripled. If oral administration is impossible, the dose is given parenterally. Mineralocorticoids (primary AI only): fludrocortisone 0.05–0.2 mg/day — replaces aldosterone deficiency, normalising blood pressure and electrolytes. Patient education — a critical component: every patient must carry a medical alert card, understand the sick day rule, and have an emergency kit with injectable hydrocortisone for crisis situations. In autoimmune AI, the underlying process cannot be reversed — adrenal tissue is permanently destroyed. Treatment aims solely at hormone replacement. When to Seek Urgent Medical Attention Call emergency services immediately for: a sudden blood pressure drop, loss of consciousness, or confusion; uncontrolled vomiting that prevents taking oral medication; acute abdominal pain in a known AI patient; high fever in an AI patient who cannot increase their steroid dose. See an endocrinologist within days for: progressive fatigue and falling blood pressure without obvious cause; unexplained skin hyperpigmentation; hyponatraemia combined with hyperkalaemia on blood tests. This article is for informational purposes only. Diagnosis and treatment of adrenal insufficiency are carried out by an endocrinologist. https://labreadai.com/en/posts/allergy-guide https://labreadai.com/en/posts/allergy-guide Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Complete guide to allergy: hay fever, food, contact and drug types. How the immune reaction works, skin prick tests and IgE blood tests, antihistamines and ASIT. Articles article One in three people will have an allergic reaction at some point in their lives — and many find out at the worst possible moment: peak pollen season, a bite of the wrong food, a bee sting. Allergy doesn't give you advance warning, doesn't pick an age, and doesn't go away on its own. But it can be understood, accurately diagnosed, and brought under control. Here's how allergic reactions work, what forms they take, how to identify the trigger, and what modern medicine offers — from antihistamines to immunotherapy. Why the Immune System Attacks Harmless Substances Think of the immune system as a security service. In most people it's well-calibrated: it ignores pollen, food proteins, and pet dander, and reacts only to genuine threats like viruses and bacteria. In a person with allergy, this system misfires: it identifies harmless substances as enemies and sounds the alarm. Allergic disease unfolds in two stages. The first is sensitization: the body encounters an allergen for the first time, remembers it, and produces specific IgE antibodies that anchor themselves to mast cells in the mucous membranes and skin. The person feels nothing. They're simply being prepared for the alarm. The second stage — the reaction — happens on re-exposure to that same allergen. Mast cells rupture and release histamine and other inflammatory mediators. Histamine is responsible for everything we associate with allergy: swelling, itching, redness, tearing, and bronchospasm. What triggers this malfunction isn't fully understood. Genetics matter (if both parents have allergies, the child's risk approaches 60–80%), as do early childhood environment and pollution. The "hygiene hypothesis" explains why allergies are more common in developed countries: an immune system that never faces real parasites and infections starts reacting to things it shouldn't. Allergic reactions fall into two categories by speed. Immediate-type reactions (the majority of allergies) develop within minutes — hay fever, hives, anaphylaxis. Delayed-type reactions develop over hours or days; here it's memory T-cells, not antibodies, doing the work. Contact dermatitis from nickel or latex is the classic example. Types of Allergy: Pollen, Food, Contact and Drugs Allergy is not one disease but a family of reactions, classified by how the allergen enters the body. Inhalant (respiratory) allergy is the most common form. Allergens are inhaled. Seasonal hay fever is the typical presentation — a reaction to tree pollen (birch, alder, hazel), grass pollen (timothy, orchard grass), or weed pollen (ragweed, wormwood). The perennial form involves dust mites, mold spores, and pet dander and saliva — triggers that are present all year. Food allergy is a reaction to specific food proteins. The top eight culprits — cow's milk, eggs, peanuts, tree nuts, soy, wheat, fish, and shellfish — account for the vast majority of serious food reactions, including anaphylaxis. Contact allergy is a skin reaction to direct physical contact: metals (nickel in jewelry and denim rivets), latex, cosmetics, household chemicals, certain plants. It always follows the delayed pattern — redness and itching appear 12–48 hours after contact, precisely at the site that touched the allergen. Drug allergy is a reaction to medications. The most common triggers are penicillin-class antibiotics, NSAIDs (aspirin, ibuprofen), and local anesthetics. The first dose is typically tolerated; the dangerous reaction comes with re-exposure. Insect venom allergy is a reaction to the venom of stinging insects — bees, wasps, hornets. In sensitized individuals, a single sting can cause anaphylaxis. Type Common Allergens Main Symptoms --------- Respiratory Pollen, dust mites, mold, dander Runny nose, sneezing, conjunctivitis, cough, wheeze Food Milk, eggs, nuts, fish Hives, lip/tongue swelling, abdominal pain, vomiting Contact Nickel, latex, cosmetics Redness, itching, blisters at site of contact Drug Antibiotics, NSAIDs, anesthetics Rash, hives, angioedema, anaphylaxis Insect venom Bee/wasp venom Local swelling, hives, anaphylaxis Allergy Symptoms: From a Runny Nose to Anaphylactic Shock Allergy is good at disguising itself. It mimics a cold, food poisoning, or atopic dermatitis — and often goes unrecognized for years. The key to identifying it is pattern: symptoms appear with contact to a specific substance and disappear when contact ends. Mild to moderate allergy targets the mucous membranes and skin. The nose responds with paroxysmal sneezing, watery discharge, and persistent itching. The eyes redden, tear, and itch — allergic conjunctivitis. The skin develops hives (raised, intensely itchy welts) or dry, scaly patches. Food allergy adds nausea, cramping, and diarrhea. Anaphylaxis is a severe systemic reaction that develops within one to two minutes and is life-threatening. The airways narrow from bronchospasm or throat swelling, blood pressure collapses, and consciousness is lost. The most common triggers are insect venom, peanuts, latex, and medications. How do you tell allergy from a cold? A cold brings fever, sore throat, and body aches — and resolves in five to seven days. Allergy produces no fever; its symptoms are tied to a specific situation (stepped outside on a windy day — symptoms started; came back indoors — gone), and seasonal allergy returns at exactly the same time each year. How to Identify the Trigger: Skin Tests and IgE Blood Tests Guessing the culprit on your own is nearly impossible — there are thousands of potential allergens, and different allergy types share similar symptoms. An allergist has two main diagnostic tools. Skin prick tests are fast and direct. Small drops of allergen extracts are placed on the forearm, and a lancet makes a tiny prick through each drop. After fifteen to twenty minutes, positive reactions show as a wheal with surrounding redness. The advantage is same-day results; the limitation is that tests can't be done during a flare-up, in pregnancy, in young children, or while taking antihistamines — these need to be stopped five to seven days beforehand. Specific IgE blood tests (ImmunoCAP, immunoblot) are more flexible. They measure IgE antibody levels to specific allergens in serum and can be done at any time of year, during or outside of symptoms, without stopping antihistamines. The laboratory checks whole panels: inhalant allergens (pollen, dust, animals), food allergens, or pediatric panels. As a supporting marker of allergic inflammation, doctors look at the complete blood count: elevated eosinophils in the differential point toward an active allergic process. This finding doesn't establish a diagnosis on its own, but it helps confirm the allergic nature of symptoms and track their activity over time. For suspected contact allergy, patch tests are used: adhesive panels loaded with allergens are applied to the back for forty-eight hours and the skin reaction is read. How Allergy Is Treated: Antihistamines, Steroids and Immunotherapy Treatment works on three levels. Only their combination produces lasting results. Elimination: Remove Contact with the Allergen The most reliable approach is removing the cause of the reaction. For hay fever that means staying indoors on dry, windy days, running HEPA air filters at home, rinsing the nose with saline after outings, and wearing wraparound sunglasses. For food allergy it means reading every ingredient label. For contact allergy it means letting go of nickel jewelry and switching away from latex gloves. The principle is simple; the practice requires rebuilding habits. Drug Therapy Second-generation antihistamines (cetirizine, fexofenadine, bilastine, desloratadine) are the first-line treatment for any form of allergy. They don't cause drowsiness, last up to twenty-four hours, and are safe for extended daily use. For hay fever, starting two weeks before the expected bloom produces a noticeably better effect than waiting for symptoms. Intranasal corticosteroids (mometasone, fluticasone) are the most effective way to control swelling and congestion in allergic rhinitis. They act locally and are barely absorbed into the bloodstream. The effect builds gradually over several days of regular use. Eye drops (azelastine, olopatadine) target allergic conjunctivitis directly. Cromones are weaker than steroid sprays but work well as preventive treatment for mild seasonal rhinitis. Severe allergic disease may require short courses of systemic corticosteroids, prescribed and monitored by a doctor. For anyone with a history of anaphylaxis, carrying an epinephrine auto-injector is not optional — administering it within the first minutes of a reaction is the difference between life and death. Allergen Immunotherapy — the Only Treatment That Changes the Disease Allergen-specific immunotherapy (AIT) doesn't suppress symptoms — it changes how the immune system responds to the allergen in the first place. Patients receive gradually increasing doses of their specific allergen (as sublingual drops or injections), slowly training the immune system to stop treating it as a threat. The full course takes three to five years. Most patients see a fifty to seventy percent symptom reduction in the first year; many achieve years-long remission after completing the course. AIT is indicated for hay fever, dust mite allergy, and insect venom allergy. It's started only during remission — outside the season and outside a flare. The approach also carries a meaningful secondary benefit: it slows the "atopic march," the progression from allergic rhinitis toward asthma. Cross-Reactivity: When There's More Than One Trigger Cross-reactivity baffles many patients. The logic is straightforward: if the protein structure of one allergen resembles the structure of another, the immune system reacts to both. The most well-known example is birch allergy. Its main protein, Bet v 1, closely resembles proteins found in apples, pears, peaches, cherries, carrots, celery, and hazelnuts. During the birch season, many patients notice itching in the mouth and tingling in the throat after eating fresh fruit — this is oral allergy syndrome. Heat destroys the allergenic protein, which is why cooked carrots are usually fine while raw ones trigger a reaction. Similar chains exist with ragweed (cross-reacts with banana, melon, and cucumber), latex allergy (avocado, banana, kiwi), and cat allergy (some cuts of pork). The longer allergy goes untreated, the wider the list of cross-reactive triggers tends to grow — another reason early diagnosis and treatment matter. When to Seek Emergency Care Call emergency services immediately if, after contact with a possible allergen, you or someone nearby develops: - Difficulty breathing, wheezing, or a feeling of suffocation. - Swelling of the lips, tongue, or throat — with the risk of airway obstruction. - A sudden drop in blood pressure, severe dizziness, or loss of consciousness. - Widespread hives across the body combined with any of the above. This is anaphylaxis. The only effective immediate step is epinephrine. Every minute matters. A routine appointment with an allergist is warranted if symptoms recur with contact to the same substance, if antihistamines stop providing adequate relief, or if you want a full workup and are considering immunotherapy. Conclusion Allergy is not something to simply live with. Without treatment it tends to progress: the list of triggers expands, reactions intensify, and the risk of asthma rises. Modern allergology can not only suppress symptoms but retrain the immune response — and that's exactly what immunotherapy is designed to do. The earlier an accurate diagnosis is established, the greater the chances of reclaiming a normal quality of life. This article is for informational purposes only. Allergy diagnosis and treatment planning are carried out by a licensed allergist. https://labreadai.com/en/posts/atopic-dermatitis-what-it-is https://labreadai.com/en/posts/atopic-dermatitis-what-it-is Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Atopic dermatitis is chronic skin inflammation with impaired barrier function. Symptoms by age group, common triggers, diagnosis, emollient therapy and biologic treatment options. Articles article Itch that keeps you awake at night, skin that cracks and flares again and again despite every cream — atopic dermatitis affects one in ten adults and one in five children. This is not simply "dry skin" or an allergy to a specific food. It is a chronic immune-mediated inflammation with its own logic, its own triggers, and — crucially — effective methods of control. Let's break down the mechanism, the symptoms, and what actually works in treatment. What Is Atopic Dermatitis and Why It Develops Atopic dermatitis (AD) is a chronic inflammatory skin disease rooted in two interconnected defects: impaired skin barrier function and immune dysregulation. Healthy skin works like a well-laid brick wall: keratinocytes are held together by a lipid "mortar" that blocks external irritants. In AD, this mortar has genetically programmed cracks — primarily due to mutations in the filaggrin gene, which governs barrier integrity. Through these cracks, allergens, microbes, and irritants enter and trigger chronic inflammation. The second component is immunological: in AD, the immune system is skewed toward a Th2 response. This is the "allergic" type of inflammation, driven by interleukins IL-4, IL-13, and IL-31 — the last of which directly activates itch-sensing nerve fibers in the skin. Dupilumab — the most effective modern drug for severe AD — works by blocking IL-4 and IL-13. An important clarification: atopic dermatitis is not an allergy to any specific substance. It is a constitutional immune trait against which allergens and irritants provoke flares. The Atopic March: Why AD Is Often Just the Beginning Atopic dermatitis rarely exists in isolation. In a significant proportion of children it is the first step in the atopic march — the sequential development of allergic diseases: 1. Atopic dermatitis — typically in the first months and years of life 2. Food allergy — the impaired skin barrier becomes a gateway for food allergen sensitization 3. Allergic rhinitis — in school-age children and adolescents 4. Bronchial asthma — in some patients by adolescence The earlier and more severe the AD, the higher the risk of subsequent steps. This is why early active treatment of AD is not merely a cosmetic goal — it is prevention of asthma. Symptoms of Atopic Dermatitis in Children and Adults The cardinal symptom is itch. In AD, itch is not a consequence of the rash — it is an independent pathological process: IL-31 directly activates cutaneous nerve endings. Scratching damages the barrier → more allergens penetrate → inflammation intensifies → itch worsens. This itch–scratch–inflammation cycle is the core of the disease. Lesion distribution depends on age: In infants and children under 2: cheeks, forehead, scalp, extensor surfaces of the limbs. Weeping eczema is characteristic. In children 2–12: flexural surfaces — antecubital and popliteal fossae, wrists, neck. Skin thickens and lichenification develops — a coarse skin texture from chronic scratching. In adolescents and adults: flexures, eyelids, perioral area, hands. Dryness and lichenification predominate over weeping. Three stages of the process: - Acute — oedema, erythema, vesicles, weeping, crusting - Subacute — erythema, scaling, papules - Chronic — lichenification, hyperpigmentation, dryness Atopic Dermatitis Triggers: What Provokes Flares Understanding triggers is the key to managing the disease. Triggers don't cause AD — they initiate flares in an already sensitized person. Aeroallergens: house dust mites are the main year-round trigger for most AD patients. Tree and grass pollen cause seasonal flares. Food allergens — relevant primarily in children under 5: cow's milk, hen's egg, peanut, wheat, soy. In adults, food triggers are far less common — see the food allergy article for the mechanism. Irritants: soaps and detergents with surfactants, synthetic fabrics, wool, sweat, chlorinated pool water, tobacco smoke, low indoor humidity in winter. Infections: Staphylococcus aureus colonizes the skin of 90% of AD patients and amplifies inflammation via superantigens. Herpes simplex virus can cause a severe disseminated form — eczema herpeticum (Kaposi's varicelliform eruption). Stress — through neuroinflammatory mechanisms, directly impairs skin barrier function and intensifies itch. Diagnosis: How Atopic Dermatitis Is Confirmed AD diagnosis is clinical: there is no specific blood test that unequivocally confirms it. Doctors apply the Hanifin-Rajka or UK Working Party diagnostic criteria (itch + characteristic morphology + typical distribution + chronic relapsing course + atopic personal or family history). That said, laboratory tests help assess severity, identify triggers, and exclude other conditions: Complete blood count — elevated eosinophils indirectly confirm atopic inflammation. Eosinophil normalization during treatment is one marker of therapeutic response. Total IgE — typically elevated in AD, especially in severe forms. However, normal IgE does not exclude the diagnosis. Specific IgE to allergens (mites, food, pollen) — identifies significant triggers and guides elimination measures or immunotherapy. Ferritin — iron deficiency independently intensifies skin itch, and when combined with atopy creates a compounding cycle. In persistent itch resistant to standard treatment, iron deficiency anaemia should be excluded. Treatment of Atopic Dermatitis: From Eczema Cream to Dupilumab Treatment follows a stepwise approach: therapy intensity matches disease severity. Basic Skin Care: Emollients Are the Foundation Emollients (moisturising and barrier-restoring products) are the cornerstone of treatment at any stage and any severity. Their role is to restore the skin's lipid barrier and retain moisture. Without regular emollient use, all other treatments will produce only temporary relief. The "soak and seal" rule: applying emollient within 3 minutes of bathing to still-damp skin is the most effective way to retain moisture. In a child with widespread AD, emollient use can reach up to 250 g per week. Step 1–2: Topical Anti-inflammatory Therapy Topical corticosteroids (TCS) — the standard for managing flares. Potency selection depends on location and age: low-potency on face and folds; mid- to high-potency on trunk and limbs in adults. Fear of TCS often leads to undertreatment and chronification — when used correctly, they are safe. Calcineurin inhibitors (tacrolimus, pimecrolimus) — TCS alternatives for sensitive areas (face, eyelids, folds) and for long-term maintenance. Do not cause skin atrophy. Step 3–4: Systemic Therapy Dupilumab — a monoclonal antibody blocking the IL-4/IL-13 receptor. A revolutionary treatment for moderate-to-severe AD: reduces itch and affected skin area in 60–70% of patients within 16 weeks. Approved from 6 months of age. JAK inhibitors (upadacitinib, abrocitinib) — oral alternatives to biologics for adults with severe AD. Ciclosporin, methotrexate, azathioprine — traditional immunosuppressants for severe forms when biological therapy is unavailable. Phototherapy (UVB 311 nm) — effective for widespread AD in adults; combines well with emollients. Trigger Control Measures to reduce dust mite load — allergen-impermeable covers for mattress and pillows, washing bedding at 60°C, keeping humidity below 50% — reduce flare frequency in most patients. For confirmed food sensitization in young children, an elimination diet under paediatric allergist supervision may be appropriate. When to Seek Urgent Medical Attention Immediately if: painful blisters spreading across AD-affected skin — possible eczema herpeticum (requires antiviral treatment); signs of bacterial infection (yellow crusting, purulent discharge, rising temperature); rapidly spreading facial and neck oedema. Routine dermatology or allergy referral: AD not controlled by basic therapy after 4–6 weeks; widespread skin involvement; recurrent skin infections; suspected food triggers in a child. Summary Atopic dermatitis is a chronic but manageable disease. Regular emollients restore the barrier, anti-inflammatory therapy resolves flares, trigger control reduces their frequency. In severe forms, biological therapy fundamentally changes quality of life. The key is not to "cure" but to build a daily care system and respond to flares promptly. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/autoimmune-hepatitis https://labreadai.com/en/posts/autoimmune-hepatitis Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Autoimmune hepatitis is liver inflammation caused by the immune system attacking its own cells. Symptoms, blood tests (ALT, AST, antibodies) and immunosuppressive treatment. Articles article Elevated ALT and AST with no viral hepatitis, no alcohol, and no toxic exposure — this is the classic presentation that frequently leads to a diagnosis of autoimmune hepatitis. In this disease, the immune system mistakenly attacks the body's own liver cells. It progresses slowly but, without treatment, inevitably leads to cirrhosis. The good news: when diagnosed in time, autoimmune hepatitis responds excellently to immunosuppressive therapy and remission is achievable in the vast majority of patients. What Autoimmune Hepatitis Is and Why It Develops Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease in which T-lymphocytes and autoantibodies attack hepatocytes, misidentifying them as foreign. The trigger mechanism is not fully understood: a genetic predisposition (HLA-DR3 and HLA-DR4 haplotypes) combined with an environmental trigger — viral infection, medications, or another immune stressor — is believed to initiate the disease. A defining characteristic of AIH is female predominance: 70–80% of patients are women. The disease can begin at any age but shows two incidence peaks: 10–30 years and after 40 (perimenopausal period). AIH is classified into two types based on the serological profile. Type 1 — the most common (80% of cases): antinuclear antibodies (ANA) and/or anti-smooth muscle antibodies (ASMA). Type 2 — less common, more frequent in children: anti-liver-kidney microsome type 1 antibodies (anti-LKM-1). Typing has no practical bearing on treatment selection but helps confirm the diagnosis. Symptoms of Autoimmune Hepatitis AIH is a master of disguise. Approximately one third of patients are diagnosed incidentally — during a routine biochemical check with no symptoms whatsoever. Symptoms of chronic disease (the most common presentation): - Fatigue and reduced work capacity — the most frequent complaint - Discomfort or heaviness in the right upper quadrant - Mild scleral icterus - Arthralgia — joint pain without overt inflammation - Acne and menstrual irregularities in women (related to hormonal changes secondary to liver disease) Acute onset — in 25–30% of patients: the picture resembles acute hepatitis with pronounced jaundice, dark urine, and pale stools. Occasionally it debuts as fulminant hepatic failure — rare but severe. Extra-hepatic manifestations — a hallmark of AIH: thyroiditis, rheumatoid arthritis, coeliac disease, inflammatory bowel disease. Their combination with elevated transaminases is a strong argument for an autoimmune aetiology. Diagnosis: Which Tests Confirm the Diagnosis AIH diagnosis is composite — established from a combination of biochemical, serological, and histological findings. The simplified IAIHG scoring system is used in practice. ALT and AST — hepatocyte injury markers. In AIH they are typically moderately or significantly elevated (2–10 times the upper limit of normal); extreme elevations, as in acute viral hepatitis, are less common. An AST/ALT ratio < 1 is typical of active inflammation; 2 suggests alcoholic liver disease. Gamma-globulins and IgG — AIH characteristically causes a substantial rise in serum immunoglobulin G (IgG): 2× the upper limit of normal. This is one of the key diagnostic criteria. Total protein may be normal or elevated. Bilirubin — elevated with active inflammation and decompensation. Normal bilirubin does not exclude active AIH. Albumin and prothrombin time — markers of hepatic synthetic function. Falling albumin and prolonged PT indicate advanced disease or acute decompensation. GGT and ALP — mildly elevated in AIH. A markedly elevated ALP alongside only moderately raised transaminases points more toward primary biliary cholangitis or primary sclerosing cholangitis — important differential diagnoses. CRP — typically mildly elevated or normal in AIH. A very high CRP suggests a bacterial complication rather than autoimmune disease activity. Autoantibodies — the serological cornerstone: - ANA (antinuclear antibodies) — positive in type 1 AIH - ASMA (anti-smooth muscle antibodies) — more specific than ANA for type 1 - Anti-LKM-1 — the type 2 AIH marker - Anti-SLA/LP (anti-soluble liver antigen) — highly specific for AIH Liver biopsy — required for definitive diagnosis and fibrosis staging. The characteristic histological pattern: interface hepatitis (periportal hepatitis) with plasma cell infiltrates. Elastography (FibroScan) is a less invasive alternative for fibrosis monitoring. Comprehensive liver assessment uses the liver function panel — the mandatory starting point for any suspected liver disease. Differential Diagnosis: What Must Be Excluded Before diagnosing AIH, other causes of chronic hepatitis must be ruled out: viral hepatitis B and C, alcoholic hepatitis, non-alcoholic steatohepatitis, drug-induced liver injury (DILI), Wilson's disease, and haemochromatosis. Distinguishing AIH from DILI is particularly important — they are clinically identical, but management differs fundamentally. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) can coexist with AIH — this is called "variant syndrome" or "overlap syndrome" and requires a specific therapeutic approach. Treatment of Autoimmune Hepatitis AIH responds well to immunosuppressive therapy — it is one of the few chronic liver diseases where medical treatment fundamentally changes the prognosis. First line — prednisolone + azathioprine: - Prednisolone 40–60 mg/day initially, tapered to a maintenance dose of 5–10 mg/day - Azathioprine 50–150 mg/day is added after 2 weeks to allow steroid dose reduction and maintain remission - Goal: normalisation of ALT, AST and IgG + histological remission Alternative agents for intolerance or inadequate response: budesonide (fewer systemic side effects, but only when cirrhosis is absent), mycophenolate mofetil, tacrolimus. Duration of treatment — minimum 2–3 years, in most cases lifelong: after withdrawal, relapse occurs in 80% of patients within 3 years. Liver transplantation — for decompensated cirrhosis or fulminant hepatic failure not responding to therapy. AIH can recur in the transplanted organ. Connection with Other Autoimmune Diseases AIH rarely exists in isolation. In 30–40% of patients, other autoimmune diseases are found simultaneously: Hashimoto's thyroiditis is the most common co-diagnosis, followed by rheumatoid arthritis and inflammatory bowel disease. This means that at the time of AIH diagnosis, thyroid function should be checked and screening for other autoimmune conditions considered. When to Seek Urgent Medical Attention Call emergency services or go to hospital immediately for: worsening jaundice with dark urine and pale stools; ascites — abdominal distension and dyspnoea; confusion or encephalopathy; sudden deterioration in a known AIH patient in the context of infection. See a hepatologist or gastroenterologist within 1–2 weeks for: ALT and AST elevated 3–5 times the upper limit of normal without an obvious cause; elevated IgG combined with abnormal transaminases; positive ANA or ASMA on routine testing. This article is for informational purposes only. Diagnosis and treatment of autoimmune hepatitis are carried out by a hepatologist or gastroenterologist. https://labreadai.com/en/posts/autoimmune-thyroiditis https://labreadai.com/en/posts/autoimmune-thyroiditis Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hashimoto's thyroiditis is the most common cause of hypothyroidism. Symptoms, lab tests (TSH, antibodies, ultrasound), hashitoxicosis phase and current treatment approaches. Articles article The thyroid gland rarely hurts — but it can be destroyed silently, over years. Hashimoto's thyroiditis is the most common thyroid disorder and the leading cause of hypothyroidism worldwide: it affects hundreds of millions of people, the vast majority of them women. The condition's insidious nature is that for many years the person may feel relatively well — until the gland exhausts its functional reserve. What Hashimoto's Thyroiditis Is and Why It Develops Autoimmune thyroiditis (Hashimoto's disease) is a chronic inflammatory disease of the thyroid gland in which the body's own immune system mistakenly attacks thyroid tissue. Immune cells — lymphocytes — infiltrate the gland, progressively destroying the follicles that produce thyroid hormones. The disease is named after Japanese surgeon Hakaru Hashimoto, who in 1912 first described the characteristic tissue changes. It was the first condition ever identified as autoimmune. Causes and risk factors: the precise trigger of the autoimmune attack is not fully understood. Key contributing factors include: - Genetics — hereditary predisposition accounts for 70–80% of risk; family history of thyroid or other autoimmune diseases is common - Sex — women are affected 7–10 times more often than men, pointing to estrogen's role in immune regulation - Iodine — excessive iodine intake in populations previously deficient in it is associated with increased Hashimoto's incidence - Viral infections — some viruses (Epstein-Barr, cytomegalovirus) are thought to trigger autoimmunity through molecular mimicry - Stress and pregnancy — periods of hormonal change can provoke or accelerate the condition - Other autoimmune diseases — Hashimoto's co-occurs with type 1 diabetes, rheumatoid arthritis, and SLE far more often than chance would predict How the Disease Progresses: Three Phases of Hashimoto's Hashimoto's is a slowly progressive disease unfolding across years or decades through three general phases. Euthyroid phase: the immune attack is already underway and antibodies are detectable in the blood — but thyroid function remains intact. TSH and free T4 are normal. The person feels nothing unusual. This phase is most often discovered incidentally during a preventive ultrasound or antibody screen. Subclinical hypothyroidism phase: the gland gradually loses functional capacity. The pituitary "senses" falling hormone levels and increases stimulation — TSH begins rising above normal while T4 and free T3 remain within range. Symptoms may be mild or absent. Overt hypothyroidism phase: functional reserve is exhausted. Free T4 falls below normal; TSH is markedly elevated. Clear symptoms emerge — fatigue, cold intolerance, weight gain, constipation, slowed thinking, facial puffiness, bradycardia. For a detailed account of this stage, see Hypothyroidism. Hashitoxicosis: When Hashimoto's Mimics Hyperthyroidism One of the least recognised but clinically important aspects of Hashimoto's is the hashitoxicosis phase. In the early stages of the disease, mass follicle destruction releases large amounts of pre-formed thyroid hormone into the blood. The result is a transient thyrotoxicosis clinically indistinguishable from true hyperthyroidism: palpitations, anxiety, weight loss, sweating, insomnia. The critical distinction from Graves' disease: hashitoxicosis is self-limiting. Within weeks to months, the hormone stores in destroyed follicles are depleted and thyrotoxicosis gives way to normal function or hypothyroidism. Prescribing antithyroid drugs for hashitoxicosis is an error — they are unnecessary and may accelerate the onset of hypothyroidism. Laboratory pattern: TSH suppressed, elevated T4 and T3, strongly positive anti-TPO antibodies. In Graves' disease: positive TSH receptor antibodies (TRAb) are the distinguishing feature. Diagnosis: Which Tests Are Needed for Suspected Hashimoto's The diagnosis of Hashimoto's rests on three criteria in combination: 1. Laboratory markers: A comprehensive thyroid panel includes: - TSH — the primary functional marker: elevated in hypothyroidism, suppressed in hashitoxicosis, normal in the euthyroid phase - Free T4 — assesses actual hormonal activity - Free T3 — important in atypical TSH/T4 patterns - Anti-thyroid peroxidase antibodies (anti-TPO) — the primary immunological marker: elevated in 90–95% of patients. Normal is generally < 35 IU/mL (varies by laboratory) - Anti-thyroglobulin antibodies (anti-TG) — supplementary marker, elevated in 60–70% Important: elevated antibodies alone are not an indication for treatment. They mark the autoimmune process but not its activity. Treatment is initiated for impaired thyroid function (elevated TSH), not for antibody positivity. 2. Thyroid ultrasound: The characteristic Hashimoto's pattern: diffusely reduced echogenicity ("dark" gland), heterogeneous texture, pseudonodularity. In advanced disease — volume reduction (atrophy). 3. Clinical presentation: Symptoms of hypothyroidism or hyperthyroidism in the context of laboratory and ultrasound findings. Symptoms of Hashimoto's: From Silent Carrier to Overt Hypothyroidism Most patients with Hashimoto's in the euthyroid phase have no specific symptoms. However, some report non-specific complaints even with normal TSH — fatigue, brain fog, dry skin, hair loss. Their relationship to autoimmune inflammation is actively studied but not fully explained. As the condition transitions to hypothyroidism, symptoms become distinct: chronic fatigue, cold intolerance, weight gain, constipation, slowed speech and cognition, facial puffiness, bradycardia, reduced libido. In women — menstrual irregularities; in pregnancy — elevated risk of miscarriage. Some patients experience mild neck discomfort — not true pain but a sense of pressure or fullness. Significant tenderness of the gland is atypical for Hashimoto's and warrants exclusion of de Quervain's (subacute) thyroiditis. Treatment of Autoimmune Thyroiditis There is no specific treatment targeting the autoimmune process itself. The goal of therapy is correcting hypothyroidism when it develops. Levothyroxine replacement therapy: Indicated for overt hypothyroidism (TSH 10 mIU/L) and for subclinical hypothyroidism with TSH of 4–10 mIU/L when symptoms are present, during pregnancy, or when pregnancy is planned. The medication is taken lifelong; the dose is titrated to a target TSH of 0.5–2.5 mIU/L for most patients. For hashitoxicosis: symptomatic treatment (beta-blockers for heart rate control) and watchful waiting. Antithyroid drugs are not indicated. For euthyroid Hashimoto's: active surveillance — TSH monitoring every 6–12 months. Reducing anti-TPO antibody levels is not a treatment goal — antibody titres are not a therapeutic target. Lifestyle measures: adequate sleep, stress management, weight normalisation. The role of selenium in reducing disease activity is under investigation — some studies show modest anti-TPO reduction at 200 mcg/day, but evidence is insufficient for routine prescription. Prognosis: with timely hypothyroidism correction, quality of life is equivalent to the general population. The risk of malignant transformation is minimal. Pregnancy is possible with well-controlled Hashimoto's — with strict TSH monitoring (target < 2.5 mIU/L in the first trimester). When to Seek Urgent Medical Attention - Rapidly worsening thyrotoxicosis symptoms (resting heart rate 100 bpm, marked tremor, weight loss) — rule out hashitoxicosis or Graves' disease; urgent endocrinology consultation. - TSH 10 mIU/L at first detection — routine consultation within 1–2 weeks to discuss treatment initiation. - Pregnancy or planning pregnancy with known Hashimoto's — mandatory TSH correction before conception; target < 2.5 mIU/L. - Rapid thyroid enlargement with pain — rule out subacute thyroiditis or, rarely, thyroid lymphoma. This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/posts/deep-vein-thrombosis https://labreadai.com/en/posts/deep-vein-thrombosis Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Deep vein thrombosis can lead to pulmonary embolism if untreated. Learn the symptoms, the role of D-dimer and ultrasound in diagnosis, anticoagulant therapy options and prevention. Articles article A swollen, painful leg after a long flight or bed rest — symptoms that are easy to write off as fatigue or a pulled muscle. Yet deep vein thrombosis is a condition that, without treatment, can progress to pulmonary embolism: a potentially fatal complication. Let's break down how to recognize it, which tests confirm the diagnosis, and how DVT is treated. What Is Deep Vein Thrombosis Deep vein thrombosis (DVT) is the formation of a blood clot in the deep veins — most often in the lower limbs: the calf, thigh, or pelvis. The clot partially or fully blocks venous return. The main danger is clot detachment and migration to the pulmonary arteries. This is pulmonary embolism (PE) — one of the leading preventable causes of in-hospital death. DVT and PE together make up venous thromboembolism (VTE). Causes and Risk Factors Virchow's triad describes three conditions for clot formation: slowed blood flow, vessel wall damage, and increased blood coagulability. In practice risk factors often combine. Triggering factors: prolonged immobility (bed rest after surgery or trauma, long flights over 4–6 hours); surgical procedures — especially joint replacement and pelvic surgery; cancer — tumors release procoagulants; pregnancy and the postpartum period; oral contraceptives and hormone replacement therapy. Background factors: thrombophilia (factor V Leiden mutation, protein C or S deficiency); elevated homocysteine — one of the key acquired prothrombotic factors that damages vascular endothelium and activates coagulation; varicose veins; heart failure; obesity; age over 60. Symptoms of DVT The danger of DVT is that nearly half of cases are asymptomatic. The clot is found incidentally or after PE develops. When symptoms are present, they are typically unilateral — an important clue: - Swelling of one limb — from calf to thigh depending on clot level - Pain and heaviness in the affected limb, worsening with walking - Redness and local warmth over the clotted vein - Homan's sign (calf pain on dorsiflexion of the foot) — low specificity, but should prompt investigation Bilateral leg swelling is not typical for DVT — it more often points to heart or kidney failure. Diagnosis: D-Dimer and Ultrasound DVT diagnosis begins with clinical probability assessment using the Wells score, followed by lab testing. D-Dimer — Screening Test D-dimer is a fibrin degradation product released when a clot dissolves. It is elevated in thrombosis. The test's main value is a negative result: a normal D-dimer with low clinical probability virtually rules out DVT and PE, making further investigation unnecessary. Key limitation: D-dimer rises with any inflammation, pregnancy, surgery, or cancer. A positive result alone does not confirm thrombosis — it requires further workup. Compression Vein Ultrasound — Confirmatory Test Compression ultrasonography of the leg veins is the diagnostic standard for DVT. The sign of thrombosis: the vein does not compress under probe pressure. Sensitivity for proximal thrombosis (femoral, popliteal veins) exceeds 95%. Coagulation Test A coagulation panel evaluates the clotting system overall and is needed before starting anticoagulants: INR, aPTT, prothrombin time. Test Role ------ D-dimer Screening: ruling out DVT at low probability Vein ultrasound Diagnosis confirmation Coagulation test Baseline clotting status before treatment Treatment of Deep Vein Thrombosis The goal is to prevent clot extension, PE, and recurrence. The foundation is anticoagulant therapy. Direct oral anticoagulants (DOACs) — apixaban, rivaroxaban — are now the first-line standard. No routine lab monitoring required. Contraindicated in severe renal failure. Warfarin — requires regular INR monitoring (target 2.0–3.0). More complex to manage but essential in certain situations (mechanical heart valves, severe CKD). Low molecular weight heparins — preferred in cancer, pregnancy. Duration: provoked DVT (post-surgery, trauma) — 3 months. Unprovoked — 6 months or more; recurrent or thrombophilia-related — indefinite. Elastic compression stockings reduce swelling, pain, and the risk of post-thrombotic syndrome — chronic venous insufficiency that develops in some patients after DVT. Prevention of DVT Prevention is especially important during high-risk periods: DOACs or LMWH are mandatory after joint replacement surgery; early mobilization, calf exercises, and compression stockings for prolonged immobility; for long flights — get up every 1–2 hours, stay hydrated, avoid alcohol. When to Seek Urgent Medical Attention Call emergency services immediately if leg swelling is accompanied by: sudden breathlessness or chest pain; coughing up blood; sudden drop in blood pressure, rapid pulse, loss of consciousness — these are signs of PE requiring emergency care. See a doctor within hours for: new asymmetric leg swelling, especially after surgery, trauma, or prolonged immobility. Summary DVT responds well to treatment when diagnosed early. A normal D-dimer with low clinical probability virtually rules out the diagnosis. A swollen leg after surgery or a long flight is a reason to see a doctor immediately — not something to wait out. This article is for informational purposes only. Interpretation of test results and treatment decisions are the responsibility of a physician. https://labreadai.com/en/posts/euthyroid-sick-syndrome https://labreadai.com/en/posts/euthyroid-sick-syndrome Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Euthyroid sick syndrome is low T3 in severe illness without thyroid disease. Mechanism, laboratory pattern, distinction from hypothyroidism and the correct clinical approach. Articles article A critically ill patient in the ICU: labs show low T3, normal TSH, and normal or slightly reduced T4. Hypothyroidism? — No. This is euthyroid sick syndrome — an adaptive response to systemic stress in which the thyroid gland is healthy and the changes in thyroid hormones reflect the underlying disease. Prescribing levothyroxine in this setting is a mistake. Understanding the mechanism is essential. What Euthyroid Sick Syndrome Is Euthyroid sick syndrome (ESS), also called non-thyroidal illness syndrome (NTI) or low T3 syndrome, is a complex of changes in thyroid hormone levels that develops in severe systemic illness without primary thyroid pathology. The term "euthyroid" is central: the gland itself is functioning normally, but the hormonal profile is altered. ESS occurs in 40–70% of ICU patients and in severe chronic disease. The degree of T3 reduction correlates with disease severity — and is an independent predictor of adverse outcomes. Mechanism: Why T3 Falls ESS is driven by impaired peripheral conversion of T4 to T3. In health, most circulating T3 is produced not by the thyroid gland itself but in peripheral tissues — primarily the liver, kidneys, and muscle — through deiodination of T4 by deiodinase enzymes. In severe illness, this process is disrupted at several levels: 1. Reduced type 1 deiodinase (D1) activity: D1 is the primary enzyme for peripheral T4→T3 conversion. In systemic inflammation, starvation, and critical illness, its activity falls sharply. Result: T4 is not converted to active T3. 2. Alternative T4 metabolism: instead of generating T3, T4 is converted to reverse T3 (rT3) — a biologically inert isomer. rT3 has no hormonal activity and competitively blocks T3 receptors. In ESS, rT3 is markedly elevated. 3. Role of cytokines: interleukin-1, interleukin-6, and TNF-α — inflammatory mediators — directly suppress intracellular T4 transport, thyroid hormone synthesis, and T3 receptor expression. 4. Altered protein binding: acute inflammation reduces thyroxine-binding globulin levels → bound T4 falls while free T4 is preserved — an important interpretive nuance. Teleological hypothesis: the fall in T3 during illness is not pathological but adaptive. T3 is the primary driver of catabolism: it accelerates energy expenditure and stimulates protein breakdown. In severe disease, reduced T3 → lower metabolic demands → conservation of energy resources for survival. This is an evolutionarily advantageous response, analogous to hibernation. Laboratory Pattern of ESS Changes in thyroid hormones in ESS evolve through phases depending on severity and duration. Mild phase (early): - Free T3 — reduced - Free T4 — normal or slightly elevated - TSH — normal - rT3 — elevated Severe phase: - Free T3 — markedly reduced - Free T4 — reduced (an adverse prognostic sign) - TSH — normal or slightly suppressed (transiently rises in the recovery phase) - rT3 — markedly elevated Recovery phase: - TSH transiently rises (the pituitary "re-engages" regulation) - T3 gradually normalises - Full recovery takes days to weeks Key diagnostic pattern: low T3 + normal or slightly low TSH + clinical context of severe illness = ESS, not hypothyroidism. How to Distinguish ESS from True Hypothyroidism This distinction is critical, as it determines management. Feature ESS Hypothyroidism --------- TSH Normal or slightly low Markedly elevated Free T4 Normal or slightly low Reduced Free T3 Markedly reduced Reduced Reverse T3 Markedly elevated Normal Clinical context Severe systemic disease Absent or subclinical Anti-TPO antibodies Negative May be positive (in Hashimoto's) Normalisation after recovery Yes No (requires therapy) The primary differentiating feature is TSH. In true primary hypothyroidism, TSH is markedly elevated. In ESS, TSH is normal or slightly suppressed (due to cytokine inhibition of the hypothalamic-pituitary axis). Exception: central hypothyroidism (pituitary or hypothalamic pathology) also presents with low TSH and low T4/T3. Additional workup is required in that case (other pituitary hormones, MRI). Causes of Euthyroid Sick Syndrome ESS develops in any severe systemic stress: Acute conditions: - Sepsis and septic shock — the most common ICU cause - Myocardial infarction - Acute kidney injury - Major trauma and burns - Major surgical procedures - Stroke Chronic diseases: - Chronic kidney disease — impaired D1 activity in uraemia - Liver cirrhosis — the liver is the primary organ of T4→T3 conversion - Malignancies - Chronic heart failure - HIV infection Metabolic stressors: - Starvation — the classic ESS model - Anorexia nervosa - Prolonged very-low-calorie diets Medications: - Amiodarone — a potent D1 and D2 inhibitor; produces a characteristic pattern: high T4, low T3, high rT3 with normal TSH - High-dose glucocorticoids - Dopamine and dobutamine — suppress TSH Should ESS Be Treated? This question has been debated, but the current consensus is clear: ESS is not treated with thyroid hormone replacement. Arguments against treatment: - ESS is an adaptive response, not a hormone deficiency - Randomised controlled trials of T3 or T4 supplementation in ESS have not shown improved survival - Administering T3 to critically ill patients increases catabolism → potentially worsens prognosis - Normalisation of T3 after recovery confirms the transient, adaptive nature of the changes The correct approach: - Treat the underlying disease — the only path to hormonal normalisation - Do not prescribe thyroid hormones without clear evidence of primary hypothyroidism (markedly elevated TSH) - Repeat thyroid function tests after recovery (6–8 weeks) — to exclude true hypothyroidism When treatment may be considered: cardiac surgery with cardiopulmonary bypass — a distinct research area with a specific hormonal profile. Clinical Significance The T3 level in ESS is an independent predictor of ICU survival. The lower the T3, the worse the prognosis. This does not mean T3 should be artificially raised — it means that low T3 reflects the severity of the underlying disease. The key clinical lesson: do not interpret thyroid hormones in severely ill patients as evidence of primary thyroid disease. Initiating replacement therapy in this setting is a common error. This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/posts/first-signs-of-pregnancy https://labreadai.com/en/posts/first-signs-of-pregnancy Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) First signs of pregnancy can appear before a missed period. Learn week-by-week symptoms, how pregnancy tests work, the role of hCG and which blood tests to take after confirmation. Articles article Many women notice changes in how they feel before a home test shows two lines. This is not a coincidence: hormonal changes begin immediately after fertilisation, and hCG — the hormone pregnancy tests detect — starts rising before a missed period. Let's look at which symptoms appear first, how to correctly interpret a test, and what to do immediately after confirming pregnancy. What Happens in the First Days After Fertilisation After fertilisation, the egg travels through the fallopian tube for 6–12 days before implanting in the endometrium. From the moment of implantation, trophoblast cells (the future placenta) begin producing human chorionic gonadotropin (hCG). This hormone maintains the corpus luteum, which continues producing progesterone and estradiol — preventing the endometrium from shedding. hCG is detectable in blood as early as 8–10 days after ovulation — roughly 4–5 days before the expected period. Urinary hCG concentration rises slightly more slowly. This is why a home test may be negative 2–3 days before a missed period — and positive on the day of the missed period or shortly after. First Pregnancy Symptoms: When They Appear Pregnancy symptoms are highly individual: some women notice changes as early as 1–2 weeks after conception; others only after a missed period. Most early signs are non-specific and overlap with premenstrual syndrome — which makes them difficult to distinguish before a test. 1–2 weeks after conception (weeks 3–4 gestational age) Implantation bleeding — light spotting, pink or brownish, appearing 6–12 days after fertilisation. Lasts 1–2 days, much lighter than a period. Many women mistake it for the start of their period and are surprised when their period "doesn't come." Key difference from threatened miscarriage: implantation bleeding occurs before the missed period, is scant, and is painless with no progression. Breast tenderness — one of the earliest changes. The breasts become sensitive and heavy, nipples painful. Caused by rapid rises in progesterone and estradiol. Similar to PMS but more pronounced and does not resolve with the start of a period. Mild fatigue — increasing tiredness, drowsiness even after a full night's sleep. Progesterone has a sedative effect on the central nervous system. Basal body temperature stays elevated — for women charting BBT: temperature remains above 37°C after ovulation and does not fall before the expected period. 3–4 weeks after conception (weeks 5–6 gestational age) Nausea — occurs in 70–80% of pregnant women, typically from weeks 4–6. Despite the name "morning sickness," it can strike at any time of day. The mechanism involves rapidly rising hCG and estrogens acting on chemoreceptors in the vomiting centre. It peaks around weeks 8–10 and resolves for most women by the end of the first trimester. Changes in smell and taste — heightened sensitivity to odours, aversion to previously liked foods or smells (often coffee, meat, cigarette smoke), unusual food cravings. Caused by rising estrogen levels. Frequent urination — increasing blood volume and rising hCG stimulate the kidneys to work harder. The growing uterus also presses on the bladder — more relevant at later stages, but begins early in some women. Bloating and constipation — progesterone relaxes smooth muscle throughout the gut, slowing peristalsis. Mood swings — rapid hormonal fluctuations affect serotonin and dopamine synthesis. How a Pregnancy Test Works Home pregnancy tests detect hCG in urine. Most tests have a sensitivity of 20–25 mIU/mL. Urinary hCG reaches this threshold roughly on the day of the missed period or 1–2 days later. When to test: - The most reliable time is the first day of a missed period or later - Morning urine is preferred — hCG concentration is at its peak - "Early" tests with 10 mIU/mL sensitivity can be used 4–5 days before the expected period, but the false-negative rate is higher - A negative test with a 1–2-day delay — repeat in 2–3 days Why a test can be wrong: - Testing too early (hCG has not yet reached the threshold) - Diluted urine (heavy fluid intake beforehand) - Rarely: biochemical pregnancy (fertilisation occurred but implantation did not complete — hCG briefly rises then falls) Blood hCG: Quantitative Testing A laboratory blood test for β-hCG is more sensitive than a home test — it detects hCG from 2–5 mIU/mL. This allows pregnancy confirmation 7–10 days after conception — earlier than any home test. Normal hCG dynamics in pregnancy: Gestational age hCG (mIU/mL) ------ Weeks 3–4 16–156 Weeks 4–5 101–4870 Weeks 5–6 1110–31500 Weeks 6–7 11500–289000 Peak (weeks 8–12) 25700–288000 The doubling rule: in a normal pregnancy, hCG doubles every 48–72 hours in the first 8–10 weeks. The trend matters far more than the absolute value: hCG 500 mIU/mL alone tells you nothing — what matters is whether it doubled 48 hours later. Failure to double may indicate a missed miscarriage or ectopic pregnancy. Ectopic pregnancy: hCG rises but more slowly than normal, often combined with abdominal pain and spotting. Requires urgent evaluation. Blood Tests to Take After Confirming Pregnancy First visit to an obstetrician-gynaecologist — ideally before weeks 8–10. Standard first-trimester screening includes: Complete blood count — assessing haemoglobin and ruling out anaemia. For pregnancy-specific norms, see the CBC in pregnancy article. Ferritin — iron store assessment. Ferritin falls before haemoglobin — early correction is critical, especially if breastfeeding is planned. TSH — thyroid function. Untreated hypothyroidism during pregnancy poses serious risks to fetal brain development. First-trimester target: below 2.5 mIU/L. Fasting glucose — screening for pre-existing diabetes. Gestational diabetes is diagnosed later (weeks 24–28), but the baseline glucose level is important for risk stratification. Vitamin D — deficiency is common and affects fetal bone formation, immunity, and preeclampsia risk. Folic acid — ideally started before conception; essential throughout the first trimester. Reduces neural tube defect risk. Standard dose: 400–800 µg/day; high-risk patients: 4 mg/day as prescribed. When to Seek Urgent Medical Attention Immediately: heavy bleeding (heavier than a period) at any stage; sudden severe abdominal or shoulder pain — possible ectopic pregnancy; hCG rising but not doubling on repeat testing with pain or spotting. Within a few days: positive test with more than 5–7 days of missed period — register with an obstetric provider; positive test with unusually severe symptoms (inability to eat or drink from vomiting — hyperemesis gravidarum). Summary The first signs of pregnancy — fatigue, breast tenderness, nausea, and implantation bleeding — can appear before a missed period. A home test is most reliable on the first day of a missed period or later. Laboratory β-hCG is more sensitive and earlier: what matters is not the absolute value but the doubling trend. After confirming pregnancy, the key tests — ferritin, TSH, glucose, and vitamin D — allow deficiencies to be corrected at the most critical time. This article is for informational purposes only. If pregnancy is suspected or any concerning symptoms arise, consultation with an obstetrician-gynaecologist is essential. https://labreadai.com/en/posts/folic-acid https://labreadai.com/en/posts/folic-acid Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Folic acid is critical in pregnancy but important for everyone. The role of folate in the body, normal blood values, deficiency symptoms, link with B12 and MTHFR polymorphism. Articles article Folic acid is often seen as a "pregnancy vitamin" — taken only during that period. Yet folate deficiency affects 10–15% of adults in developed countries, causes macrocytic anaemia, raises homocysteine, and impairs immune function. Let's look at why folate matters for everyone — not just pregnant women — how folate differs from folic acid, and what MTHFR means. Folate vs Folic Acid: What Is the Difference These two terms are often used interchangeably, but they are not the same. Folate is the general name for a group of naturally occurring vitamin B9 compounds found in food: leafy greens, legumes, liver, avocado. The primary biologically active form inside cells is 5-methyltetrahydrofolate (5-MTHF). Folic acid is the synthetic form of vitamin B9 used in supplements and fortified foods. It is not active itself: it must undergo several enzymatic conversions in the body before becoming the active form. The key enzyme in this conversion is MTHFR (methylenetetrahydrofolate reductase). Certain MTHFR gene variants reduce this conversion efficiency by 30–70%. What Folate Does: Key Functions DNA synthesis and cell division. Folate is a cofactor in nucleotide synthesis (thymidine). Without it, cells cannot divide normally. The most vulnerable are rapidly dividing cells: haematopoietic cells, intestinal epithelium, and embryonic cells. Methylation. Folate (as 5-MTHF) donates a methyl group to convert homocysteine to methionine. This reaction cannot proceed without vitamin B12 — it is a required cofactor. Folate or B12 deficiency leads to homocysteine accumulation. Hyperhomocysteinaemia is an independent risk factor for atherosclerosis, stroke, and thrombosis. Neural tube formation. The neural tube — the precursor of the spinal cord and brain — closes on day 21–28 after conception. This happens before most women know they are pregnant. Folate deficiency during this window critically raises the risk of neural tube defects: spina bifida and anencephaly. This is why folate must be taken before conception, not from the first antenatal visit. Spermatogenesis. In men, folate is involved in sperm DNA synthesis. Deficiency is associated with higher rates of chromosomal abnormalities in sperm. Normal Folate Blood Levels Group Normal (nmol/L) Normal (ng/mL) --------- Adults 7–45 nmol/L 3–20 ng/mL Pregnancy (target) 13.5 nmol/L 6 ng/mL Reference ranges vary between laboratories. Red blood cell (RBC) folate is a more reliable indicator of long-term status than serum folate, which reflects only recent intake. Symptoms and Signs of Folate Deficiency Macrocytic anaemia — the main clinical manifestation. Without folate, red cell precursors cannot divide normally: they grow but cannot split, becoming larger than normal. The complete blood count shows elevated MCV above 100 fL and reduced haemoglobin. This picture is identical to B12 deficiency anaemia — which is why both must always be checked together in macrocytosis. Neurological symptoms — here lies an important distinction from B12 deficiency. With isolated folate deficiency, neurological involvement is usually absent or minimal. With B12 deficiency — subacute spinal cord degeneration, neuropathy, and cognitive impairment occur. This is critically important: giving folic acid when B12 deficiency is unrecognised normalises the anaemia but does not stop neurological progression — masking the problem. Other symptoms: tongue inflammation (glossitis), mouth ulcers, impaired intestinal epithelial turnover (diarrhoea, malabsorption), depression and cognitive changes with prolonged deficiency, elevated homocysteine. Causes of Folate Deficiency Insufficient dietary intake — the most common cause. A diet low in leafy vegetables, legumes, and fresh produce. Alcoholism — folate absorption is impaired with chronic alcohol use. Impaired absorption — coeliac disease, inflammatory bowel disease, small bowel surgery. Increased demand — pregnancy, breastfeeding, rapid growth in children, haemolytic anaemias (accelerated red cell turnover). Drug interactions — methotrexate (blocks dihydrofolate reductase), trimethoprim, carbamazepine, and valproic acid reduce folate absorption or metabolism. MTHFR polymorphism — a genetic variant reducing conversion efficiency of synthetic folic acid. Not a disease, but a risk factor when intake is borderline. MTHFR Polymorphism: What to Know The MTHFR gene encodes the enzyme that converts synthetic folic acid into the active form 5-MTHF. The most common variants are C677T (heterozygote in 40% of the population, homozygote in 10%) and A1298C. In homozygous C677T, enzyme efficiency falls to 30–70%. This does not mean inevitable deficiency — most people with adequate dietary folate compensate for the polymorphism. But with insufficient intake or increased demand (pregnancy), deficiency risk is higher. Practically important: with MTHFR polymorphism, methylfolate (5-MTHF) is preferred over regular folic acid — it is already the active form and requires no enzymatic conversion. Many modern supplements contain it. Routine MTHFR testing is not recommended as a general screen — it is indicated for recurrent miscarriage, habitual pregnancy loss, or thrombosis at a young age. Dosage and How to Take Folic Acid Situation Recommended dose ------ Adults (maintenance) 400 µg/day Pregnancy planning 400–800 µg/day (start 3 months before conception) Pregnancy 400–800 µg/day High risk (MTHFR, previous neural tube defect) 4–5 mg/day — by prescription only Treatment of deficiency 1–5 mg/day as a course Folic acid can be taken regardless of meals. Toxicity at high doses in healthy people is essentially not described — unlike fat-soluble vitamins. Folate and Vitamin B12: An Inseparable Pair This link cannot be ignored. Folate and vitamin B12 operate in the same metabolic pathway. Deficiency of one impairs function of both. The main risk: giving high-dose folic acid when unrecognised B12 deficiency is present normalises the blood picture (anaemia resolves) but does not stop or slow neurological damage — masking the underlying problem. This is why macrocytosis always requires both markers to be checked before treatment begins. Hypothyroidism can also impair folate absorption through intestinal involvement — another reason to check TSH when investigating macrocytic anaemia. Dietary Sources of Folate Richest in folate: dark leafy greens (spinach, broccoli, romaine lettuce), legumes (lentils, chickpeas, beans), chicken and beef liver, avocado, asparagus, eggs. Important: folate is destroyed by prolonged heat — boiled spinach contains roughly half the folate of fresh spinach. Fortified grain products (bread, cereals) are a good folic acid source in countries with fortification programmes. When to See a Doctor Routine consultation: when planning pregnancy — discuss dosing considering MTHFR status; with macrocytic anaemia — always exclude B12 deficiency before starting treatment; with recurrent miscarriage or thrombosis at a young age. Summary Folic acid is not just a "pregnancy vitamin." It is critical for DNA synthesis, immune function, and cardiovascular risk reduction through homocysteine lowering. In pregnancy, supplementation should begin 3 months before conception — the neural tube closes before most women know they are pregnant. When MCV is elevated in a complete blood count, folate and vitamin B12 are always checked together — starting folate blindly is risky. This article is for informational purposes only. Dosing decisions and deficiency treatment are the responsibility of a physician. https://labreadai.com/en/posts/gallstone-disease https://labreadai.com/en/posts/gallstone-disease Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Gallstone disease is the formation of stones in the gallbladder and bile ducts. Causes, biliary colic symptoms, complications (cholecystitis, cholangitis, jaundice) and treatment. Articles article One in ten adults carries gallstones — and most have no idea. Gallstone disease can remain silent for decades, then without warning produce severe right upper quadrant pain in the middle of the night after a fatty dinner. Knowing how to recognise biliary colic, distinguish it from appendicitis, and understand when watchful waiting is appropriate versus when surgery is needed. What Gallstone Disease Is and How Stones Form Gallstone disease (cholelithiasis) is the formation of concretions (stones) in the gallbladder and bile ducts. Bile is a complex fluid: it holds cholesterol, bile acids, phospholipids, bilirubin, and mineral salts in solution. While all components remain in proper balance, bile stays liquid. When that balance is disrupted, crystallisation begins. Types of stones: Cholesterol stones (80–90% in Western countries) — form when bile is supersaturated with cholesterol. Yellowish-white, often solitary and large. Risk factors: obesity, rapid weight loss, pregnancy, female sex, oestrogen use, age 40, sedentary lifestyle. Pigment stones (10–20%) — formed from insoluble calcium-bilirubin salts. Black stones (in haemolysis, cirrhosis, Crohn's disease) and brown stones (in chronic biliary infection). In haemolytic anaemia, persistently elevated indirect bilirubin is a classic driver of pigment stone formation. The "4 F" rule (Fat, Female, Forty, Fertile) — a classic mnemonic for risk factors, though gallstones occur in all groups. Symptoms: From Silent Stones to Biliary Colic Asymptomatic cholelithiasis — the most common presentation: 70–80% of people with gallstones never experience symptoms. Stones are found incidentally on ultrasound. The risk of developing symptoms is approximately 2% per year. Biliary colic — acute episodic pain occurring when a stone temporarily obstructs the gallbladder outlet (neck or cystic duct). Pain characteristics: - Location: right upper quadrant or epigastrium - Radiation: to the right shoulder, scapula, or interscapular area - Character: intense, constant (despite the term "colic"), peaks within 15–30 minutes - Provocation: fatty food, large meals, particularly in the evening - Duration: 15 minutes to 6 hours. Pain lasting 6 hours → suspect acute cholecystitis - Associated: nausea, vomiting, occasionally low-grade fever Dyspepsia — right upper quadrant heaviness after fatty food, bitter taste, bloating. Non-specific; often accompanies gallstone disease but can reflect other conditions. Complications of Gallstone Disease Untreated gallstone disease can produce life-threatening complications. Acute cholecystitis — gallbladder inflammation, most commonly from stone obstruction. Pain lasts 6 hours, fever, positive Murphy's sign (sharp pain on deep palpation under the right costal margin during inspiration), leucocytosis. Requires hospitalisation and often emergency cholecystectomy. Choledocholithiasis — stone migration from the gallbladder into the common bile duct. Obstructive jaundice results: elevated direct bilirubin, ALP, GGT, acholic stools, dark urine, pruritus. Diagnosis: ultrasound (dilated common bile duct), MRCP, or ERCP. Cholangitis — infection of an obstructed bile duct. Charcot's triad: fever with rigors + jaundice + right upper quadrant pain. Reynolds' pentad in severe cholangitis: + hypotension + altered consciousness. A life-threatening emergency requiring immediate biliary decompression (ERCP) and antibiotics. Acute biliary pancreatitis — a stone impacted at the ampulla of Vater blocks the pancreatic duct. Severe epigastric pain radiating to the back; markedly elevated amylase and lipase. A leading cause of acute pancreatitis. Gallbladder cancer — a rare but serious complication of longstanding gallstone disease. Large stones ( 3 cm) and porcelain gallbladder are risk factors. Diagnosis of Gallstone Disease Abdominal ultrasound — the gold standard: sensitivity 95% for gallbladder stones. Identifies stones, wall thickness, duct dilation. Performed fasting (the gallbladder must be distended). Laboratory findings: In uncomplicated gallstone disease, blood tests may be entirely normal. With complications: - Complete blood count: leucocytosis with neutrophilia — cholecystitis, cholangitis - Direct bilirubin, ALP, GGT — elevated in choledocholithiasis and cholestasis - ALT, AST — mildly elevated in acute cholestasis - Amylase — markedly elevated in biliary pancreatitis - C-reactive protein — inflammatory marker in cholecystitis and cholangitis CT, MRCP — for suspected choledocholithiasis and pre-procedural planning. ERCP (endoscopic retrograde cholangiopancreatography) — simultaneous diagnosis and treatment of choledocholithiasis: stones can be removed from the duct endoscopically. Treatment of Gallstone Disease Asymptomatic cholelithiasis: watchful waiting is generally appropriate. Prophylactic cholecystectomy is considered for: very large stones ( 3 cm), calcified ("porcelain") gallbladder, sickle cell anaemia (high crisis risk), patients undergoing bariatric surgery. Symptomatic gallstone disease (biliary colic): cholecystectomy is the standard of care. Laparoscopic cholecystectomy — the gold standard: minimally invasive (4 small incisions), discharge within 1–2 days, return to work within 1–2 weeks. Performed electively for recurrent colic. Emergency cholecystectomy: for acute cholecystitis — preferably within 72 hours of onset. Medical dissolution (ursodeoxycholic acid, UDCA): effective only for small cholesterol stones (< 5–10 mm) in patients who are not surgical candidates. Treatment duration: 6–18 months; response in 30–40%, with 50% recurrence at 5 years. Not a substitute for surgery in symptomatic disease. After cholecystectomy: most patients require no special long-term diet. Temporary fat restriction for the first 1–2 months is advisable. Post-cholecystectomy syndrome (pain, diarrhoea) develops in 5–40% — usually related to sphincter of Oddi dysfunction or ductal pathology. Diet in Gallstone Disease In symptomatic gallstone disease before surgery — limiting fat reduces colic frequency (fat stimulates gallbladder contraction): - Avoid: fatty meat, lard, fried food, large amounts of butter, full-fat dairy, mayonnaise - Limit: egg yolk, spicy food, alcohol - Eat small, frequent meals — 5–6 times daily When to Seek Urgent Medical Attention Call emergency services immediately for: - Intense right upper quadrant pain lasting 6 hours — acute cholecystitis - Pain + fever 38°C + jaundice — cholangitis, life-threatening - Epigastric pain radiating to the back + vomiting — possible pancreatitis - Yellowing of the skin or sclera Routine appointment with a gastroenterologist or surgeon for: - Recurrent biliary colic — even if self-resolving - Incidentally found stones with dyspeptic symptoms - Stones 3 cm in asymptomatic disease This article is for informational purposes only and does not replace consultation with a surgeon or gastroenterologist. https://labreadai.com/en/posts/gestational-diabetes https://labreadai.com/en/posts/gestational-diabetes Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Gestational diabetes is elevated glucose during pregnancy. Screening at 24–28 weeks, OGTT criteria, risks for mother and baby, diet therapy and insulin treatment. Articles article Gestational diabetes is a condition that produces almost no symptoms — yet its consequences for the baby can be serious. This is precisely why screening at 24–28 weeks of pregnancy is not optional but a global standard of care. Gestational diabetes identified in time and properly managed allows a healthy pregnancy and a healthy baby. What Gestational Diabetes Is Gestational diabetes mellitus (GDM) is a disorder of carbohydrate metabolism first detected during pregnancy that does not meet criteria for overt (pre-existing) diabetes mellitus. This distinction is critical: if a fasting glucose ≥ 7.0 mmol/L or HbA1c ≥ 6.5% is found at the first antenatal visit, this represents overt diabetes that predated the pregnancy — a different condition requiring different management. Mechanism: the placenta synthesises counter-regulatory hormones — human placental lactogen, progesterone, cortisol, prolactin. As the placenta grows (particularly in the second and third trimester), physiological insulin resistance increases: the pregnant woman's body requires 2–3 times more insulin than usual. Most women meet this demand. When β-cell reserve is insufficient or baseline insulin resistance is present, GDM develops. Prevalence: 7–14% of all pregnancies (varying by country and diagnostic criteria); rising in parallel with the obesity epidemic. Risk factors: - BMI 25 kg/m² before pregnancy - GDM in a previous pregnancy - Previous delivery of a baby weighing 4 kg - Diabetes mellitus in a first-degree relative - Polycystic ovary syndrome (PCOS) - Age 35 years - Multiple pregnancy - Glucocorticoid use Gestational Diabetes Effects on Baby and Mother GDM poses risks primarily to the fetus — which is what makes active screening justified. Risks for the fetus and newborn: - Macrosomia (birth weight 4 kg) — the most common complication. Excess maternal glucose → fetal hyperinsulinaemia → excessive growth. Complicates delivery: shoulder dystocia, birth trauma. - Neonatal hypoglycaemia — after birth, fetal hyperinsulinaemia persists while maternal glucose supply ceases → sharp glucose drop in the first hours of life. - Respiratory distress syndrome — hyperinsulinaemia impairs fetal lung maturation. - Perinatal asphyxia, stillbirth with severe uncontrolled hyperglycaemia. - Long-term consequences for the child: increased risk of obesity and T2DM in later life. Risks for the mother: - Pre-eclampsia and gestational hypertension - Preterm birth - Caesarean section due to macrosomia - T2DM after delivery: 50% of women with GDM develop type 2 diabetes within 10 years Gestational Diabetes Diagnosis: OGTT in Pregnancy and Screening Criteria When and how screening is performed First antenatal visit (before 24 weeks): fasting glucose is measured in all pregnant women. If ≥ 7.0 mmol/L — overt diabetes. If 5.1–6.9 mmol/L — GDM diagnosed without proceeding to OGTT. 24–28 weeks — standard screening: all pregnant women without previously identified abnormalities undergo an oral glucose tolerance test (OGTT) with 75 g glucose. OGTT procedure: 1. Blood draw fasting (≥ 8 hours) 2. Ingestion of 75 g glucose dissolved in 250–300 mL water 3. Blood draw at 1 hour 4. Blood draw at 2 hours GDM diagnostic thresholds (IADPSG/WHO) GDM is diagnosed when at least one of the following is exceeded: Time point Venous plasma glucose ------ Fasting ≥ 5.1 mmol/L 1 hour ≥ 10.0 mmol/L 2 hours ≥ 8.5 mmol/L HbA1c in GDM: used with limitations — physiological changes in red cell turnover during pregnancy can produce falsely lower HbA1c values. It is not used for GDM diagnosis but is used for monitoring compensation once the diagnosis is established. Target HbA1c in GDM: < 6.0%. Self-monitored glucose targets in GDM: - Fasting: < 5.1 mmol/L - 1 hour after meals: < 7.0 mmol/L - 2 hours after meals: < 6.7 mmol/L Treatment of Gestational Diabetes The goal of treatment is maintaining normoglycaemia to protect the fetus. Management begins with diet and lifestyle change; insulin is added when glycaemic targets are not achieved. Diet therapy — the cornerstone of treatment - Limit rapid carbohydrates: eliminate sugar, honey, fruit juice, sugary drinks, white bread, pastries — these sharply elevate postprandial glucose - Frequent small meals: 5–6 meals per day in small portions; breakfast is particularly important to control (morning insulin resistance peaks at this time) - Carbohydrates: 40–45% of daily calories from complex carbohydrates with a low glycaemic index (vegetables, legumes, whole grains) - Protein: 25–30% — meeting normal pregnancy requirements - Fat: 30–35%; limit saturated fat - Fibre: at least 28 g/day — reduces postprandial glucose peaks - Caloric intake: no less than 1,800 kcal/day — severely restrictive diets are unsafe in pregnancy Physical activity Moderate aerobic exercise — walking, swimming, pregnancy-specific gymnastics — reliably lowers blood glucose and reduces insulin requirements. 30 minutes of moderate activity after meals reduces the postprandial glucose peak. Insulin therapy Initiated when glycaemic targets cannot be achieved with diet alone within 1–2 weeks: - Fasting glucose ≥ 5.1 mmol/L despite diet - Postprandial glucose ≥ 7.0 mmol/L at 1 hour despite diet - Fetal macrosomia or polyhydramnios on ultrasound even with borderline maternal glucose values Approved agents: human insulin and analogues — glargine, detemir, aspart, lispro. Metformin is used in some countries but is not the first-line standard in all guidelines. Glucose self-monitoring: at least 4–6 times daily (fasting and 1 hour after each main meal). After Delivery: What Comes Next GDM typically resolves after delivery but requires follow-up. Immediately after delivery: insulin is usually discontinued or sharply reduced. 6–12 weeks postpartum: repeat OGTT with 75 g glucose to exclude persistent diabetes or impaired glucose tolerance. Long-term: 50% of women with GDM develop T2DM within 10 years. Annual fasting glucose or HbA1c monitoring is recommended. Breastfeeding reduces the mother's risk of T2DM and the child's risk of metabolic disorders. Weight normalisation and physical activity after delivery are the key preventive measures. When to Seek Urgent Medical Attention - Fasting glucose ≥ 5.1 mmol/L at any point in pregnancy — referral to endocrinologist or GDM management centre - Glucose 10–11 mmol/L in pregnancy — urgent consultation; ketoacidosis is possible - Hypoglycaemia symptoms during insulin therapy (tremor, sweating, palpitations) — take carbohydrates immediately, measure glucose - Fetal macrosomia or polyhydramnios on ultrasound despite apparently controlled glucose — reassess management This article is for informational purposes only and does not replace consultation with an obstetrician-gynaecologist and endocrinologist. https://labreadai.com/en/posts/heart-attack-myocardial-infarction https://labreadai.com/en/posts/heart-attack-myocardial-infarction Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Heart attack symptoms in men and women, first aid before the ambulance, and how treatment works. Risk factors and how to prevent myocardial infarction. Articles article Crushing chest pain radiating to the left arm or jaw, accompanied by cold sweat — that is the textbook heart attack. But in almost one-third of cases, especially in women, the presentation is completely different: breathlessness, nausea, inexplicable fatigue. Heart attacks kill not because they are unrecognizable — but because people wait too long. Every 10 minutes of delay costs roughly another one percent of viable heart muscle. Let's break down how a heart attack works, how to recognize it, and what protects against it. What a Heart Attack Is and How It Develops A myocardial infarction is the death of heart muscle tissue caused by sudden loss of blood supply. In the vast majority of cases, the mechanism is the same: an atherosclerotic plaque in a coronary artery ruptures, a thrombus forms instantly at the rupture site, and it completely or nearly completely occludes the vessel. Heart muscle is acutely sensitive to ischemia. Within 20–40 minutes of blood flow cessation, irreversible necrosis of cardiomyocytes begins — cells that do not regenerate. The necrotic zone is eventually replaced by scar tissue, which cannot contract. The larger the area of damage and the longer the artery stays closed, the more severe the consequences. This is the precise connection between atherosclerosis and heart attack: a plaque growing silently for years can produce no symptoms until the moment of rupture — and then a chronic asymptomatic disease becomes an acute catastrophe within minutes. Heart attacks are classified by depth of damage (transmural — through the full wall thickness; non-transmural), by location (anterior, inferior, lateral, posterior), and by ECG changes (ST-elevation MI — STEMI; and non-ST-elevation MI — NSTEMI). STEMI is the most dangerous variant, requiring emergency reperfusion within the first 90–120 minutes. Symptoms of a Heart Attack: Classic and Atypical Knowing the symptoms matters not for self-treatment but to call for help without hesitation. Delayed response is the primary killer in heart attack. Classic symptoms (more common in men): - Pressure, squeezing, or burning chest pain — intense, lasting more than 15–20 minutes - Radiation to the left arm, shoulder, neck, lower jaw, or back - Cold clammy sweat, pallor - Rapidly progressing weakness, a sense of impending doom - Pain not relieved by nitroglycerin (unlike angina) Atypical symptoms occur in about 30% of patients — significantly more often in women, older adults, and people with diabetes: Atypical presentation Who is most affected ------ Breathlessness without chest pain Women, elderly, diabetics Nausea, vomiting, upper abdominal pain Inferior MI (right ventricular involvement) Unexplained sudden weakness and sweating Postmenopausal women Pain between the shoulder blades Posterior MI Dizziness or loss of consciousness Arrhythmia complicating MI Sensation of heartburn or indigestion Inferior MI — frequently confused with GI symptoms The key rule: if any of these symptoms appears for the first time, lasts more than 10–15 minutes, and has no obvious explanation — call emergency services immediately. Do not wait to see if it passes. First Aid for a Heart Attack: What to Do Before the Ambulance The right actions in the first minutes genuinely save lives and preserve heart function. Immediately: 1. Call emergency services — do not drive the person yourself if an ambulance can reach you. The ambulance carries a defibrillator and can begin thrombolysis en route 2. Place the person in a semi-reclined position — this reduces cardiac workload 3. Loosen collar, belt, and ensure fresh air access 4. Give aspirin 325 mg to chew (or 2–4 tablets of 100 mg) — if there is no allergy and no obvious bleeding. Aspirin blocks platelet aggregation and measurably reduces the size of the forming thrombus 5. Nitroglycerin — 1 tablet under the tongue; may be repeated after 5 minutes if pain persists. Contraindicated if systolic pressure is below 90 mmHg or if the person has taken a PDE-5 inhibitor (sildenafil and equivalents) within 24–48 hours If the person loses consciousness and stops breathing — begin cardiopulmonary resuscitation immediately: 30 chest compressions (5–6 cm depth, 100–120 per minute) + 2 rescue breaths. Do not stop until the ambulance arrives or signs of life return. Do not give the person anything to eat or drink. Do not let them walk around. Do not leave them alone. Diagnosis: Tests and Imaging Diagnosis in hospital runs in parallel with treatment — blood samples are drawn while the patient is already being wheeled to the catheterization lab. ECG — the first and most critical tool. ST-segment elevation in the relevant leads is the sign of acute transmural infarction and the indication for emergency reperfusion. ECG must be obtained within 10 minutes of arrival. Troponin — the gold standard of biochemical diagnosis. Troponin I and T are proteins specific to cardiomyocytes. When cells die, they release these proteins into the bloodstream: levels begin rising 2–4 hours after onset, peak at 12–24 hours, and remain elevated for 7–14 days. High-sensitivity troponin (hsTnI, hsTnT) allows MI to be excluded within 1–3 hours of symptom onset. CK-MB (MB isoenzyme of creatine kinase) — an earlier but less specific marker. It normalizes faster than troponin (within 48–72 hours), which makes it useful for diagnosing reinfarction when baseline troponin is already elevated. LDH — rises 12–24 hours after onset, peaks on days 2–4 and remains elevated for up to 14 days. Used in late-presenting patients — when troponin has already normalized but retrospective confirmation of infarction is still needed. BNP / NT-proBNP — natriuretic peptides are measured on admission to assess haemodynamic stress on the left ventricle. An elevated level at presentation predicts the risk of acute heart failure as a complication of MI and guides the intensity of supportive therapy. Coronary angiography — visualizes the occluded coronary artery and is the mandatory precursor to percutaneous coronary intervention (PCI, stenting). Echocardiography — assesses the zone of wall motion abnormality, valve function, and left ventricular ejection fraction — the key measure of damage severity. Treatment of Myocardial Infarction The goal of STEMI treatment is to restore blood flow in the occluded artery as quickly as possible. Every minute of delay destroys approximately two million cardiomyocytes. Reperfusion therapy — the cornerstone: - Primary PCI (balloon angioplasty with stenting) — the standard for STEMI: a balloon is inflated at the occlusion site and a stent is deployed. Target "door-to-balloon" time: no more than 90 minutes - Thrombolysis — intravenous thrombolytic agent (alteplase, tenecteplase) when PCI is not available within 120 minutes. Less effective than PCI but life-saving when a catheterization lab is not accessible Pharmacological therapy: - Dual antiplatelet therapy: aspirin + ticagrelor or clopidogrel — sustained suppression of platelet aggregation - Anticoagulants (heparin, enoxaparin) — in the acute phase - Beta-blockers — reduce myocardial oxygen demand and heart rate - ACE inhibitors or ARBs — prevent adverse left ventricular remodeling - High-intensity statins — stabilize plaques, lower cholesterol, and reduce the risk of recurrent events; prescribed to all post-MI patients without exception Thrombosis as a systemic problem. The clot-forming mechanism in MI shares key features with the mechanism underlying deep vein thrombosis: in both conditions, platelet activation and the coagulation cascade play a central role. The difference lies in location and trigger — not in biology. Rehabilitation After a Heart Attack Rehabilitation begins in hospital — literally the day after the patient stabilizes. Its goals: restore physical function, prevent a second event, and improve quality of life. Physical rehabilitation. Early mobilization (corridor walking on day 2–3) reduces immobilization complications: thrombosis and hypostatic pneumonia. A structured cardiac rehabilitation program — supervised aerobic exercise three to five times per week — measurably reduces five-year mortality by 20–30%. Psychological rehabilitation. Depression develops in 20–30% of post-MI patients and is an independent predictor of another cardiac event. Treating it is part of rehabilitation — not optional. Lifelong medication therapy. After a heart attack, patients take a minimum of four drug classes — aspirin, statin, beta-blocker, ACE inhibitor — and discontinuing any of them sharply raises the risk of reinfarction. Stopping the statin after a year "because cholesterol is now normal" is one of the most common and dangerous post-MI errors. Follow-up monitoring: ECG, echocardiography, and lipid profile at 4–6 weeks, then annually; unscheduled workup at any new symptom. Risk Factors and Prevention of Myocardial Infarction A heart attack is not random. In most patients presenting with acute coronary syndrome, a careful history reveals several modifiable risk factors that had been ignored for years. Non-modifiable factors: age (men 45, women 55 years), male sex, family history (MI in a first-degree relative before age 55 in men, before 65 in women). Modifiable factors — this is where prevention is concentrated: - Arterial hypertension — blood pressure control reduces MI risk by 20–25% - Smoking — doubles or triples risk; cessation delivers benefit within one year - Dyslipidemia — elevated LDL, reduced HDL; statins reduce risk by 25–35% - Diabetes and insulin resistance — accelerate atherosclerosis - Obesity, especially abdominal - Physical inactivity - Chronic stress and depression The principle of prevention is simple in theory and demanding in practice: control blood pressure, cholesterol, and blood sugar; don't smoke; stay active. Annual lipid profile monitoring from age 40 (from 35 with risk factors) is the minimum monitoring standard. This article is for informational purposes only and does not replace professional medical advice. If you experience symptoms of a heart attack, call emergency services immediately. https://labreadai.com/en/posts/hemolytic-anemia https://labreadai.com/en/posts/hemolytic-anemia Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Haemolytic anaemia is accelerated red cell destruction. Causes (autoimmune, hereditary, drug-induced), symptoms, lab tests (haemoglobin, reticulocytes, bilirubin) and treatment. Articles article Anaemia always comes down to one of three mechanisms: too little production, too much loss, or destruction that outpaces the bone marrow. Haemolytic anaemia is the third: red blood cells are destroyed faster than the marrow can replace them. What makes this type particularly deceptive is how it can masquerade as jaundice, mimic an acute abdomen, or emerge as a complication of an entirely different disease. What Haemolytic Anaemia Is Haemolytic anaemia is a group of conditions united by one mechanism: the lifespan of red blood cells is significantly shortened. Normally a red cell lives 90–120 days. In haemolysis — from a few days to a few weeks. The bone marrow attempts to compensate by ramping up production — hence reticulocytosis. But when the rate of destruction exceeds the maximum capacity of erythropoiesis, anaemia results. Haemolysis occurs in two fundamentally different settings: - Intravascular — red cells are destroyed within the bloodstream, releasing haemoglobin into the plasma. Manifests as haemoglobinuria (dark urine) and haemoglobinaemia. Seen in severe immune conflicts, incompatible blood transfusions, and paroxysmal nocturnal haemoglobinuria. - Extravascular — red cells are captured and destroyed in the spleen and liver. Characteristic of most autoimmune and hereditary forms. Manifests as splenomegaly and jaundice without haemoglobinuria. Causes of Haemolytic Anaemia Causes divide into two broad groups — inherited (a defect in the red cell itself) and acquired (an external force acting on normal red cells). Inherited (corpuscular) haemolytic anaemias Membrane defects: - Hereditary spherocytosis (Minkowski-Chauffard disease) — the most common hereditary haemolytic anaemia in Europe. A defect in membrane proteins (spectrin, ankyrin) makes red cells spherical and rigid — they become trapped in the spleen and are destroyed. Autosomal dominant inheritance. - Hereditary elliptocytosis Enzyme defects: - G6PD (glucose-6-phosphate dehydrogenase) deficiency — the world's most common enzyme disorder ( 400 million carriers). Silent until provoked: oxidative stress (infection, fava beans, certain drugs — primaquine, dapsone) triggers acute haemolysis. - Pyruvate kinase deficiency Haemoglobin defects: - Sickle cell anaemia — a single amino acid substitution in the β-chain of haemoglobin. Upon deoxygenation, haemoglobin polymerises → red cells become sickle-shaped → vascular occlusion (pain crises, organ infarcts) + haemolysis. Prevalent in sub-Saharan Africa and the Mediterranean. - Thalassaemias — impaired synthesis of α- or β-haemoglobin chains; severe forms require regular transfusions. Acquired (extracorpuscular) haemolytic anaemias Immune: - Autoimmune haemolytic anaemia (AIHA) — autoantibodies attack the patient's own red cells. Types: warm-antibody (IgG, react at 37°C — the most common form) and cold-antibody (IgM, agglutination at low temperatures — cold agglutinin disease). Primary or secondary (lymphoma, SLE, chronic lymphocytic leukaemia). - Haemolytic disease of the newborn — Rh conflict or ABO incompatibility - Post-transfusion haemolysis Microangiopathic: - TTP (thrombotic thrombocytopenic purpura) and HUS (haemolytic uraemic syndrome) — mechanical fragmentation of red cells in thrombosed microvasculature Infectious: - Malaria — plasmodium replicates inside red cells and destroys them - Babesiosis, clostridial sepsis Drug- and toxin-induced: - Drugs (quinine, methyldopa, high-dose penicillin) - Toxins (snake and spider venoms, lead) Mechanical: - March haemoglobinuria — red cell destruction in foot capillaries during prolonged running on hard surfaces - Damage in cardiopulmonary bypass circuits or from prosthetic heart valves Symptoms of Haemolytic Anaemia The clinical picture depends on the rate and severity of haemolysis. With chronic compensated haemolysis (mild form): - Moderate fatigue and pallor - Scleral icterus (mild jaundice) - Splenomegaly — the spleen enlarges as the "filter" removing destroyed cells - Gallstone disease — pigment stones from bilirubin During an acute haemolytic crisis: - Sudden severe weakness and dizziness - Marked pallor and jaundice - Dark urine ("black water" in intravascular haemolysis) - Abdominal and back pain — from vascular spasm and renal tubular obstruction - Fever, tachycardia - Potentially: acute kidney injury, shock In sickle cell anaemia — vaso-occlusive crises: intense bone pain, chest crisis, strokes, acute chest syndrome. Diagnosis: Blood Tests, Reticulocytes and Bilirubin in Haemolysis The three pillars of haemolysis: 1. Reduced haemoglobin — severity ranges from mild to severe anaemia. In chronic compensated haemolysis, haemoglobin may be normal. 2. Reticulocytosis — reticulocytes elevated ( 2%), reflecting compensatory increased erythropoiesis. Reticulocytosis is the key feature distinguishing haemolytic from hypoplastic anaemia. 3. Markers of red cell destruction: - Indirect bilirubin — elevated (haemoglobin breakdown product) - LDH — markedly elevated (intracellular enzyme released on cell death) - Haptoglobin — reduced or undetectable (binds free haemoglobin; depleted by massive haemolysis) - Free plasma haemoglobin — in intravascular haemolysis Confirmatory tests: - Direct Coombs test (direct antiglobulin test, DAT) — detects antibodies on the red cell surface. Positive in AIHA. - Blood film: spherocytes (hereditary spherocytosis), sickle cells, schistocytes (red cell fragments in microangiopathy) - Osmotic fragility — reduced in spherocytosis - G6PD assay - Haemoglobin electrophoresis — for suspected sickle cell anaemia or thalassaemia - Complete blood count with differential — essential in the workup Treatment of Haemolytic Anaemia: Autoimmune, Hereditary and Beyond Approach depends on cause and severity. Autoimmune haemolytic anaemia: - Glucocorticoids (prednisolone 1 mg/kg/day) — first line; effective in 70–80% of warm-antibody AIHA - For resistance or relapse: rituximab (anti-CD20), splenectomy - Red cell transfusion — for life-threatening severe anaemia, with awareness of cross-match difficulties Hereditary spherocytosis: - Mild forms: monitoring, folic acid supplementation - Severe forms: splenectomy — eliminates haemolysis radically (though the membrane defect persists) - Pre-splenectomy vaccination: pneumococcal, meningococcal, Haemophilus influenzae G6PD deficiency: - No specific treatment — avoid oxidative triggers (fava beans, implicated drugs) - During acute crisis: fluid therapy, transfusions for severe anaemia Sickle cell anaemia: - Hydroxycarbamide (hydroxyurea) — reduces frequency of pain crises - Bone marrow transplantation — the only curative option - Gene therapy — in clinical trials with promising early results For all forms: folic acid 1 mg/day (accelerated erythropoiesis depletes folate); caution with iron supplementation — haemolysis can cause iron accumulation, and supplementing without confirmed deficiency may worsen iron overload. When to Seek Urgent Medical Attention - Sudden severe weakness, pallor, dark urine — acute haemolytic crisis; call emergency services immediately - Jaundice + reduced urine output — risk of acute kidney injury - Chest pain or dyspnoea in sickle cell anaemia — acute chest syndrome; emergency hospitalisation - Newly discovered anaemia with reticulocytosis and jaundice — haematology referral within days This article is for informational purposes only and does not replace consultation with a qualified haematologist. https://labreadai.com/en/posts/hyperuricemia https://labreadai.com/en/posts/hyperuricemia Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Hyperuricaemia is elevated uric acid in the blood. Causes, link to gout and kidney stones, normal ranges, diet and treatment even without a gout attack. Articles article A blood test reveals elevated uric acid, but joints are fine and gout has never been diagnosed. Should you be concerned? Yes — but calmly. Hyperuricaemia — persistently elevated uric acid — can exist for years without any symptoms while silently damaging the kidneys, blood vessels, and joints. Here is where uric acid comes from, when it becomes genuinely dangerous, and what to do about it. What Uric Acid Is and Where It Comes From Uric acid is the end product of purine metabolism — purines are the nitrogen bases that make up DNA. When cells die or food is digested, purines are broken down to uric acid. It is excreted primarily by the kidneys (approximately 70%) and through the gut (30%). Under normal conditions, uric acid production and elimination are balanced. Hyperuricaemia develops when this balance fails: either too much is produced (accelerated cell turnover, excess dietary purines) or the kidneys excrete too little. Usually both mechanisms act together. Uric acid is not simply metabolic waste — at physiological concentrations it has antioxidant properties. The problem begins when its concentration exceeds the solubility threshold: urates crystallise in tissues, joints, and kidneys. Normal Uric Acid Levels Reference ranges depend on sex and, in women, menopausal status — oestrogens enhance renal urate excretion. Group Normal (µmol/L) Normal (mg/dL) --------- Men 200–420 3.4–7.0 Pre-menopausal women 140–360 2.4–6.0 Post-menopausal women 200–420 3.4–7.0 Hyperuricaemia is defined as above 420 µmol/L (7.0 mg/dL) in men and above 360 µmol/L (6.0 mg/dL) in pre-menopausal women. The crystallisation threshold for urates is approximately 420 µmol/L at normal body temperature. Causes of Hyperuricaemia Primary hyperuricaemia — genetically determined reduction in renal urate excretion or overproduction (rare enzyme defects, such as HPRT deficiency — Lesch-Nyhan syndrome). Secondary hyperuricaemia — a consequence of another condition or exposure: - Purine-rich diet: red meat, organ meats (liver, kidneys), seafood (anchovies, sardines, mussels), meat broths, yeast. Alcohol — especially beer and spirits — raises uric acid through a dual mechanism: purines in beer plus impaired renal excretion from ethanol. - Renal failure — reduced urate clearance. Rising creatinine and uric acid parallel each other in chronic kidney disease. - Metabolic syndrome and insulin resistance — insulin reduces renal urate excretion; obesity additionally increases production. - Medications: thiazide diuretics and furosemide are the most common iatrogenic causes. Low-dose aspirin, ciclosporin, and nicotinic acid also raise uric acid. - Cancer and its treatment: massive tumour cell breakdown (tumour lysis syndrome during chemotherapy) releases a surge of purines. Multiple myeloma and other haematological malignancies are typical causes of secondary hyperuricaemia. - Hypothyroidism — reduces renal urate clearance. Why Asymptomatic Hyperuricaemia Is Dangerous Many people with hyperuricaemia have never had a gout attack and regard elevated uric acid as a harmless incidental finding. This is a misconception — chronic hyperuricaemia damages organs even without visible symptoms. Gout is not the only consequence of hyperuricaemia — it is just the most dramatic one. Most people with elevated uric acid go years without a gout attack, but silent organ damage is already under way. Full details are in the gout article. Urate nephropathy — deposition of urate crystals in the renal tubules and interstitium. Manifests as reduced urinary concentrating ability, proteinuria, and a gradual rise in creatinine. Prolonged severe hyperuricaemia can lead to chronic kidney disease. Nephrolithiasis — urate stones account for 5–10% of all kidney stones. Stone formation risk rises sharply in acidic urine (pH < 5.5) — the pH at which urates transition from dissolved to crystalline form. Cardiovascular risk — hyperuricaemia is associated with elevated risks of hypertension, metabolic syndrome, and cardiovascular events, though whether it is an independent causal factor remains actively debated. Diagnostic Approach Uric acid in blood — the primary test. Drawn fasting; alcohol, purine-rich food, and intense exercise are avoided for 24 hours beforehand, as all transiently raise levels. A single elevated result is always repeated. Creatinine and eGFR — renal function assessment. In hyperuricaemia secondary to renal failure, cause and effect are closely intertwined. Urinalysis — uric acid excretion and urine pH are assessed. Persistently acidic urine (pH < 5.5) is a risk factor for urate nephrolithiasis. A 24-hour uric acid excretion above 800 mg/day indicates overproduction; a low excretion points to impaired renal clearance. Kidney function test — comprehensive renal assessment when urate nephropathy is suspected. Treatment and Uric Acid Reduction Strategy depends on the uric acid level, the presence of symptoms, and comorbidities. Diet and Lifestyle — the First Step Restrict or eliminate: red meat and organ meats; high-purine seafood (anchovies, sardines, mussels, oysters); alcohol — especially beer; fructose-containing sweet drinks (fructose accelerates uric acid synthesis). Increase: water intake (2–3 L/day) — alkalinises urine and reduces crystallisation risk; low-fat dairy products — associated with lower uricaemia; coffee — moderate consumption is linked to lower uric acid levels. Dietary measures reduce uric acid by approximately 60–90 µmol/L — meaningful, but often insufficient to normalise levels in significant hyperuricaemia. Drug Treatment Indications for drug therapy in asymptomatic hyperuricaemia are not universally agreed. Most guidelines recommend treatment when: - Gouty arthritis (any episode) has occurred - Urate nephrolithiasis is present - Urate nephropathy is established - Tophaceous gout is present - Uric acid exceeds 540 µmol/L in patients with high cardiovascular risk or chronic kidney disease Allopurinol — xanthine oxidase inhibitor, reduces uric acid synthesis. First-line treatment for most indications. Started at a low dose (100 mg/day) with gradual titration to reach the target level (< 360 µmol/L). Febuxostat — alternative to allopurinol when the latter is not tolerated or in renal impairment. Probenecid, benzbromarone — uricosuric agents (enhance renal excretion). Used when excretion is low and kidney function is preserved. When to See a Doctor Planned rheumatology or GP visit: uric acid above 480 µmol/L under any circumstances; hyperuricaemia combined with impaired kidney function or kidney stones; recurrent episodes of joint pain after heavy meals or alcohol. Urgently: acute arthritis with redness, swelling, and excruciating pain in a joint (especially the big toe) — the first sign of gout requiring immediate treatment. This article is for informational purposes only. Diagnosis and treatment are determined by a rheumatologist or general physician. https://labreadai.com/en/posts/iodine-deficiency https://labreadai.com/en/posts/iodine-deficiency Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Iodine deficiency is the leading cause of goitre and hypothyroidism worldwide. Symptoms in adults and children, diagnosis, iodised salt, daily needs and when to see a doctor. Articles article Iodine is the one micronutrient without which the thyroid gland cannot synthesise a single molecule of thyroid hormone. Yet iodine deficiency remains a global problem: according to the WHO, more than two billion people live in areas with insufficient iodine intake. Even in developed countries, pregnant women and young children remain the most vulnerable groups. Why Iodine Is Essential for the Thyroid Iodine is a structural component of thyroid hormones. The thyroxine (T4) molecule contains 4 iodine atoms; triiodothyronine (T3) contains 3. Without iodine, hormone synthesis is physically impossible. The thyroid gland has the unique ability to concentrate iodine from the blood: its iodine content is 20–50 times higher than in plasma. When iodine intake is adequate, this mechanism operates normally. In deficiency, the gland activates compensatory mechanisms: it avidly captures remaining iodine, hypertrophies (goitre), and shifts its synthetic output toward T3 (the more economical option — 3 iodine atoms instead of 4). With prolonged severe deficiency, compensatory capacity is exhausted and hypothyroidism develops. Daily Iodine Requirements Group Iodine requirement ------ Children 0–5 years 90 µg/day Children 6–12 years 120 µg/day Adolescents and adults 150 µg/day Pregnant women 220–250 µg/day Breastfeeding women 250–290 µg/day Deficiency is defined as a population median urinary iodine excretion < 100 µg/L. Individual spot urine iodine measurements are unreliable for diagnosis — only population-level studies provide a valid picture. Causes of Iodine Deficiency Geographic factor — the primary cause. Soil and water in mountainous areas and regions far from the sea contain little iodine. Iodine depletion results from glacial and erosional processes over geological time. Diet: without regular consumption of seafood, ocean fish, and iodised salt, iodine intake easily falls below requirements. Iodine is virtually absent in freshwater fish, meat, eggs (from animals raised in iodine-deficient regions), and most grains. Goitrogens — substances that impair iodine utilisation: - Thiocyanates — in cabbage, broccoli, Brussels sprouts, and turnips when consumed in excess - Perchlorates and nitrates — in drinking water in some regions - Soy in large quantities These substances are only relevant when baseline iodine intake is already deficient. With adequate iodine intake, cabbage does not affect the thyroid. Increased requirements: pregnancy and breastfeeding substantially raise iodine needs — the fetus and newborn depend entirely on the mother's iodine supply. Symptoms and Consequences of Iodine Deficiency Manifestations depend on age and severity of deficiency. In adults Goitre — thyroid gland enlargement — is the most characteristic finding. The gland hypertrophies in its attempt to capture more iodine. In early stages it is diffuse and soft; with prolonged deficiency it may become nodular. A large goitre can cause a sensation of neck pressure, difficulty swallowing, or hoarseness. Subclinical hypothyroidism — early evidence of impaired hormone synthesis: TSH mildly elevated with normal free T4. Symptoms may be absent or non-specific: fatigue, reduced concentration. Overt hypothyroidism in severe deficiency: fatigue, cold intolerance, weight gain, constipation, dry skin, hair loss, slowed cognition and speech. For detail — see the hypothyroidism article. In children and adolescents Iodine deficiency is particularly dangerous for the developing brain. Thyroid hormones are essential for neurogenesis, myelination, and synaptogenesis — critical from the first trimester of pregnancy through the first 2–3 years of life. - Mild to moderate deficiency → IQ reduction of 10–15 points, learning difficulties, impaired speech and memory - Severe fetal and neonatal deficiency → cretinism: irreversible intellectual disability, deaf-mutism, movement disorders, dwarfism Cretinism is rare wherever salt iodisation programmes operate, but has not been fully eliminated in some low-income countries. In pregnancy Iodine deficiency in pregnant women increases the risk of: - Miscarriage and stillbirth - Preterm birth - Fetal nervous system development impairment - Reduced child intelligence even with mild deficiency Diagnosis: How to Assess Iodine Status Urinary iodine excretion — the gold standard for population-level iodine assessment. A single spot urine measurement is unreliable for individual diagnosis due to large day-to-day variation. TSH — the primary screening marker of thyroid function. In moderate iodine deficiency, TSH is mildly elevated. Neonatal TSH screening is a standard programme that detects congenital hypothyroidism including iodine-induced cases. Free T4 — reduced in overt hypothyroidism resulting from iodine deficiency. Thyroid ultrasound — part of a comprehensive thyroid panel work-up — assesses gland volume. Normal: women < 18 mL, men < 25 mL. Volume increase is a goitre marker. At the population level, median thyroid volume in children aged 6–12 is used as an iodine deficiency indicator. Prevention and Treatment of Iodine Deficiency Salt iodisation — the primary prevention measure Iodised table salt is the most effective and cost-efficient approach to mass prevention. Potassium iodate (KIO₃) is used in most countries: approximately 20–40 µg iodine per gram of salt. At daily salt consumption of 5–6 g, this delivers 100–240 µg of iodine — close to or above the adult daily requirement. Practical notes: iodine in salt is lost with prolonged storage (especially in light and heat) and partially with boiling. Adding iodised salt at the end of cooking preserves more iodine. Dietary sources of iodine Food Iodine content ------ Seaweed (nori, kelp) 16–2,984 µg/100 g (highly variable) Cod, pollock, haddock 100–200 µg/100 g Shrimp, mussels 50–150 µg/100 g Milk, kefir 10–20 µg/100 mL Eggs 20–25 µg/unit Bread (made with iodised salt) 10–30 µg/100 g Seaweed (especially kelp/laminaria) contains enormous amounts of iodine — regular excess consumption can trigger iodine-induced hyperthyroidism or hypothyroidism. Individual supplementation Pregnant and breastfeeding women: potassium iodide 200–250 µg/day — recommended in all clinical guidelines. Start at the time of conception planning. Children under 2 years in iodine-deficient regions: 90–150 µg/day. Adults in iodine-deficient regions: supplementary 100–150 µg/day when seafood intake is low. With nodular goitre: iodine supplementation is only given after exclusion of functional thyroid autonomy — in autonomous nodules, iodine can precipitate thyrotoxicosis. When to See a Doctor - Visible or palpable thyroid enlargement — ultrasound and TSH are essential - Hypothyroid symptoms (fatigue, cold intolerance, weight gain) — rule out iodine deficiency and autoimmune thyroiditis - Pregnancy or conception planning without iodine supplementation — start immediately - A child from an iodine-deficient region with signs of developmental delay — endocrinologist and paediatrician This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/posts/jaundice https://labreadai.com/en/posts/jaundice Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Jaundice is yellowing of the skin and sclera from elevated bilirubin. Three types (prehepatic, hepatic, obstructive), key lab tests and warning signs requiring immediate care. Articles article Yellowing of the skin or the whites of the eyes is a symptom difficult to ignore. Jaundice is not a disease — it is a signal: something has gone wrong with the processing or excretion of bilirubin. Behind this signal can lie entirely different conditions — from the benign Gilbert's syndrome to pancreatic cancer. This is precisely why the most important thing in jaundice is not the colour of the skin, but understanding the mechanism. What Jaundice Is and Why It Occurs Jaundice (icterus) is the yellowing of the skin, sclera, and mucous membranes due to the accumulation of bilirubin in the tissues. Visible jaundice appears when total bilirubin exceeds 34–40 µmol/L. At levels of 17–34 µmol/L, subclinical hyperbilirubinaemia exists — detectable on blood tests but invisible to the eye. The most sensitive clinical indicator is the sclera: they contain abundant elastin, which binds bilirubin avidly. Scleral icterus appears before skin yellowing and persists longer during recovery. Understanding the cause of jaundice comes down to one question: at which stage of bilirubin metabolism has the disruption occurred? Bilirubin is produced from haemoglobin breakdown, binds to albumin (indirect bilirubin), enters the liver, undergoes conjugation (direct bilirubin), and is excreted in bile. A breakdown at any of these stages produces a different type of jaundice. Three Types of Jaundice: Mechanism and Distinctions Prehepatic (haemolytic) jaundice Mechanism: accelerated red cell destruction → more indirect bilirubin is produced than the liver can process. Characteristic features: - Mild to moderate yellowing (lemon-yellow hue) - Dark urine from urobilinogen — not from direct bilirubin - Dark stools — excess stercobilin - Haemoglobin reduced; reticulocytes elevated - Bilirubin: indirect elevated, direct — normal - ALT, AST — normal or mildly elevated Causes: haemolytic anaemia, malaria, incompatible blood transfusions, mechanical red cell destruction (prosthetic heart valves), Gilbert's syndrome. Hepatic (parenchymal) jaundice Mechanism: hepatocyte damage → simultaneous impairment of bilirubin uptake, conjugation, and excretion. Characteristic features: - Moderate to marked yellowing (saffron-yellow hue) - Dark urine (direct bilirubin excreted by kidneys) - Moderately pale stools - ALT and AST markedly elevated (hepatocyte cytolysis) - Both direct and indirect bilirubin elevated - Albumin reduced; INR prolonged in severe disease Causes: viral hepatitis A, B, C, E; alcoholic hepatitis; drug-induced hepatitis; liver cirrhosis; autoimmune hepatitis; non-alcoholic fatty liver disease. Posthepatic (obstructive, cholestatic) jaundice Mechanism: impaired bile outflow due to mechanical biliary obstruction → direct bilirubin cannot reach the intestine and accumulates in the blood. Characteristic features: - Marked yellowing (greenish hue with prolonged obstruction) - Acholic (clay-coloured) stools — bile does not reach the intestine; stercobilin is not produced - Dark "beer-coloured" urine — direct bilirubin excreted by the kidneys - Skin itch — bile acids irritate cutaneous receptors - ALP and GGT markedly elevated; ALT/AST moderately elevated - Direct bilirubin sharply elevated; indirect — mildly elevated Causes: gallstone disease with choledocholithiasis; pancreatic head cancer; cholangiocarcinoma; biliary strictures; primary sclerosing cholangitis. Differential Table: Three Types of Jaundice Feature Prehepatic Hepatic Posthepatic ------------ Skin hue Lemon-yellow Saffron-yellow Greenish-yellow Urine colour Dark Dark Dark ("beer") Stool colour Dark Moderately pale White (acholic) Skin itch Absent Mild Marked ALT/AST Normal Markedly ↑ Mildly ↑ ALP/GGT Normal Mildly ↑ Markedly ↑ Direct bilirubin Normal ↑↑ ↑↑↑ Indirect bilirubin ↑↑ ↑ Normal/↑ Haemoglobin ↓ Normal Normal Neonatal Jaundice: A Special Case Jaundice in newborns is physiologically normal in the first days of life. After birth, fetal haemoglobin breaks down rapidly while conjugation enzymes are still immature. Peak physiological jaundice occurs on days 3–5 and resolves by days 7–10 in term infants. When neonatal jaundice is pathological: - Appears within the first 24 hours of life — always pathological - Bilirubin exceeds age-specific thresholds (assessed using hour-specific nomograms) - Persists beyond 2–3 weeks in term infants - Direct bilirubin is elevated (sign of liver pathology or biliary atresia) Critical elevation of indirect bilirubin in newborns → kernicterus (bilirubin encephalopathy): irreversible brainstem nuclei damage. Requires emergency phototherapy or exchange transfusion. Diagnosing Jaundice: Where to Start First step — blood tests: - Bilirubin — total, direct, indirect: immediately identifies the jaundice type - Liver function panel: ALT, AST, ALP, GGT, albumin — characterises the pattern of liver injury - Complete blood count with reticulocytes — rules out haemolysis - INR / prothrombin time — hepatic synthetic function - C-reactive protein — inflammatory component Second step — imaging: Abdominal ultrasound — mandatory for any jaundice beyond mild. Dilated bile ducts confirm mechanical obstruction. When tumour is suspected — CT or MRI with cholangiopancreatography (MRCP). Third step — targeted tests based on the suspected cause: - Viral hepatitis markers (HAV IgM, HBsAg, HCV RNA) - Autoimmune markers (ANA, AMA, SMA) - Direct biliary visualisation (ERCP) for mechanical obstruction Treatment of Jaundice Jaundice is a symptom, not a disease. Treatment is directed at the cause, not the skin colour. - Haemolytic jaundice: treat the underlying disease — immunosuppression for autoimmune haemolytic anaemia, splenectomy for certain haemolytic conditions - Hepatic jaundice: direct-acting antivirals for hepatitis C (cure 95%); immunosuppression for autoimmune hepatitis; immediate alcohol cessation for alcoholic hepatitis; discontinue the offending drug in drug-induced hepatitis - Obstructive jaundice: endoscopic stone removal (ERCP), biliary stenting for malignant obstruction, surgical treatment In obstructive jaundice, biliary decompression is critical: prolonged cholestasis damages hepatocytes and leads to secondary biliary cirrhosis. When to Seek Urgent Medical Attention Call emergency services immediately if jaundice is accompanied by: - Fever, chills, and right upper quadrant pain — Charcot's triad: cholangitis, a life-threatening biliary infection - Confusion — hepatic encephalopathy in decompensated cirrhosis - Severe abdominal pain — possible perforation or acute pancreatitis - Rapidly worsening jaundice over a few days Schedule a routine appointment for: - Any newly appeared jaundice or scleral icterus in an adult - Acholic stools even with mild jaundice — suspicion of obstruction - Jaundice in a pregnant woman — obstetric cholestasis requires immediate assessment - Jaundice in a newborn within 24 hours of birth or persisting beyond 2 weeks This article is for informational purposes only and does not replace consultation with a gastroenterologist or GP. https://labreadai.com/en/posts/liver-cirrhosis https://labreadai.com/en/posts/liver-cirrhosis Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Liver cirrhosis is irreversible scarring of hepatic tissue. Causes, Child-Pugh stages, key lab markers (albumin, PT, bilirubin) and when liver transplantation is needed. Articles article Cirrhosis is not a disease in the conventional sense — it is the end point of many liver diseases. When healthy liver tissue is replaced by scar tissue, the organ loses its ability to synthesize proteins, detoxify waste, and regulate blood clotting. The insidious nature of cirrhosis is that it can remain silent for years — and then present in a stage of decompensation, when reserves are already exhausted. What Cirrhosis Is and How It Forms Liver cirrhosis is a chronic diffuse disease in which the normal architecture of hepatic tissue is irreversibly replaced by fibrotic (scar) tissue with the formation of pseudonodules. It is the final stage of any chronic liver injury, regardless of its cause. The underlying mechanism is universal. Any hepatocyte injury — whether from alcohol, viruses, fatty change, or autoimmune processes — activates hepatic stellate cells (Ito cells). These begin synthesising collagen, forming fibrous bands. Normal lobules become encircled by scar tissue; blood flow through the sinusoids is disrupted; pressure rises in the portal venous system — portal hypertension develops. The defining property of cirrhosis: fibrosis is irreversible. Treatment can halt progression but cannot remove established scar tissue. This is precisely why early diagnosis and elimination of the underlying cause are so critical. Causes of Cirrhosis Any chronic liver disease left untreated can lead to cirrhosis. The most common causes: Alcoholic cirrhosis — the leading cause in most developed countries. Daily consumption of 40–60 g pure ethanol in men and 20–40 g in women over 10–20 years leads to cirrhosis in 15–20% of heavy drinkers. Women are more vulnerable at equivalent intake levels. Viral hepatitis — chronic hepatitis B and C without treatment progress to cirrhosis in 20–30% of patients over 20–30 years. Chronic hepatitis is the most important precursor to cirrhosis. Non-alcoholic fatty liver disease (NAFLD/NASH) — a rapidly growing cause driven by the global epidemic of obesity and metabolic syndrome. Autoimmune liver diseases — primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis. Genetic disorders — haemochromatosis (iron overload), Wilson's disease (copper overload), alpha-1 antitrypsin deficiency. Drug-induced hepatitis — prolonged use of hepatotoxic agents (methotrexate, amiodarone). Stages of Cirrhosis: Compensated and Decompensated Clinically, cirrhosis divides into two fundamentally different states. Compensated cirrhosis (Child-Pugh class A): scar tissue is present, but the remaining hepatocytes manage to maintain function. The patient may have no symptoms for years. Often discovered incidentally on ultrasound or blood tests. Prognosis: 10-year survival 80%. Decompensated cirrhosis (classes B and C): functional reserve is exhausted. Life-threatening complications develop. Prognosis worsens sharply: without transplantation, 5-year survival in class C is approximately 20%. The Child-Pugh score evaluates 5 parameters (1–3 points each): bilirubin, albumin, prothrombin time, presence of ascites, and degree of encephalopathy. Class Score Characterisation 1-year survival ------------ A 5–6 Compensated 100% B 7–9 Moderate decompensation 80% C 10–15 Severe decompensation 45% Symptoms of Cirrhosis by Stage Compensated stage: often asymptomatic. Possible non-specific complaints — fatigue, right upper quadrant heaviness, reduced appetite, bloating. Physical findings: mild hepatomegaly or a shrunken liver (in advanced disease), "liver signs" — spider angiomata, palmar erythema, leukonychia. Decompensated stage — four major complications: Ascites — fluid accumulation in the peritoneal cavity due to portal hypertension and reduced oncotic pressure (from low albumin). The first manifestation of decompensation in most patients. Tense ascites causes dyspnoea and abdominal pain. Variceal haemorrhage — dilation of oesophageal and gastric veins from portal hypertension. Bleeding from varices is the most dangerous complication of cirrhosis, with mortality of 15–20% per episode. Hepatic encephalopathy — impaired brain function due to the accumulation of toxins (primarily ammonia) that the damaged liver cannot neutralise. Ranges from mild forgetfulness and personality change to coma. Spontaneous bacterial peritonitis (SBP) — infection of ascitic fluid without an obvious external source. Mortality without treatment exceeds 50%. Additionally: jaundice (impaired bilirubin excretion), bleeding tendency (reduced clotting factor synthesis), muscle wasting (sarcopenia), hepatorenal syndrome. Liver Cirrhosis Blood Tests: What and Why The laboratory picture of cirrhosis reflects the loss of the liver's synthetic and detoxifying functions. Key markers: Synthetic function: - Albumin — falls as cirrhosis progresses: < 35 g/L indicates moderate insufficiency; < 28 g/L indicates severe insufficiency - Total protein — falls in parallel with albumin - Prothrombin time (PT) / INR — prolonged; the liver cannot synthesise adequate clotting factors Metabolic function: - Bilirubin — rises during decompensation - Urea — falls in severe cirrhosis (ornithine cycle is disrupted); normal urea with elevated ammonia is a warning sign - Blood ammonia — elevated in encephalopathy Hepatocyte injury: - ALT and AST — may be mildly elevated or even normal (in "burned-out" cirrhosis, transaminases paradoxically decline in the final stages) - LDH — elevated during active hepatocyte necrosis; rises particularly markedly in congestive hepatopathy secondary to heart failure - GGT and ALP — reflect the cholestatic component Portal hypertension and complications: - Platelets — fall with hypersplenism: < 100 × 10⁹/L indicates significant portal hypertension - Sodium — hyponatraemia (< 130 mmol/L) with severe ascites carries a poor prognosis A liver function panel is the mandatory starting point for assessment and ongoing monitoring of cirrhosis. Liver Cirrhosis Treatment: Halting Progression and Managing Complications Eliminating the cause — the only way to stop progression: - Alcoholic cirrhosis: complete abstinence — even in decompensated disease, this improves prognosis - Hepatitis B: nucleoside analogues (tenofovir, entecavir) - Hepatitis C: direct-acting antivirals (DAAs) — cure in 95% of cases halts fibrosis progression - Autoimmune hepatitis: immunosuppressive therapy Managing complications: - Ascites: diuretics (spironolactone + furosemide), sodium restriction; for refractory ascites — large-volume paracentesis, transjugular intrahepatic portosystemic shunt (TIPS) - Variceal haemorrhage: non-selective beta-blockers and nitrates (prophylaxis), endoscopic band ligation (treatment), octreotide (acute episode) - Hepatic encephalopathy: lactulose (reduces ammonia production in the gut), rifaximin, protein restriction only in severe acute encephalopathy - SBP: third-generation cephalosporins; albumin infusion to prevent hepatorenal syndrome Liver transplantation — the only curative option in decompensated cirrhosis. Indications: Child-Pugh class C, MELD score 15, refractory complications, and hepatocellular carcinoma within the Milan criteria — primary liver cancer that develops against a cirrhotic background in 80–90% of patients. This is precisely why all patients with cirrhosis require ultrasound plus AFP measurement every 6 months: early HCC detection opens the door to transplantation and curative treatment. Post-transplantation 5-year survival: 70–80%. When to Seek Urgent Medical Attention - Sudden abdominal distension with dyspnoea — tense ascites requiring urgent paracentesis - Bloody vomiting or black tarry stools — variceal haemorrhage, life-threatening, call emergency services immediately - Confusion, disorientation, or inappropriate behaviour — signs of hepatic encephalopathy - Fever with abdominal pain in a patient with ascites — possible spontaneous bacterial peritonitis - Sudden drop in urine output in a patient with cirrhosis — possible hepatorenal syndrome This article is for informational purposes only and does not replace consultation with a gastroenterologist or hepatologist. https://labreadai.com/en/posts/multiple-myeloma https://labreadai.com/en/posts/multiple-myeloma Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Multiple myeloma is a malignant plasma cell disorder. CRAB symptoms, diagnosis (Bence Jones protein, M-gradient), key blood tests and current treatment approaches. Articles article Back pain in an older person that persists for months, unexplained anaemia, unexpectedly high total protein with normal albumin — this combination should immediately raise suspicion for multiple myeloma. It is the second most common haematological malignancy after lymphoma, and its insidious nature lies in how convincingly it mimics ordinary diseases of ageing. What Multiple Myeloma Is Multiple myeloma (MM) is a malignant disorder in which a monoclonal clone of plasma cells (the terminal cells of the B-lymphocyte lineage) proliferates uncontrollably in the bone marrow. Plasma cells normally produce antibodies; in myeloma, they generate vast quantities of a defective, monotypic immunoglobulin — a paraprotein (M-protein). Proliferation of myeloma cells in the bone marrow triggers a chain of damage: - Displacement of normal haematopoiesis → anaemia, thrombocytopenia, neutropenia - Osteoclast activation → bone destruction, hypercalcaemia, pathological fractures - M-protein accumulation in the blood → kidney impairment, hyperviscosity - Suppression of normal immunoglobulins → immunodeficiency, recurrent infections MM accounts for approximately 10% of all haematological malignancies. The median age at diagnosis is 65–70 years; it is rare below 40. Men are more frequently affected. With modern therapy, one-year survival exceeds 85%; five-year survival is approximately 55%. Symptoms: CRAB Criteria for Organ Damage The clinical picture of myeloma is captured by the acronym CRAB: C — Calcium (hypercalcaemia): serum calcium 2.75 mmol/L (or 0.25 mmol/L above the upper limit of normal). Symptoms: nausea, vomiting, constipation, polyuria, thirst, weakness, confusion ("stones, bones, groans, and psychic moans" — the classic mnemonic). R — Renal failure: creatinine 177 µmol/L. Causes: direct tubular toxicity from immunoglobulin light chains, hypercalcaemia, hyperuricaemia, amyloidosis, contrast-induced dehydration. A — Anaemia: haemoglobin < 100 g/L or 20 g/L below baseline. Normochromic, normocytic — due to displacement of normal erythropoiesis. B — Bone lesions: osteolytic lesions, vertebral compression fractures, pathological fractures of long bones. Typical sites: spine (especially thoracic and lumbar), ribs, pelvis, skull. Back pain is the most common symptom at diagnosis. Additional features: - Recurrent infections (pneumonia, sepsis) — from suppression of normal immunoglobulins - Hyperviscosity syndrome: headache, visual disturbances, epistaxis — at very high M-protein levels (more common in Waldenström's macroglobulinaemia) - Peripheral neuropathy — direct light chain toxicity or AL amyloidosis Diagnosis of Multiple Myeloma Diagnosis of myeloma is multi-layered. Laboratory markers Screening tests — first suspicion: - Total protein — markedly elevated ( 90–100 g/L) with normal or reduced albumin: the classic hallmark of paraproteinaemia. A/G ratio sharply reduced (< 0.8) - Calcium — elevated with active bone disease - Creatinine, urea — elevated with renal involvement - Haemoglobin, platelets — reduced from haematopoietic displacement - Uric acid — often elevated (high cell turnover) - LDH — elevated in active disease (tumour burden marker) - ESR — markedly elevated from paraprotein (sometimes 100 mm/hour) - β₂-microglobulin — a critical prognostic marker; part of the ISS staging system Specific tests — diagnostic confirmation: - Serum protein electrophoresis — identifies the M-gradient (a sharp spike in the γ-zone); immunofixation defines the immunoglobulin class (IgG, IgA, IgD, IgM) and light chain type (κ or λ) - Urine Bence Jones protein — free immunoglobulin light chains filtered by the kidneys. Present in the urine of 60–70% of MM patients. 24-hour light chain excretion is an activity criterion - Serum free light chains (FLC) — highly sensitive; detects an abnormal κ/λ ratio (normal 0.26–1.65) - Bone marrow trephine biopsy — the primary confirmatory method: plasma cells 10% of marrow cells; in MM typically 30% Imaging: - Low-dose whole-body CT — standard for detecting lytic lesions - MRI of the spine — for compression fractures and neurological symptoms - PET/CT — for staging and treatment response monitoring Diagnostic criteria (IMWG, 2014) A diagnosis of symptomatic MM requires: 1. Clonal plasma cells ≥ 10% in bone marrow (or biopsy-confirmed plasmacytoma) 2. One or more CRAB criteria or one myeloma-defining biomarker: plasma cells ≥ 60%, FLC ratio ≥ 100, 1 focal lesion on MRI It is important to distinguish MM from precursor conditions: - MGUS (monoclonal gammopathy of undetermined significance) — M-protein < 30 g/L, plasma cells < 10%, no CRAB damage. Risk of MM transformation: 1% per year. Surveillance only. - Smouldering (indolent) myeloma — M-protein ≥ 30 g/L or plasma cells 10–60%, but no CRAB damage. Risk of progression: 10% per year. Surveillance or clinical trial enrolment. Treatment of Multiple Myeloma MM is currently not curable in most patients (except a minority after allogeneic transplantation), but it is well controlled. The goal is achieving the deepest possible response and prolonging remission. First line (transplant-eligible — age < 65–70, good performance status): - Induction: VRd (bortezomib + lenalidomide + dexamethasone) or VCd (bortezomib + cyclophosphamide + dexamethasone) - Autologous stem cell transplantation (ASCT) — prolongs remission - Maintenance: lenalidomide until progression First line (transplant-ineligible): - Rd (lenalidomide + dexamethasone) — continuous until progression - VMP (bortezomib + melphalan + prednisone) - Daratumumab-based regimens (anti-CD38 monoclonal antibody) — substantially improved outcomes in older patients Relapsed/refractory MM: - Pomalidomide, carfilzomib, daratumumab, elotuzumab - CAR-T cell therapy (idecabtagene vicleucel, ciltacabtagene autoleucel) — at multiple relapses, high efficacy demonstrated Supportive and adjunctive therapy: - Bisphosphonates (zoledronic acid) — all patients with bone disease: reduce skeletal complications and slow osteolysis - Pain management — NSAIDs (cautiously with renal impairment), opioids, targeted radiotherapy for isolated lesions - Thromboprophylaxis — mandatory with immunomodulatory agents (lenalidomide, thalidomide) - Renal failure management — aggressive hydration, immediate initiation of specific therapy; dialysis if needed When to See a Doctor - Persistent back or bone pain in a person over 50 with no trauma — investigate including total protein and ESR - Unexplained anaemia + elevated serum protein with normal albumin — urgent haematology referral - Pathological fracture (fracture from minimal or no trauma) — exclude myeloma as the cause - Frothy urine + high serum protein + anaemia — three-component combination requiring myeloma exclusion - Symptoms of hypercalcaemia (thirst, polyuria, nausea, weakness) + bone pain — urgent hospitalisation This article is for informational purposes only and does not replace consultation with a haematologist-oncologist. https://labreadai.com/en/posts/nephrotic-syndrome https://labreadai.com/en/posts/nephrotic-syndrome Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Nephrotic syndrome is massive urinary protein loss. The four classic features, causes in children and adults, key lab tests (albumin, proteinuria, cholesterol) and treatment. Articles article Oedema that starts with puffy eyes in the morning and gradually spreads to the whole body, together with frothy urine and profound fatigue — this is the classic presentation of nephrotic syndrome. Behind this syndrome lies one fundamental disruption: the kidney filter has become permeable to protein. Everything else follows from that. What Nephrotic Syndrome Is Nephrotic syndrome is a clinico-laboratory complex defined by four classic features: 1. Massive proteinuria — urinary protein loss 3.5 g/day in adults ( 40 mg/m²/hour in children). This is the defining, primary feature — all others derive from it. 2. Hypoalbuminaemia — blood albumin < 35 g/L (often < 25 g/L in fully developed syndrome). 3. Generalised oedema — soft, symmetrical, beginning periorbital, then spreading to ankles, legs, scrotum, ascites, pleural effusion. 4. Hyperlipidaemia — elevated total cholesterol, LDL, and triglycerides. The liver's compensatory response to falling oncotic pressure. A fifth feature often included: lipiduria — fatty casts and "Maltese crosses" in urine sediment under polarised light. Nephrotic syndrome is not a standalone diagnosis — it is always the expression of an underlying disease of the glomerular apparatus of the kidneys. Mechanism: Why Protein Is Lost The glomerular filter normally bars large molecules — albumin (69 kDa) is retained at three levels: the endothelium, the basement membrane, and podocytes (cells with "foot processes" covering the outer surface of the basement membrane). In nephrotic syndrome, podocytes are damaged — their foot processes flatten or fuse. The filter becomes permeable to albumin and other proteins. Consequences of massive proteinuria: - Fall in plasma oncotic pressure → fluid shifts from vessels into tissues → oedema - Hypovolaemia → activation of the renin-angiotensin-aldosterone system → sodium and water retention → worsening oedema - Protein deficit signal → liver compensatorily increases synthesis of all proteins including lipoproteins → hyperlipidaemia - Loss of anticoagulant proteins (antithrombin III, protein C and S) → hypercoagulability — thrombosis risk Causes of Nephrotic Syndrome In children Minimal change disease (MCD) — the cause of 90% of nephrotic syndrome in children under 8. Light microscopy shows no changes — only electron microscopy reveals podocyte foot process fusion. Responds excellently to glucocorticoids: remission in 90% of children. Prognosis is generally very good. In adults Primary (idiopathic) glomerulopathies: - Minimal change disease (10–15%) — in adults often associated with Hodgkin's lymphoma and NSAIDs - Focal segmental glomerulosclerosis (FSGS) — the most common primary cause in US adults; frequently treatment-resistant - Membranous nephropathy — the leading primary cause in White adults; idiopathic (anti-PLA2R antibodies) or secondary - Membranoproliferative glomerulonephritis Secondary (systemic disease): - Diabetes mellitus — diabetic nephropathy: the most common cause of nephrotic syndrome in adults globally - Amyloidosis — amyloid fibril deposition in glomeruli; systemic AL-amyloidosis or reactive AA-amyloidosis - Systemic lupus erythematosus (SLE) — lupus nephritis class V - Infections — hepatitis B (membranous nephropathy), hepatitis C (MPGN), HIV (FSGS), syphilis, malaria - Drugs — NSAIDs, gold salts, penicillamine, captopril, heroin Nephrotic Syndrome Symptoms: Oedema, Proteinuria and Complications Oedema — the hallmark of nephrotic syndrome. Unlike cardiac oedema (starting inferiorly — at the ankles), nephrotic oedema characteristically begins with the face: periorbital puffiness on waking is one of the earliest signs. Over time, oedema generalises: legs, scrotum, ascites, hydrothorax. The overlying skin is pale, soft, and pitting. Frothy urine — the excess protein creates foam that persists long after the stream ends. One of the first symptoms patients notice. General weakness and fatigue — consequence of hypoalbuminaemia and anaemia (urinary loss of transferrin and erythropoietin). Hyperlipidaemia and xanthomas — with prolonged nephrotic syndrome, xanthoma deposits may appear on the skin. Complications: - Thrombosis and thromboembolism — renal vein thrombosis (classic complication of membranous nephropathy), deep vein thrombosis, pulmonary embolism. Driven by urinary loss of anticoagulant proteins and hyperfibrinogenaemia. - Infections — loss of immunoglobulins and complement components → high susceptibility to encapsulated bacteria (pneumococcus, Haemophilus). Pneumococcal peritonitis is characteristic in children with MCD. - Acute kidney injury — in 25–30% of patients; mechanisms: hypovolaemia, renal vein thrombosis, nephrotoxic drugs. - Atherosclerosis — chronic hyperlipidaemia with prolonged nephrotic syndrome accelerates arterial disease. Diagnosis: Key Lab Tests Urine: - 24-hour proteinuria 3.5 g, or urine protein-to-creatinine ratio 3.5 g/g — the diagnostic criterion - Urinalysis: protein +++, fatty casts, "Maltese crosses" under polarised light - Complete blood count with differential Blood: - Albumin — reduced (< 35 g/L); severity of hypoalbuminaemia correlates with syndrome severity - Total protein — reduced - Total cholesterol, LDL, triglycerides — elevated - Creatinine, urea — kidney function assessment - Coagulation panel — assess hypercoagulability - C-reactive protein, ESR — inflammatory markers Aetiological workup: - Anti-dsDNA, ANA — SLE - HBsAg, HCV, HIV - Anti-PLA2R antibodies — membranous nephropathy - Bence-Jones protein in urine, immunofixation — amyloidosis, multiple myeloma - Kidney biopsy — the primary method of morphological diagnosis in adults Treatment of Nephrotic Syndrome Treatment is two-pronged: specific therapy for the underlying disease + symptomatic management. Specific therapy: - Minimal change disease: glucocorticoids (prednisolone 1 mg/kg/day) — remission in 80–90% of children and 75% of adults. For relapses — tacrolimus, cyclophosphamide, rituximab. - Membranous nephropathy: 30% undergo spontaneous remission. For progression — Ponticelli regimen (corticosteroids + chlorambucil), tacrolimus, rituximab. - FSGS: glucocorticoids — first line; for resistance — calcineurin inhibitors. - Diabetic nephropathy: RAAS inhibitors (ACEi/ARB) — reduce proteinuria; SGLT2 inhibitors — nephroprotective effect; glycaemic control (target HbA1c). Symptomatic management: - Oedema: sodium restriction (< 2 g/day), loop diuretics (furosemide). With hypovolaemia — use cautiously; risk of AKI. - Hyperlipidaemia: statins — reduce cardiovascular risk in prolonged syndrome. - Thrombosis prevention: at albumin < 20–25 g/L in membranous nephropathy — anticoagulant prophylaxis is considered. - Dietary protein: moderate intake (0.8–1.0 g/kg/day) — high protein intake worsens proteinuria. - Vaccination: pneumococcal and influenza vaccines — with prolonged nephrotic syndrome. When to Seek Urgent Medical Attention - Newly appeared generalised oedema + frothy urine — nephrology referral within days - Dyspnoea with oedema — possible hydrothorax or pulmonary embolism - Leg pain + swelling + redness — deep vein thrombosis; call emergency services - Flank pain + blood in urine + worsening oedema — possible renal vein thrombosis - Fever + abdominal pain in a child with nephrotic syndrome — rule out spontaneous peritonitis This article is for informational purposes only and does not replace consultation with a qualified nephrologist. https://labreadai.com/en/posts/prediabetes https://labreadai.com/en/posts/prediabetes Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Prediabetes is the intermediate state between normal and diabetes. Diagnostic criteria (glucose, HbA1c), symptoms, reversibility and evidence-based methods to prevent T2DM. Articles article Prediabetes is called "the last chance": glucose is already above normal but has not yet reached the diagnostic threshold for diabetes. This is the only moment when the trajectory can be reversed — without medication, through lifestyle alone. The Diabetes Prevention Program demonstrated that a 7% weight reduction and 150 minutes of moderate physical activity per week reduce the risk of progression to T2DM by 58%. This outperforms metformin (31%). Prediabetes is not a verdict — it is a motivation. What Prediabetes Is and Why It Matters Prediabetes is an intermediate metabolic state in which glucose levels are above normal but below the diagnostic criteria for type 2 diabetes. The pancreas is still coping — but struggling: β-cells are working at capacity, and tissues are responding less and less to insulin (insulin resistance is increasing). Why this matters: - Without intervention, prediabetes progresses to T2DM in 25–40% of people within 3–5 years - Cardiovascular risk is already elevated in prediabetes — before diabetes develops - Early neuropathy and retinopathy can begin in the prediabetes stage - With active lifestyle change, prediabetes is reversible in 50–70% of cases Prevalence: approximately 7–9% of the world population has prediabetes; the majority are unaware — prediabetes is typically asymptomatic. Diagnostic Criteria for Prediabetes Prediabetes is diagnosed when at least one of the following is present: Marker Normal Prediabetes Diabetes ------------ Fasting glucose < 5.6 mmol/L 5.6–6.9 mmol/L ≥ 7.0 mmol/L 2-hour glucose (OGTT) < 7.8 mmol/L 7.8–11.0 mmol/L ≥ 11.1 mmol/L HbA1c < 5.7% 5.7–6.4% ≥ 6.5% Two variants of prediabetes: Impaired fasting glucose (IFG) — fasting glucose 5.6–6.9 mmol/L with normal postprandial glycaemia. The primary defect is hepatic: excess nocturnal hepatic glucose output. More common in men; higher risk of T2DM progression (especially at ≥ 6.1 mmol/L). Impaired glucose tolerance (IGT) — normal or borderline fasting glucose but 2-hour OGTT value of 7.8–11.0 mmol/L. The primary defect is in peripheral tissues (muscle, adipose): reduced postprandial glucose uptake. More common in women with obesity; higher cardiovascular risk. Combined IFG + IGT — the most unfavourable pattern: highest risk of T2DM progression. Symptoms of Prediabetes: Why It Goes Undetected Prediabetes is almost always asymptomatic — which is why most cases remain undiagnosed. Occasionally, non-specific signs may be present: - Mild thirst and slightly increased urination — less pronounced than in diabetes - Chronic fatigue, reduced stamina - Blurred vision during glucose fluctuations - Slow healing of minor wounds - Frequent fungal infections Acanthosis nigricans — darkening and thickening of skin in body folds (neck, armpits, groin) — is a marker of significant insulin resistance. A visible sign that should prompt investigation. The diagnosis of prediabetes is made exclusively on laboratory data — symptoms are unreliable. Risk Factors: Who Should Be Screened Screening for prediabetes and T2DM is recommended with any of the following: - Overweight or obesity (BMI ≥ 25 kg/m²) - Age ≥ 35 — regardless of BMI - Hypertension (BP ≥ 140/90 mmHg) - Dyslipidaemia: HDL < 0.9 mmol/L and/or triglycerides 2.8 mmol/L - Diabetes in a first-degree relative - History of gestational diabetes - PCOS - Metabolic syndrome - Physical inactivity - Family history of T2DM With risk factors: screening every 1–3 years; without risk factors: every 3 years from age 35. Prediabetes and Associated Conditions Prediabetes rarely exists in isolation. It is typically part of a metabolic cluster: - Metabolic syndrome: abdominal obesity + dyslipidaemia + hypertension + hyperglycaemia. IGT is one of the criteria for metabolic syndrome. - Dyslipidaemia: insulin resistance → elevated triglycerides, reduced HDL, mildly elevated LDL — atherogenic dyslipidaemia. - Hypertension: insulin stimulates renal sodium reabsorption and activates the sympathetic nervous system. - NAFLD (non-alcoholic fatty liver disease): insulin resistance → excess fat accumulation in hepatocytes. Treating prediabetes simultaneously addresses this entire cluster. How to Prevent Progression to Diabetes: Evidence-Based Methods Lifestyle change — the first and primary line Weight loss: the key intervention. Losing 5–7% of body weight reduces T2DM risk by 50–58%. Mechanism: reduced visceral fat → decreased insulin resistance → relief of β-cell burden. For practical strategies to lower blood sugar, see the dedicated guide. Physical activity: 150 minutes of moderate aerobic exercise per week (walking, swimming, cycling) + resistance training 2–3 times per week. Physical activity reduces muscle insulin resistance independently of weight loss — through GLUT4 transporters. Diet: - Limit rapid carbohydrates and refined foods - Mediterranean diet or DASH diet — strongest evidence base - Increase fibre (≥ 30 g/day): soluble fibre slows glucose absorption - Limit saturated and trans fats - Reduce sugar-sweetened beverages — one of the most significant dietary risk factors Sleep normalisation: chronic sleep deprivation (< 6 hours) raises insulin resistance by 30–40%. Treat sleep apnoea when present. Pharmacological prevention For high-risk progression (IFG + IGT + BMI 35 + age < 60), a physician may consider: - Metformin — reduces T2DM risk by 31%; safe for long-term use; primarily controls fasting glucose - Acarbose, orlistat — used in some countries for prediabetes - GLP-1 receptor agonists (semaglutide) — reduce weight and glucose; being studied in prediabetes Metformin is not a substitute for lifestyle change: it is less effective (31% vs 58%) and does not reverse insulin resistance. When to See a Doctor - Fasting glucose 5.6–6.9 mmol/L on first detection — routine visit to GP or endocrinologist within 2–4 weeks - HbA1c 5.7–6.4% — discuss a structured lifestyle change programme - Risk factors present without screening in the past 3 years — check fasting glucose - Rapid weight gain + thirst + fatigue — rule out progression to diabetes; measure glucose This article is for informational purposes only and does not replace consultation with a qualified physician. https://labreadai.com/en/posts/rhabdomyolysis https://labreadai.com/en/posts/rhabdomyolysis Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Rhabdomyolysis is massive skeletal muscle breakdown releasing myoglobin into the blood. Causes, classic symptom triad, key labs (CK, myoglobin, creatinine) and treatment. Articles article Dark tea- or cola-coloured urine after an intense workout, trauma, or prolonged immobility is one of the most recognisable warning signs of rhabdomyolysis. Behind this symptom lies the mass destruction of muscle cells, the release of toxic myoglobin into the bloodstream, and a real threat of acute kidney failure. Rhabdomyolysis can be mild and pass unnoticed — or fulminant, with fatal outcome without emergency intervention. What Rhabdomyolysis Is and Why It Leads to Kidney Failure Rhabdomyolysis is the breakdown of skeletal (striated) muscle tissue with the release of intracellular contents into the systemic circulation. Muscle cells (myocytes) lose membrane integrity — and myoglobin, potassium, phosphorus, uric acid, intracellular enzymes (primarily creatine kinase, CK), and other substances enter the blood. The primary danger is myoglobin. In the renal tubules, myoglobin precipitates in acidic urine, forms casts, and causes direct tubular toxicity. The result is acute kidney injury, developing in 15–50% of patients with significant rhabdomyolysis. In addition, the massive release of potassium from necrotic myocytes threatens life-threatening hyperkalaemia and cardiac arrest. Causes of Rhabdomyolysis: From Exercise and Statins to Trauma Rhabdomyolysis can develop in vastly different circumstances — from the gym to the intensive care unit. Traumatic and physical causes: - Crush syndrome — prolonged muscle compression (earthquakes, road accidents, prolonged unconscious lying) - Excessive physical exertion — "exertional rhabdomyolysis": marathons, intense CrossFit, military training. Especially dangerous in heat and dehydration - Seizures — prolonged epileptic status - Hyperthermia and heat stroke — overheating causes direct thermal myocyte injury - Electrical trauma and lightning strike - Muscle ischaemia — arterial thrombosis, positional compression syndrome Non-traumatic causes: - Drugs and toxins — the most common non-traumatic cause: - Statins — in 0.1–0.5% of patients; risk rises sharply when combined with fibrates, ciclosporin, amiodarone, or CYP3A4 inhibitors (clarithromycin, itraconazole) - Alcohol — direct myotoxicity and hypokalaemia - Cocaine, amphetamines, MDMA (ecstasy) - Toxins — snake and spider bites - Infections — viral myositis (influenza, HIV, enteroviruses), bacterial sepsis - Metabolic disturbances — hypokalaemia, hypophosphataemia, hyponatraemia, hypothyroidism - Genetic myopathies — carnitine palmitoyltransferase II deficiency, glycogen storage diseases, malignant hyperthermia - Autoimmune myositis — polymyositis, dermatomyositis Rhabdomyolysis Symptoms After Exercise: The Classic Triad The classic clinical picture of rhabdomyolysis consists of three features in combination: 1. Muscle pain and weakness — most often in muscles subjected to injury or exertion. Pain may be localised or diffuse, from mild to severe. Muscles may be swollen and tender on palpation. 2. Dark urine — brown, red-brown, or "tea-coloured" / "cola-coloured" — the hallmark of myoglobinuria. It appears when myoglobin concentration in the urine is high enough to visibly change colour. Important: in some patients, urine colour does not change — rhabdomyolysis without visible myoglobinuria occurs. 3. General symptoms — malaise, fever, tachycardia, nausea, reduced urine output (oliguria) when AKI develops. Danger signs requiring immediate hospitalisation: - Anuria or critically reduced urine output - Cardiac arrhythmia (hyperkalaemia) - Progressive weakness or confusion - Limb swelling with pain and sensory loss — compartment syndrome Blood Tests for Rhabdomyolysis: CK, Myoglobin and Key Markers Blood: CK (creatine kinase) — the primary rhabdomyolysis marker. Normal < 200 U/L. In rhabdomyolysis, CK rises tens to hundreds of times: levels of 10,000–100,000 U/L are typical; in severe cases 100,000 U/L. CK peaks 24–72 hours after the onset of injury and then declines at approximately 50% per day once injury stops. Creatinine — rises with developing AKI. Key nuance: in rhabdomyolysis, urea rises faster than creatinine (accelerated protein catabolism), and the urea/creatinine ratio may be higher than usual. Potassium — hyperkalaemia from massive K⁺ efflux from destroyed cells. Life-threatening levels ( 6.5 mmol/L) require emergency treatment. Phosphorus — hyperphosphataemia from phosphate release out of myocytes. Calcium — hypocalcaemia in the acute phase (calcium binds to damaged muscle tissue); paradoxical hypercalcaemia in the recovery phase (calcium returns from muscle to blood). Uric acid — elevated due to purine release from destroyed cells. AST — elevated (AST is present not only in the liver but also in muscle; in rhabdomyolysis — muscle-source elevation). ALT rises much less — a sharp AST rise with near-normal ALT points to muscle rather than liver origin. LDH — markedly elevated: like CK, it is an intracellular enzyme released in large quantities when myocytes die. In rhabdomyolysis, LDH rises in parallel with CK and serves as an additional marker of the severity of muscle tissue damage. Urine: - Urine dipstick positive for blood (reacts to myoglobin the same as haemoglobin), but red blood cells are absent on microscopy — the classic discrepancy pointing to myoglobinuria - Brown sediment, granular casts - Urine myoglobin (direct assay) — confirms the diagnosis, but a negative result does not exclude it Treatment of Rhabdomyolysis Aggressive intravenous fluid therapy — the cornerstone of treatment. Goal: prevent AKI by "flushing" myoglobin from the tubules and maintaining high urine output. - Volume: 1–1.5 L/hour in the first hours — in hospital under urine output and haemodynamic monitoring. Target urine output: 200–300 mL/hour until CK normalises - Solution: isotonic saline (0.9% NaCl) — first line. Adding sodium bicarbonate (urinary alkalinisation) theoretically reduces myoglobin precipitation, but clinical superiority over saline alone is not established - Mannitol — discussed as an osmotic diuretic but is not a standard recommendation Eliminate the cause: - Discontinue the offending drug (statin or other) - Treat the underlying condition (infection, seizures) - In crush syndrome — surgical decompression for compartment syndrome Manage complications: - Hyperkalaemia — standard protocols (calcium gluconate, insulin + glucose, dialysis) - AKI — renal replacement therapy when refractory - Compartment syndrome — fasciotomy Prognosis: with mild rhabdomyolysis and early aggressive hydration — full recovery. With severe rhabdomyolysis and AKI — ICU mortality 3–5%; significantly higher with multiorgan failure. When to Seek Urgent Medical Attention - Dark urine after intense exercise, trauma, electric shock, or prolonged lying — go to the emergency department immediately - Severe muscle pain and weakness after exertion in the heat — do not wait if urine darkens - Reduced or absent urine output — sign of developing AKI - Arrhythmia, weakness, or numbness — possible hyperkalaemia; call emergency services - Starting statins + unexplained muscle pain and weakness — check CK and see a doctor This article is for informational purposes only and does not replace consultation with a qualified physician. https://labreadai.com/en/posts/rickets https://labreadai.com/en/posts/rickets Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Rickets is impaired bone mineralisation in children from vitamin D deficiency. Early symptoms, classic skeletal deformities, lab tests (25-OH, calcium, phosphorus) and treatment. Articles article Rickets is a disease once considered defeated — but it is making a comeback. Against a backdrop of growing awareness about sun exposure harm, darker-skinned migrant children, and inadequate vitamin D supplementation, rickets cases are increasing again in developed countries. Understanding rickets matters for every parent: its early signs are easy to miss, and the skeletal consequences of late treatment are irreversible. What Rickets Is and How Vitamin D Deficiency Causes It Rickets is a disease of the growing skeleton in which mineralisation of cartilage and bone tissue in the growth zones is impaired. Bones remain soft and pliable instead of becoming hard — and deform under the weight of the body. In most cases, the cause is vitamin D deficiency. Without sufficient active vitamin D (calcitriol), the intestine cannot absorb calcium from food adequately. In response, parathyroid hormone rises, "leaching" calcium from bones — but even this fails to maintain calcium and phosphorus within normal range. The growth zones of bones, which are especially active in children, fill with unmineralised osteoid — soft tissue instead of solid bone. Rickets develops only in childhood — while the skeleton is growing. In adults, the same mechanism produces osteomalacia (softening of already formed bones), but without growth-related deformities. Risk factors: - Exclusive breastfeeding without vitamin D supplementation: breast milk contains only 50–80 IU/L — catastrophically insufficient - Dark skin: melanin reduces UVB synthesis by 3–6 times - Living at northern latitudes or a lifestyle with minimal sun exposure - Prematurity: vitamin D and calcium stores accumulate in the final trimester - Maternal vitamin D deficiency during pregnancy and breastfeeding - Malabsorption syndromes Rare forms of rickets unrelated to vitamin D deficiency: - Hypophosphataemic rickets (vitamin D-resistant) — genetic defect in renal phosphate reabsorption - Renal osteodystrophy in chronic kidney disease — impaired vitamin D activation - Oncogenic osteomalacia Symptoms of Rickets by Age The clinical picture of rickets changes with the child's age — different growth zones are active at different times. Early signs (2–6 months) At this stage, bony changes are minimal, but the nervous system already responds to disturbed mineral metabolism: - Increased irritability — tearfulness, restless sleep, startle response to sounds - Head sweating — especially the occiput during feeding and sleep. The baby rubs its head against the pillow → occipital alopecia (one of the most recognised, though non-specific, signs) - Craniotabes — softening of the occipital and parietal bones: gentle pressure produces a "parchment crackling" sensation. Appears at 3–6 months, then resolves spontaneously - Delayed closure of the anterior fontanelle Active disease (6–18 months) Rapid skeletal growth combined with worsening deficiency produces pronounced changes: Head: - Frontal and parietal bossing — the skull takes on a "square head" shape (caput quadratum) - Delayed tooth eruption, malocclusion Chest: - "Rachitic rosary" — bead-like enlargements at the costochondral junctions, palpable as a row of nodules along the ribs - "Pigeon chest" (pectus carinatum) — forward protrusion of the sternum - "Cobbler's chest" (pectus excavatum) — sternal depression - "Harrison's sulcus" — horizontal groove along the lower chest margin Spine: rachitic kyphosis ("rachitic hump"), less commonly scoliosis Limbs: - "Rachitic bracelets" — widening at the wrists and ankles - "String of pearls" — phalangeal widening - Genu varum (bow legs) — when walking begins - Genu valgum (knock knees) — less common, in older children Muscular hypotonia — "frog belly," delayed motor milestones: the child is slow to hold the head up, sit, or walk Late manifestations and residual changes With treatment, most changes are reversible. Permanent deformities can include pelvic narrowing (problematic for delivery in girls) and significant limb deformities when treatment is delayed. Diagnosis of Rickets: Lab Tests and X-ray Laboratory findings: Marker In rickets Normal in children --------- Vitamin D 25(OH)D < 20, often < 10 ng/mL 30–50 ng/mL Calcium Normal or reduced 2.2–2.7 mmol/L Phosphorus Reduced — key finding 1.3–2.1 mmol/L Parathyroid hormone Markedly elevated 15–65 pg/mL Alkaline phosphatase (ALP) Sharply elevated Up to 350 U/L in children Alkaline phosphatase in rickets reflects osteoblast activity as they attempt to mineralise bone — it is the primary marker of disease activity. X-ray: Radiographic changes appear later than laboratory abnormalities. Characteristic findings: widening and "fraying" (cupping) of metaphyses, concave ends of long bones, delayed ossification of epiphyseal nuclei. Treatment of Rickets: Vitamin D Dosage and Calcium Treatment depends on the cause: vitamin D-deficiency rickets — correct the deficiency; genetic forms — specialist management with a geneticist and nephrologist. Vitamin D-deficiency rickets (the main form): - Therapeutic dose of vitamin D3: 2,000–4,000 IU/day for 3 months, then maintenance (400–1,000 IU/day) until age 2–3 years - In severe deficiency — 5,000 IU/day under paediatric supervision with urine calcium monitoring - Preparation: cholecalciferol (D3) drops — the standard of care - Calcium: in cases of significant hypocalcaemia — calcium supplements (carbonate or citrate) for the first 2–4 weeks of treatment. When calcium is normal — dietary sources only - Adequate nutrition: breast milk or formula with timely introduction of complementary foods Monitoring treatment response: - At 1 month: clinical assessment, ALP, phosphorus - At 3 months: 25(OH)D, ALP, calcium, phosphorus, PTH - ALP normalisation is the most reliable marker of restored mineralisation Prognosis: When treatment begins before 18 months of age, most deformities resolve completely with growth. Deformities that develop after age 2 resolve more slowly — some require orthopaedic correction. Prevention of Rickets Prevention is a standard of paediatric practice: - All breastfed infants from the first days of life: 400 IU of vitamin D3 per day — regardless of feeding type, until 12 months (some guidelines recommend until age 2) - High-risk children (dark skin, prematurity, maternal deficiency): 800–1,000 IU/day - Pregnant women: prevent vitamin D deficiency — target 25(OH)D ≥ 30–40 ng/mL during pregnancy - Timely introduction of complementary foods with adequate calcium and phosphorus content When to See a Doctor - Visible bone deformities in a child of any age — paediatrician within the next few days - Occipital hair loss + irritability in the first months of life — routine visit with vitamin D level check - Delayed fontanelle closure after 18 months — investigation warranted - A child on exclusive breastfeeding with no vitamin D supplementation — paediatric consultation immediately This article is for informational purposes only and does not replace consultation with a paediatrician or paediatric endocrinologist. https://labreadai.com/en/posts/thrombophilia https://labreadai.com/en/posts/thrombophilia Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Thrombophilia is an increased tendency to form blood clots. Inherited and acquired forms, the role of D-dimer and homocysteine, diagnostic testing and anticoagulant treatment. Articles article Deep vein thrombosis in a young person without an obvious trigger, recurrent miscarriages in a woman with otherwise normal gynaecological findings, a stroke at age 30 — each of these scenarios demands that thrombophilia be excluded. This is not a single disease but a group of conditions united by an increased readiness of the clotting system to form thrombi. Here is what forms exist, how they are identified, and when treatment cannot be avoided. What Thrombophilia Is Thrombophilia is a disorder of haemostasis in which the balance between procoagulant and anticoagulant mechanisms is shifted towards clot formation. Normally, blood clots only where it should — at a site of vessel injury — and the clot dissolves at the right time. In thrombophilia, this process loses its regulation: clots form without apparent cause, in inappropriate locations, or fail to resolve as they should. Thrombophilia may be inherited (a genetically determined defect in clotting factors or their inhibitors) or acquired (develops during life under the influence of disease or external factors). In practice, several defects often coexist in a single patient — this dramatically amplifies the overall thrombotic risk. Thrombophilia alone does not guarantee that a thrombosis will occur. It is a risk factor that becomes manifest in combination with circumstances: pregnancy, surgery, immobility, oral contraceptives. This is precisely why a first thrombotic episode so often coincides with one of these moments. Hereditary Thrombophilia: Factor V Leiden and Other Inherited Forms Factor V Leiden mutation (FV Leiden, R506Q) — the most common inherited thrombophilia in European populations (3–8% of carriers). Factor V becomes resistant to inactivation by protein C. Heterozygotes have a 3–8-fold increased thrombotic risk; homozygotes, 50–80-fold. In heterozygotes using oral contraceptives, the risk of venous thromboembolism rises 35-fold. Prothrombin G20210A mutation — the second most common inherited thrombophilia (2–4% of the population). Leads to elevated prothrombin levels and hypercoagulability. Thrombotic risk is 2–4-fold higher; substantially greater in homozygotes. Protein C deficiency — protein C inactivates factors Va and VIIIa. Its deficiency reduces anticoagulant protection. Prevalence approximately 0.2–0.4%. First thrombosis typically occurs between ages 10 and 40. Protein S deficiency — protein S is a cofactor for protein C. Clinically indistinguishable from protein C deficiency. Antithrombin III deficiency — antithrombin is the primary inhibitor of thrombin and factors Xa and IXa. Deficiency (prevalence 0.02–0.04%) is one of the most thrombogenic inherited thrombophilias: thrombotic risk is elevated 5–50-fold. Acquired Thrombophilia: Antiphospholipid Syndrome and Other Causes Antiphospholipid syndrome (APS) — an autoimmune condition in which antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein-I) target phospholipids and related proteins. The result is a prothrombotic state affecting both the venous and arterial circulation. APS is the leading acquired cause of thrombosis in young people and recurrent miscarriage in women. Hyperhomocysteinaemia — elevated homocysteine damages vascular endothelium and activates coagulation. May be genetic (MTHFR polymorphism) or nutritional (B12, folate, B6 deficiency). Moderately increases the risk of both venous and arterial thrombosis. Nephrotic syndrome — urinary loss of antithrombin III, proteins C and S creates a significant prothrombotic state. Renal vein thrombosis is a characteristic complication of severe nephrotic syndrome. Other acquired factors: malignancy (tumours secrete procoagulants), polycythaemia and thrombocytosis, paroxysmal nocturnal haemoglobinuria, heart failure, obesity. Symptoms and Clinical Presentations Thrombophilia manifests clinically through thrombotic events — the condition itself is asymptomatic. Key signals suggesting possible thrombophilia: - Deep vein thrombosis or pulmonary embolism before age 45 without an obvious provoking factor - Recurrent thromboses — two or more episodes in the history - Thrombosis at atypical sites — mesenteric veins, portal system, cerebral venous sinuses - Arterial thrombosis in the young — stroke or myocardial infarction before age 45 without classical risk factors (characteristic of APS) - Recurrent miscarriage — three or more losses before 10 weeks or one loss after 10 weeks (APS criterion) - Thrombosis during pregnancy or on oral contraceptives - Positive family history — thrombosis in first-degree relatives before age 45 Thrombophilia Diagnosis: Blood Tests, What to Test and When Thrombophilia testing is not routine for everyone — it is indicated only when clinical criteria are met. D-dimer — a marker of active clot formation and fibrinolysis. In thrombophilia as such, D-dimer is not elevated — it rises only during an active thrombotic event. A normal D-dimer with low clinical probability reliably excludes acute thrombosis. Coagulation panel — baseline assessment of the clotting system: INR, aPTT, thrombin time, fibrinogen. A prolonged aPTT without clinical bleeding is a characteristic feature of the lupus anticoagulant in APS. Homocysteine — identifies hyperhomocysteinaemia as an acquired prothrombotic factor. Must be drawn fasting after a strict 12-hour fast — otherwise the result is unreliable. Genetic tests for inherited thrombophilia: - FV Leiden mutation (R506Q) — by PCR - Prothrombin G20210A mutation — PCR - MTHFR C677T and A1298C polymorphisms (in hyperhomocysteinaemia) APS testing (when suspected): - Lupus anticoagulant (LA) — screening and confirmatory tests - Anticardiolipin antibodies (aCL) IgG and IgM - Anti-β2-glycoprotein-I antibodies (aβ2GPI) IgG and IgM APS diagnosis requires two positive results at least 12 weeks apart. Functional tests: - Protein C and protein S activity - Antithrombin III activity Timing rule: most thrombophilia tests cannot be reliably performed during the acute thrombotic event or while on anticoagulants — they distort results. The optimal window is 3–6 months after the thrombotic episode and after anticoagulation has been completed. Genetic tests (FV Leiden, prothrombin mutation) are unaffected by timing and can be done at any time. Thrombophilia Treatment: Anticoagulants, Pregnancy and Prevention Acute thrombosis in thrombophilia is treated identically to standard thrombosis — anticoagulants (direct oral anticoagulants, warfarin, low-molecular-weight heparins). Thrombophilia does not change the approach to acute treatment; it influences the decision about duration of therapy. Duration of anticoagulant therapy is determined by the balance between recurrence risk and bleeding risk: Situation Recommended duration ------ First thrombosis + provoking factor + low-risk thrombophilia 3 months First thrombosis without provoking factor 6 months Recurrent thrombosis Indefinite High-risk thrombophilia (AT III deficiency, homozygous FV Leiden, APS) Indefinite APS with thrombosis Indefinite (warfarin, target INR 2.0–3.0) Prophylaxis during high-risk periods (pregnancy, surgery, immobility) in thrombophilia carriers — prophylactic-dose low-molecular-weight heparins. In pregnant women with inherited thrombophilia or APS, mandatory thromboprophylaxis throughout pregnancy and the postpartum period is standard care. Correcting hyperhomocysteinaemia — folic acid + vitamin B12 + vitamin B6 lower homocysteine and theoretically reduce prothrombotic risk; however, evidence for their impact on thrombosis frequency is less robust than for stroke reduction. When to See a Doctor Planned thrombophilia workup is indicated for: first thrombosis before age 45 without a clear provoking factor; recurrent thromboses; thrombosis at atypical sites; recurrent miscarriage; planning pregnancy in a woman with a personal or strong family history of thrombosis. Urgently: a first episode of deep vein thrombosis or suspected pulmonary embolism — immediate hospitalisation and anticoagulation cannot wait for genetic test results. This article is for informational purposes only. Thrombophilia workup and treatment are carried out by a haematologist or vascular specialist. https://labreadai.com/en/posts/type-1-diabetes https://labreadai.com/en/posts/type-1-diabetes Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Type 1 diabetes is autoimmune destruction of pancreatic β-cells. Onset symptoms, diagnosis (glucose, HbA1c, antibodies), insulin therapy, ketoacidosis and glucose monitoring. Articles article Type 1 diabetes is a disease that changes life in a single day. Yesterday a young person was healthy; today — thirst, frequent urination, rapid weight loss and, if the moment is missed, ketoacidosis and intensive care. Unlike type 2 diabetes, no diet will help and there is no "wait and see" period: the β-cells are gone, and insulin is needed from day one — for life. What Type 1 Diabetes Is Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease in which the immune system destroys the insulin-producing β-cells of the islets of Langerhans in the pancreas. When 80–90% of β-cells are lost, absolute insulin deficiency develops and clinical diabetes manifests. Insulin is the key anabolic hormone: it unlocks cellular access to glucose. Without it, glucose accumulates in the blood (hyperglycaemia) while cells "starve." In response, the body switches to fat breakdown → ketone bodies are produced → metabolic acidosis develops (ketoacidosis) — a direct threat to life. Epidemiology: T1DM accounts for 5–10% of all diabetes cases. Incidence is highest in children and adolescents (peak age 10–14 years), but T1DM can manifest at any age, including adults (LADA — latent autoimmune diabetes of adults). Incidence varies considerably by country and ethnicity. Genetics and triggers: 90% of T1DM patients carry HLA-DR3 or HLA-DR4 haplotypes. Concordance in identical twins is only 30–50%, confirming that external triggers are required: viral infections (Coxsackievirus B), microbiome changes, early exposure to cow's milk protein. The precise mechanism initiating the autoimmune attack remains incompletely understood. Onset Symptoms: When Time Cannot Be Wasted The classic "four Ps" of T1DM presentation: Polyuria — frequent, high-volume urination including at night. Mechanism: hyperglycaemia → glucose filtered into urine → osmotic diuresis → fluid and electrolyte loss. Polydipsia — unquenchable thirst in response to fluid loss. Weight loss — rapid loss (5–10 kg or more over a few weeks) without reduced appetite. Mechanism: cells cannot access glucose → catabolism of protein and fat. Polyphagia — increased appetite despite ongoing weight loss (the paradox of "hunger amid plenty"). Additional symptoms: fatigue and weakness, blurred vision (from osmotic lens changes in hyperglycaemia), slow wound healing, fungal infections (candidiasis). In children, onset is often rapid — progressing to full ketoacidosis within days. Secondary nocturnal enuresis in a previously toilet-trained child is a warning sign. LADA (in adults): onset after age 30, frequently misclassified as T2DM. Distinguishing features: lean patient, rapid insulin requirement, positive autoantibodies (GADA, IA-2A). Diagnosis of Type 1 Diabetes Diagnostic criteria for diabetes (WHO) Diabetes is diagnosed when at least one of the following is present: - Fasting glucose ≥ 7.0 mmol/L (on two occasions) - 2-hour glucose ≥ 11.1 mmol/L on OGTT - Random glucose ≥ 11.1 mmol/L + symptoms - HbA1c ≥ 6.5% (on two occasions) With classic symptoms and random glucose ≥ 11.1 mmol/L, repeat confirmation is not required. Specific markers of T1DM Autoantibodies — confirm autoimmune aetiology: - GADA (glutamic acid decarboxylase antibodies) — most sensitive; positive in 70–80% - IA-2A (islet antigen-2 antibodies) — in 60–70% - ZnT8A (zinc transporter 8 antibodies) — in 60–70% - IAA (insulin autoantibodies) — important before insulin therapy begins C-peptide — marker of residual insulin secretion. Markedly reduced or undetectable in T1DM. Distinguishes T1DM (low C-peptide) from T2DM (normal or elevated) and LADA. Blood glucose and HbA1c — current and medium-term glycaemic assessment. Urine ketones and blood β-hydroxybutyrate — when ketoacidosis is suspected. Ketoacidosis — The Primary Threat at Onset and Decompensation Diabetic ketoacidosis (DKA) is the most life-threatening acute complication of T1DM — often the initial presentation in undiagnosed patients or the result of missed insulin injections. Mechanism: absolute insulin deficiency → intense lipolysis → hepatic ketogenesis → accumulation of β-hydroxybutyrate and acetoacetate → metabolic acidosis. DKA symptoms: - Nausea, vomiting, abdominal pain - Acetone breath ("fruity" odour) - Kussmaul breathing — deep, rapid compensatory respiration - Dehydration, dry skin and mucous membranes - Impaired consciousness to coma Laboratory findings: glucose 11 mmol/L, urine ketones +++, pH < 7.3, bicarbonate < 15 mmol/L, potassium may be normal or elevated despite total body K⁺ depletion. DKA treatment: inpatient only — fluid resuscitation, intravenous insulin, electrolyte correction. Mortality in specialist centres < 1%; without treatment, fatal. Insulin Therapy and Glucose Monitoring in Type 1 Diabetes T1DM requires lifelong insulin replacement therapy — this is not a choice but a biological necessity. Insulin regimens Basal-bolus regimen — the physiological standard: - Basal insulin (long-acting: glargine, detemir, degludec) — once or twice daily, covering background requirements - Bolus insulin (rapid-acting: aspart, lispro, glulisine) — before each meal, dose calculated by carbohydrate content Insulin pump (CSII) — continuous subcutaneous infusion of rapid-acting insulin. More precisely mimics physiological secretion; indicated for unstable glycaemia and frequent hypoglycaemia. Glucose monitoring Traditional self-monitoring (glucometer) — minimum 4 measurements daily (before meals and before bed). Continuous glucose monitoring (CGM) — a subcutaneous sensor measures glucose every 1–5 minutes. Has revolutionised glycaemic control: reduces hypoglycaemia frequency (especially nocturnal) and time outside target range. "Time in range" (TIR, 3.9–10 mmol/L) is more informative than HbA1c alone for assessing control quality. HbA1c — every 3 months with unstable control; every 6 months when stable. Target for most T1DM patients: < 7.0%. Hypoglycaemia — the primary treatment risk Hypoglycaemia (glucose < 3.9 mmol/L) is the most frequent acute complication of insulin therapy. Mild symptoms: tremor, sweating, palpitations, anxiety, hunger — adrenergic. Severe hypoglycaemia (< 2.8 mmol/L): confusion, seizures, loss of consciousness — requires external assistance. Treatment: the "15–15 rule" — 15 g of fast-acting carbohydrates (3–4 glucose tablets, 150 mL juice), recheck after 15 minutes; repeat if symptomatic. If unconscious — intramuscular glucagon or intravenous 40% dextrose. Closed-loop technology "Artificial pancreas" systems automatically adjust the pump's insulin delivery based on real-time CGM data. Commercially available systems (Omnipod 5, MiniMed 780G) have demonstrated significant TIR improvement and reduced hypoglycaemia frequency. Long-Term Complications of T1DM Chronic hyperglycaemia damages blood vessels and nerves: Microvascular: diabetic retinopathy (leading cause of adult blindness), nephropathy (progresses to CKD), neuropathy (painful, autonomic). Macrovascular: accelerated atherosclerosis → myocardial infarction, stroke, peripheral artery disease. Each 1% reduction in HbA1c reduces the risk of microvascular complications by 25–35% — a powerful rationale for tight glycaemic control. When to Seek Urgent Medical Attention - Thirst + frequent urination + weight loss in a child or young adult — rule out T1DM; check blood glucose immediately - Acetone breath, vomiting, abdominal pain in a patient with diabetes — signs of DKA; call emergency services immediately - Loss of consciousness in a patient with diabetes — hypoglycaemia or DKA; emergency services - Glucose 15 mmol/L + urine ketones — do not wait; go to emergency care This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/posts/vitamin-b12-deficiency https://labreadai.com/en/posts/vitamin-b12-deficiency Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) B12 deficiency anaemia strikes both blood and the nervous system. Symptoms that are easy to miss, the right blood tests, causes of deficiency and treatment options explained. Articles article Pallor, exhaustion, tingling fingers, an unsteady gait — each of these can easily be attributed to stress, a sedentary job, or simply getting older. But when they appear together, one test is worth checking first: vitamin B12 in the blood. B12 deficiency is unique in that it attacks on two fronts simultaneously: it disrupts normal blood cell production and damages the nervous system. Neurological injury can progress even when anaemia is not yet present. Here is how this happens, who is at risk, and what to do about it. What Is B12-Deficiency Anaemia and Why the Vitamin Matters Vitamin B12 (cobalamin) is a water-soluble vitamin the body cannot synthesise on its own. It comes exclusively from animal-source foods: meat, fish, eggs and dairy. Liver stores are substantial — around 2–5 mg, enough for 3–5 years. This is precisely why deficiency develops slowly and goes undetected for a long time. B12 is essential for two key biochemical reactions. The first is DNA synthesis. Without B12, cells cannot divide normally. The first to suffer are the fastest-dividing cells — red blood cell precursors in the bone marrow. They grow but cannot split: the result is giant, immature cells called megaloblasts. Hence the name — megaloblastic anaemia. The second is myelin maintenance. B12 participates in the synthesis of myelin — the fatty sheath that insulates nerve fibres. Without it, nerve impulse conduction deteriorates or fails entirely. Chronic deficiency leads to degeneration of the posterior and lateral columns of the spinal cord — a condition known as subacute combined degeneration (funicular myelosis). This combination — anaemia plus neuropathy — makes B12 deficiency unique: it is the only vitamin deficiency in which neurological damage can progress with a completely normal blood count. B12 Deficiency Neurological and Anaemia Symptoms The symptom picture of B12 deficiency reflects two parallel processes — anaemia and nervous system injury. They may develop together or independently. Haematological symptoms — a consequence of ineffective blood cell production: - Pallor, sometimes with a faint yellow tinge (from breakdown of defective red cells) - Weakness and rapid fatigue with minimal exertion - Shortness of breath on ordinary walking - Palpitations and dizziness - Inflamed, smooth, red "glazed" tongue (Hunter's glossitis) — a near-pathognomonic sign seen in about 25% of patients Neurological symptoms — a consequence of demyelination: - Numbness and tingling beginning symmetrically at the fingertips and toes - Unsteady gait, imbalance in the dark or with eyes closed - Muscle weakness, especially in the legs - Cognitive disturbances: poor concentration, memory lapses, slowed thinking - In severe cases — spasticity and bladder or bowel dysfunction One critical point: neurological symptoms can precede anaemia by months or years. If treatment begins late, some neurological damage is irreversible. This is the strongest argument for early diagnosis — do not wait for the haemoglobin to fall. Causes of Vitamin B12 Deficiency: Pernicious Anaemia, Vegans and More Deficiency develops through three main mechanisms: inadequate intake, impaired absorption, and increased demand. Cause Mechanism Who is at risk --------- Strict vegetarianism / veganism B12 is found only in animal foods Vegans not taking supplements Pernicious anaemia (Addison-Biermer) Autoimmune destruction of gastric cells producing intrinsic factor Over 60, more common in women Atrophic gastritis Reduced stomach acid → impaired release of B12 from food proteins Elderly, H. pylori carriers Metformin use Impairs B12 absorption in the ileum — dose-dependent effect All type 2 diabetes patients on metformin PPI use (omeprazole etc.) Reduced gastric acid — same mechanism Those taking PPIs for 2 years Gastric or ileal resection Removal of the site of intrinsic factor production or absorption After bariatric surgery Crohn's disease, coeliac disease Inflammation or atrophy of ileal mucosa IBD patients Fish tapeworm infection Parasite competes for B12 in the gut Endemic regions Metformin use deserves special mention: it is one of the most common and underappreciated causes of B12 deficiency. Clinical guidelines call for monitoring B12 in all patients on long-term metformin — yet in practice this is rarely done. Macrocytic Anaemia Diagnosis: Which Blood Tests Are Needed Vitamin B12 in blood — the primary test. A level below 148 pmol/L (200 pg/mL) indicates frank deficiency; 148–221 pmol/L is a "grey zone" requiring further assessment. Importantly: a normal B12 level does not completely exclude functional deficiency — some patients have symptoms with "normal" values. In equivocal cases, methylmalonic acid and homocysteine are measured additionally — they rise before B12 itself falls. Complete blood count — key findings: - MCV elevated ( 100 fL) — macrocytosis, enlarged red cells - Haemoglobin reduced in established anaemia - RDW elevated — anisocytosis, red cells of varying size - Reticulocytes reduced — bone marrow production is failing - Leukopaenia and thrombocytopaenia in severe deficiency (pancytopaenia) - Blood film — hypersegmented neutrophils (5 or more nuclear lobes) — an early and specific sign Folate — must always be measured simultaneously with B12. Folate deficiency produces an identical blood picture but does not cause neurological damage. Treatment differs — so distinguishing them before starting therapy is essential. Additionally — when pernicious anaemia is suspected: anti-intrinsic factor antibodies (specificity 95%) and anti-parietal cell antibodies. Vitamin B12 Deficiency Treatment: Injections or Tablets The choice of administration route is surrounded by more myths than almost any other aspect of B12 treatment. Intramuscular injections of cyanocobalamin or hydroxocobalamin — the classical approach, mandatory when: - Intestinal absorption is impaired (pernicious anaemia, atrophic gastritis, surgical resections) - Severe anaemia with haemoglobin below 70–80 g/L - Significant neurological deficits are present Loading schedule: 1000 µg daily or on alternate days for 1–2 weeks, then a maintenance dose once monthly for life (in pernicious anaemia). High-dose oral B12 (1000–2000 µg/day) — a proven alternative when gut function is intact. About 1% of B12 is absorbed passively, without intrinsic factor — at high doses this is sufficient. Effective for dietary deficiency in vegans and for metformin-related deficiency. Follow-up tests after starting treatment: - At 7–10 days — reticulocyte crisis (a sharp rise in reticulocytes — the sign of treatment response) - At 4–8 weeks — normalisation of MCV and haemoglobin - Neurological symptoms regress more slowly — sometimes over months; when treatment begins late, partial irreversibility is possible A critical warning: when both B12 and folate are deficient, starting treatment with folate alone can worsen neurological damage by "masking" the anaemia while nerve injury continues. B12 Deficiency vs Folate Deficiency: How to Tell Them Apart Both deficiencies cause macrocytic anaemia, and the blood count alone cannot distinguish them. The one defining difference is: folate deficiency does not cause neurological damage. This is an absolute rule and the primary clinical guide. Feature B12 deficiency Folate deficiency --------- MCV (macrocytosis) ↑ ↑ Haemoglobin ↓ ↓ Neuropathy, ataxia Yes — frequently No B12 blood level ↓ Normal or mildly reduced Folate level May be secondarily low ↓ Methylmalonic acid ↑ Normal Typical causes Malabsorption, veganism, pernicious anaemia Pregnancy, alcohol, coeliac disease, dietary deficit In practice, when macrocytic anaemia is found, both markers are always measured in a single blood draw — this takes one venepuncture and eliminates the risk of a treatment error. When to See a Doctor Urgently Most B12-deficiency cases are managed electively. However, several presentations call for rapid assessment: - Progressive leg weakness or gait disturbance — possible subacute combined degeneration; delay increases the risk of irreversible cord damage - Confusion or rapid cognitive decline in an older adult — B12 deficiency is one of the reversible causes of dementia - Haemoglobin below 70 g/L with signs of heart failure — requires urgent correction - Newly discovered macrocytosis (MCV 110 fL) without explanation — warrants investigation without delay Anyone who has followed a vegan or strict vegetarian diet for more than three years without taking B12 supplements should have their levels checked routinely — not waiting for symptoms. Liver stores last a long time, but when they run out the disease is already fully established. This article is for informational purposes only. Diagnosis and treatment are the responsibility of a general practitioner or haematologist. https://labreadai.com/en/posts/vitamin-d-deficiency https://labreadai.com/en/posts/vitamin-d-deficiency Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Vitamin D deficiency is the most common nutritional deficiency. Symptoms in adults and children, causes, diagnosis by 25-OH test, treatment regimens and prevention. Articles article Fatigue, frequent colds, bone and muscle pain, low mood through the winter months — all of these can be manifestations of a single deficiency. Vitamin D insufficiency affects 40–70% of people in northern countries and most urban populations in temperate zones, yet it remains underdiagnosed: symptoms are non-specific and the clinical picture unfolds slowly — over months and years. Why Vitamin D Deficiency Is So Common Vitamin D is unique in that most of it is not obtained from food but synthesised in the skin under ultraviolet B (UVB) radiation. This dependence on sunlight makes deficiency almost inevitable for much of humanity under modern conditions. People living at latitudes above 35–40° are essentially cut off from UVB synthesis between October and April: the sun's angle is such that UVB rays are absorbed by the atmosphere before reaching the ground. Even on sunny winter days, going outside provides no vitamin D synthesis — only tanning from UVA rays. Beyond geography — lifestyle: most people spend their working day indoors. SPF-15 sunscreen blocks 99% of UVB synthesis. Darker skin requires 3–6 times more sun exposure to produce the same amount of vitamin D. In people over 65, skin synthesis efficiency is reduced fourfold. Obtaining enough vitamin D from food is practically impossible: even fatty fish (salmon, mackerel, sardines) provides 400–600 IU per 100 g — against a minimum adult requirement of 800–1,000 IU per day and a therapeutic dose of 4,000–5,000 IU for deficiency correction. Symptoms of Vitamin D Deficiency in Adults The insidious nature of vitamin D deficiency is its silence. Most people with levels of 10–15 ng/mL have no prominent complaints. Symptoms accumulate gradually and are often attributed to stress, fatigue, or ageing. Musculoskeletal symptoms: Diffuse bone pain — particularly in the ribs, spine, pelvis, and thighs — that is tender on pressure. This is osteomalacia: deficiency impairs bone mineralisation, leaving bones soft and painful. Proximal muscle weakness — difficulty rising from a chair or climbing stairs — is characteristic of severe deficiency. In older adults, vitamin D deficiency increases fall risk (impaired neuromuscular function) and fracture risk (osteoporosis with prolonged deficiency). Fatigue and low energy: Chronic fatigue is one of the most frequent but non-specific symptoms. The mechanism relates to vitamin D's role in mitochondrial metabolism and cellular energy processes. Frequent infections: Vitamin D activates innate immunity — stimulating the synthesis of antimicrobial peptides (cathelicidin, defensins) and regulating the inflammatory response. Deficiency is associated with more frequent upper respiratory infections, influenza, and severe respiratory illness. Low mood and depression: Vitamin D receptors are present in the hippocampus and other brain structures. Deficiency is associated with increased risk of depression and seasonal affective disorder (SAD). The relationship with melatonin and serotonin is actively studied. Hair loss: Vitamin D participates in the hair follicle growth cycle. Deficiency is associated with diffuse hair loss — alopecia that often worsens in autumn and winter. Sleep disturbances: Vitamin D receptors are involved in circadian rhythm regulation through interaction with melatonin. Deficiency may contribute to impaired sleep onset and quality. High-Risk Groups Children under 5: breast milk contains little vitamin D (50–80 IU/L). If the nursing mother is deficient, the infant receives almost none. Severe deficiency → rickets. Pregnant women: vitamin D deficiency during pregnancy raises the risk of pre-eclampsia, gestational diabetes, preterm birth, and impaired fetal bone mineralisation. The target level during pregnancy is at least 40 ng/mL. Older adults: reduced skin synthesis, less time outdoors, declining kidney function (impaired 25-OH → calcitriol conversion). Increased fracture and sarcopenia risk. People with darker skin: melanin competes with provitamin D3 for UVB — 3–6 times more sun exposure is needed for equivalent synthesis. Patients with obesity: vitamin D is fat-soluble and sequesters in adipose tissue — bioavailability is reduced; doses 2–3 times higher than standard are needed to reach target levels. Malabsorption syndromes: coeliac disease, Crohn's disease, bariatric surgery — impaired absorption of fat-soluble vitamins. Diagnosis: The 25-OH Vitamin D Blood Test The only reliable way to detect deficiency is a blood test for 25-hydroxyvitamin D [25(OH)D]. For detailed normal ranges and interpretation, see Vitamin D. Practical thresholds: - < 10 ng/mL — severe deficiency; risk of osteomalacia and myopathy - 10–20 ng/mL — deficiency; therapeutic doses required - 20–30 ng/mL — insufficiency; correction needed - 30–60 ng/mL — normal, target range - 100 ng/mL — possible toxicity Additional tests when deficiency is confirmed: parathyroid hormone (elevated in deficiency — secondary hyperparathyroidism), blood calcium, phosphorus, magnesium — when treatment resistance is suspected. Treatment of Vitamin D Deficiency Form selection: vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) — better absorbed and more effective at raising 25(OH)D levels. Oil-based preparations are slightly better absorbed than aqueous forms when taken with fatty food, though the clinical difference is minimal with correct administration. Treatment regimens by severity: 25(OH)D level Regimen ------ < 20 ng/mL 4,000–5,000 IU/day × 8–12 weeks, then maintenance 20–30 ng/mL 2,000–3,000 IU/day × 8–12 weeks, then maintenance Maintenance (after correction) 1,500–2,000 IU/day year-round Alternatively, bolus regimens: 50,000 IU once weekly for 8–12 weeks — equally effective but requires closer monitoring. Administration rules: - Take with a fat-containing meal — this fat-soluble vitamin is absorbed with dietary fats - Check blood levels 3 months after starting treatment - If levels exceed 60 ng/mL after treatment — switch to a preventive dose Treatment resistance — what to do: If levels do not normalise after 3 months of adequate dosing — check magnesium: deficiency blocks vitamin D activation enzymes. Also rule out malabsorption and chronic kidney disease (impaired 25-OH → calcitriol conversion). When active vitamin D is needed (alfacalcidol, calcitriol): In chronic kidney disease with significantly reduced GFR, the kidneys cannot activate standard vitamin D. Pre-activated forms are used in these cases — strictly under nephrologist supervision. Prevention - Sun exposure: 15–30 minutes of direct sun (arms, legs) between 10 AM and 3 PM, 3–4 times a week — provided latitude and season allow UVB synthesis. Do not burn. - Supplements: residents of northern latitudes (above 40–45°) are advised to take vitamin D year-round. Minimum preventive dose: 800–1,000 IU/day for adults; 400–600 IU/day for children. - Level monitoring: 25(OH)D blood test once a year — at the end of winter (February–March), when levels are lowest. - Diet: fatty fish, egg yolks, fortified foods — the contribution is modest but worth including. When to See a Doctor - Level < 10 ng/mL — severe deficiency with osteomalacia risk: endocrinology consultation within days - Deficiency not correcting with standard doses after 3 months — investigate the cause of resistance - Deficiency identified during pregnancy — urgent obstetric consultation - Deficiency in a child with signs of skeletal deformity — paediatrician or paediatric endocrinologist immediately This article is for informational purposes only and does not replace consultation with a qualified physician. https://labreadai.com/en/indicators/bilirubin https://labreadai.com/en/indicators/bilirubin Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Total, direct and indirect bilirubin: normal ranges in adults and newborns, causes of jaundice, differential diagnosis and when elevated bilirubin needs urgent care. Indicators article A yellowish tint to the skin or whites of the eyes is the visible expression of what is happening with bilirubin in the blood. But jaundice is just the tip of the iceberg: bilirubin abnormalities are frequently discovered well before jaundice becomes apparent — on a routine panel. Knowing which fraction is elevated — direct or indirect — and in what context immediately narrows the diagnostic search from "something is wrong with the liver" to a specific mechanism of disruption. What Bilirubin Is and How It Forms Bilirubin is a yellow-orange pigment, the final breakdown product of heme. Approximately 80% derives from the destruction of aging red blood cells in the reticuloendothelial system (spleen, liver, bone marrow). The remaining 20% comes from other heme-containing proteins: myoglobin, cytochromes, and catalase. The bilirubin pathway involves several steps: 1. Indirect (unconjugated) bilirubin forms from heme breakdown and enters the blood, where it binds to albumin. It is fat-soluble and toxic to nervous tissue. In this form it is transported to the liver 2. Hepatic conjugation: hepatocytes take up indirect bilirubin and attach glucuronic acid using the enzyme UGT1A1. This produces direct (conjugated) bilirubin — water-soluble and non-toxic 3. Biliary excretion: direct bilirubin is excreted into bile and passes into the intestine, where gut bacteria convert it to urobilinogen and stercobilin. Urobilinogen is partially reabsorbed into the blood and excreted in urine; stercobilin colors the stool Total bilirubin = direct + indirect. The ratio of these fractions identifies the stage at which the process broke down. Understanding this pathway explains why jaundice looks different in different diseases: in hemolysis, urine is dark but stool is normally colored; in bile duct obstruction, stool becomes pale and urine turns dark. A liver function test is always a composite view of this entire metabolic pathway. Normal Bilirubin Levels Reference values are largely sex-independent in adults. In newborns, thresholds are fundamentally different and reflect fetal hemoglobin physiology. Marker Normal in adults Units --------- Total bilirubin 3.4–17.1 µmol/L Direct (conjugated) 0–5.1 µmol/L Indirect (unconjugated) 1.7–13.6 µmol/L Clinically relevant thresholds for total bilirubin: Level (µmol/L) Interpretation ------ < 17.1 Normal 17.1–34.2 Subclinical hyperbilirubinemia — no visible jaundice 34.2 Jaundice becomes visible (scleral icterus) 85–100 Marked jaundice requiring active investigation 200–300 Severe hyperbilirubinemia — high risk of complications In newborns, jaundice in the first days of life is physiological: neonatal bilirubin peaks on days 3–5. Norms and treatment thresholds depend on gestational age and hours of life — interpretation is strictly pediatric. Unit conversion: mg/dL × 17.1 = µmol/L. How to Prepare for a Bilirubin Test Bilirubin is measured in serum and is sensitive to several pre-analytical factors. - Strictly fasting: minimum 8–12 hours. Fatty meals activate bile flow and transiently reduce direct bilirubin - Light protection: bilirubin is photosensitive — shield the sample from direct light immediately after collection - Rapid delivery to the lab: at room temperature under light, bilirubin degrades by 30–50% within a few hours - No alcohol for 24–48 hours before testing - Disclose all medications: rifampicin, certain antibiotics, and contrast agents can produce false elevation Bilirubin is a standard component of the liver function panel alongside ALT, AST, ALP, GGT, and albumin. Isolated interpretation without these companion markers frequently leads to incorrect conclusions. Causes of Elevated Direct (Conjugated) Bilirubin Direct bilirubin rises when the liver conjugates bilirubin normally but its excretion is impaired — either from the hepatocyte into bile or along the biliary tract. Cause Mechanism Characteristic features --------- Viral hepatitis (A, B, C, E) Hepatocyte injury — impaired excretion Elevated ALT/AST; viral markers positive Alcoholic hepatitis Toxic liver injury AST/ALT 2; markedly elevated GGT Gallstone disease with choledocholithiasis Mechanical bile duct obstruction Colicky pain; elevated ALP and GGT Pancreatic cancer / cholangiocarcinoma Common bile duct compression Painless progressive jaundice Primary biliary cholangitis (PBC) Autoimmune destruction of small bile ducts AMA antibodies; itch; ALP predominates Primary sclerosing cholangitis (PSC) Biliary fibrosis Association with ulcerative colitis Dubin–Johnson / Rotor syndrome Genetic defect in direct bilirubin transport Benign; family history Drug-induced hepatitis Toxic or immune liver injury Clear temporal link to drug initiation Intrahepatic cholestasis of pregnancy Impaired bile flow in late pregnancy Third trimester; intense itch When direct bilirubin is elevated, C-reactive protein helps quantify the inflammatory component and distinguish infectious hepatitis from mechanical obstruction — in the latter, CRP is often normal or only modestly elevated. Causes of Elevated Indirect (Unconjugated) Bilirubin Indirect bilirubin rises when it is produced faster than the liver can process it, or when the hepatocytes' capacity for conjugation is itself reduced. Cause Mechanism Characteristic features --------- Hemolytic anemia Accelerated red cell destruction — substrate overload Hemoglobin low; reticulocytes ↑; haptoglobin ↓ Gilbert's syndrome Genetic reduction in UGT1A1 activity Benign; triggered by fasting and stress Crigler–Najjar disease Complete or near-complete UGT1A1 absence Severe neonatal jaundice Neonatal jaundice (physiological) Immature neonatal enzyme systems Peaks days 3–5 of life Massive hematoma or hemorrhage Extravascular blood breakdown Mild elevation; link to trauma Infectious mononucleosis, malaria Hemolytic component Splenomegaly; characteristic systemic signs Right heart failure Hepatic venous congestion → hepatocyte hypoxia Hepatomegaly; edema Gilbert's syndrome is the most common cause of chronically elevated indirect bilirubin in young adults: present in 5–10% of the population, entirely benign, requires no treatment. Diagnostic pattern: total bilirubin 20–50 µmol/L with normal direct bilirubin, ALT, AST, and albumin; levels rise with fasting or physical stress. Differential Diagnosis of Jaundice by Bilirubin Fraction The first and most critical step in any jaundice workup is determining which fraction is elevated. This immediately separates three fundamentally different pathogenic mechanisms. Type of jaundice Direct Br Indirect Br ALT/AST ALP/GGT Stool color Urine color --------------------- Prehepatic (hemolysis) Normal ↑↑ Normal Normal Normal Dark Hepatic (hepatitis, cirrhosis) ↑↑ ↑ ↑↑↑ ↑ Mildly pale Dark Posthepatic (cholestasis, obstruction) ↑↑↑ Normal/↑ Mildly ↑ ↑↑↑ Completely pale Dark ("beer-colored") Pale or clay-colored stool (acholic stool) is one of the most specific signs of mechanical biliary obstruction. Abdominal ultrasound of the liver and biliary tract is the mandatory next step after any marked direct bilirubin elevation: dilated bile ducts confirm obstruction. When Bilirubin Abnormalities Require Medical Attention A mild isolated indirect bilirubin elevation in a young asymptomatic person with normal liver enzymes is most likely Gilbert's syndrome: observation, not treatment. Scheduled visit to a GP or gastroenterologist when: - Total bilirubin 34 µmol/L with any deviation in ALT, AST, ALP, or GGT - Moderate isolated elevation of direct bilirubin — even without visible jaundice - Repeatedly elevated total bilirubin without an obvious cause - Skin itch combined with any bilirubin elevation — a sign of cholestasis Seek urgent care when: - Total bilirubin 85–100 µmol/L with worsening jaundice - Pale stools combined with dark urine and jaundice - Fever with right upper quadrant pain and jaundice — cholangitis (Charcot's triad), a medical emergency - Rapid deterioration in a patient with known liver disease: worsening jaundice, confusion, or bleeding — signs of decompensated cirrhosis Confusion in the setting of marked jaundice is a sign of hepatic encephalopathy and requires immediate hospitalization. This article is for informational purposes only and does not replace professional medical advice. Consult a GP or gastroenterologist if your bilirubin is elevated. https://labreadai.com/en/indicators/bnp https://labreadai.com/en/indicators/bnp Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) BNP and NT-proBNP are the main laboratory markers of heart failure. Normal levels, causes of elevation, interpretation and when to see a doctor urgently. Indicators article Shortness of breath climbing the stairs. Swollen ankles by evening. Fatigue that sleep does not fix. These are the symptoms that prompt a doctor to order a BNP or NT-proBNP test — natriuretic peptides that the heart releases into the bloodstream when it is working under excess strain. This article explains what each marker measures, what the numbers mean, and when a high result demands immediate action. What Is BNP and Why Is It Measured? BNP stands for brain natriuretic peptide — a name rooted in a historical accident, because the molecule was first isolated from pig brain tissue. In humans it is produced almost exclusively by the ventricles of the heart. When ventricular walls are stretched by excess blood volume or elevated pressure, cardiomyocytes synthesise a precursor molecule called proBNP, which is immediately cleaved into two fragments: the biologically active BNP and the inert NT-proBNP. Think of the heart as a balloon: the more it is overfilled, the more distress signal it releases. BNP is that signal. Under normal conditions its blood concentration is negligible. In heart failure it rises in direct proportion to disease severity, making it one of the most clinically useful objective markers in cardiology. Both peptides serve the same purpose: diagnosing and monitoring heart failure. The choice between them depends on the laboratory's equipment — the two results cannot be compared against each other, as each uses entirely different reference ranges. BNP and NT-proBNP Normal Ranges: Reference Table Diagnostic thresholds recommended by European heart failure guidelines differ between the two peptides and are adjusted for patient age. BNP (pg/mL) Interpretation BNP value ------ Normal — heart failure unlikely < 100 Grey zone — further workup needed 100–400 Heart failure likely 400 NT-proBNP (pg/mL) — age-adjusted Age Chronic normal threshold Acute HF likely --------- < 50 years < 125 450 50–75 years < 125 900 75 years < 450 1800 In the acute emergency setting, a single age-independent rule applies: NT-proBNP below 300 pg/mL effectively excludes acute heart failure as the cause of sudden breathlessness, regardless of age. Older patients have physiologically higher NT-proBNP because kidney filtration declines with age and the peptide accumulates. Obesity has the opposite effect — adipose tissue accelerates BNP degradation, shifting effective thresholds downward in patients with a high body mass index. BNP vs NT-proBNP: What Is the Difference? Both peptides are cleaved from proBNP simultaneously and in equimolar amounts. The practical differences lie in their half-lives and stability. BNP is biologically active: it dilates blood vessels, promotes renal sodium and water excretion, and lowers blood pressure. Its half-life is approximately 20 minutes. NT-proBNP is inert but far more stable — it circulates for 1–2 hours, providing a more integrated picture of chronic ventricular overload. BNP, in contrast, responds more rapidly to acute haemodynamic changes. In practice the choice is made by the laboratory, not the clinician. The key rule for serial monitoring: never mix the two tests. If the baseline measurement was BNP, all follow-up measurements must also be BNP. Causes of High BNP and NT-proBNP Elevated natriuretic peptides almost always signal overload or damage to the heart muscle — but the range of causes extends well beyond heart failure alone. Cardiac causes. Chronic and acute heart failure — both with reduced and preserved ejection fraction — are the primary driver of elevated peptides. Myocardial infarction causes an acute surge: the necrotic zone stretches the ventricular wall and triggers proBNP synthesis. To distinguish infarction from pure decompensated failure, troponin is measured simultaneously — it is far more specific for cardiomyocyte necrosis. Renal causes. The kidneys are the primary clearance route for NT-proBNP. In chronic kidney disease and acute kidney injury, peptide levels rise even without underlying cardiac pathology. Evaluating creatinine alongside the natriuretic peptide is essential: an elevated NT-proBNP paired with renal failure demands careful interpretation, not an automatic heart failure label. Other causes. Pulmonary embolism overloads the right ventricle and raises both markers. Severe pneumonia, sepsis, thyrotoxicosis and anaemia — conditions that force the heart to work harder than normal — can cause moderate elevations. When interpreting results, the physician also orders a kidney function test and assesses sodium levels, which carry independent prognostic weight in heart failure patients. What Does Low BNP Mean? A low BNP is reassuring. A patient presenting with breathlessness whose BNP is below 100 pg/mL can be reliably told that heart failure is an unlikely explanation for their symptoms. This is one of medicine's most useful negative predictive values — a normal result genuinely rules out cardiac origin in the vast majority of cases. Truly low peptides despite real cardiac pathology occur in two situations: obesity (adipose tissue accelerates BNP degradation) and patients responding well to treatment. A falling natriuretic peptide on serial measurement is among the strongest signals that heart failure therapy is working. How to Prepare for a BNP Blood Test BNP and NT-proBNP are analytically stable cardiac biomarkers. A few practical steps improve the reliability of results. The test is best performed fasting or two to three hours after a light meal — not critical, but recommended. Moderate physical activity transiently raises BNP, so avoid strenuous exercise on the day of the blood draw. Most importantly, inform your doctor about all medications: sacubitril/valsartan (ARNI class) artificially elevates BNP while simultaneously lowering NT-proBNP — this substantially changes how results are interpreted. Blood is drawn from a vein, typically in the morning. No demanding twelve-hour fasting or medication holds are required. When High BNP Requires Emergency Attention A mildly elevated BNP in a patient with established chronic heart failure is a routine finding managed by a cardiologist at scheduled outpatient visits. Certain combinations of symptoms and laboratory findings, however, cannot wait. Call emergency services immediately if a high BNP coincides with: sudden severe breathlessness at rest; pink or frothy sputum; crushing chest pain radiating to the arm or jaw; loss of consciousness or near-syncope; a sharp drop in blood pressure; markedly reduced urine output alongside worsening oedema. These are signs of acute decompensated heart failure or an acute coronary event — both are time-critical emergencies. Conclusion BNP and NT-proBNP are a quantitative measure of how hard the heart is working and how close it is to its limits. A normal result practically excludes a cardiac cause of breathlessness. A high result calls for urgent cardiology workup — and combined with severe symptoms, for an immediate emergency call. Neither peptide can be interpreted in isolation from clinical findings, ECG and echocardiography. All treatment decisions are made by your physician. https://labreadai.com/en/indicators/cholesterol https://labreadai.com/en/indicators/cholesterol Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Total cholesterol in blood: normal ranges by age and sex, causes of hypercholesterolemia. How it relates to LDL, HDL and triglycerides and when statins are needed. Indicators article Cholesterol has earned a reputation as the enemy of arteries — largely warranted, but significantly oversimplified. In reality, cholesterol is essential: without it, the body cannot synthesize cell membranes, sex hormones, cortisol, or vitamin D. The problem is not cholesterol itself, but its excess and the form in which it circulates. Let's break down what total cholesterol measures, why it rises, and why a single number is insufficient for assessing cardiovascular risk. What Cholesterol Is and Why the Body Needs It Cholesterol is a fatty alcohol (sterol) found exclusively in animal tissues. Approximately 75–80% is synthesized within the body — primarily in the liver — and only 20–25% comes from food. This means that even on a strict cholesterol-free diet, the body compensates through endogenous synthesis — and conversely, when dietary cholesterol is excessive, the liver reduces its own production. The functions of cholesterol are irreplaceable: - Structural — a component of the phospholipid bilayer of every cell membrane, regulating its fluidity and permeability - Hormonal — the substrate for all steroid hormone synthesis: cortisol, aldosterone, testosterone, estrogens, progesterone - Vitamin — the precursor to vitamin D₃ synthesized in the skin under UV radiation - Digestive — bile acids formed from cholesterol are essential for intestinal fat absorption - Neural — a component of the myelin sheath of neurons In blood, cholesterol circulates not in free form but within lipoproteins — protein-lipid complexes. The type of transport carrier determines whether cholesterol works against or for vascular health. LDL carries cholesterol to cells — and in excess deposits it into artery walls. HDL collects excess cholesterol from artery walls and returns it to the liver. A lipid panel is the only way to view the complete lipid profile and assess true atherogenic risk. Normal Total Cholesterol by Age and Sex Total cholesterol aggregates all fractions: LDL-cholesterol, HDL-cholesterol, and VLDL-cholesterol (approximately TG/5 in mg/dL). Reference values differ by age and sex. Age Men (mmol/L) Women (mmol/L) --------- Under 18 2.9–5.2 2.9–5.2 18–30 years 3.2–6.3 3.1–5.8 30–40 years 3.4–6.9 3.4–6.3 40–50 years 3.8–7.1 3.8–6.9 50–60 years 4.1–7.2 4.2–7.4 Over 60 years 4.0–7.2 4.4–7.7 Clinically relevant thresholds (for all adults): Level (mmol/L) Category ------ < 5.2 Desirable 5.2–6.2 Borderline high 6.2–7.8 High 7.8 Very high Premenopausal women have lower cholesterol than men of the same age — estrogens stimulate hepatic HDL receptors. After menopause, LDL rises, and by age 60–70 total cholesterol in women frequently exceeds that in men. Pregnancy physiologically raises total cholesterol 1.5–2-fold — especially in the second and third trimesters. This is normal and requires no correction. Critical point: total cholesterol is a crude summary figure. Two people with identical total cholesterol of 6.5 mmol/L may have fundamentally different risk profiles: one driven by high HDL and normal LDL, the other by high LDL and low HDL. Clinical decisions always require a complete lipid panel. How to Prepare for a Cholesterol Blood Test Cholesterol is tested as part of the lipid panel and requires standard preparation for the full profile. - Strictly fasting — at least 12 hours. Food intake has minimal effect on total cholesterol itself (unlike triglycerides), but fasting is necessary for accurate Friedewald LDL calculation - No alcohol for 48–72 hours — alcohol raises triglycerides and affects calculated LDL - Stable diet for 2–3 weeks — a drastic dietary change before the test produces an unrepresentative result - Acute illness and myocardial infarction reduce cholesterol by 10–40% — postpone testing 6–8 weeks after recovery - For serial monitoring — same laboratory, identical conditions - Disclose all medications: statins, fibrates, estrogens, glucocorticoids, antipsychotics — all significantly affect cholesterol levels Causes of High Cholesterol (Hypercholesterolemia) Hypercholesterolemia is the most common lipid disorder worldwide, affecting over 40% of adults. Causes divide into primary (genetic) and secondary (acquired). Primary (genetic) causes: Condition Cholesterol level Features --------- Familial hypercholesterolemia (heterozygous) 7–12 mmol/L 1 in 250–500 people; tendon xanthomas Familial hypercholesterolemia (homozygous) 15–30 mmol/L 1 in 300,000; MI in childhood Polygenic hypercholesterolemia 6–8 mmol/L Most common form Familial combined hyperlipidemia Variable LDL↑ + TG↑ Secondary (acquired) causes: Cause Mechanism How to identify --------- Hypothyroidism Reduced LDL receptor activity Elevated TSH Type 2 diabetes Insulin resistance → increased VLDL synthesis Hyperglycemia; LDL↑ + TG↑ Nephrotic syndrome Compensatory lipoprotein synthesis Proteinuria; edema Chronic kidney disease Impaired lipoprotein catabolism Elevated creatinine Obstructive liver disease / cholestasis Impaired biliary cholesterol excretion Elevated ALP, GGT, bilirubin Obesity Insulin resistance → excess VLDL Abdominal pattern; TG↑ Diet high in saturated fats Reduced LDL receptor activity Responds to dietary change Glucocorticoids, progestins, retinoids Reduced LDL receptor activity Link to medication use Pregnancy Physiological increase in VLDL synthesis Normalizes postpartum Causes of Low Cholesterol (Hypocholesterolemia) Very low cholesterol (< 3.0–3.5 mmol/L) in adults is not always favorable. Cholesterol is required for steroid hormone synthesis and normal nervous system function. Main causes: - Severe liver disease (cirrhosis, acute hepatic failure) — reduced synthesis of all lipoproteins - Severe starvation, cachexia, malabsorption — substrate deficiency and impaired fat absorption - Hyperthyroidism — accelerated LDL catabolism through upregulated LDL receptors - Chronic anemia, malignancies — cholesterol consumption by tumor cells - Intensive statin therapy — deliberate reduction; values of 1.5–2.5 mmol/L are clinically safe Very low cholesterol (< 2.5 mmol/L) without an identifiable cause warrants exclusion of severe liver pathology and malignant disease. Total Cholesterol in the Lipid Profile Context Total cholesterol is a composite figure and cannot be interpreted meaningfully without understanding its fractions. It is a starting point, not a final answer. Atherogenicity index (AI) = (Total cholesterol − HDL) / HDL. Normal: < 3.0; borderline: 3.0–4.0; high risk: 4.0–5.0. With identical total cholesterol of 6.0 mmol/L: - Patient A: HDL = 2.0 → AI = 2.0 → low risk - Patient B: HDL = 0.8 → AI = 6.5 → very high risk Non-HDL cholesterol = Total cholesterol − HDL. Captures LDL + VLDL + IDL — all atherogenic fractions. When triglycerides exceed 4.5 mmol/L, non-HDL cholesterol becomes the preferred therapeutic target instead of calculated LDL. The link to atherosclerosis: excess LDL particles penetrate the subendothelial space, become oxidized, are engulfed by macrophages, and form plaques. This makes cholesterol control the central element of cardiovascular disease prevention. How to Lower Cholesterol and When Medication Is Needed Lifestyle changes (reduce cholesterol by 5–20%): - Limit saturated fats (red meat, butter, coconut and palm oil, full-fat dairy) — to < 7% of daily calories - Eliminate trans fats (industrial baked goods, margarine) — greatest impact on LDL/HDL ratio - Increase soluble fiber: oat bran, legumes, psyllium — reduces LDL by 5–10% - Plant sterols and stanols (2–3 g/day) — reduce LDL by 8–15% - Regular aerobic physical activity — modestly lowers LDL and substantially raises HDL - Weight normalization — losing 10% of body weight reduces total cholesterol by 10–20% Pharmacological treatment: - Statins — first line: reduce LDL by 30–55% and total cholesterol substantially - Ezetimibe — blocks intestinal cholesterol absorption; reduces LDL by an additional 15–20% in combination with statins - PCSK9 inhibitors — for familial hypercholesterolemia and statin-intolerant patients; reduce LDL by 50–65% The decision to start medication is based not on total cholesterol alone, but on overall cardiovascular risk — accounting for age, sex, blood pressure, smoking, diabetes, and family history. After a heart attack or stroke, statins are prescribed lifelong regardless of cholesterol level. This article is for informational purposes only and does not replace professional medical advice. If you have high cholesterol, consult a cardiologist or GP. https://labreadai.com/en/indicators/crp https://labreadai.com/en/indicators/crp Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) CRP blood test: standard and hs-CRP normal ranges, causes of high levels in infections and autoimmune disease, difference from ESR and when to see a doctor. Indicators article A doctor ordered an "inflammation test" — and the result came back with an unfamiliar value: CRP. C-reactive protein is the fastest and most sensitive laboratory marker of acute inflammation. It responds to bacterial infection, tissue injury, or necrosis within six to twelve hours, at a stage when other markers are still within normal range. Here's what it measures, why there are two fundamentally different CRP tests, and how to interpret the result depending on the clinical situation. What Is C-Reactive Protein and Why Is It Measured C-reactive protein is an acute-phase protein synthesised by the liver in response to the signalling cytokine interleukin-6 (IL-6). It got its name in 1930, when researchers discovered that a protein from the blood of pneumonia patients reacted with the C-polysaccharide of pneumococcus. It was later found that CRP is produced universally — in any inflammation, infection, or tissue necrosis, regardless of the cause. The mechanism is straightforward: when damage or threat is detected, immune cells release IL-6. The liver receives the signal and within hours sharply increases CRP synthesis. This protein binds to dead cells and pathogens, activates the complement system, and flags targets for phagocytes. CRP is among the first organised responses to tissue injury. In clinical practice, CRP is measured in two formats — and understanding which one is in front of you is essential before interpreting the result. Two Types of Test: Standard CRP and High-Sensitivity hs-CRP These are not the same test in different units — they are two fundamentally different clinical tools with different purposes. Standard CRP (sensitivity down to 5–8 mg/L) is used to diagnose and monitor acute inflammation: infections, autoimmune flares, post-surgical status. It cannot detect changes below its sensitivity threshold — which means it is not suitable for assessing low-grade chronic inflammation. High-sensitivity CRP (hs-CRP) (sensitivity down to 0.1 mg/L) is used to assess long-term cardiovascular risk in apparently healthy individuals or those at established risk. Chronic subclinical inflammation in arterial walls — invisible to the standard test — is detected by hs-CRP. Important: if the report simply says "CRP" without qualification, it is almost certainly the standard test. If it says "hs-CRP" or "high-sensitivity CRP," it is a cardiovascular risk test. Normal CRP Values: Standard Test and hs-CRP Reference ranges differ fundamentally depending on which test is used: Standard CRP: Value Interpretation ------ < 5 mg/L Normal, no inflammation 5–10 mg/L Mild elevation 10–100 mg/L Moderate to significant elevation 100 mg/L Marked elevation High-sensitivity hs-CRP (cardiovascular risk): Value Cardiovascular Event Risk ------ < 1 mg/L Low 1–3 mg/L Moderate 3 mg/L High 10 mg/L Acute inflammation present — not interpretable as cardiac risk Reference ranges may vary slightly between laboratories. Always use the values printed on your specific report. Why CRP Is Elevated: Degrees and Causes The degree of CRP elevation helps orient the clinical search — though the result alone never establishes a diagnosis without the full clinical picture. Mild elevation (5–20 mg/L): viral infections (respiratory viruses, influenza), chronic inflammatory conditions in remission, moderate physical exertion, obesity. In uncomplicated viral respiratory illness, CRP rarely exceeds 20–30 mg/L — this is a useful practical threshold. Moderate to significant elevation (20–100 mg/L): bacterial infections (pneumonia, pyelonephritis, cellulitis), autoimmune flares (rheumatoid arthritis, systemic lupus, Crohn's disease), surgical procedures and trauma. CRP above 50 mg/L during an acute respiratory illness is an argument in favour of a bacterial cause or complication. Marked elevation ( 100 mg/L): severe bacterial infection, sepsis, extensive tissue necrosis — as occurs in myocardial infarction. In septic states, CRP can exceed 300–400 mg/L. Values at this level require immediate investigation. A separate category is malignancy: in many cancers, CRP is chronically mildly elevated without infectious cause, reflecting paraneoplastic inflammation. CRP vs ESR: The Key Differences Both are inflammation markers, but with different kinetics and clinical meaning. Together they give a more complete picture than either alone. Parameter CRP ESR --------- Response to inflammation Within 6–12 hours Within 24–48 hours Normalisation Within 3–7 days Over weeks to months Specificity Higher Lower Response to viral infections Weak Moderate Effect of pregnancy Unchanged Elevated Best use Acute monitoring, antibiotic response Chronic inflammation activity In practice: CRP is better for diagnosing acute conditions and tracking antibiotic response — if CRP does not fall within 48–72 hours of therapy, the treatment plan is reassessed. ESR is more inert and better reflects the activity of chronic inflammatory disease over time. How to Prepare for the Test Blood is drawn fasting — after eight hours without food. Avoid alcohol and intense physical activity for 24 hours beforehand: physical stress mildly raises CRP through muscle inflammation. Important: do not test during an acute illness if the goal is to assess baseline cardiovascular risk using hs-CRP. Any active infection or inflammation will push the value above 10 mg/L — making the result uninformative for risk stratification. Tell your doctor about all medications. Statins reliably lower hs-CRP independently of their cholesterol effect — their use changes the interpretation of results. Oral contraceptives raise CRP. NSAIDs (ibuprofen, diclofenac) may artificially suppress the value. For a complete assessment of the inflammatory picture, CRP is always read alongside neutrophils, ESR, and when relevant, liver function tests — an elevated CRP alongside abnormal liver enzymes may point to a hepatological source of inflammation. When to Seek Urgent Medical Attention Call emergency services immediately if high CRP is accompanied by: - Temperature above 39°C with chills and rapidly worsening weakness — signs of sepsis. - Chest pain — high CRP in the context of infarction reflects the scale of myocardial necrosis. - Confusion or sudden drop in blood pressure. Schedule a routine appointment with a GP if: - CRP is elevated on repeat tests without an obvious cause. - hs-CRP is consistently above 3 mg/L — even without symptoms. - CRP is falling more slowly than expected during antibiotic treatment. Conclusion C-reactive protein is the most timely marker of inflammation: it responds earlier than ESR, rises in proportion to disease severity, and falls as recovery proceeds. The degree of elevation helps distinguish viral from bacterial infection, assess severity, and track treatment response. High-sensitivity hs-CRP is a separate tool — designed for those without acute inflammation who have questions about long-term cardiovascular risk. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/indicators/eosinophils https://labreadai.com/en/indicators/eosinophils Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal eosinophil count for adults and children. Causes of eosinophilia — allergies, parasites, medications. What low eosinophils mean and when to see a doctor. Indicators article You got a complete blood count and found an upward arrow next to "EOS" in the differential. Most people's first thought is allergy or parasites — and that's not a coincidence. Eosinophils are precisely the cells that specialize in these two threats. Here's what the normal range looks like, what drives elevated counts, and when the number deserves serious attention. What Are Eosinophils and What Do They Do Eosinophils are one of five types of white blood cells. Think of them as a chemical-weapons special unit: they step in when ordinary neutrophils can't do the job — against parasites and allergic reactions. When a parasite is detected, an eosinophil surrounds it and releases toxic proteins that destroy the worm's membrane. In allergic reactions, they release histamine and leukotrienes — triggering swelling and bronchospasm. So eosinophils protect us, but sometimes that protection overshoots and harms the body itself. In blood, eosinophils are scarce — the second rarest leukocyte after basophils. Most of them live in tissues: the gut, lungs, and skin — exactly where parasites and allergens are most likely to appear. Normal Eosinophil Count in Adults In the CBC differential, eosinophils are expressed two ways — as a percentage and as an absolute count: Parameter Normal ------ Eosinophils (%) 0.5–5% Eosinophils abs. (× 10⁹/L) 0.05–0.5 The percentage depends on the ratio to other leukocytes — during infection, rising neutrophils can make the eosinophil percentage appear falsely low even when the absolute count is normal. That's why the absolute value is the more informative number. In children, normal ranges are slightly higher than in adults and decrease with age. Reference ranges vary slightly between laboratories — always use the ranges on your specific lab report. High Eosinophils: Causes of Eosinophilia Eosinophilia is defined as eosinophils above 0.5 × 10⁹/L. The degree of elevation carries different clinical weight: Grade Absolute count Typical causes --------- Mild 0.5–1.5 × 10⁹/L Allergy, medications, post-infection recovery Moderate 1.5–5.0 × 10⁹/L Parasitic infections, autoimmune disease Severe (hypereosinophilia) 5.0 × 10⁹/L Hematologic malignancy, rare syndromes Allergic diseases — the most common cause of mild to moderate eosinophilia. Asthma, atopic dermatitis, seasonal hay fever, urticaria, food allergy — eosinophils are elevated during flares of all these conditions. ESR is also often elevated as a non-specific inflammation marker. To confirm the allergic origin of eosinophilia, an allergy panel — including total and specific IgE — is ordered. Parasitic infections — especially helminths that migrate through tissues (toxocariasis, ascariasis, trichinosis). Tissue-migrating larvae trigger the strongest eosinophilic response. Intestinal-stage helminthiasis may cause weaker elevation. Medications — a common and underappreciated cause. Antibiotics (ampicillin, cephalosporins), NSAIDs, captopril, carbamazepine, and many others can trigger drug-induced eosinophilia. It usually resolves after stopping the drug. Autoimmune and inflammatory diseases — Crohn's disease, ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus. Malignancies — Hodgkin's lymphoma, eosinophilic leukemia. Characterized by persistent severe eosinophilia above 5 × 10⁹/L, often accompanied by drops in other blood cell counts. Low Eosinophils: When It Matters Eosinopenia (eosinophils below 0.05 × 10⁹/L) is less common and rarely has independent clinical significance. Main causes: - Acute bacterial infection — at the peak of infection, cortisol suppresses eosinophils. Their temporary disappearance from the differential alongside high neutrophils is an indirect sign of acute bacterial process. - Corticosteroid therapy — prednisone and dexamethasone lower eosinophils within hours. - Cushing's syndrome — excess endogenous cortisol. Isolated eosinopenia without other CBC changes usually requires no special workup. How to Correctly Evaluate Eosinophils in a CBC Eosinophils are never assessed in isolation from the rest of the differential. Key patterns: - Mild eosinophilia + normal neutrophils — think allergy or parasites. - Eosinophilia + elevated neutrophils with left shift — infection combined with allergic background, or acute-phase parasitic invasion. - High eosinophilia + low hemoglobin + low platelets — concerning combination, exclude hematologic malignancy. - Eosinophilia across multiple consecutive tests without a clear cause — warrants comprehensive workup. A single moderate elevation after antibiotics or at the peak of pollen season is not alarming. Persistent elevation is a reason to find the cause. When to Seek Medical Attention - Eosinophils above 5.0 × 10⁹/L — severe eosinophilia, risk of organ damage - Eosinophilia rising across consecutive tests - Elevated eosinophils combined with falling hemoglobin, WBC, or platelets - Eosinophilia with symptoms: rash, shortness of breath, abdominal pain, fever Mild eosinophilia (up to 1.5 × 10⁹/L) with an obvious allergic cause — routine visit to an allergist or GP. Conclusion Eosinophils are highly specialized cells with a specific mission: fighting parasites and mediating allergic responses. A mild elevation most often points to allergy or a recent parasitic infection. Persistent high eosinophilia signals the need for deeper investigation. In both cases, the key is not to look at the number in isolation — evaluate it in the full context of the blood count. Eosinophil interpretation and further testing is directed by a doctor — a GP, allergist, or hematologist depending on the clinical picture. https://labreadai.com/en/indicators/free-t3 https://labreadai.com/en/indicators/free-t3 Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Free T3 is the most active thyroid hormone. Normal triiodothyronine ranges for adults, causes of abnormal levels, difference from T4, and when to see a doctor. Indicators article If T4 is the thyroid's "storage form," free T3 is the ready-to-act version: the most biologically potent thyroid hormone, which directly binds to cell receptors and activates metabolism. This article covers what free T3 is, its normal reference ranges, what high or low levels mean, and when to seek urgent medical attention. What Is Free T3 and Why Does the Free Fraction Matter? The thyroid gland produces two iodine-containing hormones: thyroxine (T4) and triiodothyronine (T3). T3 contains three iodine atoms — hence the "triiodo-" prefix. The difference from T4 seems minor, but the biological impact is profound: T3 is 3–4 times more potent than T4 and directly binds to nuclear cell receptors, triggering the expression of genes responsible for metabolism, growth, and tissue differentiation. Most circulating T3 is not secreted directly by the thyroid gland — it is formed in peripheral tissues (liver, muscles, kidneys) by removing one iodine atom from T4. Only about 20% of T3 comes directly from the gland. Like T4, most T3 in the blood is bound to carrier proteins and biologically inactive. Only the unbound fraction — free T3 (FT3) — acts on cells. It is measured as part of a full thyroid panel alongside TSH and free T4. How to Prepare for a Free T3 Blood Test Preparation rules mirror those for other thyroid hormones and are important to follow: - Timing: morning blood draw between 8:00–10:00 AM, when daily fluctuations are minimised. - Fasting: 8–12 hours without food; water is allowed. - Thyroid medications: take levothyroxine or T3-containing drugs (liothyronine) after the blood draw, not before. - Biotin (vitamin B7): high-dose biotin interferes with immunochemical assays — pause for 48 hours before testing. - Amiodarone: strongly inhibits T4 → T3 conversion and can produce falsely low FT3 — inform your doctor if you take it. - Exercise and stress: avoid intense physical activity and major stressors for 24 hours before the test. Free T3 Normal Ranges by Age and Sex Reference ranges depend on the specific laboratory and assay method. Always use the interval printed on your own lab report. General guideline values: Group FT3, pmol/L FT3, pg/mL --------- Adult men 3.1–6.8 2.0–4.4 Adult women 3.1–6.8 2.0–4.4 Pregnancy (all trimesters) slightly below adult range — Older adults (60+) lower end decreases — Children 1–5 years 4.0–7.4 2.6–4.8 Unit conversion: 1 pg/mL = 1.54 pmol/L. FT3 must always be interpreted alongside TSH and FT4 — a single abnormal value without the full picture leads to incorrect conclusions. High Free T3: Causes and Symptoms Elevated FT3 means the thyroid or peripheral tissues are producing too much active triiodothyronine. The body shifts into a state of chronic over-stimulation. Common causes of high FT3: - Hyperthyroidism — Graves' disease, toxic nodular goiter, toxic adenoma - Isolated T3 thyrotoxicosis — can precede classic hyperthyroidism with FT4 still in the normal range - Acute thyroiditis (autoimmune or viral) with a massive hormone release - Overdose of T3-containing medications (liothyronine, combination preparations) Symptoms: palpitations and heart rhythm disturbances, weight loss despite good appetite, muscle weakness, anxiety, tremor, sweating, sleep disturbance, diarrhoea. In older patients, hyperthyroidism often presents atypically — predominantly with cardiac symptoms. Low Free T3: Causes and Consequences Insufficient FT3 means cells are literally under-receiving the signals needed for normal function — everything slows down, from metabolism to cognition. Common causes of low FT3: - Hypothyroidism — primary (thyroid gland failure) or central (pituitary pathology) - Hashimoto's thyroiditis in the hypothyroid stage - Impaired peripheral T4 → T3 conversion: severe systemic illness, prolonged fasting, stress, liver cirrhosis, kidney failure — euthyroid sick syndrome (low T3 syndrome) - Amiodarone, propranolol, high-dose corticosteroids - Selenium deficiency — selenium is required for deiodinase enzyme activity Symptoms: fatigue, cold intolerance, bradycardia, constipation, dry skin, hair loss, depression, impaired concentration. In euthyroid sick syndrome, TSH and FT4 can remain normal — the abnormality appears only in FT3. Free T3 and Free T4: How the Two Hormones Work Together T3 and T4 cannot be fully understood in isolation — they are two parts of the same system. The thyroid primarily produces T4 (roughly 80% of total secretion), and peripheral tissues convert it into active T3 via deiodinase enzymes. This is why both values must be assessed together: if free T4 is normal but FT3 is low, the problem lies in peripheral conversion rather than the thyroid gland itself. The reverse — normal FT4 with elevated FT3 — is typical of early T3 thyrotoxicosis. Your doctor will always evaluate both hormones in the context of TSH and clinical presentation. When to See a Doctor Urgently Certain FT3 abnormalities require immediate attention rather than a routine appointment: - Sharply elevated FT3 + heart rate above 120 bpm, high fever, agitation or altered consciousness — signs of thyrotoxic crisis, a medical emergency requiring immediate hospitalisation. - Critically low FT3 + impaired consciousness, hypothermia, severe oedema — possible myxedema coma. - Newly discovered significant abnormality with symptoms — see an endocrinologist within a few days. - Isolated moderate abnormality without symptoms — routine consultation; additional tests may be needed to rule out systemic illness. Interpreting FT3 without TSH and FT4 is almost always misleading. Do not draw diagnostic conclusions from a single thyroid value. This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/indicators/free-t4 https://labreadai.com/en/indicators/free-t4 Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Free T4 is the active form of thyroxine. Normal FT4 ranges for men, women, and pregnancy, causes of high and low levels, and when to see an endocrinologist. Indicators article Noticed "FT4" on your thyroid test results and wondering what it means? Free T4 — the unbound fraction of the hormone thyroxine — is the only form that actually enters cells and drives metabolism, heart rate, and energy balance. This article explains what free T4 is, its normal reference ranges by age and sex, what high or low levels indicate, and when to seek urgent medical attention. What Is Free T4 and Why Is It Measured? The thyroid gland produces thyroxine (T4), most of which immediately binds to carrier proteins — thyroxine-binding globulin, albumin, and transthyretin. Protein-bound T4 is biologically inactive: it cannot interact with cell receptors and serves only as a circulating reserve. Only about 0.03–0.05% of total thyroxine remains unbound — this is free T4 (FT4). This small fraction penetrates tissues and triggers all the biological effects of the hormone: regulating metabolic rate, heart rate, body temperature, nervous system function, and reproductive health. FT4 is measured as part of a comprehensive thyroid panel alongside TSH and free T3. Measuring FT4 alone without TSH provides an incomplete picture and is rarely used for primary diagnosis. Unlike total T4, the free fraction is not affected by changes in carrier protein levels — making it a more reliable marker of thyroid function during pregnancy, liver disease, or oral contraceptive use. How to Prepare for a Free T4 Blood Test FT4 results are sensitive to testing conditions. Follow these steps for an accurate result: - Timing: have blood drawn in the morning between 8:00–10:00 AM when hormone concentrations are most stable. - Fasting: no food for 8–12 hours before the test; water is fine. - Levothyroxine: if you take thyroid replacement medication, take your dose after the blood draw, not before. - Biotin (vitamin B7): high-dose biotin supplements can interfere with immunochemical FT4 assays — pause for 48 hours before testing. - Other medications: amiodarone, corticosteroids, heparin, and lithium can affect thyroid hormone levels — ask your doctor whether to pause. - Physical and emotional stress: avoid intense exercise and major stressors in the 24 hours before the test. Free T4 Normal Ranges by Age and Sex Reference ranges vary by laboratory method and reagents — always use the reference interval printed on your specific lab report. Common guideline values: Group FT4, pmol/L FT4, ng/dL --------- Adult men 9.0–20.0 0.70–1.56 Adult women 9.0–20.0 0.70–1.56 Pregnancy, 1st trimester 10.0–24.0 0.78–1.87 Pregnancy, 2nd–3rd trimester 8.0–16.0 0.62–1.25 Infants under 1 year 11.5–28.3 0.89–2.20 Children 1–5 years 10.6–22.0 0.82–1.71 Unit conversion: 1 ng/dL ≈ 12.87 pmol/L. A borderline result is not a diagnosis on its own — your doctor will always interpret FT4 alongside TSH, symptoms, and medical history. High Free T4: Causes and Symptoms An FT4 level above the upper reference limit means the thyroid is producing excess thyroxine or its breakdown is slowed. The body runs in overdrive: heart rate increases, body temperature rises, and metabolism accelerates. Common causes of elevated FT4: - Hyperthyroidism — Graves' disease, toxic nodular goiter - Hashimoto's thyroiditis during a transient thyrotoxic phase (hashitoxicosis) - Subacute (de Quervain) thyroiditis in the acute inflammatory phase - Levothyroxine overdose - TSH-secreting pituitary adenoma (rare) - Thyroid hormone resistance syndrome Symptoms: resting tachycardia, weight loss despite good appetite, hand tremor, irritability, excessive sweating, insomnia, heat intolerance. In Graves' disease — characteristic eye protrusion (exophthalmos). Low Free T4: Causes and Consequences A low FT4 signals that the thyroid is not producing enough thyroxine. Every bodily process slows down — think of an engine running on depleted fuel. Common causes of low FT4: - Hypothyroidism — primary (thyroid gland damage) or central (pituitary or hypothalamic pathology) - Hashimoto's thyroiditis in the hypothyroid stage - Post-thyroidectomy or radioiodine therapy - Severe iodine deficiency - Amiodarone, lithium, or high-dose corticosteroid use Symptoms: persistent fatigue, cold intolerance, facial and limb puffiness, unexplained weight gain, constipation, dry skin and brittle hair, slowed speech, impaired memory and concentration. Free T4 and Free T3: How Thyroid Hormones Work Together T4 is often called a "prohormone" — it is relatively inactive on its own. In peripheral tissues, primarily the liver, muscles, and kidneys, enzymes called deiodinases remove one iodine atom from thyroxine and convert it into the far more potent free T3. This conversion matters for test interpretation: normal FT4 with low FT3 may point to impaired peripheral conversion rather than a problem with the thyroid gland itself — this occurs in severe stress, prolonged fasting, or systemic illness. This pattern is impossible to detect by measuring FT4 alone. Evaluating FT4, FT3, and TSH together provides a complete picture of thyroid axis function. When to See a Doctor Urgently Some situations with abnormal FT4 cannot wait for a routine appointment: - Sharply elevated FT4 + tachycardia, high fever, altered consciousness — possible thyrotoxic crisis, a life-threatening emergency requiring immediate hospitalization. - Critically low FT4 + profound drowsiness, severe edema, body temperature below 36°C (96.8°F) — signs of myxedema coma. - Newly discovered significant abnormality with symptoms — see an endocrinologist within 2–5 days. - Abnormal result without clear symptoms — schedule a routine consultation within 2–4 weeks and confirm with a repeat test. Do not attempt to interpret your FT4 result in isolation. The same FT4 level can indicate entirely different conditions depending on TSH, current medications, and clinical presentation. This article is for informational purposes only and does not replace consultation with a qualified endocrinologist. https://labreadai.com/en/indicators/hcg https://labreadai.com/en/indicators/hcg Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Human chorionic gonadotropin (hCG) is the pregnancy hormone and a tumour marker. Normal ranges by week, causes of high or low results and test interpretation. Indicators article Two lines on a pregnancy test are caused by hCG — the hormone that strip tests detect in urine and that blood tests measure earlier, more precisely and more reliably than any home test. But hCG is not exclusively a pregnancy marker: in non-pregnant women and men, a detectable level can signal a malignant process. This article covers normal hCG ranges by week of pregnancy, what high and low results mean, and when a result requires urgent evaluation. What Is hCG and Why Is It Measured? hCG stands for human chorionic gonadotropin. It is a glycoprotein hormone produced by trophoblast cells — the outer layer of the fertilised egg — from the moment it implants in the uterine wall. hCG signals the corpus luteum to continue producing progesterone, sustaining the pregnancy until the placenta is fully formed. The hCG molecule has two subunits — α and β. The alpha subunit is structurally identical to that of TSH, FSH and LH, which is why clinical testing specifically measures β-hCG: it is unique to chorionic gonadotropin and produces no cross-reactions with other hormones. hCG is measured to confirm pregnancy and monitor its progression; diagnose ectopic pregnancy; verify complete resolution after miscarriage or termination; screen for fetal chromosomal abnormalities in the first trimester; and detect certain tumours in non-pregnant individuals. hCG Normal Ranges in Pregnancy by Week hCG levels rise rapidly from the first days after conception, doubling every 48–72 hours throughout the first trimester — the fastest hormone surge in the human body. Gestational age Normal β-hCG (mIU/mL) ------ 1–2 weeks (from conception) 25–300 3–4 weeks 1,500–5,000 5–6 weeks 10,000–50,000 7–8 weeks 50,000–200,000 9–12 weeks 20,000–100,000 13–16 weeks 6,000–30,000 17–24 weeks 4,000–10,000 25–40 weeks 3,000–15,000 After peaking at weeks 7–11, hCG levels naturally fall — this is physiological, not a warning sign. Reference ranges are deliberately wide: a ten-fold difference between the lower and upper limits at the same gestational age is entirely normal. This is why a single hCG value is far less informative than the trend across two or three serial measurements. The doubling rule: in a healthy pregnancy, β-hCG doubles every 48–72 hours until week 10. A rise of less than 66% over 48 hours is a warning sign requiring obstetric review. hCG in Non-Pregnant Women and Men: Reference Values Outside of pregnancy, hCG should be undetectable or at the very lowest end of the assay's sensitivity. Group Normal (mIU/mL) ------ Non-pregnant women < 5 Postmenopausal women < 10 Men < 2.5 A mild transient rise in non-pregnant women is expected in the days immediately following pregnancy loss — hCG clears gradually and fully normalises within four to six weeks. Any persistent elevation in men or non-pregnant women requires oncological investigation without delay. How to Prepare for an hCG Blood Test Blood for β-hCG is drawn from a vein, ideally fasting or four hours after a light meal. The test is informative as early as 8–10 days after conception — three to five days before a urine home test can turn positive. For serial monitoring, it is essential to use the same laboratory each time: different assay methods produce different absolute values, and comparing results across laboratories can be misleading. If you are receiving hCG injections as part of an IVF protocol, inform your doctor — these will artificially elevate the result. A full overview of recommended blood tests during pregnancy, including hCG, is available in the pregnancy panel section. Causes of High hCG A physiological rise in pregnant women needs no explanation. Pathological elevation in other contexts is a different matter. Multiple pregnancy. In a twin pregnancy, hCG is approximately twice the singleton norm for the same gestational age — proportional to the number of embryos. Chromosomal abnormalities. Trisomy 21 (Down syndrome) is associated with hCG levels 1.5 to 2 times the normal range in the first trimester. This is why β-hCG is a core component of first-trimester combined screening alongside PAPP-A. Hydatidiform mole. Abnormal trophoblast proliferation without a viable embryo produces hCG three to ten times higher than the expected range for the assumed gestational age. Malignancy. In non-pregnant women and men, elevated hCG may indicate germ cell tumours of the testis or ovary, choriocarcinoma or other malignancies. In oncology, hCG serves as one of several tumour markers — its role in cancer diagnostics is described in detail in the tumour markers panel section. Causes of Low hCG in Pregnancy hCG below the lower limit for gestational age, or insufficient rise on serial testing, is a clinically significant finding. Threatened or missed miscarriage. When the embryo stops developing, hCG stops rising and begins to fall. This is often the first laboratory signal of a missed miscarriage, appearing before any changes become visible on ultrasound. Ectopic pregnancy. When implantation occurs outside the uterus, the trophoblast develops abnormally and hCG rises more slowly than expected. The combination of rising-but-not-doubling hCG plus an empty uterine cavity on ultrasound at 5–6 weeks constitutes a presumptive ectopic pregnancy until proven otherwise. Early pregnancy complications. When early signs of pregnancy coincide with cramping or spotting, the trajectory of serial hCG measurements becomes the primary prognostic tool alongside ultrasound. hCG as a Tumour Marker: When Men Are Tested In men, hCG is normally undetectable. Its presence is an absolute indication for oncological workup, primarily for germ cell tumours of the testis — the most common malignancy in men aged 15–35. hCG together with AFP (alpha-fetoprotein) is used for diagnosis, staging and treatment monitoring of testicular cancer. In postmenopausal women, hCG above 10 mIU/mL without an obvious cause also requires oncological exclusion — principally choriocarcinoma and ovarian tumours. When an hCG Result Requires Urgent Attention Situations that cannot wait for a scheduled appointment: - hCG is not doubling within 48–72 hours in the first trimester, especially with pelvic pain or bleeding; - hCG is falling in a confirmed ongoing pregnancy; - hCG is positive but no gestational sac is visible on ultrasound at 5–6 weeks; - hCG is detectable in a man or non-pregnant woman — even at a low level; - hCG has not normalised within 6–8 weeks after miscarriage or delivery. Alongside hCG, pregnancy monitoring routinely includes TSH assessment and, when gestational diabetes risk is present, a glycated haemoglobin test. https://labreadai.com/en/indicators/homocysteine https://labreadai.com/en/indicators/homocysteine Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Homocysteine is a cardiovascular risk marker linked to B-vitamin metabolism. Normal ranges, causes of elevation, thrombosis risk and test interpretation for adults. Indicators article A homocysteine test is ordered when investigating an unexplained thrombosis in a young person, during pre-conception screening or after a stroke without obvious risk factors. But what does this marker actually measure — and why does its level matter so much for vascular health? Homocysteine is an amino acid that the body normally clears rapidly, but when B-vitamin metabolism is disrupted it accumulates and begins to chemically erode arterial walls from within. What Is Homocysteine and Why Is It Measured? Homocysteine is a sulphur-containing amino acid and an intermediate product of methionine metabolism. The body does not obtain it from food directly: it is synthesised from methionine and must be rapidly recycled — either back into methionine (remethylation, requiring vitamin B12 and folate) or converted into cysteine (transsulphuration, requiring vitamin B6). When either pathway is impaired — due to nutrient deficiency, genetic variants or concurrent disease — homocysteine accumulates in the blood. Elevated levels damage endothelial cells, the thin inner lining of arteries: the wall loses its protective properties, becomes permeable to lipids, and the risk of thrombus formation and atherosclerosis rises substantially. Homocysteine is measured to assess cardiovascular risk, investigate the cause of thrombotic events, evaluate B-vitamin metabolism disorders and screen patients planning a pregnancy. Homocysteine Normal Ranges for Adults Reference values depend on age and sex. Levels rise physiologically with age, partly because kidney function — a key clearance route — declines over time. Group Normal range (µmol/L) ----------------------------- Women 18–45 years 5–12 Men 18–45 years 6–15 Women 45 years 5–15 Men 45 years 6–20 Pregnant women (first trimester) < 8 Elevated homocysteine — hyperhomocysteinaemia — is graded as mild (15–30 µmol/L), moderate (31–100 µmol/L) or severe ( 100 µmol/L). The severe form is rare and almost always indicates a hereditary disorder called homocystinuria. In pregnancy, thresholds are tighter: levels above 8–10 µmol/L in the first trimester are associated with increased risk of fetal neural tube defects, pre-eclampsia and miscarriage. Causes of Elevated Homocysteine Homocysteine accumulation is nearly always a consequence of impaired clearance. Several causes often act together. B-vitamin deficiency is the most common and most correctable cause. Vitamin B12 deficiency blocks the remethylation of homocysteine back to methionine: without the cofactor the reaction stalls and the amino acid builds up. Folate deficiency acts through the same mechanism — folate donates the methyl group needed for this reaction. Vitamin B6 deficiency disrupts the alternative clearance route, transsulphuration. MTHFR gene polymorphism. Mutations in the methylenetetrahydrofolate reductase gene reduce the activity of the enzyme involved in remethylation. The C677T variant is present in 10–15% of Europeans; the homozygous form causes a moderate homocysteine rise, especially when folate intake is also low. Kidney disease. The kidneys actively metabolise homocysteine, and as glomerular filtration rate falls, plasma levels rise in proportion. Medications. Methotrexate blocks folate metabolism. Metformin and proton pump inhibitors reduce vitamin B12 absorption. Smoking, excessive alcohol consumption and physical inactivity are additional contributing factors. How High Homocysteine Damages Blood Vessels Homocysteine is not merely a passive risk marker — it actively injures vascular walls. The process resembles acid running through metal pipes: the exterior looks intact while the interior corrodes progressively. Specifically, elevated homocysteine oxidises endothelial cells, enhances platelet adhesion, activates the coagulation cascade and creates a prothrombotic environment. This is directly linked to the risk of deep vein thrombosis and arterial thrombosis — particularly in young adults without conventional risk factors. In thrombophilia workups, homocysteine is a standard test alongside D-dimer and genetic coagulation markers. Over the long term, even mild hyperhomocysteinaemia approximately doubles the risk of myocardial infarction and raises ischaemic stroke risk by 40–50%. The association with heart attack is especially pronounced in patients lacking traditional risk factors, which is precisely when homocysteine testing often reveals the hidden cause. Symptoms of Hyperhomocysteinaemia Mild elevation — 15–30 µmol/L — is entirely asymptomatic. The patient feels nothing unusual until a thrombotic or vascular event occurs. This is why testing is based on risk factors rather than symptoms. In severe hyperhomocysteinaemia (homocystinuria, 100 µmol/L), clinical features are striking: ectopia lentis (lens dislocation), skeletal deformities, early-onset atherosclerosis, thrombosis in childhood and adolescence, and cognitive developmental delay. How to Prepare for a Homocysteine Blood Test Homocysteine is one of the markers where pre-analytical preparation is critically important. Failure to follow the rules can inflate the result by 50–100%. Strict fasting for 12 hours: protein-rich food — especially methionine-rich sources such as meat and eggs — sharply raises plasma homocysteine. No alcohol for 24 hours — alcohol disrupts folate metabolism and distorts the result. Cold chain is essential: after collection the tube must be immediately placed on ice and delivered to the laboratory within 30 minutes — in a warm sample, red blood cells continue to release homocysteine, falsely elevating the reading. Inform your doctor about methotrexate, metformin or proton pump inhibitors — all require consideration when interpreting results. How to Lower Homocysteine: The Role of B Vitamins When mild-to-moderate hyperhomocysteinaemia is caused by B-vitamin deficiency, correction is well studied and effective. Folic acid 0.4–5 mg/day lowers homocysteine by approximately 25%. Adding vitamin B12 produces a further 7% reduction and is essential when B12 deficiency is confirmed. Vitamin B6 is added when transsulphuration dysfunction is suspected. Combined supplementation with all three B vitamins is the standard approach when elevation is documented. An important nuance: lowering homocysteine with vitamins reliably reduces stroke recurrence — but not myocardial infarction, according to large randomised trials. This means vitamin correction addresses one component of cardiovascular risk, not the whole picture. When High Homocysteine Requires Urgent Evaluation A routine follow-up appointment is appropriate for mild elevations found on screening. Certain situations warrant prompt investigation: - Deep vein thrombosis or pulmonary embolism under the age of 45 without an obvious provoking factor; - Stroke or heart attack in a person with no conventional risk factors; - Homocysteine above 50 µmol/L on first measurement; - Recurrent miscarriage or pre-eclampsia. In these scenarios, hyperhomocysteinaemia may be part of a broader coagulation disorder requiring full haematological investigation. https://labreadai.com/en/indicators/ige https://labreadai.com/en/indicators/ige Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Total IgE is the key marker of allergic sensitisation and parasitic infection. Normal ranges by age, causes of elevated IgE in atopy, and test interpretation. Indicators article A rash after strawberries, watery eyes around cats, coughing during pollen season — all of these trace back to one immune mechanism centred on immunoglobulin E. A total IgE blood test is the first step in laboratory allergy workup: it shows how active the allergic arm of the immune system is, without yet naming the specific trigger. This article explains what your result means and where to go from there. What Is Immunoglobulin E and Why Is It Measured? Immunoglobulin E (IgE) is one of five antibody classes produced by plasma cells. By blood concentration it is the rarest of all: in healthy individuals there is hundreds of thousands of times less IgE than IgG. Despite this, IgE controls the fastest and most dramatic allergic reactions. The mechanism: IgE molecules bind to the surface of mast cells and basophils — the key effectors of the allergic response. When an allergen re-enters the body, it cross-links the IgE molecules on the cell surface, triggering an explosive release of histamine and other inflammatory mediators. The result is immediate: itching, swelling, bronchospasm. Evolutionarily, IgE developed as a defence against parasites — helminths and other multicellular organisms — for which this rapid inflammatory response is genuinely effective. In the modern world, with low parasitic burden, the immune system often redirects this mechanism toward harmless proteins: foods, pollen, pet dander. Total IgE is ordered in: suspected allergic disease; chronic urticaria or atopic dermatitis; unexplained asthma; suspected parasitic infestation; and monitoring response to allergen immunotherapy. IgE Normal Ranges for Adults and Children IgE levels are strongly age-dependent: minimal at birth, rising through childhood and stabilising in adulthood. Units are IU/mL (international units per millilitre) or kU/L — the two are equivalent. Age Normal total IgE (IU/mL) ------------------------------- Under 1 year < 15 1–5 years < 60 5–14 years < 90 14–18 years < 200 Adults 18 years < 100 Older adults 60 years < 80 The 100 IU/mL adult threshold is a guide rather than an absolute boundary: smokers and residents of high-parasitic-burden regions may have slightly elevated baseline IgE without disease. The reference interval on your laboratory report takes priority. Total IgE vs Specific IgE: What Is the Difference? Two different tests serve two different purposes — and they are frequently confused. Total IgE is the aggregate concentration of all IgE molecules in the blood, regardless of what they target. It reflects the overall degree of "allergic readiness" but does not identify the culprit allergen. Elevated total IgE with no symptoms is not a diagnosis of allergy. Specific IgE are antibodies directed against a single allergen: birch pollen, peanut, cat dander, house dust mite. Specific IgE confirms sensitisation to a particular trigger and forms the cornerstone of allergy diagnosis. Specific IgE panels are included in the comprehensive allergy panel. The typical investigation pathway: total IgE as an initial screen → if elevated and clinical picture points to allergy → specific IgE testing for suspected triggers → simultaneously check eosinophils in the blood count, as eosinophilia frequently accompanies atopic disease. Causes of Elevated IgE High IgE reflects active production of class-E antibodies by the immune system. The causes differ fundamentally in nature. Allergic diseases are the most common category. Atopic dermatitis, allergic rhinitis, asthma, food allergy and insect venom reactions all raise total IgE. The highest values — into the thousands of IU/mL — are seen in severe atopic dermatitis: skin surface area affected correlates directly with antibody level. Parasitic infections. Ascariasis, toxocariasis, trichinellosis and other helminthiases cause sharp IgE elevation — often several thousand IU/mL — combined with eosinophilia. When high IgE accompanies blood eosinophilia without obvious allergic symptoms, parasitic infestation should be ruled out first. Immunodeficiency states. Job's syndrome (hyper-IgE syndrome) is a rare primary immunodeficiency with IgE in the tens of thousands of IU/mL, accompanied by recurrent abscesses and eczema. Wiskott-Aldrich syndrome also features elevated IgE. Other causes. Certain lymphomas (Hodgkin's disease), autoimmune conditions, chronic infections and drug reactions can moderately raise IgE. Smoking is another cause of mild elevation in the absence of allergic pathology. How to Prepare for a Total IgE Blood Test The test requires no complex preparation, but a few steps improve result reliability. Fasting for four hours beforehand is preferred, though food has minimal impact on IgE levels. Avoid known allergen exposure on the day of the test — an acute allergic reaction transiently elevates IgE. Antihistamines do not directly affect IgE, but discontinuing them for three to five days before the test gives the clinician a cleaner clinical picture to interpret alongside the result. Importantly, inform your doctor about corticosteroid therapy: glucocorticoids suppress IgE production and may produce a falsely normal result in a patient with genuine allergic disease. IgE testing is informative year-round, although patients with seasonal allergy may have slightly higher levels during pollen season — a normal physiological response to allergen exposure. What to Do With a High IgE Result Elevated total IgE is a starting point, not a final diagnosis. The next steps depend on the clinical picture. With allergy symptoms: an allergist will order specific IgE panels or skin prick tests to identify the precise trigger. Without symptoms but markedly elevated IgE: parasitic infestation must be excluded (stool microscopy, serology) before rarer diagnoses such as hyper-IgE syndrome are considered. With mild elevation in a smoker: observation is usually sufficient. Falling IgE on serial measurements after starting allergen immunotherapy or antiparasitic treatment confirms treatment response. Conclusion Immunoglobulin E is a quantitative marker of how active the allergic arm of the immune system is. A normal result makes allergic disease unlikely — though it does not exclude localised reactions where total IgE may remain in range. A high result does not establish a diagnosis on its own but determines the direction of further investigation. Interpretation is performed by an allergist or immunologist in the context of the full clinical history. https://labreadai.com/en/indicators/ldh https://labreadai.com/en/indicators/ldh Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Lactate dehydrogenase (LDH) is a marker of cell damage. Normal ranges for adults and children, causes of high LDH in hemolysis, heart attack and liver disease. Indicators article You receive your blood test results and notice that LDH is flagged above the reference range. Before worrying, it helps to understand what this enzyme actually measures — and which conditions cause it to rise. Lactate dehydrogenase (LDH) is one of the most sensitive markers of cell damage in medicine, reacting to dozens of conditions, from a bruised muscle to an acute heart attack. This guide covers normal LDH levels, what elevated results mean, and when they require urgent attention. What Is LDH and Why Is This Cell Damage Marker Measured? Lactate dehydrogenase is an enzyme found in virtually every cell of the body — heart, liver, skeletal muscles, kidneys, lungs and red blood cells. Its biological role is to catalyse the reversible conversion between lactate and pyruvate, helping cells produce energy when oxygen is scarce. Think of a cell as a sealed container: while the walls are intact, LDH stays inside. The moment cells break down — through inflammation, necrosis or haemolysis — the enzyme spills into the bloodstream and blood levels rise sharply. This is why LDH is called a cell damage marker: it is not organ-specific, but it is extremely sensitive to the fact that cells are being destroyed somewhere in the body. In clinical practice, LDH is used to assess the severity of haemolysis, monitor cancer activity, help differentiate causes of jaundice, and track treatment response in liver and muscle disease. Normal LDH Levels in Adults, Children and Pregnancy Reference values depend on age, sex and the assay method used. Most laboratories use a kinetic method at 37 °C. Group LDH Normal Range (U/L) ----------------------------- Adults 18–60 years 125–220 Men over 60 years 130–230 Women over 60 years 120–215 Infants under 1 year 170–580 Children 1–14 years 150–500 Adolescents 14–18 years 130–280 Pregnant women (all trimesters) up to 250 In children, LDH levels are physiologically higher than in adults because rapid tissue growth involves intense cellular turnover. In pregnancy, a moderate rise in the third trimester is expected due to placental expansion. Always compare your result with the reference range printed on your laboratory report, as intervals vary between labs. LDH Isoenzymes: What They Reveal About Specific Organs LDH exists in five molecular forms called isoenzymes (LDH-1 through LDH-5). Each predominates in different tissues, and their ratio helps pinpoint the source of damage. Isoenzyme Main Source Clinical significance of elevation ---------------------------------------------------------- LDH-1 Heart, red blood cells Haemolysis, acute myocardial infarction LDH-2 Heart, red blood cells Normally the highest fraction in serum LDH-3 Lungs, lymphocytes Lung disease, lymphomas LDH-4 Kidneys, placenta Kidney damage LDH-5 Liver, skeletal muscle Hepatitis, rhabdomyolysis In healthy serum, LDH-2 LDH-1. In acute myocardial infarction this ratio flips — LDH-1 rises above LDH-2. Before cardiac troponin was available, this "flip pattern" was the primary laboratory criterion for heart attack. Isoenzyme analysis is ordered less frequently today, but remains useful in complex diagnostic situations. Causes of High LDH in the Blood Elevated LDH always signals cell destruction — the question is which cells. Haematological causes The most frequent cause of a dramatic LDH spike is red blood cell destruction. In haemolytic anaemia, LDH pours from millions of lysed erythrocytes, often reaching 5–10 times the upper limit of normal. In megaloblastic anaemia, immature precursor cells are destroyed in the bone marrow before they reach the bloodstream — a process called ineffective erythropoiesis — which also drives LDH sharply upward. In multiple myeloma, LDH level reflects tumour burden and serves as a prognostic marker: the higher the LDH, the more aggressive the disease. Cardiac causes Historically, LDH was a cornerstone marker of myocardial infarction. It rises 12–24 hours after the onset of chest pain, peaks on days 2–4 and normalises only after 8–14 days. Today troponin is used for early diagnosis, but LDH retains value in delayed presentations — when troponin has already returned to normal. Hepatic causes Liver cells (hepatocytes) are rich in LDH-5. In liver cirrhosis, acute viral hepatitis and toxic liver injury, this isoenzyme rises sharply. ALT, AST and bilirubin typically rise alongside LDH, and the combination helps gauge the true extent of damage. Other causes Intense physical exercise causes a moderate, transient rise in muscle LDH-5 — a physiological response that resolves within 24–48 hours. Pulmonary embolism elevates the lung-derived LDH-3. Certain medications — statins, chemotherapy agents, anaesthetics — can also alter enzyme levels. Causes of Low LDH Genuinely low LDH is clinically significant only in rare cases. The most common explanation is analytical interference: high-dose vitamin C in the blood sample suppresses enzyme activity in the test tube, producing a falsely low result. True hereditary LDH isoenzyme deficiency is an extremely rare genetic condition. Isolated low LDH with no other abnormalities generally requires no further investigation. How to Prepare for an LDH Blood Test Several factors can cause falsely elevated LDH results. To ensure an accurate reading: Fast for at least 8 hours before the test. Avoid intense exercise for 24–48 hours: muscle LDH-5 remains elevated for up to two days after strenuous training. Handle the sample gently — mechanical haemolysis from a shaken tube can multiply the LDH result two to three times; the laboratory should flag this. Tell your doctor about all medications, especially statins and cytostatic agents that alter enzyme activity. When High LDH Requires Urgent Medical Attention A mild LDH elevation — 1.5 to 2 times the upper limit — is often found incidentally and warrants elective follow-up. However, the following situations call for same-day evaluation: - LDH is more than 3 times the upper limit of normal, especially combined with chest pain, jaundice or dark urine; - LDH is rising on serial measurements (a second result 24–48 hours later is higher than the first); - High LDH is paired with a sharp drop in haemoglobin on the complete blood count; - LDH is climbing in a patient with a known cancer diagnosis — this may signal disease progression. In any of these scenarios, do not wait for a scheduled appointment — seek medical evaluation the same day. LDH Test Interpretation: Key Takeaways LDH is not a diagnosis — it is an alarm signal. An elevated level tells you that cells are breaking down somewhere in the body, but not which organ or why. It is always interpreted in context: alongside symptoms, the clinical picture, and other laboratory results. Do not try to read LDH in isolation — show the result to your doctor, who will correlate all available data and arrange appropriate investigations. All treatment decisions must be made by a qualified medical professional. https://labreadai.com/en/indicators/magnesium https://labreadai.com/en/indicators/magnesium Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Magnesium is a cofactor for 300+ enzymes. Normal ranges, causes of deficiency and excess, symptoms of hypomagnesaemia, links to vitamin D and calcium, and when to test. Indicators article Magnesium is the fourth most abundant cation in the body and the second most abundant intracellular cation after potassium. It participates in more than 300 enzymatic reactions: protein and DNA synthesis, nerve impulse transmission, muscle contraction regulation, and cardiac rhythm maintenance. Yet a blood magnesium test is one of the most frequently overlooked laboratory investigations, even though deficiency affects 10–15% of the general population and 60–65% of ICU patients. What the Magnesium Test Shows — and Why It Is Difficult to Interpret The critical limitation of serum magnesium testing: serum reflects only approximately 1% of total body magnesium stores. The remaining 99% reside intracellularly — primarily in bone, muscle, and liver. This means a normal serum magnesium result does not exclude intracellular deficiency. The body tightly maintains serum magnesium within a narrow range through renal regulation: when dietary intake falls, the kidneys increase magnesium reabsorption. Deficiency symptoms can appear before serum levels drop below the reference range — the classic "normal magnesium trap." Nevertheless, serum magnesium remains the standard clinical diagnostic tool: when it is low, intracellular deficiency is guaranteed; when it is normal, deficiency is possible but not certain. Normal Magnesium Levels Group mmol/L mg/dL --------- Adults 0.75–1.25 1.82–3.04 Children under 5 0.65–1.05 1.58–2.55 Children 5–18 years 0.70–1.20 1.70–2.92 Pregnant women 0.65–1.05 1.58–2.55 Unit conversion: 1 mmol/L = 2.43 mg/dL = 2.43 mEq/L. During pregnancy, magnesium physiologically falls — partly from haemodilution, partly from increased fetal demand. Clinically significant thresholds: - < 0.5 mmol/L — severe hypomagnesaemia; risk of arrhythmia and seizures - 1.5 mmol/L — hypermagnesaemia; neuromuscular conduction suppression - 2.5 mmol/L — life-threatening hypermagnesaemia How to Prepare for a Magnesium Blood Test - Fasting: at least 8 hours after the last meal - Magnesium supplements: stop 48–72 hours before the test — otherwise results reflect the supplement, not actual status - Haemolysis sharply elevates results — intracellular magnesium is released from lysed red cells. A haemolysed sample is unsuitable for analysis - Heparin (the tube anticoagulant) may reduce serum magnesium in some assay methods — check with the laboratory - Time of day: diurnal magnesium variation is minimal; strict timing is not required Causes of Low Magnesium (Hypomagnesaemia) Hypomagnesaemia develops from insufficient intake, impaired absorption, or excessive losses. Insufficient intake: - Poor diet, starvation, alcoholism - Parenteral nutrition without magnesium supplementation - Prolonged tube feeding without adequate magnesium Impaired intestinal absorption: - Coeliac disease, Crohn's disease, short bowel syndrome - Chronic diarrhoea of any cause - Bariatric surgery Excessive renal losses: - Diuretics (loop and thiazide) — the most common iatrogenic cause - Primary aldosteronism, Bartter syndrome - Aminoglycoside antibiotics (gentamicin, amikacin) - Cisplatin and other platinum agents — marked tubular toxicity - Proton pump inhibitors (omeprazole, esomeprazole) with long-term use — reduce intestinal Mg²⁺ absorption - Amphotericin B Endocrine causes: - Type 2 diabetes and type 1 diabetes — hyperglycaemia causes osmotic magnesium loss in urine; magnesium deficiency in turn worsens insulin sensitivity - Hyperthyroidism — accelerated catabolism and urinary magnesium wasting Other causes: - Acute pancreatitis (saponification — magnesium soaps) - Major burns - Post-parathyroidectomy hungry bone syndrome Symptoms of Magnesium Deficiency Magnesium deficiency affects multiple systems simultaneously. Neuromuscular symptoms — the most characteristic: - Muscle cramps, especially in the legs and feet (nocturnal cramps) - Tremor, muscle fasciculations - Paraesthesiae — tingling, numbness - Trousseau's sign (carpopedal spasm with blood pressure cuff inflation) - Chvostek's sign (facial muscle contraction with facial nerve tapping) Cardiovascular symptoms: - Cardiac arrhythmias — tachycardia, ectopic beats, atrial fibrillation - QT prolongation → risk of ventricular tachycardia (torsades de pointes) - Arterial hypertension Neuropsychiatric symptoms: - Irritability, anxiety, depression - Sleep disturbances - Impaired concentration and memory Associated laboratory abnormalities: - Hypokalaemia — magnesium deficiency blocks renal potassium reabsorption; treatment-resistant hypokalaemia is a classic sign of concurrent magnesium deficiency - Hypocalcaemia — magnesium deficiency impairs parathyroid hormone secretion and reduces end-organ responsiveness to PTH The Magnesium–Vitamin D–Calcium Triangle Magnesium, vitamin D, and calcium are three closely linked elements of mineral metabolism. Magnesium and vitamin D: magnesium is required for two key vitamin D activation enzymes — hepatic 25-hydroxylase (producing 25-OH D) and renal 1α-hydroxylase (producing active calcitriol). In magnesium deficiency, vitamin D supplements are not properly activated: the 25(OH)D blood level normalises, but no biological effect is achieved — classic "vitamin D resistance" that resolves with magnesium repletion. Magnesium and calcium: magnesium regulates PTH secretion and receptor sensitivity. In hypomagnesaemia, "functional hypoparathyroidism" develops — PTH is low or inadequate for the degree of hypocalcaemia. Hypocalcaemia in hypomagnesaemia does not respond to calcium supplementation until magnesium is first corrected. Practical rule: in persistent hypocalcaemia or treatment-resistant hypokalaemia, always check magnesium. Causes of High Magnesium (Hypermagnesaemia) Hypermagnesaemia is less common than deficiency and is almost always iatrogenic or related to renal failure. Main causes: - Chronic kidney disease (especially CKD stages 4–5) — kidneys cannot excrete excess magnesium; in dialysis patients, magnesium content of the dialysate must be controlled - Excessive magnesium administration: pre-eclampsia treatment (intravenous MgSO₄), overdose of magnesium supplements - Magnesium-containing antacids and laxatives — especially in older adults with CKD - Addison's disease (adrenocortical insufficiency) - Severe hypothyroidism Symptoms of hypermagnesaemia: - Mild (1.25–1.75 mmol/L): nausea, weakness, reduced deep tendon reflexes - Moderate (1.75–2.5 mmol/L): respiratory depression, hypotension, bradycardia - Severe ( 2.5 mmol/L): respiratory arrest, potentially fatal cardiac arrhythmia The antidote for acute severe hypermagnesaemia is intravenous calcium gluconate. When to Order a Magnesium Blood Test Indications: - Seizures or muscle cramps of unclear aetiology, especially nocturnal cramps - Cardiac arrhythmias, particularly atrial fibrillation - Treatment-resistant hypokalaemia or hypocalcaemia - Long-term use of diuretics, proton pump inhibitors, or cisplatin - Diabetes mellitus — magnesium monitoring when glycaemic control is poor - Severe diarrhoea or malabsorption syndromes - Alcoholism - After major surgery - Resistance to vitamin D or calcium supplementation Correcting Magnesium Deficiency Oral supplements: magnesium citrate and glycinate — best bioavailability (up to 60%). Magnesium oxide — low bioavailability (4%) but widely marketed. Magnesium sulphate orally — irritates the bowel; limited use. Therapeutic dose: 300–600 mg elemental magnesium/day in 2–3 divided doses (splitting reduces diarrhoeal side effects). Intravenous magnesium: for severe hypomagnesaemia (< 0.5 mmol/L), arrhythmias, seizures, or inability to take oral supplements — magnesium sulphate IV infusion in hospital. Dietary sources of magnesium: pumpkin seeds (550 mg/100 g), nuts (200–300 mg/100 g), dark chocolate (230 mg/100 g), legumes (130–180 mg/100 g), whole grains, spinach, avocado. This article is for informational purposes only and does not replace consultation with a qualified physician. https://labreadai.com/en/indicators/psa https://labreadai.com/en/indicators/psa Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Prostate-specific antigen (PSA) is the main marker of prostate health. Normal levels by age, causes of high PSA in prostatitis and cancer, free vs total PSA. Indicators article A man receives a PSA result above the reference range and immediately fears the worst. In reality, elevated PSA is far more often a benign finding than a cancer signal — it rises with prostate enlargement, inflammation, physical pressure on the gland and even a bicycle ride. Prostate-specific antigen is a sensitive but non-specific marker: distinguishing a benign process from a malignant one requires the right context, trends over time and additional tests. What Is PSA and Why Is It Measured? Prostate-specific antigen is a glycoprotein produced by the epithelial cells lining the prostate gland. Under normal conditions a small amount enters the bloodstream — this is physiological. A sharp rise occurs when the barrier between prostate tissue and blood vessels is disrupted: by inflammation, mechanical trauma or tumour growth. Biologically, PSA liquefies seminal fluid after ejaculation. Diagnostically, it serves as an indicator of prostate health: blood levels reflect the gland's volume, the presence of inflammation and the likelihood of malignant disease. PSA is measured for: prostate cancer screening in men over 45–50; monitoring after prostate cancer treatment (surgery, radiotherapy, hormone therapy); diagnosing chronic prostatitis; and tracking benign prostatic hyperplasia (BPH). As part of comprehensive urological screening, PSA is a standard component of the tumour marker panel. PSA Normal Ranges by Age PSA rises physiologically with age as the prostate gradually enlarges — even without pathology, more antigen is secreted. Age-specific reference ranges are therefore essential. Age Normal total PSA (ng/mL) ------------------------------- 40–49 years < 2.5 50–59 years < 3.5 60–69 years < 4.5 70 years and over < 6.5 A level above 4 ng/mL is the traditional biopsy referral threshold, but contemporary guidelines increasingly favour an individualised approach accounting for age, rate of change and the free-to-total PSA ratio. A level above 10 ng/mL substantially increases the probability of malignancy and almost always indicates the need for biopsy. Beyond the absolute value, rate of change matters: PSA velocity (PSAV) above 0.75 ng/mL per year is considered a warning sign regardless of the absolute level. Free PSA vs Total PSA: What Matters More for Diagnosis? PSA circulates in blood in two forms: bound to plasma proteins and unbound (free). The combined concentration is total PSA. Free PSA is measured separately, and their ratio is calculated. Free PSA index = (free PSA / total PSA) × 100% Free PSA index Interpretation -------------------------------- 25% Cancer unlikely — BPH or prostatitis more probable 15–25% Grey zone — further monitoring needed < 15% Elevated risk of malignant process < 10% High probability of prostate cancer In prostate cancer, tumour cells predominantly secrete bound PSA — the free fraction falls. In BPH, the free fraction is proportionally higher. The index is most useful in the 4–10 ng/mL range, where the absolute PSA value alone is insufficient to decide about biopsy. Causes of Elevated PSA High PSA is not synonymous with cancer. Any disruption of the barrier between prostate tissue and bloodstream raises the marker. Benign causes are far more common than malignant ones. Benign prostatic hyperplasia is the most frequent: an enlarged gland produces more PSA proportional to its volume without any inflammation. Acute and chronic prostatitis raises PSA sharply — sometimes to 50–100 ng/mL in bacterial infection, creating a false alarm that resolves within weeks of treatment. Mechanical interventions — prostate biopsy, cystoscopy, catheterisation — elevate PSA for days to weeks; the test should not be performed until at least four to six weeks after these procedures. Physiological triggers include ejaculation (moderate transient rise for 24–48 hours), cycling (perineal pressure), and intense physical exercise — all producing short-lived elevation without pathology. Prostate cancer — the malignant cause. PSA in cancer typically rises faster and is accompanied by a falling free PSA index. In bone metastases, alkaline phosphatase rises simultaneously — an additional marker evaluated in parallel. When prostatic obstruction causes hydronephrosis, rising creatinine signals impaired kidney function and requires urgent urological intervention. How to Prepare for a PSA Blood Test Preparation rules for PSA are stricter than for most biochemical tests because physiological factors genuinely distort results. Two days before the test: abstain from sexual activity and ejaculation; avoid cycling, motorcycling and gym equipment that compresses the perineum; refrain from intense physical exertion. Fast for at least 8 hours — blood is drawn in the morning. After medical procedures: wait 48 hours after digital rectal examination, one week after urinalysis with catheterisation, and four to six weeks after prostate biopsy or surgery. Declare all medications: finasteride and dutasteride halve PSA levels — without accounting for this, a doctor may significantly underestimate the true value. For serial monitoring, always use the same laboratory and test at the same time of day: inter-laboratory calibration differences can produce up to 20% discrepancy that mimics a real change in PSA. Interpreting Results: What to Do With a High PSA The appropriate response depends on the specific value and clinical context. PSA 0–4 ng/mL (age-adjusted) — annual monitoring from age 50 (from 45 with a family history of prostate cancer). PSA 4–10 ng/mL — grey zone: measure the free PSA index and consult a urologist. Biopsy is indicated when the index is below 15% or PSA velocity is high. PSA 10 ng/mL — high probability of malignancy; urological review within days is mandatory. PSA 20 ng/mL — possible extracapsular spread; staging workup includes pelvic MRI and bone scintigraphy. After radical prostatectomy, PSA should be undetectable (< 0.1 ng/mL). Any measurable rise indicates recurrence and requires immediate oncological assessment. When High PSA Requires Urgent Medical Attention A scheduled urology appointment is appropriate for most cases of mild PSA elevation. Certain situations, however, cannot wait. See a doctor within days if: PSA exceeds 10 ng/mL on a first measurement; PSA rises by more than 2 ng/mL in a year during surveillance; PSA becomes detectable after prostate cancer treatment. Seek emergency care or call emergency services if: urinary retention develops alongside high PSA and perineal pain; signs of sepsis appear with acute prostatitis (high fever, rigors, altered consciousness); bone pain combined with sharply rising PSA suggests metastatic disease. Conclusion PSA is a powerful tool for early prostate cancer detection, but it is far from absolute: an elevated result is more often a benign process than malignancy. The decision to proceed to biopsy is made on the basis of multiple factors — the absolute value, trend over time, free PSA index, MRI findings and the clinical picture. Self-interpretation of PSA without a urologist is not advisable. Regular PSA screening from age 45–50 remains one of the most effective strategies for catching prostate cancer when it is still curable. https://labreadai.com/en/indicators/selenium https://labreadai.com/en/indicators/selenium Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Selenium is a trace element vital for thyroid enzymes and immune defence. Normal blood levels, causes of deficiency and toxicity, test interpretation for adults. Indicators article Fatigue, hair loss, frequent infections — these symptoms are rarely linked to a specific micronutrient deficiency. Yet blood selenium below the normal range can simultaneously weaken immunity, impair thyroid hormone activation and reduce the cell's antioxidant defences. This article explains what selenium does in the body, how to interpret your test result and when a low level requires medical attention. Why the Body Needs Selenium Selenium is an essential trace element that the body cannot synthesise — it must be obtained entirely from food. Its biological functions are carried out through selenoproteins, specialised proteins that incorporate the amino acid selenocysteine. Twenty-five selenoproteins have been identified in humans. Key selenium functions: antioxidant defence through glutathione peroxidases, enzymes that neutralise lipid peroxides and protect cell membranes; activation of thyroid hormones — deiodinases that convert inactive T4 into active T3 contain selenium at their active sites; immune support for both innate and adaptive responses; anti-inflammatory activity through regulation of oxidative stress. Picture a cell as a workshop where candles constantly burn — free radicals are the dripping wax. Selenium-containing glutathione peroxidases act as the cleaning crew, preventing a fire. Without them, oxidative stress accumulates and gradually damages proteins, DNA and cell membranes. Selenium Normal Ranges for Adults and Children Most laboratories measure selenium in plasma or serum using inductively coupled plasma mass spectrometry (ICP-MS) or atomic absorption spectrophotometry. Group Normal range (µg/L) -------------------------- Adults 18–60 years 70–150 Men over 60 years 65–145 Women over 60 years 60–140 Pregnant women 60–130 Children 1–14 years 55–120 Infants under 1 year 40–100 Reference intervals vary between laboratories and methods — always compare your result against the range printed on your own report. Plasma selenium reflects current dietary intake, while erythrocyte selenium indicates long-term status over the preceding three to four months. When chronic deficiency is suspected, both measurements may be ordered. How to Prepare for a Selenium Blood Test The test requires fasting for at least eight hours before the blood draw. Avoid alcohol for 24 hours and strenuous exercise on the day of the test. If you are already taking selenium supplements, take them after the test — if you have completed a course, inform your doctor, as the result will reflect supplemented rather than baseline levels. An important pre-analytical detail: blood must be collected into certified metal-free tubes. Standard rubber-stoppered tubes can contaminate the sample and artificially raise the result. Confirm with your laboratory that they use trace-element-grade collection tubes. Causes and Symptoms of Selenium Deficiency Selenium deficiency is the most clinically relevant finding when results fall outside the reference range. Dietary deficiency is the leading cause in regions where soil selenium content is low — Central Asia, parts of Europe and certain areas of China. Crops grown on selenium-poor soil contain little of the element regardless of the plant species. Malabsorption — inflammatory bowel disease, short bowel syndrome and chronic enteropathies impair micronutrient uptake. Low selenium often accompanies low vitamin D and other nutrients, which points to an absorption problem rather than diet alone. Thyroid connection. Selenium deficiency slows the deiodinase-mediated conversion of T4 to active T3 and reduces antioxidant protection of thyroid cells, creating conditions for autoimmune inflammation. The link with Hashimoto's thyroiditis is well established: clinical trials have shown that selenium supplementation lowers anti-TPO antibody levels. In established hypothyroidism, correcting selenium deficiency does not replace levothyroxine but may improve wellbeing. Symptoms. Selenium deficiency has no pathognomonic signs. The typical picture includes chronic fatigue and muscle weakness, diffuse hair loss and brittle nails, frequent infections with prolonged recovery, and cognitive fog. In severe endemic deficiency, dilated cardiomyopathy (Keshan disease) can develop — rare and geographically restricted. Selenium Toxicity: Risks and Signs Selenium is toxic in excess — its therapeutic window is considerably narrower than that of most vitamins. Plasma levels above 400 µg/L are considered a risk zone; above 1000 µg/L, frank toxicity is possible. Causes of excess: uncontrolled high-dose supplementation, particularly with organic forms (selenomethionine); regular consumption of large amounts of Brazil nuts — a single nut provides 70–90 µg, a full day's requirement. Signs of selenosis: garlic-like breath and body odour (dimethylselenide); heavy hair loss progressing to alopecia; brittle nails with white transverse bands (Mees' lines); nausea, diarrhoea and fatigue. Chronic toxicity can cause peripheral neuropathy. Who Should Have Their Selenium Checked Selenium testing is not part of standard screening panels but is indicated in specific clinical scenarios. Consider testing if you have: an autoimmune thyroid disease — your doctor has likely already ordered TSH and free T4, and selenium fits naturally into this evaluation; malabsorption syndrome or inflammatory bowel disease; unexplained fatigue, hair loss and frequent infections with a normal thyroid panel; a vegan or vegetarian diet with a limited food variety; pregnancy with suboptimal nutrition. Do not self-prescribe supplements without a test: the symptoms of deficiency and toxicity partially overlap, and supplementing when levels are already adequate can push them into the toxic range. Conclusion Blood selenium is a focused but clinically valuable test — ordered not routinely but when there is a genuine reason: thyroid autoimmunity, malabsorption or a persistent deficiency syndrome without another explanation. A normal result closes the question. A low result calls for identifying the underlying cause before prescribing supplements. A high result means reviewing the dose of any selenium-containing products immediately. All correction decisions are made by a physician based on the full clinical picture. https://labreadai.com/en/indicators/total-protein https://labreadai.com/en/indicators/total-protein Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Total protein in blood: normal ranges in adults, causes of low levels in cirrhosis and nephrotic syndrome, high levels in myeloma, and when protein electrophoresis is needed. Indicators article Total protein is one of those biochemistry markers that simultaneously reflects several vital processes: the liver's synthetic capacity, nutritional status, and protein loss through the kidneys or intestines. Yet on its own, it is a composite figure — behind which lie dozens of different proteins with entirely different clinical significance. Understanding it requires knowing what it is made of and which fraction has shifted. What Total Protein Is: Albumin and Globulins Blood plasma contains more than 100 different proteins. Total protein is their combined concentration, conventionally divided into two broad groups. Albumin (approximately 55–65% of total protein) is the primary plasma protein, synthesized exclusively in the liver. It transports fats, hormones, drugs, and bilirubin; maintains oncotic pressure (preventing fluid from leaking into tissues); and serves as an amino acid reserve. Albumin is the best marker of hepatic synthetic function and long-term nutritional status. For more detail — see Albumin. Globulins (approximately 35–45%) are a heterogeneous group: α1, α2, β, and γ-globulins. They include immunoglobulins (antibodies), complement components, carrier proteins (transferrin, ceruloplasmin, haptoglobin), and acute-phase proteins (C-reactive protein, α2-macroglobulin). Unlike albumin, globulins are synthesized in multiple organs — the liver, immune cells, and endothelium. This is why an isolated total protein figure without fractionation is often insufficient: normal total protein with low albumin and high globulins — a "crossover" pattern — is typical of chronic inflammation or cirrhosis. How to Prepare for the Test Total protein is measured in serum. Several preparation rules apply: - Fasting: last meal 8–12 hours before. Food intake has minimal direct effect on total protein but fasting ensures comparability with other markers drawn simultaneously - Body position: prolonged standing or exercise before the draw raises total protein by 5–10% through plasma volume reduction. Optimal conditions: morning, after overnight rest - Tourniquet: prolonged venous compression concentrates protein in the sample — the tourniquet should be released immediately after needle insertion - Hydration: dehydration inflates the value; aggressive intravenous fluid therapy deflates it - Acute illness: during active infection or trauma, acute-phase globulins rise — which can produce falsely elevated total protein even as albumin falls Total protein is a standard component of liver function tests alongside ALT, ALP, bilirubin, and albumin — only in this context can it be fully interpreted. Normal Total Protein Levels Group Normal range (g/L) ------ Adults 18–60 years 64–83 Adults over 60 years 62–81 Infants under 1 year 44–73 Children 1–14 years 60–80 Pregnant (third trimester) 55–75 During pregnancy, total protein physiologically falls by 5–10 g/L due to expanded blood volume (haemodilution). This is normal and requires no intervention. Reference ranges may vary slightly by laboratory and method — always use the values printed on your specific report. Causes of Low Total Protein (Hypoproteinemia) Hypoproteinemia — total protein below the normal range — is more common than elevation and often signals significant pathology. Impaired synthesis: - Liver cirrhosis — the most common cause of marked hypoproteinemia. Hepatocyte loss reduces albumin and most globulin production. A value below 55 g/L in cirrhosis indicates decompensation - Acute hepatic failure — synthesis collapses within days - Severe chronic hepatitis Protein losses: - Nephrotic syndrome — massive proteinuria ( 3.5 g protein lost per day in urine). Albumin is predominantly lost — so nephrotic syndrome presents as low albumin with normal or elevated globulins - Protein-losing enteropathy (Crohn's disease, coeliac disease) — loss through the intestinal mucosa - Severe burns — protein loss through damaged skin - Lymphorrhoea, exudative pleural effusion, ascites Inadequate intake: - Severe protein-energy malnutrition (kwashiorkor, marasmus) - Prolonged starvation - Malabsorption syndromes Haemodilution: - Massive intravenous fluid infusion, pregnancy, heart failure with fluid retention Causes of High Total Protein (Hyperproteinemia) True hyperproteinemia is less common. It is important to distinguish it from false elevation due to dehydration. True elevation: - Multiple myeloma — malignant plasma cell proliferation with massive production of pathological immunoglobulins (paraproteins). Total protein can exceed 100–120 g/L. This is the most clinically significant cause of elevated total protein - Chronic infections (tuberculosis, chronic hepatitis B/C) — immune-driven globulin stimulation - Autoimmune diseases (SLE, rheumatoid arthritis) — polyclonal hypergammaglobulinaemia - Sarcoidosis False elevation (haemoconcentration): - Dehydration — reduced plasma volume concentrates all components - Prolonged standing before the draw - Extended tourniquet application during blood collection Albumin/Globulin Ratio: Diagnostic Value The A/G ratio = albumin / (total protein − albumin). Normal range: 1.2–2.0. A/G ratio Interpretation ------ 2.0 Rare: congenital globulin deficiency, immunodeficiency 1.2–2.0 Normal 0.8–1.2 Borderline — warrants clarification < 0.8 Cirrhosis, nephrotic syndrome, multiple myeloma, chronic inflammation A reduced A/G ratio arises from two different mechanisms: albumin falls (cirrhosis, nephrosis), or globulins rise (myeloma, autoimmune disease) — or both processes simultaneously. When Protein Electrophoresis Is Needed Total protein is a summary figure. Serum protein electrophoresis separates proteins into fractions (albumin, α1, α2, β, γ-globulins) and identifies pathological bands (M-protein in myeloma). Electrophoresis is indicated when: - A/G ratio is significantly reduced without obvious cause - Total protein exceeds 90 g/L without explanation - Paraproteinaemia is suspected (myeloma, Waldenström's macroglobulinaemia) - Chronic inflammation of unclear origin needs immune response characterisation When total protein is markedly low, check concurrent ALP and bilirubin — their deviations alongside hypoproteinaemia help identify the primary cause. When to See a Doctor Routine appointment when: - Total protein < 60 g/L or 90 g/L on repeat testing - A/G ratio < 0.8 without an obvious explanation - Total protein is normal but albumin is significantly low — "masked" hypoproteinaemia Urgent attention when: - Total protein < 50 g/L with oedema, ascites, or pleural effusion — signs of severe hypoproteinaemia with disrupted oncotic pressure - Protein 100–110 g/L without an identifiable cause — multiple myeloma must be excluded This article is for informational purposes only and does not replace professional medical advice. Consult a GP or gastroenterologist if your total protein is outside the normal range. https://labreadai.com/en/indicators/urea https://labreadai.com/en/indicators/urea Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Blood urea (BUN): normal ranges in adults, causes of elevation in kidney disease and dehydration, low levels in cirrhosis, and how to interpret alongside creatinine. Indicators article Urea is one of those markers that patients frequently confuse with uric acid — two different substances with entirely different clinical meanings. Urea is the end product of protein breakdown, and its blood level simultaneously reflects two systems: how well the kidneys are working, and how much protein is being consumed and catabolised. Unlike creatinine, urea is sensitive to diet and catabolism — which is precisely why it is best interpreted as a pair with creatinine rather than in isolation. What Urea Is and How It Forms When the body breaks down proteins — from food or its own tissues (during stress, inflammation, or tissue breakdown) — ammonia is released. Ammonia is toxic to the nervous system, so the liver neutralises it by converting it to urea through the ornithine (urea) cycle. The resulting urea enters the bloodstream and is excreted by the kidneys in urine. This two-step route — liver synthesises, kidneys excrete — explains why urea can be abnormal in disease of either organ. Elevation usually points to a problem with excretion (kidneys); reduction points to a problem with synthesis (liver) or simply to low dietary protein. Urea is a standard component of the kidney function panel alongside creatinine, electrolytes, and uric acid. Interpreting it in isolation without companion markers provides an incomplete picture. How to Prepare for a Urea Blood Test Urea is sensitive to several easily controllable factors: - Fasting: blood is drawn 8–12 hours after the last meal - Protein-rich food: a large meat-heavy dinner the evening before raises urea by 10–20% — limit red meat for 24 hours before the test - Physical exercise: intense training accelerates muscle protein breakdown and transiently elevates urea — avoid for 24 hours - Hydration: dehydration concentrates the blood and inflates the reading; drink adequate water the day before - Medications: corticosteroids, tetracyclines, and some diuretics raise urea — inform your doctor about current medications - Serial monitoring: for tracking trends, use the same laboratory and preparation conditions each time Normal Urea Levels by Age and Sex Urea depends on muscle mass and protein metabolism — so normal values are slightly higher in men and lower in children and older adults compared to working-age adults. Group mmol/L mg/dL (urea) BUN (mg/dL) ------------ Children under 14 1.8–6.4 11–38 5–18 Adult men 18–60 2.5–8.3 15–50 7–23 Adult women 18–60 2.1–7.1 13–43 6–20 Over 60 years 2.9–8.2 17–49 8–23 Pregnant women 2.0–4.5 12–27 5–12 Unit note: US laboratories commonly report Blood Urea Nitrogen (BUN) in mg/dL. To convert: urea (mmol/L) × 2.8 = BUN (mg/dL). Normal BUN/creatinine ratio (in mg/dL) is 10–20. During pregnancy, urea physiologically falls: expanding blood volume increases renal blood flow and dilutes the marker. A "normal" urea level for non-pregnant women may already indicate impairment in the second or third trimester. Causes of Elevated Urea (Azotemia) Urea elevation above the normal range is called azotemia. Like creatinine elevation, causes are classified into three categories. Prerenal causes (kidneys are intact but load or blood flow has changed): - Dehydration, vomiting, diarrhoea, heat exposure — reduced renal perfusion concentrates urea - High-protein diet or parenteral nutrition — excess substrate for urea synthesis - Catabolic states: fever, major trauma, burns, sepsis — accelerated breakdown of tissue proteins - Gastrointestinal haemorrhage: blood in the intestinal lumen is digested as dietary protein → urea spikes with normal or only mildly elevated creatinine - Heart failure — reduced cardiac output decreases renal blood flow Renal causes (intrinsic kidney damage): - Chronic kidney disease — the most common cause of persistently elevated urea - Acute kidney injury — rapid rise in both urea and creatinine over hours to days - Glomerulonephritis, severe pyelonephritis Postrenal causes (obstructed urine outflow): - Urolithiasis with ureteral obstruction - Benign prostatic hyperplasia with urinary retention Causes of Low Urea Low urea is less common than elevated and usually reflects reduced synthesis in the liver or insufficient protein substrate. Main causes: - Severe liver disease — liver cirrhosis and acute hepatic failure disrupt the ornithine cycle; the liver cannot convert ammonia to urea. This is a dangerous situation: accumulating ammonia is toxic to the brain - Low-protein diet or starvation — reduced substrate. A vegan diet with minimal protein characteristically produces urea at or below the lower normal limit - Pregnancy — physiological reduction from haemodilution and enhanced renal clearance - SIADH (syndrome of inappropriate antidiuretic hormone secretion) — overhydration dilutes all blood markers - Severe malabsorption — reduced intestinal protein absorption Isolated low urea with normal albumin and normal liver tests is almost always diet or pregnancy-related rather than pathological. But low urea combined with low albumin and elevated bilirubin is a warning sign of decompensated liver function. Urea and Creatinine Ratio: A Diagnostic Tool Both markers reflect renal excretory function, but with different sensitivity to extrarenal factors. Their ratio helps distinguish the cause of azotemia. The urea/creatinine ratio (in mmol/L) is normally 40–80. In US units, the BUN/creatinine ratio (in mg/dL) is normally 10–20. Ratio Interpretation ------ 80 (BUN/Cr 20) Prerenal azotemia: dehydration, GI bleed, hypercatabolism 40–80 (BUN/Cr 10–20) Renal azotemia or normal < 40 (BUN/Cr < 10) Reduced urea synthesis (cirrhosis) or low-protein diet A classic example: gastrointestinal haemorrhage produces disproportionately elevated urea with normal or mildly elevated creatinine — because blood in the intestinal lumen is digested as dietary protein. A ratio sharply above 80 in this context is a signal for endoscopy, not nephrology. When to See a Doctor Schedule a routine appointment when: - Urea is above the upper reference limit on repeat testing without an obvious cause (diet, dehydration) - Urea is rising steadily over serial measurements — even within the "normal" absolute range - Low urea alongside worsening weakness, jaundice, and oedema — possible liver decompensation Seek urgent care when: - Urea and creatinine rise sharply together with oliguria or anuria — acute kidney injury - Uraemic symptoms are present: nausea, vomiting, confusion, ammonia breath - Very low urea (< 1.5 mmol/L) with altered consciousness — possible hepatic encephalopathy This article is for informational purposes only and does not replace professional medical advice. Consult a GP or nephrologist if your urea level is outside the normal range. https://labreadai.com/en/indicators/vitamin-d https://labreadai.com/en/indicators/vitamin-d Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Normal 25-OH vitamin D levels for adults and children. Deficiency and toxicity symptoms, how to test, causes of low levels, doses and when to see a doctor. Indicators article Vitamin D deficiency is one of the most widespread nutritional deficiencies in the world: estimates suggest that 40–70% of people in northern countries have insufficient levels. Yet vitamin D is not simply a vitamin in the conventional sense — by its mechanism of action it is closer to a hormone, its receptors are found in almost every cell of the body, and its deficiency is linked to impaired immunity, bone metabolism, reproductive function, and even mood. This article explains what to measure, how to interpret the result, and how to correct a deficiency correctly. What Is Vitamin D and Why It Matters for Immunity and Calcium Vitamin D is a fat-soluble vitamin more accurately described as a prohormone: in the body it is converted into the active hormone calcitriol. It reaches the body via two routes: synthesised in the skin under the action of ultraviolet B (UVB) radiation, and obtained from food (fatty fish, egg yolk, fortified foods). Activation is two-step. In the liver, vitamin D is converted to 25-hydroxyvitamin D — the form measured in blood tests. Then in the kidneys (and partially in other tissues) it is converted to active calcitriol. This is why in chronic kidney disease the activation of vitamin D is impaired and functional deficiency develops even when 25-OH levels appear normal. A critical and often overlooked factor: magnesium is required for both hepatic 25-hydroxylase and renal 1α-hydroxylase — the enzymes of both activation steps. When magnesium is deficient, vitamin D cannot be properly activated: 25-OH levels may normalise with supplementation while deficiency symptoms persist. This is one of the most common causes of apparent "resistance" to vitamin D therapy. Key functions of vitamin D: - Bone metabolism. The classic primary role: it regulates intestinal calcium absorption and renal reabsorption. Deficiency → falling calcium → compensatory rise in parathyroid hormone → calcium leached from bone. This is the mechanism of rickets in children and osteomalacia in adults. - Immune regulation. Calcitriol activates innate immunity — stimulating the production of antimicrobial peptides (defensins, cathelicidin) and modulating the inflammatory response. Vitamin D deficiency is associated with higher rates of respiratory infections, tuberculosis, and autoimmune diseases. - Neuromuscular function. Participates in nerve impulse transmission and muscle contraction. Deficiency causes muscle weakness and increased fall risk in older adults. - Hormonal regulation. Vitamin D receptors are present in pituitary, adrenal, thyroid, ovarian, and testicular cells. Deficiency influences testosterone production, TSH regulation, and cortisol axis responsiveness. - Neuropsychiatric effects. The link between vitamin D deficiency and depression, cognitive decline, and sleep quality via effects on melatonin is an active area of research. Normal Vitamin D Levels: Table and Interpretation The blood test measures 25-OH vitamin D (calcidiol) — the combined stores of D2 and D3. Units: ng/mL or nmol/L (1 ng/mL = 2.5 nmol/L). Level (ng/mL) Level (nmol/L) Interpretation --------- < 10 < 25 Severe deficiency 10–20 25–50 Deficiency 20–30 50–75 Insufficiency 30–60 75–150 Normal (optimal range) 60–100 150–250 High normal 100 250 Possible toxicity 150 375 Toxicity (hypercalcaemia) The target optimal range according to most clinical guidelines is 30–60 ng/mL (75–150 nmol/L). Some experts and medical societies recommend 40–60 ng/mL for maximum immune and bone-related benefit. Interpretive categories are the same for children, but the minimum target for rickets prevention is at least 20 ng/mL, with an optimal range of 30–50 ng/mL. Causes of Vitamin D Deficiency Vitamin D deficiency is almost a pandemic of modern urban living. The main drivers: Insufficient sun exposure — by far the most common cause. Skin synthesis requires direct UVB exposure on unprotected skin. At latitudes above 35–40° (all of Russia, Scandinavia, most of Europe) from October through April, the sun's angle is such that UVB rays barely reach ground level. In winter, cutaneous synthesis is essentially zero regardless of time spent outdoors. Sunscreen use — SPF 15 reduces vitamin D synthesis by approximately 99%. Dark skin — melanin absorbs UVB, reducing synthesis by three to six times compared to light skin. Age — in adults over 65, the skin's capacity for vitamin D synthesis is reduced fourfold. Obesity — vitamin D is fat-soluble and sequesters in adipose tissue, reducing bioavailability. Malabsorption — coeliac disease, inflammatory bowel disease, intestinal resection impair absorption of fat-soluble vitamins. Chronic kidney disease — impaired conversion of 25-OH to calcitriol. Hypothyroidism — reduced thyroid function impairs vitamin D conversion through altered metabolic rate. Certain medications — glucocorticoids, anticonvulsants, and rifampicin accelerate vitamin D catabolism. Symptoms of Vitamin D Deficiency Vitamin D deficiency is largely a "silent" condition: most people have no prominent symptoms even at levels of 10–15 ng/mL. But consequences accumulate over months and years. Early and non-specific symptoms: chronic fatigue and general weakness, frequent upper respiratory infections and slow recovery, muscle aches and bone pain (particularly in the ribs, spine, and thighs), low mood and impaired concentration. With severe and prolonged deficiency: pronounced muscle weakness with difficulty climbing stairs, tenderness on bone palpation (osteomalacia), skeletal deformities in children, and stress fractures. The long-term consequence in adults is osteoporosis. For a detailed breakdown of clinical stages, diagnosis, and treatment — see Vitamin D Deficiency. Indirect markers in other tests: compensatorily elevated parathyroid hormone (secondary hyperparathyroidism), low-normal or frankly low calcium, and reduced phosphorus. How to Take a Vitamin D Blood Test Correctly The form to measure: strictly 25-OH vitamin D (calcidiol) — total D2+D3. Not 1,25-dihydroxyvitamin D (calcitriol) — the active form, which can be normal or even elevated in deficiency due to compensatory hyperparathyroidism and therefore does not reflect body stores. Preparation rules: - Fasted, morning draw — as with most biochemical tests - Stop vitamin D supplements 3–5 days before the test — otherwise the result reflects the supplement dose rather than true body status - Inform the doctor about medications affecting vitamin D metabolism (glucocorticoids, anticonvulsants) - For treatment monitoring — retest 3 months after starting supplementation For a complete assessment of bone and mineral metabolism, vitamin D is tested alongside calcium and parathyroid hormone — their combination gives the diagnostically meaningful picture. Vitamin D Deficiency Treatment: Doses, Forms and How to Raise Levels Preventive doses for maintaining an adequate level (when already sufficient): 800–2000 IU/day for adults, 400–1000 IU/day for children. Therapeutic doses for confirmed deficiency (< 20 ng/mL): 4000–10,000 IU/day for 8–12 week courses under medical supervision with blood monitoring. Doses above 4000 IU/day should be prescribed by a physician. Form: vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) — better absorbed and maintains levels for longer. Oil-based preparations are slightly better absorbed than water-based ones when taken with a fatty meal. Important: vitamin D is fat-soluble and accumulates in the body — overdose is possible with prolonged unsupervised use of high doses. Signs of hypervitaminosis D (typically at levels 100–150 ng/mL): nausea, thirst, frequent urination, weakness, and cardiac arrhythmia from hypercalcaemia. When to See a Doctor A planned appointment is warranted when: - Vitamin D is below 20 ng/mL — therapeutic dosing and monitoring are needed - Deficiency persists despite standard-dose supplementation — check magnesium levels - Parathyroid hormone is elevated with normal or borderline calcium — vitamin D deficiency may be the cause of secondary hyperparathyroidism - Symptoms of osteomalacia or rickets in a child Urgent consultation is needed for: - Symptoms of hypercalcaemia (nausea, vomiting, polyuria, arrhythmia) during high-dose vitamin D supplementation — possible toxicity - Vitamin D above 100 ng/mL on repeat measurement Vitamin D is one of the few nutrients where proactive level monitoring is justified for virtually everyone living at northern latitudes, particularly through the autumn and winter months. An annual blood test and an appropriately dosed supplement represent a simple measure with real impact on immunity, bone health, and the hormonal environment. This article is for informational purposes only. Interpreting test results and prescribing treatment is exclusively the responsibility of a physician. https://labreadai.com/en/tests/allergy-panel https://labreadai.com/en/tests/allergy-panel Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) The allergy panel includes total IgE, specific IgE antibodies and eosinophils. Learn what each test shows, how to prepare and how to interpret your results. Tests article A runny nose every spring, a rash after strawberries, a cough whenever you visit a friend with a cat — and you have long suspected allergy but still do not know exactly what triggers it. Laboratory allergy testing is not a single test but a system of markers, each answering a different question. Here is what the standard allergy panel includes, what your results mean, and how to prepare correctly. What the Allergy Panel Includes Laboratory allergy diagnosis operates on three levels: assessing the overall allergic activity of the immune system, detecting antibodies to specific allergens, and measuring indirect inflammatory markers. Total IgE — the aggregate concentration of class-E immunoglobulins in the blood. This is the screening test: it indicates the general degree of "allergic readiness" of the immune system without naming any specific trigger. Elevated total IgE is the signal to move to the next step. Specific IgE (sIgE) to individual allergens — the cornerstone of allergy diagnosis. These are antibodies directed against a single substance: birch pollen, cat dander, peanut, house dust mite. Specific IgE confirms sensitisation to a particular trigger. Multiple allergens are tested simultaneously as panels: inhalant (airborne allergens), food, or paediatric. Eosinophils in the complete blood count — an indirect marker of allergic and parasitic inflammation. They do not confirm specific allergy but help assess the activity of the atopic process and rule out parasitic causes of elevated IgE. ESR and CRP — inflammatory markers that help distinguish allergic from infectious causes of symptoms: in allergy they are typically normal or only mildly elevated. Methods of Laboratory Allergy Testing ImmunoCAP — the Gold Standard ImmunoCAP (fluorescent enzyme immunoassay) is the most accurate method for measuring specific IgE. The allergen is fixed to a solid phase, binds IgE from the patient's serum, and the signal is measured quantitatively. Results are expressed in kU/L and classified by sensitisation level. Class sIgE concentration (kU/L) Sensitisation level --------- 0 < 0.35 None 1 0.35–0.69 Very low 2 0.70–3.49 Low 3 3.50–17.49 Moderate 4 17.50–49.99 High 5 50.0–100.0 Very high 6 100.0 Extremely high Class 2 and above is considered clinically significant, although class 1 with compatible symptoms also warrants attention. Immunoblot (Multiplex Panels) An alternative method — simultaneous testing against dozens of allergens in a single assay. Less sensitive than ImmunoCAP, but allows broad screening when the diagnosis is unclear. Results are semi-quantitative: expressed as scores or crosses rather than kU/L. Molecular (Component-Resolved) Allergy Diagnostics The modern approach — testing not against a whole allergen extract (e.g. "birch") but against individual allergenic molecules (Bet v 1, Bet v 2, etc.). This allows: risk stratification for severe systemic reactions (patients with antibodies to "major" components carry higher risk), explanation of cross-reactive responses (why a birch-allergic patient reacts to apples), and more precise selection of immunotherapy targets. Standard Allergen Panels Laboratories offer ready-made allergen sets grouped by clinical logic. Inhalant (respiratory) panel — for diagnosing hay fever, allergic rhinitis and asthma: trees (birch, alder, hazel, oak), grasses (timothy, orchard, ryegrass), weeds (ragweed, wormwood), house dust mites (Der p 1, Der f 1), moulds (Alternaria, Cladosporium), cat and dog dander. Food panel — for food allergy diagnosis: cow's milk, hen's egg (white and yolk separately), peanut, tree nuts, soy, wheat, fish (cod, salmon), shellfish (shrimp, crab). Paediatric panel — adapted for children: milk, egg, wheat, soy, peanut plus the main inhalant allergens. Insect venom panel — bee, wasp, and hornet venom — for patients with severe reactions to stings. An allergist often builds an individualised panel based on the patient's history — this is more accurate than any standard set. Total IgE Normal Ranges by Age Total IgE levels are age-dependent and are significantly lower in children. Age Normal total IgE (IU/mL) ------------------------------- Under 1 year < 15 1–5 years < 60 5–14 years < 90 14–18 years < 200 Adults 18 years < 100 The normal range for specific IgE is universal across all ages: a value < 0.35 kU/L corresponds to class 0 (no sensitisation). How to Prepare and When to Test The key advantage of a blood IgE test over skin prick tests is that preparation requirements are minimal. When to test: any time of year — including peak pollen season and during active symptoms. Antihistamines and intranasal corticosteroids do not affect blood IgE levels and do not need to be stopped. This makes blood testing the preferred option when it is impossible to interrupt treatment. Basic rules: fast for 4 hours or test in the morning fasting; avoid fatty food and alcohol for 24 hours beforehand; avoid physical exertion and smoking for 30 minutes before the draw. Inform your doctor: about systemic corticosteroids (they suppress IgE and may underestimate the result) and immunosuppressive drugs. One exception to the "test any time" rule — molecular diagnostics during acute infection: acute inflammation can non-specifically alter the antibody profile. Interpreting Your Results Elevated total IgE + elevated specific IgE to particular allergens — confirmed sensitisation. This is not automatically a diagnosis of allergy: symptoms must correlate with the timing or circumstances of exposure to that allergen. Elevated total IgE + normal specific IgE — several possible explanations: the responsible allergen was not in the tested panel (the panel should be expanded); parasitic infestation (helminths cause a sharp rise in total IgE, typically combined with elevated eosinophils); rare IgE-mediated immunodeficiency. Normal total IgE + allergy symptoms — allergy is not excluded. Some allergic reactions — contact dermatitis, certain drug reactions — are not IgE-mediated and will not show up in this test. In localised allergic reactions (for example, confined to the nasal mucosa), blood total IgE may remain normal. Elevated eosinophils + high IgE without obvious allergens — parasitic infestation (ascariasis, toxocariasis) must be ruled out before attributing the pattern to atopy. When Allergy Testing Is Mandatory Routine testing is indicated for: recurrent symptoms (runny nose, sneezing, itching, rash) linked to a specific season, location or food; suspected food allergy; atopic dermatitis with unclear triggers; allergic rhinitis before starting immunotherapy — AIT can only be given when IgE-mediated sensitisation is confirmed; severe reactions to insect stings. Urgently — after any anaphylactic episode: once stabilised, the causative allergen must be identified to prevent recurrence. This article is for informational purposes only. Interpretation of results and treatment decisions are the responsibility of a qualified allergist. https://labreadai.com/en/tests/hba1c https://labreadai.com/en/tests/hba1c Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) HbA1c reflects average blood glucose over 3 months: normal levels, diabetes targets, causes of false results and how to use the test to monitor treatment. Tests article A standard blood glucose test is a snapshot: it captures your sugar level at the precise moment of the draw. Glycated hemoglobin is a fundamentally different tool — it is a three-month recording. It tells the physician what blood glucose actually looked like in daily life, not just on the morning of a clinic visit. For diagnosing and monitoring diabetes, HbA1c is irreplaceable. What Glycated Hemoglobin Is and How It Forms Glycated hemoglobin (HbA1c) is hemoglobin that has had a glucose molecule irreversibly attached to it. This process — glycation — occurs spontaneously: the higher the glucose concentration in the blood, the more actively it binds to hemoglobin inside red blood cells. A red blood cell lives approximately 90–120 days. During that time, a certain percentage of its hemoglobin becomes glycated — directly proportional to the average glucose concentration over that period. When the red cell is destroyed, the "counter" resets: new cells start glycating from scratch. This is why HbA1c reflects average glycemia over the preceding 2–3 months — not the past week, not a single day. It is resistant to situational fluctuations: a slice of cake the night before has no impact. What matters is the sustained pattern of diet and lifestyle — over months. Normal HbA1c Levels Reference values for HbA1c are largely independent of age and sex in healthy adults. However, they differ meaningfully depending on the clinical situation. Group HbA1c (%) HbA1c (mmol/mol) Interpretation ------------ Healthy adults < 5.7 < 39 Normal Prediabetes 5.7–6.4 39–46 Elevated diabetes risk Diabetes — diagnostic threshold ≥ 6.5 ≥ 48 Diabetes (requires confirmation) Target in diabetes (most patients) < 7.0 < 53 Good control Target in diabetes (elderly, high hypoglycemia risk) < 8.0 < 64 Acceptable control Target in pregnancy with diabetes < 6.0–6.5 < 42–48 Tight control Approximate HbA1c-to-glucose conversion: 6% ≈ 7.0 mmol/L; 7% ≈ 8.6 mmol/L; 8% ≈ 10.2 mmol/L; 9% ≈ 11.8 mmol/L. How to Prepare for an HbA1c Test One of HbA1c's main advantages over standard glucose testing is the simplicity of preparation. The test does not require fasting — it can be done at any time of day, regardless of recent meals. Key caveats: - Acute illness, blood transfusion, or blood loss in the preceding 2–3 months can distort the result - Inform your doctor about medications that affect red cell turnover (erythropoietin, iron supplementation) - For primary diabetes diagnosis, two confirmatory measurements on separate days are required - For serial monitoring, use the same laboratory and method each time HbA1c is not used for diabetes diagnosis in hemolytic anemia, sickle cell anemia, or certain rare hemoglobinopathies. Interpreting Your Result Clinical context is everything: the same number means different things for a healthy person, someone with prediabetes, and someone with established diabetes. HbA1c Clinical meaning Recommended action --------- < 5.7% Normal Recheck every 3 years without risk factors 5.7–6.4% Prediabetes Lifestyle modification; annual monitoring ≥ 6.5% (confirmed twice) Diabetes mellitus Endocrinology referral; start treatment < 7.0% (in diabetes) Good glycemic control Continue current treatment plan 7.0–8.0% (in diabetes) Suboptimal control Adjust treatment or lifestyle 8.0% (in diabetes) Poor control Urgent treatment revision; high complication risk 10% (in diabetes) Decompensation Hospitalization or emergency intervention Each 1% reduction in HbA1c measurably reduces the risk of diabetic complications: retinopathy by 35%, nephropathy by 25%, neuropathy by 25%. HbA1c in Type 1 and Type 2 Diabetes: Targets and Monitoring Glycated hemoglobin is the primary marker of diabetes management quality. Treatment targets are individualized and depend on patient age, diabetes duration, presence of complications, and hypoglycemia risk. In type 2 diabetes, the target for most patients is HbA1c < 7.0%. In older adults or those with frequent hypoglycemia, the target is relaxed to < 8.0%. In young patients without complications, a tighter goal of < 6.5% is sometimes appropriate. In type 1 diabetes, targeting HbA1c < 7.0% carries hypoglycemia risk with aggressive management. Continuous glucose monitoring (CGM) systems complement HbA1c with "time in range" (TIR) — capturing intraday variability that HbA1c cannot reflect. In gestational diabetes and pre-existing diabetes during pregnancy, the target is most stringent — HbA1c < 6.0–6.5% to minimise fetal risk. Monitoring frequency increases to every 4–6 weeks. When HbA1c Can Be Misleading: Sources of Error Falsely elevated HbA1c: - Iron deficiency anemia — reduced ferritin slows red cell turnover; longer-lived cells accumulate more glycated hemoglobin. HbA1c can be falsely elevated by 0.5–1.5% despite adequate glucose control - Vitamin B12 and folate deficiency — same mechanism - Chronic kidney disease with hemoglobin carbamylation — interferes with certain measurement methods - Chronic heavy alcohol use Falsely reduced HbA1c: - Hemolytic anemia — accelerated red cell destruction shortens average cell lifespan - Blood transfusion in the preceding 2–3 months — donor cells dilute the patient's own - Sickle cell anemia, thalassemia — abnormal hemoglobin variants are measured differently - Recently initiated iron therapy or erythropoietin When a false result is suspected, alternative markers are used: fructosamine (reflects glycemia over 2–3 weeks) or 1,5-anhydroglucitol. A complete blood count is an essential companion to HbA1c at initial interpretation: red cell indices, hemoglobin, and MCV immediately reveal conditions that could distort the result. When an HbA1c Result Requires Action See a doctor within the next few days if: - HbA1c ≥ 6.5% is found for the first time — full diagnostic workup and treatment initiation are needed - HbA1c 9% in a patient with known diabetes — high risk of ketoacidosis or hyperosmolar state - HbA1c is rising visit-to-visit despite treatment — the current regimen is failing - HbA1c has dropped sharply to < 5.0% in an insulin-treated patient — frequent nocturnal hypoglycemia may be occurring Seek urgent care if decompensation symptoms appear: intense thirst, frequent urination, weakness, nausea, acetone breath — possible ketoacidosis regardless of the current HbA1c value. This article is for informational purposes only and does not replace professional medical advice. HbA1c interpretation and target-setting should be performed by an endocrinologist or GP. https://labreadai.com/en/tests/pancreatic-panel https://labreadai.com/en/tests/pancreatic-panel Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) The pancreatic panel includes amylase, lipase, glucose and insulin. Normal ranges, interpretation and what elevated enzymes mean for pancreatitis and diabetes. Tests article Upper abdominal pain radiating to the back, nausea, and rising blood sugar — symptoms that call for a thorough assessment of the pancreas. Unlike the liver or kidneys, no single universal marker exists for this organ: the pancreas performs two fundamentally different functions, each requiring its own set of tests. Here is what the pancreatic panel includes, what abnormal results mean, and how to prepare correctly for the blood draw. What the Pancreatic Panel Includes The pancreas has a dual identity. Its exocrine component — about 95% of the organ's volume — produces digestive enzymes delivered through ducts into the duodenum. Its endocrine component — the islets of Langerhans — secretes hormones directly into the bloodstream: insulin, glucagon, and somatostatin. This duality determines the structure of the diagnostic panel: Markers of exocrine function (tissue damage): - Amylase in blood and urine - Lipase in blood Markers of endocrine function (carbohydrate metabolism): - Fasting glucose - Insulin and HOMA-IR index - Glycated haemoglobin HbA1c The specific combination ordered depends on the clinical question: when acute pancreatitis is suspected, enzyme tests take priority; for diabetes diagnosis, glucose and HbA1c lead the workup. A full panel is most valuable when the clinical picture is unclear. Pancreatic Enzymes: Amylase and Lipase Both enzymes are normally present in blood in small amounts. When acinar cells are damaged — by inflammation, necrosis, or ductal obstruction — they pour into the bloodstream. Amylase breaks down starch. It is produced not only by the pancreas but also by the salivary glands, which means moderate amylase elevation can reflect salivary gland pathology (parotitis, sialolithiasis) rather than a pancreatic problem. The normal range for pancreatic amylase is 13–53 U/L. Amylase rises within 2–6 hours of acute pancreatitis onset and returns to normal within 3–5 days. Lipase is more specific: it is produced almost exclusively by the pancreas. This makes lipase the preferred marker for acute pancreatitis. Normal range: 13–60 U/L. Lipase rises slightly more slowly than amylase (4–8 hours after onset) but remains elevated for much longer — up to 8–14 days. When patients present late and amylase has already normalised, lipase retains its diagnostic value. One important rule: the height of enzyme elevation does not correlate with pancreatitis severity. Mild oedematous pancreatitis sometimes produces higher amylase than severe necrotising disease — because in extensive necrosis, fewer enzyme-producing cells remain. Endocrine Function: Glucose and Insulin While enzymes reflect exocrine tissue damage, glucose and insulin reveal how well the endocrine islets are functioning. Fasting glucose is the fundamental carbohydrate metabolism screening test. Normal: 3.9–6.0 mmol/L (WHO criteria). A level of 6.1–6.9 mmol/L indicates impaired fasting glucose — a pre-diabetic state requiring further workup. A level ≥ 7.0 mmol/L on two separate measurements meets the diagnostic threshold for diabetes mellitus. Fasting insulin is paired with glucose to calculate the HOMA-IR index: HOMA-IR = (fasting glucose × fasting insulin) / 22.5 A HOMA-IR below 2.7 is considered normal; above 2.7 indicates insulin resistance. This index is particularly valuable in diagnosing metabolic syndrome and early pre-diabetes — when fasting glucose is still normal but the pancreas is already working under excess load. In chronic pancreatitis with progressive destruction of the islets of Langerhans, a distinctive "pancreatogenic" diabetes can develop — characterised by endocrine insufficiency combined with malabsorption and steatorrhoea. Glycated Haemoglobin in Pancreatic Assessment Fasting glucose captures a single moment. Glycated haemoglobin HbA1c reveals the average glucose level over the preceding 2–3 months — the lifespan of a red blood cell, during which glucose binds irreversibly to haemoglobin in proportion to its concentration. HbA1c value Interpretation ------ < 5.7% Normal 5.7–6.4% Pre-diabetes ≥ 6.5% Diabetes mellitus ≥ 7.0% Suboptimal control in a known diabetic HbA1c is independent of food intake, time of day, and acute stress — its key advantage over fasting glucose. It loses reliability in haemolytic anaemias and certain haemoglobinopathies, where fructosamine is used instead. Normal Reference Ranges for the Pancreatic Panel Test Normal range Method --------- Total amylase 28–100 U/L Kinetic Pancreatic amylase 13–53 U/L Immunoinhibition Lipase 13–60 U/L Turbidimetry Fasting glucose 3.9–6.0 mmol/L Hexokinase Fasting insulin 2.6–24.9 µIU/mL ELISA HOMA-IR < 2.7 Calculated HbA1c < 5.7% HPLC Reference intervals vary slightly between laboratories — always compare your result against the range printed on your own report. Interpreting Results: What Each Abnormality Means High amylase + high lipase — a strong argument for acute or chronic pancreatitis in flare. Ultrasound or CT of the abdomen is ordered to confirm the diagnosis and assess severity. Isolated amylase elevation with normal lipase most often points to a non-pancreatic source. High glucose with normal enzymes — endocrine dysfunction without acute inflammation. Causes: type 1 or type 2 diabetes, post-meal hyperglycaemia, stress hyperglycaemia. Requires follow-up testing and longitudinal monitoring. High enzymes + high glucose — possible severe pancreatic inflammation with islet involvement. In acute necrotising pancreatitis, transient hyperglycaemia is a poor prognostic sign. Elevated HOMA-IR with normal fasting glucose — early insulin resistance. The pancreas is compensating, but at the cost of excess insulin secretion. Lifestyle modification is most effective at this stage. HbA1c in the pre-diabetes range (5.7–6.4%) — a call to action: dietary changes, physical activity, weight management, and a repeat test in 3–6 months. How to Prepare for Pancreatic Panel Tests Preparation significantly affects results — particularly for enzyme tests and glucose. Fast strictly for 8–12 hours — essential for glucose, insulin, and HbA1c. For enzymes (amylase, lipase), fasting is recommended but not critical: a fatty meal modestly elevates lipase. No alcohol for 24 hours — alcohol directly raises amylase and can mimic pancreatitis. Avoid intense exercise the day before — physical activity affects glucose and insulin levels. Declare all medications: corticosteroids, thiazide diuretics, and oral contraceptives raise glucose; furosemide and azathioprine elevate amylase. In acute abdominal pain with suspected pancreatitis, tests are drawn immediately without preparation — the clinical situation takes absolute priority. When to Seek Urgent Medical Attention Call emergency services or go to the emergency department immediately if: acute girdle-like abdominal pain radiates to the back, especially after a heavy meal or alcohol; nausea and vomiting are persistent and bring no relief; pain worsens alongside fever and chills; glucose is markedly elevated (above 14–15 mmol/L) with thirst, polyuria, and nausea. A routine gastroenterology or endocrinology referral is warranted when: amylase or lipase is incidentally elevated without pain; HbA1c falls in the pre-diabetes or diabetes range; HOMA-IR exceeds 2.7 with normal fasting glucose. This article is for informational purposes only. Test interpretation and treatment decisions are the responsibility of a qualified physician. https://labreadai.com/en/tests/pregnancy-panel https://labreadai.com/en/tests/pregnancy-panel Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Complete list of pregnancy blood tests by trimester: hCG, haemoglobin, ferritin, TSH, glucose, vitamin D. Normal ranges and what abnormal results mean. Tests article Pregnancy is a period when laboratory monitoring becomes part of caring for two lives at once. The body changes rapidly: normal ranges for many tests differ from non-pregnant values, and some conditions — iron deficiency, thyroid dysfunction, gestational diabetes — develop silently and are only discovered through blood tests. Here is what to test, when, what the results mean, and which abnormalities cannot be ignored. Why Pregnancy Tests Differ from Standard Reference Ranges Pregnancy produces physiological changes across every organ system that directly affect laboratory results. By the end of the first trimester, circulating blood volume has increased by 40–50% — almost entirely through plasma expansion. This dilutes red cells and proteins: haemoglobin, albumin, and platelet count all fall physiologically. At the same time, demand for iron, folate, iodine, and vitamin D surges — without supplementation, deficiencies develop quickly. This is why pregnancy results must be interpreted against pregnancy-specific reference ranges — the standard non-pregnant norms simply do not apply. First Trimester (Weeks 1–13): Baseline Screening The first antenatal visit — ideally before weeks 8–10 — establishes the pregnancy diagnosis, identifies baseline deficiencies, and screens for infections that can harm the fetus. hCG (human chorionic gonadotropin) — confirms pregnancy and tracks its progression. In a healthy early pregnancy, hCG doubles every 48–72 hours through weeks 8–10. Slow rise suggests possible ectopic pregnancy or threatened miscarriage. After weeks 11–12, a physiological decline begins — this is normal. Haemoglobin and complete blood count — anaemia screening. Physiological thresholds in pregnancy: haemoglobin ≥ 110 g/L in the first and third trimesters, ≥ 105 g/L in the second. Values below these indicate pregnancy anaemia requiring treatment. Ferritin — iron stores. Falls before haemoglobin does: a level below 30 µg/L indicates depleted stores. Iron deficiency in pregnancy is the leading cause of anaemia and a common contributor to the fatigue often dismissed as "morning sickness." TSH (thyroid-stimulating hormone) — thyroid function. First-trimester norms are stricter than outside pregnancy: the target is < 2.5 mIU/L. Untreated hypothyroidism during pregnancy impairs fetal neurological development and raises the risk of preterm birth. Fasting glucose — baseline diabetes screening. A value ≥ 5.1 mmol/L at the first visit meets the WHO 2013 criterion for gestational diabetes without further testing. Values between 5.1–6.9 mmol/L establish the diagnosis on a single measurement. Vitamin D — deficiency is found in most pregnant women in countries with limited sun exposure. A level below 50 nmol/L requires correction: vitamin D is essential for fetal bone development, immune function, and reducing the risk of pre-eclampsia. Folate — critical in the first 12 weeks: deficiency during neural tube closure (days 21–28 after conception) dramatically raises the risk of fetal structural defects. Folic acid supplementation ideally begins three months before conception and continues throughout the first trimester. Blood group and Rh factor — when the mother is Rh-negative and the father Rh-positive, the risk of Rh sensitisation is assessed. Anti-D immunoglobulin is given prophylactically at week 28 and after delivery. Infection screening: antibodies to HIV, syphilis, hepatitis B (HBsAg) and hepatitis C — mandatory at the first visit and repeated in the third trimester. Urinalysis — detects urinary tract infections (asymptomatic bacteriuria in pregnancy must be treated) and proteinuria as an early sign of pre-eclampsia. Second Trimester (Weeks 14–27): Gestational Diabetes and Anaemia Screening Oral glucose tolerance test (OGTT) — 75 g glucose — the standard gestational diabetes screen at weeks 24–28, offered to all pregnant women whose fasting glucose in the first trimester was < 5.1 mmol/L. Diagnostic thresholds: fasting ≥ 5.1 mmol/L, at 1 hour ≥ 10.0 mmol/L, at 2 hours ≥ 8.5 mmol/L. Repeat complete blood count — monitoring haemoglobin and platelets. Physiological blood dilution is maximal in the second trimester, so haemoglobin often reaches its lowest values at this point. Calcium and magnesium — when symptoms are present: leg cramps, pulling pains, irritability. Hypomagnesaemia in pregnancy is a frequent and correctable cause of calf muscle cramps. Third Trimester (Weeks 28–40): Preparing for Delivery Repeat infection screening (HIV, syphilis, HBsAg) — at weeks 28–30 and 36. Coagulation panel — clotting system assessment before delivery. Pregnancy physiologically increases coagulability, raising thrombosis risk. Critical changes may indicate pre-eclampsia or HELLP syndrome. Repeat complete blood count — the final pre-delivery anaemia screen. Correcting iron deficiency at this stage is particularly important: blood loss in labour is far more dangerous in a woman with an already reduced haemoglobin. Group B Streptococcus (GBS) — vaginal swab culture at weeks 35–37. If carriage is detected, intrapartum antibiotic prophylaxis is given. Normal Ranges for Key Pregnancy Tests Test First trimester Second trimester Third trimester ------------ Haemoglobin (g/L) ≥ 110 ≥ 105 ≥ 110 Ferritin (µg/L) 30 20 15 TSH (mIU/L) < 2.5 < 3.0 < 3.5 Fasting glucose (mmol/L) < 5.1 < 5.1 < 5.1 Vitamin D (nmol/L) 50 50 50 Reference intervals may vary slightly between laboratories — always compare your result against the range on your own report. Warning Results: When to Contact Your Doctor Immediately Contact your obstetrician immediately if: haemoglobin falls below 90 g/L — severe anaemia requiring urgent correction; fasting glucose exceeds 7.0 mmol/L — possible overt diabetes; TSH is below 0.1 or above 10 mIU/L — significant thyroid dysfunction; urine protein exceeds 0.3 g per 24 hours combined with elevated blood pressure — signs of pre-eclampsia; significant coagulation abnormalities appear alongside symptoms. This article is for informational purposes only. Test ordering, result interpretation and treatment are the responsibility of a qualified obstetrician-gynaecologist. https://labreadai.com/en/tests/tumor-markers https://labreadai.com/en/tests/tumor-markers Fri, 27 Mar 2026 00:00:00 GMT labreadai@proton.me (LabReadAI) Tumour markers are substances that change with cancer. PSA, hCG, AFP, CEA, CA-125 and CA-19-9 explained: what each shows, normal ranges and method limits. Tests article You received a "tumour marker panel" result showing a value slightly above the reference range. First thought — cancer? Stop. Tumour markers are among the most overestimated and misunderstood tools in laboratory medicine. Most of them are not designed to screen for cancer in healthy people, rise with many benign conditions, and almost never establish a diagnosis on their own. Here is what tumour markers actually are, what they genuinely show, and in which context their results carry meaning. What's Included in a Tumour Marker Panel and How It Works Tumour markers are substances — proteins, hormones, antigens — whose concentration in blood, urine or other body fluids changes in association with malignant tumours. They may be produced by tumour cells themselves or by normal cells responding to the presence of a tumour. The fundamental problem: most tumour markers are not specific to cancer. The same substance can rise with inflammation, benign tumours, liver cirrhosis, pregnancy, or physical exertion. This means: - Elevated marker ≠ cancer — in most cases the cause is something else - Normal marker ≠ no cancer — many tumours produce no markers at all - Diagnostic value is greatest for monitoring an already established diagnosis and tracking treatment response The exception — a handful of markers with high organ and tumour specificity, most notably PSA for prostate cancer and hCG for germ cell tumours. Why Tumour Markers Are Ordered: Screening and Monitoring Tumour markers are used in three fundamentally different contexts, each with different diagnostic value. Treatment monitoring — the most evidence-based application. After surgery, chemotherapy or radiotherapy, a falling marker confirms treatment response. A rising marker during remission is an early sign of relapse, often preceding clinical symptoms by weeks or months. This is precisely why tumour markers are incorporated into follow-up protocols for most oncological diagnoses. Diagnosis in symptomatic patients — when there is a well-founded clinical suspicion of a specific tumour, a marker can help clarify the diagnosis or guide the investigation pathway. For example, an elevated PSA in a man with urological symptoms warrants prostate biopsy. Screening in healthy people — the least evidence-based application for most markers. The exception: PSA is used for prostate cancer screening in men over 45–50 when the patient understands and accepts the method's limitations. Key Tumour Markers and What They Show PSA (prostate-specific antigen) The most extensively studied and clinically significant tumour marker. Produced by prostate cells — both normal and malignant. Elevated in prostate cancer, benign prostatic hyperplasia, and prostatitis. Age-adjusted normal values: below 50 years < 2.5 ng/mL; 50–60 years < 3.5 ng/mL; over 60 < 4.5–6.5 ng/mL. Full details in the PSA blood test article. hCG (human chorionic gonadotropin) and β-hCG Physiologically produced during pregnancy — that is its primary function. As a tumour marker: elevated in non-seminomatous germ cell tumours of the testis, choriocarcinoma of the uterus, and some gastrointestinal and lung malignancies. In men and non-pregnant women, any detectable hCG level requires oncological evaluation. After treatment for germ cell tumours, hCG is used to monitor remission — its rise is the first signal of relapse. AFP (alpha-fetoprotein) Synthesised by the fetal liver and yolk sac — in healthy adults, levels are minimal (< 10 IU/mL). Elevated in hepatocellular carcinoma, non-seminomatous germ cell tumours, and occasionally in liver metastases from other primaries. Moderate elevation is seen in cirrhosis and viral hepatitis without malignancy. AFP is used alongside hCG in staging and monitoring germ cell tumours. CEA (carcinoembryonic antigen) One of the oldest tumour markers. Elevated in colorectal, lung, breast, and pancreatic cancers. Normal < 5 ng/mL (< 10 ng/mL in smokers). Moderate elevation occurs in inflammatory bowel disease, hepatitis, cirrhosis, and smoking — without cancer. Its primary clinical role is monitoring colorectal cancer recurrence after surgery. CA-125 The primary marker for ovarian cancer. Normal < 35 IU/mL. Elevated in ovarian, endometrial, and fallopian tube cancers. Also rises with endometriosis, uterine fibroids, pelvic inflammatory disease, and even during menstruation — which substantially limits its value as a standalone screening test. It is combined with pelvic ultrasound to improve diagnostic accuracy. CA-19-9 Marker for pancreatic, biliary tract, and occasionally gastric and colorectal cancers. Normal < 37 IU/mL. Rises markedly in obstructive jaundice of any cause — cholelithiasis, cholangitis — without malignancy. Used primarily to monitor pancreatic cancer and assess resectability. Specific markers for haematological malignancies In multiple myeloma, the key markers are M-protein (paraprotein) on serum protein electrophoresis, serum free light chains, and β₂-microglobulin — the last of which is incorporated in the ISS staging system. In lymphomas, LDH rises as a tumour burden marker. When a haematological malignancy is suspected, a complete blood count with full differential is essential. Tumour Marker Normal Ranges: An Important Caveat Each tumour marker has its own reference interval established in a healthy population. Exceeding the upper limit does not mean a tumour is present — it means the result requires interpretation in clinical context. Marker Approximate normal Main tumour associations --------- Total PSA < 4 ng/mL (age-adjusted) Prostate cancer β-hCG < 5 mIU/mL (non-pregnant / men) Germ cell tumours, choriocarcinoma AFP < 10 IU/mL Liver cancer, germ cell tumours CEA < 5 ng/mL Colorectal, lung cancer CA-125 < 35 IU/mL Ovarian cancer CA-19-9 < 37 IU/mL Pancreatic cancer Reference ranges vary slightly by method and laboratory — always compare your result against the range printed on your own report. Elevated Tumour Markers: Causes and Results Interpretation The degree of elevation matters. A mild excess of 1.5–2 times the upper limit in the absence of symptoms is more likely a false-positive. A 5–10-fold or greater elevation alongside symptoms is a substantial argument for further investigation. Approach to an elevated tumour marker: 1. Exclude physiological and benign causes (inflammation, pregnancy, cirrhosis) 2. Repeat the test in 4–6 weeks — sustained elevation is more significant than a single result 3. Order targeted imaging (ultrasound, CT, MRI) of the relevant anatomical region 4. Interpret the result together with the clinical picture Self-interpreting tumour markers without a physician carries a high risk of both over-diagnosis and missed genuine pathology. How to Prepare for Tumour Marker Testing Fast for at least 8 hours before the blood draw. For PSA — 2–3 days before the test: avoid sexual activity, cycling, and rectal procedures — all transiently elevate PSA. Draw blood before any biopsy or invasive procedure — post-procedural marker elevation can persist for weeks. Declare all medications: finasteride and dutasteride halve PSA; some chemotherapy agents affect other markers. For serial monitoring, always use the same laboratory and the same assay method — inter-laboratory calibration differences can mimic genuine marker changes. When to Seek Urgent Medical Attention Contact an oncologist or the relevant specialist promptly when: PSA exceeds 20 ng/mL on a first measurement; hCG is detectable above 100 mIU/mL in a man or non-pregnant woman; AFP exceeds 400 IU/mL alongside a newly discovered liver lesion; a marker is rising during remission in a patient with an established cancer diagnosis — possible relapse. This article is for informational purposes only. Test ordering, result interpretation and investigation strategy are determined by an oncologist or relevant specialist.